PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Denicol, AC; Block, J; Kelley, DE; Pohler, KG; Dobbs, KB; Mortensen, CJ; Ortega, MS; Hansen, PJ				Denicol, Anna C.; Block, Jeremy; Kelley, Dale E.; Pohler, Ky G.; Dobbs, Kyle B.; Mortensen, Christopher J.; Ortega, M. Sofia; Hansen, Peter J.			The WNT signaling antagonist Dickkopf-1 directs lineage commitment and promotes survival of the preimplantation embryo	FASEB JOURNAL			English	Article						embryo development; cell differentiation; pregnancy	IN-VITRO CULTURE; WNT/BETA-CATENIN; GENE-EXPRESSION; REPRODUCTIVE-TRACT; HUMAN ENDOMETRIUM; ESTROUS-CYCLE; GROWTH-FACTOR; BOVINE; PREGNANCY; PLURIPOTENCY	Successful embryonic development is dependent on factors secreted by the reproductive tract. Dickkopf-1 (DKK1), an antagonist of the wingless-related mouse mammary tumor virus (WNT) signaling pathway, is one endometrial secretory protein potentially involved in maternal-embryo communication. The purpose of this study was to investigate the roles of DKK1 in embryo cell fate decisions and competence to establish pregnancy. Using in vitro-produced bovine embryos, we demonstrate that exposure of embryos to DKK1 during the period of morula to blastocyst transition (between d 5 and 8 of development) promotes the first 2 cell fate decisions leading to increased differentiation of cells toward the trophectoderm and hypoblast lineages compared with that for control embryos treated with vehicle. Moreover, treatment of embryos with DKK1 or colony-stimulating factor 2 (CSF2; an endometrial cytokine known to improve embryo development and pregnancy establishment) between d 5 and 7 of development improves embryo survival after transfer to recipients. Pregnancy success at d 32 of gestation was 27% for cows receiving control embryos treated with vehicle, 41% for cows receiving embryos treated with DKK1, and 39% for cows receiving embryos treated with CSF2. These novel findings represent the first evidence of a role for maternally derived WNT regulators during this period and could lead to improvements in assisted reproductive technologies.	[Denicol, Anna C.; Block, Jeremy; Kelley, Dale E.; Dobbs, Kyle B.; Mortensen, Christopher J.; Ortega, M. Sofia; Hansen, Peter J.] Univ Florida, Dept Anim Sci, DH Barron Reprod & Perinatal Biol Res Program, Gainesville, FL 32611 USA; [Denicol, Anna C.; Block, Jeremy; Kelley, Dale E.; Dobbs, Kyle B.; Mortensen, Christopher J.; Ortega, M. Sofia; Hansen, Peter J.] Univ Florida, Genet Inst, Gainesville, FL USA; [Block, Jeremy] Ovatech LLC, Gainesville, FL USA; [Pohler, Ky G.] Univ Missouri, Div Anim Sci, Columbia, MO USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Missouri System; University of Missouri Columbia	Hansen, PJ (corresponding author), Univ Florida, POB 110910, Gainesville, FL 32611 USA.	pjhansen@ufl.edu	Hansen, Peter/AAI-4693-2021; Block, Jeremy/AAC-6408-2021; Ortega, Sofia/ABA-3654-2020; Mortensen, Chris J/A-4084-2011; Kelley, Dale/AAY-2430-2020; Kelley, Dale E/B-1783-2014	Hansen, Peter/0000-0003-3061-9333; Block, Jeremy/0000-0002-6279-8543; Ortega, Sofia/0000-0003-4027-7314; Kelley, Dale/0000-0002-4767-6978; Kelley, Dale E/0000-0002-4767-6978; Pohler, Ky/0000-0003-2429-0893	U.S. Department of Agriculture Agriculture and Food Research Initiative (AFRI) grants [2009-65203-05732, 2011-67015-30688]	U.S. Department of Agriculture Agriculture and Food Research Initiative (AFRI) grants	The authors thank Central Beef LLC (Center Hill, FL, USA) for providing bovine ovaries, Luciano Bonilla for assistance with embryo production and transfer, William Rembert for ovary collection, Eric Diepersloot of the University of Florida Dairy Research Unit and the owners and personnel at Alliance Dairies for support and assistance with the embryo transfer experiments, Douglas Smith and the University of Florida McKnight Brain Institute Cell and Tissue Analysis Core for technical assistance for acquisition of confocal images, and Glaucio Lopes and Accelerated Genetics for support of the trial. This research was funded by U.S. Department of Agriculture Agriculture and Food Research Initiative (AFRI) grants 2009-65203-05732 and 2011-67015-30688. A.C.D and P.J.H. designed the research; A.C.D., J.B., D.E.K., K.G.P., K.B.D., M.S.O., and C.J.M. performed the research; A.C.D. and P.J.H. analyzed the data; and A.C.D. and P.J.H. wrote the initial drafts of the article.	Aparicio IM, 2010, REPRODUCTION, V140, P83, DOI 10.1530/REP-10-0040; Atli MO, 2011, ANIM REPROD SCI, V125, P94, DOI 10.1016/j.anireprosci.2011.04.001; Bauer BK, 2010, BIOL REPROD, V83, P791, DOI 10.1095/biolreprod.110.085936; Bazer FW, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-23; Berg DK, 2011, DEV CELL, V20, P244, DOI 10.1016/j.devcel.2011.01.003; Bonilla AQS, 2011, GROWTH HORM IGF RES, V21, P107, DOI 10.1016/j.ghir.2011.03.003; Bridges GA, 2013, J ANIM SCI, V91, P3002, DOI 10.2527/jas.2013-5882; Cai KQ, 2008, DEV DYNAM, V237, P2820, DOI 10.1002/dvdy.21703; Caneparo L, 2007, GENE DEV, V21, P465, DOI 10.1101/gad.406007; Cerri RLA, 2012, J DAIRY SCI, V95, P5657, DOI 10.3168/jds.2011-5114; Cheung LP, 2003, FERTIL STERIL, V80, P727, DOI 10.1016/S0015-0282(03)00772-6; Clementi C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003863; Denicol A. C., 2013, SCI REP, V3, P1; Dobbs KB, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.113183; Fan XJ, 2012, ENDOCRINOLOGY, V153, P1063, DOI 10.1210/en.2011-1826; FARIN PW, 1995, BIOL REPROD, V52, P676, DOI 10.1095/biolreprod52.3.676; Fields SD, 2011, THERIOGENOLOGY, V75, P1466, DOI 10.1016/j.theriogenology.2010.12.007; Franco HL, 2011, FASEB J, V25, P1176, DOI 10.1096/fj.10-175349; Gad A, 2011, HUM REPROD, V26, P1693, DOI 10.1093/humrep/der110; Gad A, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099697; Giritharan G, 2012, REPROD SCI, V19, P243, DOI 10.1177/1933719111428522; Green JC, 2010, ANIM REPROD SCI, V121, P24, DOI 10.1016/j.anireprosci.2010.05.010; Green JA, 2005, THERIOGENOLOGY, V63, P1481, DOI 10.1016/j.theriogenology.2004.07.011; Green JA, 1998, REV REPROD, V3, P62; Han H., 2010, J ENDOCRINOL, V191, P505; Hayashi K, 2007, ENDOCRINOLOGY, V148, P3496, DOI 10.1210/en.2007-0283; Kao LC, 2002, ENDOCRINOLOGY, V143, P2119, DOI 10.1210/en.143.6.2119; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; Kuijk EW, 2012, DEVELOPMENT, V139, P871, DOI 10.1242/dev.071688; Lazzari G, 2010, THERIOGENOLOGY, V73, P748, DOI 10.1016/j.theriogenology.2009.08.001; Lim KT, 2013, THERIOGENOLOGY, V79, P284, DOI 10.1016/j.theriogenology.2012.08.018; Loureiro B, 2009, ENDOCRINOLOGY, V150, P5046, DOI 10.1210/en.2009-0481; Macdonald LJ, 2011, MOL HUM REPROD, V17, P626, DOI 10.1093/molehr/gar031; Minten MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069444; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morris Samantha A, 2012, Results Probl Cell Differ, V55, P203, DOI 10.1007/978-3-642-30406-4_11; Ozawa M, 2011, FERTIL STERIL, V95, P799, DOI 10.1016/j.fertnstert.2010.10.006; PARRISH JJ, 1995, THERIOGENOLOGY, V44, P859, DOI 10.1016/0093-691X(95)00271-9; Peng S, 2008, REPRODUCTION, V135, P367, DOI 10.1530/REP-07-0191; Pontes JHF, 2009, THERIOGENOLOGY, V71, P690, DOI 10.1016/j.theriogenology.2008.09.031; Rizos D, 2010, J DAIRY SCI, V93, P1022, DOI 10.3168/jds.2009-2605; Robertson I., 1998, MANUAL INT EMBRYO TR, P103; Sagirkaya H, 2007, ANIM REPROD SCI, V101, P225, DOI 10.1016/j.anireprosci.2006.09.016; Sakatani M, 2012, J DAIRY SCI, V95, P3080, DOI 10.3168/jds.2011-4986; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Satterfield MC, 2008, REPROD FERT DEVELOP, V20, P935, DOI 10.1071/RD08069; Sousa NM, 2006, J PHYSIOL PHARMACOL, V57, P153; Spencer T E, 2007, Soc Reprod Fertil Suppl, V64, P379; Tulac S, 2006, J CLIN ENDOCR METAB, V91, P1453, DOI 10.1210/jc.2005-0769; Tulac S, 2003, J CLIN ENDOCR METAB, V88, P3860, DOI 10.1210/jc.2003-030494; van der Horst PH, 2012, MOL CELL ENDOCRINOL, V358, P176, DOI 10.1016/j.mce.2011.06.010; Xenopoulos Panagiotis, 2012, Results Probl Cell Differ, V55, P185, DOI 10.1007/978-3-642-30406-4_10; Xie HR, 2008, DEVELOPMENT, V135, P717, DOI 10.1242/dev.015339; Zhang RJ, 2012, J CLIN ENDOCR METAB, V97, P543, DOI 10.1210/jc.2011-2108; Ziebe S, 2013, FERTIL STERIL, V99, P1600, DOI 10.1016/j.fertnstert.2012.12.043	55	77	78	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2014	28	9					3975	3986		10.1096/fj.14-253112	http://dx.doi.org/10.1096/fj.14-253112			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN8HU	24858280	Green Published			2022-12-25	WOS:000340845900015
J	Vartak-Sharma, N; Gelman, BB; Joshi, C; Borgamann, K; Ghorpade, A				Vartak-Sharma, Neha; Gelman, Benjamin B.; Joshi, Chaitanya; Borgamann, Kathleen; Ghorpade, Anuja			Astrocyte Elevated Gene-1 Is a Novel Modulator of HIV-1-associated Neuroinflammation via Regulation of Nuclear Factor-kappa B Signaling and Excitatory Amino Acid Transporter-2 Repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-ASSOCIATED DEMENTIA; BLOOD-BRAIN-BARRIER; VIRUS TYPE-1 TAT; CHEMOTACTIC CYTOKINES; NEURONAL INJURY; HUMAN MONOCYTES; MESSENGER-RNA; PROTEIN; EXPRESSION; ACTIVATION	Astrocyte elevated gene-1 (AEG-1), a novel human immunodeficiency virus (HIV)-1 and tumor necrosis factor (TNF)-alpha inducible oncogene, has generated significant interest in the field of cancer research as a therapeutic target for many metastatic aggressive tumors. However, little is known about its role in astrocyte responses during HIV-1 central nervous system (CNS) infection and whether it contributes toward the development of HIV-associated neurocognitive disorders (HAND). Therefore, in this study, we investigated changes in AEG-1 CNS expression in HIV-1-infected brain tissues and elucidated a potential mechanism of AEG-1-mediated regulation of HAND. Immunoblotting and immunohistochemical analyses of HIV-1 seropositive and HIV-1 encephalitic human brain tissues revealed significantly elevated levels of AEG-1 protein. Immunohistochemical analyses of HIV-1 Tat transgenic mouse brain tissues also showed a marked increase in AEG-1 staining. Similar to in vivo observations, cultured astrocytes expressing HIV-1 Tat also revealed AEG-1 and cytokine up-regulation. Astrocytes treated with HAND-relevant stimuli, TNF-alpha, interleukin (IL)1 beta, and HIV-1, also significantly induced AEG-1 expression and nuclear translocation via activation of the nuclear factor (NF)-kappa B pathway. Co-immunoprecipitation studies demonstrated IL-1 beta -or TNF-alpha-induced AEG-1 interaction with NF-kappa B p65 subunit. AEG-1 knockdown decreased NF-kappa B activation, nuclear translocation, and transcriptional output in TNF-alpha -treated astrocytes. Moreover, IL-1 beta treatment of AEG1-overexpressing astrocytes significantly lowered expression of excitatory amino acid transporter 2, increased expression of excitatory amino acid transporter 2 repressor ying yang 1, and reduced glutamate clearance, a major transducer of excitotoxic neuronal damage. Findings from this study identify a novel transcriptional co-factor function of AEG-1 and further implicate AEG-1 in HAND-associated neuroinflammation.	[Vartak-Sharma, Neha; Joshi, Chaitanya; Borgamann, Kathleen; Ghorpade, Anuja] Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Immunol, Ft Worth, TX 76107 USA; [Gelman, Benjamin B.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Gelman, Benjamin B.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA	University of North Texas System; University of North Texas Health Science Center; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Ghorpade, A (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Immunol, Ft Worth, TX 76107 USA.	Anuja.Ghorpade@unthsc.edu	Borgmann, Kathleen/ABU-3329-2022; Joshi, Chaitanya G/AAK-1842-2020	Borgmann, Kathleen/0000-0003-0897-390X; Joshi, Chaitanya G/0000-0003-4680-2861	National Institutes of Health [R01MH087345]; National Institutes of Health from the Eunice Kennedy Shriver National Institute of Child Health & Human Development [5R24HD0008836];  [U01 MH083507];  [R24NS045091];  [U01MH083506];  [R24 MH059745];  [U01MH083501];  [R24MH059724];  [U01MH083500];  [R24NS038841];  [U01MH083545];  [R01NS072005];  [R01MH79886]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD000836] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH059724, U01MH083500, U24MH100928, U01MH083545, U01MH083506, U01MH083507, R01MH079886, U24MH100930, R24MH059745, U01MH083501, R01MH087345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R24NS038841, R01NS045091, R01NS072005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from the Eunice Kennedy Shriver National Institute of Child Health & Human Development; ; ; ; ; ; ; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01MH087345 (to A. G. and the JES Edwards Foundation); U01 MH083507, R24NS045091, U01MH083506, R24 MH059745, U01MH083501, R24MH059724, U01MH083500, R24NS038841, and U01MH083545 (to the National NeuroAIDS Tissue Consortium); R01NS072005; and R01MH79886. This work was also supported by National Institutes of Health Award Number 5R24HD0008836 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development.	Aschner M, 1998, NEUROTOXICOLOGY, V19, P269; Ash SC, 2008, BIOCHEM BIOPH RES CO, V371, P333, DOI 10.1016/j.bbrc.2008.04.084; Atlante A, 2001, FEBS LETT, V497, P1, DOI 10.1016/S0014-5793(01)02437-1; BACKUS KH, 1989, J NEUROSCI RES, V22, P274, DOI 10.1002/jnr.490220307; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Benediktsson AM, 2012, GLIA, V60, P175, DOI 10.1002/glia.21249; Biber K, 1999, J NEUROCHEM, V72, P1671, DOI 10.1046/j.1471-4159.1999.721671.x; Borjabad A, 2010, J NEUROIMMUNE PHARM, V5, P44, DOI 10.1007/s11481-009-9167-1; Britt DE, 2004, EXP CELL RES, V300, P134, DOI 10.1016/j.yexcr.2004.06.026; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; Chadderton T, 1997, CELL MOL BIOL, V43, P1227; Chang JR, 2011, J BIOL CHEM, V286, P41125, DOI 10.1074/jbc.M111.268466; Chen W, 2010, NEOPLASMA, V57, P522, DOI 10.4149/neo_2010_06_522; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Ellis R, 2007, NAT REV NEUROSCI, V8, P33, DOI 10.1038/nrn2040; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Gardner J, 2006, J NEUROSCI RES, V83, P1281, DOI 10.1002/jnr.20823; Ghafouri M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-28; Ghorpade A, 1998, J VIROL, V72, P3340, DOI 10.1128/JVI.72.4.3340-3350.1998; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Johnson TP, 2013, P NATL ACAD SCI USA, V110, P13588, DOI 10.1073/pnas.1308673110; Kang DC, 2005, GENE, V353, P8, DOI [10.1016/j.gene.2005.04.006, 10.1016/j.gene.2005.04.005]; Karki P, 2014, MOL CELL BIOL, V34, P1280, DOI 10.1128/MCB.01176-13; KASAHARA T, 1990, BIOCHEM BIOPH RES CO, V167, P1242, DOI 10.1016/0006-291X(90)90657-9; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kim BO, 2003, AM J PATHOL, V162, P1693, DOI 10.1016/S0002-9440(10)64304-0; Kutsch O, 2000, J VIROL, V74, P9214, DOI 10.1128/JVI.74.19.9214-9221.2000; Lee SG, 2009, ONCOGENE, V28, P2476, DOI 10.1038/onc.2009.93; Lee SG, 2011, CANCER RES, V71, P6514, DOI 10.1158/0008-5472.CAN-11-0782; Li J, 2009, ONCOGENE, V28, P3188, DOI 10.1038/onc.2009.171; Liao WT, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-205; Liu LP, 2010, CANCER RES, V70, P3750, DOI 10.1158/0008-5472.CAN-09-3838; Lopez-Bayghen E, 2011, IUBMB LIFE, V63, P816, DOI 10.1002/iub.536; LopezVillegas D, 1997, P NATL ACAD SCI USA, V94, P9854, DOI 10.1073/pnas.94.18.9854; Manthrope M., 1986, BRAIN RES, V25, P191; Maragakis NJ, 2004, ANN NEUROL, V55, P469, DOI 10.1002/ana.20003; McManus CM, 2000, AM J PATHOL, V156, P1441, DOI 10.1016/S0002-9440(10)65013-4; Moynagh PN, 2005, J ANAT, V207, P265, DOI 10.1111/j.1469-7580.2005.00445.x; Nath A, 1999, J BIOL CHEM, V274, P17098, DOI 10.1074/jbc.274.24.17098; Nath A, 2002, J INFECT DIS, V186, pS193, DOI 10.1086/344528; Navia B. A., 2005, The neurology of AIDS, P339; Nguyen TP, 2010, AM J PATHOL, V176, P893, DOI 10.2353/ajpath.2010.090390; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; Persidsky Y, 1997, J NEUROVIROL, V3, P401, DOI 10.3109/13550289709031186; Sabri F, 2003, BRAIN PATHOL, V13, P84, DOI 10.1111/j.1750-3639.2003.tb00009.x; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sarkar D, 2008, CANCER RES, V68, P1478, DOI 10.1158/0008-5472.CAN-07-6164; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Sun W, 2011, ONCOL REP, V26, P1133, DOI 10.3892/or.2011.1387; Suryadevara R, 2003, GLIA, V44, P47, DOI 10.1002/glia.10266; Sutherland HGE, 2004, EXP CELL RES, V294, P94, DOI 10.1016/j.yexcr.2003.11.020; Thirkettle HJ, 2009, ONCOGENE, V28, P3663, DOI 10.1038/onc.2009.223; Thirkettle HJ, 2009, CLIN CANCER RES, V15, P3003, DOI 10.1158/1078-0432.CCR-08-2046; Thompson WL, 2009, BRAIN RES, V1287, P47, DOI 10.1016/j.brainres.2009.06.081; Toborek M, 2005, CELL MOL NEUROBIOL, V25, P181, DOI 10.1007/s10571-004-1383-x; Trujillo JR, 2005, CELL RES, V15, P962, DOI 10.1038/sj.cr.7290374; UGUCCIONI M, 1995, EUR J IMMUNOL, V25, P64, DOI 10.1002/eji.1830250113; UNAIDS, 2008, 17 INT AIDS C JOINT; Vartak-Sharma N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-195; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Weiss JM, 1999, J IMMUNOL, V163, P2953; Wesselingh SL, 1997, J NEUROIMMUNOL, V74, P1, DOI 10.1016/S0165-5728(96)00160-9; Xing HQ, 2009, J NEUROPATH EXP NEUR, V68, P199, DOI 10.1097/NEN.0b013e31819715df; Yoo BK, 2011, PHARMACOL THERAPEUT, V130, P1, DOI 10.1016/j.pharmthera.2011.01.008; Zheng JC, 2008, J NEUROIMMUNOL, V200, P100, DOI 10.1016/j.jneuroim.2008.06.015	69	41	43	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19599	19612		10.1074/jbc.M114.567644	http://dx.doi.org/10.1074/jbc.M114.567644			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24855648	hybrid, Green Published			2022-12-25	WOS:000339326800033
J	Weber, M; Hartmann, AM; Beyer, T; Ripperger, A; Nothwang, HG				Weber, Maren; Hartmann, Anna-Maria; Beyer, Timo; Ripperger, Anne; Nothwang, Hans Gerd			A Novel Regulatory Locus of Phosphorylation in the C Terminus of the Potassium Chloride Cotransporter KCC2 That Interferes with N-Ethylmaleimide or Staurosporine-mediated Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEMPORAL-LOBE EPILEPSY; ALANINE-RICH KINASE; AUDITORY BRAIN-STEM; K-CL; HIPPOCAMPAL-NEURONS; ION-TRANSPORT; INHIBITORY NEUROTRANSMISSION; SEQUENCE ALIGNMENT; PROTEIN-KINASES; DOWN-REGULATION	The neuron-specific cation chloride cotransporter KCC2 plays a crucial role in hyperpolarizing synaptic inhibition. Transporter dysfunction is associated with various neurological disorders, raising interest in regulatory mechanisms. Phosphorylation has been identified as a key regulatory process. Here, we retrieved experimentally observed phosphorylation sites of KCC2 from public databases and report on the systematic analysis of six phosphorylated serines, Ser(25), Ser(26), Ser(937), Ser(1022), Ser(1025), and Ser(1026). Alanine or aspartate substitutions of these residues were analyzed in HEK-293 cells. All mutants were expressed in a pattern similar to wild-type KCC2 (KCC2(WT)). Tl+ flux measurements demonstrated unchanged transport activity for Ser(25), Ser(26), Ser(1022), Ser(1025), and Ser(1026) mutants. In contrast, KCC2(S937D), mimicking phosphorylation, resulted in a significant up-regulation of transport activity. Aspartate substitution of Thr(934), a neighboring putative phosphorylation site, resulted in a comparable increase in KCC2 transport activity. Both KCC2(T934D) and KCC2(S937D) mutants were inhibited by the kinase inhibitor staurosporine and by N-ethylmaleimide, whereas KCC2(WT), KCC2(T934A), and KCC2(S937A) were activated. The inverse staurosporine effect on aspartate versus alanine substitutions reveals a cross-talk between different phosphorylation sites of KCC2. Immunoblot and cell surface labeling experiments detected no alterations in total abundance or surface expression of KCC2(T934D) and KCC2(S937D) compared with KCC2(WT). These data reveal kinetic regulation of transport activity by these residues. In summary, our data identify a novel key regulatory phosphorylation site of KCC2 and a functional interaction between different conformation-changing post-translational modifications. The action of pharmacological agents aimed to modulate KCC2 activity for therapeutic benefit might therefore be highly context-specific.	[Weber, Maren; Hartmann, Anna-Maria; Beyer, Timo; Ripperger, Anne; Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Sch Med & Hlth Sci, Neurogenet Grp, Ctr Excellence Hearing4All, D-26111 Oldenburg, Germany; [Hartmann, Anna-Maria] Carl von Ossietzky Univ Oldenburg, Inst Biol & Environm Sci, Systemat & Evolutionary Biol Grp, D-26111 Oldenburg, Germany; [Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, D-26111 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Nothwang, HG (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Neurogenet, D-26111 Oldenburg, Germany.	hans.g.nothwang@uni-oldenburg.de		Nothwang, Hans Gerd/0000-0001-7695-6437	Deutsche Forschungsgemeinschaft [428/3-1, 428/4-2];  [Ha6338/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	This work was supported by Deutsche Forschungsgemeinschaft Grants No428/3-1 and No428/4-2 (to H. G. N.) and Ha6338/2-1 (to A.-M. H).	Acton BA, 2012, J NEUROSCI, V32, P8746, DOI 10.1523/JNEUROSCI.6089-11.2012; Balakrishnan V, 2003, J NEUROSCI, V23, P4134; Becker M, 2003, CELL TISSUE RES, V312, P155, DOI 10.1007/s00441-003-0713-5; Bergeron MJ, 2006, J BIOL CHEM, V281, P15959, DOI 10.1074/jbc.M600015200; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Casula S, 2001, J BIOL CHEM, V276, P41870, DOI 10.1074/jbc.M107155200; Chamma I, 2013, J NEUROSCI, V33, P15488, DOI 10.1523/JNEUROSCI.5889-12.2013; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Coull JAM, 2009, CURR OPIN INVEST DR, V10, P56; Darman RB, 2001, J BIOL CHEM, V276, P34359, DOI 10.1074/jbc.C100368200; DeFranceschi L, 1997, J CLIN INVEST, V99, P220, DOI 10.1172/JCI119150; Delpire E, 2009, P NATL ACAD SCI USA, V106, P5383, DOI 10.1073/pnas.0812756106; Di Fulvio M, 2009, PHYSIOLOGY AND PATHOLOGY OF CHLORIDE TRANSPORTERS AND CHANNELS IN THE NERVOUS SYSTEM: FROM MOLECULES TO DISEASES, P169; Doding A, 2012, BIOCHEM BIOPH RES CO, V420, P492, DOI 10.1016/j.bbrc.2012.02.147; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Flatman PW, 1996, AM J PHYSIOL-CELL PH, V271, pC255, DOI 10.1152/ajpcell.1996.271.1.C255; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Gagnon KB, 2013, AM J PHYSIOL-CELL PH, V304, pC693, DOI 10.1152/ajpcell.00350.2012; Gagnon M, 2013, NAT MED, V19, P1524, DOI 10.1038/nm.3356; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; GEORGE JN, 1989, J MEMBRANE BIOL, V112, P51, DOI 10.1007/BF01871163; Gimenez I, 2005, AM J PHYSIOL-RENAL, V289, pF1341, DOI 10.1152/ajprenal.00214.2005; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hartmann AM, 2014, MOL BIOL EVOL, V31, P434, DOI 10.1093/molbev/mst225; Hartmann Anna-Maria, 2011, BMC Res Notes, V4, P526, DOI 10.1186/1756-0500-4-526; Hartmann AM, 2010, J BIOL CHEM, V285, P23994, DOI 10.1074/jbc.M110.144063; Hartmann AM, 2009, J NEUROCHEM, V111, P321, DOI 10.1111/j.1471-4159.2009.06343.x; Holtzman EJ, 1998, AM J PHYSIOL-RENAL, V275, pF550, DOI 10.1152/ajprenal.1998.275.4.F550; Horn Z, 2010, EUR J NEUROSCI, V31, P2142, DOI 10.1111/j.1460-9568.2010.07258.x; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Ikeda K, 2004, J NEUROSCI, V24, P10693, DOI 10.1523/JNEUROSCI.2909-04.2004; Inoue K, 2006, J NEUROCHEM, V96, P598, DOI 10.1111/j.1471-4159.2005.03560.x; Inoue K, 2012, J BIOL CHEM, V287, P20839, DOI 10.1074/jbc.M111.319418; Ivakine EA, 2013, P NATL ACAD SCI USA, V110, P3561, DOI 10.1073/pnas.1212907110; Janssen SP, 2011, NEUROSCIENCE, V184, P183, DOI 10.1016/j.neuroscience.2011.03.060; JENNINGS ML, 1990, J GEN PHYSIOL, V95, P1021, DOI 10.1085/jgp.95.6.1021; Kahle KT, 2006, PHYSIOLOGY, V21, P326, DOI 10.1152/physiol.00015.2006; Kahle KT, 2013, TRENDS NEUROSCI, V36, P726, DOI 10.1016/j.tins.2013.08.006; Kahle KT, 2010, BBA-MOL BASIS DIS, V1802, P1150, DOI 10.1016/j.bbadis.2010.07.009; Kahle KT, 2005, P NATL ACAD SCI USA, V102, P16783, DOI 10.1073/pnas.0508307102; Kelsch W, 2001, J NEUROSCI, V21, P8339, DOI 10.1523/JNEUROSCI.21-21-08339.2001; Khirug S, 2005, EUR J NEUROSCI, V21, P899, DOI 10.1111/j.1460-9568.2005.03886.x; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Lauf PK, 2000, CELL PHYSIOL BIOCHEM, V10, P341, DOI 10.1159/000016357; LAUF PK, 1995, AM J PHYSIOL-CELL PH, V269, pC1167, DOI 10.1152/ajpcell.1995.269.5.C1167; Lee HHC, 2007, J BIOL CHEM, V282, P29777, DOI 10.1074/jbc.M705053200; Lee HHC, 2011, NAT NEUROSCI, V14, P736, DOI 10.1038/nn.2806; Lee HHC, 2010, MOL CELL NEUROSCI, V45, P173, DOI 10.1016/j.mcn.2010.06.008; Li H, 2007, NEURON, V56, P1019, DOI 10.1016/j.neuron.2007.10.039; Lytle C, 2002, AM J PHYSIOL-CELL PH, V283, pC1422, DOI 10.1152/ajpcell.00130.2002; Medina I, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00027; Melo Z, 2013, J BIOL CHEM, V288, P31468, DOI 10.1074/jbc.M113.475574; Mercado A, 2006, J BIOL CHEM, V281, P1016, DOI 10.1074/jbc.M509972200; Mercado A, 2000, J BIOL CHEM, V275, P30326, DOI 10.1074/jbc.M003112200; Monette MY, 2014, J BIOL CHEM, V289, P7569, DOI 10.1074/jbc.M113.542258; Palma E, 2006, P NATL ACAD SCI USA, V103, P8465, DOI 10.1073/pnas.0602979103; Papp E, 2008, NEUROSCIENCE, V154, P677, DOI 10.1016/j.neuroscience.2008.03.072; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; Piechotta K, 2003, J BIOL CHEM, V278, P52848, DOI 10.1074/jbc.M309436200; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Schindler J, 2013, J NEUROSCI METH, V213, P153, DOI 10.1016/j.jneumeth.2012.10.003; Shulga A, 2008, J NEUROSCI, V28, P6996, DOI 10.1523/JNEUROSCI.5268-07.2008; Song LY, 2002, MOL BRAIN RES, V103, P91, DOI 10.1016/S0169-328X(02)00190-0; Uvarov P, 2007, J BIOL CHEM, V282, P30570, DOI 10.1074/jbc.M705095200; Wake H, 2007, J NEUROSCI, V27, P1642, DOI 10.1523/JNEUROSCI.3104-06.2007; Watanabe M, 2009, J BIOL CHEM, V284, P27980, DOI 10.1074/jbc.M109.043620; Wenz M, 2009, BIOCHEM BIOPH RES CO, V381, P388, DOI 10.1016/j.bbrc.2009.02.057; Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214; Zhao BB, 2008, CELL SIGNAL, V20, P1769, DOI 10.1016/j.cellsig.2008.06.011	79	24	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18668	18679		10.1074/jbc.M114.567834	http://dx.doi.org/10.1074/jbc.M114.567834			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24849604	Green Published, hybrid			2022-12-25	WOS:000339062900006
J	Zhang, JS; Gao, FD; Zhao, JH; Ogawa, T; Wang, QX; Ma, WM				Zhang, Jingsong; Gao, Fudan; Zhao, Jiaohong; Ogawa, Teruo; Wang, Quanxi; Ma, Weimin			NdhP Is an Exclusive Subunit of Large Complex of NADPH Dehydrogenase Essential to Stabilize the Complex in Synechocystis sp Strain PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPLASTIC NAD(P)H DEHYDROGENASE; CYCLIC ELECTRON-TRANSPORT; PYRIDINE-NUCLEOTIDE DEHYDROGENASE; RESPIRATORY COMPLEX; PHOTOSYSTEM-I; THERMOSYNECHOCOCCUS-ELONGATUS; EFFICIENT OPERATION; PROTEIN COMPLEXES; CYANOBACTERIUM; IDENTIFICATION	Two major complexes of NADPH dehydrogenase (NDH-1) have been identified in cyanobacteria. A large complex (NDH-1L) contains NdhD1 and NdhF1, which are absent in a medium size complex (NDH-1M). They play important roles in respiration, cyclic electron transport around photosystem I, and CO2 acquisition. Two mutants sensitive to high light for growth and impaired in NDH-1-mediated cyclic electron transfer were isolated from Synechocystis sp. strain PCC 6803 transformed with a transposon-bearing library. Both mutants had a tag in sml0013 encoding NdhP, a single transmembrane small subunit of the NDH-1 complex. During prolonged incubation of the wild type thylakoid membrane with n-dodecyl beta-D-maltoside (DM), about half of the NDH-1L was disassembled to NDH-1M and the rest decomposed completely without forming NDH-1M. In the ndhP deletion mutant (Delta ndhP), disassembling of NDH-1L to NDH-1M occurred even on ice, and decomposition to a small piece occurred at room temperature much faster than in the wild type. Deletion of the C-terminal tail of NdhP gave the same result. The C terminus of NdhP was tagged by YFP-His(6). Blue native gel electrophoresis of the DM-treated thylakoid membrane of this strain and Western analysis using the antibody against GFP revealed that NdhP-YFP-His(6) was exclusively confined to NDH-1L. During prolonged incubation of the thylakoid membrane of the tagged strain with DM at room temperature, NDH-1L was partially disassembled to NDH-1M and the 160-kDa band containing NdhP-YFP-His6 and possibly NdhD1 and NdhF1. We therefore conclude that NdhP, especially its C-terminal tail, is essential to assemble NdhD1 and NdhF1 and stabilize the NDH-1L complex.	[Zhang, Jingsong; Gao, Fudan; Zhao, Jiaohong; Wang, Quanxi; Ma, Weimin] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai 200234, Peoples R China; [Ogawa, Teruo] Nagoya Univ, Biosci Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Shanghai Normal University; Nagoya University	Ma, WM (corresponding author), Shanghai Normal Univ, Coll Life & Environm Sci, 100 Guilin Rd, Shanghai 200234, Peoples R China.	wma@shnu.edu.cn	Ma, Weimin/A-8158-2015	Ma, Weimin/0000-0003-4964-415X; Zhang, Jingsong/0000-0002-8044-7608	National Natural Science Foundation of China [31370270]; National Basic Research Program of China Grant [2009CB118500]; Shanghai Education Committee [12ZZ132]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China Grant(National Basic Research Program of China); Shanghai Education Committee	This work was supported in part by National Natural Science Foundation of China Grant 31370270, National Basic Research Program of China Grant 2009CB118500, and Project of Shanghai Education Committee Grant 12ZZ132.	ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Armbruster U, 2013, PLANT CELL, V25, P3926, DOI 10.1105/tpc.113.114785; Arteni AA, 2006, BBA-BIOENERGETICS, V1757, P1469, DOI 10.1016/j.bbabio.2006.05.042; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Battchikova N, 2005, J BIOL CHEM, V280, P2587, DOI 10.1074/jbc.M410914200; Battchikova N, 2007, PHYSIOL PLANTARUM, V131, P22, DOI 10.1111/j.1399-3054.2007.00929.x; Battchikova N, 2011, BBA-BIOENERGETICS, V1807, P935, DOI 10.1016/j.bbabio.2010.10.017; Battchikova N, 2011, J BIOL CHEM, V286, P36992, DOI 10.1074/jbc.M111.263780; Bernat G, 2011, J BACTERIOL, V193, P292, DOI 10.1128/JB.00984-10; Birungi M, 2010, BBA-BIOENERGETICS, V1797, P1681, DOI 10.1016/j.bbabio.2010.06.004; Burrows PA, 1998, EMBO J, V17, P868, DOI 10.1093/emboj/17.4.868; Dai HL, 2013, PLANT J, V75, P858, DOI 10.1111/tpj.12251; Deng Y, 2003, PLANT CELL PHYSIOL, V44, P534, DOI 10.1093/pcp/pcg067; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Endo T, 1999, FEBS LETT, V457, P5, DOI 10.1016/S0014-5793(99)00989-8; FRIEDRICH T, 1995, FEBS LETT, V367, P107, DOI 10.1016/0014-5793(95)00548-N; Friedrich T, 2000, FEBS LETT, V479, P1, DOI 10.1016/S0014-5793(00)01867-6; GOMBOS Z, 1994, P NATL ACAD SCI USA, V91, P8787, DOI 10.1073/pnas.91.19.8787; Hashimoto M, 2003, PLANT J, V36, P541, DOI 10.1046/j.1365-313X.2003.01900.x; Herranen M, 2004, PLANT PHYSIOL, V134, P470, DOI 10.1104/pp.103.032326; Ifuku K, 2011, PLANT CELL PHYSIOL, V52, P1560, DOI 10.1093/pcp/pcr098; Ishikawa N, 2008, PLANT CELL PHYSIOL, V49, P1066, DOI 10.1093/pcp/pcn083; Jansen T, 2002, J PLANT PHYSIOL, V159, P1205, DOI 10.1078/0176-1617-00829; Kaneko T, 1996, DNA Res, V3, P185, DOI 10.1093/dnares/3.3.185; Kugler M, 1997, PHOTOSYNTH RES, V53, P35, DOI 10.1023/A:1005882406718; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Long ZJ, 2011, AFR J MICROBIOL RES, V5, P3603; Ma W., 2009, FRONT BIOL CHINA, V4, P137, DOI [10.1007/s11515-009-0005-x, DOI 10.1007/S11515-009-0005-X]; Ma WM, 2005, PHYSIOL PLANTARUM, V125, P135, DOI 10.1111/j.1399-3054.2005.00555.x; McGinn PJ, 2003, PLANT PHYSIOL, V132, P218, DOI 10.1104/pp.102.019349; MI HL, 1992, PLANT CELL PHYSIOL, V33, P1233; MI HL, 1995, PLANT CELL PHYSIOL, V36, P661; Norling B, 1998, FEBS LETT, V436, P189, DOI 10.1016/S0014-5793(98)01123-5; Nowaczyk MM, 2011, BIOCHEMISTRY-US, V50, P1121, DOI 10.1021/bi102044b; OGAWA T, 1991, P NATL ACAD SCI USA, V88, P4275, DOI 10.1073/pnas.88.10.4275; Ogawa T, 2007, PHOTOSYNTH RES, V93, P69, DOI 10.1007/s11120-006-9128-y; Ohkawa H, 2000, J BIOL CHEM, V275, P31630, DOI 10.1074/jbc.M003706200; Ohkawa H, 2002, FUNCT PLANT BIOL, V29, P195, DOI 10.1071/PP01180; Ohkawa H, 2001, J BACTERIOL, V183, P4938, DOI 10.1128/JB.183.16.4938-4939.2001; Peng LW, 2012, PLANT CELL, V24, P202, DOI 10.1105/tpc.111.090597; Peng LW, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001040; Peng LW, 2011, BBA-BIOENERGETICS, V1807, P945, DOI 10.1016/j.bbabio.2010.10.015; Peng LW, 2009, PLANT CELL, V21, P3623, DOI 10.1105/tpc.109.068791; Prommeenate P, 2004, J BIOL CHEM, V279, P28165, DOI 10.1074/jbc.M401107200; Schwarz D, 2013, PLANT PHYSIOL, V163, P1191, DOI 10.1104/pp.113.224287; Shikanai T, 1998, P NATL ACAD SCI USA, V95, P9705, DOI 10.1073/pnas.95.16.9705; Sirpio S, 2009, J BIOL CHEM, V284, P905, DOI 10.1074/jbc.M805404200; Suorsa M, 2009, MOL PLANT, V2, P1127, DOI 10.1093/mp/ssp052; Torres-Bacete J, 2011, J BIOL CHEM, V286, P34007, DOI 10.1074/jbc.M111.260968; Wang P, 2006, PLANT PHYSIOL, V141, P465, DOI 10.1104/pp.105.070490; WILLIAMS JGK, 1983, GENE, V24, P37, DOI 10.1016/0378-1119(83)90129-4; Xu M, 2008, PLANT CELL PHYSIOL, V49, P994, DOI 10.1093/pcp/pcn074; Yabuta S, 2010, PLANT CELL PHYSIOL, V51, P866, DOI 10.1093/pcp/pcq060; Yamamoto H, 2011, PLANT CELL, V23, P1480, DOI 10.1105/tpc.110.080291; Zhang PP, 2012, PLANT CELL, V24, P1952, DOI 10.1105/tpc.111.094417; Zhang PP, 2005, BIOCHEM J, V390, P513, DOI 10.1042/BJ20050390; Zhang PP, 2004, PLANT CELL, V16, P3326, DOI 10.1105/tpc.104.026526	58	31	36	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18770	18781		10.1074/jbc.M114.553404	http://dx.doi.org/10.1074/jbc.M114.553404			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24847053	hybrid, Green Published			2022-12-25	WOS:000339062900013
J	Nekohashi, M; Ogawa, M; Ogihara, T; Nakazawa, K; Kato, H; Misaka, T; Abe, K; Kobayashi, S				Nekohashi, Mari; Ogawa, Mana; Ogihara, Takuo; Nakazawa, Kyoko; Kato, Hisanori; Misaka, Takumi; Abe, Keiko; Kobayashi, Shoko			Luteolin and Quercetin Affect the Cholesterol Absorption Mediated by Epithelial Cholesterol Transporter Niemann-Pick C1-Like 1 in Caco-2 Cells and Rats	PLOS ONE			English	Article							DECREASE MICELLAR SOLUBILITY; INTESTINAL-ABSORPTION; NPC1L1 PROTEIN; EZETIMIBE; BIOAVAILABILITY; POLYPHENOLS; INHIBITOR; FIBER	Niemann-Pick C1-Like 1 (NPC1L1) mediates cholesterol absorption, and ezetimibe is a potent NPC1L1 inhibitor applicable for medication of hypercholesterolemia. Epidemiological studies demonstrated that consumption of polyphenols correlates with a decreased risk for atherosclerosis due to their antioxidant effect. This activity can hardly be attributable to the antioxidant activity only, and we hypothesized that polyphenols inhibit intestinal transport of cholesterol. We elucidated the kinetic parameters of intestinal cholesterol absorption, screened several polyphenols for their ability to specifically inhibit intestinal cholesterol absorption, and determined the inhibitory effects of selected flavonoids in vitro and in vivo. The concentration-dependent uptake of cholesterol by Caco-2 cells obeyed a monophasic saturation process. This indicates the involvement of an active-passive transport, i.e., NPC1L1. Parameters of cholesterol uptake by Caco-2 cells were as follows: J(max), K-t, and K-d were 6.89 +/- 2.96 19.03 +/- 11.58 mu M, and 0.11 +/- 0.02 pmol/min/mg protein, respectively. Luteolin and quercetin inhibited cholesterol absorption by Caco-2 cells and human embryonic kidney 293T cells expressing NPC1L1. When preincubated Caco-2 cells with luteolin and quercetin before the assay, cholesterol uptake significantly decreased. The inhibitory effects of these flavonoids were maintained for up to 120 min. The level of inhibition and irreversible effects were similar to that of ezetimibe. Serum cholesterol levels significantly decreased more in rats fed both cholesterol and luteolin (or quercetin), than in those observed in the cholesterol feeding group. As quercetin induced a significant decrease in the levels of NPC1L1 mRNA in Caco-2 cells, the in vivo inhibitory effect may be due to the expression of NPC1L1. These results suggest that luteolin and quercetin reduce high blood cholesterol levels by specifically inhibiting intestinal cholesterol absorption mediated by NPC1L1.	[Nekohashi, Mari; Ogawa, Mana; Kobayashi, Shoko] Univ Tokyo, Grad Sch Agr & Life Sci, Res Ctr Food Safety, Tokyo, Japan; [Ogihara, Takuo] Takasaki Univ Hlth & Welf, Fac Pharm, Takasaki, Gunma, Japan; [Nakazawa, Kyoko; Kato, Hisanori] Univ Tokyo, Org Interdisciplinary Res Projects, Corp Sponsored Res Program Food Life, Tokyo, Japan; [Kato, Hisanori; Misaka, Takumi; Abe, Keiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan; [Abe, Keiko] Kanagawa Acad Sci & Technol, Life Sci & Environm Res Ctr 4F C4, Kawasaki, Kanagawa, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Kanagawa Academy Science & Technology	Kobayashi, S (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Res Ctr Food Safety, Tokyo, Japan.	ashoko@mail.ecc.u-tokyo.ac.jp		Misaka, Takumi/0000-0002-9547-5767	Japan Society for the Promotion of Science [22700761]; Research Project on Development of Agricultural Products and Foods with Health-promoting benefits (NARO); Grants-in-Aid for Scientific Research [26242007] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Project on Development of Agricultural Products and Foods with Health-promoting benefits (NARO); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science, a Grant-Aid for C (22700761). This work was supported in part by Research Project on Development of Agricultural Products and Foods with Health-promoting benefits (NARO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x; Annaba F, 2010, AM J PHYSIOL-GASTR L, V298, pG467, DOI 10.1152/ajpgi.00360.2009; Betters JL, 2010, FEBS LETT, V584, P2740, DOI 10.1016/j.febslet.2010.03.030; Davis HR, 2009, BBA-MOL CELL BIOL L, V1791, P679, DOI 10.1016/j.bbalip.2009.01.002; Devroey D, 2014, INT J CLIN PRACT, V68, P180, DOI 10.1111/ijcp.12315; Feng D, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-40; Gadgil MD, 2014, J ACAD NUTR DIET, V114, P238, DOI 10.1016/j.jand.2013.09.021; Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001; Ge LA, 2011, P NATL ACAD SCI USA, V108, P551, DOI 10.1073/pnas.1014434108; Guerra-Araiza C, 2013, FREE RADICAL RES, V47, P451, DOI 10.3109/10715762.2013.795649; IKEDA I, 1992, BIOCHIM BIOPHYS ACTA, V1127, P141, DOI 10.1016/0005-2760(92)90269-2; Ikeda I, 2010, J AGR FOOD CHEM, V58, P8591, DOI 10.1021/jf1015285; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; Iwayanagi Y, 2011, PHARM RES-DORDR, V28, P405, DOI 10.1007/s11095-010-0294-4; Jia L, 2011, ANNU REV PHYSIOL, V73, P239, DOI 10.1146/annurev-physiol-012110-142233; Li PS, 2014, NAT MED, V20, P80, DOI 10.1038/nm.3417; Miura S, 2008, INTERNAL MED, V47, P1165, DOI 10.2169/internalmedicine.47.1099; Opie LH, 2007, EUR HEART J, V28, P1683, DOI 10.1093/eurheartj/ehm149; Rasmussen SE, 2005, MOL NUTR FOOD RES, V49, P159, DOI 10.1002/mnfr.200400082; Ross JA, 2002, ANNU REV NUTR, V22, P19, DOI 10.1146/annurev.nutr.22.111401.144957; Schneeman BO, 1999, J NUTR, V129, p1424S, DOI 10.1093/jn/129.7.1424S; Weinglass AB, 2008, P NATL ACAD SCI USA, V105, P11140, DOI 10.1073/pnas.0800936105; Wyman M, 2010, CLEV CLIN J MED, V77, P435, DOI 10.3949/ccjm.77a.09078; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879, DOI 10.1248/bpb1978.4.879; Zern TL, 2005, J NUTR, V135, P2291, DOI 10.1093/jn/135.10.2291; Zhang JH, 2011, J BIOL CHEM, V286, P25088, DOI 10.1074/jbc.M111.244475	27	60	64	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97901	10.1371/journal.pone.0097901	http://dx.doi.org/10.1371/journal.pone.0097901			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859282	Green Published, gold, Green Submitted			2022-12-25	WOS:000336839400031
J	Escribano, BM; Moreno, A; Tasset, I; Tunez, I				Escribano, Begona M.; Moreno, Antonia; Tasset, Inmaculada; Tunez, Isaac			Impact of Light/Dark Cycle Patterns on Oxidative Stress in an Adriamycin-Induced Nephropathy Model in Rats	PLOS ONE			English	Article							HYPERLIPIDEMIC NEPHROPATHY; GLUTATHIONE-PEROXIDASE; PHARMACOLOGICAL AGENT; MELATONIN SECRETION; PLASMA LEPTIN; DAILY RHYTHM; INSULIN; METABOLISM; EXPRESSION; PROTECTION	The principal goal of this study was to determine the effect of the photoperiod on oxidative damage biomarkers in rats submitted to different light/darkness patterns, in a hyperlipidemic nephropathy model (induced by adriamycin), as well as its possible relationship with melatonin and leptin secretion rhythms. To test this hypothesis, six different groups were used (N = 6 rats per group): control (12 h/12h light: dark); exposure to permanent illumination (24 h light); exposure to darkness (22 h dark); injected with adriamycin, 12h/12h light: dark; injected with adriamycin + exposure to permanent illumination and injected with adriamycin + exposure to darkness (22 h dark). The different photoperiods were begun two weeks prior to medication and were maintained up to the day of the animal's sacrifice, ten days after medication. The following parameters were analysed: i) weight evolution; ii) in plasma: urea, creatinine, uric acid, total proteins, albumen, lactate dehydrogenase, creatinine-quinase, aspartate aminotransferase, alanine aminotransferase and total cholesterol; iii) in urine: urea, creatinine, total proteins and microalbumen; iv) biomarkers of oxidative damage in kidneys, heart, liver and brain: lipoperoxides, total glutathione, reduced glutathione, catalase, glutathione peroxidase, glutathione reductase and glutathione transferase; v) melatonin (pineal gland tissue and plasma) and leptin (plasma). From the results obtained it was concluded that the administration of adriamycin generated oxidative stress in renal, cerebral, hepatic and cardiac tissue. Additionally, in the healthy animal, but of a lesser relevance in the adriamycin animal, permanent light worsened the oxidative stress, whereas darkness improved it. This could be related to the circadian rhythm of the inverse release shown by melatonin and leptin, accentuating the release of melatonin in the darkness phase and that of leptin in the light phase. The correlation between melatonin and leptin in the healthy animal seemed to confirm the relationship between both variables and their influence on oxidative damage biomarkers.	[Escribano, Begona M.] Univ Cordoba, Fac Vet Med, Dept Cell Biol Physiol & Immunol, Cordoba, Spain; [Moreno, Antonia; Tasset, Inmaculada; Tunez, Isaac] Univ Cordoba, Maimonides Inst Biomed Res Cordoba IMIBIC, Dept Biochem & Mol Biol, Cordoba, Spain	Universidad de Cordoba; Universidad de Cordoba	Tunez, I (corresponding author), Univ Cordoba, Maimonides Inst Biomed Res Cordoba IMIBIC, Dept Biochem & Mol Biol, Cordoba, Spain.	fm2tufii@uco.es	Cuevas, Inmaculada Tasset/R-4509-2019; Escribano, Begoña/GWD-0579-2022	Cuevas, Inmaculada Tasset/0000-0003-0730-6750; Escribano Duran, Begona/0000-0002-0966-0641				AEBI H, 1984, METHOD ENZYMOL, V105, P121; Ahmed F, 2013, PHARMACOGN MAG, V9, P130, DOI 10.4103/0973-1296.111265; Alonso-Vale MIC, 2005, AM J PHYSIOL-ENDOC M, V288, pE805, DOI 10.1152/ajpendo.00478.2004; Badary OA, 2000, TOXICOLOGY, V143, P219, DOI 10.1016/S0300-483X(99)00179-1; Baydas G, 2002, NEUROSCI LETT, V323, P195, DOI 10.1016/S0304-3940(02)00144-1; Beltowski J, 2003, ATHEROSCLEROSIS, V170, P21, DOI 10.1016/S0021-9150(03)00236-3; Bocquier F, 1998, REPROD NUTR DEV, V38, P489, DOI 10.1051/rnd:19980501; Bouloumie A, 1999, FASEB J, V13, P1231, DOI 10.1096/fasebj.13.10.1231; Bubenik GA, 1998, BIOL SIGNAL RECEPT, V7, P195; Cagnacci A, 2002, J PINEAL RES, V33, P57, DOI 10.1034/j.1600-079X.2002.01893.x; Dauchy RT, 2013, J AM ASSOC LAB ANIM, V52, P146; Desassis JF, 1997, NEPHRON, V75, P336, DOI 10.1159/000189558; Dubocovich ML, 2007, SLEEP MED, V8, pS34, DOI 10.1016/j.sleep.2007.10.007; Dubocovich ML, 2005, ENDOCRINE, V27, P101, DOI 10.1385/ENDO:27:2:101; Dubocovich ML, 2003, FRONT BIOSCI-LANDMRK, V8, pD1093, DOI 10.2741/1089; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Gan EH, 2010, PROG BRAIN RES, V181, P111, DOI 10.1016/S0079-6123(08)81007-2; Gunduz B, 2002, COMP BIOCHEM PHYS A, V132, P393, DOI 10.1016/S1095-6433(02)00041-7; Guo KY, 2004, AM J PHYSIOL-REG I, V287, pR112, DOI 10.1152/ajpregu.00028.2004; Ianas O, 1991, Endocrinologie, V29, P147; Kalsbeek A, 2001, ENDOCRINOLOGY, V142, P2677, DOI 10.1210/en.142.6.2677; Licinio J, 1998, P NATL ACAD SCI USA, V95, P2541, DOI 10.1073/pnas.95.5.2541; Martin C, 2003, LIFE SCI, V73, P327, DOI 10.1016/S0024-3205(03)00271-6; Mathes AM, 2010, WORLD J GASTROENTERO, V16, P6087, DOI 10.3748/wjg.v16.i48.6087; Montilla PL, 1998, J PINEAL RES, V25, P86, DOI 10.1111/j.1600-079X.1998.tb00544.x; Fonzo LSN, 2009, HIPPOCAMPUS, V19, P869, DOI 10.1002/hipo.20571; Pablos MI, 1998, NEUROCHEM INT, V32, P69, DOI 10.1016/S0197-0186(97)00043-0; Pandi-Perumal SR, 2006, FEBS J, V273, P2813, DOI 10.1111/j.1742-4658.2006.05322.x; PANG SF, 1990, J PINEAL RES, V8, P179, DOI 10.1111/j.1600-079X.1990.tb00678.x; Peliciari-Garcia RA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/546516; Qin LQ, 2003, LIFE SCI, V73, P2467, DOI 10.1016/S0024-3205(03)00628-3; Rasmussen DD, 1999, ENDOCRINOLOGY, V140, P1009, DOI 10.1210/en.140.2.1009; Reiter RJ, 1997, AGE, V20, P201, DOI 10.1007/s11357-997-0020-2; Reiter RJ, 1998, P W PHARMACOL SOC, V41, P229; Reiter RJ, 1999, ANN NY ACAD SCI, V890, P471, DOI 10.1111/j.1749-6632.1999.tb08028.x; Reiter RJ, 1998, PROG NEUROBIOL, V56, P359, DOI 10.1016/S0301-0082(98)00052-5; REITER RJ, 1995, J PINEAL RES, V18, P1, DOI 10.1111/j.1600-079X.1995.tb00133.x; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sani M, 2006, COMP BIOCHEM PHYS B, V145, P331, DOI 10.1016/j.cbpb.2006.08.005; Schreck R, 1991, Trends Cell Biol, V1, P39, DOI 10.1016/0962-8924(91)90072-H; Sensi S, 1993, Ann Ist Super Sanita, V29, P613; Srinivasan V, 2005, NEUROTOX RES, V7, P293, DOI 10.1007/BF03033887; Ponce IT, 2012, BIOL RHYTHM RES, V43, P351, DOI 10.1080/09291016.2011.593847; Tunez I, 2002, J PHYSIOL BIOCHEM, V58, P109, DOI 10.1007/BF03179846; Tunez I, 2007, MELATONIN PRESENT FU, P315; VANCAUTER E, 1990, HORM RES, V34, P45, DOI 10.1159/000181794; Venkatesan N, 1997, P SOC EXP BIOL MED, V215, P158, DOI 10.3181/00379727-215-44122; Wagner R, 2000, HORM RES, V54, P174, DOI 10.1159/000053255; WARHOLM M, 1985, METHOD ENZYMOL, V113, P499; Wolden-Hanson T, 2000, ENDOCRINOLOGY, V141, P487, DOI 10.1210/en.141.2.487; Yamagishi SI, 2001, J BIOL CHEM, V276, P25096, DOI 10.1074/jbc.M007383200; Zieba DA, 2007, DOMEST ANIM ENDOCRIN, V33, P358, DOI 10.1016/j.domaniend.2006.06.004	52	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97713	10.1371/journal.pone.0097713	http://dx.doi.org/10.1371/journal.pone.0097713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852173	Green Submitted, Green Published, gold			2022-12-25	WOS:000338323200028
J	Ryu, J; Ahn, S; Kim, SG; Kim, T; Lee, SJ				Ryu, Jeongeun; Ahn, Sungsook; Kim, Seung-Gon; Kim, TaeJoo; Lee, Sang Joon			Interactive Ion-Mediated Sap Flow Regulation in Olive and Laurel Stems: Physicochemical Characteristics of Water Transport via the Pit Structure	PLOS ONE			English	Article							XYLEM HYDRAULIC CONDUCTIVITY; ROOT-GROWTH; CONDUCTANCE; MEMBRANE; INCREASE; VISUALIZATION; RESISTANCE; VESSEL; PLANTS; VULNERABILITY	Sap water is distributed and utilized through xylem conduits, which are vascular networks of inert pipes important for plant survival. Interestingly, plants can actively regulate water transport using ion-mediated responses and adapt to environmental changes. However, ionic effects on active water transport in vascular plants remain unclear. In this report, the interactive ionic effects on sap transport were systematically investigated for the first time by visualizing the uptake process of ionic solutions of different ion compositions (K+/Ca2+) using synchrotron X-ray and neutron imaging techniques. Ionic solutions with lower K+/Ca2+ ratios induced an increased sap flow rate in stems of Olea europaea L. and Laurus nobilis L. The different ascent rates of ionic solutions depending on K+/Ca2+ ratios at a fixed total concentration increases our understanding of ion-responsiveness in plants from a physicochemical standpoint. Based on these results, effective structural changes in the pit membrane were observed using varying ionic ratios of K+/Ca2+. The formation of electrostatically induced hydrodynamic layers and the ion-responsiveness of hydrogel structures based on Hofmeister series increase our understanding of the mechanism of ion-mediated sap flow control in plants.	[Ryu, Jeongeun; Ahn, Sungsook; Kim, Seung-Gon; Lee, Sang Joon] Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang, Gyeongbuk, South Korea; [Ryu, Jeongeun; Ahn, Sungsook; Kim, Seung-Gon; Lee, Sang Joon] Pohang Univ Sci & Technol POSTECH, Ctr Biofluid & Biomim Res, Pohang, Gyeongbuk, South Korea; [Kim, TaeJoo] KAERI, Div Neutron Sci, Taejon, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Korea Atomic Energy Research Institute (KAERI)	Lee, SJ (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang, Gyeongbuk, South Korea.	sjlee@postech.ac.kr	Angeles, Guillermo/P-6976-2014; Lee, Sang Joon/AAG-2448-2019		PAL through the abroad beam time program of the Synchrotron Radiation Facility Project of the Ministry of Education, Science and Technology (MEST); National Research Foundation of Korea (MRF) - Korean government (MSIP) [2008-006991]	PAL through the abroad beam time program of the Synchrotron Radiation Facility Project of the Ministry of Education, Science and Technology (MEST); National Research Foundation of Korea (MRF) - Korean government (MSIP)	This work was supported by PAL through the abroad beam time program of the Synchrotron Radiation Facility Project of the Ministry of Education, Science and Technology (MEST) and performed under the approval of the Photon Factory Program Advisory Committee (Proposal No. 2010G722). This work was also supported by the National Research Foundation of Korea (MRF) grant funded by the Korean government (MSIP) (No. 2008-006991). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albersheim P, 2011, PLANT CELL WALLS: FROM CHEMISTRY TO BIOLOGY, P1; Boyce CK, 2004, P NATL ACAD SCI USA, V101, P17555, DOI 10.1073/pnas.0408024101; Brodersen CR, 2010, PLANT PHYSIOL, V154, P1088, DOI 10.1104/pp.110.162396; Cherel I, 2004, J EXP BOT, V55, P337, DOI 10.1093/jxb/erh028; Choat B, 2008, NEW PHYTOL, V177, P608, DOI 10.1111/j.1469-8137.2007.02317.x; Choat B, 2006, AM J BOT, V93, P993, DOI 10.3732/ajb.93.7.993; Cochard H, 2010, J EXP BOT, V61, P275, DOI 10.1093/jxb/erp298; Cussler E.L., 1997, DIFFUSION MASS TRANS; Domec JC, 2007, TREE PHYSIOL, V27, P1389, DOI 10.1093/treephys/27.10.1389; Gasco A, 2007, PHYSIOL PLANTARUM, V129, P597, DOI 10.1111/j.1399-3054.2006.00848.x; Gasco A, 2006, PLANT CELL ENVIRON, V29, P1946, DOI 10.1111/j.1365-3040.2006.01570.x; Gilliham M, 2011, J EXP BOT, V62, P2233, DOI 10.1093/jxb/err111; Goodger JQD, 2005, J EXP BOT, V56, P2389, DOI 10.1093/jxb/eri231; Gortan E, 2011, TREE PHYSIOL, V31, P48, DOI 10.1093/treephys/tpq101; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Hofmeister F., 1888, ARCH EXP PATHOL PH, V24, P247, DOI [DOI 10.1007/BF01918191, 10.1007/BF01918191]; Jansen S, 2011, NEW PHYTOL, V189, P218, DOI 10.1111/j.1469-8137.2010.03448.x; Kim HK, 2010, NEW PHYTOL, V188, P1085, DOI 10.1111/j.1469-8137.2010.03424.x; Kim T, 2008, APPL RADIAT ISOTOPES, V66, P593, DOI 10.1016/j.apradiso.2007.12.006; Lee J, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00055; Lee SJ, 2008, ANN BOT-LONDON, V101, P595, DOI 10.1093/aob/mcm312; Lopez-Portillo J, 2005, PLANT CELL ENVIRON, V28, P1285, DOI 10.1111/j.1365-3040.2005.01366.x; Matsushima U, 2008, J APPL BOT FOOD QUAL, V82, P90; Matsushima U, 2005, NUCL INSTRUM METH A, V542, P76, DOI 10.1016/j.nima.2005.01.014; Matsushima U, 2009, NUCL INSTRUM METH A, V605, P146, DOI 10.1016/j.nima.2009.01.187; Melcher PJ, 2012, METHODS ECOL EVOL, V3, P685, DOI 10.1111/j.2041-210X.2012.00204.x; Menon M, 2007, EUR J SOIL SCI, V58, P802, DOI 10.1111/j.1365-2389.2006.00870.x; Moradi AB, 2009, PLANT SOIL, V318, P243, DOI 10.1007/s11104-008-9834-7; Nakanishi TM, 2009, NEUTRON SCATT APPL T, P305, DOI 10.1007/978-0-387-78693-3_17; Nakanishi TM, 2003, J RADIOANAL NUCL CH, V255, P149, DOI 10.1023/A:1022252419649; Nardini A, 2007, J EXP BOT, V58, P2609, DOI 10.1093/jxb/erm105; Nardini A, 2011, J EXP BOT, V62, P4701, DOI 10.1093/jxb/err208; Nardini A, 2010, TREE PHYSIOL, V30, P628, DOI 10.1093/treephys/tpq017; OBRIEN TP, 1967, PROTOPLASMA, V63, P443, DOI 10.1007/BF01252949; OBRIEN TP, 1970, PROTOPLASMA, V69, P1, DOI 10.1007/BF01276648; Oswald SE, 2008, VADOSE ZONE J, V7, P1035, DOI 10.2136/vzj2007.0156; Plavcova L, 2011, PLANT CELL ENVIRON, V34, P501, DOI 10.1111/j.1365-3040.2010.02258.x; Santiago M, 2013, PLANT PHYSIOL, V163, P999, DOI 10.1104/pp.113.219774; Siebrecht S, 2003, PLANTA, V217, P783, DOI 10.1007/s00425-003-1041-4; Smith KT, 2013, P NATL ACAD SCI USA, V110, pE3739, DOI 10.1073/pnas.1311453110; Strobl M, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/24/243001; Totzke C, 2013, ANN BOT-LONDON, V111, P723, DOI 10.1093/aob/mct014; Trifilo P, 2008, TREE PHYSIOL, V28, P1505, DOI 10.1093/treephys/28.10.1505; Tyree MT, 1999, PLANT PHYSIOL, V120, P11, DOI 10.1104/pp.120.1.11; van Doorn WG, 2011, PLANT PHYSIOL, V157, P1642, DOI 10.1104/pp.111.185314; van Ieperen W, 2000, J EXP BOT, V51, P769, DOI 10.1093/jexbot/51.345.769; van Ieperen W, 2007, TRENDS PLANT SCI, V12, P137, DOI 10.1016/j.tplants.2007.03.001; van Ieperen W, 2006, J EXP BOT, V57, P2743, DOI 10.1093/jxb/erl039; Wheeler JK, 2005, PLANT CELL ENVIRON, V28, P800, DOI 10.1111/j.1365-3040.2005.01330.x; ZIMMERMANN MH, 1978, CAN J BOT, V56, P2286, DOI 10.1139/b78-274; Zwieniecki MA, 2001, SCIENCE, V291, P1059, DOI 10.1126/science.1057175; Zwieniecki MA, 2003, J EXP BOT, V54, P1399, DOI 10.1093/jxb/erg144	52	5	5	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98484	10.1371/journal.pone.0098484	http://dx.doi.org/10.1371/journal.pone.0098484			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852943	Green Published, Green Submitted, gold			2022-12-25	WOS:000338323200073
J	Nightingale, K; Levy, CS; Hopkins, J; Grey, F; Esper, S; Dalziel, RG				Nightingale, Katie; Levy, Claire S.; Hopkins, John; Grey, Finn; Esper, Suzanne; Dalziel, Robert G.			Expression of Ovine Herpesvirus-2 Encoded MicroRNAs in an Immortalised Bovine - Cell Line	PLOS ONE			English	Article							TARGET; SEQUENCE	Ovine herpesvirus-2 (OvHV-2) infects most sheep, he e it establishes an asymptomatic, latent infection. Infection susceptible hosts e cattle and deer results in malignant catarrhal fever, a fatal lymphoproliferative disease characterised by uncontrolled lymphocyte proliferation and non MHC restricted cytotoxicity. The same cell populations are infected in both cattle and sheep but only in cattle does virus infection cause dysregulation of cell function leading to disease. The mechanism by which OvHV-2 induces this uncontrolled proliferation is unknown. A number of herpesviruses have been shown to encode microRNAs (miRNAs) that have roles in control of both viral and cellular gene expression. We hypothesised that OvHV-2 encodes miRNAs and that these play a role in pathogenesis. Analysis of massively parallel sequencing data from an OvHV-2 persistently-infected bovine lymphoid cell line (BJ1035) identified forty-five possible virus-encoded miRNAs. We previously confirmed the expression of eight OvHV-2 miRNAs by northern hybridization. In this study we used RT-PCR to confirm the expression of an additional twenty-seven OvHV-2-encoded miRNAs. All thirty-five OvHV-2 miRNAs are expressed from the same virus genome strand and the majority (30) are encoded in an approximately 9 kb region that contains no predicted virus open reading frames. Future identification of the cellular and virus targets of these miRNAs will inform our understanding of MCF pathogenesis.	[Dalziel, Robert G.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; Univ Edinburgh, R D SVS, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Dalziel, RG (corresponding author), Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland.	bob.dalziel@roslin.ed.ac.uk	Hopkins, John/C-7756-2013	Hopkins, John/0000-0002-9530-8037; Nightingale, Katie/0000-0001-9958-4699; Grey, Finn/0000-0003-4288-2059; Levy, Claire/0000-0001-9265-6645	University of Edinburgh Principal's Career Development Scholarship; Roslin Institute; Biotechnology and Biological Sciences Research Council (BBSRC) Institute Strategic Programme Grant; BBSRC [BBS/E/D/20241864] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1232430, BBS/E/D/20241864] Funding Source: researchfish	University of Edinburgh Principal's Career Development Scholarship; Roslin Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council (BBSRC) Institute Strategic Programme Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	KN is funded by a University of Edinburgh Principal's Career Development Scholarship and the Roslin Institute, SE was funded by Biotechnology and Biological Sciences Research Council (BBSRC) Institute Strategic Programme Grant to The Roslin Institute, FG is a Wellcome Trust Career Development Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BUJDOSO R, 1990, IMMUNOLOGY, V69, P45; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cullen BR, 2009, NATURE, V457, P421, DOI 10.1038/nature07757; Dolken L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001150; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Feederle R, 2011, J VIROL, V85, P9801, DOI 10.1128/JVI.05100-11; Feederle R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001294; Glazov EA, 2010, J GEN VIROL, V91, P32, DOI 10.1099/vir.0.014290-0; Gottwein E, 2010, J VIROL, V84, P5229, DOI 10.1128/JVI.00202-10; Grey F, 2008, MED MICROBIOL IMMUN, V197, P261, DOI 10.1007/s00430-007-0070-1; Grundhoff A, 2011, VIROLOGY, V411, P325, DOI 10.1016/j.virol.2011.01.002; Hart J, 2007, J GEN VIROL, V88, P28, DOI 10.1099/vir.0.82284-0; Kato M, 2010, J BIOL CHEM, V285, P34004, DOI 10.1074/jbc.M110.165027; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Levy CS, 2012, J GEN VIROL, V93, P150, DOI 10.1099/vir.0.037606-0; Levy CS, 2011, THESIS U EDINBURGH; Lu F, 2010, J VIROL, V84, P2697, DOI 10.1128/JVI.01997-09; McGeoch DJ, 2006, VIRUS RES, V117, P90, DOI 10.1016/j.virusres.2006.01.002; Meier-Trummer CS, 2010, VET MICROBIOL, V141, P199, DOI 10.1016/j.vetmic.2009.09.009; Qin ZQ, 2010, J LEUKOCYTE BIOL, V87, P25, DOI 10.1189/jlb.0409251; REID HW, 1989, RES VET SCI, V47, P90, DOI 10.1016/S0034-5288(18)31237-2; Riaz A, 2014, J GEN VIROL, V95, P472, DOI 10.1099/vir.0.059303-0; Russell GC, 2009, VET J, V179, P324, DOI 10.1016/j.tvjl.2007.11.007; Schock A, 1998, VET IMMUNOL IMMUNOP, V66, P67, DOI 10.1016/S0165-2427(98)00187-1; Seto E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001063; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Walz N, 2010, J VIROL, V84, P716, DOI 10.1128/JVI.01302-09; Yao YX, 2007, J VIROL, V81, P7164, DOI 10.1128/JVI.00112-07; Zhao YG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001305; Zhao YG, 2009, J VIROL, V83, P489, DOI 10.1128/JVI.01166-08	33	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97765	10.1371/journal.pone.0097765	http://dx.doi.org/10.1371/journal.pone.0097765			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849241	gold, Green Published, Green Submitted			2022-12-25	WOS:000336730600057
J	Veen, T; Hjernquist, MB; Van Wilgenburg, SL; Hobson, KA; Folmer, E; Font, L; Klaassen, M				Veen, Thor; Hjernquist, Marten B.; Van Wilgenburg, Steven L.; Hobson, Keith A.; Folmer, Eelke; Font, Laura; Klaassen, Marcel			Identifying the African Wintering Grounds of Hybrid Flycatchers Using a Multi-Isotope (delta H-2, delta C-13, delta N-15) Assignment Approach	PLOS ONE			English	Article							MIGRATORY DIRECTION; STABLE HYDROGEN; EVOLUTION; BIRDS; PATTERNS; ORIGINS	Migratory routes and wintering grounds can have important fitness consequences, which can lead to divergent selection on populations or taxa differing in their migratory itinerary. Collared (Ficedula albicollis) and pied (F. hypoleuca) flycatchers breeding in Europe and wintering in different sub-Saharan regions have distinct migratory routes on the eastern and western sides of the Sahara desert, respectively. In an earlier paper, we showed that hybrids of the two species did not incur reduced winter survival, which would be expected if their migration strategy had been a mix of the parent species' strategies potentially resulting in an intermediate route crossing the Sahara desert to different wintering grounds. Previously, we compared isotope ratios and found no significant difference in stable-nitrogen isotope ratios (delta N-15) in wintergrown feathers between the parental species and hybrids, but stable-carbon isotope ratios (delta C-13) in hybrids significantly clustered only with those of pied flycatchers. We followed up on these findings and additionally analyzed the same feathers for stable-hydrogen isotope ratios (delta H-2) and conducted spatially explicit multi-isotope assignment analyses. The assignment results overlapped with presumed wintering ranges of the two species, highlighting the efficacy of the method. In contrast to earlier findings, hybrids clustered with both parental species, though most strongly with pied flycatcher.	[Veen, Thor] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Veen, Thor] Univ Groningen, Theoret Biol Grp, Groningen, Netherlands; [Hjernquist, Marten B.] Uppsala Univ, Uppsala, Uppland, Sweden; [Van Wilgenburg, Steven L.; Hobson, Keith A.] Environm Canada, Saskatoon, SK, Canada; [Folmer, Eelke] Royal Netherlands Inst Sea Res, Dept Marine Ecol, Den Burg, Noord Holland, Netherlands; [Font, Laura] Vrije Univ Amsterdam, Deep Earth Cluster, Amsterdam, Noord Holland, Netherlands; [Klaassen, Marcel] Netherlands Inst Ecol, Dept Anim Ecol, Wageningen, Gelderland, Netherlands; [Klaassen, Marcel] Deakin Univ, Ctr Integrat Ecol, Geelong, Vic 3217, Australia	University of British Columbia; University of Groningen; Uppsala University; Environment & Climate Change Canada; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Vrije Universiteit Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Deakin University	Veen, T (corresponding author), Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada.	veen@biodiversity.ubc.ca	Hobson, Keith/Q-9306-2019; Klaassen, Marcel/B-4325-2008; KNAW, NIOO-KNAW/A-4320-2012	Klaassen, Marcel/0000-0003-3907-9599; Van Wilgenburg, Steven/0000-0002-6742-4567; KNAW, NIOO-KNAW/0000-0002-3835-159X	Swedish Research Council Formas; zoological foundation; Netherlands Organization for Scientific Research [NWO-ALW 812.04.001, 851.30.003]; NSERC-CREATE Training Program in Biodiversity Research; Marie Curie fellowship and program [PEOPLE-2007-2-1-IEF]; Environment Canada	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); zoological foundation; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NSERC-CREATE Training Program in Biodiversity Research; Marie Curie fellowship and program(European Commission); Environment Canada(CGIAR)	The Swedish Research Council Formas (grants to L. Gustafsson and MBH), zoological foundation (MBH), Netherlands Organization for Scientific Research (grant: NWO-ALW 812.04.001, Rubicon to TV and 851.30.003 to MK), NSERC-CREATE Training Program in Biodiversity Research to TV and the Marie Curie fellowship and program (grant: PEOPLE-2007-2-1-IEF to LF) funded this work. Data analyses were supported by an operating grant to KAH from Environment Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Alerstam T, 2006, SCIENCE, V313, P791, DOI 10.1126/science.1129048; Bearhop S, 2005, SCIENCE, V310, P502, DOI 10.1126/science.1115661; Bensch S, 2006, J AVIAN BIOL, V37, P323, DOI 10.1111/j.2006.0908-8857.03628.x; Bensch S, 1999, EVOLUTION, V53, P1925, DOI 10.1111/j.1558-5646.1999.tb04573.x; BERTHOLD P, 1991, TRENDS ECOL EVOL, V6, P254, DOI 10.1016/0169-5347(91)90072-6; BERTHOLD P, 1992, NATURE, V360, P668, DOI 10.1038/360668a0; BirdLife International and NatureServe, 2011, BIRD SPEC DISTR MAPS; Blondel Jacques, 1993, P135; Bohning-Gaese K, 1998, EVOL ECOL, V12, P767, DOI 10.1023/A:1006538414645; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Costantini D, 2013, CURR ZOOL, V59, P697, DOI 10.1093/czoolo/59.6.697; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; Cramp S., 1992, HDB BIRDS EUROPE MID; Delmore KE, 2012, P ROY SOC B-BIOL SCI, V279, P4582, DOI 10.1098/rspb.2012.1229; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Flockhart DTT, 2007, EVOL ECOL RES, V9, P887; Flockhart DTT, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1087; Gross K., 2011, MVNMLE ML ESTIMATION; Hallworth MT, 2013, AUK, V130, P273, DOI 10.1525/auk.2013.13037; HELBIG AJ, 1991, J EVOLUTION BIOL, V4, P657, DOI 10.1046/j.1420-9101.1991.4040657.x; HELBIG AJ, 1991, BEHAV ECOL SOCIOBIOL, V28, P9; Hijmans RJ., 2012, RASTER GEOGRAPHIC AN; Hjernquist MB, 2009, J AVIAN BIOL, V40, P102, DOI 10.1111/j.1600-048X.2009.04412.x; Hobson KA, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00018.1; Hobson KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035137; Hobson KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007915; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Irwin Darren E., 2005, P27; Irwin DE, 2009, CURR BIOL, V19, pR1111, DOI 10.1016/j.cub.2009.11.011; Macdonald C. A., 2013, Animal Migration, V1, P23, DOI 10.2478/ami-2012-0003; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Mettler R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081365; Mouritsen H, 1998, J EXP BIOL, V201, P2927; Mouritsen H, 2000, J THEOR BIOL, V207, P283, DOI 10.1006/jtbi.2000.2171; Prochazka P, 2013, J AVIAN BIOL, V44, P541, DOI 10.1111/j.1600-048X.2013.00185.x; Pulido F, 2003, AVIAN MIGRATION, P53; Pulido F, 2007, BIOSCIENCE, V57, P165, DOI 10.1641/B570211; R Core Team, 2012, R LANG ENV STAT COMP; Reichlin TS, 2013, OECOLOGIA, V171, P591, DOI 10.1007/s00442-012-2418-5; Rolshausen G, 2009, CURR BIOL, V19, P2097, DOI 10.1016/j.cub.2009.10.061; Rolshausen G, 2010, OECOLOGIA, V162, P175, DOI 10.1007/s00442-009-1445-3; Royle JA, 2004, ECOL APPL, V14, P1780; Salewski V, 2002, IBIS, V144, P85, DOI 10.1046/j.0019-1019.2001.00007.x; Still CJ, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P179, DOI 10.1007/978-90-481-3354-3_9; van Noordwijk AJ, 2006, J ORNITHOL, V147, P221, DOI 10.1007/s10336-005-0047-z; Van Wilgenburg SL, 2011, ECOL APPL, V21, P1340, DOI 10.1890/09-2047.1; Veen T, 2007, P R SOC B, V274, P707, DOI 10.1098/rspb.2006.0058; Veen T, 2013, MOL ECOL, V22, P4144, DOI 10.1111/mec.12441; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Wunder MB, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P251, DOI 10.1007/978-90-481-3354-3_12; Wunder MT., 2007, THESIS	52	22	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98075	10.1371/journal.pone.0098075	http://dx.doi.org/10.1371/journal.pone.0098075			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847717	gold, Green Published, Green Submitted			2022-12-25	WOS:000336730600084
J	Wilburn, DB; Bowen, KE; Doty, KA; Arumugam, S; Lane, AN; Feldhoff, PW; Feldhoff, RC				Wilburn, Damien B.; Bowen, Kathleen E.; Doty, Kari A.; Arumugam, Sengodagounder; Lane, Andrew N.; Feldhoff, Pamela W.; Feldhoff, Richard C.			Structural Insights into the Evolution of a Sexy Protein: Novel Topology and Restricted Backbone Flexibility in a Hypervariable Pheromone from the Red-Legged Salamander, Plethodon shermani	PLOS ONE			English	Article							TORSION ANGLE DYNAMICS; FEMALE RECEPTIVITY; COURTSHIP PHEROMONE; ALPHA-NEUROTOXINS; NMR; BINDING; TOXIN; VENOM; FAMILY; IDENTIFICATION	In response to pervasive sexual selection, protein sex pheromones often display rapid mutation and accelerated evolution of corresponding gene sequences. For proteins, the general dogma is that structure is maintained even as sequence or function may rapidly change. This phenomenon is well exemplified by the three-finger protein (TFP) superfamily: a diverse class of vertebrate proteins co-opted for many biological functions - such as components of snake venoms, regulators of the complement system, and coordinators of amphibian limb regeneration. All of the > 200 structurally characterized TFPs adopt the namesake "three-finger" topology. In male red-legged salamanders, the TFP pheromone Plethodontid Modulating Factor (PMF) is a hypervariable protein such that, through extensive gene duplication and pervasive sexual selection, individual male salamanders express more than 30 unique isoforms. However, it remained unclear how this accelerated evolution affected the protein structure of PMF. Using LC/MS-MS and multidimensional NMR, we report the 3D structure of the most abundant PMF isoform, PMF-G. The high resolution structural ensemble revealed a highly modified TFP structure, including a unique disulfide bonding pattern and loss of secondary structure, that define a novel protein topology with greater backbone flexibility in the third peptide finger. Sequence comparison, models of molecular evolution, and homology modeling together support that this flexible third finger is the most rapidly evolving segment of PMF. Combined with PMF sequence hypervariability, this structural flexibility may enhance the plasticity of PMF as a chemical signal by permitting potentially thousands of structural conformers. We propose that the flexible third finger plays a critical role in PMF: receptor interactions. As female receptors co-evolve, this flexibility may allow PMF to still bind its receptor(s) without the immediate need for complementary mutations. Consequently, this unique adaptation may establish new paradigms for how receptor: ligand pairs co-evolve, in particular with respect to sexual conflict.	[Wilburn, Damien B.; Bowen, Kathleen E.; Doty, Kari A.; Feldhoff, Pamela W.; Feldhoff, Richard C.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA; [Arumugam, Sengodagounder; Lane, Andrew N.] Univ Louisville, JG Brown Canc Ctr, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Feldhoff, RC (corresponding author), Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA.	rick.feldhoff@louisville.edu			National Science Foundation [IOS-1146899, IOS-1147271]; University of Louisville IRIG; Kentucky Challenge for Excellence; National Institute of Health [P20GM103482]; Direct For Biological Sciences [1146899] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103482, P30GM106396] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); University of Louisville IRIG; Kentucky Challenge for Excellence; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was supported in part by National Science Foundation (Collaborative) grants IOS-1146899 (RCF) and IOS-1147271 (LDH), a National Science Foundation Graduate Research Fellowship to DBW, the University of Louisville IRIG program, the Kentucky Challenge for Excellence, and National Institute of Health to ALN: CoBRE grant P20GM103482. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adermann K, 1999, PROTEIN SCI, V8, P810, DOI 10.1110/ps.8.4.810; Albone E.S., 1984, J WILEY; ALBRAND JP, 1995, BIOCHEMISTRY-US, V34, P5923, DOI 10.1021/bi00017a022; ARNOLD SJ, 1976, Z TIERPSYCHOL, V42, P247; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; BILWES A, 1994, J MOL BIOL, V239, P122, DOI 10.1006/jmbi.1994.1357; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Boschat C, 2002, NAT NEUROSCI, V5, P1261, DOI 10.1038/nn978; Cervenansky C., 1991, P303; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Chang C.C., 1979, SNAKE VENOMS, P309; Chouinard AJ, 2013, CHEM SIGNAL, V12, P99, DOI 10.1007/978-1-4614-5927-9_8; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; DAVIES A, 1989, J EXP MED, V170, P637, DOI 10.1084/jem.170.3.637; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DEWEILLE JR, 1991, P NATL ACAD SCI USA, V88, P2437, DOI 10.1073/pnas.88.6.2437; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Feldhoff Richard C., 1999, P117; Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405; Galat A, 2008, FEBS J, V275, P3207, DOI 10.1111/j.1742-4658.2008.06473.x; Garcia-Boronat M, 2008, NUCLEIC ACIDS RES, V36, pW35, DOI 10.1093/nar/gkn211; Garza-Garcia A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007123; GRAY WR, 1993, PROTEIN SCI, V2, P1732, DOI 10.1002/pro.5560021017; Greenwald J, 1998, BIOCHEMISTRY-US, V37, P16711, DOI 10.1021/bi981939o; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Haga S, 2010, NATURE, V466, P118, DOI 10.1038/nature09142; Harms MJ, 2013, P NATL ACAD IN PRESS; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Houck LD, 2007, ANIM BEHAV, V73, P315, DOI 10.1016/j.anbehav.2006.07.008; Houck LD, 2003, REPROD BIOL PHYLOGEN, V1, P383; HOUCK LD, 1990, ANIM BEHAV, V39, P729, DOI 10.1016/S0003-3472(05)80384-7; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; JERUSALINSKY D, 1994, TRENDS PHARMACOL SCI, V15, P424, DOI 10.1016/0165-6147(94)90092-2; JOHNSTON RE, 2000, NEUROBIOLOGY TASTE S, P101; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Kiemnec-Tyburczy KM, 2012, CHEM SENSES, V37, P335, DOI 10.1093/chemse/bjr105; Kini RM, 2010, TOXICON, V56, P855, DOI 10.1016/j.toxicon.2010.07.010; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; Laberge F, 2008, NEUROSCIENCE, V151, P329, DOI 10.1016/j.neuroscience.2007.11.006; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leinders-Zufall T, 2009, NAT NEUROSCI, V12, P1551, DOI 10.1038/nn.2452; Lienard MA, 2010, P NATL ACAD SCI USA, V107, P10955, DOI 10.1073/pnas.1000823107; Lin YL, 2004, BIOCHEM BIOPH RES CO, V319, P720, DOI 10.1016/j.bbrc.2004.05.064; Lyukmanova EN, 2007, J BIOL CHEM, V282, P24784, DOI 10.1074/jbc.M611263200; MCDOWELL RS, 1992, BIOCHEMISTRY-US, V31, P4766, DOI 10.1021/bi00135a004; McIntosh PB, 2000, J BIOMOL NMR, V16, P183, DOI 10.1023/A:1008374129366; MELROSE DR, 1971, BRIT VET J, V127, P497, DOI 10.1016/S0007-1935(17)37337-2; Mourier G, 2000, PROTEIN ENG, V13, P217, DOI 10.1093/protein/13.3.217; Mudge JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r91; Palmer CA, 2010, J MOL EVOL, V70, P427, DOI 10.1007/s00239-010-9342-2; Pearl FMG, 2003, NUCLEIC ACIDS RES, V31, P452, DOI 10.1093/nar/gkg062; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Roberts SA, 2012, SCIENCE, V338, P1462, DOI 10.1126/science.1225638; Roberts SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-75; Rollmann SM, 1999, SCIENCE, V285, P1907, DOI 10.1126/science.285.5435.1907; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sillitoe I, 2013, NUCLEIC ACIDS RES, V41, pD490, DOI 10.1093/nar/gks1211; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Symonds MRE, 2008, TRENDS ECOL EVOL, V23, P220, DOI 10.1016/j.tree.2007.11.009; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; Tsetlin V, 1999, EUR J BIOCHEM, V264, P281, DOI 10.1046/j.1432-1327.1999.00623.x; Wilburn DB, 2012, EVOLUTION, V66, P2227, DOI 10.1111/j.1558-5646.2011.01572.x; Wirsig-Wiechmann CR, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-26; Wirsig-Wiechmann CR, 2002, BRAIN RES, V952, P335, DOI 10.1016/S0006-8993(02)03369-3; Wouters MA, 2007, CURR PROTEIN PEPT SC, V8, P484, DOI 10.2174/138920307782411464; Wu PL, 2006, J BIOL CHEM, V281, P7937, DOI 10.1074/jbc.M513035200; Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322; Yoshinaga S, 2013, J BIOL CHEM, V288, P16064, DOI 10.1074/jbc.M112.436782	74	14	14	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e96975	10.1371/journal.pone.0096975	http://dx.doi.org/10.1371/journal.pone.0096975			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849290	Green Published, Green Submitted, gold			2022-12-25	WOS:000336730600018
J	Yang, Y; Zhao, W; Xu, QW; Wang, XS; Zhang, Y; Zhang, J				Yang, Ying; Zhao, Wei; Xu, Qing-Wen; Wang, Xiao-Song; Zhang, Yu; Zhang, Jun			IQGAP3 Promotes EGFR-ERK Signaling and the Growth and Metastasis of Lung Cancer Cells	PLOS ONE			English	Article							TYROSINE KINASE; HUMAN-BREAST; COPY NUMBER; RECEPTOR; THERAPY; TARGETS; CALMODULIN; EXPRESSION; FAMILY; PROLIFERATION	Proteins of the IQGAP family display complicated and often contradictory activities in tumorigenesis. IQGAP1 has well documented oncogenic potential and IQGAP2 has putative tumor-suppressive function. IQGAP3 is the latest addition to this family and its role in cancer development remains to be defined. Here we demonstrate IQGAP3 expression is markedly increased in lung cancer tissues at both mRNA and protein levels. Overexpression of IQGAP3 promoted tumor cell growth, and migration and invasion, whereas knockdown of IQGAP3 exhibited opposite effects. Moreover, suppression of IQGAP3 in a lung cancer cell line caused a reduction in the tumorigenicity of these cells in lung tissue after intravenous injection. Furthermore, we showed that IQGAP3 is able to interact with ERK1 and enhance its phosphorylation following treatment with EGF. These data suggest that IQGAP3 may contribute to the pathogenesis of lung cancer by modulating EGFR-ERK signaling.	[Yang, Ying; Zhao, Wei; Xu, Qing-Wen; Wang, Xiao-Song; Zhang, Yu; Zhang, Jun] Peking Univ, Hlth Sci Ctr, Dept Immunol, Sch Basic Med Sci,Key Lab Med Immunol,Minist Publ, Beijing 100871, Peoples R China	Peking University	Zhang, Y (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Immunol, Sch Basic Med Sci,Key Lab Med Immunol,Minist Publ, Beijing 100871, Peoples R China.	zhangyu007@hsc.pku.edu.cn; junzhang@bjmu.edu.cn			National Basic Research Program of China [2011CB946103]; National Natural Sciences Foundation of China [31330025, 30830091]; Beijing Municipal Natural Science Foundation [7122104]; 111 Project of China [B07001]	National Basic Research Program of China(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); 111 Project of China(Ministry of Education, China - 111 Project)	This work received support from the National Basic Research Program of China (2011CB946103), National Natural Sciences Foundation of China (31330025 and 30830091), Beijing Municipal Natural Science Foundation (7122104) and the 111 Project of China (B07001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonicelli A, 2013, INT J MED SCI, V10, P320, DOI 10.7150/ijms.4609; Beavon IRG, 2000, EUR J CANCER, V36, P1607, DOI 10.1016/S0959-8049(00)00158-1; Bremnes RM, 2002, LUNG CANCER, V36, P115, DOI 10.1016/S0169-5002(01)00471-8; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Brill S, 1996, MOL CELL BIOL, V16, P4869; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Dy GK, 2002, J CLIN ONCOL, V20, P2881, DOI 10.1200/JCO.2002.11.145; Dy GK, 2002, J CLIN ONCOL, V20, P3016, DOI 10.1200/JCO.2002.02.112; Ettinger DS, 2010, J NATL COMPR CANC NE, V8, P740, DOI 10.6004/jnccn.2010.0056; Hawthorn L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-460; Houwen Li, 2003, Ann Thorac Cardiovasc Surg, V9, P147; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Kim H, 2011, FEBS LETT, V585, P723, DOI 10.1016/j.febslet.2011.01.041; Koon N, 2004, NEOPLASIA, V6, P143, DOI 10.1593/neo.03385; Koudelakova V, 2013, BIOMED PAP, V157, P125, DOI 10.5507/bp.2013.034; Kunimoto K, 2009, J CELL PHYSIOL, V220, P621, DOI 10.1002/jcp.21798; Levitzki A, 2003, LUNG CANCER, V41, pS9, DOI 10.1016/S0169-5002(03)00134-X; Lv D, 2011, EUR J CANCER, V47, P2068, DOI 10.1016/j.ejca.2011.04.021; Maitah MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016068; Mataraza JM, 2003, J BIOL CHEM, V278, P41237, DOI 10.1074/jbc.M304838200; Nojima H, 2008, NAT CELL BIOL, V10, P971, DOI 10.1038/ncb1757; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Petty RD, 2004, CLIN CANCER RES, V10, P3237, DOI 10.1158/1078-0432.CCR-03-0503; Reinmuth N, 2004, LUNG CANCER, V45, pS177, DOI 10.1016/j.lungcan.2004.07.976; Romagosa C, 2011, ONCOGENE, V30, P2087, DOI 10.1038/onc.2010.614; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Schmidt VA, 2008, MOL CELL BIOL, V28, P1489, DOI 10.1128/MCB.01090-07; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536; Takeuchi K, 2010, FEBS J, V277, P316, DOI 10.1111/j.1742-4658.2009.07450.x; Vauhkonen H, 2006, CANCER GENET CYTOGEN, V167, P150, DOI 10.1016/j.cancergencyto.2005.11.014; Wang SJ, 2007, J CELL SCI, V120, P567, DOI 10.1242/jcs.03356; Wang YN, 2010, ONCOGENE, V29, P3997, DOI 10.1038/onc.2010.157; Watanabe T, 2005, NOVART FDN SYMP, V269, P223; Watanabe T, 2005, NOVART FDN SYMP, V269, P101; Watanabe Takashi, 2005, Novartis Found Symp, V269, P92; Wei QO, 2011, P NATL ACAD SCI USA, V108, P7004, DOI 10.1073/pnas.1013012108; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; Xu QW, 2012, CANCER RES, V72, P6351, DOI 10.1158/0008-5472.CAN-12-1656; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yu J, 2010, CLIN CANCER RES, V16, P2275, DOI 10.1158/1078-0432.CCR-09-2000	50	49	54	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97578	10.1371/journal.pone.0097578	http://dx.doi.org/10.1371/journal.pone.0097578			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849319	gold, Green Published, Green Submitted			2022-12-25	WOS:000336730600038
J	Dallacqua, RP; Bitondi, MMG				Dallacqua, Rodrigo Pires; Gentile Bitondi, Marcia Maria			Dimorphic Ovary Differentiation in Honeybee (Apis mellifera) Larvae Involves Caste-Specific Expression of Homologs of Ark and Buffy Cell Death Genes	PLOS ONE			English	Article							BCL-2 PROTEIN FAMILY; MOLECULAR DETERMINANTS; DEVELOPMENTAL-STAGES; PATHWAY GENES; BEE; WORKERS; APOPTOSIS; DOMAIN; MITOCHONDRIA; QUEENS	The establishment of the number of repeated structural units, the ovarioles, in the ovaries is one of the critical events that shape caste polyphenism in social insects. In early postembryonic development, honeybee (Apis mellifera) larvae have a pair of ovaries, each one consisting of almost two hundred ovariole primordia. While practically all these ovarioles continue developing in queen-destined larvae, they undergo massive programmed cell death (PCD) in worker-destined larvae. So as to gain insight into the molecular basis of this fundamental process in caste differentiation we used quantitative PCR (qPCR) and fluorescent in situ hybridization (FISH) to investigate the expression of the Amark and Ambuffy genes in the ovaries of the two honeybee castes throughout the fifth larval instar. These are the homologs of ark and buffy Drosophila melanogaster genes, respectively, involved in activating and inhibiting PCD. Caste-specific expression patterns were found during this time-window defining ovariole number. Amark transcript levels were increased when ovariole resorption was intensified in workers, but remained at low levels in queen ovaries. The transcripts were mainly localized at the apical end of all the worker ovarioles, but appeared in only a few queen ovarioles, thus strongly suggesting a function in mediating massive ovariolar cell death in worker larvae. Ambuffy was mainly expressed in the peritoneal sheath cells covering each ovariole. The levels of Ambuffy transcripts increased earlier in the developing ovaries of queens than in workers. Consistent with a protective role against cell death, Ambuffy transcripts were localized in practically all queen ovarioles, but only in few worker ovarioles. The results are indicative of a functional relationship between the expression of evolutionary conserved cell death genes and the morphological events leading to caste-specific ovary differentiation in a social insect.	[Dallacqua, Rodrigo Pires] Univ Fed Mato Grosso do Sul, Setor Biol Geral, Mato Grosso, Brazil; [Gentile Bitondi, Marcia Maria] Univ Sao Paulo, Fac Filosof, Dept Biol, BR-14049 Ribeirao Preto, SP, Brazil	Universidade Federal de Mato Grosso do Sul; Universidade de Sao Paulo	Dallacqua, RP (corresponding author), Univ Fed Mato Grosso do Sul, Setor Biol Geral, Campo Grande, Mato Grosso, Brazil.	rodrigo.dallacqua@ufms.br; mmgbit@usp.br	Dallacqua, Rodrigo P/I-6592-2012; Bitondi, Marcia MG/E-8014-2012	Bitondi, Marcia MG/0000-0002-5619-6378	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [11/03171-5];  [09/15772-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); 	Financial support was provided by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grant 11/03171-5), which also provided a Post Doc fellowship to RPD (09/15772-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdemir F, 2006, DEVELOPMENT, V133, P1457, DOI 10.1242/dev.02332; Azevedo SV, 2011, J INSECT PHYSIOL, V57, P38, DOI 10.1016/j.jinsphys.2010.09.004; Baehrecke EH, 2000, CELL DEATH DIFFER, V7, P1057, DOI 10.1038/sj.cdd.4400753; Barchuk AR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-70; Barth JMI, 2011, CELL DEATH DIFFER, V18, P915, DOI 10.1038/cdd.2010.157; Bryant B, 2008, INSECT BIOCHEM MOLEC, V38, P331, DOI 10.1016/j.ibmb.2007.11.012; Cameron RC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-903; Capella ICS, 1998, J INSECT PHYSIOL, V44, P385, DOI 10.1016/S0022-1910(98)00027-4; Capella ICS, 2002, CELL TISSUE RES, V307, P265, DOI 10.1007/s00441-001-0490-y; Cheng WC, 2006, ONCOGENE, V25, P4697, DOI 10.1038/sj.onc.1209596; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Corona M, 1999, J EXP BIOL, V202, P929; Cristino AS, 2006, INSECT MOL BIOL, V15, P703, DOI 10.1111/j.1365-2583.2006.00696.x; Cruz-Landim C, 2009, ABELHAS MORFOLOGIA F, P15; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Danial NN, 2010, ADV EXP MED BIOL, V687, P1; de Azevedo SV, 2008, J INSECT PHYSIOL, V54, P1064, DOI 10.1016/j.jinsphys.2008.04.009; Doumanis J, 2007, CELL DEATH DIFFER, V14, P907, DOI 10.1038/sj.cdd.4402082; Evans JD, 1999, P NATL ACAD SCI USA, V96, P5575, DOI 10.1073/pnas.96.10.5575; Evans JD, 2000, GEN BIOL, V2, P1, DOI DOI 10.1186/GB-2000-2-1-RESEARCH0001; Golstein P, 1997, SCIENCE, V275, P1081, DOI 10.1126/science.275.5303.1081; Gorski SM, 2003, CURR BIOL, V13, P358, DOI 10.1016/S0960-9822(03)00082-4; Hartfelder K, 1997, INVERTEBR REPROD DEV, V31, P237, DOI 10.1080/07924259.1997.9672582; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Humann FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078915; Humann FC, 2011, INSECT BIOCHEM MOLEC, V41, P602, DOI 10.1016/j.ibmb.2011.03.013; Igaki T, 2000, P NATL ACAD SCI USA, V97, P662, DOI 10.1073/pnas.97.2.662; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Kamakura M, 2011, NATURE, V473, P478, DOI 10.1038/nature10093; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Lahm A, 2003, CELL DEATH DIFFER, V10, P10, DOI 10.1038/sj.cdd.4401203; Lee CY, 2000, MOL CELL, V6, P433, DOI 10.1016/S1097-2765(00)00042-3; Leimar O, 2012, ECOL EVOL, V2, P3098, DOI 10.1002/ece3.414; Linksvayer TA, 2009, GENETICS, V183, P693, DOI 10.1534/genetics.109.105452; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Martin DN, 2004, DEVELOPMENT, V131, P275, DOI 10.1242/dev.00933; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; MICHELETTE ERD, 1993, APIDOLOGIE, V24, P431, DOI 10.1051/apido:19930410; Monserrate JP, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-63; Muro I, 2002, J BIOL CHEM, V277, P49644, DOI 10.1074/jbc.M203464200; Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509; Peterson JS, 2007, GENESIS, V45, P396, DOI 10.1002/dvg.20306; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Quinn L, 2003, EMBO J, V22, P3568, DOI 10.1093/emboj/cdg355; RACHINSKY A, 1990, GEN COMP ENDOCR, V79, P31, DOI 10.1016/0016-6480(90)90085-Z; Reginato R. D., 2003, Braz. J. Biol., V63, P121, DOI 10.1590/S1519-69842003000100016; Reginato RD, 2002, CELL BIOL INT, V26, P243, DOI 10.1006/cbir.2001.0839; Reginato RD, 2001, INVERTEBR REPROD DEV, V39, P127, DOI 10.1080/07924259.2001.9652475; REMBOLD H, 1980, APIDOLOGIE, V11, P29, DOI 10.1051/apido:19800104; Rodriguez A, 1999, NAT CELL BIOL, V1, P272, DOI 10.1038/12984; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Saunders C, 1999, BIOTECHNIQUES, V26, P186, DOI 10.2144/99262bm01; Schulman JJ, 2013, J BIOL CHEM, V288, P25340, DOI 10.1074/jbc.M113.496570; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SEVERSON DW, 1989, INSECT BIOCHEM, V19, P215, DOI 10.1016/0020-1790(89)90094-2; Snodgrass RE, 1956, ANATOMY HONEY BEE, P290; Srivastava M, 2007, CELL DEATH DIFFER, V14, P92, DOI 10.1038/sj.cdd.4401931; Tanner EA, 2011, DEVELOPMENT, V138, P327, DOI 10.1242/dev.057943; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; Wheeler DE, 2006, INSECT MOL BIOL, V15, P597, DOI 10.1111/j.1365-2583.2006.00681.x; Wu JN, 2010, MECH DEVELOP, V127, P407, DOI 10.1016/j.mod.2010.06.001; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang JY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-611; Zmasek CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008649	66	14	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98088	10.1371/journal.pone.0098088	http://dx.doi.org/10.1371/journal.pone.0098088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844304	Green Published, Green Submitted, gold			2022-12-25	WOS:000339563400093
J	Dallman, TJ; Chattaway, MA; Cowley, LA; Doumith, M; Tewolde, R; Wooldridge, DJ; Underwood, A; Ready, D; Wain, J; Foster, K; Grant, KA; Jenkins, C				Dallman, Timothy J.; Chattaway, Marie A.; Cowley, Lauren A.; Doumith, Michel; Tewolde, Rediat; Wooldridge, David J.; Underwood, Anthony; Ready, Derren; Wain, John; Foster, Kirsty; Grant, Kathie A.; Jenkins, Claire			An Investigation of the Diversity of Strains of Enteroaggregative Escherichia coli Isolated from Cases Associated with a Large Multi-Pathogen Foodborne Outbreak in the UK	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; AGGREGATIVE ADHERENCE; DIARRHEAL DISEASE; FECAL SAMPLES; AGGR REGULON; VIRULENCE; IDENTIFICATION; CHILDREN; GENES; MICROARRAY	Following a large outbreak of foodborne gastrointestinal (GI) disease, a multiplex PCR approach was used retrospectively to investigate faecal specimens from 88 of the 413 reported cases. Gene targets from a range of bacterial GI pathogens were detected, including Salmonella species, Shigella species and Shiga toxin-producing Escherichia coli, with the majority (75%) of faecal specimens being PCR positive for aggR associated with the Enteroaggregative E. coli (EAEC) group. The 20 isolates of EAEC recovered from the outbreak specimens exhibited a range of serotypes, the most frequent being O104:H4 and O131:H27. None of the EAEC isolates had the Shiga toxin (stx) genes. Multilocus sequence typing and single nucleotide polymorphism analysis of the core genome confirmed the diverse phylogeny of the strains. The analysis also revealed a close phylogenetic relationship between the EAEC O104:H4 strains in this outbreak and the strain of E. coli O104:H4 associated with a large outbreak of haemolytic ureamic syndrome in Germany in 2011. Further analysis of the EAEC plasmids, encoding the key enteroaggregative virulence genes, showed diversity with respect to FIB/FII type, gene content and genomic architecture. Known EAEC virulence genes, such as aggR, aat and aap, were present in all but one of the strains. A variety of fimbrial genes were observed, including genes encoding all five known fimbrial types, AAF/1 to AAF/V. The AAI operon was present in its entirety in 15 of the EAEC strains, absent in three and present, but incomplete, in two isolates. EAEC is known to be a diverse pathotype and this study demonstrates that a high level of diversity in strains recovered from cases associated with a single outbreak. Although the EAEC in this study did not carry the stx genes, this outbreak provides further evidence of the pathogenic potential of the EAEC O104:H4 serotype.	[Dallman, Timothy J.; Chattaway, Marie A.; Cowley, Lauren A.; Grant, Kathie A.; Jenkins, Claire] Publ Hlth England, Gastrointestinial Bacteria Reference Unit, London, England; [Doumith, Michel] Publ Hlth England, Antimicrobial Resistance & Healthcare Associated, London, England; [Tewolde, Rediat; Underwood, Anthony] Publ Hlth England, Appl Lab, London, England; [Tewolde, Rediat; Underwood, Anthony] Publ Hlth England, Bioinformat Unit, London, England; [Wooldridge, David J.] Publ Hlth England, Dept Bioanal & Horizon Technol, London, England; [Ready, Derren] Barts & London Hosp Trust, Publ Hlth Lab London, London, England; [Wain, John] Univ E Anglia, Innovat Ctr, Norwich NR4 7TJ, Norfolk, England; [Foster, Kirsty] North East Publ Hlth England Ctr, Newcastle Upon Tyne, Tyne & Wear, England	Public Health England; Public Health England; Public Health England; Public Health England; Public Health England; Barts Health NHS Trust; Public Health England; University of East Anglia	Jenkins, C (corresponding author), Publ Hlth England, Gastrointestinial Bacteria Reference Unit, London, England.	claire.jenkins@phe.gov.uk	Dallman, Timothy J/ABD-6662-2021; Wain, John Richard/B-3446-2013	Underwood, Anthony/0000-0002-8547-4277; Doumith, Michel/0000-0002-8004-0314; Cowley, Lauren/0000-0003-0835-7971; Ready, Derren/0000-0003-4894-3641; Wain, John Richard/0000-0002-1257-1148; Chattaway, Marie Anne/0000-0002-5288-9089				Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bernier C, 2002, INFECT IMMUN, V70, P4302, DOI 10.1128/IAI.70.8.4302-4311.2002; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Boisen N, 2008, INFECT IMMUN, V76, P3281, DOI 10.1128/IAI.01646-07; Boisen N, 2012, J INFECT DIS, V205, P431, DOI 10.1093/infdis/jir757; Boisen N, 2009, AM J TROP MED HYG, V80, P294, DOI 10.4269/ajtmh.2009.80.294; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Czeczulin JR, 1997, INFECT IMMUN, V65, P4135, DOI 10.1128/IAI.65.10.4135-4145.1997; Dallman T, 2012, J CLIN MICROBIOL, V50, P4116, DOI 10.1128/JCM.02047-12; Dudley EG, 2006, MOL MICROBIOL, V61, P1267, DOI 10.1111/j.1365-2958.2006.05281.x; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Grad YH, 2013, MBIO, V4, DOI 10.1128/mBio.00452-12; Grad YH, 2012, P NATL ACAD SCI USA, V109, P3065, DOI 10.1073/pnas.1121491109; Hwang J, 2010, INFECT IMMUN, V78, P4068, DOI 10.1128/IAI.00014-10; Inouye M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-338; Itoh Y, 1997, J CLIN MICROBIOL, V35, P2546, DOI 10.1128/JCM.35.10.2546-2550.1997; Jenkins C, 2007, EUR J CLIN MICROBIOL, V26, P901, DOI 10.1007/s10096-007-0388-z; Jenkins C, 2005, FEMS MICROBIOL LETT, V253, P119, DOI 10.1016/j.femsle.2005.09.040; Jenkins C, 2006, J MED MICROBIOL, V55, P1493, DOI 10.1099/jmm.0.46683-0; Jenkins C, 2006, DIAGN MICR INFEC DIS, V55, P13, DOI 10.1016/j.diagmicrobio.2005.10.019; King LA, 2012, CLIN INFECT DIS, V54, P1588, DOI 10.1093/cid/cis255; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Moran-Gilad J, 2012, EPIDEMIOL INFECT, V140, P2142, DOI 10.1017/S0950268812001835; Morin N, 2013, INFECT IMMUN, V81, P122, DOI 10.1128/IAI.00676-12; Nataro JP, 2006, CLIN INFECT DIS, V43, P402, DOI 10.1086/505867; NATARO JP, 1994, J BACTERIOL, V176, P4691, DOI 10.1128/JB.176.15.4691-4699.1994; NATARO JP, 1992, INFECT IMMUN, V60, P2297, DOI 10.1128/IAI.60.6.2297-2304.1992; NATARO JP, 1987, PEDIATR INFECT DIS J, V6, P829, DOI 10.1097/00006454-198709000-00008; Nishi J, 2003, J BIOL CHEM, V278, P45680, DOI 10.1074/jbc.M306413200; Nuesch-Inderbinen MT, 2013, J MED MICROBIOL, V62, P1828, DOI 10.1099/jmm.0.065177-0; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Okeke I N, 2001, Lancet Infect Dis, V1, P304, DOI 10.1016/S1473-3099(01)00144-X; Okeke IN, 2000, J INFECT DIS, V181, P252, DOI 10.1086/315204; Okeke IN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014093; Perry N, 2010, J MED MICROBIOL, V59, P870, DOI 10.1099/jmm.0.018671-0; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Scavia G, 2008, J MED MICROBIOL, V57, P1141, DOI 10.1099/jmm.0.2008/001362-0; Scheutz F, 2011, EUROSURVEILLANCE, V16, P5; Sheikh J, 2002, J CLIN INVEST, V110, P1329, DOI 10.1172/JCI200216172; Smith HR, 1997, LANCET, V350, P814, DOI 10.1016/S0140-6736(05)62611-6; Spencer J, 1999, EPIDEMIOL INFECT, V123, P413, DOI 10.1017/S0950268899002976; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; Wilson A, 2001, EUR J EPIDEMIOL, V17, P1125, DOI 10.1023/A:1021224915322; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	51	34	36	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98103	10.1371/journal.pone.0098103	http://dx.doi.org/10.1371/journal.pone.0098103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844597	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000339563400095
J	Rabbani, F; Ajaz, H; Zimmermann, I; Johnsson, M				Rabbani, Faiz; Ajaz, Humayun; Zimmermann, Iwan; Johnsson, Mats			Synthesis, Crystal Structure and Thermal Decomposition of the New Cadmium Selenite Chloride, Cd-4(SeO3)(2)OCl2	PLOS ONE			English	Article							MAGNETIC-PROPERTIES; CL; COPPER(II)	A synthetic study in the Cd-Se-O-Cl system led to formation of the new oxochloride compound Cd-4(SeO3)(2)OCl2 via solid state reactions. The compound crystallizes in the orthorhombic space group Fmmm with cell parameters a = 7.3610(3) angstrom, b = 15.4936(2) angstrom, c = 17.5603(3) angstrom, Z = 8, S = 0.969, F(000) = 2800, R = 0.0185, R-w = 0.0384. Single crystal X-ray data were collected at 293 K. The crystal structure can be considered as layered and the building units are distorted [Cd(1)O-6] octahedra, distorted [Cd(2)O-8] cubes, irregular [Cd(3)O4Cl2] polyhedra and SeO3E trigonal pyramids. There are two crystallographically unique Cl atoms that both are half occupied. Thermogravimetric studies show that the compound starts to decompose at 500 degrees C. The crystal structure of the new compound is closely related to the previously described compound Cd-4(SeO3)(2)Cl-4(H2O).	[Rabbani, Faiz] COMSATS Inst Informat Technol, Dept Chem, Abbottabad, Khyber Pakhtunk, Pakistan; [Ajaz, Humayun] Univ Engn & Technol, Dept Chem, Lahore, Pakistan; [Zimmermann, Iwan; Johnsson, Mats] Stockholm Univ, Dept Mat & Environm Chem, S-10691 Stockholm, Sweden	COMSATS University Islamabad (CUI); University of Engineering & Technology Lahore; Stockholm University	Johnsson, M (corresponding author), Stockholm Univ, Dept Mat & Environm Chem, S-10691 Stockholm, Sweden.	mats.johnsson@mmk.su.se		Zimmermann, Iwan/0000-0002-6183-2690; Johnsson, Mats/0000-0003-4319-1540	Higher Education Commission (HEC) in Pakistan; Swedish Research Council	Higher Education Commission (HEC) in Pakistan; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work has been carried out with financial support from the Higher Education Commission (HEC) in Pakistan and from the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK J, 1995, Z ANORG ALLG CHEM, V621, P131, DOI 10.1002/zaac.19956210124; Becker R, 2007, J SOLID STATE CHEM, V180, P1051, DOI 10.1016/j.jssc.2006.12.035; Becker R, 2007, ACTA CRYSTALLOGR C, V63, pI4, DOI 10.1107/S0108270106050621; Becker R, 2006, J AM CHEM SOC, V128, P15469, DOI 10.1021/ja064738d; Brandenburg K., 2001, CRYSTAL IMPACT; BROWN ID, 1985, ACTA CRYSTALLOGR B, V41, P244, DOI 10.1107/S0108768185002063; Chen WT, 2013, J SOLID STATE CHEM, V204, P153, DOI 10.1016/j.jssc.2013.05.035; Chen WT, 2011, CHINESE J STRUC CHEM, V30, P1798; Farrugia L.J., 1999, J APPL CRYSTALLOGR, V32, P837, DOI [DOI 10.1107/S0021889812029111, 10.1107/S0021889899006020, DOI 10.1107/S0021889899006020, 10.1107/S0021889812029111]; GALY J, 1979, ACTA CHEM SCAND A, V33, P383, DOI 10.3891/acta.chem.scand.33a-0383; Johnsson M, 2000, CHEM MATER, V12, P2853, DOI 10.1021/cm000218k; Johnsson M, 2007, ACTA CRYSTALLOGR C, V63, pI34, DOI 10.1107/S0108270107012541; Krivovichev SV, 1998, Z KRISTALLOGR, V213, P645, DOI 10.1524/zkri.1998.213.12.645; Mao JG, 2008, INORG CHEM, V47, P8498, DOI 10.1021/ic8005629; Oxford Diffraction Xcalibur CCD System, 2007, CRYSALIS CCD CRYSALI; Nguyen SD, 2011, J AM CHEM SOC, V133, P12422, DOI 10.1021/ja205456b; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sun CF, 2009, J AM CHEM SOC, V131, P9486, DOI 10.1021/ja9030566	18	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97175	10.1371/journal.pone.0097175	http://dx.doi.org/10.1371/journal.pone.0097175			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844633	Green Submitted, Green Published, gold			2022-12-25	WOS:000339563400015
J	Wang, YL; Thinakaran, G; Kar, S				Wang, Yanlin; Thinakaran, Gopal; Kar, Satyabrata			Overexpression of the IGF-II/M6P Receptor in Mouse Fibroblast Cell Lines Differentially Alters Expression Profiles of Genes Involved in Alzheimer's Disease-Related Pathology	PLOS ONE			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; AMYLOID PRECURSOR PROTEIN; GROWTH FACTOR-II/MANNOSE-6-PHOSPHATE RECEPTOR; BETA-DEGRADING ENZYMES; FACTOR-II RECEPTOR; CATHEPSIN-D; IGF-II; COGNITIVE IMPAIRMENT; LYSOSOMAL-ENZYMES; SECRETASE SITE	Alzheimer's disease (AD) is the most common type of senile dementia affecting elderly people. The processing of amyloid precursor protein (APP) leading to the generation of beta-amyloid (A beta) peptide contributes to neurodegeneration and development of AD pathology. The endocytic trafficking pathway, which comprises of the endosomes and lysosomes, acts as an important site for A beta generation, and endocytic dysfunction has been linked to increased A beta production and loss of neurons in AD brains. Since insulin-like growth factor-II (IGF-II) receptor plays a critical role in the transport of lysosomal enzymes from the trans-Golgi network to endosomes, it is likely that the receptor may have a role in regulating A beta metabolism in AD pathology. However, very little is known on how altered levels of the IGF-II receptor can influence the expression/function of various molecules involved in AD pathology. To address this issue, we evaluated the expression profiles of 87 selected genes related to AD pathology in mouse fibroblast MS cells that are deficient in murine IGF-II receptor and corresponding MS9II cells overexpressing similar to 500 times the human IGF-II receptors. Our results reveal that an elevation in IGF-II receptor levels alters the expression profiles of a number of genes including APP as well as enzymes regulating A beta production, degradation and clearance mechanisms. Additionally, it influences the expression of various lysosomal enzymes and protein kinases that are involved in A beta toxicity. IGF-II receptor overexpression also alters expression of several genes involved in intracellular signalling as well as cholesterol metabolism, which play a critical role in AD pathology. The altered gene profiles observed in this study closely match with the corresponding protein levels, with a few exceptions. These results, taken together, suggest that an elevation in IGF-II receptor levels can influence the expression profiles of transcripts as well as proteins that are involved in AD pathogenesis.	[Wang, Yanlin; Kar, Satyabrata] Univ Alberta, Dept Psychiat, Edmonton, AB, Canada; [Wang, Yanlin; Kar, Satyabrata] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada; [Thinakaran, Gopal] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Thinakaran, Gopal] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Thinakaran, Gopal] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Kar, Satyabrata] Univ Alberta, Dept Med Neurol, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Chicago; University of Chicago; University of Chicago; University of Alberta	Kar, S (corresponding author), Univ Alberta, Dept Psychiat, Edmonton, AB, Canada.	skar@ualberta.ca			Natural Sciences and Engineering Research Council of Canada [203518]; Canadian Institutes of Health Research [MOP-84480]; Alzheimer Society of Canada; Alberta Innovates Health Solutions; National Institutes on Aging [R01AG019070]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019070] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer Society of Canada; Alberta Innovates Health Solutions; National Institutes on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from Natural Sciences and Engineering Research Council of Canada (#203518) and Canadian Institutes of Health Research (MOP-84480) to SK. YW is a recipient of Doctoral Awards from Alzheimer Society of Canada and a Graduate Studentship Award from Alberta Innovates Health Solutions. GT is supported by R01AG019070 grant from National Institutes on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amritraj A, 2009, NEUROBIOL AGING, V30, P54, DOI 10.1016/j.neurobiolaging.2007.05.004; Amritraj A, 2013, J BIOL CHEM, V288, P3136, DOI 10.1074/jbc.M112.412460; Amritraj A, 2009, AM J PATHOL, V175, P2540, DOI 10.2353/ajpath.2009.081096; Bertram L, 2012, PROG MOL BIOL TRANSL, V107, P79, DOI 10.1016/B978-0-12-385883-2.00008-4; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Cataldo AM, 2004, J NEUROPATH EXP NEUR, V63, P821, DOI 10.1093/jnen/63.8.821; Cataldo AM, 1997, J NEUROSCI, V17, P6142; CATALDO AM, 1995, NEURON, V14, P671, DOI 10.1016/0896-6273(95)90324-0; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; Chu CH, 2008, J ENDOCRINOL, V197, P381, DOI 10.1677/JOE-07-0619; Dahms NM, 2002, BBA-GEN SUBJECTS, V1572, P317, DOI 10.1016/S0304-4165(02)00317-3; Di Bacco A, 2003, ONCOGENE, V22, P5436, DOI 10.1038/sj.onc.1206670; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Eckman EA, 2005, BIOCHEM SOC T, V33, P1101, DOI 10.1042/BST0331101; El-Shewy HM, 2009, VITAM HORM, V80, P667, DOI 10.1016/S0083-6729(08)00624-9; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; GABEL CA, 1983, P NATL ACAD SCI-BIOL, V80, P775, DOI 10.1073/pnas.80.3.775; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Haag MDM, 2009, J NEUROL NEUROSUR PS, V80, P13, DOI 10.1136/jnnp.2008.150433; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Haque A, 2008, CNS NEUROL DISORD-DR, V7, P270, DOI 10.2174/187152708784936653; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hawkes C, 2007, MOL NEUROBIOL, V35, P329, DOI 10.1007/s12035-007-0021-2; Hawkes C, 2006, J NEUROSCI, V26, P585, DOI 10.1523/JNEUROSCI.2730-05.2006; Hawkes C, 2004, BRAIN RES REV, V44, P117, DOI 10.1016/j.brainresrev.2003.11.002; Hemming ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008477; HILLEREHFELD A, 1995, BBA-REV BIOMEMBRANES, V1241, P177, DOI 10.1016/0304-4157(95)00004-B; Hook VYH, 2008, J BIOL CHEM, V283, P7745, DOI 10.1074/jbc.M708362200; Kar S, 2006, NEUROBIOL AGING, V27, P199, DOI 10.1016/j.neurobiolaging.2005.03.005; Kar S, 1997, P NATL ACAD SCI USA, V94, P14054, DOI 10.1073/pnas.94.25.14054; Kindy MS, 2012, J ALZHEIMERS DIS, V29, P827, DOI 10.3233/JAD-2012-111604; Kolsch H, 2002, MOL PSYCHIATR, V7, P899, DOI 10.1038/sj.mp.4001109; KYLE JW, 1988, J BIOL CHEM, V263, P16230; Leduc V, 2010, TRENDS MOL MED, V16, P469, DOI 10.1016/j.molmed.2010.07.008; Leissring MA, 2008, J BIOL CHEM, V283, P29645, DOI 10.1074/jbc.R800022200; Lopez OL, 2003, REV NEUROLOGIA, V37, P155, DOI 10.33588/rn.3702.2002441; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; Martins IJ, 2009, J NEUROCHEM, V111, P1275, DOI 10.1111/j.1471-4159.2009.06408.x; Maulik M, 2013, MOL NEUROBIOL, V47, P37, DOI 10.1007/s12035-012-8337-y; Maulik M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054605; Maulik M, 2012, HUM MOL GENET, V21, P4857, DOI 10.1093/hmg/dds322; McKinnon T, 2001, J CLIN ENDOCR METAB, V86, P3665, DOI 10.1210/jc.86.8.3665; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; MINNITI CP, 1992, J BIOL CHEM, V267, P9000; Motyka B, 2000, CELL, V103, P491, DOI 10.1016/S0092-8674(00)00140-9; Mullins C, 2001, BIOESSAYS, V23, P333, DOI 10.1002/bies.1048; Nathalie P, 2008, CURR ALZHEIMER RES, V5, P92, DOI 10.2174/156720508783954721; Nelson PT, 2009, J NEUROPATH EXP NEUR, V68, P1, DOI 10.1097/NEN.0b013e3181919a48; NISHIMOTO I, 1987, J BIOL CHEM, V262, P12120; Nixon RA, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P277; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Puglielli L, 2003, NAT NEUROSCI, V6, P345, DOI 10.1038/nn0403-345; Repnik U, 2012, BBA-PROTEINS PROTEOM, V1824, P22, DOI 10.1016/j.bbapap.2011.08.016; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Roberg K, 1998, AM J PATHOL, V152, P1151; ROGERS SA, 1990, J BIOL CHEM, V265, P9722; Schechter I, 2008, BIOL CHEM, V389, P313, DOI 10.1515/BC.2008.025; Schechter I, 2011, BIOL CHEM, V392, P555, DOI 10.1515/BC.2011.054; Selkoe Dennis J, 2008, Handb Clin Neurol, V89, P245, DOI 10.1016/S0072-9752(07)01223-7; Shibata N, 2006, NEUROSCI LETT, V391, P142, DOI 10.1016/j.neulet.2005.08.048; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Sparks DL, 2008, CURR ALZHEIMER RES, V5, P416, DOI 10.2174/156720508785132316; St George-Hyslop PH, 2005, CR BIOL, V328, P119, DOI 10.1016/j.crvi.2004.10.013; Sundelof J, 2010, J ALZHEIMERS DIS, V22, P1223, DOI 10.3233/JAD-2010-101023; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tickler AK, 2005, PROTEIN PEPTIDE LETT, V12, P513, DOI 10.2174/0929866054395905; Wahrle SE, 2008, J CLIN INVEST, V118, P671, DOI 10.1172/JCI33622; Wood RJ, 2008, J BIOL CHEM, V283, P4165, DOI 10.1074/jbc.M708723200; Zamrini E, 2004, NEUROEPIDEMIOLOGY, V23, P94, DOI 10.1159/000073981; Zhang QM, 1997, P NATL ACAD SCI USA, V94, P6232, DOI 10.1073/pnas.94.12.6232	75	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98057	10.1371/journal.pone.0098057	http://dx.doi.org/10.1371/journal.pone.0098057			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846272	Green Submitted, gold, Green Published			2022-12-25	WOS:000339563400088
J	Zhang, YL; Shi, K; Liu, XH; Zhou, YQ; Qin, BQ				Zhang, Yunlin; Shi, Kun; Liu, Xiaohan; Zhou, Yongqiang; Qin, Boqiang			Lake Topography and Wind Waves Determining Seasonal-Spatial Dynamics of Total Suspended Matter in Turbid Lake Taihu, China: Assessment Using Long-Term High-Resolution MERIS Data	PLOS ONE			English	Article							LARGE SHALLOW LAKE; SEDIMENT RESUSPENSION; WATER-QUALITY; SUBMERGED MACROPHYTES; LIGHT; PHYTOPLANKTON; MODEL; ALGAL; VARIABILITY; ALGORITHM	Multiple comprehensive in situ bio-optical investigations were conducted from 2005 to 2010 and covered a large variability of total suspended matter (TSM) in Lake Taihu to calibrate and validate a TSM concentration estimation model based on Medium Resolution Imaging Spectrometer (MERIS) data. The estimation model of the TSM concentration in Lake Taihu was developed using top-of-atmosphere (TOA) radiance of MERIS image data at band 9 in combination with a regional empirical atmospheric correction model, which was strongly correlated with the in situ TSM concentration (r(2) = 0.720, p<0.001, and n = 73). The relative root mean square error (RRMSE) and mean relative error (MRE) were 36.9% and 31.6%, respectively, based on an independent validation dataset that produced reliable estimations of the TSM concentration. The developed algorithm was applied to 50 MERIS images from 2003 to 2011 to obtain a high spatial and temporal heterogeneity of TSM concentrations in Lake Taihu. Seasonally, the highest and lowest TSM concentrations were found in spring and autumn, respectively. Spatially, TSM concentrations were high in the southern part and center of the lake and low in Xukou Bay, East Lake Taihu. The lake topography, including the water depth and distance from the shore, had a significant effect on the TSM spatial distribution. A significant correlation was found between the daily average wind speed and TSM concentration (r(2) = 0.685, p, 0.001, and n = 50), suggesting a critical role of wind speed in the TSM variations in Lake Taihu. In addition, a low TSM concentration was linked to the appearance of submerged aquatic vegetation (SAV). Therefore, TSM dynamics were controlled by the lake topography, wind-driven sediment resuspension and SAV distribution.	[Zhang, Yunlin; Shi, Kun; Liu, Xiaohan; Zhou, Yongqiang; Qin, Boqiang] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Taihu Lake Lab Ecosyst Stn, Nanjing, Peoples R China; [Liu, Xiaohan; Zhou, Yongqiang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, YL (corresponding author), Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Taihu Lake Lab Ecosyst Stn, Nanjing, Peoples R China.	ylzhang@niglas.ac.cn	Liu, Xiaohan/AGS-6555-2022; Qin, Boqiang/E-5900-2013; Zhang, Yunlin/N-5464-2014	Zhang, Yunlin/0000-0002-3382-4570; Zhou, Yongqiang/0000-0003-1402-345X; Shi, Kun/0000-0002-6124-7512	National Natural Science Foundation of China [41325001, 41230744, 41271355]; Key Program of Nanjing Institute of Geography and Limnology, Chinese Academy of Sciences [NIGLAS2012135003]; Major Projects on Control and Rectification of Water Body Pollution [2012ZX07101-010]; Provincial Natural Science Foundation of Jiangsu of China [BK2012050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of Nanjing Institute of Geography and Limnology, Chinese Academy of Sciences; Major Projects on Control and Rectification of Water Body Pollution; Provincial Natural Science Foundation of Jiangsu of China(Natural Science Foundation of Jiangsu Province)	This study was jointly funded by the National Natural Science Foundation of China (grants 41325001, 41230744, 41271355), the Key Program of Nanjing Institute of Geography and Limnology, Chinese Academy of Sciences (NIGLAS2012135003), the Major Projects on Control and Rectification of Water Body Pollution (2012ZX07101-010), and the Provincial Natural Science Foundation of Jiangsu of China (BK2012050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attila J, 2013, REMOTE SENS ENVIRON, V128, P138, DOI 10.1016/j.rse.2012.07.009; Bachmann RW, 2002, HYDROBIOLOGIA, V470, P219, DOI 10.1023/A:1015660922494; Binding CE, 2012, J GREAT LAKES RES, V38, P107, DOI 10.1016/j.jglr.2011.12.003; Carr J, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001103; Chanson H, 2011, ESTUAR COAST SHELF S, V95, P298, DOI 10.1016/j.ecss.2011.09.012; Chen SS, 2009, REMOTE SENS ENVIRON, V113, P2670, DOI 10.1016/j.rse.2009.08.005; Chen ZQ, 2010, ESTUAR COAST SHELF S, V89, P62, DOI 10.1016/j.ecss.2010.05.014; Doerffer R, 2007, INT J REMOTE SENS, V28, P517, DOI 10.1080/01431160600821127; DOERFFER R, 1989, REMOTE SENS ENVIRON, V28, P61, DOI 10.1016/0034-4257(89)90105-3; Doerffer R, 2008, MERIS LAKE WATER PRO; Dong BL, 2014, J GREAT LAK IN PRESS, V40; Duan HT, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/4/044009; Duan HT, 2009, ENVIRON SCI TECHNOL, V43, P3522, DOI 10.1021/es8031852; Duarte CM, 2007, ESTUAR COAST, V30, P652, DOI 10.1007/BF02841962; Eleveld MA, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011121; Fettweis M, 2007, CONT SHELF RES, V27, P1568, DOI 10.1016/j.csr.2007.01.017; Fragoso CR, 2008, ECOL MODEL, V219, P125, DOI 10.1016/j.ecolmodel.2008.08.004; Guanter L, 2010, REMOTE SENS ENVIRON, V114, P467, DOI 10.1016/j.rse.2009.10.004; Hakanson L, 2005, ECOL MODEL, V189, P130, DOI 10.1016/j.ecolmodel.2005.03.015; Havens KE, 2003, HYDROBIOLOGIA, V493, P173, DOI 10.1023/A:1025497621547; Istvanovics V, 2008, AQUAT BOT, V88, P317, DOI 10.1016/j.aquabot.2007.12.008; James WF, 2004, HYDROBIOLOGIA, V515, P193, DOI 10.1023/B:HYDR.0000027328.00153.b2; Koch EM, 2001, ESTUARIES, V24, P1, DOI 10.2307/1352808; Lawson SE, 2007, ESTUAR COAST, V30, P102, DOI 10.1007/BF02782971; Le CF, 2009, REMOTE SENS ENVIRON, V113, P1175, DOI 10.1016/j.rse.2009.02.005; Le Roux JP, 2009, COAST ENG, V56, P479, DOI 10.1016/j.coastaleng.2008.10.007; Liu XH, 2014, HYDROBIOLOGIA, V724, P187, DOI 10.1007/s10750-013-1733-0; Liu XH, 2013, J GEOPHYS RES-BIOGEO, V118, P713, DOI 10.1002/jgrg.20054; Ma RH, 2008, SENSORS-BASEL, V8, P3988, DOI 10.3390/s8063988; Mao ZH, 2012, REMOTE SENS ENVIRON, V124, P819, DOI 10.1016/j.rse.2012.06.014; Nechad B, 2010, REMOTE SENS ENVIRON, V114, P854, DOI 10.1016/j.rse.2009.11.022; Neil C, 2011, REMOTE SENS ENVIRON, V115, P3719, DOI 10.1016/j.rse.2011.09.010; Nguyen HL, 2005, SCI TOTAL ENVIRON, V340, P213, DOI 10.1016/j.scitotenv.2004.07.032; Olmanson LG, 2013, REMOTE SENS ENVIRON, V130, P254, DOI 10.1016/j.rse.2012.11.023; Ondrusek M, 2012, REMOTE SENS ENVIRON, V119, P243, DOI 10.1016/j.rse.2011.12.018; Qin BQ, 2007, HYDROBIOLOGIA, V581, P3, DOI 10.1007/s10750-006-0521-5; Qin BQ, 2010, ENVIRON MANAGE, V45, P105, DOI 10.1007/s00267-009-9393-6; Qin BQ, 2004, CHINESE SCI BULL, V49, P54, DOI 10.1360/03wd0174; Schallenberg M, 2004, FRESHWATER BIOL, V49, P143, DOI 10.1046/j.1365-2426.2003.01172.x; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Shen F, 2010, ESTUAR COAST, V33, P1420, DOI 10.1007/s12237-010-9313-2; Sun DY, 2009, IEEE T GEOSCI REMOTE, V47, P2957, DOI 10.1109/TGRS.2009.2014688; Takamura N, 2003, ECOL RES, V18, P381, DOI 10.1046/j.1440-1703.2003.00563.x; [唐军武 Tang Junwu], 2004, [遥感学报, Journal of Remote Sensing], V8, P37; Van den Berg MS, 2003, HYDROBIOLOGIA, V506, P611, DOI 10.1023/B:HYDR.0000008610.97044.39; van der Heide T, 2007, ECOSYSTEMS, V10, P1311, DOI 10.1007/s10021-007-9099-7; Wang MH, 2011, REMOTE SENS ENVIRON, V115, P841, DOI 10.1016/j.rse.2010.11.012; Xi HY, 2011, ENVIRON MONIT ASSESS, V177, P563, DOI 10.1007/s10661-010-1657-3; Yang W, 2011, REMOTE SENS ENVIRON, V115, P1247, DOI 10.1016/j.rse.2011.01.007; Zhang B, 2008, ENVIRON MONIT ASSESS, V145, P339, DOI 10.1007/s10661-007-0043-2; Zhang MW, 2010, REMOTE SENS ENVIRON, V114, P392, DOI 10.1016/j.rse.2009.09.016; Zhang YL, 2007, FUND APPL LIMNOL, V170, P11, DOI 10.1127/1863-9135/2007/0170-0011; Zhang YL, 2009, IEEE T GEOSCI REMOTE, V47, P1937, DOI [10.1109/TGRS.2008.2011892, 10.1109/TGRS.2009.2011892]; Zhao DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066365; Zhu GW, 2005, J ENVIRON SCI-CHINA, V17, P672	55	57	68	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98055	10.1371/journal.pone.0098055	http://dx.doi.org/10.1371/journal.pone.0098055			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846206	gold, Green Submitted, Green Published			2022-12-25	WOS:000339563400087
J	Chao, TF; Lai, YH; Yun, CH; Yen, CH; Wang, KL; Lin, YJ; Chang, SL; Lo, LW; Hu, YF; Hung, CL; Kuo, JY; Yeh, HI; Chen, SA				Chao, Tze-Fan; Lai, Yau-Huei; Yun, Chun-Ho; Yen, Chih-Hsuan; Wang, Kang-Ling; Lin, Yenn-Jiang; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Hung, Chung-Lieh; Kuo, Jen-Yuan; Yeh, Hung-I; Chen, Shih-Ann			The Association between Atrium Electromechanical Interval and Pericardial Fat	PLOS ONE			English	Article							EPICARDIAL ADIPOSE-TISSUE; CORONARY ATHEROSCLEROSIS; CATHETER ABLATION; FIBRILLATION; ECHOCARDIOGRAPHY; RECURRENCE; DISEASE; VOLUME	Objectives: Pericardial fat (PCF) may induce local inflammation and subsequent structural remodeling of the left atrium (LA). However, the adverse effects of PCF on LA are difficult to be evaluated and quantified. The atrial electromechanical interval determined by transthoracic echocardiogram was shown to be a convenient parameter which can reflect the process of LA remodeling. The goal of the present study was to investigate the association between the electromechanical interval and PCF. Methods and Results: A total of 337 patients with mean age of 51.9 +/- 9.0 years were enrolled. The electromechanical interval (PA-PDI) defined as the time interval from the initiation of the P wave deflection to the peak of the mitral inflow A wave on the pulse wave Doppler imaging was measured for every patient. The amount of PCF was determined by multi-detector computed tomography. The PA-PDI interval was significantly correlated with the amount of PCF (r = 0.641, p value <0.001). Graded prolongation of PA-PDI interval was observed across 3 groups of patients divided according to the tertile values of PCF. The AUC for the PA-PDI interval in predicting an increased amount of PCF (third tertile) was 0.796. At a cutoff value of 130 ms identified by the ROC curve, the sensitivity and specificity of PA-PDI interval in identifying patients with a highest tertile of PCF were 63.4% and 85.3%, respectively. Conclusions: The PA-PDI intervals were longer in patients with an increased amount of PCF. It may be a useful parameter to represent the degree of PCF-related atrial remodeling.	[Chao, Tze-Fan; Wang, Kang-Ling; Lin, Yenn-Jiang; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Chen, Shih-Ann] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan; [Chao, Tze-Fan; Wang, Kang-Ling; Lin, Yenn-Jiang; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Chen, Shih-Ann] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chao, Tze-Fan; Wang, Kang-Ling; Lin, Yenn-Jiang; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Chen, Shih-Ann] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Lai, Yau-Huei; Yen, Chih-Hsuan; Hung, Chung-Lieh; Kuo, Jen-Yuan; Yeh, Hung-I] Mackay Mem Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Lai, Yau-Huei; Yen, Chih-Hsuan; Hung, Chung-Lieh; Kuo, Jen-Yuan; Yeh, Hung-I] Mackay Med Coll, Dept Med, Taipei, Taiwan; [Lai, Yau-Huei; Yen, Chih-Hsuan; Hung, Chung-Lieh; Kuo, Jen-Yuan; Yeh, Hung-I] Mackay Med Nursing & Management Coll, Taipei, Taiwan; [Yun, Chun-Ho] Mackay Mem Hosp, Dept Internal Med, Div Radiol, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Mackay Medical College; Mackay Junior College of Medicine, Nursing & Management; Mackay Memorial Hospital	Hung, CL (corresponding author), Mackay Mem Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan.	jotaro3791@gmail.com; epsachen@ms41.hinet.net	Kuo, Jen-Yuan/AAX-5448-2021; Chang, Shih-Lin/AGT-1191-2022; Hu, Yu-Feng/V-1401-2019	Hu, Yu-Feng/0000-0001-5715-2070	Taipei Veterans General Hospital, Taiwan [V96C1-049, V97C1-059, V98C1-037, V99C1-120]; National Science Council, Taiwan [NSC95-2314-B-010-017, NSC95-2314-B-010-025, NSC96-2314-B-010-006, NSC96-2628-B-010-036, NSC97-2314-B-010-037-MY3, NSC97-2314-B-010-038, NSC98-2314-B-010-031-MY3]	Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by intramural grants (V96C1-049, V97C1-059, V98C1-037 and V99C1-120) from Taipei Veterans General Hospital, Taiwan and grants (NSC95-2314-B-010-017, NSC95-2314-B-010-025, NSC96-2314-B-010-006, NSC96-2628-B-010-036, NSC97-2314-B-010-037-MY3, NSC97-2314-B-010-038, NSC98-2314-B-010-031-MY3) from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Chekakie MO, 2010, J AM COLL CARDIOL, V56, P784, DOI 10.1016/j.jacc.2010.03.071; Babcock MJ, 2011, OBESITY, V19, P179, DOI 10.1038/oby.2010.121; Baker AR, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-1; Chao TF, 2011, J CARDIOVASC ELECTR, V22, P1325, DOI 10.1111/j.1540-8167.2011.02115.x; Chao TF, 2011, HEART, V97, P225, DOI 10.1136/hrt.2010.212373; De Vos CB, 2009, HEART, V95, P835, DOI 10.1136/hrt.2008.148528; Douglas PS, 2007, J AM SOC ECHOCARDIOG, V20, P787, DOI 10.1016/j.echo.2007.06.011; Konishi M, 2010, ATHEROSCLEROSIS, V209, P573, DOI 10.1016/j.atherosclerosis.2009.10.008; Lin YJ, 2010, AM J CARDIOL, V105, P495, DOI 10.1016/j.amjcard.2009.10.019; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Merckx KL, 2005, J AM SOC ECHOCARDIOG, V18, P940, DOI 10.1016/j.echo.2005.03.022; Nagashima K, 2011, CIRC J, V75, P2559, DOI 10.1253/circj.CJ-11-0554; Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019; Shin SY, 2011, J CARDIOVASC ELECTR, V22, P647, DOI 10.1111/j.1540-8167.2010.01993.x; Thanassoulis G, 2010, CIRC-ARRHYTHMIA ELEC, V3, P345, DOI 10.1161/CIRCEP.109.912055; Tsao HM, 2011, AM J CARDIOL, V107, P1498, DOI 10.1016/j.amjcard.2011.01.027; VANDENBERG BF, 1995, AM J CARDIOL, V75, P754, DOI 10.1016/S0002-9149(99)80676-6; Wong CX, 2011, J AM COLL CARDIOL, V57, P1745, DOI 10.1016/j.jacc.2010.11.045; Yerramasu A, 2012, ATHEROSCLEROSIS, V220, P223, DOI 10.1016/j.atherosclerosis.2011.09.041; Yun CH, 2012, EUR J RADIOL, V81, P749, DOI 10.1016/j.ejrad.2011.01.035	20	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97472	10.1371/journal.pone.0097472	http://dx.doi.org/10.1371/journal.pone.0097472			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841847	gold, Green Submitted, Green Published			2022-12-25	WOS:000340948600035
J	Eun, CS; Ortiz-Sanchez, JM; Da, LT; Wang, D; McCammon, JA				Eun, Changsun; Ortiz-Sanchez, Juan Manuel; Da, Lintai; Wang, Dong; McCammon, J. Andrew			Molecular Dynamics Simulation Study of Conformational Changes of Transcription Factor TFIIS during RNA Polymerase II Transcriptional Arrest and Reactivation	PLOS ONE			English	Article							ELONGATION-FACTOR TFIIS; FORCE-FIELD; DOMAIN; INITIATION; RESOLUTION; PROTEINS; CLEAVAGE; SERVER; MODEL	Transcription factor IIS (TFIIS) is a protein known for catalyzing the cleavage reaction of the 3'-end of backtracked RNA transcript, allowing RNA polymerase II (Pol II) to reactivate the transcription process from the arrested state. Recent structural studies have provided a molecular basis of protein-protein interaction between TFIIS and Pol II. However, the detailed dynamic conformational changes of TFIIS upon binding to Pol II and the related thermodynamic information are largely unknown. Here we use computational approaches to investigate the conformational space of TFIIS in the Pol II-bound and Pol II-free (unbound) states. Our results reveal two distinct conformations of TFIIS: the closed and the open forms. The closed form is dominant in the Pol II-free (unbound) state of TFIIS, whereas the open form is favorable in the Pol II-bound state. Furthermore, we discuss the free energy difference involved in the conformational changes between the two forms in the presence or absence of Pol II. Additionally, our analysis indicates that hydrophobic interactions and the protein-protein interactions between TFIIS and Pol II are crucial for inducing the conformational changes of TFIIS. Our results provide novel insights into the functional interplay between Pol II and TFIIS as well as mechanism of reactivation of Pol II transcription by TFIIS.	[Eun, Changsun; McCammon, J. Andrew] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Ortiz-Sanchez, Juan Manuel] Goethe Univ Frankfurt, Inst Phys & Theoret Chem, Frankfurt, Germany; [Da, Lintai; Wang, Dong] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Da, Lintai] Hong Kong Univ Sci & Technol, Dept Chem, Kowloon, Hong Kong, Peoples R China; [McCammon, J. Andrew] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [McCammon, J. Andrew] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; Goethe University Frankfurt; University of California System; University of California San Diego; Hong Kong University of Science & Technology; University of California System; University of California San Diego; University of California System; University of California San Diego	Eun, CS (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	ceun@ucsd.edu; dongwang@ucsd.edu	McCammon, J. Andrew/AAG-1832-2021; Ortiz Sanchez, Juan Manuel/C-9311-2016; Da, Lin-Tai/B-2356-2017	Ortiz Sanchez, Juan Manuel/0000-0003-1217-5740; McCammon, J. Andrew/0000-0003-3065-1456; Da, Lin-Tai/0000-0002-1589-5754	Howard Hughes Medical Institute; National Institute of Health; National Science Foundation; National Biomedical Computational Resource; Center for Theoretical Biological Physics; Fulbright Comission/Generalitat de Catalunya Program; Generalitat de Catalunya; NIH [GM102362]; Sidney Kimmel Foundation; Skaggs School of Pharmacy; Pharmaceutical Sciences, UCSD; Academic Senate Research Award from UCSD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102362] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Biomedical Computational Resource; Center for Theoretical Biological Physics; Fulbright Comission/Generalitat de Catalunya Program; Generalitat de Catalunya(Generalitat de Catalunya); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sidney Kimmel Foundation; Skaggs School of Pharmacy; Pharmaceutical Sciences, UCSD; Academic Senate Research Award from UCSD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Howard Hughes Medical Institute, the National Institute of Health, the National Science Foundation, the National Biomedical Computational Resource, and the Center for Theoretical Biological Physics. J.M.O.-S. acknowledges the Fulbright Comission/Generalitat de Catalunya Program and the Generalitat de Catalunya for a Fullbright and Beatriu de Pinos postdoctoral grants, respectively. D. W. acknowledges the NIH (GM102362), Kimmel Scholars award from the Sidney Kimmel Foundation for Cancer Research, start-up funds from Skaggs School of Pharmacy and Pharmaceutical Sciences, UCSD and Academic Senate Research Award from UCSD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awrey DE, 1998, J BIOL CHEM, V273, P22595, DOI 10.1074/jbc.273.35.22595; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Booth V, 2000, J BIOL CHEM, V275, P31266, DOI 10.1074/jbc.M002595200; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Da LT, 2012, J AM CHEM SOC, V134, P2399, DOI 10.1021/ja210656k; DONAHUE BA, 1994, P NATL ACAD SCI USA, V91, P8502, DOI 10.1073/pnas.91.18.8502; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Guglielmi B, 2007, P NATL ACAD SCI USA, V104, P16062, DOI 10.1073/pnas.0704534104; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jeon C, 1996, P NATL ACAD SCI USA, V93, P13677, DOI 10.1073/pnas.93.24.13677; JEON CJ, 1994, P NATL ACAD SCI USA, V91, P9106, DOI 10.1073/pnas.91.19.9106; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim B, 2007, P NATL ACAD SCI USA, V104, P16068, DOI 10.1073/pnas.0704573104; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Morin PE, 1996, P NATL ACAD SCI USA, V93, P10604, DOI 10.1073/pnas.93.20.10604; Nudler E, 2012, CELL, V149, P1438, DOI 10.1016/j.cell.2012.06.003; Peters MB, 2010, J CHEM THEORY COMPUT, V6, P2935, DOI 10.1021/ct1002626; QIAN XQ, 1993, BIOCHEMISTRY-US, V32, P9944, DOI 10.1021/bi00089a010; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shimoaraiso M, 1997, J BIOL CHEM, V272, P26550, DOI 10.1074/jbc.272.42.26550; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729	31	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97975	10.1371/journal.pone.0097975	http://dx.doi.org/10.1371/journal.pone.0097975			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842057	gold, Green Published			2022-12-25	WOS:000340948600096
J	Long, LL; Hinman, JR; Chen, CM; Escabi, MA; Chrobak, JJ				Long, Lauren L.; Hinman, James R.; Chen, Chi-Ming; Escabi, Monty A.; Chrobak, James J.			Theta Dynamics in Rat: Speed and Acceleration across the Septotemporal Axis	PLOS ONE			English	Article							HIPPOCAMPAL-THETA; VESTIBULAR LESIONS; GAMMA OSCILLATIONS; RUNNING SPEED; SLOW WAVES; RHYTHM; EEG; FREQUENCY; BEHAVIOR; NEURONS	Theta (6-12 Hz) rhythmicity in the local field potential (LFP) reflects a clocking mechanism that brings physically isolated neurons together in time, allowing for the integration and segregation of distributed cell assemblies. Variation in the theta signal has been linked to locomotor speed, sensorimotor integration as well as cognitive processing. Previously, we have characterized the relationship between locomotor speed and theta power and how that relationship varies across the septotemporal (long) axis of the hippocampus (HPC). The current study investigated the relationship between whole body acceleration, deceleration and theta indices at CA1 and dentate gyrus (DG) sites along the septotemporal axis of the HPC in rats. Results indicate that whole body acceleration and deceleration predicts a significant amount of variability in the theta signal beyond variation in locomotor speed. Furthermore, deceleration was more predictive of variation in theta amplitude as compared to acceleration as rats traversed a linear track. Such findings highlight key variables that systematically predict the variability in the theta signal across the long axis of the HPC. A better understanding of the relative contribution of these quantifiable variables and their variation as a function of experience and environmental conditions should facilitate our understanding of the relationship between theta and sensorimotor/cognitive functions.	[Long, Lauren L.; Hinman, James R.; Chen, Chi-Ming; Escabi, Monty A.; Chrobak, James J.] Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA; [Escabi, Monty A.] Univ Connecticut, Storrs, CT USA	University of Connecticut; University of Connecticut	Chrobak, JJ (corresponding author), Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA.	james.chrobak@uconn.edu	Chen, Chi-Ming/G-1321-2010	Chen, Chi-Ming/0000-0003-4419-1593; Escabi, Monty/0000-0001-7271-1061; Hinman, James/0000-0001-7139-1916	National Science Foundation [0090451]	National Science Foundation(National Science Foundation (NSF))	The current work was supported by National Science Foundation 0090451 to J. J. Chrobak and M. A. Escabi (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton JP, 2012, NEUROSCI BIOBEHAV R, V36, P1579, DOI 10.1016/j.neubiorev.2011.09.005; Ahmed OJ, 2012, J NEUROSCI, V32, P7373, DOI 10.1523/JNEUROSCI.5110-11.2012; Arnolds DEAT, 1977, BRAIN RES, V85, P194; Asaka Y, 2005, P NATL ACAD SCI USA, V102, P13284, DOI 10.1073/pnas.0506515102; Baek JH, 2010, NEUROBIOL LEARN MEM, V94, P402, DOI 10.1016/j.nlm.2010.08.007; BERRY SD, 1978, BRAIN RES BULL, V3, P509, DOI 10.1016/0361-9230(78)90080-1; Bland BH, 2001, BEHAV BRAIN RES, V127, P119, DOI 10.1016/S0166-4328(01)00358-8; Bouwman BM, 2005, BRAIN RES BULL, V64, P505, DOI 10.1016/j.brainresbull.2004.10.006; BRAGIN A, 1995, J NEUROSCI, V15, P47; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; CHROBAK JJ, 1994, J NEUROSCI, V14, P6160; Cohen BH, 2008, EXPLAINING PSYCHOL S, P571; Cohen J, 2003, APPL MULTIPLE REGRES, P64; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; FEDER R, 1973, EXP NEUROL, V41, P532, DOI 10.1016/0014-4886(73)90291-4; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Gray C M, 1994, J Comput Neurosci, V1, P11, DOI 10.1007/BF00962716; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; Hasselmo ME, 2005, HIPPOCAMPUS, V15, P936, DOI 10.1002/hipo.20116; Hinman JR, 2013, J NEUROPHYSIOL, V109, P570, DOI 10.1152/jn.00561.2012; Hinman JR, 2011, J NEUROPHYSIOL, V105, P2675, DOI 10.1152/jn.00837.2010; Jeewajee A, 2008, HIPPOCAMPUS, V18, P340, DOI 10.1002/hipo.20394; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Jutras MJ, 2009, J NEUROSCI, V29, P12521, DOI 10.1523/JNEUROSCI.0640-09.2009; Kay LM, 2005, P NATL ACAD SCI USA, V102, P3863, DOI 10.1073/pnas.0407920102; Klemm W R, 1976, Prog Neurobiol, V6, P23, DOI 10.1016/0301-0082(76)90005-8; KVIRKVELIA L, 1987, ACTA PHYSIOL HUNG, V70, P127; Lavenex P, 2006, HIPPOCAMPUS BOOK; Law JR, 2005, J NEUROSCI, V25, P5720, DOI 10.1523/JNEUROSCI.4935-04.2005; Ledberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027575; LEE MG, 1994, NEUROSCIENCE, V62, P1033, DOI 10.1016/0306-4522(94)90341-7; Lisman J, 2005, HIPPOCAMPUS, V15, P913, DOI 10.1002/hipo.20121; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; LLINAS RR, 1991, P NATL ACAD SCI USA, V88, P897, DOI 10.1073/pnas.88.3.897; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; LORCH RF, 1990, J EXP PSYCHOL LEARN, V16, P149, DOI 10.1037/0278-7393.16.1.149; Marrelec G, 2007, MAGN RESON IMAGING, V25, P1181, DOI 10.1016/j.mri.2007.02.012; Marrelec G, 2006, NEUROIMAGE, V32, P228, DOI 10.1016/j.neuroimage.2005.12.057; Maurer AP, 2005, HIPPOCAMPUS, V15, P841, DOI 10.1002/hipo.20114; MCFARLAND WL, 1975, J COMP PHYSIOL PSYCH, V88, P324, DOI 10.1037/h0076177; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Molter C, 2012, NEURON, V75, P889, DOI 10.1016/j.neuron.2012.06.036; Montgomery SM, 2009, J NEUROSCI, V29, P1381, DOI 10.1523/JNEUROSCI.4339-08.2009; Nyhus E, 2010, NEUROSCI BIOBEHAV R, V34, P1023, DOI 10.1016/j.neubiorev.2009.12.014; PAIVA T, 1976, ELECTROEN CLIN NEURO, V40, P470, DOI 10.1016/0013-4694(76)90077-8; Penley SC, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00020; Penley SC, 2012, HIPPOCAMPUS, V22, P1164, DOI 10.1002/hipo.20962; Rivas J, 1996, EXP BRAIN RES, V108, P113; Rizzuto DS, 2006, NEUROIMAGE, V31, P1352, DOI 10.1016/j.neuroimage.2006.01.009; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; Russell NA, 2003, J NEUROSCI, V23, P6490; Sabolek HR, 2009, J NEUROPHYSIOL, V101, P1192, DOI 10.1152/jn.90846.2008; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Schmidt B, 2013, J NEUROSCI, V33, P6212, DOI 10.1523/JNEUROSCI.2915-12.2013; Schmidt B, 2012, HIPPOCAMPUS, V22, P2114, DOI 10.1002/hipo.22031; Sederberg PB, 2003, J NEUROSCI, V23, P10809; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Sinnamon HM, 2006, NEUROSCIENCE, V140, P779, DOI 10.1016/j.neuroscience.2006.02.058; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Smith PF, 2005, PROG NEUROBIOL, V75, P391, DOI 10.1016/j.pneurobio.2005.04.004; SWANSON LW, 1978, J COMP NEUROL, V181, P681, DOI 10.1002/cne.901810402; TEITELBAUM H, 1971, PHYSIOL BEHAV, V7, P545, DOI 10.1016/0031-9384(71)90107-7; Ulanovsky N, 2007, NAT NEUROSCI, V10, P224, DOI 10.1038/nn1829; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; VANDERWOLF CH, 1971, PSYCHOL REV, V78, P83, DOI 10.1037/h0030672; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Wang L, 2010, NEUROIMAGE, V51, P910, DOI 10.1016/j.neuroimage.2010.02.046; Wells CE, 2013, J NEUROSCI, V33, P8650, DOI 10.1523/JNEUROSCI.5040-12.2013; WHISHAW IQ, 1973, BEHAV BIOL, V8, P461, DOI 10.1016/S0091-6773(73)80041-0; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646; Wyble BP, 2004, HIPPOCAMPUS, V14, P662, DOI 10.1002/hipo.20012; Young CK, 2009, CEREB CORTEX, V19, P24, DOI 10.1093/cercor/bhn055	78	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97987	10.1371/journal.pone.0097987	http://dx.doi.org/10.1371/journal.pone.0097987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842406	Green Published, Green Submitted, gold			2022-12-25	WOS:000340948600098
J	Appolloni, I; Barilari, M; Caviglia, S; Gambini, E; Reisoli, E; Malatesta, P				Appolloni, I.; Barilari, M.; Caviglia, S.; Gambini, E.; Reisoli, E.; Malatesta, P.			A cadherin switch underlies malignancy in high-grade gliomas	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PDGF-INDUCED OLIGODENDROGLIOMA; GROWTH-FACTOR RECEPTOR; CELL-CELL-ADHESION; CONTACT INHIBITION; R-CADHERIN; TUMOR PROGRESSION; NEURAL PROGENITORS; BREAST-CANCER; B-CHAIN	Although the infiltrative behavior of malignant gliomas is one of their most critical aspects, the mechanisms underlying it have not yet been elucidated. To migrate in the brain parenchyma, malignant glioma cells need to bypass the cell-cell contact inhibitory signals. Here we propose that the blinding of cell-cell contact sensing in gliomas is caused by an unusual mechanism of cadherin switch, involving the replacement of N-cadherin with R-cadherin (Rcad) at the cell-cell junctions and the activation of ERK and p27. In our model of malignant glioma, we found that Rcad expression is necessary and sufficient to release cells from contact inhibition of proliferation, and is necessary, although not sufficient, for overriding contact inhibition of migration and for tumorigenicity. Altogether, these observations suggest that Rcad is a potential target for malignant glioma therapies.	[Appolloni, I.; Barilari, M.; Reisoli, E.; Malatesta, P.] IRCCS AOU San Martino IST, UO Trasferimento Genico, I-16132 Genoa, Italy; [Caviglia, S.; Gambini, E.; Malatesta, P.] Univ Genoa, Dept Expt Med DiMES, Genoa, Italy	University of Genoa; IRCCS AOU San Martino IST; University of Genoa	Malatesta, P (corresponding author), IRCCS AOU San Martino IST, UO Trasferimento Genico, Largo Rosanna Benzi 10, I-16132 Genoa, Italy.	paolo.malatesta@unige.it	Malatesta, Paolo/J-3570-2012; Appolloni, Irene/AAC-1629-2019	Malatesta, Paolo/0000-0003-3045-3361; Caviglia, Sara/0000-0001-9832-2566	NUSUG grant from AIRC; Ministero della Salute [GR-2008-1135643]; Fondazione S. Paolo (Molecular and cellular basis of glioma); Fondazione CARIGE; FIRC fellowship [9887]	NUSUG grant from AIRC(Fondazione AIRC per la ricerca sul cancro); Ministero della Salute(Ministry of Health, Italy); Fondazione S. Paolo (Molecular and cellular basis of glioma); Fondazione CARIGE(Fondazione Carige); FIRC fellowship(Fondazione AIRC per la ricerca sul cancro)	We thank Dr Magdalena Gotz (Institute of Stem Cell Research-Helmholtz Centre Munich, Germany) for providing access to the time lapse equipment and Dr Masatoshi Takeichi (RIKEN Center for developmental biology, Kobe, Japan) for sharing plasmids. We acknowledge Dr Paola Briata, Dr Filippo Calzolari, Dr Federico Cremisi and Dr Roberto Gherzi for helpful comments on the manuscript. This work was supported by a NUSUG grant from AIRC, by the GR-2008-1135643 grant from Ministero della Salute, by Fondazione S. Paolo (Molecular and cellular basis of glioma) and by Fondazione CARIGE. ER salary was funded by the FIRC fellowship 9887.	Agiostratidou G, 2009, CANCER RES, V69, P5030, DOI 10.1158/0008-5472.CAN-08-4007; Appolloni I, 2012, INT J MOL SCI, V13, P14667, DOI 10.3390/ijms131114667; Appolloni I, 2012, INT J CANCER, V131, pE1078, DOI 10.1002/ijc.27606; Appolloni I, 2009, INT J CANCER, V124, P2251, DOI 10.1002/ijc.24206; Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Baum B, 2008, SEMIN CELL DEV BIOL, V19, P294, DOI 10.1016/j.semcdb.2008.02.001; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Calzolari F, 2008, NEOPLASIA, V10, P1373, DOI 10.1593/neo.08814; Charrasse S, 2002, J CELL BIOL, V158, P953, DOI 10.1083/jcb.200202034; Chin YR, 2009, CELL SIGNAL, V21, P470, DOI 10.1016/j.cellsig.2008.11.015; Cooper LAD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012548; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; De Donatis A, 2008, J BIOL CHEM, V283, P19948, DOI 10.1074/jbc.M709428200; Du CP, 2011, CANCER LETT, V309, P54, DOI 10.1016/j.canlet.2011.05.016; Gambini E, 2012, MOL THER, V20, P994, DOI 10.1038/mt.2012.22; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; HERMANSSON M, 1988, P NATL ACAD SCI USA, V85, P7748, DOI 10.1073/pnas.85.20.7748; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; Hsu YM, 2007, CANCER RES, V67, P11064, DOI 10.1158/0008-5472.CAN-07-2443; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; INUZUKA H, 1991, NEURON, V7, P69, DOI 10.1016/0896-6273(91)90075-B; Johnson E, 2004, J BIOL CHEM, V279, P31041, DOI 10.1074/jbc.M400024200; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Kucharczak J, 2008, CANCER RES, V68, P6559, DOI 10.1158/0008-5472.CAN-08-0196; KUPFER A, 1982, P NATL ACAD SCI-BIOL, V79, P2603, DOI 10.1073/pnas.79.8.2603; Le Bras GF, 2012, CELL ADHES MIGR, V6, P365, DOI 10.4161/cam.21326; Lei L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020041; Levenberg S, 1999, ONCOGENE, V18, P869, DOI 10.1038/sj.onc.1202396; Lien WH, 2006, CURR OPIN CELL BIOL, V18, P499, DOI 10.1016/j.ceb.2006.07.001; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Maeda M, 2006, ONCOGENE, V25, P4595, DOI 10.1038/sj.onc.1209396; Mayor R, 2013, DEVELOPMENT, V140, P2247, DOI 10.1242/dev.091751; Mayor R, 2010, TRENDS CELL BIOL, V20, P319, DOI 10.1016/j.tcb.2010.03.005; McClatchey AI, 2012, CURR OPIN CELL BIOL, V24, P685, DOI 10.1016/j.ceb.2012.06.009; McKinnon RD, 2005, J NEUROSCI, V25, P3499, DOI 10.1523/JNEUROSCI.5049-04.2005; Miotto E, 2004, CANCER RES, V64, P8156, DOI 10.1158/0008-5472.CAN-04-3000; Motti ML, 2005, CARCINOGENESIS, V26, P1021, DOI 10.1093/carcin/bgi050; Nabi IR, 1999, J CELL SCI, V112, P1803; Puliafito A, 2012, P NATL ACAD SCI USA, V109, P739, DOI 10.1073/pnas.1007809109; Redies C, 2000, PROG NEUROBIOL, V61, P611, DOI 10.1016/S0301-0082(99)00070-2; Sheehan KM, 2008, ONCOGENE, V27, P323, DOI 10.1038/sj.onc.1210647; Siletz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057180; Smith CL, 2010, CELL ADHES MIGR, V4, P561, DOI 10.4161/cam.4.4.12829; St Croix B, 1998, J CELL BIOL, V142, P557, DOI 10.1083/jcb.142.2.557; Szerlip NJ, 2012, P NATL ACAD SCI USA, V109, P3041, DOI 10.1073/pnas.1114033109; Terrile M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-550; Theisen U, 2012, DEV CELL, V23, P1153, DOI 10.1016/j.devcel.2012.11.005; Theveneau E, 2012, CURR OPIN CELL BIOL, V24, P677, DOI 10.1016/j.ceb.2012.08.002; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Uhrbom L, 1998, CANCER RES, V58, P5275; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Yoeli-Lerner M, 2006, CELL CYCLE, V5, P603, DOI 10.4161/cc.5.6.2561; Zou L, 2009, CELL MOTIL CYTOSKEL, V66, P1048, DOI 10.1002/cm.20407	59	23	24	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 9	2015	34	15					1991	2002		10.1038/onc.2014.122	http://dx.doi.org/10.1038/onc.2014.122			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CF7GY	24858041				2022-12-25	WOS:000352725600013
J	Ananieva, EA; Patel, CH; Drake, CH; Powell, JD; Hutson, SM				Ananieva, Elitsa A.; Patel, Chirag H.; Drake, Charles H.; Powell, Jonathan D.; Hutson, Susan M.			Cytosolic Branched Chain Aminotransferase (BCATc) Regulates mTORC1 Signaling and Glycolytic Metabolism in CD4(+) T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID CATABOLISM; NEUROTRANSMITTER METABOLISM; ARGININE METABOLISM; LEUCINE METABOLISM; PROTEIN-SYNTHESIS; IMMUNE-RESPONSES; EXPRESSION; ACTIVATION; PATHWAY; TRANSAMINATION	Here we show that expression of the cytosolic branched chain aminotransferase (BCATc) is triggered by the T cell receptor (TCR) of CD4(+) T cells. Induction of BCATc correlates with increased Leu transamination, whereas T cells from the BCATc(-/-) mouse exhibit lower Leu transamination and higher intracellular Leu concentrations than the cells from wild type (WT) mice. Induction of BCATc by TCR in WT cells is prevented by the calcineurin-nuclear factor of activated T cells (NFAT) inhibitor, cyclosporin A (CsA), suggesting that NFAT controls BCATc expression. Leu is a known activator of the mammalian target of rapamycin complex 1 (mTORC1). mTOR is emerging as a critical regulator of T cell activation, differentiation, and metabolism. Activated T cells from BCATc(-/-) mice show increased phosphorylation of mTORC1 downstream targets, S6 and 4EBP-1, indicating higher mTORC1 activation than in T cells from WT mice. Furthermore, T cells from BCATc(-/-) mice display higher rates of glycolysis, glycolytic capacity, and glycolytic reserve when compared with activated WT cells. These findings reveal BCATc as a novel regulator of T cell activation and metabolism and highlight the important role of Leu metabolism in T cells.	[Ananieva, Elitsa A.; Hutson, Susan M.] Virginia Tech, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA; [Patel, Chirag H.; Drake, Charles H.; Powell, Jonathan D.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA	Virginia Polytechnic Institute & State University; Johns Hopkins University	Ananieva, EA (corresponding author), Virginia Tech, Dept Human Nutr Foods & Exercise, ILSB Bldg,1981 Kraft Dr, Blacksburg, VA 24061 USA.	eanani75@vt.edu			National Institutes of Health Grants [DK34738, R01CA098109]; Virginia Tech; NATIONAL CANCER INSTITUTE [R01CA098109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034738, R56DK034738] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Tech; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK34738 (to S. M. H.) and R01CA098109 (to J. D. P.) and a grant from Virginia Tech (to S. M. H.).	Abraham RT, 1996, ANNU REV IMMUNOL, V14, P483, DOI 10.1146/annurev.immunol.14.1.483; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Broos S, 2011, NUCLEIC ACIDS RES, V39, pW74, DOI 10.1093/nar/gkr355; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Cobbold SP, 2009, P NATL ACAD SCI USA, V106, P12055, DOI 10.1073/pnas.0903919106; Cole JT, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00018; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Frauwirth KA, 2004, J IMMUNOL, V172, P4661, DOI 10.4049/jimmunol.172.8.4661; GARBER AJ, 1976, J BIOL CHEM, V251, P826; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; GOTO M, 1977, GANN, V68, P663; HALL TR, 1993, J BIOL CHEM, V268, P3092; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; HARRIS RA, 1995, ADV ENZYME REGUL, V35, P147, DOI 10.1016/0065-2571(94)00020-4; Harris RA, 2005, J NUTR, V135, p1527S, DOI 10.1093/jn/135.6.1527S; HARRIS RA, 1990, ADV ENZYME REGUL, V30, P245; Hidayat S, 2003, BIOCHEM BIOPH RES CO, V301, P417, DOI 10.1016/S0006-291X(02)03052-8; Huang CT, 2003, J IMMUNOL, V170, P3945, DOI 10.4049/jimmunol.170.8.3945; HUTSON SM, 1988, J BIOL CHEM, V263, P3618; Hutson SM, 2005, J NUTR, V135, p1557S, DOI 10.1093/jn/135.6.1557S; Hutson SM, 1998, J NEUROCHEM, V71, P863; ICHIHARA A, 1966, J BIOCHEM-TOKYO, V59, P160, DOI 10.1093/oxfordjournals.jbchem.a128277; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Kaesler S, 2012, EUR J IMMUNOL, V42, P831, DOI 10.1002/eji.201141690; Kimball SR, 2006, J NUTR, V136, p227S, DOI 10.1093/jn/136.1.227S; Laplante M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011593; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Li P, 2007, BRIT J NUTR, V98, P237, DOI 10.1017/S000711450769936X; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Lynch CJ, 2000, J CELL BIOCHEM, V77, P234, DOI 10.1002/(SICI)1097-4644(20000501)77:2<234::AID-JCB7>3.0.CO;2-I; Lynch CJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE854, DOI 10.1152/ajpendo.00153.2003; Lynch CJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE824, DOI 10.1152/ajpendo.00085.2002; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Michalek RD, 2010, IMMUNOL REV, V236, P190, DOI 10.1111/j.1600-065X.2010.00911.x; Mittal D, 2013, J INVEST DERMATOL, V133, P2686, DOI 10.1038/jid.2013.222; Newsholme P, 2001, J NUTR, V131, p2515S, DOI 10.1093/jn/131.9.2515S; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Pearce EL, 2010, CURR OPIN IMMUNOL, V22, P314, DOI 10.1016/j.coi.2010.01.018; Peranzoni E, 2007, IMMUNOBIOLOGY, V212, P795, DOI 10.1016/j.imbio.2007.09.008; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Powell JD, 2013, COLD SH Q B, V78, P125, DOI 10.1101/sqb.2013.78.020214; Powell JD, 2013, NAT IMMUNOL, V14, P422, DOI 10.1038/ni.2594; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rodriguez PC, 2004, CANCER RES, V64, P5839, DOI 10.1158/0008-5472.CAN-04-0465; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Sweatt AJ, 2004, J COMP NEUROL, V477, P360, DOI 10.1002/cne.20200; Sweatt AJ, 2004, AM J PHYSIOL-ENDOC M, V286, pE64, DOI 10.1152/ajpendo.00276.2003; Tonjes M, 2013, NAT MED, V19, P901, DOI 10.1038/nm.3217; Waickman AT, 2012, IMMUNOL REV, V249, P43, DOI 10.1111/j.1600-065X.2012.01152.x; WALLIN R, 1990, J BIOL CHEM, V265, P6019; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; WU GY, 1994, J NUTR, V124, P415, DOI 10.1093/jn/124.3.415; Yudkoff M, 1996, J NEUROCHEM, V66, P378; Zha XJ, 2011, CELL CYCLE, V10, P1015, DOI 10.4161/cc.10.7.15063; Zheng Y, 2009, J IMMUNOL, V183, P6095, DOI 10.4049/jimmunol.0803510; Zhou W, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-53; Zhou YS, 2010, J BIOL CHEM, V285, P33718, DOI 10.1074/jbc.M110.136846	67	53	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18793	18804		10.1074/jbc.M114.554113	http://dx.doi.org/10.1074/jbc.M114.554113			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24847056	Green Published, hybrid			2022-12-25	WOS:000339062900015
J	Coultrap, SJ; Bayer, KU				Coultrap, Steven J.; Bayer, K. Ulrich			Nitric Oxide Induces Ca2+-independent Activity of the Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHASE PHOSPHORYLATION; ALPHA-CAMKII; AUTOPHOSPHORYLATION; CALMODULIN; ACTIVATION; MECHANISM; INFORMATION; MODULATION; PLASTICITY; AUTONOMY	Both signaling by nitric oxide (NO) and by the Ca2+/calmodulin (CaM)-dependent protein kinase II alpha isoform (CaMKII alpha) are implicated in two opposing forms of synaptic plasticity underlying learning and memory, as well as in excitotoxic/ischemic neuronal cell death. For CaMKII alpha, these functions specifically involve also Ca2+-independent autonomous activity, traditionally generated by Thr-286 autophosphorylation. Here, we demonstrate that NO-induced S-nitrosylation of CaMKII alpha also directly generated autonomous activity, and that CaMKII inhibition protected from NO-induced neuronal cell death. NO induced S-nitrosylation at Cys-280/289, and mutation of either site abolished autonomy, indicating that simultaneous nitrosylation at both sites was required. Additionally, autonomy was generated only when Ca2+/CaM was present during NO exposure. Thus, generation of this form of CaMKII alpha autonomy requires simultaneous signaling by NO and Ca2+. Nitrosylation also significantly reduced subsequent CaMKII alpha autophosphorylation specifically at Thr-286, but not at Thr-305. A previously described reduction of CaMKII activity by S-nitrosylation at Cys-6 was also observed here, but only after prolonged (>5 min) exposure to NO donors. These results demonstrate a novel regulation of CaMKII by another second messenger system and indicate its involvement in excitotoxic neuronal cell death.	[Coultrap, Steven J.; Bayer, K. Ulrich] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Coultrap, SJ (corresponding author), Univ Colorado, Sch Med, Dept Pharmacol, Anschutz Med Campus,Mail Stop 8303,RC1 North, Aurora, CO 80045 USA.	steve.coultrap@ucdenver.edu; ulli.bayer@ucdenver.edu			National Institutes of Health [NS081248, NS080851]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS048154, R01NS080851, R01NS081248] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported, in whole or in part, by National Institutes of Health Grants NS081248 and NS080851 (to K. U. B.). The University of Colorado is currently seeking patent protection for a CaMKII inhibitor used in this study.	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Aarts MM, 2004, CURR MOL MED, V4, P137, DOI 10.2174/1566524043479202; Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Borgesius NZ, 2011, J NEUROSCI, V31, P10141, DOI 10.1523/JNEUROSCI.5105-10.2011; Buard I, 2010, J NEUROSCI, V30, P8214, DOI 10.1523/JNEUROSCI.1469-10.2010; Chao LH, 2011, CELL, V146, P732, DOI 10.1016/j.cell.2011.07.038; COLBRAN RJ, 1993, J BIOL CHEM, V268, P7163; Coultrap S.J., 2012, NEUROMETHODS PROTEIN, P49; Coultrap SJ, 2014, CELL REP, V6, P431, DOI 10.1016/j.celrep.2014.01.005; Coultrap SJ, 2012, TRENDS NEUROSCI, V35, P607, DOI 10.1016/j.tins.2012.05.003; Coultrap SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037176; Coultrap SJ, 2011, ACTA PHARMACOL SIN, V32, P861, DOI 10.1038/aps.2011.68; Coultrap SJ, 2010, J BIOL CHEM, V285, P17930, DOI 10.1074/jbc.M109.069351; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Erickson JR, 2013, NATURE, V502, P372, DOI 10.1038/nature12537; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Fujii H, 2013, CELL REP, V3, P978, DOI 10.1016/j.celrep.2013.03.033; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Gutierrez DA, 2013, CARDIOVASC RES, V100, P392, DOI 10.1093/cvr/cvt201; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HANSON PI, 1992, J BIOL CHEM, V267, P17216; HASHIMOTO Y, 1987, J BIOL CHEM, V262, P8051; Hayashi Y, 1999, J BIOL CHEM, V274, P20597, DOI 10.1074/jbc.274.29.20597; Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742; Hojjati MR, 2007, NAT NEUROSCI, V10, P1125, DOI 10.1038/nn1946; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jones RJ, 2007, AM J PHYSIOL-HEART C, V292, pH2634, DOI 10.1152/ajpheart.01247.2006; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; LOU LL, 1986, P NATL ACAD SCI USA, V83, P9497, DOI 10.1073/pnas.83.24.9497; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Rameau GA, 2004, J BIOL CHEM, V279, P14307, DOI 10.1074/jbc.M311103200; Rameau GA, 2007, J NEUROSCI, V27, P3445, DOI 10.1523/JNEUROSCI.4799-06.2007; Robison AJ, 2005, J BIOL CHEM, V280, P39316, DOI 10.1074/jbc.M508189200; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; SCHWORER CM, 1986, J BIOL CHEM, V261, P8581; Sen N, 2010, TRENDS NEUROSCI, V33, P493, DOI 10.1016/j.tins.2010.07.004; Song T, 2008, BIOCHEM J, V412, P223, DOI 10.1042/BJ20071195; Stanton PK, 2003, J NEUROSCI, V23, P5936; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Takao K, 2005, J NEUROSCI, V25, P3107, DOI 10.1523/JNEUROSCI.0085-05.2005; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Vest RS, 2010, J BIOL CHEM, V285, P20675, DOI 10.1074/jbc.M109.088617; Watanabe Y, 2003, BIOCHEM J, V372, P465, DOI 10.1042/BJ20030380; Zhang DM, 2014, J PHYSIOL-LONDON, V592, P971, DOI 10.1113/jphysiol.2013.264697	45	54	58	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19458	19465		10.1074/jbc.M114.558254	http://dx.doi.org/10.1074/jbc.M114.558254			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24855644	Green Published, hybrid			2022-12-25	WOS:000339326800021
J	Kiontke, S; Gnau, P; Haselsberger, R; Batschauer, A; Essen, LO				Kiontke, Stephan; Gnau, Petra; Haselsberger, Reinhard; Batschauer, Alfred; Essen, Lars-Oliver			Structural and Evolutionary Aspects of Antenna Chromophore Usage by Class II Photolyases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE-LIGHT PHOTORECEPTORS; DNA PHOTOLYASE; ANACYSTIS-NIDULANS; CRYSTAL-STRUCTURE; PHOTOLYASE/CRYPTOCHROME FAMILY; THERMUS-THERMOPHILUS; 2ND CHROMOPHORE; CRYPTOCHROMES; IDENTIFICATION; REPAIR	Light-harvesting and resonance energy transfer to the catalytic FAD cofactor are key roles for the antenna chromophores of light-driven DNA photolyases, which remove UV-induced DNA lesions. So far, five chemically diverse chromophores have been described for several photolyases and related cryptochromes, but no correlation between phylogeny and used antenna has been found. Despite a common protein topology, structural analysis of the distantly related class II photolyase from the archaeon Methanosarcina mazei (MmCPDII) as well as plantal orthologues indicated several differences in terms of DNA and FAD binding and electron transfer pathways. For MmCPDII we identify 8-hydroxydeazaflavin (8-HDF) as cognate antenna by in vitro and in vivo reconstitution, whereas the higher plant class II photolyase from Arabidopsis thaliana fails to bind any of the known chromophores. According to the 1.9 structure of theMmCPDII.8-HDF complex, its antenna binding site differs from other members of the photolyase-cryptochrome superfamily by an antenna loop that changes its conformation by 12 angstrom upon 8-HDF binding. Additionally, so-called N-and C-motifs contribute as conserved elements to the binding of deprotonated 8-HDF and allow predicting 8-HDF binding for most of the class II photolyases in the whole phylome. The 8-HDF antenna is used throughout the viridiplantae ranging from green microalgae to bryophyta and pteridophyta, i.e. mosses and ferns, but interestingly not in higher plants. Overall, we suggest that 8-hydroxydeazaflavin is a crucial factor for the survival of most higher eukaryotes which depend on class II photolyases to struggle with the genotoxic effects of solar UV exposure.	[Kiontke, Stephan; Gnau, Petra; Essen, Lars-Oliver] Univ Marburg, Biomed Res Ctr FB15, Unit Struct Biochem, D-35032 Marburg, Germany; [Haselsberger, Reinhard] Nanyang Technol Univ, Sch Phys & Math Sci, Div Phys & Appl Phys, Singapore 637371, Singapore; [Batschauer, Alfred] Univ Marburg, Fac Biol, Dept Plant Physiol & Photobiol, D-35032 Marburg, Germany	Philipps University Marburg; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Philipps University Marburg	Essen, LO (corresponding author), Univ Marburg, Biomed Res Ctr FB15, Hans Meerwein Str, D-35032 Marburg, Germany.	essen@chemie.uni-marburg.de	Essen, Lars-Oliver/L-3862-2016	Essen, Lars-Oliver/0000-0003-4272-4026	LOEWE (Landesoffensive zur Entwicklung Wissenschaftlich-Okonomischer Exzellenz) Center for Synthetic Microbiology (Marburg); Deutsche Forschungsgemeinschaft [BA985/12-1]	LOEWE (Landesoffensive zur Entwicklung Wissenschaftlich-Okonomischer Exzellenz) Center for Synthetic Microbiology (Marburg); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the LOEWE (Landesoffensive zur Entwicklung Wissenschaftlich-Okonomischer Exzellenz) Center for Synthetic Microbiology (Marburg) and Deutsche Forschungsgemeinschaft Grant BA985/12-1.	Chakrabarti P, 2007, PROG BIOPHYS MOL BIO, V95, P83, DOI 10.1016/j.pbiomolbio.2007.03.016; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; EKER APM, 1990, J BIOL CHEM, V265, P8009; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Essen LO, 2006, CURR OPIN STRUC BIOL, V16, P51, DOI 10.1016/j.sbi.2006.01.004; Fujihashi M, 2007, J MOL BIOL, V365, P903, DOI 10.1016/j.jmb.2006.10.012; Geisselbrecht Y, 2012, EMBO REP, V13, P223, DOI 10.1038/embor.2012.2; Glas AF, 2009, P NATL ACAD SCI USA, V106, P11540, DOI 10.1073/pnas.0812665106; Graham DE, 2003, ARCH MICROBIOL, V180, P455, DOI 10.1007/s00203-003-0614-8; Hitomi K, 2012, J BIOL CHEM, V287, P12060, DOI 10.1074/jbc.M111.244020; Isabelle D, 2002, APPL ENVIRON MICROB, V68, P5750, DOI 10.1128/AEM.68.11.5750-5755.2002; JOHNSON JL, 1988, P NATL ACAD SCI USA, V85, P2046, DOI 10.1073/pnas.85.7.2046; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kiontke S, 2011, EMBO J, V30, P4437, DOI 10.1038/emboj.2011.313; Klar T, 2007, J MOL BIOL, V366, P954, DOI 10.1016/j.jmb.2006.11.066; Klar T, 2006, CHEMBIOCHEM, V7, P1798, DOI 10.1002/cbic.200600206; Kort R, 2004, ACTA CRYSTALLOGR D, V60, P1205, DOI 10.1107/S0907444904009321; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Liu ZY, 2011, P NATL ACAD SCI USA, V108, P14831, DOI 10.1073/pnas.1110927108; Lucas-Lledo JI, 2009, MOL BIOL EVOL, V26, P1143, DOI 10.1093/molbev/msp029; MALHOTRA K, 1992, J BIOL CHEM, V267, P15406; Maul MJ, 2008, ANGEW CHEM INT EDIT, V47, P10076, DOI 10.1002/anie.200804268; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mees A, 2004, SCIENCE, V306, P1789, DOI 10.1126/science.1101598; Muller M, 2009, CURR OPIN STRUC BIOL, V19, P277, DOI 10.1016/j.sbi.2009.05.003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okafuji A, 2010, DNA REPAIR, V9, P495, DOI 10.1016/j.dnarep.2010.01.014; Petersen JL, 2001, NUCLEIC ACIDS RES, V29, P4472, DOI 10.1093/nar/29.21.4472; Rausher MD., 2006, SCI FLAVONOIDS, P175, DOI [10.1007/978-0-387-28822-2_7, DOI 10.1007/978-0-387-28822-2_7]; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Selby CP, 2012, BIOCHEMISTRY-US, V51, P167, DOI 10.1021/bi201536w; Thiagarajan V, 2011, P NATL ACAD SCI USA, V108, P9402, DOI 10.1073/pnas.1101026108; Ueda T, 2005, J BIOL CHEM, V280, P36237, DOI 10.1074/jbc.M507972200; WALSH C, 1986, ACCOUNTS CHEM RES, V19, P216, DOI 10.1021/ar00127a004	35	31	32	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19659	19669		10.1074/jbc.M113.542431	http://dx.doi.org/10.1074/jbc.M113.542431			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24849603	hybrid, Green Published			2022-12-25	WOS:000339326800038
J	Jokela, TA; Karna, R; Makkonen, KM; Laitinen, JT; Tammi, RH; Tammi, MI				Jokela, Tiina A.; Karna, Riikka; Makkonen, Katri M.; Laitinen, Jarmo T.; Tammi, Raija H.; Tammi, Markku I.			Extracellular UDP-Glucose Activates P2Y(14) Receptor and Induces Signal Transducer and Activator of Transcription 3 (STAT3) Tyr(705) Phosphorylation and Binding to Hyaluronan Synthase 2 (HAS2) Promoter, Stimulating Hyaluronan Synthesis of Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURINERGIC RECEPTORS; RETINOIC ACID; SERINE PHOSPHORYLATION; DIFFERENTIATION; ACCUMULATION; EPIDERMIS; CULTURES; RELEASE; CELLS; PROLIFERATION	Hyaluronan, a major matrix molecule in epidermis, is often increased by stimuli that enhance keratinocyte proliferation and migration. We found that small amounts of UDP-sugars were released from keratinocytes and that UDP-glucose (UDP-Glc) added into keratinocyte cultures induced a specific, rapid induction of hyaluronan synthase 2 (HAS2), and an increase of hyaluronan synthesis. The up-regulation of HAS2 was associated with JAK2 and ERK1/2 activation, and specific Tyr(705) phosphorylation of transcription factor STAT3. Inhibition of JAK2, STAT3, or G(i)-coupled receptors blocked the induction of HAS2 expression by UDP-Glc, the latter inhibitor suggesting that the signaling was triggered by the UDP-sugar receptor P2Y(14). Chromatin immunoprecipitations demonstrated increased promoter binding of Tyr(P)(705)-STAT3 at the time of HAS2 induction. Interestingly, at the same time Ser(P)(727)-STAT3 binding to its response element regions in the HAS2 promoter was unchanged or decreased. UDP-Glc also stimulated keratinocyte migration, proliferation, and IL-8 expression, supporting a notion that UDP-Glc signals for epidermal inflammation, enhanced hyaluronan synthesis as an integral part of it.	[Jokela, Tiina A.; Karna, Riikka; Makkonen, Katri M.; Laitinen, Jarmo T.; Tammi, Raija H.; Tammi, Markku I.] Univ Eastern Finland, Sch Med, Inst Biomed, FIN-70210 Kuopio, Finland; [Makkonen, Katri M.] Univ Eastern Finland, Sch Med, Inst Dent, FIN-70210 Kuopio, Finland	University of Eastern Finland; University of Eastern Finland	Jokela, TA (corresponding author), Univ Eastern Finland, Sch Med, Inst Biomed, POB 1627, FIN-70210 Kuopio, Finland.	tiina.jokela@gmail.com	Tammi, Markku/AAQ-7878-2021; Jokela, Tiina/O-9206-2015	Jokela, Tiina/0000-0002-7521-3866; Laitinen, Jarmo T/0000-0002-9490-3686	Academy of Finland; The Sigrid Juselius Foundation; EVO Funds of the Kuopio University Hospital; The Mizutani Foundation; Cancer Center of the University of Eastern Finland; Glycoscience Graduate School; Paavo Koistinen Foundation; Kuopio University foundation	Academy of Finland(Academy of Finland); The Sigrid Juselius Foundation(Sigrid Juselius Foundation); EVO Funds of the Kuopio University Hospital; The Mizutani Foundation; Cancer Center of the University of Eastern Finland; Glycoscience Graduate School; Paavo Koistinen Foundation; Kuopio University foundation	This work was supported by grants from the Academy of Finland (to M. I. T.), The Sigrid Juselius Foundation (to M. I. T. and R. H. T.), the EVO Funds of the Kuopio University Hospital (to M. I. T.), The Mizutani Foundation (to M. I. T.), the Cancer Center of the University of Eastern Finland (to M. I. T. and R. H. T.), Glycoscience Graduate School (to T. A. J. and M. I. T.), Paavo Koistinen Foundation (to T. A. J.), and Kuopio University foundation (to T. A. J.).	Abbracchio MP, 2003, TRENDS PHARMACOL SCI, V24, P52, DOI 10.1016/S0165-6147(02)00038-X; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bromberg J, 2001, METHOD ENZYMOL, V333, P138; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Burrell HE, 2003, J INVEST DERMATOL, V120, P440, DOI 10.1046/j.1523-1747.2003.12050.x; Ceresa BP, 1997, ENDOCRINOLOGY, V138, P4131, DOI 10.1210/en.138.10.4131; Chambers JK, 2000, J BIOL CHEM, V275, P10767, DOI 10.1074/jbc.275.15.10767; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; Fricks IP, 2009, J PHARMACOL EXP THER, V330, P162, DOI 10.1124/jpet.109.150730; Gao ZG, 2010, BIOCHEM PHARMACOL, V79, P873, DOI 10.1016/j.bcp.2009.10.024; Greig AVH, 2003, J INVEST DERMATOL, V121, P1145, DOI 10.1046/j.1523-1747.2003.12567.x; Hall CL, 1995, J NEURO-ONCOL, V26, P221, DOI 10.1007/BF01052625; Harden TK, 2010, ACTA PHYSIOL, V199, P149, DOI 10.1111/j.1748-1716.2010.02116.x; Hubbard C, 2012, J MOL BIOL, V418, P21, DOI 10.1016/j.jmb.2012.01.053; Ipata PL, 2011, INT J BIOCHEM CELL B, V43, P140, DOI 10.1016/j.biocel.2010.10.007; Jokela TA, 2008, CONNECT TISSUE RES, V49, P115, DOI 10.1080/03008200802148439; Jokela TA, 2008, J BIOL CHEM, V283, P7666, DOI 10.1074/jbc.M706001200; Jokela TA, 2011, J BIOL CHEM, V286, P33632, DOI 10.1074/jbc.M111.265637; Karvinen S, 2003, J BIOL CHEM, V278, P49495, DOI 10.1074/jbc.M310445200; KOPF GS, 1991, METHOD ENZYMOL, V195, P257; Kreda SM, 2008, BRIT J PHARMACOL, V153, P1528, DOI 10.1038/sj.bjp.0707692; Lee BC, 2003, GENE DEV, V17, P1592, DOI 10.1101/gad.1071503; Lee HK, 2009, KOREAN J PHYSIOL PHA, V13, P161, DOI 10.4196/kjpp.2009.13.3.161; Maytin EV, 2004, AM J PATHOL, V165, P1331, DOI 10.1016/S0002-9440(10)63391-3; Monslow J, 2009, J INVEST DERMATOL, V129, P2046, DOI 10.1038/jid.2009.9; Moore DJ, 2003, MOL BRAIN RES, V118, P10, DOI 10.1016/S0169-328X(03)00330-9; Muller T, 2005, AM J RESP CELL MOL, V33, P601, DOI 10.1165/rcmb.2005-0181OC; Pasonen-Seppanen S, 2003, J INVEST DERMATOL, V120, P1038, DOI 10.1046/j.1523-1747.2003.12249.x; Pasonen-Seppanen SM, 2008, J INVEST DERMATOL, V128, P797, DOI 10.1038/sj.jid.5701098; Passi A, 2004, EXP CELL RES, V296, P123, DOI 10.1016/j.yexer.2004.01.031; Pienimaki JP, 2001, J BIOL CHEM, V276, P20428, DOI 10.1074/jbc.M007601200; PREHM P, 1984, BIOCHEM J, V220, P597, DOI 10.1042/bj2200597; Rabina J, 2001, GLYCOCONJUGATE J, V18, P799, DOI 10.1023/A:1021107602535; Rilla K, 2004, J INVEST DERMATOL, V123, P708, DOI 10.1111/j.0022-202X.2004.23409.x; Rilla K, 2013, J BIOL CHEM, V288, P5973, DOI 10.1074/jbc.M112.443879; Ripple MO, 2013, J BIOL CHEM, V288, P2933, DOI 10.1074/jbc.M112.430082; Saavalainen K, 2005, J BIOL CHEM, V280, P14636, DOI 10.1074/jbc.M500206200; Saavalainen K, 2007, J BIOL CHEM, V282, P11530, DOI 10.1074/jbc.M607871200; SAMPSON PM, 1992, J CLIN INVEST, V90, P1492, DOI 10.1172/JCI116017; Sandjeu Y, 2009, J PHYSIOL PHARMACOL, V60, P23; Schuringa JJ, 2001, FEBS LETT, V495, P71, DOI 10.1016/S0014-5793(01)02354-7; Sesma JI, 2009, J BIOL CHEM, V284, P12572, DOI 10.1074/jbc.M806759200; Shirakata Y, 2010, J DERMATOL SCI, V59, P73, DOI 10.1016/j.jdermsci.2010.05.002; Siiskonen H, 2011, J HISTOCHEM CYTOCHEM, V59, P908, DOI 10.1369/0022155411417874; Tammi R, 2005, J INVEST DERMATOL, V124, P898, DOI 10.1111/j.0022-202X.2005.23697.x; TAMMI R, 1994, PROG HISTOCHEM CYTOC, V29, P1; TAMMI R, 1988, J INVEST DERMATOL, V90, P412, DOI 10.1111/1523-1747.ep12456530; Tammi R, 2001, J BIOL CHEM, V276, P35111, DOI 10.1074/jbc.M103481200; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Tammi RH, 2009, J INVEST DERMATOL, V129, P1858, DOI 10.1038/jid.2009.91; Tsukimoto M, 2010, RADIAT RES, V173, P298, DOI 10.1667/RR1732.1; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Vigetti D, 2012, J BIOL CHEM, V287, P35544, DOI 10.1074/jbc.M112.402347; Wakahara R, 2012, GENES CELLS, V17, P132, DOI 10.1111/j.1365-2443.2011.01575.x; Washburn KB, 2006, NEUROSCIENCE, V142, P411, DOI 10.1016/j.neuroscience.2006.06.034; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zippel N, 2012, STEM CELLS DEV, V21, P884, DOI 10.1089/scd.2010.0576	59	34	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18569	18581		10.1074/jbc.M114.551804	http://dx.doi.org/10.1074/jbc.M114.551804			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24847057	Green Published, hybrid			2022-12-25	WOS:000338042000053
J	Muller, I; Larsson, K; Frenzel, A; Oliynyk, G; Zirath, H; Prochownik, EV; Westwood, NJ; Henriksson, MA				Muller, Inga; Larsson, Karin; Frenzel, Anna; Oliynyk, Ganna; Zirath, Hanna; Prochownik, Edward V.; Westwood, Nicholas J.; Henriksson, Marie Arsenian			Targeting of the MYCN Protein with Small Molecule c-MYC Inhibitors	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTRA; SECONDARY STRUCTURE ANALYSES; N-MYC; NEURONAL DIFFERENTIATION; NEOPLASTIC PHENOTYPE; MYC/MAX DIMERIZATION; MURINE DEVELOPMENT; INDUCED APOPTOSIS; TUMOR DORMANCY; NEURAL-NETWORK	Members of the MYC family are the most frequently deregulated oncogenes in human cancer and are often correlated with aggressive disease and/or poorly differentiated tumors. Since patients with MYCN-amplified neuroblastoma have a poor prognosis, targeting MYCN using small molecule inhibitors could represent a promising therapeutic approach. We have previously demonstrated that the small molecule 10058-F4, known to bind to the c-MYC bHLHZip dimerization domain and inhibiting the c-MYC/MAX interaction, also interferes with the MYCN/MAX dimerization in vitro and imparts anti-tumorigenic effects in neuroblastoma tumor models with MYCN overexpression. Our previous work also revealed that MYCN-inhibition leads to mitochondrial dysfunction resulting in accumulation of lipid droplets in neuroblastoma cells. To expand our understanding of how small molecules interfere with MYCN, we have now analyzed the direct binding of 10058-F4, as well as three of its analogs; #474, #764 and 10058-F4(7RH), one metabolite C-m/z 232, and a structurally unrelated c-MYC inhibitor 10074-G5, to the bHLHZip domain of MYCN. We also assessed their ability to induce apoptosis, neurite outgrowth and lipid accumulation in neuroblastoma cells. Interestingly, all c-MYC binding molecules tested also bind MYCN as assayed by surface plasmon resonance. Using a proximity ligation assay, we found reduced interaction between MYCN and MAX after treatment with all molecules except for the 10058-F4 metabolite C-m/z 232 and the non-binder 10058-F4(7RH). Importantly, 10074-G5 and 10058-F4 were the most efficient in inducing neuronal differentiation and lipid accumulation in MYCN-amplified neuroblastoma cells. Together our data demonstrate MYCN-binding properties for a selection of small molecules, and provide functional information that could be of importance for future development of targeted therapies against MYCN-amplified neuroblastoma.	[Muller, Inga; Larsson, Karin; Frenzel, Anna; Oliynyk, Ganna; Zirath, Hanna; Henriksson, Marie Arsenian] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Prochownik, Edward V.] UMPC, Childrens Hosp Pittsburgh, Sect Hematol Oncol, Pittsburgh, PA USA; [Westwood, Nicholas J.] Univ St Andrews, Sch Chem & Biomed Sci Res Complex, St Andrews, Fife, Scotland; [Westwood, Nicholas J.] EaStCHEM, St Andrews, Fife, Scotland	Karolinska Institutet; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of St Andrews; University of St Andrews	Henriksson, MA (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	Marie.Henriksson@ki.se	Henriksson, Marie Arsenian/F-5010-2015; Larsson, Karin/AAO-7701-2021	Larsson, Karin/0000-0002-6403-2736; Oliynyk, Ganna/0000-0002-6274-4465; Arsenian Henriksson, Marie/0000-0001-6376-7792; Westwood, Nicholas/0000-0003-0630-0138	Swedish Research Council; Swedish Cancer Society; KI (KID)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); KI (KID)	This study was funded by grants from the Swedish Research Council and the Swedish Cancer Society. IM and HZ were recipients of graduate student grants from KI (KID), MAH was recipient of a Senior Investigator Award from the Swedish Cancer Society, and NJW was a Royal Society University Research Fellow when this work began. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albihn A, 2006, J CELL BIOCHEM, V98, P1597, DOI 10.1002/jcb.20816; Albihn A, 2010, ADV CANCER RES, V107, P163, DOI 10.1016/S0065-230X(10)07006-5; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Berg T, 2002, P NATL ACAD SCI USA, V99, P3830, DOI 10.1073/pnas.062036999; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Clausen DM, 2010, J PHARMACOL EXP THER, V335, P715, DOI 10.1124/jpet.110.170555; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; DOWNS KM, 1989, GENE DEV, V3, P860, DOI 10.1101/gad.3.6.860; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Edsjo A, 2007, SEMIN CANCER BIOL, V17, P248, DOI 10.1016/j.semcancer.2006.04.005; Felsher Dean W, 2010, Genes Cancer, V1, P597, DOI 10.1177/1947601910377798; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Fieber W, 2001, J MOL BIOL, V307, P1395, DOI 10.1006/jmbi.2001.4537; Follis AV, 2009, BIOORG MED CHEM LETT, V19, P807, DOI 10.1016/j.bmcl.2008.12.025; Follis AV, 2008, CHEM BIOL, V15, P1149, DOI 10.1016/j.chembiol.2008.09.011; Guo JX, 2009, CANCER CHEMOTH PHARM, V63, P615, DOI 10.1007/s00280-008-0774-y; Hammoudeh DI, 2009, J AM CHEM SOC, V131, P7390, DOI 10.1021/ja900616b; Harvey SR, 2012, J AM CHEM SOC, V134, P19384, DOI 10.1021/ja306519h; HIRVONEN H, 1990, ONCOGENE, V5, P1787; Huang MJ, 2006, EXP HEMATOL, V34, P1480, DOI 10.1016/j.exphem.2006.06.019; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Larsson LG, 2010, EXP CELL RES, V316, P1429, DOI 10.1016/j.yexcr.2010.03.025; Lin CP, 2007, ANTI-CANCER DRUG, V18, P161, DOI 10.1097/CAD.0b013e3280109424; LOKE SL, 1988, CURR TOP MICROBIOL, V141, P282; Loven J, 2010, P NATL ACAD SCI USA, V107, P1553, DOI 10.1073/pnas.0913517107; Luscher B, 1999, ONCOGENE, V18, P2955, DOI 10.1038/sj.onc.1202750; Malynn BA, 2000, GENE DEV, V14, P1390; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Michel J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041070; MUGRAUER G, 1988, J CELL BIOL, V107, P1325, DOI 10.1083/jcb.107.4.1325; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Prochownik Edward V, 2010, Genes Cancer, V1, P650; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Shachaf CM, 2005, CANCER RES, V65, P4471, DOI 10.1158/0008-5472.CAN-05-1172; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Soucek L, 2010, CURR OPIN GENET DEV, V20, P91, DOI 10.1016/j.gde.2009.11.001; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; SREERAMA N, 1994, J MOL BIOL, V242, P497, DOI 10.1006/jmbi.1994.1597; STANTON BR, 1992, BRAIN PATHOL, V2, P71; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Wang HB, 2007, MOL CANCER THER, V6, P2399, DOI 10.1158/1535-7163.MCT-07-0005; Wang HB, 2013, ONCOTARGET, V4, P936, DOI 10.18632/oncotarget.1108; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yap JL, 2013, BIOORG MED CHEM LETT, V23, P370, DOI 10.1016/j.bmcl.2012.10.013; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641; ZIMMERMAN KA, 1986, NATURE, V319, P780, DOI 10.1038/319780a0; Zirath H, 2013, P NATL ACAD SCI USA, V110, P10258, DOI 10.1073/pnas.1222404110	54	54	55	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97285	10.1371/journal.pone.0097285	http://dx.doi.org/10.1371/journal.pone.0097285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859015	Green Accepted, Green Published, gold			2022-12-25	WOS:000336839400010
J	La Sorte, FA; Butchart, SHM; Jetz, W; Bohning-Gaese, K				La Sorte, Frank A.; Butchart, Stuart H. M.; Jetz, Walter; Boehning-Gaese, Katrin			Range-Wide Latitudinal and Elevational Temperature Gradients for the World's Terrestrial Birds: Implications under Global Climate Change	PLOS ONE			English	Article							SPECIES RICHNESS; EVOLUTIONARY RESPONSES; MONTANE BIODIVERSITY; MOUNTAIN PASSES; NATAL DISPERSAL; GENE FLOW; PATTERNS; SHIFTS; EXPANSION; TRAITS	Species' geographical distributions are tracking latitudinal and elevational surface temperature gradients under global climate change. To evaluate the opportunities to track these gradients across space, we provide a first baseline assessment of the steepness of these gradients for the world's terrestrial birds. Within the breeding ranges of 9,014 bird species, we characterized the spatial gradients in temperature along latitude and elevation for all and a subset of bird species, respectively. We summarized these temperature gradients globally for threatened and non-threatened species and determined how their steepness varied based on species' geography (range size, shape, and orientation) and projected changes in temperature under climate change. Elevational temperature gradients were steepest for species in Africa, western North and South America, and central Asia and shallowest in Australasia, insular IndoMalaya, and the Neotropical lowlands. Latitudinal temperature gradients were steepest for extratropical species, especially in the Northern Hemisphere. Threatened species had shallower elevational gradients whereas latitudinal gradients differed little between threatened and non-threatened species. The strength of elevational gradients was positively correlated with projected changes in temperature. For latitudinal gradients, this relationship only held for extratropical species. The strength of latitudinal gradients was better predicted by species' geography, but primarily for extratropical species. Our findings suggest threatened species are associated with shallower elevational temperature gradients, whereas steep latitudinal gradients are most prevalent outside the tropics where fewer bird species occur year-round. Future modeling and mitigation efforts would benefit from the development of finer grain distributional data to ascertain how these gradients are structured within species' ranges, how and why these gradients vary among species, and the capacity of species to utilize these gradients under climate change.	[La Sorte, Frank A.] Cornell Univ, Cornell Lab Ornithol, Ithaca, NY 14850 USA; [Butchart, Stuart H. M.] BirdLife Int, Cambridge, England; [Jetz, Walter] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Boehning-Gaese, Katrin] Senckenberg Gesell Naturforsch, Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany; [Boehning-Gaese, Katrin] Goethe Univ, Dept Biol Sci, Frankfurt, Germany	Cornell University; BirdLife International; Yale University; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt	La Sorte, FA (corresponding author), Cornell Univ, Cornell Lab Ornithol, Ithaca, NY 14850 USA.	fal42@cornell.edu	Butchart, Stuart/AAJ-1852-2021; Butchart, Stuart HM/Y-2711-2018; Jetz, Walter/ABF-1517-2020; Böhning-Gaese, Katrin/W-2601-2019	Butchart, Stuart/0000-0002-1140-4049; Böhning-Gaese, Katrin/0000-0003-0477-5586; Jetz, Walter/0000-0002-1971-7277	Cornell Lab of Ornithology	Cornell Lab of Ornithology	This work was funded through a postdoctoral fellowship at the Cornell Lab of Ornithology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AS, 2012, GLOBAL CHANGE BIOL, V18, P2126, DOI 10.1111/j.1365-2486.2012.02683.x; Angert AL, 2011, ECOL LETT, V14, P677, DOI 10.1111/j.1461-0248.2011.01620.x; Baselga A, 2012, J BIOGEOGR, V39, P760, DOI 10.1111/j.1365-2699.2011.02612.x; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Bennie J, 2013, ECOL LETT, V16, P921, DOI 10.1111/ele.12129; BirdLife International, 2012, BIRDL CHECKL BIRDS W; BirdLife International and NatureServe, 2012, BIRD SPEC DISTR MAPS; Bocedi G, 2012, METHODS ECOL EVOL, V3, P1008, DOI 10.1111/j.2041-210X.2012.00235.x; Bohning-Gaese K, 2006, AM NAT, V167, P555, DOI 10.1086/501078; Buchanan GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029080; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; DAGUM C, 1980, ECON APPL, V33, P327; DAVIES RB, 1987, BIOMETRIKA, V74, P33, DOI 10.1093/biomet/74.1.33; Dawideit BA, 2009, J ANIM ECOL, V78, P388, DOI 10.1111/j.1365-2656.2008.01504.x; Dexter KG, 2010, J BIOGEOGR, V37, P2137, DOI 10.1111/j.1365-2699.2010.02362.x; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; Drake JM, 2005, P ROY SOC B-BIOL SCI, V272, P1823, DOI 10.1098/rspb.2005.3148; Early R, 2011, ECOL LETT, V14, P1125, DOI 10.1111/j.1461-0248.2011.01681.x; Engler R, 2011, GLOBAL CHANGE BIOL, V17, P2330, DOI 10.1111/j.1365-2486.2010.02393.x; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Forero-Medina G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028535; Forero-Medina G, 2011, CONSERV BIOL, V25, P163, DOI 10.1111/j.1523-1739.2010.01572.x; Freeman BG, P NATL ACAD IN PRESS; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; Gillies CS, 2011, ECOL APPL, V21, P944, DOI 10.1890/09-2090.1; Gillingham PK, 2012, DIVERS DISTRIB, V18, P990, DOI 10.1111/j.1472-4642.2012.00933.x; Graae BJ, 2012, OIKOS, V121, P3, DOI 10.1111/j.1600-0706.2011.19694.x; Hargrove L, 2011, OIKOS, V120, P1568, DOI 10.1111/j.1600-0706.2011.19284.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hole DG, 2011, CONSERV BIOL, V25, P305, DOI 10.1111/j.1523-1739.2010.01633.x; Hole DG, 2009, ECOL LETT, V12, P420, DOI 10.1111/j.1461-0248.2009.01297.x; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; Ibarra-Macias A, 2011, BIOL CONSERV, V144, P703, DOI 10.1016/j.biocon.2010.08.006; IPCC Intergovernmental Panel on Climate Change (IPCC), 2013, 5 ASSESSMENT REPORT; Jankowski JE, 2010, ECOLOGY, V91, P1877, DOI 10.1890/09-2063.1; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jetz W, 2012, TRENDS ECOL EVOL, V27, P151, DOI 10.1016/j.tree.2011.09.007; Jetz W, 2009, ECOL LETT, V12, P1137, DOI 10.1111/j.1461-0248.2009.01369.x; Jonas CS, 1999, AM J BOT, V86, P333, DOI 10.2307/2656755; Jones P.G., 2009, GENERATING CHARACTER; Karl TR, 2003, SCIENCE, V302, P1719, DOI 10.1126/science.1090228; Kirby JS, 2008, BIRD CONSERV INT, V18, pS49, DOI 10.1017/S0959270908000439; Koller M, 2011, COMPUT STAT DATA AN, V55, P2504, DOI 10.1016/j.csda.2011.02.014; Kremer A, 2012, ECOL LETT, V15, P378, DOI 10.1111/j.1461-0248.2012.01746.x; Kubisch A, 2013, ECOGRAPHY, V36, P873, DOI 10.1111/j.1600-0587.2012.00062.x; La Sorte FA, 2010, J EXP BIOL, V213, P862, DOI 10.1242/jeb.038356; La Sorte FA, 2007, ECOGRAPHY, V30, P649, DOI 10.1111/j.2007.0906-7590.05084.x; La Sorte FA, 2012, J ANIM ECOL, V81, P914, DOI 10.1111/j.1365-2656.2012.01958.x; La Sorte FA, 2010, P ROY SOC B-BIOL SCI, V277, P3401, DOI 10.1098/rspb.2010.0612; Laube I, 2013, GLOBAL ECOL BIOGEOGR, V22, P233, DOI 10.1111/j.1466-8238.2012.00798.x; Laube I, 2013, GLOBAL ECOL BIOGEOGR, V22, P223, DOI 10.1111/j.1466-8238.2012.00796.x; Lawler JJ, 2013, ECOL LETT, V16, P1014, DOI 10.1111/ele.12132; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Lorenz MO, 1905, J AM STAT ASSOC, V9, P209; Luoto M, 2008, GLOBAL CHANGE BIOL, V14, P483, DOI 10.1111/j.1365-2486.2007.01527.x; MacArthur R.H., 1972, pvii; Mao JF, 2013, REMOTE SENS-BASEL, V5, P1484, DOI 10.3390/rs5031484; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; McCain CM, 2011, ECOL LETT, V14, P1236, DOI 10.1111/j.1461-0248.2011.01695.x; McCain CM, 2009, ECOL LETT, V12, P550, DOI 10.1111/j.1461-0248.2009.01308.x; Menard S.W., 1995, APPL LOGISTIC REGRES, V2nd ed.; Mokhov II, 2006, IZV ATMOS OCEAN PHY+, V42, P430, DOI 10.1134/S0001433806040037; Moller AP, 2006, GLOBAL CHANGE BIOL, V12, P2005, DOI 10.1111/j.1365-2486.2006.01216.x; Moore RP, 2008, ECOL LETT, V11, P960, DOI 10.1111/j.1461-0248.2008.01196.x; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; Munch SB, 2009, P NATL ACAD SCI USA, V106, P13860, DOI 10.1073/pnas.0900300106; Mustin K, 2013, DIVERS DISTRIB, V19, P815, DOI 10.1111/ddi.12038; Naya DE, 2012, AM NAT, V179, pE172, DOI 10.1086/665646; Nichols J., 2001, DISPERSAL; Nijssen David, 1998, Coenoses, V13, P33; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pigot AL, 2010, ECOL LETT, V13, P705, DOI 10.1111/j.1461-0248.2010.01462.x; R Development Core Team, 2014, R LANG ENV STAT COMP; Randin CF, 2009, GLOBAL CHANGE BIOL, V15, P1557, DOI 10.1111/j.1365-2486.2008.01766.x; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Reif J, 2012, OIKOS, V121, P1053, DOI 10.1111/j.1600-0706.2011.20008.x; Scherrer D, 2011, INT J BIOMETEOROL, V55, P645, DOI 10.1007/s00484-010-0364-7; Schurr FM, 2012, J BIOGEOGR, V39, P2146, DOI 10.1111/j.1365-2699.2012.02737.x; Sexton JP, 2011, P NATL ACAD SCI USA, V108, P11704, DOI 10.1073/pnas.1100404108; Skelly DK, 2007, CONSERV BIOL, V21, P1353, DOI 10.1111/j.1523-1739.2007.00764.x; Somveille M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070907; Stanton-Geddes J, 2012, ECOLOGY, V93, P1604, DOI 10.1890/11-1701.1; Suggitt AJ, 2012, BIOL LETTERS, V8, P590, DOI 10.1098/rsbl.2012.0112; Suggitt AJ, 2011, OIKOS, V120, P1, DOI 10.1111/j.1600-0706.2010.18270.x; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Udvardy M.D.F., 1975, CLASSIFICATION BIOGE; Urban MC, 2012, P ROY SOC B-BIOL SCI, V279, P2072, DOI 10.1098/rspb.2011.2367; Watkinson AR, 2002, DISPERSAL ECOLOGY, P410; WEBB T, 1992, ANNU REV ECOL SYST, V23, P141, DOI 10.1146/annurev.es.23.110192.001041; Winkler DW, 2005, J ANIM ECOL, V74, P1080, DOI 10.1111/j.1365-2656.2005.01007.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Xu L, 2013, NAT CLIM CHANGE, V3, P581, DOI [10.1038/nclimate1836, 10.1038/NCLIMATE1836]; Xu YY, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052116; YOHAI VJ, 1987, ANN STAT, V15, P642, DOI 10.1214/aos/1176350366	95	25	25	5	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98361	10.1371/journal.pone.0098361	http://dx.doi.org/10.1371/journal.pone.0098361			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852009	gold, Green Submitted, Green Published			2022-12-25	WOS:000338323200067
J	Ludwig, G; Nejman, D; Hecht, M; Orlanski, S; Abu-Remaileh, M; Yanuka, O; Sandler, O; Marx, A; Roberts, D; Benvenisty, N; Bergman, Y; Mendelsohn, M; Cedar, H				Ludwig, Guy; Nejman, Deborah; Hecht, Merav; Orlanski, Shari; Abu-Remaileh, Monther; Yanuka, Ofra; Sandler, Oded; Marx, Amichai; Roberts, Douglas; Benvenisty, Nissim; Bergman, Yehudit; Mendelsohn, Monica; Cedar, Howard			Aberrant DNA Methylation in ES Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; DE-NOVO METHYLATION; CPG ISLAND; NAIVE PLURIPOTENCY; DIFFERENTIATION; GENES; METHYLTRANSFERASES; HYPERMETHYLATION; DEMETHYLATION; DERIVATION	Both mouse and human embryonic stem cells can be differentiated in vitro to produce a variety of somatic cell types. Using a new developmental tracing approach, we show that these cells are subject to massive aberrant CpG island de novo methylation that is exacerbated by differentiation in vitro. Bioinformatics analysis indicates that there are two distinct forms of abnormal de novo methylation, global as opposed to targeted, and in each case the resulting pattern is determined by molecular rules correlated with local pre-existing histone modification profiles. Since much of the abnormal methylation generated in vitro appears to be stably maintained, this modification may inhibit normal differentiation and could predispose to cancer if cells are used for replacement therapy. Excess CpG island methylation is also observed in normal placenta, suggesting that this process may be governed by an inherent program.	[Ludwig, Guy; Nejman, Deborah; Hecht, Merav; Orlanski, Shari; Abu-Remaileh, Monther; Bergman, Yehudit; Cedar, Howard] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Dev Biol & Canc Res, IL-91010 Jerusalem, Israel; [Yanuka, Ofra; Benvenisty, Nissim] Hebrew Univ Jerusalem, Dept Genet, Silberman Inst Life Sci, IL-91904 Jerusalem, Israel; [Sandler, Oded; Marx, Amichai] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, IL-91010 Jerusalem, Israel; [Roberts, Douglas] Agilent Technol, Agilent Labs, Santa Clara, CA USA; [Mendelsohn, Monica] Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Agilent Technologies; Columbia University	Cedar, H (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Dev Biol & Canc Res, IL-91010 Jerusalem, Israel.	cedar@mail.huji.ac.il	Abu-Remaileh, Monther/M-3747-2016	Abu-Remaileh, Monther/0000-0003-3772-0477	Israel Science Foundation [419/10]; Israel Cancer Research Fund; European Research Council [268614]; Israeli Centers of Research Excellence; Rosetrees Trust; Rosetrees Trust [M31-F1] Funding Source: researchfish	Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund; European Research Council(European Research Council (ERC)European Commission); Israeli Centers of Research Excellence; Rosetrees Trust(Rosetrees Trust); Rosetrees Trust(Rosetrees Trust)	This work was supported by the Israel Science Foundation (Grant no. 419/10) (http://www.isf.org.il), Israel Cancer Research Fund (http://www.icrfonline.org), European Research Council (Grant no. 268614) (http://erc.europa.eu), Israeli Centers of Research Excellence (http://www.icore-human-disease.org), The Rosetrees Trust (www.rosetreestrust.co.uk), Lew Sanders and Norton Herrick. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder O, 2010, DEVELOPMENT, V137, P2483, DOI 10.1242/dev.048363; ANTEQUERA F, 1990, CELL, V62, P503, DOI 10.1016/0092-8674(90)90015-7; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; De Marzo AM, 1999, CANCER RES, V59, P3855; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Ficz G, 2013, CELL STEM CELL, V13, P351, DOI 10.1016/j.stem.2013.06.004; FRANK D, 1991, NATURE, V351, P239, DOI 10.1038/351239a0; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Gordon L, 2012, GENOME RES, V22, P1395, DOI 10.1101/gr.136598.111; GRUENBAUM Y, 1982, NATURE, V295, P620, DOI 10.1038/295620a0; Hahn MA, 2008, CANCER RES, V68, P10280, DOI 10.1158/0008-5472.CAN-08-1957; Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; LANDEDINER L, 2005, NAT REV GENET, V6, P648; Lavon N, 2008, STEM CELLS, V26, P1874, DOI 10.1634/stemcells.2008-0156; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; O'Hagan HM, 2011, CANCER CELL, V20, P606, DOI 10.1016/j.ccr.2011.09.012; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; POLLACK Y, 1980, P NATL ACAD SCI-BIOL, V77, P6463, DOI 10.1073/pnas.77.11.6463; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; RAZIN A, 1984, P NATL ACAD SCI-BIOL, V81, P2275, DOI 10.1073/pnas.81.8.2275; REYNAUD C, 1992, CANCER LETT, V61, P255, DOI 10.1016/0304-3835(92)90296-8; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Sabag O, 2014, NAT STRUCT MOL BIOL, V21, P110, DOI 10.1038/nsmb.2734; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Senner CE, 2012, STEM CELLS, V30, P2732, DOI 10.1002/stem.1249; Shen Y, 2006, HUM MOL GENET, V15, P2623, DOI 10.1093/hmg/ddl188; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Steinfeld I, 2008, BIOINFORMATICS, V24, pI90, DOI 10.1093/bioinformatics/btn279; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167	58	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e96090	10.1371/journal.pone.0096090	http://dx.doi.org/10.1371/journal.pone.0096090			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852222	gold, Green Published, Green Accepted			2022-12-25	WOS:000338323200009
J	Shen, TC; Chung, WS; Lin, CL; Wei, CC; Chen, CH; Chen, HJ; Tu, CY; Hsia, TC; Shih, CM; Hsu, WH; Chung, CJ				Shen, Te-Chun; Chung, Wei-Sheng; Lin, Cheng-Li; Wei, Chang-Ching; Chen, Chia-Hung; Chen, Hung-Jen; Tu, Chih-Yen; Hsia, Te-Chun; Shih, Chuen-Ming; Hsu, Wu-Huei; Chung, Chi-Jung			Does Chronic Obstructive Pulmonary Disease with or without Type 2 Diabetes Mellitus Influence the Risk of Lung Cancer? Result from a Population-Based Cohort Study	PLOS ONE			English	Article							COPD; BURDEN; METAANALYSIS; EMPHYSEMA; SMOKING	Background: Previous studies have suggested that chronic obstructive pulmonary disease (COPD) is an independent risk factor for lung cancer. There are some evidence that people with diabetes are at a risk of developing many forms of cancer, but inconclusive with regard to lung cancer. The aim of this study was to evaluate whether COPD with or without type 2 diabetes mellitus (T2DM) influences the risk of developing lung cancer. Methods: This is a retrospective cohort study consisting of 20,730 subjects newly diagnosed with COPD ("cases"). Their data was collected from the National Health Insurance system of Taiwan from 1998 to 2010. Among these patients, 5,820 patients had T2DM and 14,910 patients did not have T2DM. The retrospective matched control group consisted of 20,729 subjects without either COPD or T2DM. The control group was matched with the cases for sex, age, and index year (the year that the patient was diagnosed with COPD). The subjects were followed until the end of 2011. Results: The findings of our study showed that the risk of lung cancer was higher in the COPD group than in the non-COPD group, with adjusted hazard ratio (HR) of 5.02 [95% confidence interval (CI) = 4.23-5.94] among total case group, adjusted HR was 5.38 (95% CI = 4.52-6.40) in the cohort without T2DM and adjusted HR was 4.05 (95% CI = 3.26-5.03) in the cohort with T2DM. We observed a significantly protective effect from lung cancer (adjusted HR = 0.75, 95% CI = 0.63-0.90) of diabetic cohort than non-diabetic cohort among patients with COPD. Conclusion: Patients with COPD had a significantly higher risk of developing lung cancer than healthy people. However, there was a protective effect of T2DM for lung cancer among patients with COPD. Further investigation may be needed to corroborate the mechanism or bring up reliable reasons.	[Shen, Te-Chun; Chen, Chia-Hung; Chen, Hung-Jen; Tu, Chih-Yen; Hsia, Te-Chun; Shih, Chuen-Ming; Hsu, Wu-Huei] China Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taichung, Taiwan; [Shen, Te-Chun; Wei, Chang-Ching; Chen, Chia-Hung; Chen, Hung-Jen; Tu, Chih-Yen; Hsia, Te-Chun; Shih, Chuen-Ming; Hsu, Wu-Huei] China Med Univ, Taichung, Taiwan; [Shen, Te-Chun] Chu Shang Show Chwan Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Nantou, Taiwan; [Chung, Wei-Sheng] Taichung Hosp, Dept Internal Med, Minist Hlth & Welf, Taichung, Taiwan; [Chung, Wei-Sheng] Cent Taiwan Univ Sci & Technol, Dept Healthcare Adm, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Wei, Chang-Ching] China Med Univ Hosp, Div Nephrol, Dept Pediat, Taichung, Taiwan; [Chung, Chi-Jung] China Med Univ, Coll Publ Hlth, Dept Hlth Risk Management, Taichung, Taiwan; [Chung, Chi-Jung] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Central Taiwan University Science & Technology; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chung, CJ (corresponding author), China Med Univ, Coll Publ Hlth, Dept Hlth Risk Management, Taichung, Taiwan.	d10326@mail.cmuh.org.tw	Chung, Chi-Jung/G-4755-2013	Shen, Te-Chun/0000-0002-9427-1068	Taiwan Department of Health Clinical Trial and Research Center and for Excellence [DOH102-TD-B-111-004]; Taiwan Department of Health Cancer Research Center for Excellence [DOH102-TD-C-111-005]	Taiwan Department of Health Clinical Trial and Research Center and for Excellence; Taiwan Department of Health Cancer Research Center for Excellence	This work was supported by Taiwan Department of Health Clinical Trial and Research Center and for Excellence (DOH102-TD-B-111-004) and Taiwan Department of Health Cancer Research Center for Excellence (DOH102-TD-C-111-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Atchison EA, 2011, INT J CANCER, V128, P635, DOI 10.1002/ijc.25362; Brenner DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017479; Buist AS, 2008, INT J TUBERC LUNG D, V12, P703; Buist A Sonia, 2005, COPD, V2, P277, DOI 10.1081/COPD-200057610; Cheng TM, 2009, 6 COUNTRIES 6 REFORM, P171; Dubey S, 2008, AM J RESP CRIT CARE, V177, P941, DOI 10.1164/rccm.200801-107UP; Fang XC, 2011, CHEST, V139, P920, DOI 10.1378/chest.10-1393; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Forey BA, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-36; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; Hall GC, 2005, DIABETES CARE, V28, P590, DOI 10.2337/diacare.28.3.590; Holtzman Michael J, 2005, Proc Am Thorac Soc, V2, P132, DOI 10.1513/pats.200502-015AW; Inoue M, 2006, ARCH INTERN MED, V166, P1871, DOI 10.1001/archinte.166.17.1871; Kishi K, 2002, EUR RESPIR J, V19, P1093, DOI 10.1183/09031936.02.00264202; Lai SW, 2012, CLIN LUNG CANCER, V13, P143, DOI 10.1016/j.cllc.2011.10.002; Lo SF, 2013, INT J CANCER, V132, P182, DOI 10.1002/ijc.27597; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Noto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033411; Ogunleye AA, 2009, BRIT J CANCER, V101, P1199, DOI 10.1038/sj.bjc.6605240; Petty TL, 2005, CHEST, V128, P1895, DOI 10.1378/chest.128.4.1895; Powell HA, 2013, J THORAC ONCOL, V8, P6, DOI 10.1097/JTO.0b013e318274a7dc; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Shen TC, 2014, QJM; Shen TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091821; Shen TC, 2014, AM J RESP CRIT CARE, V189, P496, DOI 10.1164/rccm.201310-1792LE; Smiechowski BB, 2013, DIABETES CARE, V36, P124, DOI 10.2337/dc12-0740; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Thun MJ, 2006, JNCI-J NATL CANCER I, V98, P691, DOI 10.1093/jnci/djj187; van Schayck C P Onno, 2006, Prim Care Respir J, V15, P81, DOI 10.1016/j.pcrj.2006.01.006; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046144; Wideroff L, 1997, J NATL CANCER I, V89, P1360, DOI 10.1093/jnci/89.18.1360; Wright JL, 2002, CHEST, V122, p301S, DOI 10.1378/chest.122.6_suppl.301S	35	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98290	10.1371/journal.pone.0098290	http://dx.doi.org/10.1371/journal.pone.0098290			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24854189	Green Published, gold, Green Submitted			2022-12-25	WOS:000338323200061
J	Szepesi, Z; Hosy, E; Ruszczycki, B; Bijata, M; Pyskaty, M; Bikbaev, A; Heine, M; Choquet, D; Kaczmarek, L; Wlodarczyk, J				Szepesi, Zsuzsanna; Hosy, Eric; Ruszczycki, Blazej; Bijata, Monika; Pyskaty, Marta; Bikbaev, Arthur; Heine, Martin; Choquet, Daniel; Kaczmarek, Leszek; Wlodarczyk, Jakub			Synaptically Released Matrix Metalloproteinase Activity in Control of Structural Plasticity and the Cell Surface Distribution of GluA1-AMPA Receptors	PLOS ONE			English	Article							LONG-TERM POTENTIATION; AMPA-RECEPTORS; DENDRITIC SPINES; NMDA RECEPTORS; EXTRACELLULAR-MATRIX; SILENT SYNAPSES; TRAFFICKING; MATRIX-METALLOPROTEINASE-9; BRAIN; MMP-9	Synapses are particularly prone to dynamic alterations and thus play a major role in neuronal plasticity. Dynamic excitatory synapses are located at the membranous neuronal protrusions called dendritic spines. The ability to change synaptic connections involves both alterations at the morphological level and changes in postsynaptic receptor composition. We report that endogenous matrix metalloproteinase (MMP) activity promotes the structural and functional plasticity of local synapses by its effect on glutamate receptor mobility and content. We used live imaging of cultured hippocampal neurons and quantitative morphological analysis to show that chemical long-term potentiation (cLTP) induces the permanent enlargement of a subset of small dendritic spines in an MMP-dependent manner. We also used a superresolution microscopy approach and found that spine expansion induced by cLTP was accompanied by MMP-dependent immobilization and synaptic accumulation as well as the clustering of GluA1-containing AMPA receptors. Altogether, our results reveal novel molecular and cellular mechanisms of synaptic plasticity.	[Szepesi, Zsuzsanna; Ruszczycki, Blazej; Bijata, Monika; Pyskaty, Marta; Kaczmarek, Leszek; Wlodarczyk, Jakub] Nencki Inst, Dept Mol & Cellular Neurobiol, Warsaw, Poland; [Hosy, Eric; Choquet, Daniel] Dynam Org & Funct Synapses, Interdisciplinary Inst Neurosci, Bordeaux, France; [Bikbaev, Arthur; Heine, Martin] Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, Magdeburg, Germany	Polish Academy of Sciences; Leibniz Institut fur Neurobiologie (LIN)	Wlodarczyk, J (corresponding author), Nencki Inst, Dept Mol & Cellular Neurobiol, Warsaw, Poland.	jwlodarc@nencki.gov.pl	Choquet, Daniel/K-7893-2018; Ruszczycki, Blazej/AAC-6385-2020; Choquet, Daniel/GOJ-8825-2022; Wlodarczyk, Jakub/A-2253-2015; Kaczmarek, Leszek/B-6171-2008; Kaczmarek, Leszek/AHA-0076-2022	Choquet, Daniel/0000-0003-4726-9763; Ruszczycki, Blazej/0000-0002-0262-1463; Choquet, Daniel/0000-0003-4726-9763; Wlodarczyk, Jakub/0000-0001-8343-2340; Kaczmarek, Leszek/0000-0002-7207-3490; Kaczmarek, Leszek/0000-0002-7207-3490; hosy, eric/0000-0002-2479-5915; Bijata, Monika/0000-0003-0589-4771; Magnowska, Marta/0000-0002-5424-6837	ERA-NET NEURON MODDIFSYN; National Science Centre [Dec-2011/01/D/NZ3/00163]; EU [264173]	ERA-NET NEURON MODDIFSYN; National Science Centre(National Science Centre, Poland); EU(European Commission)	Research was supported by ERA-NET NEURON MODDIFSYN and the National Science Centre (Dec-2011/01/D/NZ3/00163). This work was partially supported by EU FP7 Project, GA No 264173 (Bio-Imagine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; Anggono V, 2012, CURR OPIN NEUROBIOL, V22, P461, DOI 10.1016/j.conb.2011.12.006; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Bilousova TV, 2009, J MED GENET, V46, P94, DOI 10.1136/jmg.2008.061796; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Bozdagi O, 2007, J NEUROPHYSIOL, V98, P334, DOI 10.1152/jn.00202.2007; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Calo L, 2006, J NEUROCHEM, V98, P1, DOI 10.1111/j.1471-4159.2006.03844.x; Caroni P, 2012, NAT REV NEUROSCI, V13, P478, DOI 10.1038/nrn3258; Conant K, 2010, NEUROSCIENCE, V166, P508, DOI 10.1016/j.neuroscience.2009.12.061; Conant K, 2011, J NEUROCHEM, V118, P521, DOI 10.1111/j.1471-4159.2010.07153.x; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Dityatev A, 2011, CURR OPIN NEUROBIOL, V21, P353, DOI 10.1016/j.conb.2010.12.006; Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898; Dziembowska M, 2012, INT J BIOCHEM CELL B, V44, P709, DOI 10.1016/j.biocel.2012.01.023; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Esposito A, 2007, NEUROBIOL DIS, V26, P521, DOI 10.1016/j.nbd.2007.01.014; Esteban JA, 2008, BRIT J PHARMACOL, V153, pS35, DOI 10.1038/sj.bjp.0707525; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Giannone G, 2010, BIOPHYS J, V99, P1303, DOI 10.1016/j.bpj.2010.06.005; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Henley Jeremy M, 2013, Dialogues Clin Neurosci, V15, P11; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; HOSOKAWA T, 1995, J NEUROSCI, V15, P5560; Humeau Y, 2007, J NEUROSCI, V27, P10947, DOI 10.1523/JNEUROSCI.2603-07.2007; Huntley GW, 2012, NAT REV NEUROSCI, V13, P743, DOI 10.1038/nrn3320; Hutsler JJ, 2010, BRAIN RES, V1309, P83, DOI 10.1016/j.brainres.2009.09.120; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Kaczmarek L, 2013, CURR PHARM DESIGN, V19, P1085, DOI 10.2174/1381612811319060010; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kharazia VN, 1999, J COMP NEUROL, V412, P292, DOI 10.1002/(SICI)1096-9861(19990920)412:2<292::AID-CNE8>3.0.CO;2-G; Kielland A, 2009, NEURON, V62, P84, DOI 10.1016/j.neuron.2009.03.001; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Kulkarni VA, 2012, MOL CELL NEUROSCI, V50, P10, DOI 10.1016/j.mcn.2012.03.005; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Levenga J, 2012, PROG BRAIN RES, V197, P153, DOI 10.1016/B978-0-444-54299-1.00008-X; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Lonskaya I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069136; Makino H, 2009, NEURON, V64, P381, DOI 10.1016/j.neuron.2009.08.035; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Michaluk P, 2007, CELL DEATH DIFFER, V14, P1255, DOI 10.1038/sj.cdd.4402141; Michaluk P, 2011, J CELL SCI, V124, P3369, DOI 10.1242/jcs.090852; Michaluk P, 2009, J NEUROSCI, V29, P6007, DOI 10.1523/JNEUROSCI.5346-08.2009; Mokin M, 2007, J NEUROPHYSIOL, V98, P1278, DOI 10.1152/jn.00212.2007; Molnar E, 2011, SEMIN CELL DEV BIOL, V22, P506, DOI 10.1016/j.semcdb.2011.07.017; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Nair D, 2013, J NEUROSCI, V33, P13204, DOI 10.1523/JNEUROSCI.2381-12.2013; Niedringhaus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042631; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Okulski P, 2007, BIOL PSYCHIAT, V62, P359, DOI 10.1016/j.biopsych.2006.09.012; Opazo P, 2012, CURR OPIN NEUROBIOL, V22, P453, DOI 10.1016/j.conb.2011.10.010; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Peixoto RT, 2012, NEURON, V76, P396, DOI 10.1016/j.neuron.2012.07.006; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Rybakowski JK, 2013, J AFFECT DISORDERS, V146, P286, DOI 10.1016/j.jad.2012.07.019; Rybakowski JK, 2009, PSYCHIAT GENET, V19, P108, DOI 10.1097/YPG.0b013e32832080be; Samochowiec A, 2010, BRAIN RES, V1327, P103, DOI 10.1016/j.brainres.2010.02.072; Selcher JC, 2012, BRAIN RES, V1435, P8, DOI 10.1016/j.brainres.2011.11.029; Selemon LD, 2007, NEUROPSYCHOPHARMACOL, V32, P919, DOI 10.1038/sj.npp.1301179; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sweet RA, 2009, NEUROPSYCHOPHARMACOL, V34, P374, DOI 10.1038/npp.2008.67; Szepesi Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063314; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Tian L, 2007, J CELL BIOL, V178, P687, DOI 10.1083/jcb.200612097; Wang XB, 2008, P NATL ACAD SCI USA, V105, P19520, DOI 10.1073/pnas.0807248105; Wiera G, 2013, HIPPOCAMPUS, V23, P529, DOI 10.1002/hipo.22112; Wilczynski GM, 2008, J CELL BIOL, V180, P1021, DOI 10.1083/jcb.200708213; Xia ZG, 1996, J NEUROSCI, V16, P5425; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yang YL, 2008, P NATL ACAD SCI USA, V105, P11388, DOI 10.1073/pnas.0802978105; Yasumatsu N, 2008, J NEUROSCI, V28, P13592, DOI 10.1523/JNEUROSCI.0603-08.2008; Yu SY, 2008, J NEUROCHEM, V106, P889, DOI 10.1111/j.1471-4159.2008.05461.x; Yudowski GA, 2007, J NEUROSCI, V27, P11112, DOI 10.1523/JNEUROSCI.2465-07.2007; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	95	58	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98274	10.1371/journal.pone.0098274	http://dx.doi.org/10.1371/journal.pone.0098274			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853857	Green Submitted, Green Published, gold			2022-12-25	WOS:000338323200059
J	DeMiguel, D; Alba, DM; Moya-Sola, S				DeMiguel, Daniel; Alba, David M.; Moya-Sola, Salvador			Dietary Specialization during the Evolution of Western Eurasian Hominoids and the Extinction of European Great Apes	PLOS ONE			English	Article							MIDDLE MIOCENE SITE; PIEROLAPITHECUS-CATALAUNICUS PRIMATES; DENTAL MICROWEAR ANALYSIS; VALLES-PENEDES BASIN; ENAMEL THICKNESS; HISPANOPITHECUS-LAIETANUS; MOLAR MICROWEAR; OURANOPITHECUS-MACEDONIENSIS; OREOPITHECUS-BAMBOLII; QUANTITATIVE-ANALYSIS	Given the central adaptive role of diet, paleodietary inference is essential for understanding the relationship between evolutionary and paleoenvironmental change. Here we rely on dental microwear analysis to investigate the role of dietary specialization in the diversification and extinction of Miocene hominoids from Western Eurasian between 14 and 7 Ma. New microwear results for five extinct taxa are analyzed together with previous data for other Western Eurasian genera. Except Pierolapithecus (that resembles hard-object feeders) and Oreopithecus (a soft-frugivore probably foraging opportunistically on other foods), most of the extinct taxa lack clear extant dietary analogues. They display some degee of sclerocarpy, which is most clearly expressed in Griphopithecus and Ouranopithecus (adapted to more open and arid environments), whereas Anoiapithecus, Dryopithecus and, especially, Hispanopithecus species apparently relied more strongly on soft-frugivory. Thus, contrasting with the prevailing sclerocarpic condition at the beginning of the Eurasian hominoid radiation, soft-and mixed-frugivory coexisted with hard-object feeding in the Late Miocene. Therefore, despite a climatic trend towards cooling and increased seasonality, a progressive dietary diversification would have occurred (probably due to competitive exclusion and increased environmental heterogeneity), although strict folivory did not evolve. Overall, our analyses support the view that the same dietary specializations that enabled Western Eurasian hominoids to face progressive climatic deterioration were the main factor ultimately leading to their extinction when more drastic paleoenvironmental changes took place.	[DeMiguel, Daniel; Alba, David M.] Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont, E-08193 Barcelona, Spain; [Alba, David M.] Univ Turin, Dipartimento Sci Terra, Turin, Italy; [Moya-Sola, Salvador] Univ Autonoma Barcelona, ICREA, Inst Catala Paleontol Miquel Crusafont, E-08193 Barcelona, Spain; [Moya-Sola, Salvador] Univ Autonoma Barcelona, Unitat Antropol Biol, Dept BABVE, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Institut Catala de Paleontologia Miquel Crusafont (ICP); University of Turin; Autonomous University of Barcelona; ICREA; Institut Catala de Paleontologia Miquel Crusafont (ICP); Autonomous University of Barcelona	DeMiguel, D (corresponding author), Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont, E-08193 Barcelona, Spain.	daniel.demiguel@icp.cat	Alba, David/G-9716-2015	Alba, David/0000-0002-8886-5580; Moya-Sola, Salvador/0000-0001-8506-1061; DeMiguel, Daniel/0000-0001-6138-7227	Spanish Ministerio de Economia y Competitividad [CGL2011-28681/BTE, CGL2011-27343, JCI-2011-11697, RYC-2009-04533]; Generalitat de Catalunya [2009 SGR 754 GRC]; ICREA Funding Source: Custom	Spanish Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); ICREA(ICREA)	This work was funded by the Spanish Ministerio de Economia y Competitividad (CGL2011-28681/BTE, CGL2011-27343, JCI-2011-11697 (to DDM), and RYC-2009-04533 (to DMA)) and the Generalitat de Catalunya (2009 SGR 754 GRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti J, 2003, J HUM EVOL, V45, P145, DOI 10.1016/S0047-2484(03)00091-5; Alba D.M., 2006, Estudios Geologicos (Madrid), V62, P295; Alba DM, 2010, P ROY SOC B-BIOL SCI, V277, P2237, DOI 10.1098/rspb.2010.0218; Alba D.M., 2011, PALEONTOL EVOL MEM E, V6, P95; Alba DM, 2013, J HUM EVOL, V65, P573, DOI 10.1016/j.jhevol.2013.07.003; Alba DM, 2012, EVOL ANTHROPOL, V21, P254, DOI 10.1002/evan.21312; Alba DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039617; Alba DM, 2012, J HUM EVOL, V63, P231, DOI 10.1016/j.jhevol.2012.05.009; Alba DM, 2010, J ANTHROPOL SCI, V88, P11; Alba DM, 2010, J HUM EVOL, V59, P143, DOI 10.1016/j.jhevol.2010.02.002; Alba DM, 2001, HOM EVOLUT CLIMAT CH, V2, P284; Almecija S, 2007, P ROY SOC B-BIOL SCI, V274, P2375, DOI 10.1098/rspb.2007.0750; Almecija S, 2009, J HUM EVOL, V57, P284, DOI 10.1016/j.jhevol.2009.02.008; ALPAGUT B, 1990, J HUM EVOL, V19, P397, DOI 10.1016/0047-2484(90)90052-D; ANDREWS P, 1991, PHILOS T R SOC B, V334, P199, DOI 10.1098/rstb.1991.0109; Andrews P, 1996, BIOL REV, V71, P257, DOI 10.1111/j.1469-185X.1996.tb00749.x; Andrews P, 2007, FOLIA PRIMATOL, V78, P328, DOI 10.1159/000105148; Andrews Peter, 1999, P454; Begun DR, 2012, EVOL ANTHROPOL, V21, P10, DOI 10.1002/evan.20329; BEGUN DR, 1992, AM J PHYS ANTHROPOL, V87, P291, DOI 10.1002/ajpa.1330870306; BEGUN DR, 1990, J HUM EVOL, V19, P255, DOI 10.1016/0047-2484(90)90068-M; Begun DR, 2002, CAM S BIO EVOL ANTHR, V33, P339; BEGUN DR, 1992, AM J PHYS ANTHROPOL, V87, P311, DOI 10.1002/ajpa.1330870307; BEGUN DR, 1993, J HUM EVOL, V25, P271, DOI 10.1006/jhev.1993.1049; Bohme M, 2011, J HUM EVOL, V61, P332, DOI 10.1016/j.jhevol.2011.04.012; Casanovas-Vilar I, 2008, J HUM EVOL, V55, P589, DOI 10.1016/j.jhevol.2008.05.004; Casanovas-Vilar I, 2011, P NATL ACAD SCI USA, V108, P5554, DOI 10.1073/pnas.1018562108; CERLING TE, 1993, NATURE, V361, P344, DOI 10.1038/361344a0; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Costeur L, 2005, PALAEONTOGRAPHIA ITA, V90, P303; Daegling DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023095; Daegling DJ, 1999, PRIMATES, V40, P559, DOI 10.1007/BF02574831; De Bonis Louis, 1997, P317; De Bonis Louis, 1994, Evolutionary Anthropology, V3, P75, DOI 10.1002/evan.1360030303; Deane AS, 2008, J HUM EVOL, V55, P691, DOI 10.1016/j.jhevol.2008.05.005; DEBONIS L, 1993, J HUM EVOL, V24, P469, DOI 10.1006/jhev.1993.1032; DeMiguel D, 2013, AM J PHYS ANTHROPOL, V151, P573, DOI 10.1002/ajpa.22299; DeMiguel D, 2011, PALAEOGEOGR PALAEOCL, V302, P452, DOI 10.1016/j.palaeo.2011.02.005; DUMONT ER, 1995, J MAMMAL, V76, P1127, DOI 10.2307/1382604; Eastham L, 2009, J VERTEBR PALEONTOL, V29, p91A; El-Zaatari S, 2005, J HUM EVOL, V49, P180, DOI 10.1016/j.jhevol.2005.03.005; Ersoy A, 2008, J HUM EVOL, V54, P518, DOI 10.1016/j.jhevol.2007.08.004; Galbany J, 2005, FOLIA PRIMATOL, V76, P325, DOI 10.1159/000089531; Golpe Posse J.M, 1993, PALEONTOLOGIA EVOLUC, V26, P151; Grine FE, 2002, SCANNING, V24, P144, DOI 10.1002/sca.4950240307; GRINE FE, 1986, J HUM EVOL, V15, P783, DOI 10.1016/S0047-2484(86)80010-0; Grine FE, 2006, J HUM EVOL, V51, P297, DOI 10.1016/j.jhevol.2006.04.004; Grine FE, 2012, AM J PHYS ANTHROPOL, V148, P285, DOI 10.1002/ajpa.22086; Gugel IL, 2001, AM J PHYS ANTHROPOL, V114, P124, DOI 10.1002/1096-8644(200102)114:2&lt;124::AID-AJPA1012&gt;3.0.CO;2-S; Harrison Terry, 1997, P327; Harrison Terry, 2010, P429; KAY RF, 1977, AM J PHYS ANTHROPOL, V46, P327, DOI 10.1002/ajpa.1330460213; Kay Richard F., 1997, P131; Kelley J, 2008, J HUM EVOL, V54, P455, DOI 10.1016/j.jhevol.2007.08.007; King T, 2001, HOM EVOLUT CLIMAT CH, V2, P102; King T, 1999, J HUM EVOL, V36, P3, DOI 10.1006/jhev.1998.0258; Kordos L, 2001, J HUM EVOL, V40, P17, DOI 10.1006/jhev.2000.0437; Lambert JE, 2004, AM J PHYS ANTHROPOL, V125, P363, DOI 10.1002/ajpa.10403; Lee-Thorp J, 2006, YEARB PHYS ANTHROPOL, V49, P131, DOI 10.1002/ajpa.20519; Lee-Thorp JA, 2010, PHILOS T R SOC B, V365, P3389, DOI 10.1098/rstb.2010.0059; Lucas P, 2008, BIOESSAYS, V30, P374, DOI 10.1002/bies.20729; Lucas PW, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0923; LUCAS PW, 1995, FOLIA PRIMATOL, V64, P30, DOI 10.1159/000156829; Maas MC, 1999, EVOL ANTHROPOL, V8, P133; Marmi J, 2012, J HUM EVOL, V62, P412, DOI 10.1016/j.jhevol.2011.12.003; Matson SD, 2012, J HUM EVOL, V63, P127, DOI 10.1016/j.jhevol.2012.04.004; McGraw WS, 2012, AM J PHYS ANTHROPOL, V147, P326, DOI 10.1002/ajpa.21634; Merceron G, 2005, PALAIOS, V20, P551, DOI 10.2110/palo.2004.p04-17; Merceron G, 2007, J HUM EVOL, V53, P331, DOI 10.1016/j.jhevol.2007.04.008; Merceron G, 2013, J HUM EVOL, V65, P185, DOI 10.1016/j.jhevol.2013.05.003; Merceron G, 2012, J HUM EVOL, V63, P150, DOI 10.1016/j.jhevol.2012.04.006; Merceron G, 2010, P ROY SOC B-BIOL SCI, V277, P3105, DOI 10.1098/rspb.2010.0523; Merceron G, 2009, GEODIVERSITAS, V31, P865, DOI 10.5252/g2009n4a865; Merceron G, 2009, J HUM EVOL, V57, P732, DOI 10.1016/j.jhevol.2009.06.009; Mihlbachler MC, 2012, PALAEONTOL ELECTRON, V15; MORGAN ME, 1994, NATURE, V367, P162, DOI 10.1038/367162a0; Moya-Sola S, 2004, SCIENCE, V306, P1339, DOI 10.1126/science.1103094; Moya-Sola S, 2009, P NATL ACAD SCI USA, V106, P9601, DOI 10.1073/pnas.0811730106; Moya-Sola S, 2009, AM J PHYS ANTHROPOL, V139, P126, DOI 10.1002/ajpa.20891; MoyaSola S, 1996, NATURE, V379, P156, DOI 10.1038/379156a0; Nakatsukasa M, 1996, FOLIA PRIMATOL, V66, P15, DOI 10.1159/000157181; Olejniczak AJ, 2008, J HUM EVOL, V54, P187, DOI 10.1016/j.jhevol.2007.09.014; de los Rios MP, 2012, J HUM EVOL, V63, P497, DOI 10.1016/j.jhevol.2012.05.012; Potts Richard, 2004, P237, DOI 10.1017/CBO9780511542299.017; Poulsen JR, 2001, AM J PRIMATOL, V54, P91, DOI 10.1002/ajp.1015; Purnell MA, 2006, J ANIM ECOL, V75, P967, DOI 10.1111/j.1365-2656.2006.01116.x; Ramdarshan A, 2010, J HUM EVOL, V59, P96, DOI 10.1016/j.jhevol.2010.04.007; Robinson J.G., 1986, SMITHSONIAN CONTRIBU, V27, P1, DOI DOI 10.5479/SI.00810282.431; Rook L, 1996, J HUM EVOL, V30, P3, DOI 10.1006/jhev.1996.0002; Rook L, 2011, PALAEOGEOGR PALAEOCL, V305, P286, DOI 10.1016/j.palaeo.2011.03.010; Schwartz GT, 2000, AM J PHYS ANTHROPOL, V111, P221, DOI 10.1002/(SICI)1096-8644(200002)111:2<221::AID-AJPA8>3.0.CO;2-G; Scott R, 2008, J VERTEBR PALEONTOL, V28, p139A; Scott RS, 2012, AM J PHYS ANTHROPOL, V147, P551, DOI 10.1002/ajpa.22007; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Skinner MF, 2004, AM J PHYS ANTHROPOL, V123, P216, DOI 10.1002/ajpa.10314; SKINNER MF, 1995, J PALEOPATHOL, V7, P195; Sola SM, 1997, CR ACAD SCI II A, V324, P141; Sponheimer Matt, 2007, P555, DOI 10.1007/978-3-540-33761-4_18; Sponheimer M, 2013, P NATL ACAD SCI USA, V110, P10513, DOI 10.1073/pnas.1222579110; Strait DS, 2012, J HUM EVOL, V62, P165, DOI 10.1016/j.jhevol.2011.10.006; Teaford MF, 1996, AM J PHYS ANTHROPOL, V101, P527; TEAFORD MF, 1989, AM J PHYS ANTHROPOL, V80, P391, DOI 10.1002/ajpa.1330800312; Teaford MF, 1996, AM J PHYS ANTHROPOL, V100, P143; TEAFORD MF, 1989, J DENT RES, V68, P1513, DOI 10.1177/00220345890680110901; TEAFORD MF, 1988, SCANNING MICROSCOPY, V2, P1149; TEAFORD MF, 1984, AM J PHYS ANTHROPOL, V64, P191, DOI 10.1002/ajpa.1330640213; TEAFORD MF, 1985, AM J PHYS ANTHROPOL, V66, P363, DOI 10.1002/ajpa.1330660403; Ungar P., 1992, ANTHROPOL KOZLEM, V34, P141; Ungar P.S., 2005, PALAEONTOGRAPH ITAL, V90, P97; Ungar PS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002044; Ungar PS, 2013, BLACKW COMPANION ANT, P165; Ungar PS, 2012, J HUM EVOL, V63, P429, DOI 10.1016/j.jhevol.2011.04.006; UNGAR PS, 1995, P NATL ACAD SCI USA, V92, P5479, DOI 10.1073/pnas.92.12.5479; Ungar PS, 1996, J HUM EVOL, V31, P335, DOI 10.1006/jhev.1996.0065; Ungar PS, 2006, J HUM EVOL, V50, P78, DOI 10.1016/j.jhevol.2005.08.007; UNGAR PS, 1994, AM J PHYS ANTHROPOL, V94, P339, DOI 10.1002/ajpa.1330940305; UNGAR PS, 1995, AM J PHYS ANTHROPOL, V97, P93, DOI 10.1002/ajpa.1330970202; Utescher T, 2011, PALAEOGEOGR PALAEOCL, V304, P351, DOI 10.1016/j.palaeo.2010.09.031; Vogel ER, 2008, J HUM EVOL, V55, P60, DOI 10.1016/j.jhevol.2007.12.005; Ward SC, 2002, CAM S BIO EVOL ANTHR, V33, P385; Youlatos D, 1998, MAMMALIA, V62, P351, DOI 10.1515/mamm.1998.62.3.351; Zanolli C, 2010, ANN U FERRARA MUS SC, V6, P69	122	21	21	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97442	10.1371/journal.pone.0097442	http://dx.doi.org/10.1371/journal.pone.0097442			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3AL	24848272	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600029
J	Shi, M; Li, M; Cui, YZ; Adachi, Y; Ikehara, S				Shi, Ming; Li, Ming; Cui, Yunze; Adachi, Yasushi; Ikehara, Susumu			Gr-1 Ab Administered after Bone Marrow Transplantation plus Thymus Transplantation Suppresses Tumor Growth by Depleting Granulocytic Myeloid-Derived Suppressor Cells	PLOS ONE			English	Article							LYMPHOCYTE INFUSION; BEARING MICE; T-CELLS; CANCER; INFLAMMATION; PROGRESSION	It has been shown that allogeneic intra-bone marrow-bone marrow transplantation (IBM-BMT) plus thymus transplantation (TT) is effective in treating recipients with malignant tumors. Although TT increases the percentage of T cells in the early term after BMT, the myeloid-derived suppressor cells (MDSCs) are still the dominant population. We used the Gr-1 Ab to deplete the granulocytic MDSCs (G-MDSCs) in tumor-bearing mice that had received BMT+TT. Two weeks after the BMT, the mice injected with Gr-1 Ab showed smaller tumors than those in the control group. In addition, Gr-1 Ab significantly increased the percentages and numbers of CD4(+) and CD8(+) T cells, and decreased the percentages and numbers of MDSCs and G-MDSCs. No side effects of the Gr-1 Ab on recipient or donor thymus were observed. These findings indicate that Gr-1 Ab administered after BMT+TT may enhance the effectiveness of tumor suppression.	[Shi, Ming; Li, Ming; Adachi, Yasushi; Ikehara, Susumu] Kansai Med Univ, Dept Stem Cell Disorders, Hirakata, Osaka, Japan; [Shi, Ming] Guangdong Med Coll, Sch Publ Hlth, Dept Occupat & Environm Hlth, Dongguan, Guangdong, Peoples R China; [Cui, Yunze] JIMRO Co Ltd, Takasaki, Gunma, Japan; [Adachi, Yasushi] Toyooka Hosp, Div Clin Pathol, Toyooka, Hyogo, Japan	Kansai Medical University; Guangdong Medical University	Ikehara, S (corresponding author), Kansai Med Univ, Dept Stem Cell Disorders, Hirakata, Osaka, Japan.	ikehara@hirakata.kmu.ac.jp			Otsuka Pharmaceutical Company, Ltd.; Research on Allergic Disease and Immunology Committee from the Health and Labour Sciences Research of the Ministry of Health, Labour and Welfare	Otsuka Pharmaceutical Company, Ltd.(Otsuka Pharmaceutical); Research on Allergic Disease and Immunology Committee from the Health and Labour Sciences Research of the Ministry of Health, Labour and Welfare	This work was mainly supported by the Otsuka Pharmaceutical Company, Ltd., and by grants from the Research on Allergic Disease and Immunology Committee from the Health and Labour Sciences Research of the Ministry of Health, Labour and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Bunt SK, 2006, J IMMUNOL, V176, P284, DOI 10.4049/jimmunol.176.1.284; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Ikehara S, 2011, EXPERT REV CLIN IMMU, V7, P205, DOI [10.1586/eci.10.100, 10.1586/ECI.10.100]; Kamiryo Y, 2009, CANCER RES, V69, P5151, DOI 10.1158/0008-5472.CAN-08-2517; PEKAREK LA, 1995, J EXP MED, V181, P435, DOI 10.1084/jem.181.1.435; Ribechini E, 2009, EUR J IMMUNOL, V39, P3538, DOI 10.1002/eji.200939530; Ryu T, 2008, BONE MARROW TRANSPL, V41, P659, DOI 10.1038/sj.bmt.1705957; Sawanobori Y, 2008, BLOOD, V111, P5457, DOI 10.1182/blood-2008-01-136895; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; Shi M, 2013, J IMMUNOL, V190, P2976, DOI 10.4049/jimmunol.1201605; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Song XP, 2005, J IMMUNOL, V175, P8200, DOI 10.4049/jimmunol.175.12.8200; Suzuki Y, 2005, STEM CELLS, V23, P365, DOI 10.1634/stemcells.2004-0258; Welniak LA, 2007, ANNU REV IMMUNOL, V25, P139, DOI 10.1146/annurev.immunol.25.022106.141606; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Youn JI, 2010, EUR J IMMUNOL, V40, P2969, DOI 10.1002/eji.201040895; Zhao F, 2009, IMMUNOLOGY, V128, P141, DOI 10.1111/j.1365-2567.2009.03105.x	20	0	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97908	10.1371/journal.pone.0097908	http://dx.doi.org/10.1371/journal.pone.0097908			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847950	gold, Green Published, Green Submitted			2022-12-25	WOS:000336730600067
J	Guo, QF; Olden, JD				Guo, Qinfeng; Olden, Julian D.			Spatial Scaling of Non-Native Fish Richness across the United States	PLOS ONE			English	Article							FRESH-WATER FISHES; SPECIES RICHNESS; HUMAN-POPULATION; INVASIBILITY; DIVERSITY; BIODIVERSITY; COMMUNITY; INVASION; HOMOGENIZATION; PATTERNS	A major goal and challenge of invasion ecology is to describe and interpret spatial and temporal patterns of species invasions. Here, we examined fish invasion patterns at four spatially structured and hierarchically nested scales across the contiguous United States (i.e., from large to small: region, basin, watershed, and sub-watershed). All spatial relationships in both richness and fraction between species groups (e.g., natives vs. exotics) were positive at large scales. However, contrary to predictions using null/neutral models, the patterns at small scales were hump-shaped (unimodal), not simply negative. The fractions of both domestic (introduced among watersheds within the USA) and foreign (introduced from abroad) exotics increased with area across scales but decreased within each scale. The foreign exotics exhibited the highest dominance (lowest evenness) and spatial variation in distribution, followed by domestic exotics and natives, although on average natives still occupy larger areas than domestic and foreign exotics. The results provide new insight into patterns and mechanisms of fish species invasions at multiple spatial scales in the United States.	[Guo, Qinfeng] USDA FS, Eastern Forest Environm Threat Assessment Ctr, Asheville, NC 28804 USA; [Olden, Julian D.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	United States Department of Agriculture (USDA); United States Forest Service; University of Washington; University of Washington Seattle	Guo, QF (corresponding author), USDA FS, Eastern Forest Environm Threat Assessment Ctr, Asheville, NC 28804 USA.	qguo@fs.fed.us	Olden, Julian D/A-8535-2010	Olden, Julian/0000-0003-2143-1187; Higgs, Dennis/0000-0002-0771-4642	University of Washington	University of Washington(University of Washington)	We thank S. Fei and B. Iannone for helpful discussions on related topics, two anonymous reviewers for comments on the manuscript, J. Wen for assistance with data analyses, and W. Christie for assistance with GIS. Support to JDO was provided in part by the University of Washington H. Mason Keeler Endowed Professorship.	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Blanchett S, 2009, P ROY SOC B-BIOL SCI, V276, P2385, DOI 10.1098/rspb.2009.0156; Brown RL, 2003, ECOLOGY, V84, P32, DOI 10.1890/0012-9658(2003)084[0032:DAIOSA]2.0.CO;2; Byers JE, 2003, ECOLOGY, V84, P1428, DOI 10.1890/02-3131; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Clark GF, 2013, ECOLOGY, V94, P25, DOI 10.1890/12-0592.1; Davies KF, 2011, DIVERS DISTRIB, V17, P35, DOI 10.1111/j.1472-4642.2010.00721.x; Davies KF, 2005, ECOLOGY, V86, P1602, DOI 10.1890/04-1196; ELTON CS, 1958, ECOLOGY INVASIONS PL; Fridley JD, 2004, ECOLOGY, V85, P3215, DOI 10.1890/03-0676; Fuller PL, 1999, T 63 N AM WILDL NAT; Gido KB, 1999, FRESHWATER BIOL, V42, P387, DOI 10.1046/j.1365-2427.1999.444490.x; Guo QF, 2008, CONSERV BIOL, V22, P666, DOI 10.1111/j.1523-1739.2008.00915.x; Guo QF, 2010, DIVERS DISTRIB, V16, P1034, DOI 10.1111/j.1472-4642.2010.00708.x; Herben T, 2004, ECOLOGY, V85, P3223, DOI 10.1890/03-0648; Hortal J, 2007, CONSERV BIOL, V21, P853, DOI 10.1111/j.1523-1739.2007.00686.x; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Lee DC, 1997, PNW405 USDA FOR SERV, P1057; Leprieur F, 2009, J BIOGEOGR, V36, P1899, DOI 10.1111/j.1365-2699.2009.02107.x; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; Luck GW, 2007, BIOL REV, V82, P607, DOI 10.1111/j.1469-185X.2007.00028.x; McKinney ML, 2002, DIVERS DISTRIB, V8, P311, DOI 10.1046/j.1472-4642.2002.00153.x; Mitchell AL, 2009, BIOL INVASIONS, V11, P1441, DOI 10.1007/s10530-008-9352-9; NatureServe, 2010, DOWNL AN DAT; Oberdorff Thierry, 2011, International Journal of Ecology, V2011, DOI 10.1155/2011/967631; Olden JD, 2004, ECOLOGY, V85, P1867, DOI 10.1890/03-3131; Olden JD, 2008, GLOBAL ECOL BIOGEOGR, V17, P25, DOI 10.1111/j.1466-8238.2007.00340.x; Olden JD, 2010, DIVERS DISTRIB, V16, P496, DOI 10.1111/j.1472-4642.2010.00655.x; Rahel FJ, 2000, SCIENCE, V288, P854, DOI 10.1126/science.288.5467.854; Rahel FJ, 2008, CONSERV BIOL, V22, P521, DOI 10.1111/j.1523-1739.2008.00950.x; Sanchez-Fernandez D, 2008, DIVERS DISTRIB, V14, P754, DOI 10.1111/j.1472-4642.2008.00474.x; SAS Institute, 2011, SAS STAT 9 3 US GUID; Sax DF, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P447; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Tomasetto F, 2013, DIVERS DISTRIB, V19, P49, DOI 10.1111/j.1472-4642.2012.00939.x; Villeger S, 2011, P NATL ACAD SCI USA, V108, P18003, DOI 10.1073/pnas.1107614108; Von Holle B, 2013, BIOL INVASIONS, V15, P417, DOI 10.1007/s10530-012-0297-7; Williamson M., 1996, BIOL INVASIONS	39	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97727	10.1371/journal.pone.0097727	http://dx.doi.org/10.1371/journal.pone.0097727			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844226	Green Published, gold			2022-12-25	WOS:000339563400051
J	Lin, LZ; Deng, WG; Tian, Y; Chen, WB; Wang, JS; Fu, LY; Shi, DB; Zhao, MM; Luo, W				Lin, Lianzhu; Deng, Wuguo; Tian, Yun; Chen, Wangbing; Wang, Jingshu; Fu, Lingyi; Shi, Dingbo; Zhao, Mouming; Luo, Wei			Lasiodin Inhibits Proliferation of Human Nasopharyngeal Carcinoma Cells by Simultaneous Modulation of the Apaf-1/Caspase, AKT/MAPK and COX-2/NF-kappa B Signaling Pathways	PLOS ONE			English	Article							SERRA MAXIM. HARA; FACTOR-KAPPA-B; FIBROSARCOMA L929 CELLS; RABDOSIA-SERRA; ENT-KAURANE; CANCER CHEMOPREVENTION; ROSMARINIC ACID; CLINICAL-TRIAL; LEAF; DITERPENOIDS	Rabdosia serra has been widely used for the treatment of the various human diseases. However, the antiproliferative effects and underlying mechanisms of the compounds in this herb remain largely unknown. In this study, an antiproliferative compound against human nasopharyngeal carcinoma (NPC) cells from Rabdosia serra was purified and identified as lasiodin (a diterpenoid). The treatment with lasiodin inhibited cell viability and migration. Lasiodin also mediated the cell morphology change and induced apoptosis in NPC cells. The treatment with lasiodin induced the Apaf-1 expression, triggered the cytochrome-C release, and stimulated the PARP, caspase-3 and caspase-9 cleavages, thereby activating the apoptotic pathways. The treatment with lasiodin also significantly inhibited the phosphorylations of the AKT, ERK1/2, p38 and JNK proteins. The pretreatment with the AKT or MAPK-selective inhibitors considerably blocked the lasiodin-mediated inhibition of cell proliferation. Moreover, the treatment with lasiodin inhibited the COX-2 expression, abrogated NF-kappa B binding to the COX-2 promoter, and promoted the NF-kB translocation from cell nuclei to cytosol. The pretreatment with a COX-2-selective inhibitor abrogated the lasiodin-induced inhibition of cell proliferation. These results indicated that lasiodin simultaneously activated the Apaf-1/caspase-dependent apoptotic pathways and suppressed the AKT/MAPK and COX-2/NF-kappa B signaling pathways. This study also suggested that lasiodin could be a promising natural compound for the prevention and treatment of NPC.	[Lin, Lianzhu; Zhao, Mouming] S China Univ Technol, Coll Light Ind & Food Sci, Guangzhou, Guangdong, Peoples R China; [Deng, Wuguo; Tian, Yun; Chen, Wangbing; Wang, Jingshu; Fu, Lingyi; Shi, Dingbo] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Zhao, Mouming] S China Univ Technol, State Key Lab Pulp & Paper Engn, Guangzhou, Guangdong, Peoples R China; [Luo, Wei] S China Univ Technol, Anal & Test Ctr, Guangzhou, Guangdong, Peoples R China	South China University of Technology; State Key Lab Oncology South China; Sun Yat Sen University; South China University of Technology; South China University of Technology	Deng, WG (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.	dengwg@sysucc.org.cn			Science and Technology Planning Project of Guangdong Province in China [2009B011300004]; National Natural Science Foundation of China [31071638, 31101221/C200101]; Fundamental Research Funds for the Central Universities [2014ZB0010]	Science and Technology Planning Project of Guangdong Province in China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The study is supported by the grants from the Science and Technology Planning Project of Guangdong Province in China (No. 2009B011300004), the National Natural Science Foundation of China (No. 31071638), the National Natural Science Foundation of China (No. 31101221/C200101) and Fundamental Research Funds for the Central Universities (Project No. 2014ZB0010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Bai NS, 2010, PLANTA MED, V76, P140, DOI 10.1055/s-0029-1186002; BALLARD DW, 1992, P NATL ACAD SCI USA, V89, P1875, DOI 10.1073/pnas.89.5.1875; Blanco AM, 2004, ALCOHOL CLIN EXP RES, V28, p23A, DOI 10.1097/00000374-200408002-00096; Bratton SB, 2001, EMBO J, V20, P998, DOI 10.1093/emboj/20.5.998; Chen XA, 2000, CHINESE CHEM LETT, V11, P229; Cheng Y, 2009, AUTOPHAGY, V5, P430, DOI 10.4161/auto.5.3.7896; Cheng Y, 2009, FEBS J, V276, P1291, DOI 10.1111/j.1742-4658.2008.06864.x; Deng WG, 2003, ANAL BIOCHEM, V323, P12, DOI 10.1016/j.ab.2003.08.007; FUJITA E, 1976, EXPERIENTIA, V32, P203, DOI 10.1007/BF01937766; He F, 2009, PHYTOCHEMISTRY, V70, P1462, DOI 10.1016/j.phytochem.2009.07.037; Huang J, 2007, CANCER RES, V67, P1589, DOI 10.1158/0008-5472.CAN-06-2472; Jin HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040355; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kauntz H, 2011, APOPTOSIS, V16, P1042, DOI 10.1007/s10495-011-0631-z; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kucuk O, 2004, J NUTR, V134, p1262S; Leung CH, 2005, MOL PHARMACOL, V68, P286, DOI 10.1124/mol.105.012765; Li XJ, 2011, CANCER RES, V71, P3162, DOI 10.1158/0008-5472.CAN-10-3557; Lin LZ, 2013, FOOD CHEM, V139, P902, DOI 10.1016/j.foodchem.2013.01.001; Lin LZ, 2013, FOOD CHEM, V136, P555, DOI 10.1016/j.foodchem.2012.08.048; Lin LZ, 2012, FOOD CHEM, V135, P730, DOI 10.1016/j.foodchem.2012.05.029; Lin LZ, 2012, FOOD CHEM, V131, P1009, DOI 10.1016/j.foodchem.2011.09.105; Lin LZ, 2012, FOOD CHEM, V130, P417, DOI 10.1016/j.foodchem.2011.07.069; Lin LZ, 2011, FOOD CHEM, V129, P884, DOI 10.1016/j.foodchem.2011.05.039; Lin LZ, 2011, COMB CHEM HIGH T SCR, V14, P720, DOI 10.2174/138620711796504352; Lin LZ, 2011, FOOD CHEM, V126, P54, DOI 10.1016/j.foodchem.2010.10.060; Linden KG, 2003, CANCER EPIDEM BIOMAR, V12, p1280S; Liou JY, 2001, J BIOL CHEM, V276, P34975, DOI 10.1074/jbc.M105946200; Liu PW, 2010, CHROMATOGRAPHIA, V72, P265, DOI 10.1365/s10337-010-1642-6; Liu Y, 2012, BIOL PHARM BULL, V35, P1150, DOI 10.1248/bpb.b12-00197; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Prasad KN, 2010, FOOD CHEM, V118, P62, DOI 10.1016/j.foodchem.2009.04.073; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Shehzad A, 2010, ARCH PHARM, V343, P489, DOI 10.1002/ardp.200900319; Shu LM, 2010, CANCER METAST REV, V29, P483, DOI 10.1007/s10555-010-9239-y; Wang JS, 2012, J PINEAL RES, V53, P77, DOI 10.1111/j.1600-079X.2012.00973.x; Xiao C, 2001, J CHEM RES-S, P148; Xiao WW, 2011, CANCER-AM CANCER SOC, V117, P1874, DOI 10.1002/cncr.25754; Xiao XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022934; Zhang Y, 2005, INT IMMUNOPHARMACOL, V5, P1957, DOI 10.1016/j.intimp.2005.06.016; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	44	13	13	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97799	10.1371/journal.pone.0097799	http://dx.doi.org/10.1371/journal.pone.0097799			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845412	Green Published, gold, Green Submitted			2022-12-25	WOS:000339563400061
J	Paz-Gomez, D; Villanueva-Chimal, E; Navarro, RE				Paz-Gomez, Daniel; Villanueva-Chimal, Emmanuel; Navarro, Rosa E.			The DEAD Box RNA Helicase VBH-1 Is a New Player in the Stress Response in C. elegans	PLOS ONE			English	Article							MATERNAL MESSENGER-RNAS; CAENORHABDITIS-ELEGANS; GERM-LINE; HEAT-SHOCK; LIFE-SPAN; SEX DETERMINATION; STEM-CELLS; PROTEIN; VASA; TRANSLATION	For several years, DEAD box RNA helicase Vasa (DDX4) has been used as a bona fide germline marker in different organisms. C. elegans VBH-1 is a close homolog of the Vasa protein, which plays an important role in gametogenesis, germ cell survival and embryonic development. Here, we show that VBH-1 protects nematodes from heat shock and oxidative stress. Using the germline-defective mutant glp-4(bn2) we found that a potential somatic expression of vbh-1 might be important for stress survival. We also show that the VBH-1 paralog LAF-1 is important for stress survival, although this protein is not redundant with its counterpart. Furthermore, we observed that the mRNAs of the heat shock proteins hsp-1 and sip-1 are downregulated when vbh-1 or laf-1 are silenced. Previously, we reported that in C. elegans, VBH-1 was primarily expressed in P granules of germ cells and in the cytoplasm of all blastomeres. Here we show that during stress, VBH-1 co-localizes with CGH-1 in large aggregates in the gonad core and oocytes; however, VBH-1 aggregates do not overlap with CGH-1 foci in early embryos under the same conditions. These data demonstrate that, in addition to the previously described role for this protein in the germline, VBH-1 plays an important role during the stress response in C. elegans through the potential direct or indirect regulation of stress response mRNAs.	[Paz-Gomez, Daniel; Villanueva-Chimal, Emmanuel; Navarro, Rosa E.] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular & Desarrollo, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Navarro, RE (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular & Desarrollo, Mexico City 04510, DF, Mexico.	rnavarro@ifc.unam.mx	Paz-Gomez, Daniel/N-6365-2018	Paz-Gomez, Daniel/0000-0001-5040-1468; Navarro, Rosa/0000-0003-4992-4450	LOREAL/UNESCO; PAPIIT-UNAM [IN225509, IN207412]; CONACYT-MEXICO [50896Q, 103856-Q]; CONACyT-Mexico; CONACyT [103856-Q]	LOREAL/UNESCO; PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); CONACYT-MEXICO(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This project was supported by grants from LOREAL/UNESCO, PAPIIT-UNAM (IN225509 and IN207412) and CONACYT-MEXICO (50896Q and 103856-Q). This study was performed in partial fulfillment of the requirements for the Ph.D. degree in Biomedical Sciences of DP at the Universidad Nacional Autonoma de Mexico. DP received a Ph.D. fellowship from CONACyT-Mexico and a CONACyT/Grant fellowship (103856-Q) to complete his studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper S, 2010, J BIOL CHEM, V285, P1822, DOI 10.1074/jbc.M109.057323; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Arsenovic PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044038; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Bezares-Calderon LA, 2010, DEV GENES EVOL, V220, P41, DOI 10.1007/s00427-010-0327-3; Boag PR, 2008, J CELL BIOL, V182, P543, DOI 10.1083/jcb.200801183; Breitwieser W, 1996, GENE DEV, V10, P2179, DOI 10.1101/gad.10.17.2179; BRENNER S, 1974, GENETICS, V77, P71; Carrera P, 2000, MOL CELL, V5, P181, DOI 10.1016/S1097-2765(00)80414-1; Chao CH, 2006, CANCER RES, V66, P6579, DOI 10.1158/0008-5472.CAN-05-2415; Clifford R, 2000, DEVELOPMENT, V127, P5265; CLOKEY GV, 1986, MECH AGEING DEV, V35, P79, DOI 10.1016/0047-6374(86)90068-0; Conte Jr D, 2003, CURRENT PROTOCOLS MO; Ding L, 2000, BIOCHEM J, V351, P13, DOI 10.1042/0264-6021:3510013; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Frokjaer-Jensen C, 2012, NAT METHODS, V9, P117, DOI 10.1038/nmeth.1865; Goulet I, 2008, HUM MOL GENET, V17, P3055, DOI 10.1093/hmg/ddn203; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Gustafson EA, 2010, BIOESSAYS, V32, P626, DOI 10.1002/bies.201000001; Hashimoto H, 2008, GYNECOL ONCOL, V111, P312, DOI 10.1016/j.ygyno.2008.08.014; HAY B, 1988, CELL, V55, P577, DOI 10.1016/0092-8674(88)90216-4; Hernandez G, 2004, RNA, V10, P1783, DOI 10.1261/rna.7154104; Hird SN, 1996, DEVELOPMENT, V122, P1303; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hubert A, 2009, DEV BIOL, V330, P358, DOI 10.1016/j.ydbio.2009.04.003; Ihry RJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003085; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Johnstone O, 2005, DEV BIOL, V277, P92, DOI 10.1016/j.ydbio.2004.09.009; Johnstone O, 2004, DEVELOPMENT, V131, P4167, DOI 10.1242/dev.01286; Jud M, 2007, DEV GENES EVOL, V217, P221, DOI 10.1007/s00427-006-0130-3; Jud MC, 2008, DEV BIOL, V318, P38, DOI 10.1016/j.ydbio.2008.02.059; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Lai MC, 2008, MOL BIOL CELL, V19, P3847, DOI 10.1091/mbc.E07-12-1264; LASKO PF, 1990, GENE DEV, V4, P905, DOI 10.1101/gad.4.6.905; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; Li DR, 2012, BIOTECHNIQUES, V52, P173, DOI 10.2144/000113821; Li Y, 2006, CANCER RES, V66, P8520, DOI 10.1158/0008-5472.CAN-05-4364; Linder B, 1996, J BIOL CHEM, V271, P30158, DOI 10.1074/jbc.271.47.30158; Liu HY, 2002, J BIOL CHEM, V277, P2637, DOI 10.1074/jbc.M109016200; Liu NK, 2009, GENE DEV, V23, P2742, DOI 10.1101/gad.1820709; MADURO M, 1995, GENETICS, V141, P977; McGhee James D, 2007, WormBook, P1; Mendenhall AR, 2009, PHYSIOL GENOMICS, V36, P167, DOI 10.1152/physiolgenomics.90278.2008; Merritt C, 2008, CURR BIOL, V18, P1476, DOI 10.1016/j.cub.2008.08.013; Navarro RE, 2001, DEVELOPMENT, V128, P3221; Noble SL, 2008, J CELL BIOL, V182, P559, DOI 10.1083/jcb.200802128; Owttrim GW, 2006, NUCLEIC ACIDS RES, V34, P3220, DOI 10.1093/nar/gkl408; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; Pek JW, 2011, P NATL ACAD SCI USA, V108, P12007, DOI 10.1073/pnas.1106245108; Pek JW, 2011, CURR BIOL, V21, P39, DOI 10.1016/j.cub.2010.11.051; Praitis V, 2001, GENETICS, V157, P1217; Prakash JSS, 2010, MICROBIOL-SGM, V156, P442, DOI 10.1099/mic.0.031823-0; Rajyaguru P, 2009, TRENDS CELL BIOL, V19, P24, DOI 10.1016/j.tcb.2008.11.001; Raz E, 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-3-reviews1017, DOI 10.1186/GB-2000-1-3-REVIEWS1017]; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Rubtsova MP, 2003, J BIOL CHEM, V278, P22350, DOI 10.1074/jbc.M303213200; Salinas LS, 2006, CELL DEATH DIFFER, V13, P2129, DOI 10.1038/sj.cdd.4401976; Salinas LS, 2007, GENESIS, V45, P533, DOI 10.1002/dvg.20323; Salinas LS, 2012, GENESIS, V50, P801, DOI 10.1002/dvg.22043; Schade B, 2004, MOL BIOL CELL, V15, P5492, DOI 10.1091/mbc.E04-03-0167; SCHEDL T, 1988, GENETICS, V119, P43; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shibata N, 1999, DEV BIOL, V206, P73, DOI 10.1006/dbio.1998.9130; Shih JW, 2008, ONCOGENE, V27, P700, DOI 10.1038/sj.onc.1210687; Shih JW, 2012, BIOCHEM J, V441, P119, DOI 10.1042/BJ20110739; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; SNUTCH TP, 1988, GENE, V64, P241, DOI 10.1016/0378-1119(88)90339-3; Stiernagle Theresa, 2006, WormBook, P1; Strome S, 2001, MOL BIOL CELL, V12, P1751, DOI 10.1091/mbc.12.6.1751; Sun M, 2008, CELL DEATH DIFFER, V15, P1887, DOI 10.1038/cdd.2008.124; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Voronina E, 2008, DEV BIOL, V314, P276, DOI 10.1016/j.ydbio.2007.11.039; Yajima M, 2011, MOL REPROD DEV, V78, P861, DOI 10.1002/mrd.21363; Yajima M, 2011, DEVELOPMENT, V138, P2217, DOI 10.1242/dev.065052; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022	77	12	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97924	10.1371/journal.pone.0097924	http://dx.doi.org/10.1371/journal.pone.0097924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844228	Green Published, Green Submitted, gold			2022-12-25	WOS:000339563400071
J	Bochem, AE; Holleboom, AG; Romijn, JA; Hoekstra, M; Dallinga, GM; Motazacker, MM; Hovingh, GK; Kuivenhoven, JA; Stroes, ESG				Bochem, Andrea E.; Holleboom, Adriaan G.; Romijn, Johannes A.; Hoekstra, Menno; Dallinga, Geesje M.; Motazacker, Mahdi M.; Hovingh, G. Kees; Kuivenhoven, Jan A.; Stroes, Erik S. G.			Adrenal Function in Females with Low Plasma HDL-C Due to Mutations in ABCA1 and LCAT	PLOS ONE			English	Article							CHOLESTERYL ESTER UPTAKE; HIGH-DENSITY-LIPOPROTEIN; ADRENOCORTICOTROPIN STIMULATION; FAMILIAL HYPERCHOLESTEROLEMIA; CORTISOL RESPONSE; SR-BI; STEROIDOGENESIS; INTERLEUKIN-6; RECEPTOR; HORMONE	Introduction: Adrenal steroidogenesis is essential for human survival and depends on the availability of the precursor cholesterol. Male subjects with low plasma levels of high density lipoprotein (HDL) cholesterol are characterized by decreased adrenal function. Whether this is also the case in female subjects with low plasma HDL-C levels is unresolved to date. Findings: 15 female ATP binding cassette transporter AI (ABCAI) and 14 female lecithin-cholesterol acyltransferase (LCAT) were included in the study. HDL-C levels were 38% and 41% lower in ABCA1 and LCAT mutation carriers compared to controls, respectively. Urinary steroid excretion of 17-ketogenic steroids or 17-hydroxy corticosteroids did not differ between 15 female ABCA1 mutation carriers (p = 0.27 vs 0.30 respectively) and 30 matched normolipidemic controls or between 14 female LCAT mutation carriers and 28 matched normolipidemic controls (p = 0.10 and 0.14, respectively). Cosyntropin testing in an unselected subgroup of 8 ABCA1 mutation carriers and 3 LCAT mutation carriers did not reveal differences between carriers and controls. Conclusion: Adrenal function in females with molecularly defined low HDL-C levels is not different from controls. The discrepancy with the finding of impaired steroidogenesis in males with molecularly defined low HDL-C levels underscores the importance of gender specific analyses in cholesterol-related research.	[Bochem, Andrea E.; Holleboom, Adriaan G.; Dallinga, Geesje M.; Hovingh, G. Kees; Stroes, Erik S. G.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Romijn, Johannes A.] Univ Amsterdam, Acad Med Ctr, Dept Med, NL-1105 AZ Amsterdam, Netherlands; [Hoekstra, Menno] Leiden Amsterdam Ctr Drug Res, Leiden, Netherlands; [Dallinga, Geesje M.; Motazacker, Mahdi M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Kuivenhoven, Jan A.] Univ Groningen, Univ Med Ctr Groningen, Med Biol Sect, Dept Pathol & Med Biol, NL-9700 AB Groningen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen	Bochem, AE (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	a.e.bochem@amc.nl		Hoekstra, Menno/0000-0001-7463-2893; Holleboom, A.G. (Onno)/0000-0002-2911-2917	Dutch Heart Foundation [2009B027, 2008B070, 2008T070]; Fondation LeDucq; Veni Grants from the Netherlands Organisation for Scientific Research (NWO) [91612122, 91613031]	Dutch Heart Foundation(Netherlands Heart Foundation); Fondation LeDucq(Leducq Foundation); Veni Grants from the Netherlands Organisation for Scientific Research (NWO)	This study was supported by three grants from the Dutch Heart Foundation (numbers 2009B027, 2008B070 and 2008T070). A. E. B. and M. M. M. are supported by a grant from Fondation LeDucq. G. K. H. and A. G. H. are supported by Veni Grants (project numbers 91612122 and 91613031, respectively) from the Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azhar S, 2003, FRONT BIOSCI-LANDMRK, V8, pS998, DOI 10.2741/1165; Azhar S, 2002, MOL CELL ENDOCRINOL, V195, P1, DOI 10.1016/S0303-7207(02)00222-8; AZHAR S, 1989, J LIPID RES, V30, P1799; Bethin KE, 2000, P NATL ACAD SCI USA, V97, P9317, DOI 10.1073/pnas.97.16.9317; Bochem AE, 2013, J LIPID RES, V54, P1698, DOI 10.1194/jlr.P033449; BORKOWSKI A, 1972, J CLIN INVEST, V51, P1664, DOI 10.1172/JCI106968; BORKOWSKI AJ, 1967, J CLIN INVEST, V46, P797, DOI 10.1172/JCI105580; Calabresi L, 2009, CIRCULATION, V120, P628, DOI 10.1161/CIRCULATIONAHA.108.818143; Candini C, 2010, ATHEROSCLEROSIS, V213, P492, DOI 10.1016/j.atherosclerosis.2010.08.062; Clark PM, 1998, CLIN ENDOCRINOL, V49, P287; COOLENS JL, 1987, J STEROID BIOCHEM, V26, P197, DOI 10.1016/0022-4731(87)90071-9; Doi SAR, 2006, CLIN CHEM, V52, P746, DOI 10.1373/clinchem.2005.061267; Duivenvoorden R, 2011, J AM COLL CARDIOL, V58, P2481, DOI 10.1016/j.jacc.2010.11.092; Fraser R, 1999, HYPERTENSION, V33, P1364, DOI 10.1161/01.HYP.33.6.1364; Hoekstra M, 2008, J LIPID RES, V49, P738, DOI 10.1194/jlr.M700475-JLR200; Hoekstra M, 2009, J LIPID RES, V50, P1039, DOI 10.1194/jlr.M800410-JLR200; Holleboom AG, 2010, J LIPID RES, V51, P416, DOI 10.1194/P900038-JLR200; Holleboom AG, 2011, HUM MUTAT, V10; Hu J, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-47; ILLINGWORTH DR, 1984, J CLIN ENDOCR METAB, V58, P206, DOI 10.1210/jcem-58-1-206; ILLINGWORTH DR, 1983, METABOLISM, V32, P1045, DOI 10.1016/0026-0495(83)90075-6; ILLINGWORTH DR, 1982, J LAB CLIN MED, V100, P115; ILLINGWORTH DR, 1982, J CLIN ENDOCR METAB, V54, P27, DOI 10.1210/jcem-54-1-27; ILLINGWORTH DR, 1980, J CLIN ENDOCR METAB, V50, P977, DOI 10.1210/jcem-50-5-977; Marik PE, 2005, CRIT CARE MED, V33, P1254, DOI 10.1097/01.CCM.0000164541.12106.57; O'Connor MF, 2007, AM J PHYSIOL-REG I, V293, pR145, DOI 10.1152/ajpregu.00752.2006; Papadopoulos AD, 2000, NEUROIMMUNOMODULAT, V8, P39, DOI 10.1159/000026451; Path G, 1997, J CLIN ENDOCR METAB, V82, P2343, DOI 10.1210/jc.82.7.2343; Puder JJ, 2001, J CLIN ENDOCR METAB, V86, P2403, DOI 10.1210/jc.86.6.2403; REAVEN E, 1984, J CLIN INVEST, V74, P1384, DOI 10.1172/JCI111549; Silva C, 2002, ANN NY ACAD SCI, V966, P68, DOI 10.1111/j.1749-6632.2002.tb04203.x; Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516; Thaler LM, 1998, J CLIN ENDOCR METAB, V83, P2726, DOI 10.1210/jc.83.8.2726; van Dam MJ, 2002, LANCET, V359, P37, DOI 10.1016/S0140-6736(02)07277-X; van der Voort PHJ, 2003, INTENS CARE MED, V29, P2199, DOI 10.1007/s00134-003-2021-7; VANDECALSEYDE JF, 1972, CLIN CHIM ACTA, V38, P103, DOI 10.1016/0009-8981(72)90214-8; Vergeer M, 2011, NEW ENGL J MED, V364, P136, DOI 10.1056/NEJMoa0907687; WEYKAMP CW, 1989, CLIN CHEM, V35, P2281; Yaguchi H, 1998, LIFE SCI, V62, P1387, DOI 10.1016/S0024-3205(98)00077-0	39	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e90967	10.1371/journal.pone.0090967	http://dx.doi.org/10.1371/journal.pone.0090967			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842300	Green Published, Green Submitted, gold			2022-12-25	WOS:000340948600001
J	Xie, R; Xu, JY; Wen, GR; Jin, H; Liu, XM; Yang, Y; Ji, B; Jiang, YX; Song, PH; Dong, H; Tuo, BG				Xie, Rui; Xu, Jingyu; Wen, Guorong; Jin, Hai; Liu, Xuemei; Yang, Yuan; Ji, Bei; Jiang, Yixia; Song, Penghong; Dong, Hui; Tuo, Biguang			The P2Y(2) Nucleotide Receptor Mediates the Proliferation and Migration of Human Hepatocellular Carcinoma Cells Induced by ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR ATP; PURINERGIC RECEPTORS; CANCER CELLS; LIVER-CANCER; P2 RECEPTORS; INFLAMMATION; EXPRESSION; CALCIUM; HEPATOCYTES; ROLES	ATP is an abundant biochemical component of the tumor microenvironment and a physiologic ligand for the P2Y(2) nucleotide receptor (P2Y(2)R). In this study, we investigated the effect of ATP on the cellular behavior of human hepatocellular carcinoma (HCC) cells and the role of P2Y(2)R in ATP action and aimed to find a new therapeutic target against HCC. The experiments were performed in native isolated human HCC cells, normal hepatocytes, human HCC cell lines, and nude mice. We found that the mRNA and protein expression levels of P2Y(2)R in native human HCC cells and the human HCC cell lines HepG2 and BEL-7404 were enhanced markedly compared with human normal hepatocytes and the normal hepatocyte line LO2, respectively. ATP induced intracellular Ca2+ increases in HCC cells and promoted the proliferation and migration of HCC cells and the growth of HCC in nude mice. The P2Y receptor antagonist suramin, P2Y(2)R-specific shRNA, the store-operated calcium channel inhibitors 2-aminoethoxydiphenyl borate (2-APB) and 1-(beta-3-(4-methoxyphenyl) propoxyl-4-methoxyphenethyl) 1H-imidazolehydrochloride (SKF96365), and stromal interaction molecule (STIM1)-specific shRNA inhibited the action of ATP on HCC cells. In conclusion, P2Y(2)R mediated the action of ATP on the cellular behavior of HCC cells through store-operated calcium channel-mediated Ca2+ signaling, and targeting P2Y(2)R may be a promising therapeutic strategy against human HCC.	[Xie, Rui; Xu, Jingyu; Wen, Guorong; Jin, Hai; Liu, Xuemei; Yang, Yuan; Ji, Bei; Jiang, Yixia; Dong, Hui; Tuo, Biguang] Zunyi Med Coll, Affiliated Hosp, Dept Gastroenterol, Zunyi 563003, Peoples R China; [Xie, Rui; Xu, Jingyu; Wen, Guorong; Jin, Hai; Liu, Xuemei; Yang, Yuan; Ji, Bei; Jiang, Yixia; Dong, Hui; Tuo, Biguang] Digest Dis Inst Guizhou Prov, Zunyi 563003, Peoples R China; [Xu, Jingyu; Wen, Guorong; Jin, Hai; Tuo, Biguang] Zunyi Med Coll, Res Ctr Med & Biol, Zunyi 563003, Peoples R China; [Song, Penghong] Zhejiang Univ, Key Lab Combined Multiorgan Transplantat, Minist Publ Hlth, Affiliated Hosp 1,Sch Med, Hangzhou 310003, Zhejiang, Peoples R China	Zunyi Medical University; Zunyi Medical University; Zhejiang University	Dong, H (corresponding author), Zunyi Med Coll, Affiliated Hosp, Dept Gastroenterol, 149 Dalian Rd, Zunyi 563003, Peoples R China.	h2dong@ucsd.edu; tuobiguang@aliyun.com			National Natural Science Foundation of China [91129719, 81160265, 81272675]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Major Research Program of National Natural Science Foundation of China Grant 91129719 (to B. T.), by National Natural Science Foundation of China Grant 81160265 (to J. X.), and by National Natural Science Foundation of China Grant 81272675 (to P. S.).	Birrer RB, 2003, ANN CLIN LAB SCI, V33, P39; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Chiba T, 2012, GASTROENTEROLOGY, V143, P550, DOI 10.1053/j.gastro.2012.07.009; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Di Virgilio F, 2012, CANCER RES, V72, P5441, DOI 10.1158/0008-5472.CAN-12-1600; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Geschwind JFH, 2002, CANCER RES, V62, P3909; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Kolachala VL, 2008, AM J PHYSIOL-GASTR L, V294, pG401, DOI 10.1152/ajpgi.00454.2007; Kunzli BM, 2007, AM J PHYSIOL-GASTR L, V292, pG223, DOI 10.1152/ajpgi.00259.2006; Lewis RS, 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A003970; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Madsen CP, 2012, AM J PHYSIOL-CELL PH, V303, pC625, DOI 10.1152/ajpcell.00287.2011; Mbeunkui F, 2009, CANCER CHEMOTH PHARM, V63, P571, DOI 10.1007/s00280-008-0881-9; Minguez B, 2009, CURR OPIN GASTROEN, V25, P186, DOI 10.1097/MOG.0b013e32832962a1; Molnar T, 2012, J PHYSIOL-LONDON, V590, P3465, DOI 10.1113/jphysiol.2012.234641; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Nylund G., 2007, Autonomic & Autacoid Pharmacology, V27, P79, DOI 10.1111/j.1474-8673.2007.00389.x; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Roman RM, 1999, GASTROENTEROLOGY, V116, P964, DOI 10.1016/S0016-5085(99)70081-8; Sanyal AJ, 2010, ONCOLOGIST, V15, P14, DOI 10.1634/theoncologist.2010-S4-14; Schafer R, 2003, AM J PHYSIOL-LUNG C, V285, pL376, DOI 10.1152/ajplung.00447.2002; Schofl C, 1999, AM J PHYSIOL-GASTR L, V276, pG164, DOI 10.1152/ajpgi.1999.276.1.G164; Sun XF, 2013, HEPATOLOGY, V57, P205, DOI 10.1002/hep.25989; Takai E, 2012, J CELL SCI, V125, P5051, DOI 10.1242/jcs.104976; Thevananther S, 2004, HEPATOLOGY, V39, P393, DOI 10.1002/hep.20075; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; von Kugelgen I, 2011, ADV PHARMACOL, V61, P373, DOI 10.1016/B978-0-12-385526-8.00012-6; Wagstaff SC, 2000, CARCINOGENESIS, V21, P2175, DOI 10.1093/carcin/21.12.2175; Xu JY, 2012, CARCINOGENESIS, V33, P2432, DOI 10.1093/carcin/bgs277; Zhang Y, 2010, CANCER LETT, V293, P189, DOI 10.1016/j.canlet.2010.01.010	31	58	63	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19137	19149		10.1074/jbc.M113.540047	http://dx.doi.org/10.1074/jbc.M113.540047			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24847054	Green Published, hybrid			2022-12-25	WOS:000339062900043
J	Mesman, S; von Oerthel, L; Smidt, MP				Mesman, Simone; von Oerthel, Lars; Smidt, Marten P.			Mesodiencephalic Dopaminergic Neuronal Differentiation Does Not Involve GLI2A-Mediated SHH-Signaling and Is under the Direct Influence of Canonical WNT Signaling	PLOS ONE			English	Article							PROGENITORS IN-VIVO; SONIC-HEDGEHOG; FLOOR PLATE; NEURAL PLATE; MIDBRAIN; EXPRESSION; MOUSE; MICE; MESENCEPHALON; NEUROGENESIS	Sonic Hedgehog (SHH) and WNT proteins are key regulators in many developmental processes, like embryonic patterning and brain development. In the brain, SHH is expressed in a gradient starting in the floor plate (FP) progressing ventrally in the midbrain, where it is thought to be involved in the development and specification of mesodiencephalic dopaminergic (mdDA) neurons. GLI2A-mediated SHH-signaling induces the expression of Gli1, which is inhibited when cells start expressing SHH themselves. To determine whether mdDA neurons receive GLI2A-mediated SHH-signaling during differentiation, we used a BAC-transgenic mouse model expressing eGFP under the control of the Gli1 promoter. This mouse-model allowed for mapping of GLI2A-mediated SHH-signaling temporal and spatial in the mouse midbrain. Since mdDA neurons are born from E10.5, peaking at E11.0-E12.0, we examined Gli1-eGFP embryos at E11.5, E12.5, and E13.5, indicating whether Gli1 was induced before or during mdDA development and differentiation. Our data indicate that GLI2A-mediated SHH-signaling is not involved in mdDA neuronal differentiation. However, it appears to be involved in the differentiation of neurons which make up a subset of the red nucleus (RN). In order to detect whether mdDA neuronal differentiation may be under the control of canonical WNT-signaling, we used a transgenic mouse-line expressing LacZ under the influence of stable beta-catenin. Here, we show that TH+ neurons of the midbrain receive canonical WNT-signaling during differentiation. Therefore, we suggest that early SHH-signaling is indirectly involved in mdDA development through early patterning of the midbrain area, whereas canonical WNT-signaling is directly involved in the differentiation of the mdDA neuronal population.	[Mesman, Simone; von Oerthel, Lars; Smidt, Marten P.] FNWI Univ Amsterdam, CNS, Swammerdam Inst Life Sci, Amsterdam, Netherlands	University of Amsterdam	Smidt, MP (corresponding author), FNWI Univ Amsterdam, CNS, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	m.p.smidt@uva.nl		Smidt, Marten/0000-0002-8815-747X; Mesman, Simone/0000-0002-9728-5828	NWO-ALW (Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Aard en Levenswetenschappen) VICI grant [865.09.002]	NWO-ALW (Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Aard en Levenswetenschappen) VICI grant	This work was sponsored by the NWO-ALW (Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Aard en Levenswetenschappen) VICI grant (865.09.002) awarded to Prof. Dr. Marten P. Smidt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboitiz F, 2001, BRAIN RES REV, V38, P129, DOI 10.1016/S0006-8993(01)02902-X; Bai CB, 2002, DEVELOPMENT, V129, P4753; BAYER SA, 1995, EXP BRAIN RES, V105, P191; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Blaess S, 2006, DEVELOPMENT, V133, P1799, DOI 10.1242/dev.02339; Blaess S, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-29; Bonilla S, 2008, GLIA, V56, P809, DOI 10.1002/glia.20654; Brown A, 2011, J COMP NEUROL, V519, P2978, DOI 10.1002/cne.22710; BURRUS LW, 1995, EXP CELL RES, V220, P363, DOI 10.1006/excr.1995.1327; Bye CR, 2012, EXP NEUROL, V236, P58, DOI 10.1016/j.expneurol.2012.04.002; Cheng SL, 2008, J BIOL CHEM, V283, P20505, DOI 10.1074/jbc.M800851200; Demyanenko GP, 2001, DEV BRAIN RES, V126, P21, DOI 10.1016/S0165-3806(00)00129-2; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; Di Salvio M, 2010, NAT NEUROSCI, V13, P1481, DOI 10.1038/nn.2661; Elshatory Y, 2007, J COMP NEUROL, V503, P182, DOI 10.1002/cne.21390; Fenstermaker AG, 2010, J NEUROSCI, V30, P16053, DOI 10.1523/JNEUROSCI.4508-10.2010; Frizzo ME, 2007, HIPPOCAMPUS, V17, P305, DOI 10.1002/hipo.20269; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Hayes L, 2013, DEV BIOL, V374, P115, DOI 10.1016/j.ydbio.2012.11.016; Hayes L, 2011, J COMP NEUROL, V519, P3001, DOI 10.1002/cne.22711; Hebsgaard JB, 2009, GLIA, V57, P1648, DOI 10.1002/glia.20877; Hoekstra EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074049; HYNES M, 1995, CELL, V80, P95, DOI 10.1016/0092-8674(95)90454-9; HYNES M, 1995, NEURON, V15, P35, DOI 10.1016/0896-6273(95)90062-4; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jacob J, 2003, EMBO REP, V4, P761, DOI 10.1038/sj.embor.embor896; Jacobs FMJ, 2011, DEVELOPMENT, V138, P5213, DOI 10.1242/dev.071704; Joksimovic M, 2014, J MOL CELL BIOL, V6, P27, DOI 10.1093/jmcb/mjt043; Joksimovic M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030266; Joksimovic M, 2009, P NATL ACAD SCI USA, V106, P19185, DOI 10.1073/pnas.0904285106; Joksimovic M, 2009, NAT NEUROSCI, V12, P125, DOI 10.1038/nn.2243; KAWANO H, 1995, DEV BRAIN RES, V86, P101, DOI 10.1016/0165-3806(95)00018-9; Kolk SM, 2009, J NEUROSCI, V29, P12542, DOI 10.1523/JNEUROSCI.2521-09.2009; Liang HZ, 2012, BRAIN STRUCT FUNCT, V217, P221, DOI 10.1007/s00429-011-0348-3; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Mavromatakis YE, 2011, MECH DEVELOP, V128, P90, DOI 10.1016/j.mod.2010.11.002; Mittag J, 2013, J CLIN INVEST, V123, P509, DOI 10.1172/JCI65252; Nadal-Nicolas FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049830; Ohyama K, 1998, DEV BRAIN RES, V107, P219, DOI 10.1016/S0165-3806(97)00220-4; Ono Y, 2007, DEVELOPMENT, V134, P3213, DOI 10.1242/dev.02879; Park HL, 2000, DEVELOPMENT, V127, P1593; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Prakash N, 2006, DEVELOPMENT, V133, P89, DOI 10.1242/dev.02181; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Santos MTA, 2011, NEURAL DEV, V6, P23, DOI [10.1186/1749-8104-6-23, DOI 10.1186/1749-8104-6-23]; Smidt MP, 2004, DEVELOPMENT, V131, P1145, DOI 10.1242/dev.01022; Smits SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076037; Smits SM, 2006, PROG NEUROBIOL, V78, P1, DOI 10.1016/j.pneurobio.2005.12.003; Stepanenko OV, 2004, BIOCHEMISTRY-US, V43, P14913, DOI 10.1021/bi048725t; Super H, 2001, CEREB CORTEX, V11, P1101, DOI 10.1093/cercor/11.12.1101; Tang MZ, 2010, J NEUROSCI, V30, P9280, DOI 10.1523/JNEUROSCI.0860-10.2010; Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516; Wurst W, 2014, J MOL CELL BIOL, V6, P34, DOI 10.1093/jmcb/mjt046; Yang J, 2013, DEVELOPMENT, V140, P1342, DOI 10.1242/dev.080630; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010	57	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97926	10.1371/journal.pone.0097926	http://dx.doi.org/10.1371/journal.pone.0097926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865218	Green Published, Green Submitted, gold			2022-12-25	WOS:000336914100027
J	Pallante, P; Sepe, R; Federico, A; Forzati, F; Bianco, M; Fusco, A				Pallante, Pierlorenzo; Sepe, Romina; Federico, Antonella; Forzati, Floriana; Bianco, Mimma; Fusco, Alfredo			CBX7 Modulates the Expression of Genes Critical for Cancer Progression	PLOS ONE			English	Article							TRYPSIN-INHIBITOR; C-FOS; TRANSCRIPTION FACTORS; PROTEIN EXPRESSION; CHROMOBOX PROTEIN; OSTEOPONTIN; CARCINOMA; GROWTH; TRANSFORMATION; METASTASIS	Background: We have previously shown that the expression of CBX7 is drastically decreased in several human carcinomas and that its expression progressively decreases with the appearance of a highly malignant phenotype. The aim of our study has been to investigate the mechanism by which the loss of CBX7 expression may contribute to the emergence of a more malignant phenotype. Methods: We analyzed the gene expression profile of a thyroid carcinoma cell line after the restoration of CBX7 and, then, analyzed the transcriptional regulation of identified genes. Finally, we evaluated the expression of CBX7 and regulated genes in a panel of thyroid and lung carcinomas. Results: We found that CBX7 negatively or positively regulates the expression of several genes (such as SPP1, SPINK1, STEAP1, and FOS, FOSB, EGR1, respectively) associated to cancer progression, by interacting with their promoter regions and modulating their transcriptional activity. Quantitative RT-PCR analyses in human thyroid and lung carcinoma tissues revealed a negative correlation between CBX7 and its down-regulated genes, while a positive correlation was observed with up-regulated genes. Conclusion: In conclusion, the loss of CBX7 expression might play a critical role in advanced stages of carcinogenesis by deregulating the expression of specific effector genes.	[Pallante, Pierlorenzo; Sepe, Romina; Federico, Antonella; Forzati, Floriana; Bianco, Mimma; Fusco, Alfredo] Univ Naples Federico II, IEOS, CNR, DMMBM, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II	Fusco, A (corresponding author), Univ Naples Federico II, IEOS, CNR, DMMBM, Naples, Italy.	alfusco@unina.it	Pallante, Pierlorenzo/AAX-8758-2020	Fusco, Alfredo/0000-0003-3332-5197	Associazione Italiana per la Ricerca sul Cancro-AIRC [IG 5346]; Ministero dell'Universita e della Ricerca Scientifica e Tecnologica-MIUR (PRIN); Progetto di Interesse strategico Invecchiamento (PNR-CNR Aging Program) PNR-CNR; Progetto "Nuove strategie nanotecnologiche per la messa a punto di farmaci e presidi diagnostici diretti verso cellule cancerose circolanti" [PON01-02782]	Associazione Italiana per la Ricerca sul Cancro-AIRC(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Universita e della Ricerca Scientifica e Tecnologica-MIUR (PRIN)(Ministry of Education, Universities and Research (MIUR)); Progetto di Interesse strategico Invecchiamento (PNR-CNR Aging Program) PNR-CNR; Progetto "Nuove strategie nanotecnologiche per la messa a punto di farmaci e presidi diagnostici diretti verso cellule cancerose circolanti"	This work was supported by grants from: Associazione Italiana per la Ricerca sul Cancro-AIRC (IG 5346), Ministero dell'Universita e della Ricerca Scientifica e Tecnologica-MIUR (PRIN 2008), "Progetto di Interesse strategico Invecchiamento (PNR-CNR Aging Program) PNR-CNR 2012-2014" and Progetto PON01-02782: "Nuove strategie nanotecnologiche per la messa a punto di farmaci e presidi diagnostici diretti verso cellule cancerose circolanti". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves PMS, 2006, CANCER IMMUNOL IMMUN, V55, P1515, DOI 10.1007/s00262-006-0165-3; Bakin AV, 1999, SCIENCE, V283, P387, DOI 10.1126/science.283.5400.387; Calogero A, 2004, CANCER CELL INT, V4, DOI 10.1186/1475-2867-4-1; Coppola D, 2004, CLIN CANCER RES, V10, P184, DOI 10.1158/1078-0432.CCR-1405-2; FAGIN JA, 1993, J CLIN INVEST, V91, P179, DOI 10.1172/JCI116168; Federico A, 2009, CANCER RES, V69, P7079, DOI 10.1158/0008-5472.CAN-09-1542; Forzati F, 2012, J CLIN INVEST, V122, P612, DOI 10.1172/JCI58620; Furger Kara A., 2001, Current Molecular Medicine (Hilversum), V1, P621, DOI 10.2174/1566524013363339; FUSCO A, 1987, MOL CELL BIOL, V7, P3365, DOI 10.1128/MCB.7.9.3365; Gaber A, 2009, BRIT J CANCER, V100, P1540, DOI 10.1038/sj.bjc.6605047; Gaber A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-498; Geissinger E, 2002, CANCER RES, V62, P4820; Hinz S, 2008, TUMOR BIOL, V29, P323, DOI 10.1159/000170879; HU ED, 1994, EMBO J, V13, P3094, DOI 10.1002/j.1460-2075.1994.tb06608.x; Hubert RS, 1999, P NATL ACAD SCI USA, V96, P14523, DOI 10.1073/pnas.96.25.14523; HUHTALA ML, 1982, J BIOL CHEM, V257, P13713; Jiang Z, 2010, J GASTROENTEROL, V45, P17, DOI 10.1007/s00535-009-0135-6; Karamitopoulou E, 2010, EUR J CANCER, V46, P1438, DOI 10.1016/j.ejca.2010.01.033; Liu CT, 1998, CANCER GENE THER, V5, P3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahner S, 2008, BRIT J CANCER, V99, P1269, DOI 10.1038/sj.bjc.6604650; Mansueto Gelsomina, 2010, Genes Cancer, V1, P210, DOI 10.1177/1947601910366860; Mikula M, 2003, ONCOGENE, V22, P6725, DOI 10.1038/sj.onc.1206781; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Milde-Langosch K, 2004, BREAST CANCER RES TR, V86, P139, DOI 10.1023/B:BREA.0000032982.49024.71; Milde-Langosch K, 2003, BREAST CANCER RES TR, V77, P265, DOI 10.1023/A:1021887100216; Ozaki N, 2009, MOL CANCER RES, V7, P1572, DOI 10.1158/1541-7786.MCR-08-0567; Paju A, 2004, CLIN CANCER RES, V10, P4761, DOI 10.1158/1078-0432.CCR-0204-03; Paju A, 2001, J UROLOGY, V165, P959, DOI 10.1016/S0022-5347(05)66584-6; Pallante P, 2008, CANCER RES, V68, P6770, DOI 10.1158/0008-5472.CAN-08-0695; Pallante P, 2010, EUR J CANCER, V46, P2304, DOI 10.1016/j.ejca.2010.05.011; Prevarskaya N, 2007, CELL DEATH DIFFER, V14, P1295, DOI 10.1038/sj.cdd.4402162; Rudland PS, 2002, CANCER RES, V62, P3417; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Scott CL, 2007, P NATL ACAD SCI USA, V104, P5389, DOI 10.1073/pnas.0608721104; Shariat SF, 2005, EUR UROL, V48, P424, DOI 10.1016/j.eururo.2005.04.034; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Stenman UH, 2002, CLIN CHEM, V48, P1206; Takahashi F, 2002, INT J CANCER, V98, P707, DOI 10.1002/ijc.10261; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tuck AB, 1999, ONCOGENE, V18, P4237, DOI 10.1038/sj.onc.1202799; Venesmaa P, 1998, BRIT J OBSTET GYNAEC, V105, P508, DOI 10.1111/j.1471-0528.1998.tb10150.x; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Wu MY, 2001, WORLD J GASTROENTERO, V7, P490; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843	46	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98295	10.1371/journal.pone.0098295	http://dx.doi.org/10.1371/journal.pone.0098295			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865347	Green Published, Green Submitted, gold			2022-12-25	WOS:000336914100048
J	Harrold, TC; Randall, DA; Falster, MO; Lujic, S; Jorm, LR				Harrold, Timothy C.; Randall, Deborah A.; Falster, Michael O.; Lujic, Sanja; Jorm, Louisa R.			The Contribution of Geography to Disparities in Preventable Hospitalisations between Indigenous and Non-Indigenous Australians	PLOS ONE			English	Article							CARE-SENSITIVE CONDITIONS; MULTILEVEL ANALYSIS; RACIAL DISPARITIES; NEW-ZEALAND; HEALTH	Objectives: To quantify the independent roles of geography and Indigenous status in explaining disparities in Potentially Preventable Hospital (PPH) admissions between Indigenous and non-Indigenous Australians. Design, setting and participants: Analysis of linked hospital admission data for New South Wales (NSW), Australia, for the period July 1 2003 to June 30 2008. Main outcome measures: Age-standardised admission rates, and rate ratios adjusted for age, sex and Statistical Local Area (SLA) of residence using multilevel models. Results: PPH diagnoses accounted for 987,604 admissions in NSW over the study period, of which 3.7% were for Indigenous people. The age-standardised PPH admission rate was 76.5 and 27.3 per 1,000 for Indigenous and non-Indigenous people respectively. PPH admission rates in Indigenous people were 2.16 times higher than in non-Indigenous people of the same age group and sex who lived in the same SLA. The largest disparities in PPH admission rates were seen for diabetes complications, chronic obstructive pulmonary disease and rheumatic heart disease. Both rates of PPH admission in Indigenous people, and the disparity in rates between Indigenous than non-Indigenous people, varied significantly by SLA, with greater disparities seen in regional and remote areas than in major cities. Conclusions: Higher rates of PPH admission among Indigenous people are not simply a function of their greater likelihood of living in rural and remote areas. The very considerable geographic variation in the disparity in rates of PPH admission between Indigenous and non-Indigenous people indicates that there is potential to reduce unwarranted variation by characterising outlying areas which contribute the most to this disparity.	[Harrold, Timothy C.; Randall, Deborah A.; Falster, Michael O.; Lujic, Sanja; Jorm, Louisa R.] Univ Western Sydney, Ctr Hlth Res, Sydney, NSW, Australia	Western Sydney University	Harrold, TC (corresponding author), Univ Western Sydney, Ctr Hlth Res, Sydney, NSW, Australia.	tharr@doh.health.nsw.gov.au	Dalla Zuanna, Teresa/G-3133-2015; Falster, Michael/X-7118-2019; Jorm, Louisa/AAN-6874-2020	Falster, Michael/0000-0001-6444-7272; Jorm, Louisa/0000-0003-0390-661X; Lujic, Sanja/0000-0002-9555-0261; Randall, Deborah/0000-0002-5075-0227	National Health and Medical Research Council [573313]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council grant number 573313. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2008, REG POP GROWTH; Australian bureau of Statistics, 2012, 2006 CDATA ONL; Australian Bureau of Statistics, 2012, YB AUSTR 2012; Australian Bureau of Statistics, 2008, EXP EST AB TORR STRA; Australian Bureau of Statistics, 2010, HLTH WELF AUSTR AB T; Australian Institute of Health and Welfare, 2010, IND ID HOSP SEP DAT; Australian Institute of Health and Welfare, 2004, RUR REG REM HLTH GUI; Australian Institute of Health and Welfare, 2011, AUSTR HOSP STAT 2009; Australian Institute of Health Welfare, 2012, NATL HEALTHCARE AGRE; Bentley Jason P, 2012, N S W Public Health Bull, V23, P17, DOI 10.1071/NB11034; Biddle N., 2013, CAEPR INDIGENOUS POP; Brown A, 2009, HEART LUNG CIRC, V18, P96, DOI 10.1016/j.hlc.2009.01.005; Canadian Institute for Health Information, 2013, CAN I HLTH INF FACT; Council of Australian Governments, 2008, INT AGR IGA FED FIN; Craig P, 2012, J EPIDEMIOL COMMUN H, V66, P1182, DOI 10.1136/jech-2011-200375; Department of Health Victoria, 2012, VICT AMB CAR SENS CO; Gaskin DJ, 2000, MED CARE RES REV, V57, P85, DOI 10.1177/107755800773743619; Health Department of, 2010, HLTH LIF PROGR FRAM; Jackson G, 2001, AUST NZ J PUBL HEAL, V25, P212, DOI 10.1111/j.1467-842X.2001.tb00565.x; Katterl R, 2012, PHC RIS POLICY ISSUE; Laditka JN, 2006, ETHNIC HEALTH, V11, P247, DOI 10.1080/13557850600565640; Li SQ, 2009, MED J AUSTRALIA, V190, P532, DOI 10.5694/j.1326-5377.2009.tb02551.x; McDermott R, 2004, QUAL SAF HEALTH CARE, V13, P295, DOI 10.1136/qhc.13.4.295; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; National Centre for Classification in Health, 2006, INT STAT CLASS DIS H; National Statistics Service, 2013, STAT INT INV COMM DA; NSW Health, 2012, NSW HLTH STAT HOSP P; O'Neil SS, 2010, AM J PREV MED, V38, P381, DOI 10.1016/j.amepre.2009.12.026; Office of Economic and Statistical Research (OESR), 2010, SYNTH EST RES POP IN; Pellekaan SMV, 2005, POSTGRAD MED J, V81, P618, DOI 10.1136/pgmj.2004.031377; Probst JC, 2004, AM J PUBLIC HEALTH, V94, P1695, DOI 10.2105/AJPH.94.10.1695; Queensland Health, 2012, HLTH QUEENSL REP CHI; Randall DA, 2013, AUST NZ J PUBL HEAL, V37, P442, DOI 10.1111/1753-6405.12114; Rasbash J., 2012, MLWIN VERSION 2 25; Richardson K, 2009, SOC SCI MED, V69, P1252, DOI 10.1016/j.socscimed.2009.07.036; SAS Institute, 2010, SAS VERS 9 3; Scribner RA, 2009, SOC SCI MED, V69, P1584, DOI 10.1016/j.socscimed.2009.08.010; Sentell TL, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120340; Steering Committee for the Review of Government Service Provision (SCRGSP), 2010, NAT AGR PERF INF 200; Subramanian SV, 2005, AM J PUBLIC HEALTH, V95, P260, DOI 10.2105/AJPH.2003.034132; Tobias M, 2006, AUST NZ J PUBL HEAL, V30, P457, DOI 10.1111/j.1467-842X.2006.tb00464.x	41	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97892	10.1371/journal.pone.0097892	http://dx.doi.org/10.1371/journal.pone.0097892			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4ML	24859265	Green Published, gold, Green Submitted			2022-12-25	WOS:000336839400030
J	Jia, YY; Lu, J; Huang, Y; Liu, G; Gao, P; Wan, YZ; Zhang, R; Zhang, ZQ; Yang, RF; Tang, XQ; Xu, J; Wang, X; Chen, HZ; Liu, DP				Jia, Yu-Yan; Lu, Jie; Huang, Yue; Liu, Guang; Gao, Peng; Wan, Yan-Zhen; Zhang, Ran; Zhang, Zhu-Qin; Yang, Rui-Feng; Tang, Xiaoqiang; Xu, Jing; Wang, Xu; Chen, Hou-Zao; Liu, De-Pei			The Involvement of NFAT Transcriptional Activity Suppression in SIRT1-Mediated Inhibition of COX-2 Expression Induced by PMA/Ionomycin	PLOS ONE			English	Article							ACTIVATED T-CELLS; ENDOTHELIAL GROWTH-FACTOR; NUCLEAR-FACTOR; CYCLOSPORINE-A; KAPPA-B; HISTONE MODIFICATIONS; SIRT1 DEACETYLASE; GENE-EXPRESSION; PROTEIN-KINASE; CYCLOOXYGENASE-2	SIRT1, a class III histone deacetylase, acts as a negative regulator for many transcription factors, and plays protective roles in inflammation and atherosclerosis. Transcription factor nuclear factor of activated T cells (NFAT) has been previously shown to play pro-inflammatory roles in endothelial cells. Inhibition of NFAT signaling may be an attractive target to regulate inflammation in atherosclerosis. However, whether NFAT transcriptional activity is suppressed by SIRT1 remains unknown. In this study, we found that SIRT1 suppressed NFAT-mediated transcriptional activity. SIRT1 interacted with NFAT, and the NHR and RHR domains of NFAT mediated the interaction with SIRT1. Moreover, we found that SIRT1 primarily deacetylated NFATc3. Adenoviral over-expression of SIRT1 suppressed PMA and calcium ionophore Ionomycin (PMA/Io)-induced COX-2 expression in human umbilical vein endothelial cells (HUVECs), while SIRT1 RNAi reversed the effects in HUVECs. Moreover, inhibition of COX-2 expression by SIRT1 in PMA/Io-treated HUVECs was largely abrogated by inhibiting NFAT activation. Furthermore, SIRT1 inhibited NFAT-induced COX-2 promoter activity, and reduced NFAT binding to the COX-2 promoter in PMA/Io-treated HUVECs. These results suggest that suppression of NFAT transcriptional activity is involved in SIRT1-mediated inhibition of COX-2 expression induced by PMA/Io, and that the negative regulatory mechanisms of NFAT by SIRT1 may contribute to its anti-inflammatory effects in atherosclerosis.	[Jia, Yu-Yan; Lu, Jie; Gao, Peng; Wan, Yan-Zhen; Zhang, Ran; Zhang, Zhu-Qin; Yang, Rui-Feng; Tang, Xiaoqiang; Xu, Jing; Wang, Xu; Chen, Hou-Zao; Liu, De-Pei] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Biochem & Mol Biol, State Key Lab Med Mol Biol, Beijing 100730, Peoples R China; [Jia, Yu-Yan; Lu, Jie; Huang, Yue; Liu, Guang; Gao, Peng; Wan, Yan-Zhen; Zhang, Ran; Zhang, Zhu-Qin; Yang, Rui-Feng; Tang, Xiaoqiang; Xu, Jing; Wang, Xu; Chen, Hou-Zao; Liu, De-Pei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Jia, Yu-Yan; Huang, Yue; Liu, Guang] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Med Genet, State Key Lab Med Mol Biol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Chen, HZ (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Biochem & Mol Biol, State Key Lab Med Mol Biol, Beijing 100730, Peoples R China.	houzao@gmail.com; liudp@pumc.edu.cn	Zhang, Ran/GZG-8709-2022; Tang, Xiaoqiang/G-4319-2013; Gao, Peng/AAC-1510-2020	Tang, Xiaoqiang/0000-0003-1314-3417; Liu, De-Pei/0000-0002-2636-4297; Chen, Hou-Zao/0000-0001-6805-3182	National Basic Research Program of China [2011CB503902]; National Natural Science Foundation of China [31271227, 30121091, 81161120551]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (grant number 2011CB503902) and the National Natural Science Foundation of China (grant numbers 31271227, 30121091, and 81161120551). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Arroyo MV, 2002, CIRC RES, V91, P202, DOI 10.1161/01.RES.0000027562.91075.56; Amberg GC, 2004, J BIOL CHEM, V279, P47326, DOI 10.1074/jbc.M408789200; Armesilla AL, 1999, MOL CELL BIOL, V19, P2032; Bosc LVG, 2004, J BIOL CHEM, V279, P10702, DOI 10.1074/jbc.M312920200; Boss V, 1998, MOL PHARMACOL, V54, P264, DOI 10.1124/mol.54.2.264; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; COCKERILL GW, 1995, BLOOD, V86, P2689; Csiszar A, 2009, MECH AGEING DEV, V130, P518, DOI 10.1016/j.mad.2009.06.004; Dryden SC, 2003, MOL CELL BIOL, V23, P3173, DOI 10.1128/MCB.23.9.3173-3185.2003; Garcia-Rodriguez C, 1998, J EXP MED, V187, P2031, DOI 10.1084/jem.187.12.2031; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Granja AG, 2008, J IMMUNOL, V180, P2429, DOI 10.4049/jimmunol.180.4.2429; Hernandez GL, 2001, J EXP MED, V193, P607, DOI 10.1084/jem.193.5.607; Hinz B, 2002, J PHARMACOL EXP THER, V300, P367, DOI 10.1124/jpet.300.2.367; Iniguez MA, 2000, J BIOL CHEM, V275, P23627, DOI 10.1074/jbc.M001381200; Jia YY, 2013, SCI CHINA LIFE SCI, V56, P19, DOI 10.1007/s11427-012-4407-7; KOSAKA T, 1994, EUR J BIOCHEM, V221, P889, DOI 10.1111/j.1432-1033.1994.tb18804.x; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Potente M, 2008, CELL CYCLE, V7, P2117, DOI 10.4161/cc.7.14.6267; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; Stein S, 2010, AGING-US, V2, P353, DOI 10.18632/aging.100162; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Takata T, 2003, BIOCHEM BIOPH RES CO, V301, P250, DOI 10.1016/S0006-291X(02)03020-6; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhang QJ, 2008, CARDIOVASC RES, V80, P191, DOI 10.1093/cvr/cvn224; Zhang R, 2010, J BIOL CHEM, V285, P7097, DOI 10.1074/jbc.M109.038604; Zhou S, 2011, CIRC RES, V109, P639, DOI 10.1161/CIRCRESAHA.111.243592	40	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97999	10.1371/journal.pone.0097999	http://dx.doi.org/10.1371/journal.pone.0097999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859347	Green Published, gold, Green Submitted			2022-12-25	WOS:000336839400033
J	Ueno, N; Hasebe, T; Kaneko, A; Yamamoto, M; Fujiya, M; Kohgo, Y; Kono, T; Wang, CZ; Yuan, CS; Bissonnette, M; Chang, EB; Musch, MW				Ueno, Nobuhiro; Hasebe, Takumu; Kaneko, Atsushi; Yamamoto, Masahiro; Fujiya, Mikihiro; Kohgo, Yutaka; Kono, Toru; Wang, Chong-Zhi; Yuan, Chun-Su; Bissonnette, Marc; Chang, Eugene B.; Musch, Mark W.			TU-100 (Daikenchuto) and Ginger Ameliorate Anti-CD3 Antibody Induced T Cell-Mediated Murine Enteritis: Microbe-Independent Effects Involving Akt and NF-kappa B Suppression	PLOS ONE			English	Article							TRADITIONAL JAPANESE MEDICINE; TUMOR-NECROSIS-FACTOR; MONOCLONAL-ANTIBODY; BETA-GLUCOSIDASE; HERBAL MEDICINE; COLONIC TRANSIT; COMPOUND K; ACTIVATION; EXPRESSION; 6-SHOGAOL	The Japanese traditional medicine daikenchuto (TU-100) has anti-inflammatory activities, but the mechanisms remain incompletely understood. TU-100 includes ginger, ginseng, and Japanese pepper, each component possessing bioactive properties. The effects of TU-100 and individual components were investigated in a model of intestinal T lymphocyte activation using anti-CD3 antibody. To determine contribution of intestinal bacteria, specific pathogen free (SPF) and germ free (GF) mice were used. TU-100 or its components were delivered by diet or by gavage. Anti-CD3 antibody increased jejunal accumulation of fluid, increased TNF alpha, and induced intestinal epithelial apoptosis in both SPF and GF mice, which was blocked by either TU-100 or ginger, but not by ginseng or Japanese pepper. TU-100 and ginger also blocked anti-CD3-stimulated Akt and NF-kappa B activation. A co-culture system of colonic Caco2BBE and Jurkat-1 cells was used to examine Tlymphocyte/epithelial cells interactions. Jurkat-1 cells were stimulated with anti-CD3 to produce TNF alpha that activates epithelial cell NF-kappa B. TU-100 and ginger blocked anti-CD3 antibody activation of Akt in Jurkat cells, decreasing their TNF alpha production. Additionally, TU-100 and ginger alone blocked direct TNF alpha stimulation of Caco2BBE cells and decreased activation of caspase-3 and polyADP ribose. The present studies demonstrate a new anti-inflammatory action of TU-100 that is microbe-independent and due to its ginger component.	[Ueno, Nobuhiro; Hasebe, Takumu; Bissonnette, Marc; Chang, Eugene B.; Musch, Mark W.] Univ Chicago, Dept Med, Knapp Ctr Biomed Discovery, Chicago, IL 60637 USA; [Ueno, Nobuhiro; Hasebe, Takumu; Fujiya, Mikihiro; Kohgo, Yutaka] Asahikawa Med Univ, Dept Med, Div Gastroenterol & Hematol Oncol, Asahikawa, Hokkaido, Japan; [Kaneko, Atsushi; Yamamoto, Masahiro] Tsumura & Co, Tsumura Res Labs, Ami, Ibaraki, Japan; [Kono, Toru] Sapporo Higashi Tokushukai Hosp, Ctr Clin & Biomed Res, Sapporo, Hokkaido, Japan; [Kono, Toru] Asahikawa Med Univ, Div Gastroenterol & Gen Surg, Dept Surg, Asahikawa, Hokkaido, Japan; [Wang, Chong-Zhi; Yuan, Chun-Su] Univ Chicago, Dept Anesthesia & Crit Care, Tang Ctr Herbal Med Res, Chicago, IL 60637 USA	University of Chicago; Asahikawa Medical College; Tsumura & Company; Asahikawa Medical College; University of Chicago	Musch, MW (corresponding author), Univ Chicago, Dept Med, Knapp Ctr Biomed Discovery, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mmusch@medicine.bsd.uchicago.edu	Wang, Chong-Zhi/B-8337-2014; Kohgo, Yutaka/AAN-4863-2020	Wang, Chong-Zhi/0000-0002-0950-2109; Hasebe, Takumu/0000-0002-4333-4428	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [P30 DK42086, DK47722, DK097268, NCCAM AT004418, AT005362]; National Institutes of Health [CA036745]; Samuel Freedman Research Laboratories for Gastrointestinal Cancer Research; University of Chicago Comprehensive Cancer Center; Tsumura Corporation; NATIONAL CANCER INSTITUTE [R01CA036745, R37CA036745, R01CA164124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004418, K01AT005362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047722, P30DK042086, R37DK047722, R01DK097268] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Samuel Freedman Research Laboratories for Gastrointestinal Cancer Research; University of Chicago Comprehensive Cancer Center; Tsumura Corporation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): P30 DK42086 (EBC), DK47722 (EBC), DK097268 (EBC), NCCAM AT004418 (CSY) and AT005362 (CSY); the National Institutes of Health: CA036745 (MB); the Samuel Freedman Research Laboratories for Gastrointestinal Cancer Research; and the University of Chicago Comprehensive Cancer Center. The funders had no role in study design, data collection, data analysis, or decision to publish. This work was also supported by grants from the Tsumura Corporation. This funder provided support in the form of salaries for authors AK and MY but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	ABRAMOWICZ D, 1989, TRANSPLANTATION, V47, P606, DOI 10.1097/00007890-198904000-00008; Calixto JB, 2005, PHARMACOL THERAPEUT, V106, P179, DOI 10.1016/j.pharmthera.2004.11.008; CHARPENTIER B, 1992, TRANSPLANTATION, V54, P997, DOI 10.1097/00007890-199212000-00011; Chikakiyo M, 2012, SURG TODAY, V42, P60, DOI 10.1007/s00595-011-0014-7; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; Dougherty U, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-111; Dugasani S, 2010, J ETHNOPHARMACOL, V127, P515, DOI 10.1016/j.jep.2009.10.004; Endo M, 2014, J GASTROENTEROL, V49, P1026, DOI 10.1007/s00535-013-0854-6; Horiuchi A, 2010, GASTROENTEROL RES, V3, P151, DOI 10.4021/gr219w; Huang HC, 2011, BIOSCI BIOTECH BIOCH, V75, P1067, DOI 10.1271/bbb.100851; Hung JY, 2009, J AGR FOOD CHEM, V57, P9809, DOI 10.1021/jf902315e; Iturrino J, 2013, ALIMENT PHARM THER, V37, P776, DOI 10.1111/apt.12264; Iwabu J, 2010, DRUG METAB DISPOS, V38, P2040, DOI 10.1124/dmd.110.033589; Iwasa T, 2012, DIGEST DIS SCI, V57, P2571, DOI 10.1007/s10620-012-2218-0; Jin XL, 2001, DIGEST DIS SCI, V46, P1171, DOI 10.1023/A:1010690624187; Jin Y, 2008, CARCINOGENESIS, V29, P2351, DOI 10.1093/carcin/bgn211; Kaneko A, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/384057; Kim MK, 2005, J MICROBIOL, V43, P456; Kim SO, 2005, ONCOGENE, V24, P2558, DOI 10.1038/sj.onc.1208446; Kono T, 2008, J SURG RES, V150, P78, DOI 10.1016/j.jss.2008.02.057; Kono T, 2013, AM J PHYSIOL-GASTR L, V304, pG428, DOI 10.1152/ajpgi.00356.2012; Kono T, 2011, J GASTROENTEROL, V46, P1187, DOI 10.1007/s00535-011-0438-2; Kono T, 2010, J CROHNS COLITIS, V4, P161, DOI 10.1016/j.crohns.2009.09.006; Kono T, 2009, SURGERY, V146, P837, DOI 10.1016/j.surg.2009.06.012; Li XH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/146142; Lucas PC, 2004, J CELL SCI, V117, P31, DOI 10.1242/jcs.00904; Manabe N, 2010, AM J PHYSIOL-GASTR L, V298, pG970, DOI 10.1152/ajpgi.00043.2010; Masuda Y, 2004, BIOFACTORS, V21, P293, DOI 10.1002/biof.552210157; Miura N, 2005, INT IMMUNOL, V17, P513, DOI 10.1093/intimm/dxh231; Munekage M, 2011, DRUG METAB DISPOS, V39, P1784, DOI 10.1124/dmd.111.040097; Murata P, 2002, LIFE SCI, V70, P2061, DOI 10.1016/S0024-3205(01)01552-1; Musch MW, 2002, J CLIN INVEST, V110, P1739, DOI 10.1172/JCI200215695; Pan MH, 2008, MOL NUTR FOOD RES, V52, P1467, DOI 10.1002/mnfr.200700515; PETERSON MD, 1992, J CELL SCI, V102, P581; Quan LH, 2012, J AGR FOOD CHEM, V60, P3776, DOI 10.1021/jf300186a; Radojevic N, 1999, AM J PHYSIOL-REG I, V276, pR715, DOI 10.1152/ajpregu.1999.276.3.R715; Riera CE, 2009, BRIT J PHARMACOL, V157, P1398, DOI 10.1111/j.1476-5381.2009.00307.x; Tang YM, 2010, AM J PATHOL, V176, P158, DOI 10.2353/ajpath.2010.090548; Wang CC, 2003, IN VIVO, V17, P641; Wang CZ, 2012, INT J ONCOL, DOI [10.3892/ijo.2012.1399, DOI 10.3892/IJ0.2012.1399]; Wang L, 2011, J BIOTECHNOL, V156, P125, DOI 10.1016/j.jbiotec.2011.07.024; Wang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028232; Weng CJ, 2012, MOL NUTR FOOD RES, V56, P1304, DOI 10.1002/mnfr.201200173; Wu H, 2010, MOL NUTR FOOD RES, V54, P1296, DOI 10.1002/mnfr.200900409; Yasanoya H, 2011, EVIDENCE BASED COMP, DOI org/10.1155/2011/264286.; Zhang ZY, 2013, INT J MOL SCI, V14, P2980, DOI 10.3390/ijms14022980	46	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97456	10.1371/journal.pone.0097456	http://dx.doi.org/10.1371/journal.pone.0097456			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24857966	gold, Green Published, Green Submitted			2022-12-25	WOS:000336839400017
J	Fennessy, D; Grallert, A; Krapp, A; Cokoja, A; Bridge, AJ; Petersen, J; Patel, A; Tallada, VA; Boke, E; Hodgson, B; Simanis, V; Hagan, IM				Fennessy, Dorota; Grallert, Agnes; Krapp, Andrea; Cokoja, Adisa; Bridge, Alan J.; Petersen, Janni; Patel, Avinash; Tallada, Victor A.; Boke, Elvan; Hodgson, Ben; Simanis, Viesturs; Hagan, Iain M.			Extending the Schizosaccharomyces pombe Molecular Genetic Toolbox	PLOS ONE			English	Article							FISSION YEAST; MARKER CASSETTES; SEPTUM FORMATION; PROTEIN-KINASE; INTEGRATIVE TRANSFORMATION; HETEROLOGOUS MODULES; MITOTIC COMMITMENT; SELECTION MARKER; POLO KINASE; EFFICIENT	Targeted alteration of the genome lies at the heart of the exploitation of S. pombe as a model system. The rate of analysis is often determined by the efficiency with which a target locus can be manipulated. For most loci this is not a problem, however for some loci, such as fin1(+), rates of gene targeting below 5% can limit the scope and scale of manipulations that are feasible within a reasonable time frame. We now describe a simple modification of transformation procedure for directing integration of genomic sequences that leads to a 5-fold increase in the transformation efficiency when antibiotic based dominant selection markers are used. We also show that removal of the pku70(+) and pku80(+) genes, which encode DNA end binding proteins required for the non-homologous end joining DNA repair pathway, increases the efficiency of gene targeting at fin1(+) to around 75-80% (a 16-fold increase). We describe how a natMX6/rpl42(+) cassette can be used for positive and negative selection for integration at a targeted locus. To facilitate the evaluation of the impact of a series of mutations on the function of a gene of interest we have generated three vector series that rely upon different selectable markers to direct the expression of tagged/untagged molecules from distinct genomic integration sites. pINTL and pINTK vectors use ura4(+) selection to direct disruptive integration of leu1(+) and lys1(+) respectively, while pINTH vectors exploit nourseothricin resistance to detect the targeted disruption of a hygromycin B resistance conferring hphMX6 cassette that has been integrated on chromosome III. Finally, we have generated a series of multi-copy expression vectors that use resistance to nourseothricin or kanamycin/G418 to select for propagation in prototrophic hosts. Collectively these protocol modifications and vectors extend the versatility of this key model system.	[Fennessy, Dorota; Grallert, Agnes; Bridge, Alan J.; Petersen, Janni; Patel, Avinash; Tallada, Victor A.; Boke, Elvan; Hodgson, Ben; Hagan, Iain M.] Univ Manchester, Cell Div Grp, Canc Res UK Manchester Inst, Manchester, Lancs, England; [Krapp, Andrea; Cokoja, Adisa; Simanis, Viesturs] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Lausanne, Switzerland	Cancer Research UK; University of Manchester; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Simanis, V (corresponding author), Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Lausanne, Switzerland.	viesturs.simanis@epfl.ch; Iain.Hagan@cruk.manchester.ac.uk	Tallada, Victor/F-5454-2016; Boke, Elvan/O-6725-2017; Bridge, Alan/U-4209-2018	Tallada, Victor/0000-0001-9526-5957; Hagan, Iain/0000-0002-5858-9415; Petersen, Janni/0000-0003-0729-9335; Bridge, Alan/0000-0003-2148-9135; Grallert, Agnes/0000-0002-0127-3495	Swiss National Science Foundation; Ecole polytechnique federale de Lausanne; Cancer Research UK [CRUK] [C147/A6058]; Cancer Research UK [11178, 16406] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ecole polytechnique federale de Lausanne; Cancer Research UK [CRUK](Cancer Research UK); Cancer Research UK(Cancer Research UK)	Swiss National Science Foundation (www.snf.ch). Ecole polytechnique federale de Lausanne (www.epfl.ch). Cancer Research UK [CRUK] C147/A6058. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APOLINARIO E, 1993, CURR GENET, V24, P491, DOI 10.1007/BF00351711; Bahler J, 1998, J CELL BIOL, V143, P1603, DOI 10.1083/jcb.143.6.1603; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BARBET N, 1992, GENE, V114, P59, DOI 10.1016/0378-1119(92)90707-V; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; BEACH D, 1981, NATURE, V290, P140, DOI 10.1038/290140a0; Bitton DA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.90; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Brachmann CB, 1998, YEAST, V14, P115; BURKE JD, 1994, MOL GEN GENET, V242, P169, DOI 10.1007/BF00391010; BURLAND TG, 1991, GENE, V100, P241, DOI 10.1016/0378-1119(91)90374-K; CARR AM, 1989, MOL GEN GENET, V218, P41, DOI 10.1007/BF00330563; Chino A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009652; Craven RA, 1998, GENE, V221, P59, DOI 10.1016/S0378-1119(98)00434-X; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; Dischinger S, 2008, J CELL SCI, V121, P843, DOI 10.1242/jcs.021584; Drummond DR, 1998, J CELL SCI, V111, P853; EGEL R, 1971, PLANTA, V98, P89, DOI 10.1007/BF00387025; EGEL R, 1994, YEAST, V10, P1347, DOI 10.1002/yea.320101012; EKWALL K, 1995, SCIENCE, V269, P1429, DOI 10.1126/science.7660126; Erler A, 2006, YEAST, V23, P813, DOI 10.1002/yea.1396; FANKHAUSER C, 1994, EMBO J, V13, P3011, DOI 10.1002/j.1460-2075.1994.tb06600.x; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Fujita Y, 2005, YEAST, V22, P193, DOI 10.1002/yea.1201; Germino M, 2006, YEAST, V23, P763, DOI 10.1002/yea.1388; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Grallert A, 2004, GENE DEV, V18, P1007, DOI 10.1101/gad.296204; Grallert A, 2006, GENE DEV, V20, P2421, DOI 10.1101/gad.381306; Grallert A, 2013, CURR BIOL, V23, P213, DOI 10.1016/j.cub.2012.12.039; Grallert A, 2013, NAT CELL BIOL, V15, P88, DOI 10.1038/ncb2633; Grallert A, 2012, NAT CELL BIOL, V14, P738, DOI 10.1038/ncb2514; GRALLERT B, 1993, MOL GEN GENET, V238, P26, DOI 10.1007/BF00279526; GRIMM C, 1988, MOL GEN GENET, V215, P81, DOI 10.1007/BF00331307; GRIMM C, 1988, MOL GEN GENET, V215, P87, DOI 10.1007/BF00331308; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hartmuth S, 2009, J CELL SCI, V122, P1737, DOI 10.1242/jcs.049387; Hentges P, 2005, YEAST, V22, P1013, DOI 10.1002/yea.1291; HOFER F, 1979, CURR GENET, V1, P45, DOI 10.1007/BF00413306; Hoffman RL, 2006, CURR GENET, V49, P414, DOI 10.1007/s00294-006-0065-2; HOTTINGER H, 1982, MOL GEN GENET, V188, P219, DOI 10.1007/BF00332678; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; KEENEY JB, 1994, GENETICS, V136, P849; Kelly DA, 2002, BIOTECHNIQUES, V33, P978, DOI 10.2144/02335bm02; Kibe T, 2003, NUCLEIC ACIDS RES, V31, P5054, DOI 10.1093/nar/gkg718; KIKUCHI Y, 1988, CURR GENET, V14, P375, DOI 10.1007/BF00419995; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kooistra R, 2004, YEAST, V21, P781, DOI 10.1002/yea.1131; Krapp A, 2006, J CELL SCI, V119, P2882, DOI 10.1242/jcs.03025; Leupold U., 1970, METHODS CELL PHYSL, V4, P169; Li ZJ, 2010, APPL MICROBIOL BIOT, V87, P2001, DOI 10.1007/s00253-010-2676-2; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Loprieno N, 1974, HDB GENETICS, P395; Maekawa H, 2003, EMBO J, V22, P438, DOI 10.1093/emboj/cdg063; Matsuyama A, 2004, YEAST, V21, P1289, DOI 10.1002/yea.1181; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; Miyoshi T, 2003, J BIOL CHEM, V278, P1924, DOI 10.1074/jbc.M208813200; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Murone M, 1996, EMBO J, V15, P6605, DOI 10.1002/j.1460-2075.1996.tb01051.x; Naatsaari L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039720; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Ninomiya Y, 2004, P NATL ACAD SCI USA, V101, P12248, DOI 10.1073/pnas.0402780101; Petersen J, 2005, NATURE, V435, P507, DOI 10.1038/nature03590; Petersen J, 2003, CURR BIOL, V13, P590, DOI 10.1016/S0960-9822(03)00205-7; Poggeler S, 2006, GENE, V378, P1, DOI 10.1016/j.gene.2006.03.020; REAUME SE, 1949, ARCH BIOCHEM, V22, P331; Roguev A, 2007, NAT METHODS, V4, P861, DOI 10.1038/NMETH1098; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Schmidt S, 1997, GENE DEV, V11, P1519, DOI 10.1101/gad.11.12.1519; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Sivakumar S, 2004, METHODS, V33, P213, DOI 10.1016/j.ymeth.2003.11.016; Snaith HA, 2010, METHOD CELL BIOL, V97, P147, DOI 10.1016/S0091-679X(10)97009-X; Tagwerker C, 2006, YEAST, V23, P623, DOI 10.1002/yea.1380; Tanaka K, 2001, EMBO J, V20, P1259, DOI 10.1093/emboj/20.6.1259; Tay YD, 2013, J CELL SCI, V126, P5052, DOI 10.1242/jcs.135301; Villalba F, 2008, FUNGAL GENET BIOL, V45, P68, DOI 10.1016/j.fgb.2007.06.006; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WADDELL S, 1995, NUCLEIC ACIDS RES, V23, P1836, DOI 10.1093/nar/23.10.1836; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002	83	35	35	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97683	10.1371/journal.pone.0097683	http://dx.doi.org/10.1371/journal.pone.0097683			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848109	Green Published, gold			2022-12-25	WOS:000336730600049
J	Grasso, E; Paparini, D; Hauk, V; Salamone, G; Leiros, CP; Ramhorst, R				Grasso, Esteban; Paparini, Daniel; Hauk, Vanesa; Salamone, Gabriela; Perez Leiros, Claudia; Ramhorst, Rosanna			Differential Migration and Activation Profile of Monocytes after Trophoblast Interaction	PLOS ONE			English	Article							REGULATORY T-CELLS; TOLL-LIKE RECEPTORS; MATERNAL-FETAL INTERFACE; RECURRENT PREGNANCY LOSS; DENDRITIC CELLS; IMMUNE-SYSTEM; MACROPHAGES; INFLAMMATION; EXPRESSION; TOLERANCE	Macrophages at the maternal-placental interface coordinate opposite demands under the control of trophoblast cells such as the response against pathogens on one hand, and apoptotic cell clearance and wound healing with the production of suppressor cytokines. Here, we investigated whether trophoblast cells induce maternal monocyte activation towards an alternative activated macrophage profile and whether bacterial or viral stimuli modulate their migratory properties. We used an in vitro model of the maternal-placental interface represented by co-cultures of CD14+ cells isolated from fertile women with first trimester trophoblast cell line (Swan-71 cells) in the presence or absence of pathogen associated molecular pattern (PAMP) stimuli lipopolysaccharide (LPS), peptidoglycan (PGN) or poly [I: C]). Maternal CD14+ cells showed increased CD16 and CD39 expression, both markers associated to an alternative activation profile, with no changes in CD80 expression after trophoblast cell interaction. These changes were accompanied by increased IL-10 and decreased IL-12 production by CD14+ cells. After stimulation with LPS, PGN or poly [I: C], monocytes co-cultured with trophoblast cells had lower production of TNF-alpha and IL-1 beta compared with non co-cultured monocytes. Interestingly, monocyte migration towards trophoblast cells was prevented in the presence of LPS or PGN but not after 24h of stimulation with poly [I: C]. LPS or PGN also decreased CCR5, CXCL-8 and CCL5 expression. Finally, trophoblast cells co-cultured with monocytes in the presence of pathological stimuli failed to increase chemokine expression, indicating a bidirectional effect. In conclusion, trophoblast might 'instruct' maternal monocytes to express an alternative activation profile and restrain their early recruitment under pathological threats as one of the first strategies to avoid potential tissue damage at the maternal-placental interface.	[Grasso, Esteban; Paparini, Daniel; Hauk, Vanesa; Perez Leiros, Claudia; Ramhorst, Rosanna] Univ Buenos Aires, Sch Sci, Immunopharmacol Lab, Buenos Aires, DF, Argentina; [Grasso, Esteban; Paparini, Daniel; Hauk, Vanesa; Perez Leiros, Claudia; Ramhorst, Rosanna] Univ Buenos Aires, CONICET Natl Res Council, IQUIBICEN, Buenos Aires, DF, Argentina; [Salamone, Gabriela] Acad Nacl Med Buenos Aires, Inst Invest Hematol, Dept Immunol, Buenos Aires, DF, Argentina; [Salamone, Gabriela] Acad Nacl Med Buenos Aires, Inst Estudios Oncol Fdn Maissa, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Buenos Aires National Academy of Medicine; IIHEMA - Instituto de Investigaciones Hematologicas; Buenos Aires National Academy of Medicine	Ramhorst, R (corresponding author), Univ Buenos Aires, Sch Sci, Immunopharmacol Lab, Buenos Aires, DF, Argentina.	rramhorst@qb.fcen.uba.ar		Paparini, Daniel Esteban/0000-0002-3335-4564	CONICET [PIP 2659]; University of Buenos Aires (UBAcyt); ANPCyT [Pto. BID-PICT 2011-0144]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires (UBAcyt)(University of Buenos Aires); ANPCyT(ANPCyT)	This study was supported by grants to CPL and RR from: CONICET (PIP 2659), University of Buenos Aires (UBAcyt 2011-2014 and 2012-2015) and from ANPCyT (Pto. BID-PICT 2011-0144, 2012-2015). We thank Dr. Gil Mor who kindly gave us the Swan-71 cell line. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2005, J IMMUNOL, V175, P8096, DOI 10.4049/jimmunol.175.12.8096; Abrahams VM, 2005, PLACENTA, V26, P540, DOI 10.1016/j.placenta.2004.08.010; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Ambarus CA, 2012, J IMMUNOL METHODS, V375, P196, DOI 10.1016/j.jim.2011.10.013; Apps R, 2009, IMMUNOLOGY, V127, P26, DOI 10.1111/j.1365-2567.2008.03019.x; Baek KH, 2007, TRENDS MOL MED, V13, P310, DOI 10.1016/j.molmed.2007.05.005; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Caballero-Campo P, 2002, MOL HUM REPROD, V8, P375, DOI 10.1093/molehr/8.4.375; Cohen HB, 2013, BLOOD, V122, P1935, DOI 10.1182/blood-2013-04-496216; Dekel N, 2010, AM J REPROD IMMUNOL, V63, P17, DOI 10.1111/j.1600-0897.2009.00792.x; Fest S, 2007, AM J REPROD IMMUNOL, V57, P55, DOI 10.1111/j.1600-0897.2006.00446.x; Fraccaroli Laura, 2009, Front Biosci (Elite Ed), V1, P288; Fraccaroli L, 2009, HUM REPROD, V24, P166, DOI 10.1093/humrep/den344; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Guerin LR, 2009, HUM REPROD UPDATE, V15, P517, DOI 10.1093/humupd/dmp004; Gustafsson C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002078; Huang SJ, 2006, J REPROD IMMUNOL, V72, P60, DOI 10.1016/j.jri.2006.03.002; HUNT JS, 1989, J REPROD IMMUNOL, V16, P1, DOI 10.1016/0165-0378(89)90002-8; Kallikourdis M, 2007, P NATL ACAD SCI USA, V104, P594, DOI 10.1073/pnas.0604268104; Kayisli UA, 2002, AM J REPROD IMMUNOL, V47, P213, DOI 10.1034/j.1600-0897.2002.01075.x; Kim MJ, 2009, J IMMUNOL, V182, P3919, DOI 10.4049/jimmunol.0803834; Koga K, 2008, REPROD SCI, V15, P231, DOI 10.1177/1933719108316391; Koga K, 2009, J OBSTET GYNAECOL RE, V35, P191, DOI 10.1111/j.1447-0756.2008.00963.x; Kwak-Kim J, 2009, J OBSTET GYNAECOL RE, V35, P609, DOI 10.1111/j.1447-0756.2009.01079.x; Larocca L, 2011, MOL CELL ENDOCRINOL, V333, P112, DOI 10.1016/j.mce.2010.11.035; Laskarin G, 2005, HUM REPROD, V20, P1057, DOI 10.1093/humrep/deh740; Laskarin G, 2007, AM J REPROD IMMUNOL, V58, P255, DOI 10.1111/j.1600-0897.2007.00511.x; Leber A, 2010, AM J REPROD IMMUNOL, V63, P445, DOI 10.1111/j.1600-0897.2010.00821.x; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Mizuno K, 2005, CLIN EXP IMMUNOL, V142, P461, DOI 10.1111/j.1365-2005.02932.x; Mor G, 2008, ANN NY ACAD SCI, V1127, P121, DOI 10.1196/annals.1434.006; Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x; Nagamatsu T, 2010, AM J REPROD IMMUNOL, V63, P460, DOI 10.1111/j.1600-0897.2010.00813.x; Nancy P, 2012, SCIENCE, V336, P1317, DOI 10.1126/science.1220030; Park Dong-Wook, 2011, Clin Exp Reprod Med, V38, P179, DOI 10.5653/cerm.2011.38.4.179; Raman D, 2011, EXP CELL RES, V317, P575, DOI 10.1016/j.yexcr.2011.01.005; Ramhorst R, 2012, AM J REPROD IMMUNOL, V67, P17, DOI 10.1111/j.1600-0897.2011.01056.x; Rozner AE, 2011, AM J REPROD IMMUNOL, V66, P115, DOI 10.1111/j.1600-0897.2010.00979.x; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Straszewski-Chavez SL, 2009, PLACENTA, V30, P939, DOI 10.1016/j.placenta.2009.08.007; Terness P, 2007, AM J REPROD IMMUNOL, V58, P238, DOI 10.1111/j.1600-0897.2007.00510.x; Warning JC, 2011, REPRODUCTION, V141, P715, DOI 10.1530/REP-10-0360; Weiss G, 2009, REPROD SCI, V16, P216, DOI 10.1177/1933719108330087; Wood GW, 1999, CYTOKINE, V11, P1038, DOI 10.1006/cyto.1999.0513	44	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97147	10.1371/journal.pone.0097147	http://dx.doi.org/10.1371/journal.pone.0097147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849800	Green Submitted, Green Published, gold			2022-12-25	WOS:000336730600023
J	De Robertis, A; Mennillo, F; Rossi, M; Valensin, S; Tunici, P; Mori, E; Caradonna, N; Varrone, M; Salerno, M				De Robertis, Alessandra; Mennillo, Federica; Rossi, Marco; Valensin, Silvia; Tunici, Patrizia; Mori, Elisa; Caradonna, Nicola; Varrone, Maurizio; Salerno, Massimiliano			Human Sarcoma Growth Is Sensitive to Small-Molecule Mediated AXIN Stabilization	PLOS ONE			English	Article							BETA-CATENIN; SCAFFOLD PROTEIN; WNT ACTIVATION; HIGH-FREQUENCY; COMPLEX; INHIBITION; OSTEOSARCOMA; DEGRADATION; SUPPRESSION; EXPRESSION	Sarcomas are mesenchymal tumors showing high molecular heterogeneity, reflected at the histological level by the existence of more than fifty different subtypes. Genetic and epigenetic evidences link aberrant activation of the Wnt signaling to growth and progression of human sarcomas. This phenomenon, mainly accomplished by autocrine loop activity, is sustained by gene amplification, over-expression of Wnt ligands and co-receptors or epigenetic silencing of endogenous Wnt antagonists. We previously showed that pharmacological inhibition of Wnt signaling mediated by Axin stabilization produced in vitro and in vivo antitumor activity in glioblastoma tumors. Here, we report that targeting different sarcoma cell lines with the Wnt inhibitor/Axin stabilizer SEN461 produces a less transformed phenotype, as supported by modulation of anchorage-independent growth in vitro. At the molecular level, SEN461 treatment enhanced the stability of the scaffold protein Axin1, a key negative regulator of the Wnt signaling with tumor suppressor function, resulting in downstream effects coherent with inhibition of canonical Wnt signaling. Genetic phenocopy of small molecule Axin stabilization, through Axin1 over-expression, coherently resulted in strong impairment of soft-agar growth. Importantly, sarcoma growth inhibition through pharmacological Axin stabilization was also observed in a xenograft model in vivo in female CD-1 nude mice. Our findings suggest the usefulness of Wnt inhibitors with Axin stabilization activity as a potentialyl clinical relevant strategy for certain types of sarcomas.	[De Robertis, Alessandra; Mennillo, Federica; Valensin, Silvia; Salerno, Massimiliano] Siena Biotech Med Res Ctr, Mol Oncol Unit, Siena, Italy; [De Robertis, Alessandra; Mennillo, Federica; Rossi, Marco; Valensin, Silvia; Tunici, Patrizia; Mori, Elisa; Salerno, Massimiliano] Siena Biotech Med Res Ctr, Dept Pharmacol, Siena, Italy; [Rossi, Marco; Tunici, Patrizia] Siena Biotech Med Res Ctr, In Vivo Pharmacol Unit, Siena, Italy; [Mori, Elisa] Siena Biotech Med Res Ctr, Data Anal Unit, Siena, Italy; [Caradonna, Nicola] Siena Biotech Med Res Ctr, MET Profiling Unit, Siena, Italy; [Varrone, Maurizio] Siena Biotech Med Res Ctr, Dept Med Chem, Siena, Italy	Siena Biotech; Siena Biotech; Siena Biotech; Siena Biotech; Siena Biotech; Siena Biotech	Salerno, M (corresponding author), Siena Biotech Med Res Ctr, Mol Oncol Unit, Siena, Italy.	massisal67@gmail.com		SALERNO, Massimiliano/0000-0002-1093-5454	Monte Dei Paschi Foundation	Monte Dei Paschi Foundation	The study was funded by Monte Dei Paschi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiri G, 2009, ONCOGENE, V28, P2163, DOI 10.1038/onc.2009.82; Arnold HK, 2009, EMBO J, V28, P500, DOI 10.1038/emboj.2008.279; Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen YC, 2010, MOL THER, V18, P828, DOI 10.1038/mt.2009.291; Choi SH, 2010, GENE DEV, V24, P1236, DOI 10.1101/gad.1920310; Clark MA, 2005, NEW ENGL J MED, V353, P701, DOI 10.1056/NEJMra041866; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; De Robertis A, 2013, MOL CANCER THER, V12, P1180, DOI 10.1158/1535-7163.MCT-12-1176-T; Detwiller KY, 2005, CANCER RES, V65, P5881, DOI 10.1158/0008-5472.CAN-04-4078; Dieudonne FX, 2010, CANCER RES, V70, P5399, DOI 10.1158/0008-5472.CAN-10-0090; Ferguson WS, 2001, CANCER INVEST, V19, P292, DOI 10.1081/CNV-100102557; Finch AJ, 2009, MOL CELL BIOL, V29, P5306, DOI 10.1128/MCB.01745-08; Gehrke I, 2009, EUR J CANCER, V45, P2759, DOI 10.1016/j.ejca.2009.08.003; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Greasley PJ, 2000, NUCLEIC ACIDS RES, V28, P446, DOI 10.1093/nar/28.2.446; Guadamillas MC, 2011, J CELL SCI, V124, P3189, DOI 10.1242/jcs.072165; Guo Y, 2008, CANCER RES, V68, P3350, DOI 10.1158/0008-5472.CAN-07-3220; Haydon RC, 2002, INT J CANCER, V102, P338, DOI 10.1002/ijc.10719; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Iwao K, 1999, JPN J CANCER RES, V90, P205, DOI 10.1111/j.1349-7006.1999.tb00734.x; James RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050457; Karlsson A, 2003, BLOOD, V101, P2797, DOI 10.1182/blood-2002-10-3091; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim SE, 2013, SCIENCE, V340, P867, DOI 10.1126/science.1232389; Leow PC, 2010, INVEST NEW DRUG, V28, P766, DOI 10.1007/s10637-009-9311-z; LINK MP, 1986, NEW ENGL J MED, V314, P1600, DOI 10.1056/NEJM198606193142502; Liu W, 2006, EMBO J, V25, P1646, DOI 10.1038/sj.emboj.7601057; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Marina N, 2004, ONCOLOGIST, V9, P422, DOI 10.1634/theoncologist.9-4-422; Marklein D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052898; Misra RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050153; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; Rubin EM, 2010, MOL CANCER THER, V9, P731, DOI 10.1158/1535-7163.MCT-09-0147; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Saito T, 2002, J PATHOL, V196, P445, DOI 10.1002/path.1066; Salahshor S, 2005, J CLIN PATHOL, V58, P225, DOI 10.1136/jcp.2003.009506; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Stratford EW, 2014, CANCER MED-US, V3, P36, DOI 10.1002/cam4.170; TABONE MD, 1994, J CLIN ONCOL, V12, P2614, DOI 10.1200/JCO.1994.12.12.2614; Tarkkanen M, 2006, EUR J CANCER, V42, P1172, DOI 10.1016/j.ejca.2006.01.035; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Vijayakumar S, 2011, CANCER CELL, V19, P601, DOI 10.1016/j.ccr.2011.03.010; Wan XL, 2007, ONCOLOGIST, V12, P1007, DOI 10.1634/theoncologist.12-8-1007; Watson AL, 2013, CANCER DISCOV, V3, P674, DOI 10.1158/2159-8290.CD-13-0081; Wunder JS, 2007, LANCET ONCOL, V8, P513, DOI 10.1016/S1470-2045(07)70169-9	51	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97847	10.1371/journal.pone.0097847	http://dx.doi.org/10.1371/journal.pone.0097847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842792	Green Submitted, gold, Green Published			2022-12-25	WOS:000340948600082
J	Hung, CS; Wu, YW; Huang, JY; Hsu, PY; Chen, MF				Hung, Chi-Sheng; Wu, Yen-Wen; Huang, Jei-Yie; Hsu, Pei-Ying; Chen, Ming-Fong			Evaluation of Circulating Adipokines and Abdominal Obesity as Predictors of Significant Myocardial Ischemia Using Gated Single-Photon Emission Computed Tomography	PLOS ONE			English	Article							ACID-BINDING PROTEIN; CORONARY-ARTERY-DISEASE; ASYMPTOMATIC POSTMENOPAUSAL WOMEN; PROATRIAL NATRIURETIC PEPTIDE; SERUM CHEMERIN LEVELS; METABOLIC SYNDROME; ADIPOSE-TISSUE; INFLAMMATION; ADIPOCYTE; ASSOCIATION	Objective: Coronary artery disease (CAD) is associated with abdominal obesity and metabolic syndrome. Adipocytes secrete adipokines, including the newly discovered adipocyte fatty acid binding protein (A-FABP) and chemerin. Adipokines contribute to the pathogenesis of CAD. In patients with CAD, the presence of significant ischemia predicts adverse outcomes. It is unknown whether adipokines can be better predictors of the presence of significant myocardial ischemia than conventional risk factors. This study aimed to compare adipokines with clinical risk factors and abdominal obesity as predictive factors for significant myocardial ischemia. Methods: One hundred and ninety-six adults with suspected, but unproven, CAD were consecutively enrolled. The main measures were clinical and biochemical parameters and stress myocardial perfusion imaging with gated myocardial perfusion single-photon emission computed tomography (SPECT), with computed tomography (CT) attenuation correction. The abdominal visceral fat area was examined using a hybrid SPECT/CT scanner. Serum levels of high-sensitivity C-reactive protein (hs-CRP) and adipokines (adiponectin, A-FABP, and chemerin) were evaluated. Results: A-FABP levels correlated significantly with adiponectin, hs-CRP, body mass index, waist circumference, and visceral fat area. A-FABP was significantly associated with metabolic syndrome (OR 3.2, 95% CI 1.6-6.4, p = 0.001), significant myocardial ischemia (OR 1.9, 95% CI 1.0-3.4, p = 0.05), and stress lung-to-heart ratio (beta = 0.03, p = 0.03) on SPECT. Chemerin was significantly associated with serum triglyceride levels but not with metabolic syndrome, significant ischemia, or stress lung-to-heart ratio on SPECT. A-FABP was better at detecting significant inducible ischemia than other biomarkers, although this was a modest improvement (area under ROC curve 0.579, 95% CI 0.46-0.69). Conclusions: Serum A-FABP concentrations correlate significantly with visceral fat area, metabolic syndrome, and predicted significant myocardial ischemia on SPECT. This may help to more accurately assess CAD risk, especially in patients with metabolic syndrome.	[Hung, Chi-Sheng; Wu, Yen-Wen; Chen, Ming-Fong] Natl Taiwan Univ Hosp, Dept Internal Med, Div Cardiol, Taipei 100, Taiwan; [Hung, Chi-Sheng; Wu, Yen-Wen; Huang, Jei-Yie; Chen, Ming-Fong] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Wu, Yen-Wen; Huang, Jei-Yie] Natl Taiwan Univ Hosp, Dept Nucl Med, Taipei 100, Taiwan; [Wu, Yen-Wen] Far Eastern Mem Hosp, Cardiovasc Med Ctr, Div Cardiol, New Taipei City, Taiwan; [Wu, Yen-Wen] Far Eastern Mem Hosp, Dept Nucl Med, New Taipei City, Taiwan; [Wu, Yen-Wen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Hsu, Pei-Ying] Natl Taiwan Univ Hosp, Dept Nucl Med, Yun Lin Branch, Douliou City, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital	Wu, YW (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Div Cardiol, Taipei 100, Taiwan.	wuyw0502@gmail.com	Chen, Ming/GVU-8412-2022	WU, YEN-WEN/0000-0003-1520-1166	National Science Council, Taiwan [NSC 101-2314-B-418-012-MY3]; National Taiwan University Hospital, Yunlin Branch [NTUH.YL 98.S017]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital, Yunlin Branch	This work was supported by research grants from the National Science Council, Taiwan (NSC 101-2314-B-418-012-MY3), and National Taiwan University Hospital, Yunlin Branch (NTUH.YL 98.S017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Bao YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019115; Bocek T, 2005, EUR J CLIN INVEST, V35, P450, DOI 10.1111/j.1365-2362.2005.01517.x; Bozaoglu K, 2009, J CLIN ENDOCR METAB, V94, P3085, DOI 10.1210/jc.2008-1833; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Chien CL, 2011, OBESITY FACTS, V4, P372, DOI 10.1159/000333439; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Dong BK, 2011, INTERNAL MED, V50, P1093, DOI 10.2169/internalmedicine.50.5025; Ernst MC, 2010, TRENDS ENDOCRIN MET, V21, P660, DOI 10.1016/j.tem.2010.08.001; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; Gustafson B, 2007, ARTERIOSCL THROM VAS, V27, P2276, DOI 10.1161/ATVBAHA.107.147835; Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41; Hah YJ, 2011, DIABETES METAB J, V35, P248, DOI 10.4093/dmj.2011.35.3.248; Hong J, 2011, ATHEROSCLEROSIS, V217, P194, DOI 10.1016/j.atherosclerosis.2011.03.002; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Huang CL, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-105; Jin J, 2010, CLIN CHIM ACTA, V411, P1761, DOI 10.1016/j.cca.2010.07.031; Karastergiou K, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-13; KOTANI K, 1994, INT J OBESITY, V18, P207; Kralisch S, 2013, DIABETOLOGIA, V56, P10, DOI 10.1007/s00125-012-2737-4; KVIST H, 1988, AM J CLIN NUTR, V48, P1351, DOI 10.1093/ajcn/48.6.1351; Lakka HM, 2002, EUR HEART J, V23, P706, DOI 10.1053/euhj.2001.2889; Lehrke M, 2009, EUR J ENDOCRINOL, V161, P339, DOI 10.1530/EJE-09-0380; Li XT, 2012, CORONARY ARTERY DIS, V23, P412, DOI 10.1097/MCA.0b013e3283576a60; Mahabadi AA, 2009, EUR HEART J, V30, P850, DOI 10.1093/eurheartj/ehn573; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Nishikimi T, 2004, AM J MED, V116, P517, DOI 10.1016/j.amjmed.2003.12.022; Nishizawa H, 2002, DIABETES, V51, P2734, DOI 10.2337/diabetes.51.9.2734; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; See R, 2007, J AM COLL CARDIOL, V50, P752, DOI 10.1016/j.jacc.2007.04.066; Shaw LJ, 2004, J NUCL CARDIOL, V11, P171, DOI 10.1016/j.nuclcard.2003.12.004; Takahashi M, 2013, ENDOCR J, V60, P37, DOI 10.1507/endocrj.EJ12-0201; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388; von Eynatten M, 2012, ARTERIOSCL THROM VAS, V32, P2327, DOI 10.1161/ATVBAHA.112.248609; Wang SY, 2011, NUCL MED COMMUN, V32, P113, DOI 10.1097/MNM.0b013e3283422838; Weigert J, 2010, CLIN ENDOCRINOL, V72, P342, DOI 10.1111/j.1365-2265.2009.03664.x; Wu YW, 2012, EUR J NUCL MED MOL I, V39, P399, DOI 10.1007/s00259-011-1994-7; Wu YT, 2013, J WOMENS HEALTH, V22, P439, DOI 10.1089/jwh.2012.4055; Xu AM, 2006, CLIN CHEM, V52, P405, DOI 10.1373/clinchem.2005.062463; Yan Q, 2012, ENDOCRINE, V41, P281, DOI 10.1007/s12020-011-9550-6; Yoon MY, 2012, CLIN MOL HEPATOL, V18, P279, DOI 10.3350/cmh.2012.18.3.279; Zaid G, 2007, INT J CARDIOL, V117, P157, DOI 10.1016/j.ijcard.2006.06.013	45	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97710	10.1371/journal.pone.0097710	http://dx.doi.org/10.1371/journal.pone.0097710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842767	Green Published, Green Submitted, gold			2022-12-25	WOS:000340948600061
J	Roberts, B; Murphy, A; Chikovani, I; Makhashvili, N; Patel, V; McKee, M				Roberts, Bayard; Murphy, Adrianna; Chikovani, Ivdity; Makhashvili, Nino; Patel, Vikram; McKee, Martin			Individual and Community Level Risk-Factors for Alcohol Use Disorder among Conflict-Affected Persons in Georgia	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; NATIONAL EPIDEMIOLOGIC SURVEY; FORMER SOVIET-UNION; MAJOR DEPRESSION; DISPLACED PERSONS; MENTAL-HEALTH; NICOTINE DEPENDENCE; OUTLET DENSITY; DRUG-USE; CONSUMPTION	Background: The evidence on alcohol use disorder among conflict-affected civilian populations remains extremely weak, despite a number of potential risk-factors. The aim of this study is to examine patterns of alcohol use disorder among conflict-affected persons in the Republic of Georgia. Methods: A cross-sectional survey of 3600 randomly selected internally displaced persons (IDPs) and former IDPs. Two alcohol use disorder outcomes were measured: (i) having at least hazardous alcohol use (AUDIT score >= 8); (ii) episodic heavy drinking (consuming >60 grams of pure alcohol per drinking session at least once a week). Individual level demographic and socio-economic characteristics were also recorded, including mental disorders. Community level alcohol environment characteristics relating to alcohol availability, marketing and pricing were recorded in the respondents' communities and a factor analysis conducted to produce a summary alcohol environment factor score. Logistic regression analyses examined associations between individual and community level factors with the alcohol use disorder outcomes (among men only). Results: Of the total sample, 71% of men and 16% of women were current drinkers. Of the current drinkers (N = 1386), 28% of men and 1% of women were classified as having at least hazardous alcohol use; and 12% of men and 2% of women as episodic heavy drinkers. Individual characteristics significantly associated with both outcomes were age and experiencing a serious injury, while cumulative trauma events and depression were also associated with having at least hazardous alcohol use. For the community level analysis, a one unit increase in the alcohol environment factor was associated with a 1.27 fold increase in episodic heavy drinking among men (no significant association with hazardous alcohol use). Conclusion: The findings suggest potential synergies for treatment responses for alcohol use disorder and depression among conflict-affected populations in Georgia, as well as the need for stronger alcohol control policies in Georgia.	[Roberts, Bayard; Murphy, Adrianna; McKee, Martin] London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit ECOHOST, London WC1, England; [Chikovani, Ivdity] Curatio Int Fdn, Tbilisi, Georgia; [Makhashvili, Nino] Ilia State Univ, Global Initiat Psychiat Tbilisi, Tbilisi, Georgia; [Patel, Vikram] London Sch Hyg & Trop Med, Ctr Global Mental Hlth, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; Ilia State University; University of London; London School of Hygiene & Tropical Medicine	Roberts, B (corresponding author), London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit ECOHOST, London WC1, England.	bayard.roberts@lshtm.ac.uk	Chikovani, Ivdity/AAL-9870-2020; McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018; makhashvili, nino/ABF-4921-2021	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; makhashvili, nino/0000-0002-2365-2939; Patel, Vikram/0000-0003-1066-8584; Roberts, Bayard/0000-0003-4482-5859; Chikovani, Ivdity/0000-0001-6925-4904	Wellcome Trust [093562/Z/10/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (093562/Z/10/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelekan M., 2006, RAPID ASSESSMENT SUB; Anderson P, 2009, ALCOHOL ALCOHOLISM, V44, P229, DOI 10.1093/alcalc/agn115; [Anonymous], 2009, FORCED MIGRATION REV, DOI DOI 10.1016/B978-0-7020-3008-6.50008-9; Babor T.F., 2010, ALCHOL NO ORDINARY C, V2nd, DOI DOI 10.1093/ACPROF:OSO/9780199551149.003.002; Babor TF., 2001, ALCOHOL USE DISORDER; Boas M, 2005, ALCHOL DRUG CONSUMPT; Boden JM, 2011, ADDICTION, V106, P906, DOI 10.1111/j.1360-0443.2010.03351.x; Breslau N, 2003, ARCH GEN PSYCHIAT, V60, P289, DOI 10.1001/archpsyc.60.3.289; Brewin CR, 2002, BRIT J PSYCHIAT, V181, P158, DOI 10.1192/bjp.181.2.158; Bryden A, 2012, HEALTH PLACE, V18, P349, DOI 10.1016/j.healthplace.2011.11.003; Centers for Disease Control and Prevention, 2012, ALC PUBL HLTH FACT S; Chen MJ, 2010, ADDICTION, V105, P270, DOI 10.1111/j.1360-0443.2009.02772.x; Chow CK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014294; Conway KP, 2006, J CLIN PSYCHIAT, V67, P247, DOI 10.4088/JCP.v67n0211; Cook RL, 2005, SEX TRANSM DIS, V32, P156, DOI 10.1097/01.olq.0000151418.03899.97; de Jong JTVM, 2003, LANCET, V361, P2128, DOI 10.1016/S0140-6736(03)13692-6; De Jong JTVM, 2002, PL S STRESS, P1; Demaio A, 2013, PLOS CURR, V5; Ezard N, 2012, DISASTERS, V36, P533, DOI 10.1111/j.1467-7717.2011.01261.x; Ezard N, 2010, INTERVENTION, V8, P223, DOI 10.1097/WTF.0b013e3283413134; Farrell M, 2001, BRIT J PSYCHIAT, V179, P432, DOI 10.1192/bjp.179.5.432; GRANT BF, 1995, DRUG ALCOHOL DEPEN, V39, P197, DOI 10.1016/0376-8716(95)01160-4; Grant VV, 2009, PSYCHOL ADDICT BEHAV, V23, P226, DOI 10.1037/a0015006; GRUENEWALD PJ, 1993, ALCOHOL CLIN EXP RES, V17, P38, DOI 10.1111/j.1530-0277.1993.tb00723.x; Hasin DS, 2002, ARCH GEN PSYCHIAT, V59, P794, DOI 10.1001/archpsyc.59.9.794; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; IDMC, 2012, GEORG PART PROGR DUR; Inter-Agency Standing Committee (IASC), 2007, AM PSYCHOL ASS, DOI [DOI 10.1037/E518422011-002, 10.1037/e518422011-002]; IoM, 2012, MIGR HLTH SURV; Javakhishvili D, 2011, DRUG SITUATION GEORG; Johnson TP, 1996, SUBST USE MISUSE, V31, P1853, DOI 10.3109/10826089609064003; Jones E, 2011, INT REV PSYCHIATR, V23, P166, DOI 10.3109/09540261.2010.550868; Kessler RC, 1997, ARCH GEN PSYCHIAT, V54, P313; Kirk SFL, 2010, OBES REV, V11, P109, DOI 10.1111/j.1467-789X.2009.00611.x; Kizza D, 2012, CRISIS, V33, P95, DOI 10.1027/0227-5910/a000119; Kozaric-Kovacic D, 2000, CROAT MED J, V41, P173; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kuo PH, 2006, PSYCHOL MED, V36, P1153, DOI 10.1017/S0033291706007860; Kwate NOA, 2009, AM J PUBLIC HEALTH, V99, P228, DOI 10.2105/AJPH.2007.132217; Lee Juliet P, 2008, J Ethn Subst Abuse, V7, P357, DOI 10.1080/15332640802508200; Leifman H., 2002, CONTEMP DRUG PROBL, V29, P477; Luitel NP, 2013, ALCOHOL ALCOHOLISM, V48, P349, DOI 10.1093/alcalc/agt009; Makhashvili N, 2014, MENTAL DISO IN PRESS; Makhashvili N, 2010, TRAUMATOLOGY, V16, P63, DOI [DOI 10.1177/1534765610388302, 10.1177/1534765610388302]; Marshall GN, 2005, JAMA-J AM MED ASSOC, V294, P571, DOI 10.1001/jama.294.5.571; McKee M, 1998, J ROY SOC MED, V91, P402, DOI 10.1177/014107689809100802; Miller KE, 2004, MENTAL HEALTH OF REFUGEES, P1; Murphy A, 2013, USING MULTI IN PRESS; Papas MA, 2007, EPIDEMIOL REV, V29, P129, DOI 10.1093/epirev/mxm009; Piralishvili G, 2013, Georgian Med News, P28; Pollack CE, 2005, INT J EPIDEMIOL, V34, P772, DOI 10.1093/ije/dyi026; Pomerleau J, 2005, ADDICTION, V100, P1647, DOI 10.1111/j.1360-0443.2005.01233.x; Pomerleau J, 2008, ALCOHOL ALCOHOLISM, V43, P351, DOI 10.1093/alcalc/agm167; Porter M, 2005, JAMA-J AM MED ASSOC, V294, P602, DOI 10.1001/jama.294.5.602; Rehm J, 2010, ADDICTION, V105, P817, DOI 10.1111/j.1360-0443.2010.02899.x; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; RHODES JE, 1990, J CONSULT CLIN PSYCH, V58, P395, DOI 10.1037/0022-006X.58.4.395; Roberts B, 2013, INT J ENV RES PUB HE, V10, P2185, DOI 10.3390/ijerph10062185; Roberts B, 2011, ADDICT BEHAV, V36, P870, DOI 10.1016/j.addbeh.2011.03.006; Rytwinski NK, 2013, J TRAUMA STRESS, V26, P299, DOI 10.1002/jts.21814; Sacco P, 2009, J STUD ALCOHOL DRUGS, V70, P829, DOI 10.15288/jsad.2009.70.829; SAUNDERS JB, 1993, ADDICTION, V88, P349, DOI 10.1111/j.1360-0443.1993.tb00822.x; Scherrer JF, 2008, COMPR PSYCHIAT, V49, P297, DOI 10.1016/j.comppsych.2007.11.001; Silove, 2004, MEASURING TRAUMA MEA; Spiegel PB, 2010, LANCET, V375, P341, DOI 10.1016/S0140-6736(09)61873-0; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; Stewart SH, 1996, PSYCHOL BULL, V120, P83, DOI 10.1037/0033-2909.120.1.83; Streel E, 2010, INTERVENTION, V8, P268, DOI 10.1097/WTF.0b013e328341315f; Swinburn B, 1999, PREV MED, V29, P563, DOI 10.1006/pmed.1999.0585; UNHCR/WHO, 2008, RAP ASS ALC OTH SUBS; United Nations Health Council for Refugees (UNHCR), 2013, OP GUID MENT HLTH PS; United Nations Security Council, 2009, PROM PROT ALL HUM RI; USAID, 2013, INT DEPR ALC AB SCRE; van Ommeren M., 1999, TRANSCULT PSYCHIATRY, V36, P285, DOI [10.1177/136346159903600304, DOI 10.1177/136346159903600304]; VANOERS JAM, 1993, J STUD ALCOHOL, V54, P739, DOI 10.15288/jsa.1993.54.739; Wang JL, 2002, DEPRESS ANXIETY, V15, P42, DOI 10.1002/da.1084; Watson K, 2013, EUR J PUBLIC HEALTH, V23, P291, DOI 10.1093/eurpub/cks054; Weaver H, 2010, SUBST USE MISUSE; Weitzman ER, 2003, HEALTH PLACE, V9, P1, DOI 10.1016/S1353-8292(02)00014-X; WHO, 2011, GLOB STRAT RED HARMF; WHO, 2008, WHOEPIMLM9110; WHO/Children of Georgia, 2009, ASS MENT HLTH PSYCH; WHO Europe, 2007, NONC DIS RISK FACT S; WHO Europe, 2014, ALC CONTR DAT; WHO GHO, 2013, HEAV EP DRINK DRINK; World Health Organization, 2009, EV EFF COST EFF INT; World Health Organization, 2011, GLOB STAT REP ALC HL; World Health Organization, 2013, VIOL WOM PREV EST 20	90	26	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98299	10.1371/journal.pone.0098299	http://dx.doi.org/10.1371/journal.pone.0098299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5NG	24865450	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000336914100049
J	Ohba, K; Ichiyama, K; Yajima, M; Gemma, N; Nikaido, M; Wu, QQ; Chong, PP; Mori, S; Yamamoto, R; Wong, JEL; Yamamoto, N				Ohba, Kenji; Ichiyama, Koji; Yajima, Misako; Gemma, Nobuhiro; Nikaido, Masaru; Wu, Qingqing; Chong, PeiPei; Mori, Seiichiro; Yamamoto, Rain; Wong, John Eu Li; Yamamoto, Naoki			In Vivo and In Vitro Studies Suggest a Possible Involvement of HPV Infection in the Early Stage of Breast Carcinogenesis via APOBEC3B Induction	PLOS ONE			English	Article							INDUCED CYTIDINE DEAMINASE; ESTROGEN-RECEPTOR-ALPHA; HUMAN PAPILLOMA-VIRUS; MUTATIONAL PROCESSES; CANCER; PREVALENCE; EXPRESSION; DNA; MUTAGENESIS; ROLES	High prevalence of infection with high-risk human papilloma virus (HPV) ranging from 25 to 100% (average 31%) was observed in breast cancer (BC) patients in Singapore using novel DNA chip technology. Early stage of BC demonstrated higher HPV positivity, and BC positive for estrogen receptor (ER) showed significantly higher HPV infection rate. This unique association of HPV with BC in vivo prompted us to investigate a possible involvement of HPV in early stages of breast carcinogenesis. Using normal breast epithelial cells stably transfected with HPV-18, we showed apparent upregulation of mRNA for the cytidine deaminase, APOBEC3B (A3B) which is reported to be a source of mutations in BC. HPV-induced A3B overexpression caused significant gamma H2AX focus formation, and DNA breaks which were cancelled by shRNA to HPV18 E6, E7 and A3B. These results strongly suggest an active involvement of HPV in the early stage of BC carcinogenesis via A3B induction.	[Ohba, Kenji; Ichiyama, Koji; Yajima, Misako; Wu, Qingqing; Chong, PeiPei; Yamamoto, Naoki] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Program Infect Dis, Singapore 117595, Singapore; [Gemma, Nobuhiro] Toshiba Co Ltd, Toshiba Res & Dev Ctr, Kawasaki, Kanagawa 210, Japan; [Nikaido, Masaru] Toshiba Co Ltd, Mat & Devices Div, Minato Ku, Tokyo, Japan; [Chong, PeiPei] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Biomed Sci, Selangor Darul Ehsan, Malaysia; [Mori, Seiichiro] Natl Inst Infect Dis, Pathogen Genom Ctr, Shinjuku Ku, Tokyo, Japan; [Yamamoto, Rain] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Wong, John Eu Li] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Canc Inst, Dept Hematol Med Oncol, Singapore 117595, Singapore	National University of Singapore; Toshiba Corporation; Toshiba Corporation; Universiti Putra Malaysia; National Institute of Infectious Diseases (NIID); Harvard University; Harvard T.H. Chan School of Public Health; National University of Singapore	Yamamoto, N (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Program Infect Dis, Singapore 117595, Singapore.	naoki_yamamoto@nuhs.edu.sg	Chong, Pei Pei/AAP-4227-2021; Ohba, Kenji/D-8072-2015; Chong, Pei pei/G-1367-2018; Yajima, Misako/ABH-7217-2020	Chong, Pei Pei/0000-0002-8229-3593; Ohba, Kenji/0000-0002-4936-8186; Chong, Pei pei/0000-0002-8229-3593; Yamamoto, Rain/0000-0002-8928-8797; Yajima, Misako/0000-0002-6437-1404	NUS SoM Start-up Grant [R-182-000-160-733]	NUS SoM Start-up Grant	This work was supported by NUS SoM Start-up Grant (R-182-000-160-733). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo F, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-7; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Allred DC, 2004, BREAST CANCER RES, V6, P240, DOI 10.1186/bcr938; Antonsson A, 2011, J MED VIROL, V83, P2157, DOI 10.1002/jmv.22223; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; de Leon DC, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-26; Chansaenroj J, 2012, ASIAN PAC J CANCER P, V13, P1151, DOI 10.7314/APJCP.2012.13.4.1151; Chen BPC, 2012, CANCER LETT, V327, P103, DOI 10.1016/j.canlet.2011.12.004; Chiba T, 2009, J MOL MED-JMM, V87, P1023, DOI 10.1007/s00109-009-0527-3; Chung SH, 2008, CANCER RES, V68, P9928, DOI 10.1158/0008-5472.CAN-08-2051; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; De Marco F, 2013, VIRUSES-BASEL, V5, P708, DOI 10.3390/v5020708; De Marco F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034366; Dedeoglu F, 2004, INT IMMUNOL, V16, P395, DOI 10.1093/intimm/dxh042; Duensing S, 2004, INT J CANCER, V109, P157, DOI 10.1002/ijc.11691; Duensing S, 2002, CANCER RES, V62, P7075; DURST M, 1983, P NATL ACAD SCI-BIOL, V80, P3812, DOI 10.1073/pnas.80.12.3812; Endo Y, 2007, ONCOGENE, V26, P5587, DOI 10.1038/sj.onc.1210344; Engels K, 2008, APPL IMMUNOHISTO M M, V16, P521, DOI 10.1097/PAI.0b013e3181758ce5; GAGE JR, 1990, J VIROL, V64, P723, DOI 10.1128/JVI.64.2.723-730.1990; Glenn WK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048788; Handa O, 2010, INFLAMM RES, V59, P997, DOI 10.1007/s00011-010-0245-x; Heng B, 2009, BRIT J CANCER, V101, P1345, DOI 10.1038/sj.bjc.6605282; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; Khan NA, 2008, BRIT J CANCER, V99, P408, DOI 10.1038/sj.bjc.6604502; Klemm L, 2009, CANCER CELL, V16, P232, DOI 10.1016/j.ccr.2009.07.030; Kroupis C, 2006, CLIN BIOCHEM, V39, P727, DOI 10.1016/j.clinbiochem.2006.03.005; Kuong KJ, 2013, NAT GENET, V45, P964, DOI 10.1038/ng.2736; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lawson JS, 2006, FUTURE MICROBIOL, V1, P33, DOI 10.2217/17460913.1.1.33; MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210; Mammas IN, 2011, PATHOL ONCOL RES, V17, P103, DOI 10.1007/s12253-010-9288-0; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Mori S, 2011, CANCER SCI, V102, P1223, DOI 10.1111/j.1349-7006.2011.01922.x; Munger K, 2002, VIRUS RES, V89, P213, DOI 10.1016/S0168-1702(02)00190-9; MUNGER K, 1989, EMBO J, V8, P4099, DOI 10.1002/j.1460-2075.1989.tb08594.x; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Schmitz KM, 2012, SEMIN IMMUNOL, V24, P241, DOI 10.1016/j.smim.2012.07.001; Sedelnikova OA, 2010, MUTAT RES-REV MUTAT, V704, P152, DOI 10.1016/j.mrrev.2009.12.005; Shai A, 2008, CANCER RES, V68, P2622, DOI 10.1158/0008-5472.CAN-07-5266; Simoes PW, 2012, INT J GYNECOL CANCER, V22, P343, DOI 10.1097/IGC.0b013e31823c712e; Tanaka Y, 2006, BIOCHEM BIOPH RES CO, V341, P314, DOI 10.1016/j.bbrc.2005.12.192; Trinchieri G, 2012, ANNU REV IMMUNOL, V30, P677, DOI 10.1146/annurev-immunol-020711-075008; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Williams VM, 2011, FUTURE VIROL, V6, P45, DOI 10.2217/FVL.10.73; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046; zur Hausen H, 2009, ANGEW CHEM INT EDIT, V48, P5798, DOI 10.1002/anie.200901917	53	66	72	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97787	10.1371/journal.pone.0097787	http://dx.doi.org/10.1371/journal.pone.0097787			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858917	Green Published, gold, Green Submitted			2022-12-25	WOS:000336839400026
J	Piek, E; Kollen, BJ; van der Meer, K; Penninx, BWJH; Nolen, WA				Piek, Ellen; Kollen, Boudewijn J.; van der Meer, Klaas; Penninx, Brenda W. J. H.; Nolen, Willem A.			Maintenance Use of Antidepressants in Dutch General Practice: Non-Guideline Concordant	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; MENTAL-HEALTH-CARE; 5-YEAR FOLLOW-UP; RELIABILITY; INVENTORY; ANXIETY; NETHERLANDS; RECALL	Background: There is hardly evidence on maintenance treatment with antidepressants in primary care. Nevertheless, depression guidelines recommend maintenance treatment i.e. treatment to prevent recurrences, in patients with high risk of recurrence, and many patients use maintenance treatment with antidepressants. This study explores the characteristics of patients on maintenance treatment with antidepressants in general practice, and compares these characteristics with guideline recommendations for maintenance treatment. Methods: We used data (baseline, two-year and four-year follow-up) of primary care respondents with remitted depressive disorder (>= 6 months) from the Netherlands Study of Depression and Anxiety (n = 776). Maintenance treatment was defined as the use of an antidepressant for >= 12 months. Multilevel logistic regression was used to describe the association between sociodemographic, clinical and care characteristics and use of maintenance treatment with antidepressants. Results: Older patients, patients with a lower education, those using benzodiazepines or receiving psychological/psychiatric care and patients with a concurrent history of a dysthymic or anxiety disorder more often received maintenance treatment with antidepressants. Limitations: Measurements were not made at the start of an episode, but at predetermined points in time. Diagnoses were based on interview (CIDI) data and could therefore in some cases have been different from the GP diagnosis. Conclusions: Since patients with chronic or recurrent depression do not use maintenance treatment with antidepressants more often, characteristics of patients on maintenance treatment do not fully correspond with guideline recommendations. However, patients on maintenance treatment appear to be those with more severe disorder and/or more comorbidity.	[Piek, Ellen; Kollen, Boudewijn J.; van der Meer, Klaas] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands; [Penninx, Brenda W. J. H.; Nolen, Willem A.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Penninx, Brenda W. J. H.] Leiden Univ, Dept Psychiat, Med Ctr, Leiden, Netherlands; [Penninx, Brenda W. J. H.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Psychiat, Amsterdam, Netherlands	University of Groningen; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam	Piek, E (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands.	e.piek@umcg.nl	Penninx, Brenda WJH/S-7627-2017	Penninx, Brenda WJH/0000-0001-7779-9672	Geestkracht program of the Netherlands Organisation for Health Research and Development (Zon-Mw) [10-000-1002]; VU University Medical Center; GGZ inGeest; Arkin; Leiden University Medical Center; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Scientific Institute for Quality of Healthcare (IQ healthcare); Netherlands Institute for Health Services Research (NIVEL); Netherlands Institute of Mental Health and Addiction (Trimbos Institute)	Geestkracht program of the Netherlands Organisation for Health Research and Development (Zon-Mw)(Netherlands Organization for Health Research and Development); VU University Medical Center; GGZ inGeest; Arkin; Leiden University Medical Center; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Scientific Institute for Quality of Healthcare (IQ healthcare); Netherlands Institute for Health Services Research (NIVEL); Netherlands Institute of Mental Health and Addiction (Trimbos Institute)	The infrastructure for the NESDA study (www.nesda.nl) is funded through the Geestkracht program of the Netherlands Organisation for Health Research and Development (Zon-Mw, grant number 10-000-1002) and is supported by participating universities and mental health care organizations (VU University Medical Center, GGZ inGeest, Arkin, Leiden University Medical Center, GGZ Rivierduinen, University Medical Center Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Scientific Institute for Quality of Healthcare (IQ healthcare), Netherlands Institute for Health Services Research (NIVEL) and Netherlands Institute of Mental Health and Addiction (Trimbos Institute). There was no additional funding for this study. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andrews G, 1999, PSYCHOL MED, V29, P787, DOI 10.1017/S0033291799008648; Bauer M, 2007, WORLD J BIOL PSYCHIA, V8, P67, DOI 10.1080/15622970701227829; BECK AT, 1979, J CONSULT CLIN PSYCH, V47, P343, DOI 10.1037/0022-006X.47.2.343; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Burton C, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X625166; Denicoff KD, 1997, J PSYCHIAT RES, V31, P593, DOI 10.1016/S0022-3956(96)00027-1; Holma IAK, 2008, BRIT J PSYCHIAT, V193, P163, DOI 10.1192/bjp.bp.107.045708; Honig A, 2001, PATIENT EDUC COUNS, V43, P43, DOI 10.1016/S0738-3991(00)00144-0; Institute for Clinical Systems Improvement, 2009, ICSI HLTH CAR GUID M; Kaymaz N, 2008, J CLIN PSYCHIAT, V69, P1423, DOI 10.4088/JCP.v69n0910; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Korner A, 2008, PSYCHOTHER PSYCH MED, V58, P238, DOI 10.1055/s-2007-986199; Meadows G, 2000, SOC PSYCH PSYCH EPID, V35, P427, DOI 10.1007/s001270050260; Meeuwissen JAC, 2009, MULTIDISCIPLINAIRE R; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; National Collaborating Centre for Mental Health, 2009, DEPR TREATM MAN DEPR; National Institute for Clinical Excellence, 2009, DEPR AD TREATM MAN D; Patten S B, 2000, Chronic Dis Can, V21, P68; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Piek E, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-41; Piek E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014784; Piek E, 2010, EUR J GEN PRACT, V16, P106, DOI 10.3109/13814781003692463; RUSH AJ, 1986, PSYCHIAT RES, V18, P65; Saucier G, 1998, J PERS ASSESS, V70, P263, DOI 10.1207/s15327752jpa7002_6; Sunderland M, 2010, SOC PSYCH PSYCH EPID, V46, P775; Susser E, 2000, SCHIZOPHR RES, V42, P67, DOI 10.1016/S0920-9964(99)00088-2; Tacchini G, 1994, Minerva Psichiatr, V35, P63; ten Doesschate MC, 2009, J CLIN PSYCHIAT, V70, P63, DOI 10.4088/JCP.08m04119; TERLUIN B, 2004, HUISARTS WET, V47, P26; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; Van der Veen WJ, 2009, INT J METH PSYCH RES, V18, P229, DOI 10.1002/mpr.297; van Weel-Baumgarten EM, 2012, HUISARTS WETENSCHAP, V55, P252; VANMARWIJK HWJ, 2003, HUISARTS WET, V46, P614; Wells JE, 2004, PSYCHOL MED, V34, P1001, DOI 10.1017/S0033291703001843; Wilson I, 2003, FAM PRACT, V20, P685, DOI 10.1093/fampra/cmg611; WITTCHEN HU, 1991, BRIT J PSYCHIAT, V159, P645, DOI 10.1192/bjp.159.5.645	36	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97463	10.1371/journal.pone.0097463	http://dx.doi.org/10.1371/journal.pone.0097463			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858011	gold, Green Submitted, Green Published			2022-12-25	WOS:000336839400018
J	Wandall-Frostholm, C; Skaarup, LM; Sadda, V; Nielsen, G; Hedegaard, ER; Mogensen, S; Kohler, R; Simonsen, U				Wandall-Frostholm, Christine; Skaarup, Lykke Moran; Sadda, Veeranjaneyulu; Nielsen, Gorm; Hedegaard, Elise Roge; Mogensen, Susie; Kohler, Ralf; Simonsen, Ulf			Pulmonary Hypertension in Wild Type Mice and Animals with Genetic Deficit in K(Ca)2.3 and K(Ca)3.1 Channels	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNELS; NITRIC-OXIDE SYNTHASE; CA2+-ACTIVATED K+ CHANNEL; HYPERPOLARIZING FACTOR; SMALL-CONDUCTANCE; CHRONIC HYPOXIA; DEPENDENT RELAXATION; MEDIATED RELAXATION; SMOOTH-MUSCLE; ARTERIAL TONE	Objective: In vascular biology, endothelial K(Ca)2.3 and K(Ca)3.1 channels contribute to arterial blood pressure regulation by producing membrane hyperpolarization and smooth muscle relaxation. The role of K(Ca)2.3 and K(Ca)3.1 channels in the pulmonary circulation is not fully established. Using mice with genetically encoded deficit of K(Ca)2.3 and K(Ca)3.1 channels, this study investigated the effect of loss of the channels in hypoxia-induced pulmonary hypertension. Approach and Result: Male wild type and K(Ca)3.1(-/-)/K(Ca)2.3(T/T(+DOX)) mice were exposed to chronic hypoxia for four weeks to induce pulmonary hypertension. The degree of pulmonary hypertension was evaluated by right ventricular pressure and assessment of right ventricular hypertrophy. Segments of pulmonary arteries were mounted in a wire myograph for functional studies and morphometric studies were performed on lung sections. Chronic hypoxia induced pulmonary hypertension, right ventricular hypertrophy, increased lung weight, and increased hematocrit levels in either genotype. The K(Ca)3.1(-/-)/K(Ca)2.3(T/T(+DOX)) mice developed structural alterations in the heart with increased right ventricular wall thickness as well as in pulmonary vessels with increased lumen size in partially-and fully-muscularized vessels and decreased wall area, not seen in wild type mice. Exposure to chronic hypoxia up-regulated the gene expression of the K(Ca)2.3 channel by twofold in wild type mice and increased by 2.5-fold the relaxation evoked by the K(Ca)2.3 and K(Ca)3.1 channel activator NS309, whereas the acetylcholine-induced relaxation - sensitive to the combination of K(Ca)2.3 and K(Ca)3.1 channel blockers, apamin and charybdotoxin - was reduced by 2.5-fold in chronic hypoxic mice of either genotype. Conclusion: Despite the deficits of the K(Ca)2.3 and K(Ca)3.1 channels failed to change hypoxia-induced pulmonary hypertension, the up-regulation of K(Ca)2.3-gene expression and increased NS309-induced relaxation in wild-type mice point to a novel mechanism to counteract pulmonary hypertension and to a potential therapeutic utility of K(Ca)2.3/K(Ca)3.1 activators for the treatment of pulmonary hypertension.	[Wandall-Frostholm, Christine; Skaarup, Lykke Moran; Sadda, Veeranjaneyulu; Hedegaard, Elise Roge; Mogensen, Susie; Simonsen, Ulf] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Sadda, Veeranjaneyulu; Nielsen, Gorm; Kohler, Ralf] Univ Southern Denmark, Inst Mol Med Cardiovasc & Renal Res, Odense, Denmark; [Kohler, Ralf] Aragon Inst Hlth Sci I CS, Zaragoza, Spain; [Kohler, Ralf] ARAID, Zaragoza, Spain	Aarhus University; University of Southern Denmark	Wandall-Frostholm, C (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	cwf@farm.au.dk		Hedegaard, Elise/0000-0002-6687-3838; Kohler, Ralf/0000-0001-9563-2913; Skaarup, Lykke/0000-0002-1408-0027	NovoNordisk Foundation; Danish Heart Foundation; EC; Deutsche Forschungsgemeinschaft [KO1899/11-1]; Fondo de Investigacion Sanitaria [Red HERACLES RD12/0042/0014]	NovoNordisk Foundation(Novo Nordisk Foundation); Danish Heart Foundation; EC(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III)	NovoNordisk Foundation supported Ulf Simonsen and Ralf Kohler. Ulf Simonsen is supported by the Danish Heart Foundation and he is member of LiPhos (Living Photonics: Monitoring light propagation through cells), which is funded by the EC Seventh Framework programme. Ralf Kohler is supported by a grant of the Deutsche Forschungsgemeinschaft (KO1899/11-1) and the Fondo de Investigacion Sanitaria (Red HERACLES RD12/0042/0014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADNOT S, 1991, J CLIN INVEST, V87, P155, DOI 10.1172/JCI114965; Baandrup JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015859; Benza RL, 2012, CHEST, V142, P448, DOI 10.1378/chest.11-1460; Bond CT, 2000, SCIENCE, V289, P1942, DOI 10.1126/science.289.5486.1942; Brahler S, 2009, CIRCULATION, V119, P2323, DOI 10.1161/CIRCULATIONAHA.108.846634; Burnham MP, 2002, BRIT J PHARMACOL, V135, P1133, DOI 10.1038/sj.bjp.0704551; Busse R, 2002, TRENDS PHARMACOL SCI, V23, P374, DOI 10.1016/S0165-6147(02)02050-3; Bychkov R, 2002, BRIT J PHARMACOL, V137, P1346, DOI 10.1038/sj.bjp.0705057; Cahill E, 2012, CIRCULATION, V125, P920, DOI 10.1161/CIRCULATIONAHA.111.038125; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; Corriu C, 1996, BRIT J PHARMACOL, V119, P959, DOI 10.1111/j.1476-5381.1996.tb15765.x; Dalsgaard T, 2010, EXPERT OPIN THER TAR, V14, P825, DOI 10.1517/14728222.2010.500616; Dalsgaard T, 2009, INVEST OPHTH VIS SCI, V50, P3819, DOI 10.1167/iovs.08-3168; Damkjaer M, 2012, BRIT J PHARMACOL, V165, P223, DOI 10.1111/j.1476-5381.2011.01546.x; Edwards G, 1998, NATURE, V396, P269, DOI 10.1038/24388; Feletou M, 2006, ARTERIOSCL THROM VAS, V26, P1215, DOI 10.1161/01.ATV.0000217611.81085.c5; Feletou M, 2012, ANN MED, V44, P694, DOI 10.3109/07853890.2011.585658; Feletou M, 2009, BRIT J PHARMACOL, V156, P545, DOI 10.1111/j.1476-5381.2009.00052.x; Fike CD, 1998, AM J PHYSIOL-LUNG C, V274, pL517, DOI 10.1152/ajplung.1998.274.4.L517; Fisslthaler B, 1999, NATURE, V401, P493, DOI 10.1038/46816; Fuloria M, 2002, AM J PHYSIOL-LUNG C, V283, pL383, DOI 10.1152/ajplung.00444.2001; Grgic I, 2009, BRIT J PHARMACOL, V157, P509, DOI 10.1111/j.1476-5381.2009.00132.x; Guerard P, 2004, EUR J PHARMACOL, V501, P127, DOI 10.1016/j.ejphar.2004.08.007; Hercule HC, 2009, ARTERIOSCL THROM VAS, V29, P54, DOI 10.1161/ATVBAHA.108.171298; Herrera GM, 2003, J PHYSIOL-LONDON, V551, P893, DOI 10.1113/jphysiol.2003.045914; Huang CL, 2013, DIABETES, V62, P2923, DOI 10.2337/db13-0135; IGNARRO LJ, 1984, J PHARMACOL EXP THER, V228, P682; Karamsetty MR, 2001, AM J PHYSIOL-LUNG C, V280, pL458, DOI 10.1152/ajplung.2001.280.3.L458; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Kohler R, 2010, EXPERT OPIN THER TAR, V14, P143, DOI 10.1517/14728220903540257; Kroigaard C, 2013, EXP PHYSIOL, V98, P957, DOI 10.1113/expphysiol.2012.066340; Kroigaard C, 2012, BRIT J PHARMACOL, V167, P37, DOI 10.1111/j.1476-5381.2012.01986.x; Kroigaard C, 2010, AM J PHYSIOL-LUNG C, V298, pL531, DOI 10.1152/ajplung.00220.2009; Le Cras TD, 1998, J CLIN INVEST, V101, P795, DOI 10.1172/JCI786; LeCras TD, 1996, AM J PHYSIOL-LUNG C, V270, pL164, DOI 10.1152/ajplung.1996.270.1.L164; Littler CM, 2005, AM J PHYSIOL-LUNG C, V289, pL1083, DOI 10.1152/ajplung.00472.2004; Mam V, 2010, J PHARMACOL EXP THER, V332, P455, DOI 10.1124/jpet.109.160119; MONCADA S, 1978, PHARMACOL REV, V30, P293; Morimura K, 2006, J PHARMACOL SCI, V100, P237, DOI 10.1254/jphs.SC0060011; Morio Y, 2007, J VASC RES, V44, P325, DOI 10.1159/000101778; Neylon CB, 1999, CIRC RES, V85, pE33, DOI 10.1161/01.RES.85.9.e33; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Petersson J, 1997, BRIT J PHARMACOL, V120, P1344, DOI 10.1038/sj.bjp.0701032; Resta TC, 1997, AM J PHYSIOL-HEART C, V272, pH806, DOI 10.1152/ajpheart.1997.272.2.H806; SHAUL PW, 1995, AM J RESP CELL MOL, V13, P167, DOI 10.1165/ajrcmb.13.2.7542896; Si H, 2006, CIRC RES, V99, P537, DOI 10.1161/01.RES.0000238377.08219.0c; Stankevicius E, 2011, J PHARMACOL EXP THER, V339, P842, DOI 10.1124/jpet.111.179242; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Taylor MS, 2003, CIRC RES, V93, P124, DOI 10.1161/01.RES.0000081980.63146.69; Wei AD, 2005, PHARMACOL REV, V57, P463, DOI 10.1124/pr.57.4.9; Wolfle SE, 2009, CARDIOVASC RES, V82, P476, DOI 10.1093/cvr/cvp060; Xue C, 1996, HYPERTENSION, V28, P743, DOI 10.1161/01.HYP.28.5.743; Yamanaka A, 1998, J PHARMACOL EXP THER, V285, P480	53	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97687	10.1371/journal.pone.0097687	http://dx.doi.org/10.1371/journal.pone.0097687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858807	gold, Green Published, Green Submitted			2022-12-25	WOS:000336839400024
J	Xu, Y; Dugat-Bony, E; Zaheer, R; Selinger, L; Barbieri, R; Munns, K; McAllister, TA; Selinger, LB				Xu, Yong; Dugat-Bony, Eric; Zaheer, Rahat; Selinger, Lorna; Barbieri, Ruth; Munns, Krysty; McAllister, Tim A.; Selinger, L. Brent			Escherichia coli O157:H7 Super-Shedder and Non-Shedder Feedlot Steers Harbour Distinct Fecal Bacterial Communities	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; BOVINE GASTROINTESTINAL-TRACT; MICROBIAL COMMUNITY; ANIMAL VARIATION; GUT MICROBIOTA; CATTLE; O157-H7; FECES; COLONIZATION; DIVERSITY	Escherichia coli O157:H7 is a major foodborne human pathogen causing disease worldwide. Cattle are a major reservoir for this pathogen and those that shed E. coli O157: H7 at >10(4) CFU/g feces have been termed "super-shedders". A rich microbial community inhabits the mammalian intestinal tract, but it is not known if the structure of this community differs between super-shedder cattle and their non-shedding pen mates. We hypothesized that the super-shedder state is a result of an intestinal dysbiosis of the microbial community and that a "normal" microbiota prevents E. coli O157: H7 from reaching super-shedding levels. To address this question, we applied 454 pyrosequencing of bacterial 16S rRNA genes to characterize fecal bacterial communities from 11 super-shedders and 11 contemporary pen mates negative for E. coli O157: H7. The dataset was analyzed by using five independent clustering methods to minimize potential biases and to increase confidence in the results. Our analyses collectively indicated significant variations in microbiome composition between super-shedding and non-shedding cattle. Super-shedders exhibited higher bacterial richness and diversity than non-shedders. Furthermore, seventy-two operational taxonomic units, mostly belonging to Firmicutes and Bacteroidetes phyla, were identified showing differential abundance between these two groups of cattle. The operational taxonomic unit affiliation provides new insight into bacterial populations that are present in feces arising from super-shedders of E. coli O157:H7.	[Xu, Yong; Selinger, L. Brent] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada; [Dugat-Bony, Eric] INRA, AgroParisTech, Grignon, France; [Zaheer, Rahat; Selinger, Lorna; Barbieri, Ruth; Munns, Krysty; McAllister, Tim A.] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada	University of Lethbridge; AgroParisTech; INRAE; Agriculture & Agri Food Canada	Selinger, LB (corresponding author), Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada.	selibl@uleth.ca	Dugat-Bony, Eric/K-2455-2014; McAllister, Tim A./R-9201-2017	Dugat-Bony, Eric/0000-0002-5182-0063; McAllister, Tim A./0000-0002-8266-6513; Zaheer, Rahat/0000-0003-3307-4666	Genome Alberta	Genome Alberta	The project was funded by Genome Alberta (genomealberta.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, GUIDE CARE USE EXPT, V2nd ed; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bertin Y, 2011, ENVIRON MICROBIOL, V13, P365, DOI 10.1111/j.1462-2920.2010.02334.x; BOYCE TG, 1995, NEW ENGL J MED, V333, P364, DOI 10.1056/NEJM199508103330608; Cai YP, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr349; Callaway TR, 2010, J ANIM SCI, V88, P3977, DOI 10.2527/jas.2010-2900; Callaway TR, 2009, CURR ISSUES MOL BIOL, V11, P67; Cernicchiaro N, 2010, FOODBORNE PATHOG DIS, V7, P1071, DOI 10.1089/fpd.2009.0531; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Duncan SH, 2004, APPL ENVIRON MICROB, V70, P5810, DOI 10.1128/AEM.70.10.5810-5817.2004; Durso LM, 2012, LETT APPL MICROBIOL, V55, P109, DOI 10.1111/j.1472-765X.2012.03265.x; Durso LM, 2010, APPL ENVIRON MICROB, V76, P4858, DOI 10.1128/AEM.00207-10; Durso LM, 2004, APPL ENVIRON MICROB, V70, P6466, DOI 10.1128/AEM.70.11.6466-6472.2004; Dziva F, 2004, MICROBIOL-SGM, V150, P3631, DOI 10.1099/mic.0.27448-0; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edrington TS, 2009, CURR MICROBIOL, V58, P227, DOI 10.1007/s00284-008-9312-8; Erickson DL, 2002, CAN J MICROBIOL, V48, P374, DOI 10.1139/w02-022; Flint HJ, 2007, ENVIRON MICROBIOL, V9, P1101, DOI 10.1111/j.1462-2920.2007.01281.x; Gannon VPJ, 1997, J CLIN MICROBIOL, V35, P656, DOI 10.1128/JCM.35.3.656-662.1997; Gould LH, 2009, CLIN INFECT DIS, V49, P1480, DOI 10.1086/644621; Grauke LJ, 2002, APPL ENVIRON MICROB, V68, P2269, DOI 10.1128/AEM.68.5.2269-2277.2002; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hadley W., 2009, GGPLOT2 ELEGANT GRAP; Hao XL, 2011, BIOINFORMATICS, V27, P611, DOI 10.1093/bioinformatics/btq725; Hughes DT, 2010, P NATL ACAD SCI USA, V107, P9831, DOI 10.1073/pnas.1002551107; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Matthews L, 2006, P NATL ACAD SCI USA, V103, P547, DOI 10.1073/pnas.0503776103; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2012, BIOCOMPUT-PAC SYM, P235; Naylor SW, 2003, INFECT IMMUN, V71, P1505, DOI 10.1128/IAI.71.3.1505-1512.2003; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Omisakin F, 2003, APPL ENVIRON MICROB, V69, P2444, DOI 10.1128/AEM.69.5.2444-2447.2003; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Price SB, 2004, APPL ENVIRON MICROB, V70, P4792, DOI 10.1128/AEM.70.8.4792-4799.2004; Rice WC, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-25; Riley MA, 2002, BIOCHIMIE, V84, P357, DOI 10.1016/S0300-9084(02)01421-9; Robinson SE, 2009, J R SOC INTERFACE, V6, P169, DOI 10.1098/rsif.2008.0183; Romero M, 2010, FEMS MICROBIOL LETT, V304, P131, DOI 10.1111/j.1574-6968.2009.01889.x; Sawant AA, 2011, APPL ENVIRON MICROB, V77, P2345, DOI 10.1128/AEM.03150-09; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shanks OC, 2011, APPL ENVIRON MICROB, V77, P2992, DOI 10.1128/AEM.02988-10; Sheng HQ, 2006, INFECT IMMUN, V74, P4685, DOI 10.1128/IAI.00406-06; Sperandio V, 2010, GUT MICROBES, V1, P432, DOI 10.4161/gmic.1.6.14177; Stephens TP, 2009, J ANIM SCI, V87, P4151, DOI 10.2527/jas.2009-1967; Sun YJ, 2012, BRIEF BIOINFORM, V13, P107, DOI 10.1093/bib/bbr009; Yao Y, 2006, J MOL BIOL, V355, P262, DOI 10.1016/j.jmb.2005.10.041; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	54	42	43	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98115	10.1371/journal.pone.0098115	http://dx.doi.org/10.1371/journal.pone.0098115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858731	gold, Green Published, Green Submitted			2022-12-25	WOS:000336839400043
J	Dover, N; Barash, JR; Burke, JN; Hill, KK; Detter, JC; Arnon, SS				Dover, Nir; Barash, Jason R.; Burke, Julianne N.; Hill, Karen K.; Detter, John C.; Arnon, Stephen S.			Arrangement of the Clostridium baratii F7 Toxin Gene Cluster with Identification of a sigma Factor That Recognizes the Botulinum Toxin Gene Cluster Promoters	PLOS ONE			English	Article							NEUROTOXIN COMPLEX; PROTEIN GENES; MOLECULAR CHARACTERIZATION; BACTERIOCIN GENE; EXPRESSION; INFANT; ORGANIZATION; STRAIN; HOMOLOGY; SEQUENCE	Botulinum neurotoxin (BoNT) is the most poisonous substances known and its eight toxin types (A to H) are distinguished by the inability of polyclonal antibodies that neutralize one toxin type to neutralize any of the other seven toxin types. Infant botulism, an intestinal toxemia orphan disease, is the most common form of human botulism in the United States. It results from swallowed spores of Clostridium botulinum (or rarely, neurotoxigenic Clostridium butyricum or Clostridium baratii) that germinate and temporarily colonize the lumen of the large intestine, where, as vegetative cells, they produce botulinum toxin. Botulinum neurotoxin is encoded by the bont gene that is part of a toxin gene cluster that includes several accessory genes. We sequenced for the first time the complete botulinum neurotoxin gene cluster of nonproteolytic C. baratii type F7. Like the type E and the nonproteolytic type F6 botulinum toxin gene clusters, the C. baratii type F7 had an orfX toxin gene cluster that lacked the regulatory botR gene which is found in proteolytic C. botulinum strains and codes for an alternative sigma factor. In the absence of botR, we identified a putative alternative regulatory gene located upstream of the C. baratii type F7 toxin gene cluster. This putative regulatory gene codes for a predicted sigma factor that contains DNA-binding-domain homologues to the DNA-binding domains both of BotR and of other members of the TcdR-related group 5 of the sigma(70) family that are involved in the regulation of toxin gene expression in clostridia. We showed that this TcdR-related protein in association with RNA polymerase core enzyme specifically binds to the C. baratii type F7 botulinum toxin gene cluster promoters. This TcdR-related protein may therefore be involved in regulating the expression of the genes of the botulinum toxin gene cluster in neurotoxigenic C. baratii.	[Dover, Nir; Barash, Jason R.; Burke, Julianne N.; Arnon, Stephen S.] Calif Dept Publ Hlth, Infant Botulism Treatment & Prevent Program, Richmond, CA 94804 USA; [Hill, Karen K.; Detter, John C.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA	California Department of Public Health; United States Department of Energy (DOE); Los Alamos National Laboratory	Arnon, SS (corresponding author), Calif Dept Publ Hlth, Infant Botulism Treatment & Prevent Program, Richmond, CA 94804 USA.	Stephen.Arnon@cdph.ca.gov			California Department of Public Health	California Department of Public Health	These studies were supported by the California Department of Public Health. Submission of the manuscript for publication was approved by the California Department of Public Health and by Los Alamos National Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barash JR, 2005, J CLIN MICROBIOL, V43, P4280, DOI 10.1128/JCM.43.8.4280-4282.2005; Bhandari M, 1997, CURR MICROBIOL, V35, P207, DOI 10.1007/s002849900240; Bradshaw M, 2004, ANAEROBE, V10, P321, DOI 10.1016/j.anaerobe.2004.07.001; Chen Y, 2007, J BACTERIOL, V189, P8643, DOI 10.1128/JB.00784-07; Dineen SS, 2004, FEMS MICROBIOL LETT, V235, P9, DOI 10.1016/j.femsle.2004.04.002; Dover N, 2011, APPL ENVIRON MICROB, V77, P1904, DOI 10.1128/AEM.02422-10; Dover N, 2014, J INFECT DIS, V209, P192, DOI 10.1093/infdis/jit450; Dupuy B, 2006, MOL MICROBIOL, V60, P1044, DOI 10.1111/j.1365-2958.2006.05159.x; Dupuy B, 2005, MOL MICROBIOL, V55, P1196, DOI 10.1111/j.1365-2958.2004.04456.x; East AK, 1996, INT J SYST BACTERIOL, V46, P1105, DOI 10.1099/00207713-46-4-1105; Fenicia L, 1999, CLIN INFECT DIS, V29, P1381, DOI 10.1086/313497; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; GIMENEZ JA, 1992, INFECT IMMUN, V60, P518; HALL JD, 1985, J CLIN MICROBIOL, V21, P654, DOI 10.1128/JCM.21.4.654-655.1985; Han SO, 2005, J BACTERIOL, V187, P4884, DOI 10.1128/JB.187.14.4884-4889.2005; Hatheway CL, 1996, ADV EXP MED BIOL, V391, P481; HAUSER D, 1995, TOXICON, V33, P515, DOI 10.1016/0041-0101(94)00190-J; HAUSER D, 1994, MOL GEN GENET, V243, P631, DOI 10.1007/BF00279572; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Henderson I, 1996, FEMS MICROBIOL LETT, V140, P151, DOI 10.1016/0378-1097(96)00172-3; HOFFMAN RE, 1982, AM J DIS CHILD, V136, P270, DOI 10.1001/archpedi.1982.03970390084021; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Jacobson MJ, 2008, APPL ENVIRON MICROB, V74, P2778, DOI 10.1128/AEM.02828-07; Kubota T, 1998, FEMS MICROBIOL LETT, V158, P215, DOI 10.1016/S0378-1097(97)00525-9; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Marvaud JC, 1998, MOL MICROBIOL, V29, P1009, DOI 10.1046/j.1365-2958.1998.00985.x; MIDURA TF, 1972, APPL MICROBIOL, V24, P165, DOI 10.1080/10803920252931230; Nakajima H, 1998, MICROBIOL IMMUNOL, V42, P599, DOI 10.1111/j.1348-0421.1998.tb02330.x; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; PAISLEY JW, 1995, PEDIATR INFECT DIS J, V14, P912; Popoff MR, 2013, TOXICON, V75, P63, DOI 10.1016/j.toxicon.2013.05.003; Raffestin S, 2005, MOL MICROBIOL, V55, P235, DOI 10.1111/j.1365-2958.2004.04377.x; Raffestin S, 2004, ANAEROBE, V10, P93, DOI 10.1016/j.anaerobe.2004.01.001; Raffestin Stephanie, 2009, P1; Raphael BH, 2010, APPL ENVIRON MICROB, V76, P4805, DOI 10.1128/AEM.03109-09; Saujet L, 2011, J BACTERIOL, V193, P3186, DOI 10.1128/JB.00272-11; Smith TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001271; SUEN JC, 1988, J CLIN MICROBIOL, V26, P2191, DOI 10.1128/JCM.26.10.2191-2192.1988; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TRAVERS AA, 1969, NATURE, V222, P537, DOI 10.1038/222537a0	40	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97983	10.1371/journal.pone.0097983	http://dx.doi.org/10.1371/journal.pone.0097983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853378	Green Published, gold, Green Submitted			2022-12-25	WOS:000338323200037
J	Lai, YC; Lin, AC; Chiang, MK; Dai, YH; Hsu, CC; Lu, MC; Liau, CY; Chen, YT				Lai, Yi-Chyi; Lin, Ann-Chi; Chiang, Ming-Ko; Dai, Yu-Han; Hsu, Chih-Chieh; Lu, Min-Chi; Liau, Chun-Yi; Chen, Ying-Tsong			Genotoxic Klebsiella pneumoniae in Taiwan	PLOS ONE			English	Article							PYOGENIC LIVER-ABSCESS; CAPSULAR SEROTYPE K1; DOUBLE-STRAND BREAKS; ESCHERICHIA-COLI; COLORECTAL-CANCER; GENOMIC HETEROGENEITY; IONIZING-RADIATION; INFECTION; CELLS; ENDOPHTHALMITIS	Background: Colibactin is a nonribosomal peptide-polyketide synthesized by multi-enzyme complexes encoded by the pks gene cluster. Colibactin-producing Escherichia coli have been demonstrated to induce host DNA damage and promote colorectal cancer (CRC) development. In Taiwan, the occurrence of pyogenic liver abscess (PLA) has been suggested to correlate with an increasing risk of CRC, and Klebsiella pneumoniae is the predominant PLA pathogen in Taiwan Methodology/Principal Findings: At the asn tRNA loci of the newly sequenced K. pneumoniae 1084 genome, we identified a 208-kb genomic island, KPHPI208, of which a module identical to the E. coli pks colibactin gene cluster was recognized. KPHPI208 consists of eight modules, including the colibactin module and the modules predicted to be involved in integration, conjugation, yersiniabactin production, microcin production, and unknown functions. Transient infection of BALB/c normal liver cells with K. pneumoniae 1084 increased the phosphorylation of histone H2AX, indicating the induction of host DNA damage. Colibactin was required for the genotoxicity of K. pneumoniae 1084, as it was diminished by deletion of clbA gene and restored to the wild type level by trans-complementation with a clbA coding plasmid. Besides, BALB/c mice infected with K. pneumoniae 1084 exhibited enhanced DNA damage in the liver parenchymal cells when compared to the isogenic clbA deletion mutant. By PCR detection, the prevalence of pks-positive K. pneumoniae in Taiwan is 25.6%, which is higher than that reported in Europe (3.5%), and is significantly correlated with K1 type, which predominantly accounted for PLA in Taiwan. Conclusions: Our knowledge regarding how bacteria contribute to carcinogenesis has just begun. The identification of genotoxic K. pneumoniae and its genetic components will facilitate future studies to elucidate the molecular basis underlying the link between K. pneumoniae, PLA, and CRC.	[Lai, Yi-Chyi; Lu, Min-Chi] Chung Shan Med Univ, Dept Microbiol & Immunol, Taichung, Taiwan; [Lai, Yi-Chyi; Lu, Min-Chi] Chung Shan Med Univ Hosp, Dept Internal Med, Div Infect Dis, Taichung, Taiwan; [Lai, Yi-Chyi; Dai, Yu-Han; Hsu, Chih-Chieh; Lu, Min-Chi] Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan; [Lin, Ann-Chi; Chen, Ying-Tsong] Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Miaoli County, Taiwan; [Chiang, Ming-Ko] Natl Chung Cheng Univ, Dept Life Sci, Minxiong, Chia Yi County, Taiwan; [Liau, Chun-Yi; Chen, Ying-Tsong] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Chen, Ying-Tsong] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; National Health Research Institutes - Taiwan; National Chung Cheng University; National Chung Hsing University; National Chung Hsing University	Chen, YT (corresponding author), Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Miaoli County, Taiwan.	onion@nchu.edu.tw		Chen, Ying-Tsong/0000-0003-1337-4127; LAI, YICHYI/0000-0003-2396-1827	Ministry of Science and Technology (formerly National Science Council) of Taiwan [NSC 101-2311-B-005-002-, 100-2320-B-040-013-, NSC 100-2320-B-040-016-]; National Health Research Institutes [MG-102-PP-15, NHRI-EX103-10327BI]	Ministry of Science and Technology (formerly National Science Council) of Taiwan; National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	This work was supported by the Ministry of Science and Technology (formerly National Science Council) of Taiwan, NSC 101-2311-B-005-002- to Ying-Tsong Chen, 100-2320-B-040-013- to Yi-Chyi Lai, and NSC 100-2320-B-040-016- to Min-Chi Lu, and also in part by intramural grants of the National Health Research Institutes (MG-102-PP-15) to Ying-Tsong Chen and by innovative research grants of National Health Research Institutes (NHRI-EX103-10327BI) to Yi-Chyi Lai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Chung DR, 2007, J INFECTION, V54, P578, DOI 10.1016/j.jinf.2006.11.008; Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107; Fang CT, 2007, CLIN INFECT DIS, V45, P284, DOI 10.1086/519262; Fang CT, 2004, J EXP MED, V199, P697, DOI 10.1084/jem.20030857; Fung CP, 2000, J INFECT DIS, V181, P2075, DOI 10.1086/315488; Fung CP, 2002, GUT, V50, P420, DOI 10.1136/gut.50.3.420; Hsieh PF, 2008, J INFECT DIS, V197, P1717, DOI 10.1086/588383; Hsu WH, 2009, KAOHSIUNG J MED SCI, V25, P98, DOI 10.1016/S1607-551X(09)70048-8; Huang WK, 2012, COLORECTAL DIS, V14, pe794, DOI 10.1111/j.1463-1318.2012.03174.x; Jeong SW, 2012, J GASTROEN HEPATOL, V27, P248, DOI 10.1111/j.1440-1746.2011.06851.x; Johnson JR, 2008, J CLIN MICROBIOL, V46, P3906, DOI 10.1128/JCM.00949-08; Kao WY, 2012, ALIMENT PHARM THER, V36, P467, DOI 10.1111/j.1365-2036.2012.05212.x; Karama Edison Mutsinzi, 2008, International Ophthalmology, V28, P111, DOI 10.1007/s10792-007-9111-4; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Korrapati MC, J PHARM EXP THER, V343, P34; Lagos R, 1999, J BACTERIOL, V181, P212, DOI 10.1128/JB.181.1.212-217.1999; Lai HC, 2010, LIVER INT, V30, P1387, DOI 10.1111/j.1478-3231.2010.02327.x; Lim WC, 2004, J GASTROEN HEPATOL, V19, P945, DOI 10.1111/j.1440-1746.2004.03509.x; Lin AC, 2012, J BACTERIOL, V194, P6316, DOI 10.1128/JB.01548-12; Lin TL, 2008, J BACTERIOL, V190, P515, DOI 10.1128/JB.01219-07; Ma LC, 2005, J INFECT DIS, V192, P117, DOI 10.1086/430619; Nadasy KA, 2007, CLIN INFECT DIS, V45, pE25, DOI 10.1086/519424; Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Paauw A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008662; Putze J, 2009, INFECT IMMUN, V77, P4696, DOI 10.1128/IAI.00522-09; Schubert S, 2004, MOL MICROBIOL, V51, P837, DOI 10.1046/j.1365-2958.2003.03870.x; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; Smith JL, 2006, CRIT REV MICROBIOL, V32, P227, DOI 10.1080/10408410601023557; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Suzuki M, 2006, RADIAT RES, V165, P269, DOI 10.1667/RR3508.1; Syljuasen RG, 2006, CANCER RES, V66, P10253, DOI 10.1158/0008-5472.CAN-06-2144; Tang HL, 2010, EUR J CLIN MICROBIOL, V29, P689, DOI 10.1007/s10096-010-0915-1; THOMPSON W, 1993, INFECT CONT HOSP EP, V14, P203; Tu YC, 2009, INFECT IMMUN, V77, P2657, DOI 10.1128/IAI.01523-08; van Aartsen JJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-59; Wang JH, 1998, CLIN INFECT DIS, V26, P1434, DOI 10.1086/516369; Yang CS, 2007, OPHTHALMOLOGY, V114, P876, DOI 10.1016/j.ophtha.2006.12.035; Yeh CC, 2007, J BIOMED SCI, V14, P183, DOI 10.1007/s11373-006-9139-x; Yeh KM, 2007, J CLIN MICROBIOL, V45, P466, DOI 10.1128/JCM.01150-06; Yu WL, 2006, CLIN INFECT DIS, V42, P1351, DOI 10.1086/503420	43	33	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e96292	10.1371/journal.pone.0096292	http://dx.doi.org/10.1371/journal.pone.0096292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852749	Green Published, Green Submitted, gold			2022-12-25	WOS:000338323200012
J	Seo, HH; Park, S; Park, S; Oh, BJ; Back, K; Han, O; Kim, JI; Kim, YS				Seo, Hyo-Hyoun; Park, Sangkyu; Park, Soomin; Oh, Byung-Jun; Back, Kyoungwhan; Han, Oksoo; Kim, Jeong-Il; Kim, Young Soon			Overexpression of a Defensin Enhances Resistance to a Fruit-Specific Anthracnose Fungus in Pepper	PLOS ONE			English	Article							PLANT IMMUNE-SYSTEM; T-DNA INTEGRATION; COLLETOTRICHUM-GLOEOSPORIOIDES; ANTIMICROBIAL PEPTIDES; ANTIFUNGAL ACTION; HOST-DEFENSE; EXPRESSION; GENE; MECHANISM; PROTEINS	Functional characterization of a defensin 1 1 was conducted to evaluate its biotechnological potentiality in transgenic pepper plants against the causal agent of anthracnose disease, Colletotrichum gloeosporioides. To determine antifungal activity, recombinant protein was generated and tested for the activity against C. gloeosporioides, resulting in 50 inhibition of fungal growth at a protein concentration of 0.1 mg.mL(-1). To develop transgenic pepper plants resistant to anthracnose disease, J1-1 cDNA under the control of 35S promoter was introduced into pepper via Agrobacterium-mediated genetic transformation method. Southern and Northern blot analyses confirmed that a single copy of the transgene in elected transgenic plants was normally expressed and also stably transmitted to subsequent generations. The insertion of T-DNA was further analyzed in three independent homozygous lines using inverse PCR, and confirmed the integration of transgene in non-coding region of genomic DNA. Immunoblot results showed that the level of J1-1 proteins, which was not normally accumulated in unripe fruits, accumulated high in transgenic plants but appeared to differ among transgenic lines. Moreover, the expression of jasmonic acid-biosynthetic genes and pathogenesis-related genes were up-regulated in the transgenic lines, which is co-related with the resistance of transgenic plants to anthracnose disease. Consequently, the constitutive expression of J1-1 in transgenic pepper plants provided strong resistance to the anthracnose fungus that associated with highly reduced lesion formation and fungal colonization. These results implied the significance of the antifungal protein J1-1 useful agronomic trait to control fungal disease	[Seo, Hyo-Hyoun] BIO FD&C Co Ltd, Med Nanomat Inst, Inchon, South Korea; [Park, Sangkyu; Back, Kyoungwhan; Han, Oksoo; Kim, Jeong-Il; Kim, Young Soon] Chonnam Natl Univ, Dept Biotechnol, Kwangju, South Korea; [Park, Soomin] Natl Agr Prod Qual Management Serv, Expt Res Inst, Seoul, South Korea; [Oh, Byung-Jun] Jeonnam Bioind Fdn, Biol Control Ctr, Jeollanamdo, South Korea; [Kim, Jeong-Il; Kim, Young Soon] Chonnam Natl Univ, Kumho Life Sci Lab, Kwangju, South Korea	Chonnam National University; Chonnam National University	Kim, JI (corresponding author), Chonnam Natl Univ, Dept Biotechnol, Kwangju, South Korea.	kimji@chonnam.ac.kr; youngskim@chonnam.ac.kr			Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ00949101]; Technology Development Program for Agriculture and Forestry, Ministry for Agriculture, Forestry and Fisheries, Republic of Korea [309017-5]	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea; Technology Development Program for Agriculture and Forestry, Ministry for Agriculture, Forestry and Fisheries, Republic of Korea	This work was supported by Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea (Grant No. PJ00949101), and by Technology Development Program for Agriculture and Forestry, Ministry for Agriculture, Forestry and Fisheries, Republic of Korea (Grant No. 309017-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah Naglaa A, 2010, GM Crops, V1, P344, DOI 10.4161/gmcr.1.5.15091; Aerts AM, 2008, CELL MOL LIFE SCI, V65, P2069, DOI 10.1007/s00018-008-8035-0; Aerts AM, 2007, PLANT CELL REP, V26, P1391, DOI 10.1007/s00299-007-0329-4; Almeida MS, 2002, J MOL BIOL, V315, P749, DOI 10.1006/jmbi.2001.5252; BROEKAERT WF, 1995, PLANT PHYSIOL, V108, P1353, DOI [10.1104/pp.108.4.1353, 10.1016/j.chiabu.2021.105188]; Chen JJ, 2004, J AGR FOOD CHEM, V52, P2256, DOI 10.1021/jf030662i; Chilton MDM, 2003, PLANT PHYSIOL, V133, P956, DOI 10.1104/pp.103.026104; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; De Coninck B, 2013, FUNGAL BIOL REV, V26, P109, DOI 10.1016/j.fbr.2012.10.002; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Dracatos PM, 2014, MOL PLANT PATHOL, V15, P67, DOI 10.1111/mpp.12066; Fan XT, 1998, PLANTA, V204, P444, DOI 10.1007/s004250050278; FilsLycaon BR, 1996, PLANT PHYSIOL, V111, P269, DOI 10.1104/pp.111.1.269; Fritig B, 1998, CURR OPIN IMMUNOL, V10, P16, DOI 10.1016/S0952-7915(98)80025-3; Gao AG, 2000, NAT BIOTECHNOL, V18, P1307, DOI 10.1038/82436; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Hayes BME, 2013, ANTIMICROB AGENTS CH, V57, P3667, DOI 10.1128/AAC.00365-13; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kim KD, 1999, PHYTOPARASITICA, V27, P97, DOI 10.1007/BF03015074; Kitajima S, 1999, J BIOCHEM, V125, P1, DOI 10.1093/oxfordjournals.jbchem.a022244; Ko MK, 2007, HORTSCIENCE, V42, P1425, DOI 10.21273/HORTSCI.42.6.1425; Kumar S, 2002, PLANT J, V31, P543, DOI 10.1046/j.1365-313X.2002.01368.x; Lay FT, 2005, CURR PROTEIN PEPT SC, V6, P85, DOI 10.2174/1389203053027575; Lay FT, 2003, PLANT PHYSIOL, V131, P1283, DOI 10.1104/pp.102.016626; Lee SB, 2011, PLANT BIOTECHNOL J, V9, P100, DOI 10.1111/j.1467-7652.2010.00538.x; Lee YH, 2004, PLANT CELL REP, V23, P50, DOI 10.1007/s00299-004-0791-1; Liu YJ, 2006, PROTEINS, V63, P777, DOI 10.1002/prot.20962; MANANDHAR JB, 1995, PLANT DIS, V79, P361, DOI 10.1094/PD-79-0361; Meyer B, 1996, PLANT PHYSIOL, V112, P615, DOI 10.1104/pp.112.2.615; Ntui VO, 2010, PLANT CELL REP, V29, P943, DOI 10.1007/s00299-010-0880-2; Oh BJ, 1998, J PHYTOPATHOL, V146, P301, DOI 10.1111/j.1439-0434.1998.tb04695.x; Oh BJ, 1999, PLANT MOL BIOL, V41, P313, DOI 10.1023/A:1006336203621; Oomen RJFJ, 2011, NEW PHYTOL, V192, P140, DOI 10.1111/j.1469-8137.2011.03792.x; Pakdeevaraporn P, 2005, PLANT BREEDING, V124, P206, DOI 10.1111/j.1439-0523.2004.01065.x; Park CJ, 2004, PLANT J, V37, P186, DOI 10.1046/j.1365-313X.2003.01951.x; Pelegrini PB, 2005, INT J BIOCHEM CELL B, V37, P2239, DOI 10.1016/j.biocel.2005.06.011; PEREZ AG, 1993, J PLANT GROWTH REGUL, V12, P163, DOI 10.1007/BF00189648; Sagaram US, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018550; Shahzad Z, 2013, NEW PHYTOL, V200, P820, DOI 10.1111/nph.12396; Spelbrink RG, 2004, PLANT PHYSIOL, V135, P2055, DOI 10.1104/pp.104.040873; Stotz HU, 2009, PLANT SIGNAL BEHAV, V4, P1010, DOI 10.4161/psb.4.11.9755; TERRAS FRG, 1995, PLANT CELL, V7, P573, DOI 10.1105/tpc.7.5.573; Tesfaye M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058992; Than PP, 2008, J ZHEJIANG UNIV-SC B, V9, P764, DOI 10.1631/jzus.B0860007; Thevissen K, 2003, PEPTIDES, V24, P1705, DOI 10.1016/j.peptides.2003.09.014; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; Valente AP, 2013, MOLECULES, V18, P11311, DOI 10.3390/molecules180911311	47	33	34	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97936	10.1371/journal.pone.0097936	http://dx.doi.org/10.1371/journal.pone.0097936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848280	Green Submitted, Green Published, gold			2022-12-25	WOS:000336730600070
J	Wado, YD; Afework, MF; Hindin, MJ				Wado, Yohannes Dibaba; Afework, Mesganaw Fantahun; Hindin, Michelle J.			Effects of Maternal Pregnancy Intention, Depressive Symptoms and Social Support on Risk of Low Birth Weight: A Prospective Study from Southwestern Ethiopia	PLOS ONE			English	Article							COMMON MENTAL-DISORDERS; PRETERM BIRTH; COGNITIVE FUNCTION; INFANT-MORTALITY; GESTATIONAL-AGE; PRENATAL-CARE; ASSOCIATION; COHORT; DETERMINANTS; VARIABLES	Background: Low birth weight (LBW) is the principal risk factor for neonatal and infant mortality in developing countries. This study examines the effects of unwanted pregnancy, prenatal depression and social support on the risk of low birth weight in rural southwestern Ethiopia. We hypothesized that unwanted pregnancy and prenatal depression increase the risk of low birth weight, while social support mediates this association. Methods: Data for the study comes from a prospective study in which women were followed from pregnancy through to delivery. Six hundred twenty two women were followed and 537 birth weights were measured within 72 hours. Multivariable log binomial regression was used to model the risk of low birth weight. Results: The mean birth weight was 2989 grams (SD +/- 504 grams), and the incidence of LBW was 17.88%. The mean birth weight of babies after unwanted pregnancy was 114 g lower compared to births from intended pregnancy. Similarly, mean birth weight for babies among women with symptoms of antenatal depression was 116 grams lower. Results of unadjusted log-binomial regression showed that unwanted pregnancy, prenatal depression and social support were associated with LBW. The relationship between antenatal depressive symptoms and LBW was mediated by the presence of social support, while the association between LBW and unwanted pregnancy remained after multivariable adjustment. Conclusion: The incidence of low birth weight is high in the study area. Poverty, nonuse of antenatal care, low social support and unwanted pregnancy contribute to this high incidence of low birth weight. Hence, identifying women's pregnancy intention during antenatal care visits, and providing appropriate counseling and social support will help improve birth outcomes.	[Wado, Yohannes Dibaba] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Populat & Family Hlth, Jimma, Ethiopia; [Afework, Mesganaw Fantahun] Univ Addis Ababa, Coll Hlth Sci, Sch Publ Hlth, Addis Ababa, Ethiopia; [Hindin, Michelle J.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Jimma University; Addis Ababa University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Wado, YD (corresponding author), Jimma Univ, Coll Publ Hlth & Med Sci, Dept Populat & Family Hlth, Jimma, Ethiopia.	yohannes.dibaba@ju.edu.et		Hindin, Michelle/0000-0001-9941-7639; Wado, Yohannes Dibaba/0000-0002-7200-6116	PhD fellowship - STEP UP Research Programme Consortium; APHRC/the ADDRF Program; STEP UP; Addis Ababa University; Department for International Development (DFID) [201398] Funding Source: researchfish	PhD fellowship - STEP UP Research Programme Consortium; APHRC/the ADDRF Program; STEP UP; Addis Ababa University; Department for International Development (DFID)	This research was partly supported by a PhD fellowship funded in part by the STEP UP Research Programme Consortium through a sub-award grant to the African Population and Health Research Center (APHRC) for the African Doctoral Dissertation Research Fellowships (ADDRF). The authors are very grateful to APHRC/the ADDRF Program and STEP UP for the financial support to conduct this study. The authors are also grateful to Addis Ababa University for its financial support. The funders had no role in design of the study, data collection, analysis, or preparation of the manuscript.	ALEXANDER GR, 1995, FUTURE CHILD, V5, P103, DOI 10.2307/1602510; Asefa M, 2004, ETHIOP J HLTH SCI, V14, P13; Assefa N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039957; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; COLLINS NL, 1993, J PERS SOC PSYCHOL, V65, P1243, DOI 10.1037/0022-3514.65.6.1243; Copper RL, 1996, AM J OBSTET GYNECOL, V175, P1286, DOI 10.1016/S0002-9378(96)70042-X; CSA and ICF International, 2012, 2011 ETH HLTH DEM SU; Dayan J, 2002, AM J EPIDEMIOL, V155, P293, DOI 10.1093/aje/155.4.293; Dibaba Y, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-135; Dubois L, 2006, PEDIATR INT, V48, P470, DOI 10.1111/j.1442-200X.2006.02256.x; EDWARDS CH, 1994, J NUTR, V124, pS1006; Eggleston E, 2001, AM J PUBLIC HEALTH, V91, P808, DOI 10.2105/AJPH.91.5.808; Elsenbruch S, 2007, HUM REPROD, V22, P869, DOI 10.1093/humrep/del432; Evans J, 2007, BRIT J PSYCHIAT, V191, P84, DOI 10.1192/bjp.bp.105.016568; Feldman PJ, 2000, PSYCHOSOM MED, V62, P715, DOI 10.1097/00006842-200009000-00016; Gebremariam A, 2005, East Afr Med J, V82, P554; Gebremedhin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050213; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Hanlon C, 2009, TROP MED INT HEALTH, V14, P156, DOI 10.1111/j.1365-3156.2008.02198.x; Hediger ML, 2002, PAEDIATR PERINAT EP, V16, P33, DOI 10.1046/j.1365-3016.2002.00393.x; Hirve S S, 1994, Indian Pediatr, V31, P1221; Hohmann-Marriott B, 2009, MATERN CHILD HLTH J, V13, P745, DOI 10.1007/s10995-009-0467-0; KOGAN MD, 1994, JAMA-J AM MED ASSOC, V271, P1340, DOI 10.1001/jama.271.17.1340; Kramer MS, 2005, PAEDIATR PERINAT EP, V19, P445, DOI 10.1111/j.1365-3016.2005.00681.x; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; M-t Ververs, 2013, PLOS ONE; Manna N, 2013, IOSR JDMS, V4, P33; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; Messer LC, 2005, MATERN CHILD HLTH J, V9, P403, DOI 10.1007/s10995-005-0021-7; Mohanty C, 2006, J TROP PEDIATRICS, V52, P24, DOI 10.1093/tropej/fmi059; Mohllajee AP, 2007, OBSTET GYNECOL, V109, P678, DOI 10.1097/01.AOG.0000255666.78427.c5; Niemi M, 2013, TROP MED INT HEALTH, V18, P687, DOI 10.1111/tmi.12101; Orr ST, 1996, AM J PREV MED, V12, P459, DOI 10.1016/S0749-3797(18)30268-X; Osler M, 2003, J EPIDEMIOL COMMUN H, V57, P681, DOI 10.1136/jech.57.9.681; Patel V, 2006, BRIT J PSYCHIAT, V188, P284, DOI 10.1192/bjp.bp.105.012096; Rahman A, 2007, ACTA PSYCHIAT SCAND, V115, P481, DOI 10.1111/j.1600-0447.2006.00950.x; Richards M, 2001, BRIT MED J, V322, P199, DOI 10.1136/bmj.322.7280.199; Rondo PHC, 2003, EUR J CLIN NUTR, V57, P266, DOI 10.1038/sj.ejcn.1601526; Sable MR, 2000, FAM PLANN PERSPECT, V32, P288, DOI 10.2307/2648197; Sebayang SK, 2012, TROP MED INT HEALTH, V17, P938, DOI 10.1111/j.1365-3156.2012.03039.x; Sen J, 2010, J TROP PEDIATRICS, V56, P254, DOI 10.1093/tropej/fmp102; Shah PS, 2011, MATERN CHILD HLTH J, V15, P205, DOI 10.1007/s10995-009-0546-2; SHARMA R, 1994, J NATL MED ASSOC, V86, P857; Tripathi, 2013, INT J REPROD CONTRAC, V2, P130, DOI [10.5455/2320-1770.ijrcog20130604, DOI 10.5455/2320-1770.IJRCOG20130604]; Tsimbos C, 2011, J BIOSOC SCI, V43, P271, DOI 10.1017/S0021932010000726; UNICF WHO, 2004, LOW BIRTH WEIGHT COU; World Health Organization, 1992, INT STAT CLASS DIS R; Zeleke BM, 2012, PAN AFR MED J, V12	48	55	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e96304	10.1371/journal.pone.0096304	http://dx.doi.org/10.1371/journal.pone.0096304			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3AL	24848269	Green Submitted, gold, Green Published			2022-12-25	WOS:000336730600010
J	Zheng, J; Xiang, J; Zhou, J; Li, ZW; Hu, ZH; Lo, CM; Wang, WL				Zheng, Jun; Xiang, Jie; Zhou, Jie; Li, Zhiwei; Hu, Zhenhua; Lo, Chung Mau; Wang, Weilin			Liver Grafts for Transplantation from Donors with Diabetes: An Analysis of the Scientific Registry of Transplant Recipients Database	PLOS ONE			English	Article							MARGINAL DONORS; MELLITUS; SURVIVAL; PREVALENCE; STEATOSIS; RISK	Patients with a history of diabetes mellitus (DM) have worse survival than those without DM after liver transplantation. However, the effect of liver grafts from DM donors on the post-transplantation survival of recipients is unclear. Using the Scientific Registry of Transplant Recipients database (2004-2008), 25,413 patients were assessed. Among them, 2,469 recipients received grafts from donors with DM. The demographics and outcome of patients were assessed. Patient survival was assessed using Kaplan-Meier methodology and Cox regression analyses. Recipients from DM donors experienced worse graft survival than recipients from non-DM donors (one-year survival: 81% versus 85%, and five-year survival: 67% versus 74%, P<0.001, respectively). Graft survival was significantly lower for recipients from DM donors with DM duration >5 years (P<0.001) compared with those with DM duration <5 years. Cox regression analyses showed that DM donors were independently associated with worse graft survival (hazard ratio, 1.11; 95% confidence interval, 1.02-1.19). The effect of DM donors was more pronounced on certain underlying liver diseases of recipients. Increases in the risk of graft loss were noted among recipients from DM donors with hepatitis-C virus (HCV) infection, whereas those without HCV experienced similar outcomes compared with recipients from non-DM donors. These data suggest that recipients from DM donors experience significantly worse patient survival after liver transplantation. However, in patients without HCV infection, using DM donors was not independently associated with worse post-transplantation graft survival. Matching these DM donors to recipients without HCV may be safe.	[Zheng, Jun; Xiang, Jie; Zhou, Jie; Li, Zhiwei; Hu, Zhenhua; Wang, Weilin] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobiliary & Pancreat Surg,Dept Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Jun; Lo, Chung Mau] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; Minist Publ Hlth, Key Lab Organ Transplantat, Key Lab Combined Multiorgan Transplantat, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; University of Hong Kong	Lo, CM (corresponding author), Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China.	chungmlo@hku.hk; zywangwl@163.com			Major State Basic Research Development Program of China (973 Program) [491010-N51308]; National Natural Science Foundation of China [491010-N11180]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Major State Basic Research Development Program of China (973 Program) (No. 491010-N51308) and National Natural Science Foundation of China (No. 491010-N11180). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; Blanco JJ, 2001, LIVER TRANSPLANT, V7, P226, DOI 10.1053/jlts.2001.22183; Briceno J, 2007, TRANSPL P, V39, P2297, DOI 10.1016/j.transproceed.2007.07.069; Busuttil RW, 2003, LIVER TRANSPLANT, V9, P651, DOI 10.1053/jlts.2003.50105; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x; Hossain N, 2009, CLIN GASTROENTEROL H, V7, P1224, DOI 10.1016/j.cgh.2009.06.007; John PR, 2001, HEPATOLOGY, V34, P889, DOI 10.1053/jhep.2001.29134; Kim WR, 2013, AM J TRANSPLANT, V13, P73, DOI 10.1111/ajt.12021; Kotronen A, 2008, GASTROENTEROLOGY, V135, P122, DOI 10.1053/j.gastro.2008.03.021; Levine GN, 2006, AM J TRANSPLANT, V6, P1228, DOI 10.1111/j.1600-6143.2006.01277.x; Menon KVN, 2004, AM J TRANSPLANT, V4, P819, DOI 10.1111/j.1600-6143.2004.00433.x; Nadig Satish N, 2007, J Surg Educ, V64, P46, DOI 10.1016/j.cursur.2006.08.001; Nair S, 2002, HEPATOLOGY, V35, P105, DOI 10.1053/jhep.2002.30318; Nocito A, 2006, J HEPATOL, V45, P494, DOI 10.1016/j.jhep.2006.07.017; Samuelson AL, 2010, DIGEST DIS SCI, V55, P2089, DOI 10.1007/s10620-010-1267-5; Shields PL, 1999, TRANSPLANTATION, V68, P530, DOI 10.1097/00007890-199908270-00015; WAHLSTROM HE, 1991, TRANSPLANT P, V23, P1565; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029	20	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98104	10.1371/journal.pone.0098104	http://dx.doi.org/10.1371/journal.pone.0098104			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847864	gold, Green Published			2022-12-25	WOS:000336730600086
J	Gundner, AL; Hahn, I; Sendscheid, O; Aberle, H; Hoch, M				Guendner, Anna Lisa; Hahn, Ines; Sendscheid, Oliver; Aberle, Hermann; Hoch, Michael			The PIKE Homolog Centaurin gamma Regulates Developmental Timing in Drosophila	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE ENHANCER; INSULIN-RESISTANCE; BODY-SIZE; ECDYSONE; GTPASE; METAMORPHOSIS; PROTEIN; GENE; TRANSCRIPTION; DEGRADATION	Phosphoinositide-3-kinase enhancer (PIKE) proteins encoded by the PIKE/CENTG1 gene are members of the gamma subgroup of the Centaurin superfamily of small GTPases. They are characterized by their chimeric protein domain architecture consisting of a pleckstrin homology (PH) domain, a GTPase-activating (GAP) domain, Ankyrin repeats as well as an intrinsic GTPase domain. In mammals, three PIKE isoforms with variations in protein structure and subcellular localization are encoded by the PIKE locus. PIKE inactivation in mice results in a broad range of defects, including neuronal cell death during brain development and misregulation of mammary gland development. PIKE -/- mutant mice are smaller, contain less white adipose tissue, and show insulin resistance due to misregulation of AMP-activated protein kinase (AMPK) and insulin receptor/Akt signaling. here, we have studied the role of PIKE proteins in metabolic regulation in the fly. We show that the Drosophila PIKE homolog, ceng1A, encodes functional GTPases whose internal GAP domains catalyze their GTPase activity. To elucidate the biological function of ceng1A in flies, we introduced a deletion in the ceng1A gene by homologous recombination that removes all predicted functional PIKE domains. We found that homozygous ceng1A mutant animals survive to adulthood. In contrast to PIKE -/- mouse mutants, genetic ablation of Drosophila ceng1A does not result in growth defects or weight reduction. Although metabolic pathways such as insulin signaling, sensitivity towards starvation and mobilization of lipids under high fed conditions are not perturbed in ceng1A mutants, homozygous ceng1A mutants show a prolonged development in second instar larval stage, leading to a late onset of pupariation. In line with these results we found that expression of ecdysone inducible genes is reduced in ceng1A mutants. Together, we propose a novel role for Drosophila Ceng1A in regulating ecdysone signaling-dependent second to third instar larval transition.	[Guendner, Anna Lisa; Hahn, Ines; Sendscheid, Oliver; Hoch, Michael] Univ Bonn, Life & Med Sci Inst LIMES, Bonn, Germany; [Aberle, Hermann] Univ Dusseldorf, Dusseldorf, Germany	University of Bonn; Heinrich Heine University Dusseldorf	Hoch, M (corresponding author), Univ Bonn, Life & Med Sci Inst LIMES, Bonn, Germany.	m.hoch@uni-bonn.de	Hahn, Ines/V-6607-2019; Aberle, Hermann/L-8461-2017	Hahn, Ines/0000-0001-7703-8160; Aberle, Hermann/0000-0002-4864-6105	German Research Foundation [SFB 645, TR 83]; International Graduate School LIMES Chemical Biology	German Research Foundation(German Research Foundation (DFG)); International Graduate School LIMES Chemical Biology	MH obtained funding from the German Research Foundation (SFB 645 and TR 83). ALG was funded by the International Graduate School LIMES Chemical Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2005, INT J BIOL SCI, V1, P44; Ahn JY, 2004, EMBO J, V23, P3995, DOI 10.1038/sj.emboj.7600392; Ahn JY, 2004, J BIOL CHEM, V279, P16441, DOI 10.1074/jbc.M312175200; Bialecki M, 2002, DEV CELL, V3, P209, DOI 10.1016/S1534-5807(02)00204-6; Caldwell PE, 2005, CURR BIOL, V15, P1785, DOI 10.1016/j.cub.2005.09.011; Chan CB, 2007, J CELL MOL MED, V11, P39, DOI 10.1111/j.1582-4934.2007.00014.x; Chan Chi Bun, 2012, Adv Biol Regul, V52, P66; Chan CB, 2012, REV NEUROSCIENCE, V23, P153, DOI 10.1515/revneuro-2011-0066; Chan CB, 2011, EMBO J, V30, P4274, DOI 10.1038/emboj.2011.281; Chan CB, 2011, J NEUROSCI, V31, P8083, DOI 10.1523/JNEUROSCI.1129-11.2011; Chan CB, 2010, THESCIENTIFICWORLDJO, V10, P613, DOI 10.1100/tsw.2010.64; Chan CB, 2010, DIABETES, V59, P883, DOI 10.2337/db09-1404; Davis MB, 2005, DEV BIOL, V282, P385, DOI 10.1016/j.ydbio.2005.03.019; FLETCHER JC, 1995, DEVELOPMENT, V121, P1411; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Huang J, 2008, GENETICS, V180, P703, DOI 10.1534/genetics.108.090563; Jackson TR, 2000, TRENDS BIOCHEM SCI, V25, P489, DOI 10.1016/S0968-0004(00)01644-3; KARIM FD, 1991, GENE DEV, V5, P1067, DOI 10.1101/gad.5.6.1067; Layalle S, 2008, DEV CELL, V15, P568, DOI 10.1016/j.devcel.2008.08.003; Liu ZX, 2008, MOL CELL, V29, P665, DOI 10.1016/j.molcel.2008.02.017; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; Musselman LP, 2011, DIS MODEL MECH, V4, P842, DOI 10.1242/dmm.007948; Orme MH, 2005, CELL METAB, V2, P277, DOI 10.1016/j.cmet.2005.10.005; Qin QY, 2006, J CELL BIOL, V172, P497, DOI 10.1083/jcb.200505079; Reiser G, 2004, NEUROREPORT, V15, P147, DOI 10.1097/00001756-200401190-00028; Rong R, 2003, NAT NEUROSCI, V6, P1153, DOI 10.1038/nn1134; Rong YS, 2001, GENETICS, V157, P1307; Schubiger M, 1998, DEVELOPMENT, V125, P2053; Tang XL, 2008, NAT CELL BIOL, V10, P698, DOI 10.1038/ncb1732; Teleman AA, 2005, DEV CELL, V9, P271, DOI 10.1016/j.devcel.2005.07.004; Thummel CS, 1996, TRENDS GENET, V12, P306, DOI 10.1016/0168-9525(96)10032-9; Thummel CS, 2001, DEV CELL, V1, P453, DOI 10.1016/S1534-5807(01)00060-0; Xia CZ, 2003, MOL CELL BIOL, V23, P2476, DOI 10.1128/MCB.23.7.2476-2488.2003; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Ye KQ, 2000, CELL, V103, P919, DOI 10.1016/S0092-8674(00)00195-1	36	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97332	10.1371/journal.pone.0097332	http://dx.doi.org/10.1371/journal.pone.0097332			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845618	Green Published, Green Submitted, gold			2022-12-25	WOS:000339563400022
J	Kinsey-Jones, JS; Beale, KE; Cuenco, J; Li, XF; Bloom, SR; O'Byrne, KT; Murphy, KG				Kinsey-Jones, James S.; Beale, Kylie E.; Cuenco, Joy; Li, Xiao Feng; Bloom, Stephen R.; O'Byrne, Kevin T.; Murphy, Kevin G.			Quantification of Rat Kisspeptin Using a Novel Radioimmunoassay	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; PROTEIN-COUPLED RECEPTOR; MESSENGER-RNA EXPRESSION; PITUITARY-GONADAL AXIS; ARCUATE NUCLEUS; SEXUAL-DIMORPHISM; GENE-EXPRESSION; FEMALE MOUSE; NEURONS; KISS-1	Kisspeptin is a hypothalamic peptide hormone that plays a pivotal role in pubertal onset and reproductive function. Previous studies have examined hypothalamic kisspeptin mRNA expression, either through in situ hybridisation or real-time RT-PCR, as a means quantifying kisspeptin gene expression. However, mRNA expression levels are not always reflected in levels of the translated protein. Kisspeptin-immunoreactivity (IR) has been extensively examined using immunohistochemistry, enabling detection and localisation of kisspeptin perikaya in the arcuate nucleus (ARC) and anteroventral periventricular nucleus (AVPV). However, quantification of kisspeptin-IR remains challenging. We developed a specific rodent radioimmunoassay assay (RIA) capable of detecting and quantifying kisspeptin-IR in rodent tissues. The RIA uses kisspeptin-10 as a standard and radioactive tracer, combined with a commercially available antibody raised to the kisspeptin-10 fragment. Adult female wistar rat brain samples were sectioned at 300 mm and the ARC and AVPV punch micro-dissected. Brain punches were homogenised in extraction buffer and assayed with rodent kisspeptin-RIA. In accord with the pattern of kisspeptin mRNA expression, kisspeptin-IR was detected in both the ARC (47.1 +/- 6.2 fmol/punch, mean +/- SEM n = 15) and AVPV (7.6 +/- 1.3 fmol/punch, mean +/- SEM n = 15). Kisspeptin-IR was also detectable in rat placenta (1.26 +/- 0.15 fmol/mg). Reverse phase high pressure liquid chromatography analysis showed that hypothalamic kisspeptin-IR had the same elution profile as a synthetic rodent kisspeptin standard. A specific rodent kisspeptin-RIA will allow accurate quantification of kisspeptin peptide levels within specific tissues in rodent experimental models.	[Kinsey-Jones, James S.; Beale, Kylie E.; Cuenco, Joy; Bloom, Stephen R.; Murphy, Kevin G.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Sect Invest Med, London, England; [Li, Xiao Feng; O'Byrne, Kevin T.] Kings Coll London, Sch Med, Div Womens Hlth, London, England	Imperial College London; University of London; King's College London	Murphy, KG (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Sect Invest Med, London, England.	k.g.murphy@imperial.ac.uk		Murphy, Kevin/0000-0002-3417-0310	MRC; BBSRC; NIHR; Wellcome trust an Integrative Mammalian Biology (IMB) Capacity Building Award [FP7-HEALTH- 2009- 241592 EurOCHIP]; BBSRC [BB/E52708X/1, BB/J002232/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E52708X/1, BB/J002232/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10337, NF-SI-0513-10080] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIHR(National Institute for Health Research (NIHR)); Wellcome trust an Integrative Mammalian Biology (IMB) Capacity Building Award; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	The Section is funded by grants from the MRC, BBSRC, NIHR, Wellcome trust an Integrative Mammalian Biology (IMB) Capacity Building Award, an FP7-HEALTH- 2009- 241592 EurOCHIP grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Bloom SR, 1982, RADIOIMMUNOASSAY GUT; Brailoiu GC, 2005, J COMP NEUROL, V481, P314, DOI 10.1002/cne.20350; Castellano JM, 2010, AM J PHYSIOL-ENDOC M, V299, pE54, DOI 10.1152/ajpendo.00081.2010; Clarkson J, 2009, J NEUROENDOCRINOL, V21, P673, DOI 10.1111/j.1365-2826.2009.01892.x; Clarkson J, 2006, ENDOCRINOLOGY, V147, P5817, DOI 10.1210/en.2006-0787; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714, DOI 10.1073/pnas.0704114104; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Desroziers E, 2010, J NEUROENDOCRINOL, V22, P1101, DOI 10.1111/j.1365-2826.2010.02053.x; Dhillo WS, 2005, J CLIN ENDOCR METAB, V90, P6609, DOI 10.1210/jc.2005-1468; Franceschini I, 2006, NEUROSCI LETT, V401, P225, DOI 10.1016/j.neulet.2006.03.039; Funes S, 2003, BIOCHEM BIOPH RES CO, V312, P1357, DOI 10.1016/j.bbrc.2003.11.066; Gottsch ML, 2004, ENDOCRINOLOGY, V145, P4073, DOI 10.1210/en.2004-0431; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; Hrabovszky E, 2010, EUR J NEUROSCI, V31, P1984, DOI 10.1111/j.1460-9568.2010.07239.x; Iijima N, 2011, J MOL NEUROSCI, V43, P146, DOI 10.1007/s12031-010-9433-y; Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140; Kirilov M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3492; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Lapatto R, 2007, ENDOCRINOLOGY, V148, P4927, DOI 10.1210/en.2007-0078; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Mark PJ, 2013, PLACENTA, V34, P657, DOI 10.1016/j.placenta.2013.04.012; Mikkelsen JD, 2009, PEPTIDES, V30, P26, DOI 10.1016/j.peptides.2008.09.004; Mittelman-Smith MA, 2012, ENDOCRINOLOGY, V153, P2800, DOI 10.1210/en.2012-1045; Muir AI, 2001, J BIOL CHEM, V276, P28969, DOI 10.1074/jbc.M102743200; Murphy KG, 2000, J ENDOCRINOL, V166, P659, DOI 10.1677/joe.0.1660659; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Palkovits M., 1988, MAPS GUIDE MICRODISS; Roa J, 2006, ENDOCRINOLOGY, V147, P2864, DOI 10.1210/en.2005-1463; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Smith JT, 2006, J NEUROSCI, V26, P6687, DOI 10.1523/JNEUROSCI.1618-06.2006; Smith JT, 2005, ENDOCRINOLOGY, V146, P3686, DOI 10.1210/en.2005-0488; Stafford LJ, 2002, CANCER RES, V62, P5399; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Thompson EL, 2004, J NEUROENDOCRINOL, V16, P850, DOI 10.1111/j.1365-2826.2004.01240.x; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Yamada S, 2007, ENDOCRINOLOGY, V148, P2226, DOI 10.1210/en.2006-1529	38	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97611	10.1371/journal.pone.0097611	http://dx.doi.org/10.1371/journal.pone.0097611			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845101	gold, Green Published, Green Submitted			2022-12-25	WOS:000339563400039
J	Maruthi, MN; Bouvaine, S; Tufan, HA; Mohammed, IU; Hillocks, RJ				Maruthi, M. N.; Bouvaine, Sophie; Tufan, Hale A.; Mohammed, Ibrahim U.; Hillocks, Rory J.			Transcriptional Response of Virus-Infected Cassava and Identification of Putative Sources of Resistance for Cassava Brown Streak Disease	PLOS ONE			English	Article							RT-PCR ASSAYS; RNA; DISTINCT	Cassava (Manihot esculenta) is a major food staple in sub-Saharan Africa, which is severely affected by cassava brown streak disease (CBSD). The aim of this study was to identify resistance for CBSD as well as to understand the mechanism of putative resistance for providing effective control for the disease. Three cassava varieties; Kaleso, Kiroba and Albert were inoculated with cassava brown streak viruses by grafting and also using the natural insect vector the whitefly, Bemisia tabaci. Kaleso expressed mild or no disease symptoms and supported low concentrations of viruses, which is a characteristic of resistant plants. In comparison, Kiroba expressed severe leaf but milder root symptoms, while Albert was susceptible with severe symptoms both on leaves and roots. Real-time PCR was used to estimate virus concentrations in cassava varieties. Virus quantities were higher in Kiroba and Albert compared to Kaleso. The Illumina RNA-sequencing was used to further understand the genetic basis of resistance. More than 700 genes were uniquely overexpressed in Kaleso in response to virus infection compared to Albert. Surprisingly, none of them were similar to known resistant gene orthologs. Some of the overexpressed genes, however, belonged to the hormone signalling pathways and secondary metabolites, both of which are linked to plant resistance. These genes should be further characterised before confirming their role in resistance to CBSD.	[Maruthi, M. N.; Bouvaine, Sophie; Tufan, Hale A.; Mohammed, Ibrahim U.; Hillocks, Rory J.] Univ Greenwich, Nat Resources Inst, Chatham, Kent, England	University of Greenwich	Maruthi, MN (corresponding author), Univ Greenwich, Nat Resources Inst, Chatham, Kent, England.	mm02@gre.ac.uk	Gowda, Maruthi M. N./A-3507-2008	Gowda, Maruthi M. N./0000-0002-8060-866X; bouvaine, sophie/0000-0002-0788-3243	African Union Commission [AURG/2/141/2012]; University of Greenwich [E0198]	African Union Commission; University of Greenwich	The authors acknowledge the funding received for part of this work from the African Union Commission through the grant: AURG/2/141/2012. Some of the costs were covered internally by the University of Greenwich by employing HAT for carrying out this work (grant ID E0198). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarshi MM, 2012, J VIROL METHODS, V179, P176, DOI 10.1016/j.jviromet.2011.10.020; Abarshi MM, 2010, J VIROL METHODS, V163, P353, DOI 10.1016/j.jviromet.2009.10.023; Adams IP, 2013, PLANT PATHOL, V62, P233, DOI 10.1111/j.1365-3059.2012.02622.x; Alicai T, 2007, PLANT DIS, V91, P24, DOI 10.1094/PD-91-0024; COOPER JI, 1983, PHYTOPATHOLOGY, V73, P127, DOI 10.1094/Phyto-73-127; Ferguson ME, 2012, THEOR APPL GENET, V124, P685, DOI 10.1007/s00122-011-1739-9; Gedil M., 2012, African Journal of Biotechnology, V11, P15111; Hillocks R., 2002, CASSAVA BIOL PRODUCT, DOI DOI 10.1079/9780851995243.0000; Hillocks RJ, 2003, INT J PEST MANAGE, V49, P225, DOI 10.1080/0967087031000101061; Hillocks RJ, 2001, J PHYTOPATHOL, V149, P389, DOI 10.1046/j.1439-0434.2001.00641.x; Hillocks RJ, 1996, INT J PEST MANAGE, V42, P285, DOI 10.1080/09670879609372008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; JENNINGS D. L., 1960, Empire Journal of Experimental Agriculture, V28, P261; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kang BC, 2005, ANNU REV PHYTOPATHOL, V43, P581, DOI 10.1146/annurev.phyto.43.011205.141140; Legg JP, 2011, VIRUS RES, V159, P161, DOI 10.1016/j.virusres.2011.04.018; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maruthi MN, 2005, J PHYTOPATHOL, V153, P307, DOI 10.1111/j.1439-0434.2005.00974.x; Maruthi MN, 2002, VIRUS RES, V86, P71, DOI 10.1016/S0168-1702(02)00051-5; Maruthi MN, 2001, ENTOMOL EXP APPL, V99, P13, DOI 10.1023/A:1018944606924; Mbanzibwa DR, 2009, ARCH VIROL, V154, P353, DOI 10.1007/s00705-008-0301-9; McSween S, 2006, EC IMPACT FOOD 438 S, V40; Mkamilo G. S., 2005, AFR CROP SCI C P, V7, P1311; Mohammed IU, 2012, ADV VIROL, V2012, DOI 10.1155/2012/795697; Monger WA, 2010, ARCH VIROL, V155, P429, DOI 10.1007/s00705-009-0581-8; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mulimbi W., 2012, New Disease Reports, V26, P11, DOI 10.5197/j.2044-0588.2012.026.011; Mware B., 2009, GEN MOL VIROLOGY, V1, P40, DOI DOI 10.1007/S007050070078; Nakashita H, 2003, PLANT J, V33, P887, DOI 10.1046/j.1365-313X.2003.01675.x; NICHOLS R. F. W., 1950, EAST AFRICAN AGRIC JOUR, V15, P154; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Palukaitis P, 2008, J PLANT PATHOL, V90, P153; Ren T, 2000, PLANT CELL, V12, P1917, DOI 10.1105/tpc.12.10.1917; Robaglia C, 2006, TRENDS PLANT SCI, V11, P40, DOI 10.1016/j.tplants.2005.11.004; Vanderschuren H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045277; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Winter S, 2010, J GEN VIROL, V91, P1365, DOI 10.1099/vir.0.014688-0; Xie Q, 1999, PLANT MOL BIOL, V39, P647, DOI 10.1023/A:1006138221874; Yadav JS, 2011, MOL PLANT PATHOL, V12, P677, DOI 10.1111/J.1364-3703.2010.00700.X; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716	43	56	56	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e96642	10.1371/journal.pone.0096642	http://dx.doi.org/10.1371/journal.pone.0096642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846209	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000339563400007
J	Musafia, B; Oren-Banaroya, R; Noiman, S				Musafia, Boaz; Oren-Banaroya, Rony; Noiman, Silvia			Designing Anti-Influenza Aptamers: Novel Quantitative Structure Activity Relationship Approach Gives Insights into Aptamer - Virus Interaction	PLOS ONE			English	Article							RNA APTAMER; DEXTRAN SULFATE; IN-VITRO; INFLUENZA; POLYMERS; INFECTION; BLOCKING; FUSION; HEMAGGLUTININ; PREDICTION	This study describes the development of aptamers as a therapy against influenza virus infection. Aptamers are oligonucleotides (like ssDNA or RNA) that are capable of binding to a variety of molecular targets with high affinity and specificity. We have studied the ssDNA aptamer BV02, which was designed to inhibit influenza infection by targeting the hemagglutinin viral protein, a protein that facilitates the first stage of the virus' infection. While testing other aptamers and during lead optimization, we realized that the dominant characteristics that determine the aptamer's binding to the influenza virus may not necessarily be sequence-specific, as with other known aptamers, but rather depend on general 2D structural motifs. We adopted QSAR (quantitative structure activity relationship) tool and developed computational algorithm that correlate six calculated structural and physicochemical properties to the aptamers' binding affinity to the virus. The QSAR study provided us with a predictive tool of the binding potential of an aptamer to the influenza virus. The correlation between the calculated and actual binding was R-2 = 0.702 for the training set, and R-2 = 0.66 for the independent test set. Moreover, in the test set the model's sensitivity was 89%, and the specificity was 87%, in selecting aptamers with enhanced viral binding. The most important properties that positively correlated with the aptamer's binding were the aptamer length, 2D-loops and repeating sequences of C nucleotides. Based on the structure-activity study, we have managed to produce aptamers having viral affinity that was more than 20 times higher than that of the original BV02 aptamer. Further testing of influenza infection in cell culture and animal models yielded aptamers with 10 to 15 times greater anti-viral activity than the BV02 aptamer. Our insights concerning the mechanism of action and the structural and physicochemical properties that govern the interaction with the influenza virus are discussed.	[Musafia, Boaz; Oren-Banaroya, Rony] Bio Vent Ltd, Ashqelon, Israel; [Noiman, Silvia] Pontifax Inc, Herzliyya, Israel		Musafia, B (corresponding author), Bio Vent Ltd, Ashqelon, Israel.	boaz@bio-vent.com			Israeli Incubators ATI Technologies; Pontifax, Ltd; Roche Holding, Ltd.; Prof. Ruth Arnon Canada - Israel, Ltd.	Israeli Incubators ATI Technologies; Pontifax, Ltd; Roche Holding, Ltd.; Prof. Ruth Arnon Canada - Israel, Ltd.	No external funding sources for this study. All the study was supported by Bio-Vent's resources. Bio-Vent funders are: Israeli Incubators ATI Technologies (http://www.gefenbiomed.com/ati.php); Pontifax, Ltd; Roche Holding, Ltd. (www.roche.com); Prof. Ruth Arnon Canada - Israel, Ltd. (http://www.canada-israel.com). The funder provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aquino-Jarquin G, 2011, INT J MOL SCI, V12, P9155, DOI 10.3390/ijms12129155; BABA M, 1988, P NATL ACAD SCI USA, V85, P6132, DOI 10.1073/pnas.85.16.6132; Belser JA, 2007, J INFECT DIS, V196, P1493, DOI 10.1086/522609; Bernstein DI, 2008, ANTIMICROB AGENTS CH, V52, P2727, DOI 10.1128/AAC.00279-08; Bing T, 2010, BIOORGAN MED CHEM, V18, P1798, DOI 10.1016/j.bmc.2010.01.054; Binning JM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00029; Bouchard PR, 2010, ANNU REV PHARMACOL, V50, P237, DOI 10.1146/annurev.pharmtox.010909.105547; Cardin RD, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-214; Choi SK, 2012, MOL CELLS, V32, P527; De Clercq E, 2001, J PHARMACOL EXP THER, V297, P1; DELISI C, 1971, P NATL ACAD SCI USA, V68, P2682, DOI 10.1073/pnas.68.11.2682; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Este JA, 1997, MOL PHARMACOL, V52, P98, DOI 10.1124/mol.52.1.98; Fischer NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002720; Golbraikh A, 2003, J COMPUT AID MOL DES, V17, P241, DOI 10.1023/A:1025386326946; Gopinath SCB, 2006, J GEN VIROL, V87, P479, DOI 10.1099/vir.0.81508-0; Hayden FG, 2013, INFLUENZA OTHER RESP, V7, P63, DOI 10.1111/irv.12045; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hurt AC, 2009, ANTIMICROB AGENTS CH, V53, P4433, DOI 10.1128/AAC.00334-09; Huynen MA, 1996, J MOL EVOL, V43, P165; Ilyushina NA, 2007, ANTIVIR THER, V12, P363; Jeon SH, 2004, J BIOL CHEM, V279, P48410, DOI 10.1074/jbc.M409059200; Kapetanovic IM, 2008, CHEM-BIOL INTERACT, V171, P165, DOI 10.1016/j.cbi.2006.12.006; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Matsumura T, 2009, GASTROENTEROLOGY, V137, P673, DOI 10.1053/j.gastro.2009.04.048; Neurath AR, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-27; NUSSINOV R, 1978, SIAM J APPL MATH, V35, P68, DOI 10.1137/0135006; Park SY, 2011, NUCLEIC ACID THER, V21, P395, DOI 10.1089/nat.2011.0321; Peyret N., 2000, PREDICTION NUCL ACID; Platt M, 2009, INTEGR BIOL-UK, V1, P116, DOI 10.1039/b814892a; Preziosi P, 2011, EXPERT OPIN PHARMACO, V12, P1523, DOI 10.1517/14656566.2011.566557; Rockey WM, 2011, NUCLEIC ACID THER, V21, P299, DOI 10.1089/nat.2011.0313; Roulet E, 2002, NAT BIOTECHNOL, V20, P831, DOI 10.1038/nbt718; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Sidwell RW, 2000, ANTIVIR RES, V48, P1, DOI 10.1016/S0166-3542(00)00125-X; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Taubenberger JK, 2010, PUBLIC HEALTH REP, V125, P16, DOI 10.1177/00333549101250S305; Triana-Baltzer GB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007788; Vaillant A, 2006, ANTIMICROB AGENTS CH, V50, P1393, DOI 10.1128/AAC.50.4.1393-1401.2006; Weinstock DM, 2009, JAMA-J AM MED ASSOC, V301, P1066, DOI 10.1001/jama.2009.324; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	45	33	35	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97696	10.1371/journal.pone.0097696	http://dx.doi.org/10.1371/journal.pone.0097696			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846127	Green Submitted, Green Published, gold			2022-12-25	WOS:000339563400045
J	Nousiainen, HO; Quintero, IB; Myohanen, TT; Voikar, V; Mijatovic, J; Segerstrale, M; Herrala, AM; Kulesskaya, N; Pulkka, AE; Kivinummi, T; Abo-Ramadan, U; Taira, T; Piepponen, TP; Rauvala, H; Vihko, P				Nousiainen, Heidi O.; Quintero, Ileana B.; Myohanen, Timo T.; Voikar, Vootele; Mijatovic, Jelena; Segerstrale, Mikael; Herrala, Annakaisa M.; Kulesskaya, Natalia; Pulkka, Anitta E.; Kivinummi, Tanja; Abo-Ramadan, Usama; Taira, Tomi; Piepponen, T. Petteri; Rauvala, Heikki; Vihko, Pirkko			Mice Deficient in Transmembrane Prostatic Acid Phosphatase Display Increased GABAergic Transmission and Neurological Alterations	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; SNAP-25; PROTEINS; NEURONS; BRAIN; ENDOPHENOTYPES; LOCALIZATION; HIPPOCAMPUS; TRAFFICKING; INHIBITION	Prostatic acid phosphatase (PAP), the first diagnostic marker and present therapeutic target for prostate cancer, modulates nociception at the dorsal root ganglia (DRG), but its function in the central nervous system has remained unknown. We studied expression and function of TMPAP (the transmembrane isoform of PAP) in the brain by utilizing mice deficient in TMPAP (PAP(-/-) mice). Here we report that TMPAP is expressed in a subpopulation of cerebral GABAergic neurons, and mice deficient in TMPAP show multiple behavioral and neurochemical features linked to hyperdopaminergic dysregulation and altered GABAergic transmission. In addition to increased anxiety, disturbed prepulse inhibition, increased synthesis of striatal dopamine, and augmented response to amphetamine, PAP-deficient mice have enlarged lateral ventricles, reduced diazepam-induced loss of righting reflex, and increased GABAergic tone in the hippocampus. TMPAP in the mouse brain is localized presynaptically, and colocalized with SNARE-associated protein snapin, a protein involved in synaptic vesicle docking and fusion, and PAP-deficient mice display altered subcellular distribution of snapin. We have previously shown TMPAP to reside in prostatic exosomes and we propose that TMPAP is involved in the control of GABAergic tone in the brain also through exocytosis, and that PAP deficiency produces a distinct neurological phenotype.	[Nousiainen, Heidi O.; Quintero, Ileana B.; Herrala, Annakaisa M.; Pulkka, Anitta E.; Vihko, Pirkko] Univ Helsinki, Dept Clin Chem, SF-00100 Helsinki, Finland; [Nousiainen, Heidi O.; Quintero, Ileana B.; Herrala, Annakaisa M.; Pulkka, Anitta E.; Vihko, Pirkko] Univ Helsinki, Hosp Lab, Helsinki, Finland; [Myohanen, Timo T.; Mijatovic, Jelena; Kivinummi, Tanja; Piepponen, T. Petteri] Univ Helsinki, Fac Pharm, Div Pharmacol & Toxicol, Helsinki, Finland; [Voikar, Vootele; Segerstrale, Mikael; Kulesskaya, Natalia; Taira, Tomi; Rauvala, Heikki] Univ Helsinki, Neurosci Ctr, Helsinki, Finland; [Voikar, Vootele; Segerstrale, Mikael; Kulesskaya, Natalia; Taira, Tomi] Univ Helsinki, Fac Biol & Environm Sci, Dept Biosci, Helsinki, Finland; [Abo-Ramadan, Usama] Univ Helsinki, Cent Hosp, Dept Neurol, Expt MRI Lab, Helsinki, Finland; [Abo-Ramadan, Usama] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Taira, Tomi] Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki	Vihko, P (corresponding author), Univ Helsinki, Dept Clin Chem, SF-00100 Helsinki, Finland.	pirkko.vihko@helsinki.fi	Voikar, Vootele/V-4542-2019; Myohanen, Timo/N-8438-2014	Voikar, Vootele/0000-0003-4201-8666; Quintero, Ileana/0000-0001-7040-1289; Piepponen, Petteri/0000-0002-2318-1612; Myohanen, Timo/0000-0002-9277-6687; Rauvala, Heikki/0000-0001-7809-9811; Kulesskaya, Natalia/0000-0001-5517-8525	Academy of Finland [132201]; Sigrid Juselius Foundation; Biocenter Finland	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Biocenter Finland	This work was supported by grants from The Academy of Finland, http://www.aka.fi/en-GB/A/, (grant no. 132201 to Prof. P. Vihko), and The Sigrid Juselius Foundation, http://www.sigridjuselius.fi/foundation, (to Prof. P. Vihko). The Behavioral Analysis Unit (V. Voikar) is funded by Biocenter Finland, http://www.biocenter.fi/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airavaara M, 2006, SYNAPSE, V59, P321, DOI 10.1002/syn.20245; Amann LC, 2010, BRAIN RES BULL, V83, P147, DOI 10.1016/j.brainresbull.2010.04.008; [Anonymous], ALL BRAIN ATL RES; Apostolova L, 2012, NEUROBIOL AGING, V33, P2113, DOI 10.1016/j.neurobiolaging.2011.06.014; Bagga P, 2013, J NEUROCHEM, V127, P365, DOI 10.1111/jnc.12407; Barakauskas VE, 2010, NEUROPSYCHOPHARMACOL, V35, P1226, DOI 10.1038/npp.2009.228; Beyer MK, 2013, MOVEMENT DISORD, V28, P302, DOI 10.1002/mds.25282; BUNNEY BS, 1976, SCIENCE, V192, P391, DOI 10.1126/science.1257777; CARLSSON A, 1973, J NEURAL TRANSM, V34, P79, DOI 10.1007/BF01244661; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; Dalaker TO, 2011, MOVEMENT DISORD, V26, P297, DOI 10.1002/mds.23443; Dando R, 2012, J NEUROSCI, V32, P322, DOI 10.1523/JNEUROSCI.4070-11.2012; Dickman DK, 2012, J NEUROSCI, V32, P8716, DOI 10.1523/JNEUROSCI.5465-11.2012; Fatemi SH, 2001, NEUROREPORT, V12, P3257, DOI 10.1097/00001756-200110290-00023; Feng RB, 2004, P NATL ACAD SCI USA, V101, P8162, DOI 10.1073/pnas.0402733101; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Ilardi JM, 1999, NAT NEUROSCI, V2, P119, DOI 10.1038/5673; Jaaro-Peled H, 2010, SCHIZOPHRENIA BULL, V36, P301, DOI 10.1093/schbul/sbp133; Jeans AF, 2007, P NATL ACAD SCI USA, V104, P2431, DOI 10.1073/pnas.0610222104; Kovacevic N, 2005, CEREB CORTEX, V15, P639, DOI 10.1093/cercor/bhh165; Kulesskaya N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024755; Lauri SE, 2006, NEURON, V50, P415, DOI 10.1016/j.neuron.2006.03.020; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Mijatovic J, 2008, J NEUROCHEM, V105, P1716, DOI 10.1111/j.1471-4159.2008.05265.x; Myohanen TT, 2008, J COMP NEUROL, V507, P1694, DOI 10.1002/cne.21642; Myohanen TT, 2010, J NEUROCHEM, V113, P1632, DOI 10.1111/j.1471-4159.2010.06723.x; Ohtsuka N, 2013, GENESIS, V51, P234, DOI 10.1002/dvg.22370; Okada M, 1996, NEUROSCI LETT, V212, P53, DOI 10.1016/0304-3940(96)12780-4; Oliver PL, 2009, HUM MOL GENET, V18, P4576, DOI 10.1093/hmg/ddp425; Olopade FE, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-19; Quintero IB, 2007, CANCER RES, V67, P6549, DOI 10.1158/0008-5472.CAN-07-1651; Quintero IB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073072; RUIGROK TJH, 1993, MICROSC RES TECHNIQ, V24, P85, DOI 10.1002/jemt.1070240108; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Schmoranzer J, 2003, J CELL SCI, V116, P4513, DOI 10.1242/jcs.00748; Schoen SW, 1997, BRAIN RES PROTOC, V1, P33, DOI 10.1016/S1385-299X(96)00006-2; Schubert KO, 2012, MOL PSYCHIATR, V17, P669, DOI 10.1038/mp.2011.123; Street SE, 2013, J NEUROSCI, V33, P11314, DOI 10.1523/JNEUROSCI.0133-13.2013; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Tang X, 2014, HUM BRAIN MAPP; The Jackson Laboratory, 2003, JAX NOTES; Thompson PM, 2003, BIOL PSYCHIAT, V53, P1132, DOI 10.1016/S0006-3223(02)01599-8; Thompson PM, 2003, PROG NEURO-PSYCHOPH, V27, P411, DOI 10.1016/S0278-5846(03)00027-7; Tornberg J, 2007, NEUROPSYCHOPHARMACOL, V32, P911, DOI 10.1038/sj.npp.1301195; TRAMS EG, 1981, BIOCHIM BIOPHYS ACTA, V645, P63, DOI 10.1016/0005-2736(81)90512-5; VIHKO P, 1979, INVEST UROL, V16, P349; Vihko P., 2005, P AACR 96 ANN M AN C; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; Zhang JY, 2010, NEUROIMAGE, V49, P2340, DOI 10.1016/j.neuroimage.2009.10.027; Zhang Z, 2013, J NEUROSCI, V33, P9169, DOI 10.1523/JNEUROSCI.0301-13.2013; Zimmermann H, 1996, PROG NEUROBIOL, V49, P589, DOI 10.1016/0301-0082(96)00026-3; Zuo XF, 2006, NAT CELL BIOL, V8, P1383, DOI 10.1038/ncb1505; Zylka MJ, 2008, NEURON, V60, P111, DOI 10.1016/j.neuron.2008.08.024	55	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97851	10.1371/journal.pone.0097851	http://dx.doi.org/10.1371/journal.pone.0097851			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846136	Green Submitted, Green Published, gold			2022-12-25	WOS:000339563400065
J	Somfai, T; Yoshioka, K; Tanihara, F; Kaneko, H; Noguchi, J; Kashiwazaki, N; Nagai, T; Kikuchi, K				Somfai, Tamas; Yoshioka, Koji; Tanihara, Fuminori; Kaneko, Hiroyuki; Noguchi, Junko; Kashiwazaki, Naomi; Nagai, Takashi; Kikuchi, Kazuhiro			Generation of Live Piglets from Cryopreserved Oocytes for the First Time Using a Defined System for In Vitro Embryo Production	PLOS ONE			English	Article							PORCINE OOCYTES; FOLLICULAR-FLUID; MOUSE OOCYTES; DEVELOPMENTAL COMPETENCE; INTRACELLULAR ICE; BOAR SPERMATOZOA; WARMING RATE; FERTILIZATION; BLASTOCYSTS; MATURATION	We report the successful piglet production from cryopreserved oocytes for the first time by using a simple, high capacity vitrification protocol for preservation and a defined system for in vitro embryo production. Immature cumulus-oocyte complexes (COCs) from prepubertal gilts were vitrified in microdrops and stored in liquid nitrogen. After warming, COCs were subjected to in vitro maturation (IVM), fertilization (IVF), and subsequent culture (IVC). Adjusting warmplate temperature to 42 degrees C during warming prevented temperature drops in a medium below 34.0 degrees C and significantly increased the percentage of oocyte survival and thus blastocyst yields obtained from total vitrified oocytes compared with that of warming at 38 degrees C (87.1% vs 66.9% and 4.4% vs 2.7%, respectively). Nuclear maturation and fertilization of oocytes were not affected by vitrification and warming temperature. Blastocyst development on day 7 (day 0 = IVF) of the surviving oocytes after warming at 38 degrees C and 42 degrees C was not different but lower (P<0.05) than those of non-vitrified control oocytes (4.6%, 5.2% and 17.9%, respectively). However, blastocyst cell numbers in the control and vitrified groups were similar irrespective of warming temperature. Omitting porcine follicular fluid (pFF) from IVM medium (POM) did not affect maturation, fertilization and embryo development of vitrified-warmed oocytes. Transfer of blastocysts obtained on day 5 from vitrified oocytes matured either with or without pFF into 4 recipients (2 for each group) resulted in 4 pregnancies and the delivery of a total of 18 piglets. In conclusion, optimization of warming temperature was a key factor for achieving high survival rates, and surviving oocytes could be utilized in vitro using defined media. Using these modifications, live piglets could be obtained from cryopreserved oocytes for the first time.	[Somfai, Tamas] NARO Inst Livestock & Grassland Sci, Anim Breeding & Reprod Res Div, Tsukuba, Ibaraki, Japan; [Yoshioka, Koji] Natl Inst Anim Hlth, Pathol & Pathophysiol Res Div, Tsukuba, Ibaraki 305, Japan; [Tanihara, Fuminori; Kaneko, Hiroyuki; Noguchi, Junko; Kikuchi, Kazuhiro] Natl Inst Agrobiol Sci, Anim Dev & Differentiat Res Unit, Tsukuba, Ibaraki, Japan; [Tanihara, Fuminori; Kikuchi, Kazuhiro] Yamaguchi Univ, United Grad Sch Vet Sci, Yamaguchi, Japan; [Kashiwazaki, Naomi] Azabu Univ, Grad Sch Vet Sci, Sagamihara, Kanagawa, Japan; [Nagai, Takashi] Food & Fertilizer Technol Ctr, Taipei, Taiwan	National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; National Institute of Agrobiological Sciences - Japan; Yamaguchi University; Azabu University	Somfai, T (corresponding author), NARO Inst Livestock & Grassland Sci, Anim Breeding & Reprod Res Div, Tsukuba, Ibaraki, Japan.	somfai@affrc.go.jp		Tanihara, Fuminori/0000-0002-2158-5808	JSPS [25292184, 22380153]; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry from MAFF [25052C]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry from MAFF	This work was supported by a Grant-in-Aid for Scientific Research from JSPS to K.Y. (25292184) and K.K. (22380153), and Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry from MAFF to K.Y. (25052C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Algriany O, 2004, THERIOGENOLOGY, V62, P1483, DOI 10.1016/j.theriogenology.2004.02.008; Dinnyes A, 2000, BIOL REPROD, V63, P513, DOI 10.1095/biolreprod63.2.513; Egerszegi I, 2013, CRYOBIOLOGY, V67, P287, DOI 10.1016/j.cryobiol.2013.08.009; Grupen CG, 2010, REPROD FERT DEVELOP, V22, P1100, DOI 10.1071/RD09307; HASLER JF, 1995, THERIOGENOLOGY, V43, P141, DOI 10.1016/0093-691X(94)00020-U; Ju JC, 2004, MOL REPROD DEV, V68, P125, DOI 10.1002/mrd.20054; Karja NWK, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-54; KIKUCHI K, 1993, THERIOGENOLOGY, V39, P593, DOI 10.1016/0093-691X(93)90246-2; Kikuchi K, 1998, THERIOGENOLOGY, V50, P615, DOI 10.1016/S0093-691X(98)00166-6; Kikuchi K, 2002, BIOL REPROD, V66, P1033, DOI 10.1095/biolreprod66.4.1033; LELAIDIER C, 1995, FERTIL STERIL, V63, P919, DOI 10.1016/S0015-0282(16)57503-7; MCKIERNAN SH, 1994, HUM REPROD, V9, P2123, DOI 10.1093/oxfordjournals.humrep.a138403; Mito T, 2012, REPROD FERT DEVELOP, V24, P443, DOI 10.1071/RD11197; Mullen SF, 2012, THERIOGENOLOGY, V78, P1709, DOI 10.1016/j.theriogenology.2012.06.008; Nagai T, 2006, FRONT BIOSCI-LANDMRK, V11, P2565, DOI 10.2741/1991; NAITO K, 1988, GAMETE RES, V21, P289, DOI 10.1002/mrd.1120210310; PETTERS RM, 1993, J REPROD FERTIL, P61; Pribenszky C, 2012, REPROD DOMEST ANIM, V47, P197, DOI 10.1111/j.1439-0531.2012.02076.x; RATH D, 1995, THERIOGENOLOGY, V44, P529, DOI 10.1016/0093-691X(95)00224-V; Seki S, 2008, BIOL REPROD, V79, P727, DOI 10.1095/biolreprod.108.069401; Seki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036058; Seki S, 2011, REPRODUCTION, V141, P407, DOI 10.1530/REP-10-0438; Seki S, 2009, CRYOBIOLOGY, V59, P75, DOI 10.1016/j.cryobiol.2009.04.012; Shoukir Y, 1998, HUM REPROD, V13, P676, DOI 10.1093/humrep/13.3.676; Somfai T, 2013, CONTROL PIG REPROD 9, V68, P47; Somfai T, 2009, BIOL REPROD, V80, P42, DOI 10.1095/biolreprod.108.070235; Somfai T, 2013, J REPROD DEVELOP, V59, P378, DOI 10.1262/jrd.2013-015; Somfai T, 2012, J REPROD DEVELOP, V58, P17, DOI 10.1262/jrd.11-140N; Suzuki K, 2002, INT J ANDROL, V25, P84, DOI 10.1046/j.1365-2605.2002.00330.x; Tamas S, 2007, CRYOBIOLOGY, V55, P115, DOI 10.1016/j.cryobiol.2007.06.008; Tseng JK, 2006, THERIOGENOLOGY, V66, P1073, DOI 10.1016/j.theriogenology.2006.03.003; YOSHIDA M, 1992, J REPROD FERTIL, V95, P481, DOI 10.1530/jrf.0.0950481; Yoshioka K, 2003, BIOL REPROD, V69, P2092, DOI 10.1095/biolreprod.103.020081; Yoshioka K, 2008, J REPROD DEVELOP, V54, P208, DOI 10.1262/jrd.20001; Zhou GB, 2009, MOL HUM REPROD, V15, P279, DOI 10.1093/molehr/gap016	36	53	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97731	10.1371/journal.pone.0097731	http://dx.doi.org/10.1371/journal.pone.0097731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844283	Green Submitted, Green Published, gold			2022-12-25	WOS:000339563400052
J	Zennaro, C; Mariotti, M; Carraro, M; Pasqualetti, S; Corbelli, A; Armelloni, S; Li, M; Ikehata, M; Clai, M; Artero, M; Messa, P; Boscutti, G; Rastaldi, MP				Zennaro, Cristina; Mariotti, Massimo; Carraro, Michele; Pasqualetti, Sara; Corbelli, Alessandro; Armelloni, Silvia; Li, Min; Ikehata, Masami; Clai, Milan; Artero, Mary; Messa, Piergiorgio; Boscutti, Giuliano; Rastaldi, Maria Pia			Podocyte Developmental Defects Caused by Adriamycin in Zebrafish Embryos and Larvae: A Novel Model of Glomerular Damage	PLOS ONE			English	Article							EXPRESSION; PROTEIN; NEPHRIN; SYSTEM; WT1A	The zebrafish pronephros is gaining popularity in the nephrology community, because embryos are easy to cultivate in multiwell plates, allowing large number of experiments to be conducted in an in vivo model. In a few days, glomeruli reach complete development, with a structure that is similar to that of the mammalian counterpart, showing a fenestrated endothelium and a basement membrane covered by the multiple ramifications of mature podocytes. As a further advantage, zebrafish embryos are permeable to low molecular compounds, and this explains their extensive use in drug efficacy and toxicity experiments. Here we show that low concentrations of adriamycin (i.e. 10 and 20 mu M), when dissolved in the medium of zebrafish embryos at 9 hours post-fertilization and removed after 48 hours (57 hpf), alter the development of podocytes with subsequent functional impairment, demonstrated by onset of pericardial edema and reduction of expression of the podocyte proteins nephrin and wt1. Podocyte damage is morphologically confirmed by electron microscopy and functionally supported by increased clearance of microinjected 70 kDa fluorescent dextran. Importantly, besides pericardial edema and glomerular damage, which persist and worsen after adriamycin removal from the medium, larvae exposed to adriamycin 10 and 20 mu M do not show any myocardiocyte alterations nor vascular changes. The only extra-renal effect is a transient delay of cartilage formation that rapidly recovers once adriamycin is removed. In summary, this low dose adriamycin model can be applied to analyze podocyte developmental defects, such as those observed in congenital nephrotic syndrome, and can be taken in consideration for pharmacological studies of severe early podocyte injury.	[Zennaro, Cristina; Carraro, Michele] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Zennaro, Cristina; Corbelli, Alessandro; Armelloni, Silvia; Li, Min; Ikehata, Masami; Rastaldi, Maria Pia] Fdn IRCCS Ca Granda Osped Maggiore Policli, Renal Res Lab, Milan, Italy; [Zennaro, Cristina; Corbelli, Alessandro; Armelloni, Silvia; Li, Min; Ikehata, Masami; Rastaldi, Maria Pia] Fdn Amico Ric Malattie Renali, Milan, Italy; [Mariotti, Massimo] Univ Milan, Dept Biomed Surg & Dent Sci, Milan, Italy; [Mariotti, Massimo] IRCCS Orthoped Inst, Milan, Italy; [Pasqualetti, Sara] Grp Osped San Donato Fdn, Milan, Italy; [Clai, Milan; Artero, Mary; Boscutti, Giuliano] Univ Osped Riuniti Trieste, Azienda Osped, Trieste, Italy; [Corbelli, Alessandro] Mario Negri Inst Pharmacol Res, Dept Cardiovasc Res, Unit Bioimaging, Milan, Italy; [Messa, Piergiorgio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Nephrol Dialysis & Renal Transplant, Milan, Italy	University of Trieste; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Policlinico San Donato; University of Trieste; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; IRCCS Ca Granda Ospedale Maggiore Policlinico	Zennaro, C (corresponding author), Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.	czennaro@units.it	Boscutti, Giuliano/AAH-8559-2021; Corbelli, Alessandro/ABG-3900-2020; Li, Min/AFJ-8435-2022; Armelloni, Silvia/AAP-8617-2021; IKEHATA, Masami/HHR-9052-2022; Li, Min/AAL-7828-2021; Li, Min/AAF-5252-2022	Corbelli, Alessandro/0000-0001-8545-8050; Armelloni, Silvia/0000-0001-6431-2642; IKEHATA, Masami/0000-0001-9835-9991; Li, Min/0000-0003-1350-9909; CARRARO, MICHELE/0000-0002-8940-3361; ZENNARO, Cristina/0000-0003-4755-1064	ERA-EDTA/EMBO; "Fondazione la Nuova Speranza ONLUS - Lotta alla Glomerulosclerosi Focale", Rho (Mi); "Fondazione Benefica Kathleen Foreman Casali", Trieste	ERA-EDTA/EMBO; "Fondazione la Nuova Speranza ONLUS - Lotta alla Glomerulosclerosi Focale", Rho (Mi); "Fondazione Benefica Kathleen Foreman Casali", Trieste	This work was conducted thanks to a long-term ERA-EDTA/EMBO fellowship to Dr. Cristina Zennaro. Dr. Zennaro is presently the recipient of a Telethon Foundation research contract. The Laboratory of Renal Pathobiology of Trieste University and the Renal Research Laboratory of Milan Policlinic belong to the "Italian Network to fight FSGS" supported by "Fondazione la Nuova Speranza ONLUS - Lotta alla Glomerulosclerosi Focale", Rho (Mi). Funding was received also from "Fondazione Benefica Kathleen Foreman Casali", Trieste. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belyaeva NF, 2009, BIOCHEM MOSC-SUPPL S, V3, P343, DOI 10.1134/S1990750809040039; Bollig F, 2006, DEV DYNAM, V235, P554, DOI 10.1002/dvdy.20645; Bollig F, 2009, DEVELOPMENT, V136, P2883, DOI 10.1242/dev.031773; Chang C, 2014, BIO-MED MATER ENG, V24, P909, DOI 10.3233/BME-130885; Chittiprol S, 2011, AM J PHYSIOL-RENAL, V301, pF660, DOI 10.1152/ajprenal.00234.2011; Ding YH, 2011, CIRC RES, V109, P658, DOI 10.1161/CIRCRESAHA.111.248260; Drummond IA, 2010, METHOD CELL BIOL, V100, P233, DOI 10.1016/B978-0-12-384892-5.00009-8; Giardino L, 2009, J AM SOC NEPHROL, V20, P1929, DOI 10.1681/ASN.2008121286; He B, 2011, J AM SOC NEPHROL, V22, P1019, DOI 10.1681/ASN.2010121291; Hentschel DM, 2007, AM J PHYSIOL-RENAL, V293, pF1746, DOI 10.1152/ajprenal.00009.2007; Hill AJ, 2004, TOXICOL SCI, V78, P78, DOI 10.1093/toxsci/kfh056; Huang CC, 2007, TOXICOL SCI, V100, P486, DOI 10.1093/toxsci/kfm235; Huang JM, 2013, KIDNEY INT, V83, P1193, DOI 10.1038/ki.2013.6; Kari G, 2007, CLIN PHARMACOL THER, V82, P70, DOI 10.1038/sj.clpt.6100223; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Lee VWS, 2011, NEPHROLOGY, V16, P30, DOI 10.1111/j.1440-1797.2010.01383.x; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006; Oh J, 2004, PEDIATR NEPHROL, V19, P130, DOI 10.1007/s00467-003-1367-y; Perner B, 2007, DEV BIOL, V309, P87, DOI 10.1016/j.ydbio.2007.06.022; Puliti A, 2011, AM J PATHOL, V178, P1257, DOI 10.1016/j.ajpath.2010.11.050; Rocke John, 2009, Recent Pat Cardiovasc Drug Discov, V4, P1; Rudiger F, 1999, KIDNEY INT, V56, P1700, DOI 10.1046/j.1523-1755.1999.00729.x; Serbedzija G N, 1999, Angiogenesis, V3, P353, DOI 10.1023/A:1026598300052; Simunek T, 2009, PHARMACOL REP, V61, P154; Sohn RL, 2009, P NATL ACAD SCI USA, V106, P9274, DOI 10.1073/pnas.0904398106; Wallace KB, 2003, PHARMACOL TOXICOL, V93, P105, DOI 10.1034/j.1600-0773.2003.930301.x; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Zennaro C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066159; Zheng CX, 2008, KIDNEY INT, V74, P596, DOI 10.1038/ki.2008.203	29	17	18	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98131	10.1371/journal.pone.0098131	http://dx.doi.org/10.1371/journal.pone.0098131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845233	Green Published, gold, Green Submitted			2022-12-25	WOS:000339563400100
J	Zouani, OF; Gocheva, V; Durrieu, MC				Zouani, Omar F.; Gocheva, Veronika; Durrieu, Marie-Christine			Membrane Nanowaves in Single and Collective Cell Migration	PLOS ONE			English	Article							OPTICAL PROFILOMETRY; MATURE OSTEOBLASTS; DYNAMICS; BMP-2; DIFFERENTIATION; CYTOSKELETON; MODULATION; ADHESION; GTPASES; MODEL	We report the characterization of three-dimensional membrane waves for migrating single and collective cells and describe their propagation using wide-field optical profiling technique with nanometer resolution. We reveal the existence of small and large membrane waves the amplitudes of which are in the range of similar to 3-7 nm to similar to 16-25 nm respectively, through the cell. For migrating single-cells, the amplitude of these waves is about 30 nm near the cell edge. Two or more different directions of propagation of the membrane nanowaves inside the same cell can be observed. After increasing the migration velocity by BMP-2 treatment, only one wave direction of propagation exists with an increase in the average amplitude (more than 80 nm near the cell edge). Furthermore for collective-cell migration, these membrane nanowaves are attenuated on the leader cells and poor transmission of these nanowaves to follower cells was observed. After BMP-2 treatment, the membrane nanowaves are transmitted from the leader cell to several rows of follower cells. Surprisingly, the vast majority of the observed membrane nanowaves is shared between the adjacent cells. These results give a new view on how single and collective-cells modulate their motility. This work has significant implications for the therapeutic use of BMPs for the regeneration of skin tissue.	[Zouani, Omar F.; Durrieu, Marie-Christine] Univ Bordeaux 2, Bioingn Tissulaire BioTis, INSERM U1026, F-33076 Bordeaux, France; [Zouani, Omar F.; Durrieu, Marie-Christine] Univ Bordeaux 1, IECB, CNRS, UMR 5248, Pessac, France; [Gocheva, Veronika] Univ Montpellier 2, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Universite de Montpellier	Zouani, OF (corresponding author), Univ Bordeaux 2, Bioingn Tissulaire BioTis, INSERM U1026, F-33076 Bordeaux, France.	omar.zouani@avegem.com	DURRIEU, Marie-Christine/I-4358-2016	DURRIEU, Marie-Christine/0000-0003-0583-9289	Region Aquitaine; "Agence Nationale pour la Recherche" (ANR) [ANR-09-ETEC-001-01]; Advanced Materials in Aquitaine (AMA, GIS)	Region Aquitaine(Region Nouvelle-Aquitaine); "Agence Nationale pour la Recherche" (ANR)(French National Research Agency (ANR)); Advanced Materials in Aquitaine (AMA, GIS)	This work was supported in part by the "Region Aquitaine", the "Agence Nationale pour la Recherche" (ANR, grant number ANR-09-ETEC-001-01; www.agence-nationale-recherche.fr) and Advanced Materials in Aquitaine (AMA, GIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini TE, 2011, P NATL ACAD SCI USA, V108, P4714, DOI 10.1073/pnas.1010059108; Bergert M, 2012, P NATL ACAD SCI USA, V109, P14434, DOI 10.1073/pnas.1207968109; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Chen CH, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238101; Coelho Neto J, 2005, EXP CELL RES, V303, P207, DOI 10.1016/j.yexcr.2004.09.002; Das RK, 2014, BIOMATERIALS; Dobereiner HG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.038102; Driscoll MK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002392; Friedl P, 2004, INT J DEV BIOL, V48, P441, DOI 10.1387/ijdb.041821pf; Gamell C, 2008, J CELL SCI, V121, P3960, DOI 10.1242/jcs.031286; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Hsu TH, 2007, OPT EXPRESS, V15, P76, DOI 10.1364/OE.15.000076; Inai K, 2008, DEV BIOL, V315, P383, DOI 10.1016/j.ydbio.2007.12.028; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Khalil AA, 2010, INTEGR BIOL-UK, V2, P568, DOI 10.1039/c0ib00052c; Lecaudey V, 2006, CURR OPIN CELL BIOL, V18, P102, DOI 10.1016/j.ceb.2005.12.001; Lee CH, 2002, OPT LETT, V27, P1773, DOI 10.1364/OL.27.001773; Lei Y, 2012, SMALL; Lei YF, 2013, SMALL, V9, P1086, DOI 10.1002/smll.201202410; Lei YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041163; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Peleg B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018635; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Reed J, 2008, ACS NANO, V2, P841, DOI 10.1021/nn700303f; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Schutz GJ, 2000, EMBO J, V19, P892, DOI 10.1093/emboj/19.5.892; Sen S, 2005, BIOPHYS J, V89, P3203, DOI 10.1529/biophysj.105.063826; Serra-Picamal X, 2012, NAT PHYS, V8, P628, DOI [10.1038/NPHYS2355, 10.1038/nphys2355]; Shlomovitz R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.168103; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Stramer B, 2005, J CELL BIOL, V168, P567, DOI 10.1083/jcb.200405120; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Tambe DT, 2011, NAT MATER, V10, P469, DOI [10.1038/NMAT3025, 10.1038/nmat3025]; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; Wagner DO, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3107mr1; Wang CC, 2006, OPT LETT, V31, P2873, DOI 10.1364/OL.31.002873; Weijer CJ, 2009, J CELL SCI, V122, P3215, DOI 10.1242/jcs.036517; Zouani OF, 2013, BIOL OPEN, V2, P872, DOI 10.1242/bio.20134986; Zouani OF, 2013, SMALL, V9, P3070, DOI 10.1002/smll.201300124; Zouani OF, 2013, BIOMATERIALS, V34, P2157, DOI 10.1016/j.biomaterials.2012.12.007; Zouani OF, 2012, J CELL SCI, V125, P1217, DOI 10.1242/jcs.093229; Zouani OF, 2010, BIOMATERIALS, V31, P8245, DOI 10.1016/j.biomaterials.2010.07.042	48	3	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97855	10.1371/journal.pone.0097855	http://dx.doi.org/10.1371/journal.pone.0097855			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846182	Green Published, gold, Green Submitted			2022-12-25	WOS:000339563400066
J	Ahmad, Y; Sharma, NK; Ahmad, MF; Sharma, M; Garg, I; Bhargava, K				Ahmad, Yasmin; Sharma, Narendra K.; Ahmad, Mohammad Faiz; Sharma, Manish; Garg, Iti; Bhargava, Kalpana			Proteomic Identification of Novel Differentiation Plasma Protein Markers in Hypobaric Hypoxia-Induced Rat Model	PLOS ONE			English	Article							RETINOL-BINDING-PROTEIN; APOLIPOPROTEIN-A-I; INFLAMMATION; ALPHA(1)-MICROGLOBULIN; LIPOCALIN; INSULIN; CANCER; HAPTOGLOBIN; BIOMARKERS; TOLERANCE	Background: Hypobaric hypoxia causes complex changes in the expression of genes, including stress related genes and corresponding proteins that are necessary to maintain homeostasis. Whereas most prior studies focused on single proteins, newer methods allowing the simultaneous study of many proteins could lead to a better understanding of complex and dynamic changes that occur during the hypobaric hypoxia. Methods: In this study we investigated the temporal plasma protein alterations of rat induced by hypobaric hypoxia at a simulated altitude of 7620 m (25,000 ft, 282 mm Hg) in a hypobaric chamber. Total plasma proteins collected at different time points (0, 6, 12 and 24 h), separated by two-dimensional electrophoresis (2-DE) and identified using matrix assisted laser desorption ionization time of flight (MALDI-TOF/TOF). Biological processes that were enriched in the plasma proteins during hypobaric hypoxia were identified using Gene Ontology (GO) analysis. According to their properties and obvious alterations during hypobaric hypoxia, changes of plasma concentrations of Ttr, Prdx-2, Gpx -3, Apo A-I, Hp, Apo-E, Fetub and Nme were selected to be validated by Western blot analysis. Results: Bioinformatics analysis of 25 differentially expressed proteins showed that 23 had corresponding candidates in the database. The expression patterns of the eight selected proteins observed by Western blot were in agreement with 2-DE results, thus confirming the reliability of the proteomic analysis. Most of the proteins identified are related to cellular defense mechanisms involving anti-inflammatory and antioxidant activity. Their presence reflects the consequence of serial cascades initiated by hypobaric hypoxia. Conclusion/Significance: This study provides information about the plasma proteome changes induced in response to hypobaric hypoxia and thus identification of the candidate proteins which can act as novel biomarkers.	[Ahmad, Yasmin; Sharma, Narendra K.; Sharma, Manish; Bhargava, Kalpana] Minist Def, DRDO, DIPAS, Peptide & Prote Div, Delhi, India; [Ahmad, Mohammad Faiz] Jamia Millia Islamia, Dept Chem, New Delhi 110025, India; [Garg, Iti] Minist Def, DRDO, DIPAS, Dept Genom, Delhi, India	Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS); Jamia Millia Islamia; Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS)	Ahmad, Y (corresponding author), Minist Def, DRDO, DIPAS, Peptide & Prote Div, Delhi, India.	yasminchem@gmail.com	Garg, Iti/GYU-6396-2022; Sharma, Narendra/D-2451-2017	Sharma, Narendra/0000-0002-8681-3840	Defence Research Development Organization (DRDO), Ministry of Defence, Government of India [TC/321/Task-145 (YA)/DIPAS/2008]	Defence Research Development Organization (DRDO), Ministry of Defence, Government of India(Defence Research & Development Organisation (DRDO))	Financial support for this study is provided by a grant from TC/321/Task-145 (YA)/DIPAS/2008, Defence Research Development Organization (DRDO), Ministry of Defence, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Y., 2009, J PROTEOM BIOINFORM, V2, P495, DOI DOI 10.4172/JPB.1000111; Ahmad Y, 2011, FUNCT INTEGR GENOMIC, V11, P407, DOI 10.1007/s10142-011-0234-3; Ahmed FE, 2009, J CHROMATOGR B, V877, P1963, DOI 10.1016/j.jchromb.2009.05.023; Akerstrom Bo, 2011, Patent application number, Patent No. 20110190208; Allhorn M, 2005, FREE RADICAL BIO MED, V38, P557, DOI 10.1016/j.freeradbiomed.2004.12.013; Allhorn M, 2003, J INVEST DERMATOL, V121, P640, DOI 10.1046/j.1523-1747.2003.12409.x; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Bates SR, 2005, AM J PHYSIOL-LUNG C, V289, pL980, DOI 10.1152/ajplung.00234.2005; Belcher JD, 2010, ANTIOXID REDOX SIGN, V12, P233, DOI 10.1089/ars.2009.2822; Bellovino D, 1996, EXP CELL RES, V222, P77, DOI 10.1006/excr.1996.0010; Bora A, 2012, J PROTEOME RES, V11, P3143, DOI 10.1021/pr300057v; Ceciliani F, 2002, PROTEIN PEPTIDE LETT, V9, P211, DOI 10.2174/0929866023408779; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chang SI, 2007, CANCER EPIDEM BIOMAR, V16, P228, DOI 10.1158/1055-9965.EPI-06-0567; COCKERILL GW, 1995, INT REV CYTOL, V159, P113, DOI 10.1016/S0074-7696(08)62106-3; Collard CD, 1999, MOL IMMUNOL, V36, P941, DOI 10.1016/S0161-5890(99)00116-9; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coughtrie MWH, 1999, BIOCHEM J, V337, P45, DOI 10.1042/0264-6021:3370045; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; Dahl B, 2001, INTENS CARE MED, V27, P394, DOI 10.1007/s001340000837; DEUTSCH J, 1983, METHOD ENZYMAT AN, V3, P190; Duan JX, 2001, FEBS LETT, V499, P127, DOI 10.1016/S0014-5793(01)02544-3; Duverger N, 1996, SCIENCE, V273, P966, DOI 10.1126/science.273.5277.966; Eaton P, 2002, J BIOL CHEM, V277, P9806, DOI 10.1074/jbc.M111454200; Elsoe S, 2012, ATHEROSCLEROSIS, V221, P91, DOI 10.1016/j.atherosclerosis.2011.11.031; Feingold KR, 2008, ATHEROSCLEROSIS, V199, P19, DOI 10.1016/j.atherosclerosis.2007.10.007; Geiben-Lynn R, 2003, J BIOL CHEM, V278, P1569, DOI 10.1074/jbc.M209964200; George D, 2009, PROG CARDIOVASC DIS, V52, P115, DOI 10.1016/j.pcad.2009.06.005; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Glatt H, 1997, FASEB J, V11, P314, DOI 10.1096/fasebj.11.5.9141497; Gomme PT, 2004, TRENDS BIOTECHNOL, V22, P340, DOI 10.1016/j.tibtech.2004.05.001; Han CZ, 2005, ENDOCRINE, V26, P19, DOI 10.1385/ENDO:26:1:019; Hernandez R, 2013, NEUROMOL MED, V15, P82, DOI 10.1007/s12017-012-8197-7; HIGHTOWER LE, 1993, MAR ENVIRON RES, V35, P79; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Holers VM, 2008, IMMUNOL REV, V223, P300, DOI 10.1111/j.1600-065X.2008.00641.x; Honda K, 2013, JPN J CLIN ONCOL, V43, P103, DOI 10.1093/jjco/hys200; Ishigami M, 1998, J BIOL CHEM, V273, P20156, DOI 10.1074/jbc.273.32.20156; Jacobs JM, 2005, J PROTEOME RES, V4, P1073, DOI 10.1021/pr0500657; Kierny MR, 2012, NANO REV, V3, P1; Kitagawa K, 2002, J NEUROSCI RES, V68, P226, DOI 10.1002/jnr.10209; LEBRETON JP, 1979, J CLIN INVEST, V64, P1118, DOI 10.1172/JCI109551; Lee SH, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-271; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Liu F, 2003, GENE, V315, P71, DOI 10.1016/S0378-1119(03)00732-7; Meier U, 2006, CLIN CHEM, V52, P1247, DOI 10.1373/clinchem.2005.065680; Norseen J, 2012, MOL CELL BIOL, V32, P2010, DOI 10.1128/MCB.06193-11; Olsson MG, 2008, FREE RADICAL RES, V42, P725, DOI 10.1080/10715760802337265; Ostos MA, 2001, ARTERIOSCL THROM VAS, V21, P1023, DOI 10.1161/01.ATV.21.6.1023; Padhy G, 2013, HIGH ALT MED BIOL, V14, P289, DOI 10.1089/ham.2012.1095; PETERSON PA, 1971, J BIOL CHEM, V246, P44; Qin XF, 1998, AM J PHYSIOL-HEART C, V274, pH1836, DOI 10.1152/ajpheart.1998.274.5.H1836; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Rahman I, 2006, EUR J PHARMACOL, V533, P222, DOI 10.1016/j.ejphar.2005.12.087; Ren Y, 2013, MOL CELL PROTEOMICS, V12, P485, DOI 10.1074/mcp.M112.018325; Riddell DR, 1997, J BIOL CHEM, V272, P89; Rousseau AS, 2006, AVIAT SPACE ENVIR MD, V77, P551; Sarafian TA, 1997, FREE RADICAL RES, V26, P281, DOI 10.3109/10715769709097806; Schellenberg D, 1998, AM J RESP CRIT CARE, V157, P957, DOI 10.1164/ajrccm.157.3.9706106; Sharma NK, 2013, J PROTEOMICS, V79, P277, DOI 10.1016/j.jprot.2012.12.020; Shau H, 1998, BIOCHEM BIOPH RES CO, V249, P683, DOI 10.1006/bbrc.1998.9129; SHAU HG, 1994, IMMUNOGENETICS, V40, P129; Song EJ, 2000, BIOCHEMISTRY-US, V39, P10090, DOI 10.1021/bi000267a; Thiemermann C, 2003, J AM SOC NEPHROL, V14, P1833, DOI 10.1097/01.ASN.0000075552.97794.8C; Turko IV, 2003, J BIOL CHEM, V278, P35844, DOI 10.1074/jbc.M303139200; Vyssoulis GP, 2007, AM J HYPERTENS, V20, P1016, DOI 10.1016/j.amjhyper.2007.01.010; Wang JH, 2013, INT J MOL SCI, V14, P19146, DOI 10.3390/ijms140919146; Wang WL, 2010, J LIPID RES, V51, P2560, DOI 10.1194/jlr.M004549; Wang YF, 2002, LUNG CANCER, V35, P137, DOI 10.1016/S0169-5002(01)00406-8; Wang YP, 2001, REDOX REP, V6, P379, DOI 10.1179/135100001101536580; Weinshilboum RM, 1997, FASEB J, V11, P3, DOI 10.1096/fasebj.11.1.9034160; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; White P, 2000, TRENDS ENDOCRIN MET, V11, P320, DOI 10.1016/S1043-2760(00)00317-9; Wolf G, 2007, NUTR REV, V65, P251, DOI 10.1111/j.1753-4887.2007.tb00302.x; Yamamoto N, 1997, CANCER RES, V57, P2187; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6; Zhou XH, 1998, J CLIN INVEST, V101, P1717, DOI 10.1172/JCI1216	77	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e98027	10.1371/journal.pone.0098027	http://dx.doi.org/10.1371/journal.pone.0098027			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842778	Green Published, Green Submitted, gold			2022-12-25	WOS:000340948600101
J	Beirn, LA; Clarke, BB; Crouch, JA				Beirn, Lisa A.; Clarke, Bruce B.; Crouch, Jo Anne			Influence of Host and Geographic Locale on the Distribution of Colletotrichum cereale Lineages	PLOS ONE			English	Article							BLUEGRASS PUTTING GREEN; ANTHRACNOSE DISEASE; CALIFORNIA POPULATIONS; TURFGRASS; PATHOGEN; GRAMINICOLA; SEVERITY; GRASSES; GENOME	Colletotrichum cereale is an ascomycete inhabitant of cool-season Pooideae grasses. The fungus has increased in frequency over the past decade as a destructive pathogen of Poa annua and Agrostis stolonifera turfgrass. Colletotrichum cereale exists as two lineages, designated clades A and B, but little is known about the distribution of these clades in natural environments, or what role these subdivisions may play in the trajectory of disease outbreaks. In this study, our objective was to determine the frequency of C. cereale clades A and B. To rapidly discriminate between the two C. cereale clades, a real-time PCR assay was developed based on the Apn2 gene. A collection of 700 C. cereale pathogens and endophytes from twenty Pooideae grass genera were genotyped. 87% of the collection was identifed as part of clade A, 11.7% as part of clade B, and 1.3% was a mixture. Colletotrichum cereale from turfgrass hosts in North America were most commonly members of clade A (78%). The overabundance of clade A in turfgrass isolates was directly attributable to the dominance of this lineage from southern sampling sites, irrespective of host. In contrast, 111 C. cereale turfgrass isolates collected from northern sampling sites were evenly distributed between clades A and B. Only 28% of C. cereale from A. stolonifera at northern sampling sites were part of clade A. These data show that environmental factors such as geographic location and host identity likely played a role in the distribution of the major C. cereale clades in North American turfgrass.	[Beirn, Lisa A.; Clarke, Bruce B.] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ USA; [Crouch, Jo Anne] USDA ARS, Systemat Mycol & Microbiol Lab, Beltsville, MD 20705 USA	Rutgers State University New Brunswick; United States Department of Agriculture (USDA)	Crouch, JA (corresponding author), USDA ARS, Systemat Mycol & Microbiol Lab, Beltsville, MD 20705 USA.	joanne.crouch@ars.usda.gov		Crouch, Jo Anne/0000-0001-6886-8090	Rutgers Center for Turfgrass Science; U.S. Department of Agriculture (USDA) Agriculture Research Service; USDA National Institute of Food and Agriculture; ARS [ARS-0422901] Funding Source: Federal RePORTER	Rutgers Center for Turfgrass Science; U.S. Department of Agriculture (USDA) Agriculture Research Service; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was funded by the Rutgers Center for Turfgrass Science, the U.S. Department of Agriculture (USDA) Agriculture Research Service, and the USDA National Institute of Food and Agriculture. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the USDA. USDA is an equal opportunity provider and employer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolton A. T., 1981, Canadian Journal of Plant Pathology, V3, P94; Bruehl GW, 1950, USDA TECH B, V1005; Cannon PF, 2012, STUD MYCOL, P181, DOI 10.3114/sim0014; Crouch JA, 2009, FUNGAL DIVERS, V39, P19; Crouch JA, 2006, PHYTOPATHOLOGY, V96, P46, DOI 10.1094/PHYTO-96-0046; Crouch JA, 2014, IMA FUNGUS IN PRESS, V5; Crouch JA, 2005, INT TURF SOC RES J, V10, P86; Crouch JA, 2008, CROP SCI, V48, P1203, DOI 10.2135/cropsci2007.08.0427; Crouch JA, 2008, FUNGAL GENET BIOL, V45, P190, DOI 10.1016/j.fgb.2007.08.004; Crouch JA, 2012, MYCOLOGIA, V104, P1085, DOI 10.3852/11-317; Crouch JA, 2009, MYCOL RES, V113, P1411, DOI 10.1016/j.mycres.2009.09.010; Crouch JA, 2009, MYCOLOGIA, V101, P648, DOI 10.3852/08-231; Crouch JA, 2009, MOL ECOL, V18, P123, DOI 10.1111/j.1365-294X.2008.04008.x; Franco CCD, 2011, PHYTOPATHOLOGY, V101, P923, DOI 10.1094/PHYTO-12-10-0327; Herting VJ, 1982, THESIS U RHODE ISLAN; Hitchcock AS, 1971, MANUAL GRASSES US; Hyde KD, 2009, FUNGAL DIVERS, V39, P147; Inguagiato J.C., 2009, INT TURF SOC RES J, V11, P207; Inguagiato J.C., 2010, APPL TURF SCI, V7, P1, DOI [10.1094/ATS-2010-0923-01-RS, DOI 10.1094/ATS-2010-0923-01-RS]; Inguagiato JC, 2008, CROP SCI, V48, P1595, DOI 10.2135/cropsci2007.06.0343; Inguagiato JC, 2012, CROP SCI, V52, P1406, DOI 10.2135/cropsci2011.01.0010; Inguagiato JC, 2009, CROP SCI, V49, P1454, DOI 10.2135/cropsci2008.07.0435; Khan A, 2003, CAN J MICROBIOL, V49, P433, DOI [10.1139/w03-059, 10.1139/W03-059]; Murphy J.A., 2008, GOLF COURSE MANAG, V76, P93; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; Roberts JA, 2012, AGRON J, V104, P1176, DOI 10.2134/agronj2011.0269; Roberts JA, 2011, CROP SCI, V51, P1244, DOI 10.2135/cropsci2010.07.0444; Rosada LJ, 2010, J EUKARYOT MICROBIOL, V57, P383, DOI 10.1111/j.1550-7408.2010.00486.x; Selby A.D., 1909, OHIO AGR EXP STA B, V203, P187; SMITH J. DREW, 1954, JOUR SPORTS TURF RES INST, V8, P344; SUTTON BC, 1968, CAN J BOTANY, V46, P873, DOI 10.1139/b68-115; Turgeon JM, 2003, POA ANN PHYSL CULTUR; Vargas JM, 1993, INT TURF SOC RES J, V7, P324; Verkley GJM, 2014, MYCOTA B IN PRESS; Wilson GW, 1914, PHYTOPATHOLOGY, V4, P106; Wolff ET, 1947, THESIS PENN STATE U; Wong FP, 2008, PLANT DIS, V92, P239, DOI 10.1094/PDIS-92-2-0239; Wong FP, 2007, PLANT DIS, V91, P1536, DOI 10.1094/PDIS-91-12-1536; Wong FP, 2007, PLANT DIS, V91, P1547, DOI 10.1094/PDIS-91-12-1547	39	3	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97706	10.1371/journal.pone.0097706	http://dx.doi.org/10.1371/journal.pone.0097706			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842654	Green Published, gold, Green Submitted			2022-12-25	WOS:000340948600060
J	Wu, MH; Chen, YA; Chen, HH; Chang, KW; Chang, IS; Wang, LH; Hsu, HL				Wu, M-H; Chen, Y-A; Chen, H-H; Chang, K-W; Chang, I-S; Wang, L-H; Hsu, H-L			MCT-1 expression and PTEN deficiency synergistically promote neoplastic multinucleation through the Src/p190B signaling activation	ONCOGENE			English	Article							TUMOR-SUPPRESSOR PTEN; BREAST-CANCER; CHROMOSOME SEGREGATION; TRASTUZUMAB RESISTANCE; CELL-SURVIVAL; AKT PATHWAY; ONCOGENE; 3-KINASE; CYTOKINESIS; INSTABILITY	Multinucleation is associated with malignant neoplasms; however, the molecular mechanism underlying the nuclear abnormality remains unclear. Loss or mutation of PTEN promotes the development of malignant tumors. We now demonstrate that increased expression of the oncogene MCT-1 (multiple copies in T-cell malignancy 1) antagonizes PTEN gene presentation, PTEN protein stability and PTEN functional activity, thereby further promoting phosphoinositide 3 kinase/AKT signaling, survival rate and malignancies of the PTEN-deficient cells. In the PTEN-null cancer cells, MCT-1 interacts with p190B and Src in vivo, supporting that they are in proximity of the signaling complexes. MCT-1 overexpression and PTEN loss synergistically augments the Src/p190B signaling function that leads to inhibition of RhoA activity. Under such a condition, the incidence of mitotic catastrophes including spindle multipolarity and cytokinesis failure is enhanced, driving an Src/p190B/RhoA-dependent neoplastic multinucleation. Targeting MCT-1 by the short hairpin RNA markedly represses the Src/p190B function, improves nuclear structures and suppresses xenograft tumorigenicity of the PTEN-null breast cancer cells. Consistent with the oncogenic effects in vitro, clinical evidence has confirmed that MCT-1 gene stimulation is correlated with p190B gene promotion and PTEN gene suppression in human breast cancer. Accordingly, MCT-1 gene induction is recognized as a potential biomarker of breast tumor development. Abrogating MCT-1 function may be a promising stratagem for management of breast cancer involving Src hyperactivation and/or PTEN dysfunction.	[Wu, M-H; Chen, Y-A; Chen, H-H; Wang, L-H; Hsu, H-L] Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan 35053, Miaoli County, Taiwan; [Chang, K-W] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan 35053, Miaoli County, Taiwan; [Chang, I-S] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan 35053, Miaoli County, Taiwan; [Chang, I-S] Natl Hlth Res Inst, Div Biostat & Bioinformat, Zhunan 35053, Miaoli County, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan	Hsu, HL (corresponding author), Natl Hlth Res Inst, Inst Mol & Genom Med, 35 Keyan Rd, Zhunan 35053, Miaoli County, Taiwan.	hsinling88@nhri.org.tw	Chang, I-Shou/D-2084-2010; Wang, Lu-Hai/E-3986-2010; Hsu, Hsin-Ling/E-3672-2010		NSC [99-3112-B-400-002, 100-2320-B-400-013, 101-2320-B-400-014-MY3, NSC102-2319-B-400-001, DOH103-TD-C-111-004]	NSC(Ministry of Science and Technology, Taiwan)	This work was funded by NSC 99-3112-B-400-002 (to HLH), NSC 100-2320-B-400-013 (to HLH), NSC 101-2320-B-400-014-MY3 (to HLH), NSC102-2319-B-400-001 (to ISC) and DOH103-TD-C-111-004 (to LHW). We would like to acknowledge technical support from Cell Sorter Core (Chao-Yang Hsiao), Live Cell Image Core (Kang-Lin Chu) and Optical Biology Core (Shu-Fen Hu) facilities of National Health Research Institutes.	Ali IU, 1999, JNCI-J NATL CANCER I, V91, P1922, DOI 10.1093/jnci/91.22.1922; Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Chang CJ, 2008, MOL CELL BIOL, V28, P3281, DOI 10.1128/MCB.00310-08; Chung JH, 2005, CANCER RES, V65, P8096, DOI 10.1158/0008-5472.CAN-05-1888; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; Draviam VM, 2004, CURR OPIN GENET DEV, V14, P120, DOI 10.1016/j.gde.2004.02.007; Duijf PHG, 2013, ONCOGENE, V32, P4727, DOI 10.1038/onc.2012.616; Gollin SM, 2005, SEMIN CANCER BIOL, V15, P33, DOI 10.1016/j.semcancer.2004.09.004; Guigon CJ, 2009, ONCOGENE, V28, P509, DOI 10.1038/onc.2008.407; Haskell MD, 2001, J CELL SCI, V114, P1699; Hsu HL, 2007, DNA REPAIR, V6, P1319, DOI 10.1016/j.dnarep.2007.02.028; Hwang Melissa, 2012, Cancers (Basel), V4, P475, DOI 10.3390/cancers4020475; Janetopoulos C, 2005, DEV CELL, V8, P467, DOI 10.1016/j.devcel.2005.02.010; Kasiappan R, 2009, MOL CANCER RES, V7, P536, DOI 10.1158/1541-7786.MCR-08-0422; Kim J, 2012, ONCOGENE, V31, P322, DOI 10.1038/onc.2011.236; Lan KH, 2005, ANN NY ACAD SCI, V1059, P70, DOI 10.1196/annals.1339.026; Lu YL, 2003, J BIOL CHEM, V278, P40057, DOI 10.1074/jbc.M303621200; Lynch ED, 1997, AM J HUM GENET, V61, P1254, DOI 10.1086/301639; Manchinelly SAS, 2010, J BIOL CHEM, V285, P26923, DOI 10.1074/jbc.M110.103804; Muggerud AA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2466; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Papakonstanti EA, 2007, EMBO J, V26, P3050, DOI 10.1038/sj.emboj.7601763; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Radke J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056691; Regnier V, 2005, MOL CELL BIOL, V25, P3967, DOI 10.1128/MCB.25.10.3967-3981.2005; Ruggeri BA, 1998, MOL CARCINOGEN, V21, P81, DOI 10.1002/(SICI)1098-2744(199802)21:2<81::AID-MC1>3.0.CO;2-R; Sachdev P, 2002, J BIOL CHEM, V277, P17638, DOI 10.1074/jbc.M111575200; Salmena L, 2007, NAT REV CANCER, V7, P409, DOI 10.1038/nrc2145; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Shi B, 2003, BLOOD, V102, P297, DOI 10.1182/blood-2002-11-3486; Shih HJ, 2012, ONCOTARGET, V3, P1401; Shih HJ, 2012, CELL CYCLE, V11, P934, DOI 10.4161/cc.11.5.19452; Simpson L, 2001, EXP CELL RES, V264, P29, DOI 10.1006/excr.2000.5130; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Su L, 2003, J CELL BIOL, V163, P571, DOI 10.1083/jcb.200308007; Su L, 2009, EXP CELL RES, V315, P1347, DOI 10.1016/j.yexcr.2009.02.014; Tamura M, 1999, J BIOL CHEM, V274, P20693, DOI 10.1074/jbc.274.29.20693; Tokunaga Eriko, 2006, Breast Cancer, V13, P137, DOI 10.2325/jbcs.13.137; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Vicente-Duenas C, 2013, EMBO J, V32, P1502, DOI 10.1038/emboj.2013.97; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Yin Y, 2008, ONCOGENE, V27, P5443, DOI 10.1038/onc.2008.241; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	50	14	14	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 23	2014	33	43					5109	5120		10.1038/onc.2014.125	http://dx.doi.org/10.1038/onc.2014.125			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR7OF	24858043	hybrid, Green Published			2022-12-25	WOS:000343768400006
J	Barcomb, K; Buard, I; Coultrap, SJ; Kulbe, JR; O'Leary, H; Benke, TA; Bayer, KU				Barcomb, Kelsey; Buard, Isabelle; Coultrap, Steven J.; Kulbe, Jacqueline R.; O'Leary, Heather; Benke, Timothy A.; Bayer, K. Ulrich			Autonomous CaMKII requires further stimulation by Ca2+/calmodulin for enhancing synaptic strength	FASEB JOURNAL			English	Article						hippocampus; neuron; signal transduction	PROTEIN-KINASE-II; LONG-TERM POTENTIATION; INHIBITORY AUTOPHOSPHORYLATION; ALPHA-CAMKII; CALMODULIN; BINDING; CALCIUM/CALMODULIN; SUBUNIT; MECHANISM; ACTIVATION	A hallmark feature of Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) is generation of autonomous (Ca2+-independent) activity by T286 autophosphorylation. Biochemical studies have shown that "autonomous" CaMKII is similar to 5-fold further stimulated by Ca2+/CaM, but demonstration of a physiological function for such regulation within cells has remained elusive. In this study, CaMKII-induced enhancement of synaptic strength in rat hippocampal neurons required both autonomous activity and further stimulation. Synaptic strength was decreased by CaMKII alpha knockdown and rescued by reexpression, but not by mutants impaired for autonomy (T286A) or binding to NMDA-type glutamate receptor subunit 2B (GluN2B; formerly NR2B; I205K). Full rescue was seen with constitutively autonomous mutants (T286D), but only if they could be further stimulated (additional T305/306A mutation), and not with two other mutations that additionally impair Ca2+/CaM binding. Compared to rescue with wild-type CaMKII, the CaM-binding-impaired mutants even had reduced synaptic strength. One of these mutants (T305/306D) mimicked an inhibitory autophosphorylation of CaMKII, whereas the other one (Delta stim) abolished CaM binding without introducing charged residues. Inhibitory T305/306 autophosphorylation also reduced GluN2B binding, but this effect was independent of reduced Ca2+ /CaM binding and was not mimicked by T305/306D mutation. Thus, even autonomous CaMKII activity must be further stimulated by Ca2+ /CaM for enhancement of synaptic strength.-Barcomb, K., Buard, I., Coultrap, S. J., Kulbe, J. R., O'Leary, H., Benke, T. A., Bayer, K. U. Autonomous CaMKII requires further stimulation by Ca2+/calmodulin for enhancing synaptic strength.	[Barcomb, Kelsey; Buard, Isabelle; Coultrap, Steven J.; Kulbe, Jacqueline R.; O'Leary, Heather; Benke, Timothy A.; Bayer, K. Ulrich] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA; [O'Leary, Heather; Benke, Timothy A.] Univ Colorado, Sch Med, Dept Pediat, Neurol Sect, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Bayer, KU (corresponding author), Univ Colorado, Sch Med, Dept Pharmacol, Anschutz Med Campus,Mail Stop 8303,RC1 North, Aurora, CO 80045 USA.	ulli.bayer@ucdenver.edu		Barcomb, Kelsey/0000-0002-4050-0566; Benke, Timothy/0000-0002-6969-5061	U.S. National Institutes of Health [R01NS081248, R01NS076577, T32GM007635, P30NS04154]; Thorkildsen fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081248, R01NS076577, P30NS048154] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thorkildsen fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by U.S. National Institutes of Health grants R01NS081248 (to K. U. B), R01NS076577 (to T. B), T32GM007635 (to K. B. and H. O.), and P30NS04154 (to the University of Colorado Center) and by a Thorkildsen fellowship (to I.B.).	Barcomb K, 2013, MOL PHARMACOL, V84, P834, DOI 10.1124/mol.113.089045; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Buard I, 2010, J NEUROSCI, V30, P8214, DOI 10.1523/JNEUROSCI.1469-10.2010; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; COLBRAN RJ, 1993, J BIOL CHEM, V268, P7163; COLBRAN RJ, 1990, J BIOL CHEM, V265, P11213; Coultrap S.J., 2012, NEUROMETHODS PROTEIN, P49; Coultrap SJ, 2014, CELL REP, V6, P431, DOI 10.1016/j.celrep.2014.01.005; Coultrap SJ, 2012, TRENDS NEUROSCI, V35, P607, DOI 10.1016/j.tins.2012.05.003; Coultrap SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037176; Coultrap SJ, 2010, J BIOL CHEM, V285, P17930, DOI 10.1074/jbc.M109.069351; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; FONG YL, 1989, J BIOL CHEM, V264, P16759; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Griffith LC, 2004, J NEUROSCI, V24, P8394, DOI 10.1523/JNEUROSCI.3604-04.2004; Halt AR, 2012, EMBO J, V31, P1203, DOI 10.1038/emboj.2011.482; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HANSON PI, 1992, J BIOL CHEM, V267, P17216; Hoogenraad CC, 2007, DEV CELL, V12, P587, DOI 10.1016/j.devcel.2007.02.006; Jiao YX, 2011, J BIOL CHEM, V286, P24806, DOI 10.1074/jbc.M110.216010; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lengyel I, 2004, EUR J NEUROSCI, V20, P3063, DOI 10.1111/j.1460-9568.2004.03748.x; Leonard AS, 2002, J BIOL CHEM, V277, P48441, DOI 10.1074/jbc.M205164200; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; LOU LL, 1986, P NATL ACAD SCI USA, V83, P9497, DOI 10.1073/pnas.83.24.9497; Loweth JA, 2013, J NEUROSCI, V33, P1411, DOI 10.1523/JNEUROSCI.4386-13.2013; Marsden KC, 2010, P NATL ACAD SCI USA, V107, P20559, DOI 10.1073/pnas.1010346107; Merrill MA, 2005, TRENDS PHARMACOL SCI, V26, P645, DOI 10.1016/j.tips.2005.10.003; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; O'Leary H, 2006, MOL BIOL CELL, V17, P4656, DOI 10.1091/mbc.E06-03-0252; O'Leary H, 2011, J BIOL CHEM, V286, P31272, DOI 10.1074/jbc.M111.233668; Pi HJ, 2010, J NEUROSCI, V30, P8704, DOI 10.1523/JNEUROSCI.0133-10.2010; Rich RC, 1998, J BIOL CHEM, V273, P28424, DOI 10.1074/jbc.273.43.28424; Robertson HR, 2009, J NEUROSCI, V29, P7929, DOI 10.1523/JNEUROSCI.6093-08.2009; SCHWORER CM, 1986, J BIOL CHEM, V261, P8581; Steinmetz CC, 2006, J PHYSIOL-LONDON, V577, P249, DOI 10.1113/jphysiol.2006.117358; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Vest RS, 2010, J BIOL CHEM, V285, P20675, DOI 10.1074/jbc.M109.088617; WALDMANN R, 1990, BIOCHEMISTRY-US, V29, P1679, DOI 10.1021/bi00459a002	44	32	32	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2014	28	8					3810	3819		10.1096/fj.14-250407	http://dx.doi.org/10.1096/fj.14-250407			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN0HM	24843070	Green Published			2022-12-25	WOS:000340265400045
J	Gao, XQ; Usas, A; Proto, JD; Lu, AP; Cummins, JH; Proctor, A; Chen, CW; Huard, J				Gao, Xueqin; Usas, Arvydas; Proto, Jonathan D.; Lu, Aiping; Cummins, James H.; Proctor, Alexander; Chen, Chien-Wen; Huard, Johnny			Role of donor and host cells in muscle-derived stem cell-mediated bone repair: differentiation vs. paracrine effects	FASEB JOURNAL			English	Article						bone morphogenetic protein 4; inflammation; angiogenesis; monocyte chemotactic protein 1; cyclooxygenase 2	VIVO GENE-THERAPY; MONOCYTE CHEMOATTRACTANT PROTEIN-1; MESENCHYMAL STEM/STROMAL CELLS; SKELETAL-MUSCLE; REGENERATIVE MECHANISMS; MORPHOGENETIC PROTEIN-2; STEM/PROGENITOR CELLS; ENGINEERED BONE; ANGIOGENESIS; RECRUITMENT	Murine muscle-derived stem cells (MDSCs) have been shown capable of regenerating bone in a critical size calvarial defect model when transduced with BMP 2 or 4; however, the contribution of the donor cells and their interactions with the host cells during the bone healing process have not been fully elucidated. To address this question, C57/BL/6J mice were divided into MDSC/BMP4/GFP, MDSC/GFP, and scaffold groups. After transplanting MDSCs into the critical-size calvarial defects created in normal mice, we found that mice transplanted with BMP4GFP-transduced MDSCs healed the bone defect in 4 wk, while the control groups (MDSC-GFP and scaffold) demonstrated no bone healing. The newly formed trabecular bone displayed similar biomechanical properties as the native bone, and the donor cells directly participated in endochondral bone formation via their differentiation into chondrocytes, osteoblasts, and osteocytes via the BMP4-pSMAD5 and COX-2-PGE2 signaling pathways. In contrast to the scaffold group, the MDSC groups attracted more inflammatory cells initially and incurred faster inflammation resolution, enhanced angiogenesis, and suppressed initial immune responses in the host mice. MDSCs were shown to attract macrophages via the secretion of monocyte chemotactic protein 1 and promote endothelial cell proliferation by secreting multiple growth factors. Our findings indicated that BMP4GFP-transduced MDSCs not only regenerated bone by direct differentiation, but also positively influenced the host cells to coordinate and promote bone tissue repair through paracrine effects.-Gao, X., Usas, A., Proto, J. D., Lu, A., Cummins, J. H., Proctor, A., Chen, C.-W., Huard, J. Role of donor and host cells in muscle-derived stem cell-mediated bone repair: differentiation vs. paracrine effects.	[Gao, Xueqin; Usas, Arvydas; Proto, Jonathan D.; Lu, Aiping; Cummins, James H.; Chen, Chien-Wen; Huard, Johnny] Univ Pittsburgh, Dept Orthopaed Surg, Stem Cell Res Ctr, Pittsburgh, PA 15219 USA; [Proctor, Alexander] Act Life Sci, Santa Barbara, CA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Huard, J (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, Stem Cell Res Ctr, Bridgeside Point 2,450 Technol Dr, Pittsburgh, PA 15219 USA.	jhuard@pitt.edu		Gao, Xueqin/0000-0001-5833-1548; Chen, William CW/0000-0002-6891-3557	U.S. National Institutes of Health [5RO1-DE13420-09]; Henry J. Mankin endowed chair at the University of Pittsburgh; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013420] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Henry J. Mankin endowed chair at the University of Pittsburgh; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank Jessica C. Tebbets, Ying Tang, and Minakshi Poddar for their assistance in producing the retro-BMP4/GFP and retro-GFP viruses utilized in this study and Mathieu Huard for his assistance in paraffin sectioning. The authors also thank Allison Logar (Children's Hospital of Pittsburgh, Pittsburgh, PA, USA) for the FACS sorting of GFP-and BMP4GFP-transduced MDSCs. The authors also thank Dr. Burhan Gharaibeh for assistance in formatting the references and Bria King and Adam Kozemchak for their editorial assistance. This project was supported, in part, by a U.S. National Institutes of Health grant (5RO1-DE13420-09) awarded to J. H. and the Henry J. Mankin endowed chair at the University of Pittsburgh. J. H. receives remuneration as a consultant and royalties from Cook MyoSite, Inc. (Pittsburgh, PA, USA). The other authors declare no conflicts of interest. The experiments performed for this study comply with the current laws of the United States of America.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Akiyama H., 2002, GENE DEV, V16, P2183; Alhag M, 2011, ORAL MAXILLOFAC SURG, V15, P31, DOI 10.1007/s10006-010-0241-x; Ando Y, 2014, BONE, V61, P82, DOI 10.1016/j.bone.2013.12.029; Behr B, 2011, STEM CELLS, V29, P286, DOI 10.1002/stem.581; Ben-Mordechai T, 2013, J AM COLL CARDIOL, V62, P1890, DOI 10.1016/j.jacc.2013.07.057; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Duran JM, 2013, CIRC RES, V113, P539, DOI 10.1161/CIRCRESAHA.113.301202; Gao XQ, 2013, CELL TRANSPLANT, V22, P2393, DOI 10.3727/096368912X658854; Gehmert S, 2011, CLIN HEMORHEOL MICRO, V48, P5, DOI 10.3233/CH-2011-1397; Gharaibeh B, 2008, NAT PROTOC, V3, P1501, DOI 10.1038/nprot.2008.142; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Hsiao STF, 2012, STEM CELLS DEV, V21, P2189, DOI 10.1089/scd.2011.0674; Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08; Lau KHW, 2013, BONE, V53, P369, DOI 10.1016/j.bone.2013.01.003; Lee JY, 2002, HUM GENE THER, V13, P1201, DOI 10.1089/104303402320138989; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Mastrogiacomo M, 2005, J CELL PHYSIOL, V204, P594, DOI 10.1002/jcp.20325; Misener S., 2000, BIOINFORMATICS METHO; Murnaghan M, 2006, J BONE JOINT SURG AM, V88A, P140, DOI 10.2106/JBJS.F.00454; Musgrave DS, 2002, J BONE JOINT SURG BR, V84B, P120, DOI 10.1302/0301-620X.84B1.11708; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Peng HR, 2005, J BONE MINER RES, V20, P2017, DOI 10.1359/JBMR.050708; Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153; Posner LJ, 1997, BONE, V21, P321, DOI 10.1016/S8756-3282(97)00154-3; Prockop DJ, 2013, STEM CELLS, V31, P2042, DOI 10.1002/stem.1400; Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211; Qu D, 2011, J BIOMED MATER RES A, V96A, P543, DOI 10.1002/jbm.a.33009; Roddy GW, 2011, STEM CELLS, V29, P1572, DOI 10.1002/stem.708; Sanberg PR, 2010, J CELL MOL MED, V14, P553, DOI 10.1111/j.1582-4934.2009.00903.x; Shen HC, 2004, BONE, V34, P982, DOI 10.1016/j.bone.2004.01.028; Simon AM, 2002, J BONE MINER RES, V17, P963, DOI 10.1359/jbmr.2002.17.6.963; Stich S, 2008, EUR J CELL BIOL, V87, P365, DOI 10.1016/j.ejcb.2008.03.009; Tamasi JA, 2013, J BONE MINER RES, V28, P1975, DOI 10.1002/jbmr.1933; Tasso R, 2012, BIOMATERIALS, V33, P2086, DOI 10.1016/j.biomaterials.2011.11.043; Tasso R, 2010, BIOMATERIALS, V31, P2121, DOI 10.1016/j.biomaterials.2009.11.064; Tasso R, 2009, TISSUE ENG PT A, V15, P2203, DOI 10.1089/ten.tea.2008.0269; Tatebe M, 2005, CYTOTHERAPY, V7, P520, DOI 10.1080/14653240500361350; Tortelli F, 2010, BIOMATERIALS, V31, P242, DOI 10.1016/j.biomaterials.2009.09.038; Turner NJ, 2013, J TISSUE ENG REGEN M, V7, P139, DOI 10.1002/term.508; Usas A, 2009, TISSUE ENG PT A, V15, P285, DOI 10.1089/ten.tea.2008.0130; Wright VJ, 2002, MOL THER, V6, P169, DOI 10.1006/mthe.2002.0654; Xie C, 2009, AM J PATHOL, V175, P772, DOI 10.2353/ajpath.2009.081099; Zhang XP, 2002, J CLIN INVEST, V109, P1405, DOI 10.1172/JCI200215681; Zou DH, 2011, STEM CELLS, V29, P1380, DOI 10.1002/stem.693	47	37	38	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2014	28	8					3792	3809		10.1096/fj.13-247965	http://dx.doi.org/10.1096/fj.13-247965			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN0HM	24843069	Green Published			2022-12-25	WOS:000340265400044
J	Tho, NV; Trang, LTH; Murakami, Y; Ogawa, E; Ryujin, Y; Kanda, R; Nakagawa, H; Goto, K; Fukunaga, K; Higami, Y; Seto, R; Nagao, T; Oguma, T; Yamaguchi, M; Lan, LTT; Nakano, Y				Nguyen Van Tho; Le Thi Huyen Trang; Murakami, Yoshitaka; Ogawa, Emiko; Ryujin, Yasushi; Kanda, Rie; Nakagawa, Hiroaki; Goto, Kenichi; Fukunaga, Kentaro; Higami, Yuichi; Seto, Ruriko; Nagao, Taishi; Oguma, Tetsuya; Yamaguchi, Masafumi; Le Thi Tuyet Lan; Nakano, Yasutaka			Airway Wall Area Derived from 3-Dimensional Computed Tomography Analysis Differs among Lung Lobes in Male Smokers	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; THIN-SECTION CT; REFERENCE VALUES; CHEST CT; EMPHYSEMA; COPD; DIMENSIONS; SEGMENTATION; THICKNESS; ATTENUATION	Background: It is time-consuming to obtain the square root of airway wall area of the hypothetical airway with an internal perimeter of 10 mm (root Aaw at Pi10), a comparable index of airway dimensions in chronic obstructive pulmonary disease (COPD), from all airways of the whole lungs using 3-dimensional computed tomography (CT) analysis. We hypothesized that root Aaw at Pi10 differs among the five lung lobes and root Aaw at Pi10 derived from one certain lung lobe has a high level of agreement with that derived from the whole lungs in smokers. Methods: Pulmonary function tests and chest volumetric CTs were performed in 157 male smokers (102 COPD, 55 non-COPD). All visible bronchial segments from the 3rd to 5th generations were segmented and measured using commercially available 3-dimensional CT analysis software. root Aaw at Pi10 of each lung lobe was estimated from all measurable bronchial segments of that lobe. Results: Using a mixed-effects model, root Aaw at Pi10 differed significantly among the five lung lobes (R-2 = 0.78, P<0.0001). The Bland-Altman plots show that root Aaw at Pi10 derived from the right or left upper lobe had a high level of agreement with that derived from the whole lungs, while root Aaw at Pi10 derived from the right or left lower lobe did not. Conclusion: In male smokers, CT-derived airway wall area differs among the five lung lobes, and airway wall area derived from the right or left upper lobe is representative of the whole lungs.	[Nguyen Van Tho; Ogawa, Emiko; Ryujin, Yasushi; Kanda, Rie; Nakagawa, Hiroaki; Goto, Kenichi; Fukunaga, Kentaro; Higami, Yuichi; Seto, Ruriko; Nagao, Taishi; Oguma, Tetsuya; Yamaguchi, Masafumi; Nakano, Yasutaka] Shiga Univ Med Sci, Div Resp Med, Dept Med, Shiga, Japan; [Murakami, Yoshitaka] Shiga Univ Med Sci, Dept Med Stat, Shiga, Japan; [Ogawa, Emiko] Shiga Univ Med Sci, Hlth Adm Ctr, Shiga, Japan; [Nguyen Van Tho; Le Thi Huyen Trang; Le Thi Tuyet Lan] Univ Med Ctr, Resp Care Ctr, Ho Chi Minh City, Vietnam	Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science	Nakano, Y (corresponding author), Shiga Univ Med Sci, Div Resp Med, Dept Med, Shiga, Japan.	nakano@belle.shiga-med.ac.jp		Fukunaga, Kentaro/0000-0002-6261-0344; Tho, Nguyen Van/0000-0003-4004-9872; Nguyen, Tho/0000-0002-0198-6284	Japan Society for the Promotion of Science KAKENHI [24390174]; Ministry of Health, Labour and Welfare, Japan	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was partly supported by the Japan Society for the Promotion of Science KAKENHI Grant No. 24390174 and a grant to the Respiratory Failure Research Group from the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T, 2008, EUR RADIOL, V18, P2731, DOI 10.1007/s00330-008-1089-4; Aysola RS, 2008, CHEST, V134, P1183, DOI 10.1378/chest.07-2779; Bland JM, 1996, BRIT MED J, V313, P41, DOI 10.1136/bmj.313.7048.41; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Diaz AA, 2010, CHEST, V138, P880, DOI 10.1378/chest.10-0542; Gietema HA, 2011, ACAD RADIOL, V18, P661, DOI 10.1016/j.acra.2011.01.011; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011, GLOB STRAT DIAGN MAN; Grydeland TB, 2009, EUR RESPIR J, V34, P858, DOI 10.1183/09031936.00167908; Grydeland TB, 2010, AM J RESP CRIT CARE, V181, P353, DOI 10.1164/rccm.200907-1008OC; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hankinson JL, 2010, CHEST, V137, P138, DOI 10.1378/chest.09-0919; Hasegawa M, 2006, AM J RESP CRIT CARE, V173, P1309, DOI 10.1164/rccm.200601-037OC; Hu SY, 2001, IEEE T MED IMAGING, V20, P490, DOI 10.1109/42.929615; Kim V, 2011, CHEST, V140, P626, DOI 10.1378/chest.10-2948; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Montaudon M, 2007, RADIOLOGY, V242, P563, DOI 10.1148/radiol.2422060029; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102, DOI 10.1164/ajrccm.162.3.9907120; Nakano Y, 2005, AM J RESP CRIT CARE, V171, P142, DOI 10.1164/rccm.200407-874OC; Nakano Y, 1999, THORAX, V54, P384, DOI 10.1136/thx.54.5.384; Ohara T, 2006, RESPIROLOGY, V11, P579, DOI 10.1111/j.1440-1843.2006.00899.x; Orlandi I, 2005, RADIOLOGY, V234, P604, DOI 10.1148/radiol.2342040013; Patel BD, 2008, AM J RESP CRIT CARE, V178, P500, DOI 10.1164/rccm.200801-059OC; Shimizu K, 2011, RESP MED, V105, P1275, DOI 10.1016/j.rmed.2011.04.007; Tho NV, 2013, AM J RESP CRIT CARE, V187; THO NV, 2012, AM J RESP CRIT CARE, V185, pA4338; Tschirren J, 2005, IEEE T MED IMAGING, V24, P1529, DOI 10.1109/TMI.2005.857654; Tschirren J, 2005, IEEE T MED IMAGING, V24, P1540, DOI 10.1109/TMI.2005.857653; Vestbo J, 2008, EUR RESPIR J, V31, P869, DOI 10.1183/09031936.00111707; Xu Z., 2013, P MICCAI, V8150, P559; Zhang L, 2006, IEEE T MED IMAGING, V25, P1, DOI 10.1109/TMI.2005.859209	30	10	10	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98335	10.1371/journal.pone.0098335	http://dx.doi.org/10.1371/journal.pone.0098335			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865661	Green Published, gold, Green Submitted			2022-12-25	WOS:000336914100051
J	Huang, L; Kondo, F; Gosho, M; Feng, GG; Harato, M; Xia, ZY; Ishikawa, N; Fujiwara, Y; Okada, S				Huang, Lei; Kondo, Fumio; Gosho, Masahiko; Feng, Guo-Gang; Harato, Misako; Xia, Zhong-yuan; Ishikawa, Naohisa; Fujiwara, Yoshihiro; Okada, Shoshiro			Enhanced Expression of WD Repeat-Containing Protein 35 via CaMKK/AMPK Activation in Bupivacaine-Treated Neuro2a Cells (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							KINASE-KINASE-BETA; P38 MAPK; APOPTOSIS	We previously reported that bupivacaine induces reactive oxygen species (ROS) generation, p38 mitogen-activated protein kinase (MAPK) activation and nuclear factor-kappa B activation, resulting in an increase in expression of WD repeatcontaining protein 35 (WDR35) in mouse neuroblastoma Neuro2a cells. However, the identity of signaling upstream of p38 MAPK pathways to WDR35 expression remains unclear. It has been shown that AMP-activated protein kinase (AMPK) can activate p38 MAPK through diverse mechanisms. In addition, several kinases acting upstream of AMPK have been identified including Ca2+/calmodulin-dependent protein kinase kinase (CaMKK). Recent studies reported that AMPK may be involved in bupivacaine-induced cytotoxicity in Schwann cells and in human neuroblastoma SH-SY5Y cells. The present study was undertaken to test whether CaMKK and AMPK are involved in bupivacaine-induced WDR35 expression in Neuro2a cells. Our results showed that bupivacaine induced activation of AMPK and p38 MAPK in Neuro2a cells. The AMPK inhibitors, compound C and iodotubercidin, attenuated the bupivacaine-induced activation of AMPK and p38 MAPK, resulting in an inhibition of the bupivacaine-induced increase in WDR35 expression. Treatment with the CaMKK inhibitor STO-609 also attenuated the bupivacaine-induced activation of AMPK and p38 MAPK, resulting in an inhibition of the bupivacaine-induced increase in WDR35 expression. These results suggest that bupivacaine activates AMPK and p38 MAPK via CaMKK in Neuro2a cells, and that the CaMKK/AMPK/p38 MAPK pathway is involved in regulating WDR35 expression.	[Huang, Lei; Kondo, Fumio; Feng, Guo-Gang; Ishikawa, Naohisa; Okada, Shoshiro] Aichi Med Univ, Sch Med, Dept Pharmacol, Nagakute, Aichi 48011, Japan; [Gosho, Masahiko] Aichi Med Univ, Adv Med Res Ctr, Nagakute, Aichi 48011, Japan; [Harato, Misako; Fujiwara, Yoshihiro] Aichi Med Univ, Sch Med, Dept Anesthesiol, Nagakute, Aichi 48011, Japan; [Huang, Lei; Xia, Zhong-yuan] Wuhan Univ, Renmin Hosp, Dept Anesthesiol, Wuhan, Hubei, Peoples R China	Aichi Medical University; Aichi Medical University; Aichi Medical University; Wuhan University	Huang, L (corresponding author), Aichi Med Univ, Sch Med, Dept Pharmacol, Nagakute, Aichi 48011, Japan.	honey326@qq.com		xia, zhongyuan/0000-0002-5807-9554	Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan [S1101027];  [23790885]; Grants-in-Aid for Scientific Research [23592689] Funding Source: KAKEN	Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research (No. 23790885) and by a Strategic Research Foundation Grant-aided Project for Private Universities grant (S1101027) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato S, 2011, CELL CYCLE, V10, P3452, DOI 10.4161/cc.10.20.17953; Bacino CA, 2012, AM J MED GENET A, V158A, P2917, DOI 10.1002/ajmg.a.35608; Bae CH, 2011, BIOCHEM BIOPH RES CO, V409, P669, DOI 10.1016/j.bbrc.2011.05.062; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Berisha SZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016729; Cai ZY, 2012, NEUROMOL MED, V14, P1, DOI 10.1007/s12017-012-8173-2; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Carling D, 2012, BIOCHEM J, V445, P11, DOI 10.1042/BJ20120546; Fan JH, 2012, HEPATOL RES, V42, P696, DOI 10.1111/j.1872-034X.2012.00972.x; Feng GG, 2010, BIOCHEM BIOPH RES CO, V394, P153, DOI 10.1016/j.bbrc.2010.02.133; Gruzman Arie, 2009, Rev Diabet Stud, V6, P13, DOI 10.1900/RDS.2009.6.13; Harato M, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-149; Huang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086336; Karniel M, 2000, MOL GENET METAB, V69, P40, DOI 10.1006/mgme.1999.2954; Kim SH, 2013, BIOCHEM BIOPH RES CO, V439, P66, DOI 10.1016/j.bbrc.2013.08.027; Kondo A, 2012, INT J MOL MED, V30, P1487, DOI 10.3892/ijmm.2012.1159; Lee SJ, 2010, J DENT RES, V89, P797, DOI 10.1177/0022034510366823; Lirk P, 2008, ANESTH ANALG, V106, P1456, DOI 10.1213/ane.0b013e318168514b; Lu J, 2011, EUR J PHARMACOL, V657, P51, DOI 10.1016/j.ejphar.2011.01.055; Lu J, 2011, PHARMACOLOGY, V87, P121, DOI 10.1159/000323402; Lu XF, 2012, NAT GENET, V44, P890, DOI 10.1038/ng.2337; Nakamura Y, 2001, NEUROSCI RES, V39, P175, DOI 10.1016/S0168-0102(00)00209-1; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Nordlund J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034513; Park CJ, 2005, J DENT RES, V84, P852, DOI 10.1177/154405910508400914; Pfisterer SG, 2011, MOL PHARMACOL, V80, P1066, DOI 10.1124/mol.111.071761; Racioppi L, 2012, J BIOL CHEM, V287, P31658, DOI 10.1074/jbc.R112.356485; Salminen A, 2011, J NEUROCHEM, V118, P460, DOI 10.1111/j.1471-4159.2011.07331.x; Sato Y, 2010, CLIN EXP NEPHROL, V14, P205, DOI 10.1007/s10157-010-0276-1; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Tsunekawa K, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-4; Vinet J, 2003, MOL BRAIN RES, V111, P216, DOI 10.1016/S0169-328X(02)00698-8; Weisova P, 2011, ANTIOXID REDOX SIGN, V14, P1863, DOI 10.1089/ars.2010.3544; Wen XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062942	34	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98185	10.1371/journal.pone.0098185	http://dx.doi.org/10.1371/journal.pone.0098185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859235	Green Published, Green Submitted, gold			2022-12-25	WOS:000336839400051
J	Kobori, M; Ni, YH; Takahashi, Y; Watanabe, N; Sugiura, M; Ogawa, K; Nagashimada, M; Kaneko, S; Naito, S; Ota, T				Kobori, Masuko; Ni, Yinhua; Takahashi, Yumiko; Watanabe, Natsumi; Sugiura, Minoru; Ogawa, Kazunori; Nagashimada, Mayumi; Kaneko, Shuichi; Naito, Shigehiro; Ota, Tsuguhito			beta-Cryptoxanthin Alleviates Diet-Induced Nonalcoholic Steatohepatitis by Suppressing Inflammatory Gene Expression in Mice	PLOS ONE			English	Article							FATTY LIVER-DISEASE; INSULIN-RESISTANCE; SERUM CAROTENOIDS; OXIDATIVE STRESS; CELLS; MODEL; ACTIVATION; DAMAGE; CONSUMPTION; FIBROSIS	Recent nutritional epidemiological surveys showed that serum beta-cryptoxanthin inversely associates with the risks for insulin resistance and liver dysfunction. Consumption of beta-cryptoxanthin possibly prevents nonalcoholic steatohepatitis (NASH), which is suggested to be caused by insulin resistance and oxidative stress from nonalcoholic fatty liver disease. To evaluate the effect of beta-cryptoxanthin on diet-induced NASH, we fed a high-cholesterol and high-fat diet (CL diet) with or without 0.003% beta-cryptoxanthin to C56BL/6J mice for 12 weeks. After feeding, beta-cryptoxanthin attenuated fat accumulation, increases in Kupffer and activated stellate cells, and fibrosis in CL diet-induced NASH in the mice. Comprehensive gene expression analysis showed that although beta-cryptoxanthin histochemically reduced steatosis, it was more effective in inhibiting inflammatory gene expression change in NASH. beta-Cryptoxanthin reduced the alteration of expression of genes associated with cell death, inflammatory responses, infiltration and activation of macrophages and other leukocytes, quantity of T cells, and free radical scavenging. However, it showed little effect on the expression of genes related to cholesterol and other lipid metabolism. The expression of markers of M1 and M2 macrophages, T helper cells, and cytotoxic T cells was significantly induced in NASH and reduced by beta-cryptoxanthin. beta-Cryptoxanthin suppressed the expression of lipopolysaccharide (LPS)-inducible and/or TNF alpha-inducible genes in NASH. Increased levels of the oxidative stress marker thiobarbituric acid reactive substances (TBARS) were reduced by beta-cryptoxanthin in NASH. Thus, beta-cryptoxanthin suppresses inflammation and the resulting fibrosis probably by primarily suppressing the increase and activation of macrophages and other immune cells. Reducing oxidative stress is likely to be a major mechanism of inflammation and injury suppression in the livers of mice with NASH.	[Kobori, Masuko; Takahashi, Yumiko; Watanabe, Natsumi; Naito, Shigehiro] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki, Japan; [Ni, Yinhua; Nagashimada, Mayumi; Ota, Tsuguhito] Kanazawa Univ, Brain Liver Interface Med Res Ctr, Dept Cell Metab & Nutr, Kanazawa, Ishikawa, Japan; [Ni, Yinhua; Kaneko, Shuichi; Ota, Tsuguhito] Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa, Japan; [Sugiura, Minoru] Natl Agr & Food Res Org, Citrus Res Div, NARO Inst Fruit Tree Sci, Shimizu, Shizuoka, Japan; [Ogawa, Kazunori] Natl Agr & Food Res Org, Grape & Persimmon Res Div, NARO Inst Fruit Tree Sci, Higashihiroshima, Hiroshima, Japan	National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; Kanazawa University; Kanazawa University; National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan	Kobori, M (corresponding author), Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki, Japan.	kobori@affrc.go.jp	Yinhua, Ni/H-3079-2015	Yinhua, Ni/0000-0001-7738-5971	Ministry of Agriculture, Forestry and Fisheries; Kao Research Council for the Study of Healthcare Science; Japan Research Foundation for Clinical Pharmacology	Ministry of Agriculture, Forestry and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan); Kao Research Council for the Study of Healthcare Science; Japan Research Foundation for Clinical Pharmacology	Funding was provided by "New developmental project for practical technologies to promote policies for agriculture, forestry, and fisheries" (the Ministry of Agriculture, Forestry and Fisheries), Kao Research Council for the Study of Healthcare Science (T.O.), and Japan Research Foundation for Clinical Pharmacology (T.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basaranoglu M, 2013, WORLD J GASTROENTERO, V19, P1158, DOI 10.3748/wjg.v19.i8.1158; Bertola A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013577; Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Erkan M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-88; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Festing MFW, 2006, ILAR J, V47, P5, DOI 10.1093/ilar.47.1.5; FOLCH J, 1957, J BIOL CHEM, V226, P497; Haegele AD, 2000, CANCER EPIDEM BIOMAR, V9, P421; Ignatova ID, 2013, MOL ENDOCRINOL, V27, P1036, DOI 10.1210/me.2013-1051; Kitade H, 2012, DIABETES, V61, P1680, DOI 10.2337/db11-1506; Kobori M, 2008, J AGR FOOD CHEM, V56, P4004, DOI 10.1021/jf800052y; Kumashiro N, 2008, DIABETES, V57, P2083, DOI 10.2337/db08-0144; Labenski H, 2011, EUR J HUM GENET, V19, P1281, DOI 10.1038/ejhg.2011.129; Lorenzo Y, 2009, CARCINOGENESIS, V30, P308, DOI 10.1093/carcin/bgn270; Maher JJ, 2008, HEPATOLOGY, V48, P670, DOI 10.1002/hep.22399; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874; Nagai K, 2009, BRIT J PHARMACOL, V158, P907, DOI 10.1111/j.1476-5381.2009.00365.x; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Niwa M, 2009, BIOL PHARM BULL, V32, P203, DOI 10.1248/bpb.32.203; Ogawa K, 2013, J JPN SOC FOOD SCI, V60, P498; Oike H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023709; Ota T, 2007, GASTROENTEROLOGY, V132, P282, DOI 10.1053/j.gastro.2006.10.014; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Sekiya M, 2008, BIOCHEM BIOPH RES CO, V375, P602, DOI 10.1016/j.bbrc.2008.08.068; Sugiura M, 2006, J EPIDEMIOL, V16, P71, DOI 10.2188/jea.16.71; Sugiura M, 2005, J EPIDEMIOL, V15, P180, DOI 10.2188/jea.15.180; Sugiura M, 2004, J NUTR SCI VITAMINOL, V50, P196, DOI 10.3177/jnsv.50.196; Sugiura M, 2002, J HEALTH SCI, V48, P350, DOI 10.1248/jhs.48.350; Sugiura M, 2013, BIOL PHARM BULL, V36, P147, DOI 10.1248/bpb.b12-00836; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Tosello-Trampont AC, 2012, J BIOL CHEM, V287, P40161, DOI 10.1074/jbc.M112.417014; Tucker KL, 1999, J NUTR, V129, P438, DOI 10.1093/jn/129.2.438; Unno K, 2011, BIOL PHARM BULL, V34, P311, DOI 10.1248/bpb.34.311; van Kappel AL, 2001, PUBLIC HEALTH NUTR, V4, P829, DOI 10.1079/PHN2000115; Wan J., 2013, HEPATOLOGY; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Westfall PH, 2011, P MULTTEST MULT COMP, P406; Zar JH, 1999, UNDERLYING ASSUMPTIO, P185; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783	42	48	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98294	10.1371/journal.pone.0098294	http://dx.doi.org/10.1371/journal.pone.0098294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858832	Green Published, gold, Green Submitted			2022-12-25	WOS:000336839400063
J	Li, C; Sun, DX; Zhang, SL; Wang, S; Wu, XP; Zhang, Q; Liu, L; Li, YH; Qiao, L				Li, Cong; Sun, Dongxiao; Zhang, Shengli; Wang, Sheng; Wu, Xiaoping; Zhang, Qin; Liu, Lin; Li, Yanhua; Qiao, Lv			Genome Wide Association Study Identifies 20 Novel Promising Genes Associated with Milk Fatty Acid Traits in Chinese Holstein	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; PPAR-ALPHA; CARBOXYPEPTIDASE-M; SIGNALING PATHWAY; FERTILITY TRAITS; MAMMARY-GLAND; IKK-ALPHA; COA; POLYMORPHISM; LACTATION	Detecting genes associated with milk fat composition could provide valuable insights into the complex genetic networks of genes underling variation in fatty acids synthesis and point towards opportunities for changing milk fat composition via selective breeding. In this study, we conducted a genome-wide association study (GWAS) for 22 milk fatty acids in 784 Chinese Holstein cows with the PLINK software. Genotypes were obtained with the Illumina BovineSNP50 Bead chip and a total of 40,604 informative, high-quality single nucleotide polymorphisms (SNPs) were used. Totally, 83 genome-wide significant SNPs and 314 suggestive significant SNPs associated with 18 milk fatty acid traits were detected. Chromosome regions that affect milk fatty acid traits were mainly observed on BTA1, 2, 5, 6, 7, 9, 13, 14, 18, 19, 20, 21, 23, 26 and 27. Of these, 146 SNPs were associated with more than one milk fatty acid trait; most of studied fatty acid traits were significant associated with multiple SNPs, especially C18:0 (105 SNPs), C18 index (93 SNPs), and C14 index (84 SNPs); Several SNPs are close to or within the DGAT1, SCD1 and FASN genes which are well-known to affect milk composition traits of dairy cattle. Combined with the previously reported QTL regions and the biological functions of the genes, 20 novel promising candidates for C10:0, C12:0, C14:0, C14:1, C14 index, C18:0, C18:1n9c, C18 index, SFA, UFA and SFA/UFA were found, which composed of HTR1B, CPM, PRKG1, MINPP1, LIPJ, LIPK, EHHADH, MOGAT1, ECHS1, STAT1, SORBS1, NFKB2, AGPAT3, CHUK, OSBPL8, PRLR, IGF1R, ACSL3, GHR and OXCT1. Our findings provide a groundwork for unraveling the key genes and causal mutations affecting milk fatty acid traits in dairy cattle.	[Li, Cong; Sun, Dongxiao; Zhang, Shengli; Wang, Sheng; Wu, Xiaoping; Zhang, Qin] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Key Lab Anim Genet & Breeding,Minist Agr, Beijing 100094, Peoples R China; [Liu, Lin; Li, Yanhua; Qiao, Lv] Beijing Dairy Cattle Ctr, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Sun, DX (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Key Lab Anim Genet & Breeding,Minist Agr, Beijing 100094, Peoples R China.	sundx@cau.edu.cn	Wang, Sheng/G-5321-2019; Wang, Sheng/M-2681-2019	Wang, Sheng/0000-0003-2611-3559; Wang, Sheng/0000-0003-2611-3559; Li, Cong/0000-0003-2588-4781	High Technology Research and Development Program of China [2013AA102504]; National Key Technologies R D Program [2011BAD28B02, 2012BAD12B01]; Beijing Dairy Industry Innovation Team; 948 Program [2011-G2A]; Beijing Research and Technology program [D121100003312001]; Program for Changjiang Scholar and Innovation Research Team in University [IRT1191]	High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Key Technologies R D Program(National Key Technology R&D Program); Beijing Dairy Industry Innovation Team; 948 Program(Ministry of Agriculture & Rural Affairs); Beijing Research and Technology program; Program for Changjiang Scholar and Innovation Research Team in University	This work was supported by the High Technology Research and Development Program of China (2013AA102504), National Key Technologies R & D Program (2011BAD28B02, 2012BAD12B01), Beijing Dairy Industry Innovation Team, 948 Program (2011-G2A), Beijing Research and Technology program (D121100003312001), and Program for Changjiang Scholar and Innovation Research Team in University (IRT1191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 2009, GENETICA, V136, P341, DOI 10.1007/s10709-008-9312-4; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Belury MA, 2002, ANNU REV NUTR, V22, P505, DOI 10.1146/annurev.nutr.22.021302.121842; Bionaz M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-366; Blott S, 2003, GENETICS, V163, P253; Bobe G, 2008, J DAIRY SCI, V91, P1209, DOI 10.3168/jds.2007-0252; Bonakdar E, 2010, GENET MOL RES, V9, P1726, DOI 10.4238/vol9-3gmr874; Bouwknecht JA, 2001, BIOL PSYCHIAT, V49, P557, DOI 10.1016/S0006-3223(00)01018-0; Bouwman AC, 2012, BMC GENET, V13, P1, DOI 10.1186/1471-2156-13-93; Bouwman AC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-43; Brym Pawel, 2005, Journal of Applied Genetics, V46, P179; Cao JS, 2006, P NATL ACAD SCI USA, V103, P19695, DOI 10.1073/pnas.0609140103; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Cho J, 2008, P NATL ACAD SCI USA, V105, P5998, DOI 10.1073/pnas.0710980105; Cobanoglu O, 2006, J DAIRY SCI, V89, P4433, DOI 10.3168/jds.S0022-0302(06)72491-2; Cole JB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-408; Conte G, 2010, J DAIRY SCI, V93, P753, DOI 10.3168/jds.2009-2581; Cronan JE, 2002, PROG LIPID RES, V41, P407, DOI 10.1016/S0163-7827(02)00007-3; Denis CJ, 2013, CLIN CHIM ACTA, V415, P306, DOI 10.1016/j.cca.2012.11.012; Garnsworthy PC, 2006, J DAIRY SCI, V89, P1604, DOI 10.3168/jds.S0022-0302(06)72227-5; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Haas B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000511; Han B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000456; Harvatine KJ, 2006, J NUTR, V136, P2468, DOI 10.1093/jn/136.10.2468; Hayes KC, 2002, ASIA PAC J CLIN NUTR, V11, pS394, DOI 10.1046/j.1440-6047.11.s.7.13.x; Houten SM, 2012, J LIPID RES, V53, P1296, DOI 10.1194/jlr.M024463; Imanishi T, 2002, CIRC J, V66, P1060, DOI 10.1253/circj.66.1060; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Jiang SZ, 2012, BIOTECHNOL LETT, V34, P1991, DOI 10.1007/s10529-012-1009-1; Kay JK, 2005, J DAIRY SCI, V88, P3886, DOI 10.3168/jds.S0022-0302(05)73074-5; Kelsey JA, 2003, J DAIRY SCI, V86, P2588, DOI 10.3168/jds.S0022-0302(03)73854-5; Kirkpatrick BW, 2010, ANIM GENET; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Li QS, 2013, NAT MED, V19, P722, DOI 10.1038/nm.3190; Lu B, 2005, BIOCHEM J, V385, P469, DOI 10.1042/BJ20041348; Mele M, 2007, J DAIRY SCI, V90, P4458, DOI 10.3168/jds.2006-617; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Mitschke MM, 2013, FASEB J, V27, P1621, DOI 10.1096/fj.12-221580; Moioli B, 2007, J DAIRY SCI, V90, P3553, DOI 10.3168/jds.2006-855; Morris CA, 2007, MAMM GENOME, V18, P64, DOI 10.1007/s00335-006-0102-y; Munoz G, 2003, ANIM GENET, V34, P234, DOI 10.1046/j.1365-2052.2003.00987.x; Murdoch BM, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-20; Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0; Poppelreuther M, 2012, J LIPID RES, V53, P888, DOI 10.1194/jlr.M024562; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi C, 1999, J BIOL CHEM, V274, P15775, DOI 10.1074/jbc.274.22.15775; Rasmussen BM, 2006, AM J CLIN NUTR, V83, P221; Rincon G, 2012, J DAIRY RES, V79, P66, DOI 10.1017/S002202991100080X; Rodriguez-Cruz M, 2006, J LIPID RES, V47, P553, DOI 10.1194/jlr.M500407-JLR200; Sahana G, 2010, ANIM GENET, V41, P579, DOI 10.1111/j.1365-2052.2010.02064.x; Schennink A, 2008, J DAIRY SCI, V91, P2135, DOI 10.3168/jds.2007-0825; Schennink A, 2009, ANIM GENET, V40, P909, DOI 10.1111/j.1365-2052.2009.01940.x; Schennink A, 2009, J DAIRY SCI, V92, P4676, DOI 10.3168/jds.2008-1965; Schopen GCB, 2011, J DAIRY SCI, V94, P3148, DOI 10.3168/jds.2010-4030; Schulman NF, 2011, ANIM GENET, V42, P263, DOI 10.1111/j.1365-2052.2010.02149.x; Solt LA, 2009, J BIOL CHEM, V284, P27596, DOI 10.1074/jbc.M109.047563; Soyeurt H, 2007, J DAIRY SCI, V90, P4435, DOI 10.3168/jds.2007-0054; Stoop WM, 2008, J DAIRY SCI, V91, P385, DOI 10.3168/jds.2007-0181; Stoop WM, 2009, J DAIRY SCI, V92, P4664, DOI 10.3168/jds.2008-1966; Takahashi M, 2007, ANTIVIR RES, V75, P152, DOI 10.1016/j.antiviral.2007.02.002; Toulza E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r107; Tsakiris I, 2012, LAB INVEST, V92, P345, DOI 10.1038/labinvest.2011.168; Van Horn CG, 2005, BIOCHEMISTRY-US, V44, P1635, DOI 10.1021/bi047721l; Wolfgang MJ, 2006, J BIOL CHEM, V281, P37265, DOI 10.1074/jbc.R600016200; Yan D, 2008, J BIOL CHEM, V283, P332, DOI 10.1074/jbc.M705313200; Yang WS, 2003, OBES RES, V11, P586, DOI 10.1038/oby.2003.82; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899; Zhang CL, 2008, RES VET SCI, V85, P265, DOI 10.1016/j.rvsc.2007.10.014; Zhou TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021078	72	50	55	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e96186	10.1371/journal.pone.0096186	http://dx.doi.org/10.1371/journal.pone.0096186			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858810	Green Submitted, Green Published, gold			2022-12-25	WOS:000336839400002
J	Miller, KA; Motaleb, MA; Liu, J; Hu, B; Caimano, MJ; Miller, MR; Charon, NW				Miller, Kelly A.; Motaleb, Md. A.; Liu, Jun; Hu, Bo; Caimano, Melissa J.; Miller, Michael R.; Charon, Nyles W.			Initial Characterization of the FlgE Hook High Molecular Weight Complex of Borrelia burgdorferi	PLOS ONE			English	Article							LYME-DISEASE SPIROCHETE; BASAL BODY COMPLEX; FLAGELLAR-HOOK; SALMONELLA-TYPHIMURIUM; TREPONEMA-PHAGEDENIS; PERIPLASMIC FLAGELLA; O-ACETYLATION; ISOPEPTIDE BONDS; LENGTH CONTROL; MOTILITY	The spirochete periplasmic flagellum has many unique attributes. One unusual characteristic is the flagellar hook. This structure serves as a universal joint coupling rotation of the membrane-bound motor to the flagellar filament. The hook is comprised of about 120 FlgE monomers, and in most bacteria these structures readily dissociate to monomers (similar to 50 kDa) when treated with heat and detergent. However, in spirochetes the FlgE monomers form a large mass of over 250 kDa [referred to as a high molecular weight complex (HMWC)] that is stable to these and other denaturing conditions. In this communication, we examined specific aspects with respect to the formation and structure of this complex. We found that the Lyme disease spirochete Borrelia burgdorferi synthesized the HMWC throughout the in vitro growth cycle, and also in vivo when implanted in dialysis membrane chambers in rats. The HMWC was stable to formic acid, which supports the concept that the stability of the HMWC is dependent on covalent cross-linking of individual FlgE subunits. Mass spectrometry analysis of the HMWC from both wild type periplasmic flagella and polyhooks from a newly constructed Delta fliK mutant indicated that other proteins besides FlgE were not covalently joined to the complex, and that FlgE was the sole component of the complex. In addition, mass spectrometry analysis also indicated that the HMWC was composed of a polymer of the FlgE protein with both the N-and C-terminal regions remaining intact. These initial studies set the stage for a detailed characterization of the HMWC. Covalent cross-linking of FlgE with the accompanying formation of the HMWC we propose strengthens the hook structure for optimal spirochete motility.	[Miller, Kelly A.; Charon, Nyles W.] W Virginia Univ, Dept Microbiol Immunol & Cell Biol, Robert C Byrd Hlth Sci Ctr, Morgantown, WV 26506 USA; [Motaleb, Md. A.] E Carolina Univ, Dept Microbiol & Immunol, Greenville, NC USA; [Liu, Jun; Hu, Bo] Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Pathol & Lab Med, Houston, TX 77030 USA; [Caimano, Melissa J.] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT USA; [Miller, Michael R.] W Virginia Univ, Dept Biochem, Robert C Byrd Hlth Sci Ctr, Morgantown, WV 26506 USA	West Virginia University; University of North Carolina; East Carolina University; University of Texas System; University of Texas Health Science Center Houston; University of Connecticut; West Virginia University	Miller, MR (corresponding author), W Virginia Univ, Dept Biochem, Robert C Byrd Hlth Sci Ctr, Morgantown, WV 26506 USA.	mmiller@hsc.wvu.edu	Caimano, Melissa J./AAR-6578-2020; Caimano, Melissa J./AAQ-7573-2021	MOTALEB, MD/0000-0003-2761-5104	National Institutes of Health (NIH) [NIAID R21AI093917, NIH R01DE02343]; NIH [RO1AI29735]; NIH NIAMS [R01AR060834]; American Heart Association; WVU Nano graduate fellowships; NIH NIAID [R01AI087946]; Welch Foundation [AU-1714]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087946, R01AI029735, R21AI093917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023431] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); American Heart Association(American Heart Association); WVU Nano graduate fellowships; NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by funding provided by National Institutes of Health (NIH) NIAID R21AI093917 and NIH R01DE02343 to NWC and MRM; NIH RO1AI29735 to MJC; NIH NIAMS R01AR060834 to MAM; and American Heart Association and WVU Nano graduate fellowships to KAM. JJL and BH were supported by NIH NIAID R01AI087946 and Welch Foundation AU-1714. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIZAWA S, 1985, J BACTERIOL, V161, P836, DOI 10.1128/JB.161.3.836-849.1985; Akins DR, 1998, J CLIN INVEST, V101, P2240, DOI 10.1172/JCI2325; Bakker RG, 2007, APPL ENVIRON MICROB, V73, P1180, DOI 10.1128/AEM.01913-06; BARBOUR AG, 1986, INFECT IMMUN, V52, P549, DOI 10.1128/IAI.52.2.549-554.1986; Bernard E, 2011, J BIOL CHEM, V286, P23950, DOI 10.1074/jbc.M111.241414; Bonifield HR, 2000, J BACTERIOL, V182, P4044, DOI 10.1128/JB.182.14.4044-4050.2000; Bono JL, 2000, J BACTERIOL, V182, P2445, DOI 10.1128/JB.182.9.2445-2452.2000; Brooks CS, 2003, INFECT IMMUN, V71, P3371, DOI 10.1128/IAI.71.6.3371-3383.2003; Caimano Melissa J, 2005, Curr Protoc Microbiol, VChapter 12, DOI 10.1002/9780471729259.mc12c03s00; Caimano MJ, 2004, INFECT IMMUN, V72, P6433, DOI 10.1128/IAI.72.11.6433-6445.2004; CHARON NW, 1991, J BACTERIOL, V173, P4820, DOI 10.1128/jb.173.15.4820-4826.1991; Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359; Charon NW, 2012, ANNU REV MICROBIOL, V66, P349, DOI 10.1146/annurev-micro-092611-150145; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Chi B, 2002, INFECT IMMUN, V70, P2233, DOI 10.1128/IAI.70.4.2233-2237.2002; COCKAYNE A, 1987, J GEN MICROBIOL, V133, P1397; Cronan JE, 2002, CURR OPIN MICROBIOL, V5, P202, DOI 10.1016/S1369-5274(02)00297-7; DIMMITT K, 1971, J BACTERIOL, V108, P282, DOI 10.1128/JB.108.1.282-286.1971; DUPONT C, 1991, EUR J BIOCHEM, V195, P763, DOI 10.1111/j.1432-1033.1991.tb15764.x; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; Erhardt M, 2011, EMBO J, V30, P2948, DOI 10.1038/emboj.2011.185; Erhardt M, 2010, MOL MICROBIOL, V75, P1272, DOI 10.1111/j.1365-2958.2010.07050.x; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Ge YG, 1998, J BACTERIOL, V180, P2418, DOI 10.1128/JB.180.9.2418-2425.1998; Ge YG, 1997, J BACTERIOL, V179, P2289, DOI 10.1128/jb.179.7.2289-2299.1997; Harman M, 2013, BIOPHYS J, V105, P2273, DOI 10.1016/j.bpj.2013.10.004; Harman MW, 2012, P NATL ACAD SCI USA, V109, P3059, DOI 10.1073/pnas.1114362109; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; HIRANO T, 1994, J BACTERIOL, V176, P5439, DOI 10.1128/JB.176.17.5439-5449.1994; Kamal N, 2007, MICROBIOL-SGM, V153, P3099, DOI 10.1099/mic.0.2007/007401-0; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Laaberki MH, 2011, J BIOL CHEM, V286, P5278, DOI 10.1074/jbc.M110.183236; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li C, 2008, J BACTERIOL, V190, P5607, DOI 10.1128/JB.00319-08; Li CH, 2010, J BACTERIOL, V192, P2596, DOI 10.1128/JB.01502-09; Limberger RJ, 1999, J BACTERIOL, V181, P3743, DOI 10.1128/JB.181.12.3743-3750.1999; LIMBERGER RJ, 1994, J BACTERIOL, V176, P3631, DOI 10.1128/JB.176.12.3631-3637.1994; LIMBERGER RJ, 1986, J BACTERIOL, V166, P105, DOI 10.1128/jb.166.1.105-112.1986; Limberger RJ, 1996, J BACTERIOL, V178, P4628, DOI 10.1128/jb.178.15.4628-4634.1996; Liu J, 2009, J BACTERIOL, V191, P5026, DOI 10.1128/JB.00340-09; Lybecker MC, 2007, MOL MICROBIOL, V64, P1075, DOI 10.1111/j.1365-2958.2007.05716.x; Minamino T, 2009, MOL MICROBIOL, V74, P239, DOI 10.1111/j.1365-2958.2009.06871.x; Moriarty TJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000090; Morris DP, 2010, BIOCHEMISTRY-US, V49, P6386, DOI 10.1021/bi100487p; Motaleb MA, 2011, J BACTERIOL, V193, P3324, DOI 10.1128/JB.00202-11; Motaleb MA, 2000, P NATL ACAD SCI USA, V97, P10899, DOI 10.1073/pnas.200221797; Motaleb MA, 2004, J BACTERIOL, V186, P3703, DOI 10.1128/JB.186.12.3703-3711.2004; Muramoto K, 1998, J MOL BIOL, V277, P871, DOI 10.1006/jmbi.1998.1659; Murphy GE, 2006, NATURE, V442, P1062, DOI 10.1038/nature05015; Paster B.J., 2010, BERGEYS MANUAL OF SY, P471, DOI [10.1007/978-0-387-68572-4_4, DOI 10.1007/978-0-387-68572-4_4]; Pfeffer JM, 2006, J BACTERIOL, V188, P902, DOI 10.1128/JB.188.3.902-908.2006; POPA MP, 1991, J VIROL, V65, P3227, DOI 10.1128/JVI.65.6.3227-3237.1991; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Ruby JD, 1997, J BACTERIOL, V179, P1628, DOI 10.1128/jb.179.5.1628-1635.1997; Ryan KA, 2005, J BACTERIOL, V187, P5742, DOI 10.1128/JB.187.16.5742-5750.2005; Sal MS, 2008, J BACTERIOL, V190, P1912, DOI 10.1128/JB.01421-07; Son K, 2013, NAT PHYS, V9, P494, DOI 10.1038/NPHYS2676; Sultan SZ, 2013, INFECT IMMUN, V81, P2012, DOI 10.1128/IAI.01228-12; SWIM SC, 1983, INFECT IMMUN, V42, P446, DOI 10.1128/IAI.42.2.446-452.1983; Sze CW, 2011, MOL MICROBIOL, V82, P851, DOI 10.1111/j.1365-2958.2011.07853.x; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Vig DK, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.218104; West MA, 1997, BIOCHEM BIOPH RES CO, V238, P733, DOI 10.1006/bbrc.1997.7359; Williams AW, 1996, J BACTERIOL, V178, P2960, DOI 10.1128/jb.178.10.2960-2970.1996; Yang J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.268101; Yang XF, 2000, MOL MICROBIOL, V37, P1470, DOI 10.1046/j.1365-2958.2000.02104.x	67	14	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98338	10.1371/journal.pone.0098338	http://dx.doi.org/10.1371/journal.pone.0098338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859001	Green Published, Green Submitted, gold			2022-12-25	WOS:000336839400067
J	Sebastiana, M; Vieira, B; Lino-Neto, T; Monteiro, F; Figueiredo, A; Sousa, L; Pais, MS; Tavares, R; Paulo, OS				Sebastiana, Monica; Vieira, Bruno; Lino-Neto, Teresa; Monteiro, Filipa; Figueiredo, Andreia; Sousa, Lisete; Pais, Maria Salome; Tavares, Rui; Paulo, Octaavio S.			Oak Root Response to Ectomycorrhizal Symbiosis Establishment: RNA-Seq Derived Transcript Identification and Expression Profiling	PLOS ONE			English	Article							FUNGUS LACCARIA-BICOLOR; RECEPTOR-LIKE KINASES; PISOLITHUS-TINCTORIUS; ARABIDOPSIS-THALIANA; SECRETORY PATHWAY; PINUS-SYLVESTRIS; CELL-FATE; PLANT; PROTEIN; FLAVONOIDS	Ectomycorrhizal symbiosis is essential for the life and health of trees in temperate and boreal forests where it plays a major role in nutrient cycling and in functioning of the forest ecosystem. Trees with ectomycorrhizal root tips are more tolerant to environmental stresses, such as drought, and biotic stresses such as root pathogens. Detailed information on these molecular processes is essential for the understanding of symbiotic tissue development in order to optimize the benefits of this natural phenomenon. Next generation sequencing tools allow the analysis of non model ectomycorrhizal plant-fungal interactions that can contribute to find the "symbiosis toolkits'' and better define the role of each partner in the mutualistic interaction. By using 454 pyrosequencing we compared ectomycorrhizal cork oak roots with non-symbiotic roots. From the two cDNA libraries sequenced, over 2 million reads were obtained that generated 19552 cork oak root unique transcripts. A total of 2238 transcripts were found to be differentially expressed when ECM roots were compared with non-symbiotic roots. Identification of up-and down-regulated gens in ectomycorrhizal roots lead to a number of insights into the molecular mechanisms governing this important symbiosis. In cork oak roots, ectomycorrhizal colonization resulted in extensive cell wall remodelling, activation of the secretory pathway, alterations in flavonoid biosynthesis, and expression of genes involved in the recognition of fungal effectors. In addition, we identified genes with putative roles in symbiotic processes such as nutrient exchange with the fungal partner, lateral root formation or root hair decay. These findings provide a global overview of the transcriptome of an ectomycorrhizal host root, and constitute a foundation for future studies on the molecular events controlling this important symbiosis.	[Sebastiana, Monica; Monteiro, Filipa; Figueiredo, Andreia; Pais, Maria Salome] Univ Lisbon, Fac Sci, Plant Syst Biol Lab, Ctr Biodivers Funct & Integrat Genom, P-1699 Lisbon, Portugal; [Vieira, Bruno; Paulo, Octaavio S.] Univ Lisbon, Fac Sci, Ctr Environm Biol, P-1699 Lisbon, Portugal; [Lino-Neto, Teresa; Tavares, Rui] Univ Minho, Plant Funct Biol Ctr, Ctr Biodivers Funct & Integrat Genom, Braga, Portugal; [Sousa, Lisete] Univ Lisbon, Fac Sci, Dept Stat & Operat Res, Ctr Stat & Applicat Lisbon Univ, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Universidade do Minho; Universidade de Lisboa	Sebastiana, M (corresponding author), Univ Lisbon, Fac Sci, Plant Syst Biol Lab, Ctr Biodivers Funct & Integrat Genom, P-1699 Lisbon, Portugal.	mgsebastiana@fc.ul.pt	Tavares, Rui M/D-9692-2012; Lino-Neto, Teresa/D-9691-2012; Sousa, Lisete M R/M-1842-2015; Sebastiana, Monica/M-7415-2015; Monteiro, Filipa/I-6116-2012; Paulo, Octávio/D-9921-2011; Figueiredo, Andreia/G-2887-2014	Tavares, Rui M/0000-0002-1702-256X; Lino-Neto, Teresa/0000-0002-1385-4799; Sousa, Lisete M R/0000-0002-2114-720X; Sebastiana, Monica/0000-0001-8735-7632; Monteiro, Filipa/0000-0002-1505-2140; Paulo, Octávio/0000-0001-5408-5212; Figueiredo, Andreia/0000-0001-8156-7700; Vieira, Bruno/0000-0002-4878-6431	Portuguese Foundation for Science and Technology in the frame of the project Cork Oak EST Consortium [SOBREIRO/0034/2009]; Portuguese Foundation for Science and Technology [SFRH/BPD/25661/2005]	Portuguese Foundation for Science and Technology in the frame of the project Cork Oak EST Consortium; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This work was funded by the Portuguese Foundation for Science and Technology (www.fct.pt) in the frame of the project Cork Oak EST Consortium SOBREIRO/0034/2009. Post-doc grant to MS was supported by the Portuguese Foundation for Science and Technology (SFRH/BPD/25661/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barkefors I, 2011, J BIOL CHEM, V286, P24189, DOI 10.1074/jbc.M110.212209; Barratt DHP, 2009, P NATL ACAD SCI USA, V106, P13124, DOI 10.1073/pnas.0900689106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonke M, 2003, NATURE, V426, P181, DOI 10.1038/nature02100; Brodsky FM, 2012, ANNU REV CELL DEV BI, V28, P309, DOI 10.1146/annurev-cellbio-101011-155716; Brundrett MC, 2002, NEW PHYTOL, V154, P275, DOI 10.1046/j.1469-8137.2002.00397.x; Buer CS, 2010, J INTEGR PLANT BIOL, V52, P98, DOI 10.1111/j.1744-7909.2010.00905.x; Cairney JWG, 1997, MYCORRHIZA, V7, P117, DOI 10.1007/s005720050172; Capoen W, 2011, P NATL ACAD SCI USA, V108, P14348, DOI 10.1073/pnas.1107912108; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chinchilla D, 2009, TRENDS PLANT SCI, V14, P535, DOI 10.1016/j.tplants.2009.08.002; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; DENFERT C, 1992, EMBO J, V11, P4205, DOI 10.1002/j.1460-2075.1992.tb05514.x; Ditengou FA, 2000, PLANTA, V211, P722, DOI 10.1007/s004250000342; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Duplessis S, 2005, NEW PHYTOL, V165, P599, DOI 10.1111/j.1469-8137.2004.01248.x; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Eklof JM, 2010, PLANT PHYSIOL, V153, P456, DOI 10.1104/pp.110.156844; El-Kasmi F, 2011, PLANT J, V66, P268, DOI 10.1111/j.1365-313X.2011.04487.x; Endre G, 2002, NATURE, V417, P962, DOI 10.1038/nature00842; Felten J, 2010, PLANT SIGNAL BEHAV, V5, P864, DOI [10.4161/psb.5.7.11896, 10.1104/pp.109.147231]; Felten J, 2009, PLANT PHYSIOL, V151, P1991, DOI 10.1104/pp.109.147231; Flores-Monterroso A, 2013, PLANTA, V237, P1637, DOI 10.1007/s00425-013-1874-4; Fotelli MN, 2011, J EXP BOT, V62, P2959, DOI 10.1093/jxb/err009; Fujii S, 2010, PLANT CELL PHYSIOL, V51, P294, DOI 10.1093/pcp/pcp190; Gebbie LK, 2005, J EXP BOT, V56, P1079, DOI 10.1093/jxb/eri099; Gutjahr C, 2009, NEW PHYTOL, V183, P53, DOI 10.1111/j.1469-8137.2009.02871.x; Hancock KR, 2012, PLANT PHYSIOL, V159, P1204, DOI 10.1104/pp.112.195420; Heller G, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-19; Heller G, 2012, MYCORRHIZA, V22, P271, DOI 10.1007/s00572-011-0402-2; Hibbett DS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-13; Hiraga S, 2001, PLANT CELL PHYSIOL, V42, P462, DOI 10.1093/pcp/pce061; Hobson G., 1993, BIOCH FRUIT RIPENING, P405, DOI [DOI 10.1007/978-94-011-1584-1_14, 10.1007/978-94-011-1584-1_14]; HORAN DP, 1988, NEW PHYTOL, V109, P451, DOI 10.1111/j.1469-8137.1988.tb03720.x; Johansson T, 2004, MOL PLANT MICROBE IN, V17, P202, DOI 10.1094/MPMI.2004.17.2.202; Kikuchi K, 2007, MYCORRHIZA, V17, P563, DOI 10.1007/s00572-007-0131-8; Kloppholz S, 2011, CURR BIOL, V21, P1204, DOI 10.1016/j.cub.2011.06.044; Kusano H, 2008, PLANT CELL, V20, P367, DOI 10.1105/tpc.107.056119; Larsen PE, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-70; Le Quere A, 2005, MOL PLANT MICROBE IN, V18, P659, DOI 10.1094/MPMI-18-0659; Li Y, 2003, CURR OPIN PLANT BIOL, V6, P603, DOI 10.1016/j.pbi.2003.09.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo ZB, 2009, PLANT PHYSIOL, V151, P1902, DOI 10.1104/pp.109.143735; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Martin F, 2007, CURR OPIN PLANT BIOL, V10, P204, DOI 10.1016/j.pbi.2007.01.006; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Meyer HA, 2000, J BIOL CHEM, V275, P14550, DOI 10.1074/jbc.275.19.14550; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; MORANDI D, 1992, AGRONOMIE, V12, P811, DOI 10.1051/agro:19921012; Morandi D, 2009, MYCORRHIZA, V19, P435, DOI 10.1007/s00572-009-0242-5; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Muller T, 2007, PHYTOCHEMISTRY, V68, P41, DOI 10.1016/j.phytochem.2006.09.021; Nakagawa T, 2011, PLANT J, V65, P169, DOI 10.1111/j.1365-313X.2010.04411.x; Nehls U, 2007, PHYTOCHEMISTRY, V68, P82, DOI 10.1016/j.phytochem.2006.09.024; Nole-Wilson S, 2005, PLANT MOL BIOL, V57, P613, DOI 10.1007/s11103-005-0955-6; Nomura M, 2006, PLANT CELL PHYSIOL, V47, P613, DOI 10.1093/pcp/pcj028; O'Leary B, 2011, BIOCHEM J, V436, P15, DOI 10.1042/BJ20110078; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Peleg-Grossman S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008399; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; Plett JM, 2011, CURR BIOL, V21, P1197, DOI 10.1016/j.cub.2011.05.033; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rose JKC, 2010, PLANT PHYSIOL, V153, P433, DOI 10.1104/pp.110.154872; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Scheible WR, 2004, CURR OPIN PLANT BIOL, V7, P285, DOI 10.1016/j.pbi.2004.03.006; Schiefelbein J, 2003, CURR OPIN PLANT BIOL, V6, P74, DOI 10.1016/S136952660200002X; Sebastiana M, 2013, NEW FOREST, V44, P937, DOI 10.1007/s11056-013-9386-4; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI; Song SK, 2011, PLANT PHYSIOL, V157, P1196, DOI 10.1104/pp.111.185785; Splivallo R, 2009, PLANT PHYSIOL, V150, P2018, DOI 10.1104/pp.109.141325; Steinwand BJ, 2010, PLANT PHYSIOL, V153, P479, DOI 10.1104/pp.110.155887; Sulieman S, 2011, PLANT SIGNAL BEHAV, V6, P32, DOI 10.4161/psb.6.1.14318; Swindell WR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-125; Trillas MI, 2000, PHYSIOL MOL PLANT P, V56, P107, DOI 10.1006/pmpp.1999.0254; Vanneste S, 2005, PLANT CELL, V17, P3035, DOI 10.1105/tpc.105.035493; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Wang D, 2011, MOL PLANT, V4, P581, DOI 10.1093/mp/ssr053; Wang D, 2010, SCIENCE, V327, P1126, DOI 10.1126/science.1184096; Wu XQ, 2008, J PROTEOME RES, V7, P4299, DOI 10.1021/pr800241u; Zhao J, 2010, PLANT PHYSIOL, V153, P437, DOI 10.1104/pp.110.155432	87	33	34	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98376	10.1371/journal.pone.0098376	http://dx.doi.org/10.1371/journal.pone.0098376			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859293	Green Published, Green Submitted, gold			2022-12-25	WOS:000336839400072
J	Song, K; Yoon, IS; Kim, NA; Kim, DH; Lee, J; Lee, HJ; Lee, S; Choi, S; Choi, MK; Kim, HH; Jeong, SH; Son, WS; Kim, DD; Shin, YK				Song, Kyoung; Yoon, In-Soo; Kim, Nam Ah; Kim, Dong-Hwan; Lee, Jongmin; Lee, Hee Jung; Lee, Saehyung; Choi, Sunghyun; Choi, Min-Koo; Kim, Ha Hyung; Jeong, Seong Hoon; Son, Woo Sung; Kim, Dae-Duk; Shin, Young Kee			Glycoengineering of Interferon-beta 1a Improves Its Biophysical and Pharmacokinetic Properties	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; POLYETHYLENE-GLYCOL; PROTEIN AGGREGATION; RECEPTOR-BINDING; GLYCOSYLATION; SITE; PATHOGENESIS; PEGYLATION; THERAPIES; STABILITY	The purpose of this study was to develop a biobetter version of recombinant human interferon-beta 1a (rhIFN-beta 1a) to improve its biophysical properties, such as aggregation, production and stability, and pharmacokinetic properties without jeopardizing its activity. To achieve this, we introduced additional glycosylation into rhIFN-beta 1a via site-directed mutagenesis. Glycoengineering of rhIFN-beta 1a resulted in a new molecular entity, termed R27T, which was defined as a rhIFN-beta mutein with two N-glycosylation sites at 80th (original site) and at an additional 25th amino acid due to a mutation of Thr for Arg at position 27th of rhIFN-beta 1a. Glycoengineering had no effect on rhIFN-beta ligand-receptor binding, as no loss of specific activity was observed. R27T showed improved stability and had a reduced propensity for aggregation and an increased half-life. Therefore, hyperglycosylated rhIFN-beta could be a biobetter version of rhIFN-beta 1a with a potential for use as a drug against multiple sclerosis.	[Song, Kyoung; Kim, Dong-Hwan; Lee, Saehyung; Kim, Dae-Duk; Shin, Young Kee] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Song, Kyoung; Kim, Dong-Hwan; Lee, Saehyung; Kim, Dae-Duk; Shin, Young Kee] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul, South Korea; [Shin, Young Kee] Seoul Natl Univ, Inst Entrepreneurial BioConvergence, Seoul, South Korea; [Song, Kyoung; Lee, Hee Jung; Choi, Sunghyun] Res Inst Reference Biolabs Inc, Seoul, South Korea; [Yoon, In-Soo] Mokpo Natl Univ, Coll Pharm, Jeonnam, South Korea; [Yoon, In-Soo] Mokpo Natl Univ, Nat Med Res Inst, Jeonnam, South Korea; [Kim, Nam Ah; Jeong, Seong Hoon] Dongguk Univ Seoul, Coll Pharm, Gyeonggi Do, South Korea; [Lee, Jongmin] PanGen Biotech Inc, Gyeonggi Do, South Korea; [Choi, Min-Koo] DanKook Univ, Coll Pharm, Chungnam, South Korea; [Kim, Ha Hyung] Chung Ang Univ, Coll Pharm, Biotherapeut & Glyc Lab, Seoul 156756, South Korea; [Son, Woo Sung] CHA Univ, Coll Pharm, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Mokpo National University; Mokpo National University; Dongguk University; Dankook University; Chung Ang University; Pochon Cha University	Shin, YK (corresponding author), Seoul Natl Univ, Coll Pharm, Seoul, South Korea.	ykeeshin@snu.ac.kr	Shin, Young Kee/C-8929-2011; Yoon, In-Soo/ABG-2948-2021; Kim, Dae Duk/D-8864-2013	Shin, Young Kee/0000-0003-0896-718X; Yoon, In-Soo/0000-0002-0997-5723; 	Basic Science Research Program through the National Research Foundation (NRF) [NRF-2012R1A1A1043288]; Korea Drug Development Fund of Korea - Ministry of Education, Science and Technology [20100030032]	Basic Science Research Program through the National Research Foundation (NRF); Korea Drug Development Fund of Korea - Ministry of Education, Science and Technology	This research was supported by Basic Science Research Program through the National Research Foundation (NRF)(NRF-2012R1A1A1043288, URL https://www.nrf.re.kr/nrf_tot_cms/index.jsp?pmi-sso-return2=none) and Project through Korea Drug Development Fund (20100030032, URL http://www.kddf.org/Main/) of Korea funded by the Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amedei A, 2012, INT J MOL SCI, V13, P13438, DOI 10.3390/ijms131013438; Basma M, 2001, J COMPUT CHEM, V22, P1125, DOI 10.1002/jcc.1072; Castro-Borrero W, 2012, THER ADV NEUROL DISO, V5, P205, DOI 10.1177/1756285612450936; de Seze J, 2012, PATIENT PREFER ADHER, V6, P263, DOI 10.2147/PPA.S27038; DELORME E, 1992, BIOCHEMISTRY-US, V31, P9871, DOI 10.1021/bi00156a003; DERYNCK R, 1980, NATURE, V287, P193, DOI 10.1038/287193a0; DONG AC, 1995, J PHARM SCI-US, V84, P415, DOI 10.1002/jps.2600840407; Fan HH, 2005, J PHARM SCI-US, V94, P1893, DOI 10.1002/jps.20410; Fang YW, 2009, PERITON DIALYSIS INT, V29, P199; Fitzner D, 2010, CURR NEUROPHARMACOL, V8, P305, DOI 10.2174/157015910792246218; Gasperini C, 2011, EXPERT OPIN EMERG DR, V16, P697, DOI 10.1517/14728214.2011.642861; Harris JM, 2001, CLIN PHARMACOKINET, V40, P539, DOI 10.2165/00003088-200140070-00005; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hubbard S. J., 1993, NACCESS; KAGAWA Y, 1988, J BIOL CHEM, V263, P17508; Karpusas M, 1997, P NATL ACAD SCI USA, V94, P11813, DOI 10.1073/pnas.94.22.11813; Karpusas M, 1998, CELL MOL LIFE SCI, V54, P1203, DOI 10.1007/s000180050248; KATRE NV, 1993, ADV DRUG DELIVER REV, V10, P91, DOI 10.1016/0169-409X(93)90005-O; Kieseier BC, 2012, CNS DRUGS, V26, P205, DOI 10.2165/11596970-000000000-00000; Kim JE, 2013, XENOBIOTICA, V43, P579, DOI 10.3109/00498254.2012.751140; Kirschner KN, 2001, P NATL ACAD SCI USA, V98, P10541, DOI 10.1073/pnas.191362798; Kirschner KN, 2001, J PHYS CHEM A, V105, P4150, DOI 10.1021/jp004413y; KNIGHT P, 1989, BIO-TECHNOL, V7, P35, DOI 10.1038/nbt0189-35; MARK DF, 1984, P NATL ACAD SCI-BIOL, V81, P5662, DOI 10.1073/pnas.81.18.5662; Nicholas R, 2011, DRUG DES DEV THER, V5, P255, DOI 10.2147/DDDT.S10498; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Pepinsky RB, 2001, J PHARMACOL EXP THER, V297, P1059; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Quadt-Akabayov SR, 2006, PROTEIN SCI, V15, P2656, DOI 10.1110/ps.062283006; Rodriguez J, 2005, BIOTECHNOL PROGR, V21, P22, DOI 10.1021/bp049807b; Rodriguez J, 2010, J BIOTECHNOL, V150, P509, DOI 10.1016/j.jbiotec.2010.09.959; Runkel L, 1998, J BIOL CHEM, V273, P8003, DOI 10.1074/jbc.273.14.8003; Runkel L, 2000, BIOCHEMISTRY-US, V39, P2538, DOI 10.1021/bi991631c; Runkel L, 1998, PHARM RES-DORDR, V15, P641, DOI 10.1023/A:1011974512425; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Sola RJ, 2009, J PHARM SCI-US, V98, P1223, DOI 10.1002/jps.21504; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wang W, 2005, INT J PHARMACEUT, V289, P1, DOI 10.1016/j.ijpharm.2004.11.014; Wanic-Kossowska Maria, 2006, Pol Arch Med Wewn, V116, P663; Watt GM, 2003, CHEM BIOL, V10, P807, DOI 10.1016/j.chembiol.2003.08.006; Yang CH, 2004, J BIOMOL STRUCT DYN, V22, P101, DOI 10.1080/07391102.2004.10506985; Yoon I, 2012, XENOBIOTICA, V42, P1110, DOI 10.3109/00498254.2012.700139	43	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e96967	10.1371/journal.pone.0096967	http://dx.doi.org/10.1371/journal.pone.0096967			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858932	gold, Green Published, Green Submitted			2022-12-25	WOS:000336839400007
J	Julia, C; Peneau, S; Andreeva, VA; Mejean, C; Fezeu, L; Galan, P; Hercberg, S				Julia, Chantal; Peneau, Sandrine; Andreeva, Valentina A.; Mejean, Caroline; Fezeu, Leopold; Galan, Pilar; Hercberg, Serge			Weight-Loss Strategies Used by the General Population: How Are They Perceived?	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; LOSS PROGRAMS; BODY-IMAGE; GENDER-DIFFERENCES; OBESITY; HEALTH; DIETS; NUTRITION; ADULTS; OVERWEIGHT	Background: The rising prevalence of obesity and the social pressure for thinness increase the prevalence of dieting. However, little is known about the overall perception of dieting strategies actually used by the general population. Objectives: Our main objective was to investigate perceptions of weight-loss practices in an observational study in order to identify the most favourable strategy. Design: Adults from the ongoing Nutrinet-Sante cohort study who had reported engaging in dieting in the three previous years were included in the study. For each diet, detailed information was collected on types of diets, circumstances and perception of the diet, and outcomes. Perceptions were compared across diets using sex-specific mixed effects models. Result: Among the 48 435 subjects who had completed the respective questionnaire, 12 673 (26.7%, 87.8% of women) had followed at least one weight-loss diet in the previous three years. Diet plans prescribed by health professionals and diets conforming to official dietary recommendations were the most favourably perceived among all assessed weight-loss strategies. Alternatively, commercial diet plans and self-imposed dietary restrictions were more negatively perceived (Odds ratios (OR) for adherence difficulty 1.30 (95% confidence interval (0.99;1.7)) in men and OR 1.92 (1.76;2.10) in women compared to official nutritional guidelines; OR 1.06 (0.82;1.38) in men and OR 1.39 (1.26;1.54) in women respectively) compared to official nutritional guidelines. Conclusion: Official dietary recommendations could be useful tools for maintaining a dietary balance while following a weight-loss diet.	[Julia, Chantal; Peneau, Sandrine; Andreeva, Valentina A.; Mejean, Caroline; Fezeu, Leopold; Galan, Pilar; Hercberg, Serge] Univ Paris 07, Univ Paris 05, Univ Paris 13,Nutr Epidemiol Res Team, Sorbonne Paris Cite,Cnam,Epidemiol & biostat Ctr, Bobigny, France; [Julia, Chantal; Hercberg, Serge] Avicenne Hosp, Dept Publ Hlth, Bobigny, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP	Julia, C (corresponding author), Univ Paris 07, Univ Paris 05, Univ Paris 13,Nutr Epidemiol Res Team, Sorbonne Paris Cite,Cnam,Epidemiol & biostat Ctr, Bobigny, France.	c.julia@uren.smbh.univ-paris13.fr	Serge, Hercberg/F-3038-2017; Peneau, Sandrine/F-2701-2017; Chantal, Julia/F-2805-2017; Andreeva, Valentina/F-2680-2017; Mejean, Caroline/F-2792-2017; HERCBERG, Serge/B-4429-2008; Fezeu, Leopold/F-2804-2017; Galan, Pilar/F-2908-2017	Serge, Hercberg/0000-0002-3168-1350; Peneau, Sandrine/0000-0002-3463-0989; Chantal, Julia/0000-0003-2006-5269; Andreeva, Valentina/0000-0001-9480-5210; Mejean, Caroline/0000-0001-6467-5056; HERCBERG, Serge/0000-0002-3168-1350; Fezeu, Leopold/0000-0002-7589-3179; Galan, Pilar/0000-0003-1706-3107	Ministere de la Sante (DGS); Institut de Veille Sanitaire (InVS); Institut National de la Prevention et de l'Education pour la Sante (INPES); Fondation pour la Recherche Medicale (FRM); Institut de Recherche en Sante Publique (IRESP); Institut National de la Sante et de la Recherche Medicale (INSERM); Institut National de la Recherche Agronomique (INRA); Conservatoire National des Arts et Metiers (CNAM); Universite Paris 13	Ministere de la Sante (DGS); Institut de Veille Sanitaire (InVS); Institut National de la Prevention et de l'Education pour la Sante (INPES); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institut de Recherche en Sante Publique (IRESP); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut National de la Recherche Agronomique (INRA); Conservatoire National des Arts et Metiers (CNAM); Universite Paris 13	The Nutrinet-Sante study is supported by the institutions: Ministere de la Sante (DGS), Institut de Veille Sanitaire (InVS), Institut National de la Prevention et de l'Education pour la Sante (INPES), Fondation pour la Recherche Medicale (FRM), Institut de Recherche en Sante Publique (IRESP), Institut National de la Sante et de la Recherche Medicale (INSERM), Institut National de la Recherche Agronomique (INRA), Conservatoire National des Arts et Metiers (CNAM) and Universite Paris 13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agence Francaise de Securite Sanitaire des Aliments, 2009, ET IND NATL CONS AL; Agence Nationale de Securite Sanitaire de l'Alimentation dledtA, 2010, EV RISQ LIES PRAT AL; Anderson JW, 2001, AM J CLIN NUTR, V74, P579; Andreyeva T, 2010, J AM DIET ASSOC, V110, P535, DOI 10.1016/j.jada.2009.12.029; [Anonymous], 2013, MARCHES MINCEUR HORI; BLACKBURN G, 1995, OBES RES, V3, pS211, DOI 10.1002/j.1550-8528.1995.tb00466.x; Cafri G, 2005, CLIN PSYCHOL-SCI PR, V12, P421, DOI 10.1093/clipsy/bpi053; Castetbon K, 2009, BRIT J NUTR, V102, P733, DOI 10.1017/S0007114509274745; Centers for Disease Control and Prevention, 2008, MMWR-MORBID MORTAL W, V57, P1155; Dalle Grave R, 2005, OBES RES, V13, P1961, DOI 10.1038/oby.2005.241; Dansinger ML, 2005, JAMA-J AM MED ASSOC, V293, P43, DOI 10.1001/jama.293.1.43; Das SK, 2009, OBESITY, V17, P2019, DOI 10.1038/oby.2009.120; Del Corral P, 2011, OBESITY, V19, P1177, DOI 10.1038/oby.2010.298; Del Corral P, 2009, J CLIN ENDOCR METAB, V94, P1602, DOI 10.1210/jc.2008-1057; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; Drewnowski A, 1996, J AM DIET ASSOC, V96, P663, DOI 10.1016/S0002-8223(96)00185-X; Ezzati M, 2006, J ROY SOC MED, V99, P250, DOI 10.1258/jrsm.99.5.250; Finkler E, 2012, J ACAD NUTR DIET, V112, P75, DOI 10.1016/j.jada.2011.08.034; Finley CE, 2007, INT J OBESITY, V31, P292, DOI 10.1038/sj.ijo.0803395; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Freedman MR, 2001, OBES RES, V9, p1S, DOI 10.1038/oby.2001.113; Frost G, 2007, J HUM NUTR DIET, V20, P152, DOI [10.1111/j.1365-277X.2007.00775.x, 10.1111/j.1365-277X.2007.00785.x]; Hamilton M, 2004, Obes Rev, V5, P217, DOI 10.1111/j.1467-789X.2004.00153.x; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hercberg S, 2008, INT J PUBLIC HEALTH, V53, P68, DOI 10.1007/s00038-008-7016-2; Hercberg S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-242; Hill AJ, 2004, BRIT J NUTR, V92, pS15, DOI 10.1079/BJN20041135; Jakicic JM, 2009, OBESITY, V17, pS34, DOI 10.1038/oby.2009.386; Jebb SA, 2011, LANCET, V378, P1485, DOI 10.1016/S0140-6736(11)61344-5; Kesse-Guyot E, 2013, J MED INTERNET RES, V15, P148, DOI 10.2196/jmir.2488; Knauper B, 2005, APPETITE, V44, P283, DOI 10.1016/j.appet.2005.01.008; Kruger J, 2004, AM J PREV MED, V26, P402, DOI 10.1016/j.ampere.2004.02.001; Ministere du Travail dledlS, 2011, PROGR NAT NUTR SANT; Nothwehr F, 2006, J NUTR EDUC BEHAV, V38, P249, DOI 10.1016/j.jneb.2005.11.039; Phares V, 2004, J YOUTH ADOLESCENCE, V33, P421, DOI 10.1023/B:JOYO.0000037634.18749.20; Pingitore R, 1997, OBES RES, V5, P402, DOI 10.1002/j.1550-8528.1997.tb00662.x; Presnell K, 2004, INT J EAT DISORDER, V36, P389, DOI 10.1002/eat.20045; *PROGR NAT NUTR SA, 2002, SANT VIENT MANG GUID; Puhl R, 2013, INT J OBESITY, V37, P774, DOI 10.1038/ijo.2012.156; Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Rozin P, 2005, J NUTR EDUC BEHAV, V37, pS107, DOI 10.1016/S1499-4046(06)60209-1; Serdula MK, 1999, JAMA-J AM MED ASSOC, V282, P1353, DOI 10.1001/jama.282.14.1353; SPIELMAN AB, 1992, J AM COLL NUTR, V11, P36; Stubbs RJ, 1998, INT J OBESITY, V22, P980, DOI 10.1038/sj.ijo.0800715; Thomas SL, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-34; Tsai AG, 2006, OBESITY, V14, P1283; Tsai AG, 2005, ANN INTERN MED, V142, P56, DOI 10.7326/0003-4819-142-1-200501040-00012; US Department of Agriculture and US Department of Health and Human Services, 2010, DIET GUID AM 2010; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Wardle J, 2006, INT J OBESITY, V30, P644, DOI 10.1038/sj.ijo.0803050; Weiss EC, 2006, AM J PREV MED, V31, P18, DOI 10.1016/j.amepre.2006.03.016; Wing RR, 2010, JAMA-J AM MED ASSOC, V304, P1837, DOI 10.1001/jama.2010.1529; World Health Organization, 2009, GLOB HLTH RISKS MORT; *WORLD HLTH ORG, 2002, WORLD HLTH REP 2002	55	32	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97834	10.1371/journal.pone.0097834	http://dx.doi.org/10.1371/journal.pone.0097834			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK3KS	24852440	gold, Green Published, Green Submitted			2022-12-25	WOS:000338323200030
J	Nayagam, DAX; Williams, RA; Allen, PJ; Shivdasani, MN; Luu, CD; Salinas-LaRosa, CM; Finch, S; Ayton, LN; Saunders, AL; McPhedran, M; McGowan, C; Villalobos, J; Fallon, JB; Wise, AK; Yeoh, J; Xu, J; Feng, H; Millard, R; McWade, M; Thien, PC; Williams, CE; Shepherd, RK				Nayagam, David A. X.; Williams, Richard A.; Allen, Penelope J.; Shivdasani, Mohit N.; Luu, Chi D.; Salinas-LaRosa, Cesar M.; Finch, Sue; Ayton, Lauren N.; Saunders, Alexia L.; McPhedran, Michelle; McGowan, Ceara; Villalobos, Joel; Fallon, James B.; Wise, Andrew K.; Yeoh, Jonathan; Xu, Jin; Feng, Helen; Millard, Rodney; McWade, Melanie; Thien, Patrick C.; Williams, Chris E.; Shepherd, Robert K.			Chronic Electrical Stimulation with a Suprachoroidal Retinal Prosthesis: A Preclinical Safety and Efficacy Study	PLOS ONE			English	Article							RETINITIS-PIGMENTOSA; TRANSRETINAL STIMULATION; MORPHOMETRIC-ANALYSIS; CHRONIC IMPLANTATION; ELECTRODES; CORTEX; ORGANIZATION; PATHOLOGY; UPDATE; TISSUE	Purpose: To assess the safety and efficacy of chronic electrical stimulation of the retina with a suprachoroidal visual prosthesis. Methods: Seven normally-sighted feline subjects were implanted for 96-143 days with a suprachoroidal electrode array and six were chronically stimulated for 70-105 days at levels that activated the visual cortex. Charge balanced, biphasic, current pulses were delivered to platinum electrodes in a monopolar stimulation mode. Retinal integrity/function and the mechanical stability of the implant were assessed monthly using electroretinography (ERG), optical coherence tomography (OCT) and fundus photography. Electrode impedances were measured weekly and electrically-evoked visual cortex potentials (eEVCPs) were measured monthly to verify that chronic stimuli were suprathreshold. At the end of the chronic stimulation period, thresholds were confirmed with multi-unit recordings from the visual cortex. Randomized, blinded histological assessments were performed by two pathologists to compare the stimulated and non-stimulated retina and adjacent tissue. Results: All subjects tolerated the surgical and stimulation procedure with no evidence of discomfort or unexpected adverse outcomes. After an initial post-operative settling period, electrode arrays were mechanically stable. Mean electrode impedances were stable between 11-15 k Omega during the implantation period. Visually-evoked ERGs & OCT were normal, and mean eEVCP thresholds did not substantially differ over time. In 81 of 84 electrode-adjacent tissue samples examined, there were no discernible histopathological differences between stimulated and unstimulated tissue. In the remaining three tissue samples there were minor focal fibroblastic and acute inflammatory responses. Conclusions: Chronic suprathreshold electrical stimulation of the retina using a suprachoroidal electrode array evoked a minimal tissue response and no adverse clinical or histological findings. Moreover, thresholds and electrode impedance remained stable for stimulation durations of up to 15 weeks. This study has demonstrated the safety and efficacy of suprachoroidal stimulation with charge balanced stimulus currents.	[Nayagam, David A. X.; Shivdasani, Mohit N.; Saunders, Alexia L.; McPhedran, Michelle; McGowan, Ceara; Villalobos, Joel; Fallon, James B.; Wise, Andrew K.; Xu, Jin; Feng, Helen; Millard, Rodney; McWade, Melanie; Thien, Patrick C.; Williams, Chris E.; Shepherd, Robert K.] Bion Inst, East Melbourne, Vic, Australia; [Nayagam, David A. X.; Williams, Richard A.; Williams, Chris E.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Williams, Richard A.; Salinas-LaRosa, Cesar M.] St Vincents Hosp Melbourne, Dept Anat Pathol, Fitzroy, Vic, Australia; [Allen, Penelope J.; Luu, Chi D.; Ayton, Lauren N.; Yeoh, Jonathan] Univ Melbourne, Ctr Eye Res Australia, East Melbourne, Vic, Australia; [Allen, Penelope J.; Yeoh, Jonathan] Univ Melbourne, Dept Ophthalmol, East Melbourne, Vic, Australia; [Finch, Sue] Univ Melbourne, Ctr Stat Consulting, Parkville, Vic 3052, Australia; [Xu, Jin] Univ Melbourne, HEARing Cooperat Res Ctr, East Melbourne, Vic, Australia; [Wise, Andrew K.; Xu, Jin; Feng, Helen] Univ Melbourne, Dept Otolaryngol, East Melbourne, Vic, Australia; [McWade, Melanie] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Shivdasani, Mohit N.; Fallon, James B.; Wise, Andrew K.; Williams, Chris E.; Shepherd, Robert K.] Univ Melbourne, Med Bion Dept, East Melbourne, Vic, Australia	Bionics Institute; University of Melbourne; St Vincent's Hospital Melbourne; Centre for Eye Research Australia; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Vanderbilt University; University of Melbourne	Nayagam, DAX (corresponding author), Bion Inst, East Melbourne, Vic, Australia.	dnayagam@bionicsinstitute.org	SHIVDASANI, MOHIT/AAN-3438-2020; Wise, Andrew/B-5943-2014; Ayton, Lauren/AAV-2977-2021	SHIVDASANI, MOHIT/0000-0002-0692-4971; Wise, Andrew/0000-0001-9715-8784; Ayton, Lauren/0000-0001-9907-084X; Luu, Chi/0000-0002-7604-7097; Shepherd, Robert/0000-0002-4239-3362; Nayagam, David/0000-0002-4380-6640	Australian Research Council (ARC) through its Special Research Initiative (SRI) in Bionic Vision Science and Technology; NH&MRC Centre for Clinical Research Excellence [529923]; Bertalli Family Trust; J T Reid Charitable Trust	Australian Research Council (ARC) through its Special Research Initiative (SRI) in Bionic Vision Science and Technology(Australian Research Council); NH&MRC Centre for Clinical Research Excellence(National Health and Medical Research Council (NHMRC) of Australia); Bertalli Family Trust; J T Reid Charitable Trust	This research was supported by the Australian Research Council (ARC) through its Special Research Initiative (SRI) in Bionic Vision Science and Technology grant to Bionic Vision Australia (BVA). Both the Bionics Institute and the Centre for Eye Research Australia (CERA) receive Operational Infrastructure Support from the Victorian Government. CERA is supported by the NH&MRC Centre for Clinical Research Excellence (#529923) - Translational Clinical Research in Major Eye Diseases. The Bionics Institute would also like to acknowledge support from the Bertalli Family Trust and the J T Reid Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja AK, 2013, TRANSL VIS SCI TECHN, V2, DOI 10.1167/tvst.2.4.1; BRUMMER SB, 1983, ANN NY ACAD SCI, V405, P159, DOI 10.1111/j.1749-6632.1983.tb31628.x; BRUMMER SB, 1977, IEEE T BIO-MED ENG, V24, P59, DOI 10.1109/TBME.1977.326218; Butterwick A, 2007, IEEE T BIO-MED ENG, V54, P2261, DOI 10.1109/TBME.2007.908310; Cicione R, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036009; Cohen EL B., 2013, INVESTIGATIONAL DEVI; Cohen ED, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/3/035005; Colodetti L, 2007, EXP EYE RES, V85, P23, DOI 10.1016/j.exer.2007.02.014; Fallon JB, 2014, EUR J NEUROSCI, V39, P811, DOI 10.1111/ejn.12445; Fallon JB, 2009, J COMP NEUROL, V512, P101, DOI 10.1002/cne.21886; Fujikado T, 2011, INVEST OPHTH VIS SCI, V52, P4726, DOI 10.1167/iovs.10-6836; Gekeler F, 2007, GRAEF ARCH CLIN EXP, V245, P230, DOI 10.1007/s00417-006-0339-x; Gueven D, 2005, J NEURAL ENG, V2, pS65, DOI 10.1088/1741-2560/2/1/009; Huang CQ, 1999, IEEE T BIO-MED ENG, V46, P461, DOI 10.1109/10.752943; Humayun MS, 1999, VISION RES, V39, P2569, DOI 10.1016/S0042-6989(99)00052-8; Humayun MS, 1996, ARCH OPHTHALMOL-CHIC, V114, P40, DOI 10.1001/archopht.1996.01100130038006; Humayun MS, 1999, INVEST OPHTH VIS SCI, V40, P143; John SE, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036011; Kanda H, 2013, ASS RES VIS OPHTH AN; Kandel E., 2000, PRINCIPLES NEURAL SC; Laube T, 2003, GRAEF ARCH CLIN EXP, V241, P1013, DOI 10.1007/s00417-003-0758-x; Marc RE, 2003, PROG RETIN EYE RES, V22, P607, DOI 10.1016/S1350-9462(03)00039-9; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Merrill DR, 2005, J NEUROSCI METH, V141, P171, DOI 10.1016/j.jneumeth.2004.10.020; Milam AH, 1998, PROG RETIN EYE RES, V17, P175; Morimoto T, 2011, INVEST OPHTH VIS SCI, V52, P6785, DOI 10.1167/iovs.10-6971; Nayagam DAX, 2013, JOVE-J VIS EXP, DOI 10.3791/50411; Nayagam DAX, 2011, SMALL, V7, P1035, DOI 10.1002/smll.201002083; Nayagam DAX, 2012, ASS RES VIS OPHTH AN; Robblee L S, 1990, NEURAL PROSTHESES FU; ROSE TL, 1990, IEEE T BIO-MED ENG, V37, P1118, DOI 10.1109/10.61038; Santos A, 1997, ARCH OPHTHALMOL-CHIC, V115, P511, DOI 10.1001/archopht.1997.01100150513011; Saunders AL, 2014, CLIN EXP OPHTHALMOL, V42, P665, DOI 10.1111/ceo.12287; SHANNON RV, 1992, IEEE T BIO-MED ENG, V39, P424, DOI 10.1109/10.126616; SHEPHERD RK, 1991, ACTA OTO-LARYNGOL, V111, P848, DOI 10.3109/00016489109138421; Shepherd RK, 2013, TRENDS BIOTECHNOL, V31, P562, DOI 10.1016/j.tibtech.2013.07.001; Shintani K, 2009, OPTOMETRY, V80, P384, DOI 10.1016/j.optm.2008.01.026; Shivdasani MN, 2013, 3 INT C MED BION ENG, P11; Shivdasani MN, 2012, INVEST OPHTH VIS SCI, V53, P6291, DOI 10.1167/iovs.12-9434; Shivdasani MN, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036008; Stone J, 1999, PROG RETIN EYE RES, V18, P689, DOI 10.1016/S1350-9462(98)00032-9; Terasawa Y, 2013, IEEE ENG MED BIO, P3567, DOI 10.1109/EMBC.2013.6610313; TUSA RJ, 1978, J COMP NEUROL, V177, P213, DOI 10.1002/cne.901770204; Villalobos J, 2011, ASS RES VIS OPHTH AN; Villalobos J, 2013, INVEST OPHTH VIS SCI, V54, P3751, DOI 10.1167/iovs.12-10843; Villalobos J, 2012, GRAEF ARCH CLIN EXP, V250, P399, DOI 10.1007/s00417-011-1794-6; Xu Jin, 2009, Cochlear Implants Int, V10 Suppl 1, P115, DOI 10.1179/cim.2009.10.Supplement-1.115; Zhou JA, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/547428; Zrenner E, 2002, SCIENCE, V295, P1022, DOI 10.1126/science.1067996	49	33	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97182	10.1371/journal.pone.0097182	http://dx.doi.org/10.1371/journal.pone.0097182			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853376	Green Published, gold			2022-12-25	WOS:000338323200018
J	Sanchez-Puerta, MV; Abbona, CC				Virginia Sanchez-Puerta, M.; Carolina Abbona, Cinthia			The Chloroplast Genome of Hyoscyamus niger and a Phylogenetic Study of the Tribe Hyoscyameae (Solanaceae)	PLOS ONE			English	Article							GROUP-I INTRON; PLANT MITOCHONDRIAL; NICOTIANA-TABACUM; PLASTID GENOMES; TANDEM REPEATS; TREE SELECTION; DNA-SEQUENCES; EVOLUTIONARY; TRANSCRIPTS; ANGIOSPERMS	The tribe Hyoscyameae (Solanaceae) is restricted to Eurasia and includes the genera Archihyoscyamus, Anisodus, Atropa, Atropanthe, Hyoscyamus, Physochlaina, Przewalskia and Scopolia. Even though the monophyly of Hyoscyameae is strongly supported, the relationships of the taxa within the tribe remain unclear. Chloroplast markers have been widely used to elucidate plant relationships at low taxonomic levels. Identification of variable chloroplast intergenic regions has been developed based on comparative genomics of chloroplast genomes, but these regions have a narrow phylogenetic utility. In this study, we present the chloroplast genome sequence of Hyoscyamus niger and make comparisons to other solanaceous plastid genomes in terms of gene order, gene and intron content, editing sites, origins of replication, repeats, and hypothetical open reading frames. We developed and sequenced three variable plastid markers from eight species to elucidate relationships within the tribe Hyoscyameae. The presence of a horizontally transferred intron in the mitochondrial cox1 gene of some species of the tribe is considered here a likely synapomorphy uniting five genera of the Hyoscyameae. Alternatively, the cox1 intron could be a homoplasious character acquired twice within the tribe. A homoplasious inversion in the intergenic plastid spacer trnC-psbM was recognized as a source of bias and removed from the data set used in the phylogenetic analyses. Almost 12 kb of plastid sequence data were not sufficient to completely resolve relationships among genera of Hyoscyameae but some clades were identified. Two alternative hypotheses of the evolution of the genera within the tribe are proposed.	[Virginia Sanchez-Puerta, M.] Univ Nacl Cuyo, CONICET, IBAM, Fac Ciencias Exactas & Nat, RA-5500 Mendoza, Argentina; [Virginia Sanchez-Puerta, M.; Carolina Abbona, Cinthia] Univ Nacl Cuyo, Fac Ciencias Agr, RA-5500 Mendoza, Argentina; [Carolina Abbona, Cinthia] Univ Nacl Cuyo, CONICET, IBAM, RA-5500 Mendoza, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza; University Nacional Cuyo Mendoza; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza	Sanchez-Puerta, MV (corresponding author), Univ Nacl Cuyo, CONICET, IBAM, Fac Ciencias Exactas & Nat, RA-5500 Mendoza, Argentina.	mvsanchezpuerta@fca.uncu.edu.ar		Sanchez-Puerta, Maria Virginia/0000-0003-2511-5093; Abbona, Cinthia/0000-0003-4498-6783	ANCyPT [PICT193]; NIH [FIRCA-BB R03 TW008353-01]; FOGARTY INTERNATIONAL CENTER [R03TW008353] Funding Source: NIH RePORTER	ANCyPT; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by grant PICT193 from ANCyPT to MVSP and NIH grant FIRCA-BB R03 TW008353-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkatib S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003076; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bremer B, 2000, PLANT SYST EVOL, V225, P43, DOI 10.1007/BF00985458; Cho Y, 1998, P NATL ACAD SCI USA, V95, P14244, DOI 10.1073/pnas.95.24.14244; Chung HJ, 2006, PLANT CELL REP, V25, P1369, DOI 10.1007/s00299-006-0196-4; D'ARCY W G, 1992, Novon, V2, P124, DOI 10.2307/3391672; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; FRAZER KA, 2004, NUCL ACIDS RES, V32; Freyer R, 1997, P NATL ACAD SCI USA, V94, P6285, DOI 10.1073/pnas.94.12.6285; Freyer R, 1995, PLANT MOL BIOL, V29, P679, DOI 10.1007/BF00041158; Gargano D, 2012, GENET RESOUR CROP EV, V59, P419, DOI 10.1007/s10722-011-9692-7; Gemeinholzer B, 2001, SOLANACEAE ADV TAXON, P165; Gordon D, 2013, BIOINFORMATICS, V29, P2936, DOI 10.1093/bioinformatics/btt515; Graybeal A, 1998, SYST BIOL, V47, P9, DOI 10.1080/106351598260996; Hirose T, 1999, MOL GEN GENET, V262, P462, DOI 10.1007/s004380051106; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jo YD, 2011, PLANT CELL REP, V30, P217, DOI 10.1007/s00299-010-0929-2; Kahlau S, 2006, J MOL EVOL, V63, P194, DOI 10.1007/s00239-005-0254-5; Khakhlova O, 2006, PLANT J, V46, P85, DOI 10.1111/j.1365-313X.2006.02673.x; Knapp S, 1997, B NAT HIST MUS LOND, V27, P11; Kunnimalaiyaan M, 1997, NUCLEIC ACIDS RES, V25, P3681, DOI 10.1093/nar/25.18.3681; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lu An-Ming, 1997, Adansonia, V19, P135; MADDISON WP, 2000, MACCLADE VERSION 4; Millen RS, 2001, PLANT CELL, V13, P645, DOI 10.1105/tpc.13.3.645; Mower JP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-96; OLMSTEAD RG, 1994, SYST BIOL, V43, P467, DOI 10.2307/2413546; Olmstead RG, 2008, TAXON, V57, P1159, DOI 10.1002/tax.574010; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Sarkinen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082266; Sarkinen T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-214; Sanchez-Puerta MV, 2008, MOL BIOL EVOL, V25, P1762, DOI 10.1093/molbev/msn129; Sanchez-Puerta MV, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-277; Sasaki T, 2003, MOL BIOL EVOL, V20, P1028, DOI 10.1093/molbev/msg098; Schmitz-Linneweber C, 2002, MOL BIOL EVOL, V19, P1602, DOI 10.1093/oxfordjournals.molbev.a004222; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Soltis PS, 2004, AM J BOT, V91, P1614, DOI 10.3732/ajb.91.10.1614; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; TETENYI P, 1987, ANN MO BOT GARD, V74, P600, DOI 10.2307/2399328; Tu TY, 2008, MOL PHYLOGENET EVOL, V49, P561, DOI 10.1016/j.ympev.2008.07.018; Tu TY, 2010, MOL PHYLOGENET EVOL, V57, P1226, DOI 10.1016/j.ympev.2010.09.007; Tu TY, 2005, BOT J LINN SOC, V147, P457, DOI 10.1111/j.1095-8339.2005.00384.x; Uhink CH, 2009, THESIS JOHANNES GUTE; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; XIAO PG, 1983, J ETHNOPHARMACOL, V8, P1, DOI 10.1016/0378-8741(83)90086-7; Yang DZ, 2002, ACTA BOT SIN, V44, P889; Yuan YW, 2006, MOL BIOL EVOL, V23, P2263, DOI 10.1093/molbev/msl099; Yukawa M, 2006, MOL GENET GENOMICS, V275, P367, DOI 10.1007/s00438-005-0092-6; Zhang ZY, 2005, TAXON, V54, P71, DOI 10.2307/25065303; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Zwickl D., 2006, GARLI GENETIC ALGORI	57	24	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98353	10.1371/journal.pone.0098353	http://dx.doi.org/10.1371/journal.pone.0098353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24851862	Green Submitted, Green Published, gold			2022-12-25	WOS:000338323200065
J	Yamamuro, A; Kouzuma, A; Abe, T; Watanabe, K				Yamamuro, Ayaka; Kouzuma, Atsushi; Abe, Takashi; Watanabe, Kazuya			Metagenomic Analyses Reveal the Involvement of Syntrophic Consortia in Methanol/Electricity Conversion in Microbial Fuel Cells	PLOS ONE			English	Article							INTERSPECIES HYDROGEN-TRANSFER; WASTE-WATER; SP-NOV.; ELECTRICITY-GENERATION; METHANOL; METABOLISM; BACTERIUM; SEQUENCES; ANODE	Methanol is widely used in industrial processes, and as such, is discharged in large quantities in wastewater. Microbial fuel cells (MFCs) have the potential to recover electric energy from organic pollutants in wastewater; however, the use of MFCs to generate electricity from methanol has not been reported. In the present study, we developed single-chamber MFCs that generated electricity from methanol at the maximum power density of 220 mW m(-2) (based on the projected area of the anode). In order to reveal how microbes generate electricity from methanol, pyrosequencing of 16S rRNA-gene amplicons and Illumina shotgun sequencing of metagenome were conducted. The pyrosequencing detected in abundance Dysgonomonas, Sporomusa, and Desulfovibrio in the electrolyte and anode and cathode biofilms, while Geobacter was detected only in the anode biofilm. Based on known physiological properties of these bacteria, it is considered that Sporomusa converts methanol into acetate, which is then utilized by Geobacter to generate electricity. This speculation is supported by results of shotgun metagenomics of the anode-biofilm microbes, which reconstructed relevant catabolic pathways in these bacteria. These results suggest that methanol is anaerobically catabolized by syntrophic bacterial consortia with electrodes as electron acceptors.	[Yamamuro, Ayaka; Kouzuma, Atsushi; Watanabe, Kazuya] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Hachioji, Tokyo 19203, Japan; [Abe, Takashi] Niigata Univ, Grad Sch Sci & Technol, Niigata, Niigata, Japan	Tokyo University of Pharmacy & Life Sciences; Niigata University	Watanabe, K (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, 1432-1 Horinouchi, Hachioji, Tokyo 19203, Japan.	kazuyaw@toyaku.ac.jp	Kouzuma, Atsushi/M-4559-2019	Kouzuma, Atsushi/0000-0002-5076-3810	New Energy and Industrial Technology Development Organization (NEDO) of Japan	New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by the New Energy and Industrial Technology Development Organization (NEDO) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TD, 2008, INT J SYST EVOL MICR, V58, P1313, DOI 10.1099/ijs.0.65524-0; ANTHONY C, 1990, FEMS MICROBIOL LETT, V87, P209, DOI 10.1016/0378-1097(90)90456-Z; Bond DR, 2003, APPL ENVIRON MICROB, V69, P1548, DOI 10.1128/AEM.69.3.1548-1555.2003; Breznak JA, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P991, DOI 10.1007/0-387-30744-3_34; Butler JE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-40; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cheng S, 2006, ELECTROCHEM COMMUN, V8, P489, DOI 10.1016/j.elecom.2006.01.010; CORDRUWISCH R, 1986, ARCH MICROBIOL, V144, P163, DOI 10.1007/BF00414728; Dimroth P, 1998, ARCH MICROBIOL, V170, P69, DOI 10.1007/s002030050616; Gore D, 2011, BIOCOMPX, V1, P23; He Z, 2005, ENVIRON SCI TECHNOL, V39, P5262, DOI 10.1021/es0502876; HEIJTHUIJSEN JHFG, 1986, FEMS MICROBIOL ECOL, V38, P57, DOI 10.1016/0378-1097(86)90042-X; Hippler B, 1999, FEBS LETT, V449, P165, DOI 10.1016/S0014-5793(99)00429-9; Hofstad T, 2000, INT J SYST EVOL MICR, V50, P2189, DOI 10.1099/00207713-50-6-2189; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Ishii S, 2005, APPL ENVIRON MICROB, V71, P7838, DOI 10.1128/AEM.71.12.7838-7845.2005; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KELLY DP, 1994, MICROBIOL-SGM, V140, P1419, DOI 10.1099/00221287-140-6-1419; Kim JR, 2007, BIORESOURCE TECHNOL, V98, P2568, DOI 10.1016/j.biortech.2006.09.036; Kodama Y, 2012, INT J SYST EVOL MICR, V62, P3055, DOI 10.1099/ijs.0.039040-0; Kouzuma A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077443; LANGRAND G, 1990, BIOTECHNOL LETT, V12, P581, DOI 10.1007/BF01030756; Lefebvre O, 2011, APPL MICROBIOL BIOT, V89, P259, DOI 10.1007/s00253-010-2881-z; Liu H, 2004, ENVIRON SCI TECHNOL, V38, P2281, DOI 10.1021/es034923g; LJUNGDAHL LG, 1969, ANNU REV MICROBIOL, V23, P515, DOI 10.1146/annurev.mi.23.100169.002503; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5181, DOI 10.1021/es0605016; Marcus AK, 2007, BIOTECHNOL BIOENG, V98, P1171, DOI 10.1002/bit.21533; MINAMI K, 1991, J FERMENT BIOENG, V71, P270, DOI 10.1016/0922-338X(91)90280-T; Miyahara M, 2013, J BIOSCI BIOENG, V115, P176, DOI 10.1016/j.jbiosc.2012.09.003; Nakao R, 2013, ISME J, V7, P1003, DOI 10.1038/ismej.2012.171; Newton GJ, 2009, APPL ENVIRON MICROB, V75, P7674, DOI 10.1128/AEM.01142-09; Poehlein A, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00734-13; Pritchett MA, 2005, MOL MICROBIOL, V56, P1183, DOI 10.1111/j.1365-2958.2005.04616.x; REED TB, 1973, SCIENCE, V182, P1299, DOI 10.1126/science.182.4119.1299; Rozendal RA, 2008, TRENDS BIOTECHNOL, V26, P450, DOI 10.1016/j.tibtech.2008.04.008; Segura D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040036; Shimoyama T, 2009, MICROBES ENVIRON, V24, P188, DOI 10.1264/jsme2.ME09108; STUPPERICH E, 1993, APPL ENVIRON MICROB, V59, P3110, DOI 10.1128/AEM.59.9.3110-3116.1993; Sun D, 2012, BIOTECHNOL BIOENG, V109, P405, DOI 10.1002/bit.23348; SWAIN HM, 1978, J APPL BACTERIOL, V45, P147, DOI 10.1111/j.1365-2672.1978.tb04209.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Van Verseveld H.W., 1987, MICROBIAL GROWTH C1, P282; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Watanabe K, 2008, J BIOSCI BIOENG, V106, P528, DOI 10.1263/jbb.106.528; Watanabe K, 2011, APPL MICROBIOL BIOT, V92, P1307, DOI 10.1007/s00253-011-3598-3; Wiegel J, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P290, DOI 10.1007/0-387-30745-1_16; Xie CH, 2005, INT J SYST EVOL MICR, V55, P1233, DOI 10.1099/ijs.0.63406-0; Zhao F, ENV SCI TECHNOL, V42, P4971	48	24	25	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98425	10.1371/journal.pone.0098425	http://dx.doi.org/10.1371/journal.pone.0098425			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852573	Green Submitted, Green Published, gold			2022-12-25	WOS:000338323200071
J	Zhao, Y; Xu, T; Shen, CY; Xu, GH; Chen, SX; Song, LZ; Li, MJ; Wang, LL; Zhu, Y; Lv, WT; Gong, ZZ; Liu, CM; Deng, X				Zhao, Yan; Xu, Tao; Shen, Chun-Ying; Xu, Guang-Hui; Chen, Shi-Xuan; Song, Li-Zhen; Li, Mei-Jing; Wang, Li-Li; Zhu, Yan; Lv, Wei-Tao; Gong, Zhi-Zhong; Liu, Chun-Ming; Deng, Xin			Identification of a Retroelement from the Resurrection Plant Boea hygrometrica That Confers Osmotic and Alkaline Tolerance in Arabidopsis thaliana	PLOS ONE			English	Article							GENOMIC DNA FRAGMENTS; CRATEROSTIGMA-PLANTAGINEUM; RAMONDA-SERBICA; DEHYDRATION TOLERANCE; DESICCATION TOLERANCE; HABERLEA-RHODOPENSIS; STRESS RESPONSES; ABIOTIC STRESSES; BIBAC LIBRARY; SMALL RNAS	Functional genomic elements, including transposable elements, small RNAs and non-coding RNAs, are involved in regulation of gene expression in response to plant stress. To identify genomic elements that regulate dehydration and alkaline tolerance in Boea hygrometrica, a resurrection plant that inhabits drought and alkaline Karst areas, a genomic DNA library from B. hygrometrica was constructed and subsequently transformed into Arabidopsis using binary bacterial artificial chromosome (BIBAC) vectors. Transgenic lines were screened under osmotic and alkaline conditions, leading to the identification of Clone L1-4 that conferred osmotic and alkaline tolerance. Sequence analyses revealed that L1-4 contained a 49-kb retroelement fragment from B. hygrometrica, of which only a truncated sequence was present in L1-4 transgenic Arabidopsis plants. Additional subcloning revealed that activity resided in a 2-kb sequence, designated Osmotic and Alkaline Resistance 1 (OAR1). In addition, transgenic Arabidopsis lines carrying an OAR1-homologue also showed similar stress tolerance phenotypes. Physiological and molecular analyses demonstrated that OAR1-transgenic plants exhibited improved photochemical efficiency and membrane integrity and biomarker gene expression under both osmotic and alkaline stresses. Short transcripts that originated from OAR1 were increased under stress conditions in both B. hygrometrica and Arabidopsis carrying OAR1. The relative copy number of OAR1 was stable in transgenic Arabidopsis under stress but increased in B. hygrometrica. Taken together, our results indicated a potential role of OAR1 element in plant tolerance to osmotic and alkaline stresses, and verified the feasibility of the BIBAC transformation technique to identify functional genomic elements from physiological model species.	[Zhao, Yan; Xu, Tao; Shen, Chun-Ying; Xu, Guang-Hui; Chen, Shi-Xuan; Song, Li-Zhen; Li, Mei-Jing; Wang, Li-Li; Zhu, Yan; Lv, Wei-Tao; Deng, Xin] Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China; [Song, Li-Zhen; Liu, Chun-Ming] Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing, Peoples R China; [Gong, Zhi-Zhong] China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; China Agricultural University	Deng, X (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China.	deng@ibcas.ac.cn	Xin, deng/AAH-4009-2020; Gong, Zhizhong/AAS-4796-2021		National Natural Science Foundation of China [31270312, 30970431]; National High Technology Research and Development Program of China (863 Program) [2007AA021403]; National Basic Research Program of China (973 Program) [2012CB114302]; Ministry of Agriculture of China [2009ZX08009-060B]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This work was supported by the National Natural Science Foundation of China (31270312 and 30970431), the National High Technology Research and Development Program of China (863 Program, 2007AA021403), the National Basic Research Program of China (973 Program, 2012CB114302), and the Ministry of Agriculture of China (2009ZX08009-060B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2002, INSECT MOL BIOL, V11, P307, DOI 10.1046/j.1365-2583.2002.00339.x; Abraham Edit, 2011, Acta Biologica Szegediensis, V55, P53; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Boyko A, 2011, CURR OPIN PLANT BIOL, V14, P260, DOI 10.1016/j.pbi.2011.03.003; Bui Q.T., 2012, PLANT TRANSPOSABLE E, P273, DOI 10.1007/978-3-642-31842-9_14; Chang YL, 2003, THEOR APPL GENET, V106, P269, DOI 10.1007/s00122-002-1074-2; Chang YL, 2011, GENOME, V54, P437, DOI [10.1139/G11-011, 10.1139/g11-011]; Chaves MM, 2002, ANN BOT-LONDON, V89, P907, DOI 10.1093/aob/mcf105; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Correa R, 2012, NEW PHYTOL, V193, P494, DOI 10.1111/j.1469-8137.2011.03949.x; Deng X, 2003, PLANT SCI, V165, P851, DOI 10.1016/S0168-9452(03)00284-X; Dolezel J, 2005, ANN BOT-LONDON, V95, P99, DOI 10.1093/aob/mci005; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Drazic G, 1999, J PLANT PHYSIOL, V154, P379, DOI 10.1016/S0176-1617(99)80184-9; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Flavell AJ, 1997, GENETICA, V100, P185, DOI 10.1023/A:1018385713293; Furini A, 1997, EMBO J, V16, P3599, DOI 10.1093/emboj/16.12.3599; Gao P, 2011, MOL BIOL REP, V38, P237, DOI 10.1007/s11033-010-0100-8; Georgieva K, 2007, PLANTA, V225, P955, DOI 10.1007/s00425-006-0396-8; Georgieva K, 2010, ANN BOT-LONDON, V105, P117, DOI 10.1093/aob/mcp274; Gutzat R, 2012, CURR OPIN PLANT BIOL, V15, P568, DOI 10.1016/j.pbi.2012.08.007; Hamilton CM, 1999, PLANT J, V18, P223, DOI 10.1046/j.1365-313X.1999.00433.x; Havecker ER, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-225; Hilbricht T, 2008, NEW PHYTOL, V179, P877, DOI 10.1111/j.1469-8137.2008.02480.x; Jiang GQ, 2007, PLANTA, V225, P1405, DOI 10.1007/s00425-006-0449-z; Jones Jonathan D. G., 1992, Transgenic Research, V1, P285, DOI 10.1007/BF02525170; Leigh F, 2003, MOL GENET GENOMICS, V269, P464, DOI 10.1007/s00438-003-0850-2; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Liu CC, 2011, ENVIRON EXP BOT, V71, P174, DOI 10.1016/j.envexpbot.2010.11.012; Liu X, 2009, PLANT SCI, V176, P90, DOI 10.1016/j.plantsci.2008.09.012; Liu YG, 1999, P NATL ACAD SCI USA, V96, P6535, DOI 10.1073/pnas.96.11.6535; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; McCubbin AG, 2000, GENOME, V43, P820, DOI 10.1139/gen-43-5-820; Petrova G, 2014, PLANT SYST EVOL, V300, P29, DOI 10.1007/s00606-013-0857-z; Piegu B, 2006, GENOME RES, V16, P1262, DOI 10.1101/gr.5290206; Qin QL, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-247, 10.1186/1471-2164-11-501]; Quartacci MF, 2002, J EXP BOT, V53, P2159, DOI 10.1093/jxb/erf076; Rakic T, 2009, PLANT ECOL, V203, P13, DOI 10.1007/s11258-008-9498-7; Rangwala SH, 2006, PLOS GENET, V2, P270, DOI 10.1371/journal.pgen.0020036; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Sawa S, 1999, GENE DEV, V13, P1079, DOI 10.1101/gad.13.9.1079; Shapiro JA, 2005, BIOESSAYS, V27, P122, DOI 10.1002/bies.20192; Shibata D, 2000, TRENDS PLANT SCI, V5, P354, DOI 10.1016/S1360-1385(00)01689-7; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Shukla LI, 2008, BBA-GENE REGUL MECH, V1779, P743, DOI 10.1016/j.bbagrm.2008.04.004; Smith-Espinoza CJ, 2005, MOL GENET GENOMICS, V274, P364, DOI 10.1007/s00438-005-0027-2; Song J, 2003, THEOR APPL GENET, V107, P958, DOI 10.1007/s00122-003-1334-9; Suoniemi A, 1996, PLANT MOL BIOL, V31, P295, DOI 10.1007/BF00021791; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Wang WQ, 2010, PLANT MOL BIOL, V72, P91, DOI 10.1007/s11103-009-9553-3; WARDLAW IF, 1967, AUST J BIOL SCI, V20, P309, DOI 10.1071/BI9670309; Wei Yuan, 2012, African Journal of Biotechnology, V11, P14561; Xu WB, 2009, NOVON, V19, P559, DOI 10.3417/2008014; Yue B, 2006, GENETICS, V172, P1213, DOI 10.1534/genetics.105.045062; ZHANG HB, 1995, PLANT J, V7, P175, DOI 10.1046/j.1365-313X.1995.07010175.x; Zhang HB, 2012, NAT PROTOC, V7, P479, DOI 10.1038/nprot.2011.456; Zhang ZN, 2013, BIOLOGIA, V68, P651, DOI 10.2478/s11756-013-0204-4; Zheng J, 2010, PLANT MOL BIOL, V72, P407, DOI 10.1007/s11103-009-9579-6	59	14	15	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98098	10.1371/journal.pone.0098098	http://dx.doi.org/10.1371/journal.pone.0098098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24851859	Green Published, Green Submitted, gold			2022-12-25	WOS:000338323200045
J	Backman, S; Kollara, A; Haw, R; Stein, L; Brown, TJ				Backman, Stephanie; Kollara, Alexandra; Haw, Robin; Stein, Lincoln; Brown, Theodore J.			Glucocorticoid-Induced Reversal of Interleukin-1 beta-Stimulated Inflammatory Gene Expression in Human Oviductal Cells	PLOS ONE			English	Article							TUBAL INTRAEPITHELIAL CARCINOMA; HUMAN FALLOPIAN-TUBE; OVARIAN-CANCER RISK; NF-KAPPA-B; SEROUS CARCINOMA; FOLLICULAR-FLUID; RECEPTOR; CYTOKINE; ELAFIN; BRCA1	Studies indicate that high-grade serous ovarian carcinoma (HGSOC), the most common epithelial ovarian carcinoma histotype, originates from the fallopian tube epithelium (FTE). Risk factors for this cancer include reproductive parameters associated with lifetime ovulatory events. Ovulation is an acute inflammatory process during which the FTE is exposed to follicular fluid containing both pro- and anti-inflammatory molecules, such as interleukin-1 (IL1), tumor necrosis factor (TNF), and cortisol. Repeated exposure to inflammatory cytokines may contribute to transforming events in the FTE, with glucocorticoids exerting a protective effect. The global response of FTE cells to inflammatory cytokines or glucocorticoids has not been investigated. To examine the response of FTE cells and the ability of glucocorticoids to oppose this response, an immortalized human FTE cell line, OE-E6/E7, was treated with IL1 beta, dexamethasone (DEX), IL1 beta and DEX, or vehicle and genome-wide gene expression profiling was performed. IL1 beta altered the expression of 47 genes of which 17 were reversed by DEX. DEX treatment alone altered the expression of 590 genes, whereas combined DEX and IL1 beta treatment altered the expression of 784 genes. Network and pathway enrichment analysis indicated that many genes altered by DEX are involved in cytokine, chemokine, and cell cycle signaling, including NF kappa B target genes and interacting proteins. Quantitative real time RT-PCR studies validated the gene array data for IL8, IL23A, PI3 and TACC2 in OE-E6/E7 cells. Consistent with the array data, Western blot analysis showed increased levels of PTGS2 protein induced by IL1 beta that was blocked by DEX. A parallel experiment using primary cultured human FTE cells indicated similar effects on PTGS2, IL8, IL23A, PI3 and TACC2 transcripts. These findings support the hypothesis that pro-inflammatory signaling is induced in FTE cells by inflammatory mediators and raises the possibility that dysregulation of glucocorticoid signaling could contribute to increased risk for HGSOC.	[Backman, Stephanie; Kollara, Alexandra; Brown, Theodore J.] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada; [Kollara, Alexandra; Brown, Theodore J.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Haw, Robin; Stein, Lincoln] Ontario Inst Canc Res Informat & Biocomp, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Ontario Institute for Cancer Research	Brown, TJ (corresponding author), Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada.	brown@lunenfeld.ca	Brown, Theodore J./E-2192-2013; Haw, Robin/D-1393-2009	Brown, Theodore J./0000-0002-3074-4516; Haw, Robin/0000-0002-2013-7835	CIHR (Canadian Institutes of Health Research) [MOP106679]	CIHR (Canadian Institutes of Health Research)(Canadian Institutes of Health Research (CIHR))	This work was supported by CIHR (Canadian Institutes of Health Research) MOP106679. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2011, CANCER DISCOV, V1, P469, DOI 10.1158/2159-8290.CD-11-0260; Almawi WY, 1996, J LEUKOCYTE BIOL, V60, P563, DOI 10.1002/jlb.60.5.563; Ammundsen HB, 2012, ACTA OBSTET GYN SCAN, V91, P1094, DOI 10.1111/j.1600-0412.2012.01472.x; [Anonymous], 2004, PAED PERINATAL DRUG; Baandrup L, 2013, ACTA OBSTET GYN SCAN, V92, P245, DOI 10.1111/aogs.12069; Bingle L, 2001, AM J RESP CELL MOL, V25, P84, DOI 10.1165/ajrcmb.25.1.4341; Buscher U, 1999, HUM REPROD, V14, P162, DOI 10.1093/humrep/14.1.162; CALDENHOVEN E, 1995, MOL ENDOCRINOL, V9, P401, DOI 10.1210/me.9.4.401; Carlson JW, 2008, J CLIN ONCOL, V26, P4160, DOI 10.1200/JCO.2008.16.4814; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Cheng Shan, 2010, Cancer Genomics & Proteomics, V7, P67; Crum CP, 2007, CURR OPIN OBSTET GYN, V19, P3, DOI 10.1097/GCO.0b013e328011a21f; Finch A, 2006, GYNECOL ONCOL, V100, P58, DOI 10.1016/j.ygyno.2005.06.065; Fotheringham S, 2011, JOVE-J VIS EXP, DOI 10.3791/2728; Gangisetty O, 2004, ONCOGENE, V23, P2559, DOI 10.1038/sj.onc.1207424; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerard N, 2004, J ENDOCRINOL, V180, P203, DOI 10.1677/joe.0.1800203; Ghosh M, 2010, IMMUNOLOGY, V129, P207, DOI 10.1111/j.1365-2567.2009.03165.x; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gross J., 1998, GRAPH THEORY ITS APP; Henriksen PA, 2004, J IMMUNOL, V172, P4535, DOI 10.4049/jimmunol.172.7.4535; Hunn J, 2012, CLIN OBSTET GYNECOL, V55, P3, DOI 10.1097/GRF.0b013e31824b4611; Johnson ML, 1999, BIOL REPROD, V61, P1581, DOI 10.1095/biolreprod61.6.1581; Karihtala P, 2009, INT J GYNECOL CANCER, V19, P1047, DOI 10.1111/IGC.0b013e3181ad0f0d; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47; King AE, 2009, HUM REPROD, V24, P679, DOI 10.1093/humrep/den452; Kollara A, 2006, BIOCHEM BIOPH RES CO, V346, P526, DOI 10.1016/j.bbrc.2006.05.148; Kuhn E, 2012, J PATHOL, V226, P421, DOI 10.1002/path.3023; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Lauffart B, 2003, GENOMICS, V81, P192, DOI 10.1016/S0888-7543(02)00039-3; Lauffart B., 2007, CANC THERAPY, V5, P409; Lauffart Brenda, 2005, BMC Womens Health, V5, P8, DOI 10.1186/1472-6874-5-8; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Lee YL, 2001, MOL REPROD DEV, V59, P400, DOI 10.1002/mrd.1046; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Ling L, 2005, FERTIL STERIL, V84, P1095, DOI 10.1016/j.fertnstert.2005.06.006; Lokshin AE, 2006, GYNECOL ONCOL, V102, P244, DOI 10.1016/j.ygyno.2005.12.011; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Maccio A, 2012, CYTOKINE, V58, P133, DOI 10.1016/j.cyto.2012.01.015; McGuire V, 2004, AM J EPIDEMIOL, V160, P613, DOI 10.1093/aje/kwh284; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; McLaughlin JR, 2007, LANCET ONCOL, V8, P26, DOI 10.1016/S1470-2045(06)70983-4; Menter DG, 2010, CLIN CANCER RES, V16, P1384, DOI 10.1158/1078-0432.CCR-09-0788; Mikosz CA, 2001, J BIOL CHEM, V276, P16649, DOI 10.1074/jbc.M010842200; Monkkonen KS, 2007, MOL HUM REPROD, V13, P845, DOI 10.1093/molehr/gam075; Mulayim N, 2003, AM J OBSTET GYNECOL, V188, P651, DOI 10.1067/mob.2003.135; Necela Brian M, 2004, Proc Am Thorac Soc, V1, P239, DOI 10.1513/pats.200402-005MS; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Palter SF, 2001, J CLIN ENDOCR METAB, V86, P2660, DOI 10.1210/jc.86.6.2660; Piek JMJ, 2001, J PATHOL, V195, P451, DOI 10.1002/path.1000; Pujols L, 2009, EUR RESPIR J, V33, P502, DOI 10.1183/09031936.00017408; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Revelli A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-40; Roghanian A, 2006, AM J RESP CELL MOL, V34, P634, DOI 10.1165/rcmb.2005-0405OC; Runnebaum IB, 2005, CLIN CANCER RES, V11, P6325, DOI 10.1158/1078-0432.CCR-05-0182; Seidman JD, 2011, GYNECOL ONCOL, V120, P470, DOI 10.1016/j.ygyno.2010.11.020; Sen R, 2010, COLD SPRING HARB PER, V2; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sogaard M, 2006, ACTA OBSTET GYN SCAN, V85, P93, DOI 10.1080/00016340500324621; Soslow RA, 2008, INT J GYNECOL PATHOL, V27, P161, DOI 10.1097/PGP.0b013e31815ea812; Still IH, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-16; Stock SJ, 2009, REPROD SCI, V16, P1125, DOI 10.1177/1933719109341998; Sun HP, 2008, AM J PHYSIOL-CELL PH, V295, pC915, DOI 10.1152/ajpcell.90646.2007; Takayama KI, 2012, MOL ENDOCRINOL, V26, P748, DOI 10.1210/me.2011-1242; Tang SG, 2012, INT J GYNECOL PATHOL, V31, P103, DOI 10.1097/PGP.0b013e31822ea955; Teng MWL, 2010, P NATL ACAD SCI USA, V107, P8328, DOI 10.1073/pnas.1003251107; Tone AA, 2008, CLIN CANCER RES, V14, P4067, DOI 10.1158/1078-0432.CCR-07-4959; Tone AA, 2012, CLIN CANCER RES, V18, P4334, DOI 10.1158/1078-0432.CCR-12-0199; Tone AA, 2011, ENDOCR-RELAT CANCER, V18, P221, DOI 10.1530/ERC-10-0235; Trinchieri G, 2012, ANNU REV IMMUNOL, V30, P677, DOI 10.1146/annurev-immunol-020711-075008; Tung KH, 2005, AM J EPIDEMIOL, V161, P321, DOI 10.1093/aje/kwi046; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; Wang B, 2012, MODEL IDENT CONTROL, V33, P27, DOI 10.4173/mic.2012.1.3; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Wanggren K, 2008, HUM REPROD, V23, P2359, DOI 10.1093/humrep/den260; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53; Xu L, 2000, ONCOL RES, V12, P97, DOI 10.3727/096504001108747567; Zhu XO, 2009, MOL ENDOCRINOL, V23, P1839, DOI 10.1210/me.2009-0201	80	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97997	10.1371/journal.pone.0097997	http://dx.doi.org/10.1371/journal.pone.0097997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848801	Green Published, Green Submitted, gold			2022-12-25	WOS:000336730600074
J	Couturier, A; Keller, J; Most, E; Ringseis, R; Eder, K				Couturier, Aline; Keller, Janine; Most, Erika; Ringseis, Robert; Eder, Klaus			Niacin in Pharmacological Doses Alters MicroRNA Expression in Skeletal Muscle of Obese Zucker Rats	PLOS ONE			English	Article							NICOTINIC-ACID; GENE-EXPRESSION; FATTY-ACIDS; PLASMA; SUPPLEMENTATION; ADIPONECTIN; CHOLESTEROL; TRANSITION; MECHANISM; PGC-1	Administration of pharmacological niacin doses was recently reported to have pronounced effects on skeletal muscle gene expression and phenotype in obese Zucker rats, with the molecular mechanisms underlying the alteration of gene expression being completely unknown. Since miRNAs have been shown to play a critical role for gene expression through inducing miRNA-mRNA interactions which results in the degradation of specific mRNAs or the repression of protein translation, we herein aimed to investigate the influence of niacin at pharmacological doses on the miRNA expression profile in skeletal muscle of obese Zucker rats fed either a control diet with 30 mg supplemented niacin/kg diet or a high-niacin diet with 780 mg supplemented niacin/kg diet for 4 wk. miRNA microarray analysis revealed that 42 out of a total of 259 miRNAs were differentially expressed (adjusted P-value <0.05), 20 being down-regulated and 22 being up-regulated, between the niacin group and the control group. Using a biostatistics approach, we could demonstrate that the most strongly up-regulated (log2 ratio >= 0.5) and down-regulated (log2 ratio <=-0.5) miRNAs target approximately 1,800 mRNAs. Gene-term enrichment analysis showed that many of the predicted target mRNAs from the most strongly regulated miRNAs were involved in molecular processes dealing with gene transcription such as DNA binding, transcription regulator activity, transcription factor binding and in important regulatory pathways such as Wnt signaling and MAPK signaling. In conclusion, the present study shows for the first time that pharmacological niacin doses alter the expression of miRNAs in skeletal muscle of obese Zucker rats and that the niacin-regulated miRNAs target a large set of genes and pathways which are involved in gene regulatory activity indicating that at least some of the recently reported effects of niacin on skeletal muscle gene expression and phenotype in obese Zucker rats are mediated through miRNA-mRNA interactions.	[Couturier, Aline; Keller, Janine; Most, Erika; Ringseis, Robert; Eder, Klaus] Univ Giessen, Inst Anim Nutr & Nutr Physiol, D-35390 Giessen, Germany	Justus Liebig University Giessen	Couturier, A (corresponding author), Univ Giessen, Inst Anim Nutr & Nutr Physiol, D-35390 Giessen, Germany.	aline.couturier@ernaehrung.uni-giessen.de	Ringseis, Robert/AAH-1509-2021		Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	JK is financed by the Deutsche Forschungsgemeinschaft (DFG). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao BL, 2010, J NUTR, V140, P1546, DOI 10.3945/jn.110.126359; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benyo Z, 2005, J CLIN INVEST, V115, P3634, DOI 10.1172/JCI23626; Carlson LA, 2005, J INTERN MED, V258, P94, DOI 10.1111/j.1365-2796.2005.01528.x; CISTERNAS P, 2013, MOL NEUROBIOL; DISHAO LY, 2010, MITOCHONDRION, V10, P516; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ganji SH, 2003, J NUTR BIOCHEM, V14, P298, DOI 10.1016/S0955-2863(02)00284-X; Garzon R, 2007, ONCOGENE, V26, P4148, DOI 10.1038/sj.onc.1210186; Ge Q, 2012, ENDOCRINOLOGY, V153, P5285, DOI 10.1210/en.2012-1623; Gille A, 2008, ANNU REV PHARMACOL, V48, P79, DOI 10.1146/annurev.pharmtox.48.113006.094746; Guyton JR, 1998, AM J CARDIOL, V82, p18U, DOI 10.1016/S0002-9149(98)00767-X; Hemandez C, 2010, CELL METAB, V12, P411, DOI 10.1016/j.cmet.2010.09.001; Hu Y, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-16; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; JUFFER P, 2014, CELL BIOCH BIOPHYS; Kamanna VS, 2008, AM J CARDIOL, V101, p20B, DOI 10.1016/j.amjcard.2008.02.029; Karere GM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-320; Keller J, 2012, ANIMAL, V6, P70, DOI 10.1017/S1751731111001327; Khan M, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-85; Kirkland JB, 2009, CURR PHARM DESIGN, V15, P3, DOI 10.2174/138161209787185823; Knutti D, 2001, P NATL ACAD SCI USA, V98, P9713, DOI 10.1073/pnas.171184698; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kwiterovich PO, 1998, AM J CARDIOL, V82, p39U, DOI 10.1016/S0002-9149(98)00958-8; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li D, 2013, BRIT J NUTR, V110, P2156, DOI 10.1017/S0007114513001815; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu M, 2012, J CHROMATOGR B, V904, P107, DOI 10.1016/j.jchromb.2012.07.030; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; National Research Council, 1985, GUIDE CARE USE LAB A; Parra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013005; Peng XJ, 2010, J CELL BIOCHEM, V110, P1324, DOI 10.1002/jcb.22646; Plaisance EP, 2008, METABOLISM, V57, P404, DOI 10.1016/j.metabol.2007.10.018; Pohl J, 2002, J LIPID RES, V43, P1390, DOI 10.1194/jlr.M100404-JLR200; QUABBE HJ, 1983, J CLIN ENDOCR METAB, V57, P410, DOI 10.1210/jcem-57-2-410; Ring A, 2006, BBA-MOL CELL BIOL L, V1761, P416, DOI 10.1016/j.bbalip.2006.03.016; Ringseis R, 2013, J NUTR, V143, P125, DOI 10.3945/jn.112.164038; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Roepstorff C, 2004, AM J PHYSIOL-ENDOC M, V287, pE696, DOI 10.1152/ajpendo.00001.2004; Lipszyc PS, 2013, OPEN CARDIOVASC MED, V7, P90, DOI 10.2174/1874192401307010090; Scholz K, 2014, EUR J NUTR, V53, P1229, DOI 10.1007/s00394-013-0624-5; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Terao M, 2011, J BIOL CHEM, V286, P4027, DOI 10.1074/jbc.M110.184994; Wanders D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071285; Wang WLW, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-58; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Watt MJ, 2004, J MOL ENDOCRINOL, V33, P533, DOI 10.1677/jme.1.01499; Weijts BGMW, 2012, EMBO J, V31, P3871, DOI 10.1038/emboj.2012.231; Westphal S, 2007, ATHEROSCLEROSIS, V193, P361, DOI 10.1016/j.atherosclerosis.2006.06.028; Wu BJ, 2010, ARTERIOSCL THROM VAS, V30, P968, DOI 10.1161/ATVBAHA.109.201129	52	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98313	10.1371/journal.pone.0098313	http://dx.doi.org/10.1371/journal.pone.0098313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847987	Green Published, Green Submitted, gold			2022-12-25	WOS:000336730600108
J	Lee, SY; Yu, J; Ahn, KM; Kim, KW; Shin, YH; Lee, KS; Hong, SA; Jung, YH; Lee, E; Yang, SI; Seo, JH; Kwon, JW; Kim, BJ; Kim, HB; Kim, WK; Song, DJ; Jang, GC; Shim, JY; Lee, SY; Kwon, JY; Choi, SJ; Lee, KJ; Park, HJ; Won, HS; Yoo, HS; Kang, MJ; Kim, HY; Hong, SJ				Lee, So-Yeon; Yu, Jinho; Ahn, Kang-Mo; Kim, Kyung Won; Shin, Youn Ho; Lee, Kyung-shin; Hong, Seo Ah; Jung, Young-ho; Lee, Eun; Yang, Song-I; Seo, Ju-hee; Kwon, Ji-Won; Kim, Byoung-Ju; Kim, Hyo-Bin; Kim, Woo-Kyung; Song, Dae Jin; Jang, Gwang Cheon; Shim, Jung Yeon; Lee, Soo-Young; Kwon, Ja-Young; Choi, Suk-Joo; Lee, Kyung-Ju; Park, Hee Jin; Won, Hye-Sung; Yoo, Ho-Sung; Kang, Mi-Jin; Kim, Hyung-Young; Hong, Soo-Jong			Additive Effect between IL-13 Polymorphism and Cesarean Section Delivery/Prenatal Antibiotics Use on Atopic Dermatitis: A Birth Cohort Study (COCOA)	PLOS ONE			English	Article							GASTROINTESTINAL MICROBIOTA; INTESTINAL MICROBIOTA; ALLERGIC RHINITIS; KOREAN CHILDREN; DELIVERY; ECZEMA; INTERLEUKIN-13; SENSITIZATION; GENES; RISK	Background: Although cesarean delivery and prenatal exposure to antibiotics are likely to affect the gut microbiome in infancy, their effect on the development of atopic dermatitis (AD) in infancy is unclear. The influence of individual genotypes on these relationships is also unclear. To evaluate with a prospective birth cohort study whether cesarean section, prenatal exposure to antibiotics, and susceptible genotypes act additively to promote the development of AD in infancy. Methods: The Cohort for Childhood of Asthma and Allergic Diseases (COCOA) was selected from the general Korean population. A pediatric allergist assessed 412 infants for the presence of AD at 1 year of age. Their cord blood DNA was subjected to interleukin (IL)-13 (rs20541) and cluster-of-differentiation (CD) 14 (rs2569190) genotype analysis. Results: The combination of cesarean delivery and prenatal exposure to antibiotics associated significantly and positively with AD (adjusted odds ratio, 5.70; 95% CI, 1.19-27.3). The association between cesarean delivery and AD was significantly modified by parental history of allergic diseases or risk-associated IL-13 (rs20541) and CD14 (rs2569190) genotypes. There was a trend of interaction between IL-13 (rs20541) and delivery mode with respect to the subsequent risk of AD. (P for interaction = 0.039) Infants who were exposed prenatally to antibiotics and were born by cesarean delivery had a lower total microbiota diversity in stool samples at 6 months of age than the control group. As the number of these risk factors increased, the AD risk rose (trend p<0.05). Conclusion: Cesarean delivery and prenatal antibiotic exposure may affect the gut microbiota, which may in turn influence the risk of AD in infants. These relationships may be shaped by the genetic predisposition.	[Lee, So-Yeon] Hallym Univ, Coll Med, Dept Pediat, Anyang, South Korea; [Yu, Jinho; Hong, Seo Ah; Jung, Young-ho; Lee, Eun; Yang, Song-I; Hong, Soo-Jong] Asan Med Ctr, Childhood Asthma Atopy Ctr, Seoul, South Korea; [Ahn, Kang-Mo; Shim, Jung Yeon] Sungkyunkwan Univ, Sch Med, Dept Pediat, Seoul, South Korea; [Kim, Kyung Won] Yonsei Univ, Coll Med, Dept Pediat, Seoul, South Korea; [Shin, Youn Ho] CHA Univ, Sch Med, Dept Pediat, Seoul, South Korea; [Lee, Kyung-shin; Yoo, Ho-Sung; Kang, Mi-Jin] Asan Inst Life Sci, Seoul, South Korea; [Seo, Ju-hee] Korea Canc Ctr Hosp, Dept Pediat, Seoul, South Korea; [Kwon, Ji-Won] Seoul Natl Univ, Bundang Hosp, Dept Pediat, Songnam, South Korea; [Kim, Byoung-Ju; Kim, Hyo-Bin; Kim, Woo-Kyung] Inje Univ, Coll Med, Dept Pediat, Seoul, South Korea; [Song, Dae Jin] Korea Univ, Guro Hosp, Dept Pediat, Seoul, South Korea; [Jang, Gwang Cheon] Ilsan Hosp, Natl Hlth Insurance Corp, Dept Pediat, Goyang, South Korea; [Lee, Soo-Young] Ajou Univ, Sch Med, Dept Pediat, Suwon 441749, South Korea; [Kwon, Ja-Young] Yonsei Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Choi, Suk-Joo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea; [Lee, Kyung-Ju; Park, Hee Jin] CHA Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Won, Hye-Sung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea; [Kim, Hyung-Young] Kosin Univ, Coll Med, Dept Pediat, Pusan, South Korea	Hallym University; University of Ulsan; Asan Medical Center; Sungkyunkwan University (SKKU); Yonsei University; Yonsei University Health System; Pochon Cha University; National Cancer Center - Korea (NCC); Seoul National University (SNU); Inje University; Korea University; Korea University Medicine (KU Medicine); NHIS Ilsan Hospital; Ajou University; Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); Samsung Medical Center; Pochon Cha University; University of Ulsan; Asan Medical Center	Hong, SJ (corresponding author), Asan Med Ctr, Childhood Asthma Atopy Ctr, Seoul, South Korea.	sjhong@amc.seoul.kr	Hong, Soo-Jong/AAR-1788-2020; Ahn, Kangmo/F-4609-2014; Yu, Jinho/P-4293-2014; Hong, Seo Ah/E-7628-2015	Hong, Soo-Jong/0000-0003-1409-2113; Yu, Jinho/0000-0002-1226-8077; Kim, Kyung Won/0000-0003-4529-6135; Song, Dae Jin/0000-0003-0647-3186; Kwon, Ja-Young/0000-0003-3009-6325; Kim, Byoung-Ju/0000-0003-0271-9417	Research of Korea Centers for Disease Control and Prevention [2008-E33030-00, 2009-E33033-00, 2011-E33021-00, 2012-E33012-00]	Research of Korea Centers for Disease Control and Prevention	This research was supported by a fund (2008-E33030-00, 2009-E33033-00, 2011-E33021-00, 2012-E33012-00) from the Research of Korea Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscripts.	Adlerberth I, 2006, PEDIATR RES, V59, P96, DOI 10.1203/01.pdr.0000191137.12774.b2; Adlerberth I, 2007, J ALLERGY CLIN IMMUN, V120, P343, DOI 10.1016/j.jaci.2007.05.018; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Arshad SH, 2008, BRIT J DERMATOL, V158, P1315, DOI 10.1111/j.1365-2133.2008.08565.x; Dom S, 2010, CLIN EXP ALLERGY, V40, P1378, DOI 10.1111/j.1365-2222.2010.03538.x; Eder W, 2005, J ALLERGY CLIN IMMUN, V116, P601, DOI 10.1016/j.jaci.2005.05.003; Eggesbo M, 2003, J ALLERGY CLIN IMMUN, V112, P420, DOI 10.1067/mai.2003.1610; Fallani M, 2010, J PEDIATR GASTR NUTR, V51, P77, DOI 10.1097/MPG.0b013e3181d1b11e; Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; He JQ, 2003, GENES IMMUN, V4, P385, DOI 10.1038/sj.gene.6363985; Hong SJ, 2007, J ALLERGY CLIN IMMUN, V119, P398, DOI 10.1016/j.jaci.2006.10.031; Hooper LV, 2004, TRENDS MICROBIOL, V12, P129, DOI 10.1016/j.tim.2004.01.001; Kim BS, 2012, ANAEROBE, V18, P310, DOI 10.1016/j.anaerobe.2012.01.003; Kim HB, 2008, CLIN EXP ALLERGY, V38, P774, DOI 10.1111/j.1365-2222.2008.02965.x; Kim HB, 2012, J KOREAN MED SCI, V27, P1320, DOI 10.3346/jkms.2012.27.11.1320; Kim WK, 2012, J ALLERGY CLIN IMMUN, V130, P421, DOI 10.1016/j.jaci.2012.04.052; Laubereau B, 2004, ARCH DIS CHILD, V89, P993, DOI 10.1136/adc.2003.043265; Litonjua AA, 2005, J ALLERGY CLIN IMMUN, V115, P1056, DOI 10.1016/j.jaci.2005.02.006; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; McKeever TM, 2002, AM J RESP CRIT CARE, V166, P827, DOI 10.1164/rccm.200202-158OC; Namkung JH, 2011, EXP DERMATOL, V20, P915, DOI [10.1111/j.1600-0625.2010.01148.x, 10.1111/j.1600-0625.2011.01357.x]; Orrhage K, 1999, ACTA PAEDIATR, V88, P47; Pistiner M, 2008, J ALLERGY CLIN IMMUN, V122, P274, DOI 10.1016/j.jaci.2008.05.007; Sengler C, 2003, CLIN EXP ALLERGY, V33, P166, DOI 10.1046/j.1365-2222.2003.01549.x; van Nimwegen FA, 2011, J ALLERGY CLIN IMMUN, V128, P948, DOI 10.1016/j.jaci.2011.07.027; Vercelli D, 2003, CURR OPIN ALLERGY CL, V3, P343, DOI 10.1097/01.all.0000092603.76804.e4; Weidinger S, 2006, J ALLERGY CLIN IMMUN, V118, P277, DOI 10.1016/j.jaci.2006.04.034; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x	29	36	36	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e96603	10.1371/journal.pone.0096603	http://dx.doi.org/10.1371/journal.pone.0096603			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848505	Green Published, Green Submitted, gold			2022-12-25	WOS:000336730600012
J	Mihaljevic, JR; Joseph, MB; Orlofske, SA; Paull, SH				Mihaljevic, Joseph R.; Joseph, Maxwell B.; Orlofske, Sarah A.; Paull, Sara H.			The Scaling of Host Density with Richness Affects the Direction, Shape, and Detectability of Diversity-Disease Relationships	PLOS ONE			English	Article							PARASITE TRANSMISSION; COMMUNITY COMPOSITION; INFECTIOUS-DISEASE; SPECIES-DIVERSITY; BIODIVERSITY; RISK; PRODUCTIVITY; PATHOGENS; ECOLOGY; IMPACT	Pathogen transmission responds differently to host richness and abundance, two unique components of host diversity. However, the heated debate around whether biodiversity generally increases or decreases disease has not considered the relationships between host richness and abundance that may exist in natural systems. Here we use a multi-species model to study how the scaling of total host community abundance with species richness mediates diversity-disease relationships. For pathogens with density-dependent transmission, non-monotonic trends emerge between pathogen transmission and host richness when host community abundance saturates with richness. Further, host species identity drives high variability in pathogen transmission in depauperate communities, but this effect diminishes as host richness accumulates. Using simulation we show that high variability in low richness communities and the non-monotonic relationship observed with host community saturation may reduce the detectability of trends in empirical data. Our study emphasizes that understanding the patterns and predictability of host community composition and pathogen transmission mode will be crucial for predicting where and when specific diversity-disease relationships should occur in natural systems.	[Mihaljevic, Joseph R.; Joseph, Maxwell B.; Orlofske, Sarah A.; Paull, Sara H.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Orlofske, Sarah A.] NE Illinois Univ, Dept Biol, Chicago, IL 60625 USA	University of Colorado System; University of Colorado Boulder	Mihaljevic, JR (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	joseph.mihaljevic@colorado.edu	Joseph, Maxwell/Z-5422-2019	Joseph, Maxwell/0000-0002-7745-9990; Mihaljevic, Joseph/0000-0003-2320-5773	NSF [DGE 1144083]; EPA; University of Colorado Graduate School Dissertation Completion Fellowship	NSF(National Science Foundation (NSF)); EPA(United States Environmental Protection Agency); University of Colorado Graduate School Dissertation Completion Fellowship	JRM and MBJ were supported by the NSF Graduate Research Fellowship Program (DGE 1144083). SHP was supported by the EPA Science to Achieve Results graduate fellowship program and a University of Colorado Graduate School Dissertation Completion Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LJS, 2012, NAT RESOUR MODEL, V25, P5, DOI 10.1111/j.1939-7445.2011.00104.x; DeLeo GA, 1996, NATURE, V379, P720, DOI 10.1038/379720a0; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; Guo QF, 2006, ECOL LETT, V9, P1284, DOI 10.1111/j.1461-0248.2006.00980.x; Huang ZYX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054341; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Johnson PTJ, 2008, ECOL LETT, V11, P1017, DOI 10.1111/j.1461-0248.2008.01212.x; Johnson PTJ, 2013, NATURE, V494, P230, DOI 10.1038/nature11883; Johnson PTJ, 2012, ECOL LETT, V15, P235, DOI 10.1111/j.1461-0248.2011.01730.x; Joseph MB, 2013, ECOL LETT, V16, P1405, DOI 10.1111/ele.12180; KEELE L, 2008, SEMIPARAMETRIC REGRE; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Lafferty KD, 2013, TRENDS ECOL EVOL, V28, P503, DOI 10.1016/j.tree.2013.06.012; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Logiudice K, 2008, ECOLOGY, V89, P2841, DOI 10.1890/07-1047.1; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061; Ostfeld RS, 2012, ANNU REV ECOL EVOL S, V43, P157, DOI 10.1146/annurev-ecolsys-102710-145022; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Randolph SE, 2012, PARASITOLOGY, V139, P847, DOI 10.1017/S0031182012000200; Rigaud T, 2010, P ROY SOC B-BIOL SCI, V277, P3693, DOI 10.1098/rspb.2010.1163; Roche B, 2013, AM NAT, V181, P1, DOI 10.1086/668591; Roche B, 2012, PHILOS T R SOC B, V367, P2807, DOI 10.1098/rstb.2011.0364; Rudolf VHW, 2005, AM NAT, V166, P112, DOI 10.1086/430674; Team RC, 2013, R LANGUAGE ENV STAT; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Tompkins DM, 2011, J ANIM ECOL, V80, P19, DOI 10.1111/j.1365-2656.2010.01742.x; Wood CM, 2012, FISH PHYSIOL, V31B, P1, DOI 10.1016/S1546-5098(11)31023-0; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	33	45	45	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97812	10.1371/journal.pone.0097812	http://dx.doi.org/10.1371/journal.pone.0097812			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849581	gold, Green Published, Green Submitted			2022-12-25	WOS:000336730600061
J	Tangen, IL; Krakstad, C; Halle, MK; Werner, HMJ; Oyan, AM; Kusonmano, K; Petersen, K; Kalland, KH; Akslen, LA; Trovik, J; Hurtado, A; Salvesen, HB				Tangen, Ingvild Loberg; Krakstad, Camilla; Halle, Mari K.; Werner, Henrica M. J.; Oyan, Anne M.; Kusonmano, Kanthida; Petersen, Kjell; Kalland, Karl Henning; Akslen, Lars A.; Trovik, Jone; Hurtado, Antoni; Salvesen, Helga B.			Switch in FOXA1 Status Associates with Endometrial Cancer Progression	PLOS ONE			English	Article							ESTROGEN-RECEPTOR BINDING; EPIDERMAL GROWTH-FACTOR; POSITIVE BREAST-CANCER; PROSTATE-CANCER; TRANSCRIPTION FACTOR; RAT UTERUS; EXPRESSION; CARCINOMA; ALPHA; SIGNATURES	Background: The transcription factor Forkhead box A1 (FOXA1) is suggested to be important in hormone dependent cancers, although with little data for endometrial cancer. We investigated expression levels of FOXA1 in primary and metastatic endometrial cancer in relation to clinical phenotype, and transcriptional alterations related to FOXA1 status. Methods: Protein expression of FOXA1 was explored by immunohistochemistry in 529 primary and 199 metastatic endometrial carcinoma lesions. mRNA levels from corresponding 158 fresh frozen primary and 42 metastatic lesions were analyzed using Agilent Microarrays (44k) in parallel. Results: Low FOXA1 protein expression in primary tumors significantly correlated with low FOXA1 mRNA, high age, non-endometrioid histology, high grade, loss of ER alpha and PR and poor survival (all p-values <0.05). Through a Connectivity Map search, HDAC inhibitors were suggested as potential treatment for patients with low FOXA1 expression. An increase in FOXA1 expression was observed from primary to metastatic lesions and it correlated with CDKN2A expression in metastases. Conclusion: Low FOXA1 is associated with poor survival and suggests a potential for HDAC inhibitors in endometrial carcinoma. A switch in FOXA1 expression from primary to metastatic lesions is observed and gene expression indicates a link between FOXA1 and CDKN2A in metastatic lesions.	[Tangen, Ingvild Loberg; Krakstad, Camilla; Halle, Mari K.; Werner, Henrica M. J.; Oyan, Anne M.; Kusonmano, Kanthida; Kalland, Karl Henning; Akslen, Lars A.; Trovik, Jone; Salvesen, Helga B.] Univ Bergen, Dept Clin Sci, Ctr Canc Biomarkers, Bergen, Norway; [Tangen, Ingvild Loberg; Krakstad, Camilla; Halle, Mari K.; Werner, Henrica M. J.; Kusonmano, Kanthida; Trovik, Jone; Salvesen, Helga B.] Haukeland Hosp, Dept Gynecol & Obstet, N-5021 Bergen, Norway; [Oyan, Anne M.; Kalland, Karl Henning] Haukeland Hosp, Dept Microbiol, N-5021 Bergen, Norway; [Kusonmano, Kanthida; Petersen, Kjell] Univ Bergen, Computat Biol Unit, Bergen, Norway; [Akslen, Lars A.] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Hurtado, Antoni] Univ Oslo, Breast Canc Res Grp, Ctr Mol Med Norway, Oslo, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Oslo	Tangen, IL (corresponding author), Univ Bergen, Dept Clin Sci, Ctr Canc Biomarkers, Bergen, Norway.	ith027@k2.uib.no	Akslen, Lars A./AAG-6097-2021; salvesen, Helga B/C-1187-2017; Kusonmano, Kanthida/AAQ-2802-2020; Werner, henrica/ABG-1235-2021; Akslen, Lars A/C-1202-2017; Krakstad, Camilla/AAB-5138-2020; Halle, Mari K/AAT-4856-2020; Kalland, Karl-Henning/B-9445-2017	Akslen, Lars A./0000-0003-2710-9543; salvesen, Helga B/0000-0002-4438-8831; Werner, henrica/0000-0001-5186-8369; Akslen, Lars A/0000-0003-2710-9543; Krakstad, Camilla/0000-0002-0174-8139; Kalland, Karl-Henning/0000-0003-4486-2334; Halle, Mari K/0000-0002-2660-8271; Hurtado, Antoni/0000-0002-0145-4763	Helse Vest; University of Bergen; Norwegian Cancer Society; Research Council of Norway	Helse Vest; University of Bergen; Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway)	This study was supported by Helse Vest, the University of Bergen, the Norwegian Cancer Society and the Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2012, CANCER SCI, V103, P806, DOI 10.1111/j.1349-7006.2012.02201.x; Augello MA, 2011, EMBO J, V30, P3885, DOI 10.1038/emboj.2011.340; Badve S, 2007, CLIN CANCER RES, V13, P4415, DOI 10.1158/1078-0432.CCR-07-0122; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cirillo LA, 1999, MOL CELL, V4, P961, DOI 10.1016/S1097-2765(00)80225-7; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Gerhardt J, 2012, AM J PATHOL, V180, P848, DOI 10.1016/j.ajpath.2011.10.021; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hisamatsu Y, 2012, ANN SURG ONCOL, V19, P1145, DOI 10.1245/s10434-011-2094-4; HUETHUDSON YM, 1990, MOL ENDOCRINOL, V4, P510, DOI 10.1210/mend-4-3-510; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Jain RK, 2011, HISTOPATHOLOGY, V58, P766, DOI 10.1111/j.1365-2559.2011.03796.x; Jin HJ, 2013, CANCER RES, V73, P3725, DOI 10.1158/0008-5472.CAN-12-3468; Krakstad C, 2012, BRIT J CANCER, V106, P1682, DOI 10.1038/bjc.2012.91; Krum SA, 2008, MOL ENDOCRINOL, V22, P2393, DOI 10.1210/me.2008-0100; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Li Q, 2013, EMBO J, V32, P858, DOI 10.1038/emboj.2013.35; LINGHAM RB, 1988, MOL ENDOCRINOL, V2, P230, DOI 10.1210/mend-2-3-230; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Matsuda S, 2000, IMMUNOPHARMACOLOGY, V47, P119, DOI 10.1016/S0162-3109(00)00192-2; Mehta RJ, 2012, BREAST CANCER RES TR, V131, P881, DOI 10.1007/s10549-011-1482-6; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; MURPHY LJ, 1987, MOL ENDOCRINOL, V1, P445, DOI 10.1210/mend-1-7-445; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Prat J, 2004, HUM PATHOL, V35, P649, DOI 10.1016/j.humpath.2004.02.007; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Sahu B, 2011, EMBO J, V30, P3962, DOI 10.1038/emboj.2011.328; Salvesen HB, 2012, LANCET ONCOL, V13, pE353, DOI 10.1016/S1470-2045(12)70213-9; Stefansson IM, 2004, J CLIN ONCOL, V22, P1242, DOI 10.1200/JCO.2004.09.034; Trovik J, 2011, CLIN CANCER RES, V17, P3368, DOI 10.1158/1078-0432.CCR-10-2412; WEISZ A, 1988, MOL ENDOCRINOL, V2, P816, DOI 10.1210/mend-2-9-816; Wik E, 2013, CLIN CANCER RES, V19, P1094, DOI 10.1158/1078-0432.CCR-12-3039	32	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98069	10.1371/journal.pone.0098069	http://dx.doi.org/10.1371/journal.pone.0098069			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849812	Green Submitted, gold, Green Published			2022-12-25	WOS:000336730600083
J	Velasco, V; Sherwood, JS; Rojas-Garcia, PP; Logue, CM				Velasco, Valeria; Sherwood, Julie S.; Rojas-Garcia, Pedro P.; Logue, Catherine M.			Multiplex Real-Time PCR for Detection of Staphylococcus aureus, mecA and Panton-Valentine Leukocidin (PVL) Genes from Selective Enrichments from Animals and Retail Meat	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; BLOOD CULTURE BOTTLES; METHICILLIN-RESISTANT; UNITED-STATES; RAPID IDENTIFICATION; CLINICAL-SAMPLES; REACTION ASSAY; MRSA; PREVALENCE; POULTRY	The aim of this study was to compare a real-time PCR assay, with a conventional culture/PCR method, to detect S. aureus, mecA and Panton-Valentine Leukocidin (PVL) genes in animals and retail meat, using a two-step selective enrichment protocol. A total of 234 samples were examined (77 animal nasal swabs, 112 retail raw meat, and 45 deli meat). The multiplex real-time PCR targeted the genes: nuc (identification of S. aureus), mecA (associated with methicillin resistance) and PVL (virulence factor), and the primary and secondary enrichment samples were assessed. The conventional culture/PCR method included the two-step selective enrichment, selective plating, biochemical testing, and multiplex PCR for confirmation. The conventional culture/PCR method recovered 95/234 positive S. aureus samples. Application of real-time PCR on samples following primary and secondary enrichment detected S. aureus in 111/234 and 120/234 samples respectively. For detection of S. aureus, the kappa statistic was 0.68-0.88 (from substantial to almost perfect agreement) and 0.29-0.77 (from fair to substantial agreement) for primary and secondary enrichments, using real-time PCR. For detection of mecA gene, the kappa statistic was 0-0.49 (from no agreement beyond that expected by chance to moderate agreement) for primary and secondary enrichment samples. Two pork samples were mecA gene positive by all methods. The real-time PCR assay detected the mecA gene in samples that were negative for S. aureus, but positive for Staphylococcus spp. The PVL gene was not detected in any sample by the conventional culture/PCR method or the real-time PCR assay. Among S. aureus isolated by conventional culture/PCR method, the sequence type ST398, and multi-drug resistant strains were found in animals and raw meat samples. The real-time PCR assay may be recommended as a rapid method for detection of S. aureus and the mecA gene, with further confirmation of methicillin-resistant S. aureus (MRSA) using the standard culture method.	[Velasco, Valeria; Sherwood, Julie S.] N Dakota State Univ, Dept Vet & Microbiol Sci, Fargo, ND 58105 USA; [Velasco, Valeria] Univ Concepcion, Dept Anim Sci, Chillan, Chile; [Rojas-Garcia, Pedro P.] Univ Concepcion, Lab Anim Physiol & Endocrinol, Chillan, Chile; [Logue, Catherine M.] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Coll Vet Med, Ames, IA 50011 USA	North Dakota State University Fargo; Universidad de Concepcion; Universidad de Concepcion; Iowa State University	Logue, CM (corresponding author), Iowa State Univ, Dept Vet Microbiol & Prevent Med, Coll Vet Med, Ames, IA 50011 USA.	cmlogue@iastate.edu		Logue, Catherine/0000-0002-6098-2662	Dean's Office, College of Agriculture, North Dakota State University; Dean's Office, College of Veterinary Medicine, Iowa State University	Dean's Office, College of Agriculture, North Dakota State University; Dean's Office, College of Veterinary Medicine, Iowa State University	This study was funded through the Dean's Office, College of Agriculture, North Dakota State University and The Dean's Office, College of Veterinary Medicine, Iowa State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MEC, 2007, VET MICROBIOL, V122, P185, DOI 10.1016/j.vetmic.2007.01.001; Aydin A, 2011, FOODBORNE PATHOG DIS, V8, P63, DOI 10.1089/fpd.2010.0613; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Buyukcangaz E, 2013, FOODBORNE PATHOG DIS, V10, P608, DOI 10.1089/fpd.2012.1427; Costa AM, 2005, DIAGN MICR INFEC DIS, V51, P13, DOI 10.1016/j.diagmicrobio.2004.08.014; Danial J, 2011, J MED MICROBIOL, V60, P323, DOI 10.1099/jmm.0.025288-0; de Boer E, 2009, INT J FOOD MICROBIOL, V134, P52, DOI 10.1016/j.ijfoodmicro.2008.12.007; De Medici D, 2003, APPL ENVIRON MICROB, V69, P3456, DOI 10.1128/AEM.69.6.3456-3461.2003; Dufour P, 2002, CLIN INFECT DIS, V35, P819, DOI 10.1086/342576; Ebert MD, 2009, EMERG RADIOL, V16, P159, DOI 10.1007/s10140-008-0706-5; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Golding GR, 2010, EMERG INFECT DIS, V16, P587, DOI 10.3201/eid1604.091435; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Guardabassi L, 2009, EMERG INFECT DIS, V15, P1998, DOI 10.3201/eid1512.090378; Hagen RM, 2005, INT J MED MICROBIOL, V295, P77, DOI 10.1016/j.ijmm.2004.12.008; HARTMAN B, 1981, ANTIMICROB AGENTS CH, V19, P726, DOI 10.1128/AAC.19.5.726; Higashide M, 2006, INT J ANTIMICROB AG, V27, P500, DOI 10.1016/j.ijantimicag.2006.01.009; Huletsky A, 2004, J CLIN MICROBIOL, V42, P1875, DOI 10.1128/JCM.42.5.1875-1884.2004; Kassem II, 2008, J CLIN MICROBIOL, V46, P3868, DOI 10.1128/JCM.01035-08; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; Kilic A, 2010, DIAGN MICR INFEC DIS, V66, P349, DOI 10.1016/j.diagmicrobio.2009.11.010; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Makgotlho PE, 2009, FEMS IMMUNOL MED MIC, V57, P104, DOI 10.1111/j.1574-695X.2009.00585.x; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; McClure JA, 2006, J CLIN MICROBIOL, V44, P1141, DOI 10.1128/JCM.44.3.1141-1144.2006; McDonald RR, 2005, J CLIN MICROBIOL, V43, P6147, DOI 10.1128/JCM.43.12.6147-6149.2005; Moore D.S., 2007, BASIC PRACTICE STAT; Morcillo A, 2012, FOODBORNE PATHOG DIS, V9, P207, DOI 10.1089/fpd.2011.0982; O'Brien AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030092; Paule SM, 2005, AM J CLIN PATHOL, V124, P404, DOI 10.1309/6EA3U9V8NCLLGKQN; Persoons D, 2009, EMERG INFECT DIS, V15, P452, DOI 10.3201/eid1503.080696; RYFFEL C, 1990, GENE, V94, P137, DOI 10.1016/0378-1119(90)90481-6; Soderquist B, 2012, APMIS, V120, P427, DOI 10.1111/j.1600-0463.2011.02849.x; Thomas LC, 2007, J MICROBIOL METH, V68, P296, DOI 10.1016/j.mimet.2006.09.003; Tiemersma EW, 2004, EMERG INFECT DIS, V10, P1627, DOI 10.3201/eid1009.040069; van Belkum A, 2008, EMERG INFECT DIS, V14, P479, DOI 10.3201/eid1403.070760; Van De Griend P, 2009, EMERG INFECT DIS, V15, P1582, DOI 10.3201/eid1510.080877; Waters AE, 2011, CLIN INFECT DIS, V52, P1227, DOI 10.1093/cid/cir181; Weese JS, 2010, LETT APPL MICROBIOL, V51, P338, DOI 10.1111/j.1472-765X.2010.02901.x; Wertheim H, 2001, J CLIN MICROBIOL, V39, P2660, DOI 10.1128/JCM.39.7.2660-2662.2001; Zhang Wanjiang, 2011, Vet J, V190, pe125, DOI 10.1016/j.tvjl.2011.02.006	42	29	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97617	10.1371/journal.pone.0097617	http://dx.doi.org/10.1371/journal.pone.0097617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849624	Green Published, Green Submitted, gold			2022-12-25	WOS:000336730600041
J	Zhang, Z; Ding, LP; Jin, ZT; Gao, GJ; Li, HJ; Zhang, LJ; Zhang, LN; Lu, X; Hu, LH; Lu, BW; Yu, XJ; Hu, TH				Zhang, Zheng; Ding, Liping; Jin, Zhitao; Gao, Guojie; Li, Huijun; Zhang, Lijuan; Zhang, Lina; Lu, Xin; Hu, Lihua; Lu, Bingwei; Yu, Xiongjun; Hu, Taohong			Nebivolol Protects against Myocardial Infarction Injury via Stimulation of Beta 3-Adrenergic Receptors and Nitric Oxide Signaling	PLOS ONE			English	Article							HEART-FAILURE; BETA(3)-ADRENERGIC RECEPTOR; CARDIOVASCULAR-SYSTEM; SYNTHASE ACTIVATION; CONTRACTILITY; ENOS; RELEASE; CELLS	Nebivolol, third-generation beta-blocker, may activate beta 3-adrenergic receptor (AR), which has been emerged as a novel and potential therapeutic targets for cardiovascular diseases. However, it is not known whether nebivolol administration plays a cardioprotective effect against myocardial infarction (MI) injury. Therefore, the present study was designed to clarify the effects of nebivolol on MI injury and to elucidate the underlying mechanism. MI model was constructed by left anterior descending (LAD) artery ligation. Nebivolol, beta 3-AR antagonist (SR59230A), Nitro-L-arginine methylester (L-NAME) or vehicle was administered for 4 weeks after MI operation. Cardiac function was monitored by echocardiography. Moreover, the fibrosis and the apoptosis of myocardium were assessed by Masson's trichrome stain and TUNEL assay respectively 4 weeks after MI. Nebivolol administration reduced scar area by 68% compared with MI group (p<0.05). Meanwhile, nebivolol also decreased the myocardial apoptosis and improved the heart function after MI (p<0.05 vs. MI). These effects were associated with increased beta 3-AR expression. Moreover, nebivolol treatment significantly increased the phosphorylation of endothelial NOS (eNOS) and the expression of neuronal NOS (nNOS). Conversely, the cardiac protective effects of nebivolol were abolished by SR and L-NAME. These results indicate that nebivolol protects against MI injury. Furthermore, the cardioprotective effects of nebivolol may be mediated by beta 3-AR-eNOS/nNOS pathway.	[Zhang, Zheng; Ding, Liping; Jin, Zhitao; Gao, Guojie; Li, Huijun; Zhang, Lijuan; Zhang, Lina; Lu, Xin; Hu, Lihua; Lu, Bingwei; Yu, Xiongjun; Hu, Taohong] Chinese Peoples Liberat Army, Artillery Gen Hosp 2, Dept Cardiol, Beijing, Peoples R China		Hu, TH (corresponding author), Chinese Peoples Liberat Army, Artillery Gen Hosp 2, Dept Cardiol, Beijing, Peoples R China.	Hutaohong2010@163.com	Zhang, Li/GWM-7501-2022					Aragon JP, 2011, J AM COLL CARDIOL, V58, P2683, DOI 10.1016/j.jacc.2011.09.033; Braunwald E, 2000, CIRCULATION, V102, P14; Brixius K, 2006, CAN J PHYSIOL PHARM, V84, P1051, DOI 10.1139/Y06-033; Dobre D, 2007, AM HEART J, V154, P109, DOI 10.1016/j.ahj.2007.03.025; Gauthier C, 1996, J CLIN INVEST, V98, P556, DOI 10.1172/JCI118823; Gauthier C, 1998, J CLIN INVEST, V102, P1377, DOI 10.1172/JCI2191; Iwakiri Y, 2002, AM J PHYSIOL-HEART C, V282, pH2084, DOI 10.1152/ajpheart.00675.2001; Karter Yesari, 2007, Recent Pat Cardiovasc Drug Discov, V2, P152; Maffei A, 2007, HYPERTENSION, V50, P652, DOI 10.1161/HYPERTENSIONAHA.107.094458; Martin SR, 2006, CARDIOVASC RES, V70, P97, DOI 10.1016/j.cardiores.2006.02.002; Mercanoglu GO, 2010, ANATOL J CARDIOL, V10, P18; Moniotte S, 2001, CIRCULATION, V103, P1649, DOI 10.1161/01.CIR.103.12.1649; Niu XL, 2012, J AM COLL CARDIOL, V59, P1979, DOI 10.1016/j.jacc.2011.12.046; Reiken S, 2003, CIRCULATION, V107, P2459, DOI 10.1161/01.CIR.0000068316.53218.49; Roger VL, 2002, ANN INTERN MED, V136, P341, DOI 10.7326/0003-4819-136-5-200203050-00005; Rozec B, 2003, ARCH MAL COEUR VAISS, V96, P905; Rozec B, 2006, PHARMACOL THERAPEUT, V111, P652, DOI 10.1016/j.pharmthera.2005.12.002; Skeberdis VA, 2008, J CLIN INVEST, V118, P3219, DOI 10.1172/JCI32519; Sorrentino SA, 2011, J AM COLL CARDIOL, V57, P601, DOI 10.1016/j.jacc.2010.09.037; Sun DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033491; Tavernier G, 2003, CARDIOVASC RES, V59, P288, DOI 10.1016/S0008-6363(03)00359-6; Varghese P, 2000, J CLIN INVEST, V106, P697, DOI 10.1172/JCI9323; Zhang Z, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0333-5; Zhang Z, 2011, INFLAMM RES, V60, P37, DOI 10.1007/s00011-010-0232-2	24	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98179	10.1371/journal.pone.0098179	http://dx.doi.org/10.1371/journal.pone.0098179			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849208	Green Submitted, Green Published, gold			2022-12-25	WOS:000336730600096
J	Kim, EY; Kim, JW; Kim, WK; Han, BS; Park, SG; Chung, BH; Lee, SC; Bae, KH				Kim, Eun Young; Kim, Ji Won; Kim, Won Kon; Han, Baek Soo; Park, Sung Goo; Chung, Bong Hyun; Lee, Sang Chul; Bae, Kwang-Hee			Selection of Aptamers for Mature White Adipocytes by Cell SELEX Using Flow Cytometry	PLOS ONE			English	Article							PROMOTES ADIPOGENIC DIFFERENTIATION; IN-VITRO; TYROSINE PHOSPHATASE; HIGH-AFFINITY; RNA LIGANDS; OBESITY; BROWN; ACETYLATION; GENERATION; ENRICHMENT	Background: Adipose tissue, mainly composed of adipocytes, plays an important role in metabolism by regulating energy homeostasis. Obesity is primarily caused by an abundance of adipose tissue. Therefore, specific targeting of adipose tissue is critical during the treatment of obesity, and plays a major role in overcoming it. However, the knowledge of cell-surface markers specific to adipocytes is limited. Methods and Results: We applied the CELL SELEX (Systematic Evolution of Ligands by EXponential enrichment) method using flow cytometry to isolate molecular probes for specific recognition of adipocytes. The aptamer library, a mixture of FITC-tagged single-stranded random DNAs, is used as a source for acquiring molecular probes. With the increasing number of selection cycles, there was a steady increase in the fluorescence intensity toward mature adipocytes. Through 12 rounds of SELEX, enriched aptamers showing specific recognition toward mature 3T3-L1 adipocyte cells were isolated. Among these, two aptamers (MA-33 and 91) were able to selectively bind to mature adipocytes with an equilibrium dissociation constant (Kd) in the nanomolar range. These aptamers did not bind to preadipocytes or other cell lines (such as HeLa, HEK-293, or C2C12 cells). Additionally, it was confirmed that MA-33 and 91 can distinguish between mature primary white and primary brown adipocytes. Conclusions: These selected aptamers have the potential to be applied as markers for detecting mature white adipocytes and monitoring adipogenesis, and could emerge as an important tool in the treatment of obesity.	[Kim, Eun Young; Kim, Ji Won; Kim, Won Kon; Han, Baek Soo; Lee, Sang Chul; Bae, Kwang-Hee] KRIBB, Res Ctr Integrated Cellul, Taejon, South Korea; [Park, Sung Goo] KRIBB, Med Prote Res Ctr, Taejon, South Korea; [Chung, Bong Hyun] KRIBB, Bioconvergence Res Inst, BioNanotechnol Res Ctr, Taejon, South Korea; [Kim, Ji Won; Lee, Sang Chul; Bae, Kwang-Hee] Univ Sci & Technol UST Korea, Dept Funct Genom, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST)	Lee, SC (corresponding author), KRIBB, Res Ctr Integrated Cellul, Taejon, South Korea.	lesach@kribb.re.kr; khbae@kribb.re.kr		Bae, Kwang-Hee/0000-0002-5868-2556	Korea Research Institute of Bioscience and Biotechnology (KRIBB); National Research Foundation of Korea [2012M3A9C7050101, 2013M3A9A7046301, 2011-0020507]	Korea Research Institute of Bioscience and Biotechnology (KRIBB); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by grants from the Korea Research Institute of Bioscience and Biotechnology (KRIBB) and from the Research Program (grants 2012M3A9C7050101, 2013M3A9A7046301, 2011-0020507, and Global Frontier R&D Program) through the National Research Foundation of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cannon B, 2012, NATURE, V488, P286, DOI 10.1038/488286a; Cerchia L, 2005, PLOS BIOL, V3, P697, DOI 10.1371/journal.pbio.0030123; Cerchia Laura, 2009, V535, P59, DOI 10.1007/978-1-59745-557-2_5; Cinti S, 2011, ANN MED, V43, P104, DOI 10.3109/07853890.2010.535557; Cinti S, 2009, AM J PHYSIOL-ENDOC M, V297, pE977, DOI 10.1152/ajpendo.00183.2009; Cooke D, 2006, NAT REV DRUG DISCOV, V5, P919, DOI 10.1038/nrd2136; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; ELLINGTON AD, 1992, NATURE, V355, P850, DOI 10.1038/355850a0; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Famulok M, 2007, CHEM REV, V107, P3715, DOI 10.1021/cr0306743; FELSTED RL, 1983, CANCER RES, V43, P2754; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; Hanke W, 2004, DERMATOL SURG, V30, P967, DOI 10.1111/j.1524-4725.2004.30300.x; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Homann M, 1999, NUCLEIC ACIDS RES, V27, P2006, DOI 10.1093/nar/27.9.2006; Humphryes PC, 2012, CLIN VACCINE IMMUNOL, V19, P587, DOI 10.1128/CVI.05622-11; Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816; Jung H, 2009, BIOCHEM BIOPH RES CO, V383, P252, DOI 10.1016/j.bbrc.2009.04.001; Kamal AM, 2013, J PROTEOMICS, V94, P327, DOI 10.1016/j.jprot.2013.10.005; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kim EY, 2013, BIOCHEM BIOPH RES CO, V441, P77, DOI 10.1016/j.bbrc.2013.10.016; Kim EY, 2012, J LIPID RES, V53, P1864, DOI 10.1194/jlr.M026567; Kim WK, 2008, ENDOCR J, V55, P827, DOI 10.1507/endocrj.K08E-115; Kim WK, 2012, INT J BIOCHEM CELL B, V44, P327, DOI 10.1016/j.biocel.2011.11.004; Kim WK, 2011, MOL BIOL CELL, V22, P4883, DOI 10.1091/mbc.E11-03-0175; Kim WK, 2009, J CELL SCI, V122, P4160, DOI 10.1242/jcs.053009; Kwon YN, 2011, SPECTROSC-BIOMED APP, V26, P329, DOI 10.1155/2011/707216; Layzer JM, 2007, OLIGONUCLEOTIDES, V17, P1, DOI 10.1089/oli.2006.0059; Lee YH, 2004, J LIPID RES, V45, P1162, DOI 10.1194/jlr.D300028-JLR200; Leva S, 2002, CHEM BIOL, V9, P351, DOI 10.1016/S1074-5521(02)00111-4; Liu JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037559; Liu J, 2011, CURR MED CHEM, V18, P4117, DOI 10.2174/092986711797189619; Malaguarnera R, 2012, ENDOCRINOLOGY, V153, P2152, DOI 10.1210/en.2011-1843; Mayer G, 2010, NAT PROTOC, V5, P1993, DOI 10.1038/nprot.2010.163; Mendonsa SD, 2004, J AM CHEM SOC, V126, P20, DOI 10.1021/ja037832s; Nagano K, 2008, PROTEOMICS, V8, P4025, DOI 10.1002/pmic.200800073; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Park Anna, 2014, World J Stem Cells, V6, P33, DOI 10.4252/wjsc.v6.i1.33; Raddatz MSL, 2008, ANGEW CHEM INT EDIT, V47, P5190, DOI 10.1002/anie.200800216; Roberts CK, 2009, LIFE SCI, V84, P705, DOI 10.1016/j.lfs.2009.02.026; Rosen ED, 2000, GENE DEV, V14, P1293; Shamah SM, 2008, ACCOUNTS CHEM RES, V41, P130, DOI 10.1021/ar700142z; Snow V, 2005, ANN INTERN MED, V142, P525, DOI 10.7326/0003-4819-142-7-200504050-00011; Sood J, 2011, INDIAN J ANAESTH, V55, P220, DOI 10.4103/0019-5049.82652; Tang ZW, 2007, ANAL CHEM, V79, P4900, DOI 10.1021/ac070189y; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Van Simaeys D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013770; Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011; White R, 2001, MOL THER, V4, P567, DOI 10.1006/mthe.2001.0495; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Wu AY, 2012, J TRANSL MED, V10, P3; Xiao ZY, 2008, CHEM-EUR J, V14, P1769, DOI 10.1002/chem.200701330; Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62; Zhao ZL, 2009, ANALYST, V134, P1808, DOI 10.1039/b904476k; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	60	13	15	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97747	10.1371/journal.pone.0097747	http://dx.doi.org/10.1371/journal.pone.0097747			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844710	Green Submitted, Green Published, gold			2022-12-25	WOS:000339563400056
J	Liu, YS; Zhang, X; Liu, Y; Jin, XX; Fan, C; Ye, HQ; Ou, ME; Lv, LW; Wu, G; Zhou, YS				Liu, Yunsong; Zhang, Xiao; Liu, Yang; Jin, Xiaoxiao; Fan, Cong; Ye, Hongqiang; Ou, Meng'en; Lv, Longwei; Wu, Gang; Zhou, Yongsheng			Bi-Functionalization of a Calcium Phosphate-Coated Titanium Surface with Slow-Release Simvastatin and Metronidazole to Provide Antibacterial Activities and Pro-Osteodifferentiation Capabilities	PLOS ONE			English	Article							MESENCHYMAL STEM-CELL; IN-VITRO; CLOSTRIDIUM-DIFFICILE; BONE; DIFFERENTIATION; RESISTANCE; IMPLANTS; ADHESION; REGENERATION; MECHANISM	Coating the surface of titanium implants or other bone graft substitute materials with calcium phosphate (Ca-P) crystals is an effective way to enhance the osteoconduction of the implants. Ca-P coating alone cannot confer pro-osteodifferentiation and antibacterial capabilities on implants; however, it can serve as a carrier for biological agents which could improve the performance of implants and bone substitutes. Here, we constructed a novel, bi-functional Ca-P coating with combined pro-osteodifferentiation and antibacterial capabilities. Different concentrations of metronidazole (MNZ) and simvastatin (SIM) were integrated into biomimetic Ca-P coatings on the surface of titanium disks. The biological effects of this bi-functional biomimetic coating on human bone marrow mesenchymal stem cells (hBMMSCs), human adipose derived stromal cells (hASCs), and Porphyromonas gingivalis were assessed in vitro. We observed that Ca-P coatings loaded with both SIM and MNZ display favorable release kinetics without affecting cell proliferation or attachment. In the inhibition zone test, we found that the bi-functional coating showed lasting antibacterial effects when incubated with Porphyromonas gingivalis for 2 and 4 days. Moreover, the osteodifferentiation of hBMMSCs and hASCs were increased when cultured on this bi-functional coating for 7 and 14 days. Both drugs were loaded onto the Ca-P coating at specific concentrations (10 25 M SIM; 10 22 M MNZ) to achieve optimal release kinetics. Considering the safety, stability and low cost of SIM and MNZ, this novel bifunctional Ca-P coating technique represents a promising method to improve the performance of metal implants or other bone substitute materials, and can theoretically be easily translated to clinical applications.	[Liu, Yunsong; Zhang, Xiao; Jin, Xiaoxiao; Fan, Cong; Ye, Hongqiang; Ou, Meng'en; Lv, Longwei; Zhou, Yongsheng] Peking Univ, Sch & Hosp Stomatol, Dept Prosthodont, Beijing 100871, Peoples R China; [Liu, Yunsong; Zhou, Yongsheng] Natl Engn Lab Digital & Mat Technol Stomatol, Beijing, Peoples R China; [Liu, Yang] Peking Univ, Sch & Hosp Stomatol, Dept Orthodont, Beijing 100871, Peoples R China; [Wu, Gang] Vrije Univ Amsterdam, Res Inst MOVE, Acad Ctr Dentristry Amsterdam ACTA, Dept Oral Implantol & Prosthet Dent, Amsterdam, Netherlands; [Zhou, Yongsheng] Peking Univ, Sch & Hosp Stomatol, Cent Lab, Beijing 100871, Peoples R China	Peking University; Peking University; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam; Peking University	Zhou, YS (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dept Prosthodont, Beijing 100871, Peoples R China.	kqzhouysh@hsc.pku.edu.cn	Lv, Longwei/ABA-5055-2020; wu, gang/C-5072-2012	wu, gang/0000-0001-8941-2500	National Natural Science Foundation of China [30901693, 81170937]; Program for New Century Excellent Talents in University from Ministry of Education [BMU20110274]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University from Ministry of Education(Program for New Century Excellent Talents in University (NCET))	This study was supported by grants from the National Natural Science Foundation of China (No. 30901693, No. 81170937), http://www.nsfc.gov.cn/Portal0/default152.htm. This study was also supported by the Program for New Century Excellent Talents in University from Ministry of Education (BMU20110274), http://www.moe.edu.cn/publicfiles/business/htmlfiles/moe/A16/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt131; Boyanova L, 2004, ANAEROBE, V10, P261, DOI 10.1016/j.anaerobe.2004.06.001; Endres M, 2003, TISSUE ENG, V9, P689, DOI 10.1089/107632703768247386; Gaines S T, 1988, J Bone Joint Surg Am, V70, P1430; Goodman SB, 2013, BIOMATERIALS, V34, P3174, DOI 10.1016/j.biomaterials.2013.01.074; GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258; He J, 2012, J BIOMED MATER RES A, V100A, P1706, DOI 10.1002/jbm.a.34121; Herberg S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058207; Hickok NJ, 2012, ADV DRUG DELIVER REV, V64, P1165, DOI 10.1016/j.addr.2012.03.015; Huang Z, 2013, BIOMATERIALS, V34, P3303, DOI 10.1016/j.biomaterials.2013.01.054; Kang JM, 2012, ACTA BIOMATER, V8, P1759, DOI 10.1016/j.actbio.2012.01.005; Kunishima H, 2013, J INFECT CHEMOTHER, V19, P360, DOI 10.1007/s10156-013-0553-5; LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81; Leitsch D, 2009, MOL MICROBIOL, V72, P518, DOI 10.1111/j.1365-2958.2009.06675.x; Liu Y, 2007, J DENT RES, V86, P84, DOI 10.1177/154405910708600114; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Liu YL, 2010, J R SOC INTERFACE, V7, pS631, DOI 10.1098/rsif.2010.0115.focus; Liu YS, 2008, BIOMATERIALS, V29, P3338, DOI 10.1016/j.biomaterials.2008.04.037; Liu YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056002; MANKIN HJ, 1983, CLIN ORTHOP RELAT R, P69; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Nolan R, 2014, CLIN ORAL IMPLAN RES, V25, P252, DOI 10.1111/clr.12124; Pauly S, 2009, BONE, V45, P505, DOI 10.1016/j.bone.2009.05.010; Pelaez T, 2008, J CLIN MICROBIOL, V46, P3028, DOI 10.1128/JCM.00524-08; Peter B, 2005, BONE, V36, P52, DOI 10.1016/j.bone.2004.10.004; Saran N, 2011, CLIN ORTHOP RELAT R, V469, P1470, DOI 10.1007/s11999-010-1573-4; Sun LM, 2002, J BIOMED MATER RES, V62, P228, DOI 10.1002/jbm.10315; Tavakoli N, 2007, J PHARMACEUT BIOMED, V43, P325, DOI 10.1016/j.jpba.2006.06.002; Uzzan B, 2007, BONE, V40, P1581, DOI 10.1016/j.bone.2007.02.019; van der Wouden EJ, 2001, SCAND J GASTROENTERO, V36, P10, DOI 10.1080/003655201753265055; Wu G, 2010, TISSUE ENG PART C-ME, V16, P1255, DOI [10.1089/ten.tec.2009.0588, 10.1089/ten.TEC.2009.0588]; Wu G, 2010, BIOMATERIALS, V31, P7485, DOI 10.1016/j.biomaterials.2010.06.037; Yang F, 2011, ORAL SURG ORAL MED O, V111, P551, DOI 10.1016/j.tripleo.2010.06.018; Yang XF, 2009, DENT MATER, V25, P473, DOI 10.1016/j.dental.2008.09.007; Yardimci C, 2010, J CHROMATOGR SCI, V48, P95, DOI 10.1093/chromsci/48.2.95; Zhang WX, 2008, J BIOL CHEM, V283, P4723, DOI 10.1074/jbc.M704147200; Zhou W, 2010, BIOMATERIALS, V31, P3212, DOI 10.1016/j.biomaterials.2010.01.036; Zhou YS, 2010, BIOMATERIALS, V31, P5325, DOI 10.1016/j.biomaterials.2010.03.037	38	21	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97741	10.1371/journal.pone.0097741	http://dx.doi.org/10.1371/journal.pone.0097741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844416	Green Published, Green Submitted, gold			2022-12-25	WOS:000339563400054
J	Xu, W; Hu, XL; Chen, ZT; Zheng, XP; Zhang, CJ; Wang, G; Chen, Y; Zhou, XL; Tang, XX; Luo, LS; Xu, X; Pan, WS				Xu, Wen; Hu, Xinlei; Chen, Zhongting; Zheng, Xiaoping; Zhang, Chenjing; Wang, Gang; Chen, Yu; Zhou, Xinglu; Tang, Xiaoxiao; Luo, Laisheng; Xu, Xiang; Pan, Wensheng			Normal Fibroblasts Induce E-Cadherin Loss and Increase Lymph Node Metastasis in Gastric Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; MESENCHYMAL TRANSITION; CISPLATIN RESISTANCE; TUMOR PROGRESSION; GROWTH; CELLS; INHIBITION; INVASION; PROMOTES; EMT	Background: A tumor is considered a heterogeneous complex in a three-dimensional environment that is flush with pathophysiological and biomechanical signals. Cell-stroma interactions guide the development and generation of tumors. Here, we evaluate the contributions of normal fibroblasts to gastric cancer. Methodology/Principal Findings: By coculturing normal fibroblasts in monolayers of BGC-823 gastric cancer cells, tumor cells sporadically developed short, spindle-like morphological characteristics and demonstrated enhanced proliferation and invasive potential. Furthermore, the transformed tumor cells demonstrated decreased tumor formation and increased lymphomatic and intestinal metastatic potential. Non-transformed BGC-823 cells, in contrast, demonstrated primary tumor formation and delayed intestinal and lymph node invasion. We also observed E-cadherin loss and the upregulation of vimentin expression in the transformed tumor cells, which suggested that the increase in metastasis was induced by epithelial-to-mesenchymal transition. Conclusion: Collectively, our data indicated that normal fibroblasts sufficiently induce epithelial-to-mesenchymal transition in cancer cells, thereby leading to metastasis.	[Xu, Wen; Zhang, Chenjing; Wang, Gang; Zhou, Xinglu; Tang, Xiaoxiao; Luo, Laisheng; Pan, Wensheng] Zhejiang Univ, Sch Med, Dept Gastroenterol, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Xinlei] Zhejiang Univ, Sch Med, Dept Orthoped, Affiliated Hosp 2,Binjiang Branch, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Zhongting] Zhejiang Univ, Sch Med, Dept Pharm, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Xiaoping] Qujiang Peoples Hosp, Dept Pathol, Quzhou, Peoples R China; [Chen, Yu] Zhejiang Acad Tradit Chinese Med, Expt Anim Res Ctr, Hangzhou, Zhejiang, Peoples R China; [Xu, Xiang] Zhejiang Univ, Sch Med, Dept Pharm, Affiliated Hosp 2,Binjiang Branch, Hangzhou 310003, Zhejiang, Peoples R China; [Pan, Wensheng] Zhejiang Univ, Sch Med, Dept Gastroenterol, Affiliated Hosp 2,Binjiang Branch, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Pan, WS (corresponding author), Zhejiang Univ, Sch Med, Dept Gastroenterol, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China.	wspan223@163.com	Chen, Yu/Y-3292-2019		National Health Key Special Fund [200802112]; National Science Fund Committee [81372302, 81272120]; Health Department Fund [2007A093]; Key Project of Zhejiang Province [2013C030445 2009C030125]; Natural Science Fund of Zhejiang Province [Y2080001, Y12H160121, Z2080514]; Traditional Chinese Medicine Bureau Fund [2007ZA019]	National Health Key Special Fund; National Science Fund Committee; Health Department Fund; Key Project of Zhejiang Province; Natural Science Fund of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Traditional Chinese Medicine Bureau Fund	This research was supported by grants from the National Health Key Special Fund (http://program.most.gov.cn; No.200802112), the National Science Fund Committee (http://www.nsfc.gov.cn; general project No.81372302 No.81272120), the Health Department Fund (http://program.most.gov.cn; No.2007A093), the Key Project of Zhejiang Province (http://www.zjkjt.gov.cn; No.2013C030445 2009C030125). The Natural Science Fund of Zhejiang Province (http://www.zjnsf.gov.cn; No.Y2080001, Y12H160121, and Z2080514), and the Traditional Chinese Medicine Bureau Fund (http://wst.zj.gov.cn; No.2007ZA019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bougen NM, 2013, CANCER LETT, V332, P19, DOI 10.1016/j.canlet.2012.12.012; Boyd SC, 2013, J INVEST DERMATOL, V133, P1269, DOI 10.1038/jid.2012.421; Buda A, 2011, CELL COMMUN ADHES, V18, P131, DOI 10.3109/15419061.2011.636465; Chen XB, 2012, MOL BIOL REP, V39, P6707, DOI 10.1007/s11033-012-1494-2; Chen ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063854; Cho HJ, 2011, CANCER LETT, V311, P48, DOI 10.1016/j.canlet.2011.06.024; Fromigue O, 2003, ONCOGENE, V22, P8487, DOI 10.1038/sj.onc.1206918; Gal A, 2008, ONCOGENE, V27, P1218, DOI 10.1038/sj.onc.1210741; Guo S, 2013, INT J CLIN ONCOL; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Kamikihara T, 2012, PATHOL INT, V62, P161, DOI 10.1111/j.1440-1827.2011.02774.x; Kim HK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016694; KODERA Y, 1994, CANCER CHEMOTH PHARM, V34, P203; Le TVT, 2010, ARCH PHARM RES, V33, P1127, DOI 10.1007/s12272-010-0720-5; Li YH, 2013, EXP MOL PATHOL, V94, P430, DOI 10.1016/j.yexmp.2013.02.001; Lim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066558; Liu T, 2013, J SURG ONCOL, V107, P188, DOI 10.1002/jso.23240; Liu YN, 2008, MOL CELL BIOL, V28, P7096, DOI 10.1128/MCB.00449-08; Maccario C, 2012, CARCINOGENESIS, V33, P2172, DOI 10.1093/carcin/bgs244; MARTZ E, 1972, J CELL PHYSIOL, V79, P189, DOI 10.1002/jcp.1040790205; Menke A, 2001, CANCER RES, V61, P3508; Mohamet L, 2011, J ONCOL, V2011, DOI 10.1155/2011/352616; Moreno-Bueno G, 2009, NAT PROTOC, V4, P1591, DOI 10.1038/nprot.2009.152; Myong NH, 2012, KOREAN J PATHOL, V46, P341, DOI 10.4132/KoreanJPathol.2012.46.4.341; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Osada T, 1996, HEPATOLOGY, V24, P1460, DOI 10.1002/hep.510240627; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Ren J, 2013, J CELL BIOCHEM, V114, P1395, DOI 10.1002/jcb.24481; Romer AM, 2013, ANTICANCER RES, V33, P1525; Rosano L, 2011, CLIN CANCER RES, V17, P2350, DOI 10.1158/1078-0432.CCR-10-2325; Shen CH, 2011, J BUON, V16, P733; Shimada S, 2012, GUT, V61, P344, DOI 10.1136/gutjnl-2011-300050; Siebzehnrubl FA, 2013, EMBO MOL MED; Tanaka M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-237; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Udagawa T, 2010, CURR OPIN PHARMACOL, V10, P369, DOI 10.1016/j.coph.2010.06.010; Yamaguchi K, 2013, GASTRIC CANCER, V16, P175, DOI 10.1007/s10120-012-0167-0; Yang SM, 2013, TOXICOLOGY, V306, P162, DOI 10.1016/j.tox.2013.02.014; Zhang H, 2013, J CANCER RES CLIN, V139, P1033, DOI 10.1007/s00432-012-1363-3; Zhang K, 2013, INT J MOL MED; Zubeldia IG, 2013, EXP CELL RES, V319, P12, DOI 10.1016/j.yexcr.2012.11.004	43	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97306	10.1371/journal.pone.0097306	http://dx.doi.org/10.1371/journal.pone.0097306			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845259	Green Submitted, gold, Green Published			2022-12-25	WOS:000339563400020
J	Arora, M; Austin, C; Sarrafpour, B; Hernandez-Avila, M; Hu, H; Wright, RO; Tellez-Rojo, MM				Arora, Manish; Austin, Christine; Sarrafpour, Babak; Hernandez-Avila, Mauricio; Hu, Howard; Wright, Robert O.; Maria Tellez-Rojo, Martha			Determining Prenatal, Early Childhood and Cumulative Long-Term Lead Exposure Using Micro-Spatial Deciduous Dentine Levels	PLOS ONE			English	Article							MATERNAL BONE-LEAD; BLOOD; TEETH; CHILDREN; PREGNANCY; PLASMA; BIOMARKER; TOOTH	The aim of this study was to assess the validity of micro-spatial dentine lead (Pb) levels as a biomarker for accurately estimating exposure timing over the prenatal and early childhood periods and long-term cumulative exposure to Pb. In a prospective pregnancy cohort sub-sample of 85 subjects, we compared dentine Pb levels measured using laser ablation-inductively coupled plasma mass spectrometry with Pb concentrations in maternal blood collected in the second and third trimesters, maternal bone, umbilical cord blood, and childhood serial blood samples collected from the ages of 3 months to >= 6 years. We found that Pb levels (as Pb-208:Ca-43) in dentine formed at birth were significantly associated with cord blood Pb (Spearman rho = 0.69; n = 27; p<0.0001). The association of prenatal dentine Pb with maternal patella Pb (Spearman rho = 0.48; n = 59; p<0.0001) was stronger than that observed for tibia Pb levels (Spearman rho = 0.35; n = 41; p<0.03). When assessing postnatal exposure, we found that Pb levels in dentine formed at 3 months were significantly associated with Pb concentrations in children's blood collected concurrently (Spearman rho = 0.64; n = 55; p<0.0001). We also found that mean Pb concentrations in secondary dentine (that is formed from root completion to tooth shedding) correlated positively with cumulative blood lead index (Spearman rho = 0.38; n = 75; p<0.0007). Overall, our results support that micro-spatial measurements of Pb in dentine can be reliably used to reconstruct Pb exposure timing over the prenatal and early childhood periods, and secondary dentine holds the potential to estimate long-term exposure up to the time the tooth is shed.	[Arora, Manish; Austin, Christine; Wright, Robert O.] Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY 10029 USA; [Arora, Manish; Austin, Christine; Sarrafpour, Babak] Univ Sydney, Fac Dent, Sydney, NSW 2006, Australia; [Hernandez-Avila, Mauricio] Natl Inst Publ Hlth, Off Director, Cuernavaca, Morelos, Mexico; [Hu, Howard] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Maria Tellez-Rojo, Martha] Natl Inst Publ Hlth, Ctr Evaluat Res & Surveys, Div Stat, Cuernavaca, Morelos, Mexico	Icahn School of Medicine at Mount Sinai; University of Sydney; Instituto Nacional de Salud Publica; University of Toronto; Instituto Nacional de Salud Publica	Arora, M (corresponding author), Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY 10029 USA.	manish.arora@mssm.edu	Hu, Howard/AAV-5360-2021	Wright, Robert/0000-0003-1180-6459; Hu, Howard/0000-0002-3676-2707; Austin, Christine/0000-0002-9966-0492	NIEHS [R00ES019597, P42ES05947, R01ES07821, P42ES00000, R01ES013744, R01ES014930]; Australian NHMRC [APP1028372]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007821, R01ES014930, R00ES019597, R01ES020268, P42ES016454, R01ES013744, P30ES023515, P42ES005947] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by funding from NIEHS grants R00ES019597 (Arora), P42ES05947 (Hu), R01ES07821 (Hu), P42ES00000 (Hu), R01ES07821 (Hu, Wright) R01ES013744 (Wright), R01ES014930 (Wright), and Australian NHMRC grant APP1028372 (Arora). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora M, 2006, SCI TOTAL ENVIRON, V371, P55, DOI 10.1016/j.scitotenv.2006.07.035; Arora M, 2013, CURR OPIN PEDIATR, V25, P261, DOI 10.1097/MOP.0b013e32835e9084; Arora M, 2012, ENVIRON SCI TECHNOL, V46, P5118, DOI 10.1021/es203569f; Austin C, 2013, NATURE, V498, P216, DOI 10.1038/nature12169; Berkovitz BKB., 2018, ORAL ANATOMY HISTOLO, V5th ed.; Chuang HY, 2001, ENVIRON HEALTH PERSP, V109, P527, DOI 10.2307/3454713; Ettinger AS, 2009, ENVIRON HEALTH PERSP, V117, P26, DOI [10.1289/ehp.11868, 10.1289/ehp.1171c26]; GonzalezCossio T, 1997, PEDIATRICS, V100, P856, DOI 10.1542/peds.100.5.856; Grandjean P, 2006, LANCET, V368, P2167, DOI 10.1016/S0140-6736(06)69665-7; GULSON B, 1994, ARCH ENVIRON HEALTH, V49, P279, DOI 10.1080/00039896.1994.9937480; Hare D, 2011, J DENT, V39, P397, DOI 10.1016/j.jdent.2011.03.004; Hernandez-Avila M, 2002, ARCH ENVIRON HEALTH, V57, P482, DOI 10.1080/00039890209601441; Hu H, 1998, ENVIRON HEALTH PERSP, V106, P1, DOI 10.2307/3433626; Hu H, 2006, ENVIRON HEALTH PERSP, V114, P1730, DOI 10.1289/ehp.9067; MCMICHAEL AJ, 1994, AM J EPIDEMIOL, V140, P489, DOI 10.1093/oxfordjournals.aje.a117275; NEEDLEMAN HL, 1972, NATURE, V235, P111, DOI 10.1038/235111a0; NEEDLEMAN HL, 1974, NEW ENGL J MED, V290, P245, DOI 10.1056/NEJM197401312900504; Nie LH, 2011, BIOMARKERS, V16, P517, DOI 10.3109/1354750X.2011.604133; RABINOWITZ MB, 1995, B ENVIRON CONTAM TOX, V55, P853; Roels H, 1995, ENVIRON RES, V69, P75, DOI 10.1006/enrs.1995.1027; Tellez-Rojo MM, 2004, AM J EPIDEMIOL, V160, P668, DOI 10.1093/aje/kwh271; Zhang AM, 2012, ENVIRON HEALTH PERSP, V120, P445, DOI 10.1289/ehp.1103736	22	49	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97805	10.1371/journal.pone.0097805	http://dx.doi.org/10.1371/journal.pone.0097805			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841926	Green Published, gold, Green Submitted			2022-12-25	WOS:000340948600076
J	Eckert, N; Wrensch, F; Gartner, S; Palanisamy, N; Goedecke, U; Jager, N; Pohlmann, S; Winkler, M				Eckert, Nadine; Wrensch, Florian; Gaertner, Sabine; Palanisamy, Navaneethan; Goedecke, Ulrike; Jaeger, Nils; Poehlmann, Stefan; Winkler, Michael			Influenza A Virus Encoding Secreted Gaussia Luciferase as Useful Tool to Analyze Viral Replication and Its Inhibition by Antiviral Compounds and Cellular Proteins	PLOS ONE			English	Article							NIEMANN-PICK C1; IN-VIVO; NEURAMINIDASE INHIBITOR; RESISTANT INFLUENZA; REPORTER VIRUS; IFITM PROTEINS; CACO-2 CELLS; DENGUE VIRUS; MDCK CELLS; INFECTION	Reporter genes inserted into viral genomes enable the easy and rapid quantification of virus replication, which is instrumental to efficient in vitro screening of antiviral compounds or in vivo analysis of viral spread and pathogenesis. Based on a published design, we have generated several replication competent influenza A viruses carrying either fluorescent proteins or Gaussia luciferase. Reporter activity could be readily quantified in infected cultures, but the virus encoding Gaussia luciferase was more stable than viruses bearing fluorescent proteins and was therefore analyzed in detail. Quantification of Gaussia luciferase activity in the supernatants of infected culture allowed the convenient and highly sensitive detection of viral spread, and enzymatic activity correlated with the number of infectious particles released from infected cells. Furthermore, the Gaussia luciferase encoding virus allowed the sensitive quantification of the antiviral activity of the neuraminidase inhibitor (NAI) zanamivir and the host cell interferon-inducible transmembrane (IFITM) proteins 1-3, which are known to inhibit influenza virus entry. Finally, the virus was used to demonstrate that influenza A virus infection is sensitive to a modulator of endosomal cholesterol, in keeping with the concept that IFITMs inhibit viral entry by altering cholesterol levels in the endosomal membrane. In sum, we report the characterization of a novel influenza A reporter virus, which allows fast and sensitive detection of viral spread and its inhibition, and we show that influenza A virus entry is sensitive to alterations of endosomal cholesterol levels.	[Eckert, Nadine; Wrensch, Florian; Gaertner, Sabine; Palanisamy, Navaneethan; Goedecke, Ulrike; Jaeger, Nils; Poehlmann, Stefan; Winkler, Michael] German Primate Ctr, Infect Biol Unit, Gottingen, Germany	Deutsches Primatenzentrum (DPZ)	Pohlmann, S (corresponding author), German Primate Ctr, Infect Biol Unit, Gottingen, Germany.	SPoehlmann@dpz.eu; MWinkler@dpz.eu	Palanisamy, Navaneethan/AAL-1462-2020; Pöhlmann, Stefan/H-2395-2011	Palanisamy, Navaneethan/0000-0003-0369-2316; Pöhlmann, Stefan/0000-0001-6086-9136; Wrensch, Florian/0000-0002-7258-5453; Winkler, Michael/0000-0002-6198-554X	Leibniz Graduate School EIDIS; Leibniz Foundation	Leibniz Graduate School EIDIS; Leibniz Foundation	This work was supported by the Leibniz Graduate School EIDIS (FW) and the Leibniz Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006; Ataei F, 2009, PHOTOCHEM PHOTOBIOL, V85, P1162, DOI 10.1111/j.1751-1097.2009.00583.x; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; Bertram S, 2013, J VIROL, V87, P6150, DOI 10.1128/JVI.03372-12; Bertram S, 2010, J VIROL, V84, P10016, DOI 10.1128/JVI.00239-10; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Bottcher E, 2009, VACCINE, V27, P6324, DOI 10.1016/j.vaccine.2009.03.029; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; DiazGranados CA, 2012, VACCINE, V31, P49, DOI 10.1016/j.vaccine.2012.10.084; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Evdokimov AG, 2006, EMBO REP, V7, P1006, DOI 10.1038/sj.embor.7400787; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Gog JR, 2007, NUCLEIC ACIDS RES, V35, P1897, DOI 10.1093/nar/gkm087; Grimm D, 2007, P NATL ACAD SCI USA, V104, P6806, DOI 10.1073/pnas.0701849104; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Hatakeyama S, 2005, J CLIN MICROBIOL, V43, P4139, DOI 10.1128/JCM.43.8.4139-4146.2005; Heaton NS, 2013, J VIROL, V87, P8272, DOI 10.1128/JVI.00969-13; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Ito K, 2013, ANNU REV BIOCHEM, V82, P171, DOI 10.1146/annurev-biochem-080211-105026; John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13; Kittel C, 2004, VIROLOGY, V324, P67, DOI 10.1016/j.virol.2004.03.035; KLENK HD, 1975, VIROLOGY, V68, P426, DOI 10.1016/0042-6822(75)90284-6; Kupcsik L, 2011, METHODS MOL BIOL, V740, P13, DOI 10.1007/978-1-61779-108-6_3; Li F, 2010, J VIROL, V84, P12075, DOI 10.1128/JVI.00046-10; Machado AV, 2006, VIROLOGY, V345, P73, DOI 10.1016/j.virol.2005.09.050; Machado AV, 2003, VIROLOGY, V313, P235, DOI 10.1016/S0042-6822(03)00289-7; Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; MIKI T, 1992, J MOL BIOL, V225, P39, DOI 10.1016/0022-2836(92)91024-J; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Mostafa A, 2013, J VIROL METHODS, V193, P603, DOI 10.1016/j.jviromet.2013.07.021; Neumann G, 2000, J VIROL, V74, P547, DOI 10.1128/JVI.74.1.547-551.2000; Okomo-Adhiambo M, 2013, INFLUENZA OTHER RESP, V7, P44, DOI [10.1111/irv.12113, 10.1111/irv.12051]; Osterhaus A, 2011, PHILOS T R SOC B, V366, P2766, DOI 10.1098/rstb.2011.0102; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Pan WQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3369; Samson M, 2013, ANTIVIR RES, V98, P174, DOI 10.1016/j.antiviral.2013.03.014; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shoemaker CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056265; Siegrist F, 2011, J INTERF CYTOK RES, V31, P183, DOI 10.1089/jir.2010.0112; Simmons G, 2003, VIROLOGY, V305, P115, DOI 10.1006/viro.2002.1730; Sun XJ, 2013, ADV EXP MED BIOL, V790, P72, DOI 10.1007/978-1-4614-7651-1_4; Tannous BA, 2009, NAT PROTOC, V4, P582, DOI 10.1038/nprot.2009.28; Tisdale M, 2000, REV MED VIROL, V10, P45, DOI 10.1002/(SICI)1099-1654(200001/02)10:1&lt;45::AID-RMV265&gt;3.0.CO;2-R; Tran V, 2013, J VIROL, V87, P13321, DOI 10.1128/JVI.02381-13; Triana-Baltzer GB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007838; Unger T, 2010, J STRUCT BIOL, V172, P34, DOI 10.1016/j.jsb.2010.06.016; Winkler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043337; Yen HL, 2005, ANTIMICROB AGENTS CH, V49, P4075, DOI 10.1128/AAC.49.10.4075-4084.2005; Zhirnov O, 2003, VIROLOGY, V313, P198, DOI 10.1016/S0042-6822(03)00264-2; Zimmermann P, 2011, J VIROL, V85, P8133, DOI 10.1128/JVI.00712-11	58	40	41	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97695	10.1371/journal.pone.0097695	http://dx.doi.org/10.1371/journal.pone.0097695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842154	Green Submitted, Green Published, gold			2022-12-25	WOS:000340948600057
J	Mnpotra, JS; Qiao, ZH; Cai, J; Lynch, DL; Grossfield, A; Leioatts, N; Hurst, DP; Pitman, MC; Song, ZH; Reggio, PH				Mnpotra, Jagjeet S.; Qiao, Zhuanhong; Cai, Jian; Lynch, Diane L.; Grossfield, Alan; Leioatts, Nicholas; Hurst, Dow P.; Pitman, Michael C.; Song, Zhao-Hui; Reggio, Patricia H.			Structural Basis of G Protein-coupled Receptor-G(i) Protein Interaction FORMATION OF THE CANNABINOID CB2 RECEPTOR-G(i) PROTEIN COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGSTROM CRYSTAL-STRUCTURE; LIGHT-ACTIVATED RHODOPSIN; BETA-GAMMA-SUBUNITS; ALPHA-SUBUNIT; CROSS-LINKING; MOLECULAR RECOGNITION; OPIOID RECEPTOR; LIGAND-BINDING; FORCE-FIELD; DYNAMICS	In this study, we applied a comprehensive G protein-coupled receptor-G alpha(i) protein chemical cross-linking strategy to map the cannabinoid receptor subtype 2 (CB2)-G alpha(i) interface and then used molecular dynamics simulations to explore the dynamics of complex formation. Three cross-link sites were identified using LC-MS/MS and electrospray ionization-MS/MS as follows: 1) a sulfhydryl cross-link between C3.53(134) in TMH3 and the G alpha(i) C-terminal i-3 residue Cys-351; 2) a lysine cross-link between K6.35(245) in TMH6 and the G alpha(i) C-terminal i-5 residue, Lys-349; and 3) a lysine cross-link between K5.64(215) in TMH5 and the G alpha(i) alpha(4)beta(6) loop residue, Lys-317. To investigate the dynamics and nature of the conformational changes involved in CB2 center dot G(i) complex formation, we carried out microsecond-time scale molecular dynamics simulations of the CB2 R*center dot G alpha(i1)beta(1)gamma(2) complex embedded in a 1-palmitoyl-2-oleoyl-phosphatidylcholine bilayer, using cross-linking information as validation. Our results show that although molecular dynamics simulations started with the G protein orientation in the beta 2-AR*center dot G alpha(s)beta(1)gamma(2) complex crystal structure, the G alpha(i1)beta(1)gamma(2) protein reoriented itself within 300 ns. Two major changes occurred as follows. 1) The G alpha(i1) alpha 5 helix tilt changed due to the outward movement of TMH5 in CB2 R*. 2) A 25 degrees clockwise rotation of G alpha(i1)beta(1)gamma(2) underneath CB2 R* occurred, with rotation ceasing when Pro-139 (IC-2 loop) anchors in a hydrophobic pocket on G alpha(i1) (Val-34, Leu-194, Phe-196, Phe-336, Thr-340, Ile-343, and Ile-344). In this complex, all three experimentally identified cross-links can occur. These findings should be relevant for other class A G protein-coupled receptors that couple to G(i) proteins.	[Hurst, Dow P.; Pitman, Michael C.; Reggio, Patricia H.] Univ N Carolina, Dept Chem & Biochem, Greensboro, NC 27402 USA; [Qiao, Zhuanhong; Cai, Jian; Song, Zhao-Hui] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [Grossfield, Alan; Leioatts, Nicholas] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Pitman, Michael C.] IBM Thomas J Watson Res Ctr, Computat Biol Ctr, Yorktown Hts, NY 10598 USA	University of North Carolina; University of North Carolina Greensboro; University of Louisville; University of Rochester; International Business Machines (IBM)	Song, ZH (corresponding author), Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA.	zhsong@louisville.edu; phreggio@uncg.edu		Leioatts, Nicholas/0000-0001-8847-8305; Grossfield, Alan/0000-0002-5877-2789	National Institutes of Health [DA011551, GM095496, DA003934, DA021358]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA003934, R29DA011551, K05DA021358, R01DA011551] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA011551 (to Z. H. S.), GM095496 (to A. M. G.), and DA003934 and DA021358 (to P. H. R.).	Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; Bouaboula M, 1999, MOL PHARMACOL, V55, P473; Bouaboula M, 1996, EUR J BIOCHEM, V237, P704, DOI 10.1111/j.1432-1033.1996.0704p.x; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cai K, 2001, P NATL ACAD SCI USA, V98, P4877, DOI 10.1073/pnas.051632898; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Coleman DE, 1998, BIOCHEMISTRY-US, V37, P14376, DOI 10.1021/bi9810306; Demuth DG, 2006, LIFE SCI, V78, P549, DOI 10.1016/j.lfs.2005.05.055; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fass D, 2012, ANNU REV BIOPHYS, V41, P63, DOI 10.1146/annurev-biophys-050511-102321; Feng WK, 2003, BIOCHEM PHARMACOL, V65, P1077, DOI 10.1016/S0006-2952(03)00005-4; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Gara A, 2005, IBM J RES DEV, V49, P195, DOI 10.1147/rd.492.0195; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1215904, 10.1126/science.1244693]; Hu JX, 2010, NAT CHEM BIOL, V6, P541, DOI [10.1038/NCHEMBIO.385, 10.1038/nchembio.385]; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hurst DP, 2010, J BIOL CHEM, V285, P17954, DOI 10.1074/jbc.M109.041590; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kisselev OG, 1998, P NATL ACAD SCI USA, V95, P4270, DOI 10.1073/pnas.95.8.4270; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lin Y, 2011, MOL PHARMACOL, V80, P551, DOI 10.1124/mol.111.073072; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; MORO O, 1993, J BIOL CHEM, V268, P22273; Nishimura A, 2010, P NATL ACAD SCI USA, V107, P13666, DOI 10.1073/pnas.1003553107; Onrust R, 1997, SCIENCE, V275, P381, DOI 10.1126/science.275.5298.381; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PARENTI M, 1993, BIOCHEM J, V291, P349, DOI 10.1042/bj2910349; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Preininger AM, 2003, BIOCHEMISTRY-US, V42, P7931, DOI 10.1021/bi0345438; Preininger AM, 2013, J MOL BIOL, V425, P2288, DOI 10.1016/j.jmb.2013.04.011; Racz I, 2008, J NEUROSCI, V28, P12125, DOI 10.1523/JNEUROSCI.3400-08.2008; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Romo T., 2009, 31 ANN INT C IEEE EM, P2332, DOI DOI 10.1109/IEMBS.2009.5335065; SANFORD J, 1991, J BIOL CHEM, V266, P9570; Schilling B, 2003, J AM SOC MASS SPECTR, V14, P834, DOI 10.1016/S1044-0305(03)00327-1; Slessareva JE, 2003, J BIOL CHEM, V278, P50530, DOI 10.1074/jbc.M304417200; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Soskine M, 2002, P NATL ACAD SCI USA, V99, P12043, DOI 10.1073/pnas.192392899; Storr M, 2002, CAN J PHYSIOL PHARM, V80, P67, DOI 10.1139/Y02-005; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Ulloa-Aguirre A, 2007, MOL CELL ENDOCRINOL, V260, P153, DOI 10.1016/j.mce.2005.11.050; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Weis WI, 2008, CURR OPIN STRUC BIOL, V18, P734, DOI 10.1016/j.sbi.2008.09.010; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Wright KL, 2008, BRIT J PHARMACOL, V153, P263, DOI 10.1038/sj.bjp.0707486; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Yu ET, 2008, J PROTEOME RES, V7, P4848, DOI 10.1021/pr800443f; Zhang RD, 2007, PROTEIN EXPRES PURIF, V55, P225, DOI 10.1016/j.pep.2007.03.018; Zheng CX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063262	67	24	24	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20259	20272		10.1074/jbc.M113.539916	http://dx.doi.org/10.1074/jbc.M113.539916			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24855641	Green Published, hybrid			2022-12-25	WOS:000339395200038
J	Gotzke, H; Palombo, I; Muheim, C; Perrody, E; Genevaux, P; Kudva, R; Muller, M; Daley, DO				Gotzke, Hansjorg; Palombo, Isolde; Muheim, Claudio; Perrody, Elsa; Genevaux, Pierre; Kudva, Renuka; Mueller, Matthias; Daley, Daniel O.			YfgM Is an Ancillary Subunit of the SecYEG Translocon in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PROTEINS; GRAM-NEGATIVE BACTERIA; CHAPERONE; STRESS; GENE; YIDC; MECHANISMS; SECRETION; COMPONENT; INSERTION	Protein secretion in Gram-negative bacteria is essential for both cell viability and pathogenesis. The vast majority of secreted proteins exit the cytoplasm through a transmembrane conduit called the Sec translocon in a process that is facilitated by ancillary modules, such as SecA, SecDF-YajC, YidC, and PpiD. In this study we have characterized YfgM, a protein with no annotated function. We found it to be a novel ancillary subunit of the Sec translocon as it co-purifies with both PpiD and the SecYEG translocon after immunoprecipitation and blue native/SDS-PAGE. Phenotypic analyses of strains lacking yfgM suggest that its physiological role in the cell overlaps with the periplasmic chaperones SurA and Skp. We, therefore, propose a role for YfgM in mediating the trafficking of proteins from the Sec translocon to the periplasmic chaperone network that contains SurA, Skp, DegP, PpiD, and FkpA.	[Gotzke, Hansjorg; Palombo, Isolde; Muheim, Claudio; Daley, Daniel O.] Stockholm Univ, Ctr Biomembrane Res, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; [Perrody, Elsa; Genevaux, Pierre] CNRS, Lab Microbiol & Genet Mol, F-31062 Toulouse, France; [Perrody, Elsa; Genevaux, Pierre] Univ Toulouse 3, F-31062 Toulouse, France; [Kudva, Renuka; Mueller, Matthias] Univ Freiburg, Inst Biochem & Mol Biol, Zentrum Biochem & Mol, D-79104 Freiburg, Germany; [Kudva, Renuka; Mueller, Matthias] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79104 Freiburg, Germany	Stockholm University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Freiburg; University of Freiburg	Daley, DO (corresponding author), Stockholm Univ, Ctr Biomembrane Res, Dept Biochem & Biophys, Svante Arrhenius Vag 16c, SE-10691 Stockholm, Sweden.	ddaley@dbb.su.se	Genevaux, Pierre/A-4851-2015	Daley, Daniel/0000-0002-6425-5059; Kudva, Renuka/0000-0003-0426-3716; GENEVAUX, Pierre/0000-0001-7539-3126	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by a grant from the Swedish Research Council (to D. O. D.).	AKIYAMA Y, 1990, BIOCHEM BIOPH RES CO, V167, P711, DOI 10.1016/0006-291X(90)92083-C; Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; Antonoaea R, 2008, BIOCHEMISTRY-US, V47, P5649, DOI 10.1021/bi800233w; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bordes P, 2011, P NATL ACAD SCI USA, V108, P8438, DOI 10.1073/pnas.1101189108; Boy D, 2009, MOL BIOL CELL, V20, P1804, DOI 10.1091/mbc.E08-08-0886; Cajo GC, 2006, J BIOL CHEM, V281, P12436, DOI 10.1074/jbc.M511192200; Cerveny L, 2013, INFECT IMMUN, V81, P629, DOI 10.1128/IAI.01035-12; Dalbey RE, 2012, FEMS MICROBIOL REV, V36, P1023, DOI 10.1111/j.1574-6976.2012.00327.x; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Dartigalongue C, 1998, EMBO J, V17, P3968, DOI 10.1093/emboj/17.14.3968; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Duong F, 1997, EMBO J, V16, P4871, DOI 10.1093/emboj/16.16.4871; Duong F, 1997, EMBO J, V16, P2756, DOI 10.1093/emboj/16.10.2756; Economou A, 2000, FEBS LETT, V476, P18, DOI 10.1016/S0014-5793(00)01662-8; Egea PF, 2010, P NATL ACAD SCI USA, V107, P17182, DOI 10.1073/pnas.1012556107; Fang J, 2011, PROTEIN PEPTIDE LETT, V18, P601, DOI 10.2174/092986611795222713; GARDEL C, 1987, J BACTERIOL, V169, P1286, DOI 10.1128/jb.169.3.1286-1290.1987; GARDEL C, 1990, EMBO J, V9, P4205, DOI 10.1002/j.1460-2075.1990.tb07645.x; Ieva R, 2011, P NATL ACAD SCI USA, V108, pE383, DOI 10.1073/pnas.1103827108; Kato Y, 2003, FEBS LETT, V550, P114, DOI 10.1016/S0014-5793(03)00847-0; Lazar SW, 1996, J BACTERIOL, V178, P1770, DOI 10.1128/jb.178.6.1770-1773.1996; Leyton DL, 2012, NAT REV MICROBIOL, V10, P213, DOI 10.1038/nrmicro2733; Liu A, 2010, ANTIMICROB AGENTS CH, V54, P1393, DOI 10.1128/AAC.00906-09; Maddalo G, 2011, J PROTEOME RES, V10, P1848, DOI 10.1021/pr101105c; Matern Y, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-251; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; Nouwen N, 2002, MOL MICROBIOL, V44, P1397, DOI 10.1046/j.1365-2958.2002.02972.x; Okuda S, 2011, ANNU REV MICROBIOL, V65, P239, DOI 10.1146/annurev-micro-090110-102859; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Perrody E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003037; Raivio TL, 2001, ANNU REV MICROBIOL, V55, P591, DOI 10.1146/annurev.micro.55.1.591; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rapp M, 2004, PROTEIN SCI, V13, P937, DOI 10.1110/ps.03553804; Ricci DP, 2012, BBA-BIOMEMBRANES, V1818, P1067, DOI 10.1016/j.bbamem.2011.08.020; Rigel NW, 2012, CURR OPIN MICROBIOL, V15, P189, DOI 10.1016/j.mib.2011.12.007; Rizzitello AE, 2001, J BACTERIOL, V183, P6794, DOI 10.1128/JB.183.23.6794-6800.2001; Rouviere PE, 1996, GENE DEV, V10, P3170, DOI 10.1101/gad.10.24.3170; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Ruiz N, 2005, CURR OPIN MICROBIOL, V8, P122, DOI 10.1016/j.mib.2005.02.013; Sachelaru I, 2013, J BIOL CHEM, V288, P16295, DOI 10.1074/jbc.M112.446583; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Schagger H, 2002, BBA-BIOENERGETICS, V1555, P154, DOI 10.1016/S0005-2728(02)00271-2; Schwalm J, 2013, J BACTERIOL, V195, P3734, DOI 10.1128/JB.00431-13; Schweiger R, 2012, J CELL SCI, V125, P5196, DOI 10.1242/jcs.111054; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Stenberg F, 2005, J BIOL CHEM, V280, P34409, DOI 10.1074/jbc.M506479200; Toddo S, 2012, PROTEIN SCI, V21, P1571, DOI 10.1002/pro.2131; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Westphal K, 2012, J BIOL CHEM, V287, P42962, DOI 10.1074/jbc.M112.388470; Zhang M, 2011, NAT CHEM BIOL, V7, P671, DOI [10.1038/NCHEMBIO.644, 10.1038/nchembio.644]; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	57	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19089	19097		10.1074/jbc.M113.541672	http://dx.doi.org/10.1074/jbc.M113.541672			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24855643	Green Published, hybrid			2022-12-25	WOS:000339062900039
J	Madonna, R; Geng, YJ; Bolli, R; Rokosh, G; Ferdinandy, P; Patterson, C; De Caterina, R				Madonna, Rosalinda; Geng, Yong-Jian; Bolli, Roberto; Rokosh, Gregg; Ferdinandy, Peter; Patterson, Cam; De Caterina, Raffaele			Co-Activation of Nuclear Factor-kappa B and Myocardin/Serum Response Factor Conveys the Hypertrophy Signal of High Insulin Levels in Cardiac Myoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; DIABETIC CARDIOMYOPATHY; VCAM-1 EXPRESSION; MESENCHYMAL CELLS; MESSENGER-RNA; GENE; ACTIVATION; PROTEIN; OBESE; IDENTIFICATION	Hyperinsulinemia contributes to cardiac hypertrophy and heart failure in patients with the metabolic syndrome and type 2 diabetes. Here, high circulating levels of tumor necrosis factor (TNF)-alpha may synergize with insulin in signaling inflammation and cardiac hypertrophy. Wetested whether high insulin affects activation of TNF-alpha -induced NF-kappa B and myocardin/serum response factor (SRF) to convey hypertrophy signaling in cardiac myoblasts. In canine cardiac myoblasts, treatment with high insulin (10(-8) to 10(-7) M) for 0-24 h increased insulin receptor substrate (IRS)-1 phosphorylation at Ser-307, decreased protein levels of chaperone-associated ubiquitin (Ub) E3 ligase Cterminus of heat shock protein 70-interacting protein (CHIP), increased SRF activity, as well as beta-myosin heavy chain (MHC) and myocardin expressions. Here siRNAs to myocardin or NF-kappa B, as well as CHIP overexpression prevented (while siRNA-mediated CHIP disruption potentiated) high insulin-induced SR element (SRE) activation and beta-MHC expression. Insulin markedly potentiated TNF-alpha -induced NF-kappa B activation. Compared with insulin alone, insulin+TNF-alpha increased SRF/SRE binding and beta-MHC expression, which was reversed by the NF-kappa B inhibitor pyrrolidine dithiocarbamate (PDTC) and by NF-kappa B silencing. In the hearts of db/db diabetic mice, in which Akt phosphorylation was decreased, p38MAPK, Akt1, and IRS-1 phosphorylation at Ser-307 were increased, together with myocardin expression as well as SRE and NF-kappa B activities. In response to high insulin, cardiac myoblasts increase the expression or the promyogenic transcription factors myocardin/ SRF in a CHIP-dependent manner. Insulin potentiates TNF-alpha in inducing NF-kappa B and SRF/SRE activities. In hyperin-sulinemic states, myocardin may act as a nuclear effector of insulin, promoting cardiac hypertrophy.	[Madonna, Rosalinda; Geng, Yong-Jian] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX 77030 USA; [Madonna, Rosalinda; Geng, Yong-Jian] Univ Texas Med Sch Houston, Houston, TX 77030 USA; [Madonna, Rosalinda; De Caterina, Raffaele] Univ G DAnnunzio, Inst Cardiol, I-66100 Chieti, Italy; [Madonna, Rosalinda; De Caterina, Raffaele] Univ G DAnnunzio, Ctr Excellence Aging, I-66100 Chieti, Italy; [Bolli, Roberto; Rokosh, Gregg] Univ Louisville, Inst Mol Cardiol, Louisville, KY 40202 USA; [Ferdinandy, Peter] Semmelweis Univ, Dept Pharmacol & Pharmacotherapy, H-1085 Budapest, Hungary; [Patterson, Cam] Univ Texas Med Branch, Ctr Mol Cardiol, Galveston, TX 77555 USA	Saint Lukes Episcopal Hospital; Texas Heart Institute; University of Texas System; University of Texas Health Science Center Houston; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Louisville; Semmelweis University; University of Texas System; University of Texas Medical Branch Galveston	De Caterina, R (corresponding author), Univ G DAnnunzio, Osped SS Annunziata, Inst Cardiol, Via Vestini, I-66013 Chieti, Italy.	rdecater@unich.it	De Caterina, Raffaele/K-3857-2016; Ferdinandy, Péter/H-9181-2019	De Caterina, Raffaele/0000-0003-1637-574X; Rokosh, Gregg/0000-0002-9214-2254; Madonna, Rosalinda/0000-0001-6455-2777	National Institutes of Health [R01HL59249, R01HL69509]; Italian Istituto Nazionale Ricerche Cardiovascolari (I.N.R.C.); CARIPLO; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078825, R01HL059249, R01HL069509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Istituto Nazionale Ricerche Cardiovascolari (I.N.R.C.); CARIPLO(Fondazione Cariplo); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by Grants R01HL59249 and R01HL69509 from the National Institutes of Health (to Y.-J. G.) and the Italian Istituto Nazionale Ricerche Cardiovascolari (I.N.R.C.) and CARIPLO (to R. M. and R. D. C.).	Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Belaguli NS, 1997, J BIOL CHEM, V272, P18222, DOI 10.1074/jbc.272.29.18222; Belke DD, 2002, J CLIN INVEST, V109, P629, DOI 10.1172/JCI200213946; Belova L, 2006, BIOCHEM J, V400, P235, DOI 10.1042/BJ20060905; Bierhaus A, 2001, DIABETES, V50, P2792, DOI 10.2337/diabetes.50.12.2792; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Burke JR, 2003, CURR OPIN DRUG DI DE, V6, P720; Chen CY, 1996, MOL CELL BIOL, V16, P6372; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Esposito G, 2002, CIRCULATION, V105, P85, DOI 10.1161/hc0102.101365; Fernandez-Real JM, 2001, J CLIN ENDOCR METAB, V86, P1154, DOI 10.1210/jc.86.3.1154; Fonarow GC, 2006, ENDOCRIN METAB CLIN, V35, P575, DOI 10.1016/j.ecl.2006.05.003; Franzoso G, 1996, EMBO J, V15, P3403, DOI 10.1002/j.1460-2075.1996.tb00706.x; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Greene MW, 2002, BIOCHEMISTRY-US, V41, P7082, DOI 10.1021/bi015992f; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Herschkovitz A, 2007, J BIOL CHEM, V282, P18018, DOI 10.1074/jbc.M610949200; HITTINGER L, 1995, CIRCULATION, V92, P978, DOI 10.1161/01.CIR.92.4.978; Jersmann HPA, 2001, INFECT IMMUN, V69, P1273, DOI 10.1128/IAI.69.3.1273-1279.2001; Karnik AA, 2007, CURR HYPERTENS REP, V9, P467, DOI 10.1007/s11906-007-0086-3; Kim YB, 2000, DIABETES, V49, P847, DOI 10.2337/diabetes.49.5.847; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; LEE JS, 1994, AM J PHYSIOL, V266, pC319, DOI 10.1152/ajpcell.1994.266.2.C319; Li HJ, 2007, J CLIN INVEST, V117, P1314, DOI 10.1172/JCI31222; Li Y.P., 2001, FASEB J, V15, P1413; Lorenzo O, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/652097; Madonna R, 2007, INT J IMMUNOPATH PH, V20, P539, DOI 10.1177/039463200702000312; Madonna R, 2005, J BIOL CHEM, V280, P13503, DOI 10.1074/jbc.M411859200; Madonna R, 2013, INT J IMMUNOPATH PH, V26, P59, DOI 10.1177/039463201302600106; Madonna R, 2009, THROMB HAEMOSTASIS, V101, P345, DOI 10.1160/TH08-07-0484; Madonna R, 2008, BBA-MOL BASIS DIS, V1782, P511, DOI 10.1016/j.bbadis.2008.05.006; Madonna R, 2008, STEM CELLS, V26, P202, DOI 10.1634/stemcells.2007-0490; Madonna R, 2013, CIRC RES, V113, P902, DOI 10.1161/CIRCRESAHA.113.301690; Madonna R, 2013, INT J CARDIOL, V167, P2912, DOI 10.1016/j.ijcard.2012.07.017; Madonna R, 2011, THROMB HAEMOSTASIS, V106, P500, DOI 10.1160/TH10-09-0574; Madonna R, 2009, EXP CELL RES, V315, P2921, DOI 10.1016/j.yexcr.2009.07.016; Maisch B, 2011, HERZ, V36, P102, DOI 10.1007/s00059-011-3429-4; MCMILLAN DE, 1989, METABOLISM, V38, P1042, DOI 10.1016/0026-0495(89)90038-3; Mishima Y, 2001, DIABETES RES CLIN PR, V52, P119, DOI 10.1016/S0168-8227(00)00247-3; Morisco C, 2005, CIRC RES, V96, P180, DOI 10.1161/01.RES.0000152968.71868.c3; Moylan JS, 2008, AM J PHYSIOL-CELL PH, V295, pC986, DOI 10.1152/ajpcell.00041.2008; Navab M, 2008, CURR OPIN CLIN NUTR, V11, P459, DOI 10.1097/MCO.0b013e32830460c2; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; O'Neill BT, 2005, J CLIN INVEST, V115, P2059, DOI 10.1172/JCI25900; PAOLISSO G, 1995, EUR J CLIN INVEST, V25, P529, DOI 10.1111/j.1365-2362.1995.tb01740.x; Park CW, 2009, DIABETES, V58, P2666, DOI 10.2337/db09-0136; Poornima IG, 2006, CIRC RES, V98, P596, DOI 10.1161/01.RES.0000207406.94146.c2; Rutter MK, 2003, CIRCULATION, V107, P448, DOI 10.1161/01.CIR.0000045671.62860.98; SAAD MF, 1989, LANCET, V1, P1356; Samuelsson AM, 2006, AM J PHYSIOL-HEART C, V291, pH787, DOI 10.1152/ajpheart.00974.2005; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Shimizu I, 2010, J CLIN INVEST, V120, P1506, DOI 10.1172/JCI40096; Shiojima I, 2006, GENE DEV, V20, P3347, DOI 10.1101/gad.1492806; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Van der Heiden K, 2010, CLIN SCI, V118, P593, DOI 10.1042/CS20090557; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Xie P, 2009, MOL CELL BIOL, V29, P2398, DOI 10.1128/MCB.01737-08; Xing WB, 2006, CIRC RES, V98, P1089, DOI 10.1161/01.RES.0000218781.23144.3e; Zelarayan L, 2009, CARDIOVASC RES, V84, P416, DOI 10.1093/cvr/cvp237; Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782, DOI 10.1152/ajpheart.2001.280.4.H1782	66	21	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19585	19598		10.1074/jbc.M113.540559	http://dx.doi.org/10.1074/jbc.M113.540559			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24855642	Green Published, hybrid			2022-12-25	WOS:000339326800032
J	Morris, LL; Hartman, IZ; Jun, DJ; Seemann, J; DeBose-Boyd, RA				Morris, Lindsey L.; Hartman, Isamu Z.; Jun, Dong-Jae; Seemann, Joachim; DeBose-Boyd, Russell A.			Sequential Actions of the AAA-ATPase Valosin-containing Protein (VCP)/p97 and the Proteasome 19 S Regulatory Particle in Sterol-accelerated, Endoplasmic Reticulum (ER)associated Degradation of 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A REDUCTASE; HMG-COA REDUCTASE; CLEAVAGE-ACTIVATING PROTEIN; ER-ASSOCIATED DEGRADATION; LOW-DENSITY-LIPOPROTEIN; HAMSTER OVARY CELLS; MEMBRANE-PROTEIN; INDUCED DISLOCATION; UBIQUITIN LIGASE; SENSING DOMAIN	Accelerated endoplasmic reticulum (ER)-associated degradation (ERAD) of the cholesterol biosynthetic enzyme 3-hydroxy3-methylglutaryl-coenzyme A reductase results from its sterol-induced binding to ER membrane proteins called Insig-1 and Insig-2. This binding allows for subsequent ubiquitination of reductase by Insig-associated ubiquitin ligases. Once ubiquitinated, reductase becomes dislocated from ER membranes into the cytosol for degradation by 26 S proteasomes through poorly defined reactions mediated by the AAA-ATPase valosin-containing protein (VCP)/p97 and augmented by the nonsterol isoprenoid geranylgeraniol. Here, we report that the oxysterol 25-hydroxycholesterol and geranylgeraniol combine to trigger extraction of reductase across ER membranes prior to its cytosolic release. This conclusion was drawn from studies utilizing a novel assay that measures membrane extraction of reductase by determining susceptibility of a lumenal epitope in the enzyme to in vitro protease digestion. Susceptibility of the lumenal epitope to protease digestion and thus membrane extraction of reductase were tightly regulated by 25-hydroxycholesterol and geranylgeraniol. The reaction was inhibited by RNA interference-mediated knockdown of either Insigs or VCP/p97. In contrast, reductase continued to become membrane-extracted, but not cytosolically dislocated, in cells deficient for AAA-ATPases of the proteasome 19 S regulatory particle. These findings establish sequential roles for VCP/p97 and the 19 S regulatory particle in the sterol-accelerated ERAD of reductase that may be applicable to the ERAD of other substrates.	[Morris, Lindsey L.; Hartman, Isamu Z.; Jun, Dong-Jae; DeBose-Boyd, Russell A.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Seemann, Joachim] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [DeBose-Boyd, Russell A.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	DeBose-Boyd, RA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Russell.DeBose-Boyd@utsouthwestern.edu		Morris, Lindsey/0000-0001-8512-1562	National Institutes of Health, a Division of Cell and Molecular Biology Training Program [HL20948, GM090216, T32GM008203]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090216, R01GM096070, T32GM008203] Funding Source: NIH RePORTER	National Institutes of Health, a Division of Cell and Molecular Biology Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL20948, GM090216, and T32GM008203, a Division of Cell and Molecular Biology Training Program grant (to L. L. M.).	Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Bar-Nun S, 2012, BBA-MOL CELL RES, V1823, P67, DOI 10.1016/j.bbamcr.2011.07.009; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; BROWN MS, 1980, J LIPID RES, V21, P505; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045; Ehlinger A, 2013, BIOCHEMISTRY-US, V52, P3618, DOI 10.1021/bi400417a; Elkabetz Y, 2004, J BIOL CHEM, V279, P3980, DOI 10.1074/jbc.M309938200; Elsabrouty R, 2013, MOL BIOL CELL, V24, P3300, DOI 10.1091/mbc.E13-03-0157; Faulkner RA, 2013, J LIPID RES, V54, P1011, DOI 10.1194/jlr.M033639; Garza RM, 2009, J BIOL CHEM, V284, P14710, DOI 10.1074/jbc.M809607200; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hartman IZ, 2010, J BIOL CHEM, V285, P19288, DOI 10.1074/jbc.M110.134213; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; Jo Y, 2013, MOL BIOL CELL, V24, P169, DOI 10.1091/mbc.E12-07-0564; Jo Y, 2011, P NATL ACAD SCI USA, V108, P20503, DOI 10.1073/pnas.1112831108; Lee RJ, 2004, EMBO J, V23, P2206, DOI 10.1038/sj.emboj.7600232; Leichner GS, 2009, MOL BIOL CELL, V20, P3330, DOI 10.1091/mbc.E08-09-0953; Lipson C, 2008, J BIOL CHEM, V283, P7166, DOI 10.1074/jbc.M705893200; LISCUM L, 1985, J BIOL CHEM, V260, P522; LISCUM L, 1983, J BIOL CHEM, V258, P8450; Mayer TU, 1998, EMBO J, V17, P3251, DOI 10.1093/emboj/17.12.3251; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; MOSLEY ST, 1983, J BIOL CHEM, V258, P3875; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nguyen AD, 2009, J BIOL CHEM, V284, P26778, DOI 10.1074/jbc.M109.032342; Nohturfft A, 1998, J BIOL CHEM, V273, P17243, DOI 10.1074/jbc.273.27.17243; OU WJ, 1995, J BIOL CHEM, V270, P18051, DOI 10.1074/jbc.270.30.18051; Pietroni P, 2013, BIOCHEM J, V453, P435, DOI 10.1042/BJ20130133; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Roitelman J, 2004, J BIOL CHEM, V279, P6465, DOI 10.1074/jbc.M308094200; ROITELMAN J, 1992, J CELL BIOL, V117, P959, DOI 10.1083/jcb.117.5.959; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Vanslyke JK, 2000, MOL BIOL CELL, V11, P1933, DOI 10.1091/mbc.11.6.1933; Wahlman J, 2007, CELL, V129, P943, DOI 10.1016/j.cell.2007.03.046; Walter J, 2001, EMBO J, V20, P3124, DOI 10.1093/emboj/20.12.3124; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Xiong XM, 1999, J BIOL CHEM, V274, P2616, DOI 10.1074/jbc.274.5.2616	47	36	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19053	19066		10.1074/jbc.M114.576652	http://dx.doi.org/10.1074/jbc.M114.576652			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24860107	hybrid, Green Published			2022-12-25	WOS:000339062900036
J	MacDonald, BT; Hien, A; Zhang, XJ; Iranloye, O; Virshup, DM; Waterman, ML; He, X				MacDonald, Bryan T.; Hien, Annie; Zhang, Xinjun; Iranloye, Oladoyin; Virshup, David M.; Waterman, Marian L.; He, Xi			Disulfide Bond Requirements for Active Wnt Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAY; MUTATIONS; PROTEIN; WINGLESS; EXPRESSION; SECRETION; OLIGODONTIA; COMPONENTS; INHIBITOR; DYSPLASIA	Secreted Wnt lipoproteins are cysteine-rich and lipid-modified morphogens that bind to the Frizzled (FZD) receptor and LDL receptor-related protein 6 (LRP6). Wnt engages FZD through protruding thumb and index finger domains, which are each assembled from paired beta strands secured by disulfide bonds and grasp two sides of the FZD ectodomain. The importance of Wnt disulfide bonds has been assumed but uncharacterized. We systematically analyzed cysteines and associated disulfide bonds in the prototypic Wnt3a. Our data show that mutation of any individual cysteine of Wnt3a results in covalent Wnt oligomers through ectopic intermolecular disulfide bond formation and diminishes/abolishes Wnt signaling. Although individual cysteine mutations in the amino part of the saposin-like domain and in the base of the index finger are better tolerated and permit residual Wnt3a secretion/activity, those in the amino terminus, the thumb, and at the tip of the index finger are incompatible with secretion and/or activity. A few select double cysteine mutants based on the disulfide bond pattern restore Wnt secretion/activity. Further, a double cysteine mutation at the index finger tip results in a Wnt3a with normal secretion but minimal FZD binding and dominant negative properties. Our results experimentally validate predictions from the Wnt crystal structure and highlight critical but different roles of the saposin-like and cytokine-like domains, including the thumb and the index finger in Wnt folding/secretion and FZD binding. Finally, we modified existing expression vectors for 19 epitope-tagged human WNT proteins by removal of a tag-supplied ectopic cysteine, thereby generating tagged WNT ligands active in canonical and non-canonical signaling.	[He, Xi] Harvard Univ, Sch Med, Dept Neurol, FM Kirby Neurobiol Ctr,Boston Childrens Hosp, Boston, MA 02115 USA; [Virshup, David M.] Duke Natl Univ Singapore, Grad Sch Med, Program Canc & Stem Cell Biol, Singapore 169857, Singapore; [Waterman, Marian L.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; National University of Singapore; University of California System; University of California Irvine	He, X (corresponding author), Harvard Univ, Sch Med, Dept Neurol, FM Kirby Neurobiol Ctr,Boston Childrens Hosp, Boston, MA 02115 USA.	xi.he@childrens.harvard.edu	Virshup, David M/C-1449-2009	Virshup, David M/0000-0001-6976-850X	National Institutes of Health [RO1 GM074241, RO1 AR060359]; BCH Intellectual and Developmental Disabilities Research Center [P30 HD-18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA108697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074241] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BCH Intellectual and Developmental Disabilities Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM074241 and RO1 AR060359 (to X. H.).; Holder of an endowed research chair of Boston Children's Hospital (BCH) and supported by BCH Intellectual and Developmental Disabilities Research Center Grant P30 HD-18655. To whom correspondence should be addressed. Tel.: 617-919-2257; Fax: 617-919-2771; E-mail: xi. he@childrens.harvard.edu.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Arzoo PS, 2014, AM J MED GENET A, V164, P353, DOI 10.1002/ajmg.a.36243; Bazan JF, 2012, DEV CELL, V23, P227, DOI 10.1016/j.devcel.2012.07.011; Biason-Lauber A, 2007, HUM REPROD, V22, P224, DOI 10.1093/humrep/del360; Bourhis E, 2011, STRUCTURE, V19, P1433, DOI 10.1016/j.str.2011.07.005; Bruhn H, 2005, BIOCHEM J, V389, P249, DOI 10.1042/BJ20050051; Castori M, 2011, CLIN GENET, V79, P92, DOI 10.1111/j.1399-0004.2010.01513.x; Chen S, 2011, DEV CELL, V21, P848, DOI 10.1016/j.devcel.2011.09.007; Ching W, 2008, J BIOL CHEM, V283, P17092, DOI 10.1074/jbc.M802059200; Christodoulides C, 2006, DIABETOLOGIA, V49, P678, DOI 10.1007/s00125-006-0144-4; Chu MLH, 2013, STRUCTURE, V21, P1235, DOI 10.1016/j.str.2013.05.006; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cluzeau C, 2011, HUM MUTAT, V32, P70, DOI 10.1002/humu.21384; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Coudreuse D, 2007, DEVELOPMENT, V134, P3, DOI 10.1242/dev.02699; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; Dierick HA, 1998, DEVELOPMENT, V125, P4729; Fahiminiya S, 2013, J MED GENET, V50, P345, DOI 10.1136/jmedgenet-2013-101567; Faqeih E, 2013, J MED GENET, V50, P491, DOI 10.1136/jmedgenet-2013-101750; Ganguly A, 2005, DEVELOPMENT, V132, P3419, DOI 10.1242/dev.01903; Gao XX, 2014, NAT CHEM BIOL, V10, P61, DOI [10.1038/NCHEMBIO.1392, 10.1038/nchembio.1392]; Gordon MD, 2005, NATURE, V437, P746, DOI 10.1038/nature04073; Green JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058395; Holstein TW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007922; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kantaputra P, 2014, AM J MED GENET A, V164, P1041, DOI 10.1002/ajmg.a.36388; Keupp K, 2013, AM J HUM GENET, V92, P565, DOI 10.1016/j.ajhg.2013.02.010; Komekado H, 2007, GENES CELLS, V12, P521, DOI 10.1111/j.1365-2443.2007.01068.x; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Laine CM, 2013, NEW ENGL J MED, V368, P1809, DOI 10.1056/NEJMoa1215458; Lapebie P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005823; MacDonald BT, 2008, J BIOL CHEM, V283, P16115, DOI 10.1074/jbc.M800327200; MacDonald BT, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007880; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; MASON JO, 1992, MOL BIOL CELL, V3, P521, DOI 10.1091/mbc.3.5.521; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; Mostowska A, 2013, CLIN GENET, V84, P429, DOI 10.1111/cge.12061; Najdi R, 2012, DIFFERENTIATION, V84, P203, DOI 10.1016/j.diff.2012.06.004; Person AD, 2010, DEV DYNAM, V239, P327, DOI 10.1002/dvdy.22156; Plaisancie J, 2013, AM J MED GENET A, V161A, P671, DOI 10.1002/ajmg.a.35747; Pyott SM, 2013, AM J HUM GENET, V92, P590, DOI 10.1016/j.ajhg.2013.02.009; Rios-Esteves J., 2014, J BIOL CHEM, V114; Rios-Esteves J, 2013, CELL REP, V4, P1072, DOI 10.1016/j.celrep.2013.08.027; ROBINOW M, 1969, AM J DIS CHILD, V117, P645, DOI 10.1001/archpedi.1969.02100030647005; Roifman M, 2015, CLIN GENET, V87, P34, DOI 10.1111/cge.12401; Shibamoto S, 1998, GENES CELLS, V3, P659; Song SJ, 2014, HUM GENET, V133, P117, DOI 10.1007/s00439-013-1360-x; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; van Amerongen R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007914; van den Boogaard MJ, 2012, J MED GENET, V49, P327, DOI 10.1136/jmedgenet-2012-100750; VANDENHEUVEL M, 1993, EMBO J, V12, P5293, DOI 10.1002/j.1460-2075.1993.tb06225.x; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Willert K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007864; Woods CG, 2006, AM J HUM GENET, V79, P402, DOI 10.1086/506332; Wu CH, 2002, J BIOL CHEM, V277, P41762, DOI 10.1074/jbc.M207850200; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Yu HM, 2012, DEVELOPMENT, V139, P4383, DOI 10.1242/dev.083352; Zhang XJ, 2012, CELL, V149, P1565, DOI 10.1016/j.cell.2012.04.039	62	57	58	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18122	18136		10.1074/jbc.M114.575027	http://dx.doi.org/10.1074/jbc.M114.575027			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24841207	hybrid, Green Published			2022-12-25	WOS:000338042000016
J	Muta, H; Lee, YH; Kardos, J; Lin, YX; Yagi, H; Goto, Y				Muta, Hiroya; Lee, Young-Ho; Kardos, Jozsef; Lin, Yuxi; Yagi, Hisashi; Goto, Yuji			Supersaturation-limited Amyloid Fibrillation of Insulin Revealed by Ultrasonication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN CRYSTALLIZATION; NEURODEGENERATIVE DISEASES; FIBRILS; OLIGOMERS; SCRAPIE; BETA(2)-MICROGLOBULIN; AGGREGATION; MECHANISM; ACCELERATION; MICROSCOPY	Amyloid fibrils form in supersaturated solutions via a nucleation and growth mechanism. We proposed that ultrasonication may be an effective agitation to trigger nucleation that would otherwise not occur under the persistent metastability of supersaturation. However, the roles of supersaturation and effects of ultrasonication have not been elucidated in detail except for limited cases. Insulin is an amyloidogenic protein that is useful for investigating the mechanisms underlying amyloid fibrillation with biological relevance. We studied the alcohol-induced amyloid fibrillation of insulin using various concentrations of 2,2,2-trifluoroethanol and 1,1,1,3,3,3-hexafluoro-2-propanol at pH 2.0 and 4.8. Ultrasonic irradiation effectively triggered fibrillation under conditions in which insulin retained persistent supersaturation. Structural analyses by circular dichroism, Fourier transform infrared spectroscopy, transmission electron microscopy, and atomic force microscopy revealed that the dominant structures of fibrils varied between parallel and antiparallel beta-sheets depending on the solvent conditions. pH and alcohol concentration-dependent phase diagrams showed a marked difference before and after the ultrasonic treatment, which indicated that the persistent metastability of supersaturation determined the conformations of insulin. These results indicate the importance of an alternative view of amyloid fibrils as supersaturation-limited crystal-like aggregates formed above the solubility limit.	[Muta, Hiroya; Lee, Young-Ho; Lin, Yuxi; Yagi, Hisashi; Goto, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Kardos, Jozsef] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary	Osaka University; Eotvos Lorand University	Goto, Y (corresponding author), Osaka Univ, Inst Prot Res, Yamadaoka 3-2, Suita, Osaka 5650871, Japan.	ygoto@protein.osaka-u.ac.jp	Kardos, József/J-1035-2017	Kardos, József/0000-0002-2135-2932	Ministry of Education, Science, Sports, and Culture for Scientific Research, Japan; Takeda Science Foundation; Hungarian Academy of Sciences; Hungarian Scientific Research Fund [81950]; Grants-in-Aid for Scientific Research [25870407] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture for Scientific Research, Japan; Takeda Science Foundation(Takeda Science Foundation (TSF)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant from the Ministry of Education, Science, Sports, and Culture for Scientific Research, Japan, and the Takeda Science Foundation.; Supported by Bolyai Janos fellowship of the Hungarian Academy of Sciences and Hungarian Scientific Research Fund Grant 81950.	Ahmad A, 2005, J BIOL CHEM, V280, P42669, DOI 10.1074/jbc.M504298200; Asherie N, 2004, METHODS, V34, P266, DOI 10.1016/j.ymeth.2004.03.028; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; Bouchard M, 2000, PROTEIN SCI, V9, P1960, DOI 10.1110/ps.9.10.1960; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Bystrom R, 2008, CELL BIOCHEM BIOPHYS, V52, P175, DOI 10.1007/s12013-008-9033-4; Chatani E, 2005, J MOL BIOL, V352, P941, DOI 10.1016/j.jmb.2005.07.043; Chatani E, 2009, P NATL ACAD SCI USA, V106, P11119, DOI 10.1073/pnas.0901422106; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Ciryam P, 2013, CELL REP, V5, P781, DOI 10.1016/j.celrep.2013.09.043; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Crespo R, 2010, J APPL CRYSTALLOGR, V43, P1419, DOI 10.1107/S0021889810040951; Durbin SD, 1996, ANNU REV PHYS CHEM, V47, P171, DOI 10.1146/annurev.physchem.47.1.171; Dzwolak W, 2005, BIOCHEMISTRY-US, V44, P8948, DOI 10.1021/bi050281t; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Fezoui Y, 2002, J BIOL CHEM, V277, P36948, DOI 10.1074/jbc.M204168200; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; KAM Z, 1978, J MOL BIOL, V123, P539, DOI 10.1016/0022-2836(78)90206-1; Kardos J, 2005, BBA-PROTEINS PROTEOM, V1753, P108, DOI 10.1016/j.bbapap.2005.08.013; LANSBURY PT, 1995, CHEM BIOL, V2, P1, DOI 10.1016/1074-5521(95)90074-8; Lee YH, 2009, J BIOL CHEM, V284, P2169, DOI 10.1074/jbc.M806939200; Lin YX, 2014, LANGMUIR, V30, P1845, DOI 10.1021/la403100h; Loksztejn A, 2010, J MOL BIOL, V395, P643, DOI 10.1016/j.jmb.2009.10.065; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Munishkina LA, 2004, J MOL RECOGNIT, V17, P456, DOI 10.1002/jmr.699; Ohhashi Y, 2005, J BIOL CHEM, V280, P32843, DOI 10.1074/jbc.M506501200; Roeder AM, 2013, J BIOL CHEM, V288, P27638, DOI 10.1074/jbc.M113.463273; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Sekhar A, 2011, BIOCHEMISTRY-US, V50, P805, DOI 10.1021/bi101312h; Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345; So M, 2011, J MOL BIOL, V412, P568, DOI 10.1016/j.jmb.2011.07.069; Tycko R, 2013, ACCOUNTS CHEM RES, V46, P1487, DOI 10.1021/ar300282r; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wetzel R, 2006, ACCOUNTS CHEM RES, V39, P671, DOI 10.1021/ar050069h; Whitmore L, 2011, NUCLEIC ACIDS RES, V39, pD480, DOI 10.1093/nar/gkq1026; Yagi H, 2013, BBA-PROTEINS PROTEOM, V1834, P2480, DOI 10.1016/j.bbapap.2013.08.013; Yamaguchi K, 2006, J MOL BIOL, V363, P279, DOI 10.1016/j.jmb.2006.08.030; Yoshimura Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.07HA01; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109	47	39	39	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18228	18238		10.1074/jbc.M114.566950	http://dx.doi.org/10.1074/jbc.M114.566950			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24847058	Green Published, hybrid			2022-12-25	WOS:000338042000024
J	Chen, GY; Wang, W; Meng, SK; Zhang, LC; Wang, WX; Jiang, ZM; Yu, M; Cui, QH; Li, MZ				Chen, Guiyuan; Wang, Wei; Meng, Shengke; Zhang, Lichao; Wang, Wenxue; Jiang, Zongmin; Yu, Min; Cui, Qinghua; Li, Meizhang			CXC Chemokine CXCL12 and Its Receptor CXCR4 in Tree Shrews (Tupaia belangeri): Structure, Expression and Function	PLOS ONE			English	Article							PHYLOGENETIC POSITION; HIV-1 CORECEPTOR; NERVOUS-SYSTEM; CELL-SURVIVAL; STEM-CELLS; CHINENSIS; HEPATITIS; INFECTION; AMD3100; IMMUNE	Chemokines are small secreted proteins functionally involved in the immune system's regulation of lymphocyte migration across numerous mammalian species. Given its growing popularity in immunological models, we investigated the structure and function of chemokine CXCL12 protein in tree shrews. We found that CXCL12 and its receptor CXCR4 in tree shrew had structural similarities to their homologous human proteins. Phylogenetic analysis supports the view that tree shrew is evolutionarily-close to the primates. Our results also showed that the human recombinant CXCL12 protein directly enhanced the migration of tree shrew's lymphocytes in vitro, while AMD3100 enhanced the mobilization of hematopoietic progenitor cells (HPCs) from bone marrow into peripheral blood in tree shrew in vivo. Collectively, these findings suggested that chemokines in tree shrews may play the same or similar roles as those in humans, and that the tree shrew is a viable animal model for studying human immunological diseases.	[Chen, Guiyuan; Wang, Wei; Meng, Shengke; Wang, Wenxue; Jiang, Zongmin; Yu, Min; Cui, Qinghua; Li, Meizhang] Yunnan Univ, Sch Life Sci, Dept Biochem & Mol Biol, Kunming, Peoples R China; [Chen, Guiyuan] Dali Univ, Sch Basic Med, Dept Biochem & Mol Biol, Dali, Peoples R China; [Wang, Wei] Kunming Med Univ, Affiliated Hosp 1, Dept Rheumatol & Immunol, Kunming, Peoples R China; [Zhang, Lichao] Kunming Med Univ, Affiliated Hosp 2, Dept Hepatobiliary Surg, Kunming, Peoples R China	Yunnan University; Dali University; Kunming Medical University; Kunming Medical University	Li, MZ (corresponding author), Yunnan Univ, Sch Life Sci, Dept Biochem & Mol Biol, Kunming, Peoples R China.	mzhli@ynu.edu.cn			National Natural Science Foundation of China [81271330, 31160237, 31260276]; Yunnan Province Science and Technology Innovation Team [2011CI123]; Talent Program of Yunnan Province [W8110305]; Foundation of School of Life Sciences of Yunnan University [2012S301]; Natural Science Foundation of Yunnan Province [2011BC003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Province Science and Technology Innovation Team; Talent Program of Yunnan Province; Foundation of School of Life Sciences of Yunnan University; Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province)	This work was supported by grants from the National Natural Science Foundation of China (No. 81271330, No. 31160237, and No. 31260276), Yunnan Province Science and Technology Innovation Team (No. 2011CI123), Talent Program of Yunnan Province (No. W8110305), Foundation of School of Life Sciences of Yunnan University (No. 2012S301), and the Natural Science Foundation of Yunnan Province (No. 2011BC003). The funders had no roles in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amako Y, 2010, J VIROL, V84, P303, DOI 10.1128/JVI.01448-09; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Brunn A, 2013, NEUROPATH APPL NEURO, V39, P772, DOI 10.1111/nan.12039; Burman A, 2005, J IMMUNOL, V174, P1693, DOI 10.4049/jimmunol.174.3.1693; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Coulomb-L'Hermine A, 1999, P NATL ACAD SCI USA, V96, P8585, DOI 10.1073/pnas.96.15.8585; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; DeVries ME, 2006, J IMMUNOL, V176, P401, DOI 10.4049/jimmunol.176.1.401; Dimmeler S, 2010, ARTERIOSCL THROM VAS, V30, P1088, DOI 10.1161/ATVBAHA.109.191668; Endres MJ, 1996, CELL, V87, P745, DOI 10.1016/S0092-8674(00)81393-8; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Fan Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2416; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Flugge P, 2002, IMMUNOGENETICS, V53, P984, DOI 10.1007/s00251-001-0401-0; Forster R, 1998, J IMMUNOL, V160, P1522; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Gerlach LO, 2001, J BIOL CHEM, V276, P14153, DOI 10.1074/jbc.M010429200; Guergnon J, 2012, IMMUNOL LETT, V145, P15, DOI 10.1016/j.imlet.2012.04.010; Gupta SK, 2001, IMMUNOL LETT, V78, P29, DOI 10.1016/S0165-2478(01)00228-0; Hackbarth H, 2000, LAB ANIM-UK, V34, P91, DOI 10.1258/002367700780578055; Hatse S, 2001, MOL PHARMACOL, V60, P164, DOI 10.1124/mol.60.1.164; Hau J., 2008, SOURCEBOOK MODELS BI, P3, DOI DOI 10.1007/978-1-59745-285-4_1; Helgen K.M., 2005, MAMMAL SPECIES WORLD, P104; Kawasawa Y, 2003, GENOME RES, V13, P1466, DOI 10.1101/gr.1087603; Klein RS, 2004, TRENDS IMMUNOL, V25, P306, DOI 10.1016/j.it.2004.04.002; Kucia M, 2004, J MOL HISTOL, V35, P233; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Larochelle A, 2006, BLOOD, V107, P3772, DOI 10.1182/blood-2005-09-3592; Li MZ, 2008, PROG NEUROBIOL, V84, P116, DOI 10.1016/j.pneurobio.2007.11.003; Li Yao, 2011, Zoological Research, V32, P97, DOI 10.3724/SP.J.1141.2011.01097; Moll NM, 2010, EXPERT REV HEMATOL, V3, P315, DOI 10.1586/EHM.10.16; Olson LE, 2005, MOL PHYLOGENET EVOL, V35, P656, DOI 10.1016/j.ympev.2005.01.005; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Thomas AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032290; Tiveron MC, 2008, CURR OPIN NEUROBIOL, V18, P237, DOI 10.1016/j.conb.2008.06.004; Veldkamp CT, 2009, PROTEIN SCI, V18, P1359, DOI 10.1002/pro.167; Wang Q, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-170; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xu Ling, 2013, Zoological Research, V34, P70, DOI 10.3724/SP.J.1141.2013.02070; Xu L, 2012, J GENET GENOMICS, V39, P131, DOI 10.1016/j.jgg.2012.02.003; Yang ZX, 2013, J APPL MATH, DOI 10.1155/2013/367107; Zhan MY, 1981, ACTA ACAD MED SIN, V3, P148; Zhou NM, 2001, J BIOL CHEM, V276, P42826, DOI 10.1074/jbc.M106582200; Zhu B, 2012, STEM CELLS, V30, P2571, DOI 10.1002/stem.1239; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008	54	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98231	10.1371/journal.pone.0098231	http://dx.doi.org/10.1371/journal.pone.0098231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858548	Green Published, gold, Green Submitted			2022-12-25	WOS:000336839400059
J	Hossain, MI; Roulston, CL; Stapleton, DI				Hossain, Mohammed Iqbal; Roulston, Carli Lorraine; Stapleton, David Ian			Molecular Basis of Impaired Glycogen Metabolism during Ischemic Stroke and Hypoxia	PLOS ONE			English	Article							BRAIN GLYCOGEN; MEMORY CONSOLIDATION; GLUCOSE DEPRIVATION; LACTATE SHUTTLE; NEURONAL DEATH; PROTEIN-KINASE; ASTROCYTES; RECEPTOR; MECHANISMS; PHOSPHORYLASE	Background: Ischemic stroke is the combinatorial effect of many pathological processes including the loss of energy supplies, excessive intracellular calcium accumulation, oxidative stress, and inflammatory responses. The brain's ability to maintain energy demand through this process involves metabolism of glycogen, which is critical for release of stored glucose. However, regulation of glycogen metabolism in ischemic stroke remains unknown. In the present study, we investigate the role and regulation of glycogen metabolizing enzymes and their effects on the fate of glycogen during ischemic stroke. Results: Ischemic stroke was induced in rats by peri-vascular application of the vasoconstrictor endothelin-1 and forebrains were collected at 1, 3, 6 and 24 hours post-stroke. Glycogen levels and the expression and activity of enzymes involved in glycogen metabolism were analyzed. We found elevated glycogen levels in the ipsilateral hemispheres compared with contralateral hemispheres at 6 and 24 hours (25% and 39% increase respectively; P<0.05). Glycogen synthase activity and glycogen branching enzyme expression were found to be similar between the ipsilateral, contralateral, and sham control hemispheres. In contrast, the rate-limiting enzyme for glycogen breakdown, glycogen phosphorylase, had 58% lower activity (P<0.01) in the ipsilateral hemisphere (24 hours post-stroke), which corresponded with a 48% reduction in cAMP-dependent protein kinase A (PKA) activity (P<0.01). In addition, glycogen debranching enzyme expression 24 hours poststroke was 77% (P<0.01) and 72% lower (P<0.01) at the protein and mRNA level, respectively. In cultured rat primary cerebellar astrocytes, hypoxia and inhibition of PKA activity significantly reduced glycogen phosphorylase activity and increased glycogen accumulation but did not alter glycogen synthase activity. Furthermore, elevated glycogen levels provided metabolic support to astrocytes during hypoxia. Conclusion: Our study has identified that glycogen breakdown is impaired during ischemic stroke, the molecular basis of which includes reduced glycogen debranching enzyme expression level together with reduced glycogen phosphorylase and PKA activity.	[Hossain, Mohammed Iqbal; Stapleton, David Ian] Univ Melbourne, Dept Physiol, Melbourne, Vic, Australia; [Roulston, Carli Lorraine] Univ Melbourne, Dept Med, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne	Hossain, MI (corresponding author), Univ Melbourne, Dept Physiol, St Vincents Campus, Melbourne, Vic, Australia.	mihos@unimelb.edu.au			National Health and Medical Research Council [NHMRC-628698]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a grant from the National Health and Medical Research Council (NHMRC-628698) to DIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Brown AM, 2005, J NEUROSCI RES, V79, P74, DOI 10.1002/jnr.20335; Brown AM, 2004, NEUROCHEM INT, V45, P529, DOI 10.1016/j.neuint.2003.11.005; Brucklacher RM, 2002, DEV NEUROSCI-BASEL, V24, P411, DOI 10.1159/000069051; CATALDO AM, 1986, J NEUROCYTOL, V15, P511, DOI 10.1007/BF01611733; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Choi HB, 2012, NEURON, V75, P1094, DOI 10.1016/j.neuron.2012.08.032; DiNuzzo M, 2013, NEUROCHEM INT, V63, P458, DOI 10.1016/j.neuint.2013.08.004; DiNuzzo M, 2012, NEUROCHEM RES, V37, P2432, DOI 10.1007/s11064-012-0802-5; DiNuzzo M, 2010, J CEREBR BLOOD F MET, V30, P1895, DOI 10.1038/jcbfm.2010.151; DiNuzzo M, 2010, J CEREBR BLOOD F MET, V30, P586, DOI 10.1038/jcbfm.2009.232; Dong JH, 2012, J MOL NEUROSCI, V48, P456, DOI 10.1007/s12031-012-9742-4; Gibbs ME, 2006, GLIA, V54, P214, DOI 10.1002/glia.20377; Gold MG, 2013, J CELL SCI, V126, P4537, DOI 10.1242/jcs.133751; Govender Dhirendra, 2004, Ann Diagn Pathol, V8, P69, DOI 10.1053/j.anndiagpath.2004.01.002; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Hertz L, 2003, BRAIN RES, V994, P226, DOI 10.1016/j.brainres.2003.09.044; Hertz L, 2009, J NEUROCHEM, V109, P10, DOI 10.1111/j.1471-4159.2009.05939.x; Hossain MI, 2013, J BIOL CHEM, V288, P9696, DOI 10.1074/jbc.M112.419713; Kong JM, 2002, J NEUROSCI, V22, P5581; Lau X, 2013, DIABETOLOGIA, V56, P675, DOI 10.1007/s00125-012-2805-9; Laureys G, 2010, PROG NEUROBIOL, V91, P189, DOI 10.1016/j.pneurobio.2010.01.011; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Lo EH, 2010, NAT MED, V16, P1205, DOI 10.1038/nm.2226; Lombardi MS, 2004, STROKE, V35, P981, DOI 10.1161/01.STR.0000121644.82596.7e; Mamedova LK, 2003, MOL CELL BIOCHEM, V250, P11, DOI 10.1023/A:1024980710799; Mangia S, 2009, J NEUROCHEM, V109, P55, DOI 10.1111/j.1471-4159.2009.06003.x; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; NEWGARD CB, 1989, CRIT REV BIOCHEM MOL, V24, P69, DOI 10.3109/10409238909082552; Otori T, 2004, J NEUROTRAUM, V21, P707, DOI 10.1089/0897715041269623; Oz G, 2009, DIABETES, V58, P1978, DOI 10.2337/db09-0226; Paquet M, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-9; Parker GJ, 2007, BIOCHEM BIOPH RES CO, V362, P811, DOI 10.1016/j.bbrc.2007.08.080; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; PREMONT RT, 1995, FASEB J, V9, P175, DOI 10.1096/fasebj.9.2.7781920; Rahman B, 2000, NEUROSCI LETT, V290, P169, DOI 10.1016/S0304-3940(00)01369-0; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; Rossi DJ, 2007, NAT NEUROSCI, V10, P1377, DOI 10.1038/nn2004; Roulston CL, 2008, EUR J PHARMACOL, V584, P100, DOI 10.1016/j.ejphar.2008.01.046; Shearer J, 2004, EXERC SPORT SCI REV, V32, P120, DOI 10.1097/00003677-200407000-00008; Shioda N, 2007, J NEUROCHEM, V102, P1506, DOI 10.1111/j.1471-4159.2007.04600.x; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Singaravelu K, 2006, J NEUROSCI, V26, P9579, DOI 10.1523/JNEUROSCI.2604-06.2006; SORG O, 1992, J NEUROSCI, V12, P4923; Stapleton D, 2010, PROTEOMICS, V10, P2320, DOI 10.1002/pmic.200900628; Suh SW, 2007, J PHARMACOL EXP THER, V321, P45, DOI 10.1124/jpet.106.115550; Tekkok SB, 2005, J NEUROSCI RES, V81, P644, DOI 10.1002/jnr.20573; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; Vesce S, 2007, INT REV NEUROBIOL, V82, P57, DOI 10.1016/S0074-7742(07)82003-4; VILLARPA.C, 1970, ANNU REV BIOCHEM, V39, P639, DOI 10.1146/annurev.bi.39.070170.003231; Walls AB, 2008, J NEUROCHEM, V105, P1462, DOI 10.1111/j.1471-4159.2008.05250.x; Wang DJ, 2013, DIABETES, V62, P1697, DOI 10.2337/db12-1025; Wender R, 2000, J NEUROSCI, V20, P6804, DOI 10.1523/JNEUROSCI.20-18-06804.2000; Weston RM, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/648061; Xu JN, 2013, NEUROCHEM RES, V38, P472, DOI 10.1007/s11064-012-0938-3; Xu L, 2010, MINI-REV MED CHEM, V10, P1188, DOI 10.2174/1389557511009011188; Zhang TF, 2012, CELL METAB, V15, P75, DOI 10.1016/j.cmet.2011.12.005	60	19	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97570	10.1371/journal.pone.0097570	http://dx.doi.org/10.1371/journal.pone.0097570			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858129	Green Published, gold			2022-12-25	WOS:000336839400019
J	Naldi, I; Taranta, M; Gherardini, L; Pelosi, G; Viglione, F; Grimaldi, S; Pani, L; Cinti, C				Naldi, Ilaria; Taranta, Monia; Gherardini, Lisa; Pelosi, Gualtiero; Viglione, Federica; Grimaldi, Settimio; Pani, Luca; Cinti, Caterina			Novel Epigenetic Target Therapy for Prostate Cancer: A Preclinical Study	PLOS ONE			English	Article							DNA METHYLTRANSFERASE INHIBITORS; 5-AZA-2'-DEOXYCYTIDINE DECITABINE; CARRIER ERYTHROCYTES; RADIATION-THERAPY; CELLS; METHYLATION; EXPRESSION; DNMT1; TRIAL; PROGRESSION	Epigenetic events are critical contributors to the pathogenesis of cancer, and targeting epigenetic mechanisms represents a novel strategy in anticancer therapy. Classic demethylating agents, such as 5-Aza-2'-deoxycytidine (Decitabine), hold the potential for reprograming somatic cancer cells demonstrating high therapeutic efficacy in haematological malignancies. On the other hand, epigenetic treatment of solid tumours often gives rise to undesired cytotoxic side effects. Appropriate delivery systems able to enrich Decitabine at the site of action and improve its bioavailability would reduce the incidence of toxicity on healthy tissues. In this work we provide preclinical evidences of a safe, versatile and efficient targeted epigenetic therapy to treat hormone sensitive (LNCap) and hormone refractory (DU145) prostate cancers. A novel Decitabine formulation, based on the use of engineered erythrocyte (Erythro-Magneto-Hemagglutinin Virosomes, EMHVs) drug delivery system (DDS) carrying this drug, has been refined. Inside the EMHVs, the drug was shielded from the environment and phosphorylated in its active form. The novel magnetic EMHV DDS, endowed with fusogenic protein, improved the stability of the carried drug and exhibited a high efficiency in confining its delivery at the site of action in vivo by applying an external static magnetic field. Here we show that Decitabine loaded into EMHVs induces a significant tumour mass reduction in prostate cancer xenograft models at a concentration, which is seven hundred times lower than the therapeutic dose, suggesting an improved pharmacokinetics/pharmacodynamics of drug. These results are relevant for and discussed in light of developing personalised autologous therapies and innovative clinical approach for the treatment of solid tumours.	[Naldi, Ilaria; Taranta, Monia; Gherardini, Lisa; Cinti, Caterina] CNR, Inst Clin Physiol, Expt Oncol Unit, Siena, Italy; [Pelosi, Gualtiero; Viglione, Federica] CNR, Inst Clin Physiol, I-56100 Pisa, Italy; [Grimaldi, Settimio] CNR, Inst Translat Pharmacol, Rome, Italy; [Pani, Luca] CNR, Inst Translat Pharmacol, Cagliari, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR)	Cinti, C (corresponding author), CNR, Inst Clin Physiol, Expt Oncol Unit, Siena, Italy.	ccinti@ifc.cnr.it	Pelosi, Gualtiero/F-7696-2015; Pani, Luca/AAM-9467-2020	Pelosi, Gualtiero/0000-0001-7472-2186; Pani, Luca/0000-0001-9273-2839; Cinti, Caterina/0000-0001-8049-0369; gherardini, lisa/0000-0002-7003-4295	Consiglio Nazionale delle Ricerche (CNR); European Community	Consiglio Nazionale delle Ricerche (CNR)(Consiglio Nazionale delle Ricerche (CNR)); European Community(European Commission)	This work was supported by Consiglio Nazionale delle Ricerche (CNR) funding and by European Community funding for POR CReO FESR 2007-2013, BANDO UNICO R&S-ANNO 2012 of Regione Toscana-Project acronym Title: ACTILA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswal BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053003; Chiam K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025634; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Chu SH, 2012, MOL MED REP, V5, P138, DOI 10.3892/mmr.2011.620; Cinti C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017132; Fialova B, 2013, ONCOL REP, V29, P2039, DOI 10.3892/or.2013.2344; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; Gnanapragasam VJ, 2012, BJU INT, V109, P648, DOI 10.1111/j.1464-410X.2011.10596.x; Gnyszka A, 2013, ANTICANCER RES, V33, P2989; Goering Wolfgang, 2012, Methods Mol Biol, V863, P47, DOI 10.1007/978-1-61779-612-8_4; Graham JS, 2009, EUR J CANCER, V45, P1129, DOI 10.1016/j.ejca.2009.01.003; Hagelgans A, 2013, EXP MOL PATHOL, V94, P458, DOI 10.1016/j.yexmp.2013.03.006; Hamidi M, 2007, J CONTROL RELEASE, V118, P145, DOI 10.1016/j.jconrel.2006.06.032; Heidenreich A, 2004, CANCER-AM CANCER SOC, V101, P948, DOI 10.1002/cncr.20455; Hu CMJ, 2012, ADV HEALTHC MATER, V1, P537, DOI 10.1002/adhm.201200138; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Karahoca M, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-3; Kim HJ, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-39; Kirchin Miles A, 2003, Top Magn Reson Imaging, V14, P426, DOI 10.1097/00002142-200310000-00007; Lande C, 2012, CARDIOVASC HEMATOL D; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Lenka G, 2013, INT J ONCOL, V43, P1960, DOI 10.3892/ijo.2013.2117; Li W, 2013, MINI-REV MED CHEM, V13, P643, DOI 10.2174/1389557511313050003; Liu ZF, 2006, RAPID COMMUN MASS SP, V20, P1117, DOI 10.1002/rcm.2423; Magnani M, 2012, THER DELIV, V3, P405, DOI 10.4155/TDE.12.6; Millan CG, 2004, BLOOD CELL MOL DIS, V33, P132, DOI 10.1016/j.bcmd.2004.06.004; Mishra MV, 2008, MOL CANCER RES, V6, P243, DOI 10.1158/1541-7786.MCR-07-0373; Momparler RL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00188; Momparler RL, 2005, SEMIN HEMATOL, V42, pS9, DOI 10.1053/j.seminhematol.2005.05.002; Mossman D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-366; Niemirowicz K, 2012, ADV MED SCI-POLAND, V57, P196, DOI 10.2478/v10039-012-0031-9; Patra A, 2011, CLIN EPIGENETICS, V2, P339, DOI 10.1007/s13148-010-0019-x; Peeters STH, 2006, J CLIN ONCOL, V24, P1990, DOI 10.1200/JCO.2005.05.2530; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Sabatino MA, 2013, EPIGENETICS-US, V8, P656, DOI 10.4161/epi.24916; Saraon P, 2011, CLIN CHEM, V57, P1366, DOI 10.1373/clinchem.2011.165977; Sartor AO, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-18; Schmitges J, 2011, THER ADV UROL, V3, P173, DOI 10.1177/1756287211418722; Scosyrev E, 2012, CANCER-AM CANCER SOC, V118, P3062, DOI 10.1002/cncr.26392; Shipley WU, 1999, JAMA-J AM MED ASSOC, V281, P1598, DOI 10.1001/jama.281.17.1598; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Taranta MN, 2011, BIOANALYSIS BIOMEDIC, V2011, ps5; Tian J, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.395574; Tsai HC, 2011, CELL RES, V21, P502, DOI 10.1038/cr.2011.24; Vijayaraghavalu S, 2013, CANCER LETT, V331, P122, DOI 10.1016/j.canlet.2012.12.009; Yadav N, 2012, MINERVA UROL NEFROL, V64, P35; Zietman AL, 2005, JAMA-J AM MED ASSOC, V294, P1233, DOI 10.1001/jama.294.10.1233	48	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98101	10.1371/journal.pone.0098101	http://dx.doi.org/10.1371/journal.pone.0098101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24851905	Green Published, Green Submitted, gold			2022-12-25	WOS:000338323200046
J	Rong, Y; Walston, S; Welliver, MX; Chakravarti, A; Quick, AM				Rong, Yi; Walston, Steve; Welliver, Meng Xu; Chakravarti, Arnab; Quick, Allison M.			Improving Intra-Fractional Target Position Accuracy Using a 3D Surface Surrogate for Left Breast Irradiation Using the Respiratory-Gated Deep-Inspiration Breath-Hold Technique	PLOS ONE			English	Article							MAMMARY LYMPH-NODES; DOSIMETRIC IMPACT; CANCER PATIENTS; IMAGING-SYSTEM; HEART-DISEASE; ORGAN MOTION; RADIOTHERAPY; RADIATION; MORTALITY; REDUCTION	Purpose: To evaluate the use of 3D optical surface imaging as a surrogate for respiratory gated deep-inspiration breath-hold (DIBH) for left breast irradiation. Material and Methods: Patients with left-sided breast cancer treated with lumpectomy or mastectomy were selected as candidates for DIBH treatment for their external beam radiation therapy. Treatment plans were created on both free breathing (FB) and DIBH computed tomography (CT) simulation scans to determine dosimetric benefits from DIBH. The Real-time Position Management (RPM) system was used to acquire patient's breathing trace during DIBH CT acquisition and treatment delivery. The reference 3D surface models from FB and DIBH CT scans were generated and transferred to the "AlignRT" system for patient positioning and real-time treatment monitoring. MV Cine images were acquired during treatment for each beam as quality assurance for intra-fractional position verification. The chest wall excursions measured on these images were used to define the actual target position during treatment, and to investigate the accuracy and reproducibility of RPM and AlignRT. Results: Reduction in heart dose can be achieved using DIBH for left breast/chest wall radiation. RPM was shown to have inferior correlation with the actual target position, as determined by the MV Cine imaging. Therefore, RPM alone may not be an adequate surrogate in defining the breath-hold level. Alternatively, the AlignRT surface imaging demonstrated a superior correlation with the actual target positioning during DIBH. Both the vertical and magnitude real-time deltas (RTDs) reported by AlignRT can be used as the gating parameter, with a recommended threshold of +/- 3 mm and 5 mm, respectively. Conclusion: The RPM system alone may not be sufficient for the required level of accuracy in left-sided breast/CW DIBH treatments. The 3D surface imaging can be used to ensure patient setup and monitor inter-and intra-fractional motions. Furthermore, the target position accuracy during DIBH treatment can be improved by AlignRT as a superior surrogate, in addition to the RPM system.	[Rong, Yi; Walston, Steve; Welliver, Meng Xu; Chakravarti, Arnab; Quick, Allison M.] Ohio State Univ, James Canc Hosp, Wexner Med Ctr, Dept Radiat Oncol, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Rong, Y (corresponding author), Ohio State Univ, James Canc Hosp, Wexner Med Ctr, Dept Radiat Oncol, Columbus, OH 43210 USA.	yi.rong@osumc.edu	Quick, Allison/AAH-8533-2020; Quick, Allison/AAH-7715-2020	Quick, Allison/0000-0002-2260-6586; 	NIH/NCI/CTEP [1R01CA169368]; NIH/NCI [1RC2CA148190, 1U10CA180850-01]; OSU-CCC Funds; NATIONAL CANCER INSTITUTE [U10CA180850, R01CA169368, RC2CA148190, P30CA016058] Funding Source: NIH RePORTER	NIH/NCI/CTEP; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OSU-CCC Funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Arnab Chakravarti was supported by NIH/NCI/CTEP 1R01CA169368; NIH/NCI 1RC2CA148190; NIH/NCI 1U10CA180850-01; and OSU-CCC Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V366, P2087; Alderliesten T, 2013, INT J RADIAT ONCOL, V85, P536, DOI 10.1016/j.ijrobp.2012.04.004; Arthur DW, 2000, INT J RADIAT ONCOL, V48, P139, DOI 10.1016/S0360-3016(00)00633-7; Betgen A, 2013, RADIOTHER ONCOL, V106, P225, DOI 10.1016/j.radonc.2012.12.016; Bouillon K, 2011, J AM COLL CARDIOL, V57, P445, DOI 10.1016/j.jacc.2010.08.638; Cervino LI, 2009, PHYS MED BIOL, V54, P6853, DOI 10.1088/0031-9155/54/22/007; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Djajaputra D, 2005, MED PHYS, V32, P65, DOI 10.1118/1.1828251; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Furuya T, 2013, J RADIAT RES, V54, P157, DOI 10.1093/jrr/rrs064; Gierga DP, 2012, INT J RADIAT ONCOL, V84, pE663, DOI 10.1016/j.ijrobp.2012.07.2379; Gutt R, 2008, CLIN BREAST CANCER, V8, P443, DOI 10.3816/CBC.2008.n.054; Hjelstuen MHB, 2012, ACTA ONCOL, V51, P333, DOI 10.3109/0284186X.2011.618510; Korreman SS, 2005, RADIOTHER ONCOL, V76, P311, DOI 10.1016/j.radonc.2005.07.009; Lu HM, 2000, INT J RADIAT ONCOL, V47, P895, DOI 10.1016/S0360-3016(00)00512-5; Mageras GS, 2004, SEMIN RADIAT ONCOL, V14, P65, DOI 10.1053/j.semradonc.2003.10.009; McGale P, 2011, RADIOTHER ONCOL, V100, P167, DOI 10.1016/j.radonc.2011.06.016; Meeks SL, 2005, SEMIN RADIAT ONCOL, V15, P192, DOI 10.1016/j.semradonc.2005.01.004; Mege A, 2011, CANCER RADIOTHER, V15, P495, DOI 10.1016/j.canrad.2011.06.003; Nemoto K, 2009, JPN J RADIOL, V27, P259, DOI 10.1007/s11604-009-0336-1; Peng JL, 2010, MED PHYS, V37, P5421, DOI 10.1118/1.3483783; Pepin EW, 2011, MED PHYS, V38, P1912, DOI 10.1118/1.3556588; Qi XS, 2010, INT J RADIAT ONCOL, V78, P609, DOI 10.1016/j.ijrobp.2009.11.053; Remouchamps VM, 2003, INT J RADIAT ONCOL, V55, P392, DOI 10.1016/S0360-3016(02)04143-3; Remouchamps VM, 2003, INT J RADIAT ONCOL, V56, P704, DOI 10.1016/S0360-3016(03)00010-5; RUTQVIST LE, 1990, BRIT J CANCER, V61, P866, DOI 10.1038/bjc.1990.193; Schoffel PJ, 2007, PHYS MED BIOL, V52, P3949, DOI 10.1088/0031-9155/52/13/019; Sixel KE, 2001, INT J RADIAT ONCOL, V49, P199, DOI 10.1016/S0360-3016(00)01455-3; Stranzl H, 2009, STRAHLENTHER ONKOL, V185, P155, DOI 10.1007/s00066-009-1939-2; Tang X, 2013, CLIN EXPERI IN PRESS; Vikstrom J, 2011, ACTA ONCOL, V50, P42, DOI 10.3109/0284186X.2010.512923; Wagner TH, 2007, MED DOSIM, V32, P111, DOI 10.1016/j.meddos.2007.01.008; Yue NJ, 2007, MED PHYS, V34, P2789, DOI 10.1118/1.2739815	34	36	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97933	10.1371/journal.pone.0097933	http://dx.doi.org/10.1371/journal.pone.0097933			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853144	Green Submitted, Green Published, gold			2022-12-25	WOS:000338323200035
J	Lin, YJ; Chen, YT; Hsu, SN; Peng, CH; Tang, CY; Yen, TC; Hsieh, WP				Lin, Yen-Jen; Chen, Yu-Tin; Hsu, Shu-Ni; Peng, Chien-Hua; Tang, Chuan-Yi; Yen, Tzu-Chen; Hsieh, Wen-Ping			HaplotypeCN: Copy Number Haplotype Inference with Hidden Markov Model and Localized Haplotype Clustering	PLOS ONE			English	Article							SNP; POPULATION; POLYMORPHISM; MUTATIONS; DISEASE; GENES	Copy number variation (CNV) has been reported to be associated with disease and various cancers. Hence, identifying the accurate position and the type of CNV is currently a critical issue. There are many tools targeting on detecting CNV regions, constructing haplotype phases on CNV regions, or estimating the numerical copy numbers. However, none of them can do all of the three tasks at the same time. This paper presents a method based on Hidden Markov Model to detect parent specific copy number change on both chromosomes with signals from SNP arrays. A haplotype tree is constructed with dynamic branch merging to model the transition of the copy number status of the two alleles assessed at each SNP locus. The emission models are constructed for the genotypes formed with the two haplotypes. The proposed method can provide the segmentation points of the CNV regions as well as the haplotype phasing for the allelic status on each chromosome. The estimated copy numbers are provided as fractional numbers, which can accommodate the somatic mutation in cancer specimens that usually consist of heterogeneous cell populations. The algorithm is evaluated on simulated data and the previously published regions of CNV of the 270 HapMap individuals. The results were compared with five popular methods: PennCNV, genoCN, COKGEN, QuantiSNP and cnvHap. The application on oral cancer samples demonstrates how the proposed method can facilitate clinical association studies. The proposed algorithm exhibits comparable sensitivity of the CNV regions to the best algorithm in our genome-wide study and demonstrates the highest detection rate in SNP dense regions. In addition, we provide better haplotype phasing accuracy than similar approaches. The clinical association carried out with our fractional estimate of copy numbers in the cancer samples provides better detection power than that with integer copy number states.	[Lin, Yen-Jen; Chen, Yu-Tin; Tang, Chuan-Yi] Natl Tsing Hua Univ, Dept Comp Sci, Hsinchu 30043, Taiwan; [Hsu, Shu-Ni; Hsieh, Wen-Ping] Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan; [Tang, Chuan-Yi] Providence Univ, Dept Comp Sci & Informat Engn, Taichung, Taiwan; [Peng, Chien-Hua] Chang Gung Mem Hosp, Dept Resource Ctr Clin Res, Taoyuan, Taiwan; [Yen, Tzu-Chen] Chang Gung Mem Hosp, Head & Neck Oncol Grp, Taoyuan, Taiwan; [Yen, Tzu-Chen] Chang Gung Mem Hosp, Nucl Med & Mol Imaging Ctr, Taoyuan, Taiwan	National Tsing Hua University; National Tsing Hua University; Providence University - Taiwan; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Hsieh, WP (corresponding author), Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan.	wphsieh@stat.nthu.edu.tw			National Council of Science [NSC99-2118-M-007-006]	National Council of Science	This work was supported by the National Council of Science [NSC99-2118-M-007-006]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Browning SR, 2006, AM J HUM GENET, V78, P903, DOI 10.1086/503876; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Chen H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001060; Coin LJM, 2010, NAT METHODS, V7, P541, DOI [10.1038/NMETH.1466, 10.1038/nmeth.1466]; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Huang J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-83; Huang YT, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-194; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kilpivaara O, 2009, NAT GENET, V41, P455, DOI 10.1038/ng.342; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Laframboise T, 2007, BIOSTATISTICS, V8, P323, DOI 10.1093/biostatistics/kxl012; Mangs AH, 2007, CURR GENOMICS, V8, P129, DOI 10.2174/138920207780368141; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Olshen AB, 2011, BIOINFORMATICS, V27, P2038, DOI 10.1093/bioinformatics/btr329; Peng CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023452; Pique-Regi R, 2009, BIOINFORMATICS, V25, P1223, DOI 10.1093/bioinformatics/btp119; Podlaha O, 2012, TRENDS GENET, V28, P155, DOI 10.1016/j.tig.2012.01.003; Rasmussen M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r108; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Simon-Sanchez J, 2008, HUM MUTAT, V29, P315, DOI 10.1002/humu.20626; Smith AG, 2012, TISSUE ANTIGENS, V79, P359, DOI 10.1111/j.1399-0039.2012.01868.x; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sun JS, 2007, PROSTATE, V67, P692, DOI 10.1002/pros.20543; Sun W, 2009, NUCLEIC ACIDS RES, V37, P5365, DOI 10.1093/nar/gkp493; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Yavas G, 2010, BIOCOMPUT-PAC SYM, P371; Zhang Y, 2009, CANCER RES, V69, P3795, DOI 10.1158/0008-5472.CAN-08-4596; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	39	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e96841	10.1371/journal.pone.0096841	http://dx.doi.org/10.1371/journal.pone.0096841			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849202	Green Published, Green Submitted, gold			2022-12-25	WOS:000336730600017
J	Ochiai, Y; Hoshi, T; Rekimoto, J				Ochiai, Yoichi; Hoshi, Takayuki; Rekimoto, Jun			Three-Dimensional Mid-Air Acoustic Manipulation by Ultrasonic Phased Arrays	PLOS ONE			English	Article							LEVITATION	The essence of levitation technology is the countervailing of gravity. It is known that an ultrasound standing wave is capable of suspending small particles at its sound pressure nodes. The acoustic axis of the ultrasound beam in conventional studies was parallel to the gravitational force, and the levitated objects were manipulated along the fixed axis (i.e. one-dimensionally) by controlling the phases or frequencies of bolted Langevin-type transducers. In the present study, we considered extended acoustic manipulation whereby millimetre-sized particles were levitated and moved three-dimensionally by localised ultrasonic standing waves, which were generated by ultrasonic phased arrays. Our manipulation system has two original features. One is the direction of the ultrasound beam, which is arbitrary because the force acting toward its centre is also utilised. The other is the manipulation principle by which a localised standing wave is generated at an arbitrary position and moved three-dimensionally by opposed and ultrasonic phased arrays. We experimentally confirmed that expanded-polystyrene particles of 0.6 mm, 1 mm, and 2 mm in diameter could be manipulated by our proposed method.	[Ochiai, Yoichi; Rekimoto, Jun] Univ Tokyo, Grad Sch Interdisciplinary Informat Studies, Tokyo, Japan; [Hoshi, Takayuki] Nagoya Inst Technol, Ctr Fostering Young & Innovat Researchers, Nagoya, Aichi, Japan; [Rekimoto, Jun] Sony CSL, Tokyo, Japan	University of Tokyo; Nagoya Institute of Technology	Ochiai, Y (corresponding author), Univ Tokyo, Grad Sch Interdisciplinary Informat Studies, Tokyo, Japan.	yoichi.ochiai@me.com			Japan Society for the Promotion Science	Japan Society for the Promotion Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research is funded by Japan Society for the Promotion Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gor'kov L.P., 1962, SOV PHYS DOKL, V6, P773, DOI DOI 10.1039/C004504G; Hoshi T., 2012, P ADV COMP ENT C, P502; Hoshi T, 2010, IEEE T HAPTICS, V3, P155, DOI [10.1109/ToH.2010.4, 10.1109/TOH.2010.4]; Kozuka T, 2007, JPN J APPL PHYS 1, V46, P4948, DOI 10.1143/JJAP.46.4948; Nyborg WL, 1967, J ACOUST SOC AM, V42, P497; Weber RJK, 2012, EUR BIOPHYS J BIOPHY, V41, P397, DOI 10.1007/s00249-011-0767-3; WHYMARK RR, 1975, ULTRASONICS, V13, P251, DOI 10.1016/0041-624X(75)90072-4; Xie WJ, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2396893	8	68	69	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97590	10.1371/journal.pone.0097590	http://dx.doi.org/10.1371/journal.pone.0097590			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849371	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600039
J	Viaene, L; Thijs, L; Jin, Y; Liu, YP; Gu, YM; Meijers, B; Claes, K; Staessen, J; Evenepoel, P				Viaene, Liesbeth; Thijs, Lutgarde; Jin, Yu; Liu, Yanping; Gu, Yumei; Meijers, Bjorn; Claes, Kathleen; Staessen, Jan; Evenepoel, Pieter			Heritability and Clinical Determinants of Serum Indoxyl Sulfate and p-Cresyl Sulfate, Candidate Biomarkers of the Human Microbiome Enterotype	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; HEMODIALYSIS-PATIENTS; BACTERIAL METABOLITES; RESISTANT STARCH; OXIDATIVE STRESS; UREMIC SOLUTES; GUT MICROBIOME; PROTEIN; CRESYLSULPHATE; MORTALITY	Background: Indoxyl sulfate and p-cresyl sulfate are unique microbial co-metabolites. Both co-metabolites have been involved in the pathogenesis of accelerated cardiovascular disease and renal disease progression. Available evidence suggests that indoxyl sulfate and p-cresyl sulfate may be considered candidate biomarkers of the human enterotype and may help to explain the link between diet and cardiovascular disease burden. Objective and Design: Information on clinical determinants and heritability of indoxyl sulfate and p-cresyl sulfate serum is non-existing. To clarify this issue, the authors determined serum levels of indoxyl sulfate and p-cresyl sulfate in 773 individuals, recruited in the frame of the Flemish Study on Environment, Genes and Health Outcomes (FLEMENGHO study). Results: Serum levels of indoxyl sulfate and p-cresyl sulfate amounted to 3.1 (2.4-4.3) and 13.0 (7.4-21.5) mu M, respectively. Regression analysis identified renal function, age and sex as independent determinants of both co-metabolites. Both serum indoxyl sulfate (h(2) = 0.17) and p-cresyl sulfate (h(2) = 0.18) concentrations showed moderate but significant heritability after adjustment for covariables, with significant genetic and environmental correlations for both co-metabolites. Limitations: Family studies cannot provide conclusive evidence for a genetic contribution, as confounding by shared environmental effects can never be excluded. Conclusions: The heritability of indoxyl sulfate and p-cresyl sulfate is moderate. Besides genetic host factors and environmental factors, also renal function, sex and age influence the serum levels of these co-metabolites.	[Viaene, Liesbeth; Meijers, Bjorn; Claes, Kathleen; Evenepoel, Pieter] Katholieke Univ Leuven Hosp, Div Nephrol Dialysis & Renal Transplantat, Dept Med, Louvain, Belgium; [Thijs, Lutgarde; Jin, Yu; Liu, Yanping; Gu, Yumei; Staessen, Jan] Univ Louvain, Dept Cardiovasc Dis, Studies Coordinating Ctr, Div Hypertens & Cardiovasc Rehabil, Louvain, Belgium; [Staessen, Jan] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands	Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Maastricht University	Evenepoel, P (corresponding author), Katholieke Univ Leuven Hosp, Div Nephrol Dialysis & Renal Transplantat, Dept Med, Louvain, Belgium.	Pieter.Evenepoel@uz.kuleuven.ac.be	liu, yan/HGV-1365-2022; Meijers, Bjorn/D-6169-2018; Staessen, Jan A/A-1065-2011; P, Evenepoel/D-9597-2018; liu, yan/HCI-5542-2022	Meijers, Bjorn/0000-0002-2846-2026; Staessen, Jan A/0000-0002-3026-1637; P, Evenepoel/0000-0002-2846-2026; Thijs, Lutgarde/0000-0002-8108-2356	European Union [IC15-CT98-0329-EPOGH, LSHM-CT-2006-037093 InGenious HyperCare, HEALTH-F4-2007-201550 HyperGenes, HEALTH-F7-2011-278249 EU-MASCARA]; European Research Council Advanced Research Grant [294713 EPLORE]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium [G.0575.06, G.0734.09]; Katholieke Universiteit Leuven, Belgium [OT/00/25, OT/05/49]	European Union(European Commission); European Research Council Advanced Research Grant; Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium(FWO); Katholieke Universiteit Leuven, Belgium(KU Leuven)	The European Union (grants IC15-CT98-0329-EPOGH, LSHM-CT-2006-037093 InGenious HyperCare, HEALTH-F4-2007-201550 HyperGenes and HEALTH-F7-2011-278249 EU-MASCARA), and the European Research Council Advanced Research Grant 294713 EPLORE, the Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium (grants G.0575.06 and G.0734.09), and the Katholieke Universiteit Leuven, Belgium (grants OT/00/25 and OT/05/49) supported the Studies Coordinating Centre (Leuven, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronov PA, 2011, J AM SOC NEPHROL, V22, P1769, DOI 10.1681/ASN.2010121220; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bammens B, 2004, AM J CLIN NUTR, V80, P1536, DOI 10.1093/ajcn/80.6.1536; Bammens B, 2006, KIDNEY INT, V69, P1081, DOI 10.1038/sj.ki.5000115; Benjamin JL, 2011, INFLAMM BOWEL DIS; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Birkett A, 1996, AM J CLIN NUTR, V63, P766, DOI 10.1093/ajcn/63.5.766; CUMMINGS JH, 1979, AM J CLIN NUTR, V32, P2094, DOI 10.1093/ajcn/32.10.2094; CURTIUS HC, 1976, J CHROMATOGR, V126, P569, DOI 10.1016/S0021-9673(01)84102-9; Dallongeville J, 1998, J NUTR, V128, P1450; de Loor H, 2009, J CHROMATOGR A, V1216, P4684, DOI 10.1016/j.chroma.2009.04.015; Dominguez-Bello MG, 2011, GASTROENTEROLOGY, V140, P1713, DOI 10.1053/j.gastro.2011.02.011; Dou L, 2004, KIDNEY INT, V65, P442, DOI 10.1111/j.1523-1755.2004.00399.x; Francois IEJA, 2012, BRIT J NUTR, V108, P2229, DOI 10.1017/S0007114512000372; Geypens B, 1997, GUT, V41, P70, DOI 10.1136/gut.41.1.70; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; Holmes E, 2008, CELL, V134, P714, DOI 10.1016/j.cell.2008.08.026; Jacobs DM, 2012, J AGR FOOD CHEM, V60, P3078, DOI 10.1021/jf2044247; Le Leu RK, 2007, CARCINOGENESIS, V28, P240, DOI 10.1093/carcin/bgl245; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P1183, DOI 10.1093/ndt/gfp592; Lin CJ, 2010, NEPHROL DIAL TRANSPL, V25, P3693, DOI 10.1093/ndt/gfq251; Lou YJ, 2011, TOXICOL LETT, V201, P72, DOI 10.1016/j.toxlet.2010.12.007; Meijers BKI, 2010, NEPHROL DIAL TRANSPL, V25, P219, DOI 10.1093/ndt/gfp414; Meijers BKI, 2010, CLIN J AM SOC NEPHRO, V5, P1182, DOI 10.2215/CJN.07971109; Melamed ML, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-134; Meyer TW, 2007, NEW ENGL J MED, V357, P1316, DOI 10.1056/NEJMra071313; Muteliefu G, 2009, NEPHROL DIAL TRANSPL, V24, P2051, DOI 10.1093/ndt/gfn757; Patel KP, 2012, CLIN J AM SOC NEPHRO, V7, P982, DOI 10.2215/CJN.12491211; Schepers E, 2007, NEPHROL DIAL TRANSPL, V22, P592, DOI 10.1093/ndt/gfl584; Shivanna S, 2013, NY TIMES        1026, V127, P365; Smith EA, 1996, J APPL BACTERIOL, V81, P288, DOI 10.1111/j.1365-2672.1996.tb04331.x; Tiihonen K, 2010, AGEING RES REV, V9, P107, DOI 10.1016/j.arr.2009.10.004; Tumur Z, 2009, AM J NEPHROL, V29, P551, DOI 10.1159/000191468; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vaziri ND, 2013, KIDNEY INT, V83, P308, DOI 10.1038/ki.2012.345; Wang CP, 2010, ATHEROSCLEROSIS, V211, P579, DOI 10.1016/j.atherosclerosis.2010.03.036; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Windey K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052387; Woodmansey EJ, 2007, J APPL MICROBIOL, V102, P1178, DOI 10.1111/j.1365-2672.2007.03400.x; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu IW, 2011, NEPHROL DIAL TRANSPL, V26, P938, DOI 10.1093/ndt/gfq580	43	27	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e79682	10.1371/journal.pone.0079682	http://dx.doi.org/10.1371/journal.pone.0079682			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24850265	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600001
J	Yamada, A; Minamiguchi, S; Sakai, Y; Horimatsu, T; Muto, M; Chiba, T; Boland, CR; Goel, A				Yamada, Atsushi; Minamiguchi, Sachiko; Sakai, Yoshiharu; Horimatsu, Takahiro; Muto, Manabu; Chiba, Tsutomu; Boland, C. Richard; Goel, Ajay			Colorectal Advanced Neoplasms Occur through Dual Carcinogenesis Pathways in Individuals with Coexisting Serrated Polyps	PLOS ONE			English	Article							NORMAL COLONIC-MUCOSA; DNA METHYLATION; CANCER; HYPERMETHYLATION; CLASSIFICATION; MULTIPLICITY; FEATURES; LESIONS; FIELD; RISK	Background: Individuals with serrated polyps (SP) are at higher risk for synchronous colorectal advanced neoplasms (AN) and cancers. However, it remains unclear whether there is a unique involvement of the serrated pathway and/or the classical adenoma-carcinoma sequence in this setting. Methods: Colorectal ANs, which include tubular adenomas >= 10 mm, adenomas with villous histology, high-grade intraepithelial neoplasms, and cancers, were collected retrospectively. The groups included ANs with (AN+SP) or without (AN-only) coexisting SPs. Clinicopathological findings were compared between groups. BRAF and KRAS mutations in ANs and SPs, and methylation levels at long interspersed element-1 (LINE-1) in adjacent mucosa were determined by pyrosequencing. Results: Seventy-five ANs from 40 patients in the AN+SP group, and 179 ANs from 119 patients in the AN-only group were analyzed. There were no significant differences in clinicopathological findings between the two groups, except that intraepithelial neoplasia in the AN+SP group was more likely to be located in the right colon (P = 0.018). BRAF mutations were significantly more frequent in the AN+SP group (P = 0.003), while KRAS mutations showed no significant differences between groups (P = 0.142). The majority of high-grade intraepithelial neoplasms in both groups showed a contiguous component of conventional adenoma. Individuals with large and right-sided SPs had significantly more conventional adenomas compared to those without such SPs (P = 0.027 and P = 0.031, respectively). Adjacent mucosa from individuals with multiple and large SPs showed significantly lower methylation levels at LINE-1 compared to individuals without such associated SPs (P = 0.049 and P = 0.015, respectively). Conclusion: Our data suggest that both the adenoma-carcinoma sequence and the serrated pathway are operational in individuals with coexisting ANs and SPs. The reduced methylation levels at LINE-1 in the background mucosa suggest the possibility of an underlying 'field defect'.	[Yamada, Atsushi; Boland, C. Richard; Goel, Ajay] Baylor Univ, Med Ctr, Baylor Res Inst, Gastrointestinal Canc Res Lab, Dallas, TX USA; [Yamada, Atsushi; Chiba, Tsutomu] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan; [Minamiguchi, Sachiko] Kyoto Univ Hosp, Dept Diagnost Pathol, Kyoto 606, Japan; [Sakai, Yoshiharu] Kyoto Univ, Dept Surg, Grad Sch Med, Kyoto, Japan; [Horimatsu, Takahiro] Kyoto Univ Hosp, Dept Expt Therapeut, Inst Adv Clin & Translat Sci iACT, Kyoto 606, Japan; [Muto, Manabu] Kyoto Univ Hosp, Dept Therapeut Oncol, Kyoto 606, Japan	Baylor Scott & White Health; Baylor University; Baylor University Medical Center; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University	Boland, CR (corresponding author), Baylor Univ, Med Ctr, Baylor Res Inst, Gastrointestinal Canc Res Lab, Dallas, TX USA.	rickbo@baylorhealth.edu; ajay.goel@baylorhealth.edu		Goel, Ajay/0000-0003-1396-6341; Horimatsu, Takahiro/0000-0002-4188-9059	National Cancer Institute, National Institutes of Health [R01 CA72851, CA129286]; Baylor Research Institute; NATIONAL CANCER INSTITUTE [R01CA129286, R01CA072851] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Baylor Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The present work was supported by grants R01 CA72851 and CA129286 from the National Cancer Institute, National Institutes of Health, and funds from the Baylor Research Institute to CRB and AG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist T, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-94; Axon A, 2005, ENDOSCOPY, V37, P570, DOI 10.1055/s-2005-861352; Goel A, 2010, GASTROENTEROLOGY, V138, P1854, DOI 10.1053/j.gastro.2010.01.035; Hiraoka S, 2010, GASTROENTEROLOGY, V139, P1503, DOI 10.1053/j.gastro.2010.07.011; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; JASS JR, 1992, GUT, V33, P1508, DOI 10.1136/gut.33.11.1508; Kamiyama H, 2012, ONCOGENE, V31, P5029, DOI 10.1038/onc.2011.652; Kawakami K, 2006, BRIT J CANCER, V94, P593, DOI 10.1038/sj.bjc.6602940; Li D, 2009, AM J GASTROENTEROL, V104, P695, DOI 10.1038/ajg.2008.166; Lin OS, 2005, ARCH INTERN MED, V165, P382, DOI 10.1001/archinte.165.4.382; Matsuzaki K, 2005, CLIN CANCER RES, V11, P8564, DOI 10.1158/1078-0432.CCR-05-0859; Minoo P, 2006, GUT, V55, DOI 10.1136/gut.2005.082859; Nakagawa H, 2001, CANCER RES, V61, P6991; Nosho K, 2009, GASTROENTEROLOGY, V137, P1609, DOI 10.1053/j.gastro.2009.08.002; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161; Rosty C, 2013, AM J SURG PATHOL, V37, P434, DOI 10.1097/PAS.0b013e318270f748; Schreiner MA, 2010, GASTROENTEROLOGY, V139, P1497, DOI 10.1053/j.gastro.2010.06.074; Shen LL, 2005, JNCI-J NATL CANCER I, V97, P1330, DOI 10.1093/jnci/dji275; Silviera ML, 2012, CANCER PREV RES, V5, P374, DOI 10.1158/1940-6207.CAPR-11-0336; Snover DC, 2010, WHO CLASSIFICATION T, P160; Sobin L, 2009, TNM CLASSIFICATION M; Torlakovic E, 2003, AM J SURG PATHOL, V27, P65, DOI 10.1097/00000478-200301000-00008; Ushijima T, 2007, J BIOCHEM MOL BIOL, V40, P142; Vu HT, 2011, DIS COLON RECTUM, V54, P1216, DOI 10.1097/DCR.0b013e318228f8a9; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Worthley DL, 2010, ONCOGENE, V29, P1653, DOI 10.1038/onc.2009.449; Yamada A, 2011, HEPATO-GASTROENTEROL, V58, P45; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032	29	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98059	10.1371/journal.pone.0098059	http://dx.doi.org/10.1371/journal.pone.0098059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849572	gold, Green Published, Green Submitted			2022-12-25	WOS:000336730600081
J	Zhang, W; Kan, SL; Zhao, H; Li, ZY; Wang, XQ				Zhang, Wei; Kan, Sheng-long; Zhao, Hong; Li, Zhen-yu; Wang, Xiao-quan			Molecular Phylogeny of Tribe Theeae (Theaceae s.s.) and Its Implications for Generic Delimitation	PLOS ONE			English	Article							APTEROSPERMA-OBLATA THEACEAE; DNA; SEQUENCES; MIOCENE; HYBRIDIZATION; ANGIOSPERMS; CHARACTERS; INFERENCE; TORTOISE; WOODS	Tribe Theeae, which includes some economically important and widely grown plants, such as beverage tea and a number of woody ornamentals, is the largest member of the Theaceae family. Using five genomic regions (chloroplast: atpI-H, matK, psbA5'R-ALS-11F, rbcL; nuclear: LEAFY) and 30 species representing four of the five genera in this tribe (Apterosperma, Camellia, Polyspora, and Pyrenaria s.l.), we investigated the phylogeny of Theeae and assessed the delimitation of genera in the tribe. Our results showed that Polyspora was monophyletic and the sister of the three other genera of Theeae investigated, Camellia was paraphyletic and Pyrenaria was polyphyletic. The inconsistent phylogenetic placement of some species of Theeae between the nuclear and chloroplast trees suggested widespread hybridization between Camellia and Pyrenaria, Polyspora and Parapyrenaria. These results indicate that hybridization, rather than morphological homoplasy, has confused the current classification of Theeae. In addition, the phylogenetic placement and possible allies of Laplacea are also discussed.	[Zhang, Wei; Kan, Sheng-long; Zhao, Hong] Shandong Univ Weihai, Marine Coll, Weihai, Peoples R China; [Zhang, Wei; Li, Zhen-yu; Wang, Xiao-quan] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China	Shandong University; Chinese Academy of Sciences; Institute of Botany, CAS	Li, ZY (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	lizy@ibcas.ac.cn; xiaoq_wang@ibcas.ac.cn	ZHANG, WEI/AAJ-2716-2020		National Natural Science Foundation of China [31300194]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported National Natural Science Foundation of China (Grant No. 31300194). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN WL, 1973, J HERED, V64, P356, DOI 10.1093/oxfordjournals.jhered.a108440; Airy-Shaw HK, 1936, KEW B, V1936, P496; Baack EJ, 2007, CURR OPIN GENET DEV, V17, P513, DOI 10.1016/j.gde.2007.09.001; Bentham G, 1862, GENERA PLANTARUM, V1, P177; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Chang H.T., 1998, FLORA REIPUBLICAE PO, V49; De Candolle AP, 1824, PRODROMUS SYSTEMATIS, V1, P523; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Frankham R., 2004, PRIMER CONSERVATION, DOI [10.1017/CBO9780511817359, DOI 10.1017/CBO9780511817359]; Frohlich MW, 2000, SYST BOT, V25, P155, DOI 10.2307/2666635; Frohlich MW, 1997, INT J PLANT SCI, V158, pS131, DOI 10.1086/297513; Fu LG, 1992, RED LIST ENDANGERED; GROTE PJ, 1992, AM J BOT, V79, P744, DOI 10.2307/2444939; GROTE PJ, 1989, BOT GAZ, V150, P190, DOI 10.1086/337764; GU Z, 1988, Acta Botanica Yunnanica, V10, P291; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hilton-Taylor C., 2000, 2000 IUCN RED LIST T; Holder MT, 2001, SYST BIOL, V50, P978, DOI 10.1080/106351501753462911; Jeong EK, 2004, J PLANT RES, V117, P183, DOI 10.1007/s10265-004-0144-8; Joly S, 2009, AM NAT, V174, pE54, DOI 10.1086/600082; KENG H, 1980, Gardens' Bulletin (Singapore), V33, P303; KENG H, 1972, Gardens' Bulletin (Singapore), V26, P127; KENG H., 1962, Univiversity of California Publications in Botany, V33, P269; KONDO K, 1977, BIOTROPICA, V9, P86, DOI 10.2307/2387663; Kondo K, 1979, AM CAMELLIA YB, V34, P42; Li C.-Y., 2003, COLLECT RES, V16, P71, DOI [10.6693/CAR.2003.16.8, DOI 10.6693/CAR.2003.16.8]; LI GT, 1990, GUIHAIA, V10, P127; Li MM, 2013, J SYST EVOL, V51, P396, DOI 10.1111/jse.12017; Li R, 2011, NORD J BOT, V29, P780, DOI 10.1111/j.1756-1051.2011.01175.x; Lim JD, 2010, GEOSCI J, V14, P11, DOI 10.1007/s12303-010-0002-8; Luna I, 2004, CLADISTICS, V20, P223, DOI 10.1111/j.1096-0031.2004.00024.x; Maizel A, 2005, SCIENCE, V308, P260, DOI 10.1126/science.1108229; Melchior H., 1925, NATURL PFLANZ, P109; Meng C, 2009, THEOR POPUL BIOL, V75, P35, DOI 10.1016/j.tpb.2008.10.004; Ming T. L., 2000, MONOGRAPH GENUS CAME; Ming TL, 2007, FLORA CHINA, V12; Nylander J, 2004, MR MODELTEST V2 PROG; Parks C.R., 1990, INT CAMELLIA J, V22, P37; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prince Linda M., 2007, Aliso, V24, P105; Prince LM, 2001, AM J BOT, V88, P2309, DOI 10.2307/3558391; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sang T, 2000, SYST BIOL, V49, P422, DOI 10.1080/10635159950127321; SANTAMOUR FRANK S., 1963, MORRIS ARBOR BULL, V14, P51; Sauquet H, 2013, CR PALEVOL, V12, P355, DOI 10.1016/j.crpv.2013.07.003; Schonenberger J, 2005, INT J PLANT SCI, V166, P265, DOI 10.1086/427198; SEALY J. R., 1958, A Revision of the Genus Camellia.; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Shen SK, 2010, PLANT SPEC BIOL, V25, P158, DOI 10.1111/j.1442-1984.2010.00278.x; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Simura T., 1953, JAPAN J BREED, V2, P205; Su YJ, 2008, BIOCHEM SYST ECOL, V36, P619, DOI 10.1016/j.bse.2008.05.008; Suzuki M, 1996, IAWA J, V17, P365, DOI 10.1163/22941932-90000634; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Szyszylowicz IV, 1895, NATURL PFLANZ, P175; Takhtadzhian A.L., 1997, DIVERSITY CLASSIFICA; Thakor BH, 1998, THESIS U N CAROLINA; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsou CH, 1998, AM J BOT, V85, P1531, DOI 10.2307/2446480; Tsou CH, 1997, AM J BOT, V84, P369, DOI 10.2307/2446010; Wang YH, 2006, PLANT SYST EVOL, V260, P39, DOI 10.1007/s00606-006-0426-9; Wei Zhongxin, 1997, Acta Botanica Yunnanica, V19, P143; Wendel J. F, 1998, MOL SYSTEMATICS PLAN, P265, DOI DOI 10.1007/978-1-4615-5419-6_10; Yang Jun-Bo, 2006, Acta Botanica Yunnanica, V28, P29; Yang Shi-Xiong, 1995, Acta Botanica Yunnanica, V17, P192; Yang SX, 2004, PLANT SYST EVOL, V248, P45, DOI 10.1007/s00606-004-0178-3; Ye CX., 1990, ACTA SCI NAT UNIV S, V29, P74; Ye CX, 1990, GUIHAIA, V10, P99; Young ND, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-6; Zhang Wen-Ju, 1999, Acta Botanica Yunnanica, V21, P184	77	25	27	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98133	10.1371/journal.pone.0098133	http://dx.doi.org/10.1371/journal.pone.0098133			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848365	gold, Green Published, Green Submitted			2022-12-25	WOS:000336730600090
J	Li, SD; Kennedy, M; Payne, S; Kennedy, K; Seewaldt, VL; Pizzo, SV; Bachelder, RE				Li, Shenduo; Kennedy, Margaret; Payne, Sturgis; Kennedy, Kelly; Seewaldt, Victoria L.; Pizzo, Salvatore V.; Bachelder, Robin E.			Model of Tumor Dormancy/Recurrence after Short-Term Chemotherapy	PLOS ONE			English	Article							BREAST-CANCER CELLS; DRUG-RESISTANCE; DOCETAXEL	Although many tumors regress in response to neoadjuvant chemotherapy, residual tumor cells are detected in most cancer patients post-treatment. These residual tumor cells are thought to remain dormant for years before resuming growth, resulting in tumor recurrence. Considering that recurrent tumors are most often responsible for patient mortality, there exists an urgent need to study signaling pathways that drive tumor dormancy/recurrence. We have developed an in vitro model of tumor dormancy/recurrence. Short-term exposure of tumor cells (breast or prostate) to chemotherapy at clinically relevant doses enriches for a dormant tumor cell population. Several days after removing chemotherapy, dormant tumor cells regain proliferative ability and establish colonies, resembling tumor recurrence. Tumor cells from "recurrent'' colonies exhibit increased chemotherapy resistance, similar to the therapy resistance of recurrent tumors in cancer patients. Previous studies using long-term chemotherapy selection models identified acquired mutations that drive tumor resistance. In contrast, our short term chemotherapy exposure model enriches for a slow-cycling, dormant, chemo-resistant tumor cell sub-population that can resume growth after drug removal. Studying unique signaling pathways in dormant tumor cells enriched by short-term chemotherapy treatment is expected to identify novel therapeutic targets for preventing tumor recurrence.	[Li, Shenduo; Kennedy, Margaret; Payne, Sturgis; Kennedy, Kelly; Pizzo, Salvatore V.; Bachelder, Robin E.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Seewaldt, Victoria L.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University	Bachelder, RE (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	robin.bachelder@duke.edu			National Cancer Institute [R21 CA141223, R01 CA155664]; Department of Defense Congressionally Directed Medical Research [W81XWH-12-1-0478, W81XWH-13-1-0404]; NATIONAL CANCER INSTITUTE [R21CA141223, R01CA155664] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense Congressionally Directed Medical Research(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute R21 CA141223, www.cancer.gov; National Cancer Institute R01 CA155664, www.cancer.gov; Department of Defense Congressionally Directed Medical Research W81XWH-12-1-0478, cdmrp.army.mil/; Department of Defense Congressionally Directed Medical Research W81XWH-13-1-0404, cdmrp.army.mil/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunsvig PF, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-197; Calcagno AM, 2010, JNCI-J NATL CANCER I, V102, P1637, DOI 10.1093/jnci/djq361; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Kuczynski EA, 2013, NAT REV CLIN ONCOL, V10, P571, DOI 10.1038/nrclinonc.2013.158; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lin WC, 2014, CANCER RES, V74, P2138, DOI 10.1158/0008-5472.CAN-13-3437; Liu JB, 2008, AM J PHYSIOL-HEART C, V295, pH2541, DOI 10.1152/ajpheart.01052.2008; Moore N, 2012, STEM CELLS DEV, V21, P1822, DOI 10.1089/scd.2011.0477; Puhr M, 2012, AM J PATHOL, V181, P2188, DOI 10.1016/j.ajpath.2012.08.011; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Weiss RB, 2003, J CLIN ONCOL, V21, P1825, DOI 10.1200/JCO.2003.09.006; Williams KP, 2013, CANCER LETT, V337, P77, DOI 10.1016/j.canlet.2013.05.017	14	43	44	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98021	10.1371/journal.pone.0098021	http://dx.doi.org/10.1371/journal.pone.0098021			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845582	Green Published, gold, Green Submitted			2022-12-25	WOS:000339563400082
J	Monecke, S; Muller, E; Dorneanu, OS; Vremera, T; Ehricht, R				Monecke, Stefan; Mueller, Elke; Dorneanu, Olivia Simona; Vremera, Teodora; Ehricht, Ralf			Molecular Typing of MRSA and of Clinical Staphylococcus aureus Isolates from Iasi, Romania	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; METHICILLIN-RESISTANT; GENETIC DIVERSITY; HEALTH-CARE; COMMUNITY; STRAINS; EPIDEMIOLOGY; SUSCEPTIBILITY; CLONES; COLONIZATION	Romania is one of the countries with the highest prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in the world. To obtain data on affiliation of MRSA to strains and clonal complexes and on the population of methicillin susceptible S. aureus (MSSA), clinical isolates from bloodstream infections, skin and soft tissue infections as well as from screening swabs were collected at hospitals in Ia?i, a city in the North-Eastern part of Romania. Isolates were characterised by microarray hybridisation. Nearly half of all isolates (47%), and about one third (34%) of bloodstream isolates were MRSA. The prevalence of the Panton-Valentine leukocidin (PVL) was also high (31% among MRSA, 14% among MSSA). The most common MRSA strain was a PVL-negative CC1-MRSA-IV that might have emerged locally, as a related MSSA was also common. PVL-positive CC8-MRSA-IV ("USA300") and PVL-negative ST239-like MRSA-III were also frequently found while other MRSA strains were only sporadically detected. Among MSSA, PVL-positive CC121 as well as PVL-negative CC1, CC22 and CC45 predominated. Although this study provides only a snapshot of S. aureus/MRSA epidemiology in Romania, it confirms the high burden of MRSA and PVL on Romanian healthcare settings.	[Monecke, Stefan] Tech Univ Dresden, Med Fak Carl Gustav Carus, Inst Med Microbiol & Hyg, D-01062 Dresden, Germany; [Monecke, Stefan; Mueller, Elke; Ehricht, Ralf] Alere Technol GmbH, Jena, Germany; [Dorneanu, Olivia Simona; Vremera, Teodora] Univ Med & Pharm Grigore T Popa Iasi, Dept Microbiol, Iasi, Romania	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Alere; Grigore T Popa University of Medicine & Pharmacy	Monecke, S (corresponding author), Tech Univ Dresden, Med Fak Carl Gustav Carus, Inst Med Microbiol & Hyg, D-01062 Dresden, Germany.	monecke@rocketmail.com	Dorneanu, Olivia/AAV-7263-2021	Dorneanu, Olivia/0000-0001-7720-4499	CNCSIS -UEFISCSU [PNII - IDEI, ID_1586/2008]	CNCSIS -UEFISCSU(Consiliul National al Cercetarii Stiintifice (CNCS))	Most of the isolates were collected during project number PNII - IDEI code ID_1586/2008 supported by CNCSIS -UEFISCSU. There was no external funding for this project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamot HV, 2012, J CLIN MICROBIOL, V50, P3111, DOI 10.1128/JCM.01352-12; Akpaka Patrick E, 2011, J Med Case Rep, V5, P157, DOI 10.1186/1752-1947-5-157; Arias CA, 2008, NEW ENGL J MED, V359, P2177, DOI 10.1056/NEJMc0804021; Bara AC, 2002, CROAT MED J, V43, P446; Baranovich T, 2010, CLIN MICROBIOL INFEC, V16, P575, DOI 10.1111/j.1469-0691.2009.02891.x; Bekkhoucha SN, 2009, EUR J CLIN MICROBIOL, V28, P553, DOI 10.1007/s10096-008-0660-x; Chen HB, 2010, ANTIMICROB AGENTS CH, V54, P1842, DOI 10.1128/AAC.01563-09; Chen LA, 2010, ANTIMICROB AGENTS CH, V54, P3347, DOI 10.1128/AAC.00001-10; Chini V, 2006, CLIN MICROBIOL INFEC, V12, P29, DOI 10.1111/j.1469-0691.2005.01295.x; Cirkovic I, 2012, J MED MICROBIOL; Cirlan Maria, 2005, Infection Genetics and Evolution, V5, P335, DOI 10.1016/j.meegid.2004.09.005; Conceicao T, 2007, CLIN MICROBIOL INFEC, V13, P971, DOI 10.1111/j.1469-0691.2007.01794.x; Conceicao T, 2011, EUR J CLIN MICROBIOL, V30, P293, DOI 10.1007/s10096-010-1087-8; Coombs GW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-215; Coombs GW, 2004, J CLIN MICROBIOL, V42, P4735, DOI 10.1128/JCM.42.10.4735-4743.2004; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P2027, DOI 10.1128/JCM.41.5.2027-2032.2003; Dorneanu O, 2006, J PREVENTIVE MED, V14, P66; Dorobat Olga Mihaela, 2010, Bacteriol Virusol Parazitol Epidemiol, V55, P83; Ellington MJ, 2007, J ANTIMICROB CHEMOTH, V60, P402, DOI 10.1093/jac/dkm206; Ghebremedhin B, 2009, J CLIN MICROBIOL, V47, P2975, DOI 10.1128/JCM.00648-09; Holt E, 2010, LANCET, V376, P1211, DOI 10.1016/S0140-6736(10)61864-8; Ionescu R, 2010, MICROB DRUG RESIST, V16, P263, DOI 10.1089/mdr.2010.0059; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Kock R, 2010, EUROSURVEILLANCE, V15, P12, DOI 10.2807/ese.15.41.19688-en; Krcmery V, 1999, J HOSP INFECT, V43, pS269, DOI 10.1016/S0195-6701(99)90098-1; Lakey CK, 1996, J ADV NURS, V23, P1045, DOI 10.1046/j.1365-2648.1996.10826.x; Li M, 2012, NAT MED, V18, P816, DOI 10.1038/nm.2692; Luedicke C, 2010, EUR J CLIN MICROBIOL, V29, P457, DOI 10.1007/s10096-010-0884-4; Megevand C, 2010, CLIN MICROBIOL INFEC, V16, P1414, DOI 10.1111/j.1469-0691.2009.03090.x; Monecke S, 2007, CLIN MICROBIOL INFEC, V13, P1157, DOI 10.1111/j.1469-0691.2007.01833.x; Monecke S, 2006, CLIN MICROBIOL INFEC, V12, P718, DOI 10.1111/j.1469-0691.2006.01420.x; Monecke S, 2012, EUR J CLIN MICROBIOL, V31, P1497, DOI 10.1007/s10096-011-1469-6; Monecke S, 2009, EUR J CLIN MICROBIOL, V28, P1159, DOI 10.1007/s10096-009-0752-2; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2013, J CLIN MICROBIOL, V51, P487, DOI 10.1128/JCM.02285-12; Monecke S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-146; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Nashev D, 2007, EUROSURVEILLANCE, V12; Nastase E, 2010, Rev Med Chir Soc Med Nat Iasi, V114, P1162; NEJMA MB, 2008, DIAGN MICROBIOL INFE; Nica Maria, 2010, Bacteriol Virusol Parazitol Epidemiol, V55, P161; Nimmo GR, 2006, MED J AUSTRALIA, V184, P384, DOI 10.5694/j.1326-5377.2006.tb00287.x; Nimmo GR, 2008, INT J ANTIMICROB AG, V31, P401, DOI 10.1016/j.ijantimicag.2007.08.011; R Core Team, 2021, R LANG ENV STAT COMP; Sakwinska O, 2009, APPL ENVIRON MICROB, V75, P175, DOI 10.1128/AEM.01860-08; Smyth DS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008582; Szekely E, 2008, ACTA MICROBIOL IMM H, V55, P1, DOI 10.1556/AMicr.55.2008.1.1; Szekely E, 2012, REV ROMANA MED LAB, V20, P371; van Belkum A, 2006, J CLIN MICROBIOL, V44, P1555, DOI 10.1128/JCM.44.4.1555-1557.2006; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Vorobieva V, 2008, APMIS, V116, P877, DOI 10.1111/j.1600-0463.2008.01092.x; Vremera T, 2011, MED-SURG J, V115, P927; Weber S, 2010, GENETIC FINGERPRINTI	53	29	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97833	10.1371/journal.pone.0097833	http://dx.doi.org/10.1371/journal.pone.0097833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846009	Green Submitted, Green Published, gold			2022-12-25	WOS:000339563400064
J	Chen, T; Cai, MX; Li, YY; He, ZX; Shi, XC; Song, W; Wang, YH; Xi, Y; Kang, YM; Tian, ZJ				Chen, Ting; Cai, Meng-Xin; Li, You-You; He, Zhi-Xiong; Shi, Xiu-Chao; Song, Wei; Wang, You-Hua; Xi, Yue; Kang, Yu-Ming; Tian, Zhen-Jun			Aerobic Exercise Inhibits Sympathetic Nerve Sprouting and Restores beta-Adrenergic Receptor Balance in Rats with Myocardial Infarction	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ALTERED CONTRACTILE RESPONSE; ISCHEMIA-REPERFUSION INJURY; VENTRICULAR-FIBRILLATION; HEART-FAILURE; UP-REGULATION; SUDDEN-DEATH; IN-VIVO; STIMULATION; BETA(3)-ADRENOCEPTOR	Background: Cardiac sympathetic nerve sprouting and the dysregulation of beta-adrenergic receptor (beta-AR) play a critical role in the deterioration of cardiac function after myocardial infarction (MI). Growing evidence indicates that exercise provides protection against MI. The aims of this study were to investigate whether aerobic exercise following MI could inhibit sympathetic nerve sprouting and restore the balance of beta 3-AR/beta 1-AR. Methods: Male Sprague-Dawley rats were divided into three groups: sham-operated control group (SC), MI group (MI), and MI with aerobic exercise group (ME). The rats in ME group were assigned to 8 weeks of exercise protocol (16 m/min, 50 min/d, 5 d/wk). The expression of nerve growth factor (NGF), the sympathetic nerve marker-tyrosine hydroxylase (TH), the nerve sprouting marker-growth associated protein 43 (GAP43), and beta 1- and beta 2-AR expression in the peri-infarct area of the left ventricle (LV) were measured by Western blot and immunohistochemistry, while beta 3-AR expression was determined by Western blot and immunofluorescence. Endothelial nitric oxide synthase (NOS2), phospho-NOS2 (p-NOS2), and neuronal nitric oxide synthase (NOS1) were measured by Western blot. Results: MI increased LV end-diastolic pressure (LVEDP), and decreased LV systolic pressure (LVSP). Compared with the MI group, aerobic exercise significantly decreased LVEDP and increased LVSP. The protein expression of TH, GAP43 and NGF was significantly increased after MI, which was normalized by exercise. Compared with the SC group, the ratios of beta 2-AR/beta 1-AR and beta 3-AR/beta 1-AR were elevated in the MI group, and the protein expression of beta 3-AR and NOS1 increased after MI. Compared with the MI group, the ratios of beta 2-AR/beta 1-AR and beta 3-AR/beta 1-AR were normalized in the ME group, while the protein expression of beta 3-AR and NOS1 significantly increased, and NOS2 was activated by exercise. Conclusions: Aerobic exercise inhibits cardiac sympathetic nerve sprouting, restores beta 3-AR/beta 1-AR balance and increases beta 3-AR expression through the activation of NOS2 and NOS1 after myocardial infarction.	[Chen, Ting; Cai, Meng-Xin; He, Zhi-Xiong; Shi, Xiu-Chao; Song, Wei; Wang, You-Hua; Xi, Yue; Tian, Zhen-Jun] Shaanxi Normal Univ, Inst Sports & Exercise Biol, Xian, Shaanxi, Peoples R China; [Chen, Ting] Tibet Univ Nationalities, Dept Sports & Exercise, Xian Yang, Shaanxi, Peoples R China; [Li, You-You] Fourth Mil Med Univ, Dept Physiol, Xian 710032, Shaanxi, Peoples R China; [Li, You-You] Fourth Mil Med Univ, Dept Cardiol, Xian 710032, Shaanxi, Peoples R China; [Kang, Yu-Ming] Xi An Jiao Tong Univ, Cardiovasc Res Ctr, Sch Med, Dept Physiol & Pathophysiol, Xian 710049, Shaanxi, Peoples R China	Shaanxi Normal University; Xizang Minzu University; Air Force Military Medical University; Air Force Military Medical University; Xi'an Jiaotong University	Tian, ZJ (corresponding author), Shaanxi Normal Univ, Inst Sports & Exercise Biol, Xian, Shaanxi, Peoples R China.	tianzhenjun1965@yahoo.cn			National Natural Science Foundation of China [81360297, 31040045, 81100174, 31171141]; National Basic Research Program of China [2012CB517805]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (Grant No. 81360297, 31040045, 81100174 and 31171141) and National Basic Research Program of China (No. 2012CB517805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajijola OA, 2012, J AM COLL CARDIOL, V59, P962, DOI 10.1016/j.jacc.2011.11.031; Amour J, 2007, ANESTHESIOLOGY, V107, P452, DOI 10.1097/01.anes.0000278909.40408.24; [Anonymous], 2002, AM J PHYSL REGUL INT, VIII, P283; Aragon JP, 2011, J AM COLL CARDIOL, V58, P2683, DOI 10.1016/j.jacc.2011.09.033; Nguyen BL, 2012, CARDIOVASC PATHOL, V21, P143, DOI 10.1016/j.carpath.2011.08.001; Billman GE, 1997, CIRCULATION, V96, P1914, DOI 10.1161/01.CIR.96.6.1914; Billman GE, 2006, AM J PHYSIOL-HEART C, V290, pH2590, DOI 10.1152/ajpheart.01220.2005; Billman GE, 2009, AM J PHYSIOL-HEART C, V297, pH1171, DOI 10.1152/ajpheart.00534.2009; Bostrom P, 2010, CELL, V143, P1072, DOI 10.1016/j.cell.2010.11.036; Calvert JW, 2011, CIRC RES, V108, P1448, DOI 10.1161/CIRCRESAHA.111.241117; Cao JM, 2000, CIRCULATION, V101, P1960, DOI 10.1161/01.CIR.101.16.1960; Cheng HJ, 2001, CIRC RES, V89, P599, DOI 10.1161/hh1901.098042; de Waard MC, 2007, CIRC RES, V100, P1079, DOI 10.1161/01.RES.0000262655.16373.37; de Waard MC, 2010, J MOL CELL CARDIOL, V48, P1041, DOI 10.1016/j.yjmcc.2010.02.005; French JP, 2008, FASEB J, V22, P2862, DOI 10.1096/fj.07-102541; Giallauria F, 2013, EUR J NUCL MED MOL I, V40, P315, DOI 10.1007/s00259-012-2302-x; Heusch G, 2011, J AM COLL CARDIOL, V58, P2692, DOI 10.1016/j.jacc.2011.09.034; HOCHMAN JS, 1982, CIRCULATION, V65, P1446, DOI 10.1161/01.CIR.65.7.1446; Holycross BJ, 2007, AM J PHYSIOL-HEART C, V293, pH2702, DOI 10.1152/ajpheart.00763.2007; Houle MS, 2001, J APPL PHYSIOL, V91, P1627, DOI 10.1152/jappl.2001.91.4.1627; Kimura K, 2012, CIRC RES, V110, P325, DOI 10.1161/CIRCRESAHA.111.257253; Kraljevic J, 2013, CARDIOVASC RES, V99, P55, DOI 10.1093/cvr/cvt080; Kulandavelu S, 2012, J AM COLL CARDIOL, V59, P1988, DOI 10.1016/j.jacc.2012.01.058; Leosco D, 2008, CARDIOVASC RES, V78, P385, DOI 10.1093/cvr/cvm109; Lu J, 2012, J MOL NEUROSCI, V48, P448, DOI 10.1007/s12031-012-9720-x; Mann N, 2012, CIRCULATION, V126, P2625, DOI 10.1161/CIRCULATIONAHA.111.060376; Marshall KD, 2013, J APPL PHYSIOL, V114, P131, DOI 10.1152/japplphysiol.01059.2012; Martinez DG, 2011, HYPERTENSION, V58, P1049, DOI 10.1161/HYPERTENSIONAHA.111.176644; Moens AL, 2009, J MOL CELL CARDIOL, V47, P576, DOI 10.1016/j.yjmcc.2009.06.005; Moniotte S, 2001, CIRCULATION, V103, P1649, DOI 10.1161/01.CIR.103.12.1649; Niu XL, 2012, J AM COLL CARDIOL, V59, P1979, DOI 10.1016/j.jacc.2011.12.046; Ren CY, 2008, AUTON NEUROSCI-BASIC, V144, P22, DOI 10.1016/j.autneu.2008.08.004; Ribeiro F, 2012, REV PORT CARDIOL, V31, P135, DOI 10.1016/j.repc.2011.12.009; Roof SR, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0332-6; Sasano T, 2008, J AM COLL CARDIOL, V51, P2266, DOI 10.1016/j.jacc.2008.02.062; Saygili E, 2010, J MOL CELL CARDIOL, V49, P79, DOI 10.1016/j.yjmcc.2010.01.019; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Ursino MG, 2009, PHARMACOL RES, V59, P221, DOI 10.1016/j.phrs.2009.01.002; Veras-Silva AS, 1997, AM J PHYSIOL-HEART C, V273, pH2627, DOI 10.1152/ajpheart.1997.273.6.H2627; Waring C.D., 2012, EUR HEART J; Watts VL, 2013, J MOL CELL CARDIOL, V62, P8, DOI 10.1016/j.yjmcc.2013.04.025; Xu XH, 2008, J MOL CELL CARDIOL, V44, P114, DOI 10.1016/j.yjmcc.2007.10.004; Zhou SM, 2004, CIRC RES, V95, P76, DOI 10.1161/01.RES.0000133678.22968.e3	43	14	20	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97810	10.1371/journal.pone.0097810	http://dx.doi.org/10.1371/journal.pone.0097810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842290	gold, Green Published, Green Submitted			2022-12-25	WOS:000340948600078
J	Hum, JM; Day, RN; Bidwell, JP; Wang, YX; Pavalko, FM				Hum, Julia M.; Day, Richard N.; Bidwell, Joseph P.; Wang, Yingxiao; Pavalko, Fredrick M.			Mechanical Loading in Osteocytes Induces Formation of a Src/Pyk2/MBD2 Complex That Suppresses Anabolic Gene Expression	PLOS ONE			English	Article							FOCAL ADHESION KINASE; TYROSINE PHOSPHORYLATION; SARACATINIB AZD0530; CELL-PROLIFERATION; BONE TURNOVER; FLUID-FLOW; SRC; PROTEIN; STRESS; BINDING	Mechanical stimulation of the skeleton promotes bone gain and suppresses bone loss, ultimately resulting in improved bone strength and fracture resistance. The molecular mechanisms directing anabolic and/or anti-catabolic actions on the skeleton during loading are not fully understood. Identifying molecular mechanisms of mechanotransduction (MTD) signaling cascades could identify new therapeutic targets. Most research into MTD mechanisms is typically focused on understanding the signaling pathways that stimulate new bone formation in response to load. However, we investigated the structural, signaling and transcriptional molecules that suppress the stimulatory effects of loading. The high bone mass phenotype of mice with global deletion of either Pyk2 or Src suggests a role for these tyrosine kinases in repression of bone formation. We used fluid shear stress as a MTD stimulus to identify a novel Pyk2/Src-mediated MTD pathway that represses mechanically-induced bone formation. Our results suggest Pyk2 and Src function as molecular switches that inhibit MTD in our mechanically stimulated osteocyte culture experiments. Once activated by oscillatory fluid shear stress (OFSS), Pyk2 and Src translocate to and accumulate in the nucleus, where they associate with a protein involved in DNA methylation and the interpretation of DNA methylation patterns -methyl-CpG-binding domain protein 2 (MBD2). OFSS-induced Cox-2 and osteopontin expression was enhanced in Pyk2 KO osteoblasts, while inhibition of Src enhanced osteocalcin expression in response to OFSS. We found that Src kinase activity increased in the nucleus of osteocytes in response to OFSS and an interaction activated between Src (Y418) and Pyk2 (Y402) increased in response to OFSS. Thus, as a mechanism to prevent an over-reaction to physical stimulation, mechanical loading may induce the formation of a Src/Pyk2/MBD2 complex in the nucleus that functions to suppress anabolic gene expression.	[Hum, Julia M.; Day, Richard N.; Pavalko, Fredrick M.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Bidwell, Joseph P.] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Wang, Yingxiao] Univ Calif San Diego, Sch Engn, San Diego, CA 92103 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of California System; University of California San Diego	Pavalko, FM (corresponding author), Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA.	fpavalko@iupui.edu			NIH [5R01AR052682]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052682] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Grant support was provided by NIH 5R01AR052682 (https://public.era.nih.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Bidwell JP, 2011, SCI SIGNAL, V3, ppe51; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Boeke J, 2000, J BIOL CHEM, V275, P34963, DOI 10.1074/jbc.M005929200; Boufker HI, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-298; Boutahar N, 2004, J BIOL CHEM, V279, P30588, DOI 10.1074/jbc.M313244200; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Buckbinder L, 2007, P NATL ACAD SCI USA, V104, P10619, DOI 10.1073/pnas.0701421104; BUSS JE, 1986, J VIROL, V58, P468, DOI 10.1128/JVI.58.2.468-474.1986; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906; DAVIDPFEUTY T, 1993, J CELL SCI, V105, P613; DELMAS PD, 1990, J BONE MINER RES, V5, P3, DOI 10.1002/jbmr.5650050103; Faure C, 2007, J CELL SCI, V120, P3034, DOI 10.1242/jcs.009613; Faure C, 2013, CELL MOL LIFE SCI, V70, P137, DOI 10.1007/s00018-012-1075-5; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Guignandon A, 2006, BIOCHEM BIOPH RES CO, V343, P407, DOI 10.1016/j.bbrc.2006.02.162; Hall JE, 2011, INT REV CEL MOL BIO, V288, P185, DOI 10.1016/B978-0-12-386041-5.00005-4; Hannon RA, 2012, BONE, V50, P885, DOI 10.1016/j.bone.2011.12.017; Hannon RA, 2010, J BONE MINER RES, V25, P463, DOI 10.1359/jbmr.090830; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; HORNE WC, 1992, J CELL BIOL, V119, P1003, DOI 10.1083/jcb.119.4.1003; Inoue D, 2004, J BIOL CHEM, V279, P49795, DOI 10.1074/jbc.M404096200; Kannus P, 1996, J BONE MINER RES, V11, P79; Kido S, 2009, BONE, V45, P1125, DOI 10.1016/j.bone.2009.07.087; Leonhardt H, 2000, J CELL BIOCHEM, P78; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Lim ST, 2010, J BIOL CHEM, V285, P1743, DOI 10.1074/jbc.M109.064212; LOWE C, 1993, P NATL ACAD SCI USA, V90, P4485, DOI 10.1073/pnas.90.10.4485; Luo SW, 2009, EMBO J, V28, P2568, DOI 10.1038/emboj.2009.178; Marzia M, 2000, J CELL BIOL, V151, P311, DOI 10.1083/jcb.151.2.311; Miller JD, 2007, ORTHOPAEDIC BASIC SC, P129; Missbach M, 1999, BONE, V24, P437, DOI 10.1016/S8756-3282(99)00020-4; MONTGOMERY RJ, 1988, MICROVASC RES, V35, P295, DOI 10.1016/0026-2862(88)90084-2; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Nicolella D. P., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P330; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Ossovskaya V, 2008, FEBS LETT, V582, P2402, DOI 10.1016/j.febslet.2008.06.004; Pavalko FM, 2003, J CELL PHYSIOL, V194, P194, DOI 10.1002/jcp.10221; Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284; Plotkin LI, 2005, AM J PHYSIOL-CELL PH, V289, pC633, DOI 10.1152/ajpcell.00278.2004; RAABCULLEN DM, 1994, CALCIFIED TISSUE INT, V55, P473, DOI 10.1007/BF00298562; Rangaswami H, 2012, J BIOL CHEM, V287, P21509, DOI 10.1074/jbc.M112.347245; Rangaswami H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001423; Redford GI, 2005, J FLUORESC, V15, P805, DOI 10.1007/s10895-005-2990-8; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Robling AG, 2009, CRIT REV EUKAR GENE, V19, P319, DOI 10.1615/CritRevEukarGeneExpr.v19.i4.50; Sakai K, 1999, J BONE MINER RES, V14, P2089, DOI 10.1359/jbmr.1999.14.12.2089; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SHEFFIELD JB, 1987, ANAL BIOCHEM, V166, P49, DOI 10.1016/0003-2697(87)90544-6; Smalt R, 1997, ADV EXP MED BIOL, V433, P311; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Tate MLK, 1998, AM J MED SCI, V316, P189, DOI 10.1097/00000441-199809000-00007; Turner C H, 1998, J Orthop Sci, V3, P346, DOI 10.1007/s007760050064; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Wolf G, 1996, NUTR REV, V54, P332, DOI 10.1111/j.1753-4887.1996.tb03798.x; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413; Young SRL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016026; Young SRL, 2009, J BONE MINER RES, V24, P411, DOI 10.1359/JBMR.081102	60	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97942	10.1371/journal.pone.0097942	http://dx.doi.org/10.1371/journal.pone.0097942			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841674	gold, Green Submitted, Green Published			2022-12-25	WOS:000340948600094
J	Yang, XL; Gao, H; Zhang, J; Xu, XJ; Liu, XY; Wu, XR; Wei, LP; Zhang, YH				Yang, Xiaoling; Gao, Hua; Zhang, Jie; Xu, Xiaojing; Liu, Xiaoyan; Wu, Xiru; Wei, Liping; Zhang, Yuehua			ATP1A3 Mutations and Genotype-Phenotype Correlation of Alternating Hemiplegia of Childhood in Chinese Patients	PLOS ONE			English	Article							ONSET DYSTONIA-PARKINSONISM; DE-NOVO MUTATIONS; CRYSTAL-STRUCTURE; SEQUENCING DATA; GENE MUTATION; SWISS-MODEL; WEB SERVER; MIGRAINE; IDENTIFICATION; ENVIRONMENT	Alternating hemiplegia of childhood (AHC) is a rare and severe neurological disorder. ATP1A3 was recently identified as the causative gene. Here we report the first genetic study in Chinese AHC cohort. We performed whole-exome sequencing on three trios and three unrelated patients, and screened additional 41 typical cases and 100 controls by PCR-Sanger sequencing. ATP1A3 mutations were detected in 95.7% of typical AHC patients. At least 93.3% were de novo. Four late onset, atypical AHC patients were also mutation positive, suggesting the need for testing ATP1A3 mutations in atypical cases. Totally, 13 novel missense mutations (T370N, G706R, L770R, T771N, T771I, S772R, L802P, D805H, M806K, P808L, I810N, L839P and G893R) were identified in our study. By homology modeling of the mutant protein structures and calculation of an extensive list of molecular features, we identified two statistically significant molecular features, solvent accessibility and distance to metal ion, that distinguished disease-associated mutations from neutral variants. A logistic regression classifier achieved 92.9% accuracy by the average of 100 times of five-fold cross validations. Genotype-phenotype correlation analysis showed that patients with epilepsy were more likely to carry E815K mutation. In summary, ATP1A3 is the major pathogenic gene of AHC in Chinese patients; mutations have distinctive molecular features that discriminate them from neutral variants and are correlated with phenotypes.	[Yang, Xiaoling; Xu, Xiaojing; Liu, Xiaoyan; Wu, Xiru; Zhang, Yuehua] Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China; [Gao, Hua; Wei, Liping] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Ctr Bioinformat, Beijing 100871, Peoples R China; [Zhang, Jie; Wei, Liping] Natl Inst Biol Sci, Beijing, Peoples R China	Peking University; Peking University; National Institute of Biological Sciences, Beijing	Wei, LP (corresponding author), Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Ctr Bioinformat, Beijing 100871, Peoples R China.	weilp@mail.cbi.pku.edu.cn; zhangyhd@hotmail.com		GAO, Hua/0000-0002-1029-1476; Zhang, Yuehua/0000-0003-1432-5423	Key Construction Program of the National "985'' Project [BMU20120308]; National Outstanding Young Investigator Award [31025014]; Ministry of Science and Technology of China 973 grant [2012CB837600]; Doctoral Fund of Ministry of Education of China [20130001110071]	Key Construction Program of the National "985'' Project; National Outstanding Young Investigator Award; Ministry of Science and Technology of China 973 grant; Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This work was supported by Key Construction Program of the National "985'' Project (No: BMU20120308), National Outstanding Young Investigator Award (No: 31025014), Ministry of Science and Technology of China 973 grant (No: 2012CB837600), and Doctoral Fund of Ministry of Education of China (No: 20130001110071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; AMERY WK, 1983, HEADACHE, V23, P70, DOI 10.1111/j.1526-4610.1983.hed2302070.x; Anselm IA, 2009, NEUROLOGY, V73, P400, DOI 10.1212/WNL.0b013e3181b04acd; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOURGEOIS M, 1993, J PEDIATR-US, V122, P673, DOI 10.1016/S0022-3476(06)80003-X; CHURCH J, 1980, CAN J PHYSIOL PHARM, V58, P254, DOI 10.1139/y80-044; Clapcote SJ, 2009, P NATL ACAD SCI USA, V106, P14085, DOI 10.1073/pnas.0904817106; Cooper DN, 1996, HUM GENET, V98, P629, DOI 10.1007/s004390050272; de Vries B, 2006, NEUROPEDIATRICS, V37, P302, DOI 10.1055/s-2006-924609; Dehouck Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-151; Dosztanyi Z, 1997, J MOL BIOL, V272, P597, DOI 10.1006/jmbi.1997.1242; Fons C, 2012, EUR J PAEDIATR NEURO, V16, P10, DOI 10.1016/j.ejpn.2011.08.006; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haan J, 2000, CEPHALALGIA, V20, P696, DOI 10.1046/j.0333-1024.2000.00095.x; Heinzen EL, 2012, NAT GENET, V44, P1030, DOI 10.1038/ng.2358; Ishii A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056120; Kors EE, 2004, NEUROPEDIATRICS, V35, P293, DOI 10.1055/s-2004-821082; Li ST, 2013, GENOME RES, V23, P195, DOI 10.1101/gr.132480.111; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mikati MA, 2000, PEDIATR NEUROL, V23, P134, DOI 10.1016/S0887-8994(00)00157-0; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Neville BGR, 2007, DEV MED CHILD NEUROL, V49, P777, DOI 10.1111/j.1469-8749.2007.00777.x; Nielsen R, 2013, INTRODUCTION TO POPULATION GENETICS: THEORY AND APPLICATIONS, P1; Nyblom M, 2013, SCIENCE, V342, P123, DOI 10.1126/science.1243352; Panagiotakaki E, 2010, BRAIN, V133, P3598, DOI 10.1093/brain/awq295; Rosewich H, 2012, LANCET NEUROL, V11, P764, DOI 10.1016/S1474-4422(12)70182-5; Roubergue A, 2013, MOVEMENT DISORD, V28, P1457, DOI 10.1002/mds.25396; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sweney MT, 2009, PEDIATRICS, V123, pe534, DOI 10.1542/peds.2008-2027; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; VERRETT S, 1971, PEDIATRICS, V47, P675; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Ye ZQ, 2007, BIOINFORMATICS, V23, P1444, DOI 10.1093/bioinformatics/btm119; Zanotti-Fregonara P, 2008, J NEUROL SCI, V273, P148, DOI 10.1016/j.jns.2008.06.033	40	38	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97274	10.1371/journal.pone.0097274	http://dx.doi.org/10.1371/journal.pone.0097274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842602	Green Submitted, Green Published, gold			2022-12-25	WOS:000340948600020
J	Gromek, KA; Suchy, FP; Meddaugh, HR; Wrobel, RL; LaPointe, LM; Chu, UB; Primm, JG; Ruoho, AE; Senes, A; Fox, BG				Gromek, Katarzyna A.; Suchy, Fabian P.; Meddaugh, Hannah R.; Wrobel, Russell L.; LaPointe, Loren M.; Chu, Uyen B.; Primm, John G.; Ruoho, Arnold E.; Senes, Alessandro; Fox, Brian G.			The Oligomeric States of the Purified Sigma-1 Receptor Are Stabilized by Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; DOMAIN-LIKE-I; BINDING-SITE; STEROID-BINDING; GXXXG MOTIF; TRANSMEMBRANE DOMAIN; CHANNEL MODULATION; HELIX ASSOCIATION; MEMBRANE-PROTEINS; OXIDATIVE STRESS	Sigma-1 receptor (S1R) is a mammalian member of the ERG2 and sigma-1 receptor-like protein family (pfam04622). It has been implicated in drug addiction and many human neurological disorders, including Alzheimer and Parkinson diseases and amyotrophic lateral sclerosis. A broad range of synthetic small molecules, including cocaine, (+)-pentazocine, haloperidol, and small endogenous molecules such as N,N-dimethyltryptamine, sphingosine, and steroids, have been identified as regulators of S1R. However, the mechanism of activation of S1R remains obscure. Here, we provide evidence in vitro that S1R has ligand binding activity only in an oligomeric state. The oligomeric state is prone to decay into an apparent monomeric form when exposed to elevated temperature, with loss of ligand binding activity. This decay is suppressed in the presence of the known S1R ligands such as haloperidol, BD-1047, and sphingosine. S1R has a GXXXG motif in its second transmembrane region, and these motifs are often involved in oligomerization of membrane proteins. Disrupting mutations within the GXXXG motif shifted the fraction of the higher oligomeric states toward smaller states and resulted in a significant decrease in specific (+)-[H-3]pentazocine binding. Results presented here support the proposal that S1R function may be regulated by its oligomeric state. Possible mechanisms of molecular regulation of interacting protein partners by S1R in the presence of small molecule ligands are discussed.	[Gromek, Katarzyna A.; Suchy, Fabian P.; Meddaugh, Hannah R.; Wrobel, Russell L.; Primm, John G.; Fox, Brian G.] Univ Wisconsin, Transmembrane Prot Ctr, Madison, WI 53706 USA; [LaPointe, Loren M.; Senes, Alessandro; Fox, Brian G.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Chu, Uyen B.; Ruoho, Arnold E.] Univ Wisconsin, Dept Neurosci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ruoho, AE (corresponding author), Univ Wisconsin, Dept Neurosci, Madison, WI 53706 USA.	aeruoho@wisc.edu; bgfox@biochem.wisc.edu		SENES, ALESSANDRO/0000-0002-3807-2275	National Institutes of Health [1S10RR023748-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094584, R01GM099752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS075820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs. Emily T. Beebe, Ronnie O. Frederick, and Shin-ichi Makino for helpful comments on experimental procedures and analysis of results. Light scattering experiments performed at the Yale University W. M. Keck Foundation were supported by National Institutes of Health Grant 1S10RR023748-01.	Al-Saif A, 2011, ANN NEUROL, V70, P913, DOI 10.1002/ana.22534; Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Balasuriya D, 2012, J BIOL CHEM, V287, P37021, DOI 10.1074/jbc.M112.382077; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Brune S, 2012, ASSAY DRUG DEV TECHN, V10, P365, DOI 10.1089/adt.2011.0376; Bucolo C, 2006, NEUROREPORT, V17, P287, DOI 10.1097/01.wnr.0000199469.21734.e1; Carnally SM, 2010, BIOPHYS J, V98, P1182, DOI 10.1016/j.bpj.2009.12.4293; Casado V, 2009, PHARMACOL THERAPEUT, V124, P248, DOI 10.1016/j.pharmthera.2009.07.005; Chen YM, 2007, BIOCHEMISTRY-US, V46, P3532, DOI 10.1021/bi061727o; Chu UB, 2013, BIOCHEMISTRY-US, V52, P859, DOI 10.1021/bi301517u; Cobos EJ, 2008, CURR NEUROPHARMACOL, V6, P344, DOI 10.2174/157015908787386113; Colabufo Nicola Antonio, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P161; Ferre S, 2010, CURR OPIN PHARMACOL, V10, P1, DOI 10.1016/j.coph.2009.11.002; Fontanilla D, 2008, BIOCHEMISTRY-US, V47, P7205, DOI 10.1021/bi800564j; Fontanilla D, 2009, SCIENCE, V323, P934, DOI 10.1126/science.1166127; Ganapathy ME, 1999, J PHARMACOL EXP THER, V289, P251; Gromek KA, 2013, PROTEIN EXPRES PURIF, V89, P203, DOI 10.1016/j.pep.2013.03.013; GUNDLACH AL, 1986, J NEUROSCI, V6, P1757; Ha YJ, 2011, INVEST OPHTH VIS SCI, V52, P527, DOI 10.1167/iovs.10-5731; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Hayashi T, 2001, P NATL ACAD SCI USA, V98, P491, DOI 10.1073/pnas.021413698; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hayashi T, 2010, MOL PHARMACOL, V77, P517, DOI 10.1124/mol.109.062539; Hayashi T, 2010, J PHARMACOL EXP THER, V332, P1054, DOI 10.1124/jpet.109.159244; Herrmann JR, 2009, J MOL BIOL, V385, P912, DOI 10.1016/j.jmb.2008.10.058; Hiranita T, 2010, J PHARMACOL EXP THER, V332, P515, DOI 10.1124/jpet.109.159236; ITZHAK Y, 1987, EUR J PHARMACOL, V136, P231, DOI 10.1016/0014-2999(87)90715-1; Jbilo O, 1997, J BIOL CHEM, V272, P27107, DOI 10.1074/jbc.272.43.27107; Johannessen M, 2009, AM J PHYSIOL-CELL PH, V296, pC1049, DOI 10.1152/ajpcell.00431.2008; Kekuda R, 1996, BIOCHEM BIOPH RES CO, V229, P553, DOI 10.1006/bbrc.1996.1842; Kim FJ, 2010, MOL PHARMACOL, V77, P695, DOI 10.1124/mol.109.057083; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; LARGENT BL, 1986, EUR J PHARMACOL, V124, P183, DOI 10.1016/0014-2999(86)90142-1; Low C, 2013, BBA-GEN SUBJECTS, V1830, P3497, DOI 10.1016/j.bbagen.2013.02.001; Lupardus PJ, 2000, J PHYSIOL-LONDON, V526, P527, DOI 10.1111/j.1469-7793.2000.00527.x; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; MATSUMOTO RR, 1995, EUR J PHARMACOL, V280, P301, DOI 10.1016/0014-2999(95)00208-3; Mavlyutov TA, 2012, NEUROSCIENCE, V206, P60, DOI 10.1016/j.neuroscience.2011.12.040; Mavlyutov TA, 2010, NEUROSCIENCE, V167, P247, DOI 10.1016/j.neuroscience.2010.02.022; Mishina M, 2005, ACTA NEUROL SCAND, V112, P103, DOI 10.1111/j.1600-0404.2005.00432.x; Mishina M, 2008, ANN NUCL MED, V22, P151, DOI 10.1007/s12149-007-0094-z; Moebius FF, 1996, BIOCHEMISTRY-US, V35, P16871, DOI 10.1021/bi961996m; Moriguchi S, 2011, J NEUROCHEM, V117, P879, DOI 10.1111/j.1471-4159.2011.07256.x; Na JH, 2013, PROTEIN EXPRES PURIF, V88, P190, DOI 10.1016/j.pep.2013.01.001; Narayanan S, 2011, FUTURE MED CHEM, V3, P79, DOI 10.4155/FMC.10.279; Navarro G, 2010, P NATL ACAD SCI USA, V107, P18676, DOI 10.1073/pnas.1008911107; Ortega-Roldan JL, 2013, J BIOL CHEM, V288, P21448, DOI 10.1074/jbc.M113.450379; Pal A, 2007, MOL PHARMACOL, V72, P921, DOI 10.1124/mol.107.038307; Pal A, 2012, EUR J PHARMACOL, V682, P12, DOI 10.1016/j.ejphar.2012.01.030; Pal A, 2008, J BIOL CHEM, V283, P19646, DOI 10.1074/jbc.M802192200; Ramachandran S, 2007, PROTEIN EXPRES PURIF, V51, P283, DOI 10.1016/j.pep.2006.07.019; Ramachandran S, 2009, EUR J PHARMACOL, V609, P19, DOI 10.1016/j.ejphar.2009.03.003; Rovira X, 2010, TRENDS PHARMACOL SCI, V31, P15, DOI 10.1016/j.tips.2009.10.008; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; SCHUSTER DI, 1995, BRAIN RES, V670, P14, DOI 10.1016/0006-8993(94)01123-Y; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Seth P, 1997, BIOCHEM BIOPH RES CO, V241, P535, DOI 10.1006/bbrc.1997.7840; Seth P, 2001, BBA-MOL CELL RES, V1540, P59, DOI 10.1016/S0167-4889(01)00117-3; Shaw W V, 1975, Methods Enzymol, V43, P737; Smith SB, 2008, INVEST OPHTH VIS SCI, V49, P4154, DOI 10.1167/iovs.08-1824; Su TP, 2003, CURR MED CHEM, V10, P2073, DOI 10.2174/0929867033456783; SU TP, 1988, SCIENCE, V240, P219, DOI 10.1126/science.2832949; Su TP, 2010, TRENDS PHARMACOL SCI, V31, P557, DOI 10.1016/j.tips.2010.08.007; Ujike H, 1996, EUR J PHARMACOL, V296, P123, DOI 10.1016/0014-2999(95)00693-1; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Villard V, 2011, J PSYCHOPHARMACOL, V25, P1101, DOI 10.1177/0269881110379286; Vukoti K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046290; Wang LX, 2012, MECH AGEING DEV, V133, P665, DOI 10.1016/j.mad.2012.09.005; Wilke RA, 1999, J PHYSIOL-LONDON, V517, P391, DOI 10.1111/j.1469-7793.1999.00391.x; Wu ZP, 2008, J BIOL CHEM, V283, P28198, DOI 10.1074/jbc.M802099200; Yamamoto H, 1999, FEBS LETT, V445, P19, DOI 10.1016/S0014-5793(99)00084-8; Zhang MR, 2002, NUCL MED BIOL, V29, P469, DOI 10.1016/S0969-8051(02)00293-7	74	72	75	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20333	20344		10.1074/jbc.M113.537993	http://dx.doi.org/10.1074/jbc.M113.537993			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24847081	Green Published, hybrid			2022-12-25	WOS:000339395200044
J	Knoblauch, A; Korner, E; Korner, U; Sommer, FT				Knoblauch, Andreas; Koerner, Edgar; Koerner, Ursula; Sommer, Friedrich T.			Structural Synaptic Plasticity Has High Memory Capacity and Can Explain Graded Amnesia, Catastrophic Forgetting, and the Spacing Effect	PLOS ONE			English	Article							NEURAL ASSOCIATIVE MEMORY; STORAGE CAPACITY; VISUAL-CORTEX; PYRAMIDAL NEURONS; HIPPOCAMPAL; MODEL; CONSOLIDATION; DYNAMICS; SYNCHRONIZATION; CONNECTIVITY	Although already William James and, more explicitly, Donald Hebb's theory of cell assemblies have suggested that activity-dependent rewiring of neuronal networks is the substrate of learning and memory, over the last six decades most theoretical work on memory has focused on plasticity of existing synapses in prewired networks. Research in the last decade has emphasized that structural modification of synaptic connectivity is common in the adult brain and tightly correlated with learning and memory. Here we present a parsimonious computational model for learning by structural plasticity. The basic modeling units are "potential synapses'' defined as locations in the network where synapses can potentially grow to connect two neurons. This model generalizes well-known previous models for associative learning based on weight plasticity. Therefore, existing theory can be applied to analyze how many memories and how much information structural plasticity can store in a synapse. Surprisingly, we find that structural plasticity largely outperforms weight plasticity and can achieve a much higher storage capacity per synapse. The effect of structural plasticity on the structure of sparsely connected networks is quite intuitive: Structural plasticity increases the "effectual network connectivity'', that is, the network wiring that specifically supports storage and recall of the memories. Further, this model of structural plasticity produces gradients of effectual connectivity in the course of learning, thereby explaining various cognitive phenomena including graded amnesia, catastrophic forgetting, and the spacing effect.	[Knoblauch, Andreas] Albstadt Sigmaringen Univ, Fac Engn, Albstadt, Germany; [Knoblauch, Andreas; Koerner, Edgar; Koerner, Ursula] Honda Res Inst Europe, Offenbach, Germany; [Sommer, Friedrich T.] Univ Calif Berkeley, Redwood Ctr Theoret Neurosci, Berkeley, CA 94720 USA	Honda Motor Company; University of California System; University of California Berkeley	Knoblauch, A (corresponding author), Albstadt Sigmaringen Univ, Fac Engn, Albstadt, Germany.	knoblauch@hs-albsig.de			National Science Foundation [NSF-0855272, NSF-1219212]	National Science Foundation(National Science Foundation (NSF))	FTS received support from the National Science Foundation through the grants NSF-0855272 and NSF-1219212. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Abraham WC, 2005, TRENDS NEUROSCI, V28, P73, DOI 10.1016/j.tins.2004.12.003; ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; [Anonymous], 1881, MALADIES MEMOIRE; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Aviel Y, 2005, NEURAL COMPUT, V17, P691, DOI 10.1162/0899766053019962; Baddeley AD., 1990, HUMAN MEMORY THEORY; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bosch H, 1998, NEURAL NETWORKS, V11, P869, DOI 10.1016/S0893-6080(98)00035-5; BOURGEOIS JP, 1993, J NEUROSCI, V13, P2801; Braitenberg V, 1991, ANATOMY CORTEX STAT; BREGMAN AS, 1967, CAN J PSYCHOLOGY, V21, P1, DOI 10.1037/h0082962; BUCKINGHAM J, 1993, NETWORK-COMP NEURAL, V4, P441, DOI 10.1088/0954-898X/4/4/003; BUCKINGHAM J, 1992, NETWORK-COMP NEURAL, V3, P407, DOI 10.1088/0954-898X/3/4/005; Butz M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003259; Butz M, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.010.2009; Butz M, 2009, BRAIN RES REV, V60, P287, DOI 10.1016/j.brainresrev.2008.12.023; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Carpenter G.A., 2003, HDB BRAIN THEORY NEU, P87, DOI DOI 10.1016/J.NEUNET.2012.09.017]; Cepeda NJ, 2006, PSYCHOL BULL, V132, P354, DOI 10.1037/0033-2909.132.3.354; Cepeda NJ, 2008, PSYCHOL SCI, V19, P1095, DOI 10.1111/j.1467-9280.2008.02209.x; Chechik G, 1998, NEURAL COMPUT, V10, P1759, DOI 10.1162/089976698300017124; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Crowder R.G., 1976, PRINCIPLES LEARNING; Dammasch I, 1989, MODELS BRAIN FUNCTIO, P539; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; Deger M, 2011, FRONT COMP NEUR C CO; Deger M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002689; DEUCHARS J, 1994, J PHYSIOL-LONDON, V478, P423, DOI 10.1113/jphysiol.1994.sp020262; Ebbinghaus H., 1885, BER GED CHTNIS UNTER; Elston GN, 2009, J NEUROSCI, V29, P3271, DOI 10.1523/JNEUROSCI.5216-08.2009; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fares T, 2009, P NATL ACAD SCI USA, V106, P16463, DOI 10.1073/pnas.0813265106; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Freedman DJ, 2006, CEREB CORTEX, V16, P1631, DOI 10.1093/cercor/bhj100; French R. M., 1992, Connection Science, V4, P365, DOI 10.1080/09540099208946624; French RM, 1999, TRENDS COGN SCI, V3, P128, DOI 10.1016/S1364-6613(99)01294-2; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Fu M, 2011, TRENDS NEUROSCI, V34, P177, DOI 10.1016/j.tins.2011.02.001; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; GARDNER E, 1988, J PHYS A-MATH GEN, V21, P271, DOI 10.1088/0305-4470/21/1/031; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; GLENBERG AM, 1979, MEM COGNITION, V7, P95, DOI 10.3758/BF03197590; GRAHAM B, 1995, BIOL CYBERN, V72, P337, DOI 10.1007/BF00202789; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; GREENE RL, 1989, J EXP PSYCHOL LEARN, V15, P371, DOI 10.1037/0278-7393.15.3.371; GROSSBERG S, 1987, COGNITIVE SCI, V11, P23, DOI 10.1111/j.1551-6708.1987.tb00862.x; GROSSBERG S, 1980, PSYCHOL REV, V87, P1, DOI 10.1037/0033-295X.87.1.1; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Helias M, 2008, FRONT COMPUT NEUROSC, V2, DOI 10.3389/neuro.10.007.2008; Hellwig B, 2000, BIOL CYBERN, V82, P111, DOI 10.1007/PL00007964; Hertz JA, 2018, INTRO THEORY NEURAL; Hofer S, 2009, J MOL MED, V88, P235; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; HUTTENLOCHER PR, 1982, NEUROSCI LETT, V33, P247, DOI 10.1016/0304-3940(82)90379-2; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Keck T, 2008, NAT NEUROSCI, V11, P1162, DOI 10.1038/nn.2181; Knoblauch A, 2003, NEUROCOMPUTING, V52-4, P301, DOI 10.1016/S0925-2312(02)00792-0; Knoblauch A, 2002, BIOL CYBERN, V87, P168, DOI 10.1007/s00422-002-0332-3; Knoblauch A, 2009, PROG NEURAL PROCESS, V18, P79, DOI 10.1142/9789812834232_0007; Knoblauch A, 2001, NEURAL NETWORKS, V14, P763, DOI 10.1016/S0893-6080(01)00084-3; KNOBLAUCH A, 2006, 0602 HRIEU; Knoblauch A., 2007, 0705 HRIEU; Knoblauch A, 2013, EFFICIENT ASS UNPUB; Knoblauch A, 2010, P 14 INT C COGN NEUR, P66; Knoblauch A., 2010, P INT JOINT C NEUR N, P4271; Knoblauch A, 2008, 0804 HRIEU; Knoblauch A, 2009, 0903 HRIEU; Knoblauch A, 2009, BMC NEUROSCIENCE S1, pO16; Knoblauch A., 2008, 0805 HRIEU; Knoblauch A, 2010, FRONT SYST NEUR C CO; Knoblauch A, 2014, STRUCTURAL PLA UNPUB; Knoblauch A, 2003, THESIS U ULM GERMANY; Knoblauch A, 2014, EFFICIENT SIMU UNPUB; Knoblauch A, 2012, FRONTIERS COMPUTATIO, V6, P1; Knoblauch A., 2010, P INT JOINT C NEUR N, P3205; Knoblauch A, 2008, SIAM J APPL MATH, V69, P169, DOI 10.1137/070700012; Knoblauch A, 2011, NEURAL COMPUT, V23, P1393, DOI 10.1162/NECO_a_00127; Knoblauch A, 2010, NEURAL COMPUT, V22, P289, DOI 10.1162/neco.2009.08-07-588; KOSKO B, 1988, IEEE T SYST MAN CYB, V18, P49, DOI 10.1109/21.87054; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lansner A, 2009, TRENDS NEUROSCI, V32, P178, DOI 10.1016/j.tins.2008.12.002; Latham PE, 2004, NEURAL COMPUT, V16, P1385, DOI 10.1162/089976604323057434; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Leuner B, 2010, ANNU REV PSYCHOL, V61, P111, DOI 10.1146/annurev.psych.093008.100359; London M, 2001, NAT NEUROSCI, V4, P853, DOI 10.1038/nn0901-853; Lubenov EV, 2008, NEURON, V58, P118, DOI 10.1016/j.neuron.2008.01.036; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McCloskey M., 1989, PSYCHOL LEARNING MOT, V24, P109, DOI [10.1016/S0079-7421(08)60536-8, DOI 10.1016/S0079-7421(08)60536-8]; McNamara A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003845; Meeter M, 2005, COGN NEUROPSYCHOL, V22, P559, DOI 10.1080/02643290442000194; Miyoshi S, 2004, IEEE T NEURAL NETWOR, V15, P1215, DOI 10.1109/TNN.2004.832711; Montgomery JM, 2004, TRENDS NEUROSCI, V27, P744, DOI 10.1016/j.tins.2004.10.006; Murre J. M., 1992, LEARNING CATEGORIZAT; NADAL JP, 1986, EUROPHYS LETT, V1, P535, DOI 10.1209/0295-5075/1/10/008; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; O'Connor DH, 2005, P NATL ACAD SCI USA, V102, P9679, DOI 10.1073/pnas.0502332102; Pagani MR, 2009, CELL, V139, P186, DOI 10.1016/j.cell.2009.08.033; PALM G, 1980, BIOL CYBERN, V36, P19, DOI 10.1007/BF00337019; Palm G., 1991, CONCEPTS NEUROSCI, V2, P97; Palm G., 1996, MODELS NEURAL NETWOR, P79, DOI 10.1007/978-1-4612-0723-8_3; Paulsen O, 2000, CURR OPIN NEUROBIOL, V10, P172, DOI 10.1016/S0959-4388(00)00076-3; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; RAISMAN G, 1969, BRAIN RES, V14, P25, DOI 10.1016/0006-8993(69)90029-8; Robins A, 1998, CONNECT SCI, V10, P121, DOI 10.1080/095400998116530; Ross RS, 2006, J NEUROSCI, V26, P4852, DOI 10.1523/JNEUROSCI.0659-06.2006; Sandberg A, 2000, NEUROCOMPUTING, V32, P987, DOI 10.1016/S0925-2312(00)00270-8; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Schuemann A, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00113; Schwenker F, 1996, NEURAL NETWORKS, V9, P445, DOI 10.1016/0893-6080(95)00112-3; Shannon C., 1964, MATH THEORY COMMUNIC; Silver RA, 2003, SCIENCE, V302, P1981, DOI 10.1126/science.1087160; Sommer FT, 1999, NEURAL NETWORKS, V12, P281, DOI 10.1016/S0893-6080(98)00125-7; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Sporns O., 2007, SCHOLARPEDIA, V2, P4695, DOI [10.4249/scholarpedia.4695, DOI 10.4249/SCHOLARPEDIA.4695, DOI 10.4249/SCH0LARPEDIA.4695]; Squire LR, 2007, CURR OPIN NEUROBIOL, V17, P185, DOI 10.1016/j.conb.2007.02.006; STEINBUCH K, 1961, KYBERNETIK, V1, P36, DOI 10.1007/BF00293853; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Teyler TJ, 2007, HIPPOCAMPUS, V17, P1158, DOI 10.1002/hipo.20350; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; TSODYKS MV, 1988, EUROPHYS LETT, V6, P101, DOI 10.1209/0295-5075/6/2/002; VANHEMMEN JL, 1988, EUROPHYS LETT, V5, P663, DOI 10.1209/0295-5075/5/7/016; Waydo S, 2006, J NEUROSCI, V26, P10232, DOI 10.1523/JNEUROSCI.2101-06.2006; Weinberger NM, 2009, NEUROBIOL LEARN MEM, V91, P273, DOI 10.1016/j.nlm.2008.10.012; WILLSHAW DJ, 1969, NATURE, V222, P960, DOI 10.1038/222960a0; Witte S, 1996, J NEUROBIOL, V31, P219, DOI 10.1002/(SICI)1097-4695(199610)31:2<219::AID-NEU7>3.0.CO;2-E; WOOLLEY CS, 1999, DENDRITES, P339; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yu XZ, 2011, CURR OPIN NEUROBIOL, V21, P169, DOI 10.1016/j.conb.2010.07.010; Zola S, 2000, PATIENT BASED APPROA, P275	145	29	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e96485	10.1371/journal.pone.0096485	http://dx.doi.org/10.1371/journal.pone.0096485			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858841	gold, Green Published, Green Submitted			2022-12-25	WOS:000336839400004
J	Gjelsvik, B; Heyerdahl, F; Lunn, D; Hawton, K				Gjelsvik, Bergljot; Heyerdahl, Fridtjof; Lunn, Daniel; Hawton, Keith			Change in Access to Prescribed Medication following an Episode of Deliberate Self-Poisoning: A Multilevel Approach	PLOS ONE			English	Article							HARM; POLYPHARMACY; DEATH; TIME	Objective: Patients with a history of deliberate self-poisoning (DSP) are prescribed a greater amount of medication than the general public. DSP is the most robust risk factor for repeat episodes of DSP and subsequent death by suicide, and one might therefore expect that access to prescribed medication would be reduced following an episode of DSP. However, it is unclear whether access to prescribed medication changes after an episode of DSP. The objectives of this study were to investigate changes in 1) overall, psychotropic, non-psychotropic and the psychotropic subgroup antidepressant prescribed medication availability in DSP patients following an episode of DSP, 2) prescribing of the medication ingested in the episode, and 3) potential effects of gender, age and repeater status on such change. Methods: The design was longitudinal. We included 171 patients admitted for DSP between January 2006 and March 2007. Data on patients' prescriptions prior to admission were retrieved from The Norwegian Prescription Database. The outcome measure was the difference between medication load in the year following compared to the year prior to the DSP episode. Results: There was a significant increase in total medication load following DSP, including both psychotropic and non-psychotropic medication. Antidepressant medication load remained stable. There was a tendency for access to drugs ingested in the episode to increase following the episode, albeit not significantly. Medication load increased with age across all medication groups irrespective of time period and gender. Conclusions: The findings show that physicians do not curb prescribing to patients who have recently deliberately self-poisoned. Moreover, they highlight the need for cautious and judicious prescribing for these patients, in combination with psychological and social interventions.	[Gjelsvik, Bergljot] Univ Oslo, Dept Psychol, Oslo, Norway; [Heyerdahl, Fridtjof] Oslo Univ Hosp, Dept Acute Med, Oslo, Norway; [Lunn, Daniel] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Hawton, Keith] Univ Oxford, Ctr Suicide Res, Dept Psychiat, Oxford, England	University of Oslo; University of Oslo; University of Oxford; University of Oxford	Gjelsvik, B (corresponding author), Univ Oslo, Dept Psychol, Oslo, Norway.	bergljot.gjelsvik@psykologi.uio.no			Ministry of Education and Research; Ministry of Health and Care in Norway; National Institute for Health Research [NF-SI-0508-10053] Funding Source: researchfish	Ministry of Education and Research; Ministry of Health and Care in Norway; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded jointly by the Ministry of Education and Research and The Ministry of Health and Care in Norway. Professor Keith Hawton is a UK National Institute for Health Research senior investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergen H, 2012, LANCET, V380, P1568, DOI 10.1016/S0140-6736(12)61141-6; Bjornaas MA, 2009, CLIN TOXICOL, V47, P116, DOI 10.1080/15563650701771981; de Leo D, 1999, INT J PSYCHIAT MED, V29, P149, DOI 10.2190/E87K-FG03-CHEE-UJD3; Deisenhammer EA, 2009, J CLIN PSYCHIAT, V70, P19, DOI 10.4088/JCP.07m03904; Furlanetto LM, 2005, J AFFECT DISORDERS, V86, P87, DOI 10.1016/j.jad.2004.12.011; Gjelsvik B, 2013, J CLIN PSYCHIAT, V74, P630, DOI 10.4088/JCP.12l08298; Gjelsvik Bergljot, 2012, J Clin Psychiatry, V73, pe548, DOI 10.4088/JCP.11m07209; Gvion Y, 2011, ARCH SUICIDE RES, V15, P93, DOI 10.1080/13811118.2011.565265; Hawton K, 2006, PSYCHOL MED, V36, P397, DOI 10.1017/S0033291705006914; Hawton K, 2003, PSYCHOL MED, V33, P987, DOI 10.1017/S0033291703007943; HAWTON K, 2005, PREVENTION TREATMENT, P279; Hoiseth G, 2007, INT J LEGAL MED, V121, P403, DOI 10.1007/s00414-006-0139-1; Hovstadius B, 2012, CLIN GERIATR MED, V28, P159, DOI 10.1016/j.cger.2012.01.001; International language for drug utilization research, 2013, INT LANGUAGE DRUG UT; Kjosavik SR, 2009, PHARMACOEPIDEM DR S, V18, P572, DOI 10.1002/pds.1756; National Institute for Health and Clinical Excellence, 2011, SELF HARM LONG TERM; Neutel CI, 2012, PHARMACOEPIDEM DR S, V21, P172; Neutel CI, 2012, PHARMACOEPIDEM DR S, V21, P199, DOI 10.1002/pds.2214; Prescott K, 2009, BRIT J CLIN PHARMACO, V68, P260, DOI 10.1111/j.1365-2125.2009.03458.x; Tang NKY, 2006, PSYCHOL MED, V36, P575, DOI 10.1017/S0033291705006859	20	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98086	10.1371/journal.pone.0098086	http://dx.doi.org/10.1371/journal.pone.0098086			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK3KS	24854351	Green Published, gold			2022-12-25	WOS:000338323200043
J	Blogowski, W; Deskur, A; Budkowska, M; Salata, D; Madej-Michniewicz, A; Dabkowski, K; Dolegowska, B; Starzynska, T				Blogowski, Wojciech; Deskur, Anna; Budkowska, Marta; Salata, Daria; Madej-Michniewicz, Anna; Dabkowski, Krzysztof; Dolegowska, Barbara; Starzynska, Teresa			Selected Cytokines in Patients with Pancreatic Cancer: A Preliminary Report	PLOS ONE			English	Article							STEM-CELLS; INDUCED IMMUNOSUPPRESSION; ALLOGRAFT FUNCTION; ANGIOGENESIS; CARCINOMA; INVASIVENESS; EPIDEMIOLOGY; GROWTH; INJURY	Background/Aims: Recent experimental studies have suggested that various cytokines may be important players in the development and progression of pancreatic cancer. However, these findings have not yet been verified in a clinical setting. Methods: In this study, we examined the levels of a broad panel of cytokines, including interleukin (IL)-1, IL-6, IL-8, IL-10, IL-2, IL-17, and IL-23, as well as tumor necrosis factor alpha (TNF alpha) and granulocyte-colony stimulating factor (G-CSF) in patients with pancreatic adenocarcinoma (n = 43), other pancreatic malignancies (neuroendocrine [n = 10] and solid pseudopapillary tumors [n = 3]), and healthy individuals (n = 41). Results: We found that there were higher levels of IL-6, IL-8, IL-10 and TNFa in patients with pancreatic cancer compared to healthy controls (for all, at least p<0.03). Cancer patients had lower IL-23 concentrations than healthy individuals and patients diagnosed with other types of malignancies (for both, p = 0.002). Levels of IL-6, IL-8, IL-10, and IL-23 were significantly associated with the direct number of circulating bone marrow (BM)-derived mesenchymal or very small embryonic/epiblast-like stem cells (SCs) in patients with pancreatic cancer. Moreover, our study identified a potential ability of IL-6, IL-8, IL-10, IL-23, and TNF alpha levels to enable discrimination of pancreatic cancer from other pancreatic tumors and diseases, including acute and chronic pancreatitis and post-pancreatitis cysts (with sensitivity and specificity ranging between 70%-82%). Conclusions: Our study i) supports the significance of selected cytokines in the clinical presentation of pancreatic cancer, ii) highlights numerous associations between selected interleukins and intensified BMSCs trafficking in patients with pancreatic cancer, and iii) preliminarily characterizes the diagnostic potential of several cytokines as potential novel clinical markers of pancreatic cancer in humans.	[Blogowski, Wojciech] Univ Zielona Gora, Dept Publ Hlth, Zielona Gora, Poland; [Deskur, Anna; Madej-Michniewicz, Anna; Dabkowski, Krzysztof; Starzynska, Teresa] Pomeranian Med Univ, Dept Gastroenterol, Szczecin, Poland; [Budkowska, Marta; Salata, Daria; Dolegowska, Barbara] Pomeranian Med Univ, Dept Med Analyt, Szczecin, Poland	University of Zielona Gora; Pomeranian Medical University; Pomeranian Medical University	Blogowski, W (corresponding author), Univ Zielona Gora, Dept Publ Hlth, Zielona Gora, Poland.	drannab@wp.pl	Budkowska, Marta/T-4526-2019; Dolegowska, Barbara/O-4851-2014; Deskur, Anna/B-6580-2016; Budkowska, Marta/A-2298-2016; Dąbkowski, Krzysztof/AAI-3889-2020; Starzynska, Teresa/B-1549-2015	Dolegowska, Barbara/0000-0003-3138-1013; Deskur, Anna/0000-0001-6809-5243; Budkowska, Marta/0000-0002-8228-278X; Dąbkowski, Krzysztof/0000-0002-5386-9004; Starzynska, Teresa/0000-0001-5573-2397	Polish Ministry of Science and Higher Education [402 423038]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This study was financed by a grant awarded by the Polish Ministry of Science and Higher Education (402 423038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel EV, 2013, GASTROENTEROLOGY, V144, P1241, DOI 10.1053/j.gastro.2013.01.072; Bellone G, 1999, AM J PATHOL, V155, P537, DOI 10.1016/S0002-9440(10)65149-8; Benatar T, 2008, CANCER IMMUNOL IMMUN, V57, P1757, DOI 10.1007/s00262-008-0502-9; Benatar T, 2010, CANCER IMMUNOL IMMUN, V59, P805, DOI 10.1007/s00262-009-0802-8; Blogowski W, 2014, INNATE IMMUN-LONDON, V20, P126, DOI 10.1177/1753425913482018; Blogowski W, 2012, CLIN J AM SOC NEPHRO, V7, P1843, DOI 10.2215/CJN.02200312; Choi JJ, 2008, CLIN EXP IMMUNOL, V153, P269, DOI 10.1111/j.1365-2249.2008.03683.x; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Dolegowska B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029779; Dolegowska B, 2010, NEPHROL DIAL TRANSPL, V25, P4061, DOI 10.1093/ndt/gfq320; Dolegowska B, 2010, J AM COLL SURGEONS, V211, P587, DOI 10.1016/j.jamcollsurg.2010.06.391; Hayata K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053131; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Kuwada Y, 2003, INT J ONCOL, V22, P765; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lonardo E, 2010, MOL ONCOL, V4, P431, DOI 10.1016/j.molonc.2010.06.002; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Malvicini M, 2011, MOL ONCOL, V5, P242, DOI 10.1016/j.molonc.2011.03.007; Marchesi F, 2012, CURR PHARM DESIGN, V18, P2432, DOI 10.2174/13816128112092432; Matsuo Y, 2004, PANCREAS, V28, P344, DOI 10.1097/00006676-200404000-00025; Matsuo Y, 2012, CURR PHARM DESIGN, V18, P2416, DOI 10.2174/13816128112092416; Matsuo Y, 2009, INT J CANCER, V124, P853, DOI 10.1002/ijc.24040; Morse MA, 2009, EXPERT OPIN BIOL TH, V9, P331, DOI 10.1517/14712590802715756 ; Mroczko B, 2005, CLIN CHEM LAB MED, V43, P146, DOI 10.1515/CCLM.2005.024; Ni C, 2013, CLIN TRANSL ONCOL, V15, P253, DOI 10.1007/s12094-012-0927-7; Oberstein PE, 2013, THER ADV GASTROENTER, V6, P321, DOI 10.1177/1756283X13478680; Quail DF, 2012, CURR STEM CELL RES T, V7, P197; Raimondi S, 2009, NAT REV GASTRO HEPAT, V6, P699, DOI 10.1038/nrgastro.2009.177; Sakamoto H, 2012, JPN J CLIN ONCOL, V42, P105, DOI 10.1093/jjco/hyr178; Schultz NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067059; Sordi Valeria, 2010, Rev Diabet Stud, V7, P132, DOI 10.1900/RDS.2010.7.132; Starzynska T, 2013, J CELL MOL MED, V17, P792, DOI 10.1111/jcmm.12065; Tjomsland V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070874; Tjomsland V, 2011, NEOPLASIA, V13, P664, DOI 10.1593/neo.11332; Vizio B, 2010, CANCER SCI, V101, P2448, DOI 10.1111/j.1349-7006.2010.01692.x; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Xu DH, 2010, J SURG ONCOL, V102, P469, DOI 10.1002/jso.21530; Yadav D, 2013, GASTROENTEROLOGY, V144, P1252, DOI 10.1053/j.gastro.2013.01.068; Zhang YQ, 2013, CANCER RES, V73, P6359, DOI 10.1158/0008-5472.CAN-13-1558-T	39	45	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97613	10.1371/journal.pone.0097613	http://dx.doi.org/10.1371/journal.pone.0097613			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849506	Green Submitted, Green Published, gold			2022-12-25	WOS:000336730600040
J	Jia, Y; Domenico, J; Swasey, C; Wang, MQ; Gelfand, EW; Lucas, JJ				Jia, Yi; Domenico, Joanne; Swasey, Christina; Wang, Meiqin; Gelfand, Erwin W.; Lucas, Joseph J.			Modulated Expression of Genes Encoding Estrogen Metabolizing Enzymes by G1-Phase Cyclin-Dependent Kinases 6 and 4 in Human Breast Cancer Cells	PLOS ONE			English	Article							ETS2 TRANSCRIPTION FACTOR; ALDO-KETO REDUCTASES; DEHYDROGENASE ISOFORMS; STEROID-HORMONE; REVEALS ROLES; G(1) PHASE; MAST-CELLS; RECEPTOR; CDK6; PROLIFERATION	G1-phase cell cycle defects, such as alterations in cyclin D1 or cyclin-dependent kinase (cdk) levels, are seen in most tumors. For example, increased cyclin D1 and decreased cdk6 levels are seen in many human breast tumors. Overexpression of cdk6 in breast tumor cells in culture has been shown to suppress proliferation, unlike the growth stimulating effects of its close homolog, cdk4. In addition to directly affecting proliferation, alterations in cdk6 or cdk4 levels in breast tumor cells also differentially influence levels of numerous steroid metabolic enzymes (SMEs), including those involved in estrogen metabolism. Overexpression of cdk6 in tumor cell lines having low cdk6 resulted in decreased levels of mRNAs encoding aldo-keto reductase (AKR)1C1, AKR1C2 and AKR1C3, which are hydroxysteroid dehydrogenases (HSDs) involved in steroid hormone metabolism. In contrast, increasing cdk4 dramatically increased these transcript levels, especially those encoding AKR1C3, an enzyme that converts estrone to 17 beta-estradiol, a change that could result in a pro-estrogenic state favoring tumor growth. Effects on other estrogen metabolizing enzymes, including cytochrome P450 (CYP) 19 aromatase, 17 beta-HSD2, and CYP1B1 transcripts, were also observed. Interactions of cdk6 and cdk4, but not cyclin D1, with the promoter region of a cdk-regulated gene, 17 beta-HSD2, were detected. The results uncover a previously unsuspected link between the cell cycle and hormone metabolism and differential roles for cdk6 and cdk4 in a novel mechanism for pre-receptor control of steroid hormone action, with important implications for the origin and treatment of steroid hormone-dependent cancers.	[Jia, Yi; Domenico, Joanne; Swasey, Christina; Wang, Meiqin; Gelfand, Erwin W.; Lucas, Joseph J.] Natl Jewish Hlth, Dept Pediat, Div Cell Biol, Denver, CO 80206 USA	National Jewish Health	Gelfand, EW (corresponding author), Natl Jewish Hlth, Dept Pediat, Div Cell Biol, Denver, CO 80206 USA.	GelfandE@NJHealth.org		CIRERA SALINAS, DANIEL/0000-0003-2171-5032	DoD from the Department of the Army [W81XWH-08-1-0630 (BC073945)]; University of Colorado Cancer Center; Colorado Bioscience Discovery Evaluation Grant Program from State of Colorado/National Jewish Health; Eugene F. and Easton M. Crawford Charitable Lead Unitrust	DoD from the Department of the Army; University of Colorado Cancer Center; Colorado Bioscience Discovery Evaluation Grant Program from State of Colorado/National Jewish Health; Eugene F. and Easton M. Crawford Charitable Lead Unitrust	This research was supported in part by DoD Grant W81XWH-08-1-0630 (BC073945) from the Department of the Army and by the University of Colorado Cancer Center, Colorado Bioscience Discovery Evaluation Grant Program from State of Colorado/National Jewish Health and a fellowship from The Eugene F. and Easton M. Crawford Charitable Lead Unitrust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altucci L., 1996, ONCOGENE, V12, P2315; An HX, 1999, AM J PATHOL, V154, P113, DOI 10.1016/S0002-9440(10)65257-1; Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001; Bagella L, 2006, J CELL BIOCHEM, V99, P978, DOI 10.1002/jcb.20981; Bauman DR, 2005, MOL PHARMACOL, V67, P60, DOI 10.1124/mol.104.006569; Bienvenu F, 2001, J BIOL CHEM, V276, P16840, DOI 10.1074/jbc.M100795200; Byrns MC, 2010, J STEROID BIOCHEM, V118, P177, DOI 10.1016/j.jsbmb.2009.12.009; Byrns MC, 2009, CHEM-BIOL INTERACT, V178, P221, DOI 10.1016/j.cbi.2008.10.024; Chilosi M, 1998, AM J PATHOL, V152, P209; Cirera-Salinas D, 2012, CELL CYCLE, V11, P922, DOI 10.4161/cc.11.5.19421; DUBIK D, 1992, ONCOGENE, V7, P1587; Easton J, 1998, CANCER RES, V58, P2624; Ericson KK, 2003, MOL CANCER RES, V1, P654; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Fujimoto T, 2007, EMBO J, V26, P2361, DOI 10.1038/sj.emboj.7601675; Grigoriadis A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1604; Grossel MJ, 1999, J BIOL CHEM, V274, P29960, DOI 10.1074/jbc.274.42.29960; Grossel MJ, 2006, J CELL BIOCHEM, V97, P485, DOI 10.1002/jcb.20712; Ho A, 2002, CURR OPIN GENET DEV, V12, P47, DOI 10.1016/S0959-437X(01)00263-5; Ito K, 2013, ONCOGENE IN PRESS; Jansson A, 2009, J STEROID BIOCHEM, V114, P64, DOI 10.1016/j.jsbmb.2008.12.012; Kang KW, 2008, J CLIN PHARMACOL, V48, P1430, DOI 10.1177/0091270008323262; Kasten M, 2001, ONCOGENE, V20, P1832, DOI 10.1038/sj.onc.1204295; Li GM, 2005, CELL IMMUNOL, V238, P10, DOI 10.1016/j.cellimm.2005.12.001; Li GM, 2009, INT ARCH ALLERGY IMM, V150, P122, DOI 10.1159/000218115; Lim JTE, 2005, P NATL ACAD SCI USA, V102, P5156, DOI 10.1073/pnas.0501203102; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Lin HK, 2004, STEROIDS, V69, P795, DOI 10.1016/j.steroids.2004.09.014; Lucas JJ, 2004, MOL CANCER RES, V2, P105; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Matushansky I, 2000, BLOOD, V96, P2755, DOI 10.1182/blood.V96.8.2755.h8002755_2755_2764; McInnes C, 2008, DRUG DISCOV TODAY, V13, P875, DOI 10.1016/j.drudis.2008.06.012; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Milne SA, 2003, J CLIN ENDOCR METAB, V88, P1825, DOI 10.1210/jc.2002-021368; Nagasawa M, 2001, ONCOGENE, V20, P2889, DOI 10.1038/sj.onc.1204396; Neuman E, 1997, MOL CELL BIOL, V17, P5338, DOI 10.1128/MCB.17.9.5338; Novotna R, 2008, TOXICOL LETT, V181, P1, DOI 10.1016/j.toxlet.2008.06.858; Penning TM, 2000, BIOCHEM J, V351, P67, DOI 10.1042/0264-6021:3510067; Penning TM, 2007, ARCH BIOCHEM BIOPHYS, V464, P241, DOI 10.1016/j.abb.2007.04.024; Penning TM, 2009, ANN NY ACAD SCI, V1155, P33, DOI 10.1111/j.1749-6632.2009.03700.x; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; Rotllan N, 2012, CHOLESTEROL, DOI 10.1155/2012/847849; Sasano Hironobu, 2006, Breast Cancer, V13, P129, DOI 10.2325/jbcs.13.129; Shimada T, 1996, CANCER RES, V56, P2979; Sissung TM, 2006, MOL CANCER RES, V4, P135, DOI 10.1158/1541-7786.MCR-05-0101; Stoffel-Wagner B, 2003, EPILEPSY RES, V54, P11, DOI 10.1016/S0920-1211(03)00036-6; Tay SP, 2010, J BIOL CHEM, V285, P29231, DOI 10.1074/jbc.M110.108241; Timmermann S, 1997, CELL GROWTH DIFFER, V8, P361; Tomita T, 2004, PATHOLOGY, V36, P566, DOI 10.1080/00313020400011342; Wang X, 2011, AM J PATHOL, V178, P345, DOI 10.1016/j.ajpath.2010.11.032; Yang SJ, 2001, MOL ENDOCRINOL, V15, P2093, DOI 10.1210/me.15.12.2093; Yu QY, 2006, CANCER CELL, V9, P23, DOI 10.1016/j.ccr.2005.12.012; Zwijsen RML, 1998, GENE DEV, V12, P3488, DOI 10.1101/gad.12.22.3488	53	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97448	10.1371/journal.pone.0097448	http://dx.doi.org/10.1371/journal.pone.0097448			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848372	Green Submitted, gold, Green Published			2022-12-25	WOS:000336730600030
J	Koenker, H; Kilian, A				Koenker, Hannah; Kilian, Albert			Recalculating the Net Use Gap: A Multi-Country Comparison of ITN Use versus ITN Access	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; RANDOMIZED CONTROLLED-TRIAL; BED-NETS; UNIVERSAL COVERAGE; MOSQUITO NETS; MALARIA TRANSMISSION; PREGNANT-WOMEN; OWNERSHIP; CHILDREN; POSSESSION	Use of insecticide treated nets is widely recognized as one of the main interventions to prevent malaria and high use rates are a central goal of malaria programs. The gap between household ownership of at least one ITN and population use of ITN has in the past been seen as evidence for failure to achieve appropriate net use. However, past studies compared net use with ownership of at least one net, not access to sufficient nets within households. This study recalculates the net use gap in recent large household surveys using the comparison indicator of 'access to nets within the household' as now recommended by Roll Back Malaria and the World Health Organization. Data from 41 Demographic Health Surveys (DHS) and Malaria Indicator Surveys (MIS) (2005-2012) in sub-Saharan Africa were used. For each dataset three indicators were calculated: population access to ITN, population use of ITN, and household ownership of at least one ITN. The ITN use gap was expressed as the difference between one and the ratio of use to access. The median proportion of users compared to those with access was high, at 82.1%. Even at population access levels below 50%, a median 80.6% used an ITN given they had access, and this rate increased to 91.2% for access rates above 50%. Linear regression of use against access showed that 89.0% of household members with access to nets used them the night before. These results clearly show that previous interpretations of the net use gap as a failure of behavioral change communication interventions were not justified and that the gap was instead primarily driven by lack of intra-household access. They also demonstrate the usefulness of the newly recommended ITN indicators; access to an ITN within the household provides a much more accurate comparison of ITN use than ownership.	[Koenker, Hannah] Johns Hopkins Univ, Sch Publ Hlth, Ctr Commun Programs, Baltimore, MD 21218 USA; [Kilian, Albert] Trop Hlth LLP, Montagut, Spain	Johns Hopkins University	Koenker, H (corresponding author), Johns Hopkins Univ, Sch Publ Hlth, Ctr Commun Programs, Baltimore, MD 21218 USA.	hkoenker@jhuccp.org			United States Agency for International Development (USAID) [GHS-A-00-09-00014-00]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR)	This study was made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the terms of USAID/JHU Cooperative Agreement No. GHS-A-00-09-00014-00 for the NetWorks Project. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyepong IA, 1999, J BIOSOC SCI, V31, P79, DOI 10.1017/S0021932099000796; Ahmed SM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-357; Alaii JA, 2003, AM J TROP MED HYG, V68, P137, DOI 10.4269/ajtmh.2003.68.137; [Anonymous], TROP MED INT HLTH; [Anonymous], HLTH POLICY PLAN; [Anonymous], HOUS SURV IND MAL CO; [Anonymous], MAL BEH CHANG COMM I; [Anonymous], PLOSONE IN PRESS; Baume CA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-265; Baume CA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-264; Baume CA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-153; Beer N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-606; Belay M, 2008, TROP MED INT HEALTH, V13, P1303, DOI 10.1111/j.1365-3156.2008.02159.x; Bennett A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037927; Bowen HL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-36; Deribew A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-99; Eisele TP, 2009, AM J TROP MED HYG, V80, P209, DOI 10.4269/ajtmh.2009.80.209; Eng JLV, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-133; Fernando SD, 2009, T ROY SOC TROP MED H, V103, P1204, DOI 10.1016/j.trstmh.2008.10.018; Galvin KT, 2011, J MULTIDISCIP HEALTH, V4, P73, DOI 10.2147/JMDH.S15917; Garley AE, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-119; Githinji S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-250; Graves PM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-354; Grietens KP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050294; Gunasekaran K, 2009, ACTA TROP, V112, P149, DOI 10.1016/j.actatropica.2009.07.013; Hetzel MW, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-192; Iwashita H, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-176; Kilian A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-314; Kilian A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-259; Koenker H, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-218; Koenker HM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-203; Korenromp EL, 2003, TROP MED INT HEALTH, V8, P693, DOI 10.1046/j.1365-3156.2003.01084.x; Loha E, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-23; Loll DK, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-337; Macintyre K, 2006, TROP MED INT HEALTH, V11, P824, DOI 10.1111/j.1365-3156.2006.01637.x; Monroe A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-82; Ndjinga JK, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-279; Noor AM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-369; Pulford J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-83; Rickard DG, 2011, PROG COMM HLTH PARTN, V5, P123, DOI 10.1353/cpr.2011.0018; Singh M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-268; Stevens ER, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-162; TANAHASHI T, 1978, B WORLD HEALTH ORGAN, V56, P295; Thwing J, 2008, TROP MED INT HEALTH, V13, P827, DOI 10.1111/j.1365-3156.2008.02070.x; Thwing JI, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-86; Toe LP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-175; Tsuang A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-211; West PA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-273; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WINCH PJ, 1994, SOC SCI MED, V39, P63, DOI 10.1016/0277-9536(94)90166-X	53	50	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97496	10.1371/journal.pone.0097496	http://dx.doi.org/10.1371/journal.pone.0097496			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848768	Green Published, Green Submitted, gold			2022-12-25	WOS:000336730600033
J	Tani, M; Ishii, D; Ito, S; Hariyama, T; Shimomura, M; Okumura, K				Tani, Marie; Ishii, Daisuke; Ito, Shuto; Hariyama, Takahiko; Shimomura, Masatsugu; Okumura, Ko			Capillary Rise on Legs of a Small Animal and on Artificially Textured Surfaces Mimicking Them	PLOS ONE			English	Article							WATER-UPTAKE; TRANSPORT; PAPER	The wharf roach Ligia exotica is a small animal that lives by the sea and absorbs water from the sea through its legs by virtue of a remarkable array of small blades of micron scale. We find that the imbibition dynamics on the legs is rather complex on a microscopic scale, but on a macroscopic scale the imbibition length seems to simply scale linearly with elapsed time. This unusual dynamics of imbibition, which usually slows down with time, is advantageous for long-distance water transport and results from repetition of unit dynamics. Inspired by the remarkable features, we study artificially textured surfaces mimicking the structure on the legs of the animal. Unlike the case of the wharf roach, the linear dynamics were not reproduced on the artificial surfaces, which may result from more subtle features on the real legs that are not faithfully reflected on the artificial surfaces. Instead, the nonlinear dynamics revealed that hybrid structures on the artificial surfaces speed up the water transport compared with non-hybrid ones. In addition, the dynamics on the artificial surfaces turn out to be well described by a composite theory developed here, with the theory giving useful guiding principles for designing hybrid textured surfaces for rapid imbibition and elucidating physical advantages of the microscopic design on the legs.	[Tani, Marie; Okumura, Ko] Ochanomizu Univ, Fac Sci, Dept Phys, Bunkyo Ku, Tokyo 112, Japan; [Ishii, Daisuke] Nagoya Inst Technol, Ctr Fostering Young & Innovat Researchers, Fac Engn, Showa Ku, Nagoya, Aichi, Japan; [Ito, Shuto] Nagoya Inst Technol, Dept Life & Mat Engn, Fac Engn, Showa Ku, Nagoya, Aichi, Japan; [Hariyama, Takahiko] Hamamatsu Univ Sch Med, Dept Biol, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Shimomura, Masatsugu] Tohoku Univ, WPI Adv Inst Mat Res WPI AIMR, Aoba Ku, Sendai, Miyagi 980, Japan; [Ishii, Daisuke; Hariyama, Takahiko; Shimomura, Masatsugu; Okumura, Ko] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Ochanomizu University; Nagoya Institute of Technology; Nagoya Institute of Technology; Hamamatsu University School of Medicine; Tohoku University; Japan Science & Technology Agency (JST)	Okumura, K (corresponding author), Ochanomizu Univ, Fac Sci, Dept Phys, Bunkyo Ku, Tokyo 112, Japan.	okumura@phys.ocha.ac.jp	Okumura, Ko/A-2132-2011; Ito, Shuto/AAD-6654-2019	Okumura, Ko/0000-0002-8554-7173; Ito, Shuto/0000-0003-2939-1693; Tani, Marie/0000-0002-5062-8520	JSPS [24686076, 24244066]; MEXT, Japan [24120004]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was partly supported by Grant-in-Aid for Young Scientists (A) (No. 24686076) of JSPS, Grant-in-Aid for Scientific Research on Innovative Areas "Engineering Neo-Biomimetics" (No. 24120004) of MEXT, Japan, and Grant-in-Aid for Scientific Research (A) (No. 24244066) of JSPS. The funders had no role in study design, data collection adn analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, GOUTTES BULLES PERLE; Balankin AS, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.056101; Bico J, 2001, EUROPHYS LETT, V55, P214, DOI 10.1209/epl/i2001-00402-x; Blow ML, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/46/464125; Chu KH, 2010, NAT MATER, V9, P413, DOI [10.1038/nmat2726, 10.1038/NMAT2726]; Courbin L, 2007, NAT MATER, V6, P661, DOI 10.1038/nmat1978; Gau H, 1999, SCIENCE, V283, P46, DOI 10.1126/science.283.5398.46; Hamamoto-Kurosaki M, 2009, EUR PHYS J E, V30, P283, DOI 10.1140/epje/i2009-10526-3; Horiguchi H, 2007, BIOL BULL-US, V213, P196, DOI 10.2307/25066635; Ishii D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03024; Ishino C, 2007, EPL-EUROPHYS LETT, V79, DOI 10.1209/0295-5075/79/56005; Kim J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.264501; Kwon TH, 1996, PHYS REV E, V54, P685, DOI 10.1103/PhysRevE.54.685; Lafuma A, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/56001; Lafuma A, 2003, NAT MATER, V2, P457, DOI 10.1038/nmat924; Lagubeau G, 2011, NAT PHYS, V7, P395, DOI 10.1038/NPHYS1925; Liu MJ, 2010, ACCOUNTS CHEM RES, V43, P368, DOI 10.1021/ar900205g; Malvadkar NA, 2010, NAT MATER, V9, P1023, DOI 10.1038/NMAT2864; Martinez AW, 2008, P NATL ACAD SCI USA, V105, P19606, DOI 10.1073/pnas.0810903105; Miranda AM, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.086101; Obara N, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.020601; Ohzono T, 2009, SOFT MATTER, V5, P4658, DOI 10.1039/b912235d; Parker AR, 2001, NATURE, V414, P33, DOI 10.1038/35102108; Ponomarenko A, 2011, J FLUID MECH, V666, P146, DOI 10.1017/S0022112010005276; Prakash M, 2008, SCIENCE, V320, P931, DOI 10.1126/science.1156023; Quere D, 2008, ANNU REV MATER RES, V38, P71, DOI 10.1146/annurev.matsci.38.060407.132434; Reis PM, 2010, SCIENCE, V330, P1231, DOI 10.1126/science.1195421; Squires TM, 2005, REV MOD PHYS, V77, P977, DOI 10.1103/RevModPhys.77.977; TANG LH, 1994, J PHYS II, V4, P881, DOI 10.1051/jp2:1994172; Tuteja A, 2007, SCIENCE, V318, P1618, DOI 10.1126/science.1148326; Wong TS, 2011, NATURE, V477, P443, DOI 10.1038/nature10447	31	17	17	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e96813	10.1371/journal.pone.0096813	http://dx.doi.org/10.1371/journal.pone.0096813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849071	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600016
J	Wang, Z; Ji, CY; Wu, LY; Qiu, JX; Li, Q; Shao, Z; Chen, G				Wang, Zhong; Ji, Chengyuan; Wu, Lingyun; Qiu, Jiaoxue; Li, Qi; Shao, Zhong; Chen, Gang			Tert-Butylhydroquinone Alleviates Early Brain Injury and Cognitive Dysfunction after Experimental Subarachnoid Hemorrhage: Role of Keap1/Nrf2/ARE Pathway	PLOS ONE			English	Article							CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; DEFICITS; VASOSPASM; RECOVERY	Tert-butylhydroquinone (tBHQ), an Nrf2 activator, has demonstrated neuroprotection against brain trauma and ischemic stroke in vivo. However, little work has been done with respect to its effect on early brain injury (EBI) after subarachnoid hemorrhage (SAH). At the same time, as an oral medication, it may have extensive clinical applications for the treatment of SAH-induced cognitive dysfunction. This study was undertaken to evaluate the influence of tBHQ on EBI, secondary deficits of learning and memory, and the Keap1/Nrf2/ARE pathway in a rat SAH model. SD rats were divided into four groups: (1) Control group (n = 40); (2) SAH group (n = 40); (3) SAH+ vehicle group (n = 40); and (4) SAH+ tBHQ group (n = 40). All SAH animals were subjected to injection of autologous blood into the prechiasmatic cistern once in 20 s. In SAH+ tBHQ group, tBHQ was administered via oral gavage at a dose of 12.5 mg/kg at 2 h, 12 h, 24 h, and 36 h after SAH. In the first set of experiments, brain samples were extracted and evaluated 48 h after SAH. In the second set of experiments, changes in cognition and memory were investigated in a Morris water maze. Results shows that administration of tBHQ after SAH significantly ameliorated EBI-related problems, such as brain edema, blood-brain barrier (BBB) impairment, clinical behavior deficits, cortical apoptosis, and neurodegeneration. Learning deficits induced by SAH was markedly alleviated after tBHQ therapy. Treatment with tBHQ markedly up-regulated the expression of Keap1, Nrf2, HO-1, NQO1, and GST alpha 1 after SAH. In conclusion, the administration of tBHQ abated the development of EBI and cognitive dysfunction in this SAH model. Its action was probably mediated by activation of the Keap1/Nrf2/ARE pathway.	[Wang, Zhong; Ji, Chengyuan; Wu, Lingyun; Qiu, Jiaoxue; Li, Qi; Shao, Zhong; Chen, Gang] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Jiangsu, Peoples R China	Soochow University - China	Chen, G (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Jiangsu, Peoples R China.	nju_neurosurgery@163.com	Wu, Ling/GZN-2235-2022	Chen, Gang/0000-0002-0758-1907	National Natural Science Foundation of China [81171105, 81271300, 81371279]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81171105, 81271300, and 81371279, http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Caner B, 2012, J NEUROCHEM, V123, P12, DOI 10.1111/j.1471-4159.2012.07939.x; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Chen G, 2011, J NEUROSCI RES, V89, P515, DOI 10.1002/jnr.22577; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; de Rooij NK, 2013, STROKE, V44, P43, DOI 10.1161/STROKEAHA.112.674291; de Vries HE, 2008, FREE RADICAL BIO MED, V45, P1375, DOI 10.1016/j.freeradbiomed.2008.09.001; Haug T, 2007, NEUROSURGERY, V60, P649, DOI 10.1227/01.NEU.0000255414.70807.A0; HUTTER BO, 1993, NEUROSURGERY, V33, P999; Jeon H, 2010, NEUROSCIENCE, V169, P1805, DOI 10.1016/j.neuroscience.2010.06.039; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kreiter KT, 2002, STROKE, V33, P200, DOI 10.1161/hs0102.101080; Le W, 1999, J NEUROSCI RES, V56, P652; Lu H, 2009, J CLIN NEUROSCI, V16, P684, DOI 10.1016/j.jocn.2008.04.021; Mavaddat N, 1999, J NEUROSURG, V91, P402, DOI 10.3171/jns.1999.91.3.0402; Negi G, 2011, J PINEAL RES, V50, P124, DOI 10.1111/j.1600-079X.2010.00821.x; Niture SK, 2013, FREE RADIC IN PRESS; OGDEN JA, 1993, NEUROSURGERY, V33, P572, DOI 10.1227/00006123-199310000-00004; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Saykally JN, 2012, NEUROSCIENCE, V223, P305, DOI 10.1016/j.neuroscience.2012.07.070; Sehba FA, 2012, PROG NEUROBIOL, V97, P14, DOI 10.1016/j.pneurobio.2012.02.003; Shih AY, 2005, J NEUROSCI, V25, P10321, DOI 10.1523/JNEUROSCI.4014-05.2005; STENHOUSE LM, 1991, J NEUROL NEUROSUR PS, V54, P909, DOI 10.1136/jnnp.54.10.909; Takata K, 2008, EXP NEUROL, V213, P336, DOI 10.1016/j.expneurol.2008.06.009; Yamaguchi M, 2004, STROKE, V35, P1750, DOI 10.1161/01.STR.0000129898.68350.9f; Zhuang Z, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-47	27	24	24	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97685	10.1371/journal.pone.0097685	http://dx.doi.org/10.1371/journal.pone.0097685			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848277	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600050
J	Zhu, LD; Liu, J; Liang, FJ; Rayner, S; Xiong, JH				Zhu, Lida; Liu, Juan; Liang, Fengji; Rayner, Simon; Xiong, Jianghui			Predicting Response to Preoperative Chemotherapy Agents by Identifying Drug Action on Modeled MicroRNA Regulation Networks	PLOS ONE			English	Article							BREAST-CANCER; DIFFERENTIAL EXPRESSION; SMALL MOLECULES; GENES; MIRNAS; PACLITAXEL; RISK; CYCLOPHOSPHAMIDE; IDENTIFICATION; FLUOROURACIL	Identifying patients most responsive to specific chemotherapy agents in neoadjuvant settings can help to maximize the benefits of treatment and minimize unnecessary side effects. Metagene approaches that predict response based on gene expression signatures derived from an associative analysis of clinical data can identify chance associations caused by the heterogeneity of a tumor, leading to reproducibility issues in independent validations. In this study, to incorporate information from drug mechanisms of action, we explore the potential of microRNA regulation networks as a new feature space for identifying predictive markers. We introduce a measure we term the CoMi (Context-specific-miRNA-regulation) pattern to represent a descriptive feature of the miRNA regulation network in the transcriptome. We examine whether the modifications to the CoMi pattern on specific biological processes are a useful representation of drug action by predicting the response to neoadjuvant Paclitaxel treatment in breast cancer and show that the drug counteracts the CoMi network dysregulation induced by tumorigenesis. We then generate a quantitative testbed to investigate the ability of the CoMi pattern to distinguish FDA approved breast cancer drugs from other FDA approved drugs not related to breast cancer. We also compare the ability of the CoMi and metagene methods to predict response to neoadjuvant Paclitaxel treatment in clinical cohorts. We find the CoMi method outperforms the metagene method, achieving area under curve (AUC) values of 0.78 and 0.66 respectively. Furthermore, several of the predicted CoMi features highlight the network-based mechanism of drug resistance. Thus, our study suggests that explicitly modeling the drug action using network biology provides a promising approach for predictive marker discovery.	[Zhu, Lida; Liu, Juan] Wuhan Univ, Sch Comp Sci, Wuhan 430072, Peoples R China; [Liang, Fengji; Xiong, Jianghui] China Astronaut Res & Training Ctr ACC, State Key Lab Space Med Fundamentals & Applicat S, Beijing, Peoples R China; [Rayner, Simon] Wuhan Inst Virol, Key Lab Agr & Environm Microbiol, Wuhan, Peoples R China; [Xiong, Jianghui] Chinese Univ Hong Kong, Shenzhen Res Inst, CUHK ACC Space Med Ctr Hlth Maintenance Musculosk, Shenzhen, Peoples R China	Wuhan University; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese University of Hong Kong, Shenzhen	Liu, J (corresponding author), Wuhan Univ, Sch Comp Sci, Wuhan 430072, Peoples R China.	liujuan@whu.edu.cn; s.raynere@wh.iov.cn; laserxiong@gmail.com			Chinese Scientific and Technological Major Special Project [2012ZX09301003-002-003]; National Natural Science Foundation of China [61272274, 91129708]; Program for New Century Excellent Talents in Universities [NCET-10-0644]; Open Research Fund of State Key Laboratory of Hybrid Rice (Wuhan University) [KF201301]; State Key Lab of Space Medicine Fundamentals and Application [SMFA09A07, SMFA10A03]; Shenzhen [JCYJ20120619151640947]	Chinese Scientific and Technological Major Special Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in Universities(Program for New Century Excellent Talents in University (NCET)); Open Research Fund of State Key Laboratory of Hybrid Rice (Wuhan University); State Key Lab of Space Medicine Fundamentals and Application; Shenzhen	This work was supported by the grant from the Chinese Scientific and Technological Major Special Project (2012ZX09301003-002-003), the National Natural Science Foundation of China (61272274, 91129708), Program for New Century Excellent Talents in Universities (NCET-10-0644), and the Open Research Fund of State Key Laboratory of Hybrid Rice (Wuhan University) (KF201301), the grant from State Key Lab of Space Medicine Fundamentals and Application (SMFA09A07, SMFA10A03) and a grant from Shenzhen (JCYJ20120619151640947). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albain KS, 2010, LANCET ONCOL, V11, P55, DOI 10.1016/S1470-2045(09)70314-6; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Ben-Moshe NB, 2012, NUCLEIC ACIDS RES, V40, P10614, DOI 10.1093/nar/gks841; Besemann C, 2006, SOURCE CODE BIOL MED, V1, DOI 10.1186/1751-0473-1-8; Blattner C, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.68; Bogdanova N, 2008, INT J CANCER, V122, P802, DOI 10.1002/ijc.23168; Brosh R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.65; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Fassan M, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2348; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gamazon ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013534; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837; Huang L, 2012, BIOCHEM BIOPH RES CO, V425, P127, DOI 10.1016/j.bbrc.2012.07.025; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Jiang W, 2012, SCI REP-UK, V2, DOI 10.1038/srep00282; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Juul N, 2010, LANCET ONCOL, V11, P358, DOI 10.1016/S1470-2045(10)70018-8; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krull M, 2006, NUCLEIC ACIDS RES, V34, pD546, DOI 10.1093/nar/gkj107; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Y, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn610; Lida Zhu, 2011, 2011 IEEE International Conference on Systems Biology (ISB), P292, DOI 10.1109/ISB.2011.6033168; Liu WH, 2009, GASTROENTEROLOGY, V136, P683, DOI 10.1053/j.gastro.2008.10.029; Manavalan TT, 2011, CANCER LETT, V313, P26, DOI 10.1016/j.canlet.2011.08.018; Marsit CJ, 2006, CANCER RES, V66, P10843, DOI 10.1158/0008-5472.CAN-06-1894; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Mestdagh P, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr646; Monga M, 2002, LEUKEMIA, V16, P520, DOI 10.1038/sj.leu.2402464; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Redova M, 2011, BIOCHEM BIOPH RES CO, V405, P153, DOI 10.1016/j.bbrc.2011.01.019; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Schmittgen TD, 2008, J CELL MOL MED, V12, P1811, DOI 10.1111/j.1582-4934.2008.00483.x; Seemanov E, 2007, JNCI-J NATL CANCER I, V99, P1875, DOI 10.1093/jnci/djm251; Shigemizu D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002347; Silver DP, 2010, J CLIN ONCOL, V28, P1145, DOI 10.1200/JCO.2009.22.4725; Slattery ML, 2011, GENE CHROMOSOME CANC, V50, P196, DOI 10.1002/gcc.20844; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Steffen J, 2006, INT J CANCER, V119, P472, DOI 10.1002/ijc.21853; Swanton C, 2009, P NATL ACAD SCI USA, V106, P8671, DOI 10.1073/pnas.0811835106; Tabchy A, 2010, CLIN CANCER RES, V16, P5351, DOI 10.1158/1078-0432.CCR-10-1265; Ulitsky I, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq570; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; van 't Veer LJ, 2008, NATURE, V452, P564, DOI 10.1038/nature06915; VandenBoom TG, 2008, CURR GENOMICS, V9, P97, DOI 10.2174/138920208784139555; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005878; Weigelt B, 2012, NAT REV CLIN ONCOL, V9, P58, DOI 10.1038/nrclinonc.2011.125; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Xiong JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013937; Yeung KY, 2001, BIOINFORMATICS, V17, P309, DOI 10.1093/bioinformatics/17.4.309; Zhou YM, 2010, P NATL ACAD SCI USA, V107, P7904, DOI 10.1073/pnas.0908441107	62	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98140	10.1371/journal.pone.0098140	http://dx.doi.org/10.1371/journal.pone.0098140			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848634	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600092
J	Koga, M; Satoh, T; Takasaki, I; Kawamura, Y; Yoshida, M; Kaida, D				Koga, Mitsunori; Satoh, Takayuki; Takasaki, Ichiro; Kawamura, Yumi; Yoshida, Minoru; Kaida, Daisuke			U2 snRNP Is Required for Expression of the 3 ' End of Genes	PLOS ONE			English	Article							RNA-POLYMERASE-II; PRE-MESSENGER-RNA; NUCLEAR RETENTION; ANTITUMOR SUBSTANCES; MAMMALIAN-CELLS; TRANSCRIPTION; ELONGATION; SPLICEOSTATIN; DEGRADATION; COMPLEX	Pre-mRNA in eukaryotes is subjected to mRNA processing, which includes capping, polyadenylation, and splicing. Transcription and mRNA processing are coupled, and this coupling stimulates mRNA processing; however, the effects of mRNA processing on transcription are not fully understood. In this study, we found that inhibition of U2 snRNP by a splicing inhibitor, spliceostatin A (SSA), or by an antisense oligonucleotide to U2 snRNA, caused gene-specific 3'-end down-regulation. Removal of SSA from the culture media restored expression of the 3' ends of genes, suggesting that U2 snRNP is required for expression of the 3' end of genes. Finally, we found that SSA treatment caused accumulation of Pol II near the 5' end of 3'-end down regulated genes, such as CDK6, SMEK2 and EGFR, indicating that SSA treatment led to transcription elongation arrest on these genes. These findings suggest that U2 snRNP is important for production of full length mRNA probably through regulation of transcription elongation, and that a novel checkpoint mechanism prevents pre-mRNA from accumulating as a result of splicing deficiencies, and thereby prevents production of aberrant proteins that might be translated from pre-mRNAs through the arrest of transcription elongation.	[Koga, Mitsunori; Satoh, Takayuki; Kaida, Daisuke] Toyama Univ, Frontier Res Core Life Sci, Toyama 930, Japan; [Takasaki, Ichiro] Toyama Univ, Life Sci Res Ctr, Div Mol Genet Res, Toyama 930, Japan; [Kawamura, Yumi] RIKEN Ctr Sustainable Resource Sci, Mol Ligand Target Res Team, Wako, Saitama, Japan; [Yoshida, Minoru] RIKEN, Chem Genet Lab, Wako, Saitama, Japan; [Yoshida, Minoru] CREST, JST, Kawaguchi, Saitama, Japan	University of Toyama; University of Toyama; RIKEN; RIKEN; Japan Science & Technology Agency (JST)	Kaida, D (corresponding author), Toyama Univ, Frontier Res Core Life Sci, Toyama 930, Japan.	kaida@med.u-toyama.ac.jp	Yoshida, Minoru/C-8049-2014	Yoshida, Minoru/0000-0002-4376-5674; Kaida, Daisuke/0000-0003-4014-5231	Program to Disseminate Tenure Tracking System, JST; JSPS [23870010, 25711001]; Sumitomo Foundation; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Sagawa Foundation for Promotion of Cancer Research; Kowa Life Science Foundation; Human Frontier Science Program [RGY0080/2013]; Grants-in-Aid for Scientific Research [21228003] Funding Source: KAKEN	Program to Disseminate Tenure Tracking System, JST; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sumitomo Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Sagawa Foundation for Promotion of Cancer Research; Kowa Life Science Foundation; Human Frontier Science Program(Human Frontier Science Program); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Program to Disseminate Tenure Tracking System, JST, and Grants-in-Aid from JSPS (23870010, 25711001), the Sumitomo Foundation, Takeda Science Foundation, Mochida Memorial Foundation for Medical and Pharmaceutical Research, The Sagawa Foundation for Promotion of Cancer Research, Kowa Life Science Foundation and Human Frontier Science Program (RGY0080/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; Bhuvanagiri M, 2010, BIOCHEM J, V430, P365, DOI 10.1042/BJ20100699; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Brody Y, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000573; Chathoth KT, 2014, MOL CELL, V53, P779, DOI 10.1016/j.molcel.2014.01.017; Cheung ACM, 2012, CELL, V149, P1431, DOI 10.1016/j.cell.2012.06.006; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; Danckwardt S, 2008, EMBO J, V27, P482, DOI 10.1038/sj.emboj.7601932; Dziembowski A, 2004, EMBO J, V23, P4847, DOI 10.1038/sj.emboj.7600482; Furumai R, 2010, CANCER SCI, V101, P2483, DOI 10.1111/j.1349-7006.2010.01686.x; Galy V, 2004, CELL, V116, P63, DOI 10.1016/S0092-8674(03)01026-2; Gowher H, 2012, P NATL ACAD SCI USA, V109, P2370, DOI 10.1073/pnas.1121538109; Gozani O, 1998, MOL CELL BIOL, V18, P4752, DOI 10.1128/MCB.18.8.4752; Gromak N, 2006, MOL CELL BIOL, V26, P3986, DOI 10.1128/MCB.26.10.3986-3996.2006; Gu MG, 2005, CURR OPIN STRUC BIOL, V15, P99, DOI 10.1016/j.sbi.2005.01.009; Gudipati RK, 2012, MOL CELL, V48, P409, DOI 10.1016/j.molcel.2012.08.018; Hagiwara M, 2007, J BIOCHEM, V142, P11, DOI 10.1093/jb/mvm123; Ji X, 2013, CELL, V153, P855, DOI 10.1016/j.cell.2013.04.028; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Kim S, 2011, N KOREAN REV, V7, P3; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Martins SB, 2011, NAT STRUCT MOL BIOL, V18, P1115, DOI 10.1038/nsmb.2124; Matter N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni041; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Nakajima H, 1996, J ANTIBIOT, V49, P1204; Nudler E, 2012, CELL, V149, P1438, DOI 10.1016/j.cell.2012.06.003; Robson-Dixon ND, 2004, J BIOL CHEM, V279, P29075, DOI 10.1074/jbc.M312747200; Rutz B, 2000, EMBO J, V19, P1873, DOI 10.1093/emboj/19.8.1873; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Takemura R, 2011, GENES CELLS, V16, P1035, DOI 10.1111/j.1365-2443.2011.01548.x; Tomecki R, 2010, CHEMBIOCHEM, V11, P938, DOI 10.1002/cbic.201000025; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	39	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98015	10.1371/journal.pone.0098015	http://dx.doi.org/10.1371/journal.pone.0098015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845214	gold, Green Published, Green Submitted			2022-12-25	WOS:000339563400080
J	Nan, HY; Cao, D; Zhang, DY; Li, Y; Lu, SJ; Tang, LL; Yuan, XH; Liu, BH; Kong, FJ				Nan, Haiyang; Cao, Dong; Zhang, Dayong; Li, Ying; Lu, Sijia; Tang, Lili; Yuan, Xiaohui; Liu, Baohui; Kong, Fanjiang			GmFT2a and GmFT5a Redundantly and Differentially Regulate Flowering through Interaction with and Upregulation of the bZIP Transcription Factor GmFDL19 in Soybean	PLOS ONE			English	Article							MAP-BASED CLONING; LOCUS-T; PHOTOPERIOD RESPONSE; GENETIC-VARIATION; MATURITY; TIME; PROTEIN; FT; ACTIVATION; SIGNALS	FLOWERING LOCUS T (FT) is the key flowering integrator in Arabidopsis (Arabidopsis thaliana), and its homologs encode florigens in many plant species regardless of their photoperiodic response. Two FT homologs, GmFT2a and GmFT5a, are involved in photoperiod-regulated flowering and coordinately control flowering in soybean. However, the molecular and genetic understanding of the roles played by GmFT2a and GmFT5a in photoperiod-regulated flowering in soybean is very limited. In this study, we demonstrated that GmFT2a and GmFT5a were able to promote early flowering in soybean by overexpressing these two genes in the soybean cultivar Williams 82 under noninductive long-day (LD) conditions. The soybean homologs of several floral identity genes, such as GmAP1, GmSOC1 and GmLFY, were significantly upregulated by GmFT2a and GmFT5a in a redundant and differential pattern. A bZIP transcription factor, GmFDL19, was identified as interacting with both GmFT2a and GmFT5a, and this interaction was confirmed by yeast two-hybridization and bimolecular fluorescence complementation (BiFC). The overexpression of GmFDL19 in soybean caused early flowering, and the transcription levels of the flowering identity genes were also upregulated by GmFDL19, as was consistent with the upregulation of GmFT2a and GmFT5a. The transcription of GmFDL19 was also induced by GmFT2a. The results of the electrophoretic mobility shift assay (EMSA) indicated that GmFDL19 was able to bind with the cis-elements in the promoter of GmAP1a. Taken together, our results suggest that GmFT2a and GmFT5a redundantly and differentially control photoperiod-regulated flowering in soybean through both physical interaction with and transcriptional upregulation of the bZIP transcription factor GmFDL19, thereby inducing the expression of floral identity genes.	[Nan, Haiyang; Cao, Dong; Lu, Sijia; Tang, Lili; Yuan, Xiaohui; Liu, Baohui; Kong, Fanjiang] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Harbin, Peoples R China; [Nan, Haiyang; Lu, Sijia] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Dayong] Jiangsu Acad Agr Sci, Inst Biotechnol, Nanjing, Jiangsu, Peoples R China; [Li, Ying] Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin, Peoples R China	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Jiangsu Academy of Agricultural Sciences; Northeast Forestry University - China	Liu, BH (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Harbin, Peoples R China.	liubh@iga.ac.cn; kongfj@iga.ac.cn	Kong, Fanjiang/AGQ-2334-2022	Kong, Fanjiang/0000-0001-7138-1478	National Natural Science Foundation of China [31071445, 31171579, 31201222, 31371643]; Open Foundation of the Key Laboratory of Soybean Molecular Design Breeding, Chinese Academy of Sciences; Chinese Academy of Sciences; Strategic Action Plan for Science and Technology Innovation of the Chinese Academy of Sciences [XDA08030108]; Heilongjiang Natural Science Foundation of China [ZD201001, JC201313]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Foundation of the Key Laboratory of Soybean Molecular Design Breeding, Chinese Academy of Sciences; Chinese Academy of Sciences(Chinese Academy of Sciences); Strategic Action Plan for Science and Technology Innovation of the Chinese Academy of Sciences; Heilongjiang Natural Science Foundation of China(Natural Science Foundation of Heilongjiang Province)	National Natural Science Foundation of China (31071445, 31171579, 31201222 and 31371643); the Open Foundation of the Key Laboratory of Soybean Molecular Design Breeding, Chinese Academy of Sciences; the "Hundred Talents" Program of the Chinese Academy of Sciences; the Strategic Action Plan for Science and Technology Innovation of the Chinese Academy of Sciences (XDA08030108); and the Heilongjiang Natural Science Foundation of China (ZD201001, JC201313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; BERNARD RL, 1971, CROP SCI, V11, P242, DOI 10.2135/cropsci1971.0011183X001100020022x; Blazquez MA, 2000, J CELL SCI, V113, P3547; Bonato ER, 1999, GENET MOL BIOL, V22, P229, DOI 10.1590/S1415-47571999000200016; Bradley D, 1997, SCIENCE, V275, P80, DOI 10.1126/science.275.5296.80; Buzzell R. I., 1980, SOYBEAN GENETICS NEW, V7, P26, DOI DOI 10.1093/JHERED/ESP113; BUZZELL RI, 1971, CAN J GENET CYTOL, V13, P703, DOI 10.1139/g71-100; Chi YJ, 2011, J PLANT PHYSIOL, V168, P2251, DOI 10.1016/j.jplph.2011.08.007; Cober ER, 2010, CROP SCI, V50, P524, DOI 10.2135/cropsci2009.04.0174; Cober ER, 1996, CROP SCI, V36, P601, DOI 10.2135/cropsci1996.0011183X003600030013x; Cober ER, 2001, CROP SCI, V41, P698, DOI 10.2135/cropsci2001.413698x; Flores T, 2008, TRANSGENIC RES, V17, P839, DOI 10.1007/s11248-008-9167-6; Jang S, 2009, PLANT J, V60, P614, DOI 10.1111/j.1365-313X.2009.03986.x; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi K, 2012, PLANT CELL, V24, P1848, DOI 10.1105/tpc.112.097105; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Lee J, 2010, J EXP BOT, V61, P2247, DOI 10.1093/jxb/erq098; Li CX, 2008, PLANT J, V55, P543, DOI 10.1111/j.1365-313X.2008.03526.x; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Lin MK, 2007, PLANT CELL, V19, P1488, DOI 10.1105/tpc.107.051920; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; Liu B, 2007, ANN BOT-LONDON, V100, P1027, DOI 10.1093/aob/mcm149; MCBLAIN BA, 1987, J HERED, V78, P160, DOI 10.1093/oxfordjournals.jhered.a110349; Meng QC, 2007, SEED SCI RES, V17, P297, DOI 10.1017/S0960258507836282; Michaels SD, 2005, PLANT PHYSIOL, V137, P149, DOI 10.1104/pp.104.052811; Mimida N, 2001, GENES CELLS, V6, P327, DOI 10.1046/j.1365-2443.2001.00425.x; Moon J, 2005, PLANT CELL PHYSIOL, V46, P292, DOI 10.1093/pcp/pci024; Na XF, 2013, PLANT CELL REP, V32, P1219, DOI 10.1007/s00299-013-1419-0; Paz MM, 2004, EUPHYTICA, V136, P167, DOI 10.1023/B:EUPH.0000030670.36730.a4; RAY JD, 1995, CROP SCI, V35, P1001, DOI 10.2135/cropsci1995.0011183X003500040012x; RuizGarcia L, 1997, PLANT CELL, V9, P1921, DOI 10.1105/tpc.9.11.1921; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Sheen J, 2002, SCIENCE, V296, P1650, DOI 10.1126/science.1071883; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Taoka K, 2011, NATURE, V476, P332, DOI 10.1038/nature10272; Thakare D, 2011, PLANTA, V234, P933, DOI 10.1007/s00425-011-1450-8; Tsubokura Y, 2013, AGRONOMY-BASEL, V3, P117, DOI 10.3390/agronomy3010117; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Xia ZJ, 2012, PLANT SYST EVOL, V298, P1217, DOI 10.1007/s00606-012-0628-2; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Xu ML, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-91; Yamaguchi A, 2005, PLANT CELL PHYSIOL, V46, P1175, DOI 10.1093/pcp/pci151; Yoo SJ, 2010, PLANT J, V63, P241, DOI 10.1111/j.1365-313X.2010.04234.x; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928; Yoo SY, 2004, MOL CELLS, V17, P95; Zhong XF, 2012, MOL BIOL REP, V39, P6967, DOI 10.1007/s11033-012-1524-0	53	83	101	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97669	10.1371/journal.pone.0097669	http://dx.doi.org/10.1371/journal.pone.0097669			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845624	Green Submitted, gold, Green Published			2022-12-25	WOS:000339563400042
J	Feldblum, PJ; Enosse, S; Dube, K; Arnaldo, P; Muluana, C; Banze, R; Nhanala, A; Cunaca, J; Chen, PL; Robb, ML; Thompson, R				Feldblum, Paul J.; Enosse, Sonia; Dube, Karine; Arnaldo, Paulo; Muluana, Chadreque; Banze, Reginaldo; Nhanala, Aristides; Cunaca, Joana; Chen, Pai-Lien; Robb, Merlin L.; Thompson, Ricardo			HIV Prevalence and Incidence in a Cohort of Women at Higher Risk for HIV Acquisition in Chokwe, Southern Mozambique	PLOS ONE			English	Article								Background: Reliable HIV incidence estimates for Mozambique are limited. We conducted a prospective HIV incidence study as part of a clinical research site development initiative in Chokwe district, Gaza Province, southern Mozambique. Methods: Between June 2010 and October 2012, we recruited women at sites where women at higher risk of HIV infection would likely be found. We enrolled and tested 1,429 sexually active women in the screening phase and 479 uninfected women in the prospective phase. Participants were scheduled for 12+ months follow-up, when they underwent face-to-face interviews, HIV counseling and testing, and pregnancy testing. We observed a total of 373.1 woman-years (WY) of follow-up, with mean (median) of 9.4 (9.7) women-months per participant. Results: The prevalence of HIV was 29.4% (95% confidence interval [CI]: 27.0-31.8%). In multivariable logistic regression analysis, factors that remained significantly associated with prevalent HIV were: older age (OR: 0.6; 95% CI: 0.4-0.7), lower educational level (OR: 0.4; 95% CI: 0.3-0.7), and using hormonal contraception (OR: 0.6; 95% CI: 0.4-0.7) or condoms (OR: 0.5; 95% CI: 0.3-0.7). We observed an HIV incidence rate of 4.6 per 100 WY (95% CI: 2.7, 7.3). The HIV incidence was 4.8 per 100 WY (95% CI: 2.5, 8.3) in women aged 18-24 years, 4.5 per 100 WY (95% CI: 1.2, 11.4) in women aged 25-29 years and 3.2 per 100 WY (95% CI: 0.1, 18.0) in the 30-35 years stratum. None of the demographic factors or time-varying behavioral factors examined was significantly associated with incident HIV infection in bivariable analysis at p <= 0.10. Conclusions: We found a high HIV incidence among sexually active young women in Chokwe, Mozambique. HIV prevention programs should be strengthened in the area, with more comprehensive reproductive health services, regular HIV testing, condom promotion, and messaging about multiple sexual partners.	[Feldblum, Paul J.; Chen, Pai-Lien] FHI 360, Durham, NC 27701 USA; [Enosse, Sonia; Arnaldo, Paulo; Muluana, Chadreque; Banze, Reginaldo; Nhanala, Aristides; Cunaca, Joana; Thompson, Ricardo] Natl Inst Hlth, Chokwe Hlth Res & Training Ctr, Ctr Invest & Treino Saude Chokwe, Hygiene, Mozambique; [Dube, Karine] Univ N Carolina, Inst Global Hlth & Infect Dis, Chapel Hill, NC USA; [Robb, Merlin L.] Henry M Jackson Fdn Adv Mil Med Inc HJF, United States Mil HIV Res Program MHRP, Bethesda, MD USA	FHI 360; University of North Carolina; University of North Carolina Chapel Hill; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed Army Institute of Research (WRAIR)	Feldblum, PJ (corresponding author), FHI 360, Durham, NC 27701 USA.	pfeldblum@fhi360.org		Arnaldo, Paulo/0000-0001-8747-5209; Enosse, Sonia Maria Mauricio/0000-0002-2586-2083	United States Agency for International Development (USAID); United States Military HIV Research Program (MHRP)/Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; USAID [GHO A 00 09 00016-00]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); United States Military HIV Research Program (MHRP)/Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; USAID(United States Agency for International Development (USAID))	This work is made possible by the the United States Agency for International Development (USAID) and by the United States Military HIV Research Program (MHRP)/Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF). Financial assistance was provided by USAID to FHI 360 under the terms of the Preventive Technologies Agreement No. GHO A 00 09 00016-00. The views expressed are those of the authors and should not be construed to represent the positions of FHI 360, USAID, the United States Army, the United States Department of Defense, or the United States government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, WORLD AIDS DAY 2014; Collins C J L., 2006, MOZAMBIQUES HIV AIDS; Crush J., 2010, MIGRATION POLICY SER, V53; De Schacht C, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18808; Dube K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084979; Instituto Nacional de Saude (INS) Instituto Nacional de Estatistica (INE) e ICF Macro, 2010, NAT SURV PREV BEH RI; Speizer IS, 2008, AIDS EDUC PREV, V20, P531, DOI 10.1521/aeap.2008.20.6.531; Zango A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063427	8	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97547	10.1371/journal.pone.0097547	http://dx.doi.org/10.1371/journal.pone.0097547			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842811	Green Submitted, Green Published, gold			2022-12-25	WOS:000340948600042
J	Jackson, D; Vandermeer, J; Perfecto, I; Philpott, SM				Jackson, Doug; Vandermeer, John; Perfecto, Ivette; Philpott, Stacy M.			Population Responses to Environmental Change in a Tropical Ant: The Interaction of Spatial and Temporal Dynamics	PLOS ONE			English	Article							COFFEE BERRY BORER; SELF-ORGANIZATION; LECANICILLIUM-LECANII; ENTOMOGENOUS FUNGUS; SIZE DISTRIBUTIONS; HEMILEIA-VASTATRIX; ARBOREAL ANT; MUTUALISM; PATTERNS; SCALE	Spatial structure can have a profound, but often underappreciated, effect on the temporal dynamics of ecosystems. Here we report on a counterintuitive increase in the population of a tree-nesting ant, Azteca sericeasur, in response to a drastic reduction in the number of potential nesting sites. This surprising result is comprehensible when viewed in the context of the self-organized spatial dynamics of the ants and their effect on the ants' dispersal-limited natural enemies. Approximately 30% of the trees in the study site, a coffee agroecosystem in southern Mexico, were pruned or felled over a two-year period, and yet the abundance of the ant nests more than doubled over the seven-year study. Throughout the transition, the spatial distribution of the ants maintained a power-law distribution - a signal of spatial self organization - but the local clustering of the nests was reduced post-pruning. A cellular automata model incorporating the changed spatial structure of the ants and the resulting partial escape from antagonists reproduced the observed increase in abundance, highlighting how self-organized spatial dynamics can profoundly influence the responses of ecosystems to perturbations.	[Jackson, Doug; Vandermeer, John] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Vandermeer, John; Perfecto, Ivette] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Philpott, Stacy M.] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California Santa Cruz	Jackson, D (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	dougjack@dougjackson.net	Philpott, Stacy/M-3486-2019; Philpott, Stacy M/F-2330-2011	Philpott, Stacy/0000-0002-8338-3806; Philpott, Stacy M/0000-0002-8338-3806	NSF [DEB-0349388, DEB-1020096]; Graham Environmental Sustainability Institute; Direct For Biological Sciences [1262086] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Graham Environmental Sustainability Institute; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	NSF grant to J.V. and I. P.: DEB-0349388; NSF grant to S. P.: DEB-1020096; Graham Environmental Sustainability Institute Doctoral Fellowship to D.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bak P., 1996, NATURE WORKS; Bascompte J, 1998, TRENDS ECOL EVOL, V13, P173, DOI 10.1016/S0169-5347(98)01325-1; CONNELL J H, 1971, P298; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Haase P, 1995, J VEG SCI, V10, P433; Holldobler B., 1990, pi; Jackson D., 2012, Tropical and Subtropical Agroecosystems, V15, P389; Jackson D., 2009, Open Ecology Journal, V2, P62, DOI 10.2174/1874213000902010062; Jackson D, 2014, OIKOS, V123, P751, DOI 10.1111/j.1600-0706.2013.00827.x; Jackson D, 2012, BIOL CONTROL, V61, P89, DOI 10.1016/j.biocontrol.2012.01.004; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Jensen H.J., 1998, SELF ORG CRITICALITY; Jimenez-Soto E, 2013, ENVIRON ENTOMOL, V42, P915, DOI 10.1603/EN12202; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; Kefi S, 2011, ECOL LETT, V14, P29, DOI 10.1111/j.1461-0248.2010.01553.x; Klausmeier CA, 1999, SCIENCE, V284, P1826, DOI 10.1126/science.284.5421.1826; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Liere H, 2008, ENVIRON ENTOMOL, V37, P143, DOI 10.1603/0046-225X(2008)37[143:COAMIB]2.0.CO;2; Liere H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045508; Liere H, 2010, OIKOS, V119, P1394, DOI 10.1111/j.1600-0706.2010.17985.x; Pardee GL, 2011, ENVIRON ENTOMOL, V40, P581, DOI 10.1603/EN11015; Pascual M, 1999, ECOLOGY, V80, P2225, DOI 10.1890/0012-9658(1999)080[2225:FITPDS]2.0.CO;2; Pascual M, 2002, PHILOS T ROY SOC B, V357, P657, DOI 10.1098/rstb.2001.0983; Perfecto I, 2008, ANN NY ACAD SCI, V1134, P173, DOI 10.1196/annals.1439.011; Perfecto I, 2008, ECOLOGY, V89, P915, DOI 10.1890/06-2121.1; Perfecto I, 2006, AGR ECOSYST ENVIRON, V117, P218, DOI 10.1016/j.agee.2006.04.007; Philpott SM, 2006, BIODIVERS CONSERV, V15, P139, DOI 10.1007/s10531-004-4247-2; Philpott SM, 2012, ECOLOGY, V93, P992, DOI 10.1890/11-1431.1; Philpott SM, 2009, ENVIRON ENTOMOL, V38, P790, DOI 10.1603/022.038.0331; Rietkerk M, 2002, AM NAT, V160, P524, DOI 10.1086/342078; Rietkerk M, 2008, TRENDS ECOL EVOL, V23, P169, DOI 10.1016/j.tree.2007.10.013; Rohani P, 1997, TRENDS ECOL EVOL, V12, P70, DOI 10.1016/S0169-5347(96)20103-X; Ruiz J, 2010, REV BIOL TROP, V58, P991; STAUFFER D, 1994, INTRO PERCOLATION TH; Strassmann JE, 2007, P NATL ACAD SCI USA, V104, P8619, DOI 10.1073/pnas.0701285104; Uno S, 2007, THESIS U MICHIGAN AN; Vandermeer J, 2006, SCIENCE, V311, P1000, DOI 10.1126/science.1121432; Vandermeer J, 2009, PLANT PATHOL, V58, P636, DOI 10.1111/j.1365-3059.2009.02067.x; Vandermeer J, 2008, NATURE, V451, P457, DOI 10.1038/nature06477; Vandermeer J, 2010, BIOSCIENCE, V60, P527, DOI 10.1525/bio.2010.60.7.8	40	5	6	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97809	10.1371/journal.pone.0097809	http://dx.doi.org/10.1371/journal.pone.0097809			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842117	Green Published, gold			2022-12-25	WOS:000340948600077
J	Hanuszkiewicz, A; Pittock, P; Humphries, F; Moll, H; Rosales, AR; Molinaro, A; Moynagh, PN; Lajoie, GA; Valvano, MA				Hanuszkiewicz, Anna; Pittock, Paula; Humphries, Fiachra; Moll, Hermann; Rosales, Amanda Roa; Molinaro, Antonio; Moynagh, Paul N.; Lajoie, Gilles A.; Valvano, Miguel A.			Identification of the Flagellin Glycosylation System in Burkholderia cenocepacia and the Contribution of Glycosylated Flagellin to Evasion of Human Innate Immune Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTIC-FIBROSIS; CEPACIA COMPLEX; BIOCHEMICAL-CHARACTERIZATION; AMINO-ACIDS; LIPOPOLYSACCHARIDE; BIOSYNTHESIS; PATHWAYS; MOTILITY; RECONSTITUTION; AMINOARABINOSE	Burkholderia cenocepacia is an opportunistic pathogen threatening patients with cystic fibrosis. Flagella are required for biofilm formation, as well as adhesion to and invasion of epithelial cells. Recognition of flagellin via the Toll-like receptor 5 (TLR5) contributes to exacerbate B. cenocepacia-induced lung epithelial inflammatory responses. In this study, we report that B. cenocepacia flagellin is glycosylated on at least 10 different sites with a single sugar, 4,6-dideoxy-4-(3-hydroxybutanoylamino)- D-glucose. We have identified key genes that are required for flagellin glycosylation, including a predicted glycosyltransferase gene that is linked to the flagellin biosynthesis cluster and a putative acetyltransferase gene located within the O-antigen lipopolysaccharide cluster. Another O-antigen cluster gene, rmlB, which is required for flagellin glycan and O-antigen biosynthesis, was essential for bacterial viability, uncovering a novel target against Burkholderia infections. Using glycosylated and nonglycosylated purified flagellin and a cell reporter system to assess TLR5-mediated responses, we also show that the presence of glycan in flagellin significantly impairs the inflammatory response of epithelial cells. We there-fore suggest that flagellin glycosylation reduces recognition of flagellin by host TLR5, providing an evasive strategy to infecting bacteria.	[Hanuszkiewicz, Anna; Moynagh, Paul N.; Valvano, Miguel A.] Queens Univ Belfast, Ctr Infect & Immun, Sch Med Dent & Biomed Sci, Belfast BT9 7AE, Antrim, North Ireland; [Pittock, Paula; Lajoie, Gilles A.] Univ Western Ontario, Dept Biochem, Don Rix Prot Identificat Facil, London, ON N6A 5C1, Canada; [Humphries, Fiachra; Moynagh, Paul N.] Natl Univ Ireland Maynooth, Inst Immunol, Dept Biol, Maynooth, Kildare, Ireland; [Moll, Hermann] Res Ctr Borstel, D-23845 Borstel, Germany; [Rosales, Amanda Roa; Valvano, Miguel A.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; [Molinaro, Antonio] Univ Naples Federico II, Dipartimento Sci Chim, I-80134 Naples, Italy	Queens University Belfast; Western University (University of Western Ontario); Maynooth University; Forschungszentrum Borstel; Western University (University of Western Ontario); University of Naples Federico II	Valvano, MA (corresponding author), Queens Univ Belfast, Ctr Infect & Immun, 97 Lisburn Rd, Belfast BT9 7AE, Antrim, North Ireland.	m.valvano@qub.ac.uk	Valvano, Miguel A/G-8759-2012	Valvano, Miguel A/0000-0001-8229-3641; Moynagh, Paul/0000-0002-4139-3061; Humphries, Fiachra/0000-0003-0216-5776; Molinaro, Antonio/0000-0002-3456-7369	Canadian Institutes of Health Research; United Kingdom Cystic Fibrosis Trust; COST Action [BM1003]; Cystic Fibrosis Trust [PJ564] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); United Kingdom Cystic Fibrosis Trust; COST Action(European Cooperation in Science and Technology (COST)); Cystic Fibrosis Trust	This work was supported by grants from the Canadian Institutes of Health Research and the United Kingdom Cystic Fibrosis Trust (to M. A. V.) and COST Action BM1003 "Microbial Cell Surface Determinants of Virulence as Targets for New Therapeutics in Cystic Fibrosis" (to A. M. and M. A. V.).	Batt SM, 2010, J BIOL CHEM, V285, P37741, DOI 10.1074/jbc.M110.165407; Blohmke CJ, 2008, J IMMUNOL, V180, P7764, DOI 10.4049/jimmunol.180.11.7764; BRETT PJ, 1994, INFECT IMMUN, V62, P1914, DOI 10.1128/IAI.62.5.1914-1919.1994; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; De Castro C, 2010, METHOD ENZYMOL, V480, P89, DOI 10.1016/S0076-6879(10)80005-9; De Soyza A, 2004, THORAX, V59, P526, DOI 10.1136/thx.2003.010801; de Zoete MR, 2010, J BIOL CHEM, V285, P12149, DOI 10.1074/jbc.M109.070227; DRAKE D, 1988, J GEN MICROBIOL, V134, P43; Drevinek P, 2010, CLIN MICROBIOL INFEC, V16, P821, DOI 10.1111/j.1469-0691.2010.03237.x; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; EDGE ASB, 1981, ANAL BIOCHEM, V118, P131, DOI 10.1016/0003-2697(81)90168-8; Erhardt M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000299; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Flannagan RS, 2008, ENVIRON MICROBIOL, V10, P1652, DOI 10.1111/j.1462-2920.2008.01576.x; Giraud MF, 2000, CURR OPIN STRUC BIOL, V10, P687, DOI 10.1016/S0959-440X(00)00145-7; Graindorge A, 2010, DIAGN MICR INFEC DIS, V66, P29, DOI 10.1016/j.diagmicrobio.2009.06.008; Guerry P, 2007, TRENDS MICROBIOL, V15, P456, DOI 10.1016/j.tim.2007.09.006; Hamad MA, 2012, MOL MICROBIOL, V85, P962, DOI 10.1111/j.1365-2958.2012.08154.x; Hamad MA, 2010, APPL ENVIRON MICROB, V76, P3170, DOI 10.1128/AEM.03024-09; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hirai H, 2011, J BIOL CHEM, V286, P25519, DOI 10.1074/jbc.M111.254029; Hitchen PG, 2010, BIOCHEM SOC T, V38, P1307, DOI 10.1042/BST0381307; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; ISLES A, 1984, J PEDIATR-US, V104, P206, DOI 10.1016/S0022-3476(84)80993-2; Juhas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040064; Katsiari M, 2012, HIPPOKRATIA, V16, P317; Knirel YA, 2011, BACTERIAL LIPOPOLYSACCHARIDES: STRUCTURE, CHEMICAL SYNTHESIS, BIOGENESIS AND INTERACTION WITH HOST CELLS, P1, DOI 10.1007/978-3-7091-0733-1; Kotrange S, 2011, J LEUKOCYTE BIOL, V89, P481, DOI 10.1189/jlb.0910513; Lazarus MB, 2012, NAT CHEM BIOL, V8, P966, DOI [10.1038/nchembio.1109, 10.1038/NCHEMBIO.1109]; Lee S, 2013, AM J INFECT CONTROL, V41, pE93, DOI 10.1016/j.ajic.2013.01.024; LIU HW, 1994, ANNU REV MICROBIOL, V48, P223, DOI 10.1146/annurev.micro.48.1.223; Logan SM, 2006, MICROBIOL-SGM, V152, P1249, DOI 10.1099/mic.0.28735-0; Mahenthiralingam E, 2008, J APPL MICROBIOL, V104, P1539, DOI 10.1111/j.1365-2672.2007.03706.x; Mahenthiralingam E, 2005, Chron Respir Dis, V2, P209, DOI 10.1191/1479972305cd053ra; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Marolda CL, 1999, MICROBIOL-UK, V145, P2485, DOI 10.1099/00221287-145-9-2485; MAROLDA CL, 1990, J BACTERIOL, V172, P3590, DOI 10.1128/jb.172.7.3590-3599.1990; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; McDowell A, 2004, J MED MICROBIOL, V53, P663, DOI 10.1099/jmm.0.45557-0; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Morrison MJ, 2013, J BIOL CHEM, V288, P32248, DOI 10.1074/jbc.M113.510560; Morrison MJ, 2013, ARCH BIOCHEM BIOPHYS, V536, P72, DOI 10.1016/j.abb.2013.05.011; Nguyen LC, 2009, MOL GENET GENOMICS, V282, P595, DOI 10.1007/s00438-009-0489-8; Novotny LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067629; Ortega X, 2005, J BACTERIOL, V187, P1324, DOI 10.1128/JB.187.4.1324-1333.2005; Ortega X, 2009, J BIOL CHEM, V284, P21738, DOI 10.1074/jbc.M109.008532; Ortega XP, 2007, J BACTERIOL, V189, P3639, DOI 10.1128/JB.00153-07; Ovchinnikova OG, 2007, CARBOHYD RES, V342, P1116, DOI 10.1016/j.carres.2007.02.028; Pachathundikandi SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019614; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Saldias MS, 2008, INFECT IMMUN, V76, P1059, DOI 10.1128/IAI.01167-07; Saldias MS, 2009, J MED MICROBIOL, V58, P1542, DOI 10.1099/jmm.0.013235-0; Sambrook J., 2001, MOL CLONING LAB MANU, P1881; Satpute MG, 2011, AM J INFECT CONTROL, V39, pE21, DOI 10.1016/j.ajic.2010.10.034; Schirm M, 2004, J BACTERIOL, V186, P2523, DOI 10.1128/JB.186.9.2523-2531.2004; Schirm M, 2003, MOL MICROBIOL, V48, P1579, DOI 10.1046/j.1365-2958.2003.03527.x; Scott AE, 2011, J BACTERIOL, V193, P3577, DOI 10.1128/JB.01385-10; Seo ST, 2005, FEMS MICROBIOL LETT, V245, P19, DOI 10.1016/j.femsle.2005.02.020; Shanks KK, 2010, CLIN VACCINE IMMUNOL, V17, P1196, DOI 10.1128/CVI.00167-10; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Taguchi F, 2006, CELL MICROBIOL, V8, P923, DOI 10.1111/j.1462-5822.2005.00674.x; Taguchi F, 2010, MICROBIOL-SGM, V156, P72, DOI 10.1099/mic.0.030700-0; Thibodeaux CJ, 2008, ANGEW CHEM INT EDIT, V47, P9814, DOI 10.1002/anie.200801204; Toguchi A, 2000, J BACTERIOL, V182, P6308, DOI 10.1128/JB.182.22.6308-6321.2000; Tomich M, 2002, INFECT IMMUN, V70, P1799, DOI 10.1128/IAI.70.4.1799-1806.2002; Urban TA, 2004, INFECT IMMUN, V72, P5126, DOI 10.1128/IAI.72.9.5126-5134.2004; Vandamme P, 2003, RES MICROBIOL, V154, P91, DOI 10.1016/S0923-2508(03)00026-3; VanDamme P, 2003, J NEMATOL, V35, P208; Ventura GMDC, 2008, FEMS IMMUNOL MED MIC, V54, P37, DOI 10.1111/j.1574-695X.2008.00453.x; Vergunst AC, 2010, INFECT IMMUN, V78, P1495, DOI 10.1128/IAI.00743-09; Verma A, 2005, INFECT IMMUN, V73, P8237, DOI 10.1128/IAI.73.12.8237-8246.2005; Wang Y, 2007, J BACTERIOL, V189, P8626, DOI 10.1128/JB.00777-07; Wei CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041056; West TE, 2013, J IMMUNOL, V190, P3373, DOI 10.4049/jimmunol.1202974	75	42	43	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19231	19244		10.1074/jbc.M114.562603	http://dx.doi.org/10.1074/jbc.M114.562603			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24841205	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000339062900050
J	Poirier, S; Samami, S; Mamarbachi, M; Demers, A; Chang, TY; Vance, DE; Hatch, GM; Mayer, G				Poirier, Steve; Samami, Samaneh; Mamarbachi, Maya; Demers, Annie; Chang, Ta Yuan; Vance, Dennis E.; Hatch, Grant M.; Mayer, Gaetan			The Epigenetic Drug 5-Azacytidine Interferes with Cholesterol and Lipid Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; ELEMENT-BINDING PROTEIN-2; DNA METHYLTRANSFERASE INHIBITORS; ENDOPLASMIC-RETICULUM; GENE-EXPRESSION; MYELODYSPLASTIC SYNDROMES; KNOCKOUT MICE; TARGET GENES; LIVER; CANCER	DNA methylation and histone acetylation inhibitors are widely used to study the role of epigenetic marks in the regulation of gene expression. In addition, several of these molecules are being tested in clinical trials or already in use in the clinic. Antimetabolites, such as the DNA-hypomethylating agent 5-azacytidine (5-AzaC), have been shown to lower malignant progression to acute myeloid leukemia and to prolong survival in patients with myelodysplastic syndromes. Here we examined the effects of DNA methylation inhibitors on the expression of lipid biosynthetic and uptake genes. Our data demonstrate that, independently of DNA methylation, 5-AzaC selectively and very potently reduces expression of key genes involved in cholesterol and lipid metabolism (e. g. PCSK9, HMGCR, and FASN) in all tested cell lines and in vivo in mouse liver. Treatment with 5-AzaC disturbed subcellular cholesterol homeostasis, thereby impeding activation of sterol regulatory element-binding proteins (key regulators of lipid metabolism). Through inhibition of UMP synthase, 5-AzaC also strongly induced expression of 1-acylglycerol-3-phosphate O-acyltransferase 9 (AGPAT9) and promoted triacylglycerol synthesis and cytosolic lipid droplet formation. Remarkably, complete reversal was obtained by the co-addition of either UMP or cytidine. Therefore, this study provides the first evidence that inhibition of the de novo pyrimidine synthesis by 5-AzaC disturbs cholesterol and lipid homeostasis, probably through the glycerolipid biosynthesis pathway, which may contribute mechanistically to its beneficial cytostatic properties.	[Poirier, Steve; Samami, Samaneh; Mamarbachi, Maya; Demers, Annie; Mayer, Gaetan] Montreal Heart Inst, Mol Cell Biol Lab, Montreal, PQ H1T 1C8, Canada; [Poirier, Steve; Samami, Samaneh; Mayer, Gaetan] Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Chang, Ta Yuan] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; [Vance, Dennis E.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada; [Vance, Dennis E.] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; [Hatch, Grant M.] Univ Manitoba, DREAM Theme, Manitoba Inst Child Hlth, Dept Pharmacol & Therapeut, Winnipeg, MB R3E 0T6, Canada; [Hatch, Grant M.] Univ Manitoba, DREAM Theme, Manitoba Inst Child Hlth, Dept Biochem, Winnipeg, MB R3E 0T6, Canada; [Hatch, Grant M.] Univ Manitoba, DREAM Theme, Manitoba Inst Child Hlth, Dept Med Genet, Winnipeg, MB R3E 0T6, Canada; [Mayer, Gaetan] Univ Montreal, Fac Med, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Dartmouth College; University of Alberta; University of Alberta; University of Manitoba; University of Manitoba; University of Manitoba; Universite de Montreal	Mayer, G (corresponding author), Montreal Heart Inst, Mol Cell Biol Lab, Montreal, PQ H1T 1C8, Canada.	gaetan.mayer@icm-mhi.org		Chang, Ta-Yuan/0000-0002-3249-0468	TFF Oncometabolism Team Grant [116128]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060306] Funding Source: NIH RePORTER	TFF Oncometabolism Team Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Gilles Corbeil (University of Montreal Hospital Research Centre) for excellent technical and analytical support regarding microarray data. We also thank Susanne Lingrell (University of Alberta) and Dr. Fred Xu (University of Manitoba) for excellent technical assistance. We also thank Gaelle Bridon and Dr. Daina Avizonis (Rosalind and Morris Goodman Cancer Research Centre Metabolomics Core Facility), who performed nucleotide measurements. We thank Gaelle Bridon and Dr. Daina Avizonis who performed nucleotide measurements at the Rosalind and Morris Goodman Cancer Research Centre Metabolomics Core Facility, which is supported by the Canada Foundation for Innovation, the Dr. John R. and Clara M. Fraser Memorial Trust, the Terry Fox Foundation (TFF Oncometabolism Team Grant 116128), and McGill University.	Abbas KS, 2012, J CLIN ONCOL, V30; Abidi P, 2005, ARTERIOSCL THROM VAS, V25, P2170, DOI 10.1161/01.ATV.0000181761.16341.2b; Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Aimiuwu J, 2012, BLOOD, V119, P5229, DOI 10.1182/blood-2011-11-382226; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Cameron J, 2008, ATHEROSCLEROSIS, V201, P266, DOI 10.1016/j.atherosclerosis.2008.02.004; Cao JS, 2006, P NATL ACAD SCI USA, V103, P19695, DOI 10.1073/pnas.0609140103; CARTER JR, 1966, J LIPID RES, V7, P678; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; CIHAK A, 1974, ONCOLOGY-BASEL, V30, P405; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Ehara T, 2012, DIABETES, V61, P2442, DOI 10.2337/db11-1834; Ellis MH, 2012, EXP HEMATOL, V40, P540, DOI 10.1016/j.exphem.2012.02.003; Estey EH, 2013, LEUKEMIA, V27, P1803, DOI 10.1038/leu.2013.173; Flotho C, 2009, LEUKEMIA, V23, P1019, DOI 10.1038/leu.2008.397; Gnyszka A, 2013, ANTICANCER RES, V33, P2989; Hatch GM, 1996, J BIOL CHEM, V271, P25810, DOI 10.1074/jbc.271.42.25810; Hollenbach PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009001; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; JAMAL Z, 1991, J BIOL CHEM, V266, P2988; Jeong HJ, 2008, J LIPID RES, V49, P399, DOI 10.1194/jlr.M700443-JLR200; Keating GM, 2012, DRUGS, V72, P1111, DOI 10.2165/11209430-000000000-00000; Kidani Y, 2013, NAT IMMUNOL, V14, P489, DOI 10.1038/ni.2570; Lagace TA, 2013, BBA-MOL CELL RES, V1833, P2499, DOI 10.1016/j.bbamcr.2013.05.018; Lehner R, 2012, ARTERIOSCL THROM VAS, V32, P1087, DOI 10.1161/ATVBAHA.111.241497; Li H, 2009, J BIOL CHEM, V284, P28885, DOI 10.1074/jbc.M109.052407; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; Meza-Avina ME, 2010, BIOORGAN MED CHEM, V18, P4032, DOI 10.1016/j.bmc.2010.04.017; Moon YA, 2012, CELL METAB, V15, P240, DOI 10.1016/j.cmet.2011.12.017; Newberry EP, 2003, J BIOL CHEM, V278, P51664, DOI 10.1074/jbc.M309377200; PELECH SL, 1981, J BIOL CHEM, V256, P8283; Poirier S, 2013, DRUG DES DEV THER, V7, P1135, DOI 10.2147/DDDT.S36984; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Sato R, 1996, J BIOL CHEM, V271, P26461, DOI 10.1074/jbc.271.43.26461; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Seidah NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041865; Shan DD, 2010, J LIPID RES, V51, P1971, DOI 10.1194/jlr.M006304; Shao W, 2012, CELL METAB, V16, P414, DOI 10.1016/j.cmet.2012.09.002; Sokolov A, 2010, J BIOL CHEM, V285, P29480, DOI 10.1074/jbc.M110.148254; Sturley SL, 2012, J LIPID RES, V53, P1800, DOI 10.1194/jlr.R028290; Tang JJ, 2011, CELL METAB, V13, P44, DOI 10.1016/j.cmet.2010.12.004; van Besien H, 2013, LEUKEMIA LYMPHOMA, V54, P2601, DOI 10.3109/10428194.2013.790022; Vance DE, 2008, N COMP BIOC, P213, DOI 10.1016/B978-044453219-0.50010-6; Vigna E, 2011, EXPERT OPIN INV DRUG, V20, P465, DOI 10.1517/13543784.2011.559164; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Williams KJ, 2013, CANCER RES, V73, P2850, DOI 10.1158/0008-5472.CAN-13-0382-T	55	23	23	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18736	18751		10.1074/jbc.M114.563650	http://dx.doi.org/10.1074/jbc.M114.563650			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24855646	Green Published, hybrid			2022-12-25	WOS:000339062900011
J	Afonso, P; McGinty, N; Graca, G; Fontes, J; Inacio, M; Totland, A; Menezes, G				Afonso, Pedro; McGinty, Niall; Graca, Goncalo; Fontes, Jorge; Inacio, Monica; Totland, Atle; Menezes, Gui			Vertical Migrations of a Deep-Sea Fish and Its Prey	PLOS ONE			English	Article							SHARK ALOPIAS-SUPERCILIOSUS; TUNA THUNNUS-OBESUS; AZORES NE ATLANTIC; CONDOR SEAMOUNT; VARIABILITY; ZOOPLANKTON; PATTERNS; OCEAN	It has been speculated that some deep-sea fishes can display large vertical migrations and likely doing so to explore the full suite of benthopelagic food resources, especially the pelagic organisms of the deep scattering layer (DSL). This would help explain the success of fishes residing at seamounts and the increased biodiversity found in these features of the open ocean. We combined active plus passive acoustic telemetry of blackspot seabream with in situ environmental and biological (backscattering) data collection at a seamount to verify if its behaviour is dominated by vertical movements as a response to temporal changes in environmental conditions and pelagic prey availability. We found that seabream extensively migrate up and down the water column, that these patterns are cyclic both in short-term (tidal, diel) as well as long-term (seasonal) scales, and that they partially match the availability of potential DSL prey components. Furthermore, the emerging pattern points to a more complex spatial behaviour than previously anticipated, suggesting a seasonal switch in the diel behaviour mode (benthic vs. pelagic) of seabream, which may reflect an adaptation to differences in prey availability. This study is the first to document the fine scale three-dimensional behaviour of a deep-sea fish residing at seamounts.	[Afonso, Pedro; McGinty, Niall; Graca, Goncalo; Fontes, Jorge; Inacio, Monica; Menezes, Gui] Univ Azores, Dept Oceanog & Fisheries, IMAR Inst Marine Res, Horta, Portugal; [Afonso, Pedro; Graca, Goncalo; Fontes, Jorge; Inacio, Monica; Menezes, Gui] LARSyS Lab Robot & Syst Engn & Sci, Lisbon, Portugal; [McGinty, Niall] Univ Iceland, Fac Life & Environm Sci, MARICE, Reykjavik, Iceland; [Totland, Atle] Inst Marine Res, N-5024 Bergen, Norway	Universidade dos Acores; University of Iceland; Institute of Marine Research - Norway	Afonso, P (corresponding author), Univ Azores, Dept Oceanog & Fisheries, IMAR Inst Marine Res, Horta, Portugal.	afonso@uac.pt	Menezes, Gui M./A-3956-2009; Afonso, Pedro/B-7815-2013	Menezes, Gui M./0000-0003-0781-4579; Afonso, Pedro/0000-0002-4618-2589; Fontes, Jorge/0000-0002-8451-5532	Portuguese Science and Technology Foundation (FCT/MCTES); European FEDER/COMPETE program through the Seamov Project [PTDC/MAR/108232/2008]; Laboratory of Robotics and Systems in Engineering and Science (LARSyS) Strategic Project [PEst/OE/EEI/LA00009/2011]; EEA Grants through the Condor project [PT-0040]; Ocean Tracking Network	Portuguese Science and Technology Foundation (FCT/MCTES)(Portuguese Foundation for Science and Technology); European FEDER/COMPETE program through the Seamov Project; Laboratory of Robotics and Systems in Engineering and Science (LARSyS) Strategic Project; EEA Grants through the Condor project; Ocean Tracking Network	This work was funded by the Portuguese Science and Technology Foundation (FCT/MCTES) and the European FEDER/COMPETE program through the Seamov Project (PTDC/MAR/108232/2008), the Laboratory of Robotics and Systems in Engineering and Science (LARSyS) Strategic Project (PEst/OE/EEI/LA00009/2011), and through individual support to PA (Ciencia 2008/POPH/QREN) and JF (COMPETE/FRH/BD/12788/2003); by EEA Grants through the Condor project (PT-0040); and by the Ocean Tracking Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso P, 2012, J EXP MAR BIOL ECOL, V436, P1, DOI 10.1016/j.jembe.2012.08.003; Afonso P, 2009, MAR ECOL PROG SER, V381, P273, DOI 10.3354/meps07946; Carmo V, 2013, DEEP-SEA RES PT II, V98, P63, DOI 10.1016/j.dsr2.2013.08.007; Colaco A, 2013, DEEP-SEA RES PT II, V98, P178, DOI 10.1016/j.dsr2.2013.01.010; Dagorn L, 2000, MAR BIOL, V136, P361, DOI 10.1007/s002270050694; Genin A, 2004, J MARINE SYST, V50, P3, DOI 10.1016/j.jmarsys.2003.10.008; Harris PT, 2012, ELSEV INSIGHT, P1; HOLLAND KN, 1992, NATURE, V358, P410, DOI 10.1038/358410a0; Jarvis ET, 2008, CAN J FISH AQUAT SCI, V65, P1286, DOI 10.1139/F08-071; MacLennan DN, 2002, ICES J MAR SCI, V59, P365, DOI 10.1006/jmsc.2001.1158; Menezes GM, 2006, MAR ECOL PROG SER, V324, P241, DOI 10.3354/meps324241; Menezes GM, 2013, DEEP-SEA RES PT II, V98, P101, DOI 10.1016/j.dsr2.2013.08.010; Morato T, 2001, B MAR SCI, V69, P1073; Morato T, 1999, LIFE MAR SCI A, V17A, P51, DOI 10.1111/j.1439-0426.2010.01467.x; Morato T, 2007, SEAMOUNTS ECOLOGY FI; Morato T, 2010, OCEANOGRAPHY, V23, P190, DOI 10.5670/oceanog.2010.71; Morato T, 2009, DEEP-SEA RES PT II, V56, P2713, DOI 10.1016/j.dsr2.2008.12.029; Nakano H, 2003, MAR ECOL PROG SER, V265, P255, DOI 10.3354/meps265255; Porteiro FM, 2013, DEEP-SEA RES PT II, V98, P114, DOI 10.1016/j.dsr2.2013.09.015; ROGERS AD, 1994, ADV MAR BIOL, V30, P305, DOI 10.1016/S0065-2881(08)60065-6; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P226, DOI 10.1111/j.1439-0485.2010.00400.x; Sanchez F, 1983, ICES COUNC M 1983; Santos M, 2013, DEEP-SEA RES PT II, V98, P52, DOI 10.1016/j.dsr2.2013.05.037; Simpfendorfer CA, 2012, CAN J FISH AQUAT SCI, V69, P565, DOI 10.1139/F2011-179; Stevens JD, 2010, MAR BIOL, V157, P575, DOI 10.1007/s00227-009-1343-6; Weng KC, 2004, FISH B-NOAA, V102, P221	26	25	25	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97884	10.1371/journal.pone.0097884	http://dx.doi.org/10.1371/journal.pone.0097884			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859231	gold, Green Published, Green Submitted			2022-12-25	WOS:000336839400029
J	Dier, U; Shin, DH; Hemachandra, LPMP; Uusitalo, LM; Hempel, N				Dier, Usawadee; Shin, Dong-Hui; Hemachandra, L. P. Madhubhani P.; Uusitalo, Larissa M.; Hempel, Nadine			Bioenergetic Analysis of Ovarian Cancer Cell Lines: Profiling of Histological Subtypes and Identification of a Mitochondria-Defective Cell Line	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; DYNAMIN-RELATED PROTEIN-1; DNA CONTENT; MUTATIONS; CARCINOMA; DRP1; CARCINOGENESIS; ENDOMETRIOSIS; PROGRESSION; ASSOCIATION	Epithelial ovarian cancer (EOC) is the most lethal of all gynecological cancers, and encompasses distinct histological subtypes that have specific genetic and tissues-of-origin differences. Ovarian clear cell carcinoma (OCCC) represents approximately 10% of cases and has been termed a stress responsive cancer. OCCC is characterized by increased expression of oxidative stress and glycolysis-related genes. In the present study, we hypothesized that bioenergetic profiling might uniquely distinguish OCCC from other EOC histological subtypes. Using an extracellular flux analyzer, OCCC lines (ES-2, TOV-21-G) were shown to be highly metabolically active, with high oxygen consumption rate (OCR) and high extracellular acidification rate (ECAR), indicative of enhanced mitochondrial oxidative phosphorylation and glycolytic rate, respectively. A high bioenergetics profile was associated with the cell lines' ability to form anchorage independent spheroids. Given their high glycolytic and mitochondrial activity, OCCC cells displayed strong sensitivity to 2-deoxy-D-glucose and Rotenone growth inhibition, although this chemosensitivity profile was not specific to only OCCC cells. Bioenergetic profiling also identified a non-OCCC cell line, OVCA420, to have severely compromised mitochondrial function, based on low OCR and a lack of stimulation of maximal respiration following application of the uncoupler FCCP. This was accompanied by mitochondrial morphology changes indicative of enhanced fission, increased expression of the mitochondrial fission protein Drp1, a loss of mitochondrial membrane potential and dependence on glycolysis. Importantly, this loss of mitochondrial function was accompanied by the inability of OVCA420 cells to cope with hypoxic stress, and a compromised ability to stabilize HIF-1 alpha in response to 1% O-2 hypoxia. This knowledge may be imperative for researchers planning to utilize this cell line for further studies of metabolism and hypoxia, and suggests that altered mitochondrial fission dynamics represents a phenotype of a subpopulation of EOCs.	[Dier, Usawadee; Shin, Dong-Hui; Hemachandra, L. P. Madhubhani P.; Uusitalo, Larissa M.; Hempel, Nadine] SUNY Albany, Coll Nanoscale Sci & Engn, Albany, NY 12222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; SUNY Polytechnic Institute	Hempel, N (corresponding author), SUNY Albany, Coll Nanoscale Sci & Engn, Albany, NY 12222 USA.	nhempel@albany.edu	Hempel, Nadine/F-1700-2014	Hempel, Nadine/0000-0002-5574-8783; Hemachandra, L P Madhubhani/0000-0001-7756-6190	National Institutes of Health (NIH) grant from the National Cancer Institute [R00CA143229]; NATIONAL CANCER INSTITUTE [R00CA143229] Funding Source: NIH RePORTER	National Institutes of Health (NIH) grant from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) grant R00CA143229 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Anderson AS, 2013, EXP CELL RES, V319, P1431, DOI 10.1016/j.yexcr.2013.02.017; Andre N, 2000, CANCER RES, V60, P5349; Andre N, 2002, FEBS LETT, V532, P256, DOI 10.1016/S0014-5793(02)03691-8; BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chandel NS, 2010, ADV EXP MED BIOL, V661, P339, DOI 10.1007/978-1-60761-500-2_22; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chung HH, 2012, ANN SURG ONCOL, V19, P1966, DOI 10.1245/s10434-011-2153-x; Cuff J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074562; Dehne N, 2012, ANTIOXID REDOX SIGNA; Dilokthornsakul P, 2013, INT J GYNECOL CANCER, V23, P1544, DOI 10.1097/IGC.0b013e3182a80a21; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Fabian C, 2012, FEBS J, V279, P882, DOI 10.1111/j.1742-4658.2012.08479.x; Ferlini C, 2003, MOL PHARMACOL, V64, P51, DOI 10.1124/mol.64.1.51; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hagenbuchner J, 2013, ONCOGENE, V32, P4748, DOI 10.1038/onc.2012.500; Hamanaka RB, 2009, CURR OPIN CELL BIOL, V21, P894, DOI 10.1016/j.ceb.2009.08.005; Hashiguchi Y, 2006, GYNECOL ONCOL, V101, P71, DOI 10.1016/j.ygyno.2005.09.047; Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Konstantinopoulos PA, 2011, CANCER RES, V71, P5081, DOI 10.1158/0008-5472.CAN-10-4668; Kueck A, 2007, GYNECOL ONCOL, V107, P450, DOI 10.1016/j.ygyno.2007.07.065; Kuo KT, 2009, AM J PATHOL, V174, P1597, DOI 10.2353/ajpath.2009.081000; Kurman RJ, 2011, HUM PATHOL, V42, P918, DOI 10.1016/j.humpath.2011.03.003; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Loar P, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.883; Mandai M, 2011, CANCER LETT, V310, P129, DOI 10.1016/j.canlet.2011.06.039; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Munksgaard PS, 2012, GYNECOL ONCOL, V124, P164, DOI 10.1016/j.ygyno.2011.10.001; Okamoto T, 2013, MOL CARCINOG; Pejznochova M, 2008, PHYSIOL RES, V57, P947, DOI 10.33549/physiolres.931246; Qian W, 2013, EXPERT OPIN THER TAR, V17, P997, DOI 10.1517/14728222.2013.823160; RAMAKRISHNAN S, 1989, J CLIN INVEST, V83, P921, DOI 10.1172/JCI113977; Rattan R, 2011, J CELL MOL MED, V15, P166, DOI 10.1111/j.1582-4934.2009.00954.x; Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543; Rescigno P, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/852839; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stany MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021121; Strack S, 2013, J CELL BIOL, V201, P1037, DOI 10.1083/jcb.201210045; Sullivan EJ, 2013, CANC CHEMOTHER PHARM; Tan DSP, 2013, BRIT J CANCER, V108, P1553, DOI 10.1038/bjc.2013.126; Tan DSP, 2011, CLIN CANCER RES, V17, P1521, DOI 10.1158/1078-0432.CCR-10-1688; Taylor CT, 2008, BIOCHEM J, V409, P19, DOI 10.1042/BJ20071249; Thrall MM, 2007, GYNECOL ONCOL, V105, P17, DOI 10.1016/j.ygyno.2006.10.060; Tian CQ, 2009, CANCER-AM CANCER SOC, V115, P1395, DOI 10.1002/cncr.24152; Tsuchiya A, 2003, AM J PATHOL, V163, P2503, DOI 10.1016/S0002-9440(10)63605-X; Uo T, 2009, EXP NEUROL, V218, P274, DOI 10.1016/j.expneurol.2009.05.010; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Wang Y, 2006, BRIT J CANCER, V95, P1087, DOI 10.1038/sj.bjc.6603377; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Yamaguchi K, 2010, ONCOGENE, V29, P1741, DOI 10.1038/onc.2009.470; Yamaguchi K, 2008, CLIN CANCER RES, V14, P32, DOI 10.1158/1078-0432.CCR-07-1614; Yamamoto Y, 2008, INT J GYNECOL OBSTET, V102, P124, DOI 10.1016/j.ijgo.2008.02.019; Zhang XD, 2006, ANTICANCER RES, V26, P3561	59	55	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98479	10.1371/journal.pone.0098479	http://dx.doi.org/10.1371/journal.pone.0098479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858344	gold, Green Published, Green Submitted			2022-12-25	WOS:000336839400078
J	Huang, HS; Yoon, BJ; Brooks, S; Bakal, R; Berrios, J; Larsen, RS; Wallace, ML; Han, JE; Chung, EH; Zylka, MJ; Philpot, BD				Huang, Hsien-Sung; Yoon, Bong-June; Brooks, Sherian; Bakal, Robert; Berrios, Janet; Larsen, Rylan S.; Wallace, Michael L.; Han, Ji Eun; Chung, Eui Hwan; Zylka, Mark J.; Philpot, Benjamin D.			Snx14 Regulates Neuronal Excitability, Promotes Synaptic Transmission, and Is Imprinted in the Brain of Mice	PLOS ONE			English	Article							ORIGIN ALLELIC EXPRESSION; SORTING NEXIN 27; POTASSIUM CHANNELS; DNA METHYLATION; MOUSE-BRAIN; GENOMES; DOMAIN; GENES	Genomic imprinting describes an epigenetic process through which genes can be expressed in a parent-of-origin-specific manner. The monoallelic expression of imprinted genes renders them particularly susceptible to disease causing mutations. A large proportion of imprinted genes are expressed in the brain, but little is known about their functions. Indeed, it has proven difficult to identify cell type-specific imprinted genes due to the heterogeneity of cell types within the brain. Here we used laser capture microdissection of visual cortical neurons and found evidence that sorting nexin 14 (Snx14) is a neuronally imprinted gene in mice. SNX14 protein levels are high in the brain and progressively increase during neuronal development and maturation. Snx14 knockdown reduces intrinsic excitability and severely impairs both excitatory and inhibitory synaptic transmission. These data reveal a role for monoallelic Snx14 expression in maintaining normal neuronal excitability and synaptic transmission.	[Huang, Hsien-Sung; Brooks, Sherian; Bakal, Robert; Larsen, Rylan S.; Han, Ji Eun; Zylka, Mark J.; Philpot, Benjamin D.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA; [Yoon, Bong-June] Korea Univ, Div Life Sci, Seoul, South Korea; [Berrios, Janet; Wallace, Michael L.; Zylka, Mark J.; Philpot, Benjamin D.] Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC USA; [Chung, Eui Hwan] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Zylka, Mark J.; Philpot, Benjamin D.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC USA; [Zylka, Mark J.; Philpot, Benjamin D.] Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Korea University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Philpot, BD (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA.	bphilpot@med.unc.edu	Ariel, Pablo/AGJ-4118-2022; , UNC Flow Cytometry Core/AGU-9839-2022; Yoon, Bong June/L-7126-2017; , UNC Neuroscience Microscopy Core/AAE-8305-2022	Larsen, Rylan/0000-0002-7136-1175; Wallace, Michael/0000-0002-7270-8521; Huang, Hsien-Sung/0000-0003-2657-3635	NARSAD grant from the Brain and Behavior Research Foundation Young Investigator Award; NC TraCS [2KR30907]; Simons Foundation; NIMH [R01MH093372]; National Research Foundation of Korea (NRF) [NRF-2009-0075797]; NINDS [5P30NS045892]; NICHD [P30HD03110]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003110, U54HD079124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892] Funding Source: NIH RePORTER	NARSAD grant from the Brain and Behavior Research Foundation Young Investigator Award; NC TraCS; Simons Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	HSH was supported by a NARSAD grant from the Brain and Behavior Research Foundation Young Investigator Award and NC TraCS (2KR30907). MJZ and BDP were supported by grants from The Simons Foundation and NIMH (R01MH093372). BJY was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) (NRF-2009-0075797). Laser capture microdissection was performed in the Microscopy Services Laboratory, UNC Department of Pathology and Laboratory Medicine. Confocal imaging was performed at the UNC Confocal and Multiphoton Imaging Facility, which is funded by grants from NINDS (5P30NS045892) and NICHD (P30HD03110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balana B, 2011, P NATL ACAD SCI USA, V108, P5831, DOI 10.1073/pnas.1018645108; Barlow DP, 2011, ANNU REV GENET, V45, P379, DOI 10.1146/annurev-genet-110410-132459; BARTON SC, 1984, NATURE, V311, P374, DOI 10.1038/311374a0; Becker K, 2012, EUR J MED GENET, V55, P490, DOI 10.1016/j.ejmg.2012.03.003; Cai L, 2011, MOL CELL BIOL, V31, P1734, DOI 10.1128/MCB.01044-10; Crespi B, 2008, BIOL REV, V83, P441, DOI 10.1111/j.1469-185X.2008.00050.x; DeVeale B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002600; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Guez-Barber D, 2012, J NEUROSCI METH, V203, P10, DOI 10.1016/j.jneumeth.2011.08.045; Huang HS, 2012, NATURE, V481, P185, DOI 10.1038/nature10726; Kamikihara T, 2005, INT J CANCER, V115, P690, DOI 10.1002/ijc.20971; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Luedi PP, 2005, GENOME RES, V15, P875, DOI 10.1101/gr.3303505; Lunn ML, 2007, NAT NEUROSCI, V10, P1249, DOI 10.1038/nn1953; Maenaka S, 2006, ONCOL REP, V15, P791; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Seelan RS, 2008, NEUROSCIENCE, V151, P1184, DOI 10.1016/j.neuroscience.2007.10.045; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; Teasdale RD, 2012, BIOCHEM J, V441, P39, DOI 10.1042/BJ20111226; Vervoort VS, 2002, J MED GENET, V39, P893, DOI 10.1136/jmg.39.12.893; Wang X, 2013, NAT MED, V19, P473, DOI 10.1038/nm.3117; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Yoon BJ, 2002, NAT GENET, V30, P92, DOI 10.1038/ng795	25	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98383	10.1371/journal.pone.0098383	http://dx.doi.org/10.1371/journal.pone.0098383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859318	Green Published, gold, Green Submitted			2022-12-25	WOS:000336839400073
J	Chen, Y; Yang, SJ; Yao, WJ; Zhu, HY; Xu, XL; Meng, GL; Zhang, W				Chen, Yun; Yang, Shengju; Yao, Wenjuan; Zhu, Hongyan; Xu, Xiaole; Meng, Guoliang; Zhang, Wei			Prostacyclin Analogue Beraprost Inhibits Cardiac Fibroblast Proliferation Depending on Prostacyclin Receptor Activation through a TGF beta-Smad Signal Pathway	PLOS ONE			English	Article							NF-KAPPA-B; ISCHEMIA-REPERFUSION INJURY; CREB-BINDING-PROTEIN; SMOOTH-MUSCLE-CELLS; MYOCARDIAL FIBROSIS; MOLECULAR PATHWAYS; TYROSINE NITRATION; PROSTAGLANDIN I-2; MICE LACKING; ANGIOTENSIN	Previous studies showed that prostacyclin inhibited fibrosis. However, both receptors of prostacyclin, prostacyclin receptor (IP) and peroxisome proliferator-activated receptor (PPAR), are abundant in cardiac fibroblasts. Here we investigated which receptor was vital in the anti-fibrosis effect of prostacyclin. In addition, the possible mechanism involved in protective effects of prostacyclin against cardiac fibrosis was also studied. We found that beraprost, a prostacyclin analogue, inhibited angiotensin II (Ang II)-induced neonatal rat cardiac fibroblast proliferation in a concentration-dependent and time-dependent manner. Beraprost also suppressed Ang II-induced collagen I mRNA expression and protein synthesis in cardiac fibroblasts. After IP expression was knocked down by siRNA, Ang II-induced proliferation and collagen I synthesis could no longer be rescued by beraprost. However, treating cells with different specific inhibitors of PPAR subtypes prior to beraprost and Ang II stimulation, all of the above attenuating effects of beraprost were still available. Moreover, beraprost significantly blocked transforming growth factor beta (TGF beta) expression as well as Smad2 phosphorylation and reduced Smad-DNA binding activity. Beraprost also increased phosphorylation of cAMP response element binding protein (CREB) at Ser133 in the nucleus. Co-immunoprecipitation analysis revealed that beraprost increased CREB but decreased Smad2 binding to CREB-binding protein (CBP) in nucleus. In conclusion, beraprost inhibits cardiac fibroblast proliferation by activating IP and suppressing TGF beta-Smad signal pathway.	[Chen, Yun; Yao, Wenjuan; Zhu, Hongyan; Xu, Xiaole; Meng, Guoliang; Zhang, Wei] Nantong Univ, Sch Pharm, Dept Pharmacol, Nantong, Jiangsu, Peoples R China; [Yang, Shengju] Nantong Univ, Affiliated Hosp, Nantong, Jiangsu, Peoples R China	Nantong University; Nantong University	Meng, GL (corresponding author), Nantong Univ, Sch Pharm, Dept Pharmacol, Nantong, Jiangsu, Peoples R China.	mengguoliang@ntu.edu; zwei@ntu.edu.cn			National Natural Science Foundation of China [81202879, 81202467, 81200079]; Nature Science Foundation of Jiangsu Province University [12KJB310012, 11KJB350004]; Nature Science Foundation of Nantong City [BK2011044]; Nature Science Foundation of Nantong University [13ZY004]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Jiangsu Province University; Nature Science Foundation of Nantong City; Nature Science Foundation of Nantong University; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	This work was supported by grants from the National Natural Science Foundation of China (Grant Nos. 81202879, 81202467, 81200079), Nature Science Foundation of Jiangsu Province University (Grant Nos. 12KJB310012, 11KJB350004), Nature Science Foundation of Nantong City (Grant No. BK2011044), Nature Science Foundation of Nantong University (Grant No. 13ZY004), and a project funded by the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshin S, 2013, NEUROCHEM INT, V63, P322, DOI 10.1016/j.neuint.2013.06.012; Arehart E, 2008, CIRC RES, V102, P986, DOI 10.1161/CIRCRESAHA.107.165936; Baarsma HA, 2013, BRIT J PHARMACOL, V169, P590, DOI 10.1111/bph.12098; Bai J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072120; Barbieri SS, 2012, CIRCULATION, V126, P1373, DOI 10.1161/CIRCULATIONAHA.112.097295; Barroso E, 2011, BIOCHEM PHARMACOL, V81, P534, DOI 10.1016/j.bcp.2010.12.004; Binello E, 2014, J NEUROONCOL; Birrane G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053819; Cardinaux JR, 2000, MOL CELL BIOL, V20, P1546, DOI 10.1128/MCB.20.5.1546-1552.2000; Chan EC, 2010, J MOL CELL CARDIOL, V49, P176, DOI 10.1016/j.yjmcc.2010.04.006; Chao HH, 2010, J NUTR BIOCHEM, V21, P580, DOI 10.1016/j.jnutbio.2009.03.003; Chen HH, 2009, AM J PHYSIOL-RENAL, V297, pF1109, DOI 10.1152/ajprenal.00057.2009; Cheng CF, 2012, J CELL PHYSIOL, V227, P239, DOI 10.1002/jcp.22726; Dai Y, 2013, HYPERTENSION, V61, P751, DOI 10.1161/HYPERTENSIONAHA.111.00654; Dobaczewski M, 2012, J CARDIOVASC TRANSL, V5, P837, DOI 10.1007/s12265-012-9406-3; Dorris SL, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/926968; Elnakish MT, 2013, J PATHOL, V229, P347, DOI 10.1002/path.4111; Fujita K, 2008, ARTERIOSCL THROM VAS, V28, P863, DOI 10.1161/ATVBAHA.107.156687; Haack KKV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078695; Hara A, 2005, CIRCULATION, V112, P84, DOI 10.1161/CIRCULATIONAHA.104.527077; Harding P, 2011, LIFE SCI, V89, P671, DOI 10.1016/j.lfs.2011.07.025; He CY, 2010, AM J PATHOL, V176, P2542, DOI 10.2353/ajpath.2010.090783; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hou XY, 2013, EUR J PHARMACOL, V715, P196, DOI 10.1016/j.ejphar.2013.05.021; Jiang DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079215; Jin LH, 2011, J BIOL CHEM, V286, P31473, DOI 10.1074/jbc.M111.266023; Kaneshige T, 2007, J VET MED SCI, V69, P1271, DOI 10.1292/jvms.69.1271; Katusic ZS, 2012, TRENDS PHARMACOL SCI, V33, P559, DOI 10.1016/j.tips.2012.05.005; Kulkarni AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015909; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Li L, 2011, CARDIOVASC RES, V91, P80, DOI 10.1093/cvr/cvr067; Li Y, 2012, AM J RESP CELL MOL, V46, P372, DOI 10.1165/rcmb.2010-0428OC; Lian WS, 2013, CURR VASC PHARM; Lin H, 2008, J CELL PHYSIOL, V214, P434, DOI 10.1002/jcp.21214; Lu D, 2012, FASEB J, V26, P2580, DOI 10.1096/fj.12-204677; Ma FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035144; Marathe HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069037; Matsuda Satoru, 2013, Cancers (Basel), V5, P1261, DOI 10.3390/cancers5041261; Meng GL, 2009, J CARDIOVASC PHARM, V54, P16, DOI 10.1097/FJC.0b013e3181a98b31; Nakayama K, 2013, J BIOL CHEM, V288, P22584, DOI 10.1074/jbc.M112.421636; Nasu T, 2012, AM J PHYSIOL-RENAL, V302, pF1616, DOI 10.1152/ajprenal.00538.2011; Nemenoff R, 2008, CANCER PREV RES, V1, P349, DOI 10.1158/1940-6207.CAPR-08-0145; Ng HK, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-188; Ogo T, 2013, AM J RESP CELL MOL, V48, P733, DOI 10.1165/rcmb.2012-0049OC; Rossoni G, 2006, PHARMACOL RES, V53, P359, DOI 10.1016/j.phrs.2006.01.004; Shahbaz AU, 2010, J HYPERTENS, V28, pS25, DOI 10.1097/01.hjh.0000388491.35836.d2; Song BS, 2009, REPROD FERT DEVELOP, V21, P400, DOI 10.1071/RD08180; Spinale FG, 2013, CIRC RES, V112, P195, DOI 10.1161/CIRCRESAHA.112.266882; Stratton R, 2002, FASEB J, V16, P1949, DOI 10.1096/fj.02-0204fje; Sue YM, 2009, AM J PHYSIOL-CELL PH, V297, pC321, DOI 10.1152/ajpcell.00069.2009; Sun DX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041857; Sun Y, 2005, METH MOLEC MED, V117, P273; Teunissen BEJ, 2007, CARDIOVASC RES, V75, P519, DOI 10.1016/j.cardiores.2007.04.026; Tsai CT, 2007, CIRC RES, V100, P1476, DOI 10.1161/01.RES.0000268497.93085.e1; Tsai MC, 2009, CIRC RES, V105, P471, DOI 10.1161/CIRCRESAHA.109.193656; Weber KT, 2013, NAT REV CARDIOL, V10, P15, DOI 10.1038/nrcardio.2012.158; Xiao CY, 2001, CIRCULATION, V104, P2210, DOI 10.1161/hc4301.098058; Xu Q, 2013, BIOMED RES-TOKYO, V34, P241; Yamabayashi C, 2012, AM J RESP CELL MOL, V47, P170, DOI 10.1165/rcmb.2011-0350OC; Yang J, 2010, CIRC RES, V107, P252, DOI 10.1161/CIRCRESAHA.109.209940; Yu H, 1997, HYPERTENSION, V30, P1047, DOI 10.1161/01.HYP.30.5.1047; Yuan H, 2013, AM J PHYSIOL-RENAL, V304, pF601, DOI 10.1152/ajprenal.00523.2012; Zhou TB, 2013, J RECEPT SIG TRANSD, V33, P349, DOI 10.3109/10799893.2013.838786; Zou MH, 2011, AM J PATHOL, V179, P2835, DOI 10.1016/j.ajpath.2011.08.041	64	25	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98483	10.1371/journal.pone.0098483	http://dx.doi.org/10.1371/journal.pone.0098483			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852754	Green Submitted, Green Published, gold			2022-12-25	WOS:000338323200072
J	Das, U; Manna, K; Sinha, M; Datta, S; Das, DK; Chakraborty, A; Ghosh, M; Das Saha, K; Dey, S				Das, Ujjal; Manna, Krishnendu; Sinha, Mahuya; Datta, Sanjukta; Das, Dipesh Kr; Chakraborty, Anindita; Ghosh, Mahua; Das Saha, Krishna; Dey, Sanjit			Role of Ferulic Acid in the Amelioration of Ionizing Radiation Induced Inflammation: A Murine Model	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; TRANSCRIPTION FACTOR; ANTIOXIDANT STATUS; GENE-EXPRESSION; ACTIVATION; INVOLVEMENT; DAMAGE; INTERLEUKIN-1	Ionizing radiation is responsible for oxidative stress by generating reactive oxygen species (ROS), which alters the cellular redox potential. This change activates several redox sensitive enzymes which are crucial in activating signaling pathways at molecular level and can lead to oxidative stress induced inflammation. Therefore, the present study was intended to assess the anti-inflammatory role of ferulic acid (FA), a plant flavonoid, against radiation-induced oxidative stress with a novel mechanistic viewpoint. FA was administered (50 mg/kg body wt) to Swiss albino mice for five consecutive days prior to exposing them to a single dose of 10 Gy Co-60 gamma-irradiation. The dose of FA was optimized from the survival experiment and 50 mg/kg body wt dose showed optimum effect. FA significantly ameliorated the radiation induced inflammatory response such as phosphorylation of IKK alpha/beta and I kappa B alpha and consequent nuclear translocation of nuclear factor kappa B (NF-kappa B). FA also prevented the increase of cycloxygenase-2 (Cox-2) protein, inducible nitric oxide synthase-2 (iNOS-2) gene expression, lipid peroxidation in liver and the increase of tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) in serum. It was observed that exposure to radiation results in decreased activity of superoxide dismutase (SOD), catalase (CAT) and the pool of reduced glutathione (GSH) content. However, FA treatment prior to irradiation increased the activities of the same endogenous antioxidants. Thus, pretreatment with FA offers protection against gamma radiation induced inflammation.	[Das, Ujjal; Manna, Krishnendu; Sinha, Mahuya; Das, Dipesh Kr; Dey, Sanjit] Univ Calcutta, Ctr Nanosci & Nanotechnol, Dept Physiol, Kolkata, W Bengal, India; [Das, Ujjal; Manna, Krishnendu; Sinha, Mahuya; Das, Dipesh Kr; Dey, Sanjit] Univ Calcutta, CPEPA, Kolkata, W Bengal, India; [Datta, Sanjukta; Ghosh, Mahua] Univ Calcutta, Dept Chem Technol, Kolkata, W Bengal, India; [Chakraborty, Anindita] UGC DAE CSR, Ctr Kolkata, Dept Radiat Biol, Kolkata, W Bengal, India; [Das Saha, Krishna] IICB, Canc Biol & Inflammatory Disorder Div, Kolkata, W Bengal, India	University of Calcutta; University of Calcutta; University of Calcutta; UGC DAE Consortium for Scientific Research; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Dey, S (corresponding author), Univ Calcutta, Ctr Nanosci & Nanotechnol, Dept Physiol, Kolkata, W Bengal, India.	sanjitdey2003@yahoo.com	Dey, Sanjit/AAM-6497-2020	Dey, Sanjit/0000-0001-6534-0522; Manna, Krishnendu/0000-0002-5782-1585	Life Science Research Board (LSRB); CSIR; Coconut Development Board; West Bengal DBT; Department of Science and technology (DST); UGC, Government India; CRNN	Life Science Research Board (LSRB); CSIR(Council of Scientific & Industrial Research (CSIR) - India); Coconut Development Board; West Bengal DBT; Department of Science and technology (DST)(Department of Science & Technology (India)); UGC, Government India; CRNN	SD acknowledges the support of funding by Life Science Research Board (LSRB), CSIR, Coconut Development Board, and West Bengal DBT for funding. SD acknowledges the support of Department of Science and technology (DST) for PURSE scheme to the Department of Physiology and UGC, Government India, for support under CPEPA scheme granted and CRNN to University of Calcutta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; BRACH MA, 1991, J CLIN INVEST, V88, P691, DOI 10.1172/JCI115354; Buege J A, 1978, Methods Enzymol, V52, P302; Chen CY, 2007, LIFE SCI, V81, P1602, DOI 10.1016/j.lfs.2007.09.028; CHEN QL, 1995, J BIOL CHEM, V270, P28499, DOI 10.1074/jbc.270.48.28499; Chiarugi P, 2003, TRENDS BIOCHEM SCI, V28, P509, DOI 10.1016/S0968-0004(03)00174-9; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Crofford LJ, 1997, ARTHRITIS RHEUM-US, V40, P226, DOI 10.1002/art.1780400207; Das DKR, 2013, INT J RADIAT BIOL, V89, P471, DOI 10.3109/09553002.2013.767989; FAJARDO LF, 1978, AM J SURG PATHOL, V2, P159, DOI 10.1097/00000478-197806000-00005; Giusti AM, 1998, INT J RADIAT BIOL, V74, P595, DOI 10.1080/095530098141177; GOYAL PK, 1983, STRAHLENTHER ONKOL, V159, P239; Greenberg ME, 2008, J BIOL CHEM, V283, P2385, DOI 10.1074/jbc.M707348200; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Hensley ML, 1999, J CLIN ONCOL, V17, P3333, DOI 10.1200/JCO.1999.17.10.3333; INGOLD JA, 1965, AMER J ROENTGENOL RA, V93, P200; Jagetia GC, 2005, LIFE SCI, V77, P780, DOI 10.1016/j.lfs.2005.01.015; Kesh SB, 2013, LIFE SCI, V92, P938, DOI 10.1016/j.lfs.2013.03.015; Krasteva Ilina, 2004, Acta Pharmaceutica (Zagreb), V54, P151; LEWIN K, 1973, ARCH PATHOL, V96, P21; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma ZC, 2011, INT J RADIAT BIOL, V87, P130, DOI 10.3109/09553002.2011.523510; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; MEIER B, 1989, BIOCHEM J, V263, P539, DOI 10.1042/bj2630539; MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7; NEMOTO K, 1995, RADIAT RES, V141, P223, DOI 10.2307/3579052; OHBA M, 1994, J CELL BIOL, V126, P1079, DOI 10.1083/jcb.126.4.1079; Ou SY, 2004, J SCI FOOD AGR, V84, P1261, DOI 10.1002/jsfa.1873; PARASASSI T, 1994, INT J RADIAT BIOL, V65, P329, DOI 10.1080/09553009414550391; Ramadori G, 2008, J PHYSIOL PHARMACOL, V59, P107; REED GB, 1966, AM J PATHOL, V48, P597; SCHMIDT KN, 1995, J BIOL CHEM, V270, P27136, DOI 10.1074/jbc.270.45.27136; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Selim NS, 2010, APPL RADIAT ISOTOPES, V68, P1018, DOI 10.1016/j.apradiso.2010.01.020; Sinha M, 2012, FREE RADICAL RES, V46, P842, DOI 10.3109/10715762.2012.684245; Srinivasan M, 2006, TOXICOLOGY, V228, P249, DOI 10.1016/j.tox.2006.09.004; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Thannickal VJ, 1995, J BIOL CHEM, V270, P30334, DOI 10.1074/jbc.270.51.30334; van Buerck L, 2012, MOL CELL ENDOCRINOL, V362, P139, DOI 10.1016/j.mce.2012.06.001; Yumoto I, 2000, J BACTERIOL, V182, P1903, DOI 10.1128/JB.182.7.1903-1909.2000; Yvonne YC, 2005, J BIOL CHEM, V270, P11727	44	60	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97599	10.1371/journal.pone.0097599	http://dx.doi.org/10.1371/journal.pone.0097599			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24854039	Green Published, Green Submitted, gold			2022-12-25	WOS:000338323200022
J	Gingery, A; Subramaniam, M; Pitel, KS; Reese, JM; Cicek, M; Lindenmaier, LB; Ingle, JN; Goetz, MP; Turner, RT; Iwaniec, UT; Spelsberg, TC; Hawse, JR				Gingery, Anne; Subramaniam, Malayannan; Pitel, Kevin S.; Reese, Jordan M.; Cicek, Muzaffer; Lindenmaier, Laurence B.; Ingle, James N.; Goetz, Matthew P.; Turner, Russell T.; Iwaniec, Urszula T.; Spelsberg, Thomas C.; Hawse, John R.			The Effects of a Novel Hormonal Breast Cancer Therapy, Endoxifen, on the Mouse Skeleton	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; BONE-MINERAL DENSITY; FIRST-LINE THERAPY; POSTMENOPAUSAL WOMEN; AMERICAN SOCIETY; ZOLEDRONIC ACID; TAMOXIFEN; RALOXIFENE; METABOLISM; OSTEOCLAST	Endoxifen has recently been identified as the predominant active metabolite of tamoxifen and is currently being developed as a novel hormonal therapy for the treatment of endocrine sensitive breast cancer. Based on past studies in breast cancer cells and model systems, endoxifen classically functions as an anti-estrogenic compound. Since estrogen and estrogen receptors play critical roles in mediating bone homeostasis, and endoxifen is currently being implemented as a novel breast cancer therapy, we sought to comprehensively characterize the in vivo effects of endoxifen on the mouse skeleton. Two month old ovariectomized C57BL/6 mice were treated with vehicle or 50 mg/kg/day endoxifen hydrochloride via oral gavage for 45 days. Animals were analyzed by dual-energy x-ray absorptiometry, peripheral quantitative computed tomography, micro-computed tomography and histomorphometry. Serum from control and endoxifen treated mice was evaluated for bone resorption and bone formation markers. Gene expression changes were monitored in osteoblasts, osteoclasts and the cortical shells of long bones from endoxifen treated mice and in a human fetal osteoblast cell line. Endoxifen treatment led to significantly higher bone mineral density and bone mineral content throughout the skeleton relative to control animals. Endoxifen treatment also resulted in increased numbers of osteoblasts and osteoclasts per tissue area, which was corroborated by increased serum levels of bone formation and resorption markers. Finally, endoxifen induced the expression of osteoblast, osteoclast and osteocyte marker genes. These studies are the first to examine the in vivo and in vitro impacts of endoxifen on bone and our results demonstrate that endoxifen increases cancellous as well as cortical bone mass in ovariectomized mice, effects that may have implications for postmenopausal breast cancer patients.	[Gingery, Anne; Subramaniam, Malayannan; Pitel, Kevin S.; Reese, Jordan M.; Cicek, Muzaffer; Spelsberg, Thomas C.; Hawse, John R.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Reese, Jordan M.; Goetz, Matthew P.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA; [Lindenmaier, Laurence B.; Turner, Russell T.; Iwaniec, Urszula T.] Oregon State Univ, Sch Biol & Populat Hlth Sci, Skeletal Biol Lab, Corvallis, OR 97331 USA; [Ingle, James N.; Goetz, Matthew P.] Mayo Clin, Dept Oncol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Oregon State University; Mayo Clinic	Hawse, JR (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	hawse.john@mayo.edu	Goetz, Matthew P/AAH-2333-2020	Harrington, Jon/0000-0003-1293-5201; Gingery, Anne/0000-0002-1690-7382	NIH [AR063596, T32AR056950]; Mayo Clinic Breast Cancer [SPORE: P50CA116201]; Breast Cancer Research Foundation; Susan G. Komen for the Cure [KG100142]; Paul Calabresi K12 award NCI [CA90628]; Mayo Clinic Graduate School; Mayo Foundation; NATIONAL CANCER INSTITUTE [P50CA116201, P30CA015083, K12CA090628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR063596, T32AR056950] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Breast Cancer; Breast Cancer Research Foundation; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Paul Calabresi K12 award NCI; Mayo Clinic Graduate School; Mayo Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work presented here was supported by two NIH training grants: AR063596 (AG) and T32AR056950 (AG), the Mayo Clinic Breast Cancer SPORE: P50CA116201 (JNI, MPG and JRH), a Breast Cancer Research Foundation grant (JNI), Susan G. Komen for the Cure KG100142 (JRH), a Paul Calabresi K12 award NCI CA90628 (JRH), a generous gift from Bruce and Martha Atwater (TCS, JRH, MPG, JNI), the Mayo Clinic Graduate School (JMR) and the Mayo Foundation (TCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara T, 2010, ONCOLOGY-BASEL, V79, P376, DOI 10.1159/000323489; Amir E, 2011, JNCI-J NATL CANCER I, V103, P1299, DOI 10.1093/jnci/djr242; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; [Anonymous], 2003, World Health Organ Tech Rep Ser, V921, P1; [Anonymous], 2010, CLIN GUID PREV TREAT; Arnett TR, 1996, J ENDOCRINOL, V149, P503, DOI 10.1677/joe.0.1490503; Becker T, 2012, J AM GERIATR SOC, V60, P1761, DOI 10.1111/j.1532-5415.2012.04107.x; Bensamoun SF, 2006, BONE, V39, P1244, DOI 10.1016/j.bone.2006.05.021; Bijl MJ, 2009, BREAST CANCER RES TR, V118, P125, DOI 10.1007/s10549-008-0272-2; Bonneterre J, 2000, J CLIN ONCOL, V18, P3748, DOI 10.1200/JCO.2000.18.22.3748; Bord S, 2001, J CLIN ENDOCR METAB, V86, P2309, DOI 10.1210/jc.86.5.2309; Brufsky AM, 2009, CLIN BREAST CANCER, V9, P77, DOI 10.3816/CBC.2009.n.015; Cano A, 2008, OSTEOPOROSIS INT, V19, P793, DOI 10.1007/s00198-007-0498-6; Celil AB, 2005, J CELL BIOCHEM, V95, P518, DOI 10.1002/jcb.20429; Choleris E, 2008, CURR OPIN INVEST DR, V9, P760; Cicek M, 2007, CANCER RES, V67, P10106, DOI 10.1158/0008-5472.CAN-07-1362; Cicek M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017522; Coates AS, 2007, J CLIN ONCOL, V25, P486, DOI 10.1200/JCO.2006.08.8617; Cummings SR, 2010, NEW ENGL J MED, V362, P686, DOI 10.1056/NEJMoa0808692; Delmas PD, 1997, NEW ENGL J MED, V337, P1641, DOI 10.1056/NEJM199712043372301; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Deshmane V, 2007, J CLIN ONCOL, V25, P4967, DOI 10.1200/JCO.2006.09.5992; Desta Z, 2004, J PHARMACOL EXP THER, V310, P1062, DOI 10.1124/jpet.104.065607; Eidtmann H, 2010, ANN ONCOL, V21, P2188, DOI 10.1093/annonc/mdq217; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; EVANS G, 1994, ENDOCRINOLOGY, V134, P2283, DOI 10.1210/en.134.5.2283; Evans GL, 1996, ENDOCRINOLOGY, V137, P4139, DOI 10.1210/en.137.10.4139; Gingery A, 2003, J CELL BIOCHEM, V89, P165, DOI 10.1002/jcb.10503; Goetz MP, 2007, BREAST CANCER RES TR, V101, P113, DOI 10.1007/s10549-006-9428-0; Goetz MP, 2013, CLIN CANCER RES, V19, P500, DOI 10.1158/1078-0432.CCR-12-2153; Goetz MP, 2005, J CLIN ONCOL, V23, P9312, DOI 10.1200/JCO.2005.03.3266; Goldstein SR, 2000, HUM REPROD UPDATE, V6, P212, DOI 10.1093/humupd/6.3.212; HARRIS SA, 1995, J CELL BIOCHEM, V59, P193, DOI 10.1002/jcb.240590209; Hawse JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054613; Hillner BE, 2003, J CLIN ONCOL, V21, P4042, DOI 10.1200/JCO.2003.08.017; Iwaniec Urszula T., 2008, V447, P325, DOI 10.1007/978-1-59745-242-7_21; Kawai M, 2011, NAT REV DRUG DISCOV, V10, P141, DOI 10.1038/nrd3299; Kisanga ER, 2003, J STEROID BIOCHEM, V84, P361, DOI 10.1016/S0960-0760(03)00051-7; Kiyotani K, 2008, CANCER SCI, V99, P995, DOI 10.1111/j.1349-7006.2008.00780.x; Ligibel JA, BREAST CANC RES TREA, V134, P1305; Parra-Palau JL, 2010, CANCER RES, V70, P8537, DOI 10.1158/0008-5472.CAN-10-1701; LONNING PE, 1992, CLIN PHARMACOKINET, V22, P327, DOI 10.2165/00003088-199222050-00002; Maran A., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P83; McClung MR, 2006, MENOPAUSE, V13, P377, DOI 10.1097/01.gme.0000188736.69617.4f; Migliaccio S, 2007, CLIN INTERV AGING, V2, P55, DOI 10.2147/ciia.2007.2.1.55; Nabholtz JM, 2000, J CLIN ONCOL, V18, P3758, DOI 10.1200/JCO.2000.18.22.3758; Newman WG, 2008, CLIN CANCER RES, V14, P5913, DOI 10.1158/1078-0432.CCR-07-5235; Nowell SA, 2005, BREAST CANCER RES TR, V91, P249, DOI 10.1007/s10549-004-7751-x; Paridaens R, 2000, Clin Breast Cancer, V1 Suppl 1, pS19, DOI 10.3816/CBC.2000.s.004; Qu Q, 1999, J CELL BIOCHEM, V73, P500, DOI 10.1002/(SICI)1097-4644(19990615)73:4<500::AID-JCB8>3.0.CO;2-E; Ramalho AC, 2002, EUR CYTOKINE NETW, V13, P39; Rizzoli R, OSTEOPOROS INT, V23, P2567; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Schroth W, 2007, J CLIN ONCOL, V25, P5187, DOI 10.1200/JCO.2007.12.2705; STEWART PJ, 1986, ENDOCRINOLOGY, V118, P125, DOI 10.1210/endo-118-1-125; Sugiyama T, 2010, ENDOCRINOLOGY, V151, P5582, DOI 10.1210/en.2010-0645; Taranta A, 2002, BONE, V30, P368, DOI 10.1016/S8756-3282(01)00685-8; Tou LQ, 2001, MOL CELL ENDOCRINOL, V183, P71, DOI 10.1016/S0303-7207(01)00594-9; TURNER RT, 1987, J BONE MINER RES, V2, P449; TURNER RT, 1988, ENDOCRINOLOGY, V122, P1146, DOI 10.1210/endo-122-3-1146; van den Wijngaard A, 2000, MOL ENDOCRINOL, V14, P623, DOI 10.1210/me.14.5.623; Van Poznak C, 2010, J CLIN ONCOL, V28, P967, DOI 10.1200/JCO.2009.24.5902; Visvanathan K, 2009, J CLIN ONCOL, V27, P3235, DOI 10.1200/JCO.2008.20.5179; Vogel VG, 2010, CANCER PREV RES, V3, P696, DOI 10.1158/1940-6207.CAPR-10-0076; Wegman P, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1640; Weinstein RS, 2009, NEW ENGL J MED, V360, P53, DOI 10.1056/NEJMoa0802633; Wells G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004523.pub3; Wu XL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2844; Wu XL, 2009, CANCER RES, V69, P1722, DOI 10.1158/0008-5472.CAN-08-3933; Yang NN, 1996, ENDOCRINOLOGY, V137, P2075, DOI 10.1210/en.137.5.2075	70	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98219	10.1371/journal.pone.0098219	http://dx.doi.org/10.1371/journal.pone.0098219			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853369	gold, Green Published			2022-12-25	WOS:000338323200056
J	Yu, TL; Lin, HD; Weng, CF				Yu, Teng-Lang; Lin, Hung-Du; Weng, Ching-Feng			A New Phylogeographic Pattern of Endemic Bufo bankorensis in Taiwan Island Is Attributed to the Genetic Variation of Populations	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; ARC-CONTINENT COLLISION; MITOCHONDRIAL-DNA; TOAD; CONSEQUENCES; DIFFERENTIATION; DIVERGENCE; GLACIATION; CYPRINIDAE; DISPERSAL	Aim: To comprehend the phylogeographic patterns of genetic variation in anurans at Taiwan Island, this study attempted to examine (1) the existence of various geological barriers (Central Mountain Ranges, CMRs); and (2) the genetic variation of Bufo bankorensis using mtDNA sequences among populations located in different regions of Taiwan, characterized by different climates and existing under extreme conditions when compared available sequences of related species B. gargarizans of mainland China. Methodology/Principal Findings: Phylogenetic analyses of the dataset with mitochondrial DNA (mtDNA) D-loop gene (348 bp) recovered a close relationship between B. bankorensis and B. gargarizans, identified three distinct lineages. Furthermore, the network of mtDNA D-loop gene (564 bp) amplified (279 individuals, 27 localities) from Taiwan Island indicated three divergent clades within B. bankorensis (Clade W, E and S), corresponding to the geography, thereby verifying the importance of the CMRs and Kaoping River drainage as major biogeographic barriers. Mismatch distribution analysis, neutrality tests and Bayesian skyline plots revealed that a significant population expansion occurred for the total population and Clade W, with horizons dated to approximately 0.08 and 0.07 Mya, respectively. These results suggest that the population expansion of Taiwan Island species B. bankorensis might have resulted from the release of available habitat in post-glacial periods, the genetic variation on mtDNA showing habitat selection, subsequent population dispersal, and co-distribution among clades. Conclusions: The multiple origins (different clades) of B. bankorensis mtDNA sequences were first evident in this study. The divergent genetic clades found within B. bankorensis could be independent colonization by previously diverged lineages; inferring B. bankorensis originated from B. gargarizans of mainland China, then dispersal followed by isolation within Taiwan Island. Highly divergent clades between W and E of B. bankorensis, implies that the CMRs serve as a genetic barrier and separated the whole island into the western and eastern phylogroups.	[Yu, Teng-Lang; Weng, Ching-Feng] Natl Dong Hwa Univ, Dept Life Sci & Inst Biotechnol, Hualien, Taiwan; [Lin, Hung-Du] Natl Tainan First Senior High Sch, Affiliated Sch, Tainan, Taiwan	National Dong Hwa University	Weng, CF (corresponding author), Natl Dong Hwa Univ, Dept Life Sci & Inst Biotechnol, Hualien, Taiwan.	cfweng@mail.ndhu.edu.tw		Weng, Ching-Feng/0000-0002-9747-8697	Yushan National Park; Taroko National Park Headquarters	Yushan National Park; Taroko National Park Headquarters	We are grateful to the Yushan National Park and Taroko National Park Headquarters grants for Ching-Feng Weng. We thank our field assistants, particularly Ho-Tsung Chu, Kou-Wei Li and Li-Hsuen Chen, and Institutes granted access to collections including Kenting National Park, Taroko National Park, Yangmingshan National Park and Yushan National Park Headquarters. We address sincerely thank to senior Professor Sin-Che Lee and Dr. Chien-Hsien Kuo for incredible advice, and Hui-Ling Chang and Yu-Bao Wang for technical assistance. We would like to extend our thanks to all staff of the Yushan National Park involved in the B. bankorensis collaboration. Of course, this work also dedicates a memorial to the animals of Taiwan.	AVISE JC, 1986, PHILOS T ROY SOC B, V312, P325, DOI 10.1098/rstb.1986.0011; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 2010, MIGRATE DOCUMENTATIO; Bollmer JL, 2006, MOL PHYLOGENET EVOL, V39, P237, DOI 10.1016/j.ympev.2005.11.014; Bossart JL, 1998, TRENDS ECOL EVOL, V13, P202, DOI 10.1016/S0169-5347(97)01284-6; Chen CC, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-48; Clegg S, 2010, THEORY OF ISLAND BIOGEOGRAPHY REVISITED, P293; Creer S, 2001, MOL ECOL, V10, P1967, DOI 10.1046/j.0962-1083.2001.01332.x; Degani G, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-18; Drummond A.J., 2007, TRACER VERSION 15; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duellman WE, 1999, PATTERNS DISTRIBUTIO; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; EXCOFFIER L, 1994, GENETICS, V136, P343; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Frost DR., 2022, AMPHIBIAN SPECIES WO; Fu JZ, 2005, MOL PHYLOGENET EVOL, V37, P202, DOI 10.1016/j.ympev.2005.03.023; Fu YX, 1997, GENETICS, V147, P915; Goudie AS, 1999, ENV HIST CHANGE, P10; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamer AJ, 2008, BIOL CONSERV, V141, P2432, DOI 10.1016/j.biocon.2008.07.020; HARPENDING HC, 1994, HUM BIOL, V66, P591; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; Harrison S, 1996, TRENDS ECOL EVOL, V11, P180, DOI 10.1016/0169-5347(96)20008-4; Hebenstreit R, 2006, QUATERN INT, V147, P76, DOI 10.1016/j.quaint.2005.09.009; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hisai N, 1987, MISCELLANEOUS REPORT, V18, P1; Hu YL, 2007, BIOCHEM GENET, V45, P697, DOI 10.1007/s10528-007-9107-9; Huang CY, 1997, TECTONOPHYSICS, V281, P31, DOI 10.1016/S0040-1951(97)00157-1; Huang WS, 1996, ZOOL STUD, V35, P128; Igawa T, 2006, MOL PHYLOGENET EVOL, V38, P250, DOI 10.1016/j.ympev.2005.09.003; Inger R. F, 1972, EVOLUTION GENUS BUFO; Inger RF, 1972, BUFO EURASIA; Jaeger JR, 2005, MOL ECOL, V14, P3033, DOI 10.1111/j.1365-294X.2005.02645.x; Jang-Liaw NH, 2008, ZOOL SCI, V25, P68, DOI 10.2108/zsj.25.68; Jang-Liaw NH, 2009, ZOOL SCI, V26, P608, DOI 10.2108/zsj.26.608; Johns GC, 1998, MOL BIOL EVOL, V15, P1481, DOI 10.1093/oxfordjournals.molbev.a025875; KAWAMURA T, 1982, JPN J GENET, V57, P677; KAWAMURA T, 1980, Scientific Report of the Laboratory for Amphibian Biology Hiroshima University, V4, P1; Knowles LL, 2009, ANNU REV ECOL EVOL S, V40, P593, DOI 10.1146/annurev.ecolsys.38.091206.095702; Kusano T, 1995, J HERPETOL, V29, P633, DOI 10.2307/1564755; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin C.C., 1966, B DEP ARCHAEOL ANTHR, V23, P7; Lin HD, 2008, J FISH BIOL, V72, P2011, DOI 10.1111/j.1095-8649.2008.01836.x; Lin HC, 2008, CONSERV GENET, V9, P1089, DOI 10.1007/s10592-007-9418-8; Lin HD, 2012, MOL PHYLOGENET EVOL, V62, P251, DOI 10.1016/j.ympev.2011.09.022; Liu TK, 2000, TECTONOPHYSICS, V320, P69, DOI 10.1016/S0040-1951(00)00028-7; Liu WZ, 2000, MOL PHYLOGENET EVOL, V14, P423, DOI 10.1006/mpev.1999.0716; Lue GY, 1982, AMPHIBIANS TAIWAN, P1; Lue KY, 1990, WILDLIFE DATA BANK T; Macey JR, 1998, MOL PHYLOGENET EVOL, V9, P80, DOI 10.1006/mpev.1997.0440; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; MANTEL N, 1967, CANCER RES, V27, P209; Masta SE, 2003, MOL ECOL, V12, P1541, DOI 10.1046/j.1365-294X.2003.01829.x; MATSUI M, 1986, COPEIA, P561; MATSUI M, 1984, Contributions from the Biological Laboratory Kyoto University, V26, P209; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; NEI M, 1983, GENETICS, V105, P207; Nei M., 1987, MOL EVOLUTIONARY GEN; NICHOLS RA, 1994, HEREDITY, V72, P312, DOI 10.1038/hdy.1994.41; NISHIOKA M, 1990, Scientific Report of the Laboratory for Amphibian Biology Hiroshima University, V10, P53; Ono YG, 2005, QUATERN INT, V138, P79, DOI 10.1016/j.quaint.2005.02.007; Oshida T, 2006, J MAMMAL, V87, P247, DOI 10.1644/05-MAMM-A-123R1.1; Oshida T, 2011, BIOL J LINN SOC, V102, P404, DOI 10.1111/j.1095-8312.2010.01576.x; Pons O, 1996, GENETICS, V144, P1237; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prohl H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-146; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowe G, 2006, MOL PHYLOGENET EVOL, V39, P335, DOI 10.1016/j.ympev.2005.08.021; Semlitsch RD, 2009, BIOSCIENCE, V59, P853, DOI 10.1525/bio.2009.59.10.7; Shih HT, 2006, J BIOGEOGR, V33, P980, DOI 10.1111/j.1365-2699.2006.01472.x; Sibuet JC, 2004, TECTONOPHYSICS, V379, P159, DOI 10.1016/j.tecto.2003.10.022; Smith MA, 2004, MOL ECOL, V13, P3723, DOI 10.1111/j.1365-294X.2004.02301.x; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TENG LS, 1990, TECTONOPHYSICS, V183, P57, DOI 10.1016/0040-1951(90)90188-E; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toda M, 1998, HERPETOLOGICA, V54, P73; TZENG C-S, 1986, Journal of Taiwan Museum, V39, P127; VENCES M, 2007, AMPHIBIAN BIOL, V7; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wang CF, 2011, ZOOL J LINN SOC-LOND, V161, P613, DOI 10.1111/j.1096-3642.2010.00646.x; Wang HY, 1999, MOL ECOL, V8, P1879, DOI 10.1046/j.1365-294x.1999.00787.x; Wang JP, 2004, MOL PHYLOGENET EVOL, V31, P1143, DOI 10.1016/j.ympev.2003.10.001; Wang JP, 2000, MOL ECOL, V9, P1483, DOI 10.1046/j.1365-294x.2000.01023.x; Wang TY, 2007, ZOOL STUD, V46, P569; Wang TY, 2007, ZOOL STUD, V46, P547; Watanabe K, 2007, ICHTHYOL RES, V54, P253, DOI 10.1007/s10228-007-0398-y; Yeh WB, 2004, ANN ENTOMOL SOC AM, V97, P613, DOI 10.1603/0013-8746(2004)097[0613:GDOLAC]2.0.CO;2; YU HT, 1995, BIOL J LINN SOC, V55, P69, DOI 10.1111/j.1095-8312.1995.tb01050.x; Zeisset I, 2008, HEREDITY, V101, P109, DOI 10.1038/hdy.2008.30; Zhao E, 1993, HERPETOLOGY CHINA, V10; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	101	19	19	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98029	10.1371/journal.pone.0098029	http://dx.doi.org/10.1371/journal.pone.0098029			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853679	Green Submitted, gold, Green Published			2022-12-25	WOS:000338323200039
J	Zheng, SH; Jiang, X; Wu, LB; Wang, ZH; Huang, LF				Zheng, Sihao; Jiang, Xue; Wu, Labin; Wang, Zenghui; Huang, Linfang			Chemical and Genetic Discrimination of Cistanches Herba Based on UPLC-QTOF/MS and DNA Barcoding	PLOS ONE			English	Article							DIODE-ARRAY DETECTION; PHENYLPROPANOID GLYCOSIDES; PHENYLETHANOID GLYCOSIDES; CONSTITUENTS; IDENTIFICATION; DESERTICOLA; TUBULOSA; OLIGOGLYCOSIDES; FINGERPRINT; FTIR	Cistanches Herba (Rou Cong Rong), known as "Ginseng of the desert", has a striking curative effect on strength and nourishment, especially in kidney reinforcement to strengthen yang. However, the two plant origins of Cistanches Herba, Cistanche deserticola and Cistanche tubulosa, vary in terms of pharmacological action and chemical components. To discriminate the plant origin of Cistanches Herba, a combined method system of chemical and genetic -UPLC-QTOF/MS technology and DNA barcoding-were firstly employed in this study. The results indicated that three potential marker compounds (isomer of campneoside II, cistanoside C, and cistanoside A) were obtained to discriminate the two origins by PCA and OPLS-DA analyses. DNA barcoding enabled to differentiate two origins accurately. NJ tree showed that two origins clustered into two clades. Our findings demonstrate that the two origins of Cistanches Herba possess different chemical compositions and genetic variation. This is the first reported evaluation of two origins of Cistanches Herba, and the finding will facilitate quality control and its clinical application.	[Zheng, Sihao; Jiang, Xue; Wu, Labin; Wang, Zenghui; Huang, Linfang] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College	Huang, LF (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Beijing 100730, Peoples R China.	lfhuang@implad.ac.cn			National Natural Science Foundation of China [81274013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by grants from the National Natural Science Foundation of China (No. 81274013, website: www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen J, 2009, SPECTROSC SPECT ANAL, V29, P1502, DOI 10.3964/j.issn.1000-0593(2009)06-1502-06; [陈培 CHEN Pei], 2006, [中草药, Chinese Traditional and Herbal Drugs], V37, P1399; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Gan XY, 2011, NO HORTICULTURE, P141; Gu XY, 2013, W CHIN MED, V26, P17; Han Jian-ping, 2010, Yaoxue Xuebao, V45, P126; Han LF, 2012, PHYTOCHEM ANALYSIS, V23, P668, DOI 10.1002/pca.2371; He Y, 1997, Zhong Yao Cai, V20, P117; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; [黄林芳 Huang Linfang], 2014, [中国科学. 生命科学, Scientia Sinica Vitae], V44, P318; Huang LX, 2011, XINJIANG J TRADITION, V29, P54; Huang M, 2004, HUBEI J TRADITIONAL, V26, P54; Jiang X, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/942384; Jiang Y, 2009, J CHROMATOGR A, V1216, P2156, DOI 10.1016/j.chroma.2008.04.040; Jiang Y, 2009, J CHROMATOGR A, V1216, P1970, DOI 10.1016/j.chroma.2008.07.031; KOBAYASHI H, 1987, CHEM PHARM BULL, V35, P3309; KOBAYASHI H, 1985, CHEM PHARM BULL, V33, P3645; KOBAYASHI H, 1984, CHEM PHARM BULL, V32, P3009; KOBAYASHI H, 1984, CHEM PHARM BULL, V32, P3880; KOBAYASHI H, 1985, CHEM PHARM BULL, V33, P1452; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; [雷丽 Lei Li], 2003, [中草药, Chinese Traditional and Herbal Drugs], V34, P473; Li JS, 2000, SHIZHEN MED MATERIA, V11, P317; Li L, 2008, FOOD CHEM, V108, P702, DOI 10.1016/j.foodchem.2007.10.082; [刘晓明 LIU Xiaoming], 2011, [中国药学杂志, Chinese Pharmaceutical Journal], V46, P1053; Liu YG, 2009, WORLD SCI TECHNOLOGY, V11, P439; Lu DY, 2013, J SEP SCI, V36, P1945, DOI 10.1002/jssc.201300135; [马志国 MA Zhi guo], 2011, [中国药学杂志, Chinese Pharmaceutical Journal], V46, P899; Masssart DL, 1988, DATA HANDLING SCI TE; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Morikawa T, 2010, CHEM PHARM BULL, V58, P1403, DOI 10.1248/cpb.58.1403; Morikawa T, 2010, BIOORGAN MED CHEM, V18, P1882, DOI 10.1016/j.bmc.2010.01.047; Moriya Akira, 1995, Natural Medicines, V49, P383; Moriya Akira, 1995, Natural Medicines, V49, P394; Shi HM, 2009, BIOL PHARM BULL, V32, P142, DOI 10.1248/bpb.32.142; Shimoda H, 2009, AM J CHINESE MED, V37, P1125, DOI 10.1142/S0192415X09007545; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tu PF, 1996, J CHINESE MED MAT, V19, P420; Tu PF, 2011, J CHINESE PHARM, V46, P882; Wu LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064178; [谢洁娜 Xie Jiena], 2005, [中草药, Chinese Traditional and Herbal Drugs], V36, P268; Xu R, 2010, SPECTROSC SPECT ANAL, V30, P897, DOI 10.3964/j.issn.1000-0593(2010)04-0897-04; [徐荣 XU Rong], 2007, [中草药, Chinese Traditional and Herbal Drugs], V38, P1703; Xu XQ, 2013, SHIZHEN MED MATERIA, V24, P881; Yamada P, 2010, PLANTA MED, V76, P1512, DOI 10.1055/s-0030-1249775; [杨瀚春 YANG Hanchun], 2008, [药学服务与研究, Pharmaceutical Care and Research], V8, P255; Yoshikawa M, 2006, BIOORGAN MED CHEM, V14, P7468, DOI 10.1016/j.bmc.2006.07.018; Zhang HJ, IDENTIFICATION CISTA, V183; Zhang Mian, 2004, Zhong Yao Cai, V27, P400; Zhang Yong, 1994, Zhongguo Zhongyao Zazhi, V19, P169; Zhu SY, 2001, J CHIN MED MAT, V24, P24	51	34	37	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98061	10.1371/journal.pone.0098061	http://dx.doi.org/10.1371/journal.pone.0098061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24854031	Green Published, gold, Green Submitted			2022-12-25	WOS:000338323200041
J	Hammarstrom, A; Haukenes, I; Wiklund, AF; Lehti, A; Wiklund, M; Evengard, B; Stalnacke, BM				Hammarstrom, Anne; Haukenes, Inger; Wiklund, Anncristine Fjellman; Lehti, Arja; Wiklund, Maria; Evengard, Birgitta; Stalnacke, Britt-Marie			Low-Educated Women with Chronic Pain Were Less Often Selected to Multidisciplinary Rehabilitation Programs	PLOS ONE			English	Article							WIDESPREAD MUSCULOSKELETAL PAIN; CARDIAC REHABILITATION; SOCIOECONOMIC-STATUS; DEPRESSION SCALE; HOSPITAL ANXIETY; GENDER BIAS; NECK PAIN; FOLLOW-UP; HEALTH; CARE	Background: There is a lack of research about a potential education-related bias in assessment of patients with chronic pain. The aim of this study was to analyze whether low-educated men and women with chronic pain were less often selected to multidisciplinary rehabilitation than those with high education. Methods: The population consisted of consecutive patients (n = 595 women, 266 men) referred during a three-year period from mainly primary health care centers for a multidisciplinary team assessment at a pain rehabilitation clinic at a university hospital in Northern Sweden. Patient data were collected from the Swedish Quality Registry for Pain Rehabilitation National Pain Register. The outcome variable was being selected by the multidisciplinary team assessment to a multidisciplinary rehabilitation program. The independent variables were: sex, age, born outside Sweden, education, pain severity as well as the hospital, anxiety and depression scale (HADS). Results: Low-educated women were less often selected to multidisciplinary rehabilitation programs than high-educated women (OR 0.55, CI 0.30-0.98), even after control for age, being born outside Sweden, pain intensity and HADS. No significant findings were found when comparing the results between high-and low-educated men. Conclusion: Our findings can be interpreted as possible discrimination against low-educated women with chronic pain in hospital referrals to pain rehabilitation. There is a need for more gender-theoretical research emphasizing the importance of taking several power dimensions into account when analyzing possible bias in health care.	[Hammarstrom, Anne; Haukenes, Inger; Lehti, Arja] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Hammarstrom, Anne; Haukenes, Inger; Wiklund, Anncristine Fjellman; Lehti, Arja; Wiklund, Maria; Stalnacke, Britt-Marie] Umea Univ, Umea Ctr Gender Studies Med, Umea, Sweden; [Haukenes, Inger] Norwegian Inst Publ Hlth, Dept Publ Mental Hlth, Div Mental Hlth, Bergen, Norway; [Wiklund, Anncristine Fjellman; Wiklund, Maria; Stalnacke, Britt-Marie] Umea Univ, Dept Community Med & Rehabil, Umea, Sweden; [Evengard, Birgitta] Umea Univ, Div Infect Dis, Dept Clin Microbiol, Umea, Sweden	Umea University; Umea University; Norwegian Institute of Public Health (NIPH); Umea University; Umea University	Hammarstrom, A (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden.	anne.hammarstrom@umu.se		Hammarstrom, Anne/0000-0002-4095-7961	Swedish Research Council [344-2009-5839]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Research Council (grant no: 344-2009-5839). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apesoa-Varano EC, 2010, AM J GERIAT PSYCHIAT, V18, P586, DOI 10.1097/JGP.0b013e3181d145ea; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Beswick AD, 2005, J ADV NURS, V49, P538, DOI 10.1111/j.1365-2648.2004.03327.x; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bjoornsdoottir SV, 2013, SCAND J RHEUMATOL, V42, P59, DOI 10.3109/03009742.2012.697916; Bosner S, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-45; Boman KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057556; Borkhoff CM, 2008, CAN MED ASSOC J, V178, P681, DOI 10.1503/cmaj.071168; Carr JL, 2005, CHRONIC ILLN, V1, P121, DOI 10.1179/174239505X44826; Cosco TD, 2012, J PSYCHOSOM RES, V72, P180, DOI 10.1016/j.jpsychores.2011.06.008; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Friedrich M, 2009, PHYS THER, V89, P786, DOI 10.2522/ptj.20080100; Hamberg K, 2002, J WOMEN HEALTH GEN-B, V11, P653, DOI 10.1089/152460902760360595; Hankivsky O, 2012, SOC SCI MED, V74, P1712, DOI 10.1016/j.socscimed.2011.11.029; Holmner EP, 2013, AM J PHYS MED REHAB, V92, P77, DOI 10.1097/PHM.0b013e318278b28e; Jensen IB, 2005, PAIN, V115, P273, DOI 10.1016/j.pain.2005.03.005; Jordan Kevin D, 2011, J Pain Palliat Care Pharmacother, V25, P231, DOI 10.3109/15360288.2011.596922; Kapral MK, 2002, STROKE, V33, P268, DOI 10.1161/hs0102.101169; KERNS RD, 1985, PAIN, V23, P345, DOI 10.1016/0304-3959(85)90004-1; Lofmark U, 2007, NEUROEPIDEMIOLOGY, V28, P135, DOI 10.1159/000102141; Macfarlane GJ, 2009, ANN RHEUM DIS, V68, P1591, DOI 10.1136/ard.2008.093088; Melville MR, 1999, HEART, V82, P373, DOI 10.1136/hrt.82.3.373; Merrick D, 2012, J REHABIL MED, V44, P764, DOI 10.2340/16501977-1022; Noone JH, 2008, SOCIOL HEALTH ILL, V30, P711, DOI 10.1111/j.1467-9566.2008.01095.x; Nyberg F, 2008, INT J DERMATOL, V47, P144, DOI 10.1111/j.1365-4632.2008.03485.x; Nyberg V, 2011, J REHABIL MED, V43, P50, DOI 10.2340/16501977-0631; Overland S, 2012, EUR J PAIN, V16, P611, DOI 10.1016/j.ejpain.2011.08.005; Perruccio AV, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-83; Raine R, 2000, J Health Serv Res Policy, V5, P237; Risberg G, 2004, THESIS UMEA U; Ruiz-Cantero MT, 2007, J EPIDEMIOL COMMUN H, V61, P46, DOI 10.1136/jech.2007.062034; SBU, 2010, CHRON PAIN REH; SBU, 2006, 177 SBU SWED COUNC T; Scascighini L, 2008, RHEUMATOLOGY, V47, P670, DOI 10.1093/rheumatology/ken021; Shields SA, 2008, SEX ROLES, V59, P301, DOI 10.1007/s11199-008-9501-8; Springer KW, 2012, SOC SCI MED, V74, P1661, DOI 10.1016/j.socscimed.2012.03.001; Stubbs D, 2010, PAIN MED, V11, P232, DOI 10.1111/j.1526-4637.2009.00760.x; Toivanen S, 2011, AM J IND MED, V54, P780, DOI 10.1002/ajim.20982; van den Bos GAM, 2002, J EPIDEMIOL COMMUN H, V56, P943, DOI 10.1136/jech.56.12.943; van Doorslaer E, 2006, CAN MED ASSOC J, V174, P177, DOI 10.1503/cmaj.050584; Winjhoven HA, 2006, CLIN J PAIN, V22, P717; Zigmond AS, 1983, PSYCHIAT SCAND, V76, P361, DOI [DOI 10.1111/J.1600-0447.1983.TB09716.X, DOI 10.1111/J.1600-0447.1983.TB09716.X.PUBMED:6880820]	42	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97134	10.1371/journal.pone.0097134	http://dx.doi.org/10.1371/journal.pone.0097134			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3AL	24849625	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600022
J	Saben, JL; Bales, ES; Jackman, MR; Orlicky, D; MacLean, PS; McManaman, JL				Saben, Jessica L.; Bales, Elise S.; Jackman, Matthew R.; Orlicky, David; MacLean, Paul S.; McManaman, James L.			Maternal Obesity Reduces Milk Lipid Production in Lactating Mice by Inhibiting Acetyl-CoA Carboxylase and Impairing Fatty Acid Synthesis	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MEDIUM-CHAIN TRIGLYCERIDES; MAMMARY-GLAND; ADIPOSE-TISSUE; INSULIN-RESISTANCE; DIETARY-FAT; METABOLISM; OXIDATION; LIVER; ADIPOPHILIN	Maternal metabolic and nutrient trafficking adaptations to lactation differ among lean and obese mice fed a high fat (HF) diet. Obesity is thought to impair milk lipid production, in part, by decreasing trafficking of dietary and de novo synthesized lipids to the mammary gland. Here, we report that de novo lipogenesis regulatory mechanisms are disrupted in mammary glands of lactating HF-fed obese (HF-Ob) mice. HF feeding decreased the total levels of acetyl-CoA carboxylase-1 (ACC), and this effect was exacerbated in obese mice. The relative levels of phosphorylated (inactive) ACC, were elevated in the epithelium, and decreased in the adipose stroma, of mammary tissue from HF-Ob mice compared to those of HF-fed lean (HF-Ln) mice. Mammary gland levels of AMP-activated protein kinase (AMPK), which catalyzes formation of inactive ACC, were also selectively elevated in mammary glands of HF-Ob relative to HF-Ln dams or to low fat fed dams. These responses correlated with evidence of increased lipid retention in mammary adipose, and decreased lipid levels in mammary epithelial cells, of HF-Ob dams. Collectively, our data suggests that maternal obesity impairs milk lipid production, in part, by disrupting the balance of de novo lipid synthesis in the epithelial and adipose stromal compartments of mammary tissue through processes that appear to be related to increased mammary gland AMPK activity, ACC inhibition, and decreased fatty acid synthesis.	[Saben, Jessica L.; Bales, Elise S.; McManaman, James L.] Univ Colorado, Div Basic Reprod Sci, Aurora, CO USA; [Saben, Jessica L.; McManaman, James L.] Univ Colorado, Grad Program Reprod Sci, Aurora, CO USA; [Jackman, Matthew R.; MacLean, Paul S.; McManaman, James L.] Univ Colorado, Ctr Human Nutr, Aurora, CO USA; [Jackman, Matthew R.; MacLean, Paul S.] Univ Colorado, Dept Med, Div Endocrinol Diabet & Metab, Aurora, CO USA; [Orlicky, David] Univ Colorado, Dept Pathol, Aurora, CO USA; [MacLean, Paul S.; McManaman, James L.] Univ Colorado, Dept Physiol & Biophys, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	McManaman, JL (corresponding author), Univ Colorado, Div Basic Reprod Sci, Anschutz Med Campus, Aurora, CO USA.	jim.mcmanaman@ucdenver.edu			National Institutes of Health [R21-HD050863, 2R01-HD045962, P01-HD38129, R01-HD075285, DK-038088]; Colorado Clinical Translational Sciences Institute [TL1RR025778]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD075285, P01HD038129] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD050863] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001081, UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520, R01DK038088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado Clinical Translational Sciences Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institutes of Health grants R21-HD050863, 2R01-HD045962 and P01-HD38129 (JLM), R01-HD075285 (JLM and PSM), and DK-038088 (PSM), and a Colorado Clinical Translational Sciences Institute Predoctoral T32 Training Grant TL1RR025778 (JLS, JLM, PSM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailhaud G, 2004, Obes Rev, V5, P21, DOI 10.1111/j.1467-789X.2004.00121.x; Aoki N, 1999, BIOSCI BIOTECH BIOCH, V63, P1749, DOI 10.1271/bbb.63.1749; Barber MC, 2005, BBA-MOL CELL BIOL L, V1733, P1, DOI 10.1016/j.bbalip.2004.12.001; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Bartok CJ, 2009, INT J PEDIATR OBES, V4, P196, DOI 10.3109/17477160902763309; Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223; Burcelin M, 2002, AM J PHYSIOL-ENDOC M, V282, pE834, DOI 10.1152/ajpendo.00332.2001; Butz DE, 2007, AM J PHYSIOL-REG I, V293, pR669, DOI 10.1152/ajpregu.00005.2007; Carlson CL, 1999, J APPL PHYSIOL, V86, P669, DOI 10.1152/jappl.1999.86.2.669; Chen H, 2008, ENDOCRINOLOGY, V149, P5348, DOI 10.1210/en.2008-0582; Chong BM, 2011, J BIOL CHEM; Collins S, 2001, RECENT PROG HORM RES, V56, P309, DOI 10.1210/rp.56.1.309; Commerford SR, 2001, AM J PHYSIOL-REG I, V280, pR1680, DOI 10.1152/ajpregu.2001.280.6.R1680; de Ferranti S, 2008, CLIN CHEM, V54, P945, DOI 10.1373/clinchem.2007.100156; Dils R. R., 1983, Biochemistry of lactation, P141; DOLE VP, 1960, J BIOL CHEM, V235, P2595; Flint DJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1179, DOI 10.1152/ajpendo.00433.2004; FOLCH J, 1957, J BIOL CHEM, V226, P497; Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008; GIOVANNINI M, 1991, J INT MED RES, V19, P351, DOI 10.1177/030006059101900501; Gluckman PD, 2008, FRONT HORM RES, V36, P61, DOI 10.1159/000115337; Gorski JN, 2006, AM J PHYSIOL-REG I, V291, pR768, DOI 10.1152/ajpregu.00138.2006; Guesnet P, 2011, BIOCHIMIE, V93, P7, DOI 10.1016/j.biochi.2010.05.005; Ha TZ, 2006, AM J PHYSIOL-HEART C, V290, pH985, DOI 10.1152/ajpheart.00720.2005; Hardie DG, 2002, BIOCHEM SOC T, V30, P1064, DOI 10.1042/BST0301064; Hilson JA, 2004, J HUM LACT, V20, P18, DOI 10.1177/0890334403261345; Jackman MR, 2008, AM J PHYSIOL-REG I, V294, pR1117, DOI 10.1152/ajpregu.00808.2007; Jackman MR, 2010, AM J PHYSIOL-REG I, V299, pR1097, DOI 10.1152/ajpregu.00549.2009; Kola B, 2008, FRONT HORM RES, V36, P198, DOI 10.1159/000115366; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Madsen AN, 2010, J ENDOCRINOL, V206, P287, DOI 10.1677/JOE-10-0004; Martin-Hidalgo A, 2005, J LIPID RES, V46, P658, DOI 10.1194/jlr.M400370-JLR200; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; McFadden JW, 2009, BIOCHEM BIOPH RES CO, V390, P388, DOI 10.1016/j.bbrc.2009.09.017; MELLENBERGER RW, 1973, BIOCHEM J, V136, P741, DOI 10.1042/bj1360741; Muoio DM, 1999, BIOCHEM J, V338, P783, DOI 10.1042/0264-6021:3380783; Neville MC, 1997, ANNU REV NUTR, V17, P159, DOI 10.1146/annurev.nutr.17.1.159; Novak EM, 2011, AM J PHYSIOL-ENDOC M, V301, pE807, DOI 10.1152/ajpendo.00225.2011; Odle J, 1997, J NUTR, V127, P1061, DOI 10.1093/jn/127.6.1061; Olson LK, 2010, INT J OBESITY, V34, P1415, DOI 10.1038/ijo.2010.51; Rasmussen KM, 2007, ANNU REV NUTR, V27, P103, DOI 10.1146/annurev.nutr.27.061406.093738; Rasmussen KM, 1998, J NUTR, V128, p390S, DOI 10.1093/jn/128.2.390S; Reifsnyder PC, 2000, GENOME RES, V10, P1568, DOI 10.1101/gr.147000; ROLLS BA, 1986, PHYSIOL BEHAV, V38, P185, DOI 10.1016/0031-9384(86)90153-8; Rudolph MC, 2007, J MAMMARY GLAND BIOL, V12, P269, DOI 10.1007/s10911-007-9061-5; Rudolph MC, 2007, PHYSIOL GENOMICS, V28, P323, DOI 10.1152/physiolgenomics.00020.2006; Rudolph MC, 2010, AM J PHYSIOL-ENDOC M, V299, pE918, DOI 10.1152/ajpendo.00376.2010; Russell TD, 2008, J LIPID RES, V49, P206, DOI 10.1194/jlr.M700396-JLR200; Russell TD, 2007, J LIPID RES, V48, P1463, DOI 10.1194/jlr.M600474-JLR200; Russell TD, 2011, J CELL SCI, V124, P3247, DOI 10.1242/jcs.082974; Schwertfeger KL, 2003, J LIPID RES, V44, P1100, DOI 10.1194/jlr.M300045-JLR200; SILVERMAN J, 1992, LAB ANIM, V26, P127, DOI 10.1258/002367792780745832; SMITH S, 1994, FASEB J, V8, P1248, DOI 10.1096/fasebj.8.15.8001737; SMITH S, 1966, BIOCHIM BIOPHYS ACTA, V116, P23, DOI 10.1016/0005-2760(66)90089-0; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; St-Onge MP, 2002, J NUTR, V132, P329; Tolwani RJ, 2005, PLOS GENET, V1, P205, DOI 10.1371/journal.pgen.0010023; Travers MT, 1997, J MOL ENDOCRINOL, V19, P99, DOI 10.1677/jme.0.0190099; VERNON RG, 1987, J ANIM SCI, V64, P1395, DOI 10.2527/jas1987.6451395x; VERNON RG, 1989, P NUTR SOC, V48, P23, DOI 10.1079/PNS19890006; Vernon RG, 1997, J MAMMARY GLAND BIOL, V2, P231, DOI 10.1023/A:1026380220364; Wahlig JL, 2012, OBESITY, V20, P65, DOI 10.1038/oby.2011.196; Watt MJ, 2006, J PHYSIOL-LONDON, V574, P139, DOI 10.1113/jphysiol.2006.107318; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560; Yang YA, 2003, EXP CELL RES, V282, P132, DOI 10.1016/S0014-4827(02)00023-X; Zhao JP, 2009, PROSTAG LEUKOTR ESS, V81, P349, DOI 10.1016/j.plefa.2009.09.005	66	29	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98066	10.1371/journal.pone.0098066	http://dx.doi.org/10.1371/journal.pone.0098066			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849657	Green Published, Green Submitted, gold			2022-12-25	WOS:000336730600082
J	Sarkar, G; Curran, GL; Sarkaria, JN; Lowe, VJ; Jenkins, RB				Sarkar, Gobinda; Curran, Geoffry L.; Sarkaria, Jann N.; Lowe, Val J.; Jenkins, Robert B.			Peptide Carrier-Mediated Non-Covalent Delivery of Unmodified Cisplatin, Methotrexate and Other Agents via Intravenous Route to the Brain	PLOS ONE			English	Article							CONVECTION-ENHANCED DELIVERY; CANCER RESISTANCE PROTEIN; INCREASING DRUG-DELIVERY; BLOOD-BRAIN; IN-VIVO; BARRIER DISRUPTION; THERAPEUTIC ENZYME; TROJAN HORSE; ULTRASOUND; RECEPTOR	Background: Rapid pre-clinical evaluation of chemotherapeutic agents against brain cancers and other neurological disorders remains largely unattained due to the presence of the blood-brain barrier (BBB), which limits transport of most therapeutic compounds to the brain. A synthetic peptide carrier, K16ApoE, was previously developed that enabled transport of target proteins to the brain by mimicking a ligand-receptor system. The peptide carrier was found to generate transient BBB permeability, which was utilized for non-covalent delivery of cisplatin, methotrexate and other compounds to the brain. Approach: Brain delivery of the chemotherapeutics and other agents was achieved either by injecting the carrier peptide and the drugs separately or as a mixture, to the femoral vein. A modification of the method comprised injection of K16ApoE pre-mixed with cetuximab, followed by injection of a 'small-molecule' drug. Principal findings: Seven-of-seven different small molecules were successfully delivered to the brain via K16ApoE. Depending on the method, brain uptake with K16ApoE was 0.72-1.1% for cisplatin and 0.58-0.92% for methotrexate (34-50-fold and 54-92 fold greater for cisplatin and methotrexate, respectively, with K16ApoE than without). Visually intense brain-uptake of Evans Blue, Light Green SF and Crocein scarlet was also achieved. Direct intracranial injection of EB show locally restricted distribution of the dye in the brain, whereas K16ApoE-mediated intravenous injection of EB resulted in the distribution of the dye throughout the brain. Experiments with insulin suggest that ligand-receptor signaling intrinsic to the BBB provides a natural means for passive transport of some molecules across the BBB. Significance: The results suggest that the carrier peptide can non-covalently transport various chemotherapeutic agents to the brain. Thus, the method offers an avenue for pre-clinical evaluation of various small and large therapeutic molecules against brain tumors and other neurological disorders.	[Sarkar, Gobinda; Jenkins, Robert B.] Mayo Clin & Mayo Fdn, Dept Expt Pathol, Rochester, MN 55905 USA; [Curran, Geoffry L.] Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA; [Sarkaria, Jann N.] Mayo Clin & Mayo Fdn, Dept Radiat Oncol, Rochester, MN 55905 USA; [Lowe, Val J.] Mayo Clin & Mayo Fdn, Dept Nucl Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Sarkar, G (corresponding author), Mayo Clin & Mayo Fdn, Dept Expt Pathol, 200 1st St SW, Rochester, MN 55905 USA.	sarkar.gobinda@mayo.edu; rjenkins@mayo.edu			Mayo Clinic; Bernie and Edith Waterman Foundation; Ting Tsung and Wei Fong Chao Family Foundation	Mayo Clinic; Bernie and Edith Waterman Foundation; Ting Tsung and Wei Fong Chao Family Foundation	This work has been funded by the Mayo Clinic and by Bernie and Edith Waterman and the Ting Tsung and Wei Fong Chao Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2010, J PHARMACOL EXP THER, V334, P147, DOI 10.1124/jpet.110.167601; Allard E, 2009, BIOMATERIALS, V30, P2302, DOI 10.1016/j.biomaterials.2009.01.003; Angelov L, 2009, J CLIN ONCOL, V27, P3503, DOI 10.1200/JCO.2008.19.3789; Banks WA, 1999, J NEUROVIROL, V5, P538, DOI 10.3109/13550289909021284; Banks WA, 2012, PHARMACOL THERAPEUT, V136, P82, DOI 10.1016/j.pharmthera.2012.07.006; Bartus RT, 1996, EXP NEUROL, V142, P14, DOI 10.1006/exnr.1996.0175; Bellavance MA, 2008, AAPS J, V10, P166, DOI 10.1208/s12248-008-9018-7; Blanchette M, 2011, METHODS MOL BIOL, V686, P447, DOI 10.1007/978-1-60761-938-3_23; Boado RJ, 2010, J PHARMACOL EXP THER, V333, P961, DOI 10.1124/jpet.109.165092; Carlson SK, 2006, MOL IMAGING BIOL, V8, P324, DOI 10.1007/s11307-006-0058-z; Carman AJ, 2011, J NEUROSCI, V31, P13272, DOI 10.1523/JNEUROSCI.3337-11.2011; Choi JJ, 2010, IEEE T BIO-MED ENG, V57, P145, DOI 10.1109/TBME.2009.2034533; Cosolo W.C., 1989, AM J PHYSIOL, V256, P443; Cote J, 2010, NEUROPEPTIDES, V44, P177, DOI 10.1016/j.npep.2009.12.009; CROWLE AJ, 1977, J IMMUNOL METHODS, V17, P379, DOI 10.1016/0022-1759(77)90122-3; Deeken JF, 2007, CLIN CANCER RES, V13, P1663, DOI 10.1158/1078-0432.CCR-06-2854; Deng CX, 2010, THER DELIV, V1, P819, DOI 10.4155/TDE.10.66; Dhanikula RS, 2008, MOL PHARM, V5, P105, DOI 10.1021/mp700086j; Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005; GREIG NH, 1990, CANCER CHEMOTH PHARM, V25, P320, DOI 10.1007/BF00686230; Groothuis DR, 2000, NEURO-ONCOLOGY, V2, P45, DOI 10.1093/neuonc/2.1.45; Hdeib A, 2011, EXPERT OPIN BIOL TH, V11, P799, DOI 10.1517/14712598.2011.579097; Hynynen K, 2006, J NEUROSURG, V105, P445, DOI 10.3171/jns.2006.105.3.445; JEFFERIES WA, 1984, NATURE, V312, P162, DOI 10.1038/312162a0; Karkan D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002469; Kioi M, 2006, TECHNOL CANCER RES T, V5, P239, DOI 10.1177/153303460600500307; Kudawara I, 2013, J CHEMOTHERAPY, V25, P41, DOI 10.1179/1973947812Y.0000000055; Lagas JS, 2010, MOL CANCER THER, V9, P319, DOI 10.1158/1535-7163.MCT-09-0663; Lee JH, 2011, CANCER BIOL THER, V11, P108, DOI 10.4161/cbt.11.1.14526; Lillehei KO, 1996, NEUROSURGERY, V39, P1191, DOI 10.1097/00006123-199612000-00023; Marquet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022598; Meng Y, 2014, MOL THER, V22, P547, DOI 10.1038/mt.2013.267; Mesiwala AH, 2002, ULTRASOUND MED BIOL, V28, P389, DOI 10.1016/S0301-5629(01)00521-X; Minami T, 1998, TOXICOLOGY, V130, P107, DOI 10.1016/S0300-483X(98)00103-6; Mittal A, 2009, J HAZARD MATER, V163, P568, DOI 10.1016/j.jhazmat.2008.07.005; Mouzon A, 2013, CHEMOTHERAPY, V59, P85, DOI 10.1159/000351133; Sands MS, 2014, MOL THER, V22, P483, DOI 10.1038/mt.2014.12; Sarkar G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028881; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Sheikov N, 2004, ULTRASOUND MED BIOL, V30, P979, DOI 10.1016/j.ultrasmedbio.2004.04.010; Siegal T, 2002, CLIN PHARMACOKINET, V41, P171, DOI 10.2165/00003088-200241030-00002; Siegal T, 2013, NEURO-ONCOLOGY, V15, P656, DOI 10.1093/neuonc/not016; Spencer BJ, 2007, P NATL ACAD SCI USA, V104, P7594, DOI 10.1073/pnas.0702170104; Steeg PS, 2011, NAT REV CANCER, V11, P352, DOI 10.1038/nrc3053; Stopa B, 2006, INT J BIOL MACROMOL, V40, P1, DOI 10.1016/j.ijbiomac.2006.05.002; Wang DR, 2013, P NATL ACAD SCI USA, V110, P2999, DOI 10.1073/pnas.1222742110; Waterhouse Rikki N, 2003, Mol Imaging Biol, V5, P376, DOI 10.1016/j.mibio.2003.09.014; Zhou JB, 2013, P NATL ACAD SCI USA, V110, P11751, DOI 10.1073/pnas.1304504110; Zlokovic BV, 2000, ENDOCRINOLOGY, V141, P1434, DOI 10.1210/en.141.4.1434	49	20	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97655	10.1371/journal.pone.0097655	http://dx.doi.org/10.1371/journal.pone.0097655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847943	Green Published, Green Submitted, gold			2022-12-25	WOS:000336730600047
J	Wang, XF; Chen, Y; Truesdell, S; Xu, LX; Cao, J; Guan, WJ				Wang, Xuefang; Chen, Yong; Truesdell, Samuel; Xu, Liuxiong; Cao, Jie; Guan, Wenjiang			The Large-Scale Deployment of Fish Aggregation Devices Alters Environmentally-Based Migratory Behavior of Skipjack Tuna in the Western Pacific Ocean	PLOS ONE			English	Article							FISHERIES; OBESUS	Fish aggregation devices (FADs) have been used extensively in the tuna purse seine fishery since the 1980s. This long-term modification of natural habitat has generated discussions as to whether FADs impact movement patterns of tuna species. We examined this question using data collected from the skipjack tuna (Katsuwonus pelamis) fishery. We used the longitudinal gravitational center of catch (G) to examine temporal variability in skipjack movement in the Western and Central Pacific Ocean, and related this to El Nino Southern Oscillation (ENSO) events. We found that in most cases G for free-swimming school sets changed with the onset of ENSO events, while G for floating-object-associated school sets remained relatively constant. This suggests that skipjack exhibit distinguishable behavioral strategies in response to ENSO events: they either react by moving long distances or they associate with floating objects. There has been no previous attempt to evaluate the interaction between FADs and the environmentally-determined movement of skipjack; this study shows evidence of an interaction, which should be considered when managing skipjack populations.	[Wang, Xuefang; Xu, Liuxiong; Guan, Wenjiang] Shanghai Ocean Univ, Coll Marine Sci, Shanghai, Peoples R China; [Wang, Xuefang; Xu, Liuxiong; Guan, Wenjiang] Natl Engn Res Ctr Ocean Fisheries, Shanghai, Peoples R China; [Wang, Xuefang; Chen, Yong; Xu, Liuxiong; Guan, Wenjiang] Minist Educ, Key Lab Sustainable Exploitat Ocean Fisheries Res, Shanghai, Peoples R China; [Chen, Yong; Truesdell, Samuel; Cao, Jie] Univ Maine, Sch Marine Sci, Orono, ME USA	Shanghai Ocean University; National Engineering Research Center for Oceanic Fisheries; University of Maine System; University of Maine Orono	Xu, LX (corresponding author), Shanghai Ocean Univ, Coll Marine Sci, Shanghai, Peoples R China.	lxxu@shou.edu.cn	Cao, Jie/AGM-7735-2022	CAO, JIE/0000-0002-6250-586X	National High Technology Research and Development Program of China [2012AA092302]; Shanghai Ocean University International Center for Marine Sciences [3606120001]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Shanghai Ocean University International Center for Marine Sciences	This study was partially sponsored by the National High Technology Research and Development Program of China (No. 2012AA092302). The involvement of Y. Chen, S. Truesdell and J. Cao in this project were supported by the Shanghai Ocean University International Center for Marine Sciences (No. 3606120001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, USE FADS TUNA FISHER; Auster Peter J., 1996, Reviews in Fisheries Science, V4, P185; Blackburn M, 1969, B JAP SOC FISH OCEAN, V9-11, P221; Bromhead D, 2000, REV IMPACT FISH AGGR; Dagorn L, 2007, MAR BIOL, V151, P595, DOI 10.1007/s00227-006-0511-1; Dagorn L, 2013, FISH FISH, V14, P391, DOI 10.1111/j.1467-2979.2012.00478.x; Dufour P, 1973, DOC SCI CENT RECH OC, V4, P99; Fogarty MJ, 1998, ECOL APPL, V8, pS6, DOI 10.2307/2641359; Fonteneau A., 2000, PECHE THONIERE DISPO, V28, P15; Freon P, 2000, REV FISH BIOL FISHER, V10, P183, DOI 10.1023/A:1016666108540; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gillett R. D., 2003, SURVEY PURSE SEINE F; Hallier JP, 2008, MAR ECOL PROG SER, V353, P255, DOI 10.3354/meps07180; Harley S, 2009, 5 REG SESS WCPFC SCI; Heino M, 2002, B MAR SCI, V70, P639; ICCAT, 2008, REC ICCAT AM REC MUL; Itano D, 2005, 1 M WCPFC SCI COMM N; Jaquemet S, 2011, FISH RES, V107, P283, DOI 10.1016/j.fishres.2010.11.011; Lehodey P, 1997, NATURE, V389, P715, DOI 10.1038/39575; Leroy B, 2013, AQUAT LIVING RESOUR, V26, P49, DOI 10.1051/alr/2012033; Menard F, 2000, AQUAT LIVING RESOUR, V13, P233, DOI 10.1016/S0990-7440(00)01066-4; Menard F, 2000, ICES J MAR SCI, V57, P525, DOI 10.1006/jmsc.2000.0717; PITCHER TJ, 1995, SCI MAR, V59, P295; SAKAGAWA G, 2000, PECHE THONIERE DISPO, P371; Schaefer KM, 2010, MAR BIOL, V157, P2625, DOI 10.1007/s00227-010-1524-3; Wang XF, 2012, AQUAT ECOL, V46, P343, DOI 10.1007/s10452-012-9405-0; WCPFC, 2008, 5 REG SESS WCPFC TEC; WCPFC, 2004, 6 SESS WCPFC PREP C; Zainuddin M, 2008, FISH OCEANOGR, V17, P61, DOI 10.1111/j.1365-2419.2008.00461.x	29	8	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98226	10.1371/journal.pone.0098226	http://dx.doi.org/10.1371/journal.pone.0098226			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849561	Green Published, Green Submitted, gold			2022-12-25	WOS:000336730600100
J	Wu, XL; Zhou, B; Yin, C; Guo, Y; Lin, Y; Pan, L; Wang, B				Wu, Xinliang; Zhou, Bin; Yin, Chao; Guo, Yong; Lin, Ying; Pan, Li; Wang, Bin			Characterization of Natural Antisense Transcript, Sclerotia Development and Secondary Metabolism by Strand-Specific RNA Sequencing of Aspergillus flavus	PLOS ONE			English	Article							AFLATOXIN PRODUCTION; GENE-EXPRESSION; BINDING PROTEIN; SWISS-MODEL; GENOME; VEA; DNA; IDENTIFICATION; BIOSYNTHESIS; CONIDIATION	Aspergillus flavus has received much attention owing to its severe impact on agriculture and fermented products induced by aflatoxin. Sclerotia morphogenesis is an important process related to A. flavus reproduction and aflatoxin biosynthesis. In order to obtain an extensive transcriptome profile of A. flavus and provide a comprehensive understanding of these physiological processes, the isolated mRNA of A. flavus CA43 cultures was subjected to high-throughput strand-specific RNA sequencing (ssRNA-seq). Our ssRNA-seq data profiled widespread transcription across the A. flavus genome, quantified vast transcripts (73% of total genes) and annotated precise transcript structures, including untranslated regions, upstream open reading frames (ORFs), alternative splicing variants and novel transcripts. We propose natural antisense transcripts in A. flavus might regulate gene expression mainly on the post-transcriptional level. This regulation might be relevant to tune biological processes such as aflatoxin biosynthesis and sclerotia development. Gene Ontology annotation of differentially expressed genes between the mycelia and sclerotia cultures indicated sclerotia development was related closely to A. flavus reproduction. Additionally, we have established the transcriptional profile of aflatoxin biosynthesis and its regulation model. We identified potential genes linking sclerotia development and aflatoxin biosynthesis. These genes could be used as targets for controlled regulation of aflatoxigenic strains of A. flavus.	[Wu, Xinliang; Zhou, Bin; Yin, Chao; Guo, Yong; Lin, Ying; Pan, Li; Wang, Bin] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China	South China University of Technology	Wang, B (corresponding author), S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China.	btbinwang@scut.edu.cn			National Natural Science Foundation of China [31100026]; 863 (Hi-tech research and development program of China) program [2012AA022108]; Guangdong Provincial Department of Science and Technology Research Project [2012B010900028, 2012A080800013]; Guangdong Provincial Natural Science Foundation of China [S2011040003020]; Fundamental Research Funds for the Central Universities [2012ZM0080]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 (Hi-tech research and development program of China) program(National High Technology Research and Development Program of China); Guangdong Provincial Department of Science and Technology Research Project; Guangdong Provincial Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors wish to acknowledge the financial support by National Natural Science Foundation of China (Project 31100026), the 863 (Hi-tech research and development program of China) program (contract NO. 2012AA022108), Guangdong Provincial Department of Science and Technology Research Project (NO. 2012B010900028 and 2012A080800013). Part of this work was supported by Guangdong Provincial Natural Science Foundation of China (No. S2011040003020) and the Fundamental Research Funds for the Central Universities (NO. 2012ZM0080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaike S, 2009, EUKARYOT CELL, V8, P1051, DOI 10.1128/EC.00088-09; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andersen AA, 2003, CURR OPIN CELL BIOL, V15, P281, DOI 10.1016/S0955-0674(03)00041-3; Arentshorst M, 2012, METHODS MOL BIOL, V835, P133, DOI 10.1007/978-1-61779-501-5_9; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAYMAN P, 1993, CAN J BOT, V71, P23, DOI 10.1139/b93-003; BENNETT JW, 1978, MYCOLOGIA, V70, P104, DOI 10.2307/3758691; Calvo AM, 2004, APPL ENVIRON MICROB, V70, P4733, DOI 10.1128/AEM.70.8.4733-4739.2004; Calvo AM, 2008, FUNGAL GENET BIOL, V45, P1053, DOI 10.1016/j.fgb.2008.03.014; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cary JW, 2007, APPL MICROBIOL BIOT, V76, P1107, DOI 10.1007/s00253-007-1081-y; Chang PK, 2007, LETT APPL MICROBIOL, V44, P131, DOI 10.1111/j.1472-765X.2006.02056.x; Chang PK, 2007, APPL MICROBIOL BIOT, V77, P917, DOI 10.1007/s00253-007-1224-1; Chang PK, 2002, MYCOPATHOLOGIA, V153, P41, DOI 10.1023/A:1015211915310; Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818; Chen NS, 2006, GENOME RES, V16, P606, DOI 10.1101/gr.4515306; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; COTTY PJ, 1988, PHYTOPATHOLOGY, V78, P1250, DOI 10.1094/Phyto-78-1250; COTTY PJ, 1989, PHYTOPATHOLOGY, V79, P808, DOI 10.1094/Phyto-79-808; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Donaldson ME, 2012, MOL MICROBIOL, V85, P405, DOI 10.1111/j.1365-2958.2012.08125.x; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Geiser DM, 1996, MOL BIOL EVOL, V13, P809, DOI 10.1093/oxfordjournals.molbev.a025641; Georgianna DR, 2009, FUNGAL GENET BIOL, V46, P113, DOI 10.1016/j.fgb.2008.10.011; Georgiou CD, 2006, INTEGR COMP BIOL, V46, P691, DOI 10.1093/icb/icj034; Horn BW, 1999, APPL ENVIRON MICROB, V65, P1444; Imamura T, 2004, BIOCHEM BIOPH RES CO, V322, P593, DOI 10.1016/j.bbrc.2004.07.159; Jiu Jiang Yu W. C. N., 2011, Mycology - An International Journal on Fungal Biology, V2, P218; Jorgensen TR, 2011, APPL ENVIRON MICROB, V77, P5270, DOI 10.1128/AEM.00118-11; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kawasaki H, 2004, NATURE, V431, P211, DOI 10.1038/nature02889; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; Lackner DH, 2007, MOL CELL, V26, P145, DOI 10.1016/j.molcel.2007.03.002; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liang SL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-738; LITTLEY ER, 1992, CAN J BOT, V70, P772, DOI 10.1139/b92-098; Machida M, 2008, DNA RES, V15, P173, DOI 10.1093/dnares/dsn020; Mamanova L, 2011, NAT PROTOC, V6, P1736, DOI 10.1038/nprot.2011.399; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; McGuire AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r50; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; MISRA S, 2002, GENOME BIOL, V3, P83, DOI [DOI 10.1186/GB-2002-3-12-RESEARCH0083, 10.1186/gb-2002-3-12-research0083]; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Osato N, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2003-5-1-r5; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Payne GA, 2006, MED MYCOL, V44, pS9, DOI 10.1080/13693780600835716; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Rollins JA, 1998, APPL ENVIRON MICROB, V64, P2539; Ruiz-Echevarria MJ, 2000, CELL, V101, P741, DOI 10.1016/S0092-8674(00)80886-7; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sibthorp C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-847; Smith CA, 2008, CURR GENET, V54, P241, DOI 10.1007/s00294-008-0215-9; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vilela C, 2003, MOL MICROBIOL, V49, P859, DOI 10.1046/j.1365-2958.2003.03622.x; Vivancos AP, 2010, GENOME RES, V20, P989, DOI 10.1101/gr.094318.109; Wang B, 2010, NUCLEIC ACIDS RES, V38, P5075, DOI 10.1093/nar/gkq256; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026426; Wang XJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r30; WIESER J, 1995, GENE DEV, V9, P491, DOI 10.1101/gad.9.4.491; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wilkinson JR, 2007, APPL MICROBIOL BIOT, V74, P1308, DOI 10.1007/s00253-006-0768-9; WILLETTS HJ, 1992, MYCOL RES, V96, P801, DOI 10.1016/S0953-7562(09)81027-7; Yamada O, 1999, J BIOSCI BIOENG, V87, P424, DOI 10.1016/S1389-1723(99)80089-9; Yassour M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r87; Yavatkar AS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-106; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu J, 2006, Mycotoxin Res, V22, P16, DOI 10.1007/BF02954552; Yu Jiujiang, 2005, Revista Iberoamericana de Micologia, V22, P194; Yu JJ, 2011, FEMS MICROBIOL LETT, V322, P145, DOI 10.1111/j.1574-6968.2011.02345.x; Yu JJ, 2004, FEMS MICROBIOL LETT, V237, P333, DOI 10.1016/j.femsle.2004.06.054; Zhong Silin, 2011, Cold Spring Harb Protoc, V2011, P940, DOI 10.1101/pdb.prot5652; Zhoug Sen, 1998, World J Gastroenterol, V4, P434	81	13	14	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97814	10.1371/journal.pone.0097814	http://dx.doi.org/10.1371/journal.pone.0097814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849659	Green Published, Green Submitted, gold			2022-12-25	WOS:000336730600062
J	Kim, M; Lee, EJ; Seo, JH; Kim, TW				Kim, Mijin; Lee, Eun Ji; Seo, Je Hyun; Kim, Tae-Woo			Relationship of Spontaneous Retinal Vein Pulsation with Ocular Circulatory Cycle	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; INTRACRANIAL-PRESSURE; VENOUS PULSATION; FREQUENCY; PHASE; FLOW; CAT	Purpose: To determine the timing of spontaneous venous pulsation (SVP) relative to the ocular circulatory cycle by using the movie tool of confocal scanning laser ophthalmoloscope. Methods: A video recording of the fundus was obtained using a confocal scanning laser ophthalmoscope (Spectralis HRA, Heidelberg Engineering, Heidelberg, Germany) at 8 frames/s in 47 eyes (15 glaucoma patients and 32 glaucoma suspects) with visible pulsation of both the central retinal artery (CRA) and vein (CRV). The timing of the maximum and minimum diameters of the CRA (CRA(max) and CRA(min), respectively) and CRV (CRVmax and CRVmin, respectively) was identified during four pulse cycles. The interval between CRVmin and CRA(min), and between CRVmax and CRA(max) was expressed as the number of frames and as a percentage of the ocular circulatory cycle. Results: The ocular circulatory cycle (from one CRA(max) to the next) lasted 7.7 +/- 1.0 frames (958.8 +/- 127.2 ms, mean +/- SD), with a mean pulse rate of 62.6 beats/min. The diameter of the CRA was increased for 2.4 +/- 0.5 frames (301.9 +/- 58.8 ms) and decreased for 5.3 +/- 0.9 frames (656.9 +/- 113.5 ms). CRVmax occurred 1.0 +/- 0.2 frames after CRA(max) (equivalent to 13.0% of the ocular circulatory cycle), while CRVmin occurred 1.1 +/- 0.4 frames after CRA(min) (equivalent to 14.6% of the ocular circulatory cycle). Conclusions: During SVP, the diameter of the CRV began to decrease at early diastole, and the reduction persisted until early systole. This finding supports that CRV collapse occurs during ocular diastole.	[Kim, Mijin] Konyang Univ, Kims Eye Hosp, Myung Gok Eye Res Inst, Dept Ophthalmol, Seoul, South Korea; [Kim, Mijin; Lee, Eun Ji; Kim, Tae-Woo] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Songnam, South Korea; [Seo, Je Hyun] Pusan Natl Univ, Yangsan Hosp, Dept Ophthalmol, Pusan 609735, South Korea	Konyang University; Seoul National University (SNU); Pusan National University; Pusan National University Hospital	Kim, TW (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Songnam, South Korea.	twkim7@snu.ac.kr		Seo, Je Hyun/0000-0003-3127-7160; Kim, Tae-Woo/0000-0002-5180-0978	National Research Foundation of Korea - Korean Government [2013R1A1A1A05004781]	National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government)	Supported by National Research Foundation of Korea Grant funded by the Korean Government (2013R1A1A1A05004781). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATTARIWALA R, 1994, INVEST OPHTH VIS SCI, V35, P1019; Bailliart P, 1918, ANN OCUL, V155, P453; Baurmann M, 1925, DTSCH OPHTHALMOL GES, V45, P53; Coccius EA, 1853, UEBER ANWENDUNG AUGE; DARDENNE G, 1969, EUR NEUROL, V2, P193, DOI 10.1159/000113796; Davson H, 1996, PHYSL CSF BLOOD BRAI, P697; Duke-Elder WS, 1926, J PHYSIOL-LONDON, V61, P409, DOI 10.1113/jphysiol.1926.sp002303; Elliot R H, 1921, Br J Ophthalmol, V5, P481, DOI 10.1136/bjo.5.11.481; Evans DW, 2002, GRAEF ARCH CLIN EXP, V240, P475, DOI 10.1007/s00417-002-0460-4; GLUCKSBERG MR, 1993, MICROVASC RES, V45, P158, DOI 10.1006/mvre.1993.1015; Harder B, 2007, BRIT J OPHTHALMOL, V91, P401, DOI 10.1136/bjo.2006.103341; Hayashi S, 1998, J BIOMECH ENG-T ASME, V120, P468, DOI 10.1115/1.2798016; Jonas JB, 2005, OPHTHALMOLOGY, V112, P948, DOI 10.1016/j.ophtha.2004.11.014; Jonas JB, 2003, BRIT J OPHTHALMOL, V87, P949, DOI 10.1136/bjo.87.8.949; Jonas JB, 2012, INVEST OPHTH VIS SCI, V53, P6045, DOI 10.1167/iovs.12-10623; Jones HC, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-1; Kain S, 2010, BRIT J OPHTHALMOL, V94, P854, DOI 10.1136/bjo.2009.169813; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Legler U, 2007, CLIN EXP OPHTHALMOL, V35, P870, DOI 10.1111/j.1442-9071.2007.01641.x; Legler U, 2009, J GLAUCOMA, V18, P210, DOI 10.1097/IJG.0b013e318182edd2; Levine DN, 1998, MICROVASC RES, V56, P154, DOI 10.1006/mvre.1998.2098; LOW HT, 1995, MED BIOL ENG COMPUT, V33, P545, DOI 10.1007/BF02522512; MEYERSCHWICKERATH R, 1995, GRAEF ARCH CLIN EXP, V233, P783, DOI 10.1007/BF00184090; Morgan WH, 2005, INVEST OPHTH VIS SCI, V46, P1307, DOI 10.1167/iovs.04-1126; Morgan WH, 2004, OPHTHALMOLOGY, V111, P1489, DOI 10.1016/j.ophtha.2003.12.053; Morgan W, 2012, INVEST OPHTH VIS SCI, V53, P6880, DOI 10.1167/iovs.12-10943; Morgan WH, 2012, INVEST OPHTH VIS SCI, V53, P4676, DOI 10.1167/iovs.12-9837; Nicolela MT, 2007, BRIT J OPHTHALMOL, V91, P405, DOI 10.1136/bjo.2006.107797; Seo JH, 2012, OPHTHALMOLOGY, V119, P2254, DOI 10.1016/j.ophtha.2012.06.007	29	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97943	10.1371/journal.pone.0097943	http://dx.doi.org/10.1371/journal.pone.0097943			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844298	Green Submitted, gold, Green Published			2022-12-25	WOS:000339563400073
J	Sunguya, BF; Poudel, KC; Mlunde, LB; Urassa, DP; Yasuoka, J; Jimba, M				Sunguya, Bruno F.; Poudel, Krishna C.; Mlunde, Linda B.; Urassa, David P.; Yasuoka, Junko; Jimba, Masamine			Poor Nutrition Status and Associated Feeding Practices among HIV-Positive Children in a Food Secure Region in Tanzania: A Call for Tailored Nutrition Training	PLOS ONE			English	Article							DAR-ES-SALAAM; ANTIRETROVIRAL THERAPY; INSECURITY; UNDERNUTRITION; HIV/AIDS; MALNUTRITION; INFECTION; CONTEXT; GROWTH; DIETS	Undernutrition among HIV-positive children can be ameliorated if they are given adequate foods in the right frequency and diversity. Food insecurity is known to undermine such efforts, but even in food rich areas, people have undernutrition. As yet no study has examined feeding practices and their associations with nutrition status among as HIV-positive children in regions with high food production. We therefore examined the magnitude of undernutrition and its association with feeding practices among HIV-positive children in a high food production region in Tanzania. Methods: We conducted this mixed-method study among 748 children aged 6 months-14 years attending 9 of a total of 32 care and treatment centers in Tanga region, Tanzania. We collected quantitative data using a standard questionnaire and qualitative data through seven focus group discussions (FGDs). Results: HIV-positive children had high magnitudes of undernutrition. Stunting, underweight, wasting, and thinness were prevalent among 61.9%, 38.7%, 26.0%, and 21.1% of HIV-positive children, respectively. They also had poor feeding practices: 88.1% were fed at a frequency below the recommendations, and 62.3% had a low level of dietary diversity. Lower feeding frequency was associated with stunting (beta = 0.11, p = 0.016); underweight (beta = 0.12, p = 0.029); and thinness (beta = 0.11, p = 0.026). Lower feeding frequency was associated with low wealth index (beta = 0.06, p<0.001), food insecurity (beta = 20.05, p<0.001), and caregiver's education. In the FGDs, participants discussed the causal relationships among the key associations; undernutrition was mainly due to low feeding frequency and dietary diversity. Such poor feeding practices resulted from poor nutrition knowledge, food insecurity, low income, and poverty. Conclusion: Feeding practices and nutrition status were poor among HIV-positive children even in food rich areas. Improving feeding frequency may help to ameliorate undernutrition. To improve it, tailored interventions should target children of poor households, the food insecure, and caregivers who have received only a low level of education.	[Sunguya, Bruno F.; Mlunde, Linda B.; Yasuoka, Junko; Jimba, Masamine] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan; [Poudel, Krishna C.] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Dept Publ Hlth, Amherst, MA 01003 USA; [Urassa, David P.] Muhimbili Univ Hlth & Allied Sci, Sch Publ Hlth & Social Sci, Dar Es Salaam, Tanzania	University of Tokyo; University of Massachusetts System; University of Massachusetts Amherst; Muhimbili University of Health & Allied Sciences	Yasuoka, J (corresponding author), Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan.	jyasuoka@post.harvard.edu	Jimba, Masamine/AAF-5630-2020; Yasuoka, Junko/GVT-8950-2022	Sunguya, Bruno/0000-0003-3625-0725	Directorate of Research and Publication of the Muhimbili University of Health and Allied Sciences [MU/01/1022/0130/21]; Ministry of Health, Labor and Welfare of Japan [H24-Chikyukibo-Ippan-008]	Directorate of Research and Publication of the Muhimbili University of Health and Allied Sciences; Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study is funded by a grant from the Directorate of Research and Publication of the Muhimbili University of Health and Allied Sciences (Ref. No: MU/01/1022/0130/21), and the Ministry of Health, Labor and Welfare of Japan (Research Grant No: H24-Chikyukibo-Ippan-008). Funders did not have influence on the results or conduct of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2011, EUR J CLIN NUTR, V65, P1059, DOI 10.1038/ejcn.2011.72; Anema Aranka, 2009, Curr HIV/AIDS Rep, V6, P224, DOI 10.1007/s11904-009-0030-z; [Anonymous], 1978, GROWTH CHART INT US; [Anonymous], 1995, PHYS STAT US INT ANT; [Anonymous], 2009, GUIDELINES INTEGRATE; Bachou H, 2006, SEVERE MALNUTRITION; Belachew T, 2013, PLOS ONE, V8; Berkley JA, 2009, CLIN INFECT DIS, V49, P336, DOI 10.1086/600299; Bilinsky Paula, 2007, HOUSEHOLD FOOD INSEC, V3; Broeck J, 2009, EUR J PEDIATR, V168, P247, DOI 10.1007/s00431-008-0796-9; Buonomo E, 2012, INT J ENV RES PUB HE, V9, P421, DOI 10.3390/ijerph9020421; Choi Eun-Suil, 2008, Nutr Res Pract, V2, P308, DOI 10.4162/nrp.2008.2.4.308; FAO, 1999, DEV FOOD INS VULN MA; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Howe LD, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-3; ICF Macro, 2011, MICR RES 2010 TANZ D; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S25; Ivers LC, 2011, AM J CLIN NUTR, V94, p1740S, DOI 10.3945/ajcn.111.012617; Ivers LC, 2009, CLIN INFECT DIS, V49, P1096, DOI 10.1086/605573; Kadiyala S, 2012, PUBLIC HEALTH NUTR, P1; Katz MH, 1999, MULTIVARIABLE ANAL P; Keenan DP, 2001, J NUTR EDUC, V33, pS49, DOI 10.1016/S1499-4046(06)60069-9; Lutter CK, 2011, PEDIATRICS, V128, pE1418, DOI 10.1542/peds.2011-1392; Mpontshane N, 2008, J NUTR, V138, P1705, DOI 10.1093/jn/138.9.1705; Mullie P, 2010, EUR J CLIN NUTR, V64, P231, DOI 10.1038/ejcn.2009.145; NACP Tanzania TURo Health Mo Programme NAC Health Mo Programme NAC, 2009, NATL GUIDELINE MANAG; Nagata JM, 2012, AIDS CARE, V24, P728, DOI 10.1080/09540121.2011.630358; NBS ORC- Macro, 2010, TANZ DEM HLTH SURV 2; NBS ORC-Macro, 2005, TANZ DEM HLTH SURV 2; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; Palwala M, 2009, FOOD NUTR BULL, V30, P317, DOI 10.1177/156482650903000402; Patton M. Q., 2001, QUALITATIVE RES EVAL; Paul KH, 2012, MATERN CHILD NUTR, V8, P225, DOI 10.1111/j.1740-8709.2010.00265.x; Paul KH, 2011, FOOD NUTR BULL, V32, P244, DOI 10.1177/156482651103200308; Saaka M, 2013, INT J POPULATION RES; Saloojee H, 2007, SCAND J PUBLIC HEALT, V35, P96, DOI 10.1080/14034950701356435; Shi L, 2011, J TROP PEDIATRICS, V57, P91, DOI 10.1093/tropej/fmq053; Shi L, 2010, PUBLIC HEALTH NUTR, V13, P556, DOI 10.1017/S1368980009991364; Sunguya B F P, 2006, Tanzan Health Res Bull, V8, P189; Sunguya Bruno F, 2013, Front Public Health, V1, P37, DOI 10.3389/fpubh.2013.00037; Sunguya BF, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-352; Sunguya BF, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-66; Sunguya BF, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-60; Sunguya BF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-869; Swindale A., 2006, FHI 360FANTA; Tanzania Commission for AIDS (TACAIDS) Zanzibar AIDS Commission (ZAC) National Bureau of Statistics (NBS) Office of the Chief Government Statistician (OCGS) ICF International, 2013, TANZ HIV AIDS MAL IN, DOI Dares Salaam, Tanzania, and Calverton, Maryland, USA; Tiyou A, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-51; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tsai AC, 2012, SOC SCI MED, V74, P2012, DOI 10.1016/j.socscimed.2012.02.033; Tsai AC, 2011, SOC SCI MED, V73, P1717, DOI 10.1016/j.socscimed.2011.09.026; Vitolo MR, 2010, J NUTR, V140, P2002, DOI 10.3945/jn.110.125211; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Weiser SD, 2012, J ACQUIR IMMUNE DEFI; Weiser SD, 2011, AM J CLIN NUTR, V94, p1729S, DOI 10.3945/ajcn.111.012070; Weiser SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010340; World Health Organisation, 2003, NUTR REQ PEOPL LIV H; World Health Organization, 2005, NUTR HIV AIDS; World Health Organization, 2006, WHO CAS DEF HIV SURV; World Health Organization (WHO), 2009, WHO ANTHROPLUS PERS; Yeung S, 2000, J TROP PEDIATRICS, V46, P107, DOI 10.1093/tropej/46.2.107	60	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98308	10.1371/journal.pone.0098308	http://dx.doi.org/10.1371/journal.pone.0098308			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0UW	24846016	gold, Green Published			2022-12-25	WOS:000339563400104
J	Wang, N; Zhang, WW; Cui, J; Zhang, HM; Chen, X; Li, RD; Wu, NN; Chen, X; Wen, S; Zhang, JH; Yin, LJ; Deng, F; Liao, Z; Zhang, ZL; Zhang, Q; Yan, ZJ; Liu, W; Ye, JX; Deng, YL; Wang, ZL; Qiao, M; Luu, HH; Haydon, RC; Shi, LL; Liang, HJ; He, TC				Wang, Ning; Zhang, Wenwen; Cui, Jing; Zhang, Hongmei; Chen, Xiang; Li, Ruidong; Wu, Ningning; Chen, Xian; Wen, Sheng; Zhang, Junhui; Yin, Liangjun; Deng, Fang; Liao, Zhan; Zhang, Zhonglin; Zhang, Qian; Yan, Zhengjian; Liu, Wei; Ye, Jixing; Deng, Youlin; Wang, Zhongliang; Qiao, Min; Luu, Hue H.; Haydon, Rex C.; Shi, Lewis L.; Liang, Houjie; He, Tong-Chuan			The piggyBac Transposon-Mediated Expression of SV40 T Antigen Efficiently Immortalizes Mouse Embryonic Fibroblasts (MEFs)	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BONE MORPHOGENETIC PROTEINS; BMP-9-INDUCED OSTEOGENIC DIFFERENTIATION; MARROW STROMAL CELLS; OSTEOBLAST DIFFERENTIATION; ADIPOSE-TISSUE; TUMOR-GROWTH; NEURAL STEM; PLAYS; FETAL	Mouse embryonic fibroblasts (MEFs) are mesenchymal stem cell (MSC)-like multipotent progenitor cells and can undergo self-renewal and differentiate into to multiple lineages, including bone, cartilage and adipose. Primary MEFs have limited life span in culture, which thus hampers MEFs' basic research and translational applications. To overcome this challenge, we investigate if piggyBac transposon-mediated expression of SV40 T antigen can effectively immortalize mouse MEFs and that the immortalized MEFs can maintain long-term cell proliferation without compromising their multipotency. Using the piggyBac vector MPH86 which expresses SV40 T antigen flanked with flippase (FLP) recognition target (FRT) sites, we demonstrate that mouse embryonic fibroblasts (MEFs) can be efficiently immortalized. The immortalized MEFs (piMEFs) exhibit an enhanced proliferative activity and maintain long-term cell proliferation, which can be reversed by FLP recombinase. The piMEFs express most MEF markers and retain multipotency as they can differentiate into osteogenic, chondrogenic and adipogenic lineages upon BMP9 stimulation in vitro. Stem cell implantation studies indicate that piMEFs can form bone, cartilage and adipose tissues upon BMP9 stimulation, whereas FLP-mediated removal of SV40 T antigen diminishes the ability of piMEFs to differentiate into these lineages, possibly due to the reduced expansion of progenitor populations. Our results demonstrate that piggyBac transposon-mediated expression of SV40 T can effectively immortalize MEFs and that the reversibly immortalized piMEFs not only maintain long-term cell proliferation but also retain their multipotency. Thus, the high transposition efficiency and the potential footprint-free natures may render piggyBac transposition an effective and safe strategy to immortalize progenitor cells isolated from limited tissue supplies, which is essential for basic and translational studies.	[Wang, Ning; Liang, Houjie] Third Mil Med Univ, Dept Oncol, Southwest Hosp, Chongqing, Peoples R China; [Wang, Ning; Liang, Houjie] Third Mil Med Univ, Southwest Canc Ctr, Southwest Hosp, Chongqing, Peoples R China; [Wang, Ning; Zhang, Wenwen; Cui, Jing; Zhang, Hongmei; Chen, Xiang; Li, Ruidong; Wu, Ningning; Chen, Xian; Wen, Sheng; Zhang, Junhui; Yin, Liangjun; Deng, Fang; Liao, Zhan; Zhang, Zhonglin; Zhang, Qian; Yan, Zhengjian; Liu, Wei; Ye, Jixing; Deng, Youlin; Wang, Zhongliang; Qiao, Min; Luu, Hue H.; Haydon, Rex C.; Shi, Lewis L.; He, Tong-Chuan] Univ Chicago, Med Ctr, Mol Oncol Lab, Dept Orthopaed Surg, Chicago, IL 60637 USA; [Zhang, Wenwen; Cui, Jing; Zhang, Hongmei; Li, Ruidong; Wu, Ningning; Chen, Xian; Wen, Sheng; Zhang, Junhui; Yin, Liangjun; Zhang, Qian; Yan, Zhengjian; Liu, Wei; Deng, Youlin; Wang, Zhongliang; Qiao, Min; He, Tong-Chuan] Chongqing Med Univ, Minist Educ Key Lab Diagnost Med, Affiliated Hosp, Chongqing, Peoples R China; [Zhang, Wenwen] Binzhou Med Univ, Dept Lab Med, Affiliated Hosp, Yantai, Shandong, Peoples R China; [Deng, Fang] Third Mil Med Univ, Dept Cell Biol, Chongqing, Peoples R China; [Liao, Zhan] Cent S Univ, Dept Orthopaed Surg, Xiang Ya Hosp, Changsha, Hunan, Peoples R China; [Zhang, Zhonglin] Wuhan Univ, Dept Surg, Zhongnan Hosp, Wuhan 430072, Peoples R China; [Ye, Jixing] Chongqing Univ, Sch Bioengn, Chongqing 630044, Peoples R China	Army Medical University; Army Medical University; University of Chicago; University of Chicago Medical Center; Chongqing Medical University; Binzhou Medical University; Army Medical University; Central South University; Wuhan University; Chongqing University	Liang, HJ (corresponding author), Third Mil Med Univ, Dept Oncol, Southwest Hosp, Chongqing, Peoples R China.	lianghoujie@sina.com; tche@uchicago.edu		Yin, Liang-jun/0000-0002-9244-4965; Chen, Xiang/0000-0001-7628-516X; Deng, Fang/0000-0002-7927-5394	National Institutes of Health [AT004418, AR50142, AR054381]; 973 Program of Ministry of Science and Technology (MOST) of China [2011CB707900]; National Natural Science Foundation of China [81172115, 81272364]; University of Chicago Core Facility Subsidy grant from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health [UL1 TR000430]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR054381, K08AR050142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 973 Program of Ministry of Science and Technology (MOST) of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of Chicago Core Facility Subsidy grant from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The reported work was supported in part by research grants from the National Institutes of Health (AT004418, AR50142, and AR054381 to TCH, RCH and HHL), the 973 Program of Ministry of Science and Technology (MOST) of China (#2011CB707900 to TCH), and the National Natural Science Foundation of China (#81172115 and #81272364 to HL). This work was also supported in part by The University of Chicago Core Facility Subsidy grant from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health through Grant Number UL1 TR000430. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON SA, 1968, J CELL PHYSIOL, V72, P141, DOI 10.1002/jcp.1040720208; Amoh Y, 2005, P NATL ACAD SCI USA, V102, P17734, DOI 10.1073/pnas.0508440102; Bi Y, 2009, J CELL BIOCHEM, V108, P295, DOI 10.1002/jcb.22254; Bjerknes M, 2006, METHOD ENZYMOL, V419, P337, DOI 10.1016/S0076-6879(06)19014-X; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0; Chan JL, 2006, BLOOD, V107, P4817, DOI 10.1182/blood-2006-01-0057; Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Coles BLK, 2004, P NATL ACAD SCI USA, V101, P15772, DOI 10.1073/pnas.0401596101; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; Di Matteo Mario, 2012, Methods Mol Biol, V859, P241, DOI 10.1007/978-1-61779-603-6_14; Djouad F, 2007, STEM CELLS, V25, P2025, DOI 10.1634/stemcells.2006-0548; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; FRASER MJ, 1983, J VIROL, V47, P287, DOI 10.1128/JVI.47.2.287-300.1983; Haydon RC, 2002, CLIN CANCER RES, V8, P1288; He BC, 2011, MOL PHARMACOL, V79, P211, DOI 10.1124/mol.110.068668; He BC, 2010, CLIN CANCER RES, V16, P2235, DOI 10.1158/1078-0432.CCR-09-2499; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hu N, 2013, J CELL SCI, V126, P532, DOI 10.1242/jcs.114231; Huang EY, 2012, J BONE MINER RES, V27, P1566, DOI 10.1002/jbmr.1622; Huang EY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032428; Huang JY, 2009, LIVER INT, V29, P1569, DOI 10.1111/j.1478-3231.2009.02111.x; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Keilhoff G, 2006, EUR J CELL BIOL, V85, P11, DOI 10.1016/j.ejcb.2005.09.021; Kim A, 2011, MOL CELL BIOCHEM, V354, P301, DOI 10.1007/s11010-011-0832-3; Lamplot JD, 2013, AM J STEM CELLS, V2, P1; Li M, 2013, INT J MED SCI, V10, P1035, DOI 10.7150/ijms.6639; Li XH, 2013, P NATL ACAD SCI USA, V110, pE2279, DOI 10.1073/pnas.1305987110; Liu Z, 2004, J NEUROTRAUM, V21, P1479, DOI 10.1089/neu.2004.21.1479; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Luo JY, 2010, J BIOL CHEM, V285, P29588, DOI 10.1074/jbc.M110.130518; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Luo XJ, 2008, LAB INVEST, V88, P1264, DOI 10.1038/labinvest.2008.98; Luther G, 2011, CURR GENE THER, V11, P229; Luther GA, 2013, CANCER LETT, V336, P222, DOI 10.1016/j.canlet.2013.05.002; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Noel Daniele, 2002, Curr Opin Investig Drugs, V3, P1000; Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200; Peng Y, 2003, J CELL BIOCHEM, V90, P1149, DOI 10.1002/jcb.10744; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Phinney DG, 2013, CYTOTHERAPY, V15, P140, DOI 10.1016/j.jcyt.2012.11.005; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; PRIVES C, 1990, CELL, V61, P735, DOI 10.1016/0092-8674(90)90179-I; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rastegar Farbod, 2010, World J Stem Cells, V2, P67, DOI 10.4252/wjsc.v2.i4.67; Rastegar F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014182; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ringe J, 2008, J TISSUE ENG REGEN M, V2, P136, DOI 10.1002/term.75; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Shenaq DS, 2010, STEM CELLS INT, V2010, DOI 10.4061/2010/519028; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Sinanan ACM, 2004, BIOTECHNOL APPL BIOC, V40, P25, DOI 10.1042/BA20030185; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614; vom Brocke J, 2006, CARCINOGENESIS, V27, P2141, DOI 10.1093/carcin/bg1101; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Wang XJ, 2014, J BIOMED MATER RES A, V102, P1017, DOI 10.1002/jbm.a.34764; Westerman KA, 1996, P NATL ACAD SCI USA, V93, P8971, DOI 10.1073/pnas.93.17.8971; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Wislet-Gendebien S, 2005, BRAIN RES BULL, V68, P95, DOI 10.1016/j.brainresbull.2005.08.016; Wu SCY, 2006, P NATL ACAD SCI USA, V103, P15008, DOI 10.1073/pnas.0606979103; Yang K, 2012, J INVEST DERMATOL, V132, P2479, DOI 10.1038/jid.2012.145; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Zhang WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011917; Zhu GH, 2009, DIFFERENTIATION, V78, P195, DOI 10.1016/j.diff.2009.06.001; ZHU JY, 1991, J VIROL, V65, P6872, DOI 10.1128/JVI.65.12.6872-6880.1991; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	75	58	59	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97316	10.1371/journal.pone.0097316	http://dx.doi.org/10.1371/journal.pone.0097316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845466	Green Published, Green Submitted, gold			2022-12-25	WOS:000339563400021
J	Jin, HN; Nikolau, BJ				Jin, Huanan; Nikolau, Basil J.			Evaluating PHA Productivity of Bioengineered Rhodosprillum rubrum	PLOS ONE			English	Article							POLY-BETA-HYDROXYBUTYRATE; BACTERIUM RHODOSPIRILLUM-RUBRUM; POLYHYDROXYALKANOATE BIOSYNTHESIS; PSEUDOMONAS-OLEOVORANS; RALSTONIA-EUTROPHA; EXPRESSION; FERMENTATION; DEGRADATION; HYDRATASE; ROLES	This study explored the potential of using Rhodosprillum rubrum as the biological vehicle to convert chemically simple carbon precursors to a value-added bio-based product, the biopolymer PHA. R. rubrum strains were bioengineered to overexpress individually or in various combinations, six PHA biosynthetic genes (phaC1, phaA, phaB, phaC2, phaC3, and phaJ), and the resulting nine over-expressing strains were evaluated to assess the effect on PHA content, and the effect on growth. These experiments were designed to genetically evaluate: 1) the role of each apparently redundant PHA polymerase in determining PHA productivity; 2) identify the key gene(s) within the pha biosynthetic operon that determines PHA productivity; and 3) the role of phaJ to support PHA productivity. The result of overexpressing each PHA polymerase-encoding gene indicates that phaC1 and phaC2 are significant contributors to PHA productivity, whereas phaC3 has little effect. Similarly, over-expressing individually or in combination the three PHA biosynthesis genes located in the pha operon indicates that phaB is the key determinant of PHA productivity. Finally, analogous experiments indicate that phaJ does not contribute significantly to PHA productivity. These bioengineering strains achieved PHA productivity of up to 30% of dry biomass, which is approximately 2.5-fold higher than the non-engineered control strain, indicating the feasibility of using this approach to produce value added bio-based products.	[Jin, Huanan; Nikolau, Basil J.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Jin, Huanan; Nikolau, Basil J.] Iowa State Univ, Ctr Metab Biol, Ames, IA USA; [Nikolau, Basil J.] Iowa State Univ, Ctr Biorenewable Chem, Ames, IA USA	Iowa State University; Iowa State University; Iowa State University	Nikolau, BJ (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	dimmas@iastate.edu			U.S. National Science Foundation [EEC-0813570]; Bioeconomy Institute of Iowa State University	U.S. National Science Foundation(National Science Foundation (NSF)); Bioeconomy Institute of Iowa State University	This work was supported by the U.S. National Science Foundation (www.nsf.gov), through its Engineering Research Center Program (Award No. EEC-0813570), which is supporting the Center for Biorenewable Chemicals (CBiRC), headquartered at Iowa State University and includes Rice University, the University of California, Irvine, the University of New Mexico, the University of Virginia, and the University of Wisconsin-Madison. Support was also provided by the Bioeconomy Institute of Iowa State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aich S, 2001, BIOTECHNIQUES, V30, P846, DOI 10.2144/01304rr02; BRANDL H, 1989, INT J BIOL MACROMOL, V11, P49, DOI 10.1016/0141-8130(89)90040-8; BRANDL H, 1988, APPL ENVIRON MICROB, V54, P1977, DOI 10.1128/AEM.54.8.1977-1982.1988; Brigham CJ, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-26; Choi D, 2010, APPL BIOCHEM BIOTECH, V160, P1032, DOI 10.1007/s12010-009-8560-9; Clemente T, 2000, APPL MICROBIOL BIOT, V53, P420, DOI 10.1007/s002530051636; Do YS, 2007, BIOTECHNOL BIOENG, V97, P279, DOI 10.1002/bit.21226; DOI Y, 1992, FEMS MICROBIOL LETT, V103, P103, DOI 10.1111/j.1574-6968.1992.tb05827.x; Fukui T, 1998, J BACTERIOL, V180, P667, DOI 10.1128/JB.180.3.667-673.1998; Fukui T, 2001, BIOMACROMOLECULES, V2, P148, DOI 10.1021/bm0056052; Guehenneux G, 2005, FUEL, V84, P733, DOI 10.1016/j.fuel.2004.11.005; Han J, 2004, FEMS MICROBIOL LETT, V239, P195, DOI 10.1016/j.femsle.2004.08.044; He YP, 1999, J BIOL CHEM, V274, P10840, DOI 10.1074/jbc.274.16.10840; Henstra AM, 2007, CURR OPIN BIOTECH, V18, P200, DOI 10.1016/j.copbio.2007.03.008; HUSTEDE E, 1992, FEMS MICROBIOL LETT, V93, P285, DOI 10.1016/0378-1097(92)90476-5; Jarboe LR, 2011, APPL MICROBIOL BIOT, V91, P1519, DOI 10.1007/s00253-011-3495-9; Jendrossek D, 2009, J BACTERIOL, V191, P3195, DOI 10.1128/JB.01723-08; Jin HN, 2012, J BACTERIOL, V194, P5522, DOI 10.1128/JB.01111-12; KERBY RL, 1995, J BACTERIOL, V177, P2241, DOI 10.1128/jb.177.8.2241-2244.1995; KERBY RL, 1992, J BACTERIOL, V174, P5284, DOI 10.1128/JB.174.16.5284-5294.1992; Kim YB, 2001, ADV BIOCHEM ENG BIOT, V71, P51; Kraak MN, 1997, J BACTERIOL, V179, P4985, DOI 10.1128/jb.179.16.4985-4991.1997; Kunkes EL, 2008, SCIENCE, V322, P417, DOI 10.1126/science.1159210; LIANG JH, 1991, J BACTERIOL, V173, P6903, DOI 10.1128/jb.173.21.6903-6909.1991; Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21, DOI 10.1128/MMBR.63.1.21-53.1999; Maurer S, 2013, J PHYS CHEM B, V117, P13872, DOI 10.1021/jp403893n; Nikolau BJ, 2008, PLANT J, V54, P536, DOI 10.1111/j.1365-313X.2008.03484.x; OEDING V, 1973, BIOCHEM J, V134, P239, DOI 10.1042/bj1340239; Pfennig N, 1978, TAXONOMY RHODOSPIRIL, P17; Potter M, 2002, MICROBIOL-SGM, V148, P2413, DOI 10.1099/00221287-148-8-2413; Purkrtova Z, 2008, CR BIOL, V331, P746, DOI 10.1016/j.crvi.2008.07.016; Reiser SE, 2000, APPL MICROBIOL BIOT, V53, P209, DOI 10.1007/s002530050010; Ruiz JA, 2001, APPL ENVIRON MICROB, V67, P225, DOI 10.1128/AEM.67.1.225-230.2001; Sambrook J., 2001, MOL CLONING LAB MANU; SENIOR PJ, 1971, BIOCHEM J, V125, P55, DOI 10.1042/bj1250055; Steinbuchel A, 2001, ADV BIOCHEM ENG BIOT, V71, P81; Steinbuchel A, 2001, MACROMOL BIOSCI, V1, P1; TAL S, 1985, CAN J MICROBIOL, V31, P608, DOI 10.1139/m85-115; Zhang YP, 2001, J BACTERIOL, V183, P6159, DOI 10.1128/JB.183.21.6159-6168.2001	39	8	10	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e96621	10.1371/journal.pone.0096621	http://dx.doi.org/10.1371/journal.pone.0096621			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24840941	Green Published, Green Submitted, gold			2022-12-25	WOS:000340948600010
J	Kim, MW; Ahn, KH; Ryu, KJ; Hong, SC; Lee, JS; Nava-Ocampo, AA; Oh, MJ; Kim, HJ				Kim, Min Woo; Ahn, Ki Hoon; Ryu, Ki-Jin; Hong, Soon-Cheol; Lee, Ji Sung; Nava-Ocampo, Alejandro A.; Oh, Min-Jeong; Kim, Hai-Joong			Preventive Effects of Folic Acid Supplementation on Adverse Maternal and Fetal Outcomes	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; NEURAL-TUBE DEFECTS; FOLATE CONCENTRATIONS; PREGNANCY OUTCOMES; SERUM FOLATE; HOMOCYSTEINE; WOMEN; PREECLAMPSIA; BIRTH; HYPERHOMOCYSTEINEMIA	Although there is accumulating evidence regarding the additional protective effect of folic acid against adverse pregnancy outcomes other than neural tube defects, these effects have not been elucidated in detail. We evaluated whether folic acid supplementation is associated with favorable maternal and fetal outcomes. This was a secondary analysis of 215 pregnant women who were enrolled in our prior study. With additional data from telephone interviews regarding prenatal folic acid supplementation, existing demographic, maternal and fetal data were statistically analyzed. The concentration of folic acid in maternal blood was significantly higher following folic acid supplementation (24.6 ng/mL vs. 11.8 ng/mL). In contrast, homocysteine level in maternal blood decreased with folic acid supplementation (5.5 mmol/mL vs. 6.8 mmol/mL). The rates of both preeclampsia (odds ratio [OR], 0.27; 95% confidence interval [CI], 0.09-0.76) and small for gestational age (SGA; 9.2% vs. 20.0%; OR, 0.42; 95% CI, 0.18-0.99) were lower in the folic acid supplementation group than those in the control group. Other pregnancy outcomes had no association with folic acid supplementation. The findings indicate that folic acid supplementation may help to prevent preeclampsia and SGA. Further studies are warranted to elucidate the favorable effects of folic acid supplementation on pregnancy outcomes.	[Kim, Min Woo; Ahn, Ki Hoon; Ryu, Ki-Jin; Hong, Soon-Cheol; Oh, Min-Jeong; Kim, Hai-Joong] Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul 136705, South Korea; [Lee, Ji Sung] Soonchunhyang Univ, Med Ctr, Biostat Consulting Unit, Seoul, South Korea; [Nava-Ocampo, Alejandro A.] Hosp Sick Children, Div Clin Pharmacol & Toxicol, Toronto, ON M5G 1X8, Canada; [Nava-Ocampo, Alejandro A.] Pharmacol Res & Appl Solut PharmaReasons, Toronto, ON, Canada	Korea University; Korea University Medicine (KU Medicine); Soonchunhyang University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Hong, SC (corresponding author), Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul 136705, South Korea.	novak082@naver.com	Rhim, Sonny H./W-9532-2019; Nava-Ocampo, Alejandro/K-3850-2012		Korea University College of Medicine [K1220211]; National Research Foundation of Korea - Ministry of Education, Science and Technology [2012-0003134]; harmacological Research and Applied Solutions- PharmaReasons	Korea University College of Medicine; National Research Foundation of Korea - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); harmacological Research and Applied Solutions- PharmaReasons	This study was supported by grant No. K1220211 from Korea University College of Medicine and a grant (2012-0003134) from the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology. harmacological Research and Applied Solutions- PharmaReasons provided support in the form of a salary for author AANO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bukowski R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000061; BURKE G, 1992, NEW ENGL J MED, V326, P69; Charles DHM, 2005, PAEDIATR PERINAT EP, V19, P112, DOI 10.1111/j.1365-3016.2005.00633.x; Chiaffarino F, 2010, Minerva Ginecol, V62, P293; Christian P, 2010, JAMA-J AM MED ASSOC, V304, P2716, DOI 10.1001/jama.2010.1861; CNATTINGIUS S, 1993, AM J OBSTET GYNECOL, V168, P16, DOI 10.1016/S0002-9378(12)90878-9; Colapinto CK, 2012, APPL PHYSIOL NUTR ME, V37, P284, DOI [10.1139/h11-161, 10.1139/H11-161]; Czeizel AE, 2010, EUR J OBSTET GYN R B, V148, P135, DOI 10.1016/j.ejogrb.2009.10.016; De-Regil LM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007950.pub2; DEKKER GA, 1995, AM J OBSTET GYNECOL, V173, P1042, DOI 10.1016/0002-9378(95)91324-6; Falcao S, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.003; GOLDENBERG RL, 1992, OBSTET GYNECOL, V79, P719; IYENGAR L, 1975, AM J OBSTET GYNECOL, V122, P332, DOI 10.1016/0002-9378(75)90179-9; Kim MW, 2012, J OBSTET GYNAECOL, V32, P520, DOI 10.3109/01443615.2012.693984; Krishnaveni GV, 2009, DIABETOLOGIA, V52, P2350, DOI 10.1007/s00125-009-1499-0; Lane IR, 2011, J OBSTET GYNAECOL, V31, P581, DOI 10.3109/01443615.2011.594917; McDowell IFW, 2000, J NUTR, V130, p369S, DOI 10.1093/jn/130.2.369S; McNulty B, 2011, HUM REPROD, V26, P1530, DOI 10.1093/humrep/der078; McNulty H, 2008, P NUTR SOC, V67, P232, DOI 10.1017/S0029665108007076; Mislanova C, 2011, REPRODUCTION, V142, P467, DOI 10.1530/REP-10-0484; Rajkovic A, 1999, OBSTET GYNECOL, V94, P355, DOI 10.1016/S0029-7844(99)00304-X; Scholl TO, 1996, AM J CLIN NUTR, V63, P520, DOI 10.1093/ajcn/63.4.520; Scott J, 2011, ANN NUTR METAB, V59, P46, DOI 10.1159/000332127; SHOHAMVARDI I, 1994, EUR J OBSTET GYN R B, V53, P95, DOI 10.1016/0028-2243(94)90214-3; Solanky N, 2010, PLACENTA, V31, P134, DOI 10.1016/j.placenta.2009.11.017; Steegers-Theunissen RP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007845; STEEGERSTHEUNISSEN RPM, 1992, LANCET, V339, P1122, DOI 10.1016/0140-6736(92)90725-I; Timmermans S, 2009, BRIT J NUTR, V102, P777, DOI 10.1017/S0007114509288994; van der Molen EF, 2000, BRIT J OBSTET GYNAEC, V107, P785; Vollset SE, 2000, AM J CLIN NUTR, V71, P962; Wang J, 2000, BRIT J OBSTET GYNAEC, V107, P935, DOI 10.1111/j.1471-0528.2000.tb11095.x; Wen SW, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.067; Williams PJ, 2011, BIOL REPROD, V84, P1148, DOI 10.1095/biolreprod.110.088351; WOUTERS MGAJ, 1993, FERTIL STERIL, V60, P820; Yajnik CS, 2008, DIABETOLOGIA, V51, P29, DOI 10.1007/s00125-007-0793-y	35	30	35	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97273	10.1371/journal.pone.0097273	http://dx.doi.org/10.1371/journal.pone.0097273			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842467	Green Published, Green Submitted, gold			2022-12-25	WOS:000340948600019
J	Cook, KL; Clarke, PAG; Parmar, J; Hu, R; Schwartz-Roberts, JL; Abu-Asab, M; Warri, A; Baumann, WT; Clarke, R				Cook, Katherine L.; Clarke, Pamela A. G.; Parmar, Jignesh; Hu, Rong; Schwartz-Roberts, Jessica L.; Abu-Asab, Mones; Waerri, Anni; Baumann, William T.; Clarke, Robert			Knockdown of estrogen receptor-alpha induces autophagy and inhibits antiestrogen-mediated unfolded protein response activation, promoting ROS-induced breast cancer cell death	FASEB JOURNAL			English	Article						fulvestrant; ICI 182780; apoptosis; reactive oxygen species	BOX BINDING PROTEIN-1; ACQUIRED-RESISTANCE; FACTOR-I; APOPTOSIS; MACROAUTOPHAGY; MITOCHONDRIA; EXPRESSION; INDUCTION; CONFERS	Approximately 70% of all newly diagnosed breast cancers express estrogen receptor (ER)-alpha. Although inhibiting ER action using targeted therapies such as fulvestrant (ICI) is often effective, later emergence of antiestrogen resistance limits clinical use. We used antiestrogen-sensitive and -resistant cells to determine the effect of antiestrogens/ER alpha on regulating autophagy and unfolded protein response (UPR) signaling. Knockdown of ER alpha significantly increased the sensitivity of LCC1 cells (sensitive) and also resensitized LCC9 cells (resistant) to antiestrogen drugs. Interestingly, ER alpha knockdown, but not ICI, reduced nuclear factor (erythroid-derived 2)-like (NRF)-2 (UPR-induced antioxidant protein) and increased cytosolic kelch-like ECH-associated protein (KEAP)-1 (NRF2 inhibitor), consistent with the observed increase in ROS production. Furthermore, autophagy induction by antiestrogens was prosurvival but did not prevent ER alpha knockdown-mediated death. We built a novel mathematical model to elucidate the interactions among UPR, autophagy, ER signaling, and ROS regulation of breast cancer cell survival. The experimentally validated mathematical model explains the counterintuitive result that knocking down the main target of ICI (ER alpha) increased the effectiveness of ICI. Specifically, the model indicated that ER alpha is no longer present in excess and that the effect on proliferation from further reductions in its level by ICI cannot be compensated for by increased autophagy. The stimulation of signaling that can confer resistance suggests that combining autophagy or UPR inhibitors with antiestrogens would reduce the development of resistance in some breast cancers.	[Cook, Katherine L.; Clarke, Pamela A. G.; Hu, Rong; Schwartz-Roberts, Jessica L.; Waerri, Anni; Clarke, Robert] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20057 USA; [Cook, Katherine L.; Clarke, Pamela A. G.; Hu, Rong; Schwartz-Roberts, Jessica L.; Waerri, Anni; Clarke, Robert] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [Parmar, Jignesh] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA; [Baumann, William T.] Virginia Polytech Inst & State Univ, Bradley Dept Elect & Comp Engn, Blacksburg, VA 24061 USA; [Abu-Asab, Mones] NEI, US NIH, Immunopathol Sect, Bethesda, MD 20892 USA; [Abu-Asab, Mones] NEI, US NIH, Immunol Lab, Bethesda, MD 20892 USA	Georgetown University; Georgetown University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Clarke, R (corresponding author), Georgetown Univ, Med Ctr, W405A Res Bldg,3970 Reservoir Rd NW, Washington, DC 20057 USA.	clarker@georgetown.edu	Clarke, Robert/A-6485-2008	Clarke, Robert/0000-0002-9278-0854; Warri, Anni/0000-0002-0535-847X; Cook, Katherine/0000-0001-6241-0214	U.S. Department of Defense Breast Cancer Research Program Postdoctoral Fellowship [BC112023]; U.S. Department of Health and Human Services [U54-CA149147, R01-CA131465]; NATIONAL CANCER INSTITUTE [U01CA184902, U54CA149147, R01CA131465, T32CA009686] Funding Source: NIH RePORTER	U.S. Department of Defense Breast Cancer Research Program Postdoctoral Fellowship(United States Department of Defense); U.S. Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a U.S. Department of Defense Breast Cancer Research Program Postdoctoral Fellowship (BC112023; to K. C.) and in part by awards from the U.S. Department of Health and Human Services (U54-CA149147 and R01-CA131465) (to R. C.). The authors declare no conflicts of interest.	Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107; Bourdeau V, 2004, MOL ENDOCRINOL, V18, P1411, DOI 10.1210/me.2003-0441; Brunner N, 1997, CANCER RES, V57, P3486; BRUNNER N, 1993, CANCER RES, V53, P283; Chen CS, 2013, NEUROENDOCRINOLOGY, V97, P232, DOI 10.1159/000342692; Clarke R, 2001, J STEROID BIOCHEM, V76, P71, DOI 10.1016/S0960-0760(00)00193-X; Clarke R, 2001, PHARMACOL REV, V53, P25; Clarke R, 2012, CANCER RES, V72, P1321, DOI 10.1158/0008-5472.CAN-11-3213; Clarke Robert, 2011, Horm Mol Biol Clin Investig, V5, P35, DOI 10.1515/HMBCI.2010.073; Clarke R, 2009, J STEROID BIOCHEM, V114, P8, DOI 10.1016/j.jsbmb.2008.12.023; Cook KL, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-16; Cook KL, 2013, FUTURE MED CHEM, V5, P1047, DOI 10.4155/fmc.13.77; Cook KL, 2012, AUTOPHAGY, V8, P1827, DOI 10.4161/auto.21765; Cook KL, 2011, EXPERT REV ANTICANC, V11, P1283, DOI [10.1586/ERA.11.111, 10.1586/era.11.111]; Crawford AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008604; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Ding LH, 2003, NUCLEIC ACIDS RES, V31, P5266, DOI 10.1093/nar/gkg731; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Gomez BP, 2007, FASEB J, V21, P4013, DOI 10.1096/fj.06-7990com; Gu ZP, 2002, CANCER RES, V62, P3428; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Ishii Y, 2011, CLIN CANCER RES, V17, P2292, DOI 10.1158/1078-0432.CCR-10-1745; Jager R, 2012, BIOL CELL, V104, P259, DOI 10.1111/boc.201100055; Kiewlich D., 2009, THESIS U CALIFORNIA; Kuske B, 2006, ENDOCR-RELAT CANCER, V13, P1121, DOI 10.1677/erc.1.01257; Long XH, 2006, J BIOL CHEM, V281, P9607, DOI 10.1074/jbc.M510809200; Lozon TI, 2011, AM J PHYSIOL-LUNG C, V300, pL422, DOI 10.1152/ajplung.00166.2010; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mattingly KA, 2008, MOL ENDOCRINOL, V22, P609, DOI 10.1210/me.2007-0029; Papa L, 2011, J CELL SCI, V124, P1396, DOI 10.1242/jcs.078220; Parmar JH, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2013.0012; Pedram A, 2006, MOL BIOL CELL, V17, P2125, DOI 10.1091/mbc.E05-11-1013; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Riggins RB, 2005, VITAM HORM, V71, P201, DOI 10.1016/S0083-6729(05)71007-4; Samaddar JS, 2008, MOL CANCER THER, V7, P2977, DOI 10.1158/1535-7163.MCT-08-0447; Schoenlein PV, 2009, AUTOPHAGY, V5, P400, DOI 10.4161/auto.5.3.7784; Scriven P, 2009, BRIT J CANCER, V101, P1692, DOI 10.1038/sj.bjc.6605365; Shajahan AN, 2009, DRUG NEWS PERSPECT, V22, P241, DOI 10.1358/dnp.2009.22.5.1378631; Soto-Pantoja DR, 2012, AUTOPHAGY, V8, P1628, DOI 10.4161/auto.21562; Verfaillie T, 2010, CANC LETT, V332, P249; Verfaillie T, 2010, INT J CELL BIOL, V2010; Wong CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009996	43	56	57	0	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2014	28	9					3891	3905		10.1096/fj.13-247353	http://dx.doi.org/10.1096/fj.13-247353			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN8HU	24858277	Green Published			2022-12-25	WOS:000340845900008
J	Gupta, A; Gomes, I; Wardman, J; Devi, LA				Gupta, Achla; Gomes, Ivone; Wardman, Jonathan; Devi, Lakshmi A.			Opioid Receptor Function Is Regulated by Post-endocytic Peptide Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIN-CONVERTING ENZYME-2; PROTEIN-COUPLED RECEPTORS; BOVINE ADRENAL-MEDULLA; NEUROKININ 1 RECEPTOR; CEREBRAL-CORTEX; ACTIVITY INVIVO; BETA-ARRESTINS; PROENKEPHALIN; TRAFFICKING; INTERNALIZATION	Most neuroendocrine peptides are generated in the secretory compartment by proteolysis of the precursors at classical cleavage sites consisting of basic residues by well studied endopeptidases belonging to the subtilisin superfamily. In contrast, a subset of bioactive peptides is generated by processing at non-classical cleavage sites that do not contain basic residues. Neither the peptidases responsible for non-classical cleavages nor the compartment involved in such processing has been well established. Members of the endothelin-converting enzyme (ECE) family are considered good candidate enzymes because they exhibit functional properties that are consistent with such a role. In this study we have explored a role for ECE2 in endocytic processing of delta opioid peptides and its effect on modulating delta opioid receptor function by using selective inhibitors of ECE2 that we had identified previously by homology modeling and virtual screening of a library of small molecules. We found that agonist treatment led to intracellular co-localization of ECE2 with delta opioid receptors. Furthermore, selective inhibitors of ECE2 and reagents that increase the pH of the acidic compartment impaired receptor recycling by protecting the endocytosed peptide from degradation. This, in turn, led to a substantial decrease in surface receptor signaling. Finally, we showed that treatment of primary neurons with the ECE2 inhibitor during recycling led to increased intracellular co-localization of the receptors and ECE2, which in turn led to decreased receptor recycling and signaling by the surface receptors. Together, these results support a role for differential modulation of opioid receptor signaling by post-endocytic processing of peptide agonists by ECE2.	[Gupta, Achla; Gomes, Ivone; Wardman, Jonathan; Devi, Lakshmi A.] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Devi, Lakshmi A.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Devi, LA (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, 19-84 Annenberg Bldg,One Gustave L Levy Pl, New York, NY 10029 USA.	lakshmi.devi@mssm.edu	Devi P, Lakshmi/GXM-5982-2022	Devi P, Lakshmi/0000-0001-9274-4776	National Institutes of Health [NS26880, DA 019521, T32 DA-007135]; National Institute on Drug Abuse [DA007135]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026880, R29NS026880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA008863, T32DA007135, K05DA019521] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants NS26880, DA 019521, and T32 DA-007135 (to L. A. D.).; Supported by Training Grant DA007135 from the National Institute on Drug Abuse.	Breit A, 2006, MOL PHARMACOL, V70, P686, DOI 10.1124/mol.106.022897; Bunnett NW, 2010, CNS NEUROL DISORD-DR, V9, P539; Cattaruzza F, 2009, BRIT J PHARMACOL, V156, P730, DOI 10.1111/j.1476-5381.2008.00039.x; CHAVKIN C, 1985, J NEUROSCI, V5, P808; Cheng SB, 2012, J BIOL CHEM, V287, P14178, DOI 10.1074/jbc.M111.323782; Chow KM, 2003, BIOCHEMISTRY-US, V42, P2239, DOI 10.1021/bi027178d; Cottrell GS, 2009, J BIOL CHEM, V284, P22411, DOI 10.1074/jbc.M109.026674; Cvejic S, 1996, J BIOL CHEM, V271, P4073; DAVIS TP, 1990, EUR J PHARMACOL, V191, P253, DOI 10.1016/0014-2999(90)94157-S; DAVIS TP, 1985, EUR J PHARMACOL, V111, P177, DOI 10.1016/0014-2999(85)90754-X; DRAY A, 1985, J PHARMACOL EXP THER, V235, P670; EIPPER BA, 1988, ANNU REV PHYSIOL, V50, P333, DOI 10.1146/annurev.ph.50.030188.002001; EMOTO N, 1995, J BIOL CHEM, V270, P15262, DOI 10.1074/jbc.270.25.15262; Fricker L.D., 2012, NEUROPEPTIDES OTHER; Gagnidze K, 2008, J MED CHEM, V51, P3378, DOI 10.1021/jm7015478; Gaudriault G, 1997, J BIOL CHEM, V272, P2880, DOI 10.1074/jbc.272.5.2880; Gomes I, 2004, P NATL ACAD SCI USA, V101, P5135, DOI 10.1073/pnas.0307601101; Gomes I, 2003, METH MOLEC MED, V84, P157; Gomes I, 2013, P NATL ACAD SCI USA, V110, P16211, DOI 10.1073/pnas.1312938110; Gomes I, 2013, METHOD ENZYMOL, V521, P219, DOI 10.1016/B978-0-12-391862-8.00012-0; Gupta A, 2008, J BIOL CHEM, V283, P10735, DOI 10.1074/jbc.M709454200; Gupta A, 2007, J BIOL CHEM, V282, P5116, DOI 10.1074/jbc.M609254200; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hasdemir B, 2012, MOL ENDOCRINOL, V26, P681, DOI 10.1210/me.2011-1361; HOLLT V, 1982, LIFE SCI, V31, P1883, DOI 10.1016/0024-3205(82)90234-X; Hong YG, 2004, BRIT J PHARMACOL, V141, P423, DOI 10.1038/sj.bjp.0705637; Hook VYH, 1996, ARCH BIOCHEM BIOPHYS, V328, P107, DOI 10.1006/abbi.1996.0149; HURLBUT DE, 1987, EUR J PHARMACOL, V138, P359, DOI 10.1016/0014-2999(87)90474-2; Ippoliti R, 1998, CELL MOL LIFE SCI, V54, P866, DOI 10.1007/s000180050214; KUKKOLA PJ, 1995, J CARDIOVASC PHARM, V26, pS65; Law IKM, 2012, J BIOL CHEM, V287, P15066, DOI 10.1074/jbc.M111.327262; Law PY, 2000, J BIOL CHEM, V275, P32057, DOI 10.1074/jbc.M002395200; Lembo PMC, 2002, NAT NEUROSCI, V5, P201, DOI 10.1038/nn815; MCGINTY JF, 1985, NEUROPEPTIDES, V5, P465, DOI 10.1016/0143-4179(85)90055-1; MCGINTY JF, 1984, J NEUROSCI, V4, P1104; MIZUNO K, 1980, BIOCHEM BIOPH RES CO, V97, P1283, DOI 10.1016/S0006-291X(80)80005-2; MIZUNO K, 1980, BIOCHEM BIOPH RES CO, V95, P1482, DOI 10.1016/S0006-291X(80)80064-7; Molineaux C, 1991, PEPTIDE BIOSYNTHESIS, P251; Mzhavia N, 2003, J BIOL CHEM, V278, P14704, DOI 10.1074/jbc.M211242200; Oliveira V, 2005, FEBS J, V272, P2978, DOI 10.1111/j.1742-4658.2005.04692.x; Ouimet T, 2010, J BIOL CHEM, V285, P34390, DOI 10.1074/jbc.M110.120576; Pacheco-Quinto J, 2013, J BIOL CHEM, V288, P5606, DOI 10.1074/jbc.M112.422964; Padilla BE, 2007, J CELL BIOL, V179, P981, DOI 10.1083/jcb.200704053; Pan H, 2004, PROTEIN PEPTIDE LETT, V11, P461, DOI 10.2174/0929866043406463; Pelayo JC, 2011, J PHYSIOL-LONDON, V589, P5213, DOI 10.1113/jphysiol.2011.214452; Rodriguiz RM, 2008, GENES BRAIN BEHAV, V7, P418, DOI 10.1111/j.1601-183X.2007.00365.x; Roosterman D, 2008, ENDOCRINOLOGY, V149, P2200, DOI 10.1210/en.2007-1628; Roosterman D, 2007, P NATL ACAD SCI USA, V104, P11838, DOI 10.1073/pnas.0701910104; Rozenfeld R, 2008, FASEB J, V22, P2311, DOI 10.1096/fj.07-102731; Rozenfeld R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029239; Schulz R, 1991, J Enzyme Inhib, V4, P347, DOI 10.3109/14756369109030399; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seto S, 1989, Adv Exp Med Biol, V247B, P49; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; Swanson TA, 2004, PROTEIN PEPTIDE LETT, V11, P471, DOI 10.2174/0929866043406607; Trapaidze N, 1996, J BIOL CHEM, V271, P29279, DOI 10.1074/jbc.271.46.29279; Turner AJ, 1996, BIOCHEM PHARMACOL, V51, P91, DOI 10.1016/0006-2952(95)02036-5; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Turner AJ, 1996, ADV EXP MED BIOL, V389, P141; UMEZAWA H, 1976, J ANTIBIOT, V29, P97, DOI 10.7164/antibiotics.29.97; Vermeirssen V, 2002, J BIOCHEM BIOPH METH, V51, P75, DOI 10.1016/S0165-022X(02)00006-4; Williams JT, 2013, PHARMACOL REV, V65, P223, DOI 10.1124/pr.112.005942; Wood DE, 1998, ONCOGENE, V17, P1069, DOI 10.1038/sj.onc.1202034; Yanagisawa H, 2000, J CLIN INVEST, V105, P1373, DOI 10.1172/JCI7447; Zhang L, 2006, MOL PHARMACOL, V69, P1810, DOI 10.1124/mol.105.021352; Zhao PS, 2013, J BIOL CHEM, V288, P25689, DOI 10.1074/jbc.M113.496414	66	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19613	19626		10.1074/jbc.M113.537704	http://dx.doi.org/10.1074/jbc.M113.537704			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24847082	hybrid, Green Published			2022-12-25	WOS:000339326800034
J	Bezerra, GA; Viertlmayr, R; Moura, TR; Delatorre, P; Rocha, BAM; do Nascimento, KS; Figueiredo, JG; Bezerra, IG; Teixeira, CS; Simoes, RC; Nagano, CS; de Alencar, NMN; Gruber, K; Cavada, BS				Bezerra, Gustavo Arruda; Viertlmayr, Roland; Moura, Tales Rocha; Delatorre, Plinio; Matias Rocha, Bruno Anderson; do Nascimento, Kyria Santiago; Figueiredo, Jozi Godoy; Bezerra, Ingrid Goncalves; Teixeira, Cicero Silvano; Simoes, Rafael Conceicao; Nagano, Celso Shiniti; Nunes de Alencar, Nylane Maria; Gruber, Karl; Cavada, Benildo Sousa			Structural Studies of an Anti-Inflammatory Lectin from Canavalia boliviana Seeds in Complex with Dimannosides	PLOS ONE			English	Article							DIMER-TETRAMER EQUILIBRIUM; X-RAY DIFFRACTION; CRYSTAL-STRUCTURE; PLANT-LECTINS; PAW EDEMA; CARBOHYDRATE-RECOGNITION; BIOLOGICAL-ACTIVITY; SOLUTION SCATTERING; GRANDIFLORA SEEDS; CONCANAVALIN-A	Plant lectins, especially those purified from species of the Leguminosae family, represent the best-studied group of carbohydrate-binding proteins. Lectins purified from seeds of the Diocleinae subtribe exhibit a high degree of sequence identity notwithstanding that they show very distinct biological activities. Two main factors have been related to this feature: variance in key residues influencing the carbohydrate-binding site geometry and differences in the pH-dependent oligomeric state profile. In this work, we have isolated a lectin from Canavalia boliviana (Cbol) and solved its x-ray crystal structure in the unbound form and in complex with the carbohydrates Man(alpha 1-3)Man(alpha 1-O)Me, Man(alpha 1-4) Man(alpha 1-O) Me and 5-bromo-4-chloro-3-indolyl-alpha-D-mannose. We evaluated its oligomerization profile at different pH values using Small Angle X-ray Scattering and compared it to that of Concanavalin A. Based on predicted pKa-shifts of amino acids in the subunit interfaces we devised a model for the dimer-tetramer equilibrium phenomena of these proteins. Additionally, we demonstrated Cbol anti-inflammatory properties and further characterized them using in vivo and in vitro models.	[Bezerra, Gustavo Arruda; Viertlmayr, Roland; Gruber, Karl] Graz Univ, Inst Mol Biosci, Graz, Austria; [Moura, Tales Rocha; Matias Rocha, Bruno Anderson; do Nascimento, Kyria Santiago; Teixeira, Cicero Silvano; Simoes, Rafael Conceicao; Cavada, Benildo Sousa] Univ Fed Ceara, Dept Biochem & Mol Biol, Fortaleza, Ceara, Brazil; [Delatorre, Plinio] Univ Fed Paraiba, Dept Mol Biol, BR-58059900 Joao Pessoa, Paraiba, Brazil; [Figueiredo, Jozi Godoy; Bezerra, Ingrid Goncalves; Nunes de Alencar, Nylane Maria] Univ Fed Ceara, Dept Physiol & Pharmacol, Fortaleza, Ceara, Brazil; [Nagano, Celso Shiniti] Univ Fed Ceara, Dept Fishing Engn, Fortaleza, Ceara, Brazil	University of Graz; Universidade Federal do Ceara; Universidade Federal da Paraiba; Universidade Federal do Ceara; Universidade Federal do Ceara	Bezerra, GA (corresponding author), Graz Univ, Inst Mol Biosci, Graz, Austria.	gustavo.bezerra@univie.ac.at; bscavada@ufc.br	Cavada, Benildo/CEA-4997-2022; Nagano, Celso Shiniti/J-9649-2012; Rocha, B.A.M./E-2919-2015; Gruber, Karl/GPP-6706-2022	Cavada, Benildo/0000-0002-5791-6170; Nagano, Celso Shiniti/0000-0001-5988-5868; Rocha, B.A.M./0000-0002-7157-0321; Gruber, Karl/0000-0002-3485-9740; Rocha de Moura, Tales/0000-0001-5492-8419; Arruda Bezerra, Gustavo/0000-0003-4471-821X	Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico - FUNCAP; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES; National Synchrotron Light Laboratory - LNLS, Brazil; Doktoratskolleg "Molecular Enzymology" Grant from the Austrian Science Fund [W901-B05]; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico - FUNCAP(Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Synchrotron Light Laboratory - LNLS, Brazil; Doktoratskolleg "Molecular Enzymology" Grant from the Austrian Science Fund; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work is funded by Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico - FUNCAP, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES, National Synchrotron Light Laboratory - LNLS, Brazil. BSC is senior investigator of CNPq. Additional funding was provided by the Doktoratskolleg "Molecular Enzymology" Grant W901-B05 from the Austrian Science Fund (to KG and GAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AGRAWAL BBL, 1968, ARCH BIOCHEM BIOPHYS, V124, P218, DOI 10.1016/0003-9861(68)90322-6; Alencar NMN, 1999, MEDIAT INFLAMM, V8, P107, DOI 10.1080/09629359990603; Alencar NMN, 2004, PROTEIN PEPTIDE LETT, V11, P195, DOI 10.2174/0929866043478284; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrade JL, 1999, CELL IMMUNOL, V194, P98, DOI 10.1006/cimm.1999.1494; Arraes SMA, 2006, BLOOD, V108, P2906, DOI 10.1182/blood-2006-05-024638; Assreuy AMS, 1997, MEDIAT INFLAMM, V6, P201, DOI 10.1080/09629359791695; BENTO CAM, 1993, AGENTS ACTIONS, V38, P48, DOI 10.1007/BF02027213; Bezerra GA, 2007, J STRUCT BIOL, V160, P168, DOI 10.1016/j.jsb.2007.07.012; Blanchet CE, 2012, J APPL CRYSTALLOGR, V45, P489, DOI 10.1107/S0021889812013490; Bouckaert J, 1999, J BIOL CHEM, V274, P29188, DOI 10.1074/jbc.274.41.29188; Cavada BS, 2001, CURR PROTEIN PEPT SC, V2, P123, DOI 10.2174/1389203013381152; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; de Oliveira TM, 2008, J STRUCT BIOL, V164, P177, DOI 10.1016/j.jsb.2008.05.012; Deacon A, 1997, J CHEM SOC FARADAY T, V93, P4305, DOI 10.1039/a704140c; Delatorre P, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-52; Delatorre P, 2006, J STRUCT BIOL, V154, P280, DOI 10.1016/j.jsb.2006.03.011; DESOUZA GEP, 1985, AGENTS ACTIONS, V17, P97; DIROSA M, 1972, J PATHOL, V105, P239; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FERRIGE AG, 1992, RAPID COMMUN MASS SP, V6, P707, DOI 10.1002/rcm.1290061115; Figueiredo JG, 2009, TOXICON, V54, P736, DOI 10.1016/j.toxicon.2009.05.037; Gabius H.-J., 1997, GLYCOSCIENCE STATUS; Gadelha CAD, 2005, J STRUCT BIOL, V152, P185, DOI 10.1016/j.jsb.2005.07.012; Golias C, 2011, CELL COMMUN ADHES, V18, P19, DOI 10.3109/15419061.2011.606381; Havt A, 2003, PROTEIN PEPTIDE LETT, V10, P191, DOI 10.2174/0929866033479130; Jancarik J, 2004, ACTA CRYSTALLOGR D, V60, P1670, DOI 10.1107/S0907444904010972; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LANDUCCI ECT, 1995, BRIT J PHARMACOL, V114, P578, DOI 10.1111/j.1476-5381.1995.tb17178.x; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lipson H., 1956, ACTA CRYSTALLOGR, V9, P839; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lopes FC, 2005, BRAZ J MED BIOL RES, V38, P935, DOI 10.1590/S0100-879X2005000600016; Loris R, 2004, J MOL BIOL, V335, P1227, DOI 10.1016/j.jmb.2003.11.043; Loris R, 2002, BBA-GEN SUBJECTS, V1572, P198, DOI 10.1016/S0304-4165(02)00309-4; Loris R, 1998, BBA-PROTEIN STRUCT M, V1383, P9, DOI 10.1016/S0167-4838(97)00182-9; Mackay CR, 2008, NAT IMMUNOL, V9, P988, DOI 10.1038/ni.f.210; MANDAL DK, 1994, BIOCHEMISTRY-US, V33, P1149, DOI 10.1021/bi00171a014; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moura TR, 2009, ACTA CRYSTALLOGR F, V65, P213, DOI 10.1107/S1744309109000797; Nagano CS, 2008, BIOCHEM J, V409, P417, DOI 10.1042/BJ20070942; Nunes BS, 2009, N-S ARCH PHARMACOL, V379, P609, DOI 10.1007/s00210-009-0397-9; Pusztai A, 2008, FRONT BIOSCI-LANDMRK, V13, P1130, DOI 10.2741/2750; Ribeiro RA, 1997, INT ARCH ALLERGY IMM, V112, P27, DOI 10.1159/000237427; Rocha BAM, 2011, BIOCHIMIE, V93, P806, DOI 10.1016/j.biochi.2011.01.006; Round AR, 2008, J APPL CRYSTALLOGR, V41, P913, DOI 10.1107/S0021889808021018; ROZDZINSKI E, 1993, J EXP MED, V178, P917, DOI 10.1084/jem.178.3.917; Bezerra EHS, 2011, BIOCHEM BIOPH RES CO, V408, P566, DOI 10.1016/j.bbrc.2011.04.061; SanzAparicio J, 1997, FEBS LETT, V405, P114, DOI 10.1016/S0014-5793(97)00137-3; Sharon N, 2004, GLYCOBIOLOGY, V14, p53R, DOI 10.1093/glycob/cwh122; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Simoes RC, 2012, RAPID COMMUN MASS SP, V26, P811, DOI 10.1002/rcm.6171; Srimal S, 1996, BIOCHEM J, V315, P679, DOI 10.1042/bj3150679; Srinivas VR, 2001, BBA-GEN SUBJECTS, V1527, P102, DOI 10.1016/S0304-4165(01)00153-2; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Damme EJM, 1998, CRIT REV PLANT SCI, V17, P575, DOI 10.1016/S0735-2689(98)00365-7; Wah DA, 2001, J MOL BIOL, V310, P885, DOI 10.1006/jmbi.2001.4814; YANG AS, 1993, J MOL BIOL, V231, P459, DOI 10.1006/jmbi.1993.1294	62	20	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97015	10.1371/journal.pone.0097015	http://dx.doi.org/10.1371/journal.pone.0097015			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865454	Green Published, Green Submitted, gold			2022-12-25	WOS:000336914100009
J	Yanagawa, H; Suzuki, H; Suzuki, Y; Kiryluk, K; Gharavi, AG; Matsuoka, K; Makita, Y; Julian, BA; Novak, J; Tomino, Y				Yanagawa, Hiroyuki; Suzuki, Hitoshi; Suzuki, Yusuke; Kiryluk, Krzysztof; Gharavi, Ali G.; Matsuoka, Kiyoshi; Makita, Yuko; Julian, Bruce A.; Novak, Jan; Tomino, Yasuhiko			A Panel of Serum Biomarkers Differentiates IgA Nephropathy from Other Renal Diseases	PLOS ONE			English	Article							CIRCULATING IMMUNE-COMPLEXES; GALACTOSE-DEFICIENT IGA1; O-GLYCOSYLATION; HINGE REGION; ANTIBODIES	Background and Objectives: There is increasing evidence that galactose-deficient IgA1 (Gd-IgA1) and Gd-IgA1-containing immune complexes are important for the pathogenesis of IgA nephropathy (IgAN). In the present study, we assessed a novel noninvasive multi-biomarker approach in the diagnostic test for IgAN. Materials and Methods: We compared serum levels of IgA, IgG, Gd-IgA1, Gd-IgA1-specific IgG and Gd-IgA1-specific IgA in 135 IgAN patients, 79 patients with non-IgAN chronic kidney disease (CKD) controls and 106 healthy controls. Serum was collected at the time of kidney biopsy from all IgAN and CKD patients. Results: Each serum marker was significantly elevated in IgAN patients compared to CKD (P<0.001) and healthy controls (P<0.001). While 41% of IgAN patients had elevated serum Gd-IgA1 levels, 91% of these patients exhibited Gd-IgA1-specific IgG levels above the 90th percentile for healthy controls (sensitivity 89%, specificity 92%). Although up to 25% of CKD controls, particularly those with immune-mediated glomerular diseases including lupus nephritis, also had elevated serum levels of Gd-IgA1-specific IgG, most IgAN patients had elevated levels of Gd-IgA1-specific antibody of both isotypes. Serum levels of Gd-IgA1-specific IgG were associated with renal histological grading. Furthermore, there was a trend toward higher serum levels of Gd-IgA1-specific IgG in IgAN patients with at least moderate proteinuria (>= 1.0 g/g), compared to patients with less proteinuria. Conclusions: Serum levels of Gd-IgA1-specific antibodies are elevated in most IgAN patients, and their assessment, together with serum levels of Gd-IgA1, improves the specificity of the assays. Our observations suggest that a panel of serum biomarkers may be helpful in differentiating IgAN from other glomerular diseases.	[Yanagawa, Hiroyuki; Suzuki, Hitoshi; Suzuki, Yusuke; Makita, Yuko; Tomino, Yasuhiko] Juntendo Univ, Fac Med, Dept Internal Med, Div Nephrol, Tokyo, Japan; [Kiryluk, Krzysztof; Gharavi, Ali G.] Columbia Univ Coll Phys & Surg, Dept Med, Div Nephrol, New York, NY 10032 USA; [Matsuoka, Kiyoshi] Juntendo Univ, Fac Med, Clin Res Ctr, Tokyo, Japan; [Julian, Bruce A.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Julian, Bruce A.; Novak, Jan] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	Juntendo University; Columbia University; Juntendo University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Tomino, Y (corresponding author), Juntendo Univ, Fac Med, Dept Internal Med, Div Nephrol, Tokyo, Japan.	yasu@juntendo.ac.jp			Study Group on IgA Nephropathy; Ministry of Health, Labour and Welfare of Japan; KAKENHI [22790802]; National Institutes of Health [DK078244, DK082753, DK083663, DK075868, GM098539]; Glomerular Center at Columbia University; National Institute of Health [K23DK090207, R03-DK099654]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK083663, R01DK082753, K23DK090207, R01DK078244, R21DK075868, R56DK078244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098539] Funding Source: NIH RePORTER	Study Group on IgA Nephropathy; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glomerular Center at Columbia University; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported, in part, by a research grant from the Study Group on IgA Nephropathy, a Grant-in-Aid for Progressive Renal Disease Research, Research on Intractable Disease from the Ministry of Health, Labour and Welfare of Japan, and by KAKENHI (22790802). BAJ and JN were supported, in part, by National Institutes of Health grants DK078244, DK082753, DK083663, DK075868, and GM098539. KK was supported by the Glomerular Center at Columbia University and the National Institute of Health grant K23DK090207 and R03-DK099654. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allen AC, 2001, KIDNEY INT, V60, P969, DOI 10.1046/j.1523-1755.2001.060003969.x; Barratt J, 2005, J AM SOC NEPHROL, V16, P2088, DOI 10.1681/ASN.2005020134; COPPO R, 1984, CLIN EXP IMMUNOL, V57, P583; Coppo R, 2004, KIDNEY INT, V65, P1544, DOI 10.1111/j.1523-1755.2004.05407.x; CZERKINSKY C, 1986, J CLIN INVEST, V77, P1931, DOI 10.1172/JCI112522; D'Amico G, 2000, AM J KIDNEY DIS, V36, P227, DOI 10.1053/ajkd.2000.8966; DAMICO G, 1987, Q J MED, V64, P709; Gharavi AG, 2008, J AM SOC NEPHROL, V19, P1008, DOI 10.1681/ASN.2007091052; Hiki Y, 2001, KIDNEY INT, V59, P1077, DOI 10.1046/j.1523-1755.2001.00591.x; HIKI Y, 1995, CONTRIB NEPHROL, V111, P73; Julian BA, 2004, CURR OPIN NEPHROL HY, V13, P171, DOI 10.1097/00041552-200403000-00005; JULIAN BA, 1988, AM J MED, V84, P129, DOI 10.1016/0002-9343(88)90019-8; Lai KN, 2008, AM J PHYSIOL-RENAL, V294, pF945, DOI 10.1152/ajprenal.00423.2007; Lai KN, 2009, NEPHROL DIAL TRANSPL, V24, P62, DOI 10.1093/ndt/gfn441; MESTECKY J, 1993, CONTRIB NEPHROL, V104, P172; Mietzner B, 2008, P NATL ACAD SCI USA, V105, P9727, DOI 10.1073/pnas.0803644105; Moldoveanu Z, 2007, KIDNEY INT, V71, P1148, DOI 10.1038/sj.ki.5002185; Moore JS, 2007, MOL IMMUNOL, V44, P2598, DOI 10.1016/j.molimm.2006.12.011; Novak J, 2005, KIDNEY INT, V67, P504, DOI 10.1111/j.1523-1755.2005.67107.x; Novak J, 2002, KIDNEY INT, V62, P465, DOI 10.1046/j.1523-1755.2002.00477.x; Novak J, 2001, J CLIN IMMUNOL, V21, P310, DOI 10.1023/A:1012284402054; Novak J, 2008, SEMIN NEPHROL, V28, P78, DOI 10.1016/j.semnephrol.2007.10.009; RUSSELL MW, 1986, J CLIN IMMUNOL, V6, P74, DOI 10.1007/BF00915367; Suzuki H, 2008, J CLIN INVEST, V118, P629, DOI 10.1172/JCI33189; Suzuki H, 2011, J AM SOC NEPHROL, V22, P1795, DOI 10.1681/ASN.2011050464; Suzuki H, 2009, J CLIN INVEST, V119, P1668, DOI 10.1172/JCI38468; Takahashi K, 2010, MOL CELL PROTEOMICS, V9, P2545, DOI 10.1074/mcp.M110.001834; Tomana M, 1999, J CLIN INVEST, V104, P73, DOI 10.1172/JCI5535; Tomana M, 1997, KIDNEY INT, V52, P509, DOI 10.1038/ki.1997.361; Tomino Yasuhiko, 2003, Clin Exp Nephrol, V7, P93, DOI 10.1007/s10157-003-0232-4; van der Boog PJM, 2004, NEPHROL DIAL TRANSPL, V19, P2487, DOI 10.1093/ndt/gfh394; Zhang J, 2009, J AUTOIMMUN, V33, P270, DOI 10.1016/j.jaut.2009.03.011	33	66	71	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98081	10.1371/journal.pone.0098081	http://dx.doi.org/10.1371/journal.pone.0098081			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858067	Green Published, Green Submitted, gold			2022-12-25	WOS:000336839400038
J	Aref-Eshghi, E; Zhang, YH; Hart, D; Valdes, AM; Furey, A; Martin, G; Sun, G; Rahman, P; Arden, N; Spector, TD; Zhai, GJ				Aref-Eshghi, Erfan; Zhang, Yuhua; Hart, Deborah; Valdes, Ana M.; Furey, Andrew; Martin, Glynn; Sun, Guang; Rahman, Proton; Arden, Nigel; Spector, Tim D.; Zhai, Guangju			SMAD3 Is Associated with the Total Burden of Radiographic Osteoarthritis: The Chingford Study	PLOS ONE			English	Article							THORACIC AORTIC-ANEURYSM; KNEE OSTEOARTHRITIS; FAMILIAL AGGREGATION; ARTICULAR-CARTILAGE; JOINT INVOLVEMENT; TGF-BETA; MUTATION; WOMEN; RISK; DIFFERENTIATION	Background: A newly-described syndrome called Aneurysm-Osteoarthritis Syndrome (AOS) was recently reported. AOS presents with early onset osteoarthritis (OA) in multiple joints, together with aneurysms in major arteries, and is caused by rare mutations in SMAD3. Because of the similarity of AOS to idiopathic generalized OA (GOA), we hypothesized that SMAD3 is also associated with GOA and tested the hypothesis in a population-based cohort. Methods: Study participants were derived from the Chingford study. Kellgren-Lawrence (KL) grades and the individual features of osteophytes and joint space narrowing (JSN) were scored from radiographs of hands, knees, hips, and lumbar spines. The total KL score, osteophyte score, and JSN score were calculated and used as indicators of the total burden of radiographic OA. Forty-one common SNPs within SMAD3 were genotyped using the Illumina HumanHap610Q array. Linear regression modelling was used to test the association between the total KL score, osteophyte score, and JSN score and each of the 41 SNPs, with adjustment for patient age and BMI. Permutation testing was used to control the false positive rate. Results: A total of 609 individuals were included in the analysis. All were Caucasian females with a mean age of 60.9 +/- 5.8. We found that rs3825977, with a minor allele (T) frequency of 20%, in the last intron of SMAD3, was significantly associated with total KL score (beta = 0.14, P-permutation = 0.002). This association was stronger for the total JSN score (beta = 0.19, P-permutation = 0.002) than for total osteophyte score (beta = 0.11, P-permutation = 0.02). The T allele is associated with a 1.47-fold increased odds for people with 5 or more joints to be affected by radiographic OA (P-permutation = 0.046). Conclusion: We found that SMAD3 is significantly associated with the total burden of radiographic OA. Further studies are required to reveal the mechanism of the association.	[Aref-Eshghi, Erfan; Zhang, Yuhua; Furey, Andrew; Martin, Glynn; Sun, Guang; Rahman, Proton; Zhai, Guangju] Mem Univ Newfoundland, Fac Med, St John, NF, Canada; [Hart, Deborah; Valdes, Ana M.; Spector, Tim D.; Zhai, Guangju] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Arden, Nigel] Univ Oxford, Oxford, England; [Arden, Nigel] Univ Oxford, Biobank, Oxford, England	Memorial University Newfoundland; University of London; King's College London; University of Oxford; University of Oxford	Zhai, GJ (corresponding author), Mem Univ Newfoundland, Fac Med, St John, NF, Canada.	guangju.zhai@med.mun.ca		Valdes, Ana M./0000-0003-1141-4471; Martin, Glynn/0000-0002-5527-213X	Newfoundland and Labrador RDC Ignite program; Memorial University of Newfoundland; Dean's Fellowship of Faculty of Medicine, Memorial University of Newfoundland; Welcome Trust; Arthritis Research UK	Newfoundland and Labrador RDC Ignite program; Memorial University of Newfoundland; Dean's Fellowship of Faculty of Medicine, Memorial University of Newfoundland; Welcome Trust(Wellcome Trust); Arthritis Research UK(Versus Arthritis)	The study was supported financially by Newfoundland and Labrador RDC Ignite program, and Memorial University of Newfoundland. EAE was supported by The Dean's Fellowship of Faculty of Medicine, Memorial University of Newfoundland. The Chingford Study was supported by Welcome Trust and Arthritis Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez J, 2004, DEV DYNAM, V230, P685, DOI 10.1002/dvdy.20100; Arden N, 2006, BEST PRACT RES CL RH, V20, P3, DOI 10.1016/j.berh.2005.09.007; Arthritis community research & evaluation unit Toronto Western Research Institute, 2010, PREV ARTHR RHEUM DIS; Bijkerk C, 1999, ARTHRITIS RHEUM, V42, P1729, DOI 10.1002/1529-0131(199908)42:8<1729::AID-ANR23>3.0.CO;2-H; Bucsi L, 1998, OSTEOARTHR CARTILAGE, V6, P31, DOI 10.1016/S1063-4584(98)80009-5; Burnett S, 1994, RADIOGRAPHIC ATLAS O; Centers for Disease Control and Prevention, 2010, NAT PUBL HLTH AG OST; Charcot J, 1881, NEW SYD SOC CLIN LEC; Chen CG, 2012, ARTHRITIS RHEUM-US, V64, P3278, DOI 10.1002/art.34566; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Cooper C, 1996, J RHEUMATOL, V23, P1938; Doerge RW, 1996, GENETICS, V142, P285; Felson DT, 2004, RADIOL CLIN N AM, V42, P1, DOI 10.1016/S0033-8389(03)00161-1; Finnson Kenneth W, 2012, Front Biosci (Schol Ed), V4, P251; GOOD P, 1994, PRACTICAL GUIDE RESA; Hannan MT, 2000, J RHEUMATOL, V27, P1513; HART DJ, 1993, J RHEUMATOL, V20, P331; Hilhorst-Hofstee Y, 2013, CLIN GENET, V83, P337, DOI 10.1111/j.1399-0004.2012.01931.x; Hirsch R, 1998, ARTHRITIS RHEUM, V41, P1227, DOI 10.1002/1529-0131(199807)41:7<1227::AID-ART13>3.0.CO;2-N; Jiang LY, 2013, RHEUMATOL INT, V33, P1763, DOI 10.1007/s00296-012-2593-z; Jordan KM, 2006, ANN RHEUM DIS, V65, P871, DOI 10.1136/ard.2005.042895; Kellgren JH, 1963, ATLAS STANDARD RADIO; Knuppel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068941; Livshits G, 2007, ANN RHEUM DIS, V66, P623, DOI 10.1136/ard.2006.060236; Loughlin J, 2011, CURR OPIN RHEUMATOL, V23, P479, DOI 10.1097/BOR.0b013e3283493ff0; Meulenbelt I, 2012, OSTEOARTHR CARTILAGE, V20, P218, DOI 10.1016/j.joca.2012.01.007; Murphy L, 2008, ARTHRIT RHEUM-ARTHR, V59, P1207, DOI 10.1002/art.24021; Pritzker K. P. H, 2003, OSTEOARTHRITIS, P49; Regalado ES, 2011, CIRC RES, V109, P680, DOI 10.1161/CIRCRESAHA.111.248161; Riyazi N, 2005, ANN RHEUM DIS, V64, P438, DOI 10.1136/ard.2004.024661; Spector TD, 1996, BRIT MED J, V312, P940; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Valdes AM, 2011, NAT REV RHEUMATOL, V7, P23, DOI 10.1038/nrrheum.2010.191; Valdes AM, 2010, ARTHRITIS RHEUM-US, V62, P2347, DOI 10.1002/art.27530; van de Laar IMBH, 2012, J MED GENET, V49, P47, DOI 10.1136/jmedgenet-2011-100382; van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744; Walker LC, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2785; Wischmeijer A, 2013, AM J MED GENET A, V161A, P1028, DOI 10.1002/ajmg.a.35852; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Yao JY, 2003, EUR J HUM GENET, V11, P714, DOI 10.1038/sj.ejhg.5201034	40	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97786	10.1371/journal.pone.0097786	http://dx.doi.org/10.1371/journal.pone.0097786			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852296	Green Accepted, gold, Green Published			2022-12-25	WOS:000338323200029
J	Ryall, B; Carrara, M; Zlosnik, JEA; Behrends, V; Lee, XY; Wong, Z; Lougheed, KE; Williams, HD				Ryall, Ben; Carrara, Marta; Zlosnik, James E. A.; Behrends, Volker; Lee, Xiaoyun; Wong, Zhen; Lougheed, Kathryn E.; Williams, Huw D.			The Mucoid Switch in Pseudomonas aeruginosa Represses Quorum Sensing Systems and Leads to Complex Changes to Stationary Phase Virulence Factor Regulation	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; CONTROLS CYANIDE PRODUCTION; SIGMA-FACTOR ALGU; HYDROGEN-CYANIDE; LUNG-FUNCTION; SMALL RNAS; CONVERSION; ALGINATE; GENES; EXPRESSION	The opportunistic pathogen Pseudomonas aeruginosa chronically infects the airways of Cystic Fibrosis (CF) patients during which it adapts and undergoes clonal expansion within the lung. It commonly acquires inactivating mutations of the anti-sigma factor MucA leading to a mucoid phenotype, caused by excessive production of the extracellular polysaccharide alginate that is associated with a decline in lung function. Alginate production is believed to be the key benefit of mucA mutations to the bacterium in the CF lung. A phenotypic and gene expression characterisation of the stationary phase physiology of mucA22 mutants demonstrated complex and subtle changes in virulence factor production, including cyanide and pyocyanin, that results in their down-regulation upon entry into stationary phase but, (and in contrast to wildtype strains) continued production in prolonged stationary phase. These findings may have consequences for chronic infection if mucoid P. aeruginosa were to continue to make virulence factors under non-growing conditions during infection. These changes resulted in part from a severe down-regulation of both AHL- and AQ (PQS)-dependent quorum sensing systems. In trans expression of the cAMP-dependent transcription factor Vfr restored both quorum sensing defects and virulence factor production in early stationary phase. Our findings have implications for understanding the evolution of P. aeruginosa during CF lung infection and it demonstrates that mucA22 mutation provides a second mechanism, in addition to the commonly occurring lasR mutations, of down-regulating quorum sensing during chronic infection this may provide a selection pressure for the mucoid switch in the CF lung.	[Ryall, Ben; Carrara, Marta; Zlosnik, James E. A.; Behrends, Volker; Lee, Xiaoyun; Wong, Zhen; Lougheed, Kathryn E.; Williams, Huw D.] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Dept Life Sci, London, England; [Behrends, Volker] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, London, England	Imperial College London; Imperial College London	Williams, HD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Dept Life Sci, London, England.	h.d.williams@imperial.ac.uk		Williams, Huw/0000-0003-2225-6413; Zlosnik, James/0000-0002-9708-9034; Behrends, Volker/0000-0003-4855-5497	BBSRC	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	BBSRC PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RD, 2010, J CYST FIBROS, V9, P158, DOI 10.1016/j.jcf.2009.12.003; Behrends V, 2010, MOL BIOSYST, V6, P562, DOI 10.1039/b918710c; Bordi C, 2010, MOL MICROBIOL, V76, P1427, DOI 10.1111/j.1365-2958.2010.07146.x; Boucher JC, 2000, MOL MICROBIOL, V36, P341, DOI 10.1046/j.1365-2958.2000.01846.x; Brencic A, 2009, MOL MICROBIOL, V73, P434, DOI 10.1111/j.1365-2958.2009.06782.x; Broderick KE, 2008, J INFECT DIS, V197, P457, DOI 10.1086/525282; Burrowes E, 2006, MICROBIOL-SGM, V152, P405, DOI 10.1099/mic.0.28324-0; Carterson AJ, 2004, J BACTERIOL, V186, P6837, DOI 10.1128/JB.186.20.6837-6844.2004; CASTRIC PA, 1983, CAN J MICROBIOL, V29, P1344, DOI 10.1139/m83-209; Cipollone R, 2008, J MOL MICROB BIOTECH, V15, P199, DOI 10.1159/000121331; Cody WL, 2009, J BACTERIOL, V191, P2993, DOI 10.1128/JB.01156-08; Cunningham L, 1997, MOL MICROBIOL, V24, P579, DOI 10.1046/j.1365-2958.1997.3561728.x; ELSTON HR, 1967, AM J CLIN PATHOL, V48, P519, DOI 10.1093/ajcp/48.5_ts.519; Enderby B, 2009, PEDIATR PULM, V44, P142, DOI 10.1002/ppul.20963; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Filiatrault MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055594; Firoved AM, 2003, J BACTERIOL, V185, P1071, DOI 10.1128/JB.185.3.1071-1081.2003; Firoved AM, 2002, J BACTERIOL, V184, P1057, DOI 10.1128/jb.184.4.1057-1064.2002; Fletcher MP, 2007, ENVIRON MICROBIOL, V9, P2683, DOI 10.1111/j.1462-2920.2007.01380.x; Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001; Garrett ES, 1999, J BACTERIOL, V181, P7401, DOI 10.1128/JB.181.23.7401-7404.1999; Gilchrist FJ, 2011, EUR RESPIR J, V38, P409, DOI 10.1183/09031936.00166510; GOLDFARB WB, 1967, ANN SURG, V165, P104, DOI 10.1097/00000658-196701000-00014; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; GOVAN JRW, 1988, BACTERIAL INFECT OD; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Heurlier K, 2004, J BACTERIOL, V186, P2936, DOI 10.1128/JB.186.10.2936-2945.2004; Jones AK, 2010, J BACTERIOL, V192, P5709, DOI 10.1128/JB.00526-10; Kay E, 2006, J BACTERIOL, V188, P6026, DOI 10.1128/JB.00409-06; Lenney W, 2011, EUR RESPIR J, V37, P482, DOI 10.1183/09031936.00122810; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; MARTIN DW, 1993, P NATL ACAD SCI USA, V90, P8377, DOI 10.1073/pnas.90.18.8377; MARTIN DW, 1994, J BACTERIOL, V176, P6688, DOI 10.1128/JB.176.21.6688-6696.1994; Mathee K, 1999, MICROBIOL-SGM, V145, P1349, DOI 10.1099/13500872-145-6-1349; MOHR CD, 1992, J BACTERIOL, V174, P6624, DOI 10.1128/JB.174.20.6624-6633.1992; MOHR CD, 1990, MOL MICROBIOL, V4, P2103, DOI 10.1111/j.1365-2958.1990.tb00571.x; Morici LA, 2007, J BACTERIOL, V189, P7752, DOI 10.1128/JB.01797-06; OHMAN DE, 1980, J BACTERIOL, V142, P836, DOI 10.1128/JB.142.3.836-842.1980; OHMAN DE, 1990, PSEUDOMONAS BIOTRANS; Pedersen S S, 1992, APMIS Suppl, V28, P1; PEDERSEN SS, 1992, APMIS, V100, P326, DOI 10.1111/j.1699-0463.1992.tb00879.x; Pessi G, 2000, J BACTERIOL, V182, P6940, DOI 10.1128/JB.182.24.6940-6949.2000; Rau MH, 2010, ENVIRON MICROBIOL, V12, P1643, DOI 10.1111/j.1462-2920.2010.02211.x; Rowen DW, 2000, MOL MICROBIOL, V36, P314, DOI 10.1046/j.1365-2958.2000.01830.x; Ryall B, 2008, EUR RESPIR J, V32, P740, DOI 10.1183/09031936.00159607; Sanderson K, 2008, EUR RESPIR J, V32, P329, DOI 10.1183/09031936.00152407; Sautter R, 2012, GENE, V498, P242, DOI 10.1016/j.gene.2011.11.005; Schaedel C, 2002, PEDIATR PULM, V33, P483, DOI 10.1002/ppul.10100; SCHURR MJ, 1994, J BACTERIOL, V176, P3375, DOI 10.1128/jb.176.11.3375-3382.1994; SIMPSON JA, 1989, FREE RADICAL BIO MED, V6, P347, DOI 10.1016/0891-5849(89)90078-6; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Stutz MD, 2011, EUR RESPIR J, V37, P553, DOI 10.1183/09031936.00024210; Tart AH, 2006, J BACTERIOL, V188, P6483, DOI 10.1128/JB.00636-06; Williams HD, 2007, ADV MICROB PHYSIOL, V52, P1, DOI 10.1016/S0065-2911(06)52001-6; Williams HD, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00120; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P185, DOI 10.1111/j.1574-6968.1998.tb13044.x; WOODS DE, 1991, J INFECT DIS, V163, P143, DOI 10.1093/infdis/163.1.143; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Wu WH, 2004, J BACTERIOL, V186, P7575, DOI 10.1128/JB.186.22.7575-7585.2004; Zlosnik JEA, 2006, MICROBIOL-SGM, V152, P1407, DOI 10.1099/mic.0.28396-0; Zlosnik JEA, 2004, LETT APPL MICROBIOL, V38, P360, DOI 10.1111/j.1472-765X.2004.01489.x	62	34	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e96166	10.1371/journal.pone.0096166	http://dx.doi.org/10.1371/journal.pone.0096166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852379	Green Submitted, Green Published, gold			2022-12-25	WOS:000338323200010
J	Siva, AB; Panneerdoss, S; Sailasree, P; Singh, DK; Kameshwari, DB; Shivaji, S				Siva, Archana B.; Panneerdoss, Subbarayalu; Sailasree, Purnima; Singh, Durgesh K.; Kameshwari, Duvurri B.; Shivaji, Sisinthy			Inhibiting Sperm Pyruvate Dehydrogenase Complex and Its E3 Subunit, Dihydrolipoamide Dehydrogenase Affects Fertilization in Syrian Hamsters	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; PHOSPHOLIPASE-C ZETA; SIGNALING PATHWAYS; ACROSOME REACTION; INTRACELLULAR PH; IDIOPATHIC INFERTILITY; METABOLIC ENZYME; CALCIUM INFLUX; BOVINE SPERM; CAPACITATION	Background/Aims: The importance of sperm capacitation for mammalian fertilization has been confirmed in the present study via sperm metabolism. Involvement of the metabolic enzymes pyruvate dehydrogenase complex (PDHc) and its E3 subunit, dihydrolipoamide dehydrogenase (DLD) in hamster in vitro fertilization (IVF) via in vitro sperm capacitation is being proposed through regulation of sperm intracellular lactate, pH and calcium. Methodology and Principal Findings: Capacitated hamster spermatozoa were allowed to fertilize hamster oocytes in vitro which were then assessed for fertilization, microscopically. PDHc/DLD was inhibited by the use of the specific DLD-inhibitor, MICA (5-methoxyindole-2-carboxylic acid). Oocytes fertilized with MICA-treated (MT) [and thus PDHc/DLD-inhibited] spermatozoa showed defective fertilization where 2 nd polar body release and pronuclei formation were not observed. Defective fertilization was attributable to capacitation failure owing to high lactate and low intracellular pH and calcium in MT-spermatozoa during capacitation. Moreover, this defect could be overcome by alkalinizing spermatozoa, before fertilization. Increasing intracellular calcium in spermatozoa pre-IVF and in defectively-fertilized oocytes, post-fertilization rescued the arrest seen, suggesting the role of intracellular calcium from either of the gametes in fertilization. Parallel experiments carried out with control spermatozoa capacitated in medium with low extracellular pH or high lactate substantiated the necessity of optimal sperm intracellular lactate levels, intracellular pH and calcium during sperm capacitation, for proper fertilization. Conclusions: This study confirms the importance of pyruvate/lactate metabolism in capacitating spermatozoa for successful fertilization, besides revealing for the first time the importance of sperm PDHc/DLD in fertilization, via the modulation of sperm intracellular lactate, pH and calcium during capacitation. In addition, the observations made in the IVF studies in hamsters suggest that capacitation failures could be a plausible cause of unsuccessful fertilization encountered during human assisted reproductive technologies, like IVF and ICSI. Our studies indicate a role of sperm capacitation in the post-penetration events during fertilization.	[Siva, Archana B.; Panneerdoss, Subbarayalu; Sailasree, Purnima; Singh, Durgesh K.; Kameshwari, Duvurri B.; Shivaji, Sisinthy] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Siva, AB (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	abs@ccmb.res.in; shivas@ccmb.res.in			Council for Scientific and Industrial Research, Government of India	Council for Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	SP and DKS thank Council for Scientific and Industrial Research, Government of India, for the Research Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOTT TS, 1984, BIOL REPROD, V30, P926, DOI 10.1095/biolreprod30.4.926; Ambrosini A, 2003, MOL HUM REPROD, V9, P381, DOI 10.1093/molehr/gag056; ASCH R, 1995, HUM REPROD, V10, P1897, DOI 10.1093/oxfordjournals.humrep.a136204; AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581; Barroso G, 2009, FERTIL STERIL, V92, P835, DOI 10.1016/j.fertnstert.2009.06.030; BAVISTER BD, 1989, GAMETE RES, V23, P139, DOI 10.1002/mrd.1120230202; CHANG MC, 1984, J ANDROL, V5, P45; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; deLamirande E, 1997, MOL HUM REPROD, V3, P175, DOI 10.1093/molehr/3.3.175; Demyda-Peyras S, 2013, REPROD FERTIL DEV; Douglas T, 2013, PATERNAL INFLUENCES; Fissore RA, 1999, MOL HUM REPROD, V5, P189, DOI 10.1093/molehr/5.3.189; Fraire-Zamora JJ, 2004, AM J PHYSIOL-CELL PH, V287, pC1688, DOI 10.1152/ajpcell.00141.2004; FRASER LR, 1988, GAMETE RES, V20, P491, DOI 10.1002/mrd.1120200409; Gawecka JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056385; Harrison RAP, 2005, THERIOGENOLOGY, V63, P342, DOI 10.1016/j.theriogenology.2004.09.016; Hereng TH, 2011, HUM REPROD, V26, P3249, DOI 10.1093/humrep/der317; Horner VL, 2008, DEV DYNAM, V237, P527, DOI 10.1002/dvdy.21454; Irvine DS, 2000, J ANDROL, V21, P33; Jha KN, 2003, CELL MOL BIOL, V49, P329; Johnson MT, 2007, BIOL REPROD, V77, P2, DOI 10.1095/biolreprod.106.059899; Johnson MT, 1997, P NATL ACAD SCI USA, V94, P14512, DOI 10.1073/pnas.94.26.14512; Kashir J, 2010, HUM REPROD UPDATE, V16, P690, DOI 10.1093/humupd/dmq018; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Kumar M, 2013, CLINICS, V68, P5, DOI 10.6061/clinics/2013(Sup01)02; Kumar V, 2008, BIOL REPROD, V79, P190, DOI 10.1095/biolreprod.107.066704; Liu DY, 1998, HUM REPROD, V13, P905, DOI 10.1093/humrep/13.4.905; Liu Tao, 2010, Front Biosci (Elite Ed), V2, P566, DOI 10.2741/e115; McPartlin LA, 2009, BIOL REPROD, V81, P199, DOI 10.1095/biolreprod.108.074880; Mehta A, 2014, UROL CLIN N AM, V41, P169, DOI 10.1016/j.ucl.2013.08.005; Miao YL, 2012, P NATL ACAD SCI USA, V109, P4169, DOI 10.1073/pnas.1112333109; Mitra K, 2005, J BIOL CHEM, V280, P25743, DOI 10.1074/jbc.M500310200; Mitra K, 2004, BIOL REPROD, V70, P887, DOI 10.1095/biolreprod.103.022780; Navarro B, 2007, P NATL ACAD SCI USA, V104, P7688, DOI 10.1073/pnas.0702018104; Odet F, 2008, BIOL REPROD, V79, P26, DOI 10.1095/biolreprod.108.068353; Oehninger S, 2011, INT J ANDROL, V34, pE319, DOI 10.1111/j.1365-2605.2011.01143.x; Panneerdoss S, 2012, J ANDROL, V33, P699, DOI 10.2164/jandrol.111.013151; Pons-Rejraji H, 2009, REPROD FERT DEVELOP, V21, P511, DOI 10.1071/RD07169; Quill TA, 2003, P NATL ACAD SCI USA, V100, P14869, DOI 10.1073/pnas.2136654100; Ren DJ, 2010, PHYSIOLOGY, V25, P165, DOI 10.1152/physiol.00049.2009; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Ruffenach S, 2009, SPERM CAPACITATION; Santi CM, 1998, J GEN PHYSIOL, V112, P33, DOI 10.1085/jgp.112.1.33; SUAREZ SS, 1991, BIOL REPROD, V44, P375, DOI 10.1095/biolreprod44.2.375; Tesarik J, 2004, HUM REPROD, V19, P611, DOI 10.1093/humrep/deh127; Tesarik J, 2002, HUM REPROD, V17, P184, DOI 10.1093/humrep/17.1.184; TUCKER MJ, 1987, J IN VITRO FERTIL EM, V4, P245, DOI 10.1007/BF01533766; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; VREDENBURGHWILBERG WL, 1995, MOL REPROD DEV, V40, P490, DOI 10.1002/mrd.1080400413; Wakai T, 2011, COLD SPRING HARB PER, V3; Wang D, 2003, NAT CELL BIOL, V5, P1117, DOI 10.1038/ncb1072; WORKING PK, 1983, J EXP ZOOL, V227, P97, DOI 10.1002/jez.1402270114; Yanagimachi R., 1994, P189; Young C, 2009, FERTIL STERIL, V91, P2230, DOI 10.1016/j.fertnstert.2008.05.021	54	5	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97916	10.1371/journal.pone.0097916	http://dx.doi.org/10.1371/journal.pone.0097916			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852961	Green Submitted, gold, Green Published			2022-12-25	WOS:000338323200033
J	Williams, JP; Kim, I; Ito, E; Shi, W; Yue, SJ; Siu, LL; Waldron, J; O'Sullivan, B; Yip, KW; Liu, FF				Williams, Justin P.; Kim, Inki; Ito, Emma; Shi, Wei; Yue, Shijun; Siu, Lillian L.; Waldron, John; O'Sullivan, Brian; Yip, Kenneth W.; Liu, Fei-Fei			Pre-Clinical Characterization of Dacomitinib (PF-00299804), an Irreversible Pan-ErbB Inhibitor, Combined with Ionizing Radiation for Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; GENE COPY NUMBER; EGFR INHIBITORS; LUNG-CANCER; GASTRIC-CANCER; VARIANT III; RADIOTHERAPY; COMBINATION; RESISTANCE; THERAPY	Epidermal growth factor receptor (EGFR) is over-expressed in nearly all cases of squamous cell carcinoma of the head and neck (SCCHN), and is an important driver of disease progression. EGFR targeted therapies have demonstrated clinical benefit for SCCHN treatment. In this report, we investigated the pre-clinical efficacy of Dacomitinib (PF-00299804), an irreversible pan-ErbB inhibitor, both alone and in combination with ionizing radiation (IR), a primary curative modality for SCCHN. One normal oral epithelial (NOE) and three SCCHN (FaDu, UT-SCC-8, UT-SCC-42a) cell lines were used to conduct cell viability, clonogenic survival, cell cycle, and immunoblotting assays in vitro, using increasing doses of Dacomitinib (10-500 nM), both with and without IR (2-4 Gy). The FaDu xenograft model was utilized for tumor growth delay assays in vivo, and immunohistochemical analyses were conducted on extracted tumors. A dose-dependent reduction in cell viability and clonogenic survival after Dacomitinib treatment was observed in all three SCCHN models. Treatment led to a significant reduction in EGFR signalling, with a subsequent decrease in phosphorylation of downstream targets such as ERK, AKT, and mTOR. In vivo, Dacomitinib treatment delayed tumor growth, while decreasing phospho-EGFR and Ki-67 immunoexpression. These effects were further enhanced when combined with IR, both in vitro and in vivo. The preclinical data support the further evaluations of Dacomitinib combined with IR for the future management of patients with SCCHN.	[Williams, Justin P.; Ito, Emma; Shi, Wei; Yue, Shijun; Siu, Lillian L.; Yip, Kenneth W.; Liu, Fei-Fei] Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada; [Kim, Inki] Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Siu, Lillian L.] Princess Margaret Canc Ctr, Div Med Oncol, Toronto, ON, Canada; [Siu, Lillian L.; Waldron, John; O'Sullivan, Brian; Liu, Fei-Fei] Univ Toronto, Toronto, ON, Canada; [Liu, Fei-Fei] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Waldron, John; O'Sullivan, Brian; Liu, Fei-Fei] Princess Margaret Canc Ctr, Dept Radiat Oncol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Ulsan; Asan Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Liu, FF (corresponding author), Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada.	Fei-Fei.Liu@rmp.uhn.on.ca		O'Sullivan, Brian/0000-0001-8887-843X; Waldron, John/0000-0002-1050-7329; Liu, Fei-Fei/0000-0003-4344-6486; Spence, Tara/0000-0001-7098-4103	Pfizer Canada Inc.; Princess Margaret Cancer Foundation; Princess Margaret Cancer Centre Head and Neck Translational Research Program	Pfizer Canada Inc.; Princess Margaret Cancer Foundation(University of Toronto); Princess Margaret Cancer Centre Head and Neck Translational Research Program	This work was partially funded by a grant from Pfizer Canada Inc. Additional funding was provided by the Joe's Team Fund, through the Princess Margaret Cancer Foundation and the Princess Margaret Cancer Centre Head and Neck Translational Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ather F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056112; Baumann M, 2004, RADIOTHER ONCOL, V72, P257, DOI 10.1016/j.radonc.2004.07.007; Boehm AL, 2008, MOL PHARMACOL, V73, P1632, DOI 10.1124/mol.107.044636; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Cerniglia GJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006539; Chau NG, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-11; Chen DJ, 2007, CLIN CANCER RES, V13, P6555, DOI 10.1158/1078-0432.CCR-07-1610; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Chung CH, 2006, J CLIN ONCOL, V24, P4170, DOI 10.1200/JCO.2006.07.2587; Egloff AM, 2008, SEMIN ONCOL, V35, P286, DOI 10.1053/j.seminoncol.2008.03.008; Engelman JA, 2007, CANCER RES, V67, P11924, DOI 10.1158/0008-5472.CAN-07-1885; Ford AC, 2003, HEAD NECK-J SCI SPEC, V25, P67, DOI 10.1002/hed.10224; Fury MG, 2011, J NATL COMPR CANC NE, V9, P681, DOI 10.6004/jnccn.2011.0056; Galizia G, 2007, WORLD J SURG, V31, P1458, DOI 10.1007/s00268-007-9016-4; Gonzales AJ, 2008, MOL CANCER THER, V7, P1880, DOI 10.1158/1535-7163.MCT-07-2232; GRANDIS JR, 1993, CANCER RES, V53, P3579; Gupta AK, 2002, CLIN CANCER RES, V8, P885; Haikonen J, 2003, INT J CANCER, V103, P784, DOI 10.1002/ijc.10890; Harari PM, 2004, INT J RADIAT ONCOL, V58, P976, DOI 10.1016/j.ijrobp.2003.09.097; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Hui ABY, 2013, CLIN CANCER RES, V19, P2154, DOI 10.1158/1078-0432.CCR-12-3572; Hui ABY, 2009, CLIN CANCER RES, V15, P3716, DOI 10.1158/1078-0432.CCR-08-2790; Janne PA, 2011, CLIN CANCER RES, V17, P1131, DOI 10.1158/1078-0432.CCR-10-1220; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Kato H, 2010, CLIN CANCER RES, V16, P898, DOI 10.1158/1078-0432.CCR-09-1945; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeffler-Ragy J, 2006, EUR J CANCER, V42, P109, DOI 10.1016/j.ejca.2005.08.034; Martin V, 2012, HISTOL HISTOPATHOL, V27, P785, DOI 10.14670/HH-27.785; Nam HJ, 2012, MOL CANCER THER, V11, P439, DOI 10.1158/1535-7163.MCT-11-0494; Ooi A, 2004, MODERN PATHOL, V17, P895, DOI 10.1038/modpathol.3800137; Ou SHI, 2012, CRIT REV ONCOL HEMAT, V83, P407, DOI 10.1016/j.critrevonc.2011.11.010; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Pogorzelski M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.62; Quesnelle KM, 2007, J CELL BIOCHEM, V102, P311, DOI 10.1002/jcb.21475; Shi W, 2009, J CLIN ONCOL, V27, P6213, DOI 10.1200/JCO.2009.23.1670; Shin DM, 2013, HEAD NECK-J SCI SPEC, V35, P443, DOI 10.1002/hed.21910; Shintani Satoru, 2003, Am J Clin Oncol, V26, pe150, DOI 10.1097/01.coc.0000091356.25759.69; Sok JC, 2006, CLIN CANCER RES, V12, P5064, DOI 10.1158/1078-0432.CCR-06-0913; Solomon B, 2003, INT J RADIAT ONCOL, V55, P713, DOI 10.1016/S0360-3016(02)04357-2; Sriuranpong V, 2003, CANCER RES, V63, P2948; Strojan P, 2013, HEAD NECK; Suzuki M, 2005, HUM PATHOL, V36, P1127, DOI 10.1016/j.humpath.2005.08.007; Takano T, 2005, J CLIN ONCOL, V23, P6829, DOI 10.1200/JCO.2005.01.0793; Tejani MA, 2010, BIOL-TARGETS THER, V4, P173; Thariat J, 2007, INT J CLIN ONCOL, V12, P99, DOI 10.1007/s10147-006-0663-5; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Wheeler SE, 2010, ONCOGENE, V29, P5135, DOI 10.1038/onc.2009.279; Yip KW, 2005, CLIN CANCER RES, V11, P8131, DOI 10.1158/1078-0432.CCR-05-1266; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Zhang Q, 2004, CANCER RES, V64, P6166, DOI 10.1158/0008-5472.CAN-04-0504; Zimmermann M, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-11	55	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98557	10.1371/journal.pone.0098557	http://dx.doi.org/10.1371/journal.pone.0098557			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853121	Green Submitted, Green Published, gold			2022-12-25	WOS:000338323200075
J	Wood, DA; Fisher, RN; Vandergast, AG				Wood, Dustin A.; Fisher, Robert N.; Vandergast, Amy G.			Fuzzy Boundaries: Color and Gene Flow Patterns among Parapatric Lineages of the Western Shovel-Nosed Snake and Taxonomic Implication	PLOS ONE			English	Article							EVOLUTIONARY PROCESSES; BIOLOGICAL DIVERSITY; ELAPHE-OBSOLETA; CONSERVATION; PHYLOGEOGRAPHY; POPULATION; SOFTWARE; DIFFERENTIATION; HYBRIDIZATION; DIVERGENCE	Accurate delineation of lineage diversity is increasingly important, as species distributions are becoming more reduced and threatened. During the last century, the subspecies category was often used to denote phenotypic variation within a species range and to provide a framework for understanding lineage differentiation, often considered incipient speciation. While this category has largely fallen into disuse, previously recognized subspecies often serve as important units for conservation policy and management when other information is lacking. In this study, we evaluated phenotypic subspecies hypotheses within shovel-nosed snakes on the basis of genetic data and considered how evolutionary processes such as gene flow influenced possible incongruence between phenotypic and genetic patterns. We used both traditional phylogenetic and Bayesian clustering analyses to infer range-wide genetic structure and spatially explicit analyses to detect possible boundary locations of lineage contact. Multilocus analyses supported three historically isolated groups with low to moderate levels of contemporary gene exchange. Genetic data did not support phenotypic subspecies as exclusive groups, and we detected patterns of discordance in areas where three subspecies are presumed to be in contact. Based on genetic and phenotypic evidence, we suggested that species-level diversity is underestimated in this group and we proposed that two species be recognized, Chionactis occipitalis and C. annulata. In addition, we recommend retention of two subspecific designations within C. annulata (C. a. annulata and C. a. klauberi) that reflect regional shifts in both genetic and phenotypic variation within the species. Our results highlight the difficultly in validating taxonomic boundaries within lineages that are evolving under a time-dependent, continuous process.	[Wood, Dustin A.; Fisher, Robert N.; Vandergast, Amy G.] US Geol Survey, Western Ecol Res Ctr, San Diego Field Stn, San Diego, CA 92101 USA	United States Department of the Interior; United States Geological Survey	Wood, DA (corresponding author), US Geol Survey, Western Ecol Res Ctr, San Diego Field Stn, San Diego, CA 92101 USA.	dawood@usgs.gov	Fisher, Robert/AAA-7301-2022	Fisher, Robert/0000-0002-2956-3240; Wood, Dustin/0000-0002-7668-9911; Vandergast, Amy/0000-0002-7835-6571	USGS; USFWS; Arizona Game and Fish Department; US Geological Survey, Western Ecological Research Center	USGS(United States Geological Survey); USFWS(US Fish & Wildlife Service); Arizona Game and Fish Department; US Geological Survey, Western Ecological Research Center(United States Geological Survey)	This project was funded by the Science Support Partnership between USGS and USFWS, Arizona Game and Fish Department, and by the US Geological Survey, Western Ecological Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVISE JC, 1989, TRENDS ECOL EVOL, V4, P279, DOI 10.1016/0169-5347(89)90203-6; Avise John C., 1994, pi; Bailey R. G., 1995, MISCELLANEOUS PUBLIC, V1391; BAIRd S. F., 1859, US MEXICAN BOUNDARY, P1; BALL RM, 1992, AUK, V109, P626; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Ballentine B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010229; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Bowen BW, 1999, MOL ECOL, V8, pS5, DOI 10.1046/j.1365-294X.1999.00798.x; BULL CM, 1991, ANNU REV ECOL SYST, V22, P19, DOI 10.1146/annurev.es.22.110191.000315; Burbrink FT, 2000, EVOLUTION, V54, P2107, DOI 10.1554/0014-3820(2000)054[2107:MDPOTP]2.0.CO;2; Carvalho SB, 2011, DIVERS DISTRIB, V17, P408, DOI 10.1111/j.1472-4642.2011.00752.x; Center for Biological Diversity, 2004, PET LIST TUCS SHOV N; Chan LM, 2012, MOL ECOL, V21, P3839, DOI 10.1111/j.1365-294X.2012.05651.x; Cracraft J., 1983, Current Ornithology, V1, P159; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Darwin C, 1859, ORIGINS SPECIES MEAN; de Queiroz K, 1998, ENDLESS FORMS, P57; Degner JF, 2010, MOL ECOL, V19, P2501, DOI 10.1111/j.1365-294X.2010.04661.x; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Ebert D, 2002, SCIENCE, V295, P485, DOI 10.1126/science.1067485; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; Endler J.A., 1977, Monographs in Population Biology, pi; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Fitzpatrick BM, 2008, MOL ECOL, V17, P4107, DOI 10.1111/j.1365-294X.2008.03885.x; FROST DR, 1990, HERPETOLOGICA, V46, P87; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Garant D, 2005, NATURE, V433, P60, DOI 10.1038/nature03051; Gavrilets S, 2000, EVOLUTION, V54, P1126; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Haig Susan M., 2010, Ornithological Monographs, V67, P24; Haig SM, 2006, CONSERV BIOL, V20, P1584, DOI 10.1111/j.1523-1739.2006.00530.x; Hallowell E, 1854, P ACAD NATURAL SCI, V7, P91; Hamilton MB, 1999, BIOTECHNIQUES, V27, P500, DOI 10.2144/99273st03; Hawlitschek O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042970; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Janzen FJ, 2002, MOL ECOL, V11, P1739, DOI 10.1046/j.1365-294X.2002.01571.x; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; King TL, 2006, MOL ECOL, V15, P4331, DOI 10.1111/j.1365-294X.2006.03080.x; Klauber L. M., 1951, Transactions of the San Diego Society for Natural History, V11, P141; Kodandaramaiah U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041058; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Mahrdt CR, 2001, CATALOG AM AMPHIB RE, V731, P1; MANTEL N, 1967, CANCER RES, V27, P209; MAYR E., 1942, Systematics and the origin of species from the viewpoint of a zoologist.; MAYR E, 1982, AUK, V99, P593; Mayr E., 1954, EVOLUTION PROCESS, P157; McNab WH, 2005, DESCRIPTION ECOLOGIC, P80; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Mulcahy DG, 2008, MOL PHYLOGENET EVOL, V46, P1095, DOI 10.1016/j.ympev.2007.12.012; Nadachowska K, 2009, MOL BIOL EVOL, V26, P829, DOI 10.1093/molbev/msp004; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; OBRIEN SJ, 1991, SCIENCE, V251, P1187, DOI 10.1126/science.251.4998.1187; Patten Michael A., 2010, Ornithological Monographs, V67, P35; Peakall R., 2012, BIOINFORMATICS; Phillimore AB, 2006, P R SOC B, V273, P1049, DOI 10.1098/rspb.2005.3425; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A., 2007, TRACER V1 5; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reilly SB, 2012, MOL ECOLOGY; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Santamaria L, 2012, EVOL APPL, V5, P202, DOI 10.1111/j.1752-4571.2011.00229.x; SMITH HOBART M., 1950, UNIV KANSAS SCI BULL, V33, P313; Stickel William H., 1941, BULL CHICAGO ACAD SCI, V6, P135; Stickel William H., 1943, PROC BIOL SOC WASHINGTON, V56, P109; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Tallmon DA, 2004, TRENDS ECOL EVOL, V19, P489, DOI 10.1016/j.tree.2004.07.003; U.S. Fish and Wildlife Service, 2012, FED REGISTER, p[77, 70018]; U.S. Fish and Wildlife Service, 2011, FED REGISTER, V76, P66396; U.S. Fish and Wildlife Service, 2010, FED REGISTER, V75, P16050; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vandewege MW, 2012, J HERPETOL, V46, P56, DOI 10.1670/09-220; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WILEY EO, 1978, SYST ZOOL, V27, P17, DOI 10.2307/2412809; WILSON EO, 1953, SYST ZOOL, V2, P97, DOI 10.2307/2411818; Wood DA, 2008, CONSERV GENET, V9, P1489, DOI 10.1007/s10592-007-9482-0; Wood DA, 2013, DIVERS DISTRIB, V19, P722, DOI 10.1111/ddi.12022; Wright S, 1931, GENETICS, V16, P0097; Zink RM, 2004, P ROY SOC B-BIOL SCI, V271, P561, DOI 10.1098/rspb.2003.2617	85	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97494	10.1371/journal.pone.0097494	http://dx.doi.org/10.1371/journal.pone.0097494			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848638	gold, Green Submitted, Green Published			2022-12-25	WOS:000336730600032
J	Benoit-Bird, KJ; McManus, MA				Benoit-Bird, Kelly J.; McManus, Margaret A.			A Critical Time Window for Organismal Interactions in a Pelagic Ecosystem	PLOS ONE			English	Article							PREDATOR-PREY INTERACTIONS; MARINE PREDATOR; ZOOPLANKTON COMMUNITIES; VERTICAL MIGRATION; SOUND-SCATTERING; HAWAIIAN WATERS; DIEL MIGRATION; BERING-SEA; PATTERNS; AVAILABILITY	To measure organismal coherence in a pelagic ecosystem, we used moored sensors to describe the vertical dynamics of each step in the food chain in shelf waters off the west shore of Oahu, Hawaii. Horizontally extensive, intense aggregations of phytoplankton, zooplankton, and micronekton exhibited strong diel patterns in abundance and vertical distribution, resulting in a highly variable potential for interaction amongst trophic levels. Only around dusk did zooplankton layers overlap with phytoplankton layers. Shortly after sunset, micronekton ascended from the deep, aggregating on the island's shelf. Short-lived departures in migration patterns were detected in depth, vertical distribution, density, and total abundance of micronekton when zooplankton layers were present with typical patterns resuming within one hour. Layers of zooplankton began to disappear within 20 minutes of the arrival of micronekton with no layers present after 50 minutes. The effects of zooplankton layers cascaded even further up the food chain, affecting many behaviors of dolphins observed at dusk including their depth, group size, and inter-individual spacing. As a result of these changes in behavior, during a 30-minute window just after dusk, the number of feeding events observed for each dolphin and consequently the feeding time for each individual more than doubled when zooplankton layers were present. Dusk is a critical period for interactions amongst species in this system from phytoplankton to top predators. Our observations that short time windows can drive the structure and function of a complex suite of organisms highlight the importance of explicitly adding a temporal dimension at a scale relevant to individual organisms to our descriptions of heterogeneity in ocean ecosystems.	[Benoit-Bird, Kelly J.] Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [McManus, Margaret A.] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA	Oregon State University; University of Hawaii System; University of Hawaii Manoa	Benoit-Bird, KJ (corresponding author), Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	kbenoit@coas.oregonstate.edu	McManus, Margaret Anne/AAA-2604-2020		US Office of Naval Research [N00014-08-1-1212, N00014-08-1-1210]	US Office of Naval Research(Office of Naval Research)	This work was funded by the US Office of Naval Research, awards #N00014-08-1-1212 (MAM), and #N00014-08-1-1210 (KJBB); http://www.onr.navy.mil/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMS MV, 1993, ECOLOGY, V74, P258, DOI 10.2307/1939521; Alldredge AL, 2002, MAR ECOL PROG SER, V233, P1, DOI 10.3354/meps233001; [Anonymous], ECOLOGY PREDATOR PRE; Bell AV, 2009, THEOR POPUL BIOL, V76, P52, DOI 10.1016/j.tpb.2009.03.008; Benoit-Bird KJ, 2008, MAR ECOL PROG SER, V367, P109, DOI 10.3354/meps07571; Benoit-Bird KJ, 2006, MAR ECOL PROG SER, V319, P1, DOI 10.3354/meps319001; Benoit-Bird KJ, 2012, BIOL LETTERS, V8, P813, DOI 10.1098/rsbl.2012.0232; Benoit-Bird KJ, 2011, MAR ECOL PROG SER, V443, P217, DOI 10.3354/meps09408; Benoit-Bird KJ, 2010, CONT SHELF RES, V30, P17, DOI 10.1016/j.csr.2009.08.001; Benoit-Bird KJ, 2009, ICES J MAR SCI, V66, P582, DOI 10.1093/icesjms/fsp013; Benoit-Bird KJ, 2009, J ACOUST SOC AM, V125, P125, DOI 10.1121/1.2967480; Benoit-Bird KJ, 2004, DEEP-SEA RES PT I, V51, P707, DOI 10.1016/j.dsr.2004.01.004; Benoit-Bird KJ, 2003, J ACOUST SOC AM, V114, P1888, DOI 10.1121/1.1612484; Benoit-Bird KJ, 2013, GEOPHYS RES IN PRESS; Beyer JE, 1995, ICES COUNC M, V14; CLARKE TA, 1980, FISH B-NOAA, V78, P619; Dupuch A, 2009, ANIM BEHAV, V78, P705, DOI 10.1016/j.anbehav.2009.05.033; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; ENRIGHT JT, 1977, LIMNOL OCEANOGR, V22, P856, DOI 10.4319/lo.1977.22.5.0856; Fauchald P, 2009, MAR ECOL PROG SER, V391, P139, DOI 10.3354/meps07818; Foote K.G, 1987, ICES COOP RES REP, V144; FORWARD RB, 1988, OCEANOGR MAR BIOL, V26, P361; Freon P, 1996, ICES J MAR SCI, V53, P459; Goss C, 1997, MAR ECOL PROG SER, V154, P41, DOI 10.3354/meps154041; Grunbaum D, 2002, HYDROBIOLOGIA, V480, P175, DOI 10.1023/A:1021296103358; Hampton SE, 2004, OECOLOGIA, V138, P475, DOI 10.1007/s00442-003-1446-6; Hazen EL, 2009, MAR ECOL PROG SER, V395, P75, DOI 10.3354/meps08108; Holliday D. V, 1977, OCEAN SOUND SCATT PR, P619; HOLLIDAY DV, 1995, ICES J MAR SCI, V52, P279, DOI 10.1016/1054-3139(95)80044-1; HORNE JK, 1995, OIKOS, V74, P18, DOI 10.2307/3545670; Hunt G.L. Jr, 1990, Polar Research, V8, P43, DOI 10.1111/j.1751-8369.1990.tb00374.x; Hunt GL, 2008, DEEP-SEA RES PT II, V55, P1919, DOI 10.1016/j.dsr2.2008.04.032; Kang M, 2002, ICES J MAR SCI, V59, P794, DOI 10.1006/jmsc.2002.1229; Korneliussen RJ, 2000, ICES J MAR SCI, V57, P1204, DOI 10.1006/jmsc.2000.0806; Krebs J.R., 1978, P23; LASKER R, 1975, FISH B-NOAA, V73, P453; Leising AW, 2001, MAR ECOL PROG SER, V216, P167, DOI 10.3354/meps216167; Lima SL, 2002, TRENDS ECOL EVOL, V17, P70, DOI 10.1016/S0169-5347(01)02393-X; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; LOBEL PS, 1978, PAC SCI, V32, P193; MACKAS D, 1976, J EXP MAR BIOL ECOL, V25, P77, DOI 10.1016/0022-0981(76)90077-0; MacLennan D.N., 1992, SPRINGER SCI BUS MED; McManus MA, 2012, ESTUAR COAST, P1; Medwin H., 1997, FUNDAMENTALS ACOUSTI, DOI [10.1016/B978-0-12-487570-8.X5000-4, DOI 10.1016/B978-0-12-487570-8.X5000-4]; Nachman G, 1981, J ANIM ECOL, P435; RINGELBERG J, 1995, J MAR BIOL ASSOC UK, V75, P15, DOI 10.1017/S0025315400015162; ROSE GA, 1990, ECOLOGY, V71, P33, DOI 10.2307/1940245; Roughgarden J, 1974, AM NAT, P649; RUSSELL RW, 1992, LANDSCAPE ECOL, V7, P195, DOI 10.1007/BF00133310; Schneider DC, 2001, BIOSCIENCE, V51, P545, DOI 10.1641/0006-3568(2001)051[0545:TROTCO]2.0.CO;2; Sevadjian J, 2012, CONT SHELF RES; Sevadjian JC, 2014, CONT SHELF RES, V72, P138, DOI 10.1016/j.csr.2013.09.018; Sevadjian JC, 2010, MAR ECOL PROG SER, V409, P95, DOI 10.3354/meps08614; Sigler MF, 2012, DEEP-SEA RES PT II, V65-70, P292, DOI 10.1016/j.dsr2.2012.02.017; SIH A, 1984, AM NAT, V123, P143, DOI 10.1086/284193; Silvertown J, 1992, J ECOL, P527; Simila T, 1996, CAN J FISH AQUAT SCI, V53, P769, DOI 10.1139/cjfas-53-4-769; Sims DW, 2006, P ROY SOC B-BIOL SCI, V273, P1195, DOI 10.1098/rspb.2005.3444; Stanton TK, 1998, J ACOUST SOC AM, V103, P236, DOI 10.1121/1.421110; Sullivan JM, 2010, CONT SHELF RES, V30, P50, DOI 10.1016/j.csr.2009.07.009; WILLIAMSON CE, 1989, OECOLOGIA, V79, P76, DOI 10.1007/BF00378242; WILLIAMSON CE, 1990, HYDROBIOLOGIA, V198, P125, DOI 10.1007/BF00048629; Womble JN, 2006, MAR ECOL PROG SER, V325, P281, DOI 10.3354/meps325281	63	10	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97763	10.1371/journal.pone.0097763	http://dx.doi.org/10.1371/journal.pone.0097763			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844981	Green Published, Green Submitted, gold			2022-12-25	WOS:000339563400058
J	Fliedner, SMJ; Engel, T; Lendvai, NK; Shankavaram, U; Nolting, S; Wesley, R; Elkahloun, AG; Ungefroren, H; Oldoerp, A; Lampert, G; Lehnert, H; Timmers, H; Pacak, K				Fliedner, Stephanie M. J.; Engel, Tobias; Lendvai, Nikoletta K.; Shankavaram, Uma; Noelting, Svenja; Wesley, Robert; Elkahloun, Abdel G.; Ungefroren, Hendrik; Oldoerp, Angela; Lampert, Gary; Lehnert, Hendrik; Timmers, Henri; Pacak, Karel			Anti-Cancer Potential of MAPK Pathway Inhibition in Paragangliomas-Effect of Different Statins on Mouse Pheochromocytoma Cells	PLOS ONE			English	Article							SIGNALING PATHWAYS; MEVALONATE PATHWAY; MELANOMA-CELLS; SPORADIC PHEOCHROMOCYTOMA; REDUCTASE INHIBITORS; GERMLINE MUTATIONS; RET PROTOONCOGENE; SOMATIC MUTATIONS; INDUCE APOPTOSIS; DOWN-REGULATION	To date, malignant pheochromocytomas and paragangliomas (PHEOs/PGLs) cannot be effectively cured and thus novel treatment strategies are urgently needed. Lovastatin has been shown to effectively induce apoptosis in mouse PHEO cells (MPC) and the more aggressive mouse tumor tissue-derived cells (MTT), which was accompanied by decreased phosphorylation of mitogen-activated kinase (MAPK) pathway players. The MAPK pathway plays a role in numerous aggressive tumors and has been associated with a subgroup of PHEOs/PGLs, including K-RAS-, RET-, and NF1-mutated tumors. Our aim was to establish whether MAPK signaling may also play a role in aggressive, succinate dehydrogenase (SDH) B mutation-derived PHEOs/PGLs. Expression profiling and western blot analysis indicated that specific aspects of MAPK-signaling are active in SDHB PHEOs/PGLs, suggesting that inhibition by statin treatment could be beneficial. Moreover, we aimed to assess whether the anti-proliferative effect of lovastatin on MPC and MTT differed from that exerted by fluvastatin, simvastatin, atorvastatin, pravastatin, or rosuvastatin. Simvastatin and fluvastatin decreased cell proliferation most effectively and the more aggressive MTT cells appeared more sensitive in this respect. Inhibition of MAPK1 and 3 phosphorylation following treatment with fluvastatin, simvastatin, and lovastatin was confirmed by western blot. Increased levels of CASP-3 and PARP cleavage confirmed induction of apoptosis following the treatment. At a concentration low enough not to affect cell proliferation, spontaneous migration of MPC and MTT was significantly inhibited within 24 hours of treatment. In conclusion, lipophilic statins may present a promising therapeutic option for treatment of aggressive human paragangliomas by inducing apoptosis and inhibiting tumor spread.	[Fliedner, Stephanie M. J.; Engel, Tobias; Lendvai, Nikoletta K.; Noelting, Svenja; Pacak, Karel] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Med Neuroendocrinol, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD 20892 USA; [Fliedner, Stephanie M. J.; Ungefroren, Hendrik; Oldoerp, Angela; Lehnert, Hendrik] Univ Med Ctr Schleswig Holstein, Dept Med 1, Lubeck, Germany; [Engel, Tobias; Timmers, Henri] Radboud Univ Nijmegen, Med Ctr, Dept Endocrinol, NL-6525 ED Nijmegen, Netherlands; [Shankavaram, Uma] NCI, Radiat Oncol Branch, NIH, Bethesda, MD 20892 USA; [Noelting, Svenja] Queen Mary Univ London, William Harvey Res Inst, Dept Endocrinol, London, England; [Noelting, Svenja] Queen Mary Univ London, Barts & London Sch Med, Barts Canc Inst, London, England; [Wesley, Robert] NIH, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA; [Elkahloun, Abdel G.] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Kiel; Schleswig Holstein University Hospital; Radboud University Nijmegen; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of London; Queen Mary University London; University of London; Queen Mary University London; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Fliedner, SMJ (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Med Neuroendocrinol, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD 20892 USA.	Stephanie.fliedner@uksh.de	Fliedner, Stephanie MJ/D-3406-2012; Timmers, Henri JLM/A-4641-2010; Engel, Tobias GP/E-5807-2016	Engel, Tobias GP/0000-0002-3105-4867; Nolting, Svenja/0000-0002-7064-590X; Fliedner, Stephanie/0000-0001-5515-8196	Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA; 1st Department of Medicine, University Medical Center Schleswig-Holstein, Lubeck, Germany; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008735] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200365] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); 1st Department of Medicine, University Medical Center Schleswig-Holstein, Lubeck, Germany; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funding was provided by the Intramural Research Programs of the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA and the 1st Department of Medicine, University Medical Center Schleswig-Holstein, Lubeck, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar L, 2005, J CLIN ONCOL, V23, P8812, DOI 10.1200/JCO.2005.03.1484; Amar L, 2007, J CLIN ENDOCR METAB, V92, P3822, DOI 10.1210/jc.2007-0709; Ayala-Ramirez M, 2012, J CLIN ENDOCR METAB, V97, P4040, DOI 10.1210/jc.2012-2356; Bouterfa HL, 2000, ANTICANCER RES, V20, P2761; Brouwers FM, 2006, J CLIN ENDOCR METAB, V91, P4505, DOI 10.1210/jc.2006-0423; Burnichon N, 2012, HUM MOL GENET, V21, P5397, DOI 10.1093/hmg/dds374; Burnichon N, 2011, HUM MOL GENET, V20, P3974, DOI 10.1093/hmg/ddr324; Campbell MJ, 2006, CANCER RES, V66, P8707, DOI 10.1158/0008-5472.CAN-05-4061; Chae YC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3139; Clendening JW, 2012, ONCOGENE, V31, P4967, DOI 10.1038/onc.2012.6; Clendening JW, 2010, P NATL ACAD SCI USA, V107, P15051, DOI 10.1073/pnas.0910258107; Collisson EA, 2003, MOL CANCER THER, V2, P941; Comino-Mendez I, 2011, NAT GENET, V43, P663, DOI 10.1038/ng.861; Crona J, 2013, J CLIN ENDOCR METAB, V98, pE1266, DOI 10.1210/jc.2012-4257; De Luca A, 2012, EXPERT OPIN THER TAR, V16, pS17, DOI 10.1517/14728222.2011.639361; ENG C, 1995, J MED GENET, V32, P934, DOI 10.1136/jmg.32.12.934; Gauthaman K, 2009, BRIT J PHARMACOL, V157, P962, DOI 10.1111/j.1476-5381.2009.00241.x; Gauthaman K, 2009, J CELL BIOCHEM, V106, P975, DOI 10.1002/jcb.22092; Gazzerro P, 2012, PHARMACOL REV, V64, P102, DOI 10.1124/pr.111.004994; Giubellino A, 2013, ENDOCRINOLOGY, V154, P646, DOI 10.1210/en.2012-1854; Glynn SA, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-9; Holstein SA, 2006, CANCER CHEMOTH PHARM, V57, P155, DOI 10.1007/s00280-005-0013-8; Hrascan R, 2008, J NEUROENDOCRINOL, V20, P1015, DOI 10.1111/j.1365-2826.2008.01755.x; Kidera Yasuhiro, 2010, J Exp Clin Cancer Res, V29, P127, DOI 10.1186/1756-9966-29-127; Kochuparambil ST, 2011, J PHARMACOL EXP THER, V336, P496, DOI 10.1124/jpet.110.174870; Kohno M, 2006, ANN MED, V38, P200, DOI 10.1080/07853890600551037; Lai EW, 2009, J CLIN ENDOCR METAB, V94, P2952, DOI 10.1210/jc.2009-0309; Leszczynska A, 2011, ACTA BIOCHIM POL, V58, P635; Lin Y, 2013, ONCOTARGETS THER, V6, P1559, DOI 10.2147/OTT.S53813; Mandel K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056591; Martiniova L, 2009, CLIN EXP METASTAS, V26, P239, DOI 10.1007/s10585-009-9236-0; Mohammed A, 2012, INT J CANCER, V131, P1951, DOI 10.1002/ijc.27456; MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0; Neuvonen PJ, 2008, CLIN PHARMACOKINET, V47, P463, DOI 10.2165/00003088-200847070-00003; Ni Y, 2008, AM J HUM GENET, V83, P261, DOI 10.1016/j.ajhg.2008.07.011; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Nolting S, 2012, J MOL ENDOCRINOL, V49, P79, DOI 10.1530/JME-12-0028; Ogunwobi OO, 2008, AM J GASTROENTEROL, V103, P825, DOI 10.1111/j.1572-0241.2007.01773.x; Osmak M, 2012, CANCER LETT, V324, P1, DOI 10.1016/j.canlet.2012.04.011; Pelaia G, 2012, CELL PROLIFERAT, V45, P557, DOI 10.1111/j.1365-2184.2012.00846.x; Powers JF, 2000, CELL TISSUE RES, V302, P309, DOI 10.1007/s004410000290; Qi XF, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.44; Sekine Y, 2008, BIOCHEM BIOPH RES CO, V372, P356, DOI 10.1016/j.bbrc.2008.05.043; Shankavaram U, 2013, NEOPLASIA, V15, P435, DOI 10.1593/neo.122132; Shi YD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045354; SINENSKY M, 1990, J BIOL CHEM, V265, P19937; Takeda I, 2007, CANCER SCI, V98, P890, DOI 10.1111/j.1349-7006.2007.00471.x; Thurnher M, 2012, CLIN CANCER RES, V18, P3524, DOI 10.1158/1078-0432.CCR-12-0489; Welander J, 2012, HUM MOL GENET, V21, P5406, DOI 10.1093/hmg/dds402; Wong WWL, 2001, CLIN CANCER RES, V7, P2067; Wu HT, 2009, NEUROSURGERY, V65, P1087, DOI 10.1227/01.NEU.0000360130.52812.1D; XU W, 1992, GENE CHROMOSOME CANC, V4, P337, DOI 10.1002/gcc.2870040411; Zhang SL, 2011, ANTICANCER RES, V31, P3259; Ziegler CG, 2013, MOL CELL ENDOCRINOL, V371, P189, DOI 10.1016/j.mce.2012.12.011	54	17	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97712	10.1371/journal.pone.0097712	http://dx.doi.org/10.1371/journal.pone.0097712			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846270	gold, Green Published, Green Submitted			2022-12-25	WOS:000339563400048
J	Berry, MS; Sweeney, MM; Morath, J; Odum, AL; Jordan, KE				Berry, Meredith S.; Sweeney, Mary M.; Morath, Justice; Odum, Amy L.; Jordan, Kerry E.			The Nature of Impulsivity: Visual Exposure to Natural Environments Decreases Impulsive Decision-Making in a Delay Discounting Task	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; SELF-CONTROL; PROBABILISTIC REWARDS; FADING PROCEDURE; FUTURE; BIODIVERSITY; CHOICE; REINFORCEMENT; MONEY; ADOLESCENTS	The benefits of visual exposure to natural environments for human well-being in areas of stress reduction, mood improvement, and attention restoration are well documented, but the effects of natural environments on impulsive decision-making remain unknown. Impulsive decision-making in delay discounting offers generality, predictive validity, and insight into decision-making related to unhealthy behaviors. The present experiment evaluated differences in such decision-making in humans experiencing visual exposure to one of the following conditions: natural (e. g., mountains), built (e. g., buildings), or control (e. g., triangles) using a delay discounting task that required participants to choose between immediate and delayed hypothetical monetary outcomes. Participants viewed the images before and during the delay discounting task. Participants were less impulsive in the condition providing visual exposure to natural scenes compared to built and geometric scenes. Results suggest that exposure to natural environments results in decreased impulsive decision-making relative to built environments.	[Berry, Meredith S.; Sweeney, Mary M.; Morath, Justice; Odum, Amy L.; Jordan, Kerry E.] Utah State Univ, Dept Psychol, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Berry, MS (corresponding author), Univ Montana, Dept Soc & Conservat, Missoula, MT 59812 USA.	meredith.berry@umontana.edu	Odum, Amy L./A-9641-2010	Sweeney, Mary Margaret/0000-0001-6931-4321	Cambridge Center for Behavioral Studies	Cambridge Center for Behavioral Studies	The Cambridge Center for Behavioral Studies supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011554; Anokhin AP, 2011, BEHAV GENET, V41, P175, DOI 10.1007/s10519-010-9384-7; Arbuthnott KD, 2010, ANAL SOC ISS PUB POL, V10, P4, DOI 10.1111/j.1530-2415.2009.01196.x; Baker F, 2003, J ABNORM PSYCHOL, V112, P382, DOI 10.1037/0021-843X.112.3.382; Barkley RA, 2001, J ABNORM CHILD PSYCH, V29, P541, DOI 10.1023/A:1012233310098; Baumann AA, 2012, BEHAV PROCESS, V90, P408, DOI 10.1016/j.beproc.2012.04.005; Beck RC, 2009, EXP CLIN PSYCHOPHARM, V17, P345, DOI 10.1037/a0017078; Berman MG, 2008, PSYCHOL SCI, V19, P1207, DOI 10.1111/j.1467-9280.2008.02225.x; Berto R, 2005, J ENVIRON PSYCHOL, V25, P249, DOI 10.1016/j.jenvp.2005.07.001; Berto R, 2008, J ENVIRON PSYCHOL, V28, P185, DOI 10.1016/j.jenvp.2007.11.004; Bickel WK, 2011, BIOL PSYCHIAT, V69, P260, DOI 10.1016/j.biopsych.2010.08.017; Black AC, 2011, ADDICT BEHAV, V36, P125, DOI 10.1016/j.addbeh.2010.08.014; Bowler Diana E, 2010, BMC Public Health, V10, P456, DOI 10.1186/1471-2458-10-456; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; Chivian E, 2008, SUSTAINING LIFE HUMA; CLIFF N, 1993, PSYCHOL BULL, V114, P494, DOI 10.1037/0033-2909.114.3.494; de Wit H, 2009, ADDICT BIOL, V14, P22, DOI 10.1111/j.1369-1600.2008.00129.x; Dixon MR, 2006, J APPL BEHAV ANAL, V39, P413, DOI 10.1901/jaba.2006.173-05; Dixon MR, 2009, J APPL BEHAV ANAL, V42, P243, DOI 10.1901/jaba.2009.42-243; Dixon MR, 2004, J APPL BEHAV ANAL, V37, P101, DOI 10.1901/jaba.2004.37-101; Dixon MR, 2001, J APPL BEHAV ANAL, V34, P491, DOI 10.1901/jaba.2001.34-491; Dixon MR, 1998, J APPL BEHAV ANAL, V31, P203, DOI 10.1901/jaba.1998.31-203; Dixon MR, 2000, J APPL BEHAV ANAL, V33, P611, DOI 10.1901/jaba.2000.33-611; Du WJ, 2002, PSYCHOL REC, V52, P479, DOI 10.1007/BF03395199; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fisher WW, 2000, BEHAV MODIF, V24, P3, DOI 10.1177/0145445500241001; GREEN L, 1994, PSYCHOL SCI, V5, P33, DOI 10.1111/j.1467-9280.1994.tb00610.x; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Hardisty DJ, 2009, J EXP PSYCHOL GEN, V138, P329, DOI 10.1037/a0016433; Hirsh JB, 2010, EMOTION, V10, P717, DOI 10.1037/a0019466; Johnson MW, 2008, EXP CLIN PSYCHOPHARM, V16, P264, DOI 10.1037/1064-1297.16.3.264; Johnson MW, 2002, J EXP ANAL BEHAV, V77, P129, DOI 10.1901/jeab.2002.77-129; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; Leopold A., 1949, S COUNTY ALMANAC; LOGUE AW, 1981, BEHAV ANAL LETT, V1, P131; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Madden GJ., 2010, IMPULSIVITY BEHAV NE, P11, DOI [10.1037/12069-001, DOI 10.1037/12069-000]; Mazur J.E., 1987, QUANTITATIVE ANAL BE, V5, P55; MAZUR JE, 1978, J EXP ANAL BEHAV, V30, P11, DOI 10.1901/jeab.1978.30-11; McAdams DP, 2010, ANNU REV PSYCHOL, V61, P517, DOI 10.1146/annurev.psych.093008.100507; Morrison KL, 2014, BEHAV THERA IN PRESS; Muir John, 1894, MOUNTAINS CALIFORNIA; Neef NA, 2001, J APPL BEHAV ANAL, V34, P397, DOI 10.1901/jaba.2001.34-397; Odum AL, 2011, J EXP ANAL BEHAV, V96, P427, DOI 10.1901/jeab.2011.96-423; Odum AL, 2011, BEHAV PROCESS, V87, P1, DOI 10.1016/j.beproc.2011.02.007; Ohmura Y, 2006, EXP CLIN PSYCHOPHARM, V14, P318, DOI 10.1037/1064-1297.14.3.318; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Purcell T, 2001, ENVIRON BEHAV, V33, P93, DOI 10.1177/00139160121972882; Rachlin H, 2006, J EXP ANAL BEHAV, V85, P425, DOI 10.1901/jeab.2006.85-05; RACHLIN H, 1991, J EXP ANAL BEHAV, V55, P233, DOI 10.1901/jeab.1991.55-233; RAGOTZY SP, 1988, J EXP ANAL BEHAV, V49, P191, DOI 10.1901/jeab.1988.49-191; Rodzon K, 2011, BEHAV PROCESS, V86, P164, DOI 10.1016/j.beproc.2010.09.007; Rudd M, 2012, PSYCHOL SCI, V23, P1130, DOI 10.1177/0956797612438731; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; SCHWEITZER JB, 1988, J EXP ANAL BEHAV, V50, P173, DOI 10.1901/jeab.1988.50-173; Sharma L, 2013, J PERS SOC PSYCHOL, V104, P559, DOI 10.1037/a0031181; Simpson CA, 2000, PSYCHOL REC, V50, P3, DOI 10.1007/BF03395339; Takahashi T, 2007, NEUROENDOCRINOL LETT, V28, P131; Takahashi T, 2007, PHYSICA A, V385, P637, DOI 10.1016/j.physa.2007.07.020; Thompson CW, 2012, LANDSCAPE URBAN PLAN, V105, P221, DOI 10.1016/j.landurbplan.2011.12.015; Thoreau D, 1864, THE MAINE WOODS, P39; ULRICH RS, 1981, ENVIRON BEHAV, V13, P523, DOI 10.1177/0013916581135001; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; White MP, 2013, PSYCHOL SCI, V24, P920, DOI 10.1177/0956797612464659; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	65	54	58	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97915	10.1371/journal.pone.0097915	http://dx.doi.org/10.1371/journal.pone.0097915			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9SK	24841421	Green Published, Green Submitted, gold			2022-12-25	WOS:000340948600093
J	Duan, DN; Zhang, SX; Li, XL; Guo, H; Chen, MM; Zhang, YQ; Han, JY; Lv, YJ				Duan, Dianning; Zhang, Shuxia; Li, Xiaolin; Guo, Hua; Chen, Mengmeng; Zhang, Yaqun; Han, Junyuan; Lv, Yingjun			Activation of the TLR/MyD88/NF-kappa B Signal Pathway Contributes to Changes in IL-4 and IL-12 Production in Piglet Lymphocytes Infected with Porcine Circovirus Type 2 In Vitro	PLOS ONE			English	Article							MULTISYSTEMIC WASTING SYNDROME; NF-KAPPA-B; SYNDROME PMWS; ALVEOLAR MACROPHAGES; PIGS; APOPTOSIS; PCV2; INOCULATION; INTERFERON; DISEASE	Porcine circovirus type 2 (PCV2) causes immunosuppression in pigs. One causative factor is an imbalance in cytokine levels in the blood and lymphoid tissues. Many studies have reported changes in cytokine production, but the regulatory mechanisms involved have not yet been elucidated. In this study, we investigated alteration and regulation of IL-4 and IL-12 production in lymphocytes following incubation with PCV2 in vitro. The levels of IL-4 decreased and levels of IL-12 increased in lymphocyte supernatants, and the DNA-binding activity of NF-kappa B and the expression of p65 in the nucleus and p-I kappa B in the cytoplasm of lymphocytes increased after incubation with PCV2. However, these effects were reversed when lymphocytes were coincubated with PCV2 and the NF-kappa B inhibitor BAY11-7082. In addition, the expression of MyD88 protein increased and the expression of mRNA for the toll-like receptors (TLRs) TLR2, TLR3, TLR4 and TLR9 was upregulated when lymphocytes were incubated with PCV2. However, no change was seen in TLR7 and TLR8 mRNA expression. In conclusion, this study showed that PCV2 induced a decrease in IL-4 and an increase in IL-12 production in lymphocytes, and these changes were regulated by the TLR-MyD88-NF-kappa B signal pathway.	[Duan, Dianning; Zhang, Shuxia; Li, Xiaolin; Guo, Hua; Chen, Mengmeng; Zhang, Yaqun; Han, Junyuan; Lv, Yingjun] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Lv, YJ (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	lyj@njau.edu.cn			Natural Science Foundation of China [31172292, 31101786]; Natural Science Foundation of Jiangsu province [BK2011646]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported and by a grant (31172292, 31101786) from the Natural Science Foundation of China and by a grant (BK2011646) from the Natural Science Foundation of Jiangsu province and by A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan GM, 1998, J VET DIAGN INVEST, V10, P3, DOI 10.1177/104063879801000102; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Chang HW, 2007, VET MICROBIOL, V122, P72, DOI 10.1016/j.vetmic.2007.01.013; Chang HW, 2006, VET IMMUNOL IMMUNOP, V110, P207, DOI 10.1016/j.vetimm.2005.09.016; Darwich L, 2003, J GEN VIROL, V84, P2117, DOI 10.1099/vir.0.19124-0; Ellis J, 2004, VET MICROBIOL, V98, P159, DOI 10.1016/j.vetmic.2003.10.008; Gilpin DF, 2003, VET IMMUNOL IMMUNOP, V94, P149, DOI 10.1016/S0165-2427(03)00087-4; Hertzog PJ, 2003, TRENDS IMMUNOL, V24, P534, DOI 10.1016/j.it.2003.08.006; Karuppannan AK, 2011, VIROLOGY, V410, P248, DOI 10.1016/j.virol.2010.11.009; Kekarainen T, 2008, J GEN VIROL, V89, P760, DOI 10.1099/vir.0.83354-0; Kopp E, 2003, CURR OPIN IMMUNOL, V15, P396, DOI 10.1016/S0952-7915(03)00080-3; Krakowka S, 2007, CAN VET J, V48, P716; Li XW, 2003, INFECT IMMUN, V71, P4414, DOI 10.1128/IAI.71.8.4414-4420.2003; Liu CH, 2009, VET MICROBIOL, V136, P266, DOI 10.1016/j.vetmic.2008.11.016; Lv YJ, 2013, RES VET SCI, V95, P1235, DOI 10.1016/j.rvsc.2013.08.006; Lv YJ, 2012, RES VET SCI, V93, P1525, DOI 10.1016/j.rvsc.2012.04.003; Mandrioli L, 2004, VET IMMUNOL IMMUNOP, V97, P25, DOI 10.1016/j.vetimm.2003.08.017; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Miguel JC, 2010, VET IMMUNOL IMMUNOP, V135, P314, DOI 10.1016/j.vetimm.2010.01.002; Rosell C, 1999, J COMP PATHOL, V120, P59, DOI 10.1053/jcpa.1998.0258; Segales J, 2002, VET QUART, V24, P109, DOI 10.1080/01652176.2002.9695132; Shi KC, 2010, VET MICROBIOL, V140, P155, DOI 10.1016/j.vetmic.2009.07.021; Song S, 2013, DEV COMP IMMUNOL, V39, P265, DOI 10.1016/j.dci.2012.10.001; Wang XW, 2007, VET MICROBIOL, V121, P215, DOI 10.1016/j.vetmic.2006.11.027; Wei L, 2008, VIROLOGY, V378, P177, DOI 10.1016/j.virol.2008.05.013; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; YASUMOTO K, 1992, J BIOL CHEM, V267, P22506; Zhang HL, 2013, ARCH VIROL, V158, P2285, DOI 10.1007/s00705-013-1750-3	28	32	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97653	10.1371/journal.pone.0097653	http://dx.doi.org/10.1371/journal.pone.0097653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841678	Green Published, gold, Green Submitted			2022-12-25	WOS:000340948600054
J	Koch, N; Kobler, O; Thomas, U; Qualmann, B; Kessels, MM				Koch, Nicole; Kobler, Oliver; Thomas, Ulrich; Qualmann, Britta; Kessels, Michael M.			Terminal Axonal Arborization and Synaptic Bouton Formation Critically Rely on Abp1 and the Arp2/3 Complex	PLOS ONE			English	Article							ACTIN-BINDING-PROTEIN; F-ACTIN; NEURONAL CONNECTIVITY; MOTOR-NEURONS; DISCS-LARGE; DROSOPHILA; GROWTH; CYTOSKELETON; ENDOCYTOSIS; WASP	Neuronal network formation depends on properly timed and localized generation of presynaptic as well as postsynaptic structures. Although of utmost importance for understanding development and plasticity of the nervous system and neurodegenerative diseases, the molecular mechanisms that ensure the fine-control needed for coordinated establishment of pre-and postsynapses are still largely unknown. We show that the F-actin-binding protein Abp1 is prominently expressed in the Drosophila nervous system and reveal that Abp1 is an important regulator in shaping glutamatergic neuromuscular junctions (NMJs) of flies. STED microscopy shows that Abp1 accumulations can be found in close proximity of synaptic vesicles and at the cell cortex in nerve terminals. Abp1 knock-out larvae have locomotion defects and underdeveloped NMJs that are characterized by a reduced number of both type Ib synaptic boutons and branches of motornerve terminals. Abp1 is able to indirectly trigger Arp2/3 complex-mediated actin nucleation and interacts with both WASP and Scar. Consistently, Arp2 and Arp3 loss-of-function also resulted in impairments of bouton formation and arborization at NMJs, i. e. fully phenocopied abp1 knock-out. Interestingly, neuron-and muscle-specific rescue experiments revealed that synaptic bouton formation critically depends on presynaptic Abp1, whereas the NMJ branching defects can be compensated for by restoring Abp1 functions at either side. In line with this presynaptic importance of Abp1, also presynaptic Arp2 and Arp3 are crucial for the formation of type Ib synaptic boutons. Interestingly, presynaptic Abp1 functions in NMJ formation were fully dependent on the Arp2/3 complex, as revealed by suppression of Abp1-induced synaptic bouton formation and branching of axon terminals upon presynaptic Arp2 RNAi. These data reveal that Abp1 and Arp2/3 complex-mediated actin cytoskeletal dynamics drive both synaptic bouton formation and NMJ branching. Our data furthermore shed light on an intense bidirectional functional crosstalk between pre-and postsynapses during the development of synaptic contacts.	[Koch, Nicole; Qualmann, Britta; Kessels, Michael M.] Univ Jena, Jena Univ Hosp, Inst Biochem 1, Jena, Germany; [Koch, Nicole; Kessels, Michael M.] Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, Res Grp Membrane Trafficking & Cytoskeleton, Magdeburg, Germany; [Kobler, Oliver; Thomas, Ulrich] Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, Res Grp Funct Genet Synapse, Magdeburg, Germany	Friedrich Schiller University of Jena; Leibniz Institut fur Neurobiologie (LIN); Leibniz Institut fur Neurobiologie (LIN)	Thomas, U (corresponding author), Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, Res Grp Funct Genet Synapse, Magdeburg, Germany.	Ulrich.Thomas@ifn-magdeburg.de; Britta.Qualmann@med.uni-jena.de; Michael.Kessels@med.uni-jena.de		Kobler, Oliver/0000-0001-7173-9919	DFG [SFB854, KE685/2-3, KE685/3-1, QU116/3-2]	DFG(German Research Foundation (DFG))	This work was supported by DFG SFB854 to UT as well as by DFG grants KE685/2-3 and 3-1 to MMK and QU116/3-2 to MMK and BQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball RW, 2010, NEURON, V66, P536, DOI 10.1016/j.neuron.2010.04.011; Ben-Yaacov S, 2001, J CELL BIOL, V152, P1, DOI 10.1083/jcb.152.1.1; Bogdan S, 2005, NAT CELL BIOL, V7, P977, DOI 10.1038/ncb1305; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Collins CA, 2007, CURR OPIN NEUROBIOL, V17, P35, DOI 10.1016/j.conb.2007.01.001; Connert S, 2006, EMBO J, V25, P1611, DOI 10.1038/sj.emboj.7601053; Coyle IP, 2004, NEURON, V41, P521, DOI 10.1016/S0896-6273(04)00016-9; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Dickman DK, 2006, CURR BIOL, V16, P591, DOI 10.1016/j.cub.2006.02.058; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Fricke R, 2009, CURR BIOL, V19, P1429, DOI 10.1016/j.cub.2009.07.058; Gallo G, 1998, CURR BIOL, V8, pR80, DOI 10.1016/S0960-9822(98)70051-X; Goldstein LSB, 1994, DROSOPHILA MELANOGAS; Goode BL, 2001, J CELL BIOL, V153, P627, DOI 10.1083/jcb.153.3.627; Gorczyca D, 2007, J NEUROSCI, V27, P1033, DOI 10.1523/JNEUROSCI.3160-06.2007; Haag N, 2012, J NEUROSCI, V32, P17842, DOI 10.1523/JNEUROSCI.0843-12.2012; Haeckel A, 2008, J NEUROSCI, V28, P10031, DOI 10.1523/JNEUROSCI.0336-08.2008; Hatan M, 2011, J CELL BIOL, V192, P307, DOI 10.1083/jcb.201007095; Johnson C, 2012, GENES BRAIN BEHAV, V11, P848, DOI 10.1111/j.1601-183X.2012.00822.x; Kessels MM, 2000, MOL BIOL CELL, V11, P393, DOI 10.1091/mbc.11.1.393; Kessels MM, 2006, J BIOL CHEM, V281, P13285, DOI 10.1074/jbc.M510226200; Kessels MM, 2001, J CELL BIOL, V153, P351, DOI 10.1083/jcb.153.2.351; Khuong TM, 2010, P NATL ACAD SCI USA, V107, P17379, DOI 10.1073/pnas.1001794107; Koch N, 2012, J CELL SCI, V125, P3578, DOI 10.1242/jcs.101451; Krause M, 2004, DEV CELL, V7, P571, DOI 10.1016/j.devcel.2004.07.024; Lucido AL, 2009, J NEUROSCI, V29, P12449, DOI 10.1523/JNEUROSCI.1381-09.2009; Mahr A, 2006, GENE EXPR PATTERNS, V6, P299, DOI 10.1016/j.modgep.2005.07.006; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Mise-Omata S, 2003, BIOCHEM BIOPH RES CO, V301, P704, DOI 10.1016/S0006-291X(02)02972-8; Nahm M, 2010, J NEUROSCI, V30, P8138, DOI 10.1523/JNEUROSCI.0256-10.2010; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Pawson C, 2008, J NEUROSCI, V28, P11111, DOI 10.1523/JNEUROSCI.0833-08.2008; Pinyol R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000400; Qualmann B, 2004, J NEUROSCI, V24, P2481, DOI 10.1523/JNEUROSCI.5479-03.2004; Qurashi A, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-18; Ramachandran P, 2009, DEV NEUROBIOL, V69, P583, DOI 10.1002/dneu.20728; Regehr WG, 2009, NEURON, V63, P154, DOI 10.1016/j.neuron.2009.06.021; Rodriguez-Mesa E, 2012, DEV DYNAM, V241, P608, DOI 10.1002/dvdy.23742; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Ruiz-Canada C, 2006, INT REV NEUROBIOL, V75, P1, DOI 10.1016/S0074-7742(06)75001-2; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; Schenck A, 2004, DEV BIOL, V274, P260, DOI 10.1016/j.ydbio.2004.07.009; Schulz C, 2001, DEV GENES EVOL, V211, P581, DOI 10.1007/s00427-001-0194-z; Spradling AC, 1999, GENETICS, V153, P135; Stavoe AKH, 2012, J CELL BIOL, V197, P75, DOI 10.1083/jcb.201110127; Thomas U, 2000, CURR BIOL, V10, P1108, DOI 10.1016/S0960-9822(00)00696-5; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Zallen JA, 2002, J CELL BIOL, V156, P689, DOI 10.1083/jcb.200109057; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001; Zhao L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003450; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	52	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97692	10.1371/journal.pone.0097692	http://dx.doi.org/10.1371/journal.pone.0097692			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841972	Green Published, gold, Green Submitted			2022-12-25	WOS:000340948600056
J	Rueda-Martinez, C; Lamas, O; Mataro, MJ; Robledo-Carmona, J; Sanchez-Espin, G; Jimenez-Navarro, M; Such-Martinez, M; Fernandez, B				Rueda-Martinez, Carmen; Lamas, Oscar; Mataro, Maria Jose; Robledo-Carmona, Juan; Sanchez-Espin, Gemma; Jimenez-Navarro, Manuel; Such-Martinez, Miguel; Fernandez, Borja			Selection of Reference Genes for Quantitative Real Time PCR (qPCR) Assays in Tissue from Human Ascending Aorta	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RT-PCR; VALVE; EXPRESSION; ANEURYSMS; NORMALIZATION; PATTERNS; MODEL; EFFICIENCY; MESSENGER	Dilatation of the ascending aorta (AAD) is a prevalent aortopathy that occurs frequently associated with bicuspid aortic valve (BAV), the most common human congenital cardiac malformation. The molecular mechanisms leading to AAD associated with BAV are still poorly understood. The search for differentially expressed genes in diseased tissue by quantitative real-time PCR (qPCR) is an invaluable tool to fill this gap. However, studies dedicated to identify reference genes necessary for normalization of mRNA expression in aortic tissue are scarce. In this report, we evaluate the qPCR expression of six candidate reference genes in tissue from the ascending aorta of 52 patients with a variety of clinical and demographic characteristics, normal and dilated aortas, and different morphologies of the aortic valve (normal aorta and normal valve n = 30; dilated aorta and normal valve n = 10; normal aorta and BAV n = 4; dilated aorta and BAV n = 8). The expression stability of the candidate reference genes was determined with three statistical algorithms, GeNorm, NormFinder and Bestkeeper. The expression analyses showed that the most stable genes for the three algorithms employed were CDKN1 beta, POLR2A and CASC3, independently of the structure of the aorta and the valve morphology. In conclusion, we propose the use of these three genes as reference genes for mRNA expression analysis in human ascending aorta. However, we suggest searching for specific reference genes when conducting qPCR experiments with new cohort of samples.	[Rueda-Martinez, Carmen; Lamas, Oscar; Mataro, Maria Jose; Robledo-Carmona, Juan; Sanchez-Espin, Gemma; Jimenez-Navarro, Manuel; Such-Martinez, Miguel] Hosp Clin Univ Virgen de la Victoria, Inst Invest Biomed Malaga IBIMA, UGC Corazon, Malaga, Spain; [Jimenez-Navarro, Manuel] Univ Malaga, Fac Med, Dept Med, E-29071 Malaga, Spain; [Fernandez, Borja] Univ Malaga, Fac Ciencias, Inst Invest Biomed Malaga IBIMA, Dept Biol Anim, E-29071 Malaga, Spain	Universidad de Malaga; Universidad de Malaga; Universidad de Malaga	Fernandez, B (corresponding author), Univ Malaga, Fac Ciencias, Inst Invest Biomed Malaga IBIMA, Dept Biol Anim, E-29071 Malaga, Spain.	borjafe@uma.es	Such, Miguel/J-4959-2016; Corujo, Francisco Borja Fernández/AAG-8258-2020; Sánchez-Espín, Gemma/E-7688-2018; jimenez-navarro, manuel/AAJ-3236-2020	Such, Miguel/0000-0002-1521-7419; Corujo, Francisco Borja Fernández/0000-0001-9179-910X; Sánchez-Espín, Gemma/0000-0001-5292-8335; Rueda Martinez, Carmen/0000-0002-3278-8475; Jimenez Navarro, Manuel Francisco/0000-0002-6759-0514	Consejeria de Salud, Junta de Andalucia, Spain [PI-0689/2010]; Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia, Spain [P10-CTS-06068]; Red de Investigacion Cardiovascular (RIC) from Redes Tematicas de Investigacion Cooperativa (RETIC)	Consejeria de Salud, Junta de Andalucia, Spain(Junta de Andalucia); Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia, Spain(Junta de Andalucia); Red de Investigacion Cardiovascular (RIC) from Redes Tematicas de Investigacion Cooperativa (RETIC)	This work was supported in part by grants PI-0689/2010 (Consejeria de Salud, Junta de Andalucia, Spain), P10-CTS-06068 (Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia, Spain), and Red de Investigacion Cardiovascular (RIC) from Redes Tematicas de Investigacion Cooperativa (RETIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Boon RA, 2011, CIRC RES, V109, P1115, DOI 10.1161/CIRCRESAHA.111.255737; Boyum J, 2004, J THORAC CARDIOV SUR, V127, P686, DOI 10.1016/j.jtcvs.2003.11.049; Brattelid T, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-22; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067360; Cotrufo M, 2005, J THORAC CARDIOV SUR, V130, P504, DOI 10.1016/j.jtcvs.2005.01.016; Della Corte A, 2008, J THORAC CARDIOV SUR, V135, P8, DOI 10.1016/j.jtcvs.2007.09.009; Fedak PWM, 2008, EUR HEART J, V29, P432, DOI 10.1093/eurheartj/ehm609; Fedak PWM, 2002, CIRCULATION, V106, P900, DOI 10.1161/01.CIR.0000027905.26586.E8; Folkersen L, 2011, MOL MED, V17, P1365, DOI 10.2119/molmed.2011.00286; Gomez D, 2011, CARDIOVASC RES, V89, P446, DOI 10.1093/cvr/cvq291; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Henn D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054132; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jackson V, 2012, J THORAC CARDIOV SUR, V144, P459, DOI 10.1016/j.jtcvs.2011.08.043; LeMaire SA, 2005, J SURG RES, V123, P40, DOI 10.1016/j.jss.2004.06.007; LeMaire SA, 2011, NAT REV CARDIOL, V8, P103, DOI 10.1038/nrcardio.2010.187; Losenno KL, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/145202; Majumdar R, 2007, CARDIOVASC PATHOL, V16, P144, DOI 10.1016/j.carpath.2006.12.001; Maleki S, 2013, J MOL MED, V91, P129, DOI 10.1007/s00109-012-0942-8; Moniotte S, 2001, J MOL CELL CARDIOL, V33, P2121, DOI 10.1006/jmcc.2001.1475; Noutsias M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-3; Paloschi V, 2011, ARTERIOSCL THROM VAS, V31, P691, DOI 10.1161/ATVBAHA.110.218461; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfister Christina, 2011, BMC Res Notes, V4, P275, DOI 10.1186/1756-0500-4-275; Phillippi JA, 2010, ANN THORAC SURG, V90, P1893, DOI 10.1016/j.athoracsur.2010.07.069; Pilbrow AP, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-64; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Robledo-Carmona J, 2013, INT J CARDIOL, V168, P3443, DOI 10.1016/j.ijcard.2013.04.180; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Rutledge RG, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-47; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Sciacca S, 2013, HEART VESSELS, V28, P268, DOI 10.1007/s00380-012-0238-5; Siu SC, 2010, J AM COLL CARDIOL, V55, P2789, DOI 10.1016/j.jacc.2009.12.068; Solanas M, 2001, ANAL BIOCHEM, V288, P99, DOI 10.1006/abio.2000.4889; SPANAKIS E, 1993, NUCLEIC ACIDS RES, V21, P3809, DOI 10.1093/nar/21.16.3809; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; Tuomi JM, 2010, METHODS, V50, P313, DOI 10.1016/j.ymeth.2010.02.003; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vesentini Nicoletta, 2012, BMC Res Notes, V5, P124, DOI 10.1186/1756-0500-5-124; Wang Q, 2012, INT J LEGAL MED, V126, P943, DOI 10.1007/s00414-012-0774-7; Yperman J, 2004, J HEART VALVE DIS, V13, P848; Zyzynska-Granica B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051547	48	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97449	10.1371/journal.pone.0097449	http://dx.doi.org/10.1371/journal.pone.0097449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841551	gold, Green Published, Green Submitted			2022-12-25	WOS:000340948600033
J	Chan, NC; den Besten, W; Sweredoski, MJ; Hess, S; Deshaies, RJ; Chan, DC				Chan, Nickie C.; den Besten, Willem; Sweredoski, Michael J.; Hess, Sonja; Deshaies, Raymond J.; Chan, David C.			Degradation of the Deubiquitinating Enzyme USP33 Is Mediated by p97 and the Ubiquitin Ligase HERC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AAA-ATPASE; PROTEASOME SYSTEM; LARGE PROTEIN; CDC48; VCP/P97; COMPLEX; IDENTIFICATION; DEFICIENT; SUBUNIT; BINDING	Because the deubiquitinating enzyme USP33 is involved in several important cellular processes (beta-adrenergic receptor recycling, centrosome amplification, RalB signaling, and cancer cell migration), its levels must be carefully regulated. Using quantitative mass spectrometry, we found that the intracellular level of USP33 is highly sensitive to the activity of p97. Knockdown or chemical inhibition of p97 causes robust accumulation of USP33 due to inhibition of its degradation. The p97 adaptor complex involved in this function is the Ufd1-Npl4 heterodimer. Furthermore, we identified HERC2, a HECT domain-containing E3 ligase, as being responsible for polyubiquitination of USP33. Inhibition of p97 causes accumulation of polyubiquitinated USP33, suggesting that p97 is required for postubiquitination processing. Thus, our study has identified several key molecules that control USP33 degradation within the ubiquitin-proteasome system.	[Chan, Nickie C.; den Besten, Willem; Sweredoski, Michael J.; Hess, Sonja; Deshaies, Raymond J.; Chan, David C.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Chan, Nickie C.; Deshaies, Raymond J.; Chan, David C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Sweredoski, Michael J.; Hess, Sonja] CALTECH, Proteome Explorat Lab, Beckman Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Chan, DC (corresponding author), CALTECH, Howard Hughes Med Inst, 1200 E Calif Blvd,MC114-96, Pasadena, CA 91125 USA.	dchan@caltech.edu	Deshaies, Raymond/B-8354-2014	Deshaies, Raymond/0000-0002-3671-9354	Gordon and Betty Moore Foundation [GBMF775]; Beckman Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062967] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Beckman Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Tomohiko Ohta for HERC2 constructs that helped us reconstruct full-length HERC2; William G. Kaelin Jr. for the 786-O and RCC4 cell lines; Tsui-Fen Chou (Harbor-UCLA Medical Center) for helpful discussions and reagents during the early stage of this work; Robert Graham (currently at University of Manchester) from the Proteosome Exploration Laboratory (PEL) for technical help with the mass spectrometry experiments; and Michael Walters and Lev G. Lis (University of Minnesota) for NMS-873. The PEL is supported by the Gordon and Betty Moore Foundation through Grant GBMF775 and the Beckman Institute.	Al-Hakim AK, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014233; Alberts SM, 2009, J BIOL CHEM, V284, P16082, DOI 10.1074/jbc.M809282200; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Baek G.H., 2013, J AMINO ACIDS, V2013, DOI DOI 10.1155/2013/183421; Barbin L, 2010, BIOCHEM BIOPH RES CO, V394, P335, DOI 10.1016/j.bbrc.2010.03.005; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Bug M, 2012, J STRUCT BIOL, V179, P78, DOI 10.1016/j.jsb.2012.03.003; Carroll CW, 2002, NAT CELL BIOL, V4, P880, DOI 10.1038/ncb871; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Curcio-Morelli C, 2003, J CLIN INVEST, V112, P189, DOI 10.1172/JCI200318348; Dantuma NP, 2012, TRENDS CELL BIOL, V22, P483, DOI 10.1016/j.tcb.2012.06.003; Dreveny I, 2004, BIOCHEM SOC T, V32, P715, DOI 10.1042/BST0320715; Elias JE, 2010, METHODS MOL BIOL, V604, P55, DOI 10.1007/978-1-60761-444-9_5; Garcia-Gonzalo FR, 2005, CELL MOL LIFE SCI, V62, P1826, DOI 10.1007/s00018-005-5119-y; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Hadjebi O, 2008, BBA-MOL CELL RES, V1783, P1467, DOI 10.1016/j.bbamcr.2008.03.015; Harlalka GV, 2013, J MED GENET, V50, P65, DOI 10.1136/jmedgenet-2012-101367; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Ji YG, 1999, HUM MOL GENET, V8, P533, DOI 10.1093/hmg/8.3.533; Kalli A, 2013, J PROTEOME RES, V12, P3071, DOI 10.1021/pr3011588; Kloppsteck P, 2012, BBA-MOL CELL RES, V1823, P125, DOI 10.1016/j.bbamcr.2011.09.006; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lee TH, 2014, ONCOGENE, V33, P19, DOI 10.1038/onc.2012.539; Lehman AL, 1998, P NATL ACAD SCI USA, V95, P9436, DOI 10.1073/pnas.95.16.9436; Li J, 2013, NATURE, V495, P255, DOI 10.1038/nature11941; Li LJ, 2007, MOL CELL BIOL, V27, P5381, DOI 10.1128/MCB.00282-07; Li ZB, 2002, BIOCHEM BIOPH RES CO, V294, P700, DOI 10.1016/S0006-291X(02)00534-X; Li ZB, 2002, J BIOL CHEM, V277, P4656, DOI 10.1074/jbc.M108269200; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Pierce NW, 2013, CELL, V153, P206, DOI 10.1016/j.cell.2013.02.024; Polucci P, 2013, J MED CHEM, V56, P437, DOI 10.1021/jm3013213; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P11, DOI 10.1016/0968-0004(96)80878-4; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Simicek M, 2013, NAT CELL BIOL, V15, P1220, DOI 10.1038/ncb2847; Soetandyo N, 2010, J BIOL CHEM, V285, P32352, DOI 10.1074/jbc.M110.131649; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Thorne C, 2011, TRAFFIC, V12, P1563, DOI 10.1111/j.1600-0854.2011.01261.x; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Wendt KS, 2001, NAT STRUCT BIOL, V8, P784, DOI 10.1038/nsb0901-784; Wu WW, 2010, CANCER RES, V70, P6384, DOI 10.1158/0008-5472.CAN-10-1304; Xu S, 2011, MOL BIOL CELL, V22, P291, DOI 10.1091/mbc.E10-09-0748; Yeung HO, 2008, BIOCHEM SOC T, V36, P62, DOI 10.1042/BST0360062; Yuasa-Kawada J, 2009, NAT NEUROSCI, V12, P1087, DOI 10.1038/nn.2382; Yuasa-Kawada J, 2009, P NATL ACAD SCI USA, V106, P14530, DOI 10.1073/pnas.0801262106; Zhang ZR, 2013, CELL, V154, P609, DOI 10.1016/j.cell.2013.06.038	54	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19789	19798		10.1074/jbc.M114.569392	http://dx.doi.org/10.1074/jbc.M114.569392			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24855649	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000339326800050
J	Kohli, A; Islam, A; Moyes, DL; Murciano, C; Shen, CG; Challacombe, SJ; Naglik, JR				Kohli, Arinder; Islam, Ayesha; Moyes, David L.; Murciano, Celia; Shen, Chengguo; Challacombe, Stephen J.; Naglik, Julian R.			Oral and Vaginal Epithelial Cell Lines Bind and Transfer Cell-Free Infectious HIV-1 to Permissive Cells but Are Not Productively Infected	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; FEMALE REPRODUCTIVE-TRACT; HUMAN CERVICAL TISSUE; CD4(+) T-CELLS; SEXUAL TRANSMISSION; DENDRITIC CELLS; TYPE-1 RNA; IN-VITRO; INTRAVAGINAL INOCULATION; MUCOSAL TRANSMISSION	The majority of HIV-1 infections worldwide are acquired via mucosal surfaces. However, unlike the vaginal mucosa, the issue of whether the oral mucosa can act as a portal of entry for HIV-1 infection remains controversial. To address potential differences with regard to the fate of HIV-1 after exposure to oral and vaginal epithelium, we utilized two epithelial cell lines representative of buccal (TR146) and pharyngeal (FaDu) sites of the oral cavity and compared them with a cell line derived from vaginal epithelium (A431) in order to determine (i) HIV-1 receptor gene and protein expression, (ii) whether HIV-1 genome integration into epithelial cells occurs, (iii) whether productive viral infection ensues, and (iv) whether infectious virus can be transferred to permissive cells. Using flow cytometry to measure captured virus by HIV-1 gp120 protein detection and western blot to detect HIV-1 p24 gag protein, we demonstrate that buccal, pharyngeal and vaginal epithelial cells capture CXCR4- and CCR5-utilising virus, probably via non-canonical receptors. Both oral and vaginal epithelial cells are able to transfer infectious virus to permissive cells either directly through cell-cell attachment or via transcytosis of HIV-1 across epithelial cells. However, HIV-1 integration, as measured by real-time PCR and presence of early gene mRNA transcripts and de novo protein production were not detected in either epithelial cell type. Importantly, both oral and vaginal epithelial cells were able to support integration and productive infection if HIV-1 entered via the endocytic pathway driven by VSV-G. Our data demonstrate that under normal conditions productive HIV-1 infection of epithelial cells leading to progeny virion production is unlikely, but that epithelial cells can act as mediators of systemic viral dissemination through attachment and transfer of HIV-1 to permissive cells.	[Kohli, Arinder; Islam, Ayesha; Moyes, David L.; Murciano, Celia; Shen, Chengguo; Challacombe, Stephen J.; Naglik, Julian R.] Kings Coll London, Inst Dent, Dept Oral Immunol Clin & Diagnost Sci, London WC2R 2LS, England; [Islam, Ayesha] Boston Univ, Sch Med, Dept Obstet & Gynecol, Boston, MA 02118 USA; [Murciano, Celia] Univ Valencia, Dept Microbiol & Ecol, Valencia, Spain	University of London; King's College London; Boston University; University of Valencia	Naglik, JR (corresponding author), Kings Coll London, Inst Dent, Dept Oral Immunol Clin & Diagnost Sci, London WC2R 2LS, England.	julian.naglik@kcl.ac.uk	Challacombe, Stephen J/ABE-2105-2021; Murciano, Celia/K-8816-2014	Murciano, Celia/0000-0003-0035-5306; Kohli, Arinder/0000-0003-3199-3554; Shen, Chengguo/0000-0003-2813-8143; Moyes, David/0000-0002-1657-918X; challacombe, stephen/0000-0002-7327-6927; Naglik, Julian/0000-0002-8072-7917	NIDCR [DE017514]; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; King's College London; King's College Hospital NHS Foundation Trust; King's College London Overseas Research Studentship; Wellcome VIP award; Federation of European Microbiological Societies Advanced Fellowship; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017514] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); King's College London; King's College Hospital NHS Foundation Trust; King's College London Overseas Research Studentship; Wellcome VIP award; Federation of European Microbiological Societies Advanced Fellowship; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors acknowledge financial support from by the NIDCR (DE017514) and from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. A. I. was supported by King's College London Overseas Research Studentship, D. M. was supported by a Wellcome VIP award, and C. M. was supported by a Federation of European Microbiological Societies Advanced Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfsen A, 2002, J BIOL CHEM, V277, P25649, DOI 10.1074/jbc.M200554200; Anderson DJ, 2010, AIDS, V24, P163, DOI 10.1097/QAD.0b013e32833424c8; Asin SN, 2004, J INFECT DIS, V190, P236, DOI 10.1086/421910; Baba TW, 1996, SCIENCE, V272, P1486, DOI 10.1126/science.272.5267.1486; Ballweber L, 2011, J VIROL, V85, P13443, DOI 10.1128/JVI.05615-11; Berlier W, 2005, J MED VIROL, V77, P465, DOI 10.1002/jmv.20478; Besnier C, 2002, P NATL ACAD SCI USA, V99, P11920, DOI 10.1073/pnas.172384599; Bhoopat L, 2001, MODERN PATHOL, V14, P1263, DOI 10.1038/modpathol.3880472; Blaskewicz CD, 2011, BIOL REPROD, V85, P97, DOI 10.1095/biolreprod.110.090423; Bobardt MD, 2003, IMMUNITY, V18, P27, DOI 10.1016/S1074-7613(02)00504-6; Bobardt MD, 2007, J VIROL, V81, P395, DOI 10.1128/JVI.01303-06; Bomsel M, 1997, NAT MED, V3, P42, DOI 10.1038/nm0197-42; BREAU AP, 1984, CELL BIOL TOXICOL, V1, P21, DOI 10.1007/BF00125562; Challacombe S J, 2006, Adv Dent Res, V19, P29; Cohen MS, 2000, LANCET, V356, P272, DOI 10.1016/S0140-6736(00)02500-9; Coombs RW, 1998, J INFECT DIS, V177, P320, DOI 10.1086/514213; Cutler C W, 2006, Adv Dent Res, V19, P49; Delezay O, 1997, AIDS, V11, P1311, DOI 10.1097/00002030-199711000-00004; Dezzutti CS, 2001, J INFECT DIS, V183, P1204, DOI 10.1086/319676; Dietrich EA, 2012, AIDS RES HUM RETROV, V28, P1574, DOI [10.1089/aid.2011.0069, 10.1089/AID.2011.0069]; Dorosko SM, 2010, J VIROL, V84, P10533, DOI 10.1128/JVI.01263-10; Dulioust E, 1998, J REPROD IMMUNOL, V41, P27, DOI 10.1016/S0165-0378(98)00047-3; Fanibunda SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028014; FURUTA Y, 1994, P NATL ACAD SCI USA, V91, P12559, DOI 10.1073/pnas.91.26.12559; GAFFNEY RA, 1995, J INFECT DIS, V172, P1528, DOI 10.1093/infdis/172.6.1528; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Giacaman RA, 2007, J IMMUNOL, V179, P2542, DOI 10.4049/jimmunol.179.4.2542; Giavedoni LD, 2013, J VIROL, V87, P1750, DOI 10.1128/JVI.02079-12; Goulston C, 1998, J INFECT DIS, V177, P1100, DOI 10.1086/517404; Greenhead P, 2000, J VIROL, V74, P5577, DOI 10.1128/JVI.74.12.5577-5586.2000; Han Y, 2000, ORAL MICROBIOL IMMUN, V15, P82, DOI 10.1034/j.1399-302x.2000.150203.x; HAROUSE JM, 1991, SCIENCE, V253, P320, DOI 10.1126/science.1857969; Hernandez Rosa, 2009, V470, P105, DOI 10.1007/978-1-59745-204-5_10; Herz AM, 2002, J MED PRIMATOL, V31, P29, DOI 10.1034/j.1600-0684.2002.1o005.x; Herzberg M C, 2006, Adv Dent Res, V19, P158; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; Hocini H, 1999, J INFECT DIS, V179, pS448, DOI 10.1086/314802; Hocini H, 2001, J VIROL, V75, P5370, DOI 10.1128/JVI.75.11.5370-5374.2001; Howell AL, 1997, J VIROL, V71, P3498, DOI 10.1128/JVI.71.5.3498-3506.1997; Hu JJ, 1998, LAB INVEST, V78, P435; Hu JJ, 2000, J VIROL, V74, P6087, DOI 10.1128/JVI.74.13.6087-6095.2000; Hu QX, 2004, J EXP MED, V199, P1065, DOI 10.1084/jem.20022212; Iversen AKN, 1998, J INFECT DIS, V177, P1214, DOI 10.1086/515266; Janoff EN, 2001, GASTROENTEROLOGY, V120, P607, DOI 10.1053/gast.2001.22427; Joag SV, 1997, J VIROL, V71, P4016, DOI 10.1128/JVI.71.5.4016-4023.1997; Jotwani R, 2004, J DENT RES, V83, P371, DOI 10.1177/154405910408300504; Kage A, 1998, J VIROL, V72, P4231, DOI 10.1128/JVI.72.5.4231-4236.1998; Kaldensjo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021344; Kazmi SH, 2006, CLIN VACCINE IMMUNOL, V13, P1111, DOI 10.1128/CDLI.00426-05; Khanna KV, 2002, J CLIN INVEST, V109, P205; KNUECHEL R, 1990, AM J PATHOL, V137, P725; Kumar RB, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-25; Lefever S, 2009, NUCLEIC ACIDS RES, V37, pD942, DOI 10.1093/nar/gkn777; Liu XA, 2003, J VIROL, V77, P3470, DOI 10.1128/JVI.77.6.3470-3476.2003; Liuzzi G, 1996, AIDS, V10, pF51, DOI 10.1097/00002030-199612000-00001; Maher D, 2005, P NATL ACAD SCI USA, V102, P11504, DOI 10.1073/pnas.0500848102; Maher D, 2004, J INFECT DIS, V190, P1989, DOI 10.1086/425423; Malamud D, 2010, AIDS, V24, P5, DOI 10.1097/QAD.0b013e328333525f; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; Mbisa Jean L., 2009, V485, P55, DOI 10.1007/978-1-59745-170-3_5; Miller CJ, 1998, J REPROD IMMUNOL, V41, P331, DOI 10.1016/S0165-0378(98)00069-2; Miller CJ, 2003, MICROBES INFECT, V5, P59, DOI 10.1016/S1286-4579(02)00056-4; MILMAN G, 1994, AIDS RES HUM RETROV, V10, P1305, DOI 10.1089/aid.1994.10.1305; Milush JA, 2004, AIDS, V18, P2371; Mondor I, 1998, J VIROL, V72, P3623, DOI 10.1128/JVI.72.5.3623-3634.1998; Moore JS, 2002, VIROLOGY, V297, P89, DOI 10.1006/viro.2002.1469; Moore JS, 2003, VIROLOGY, V313, P343, DOI 10.1016/S0042-6822(03)00283-6; Moutsopoulos NM, 2007, AM J PATHOL, V171, P571, DOI 10.2353/ajpath.2007.061006; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Navarrete P, 2003, ANTIVIR THER, V8, P635; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Pang S, 2000, J VIROL, V74, P10994, DOI 10.1128/JVI.74.23.10994-11000.2000; Phillips David M., 1994, Trends in Microbiology, V2, P454, DOI 10.1016/0966-842X(94)90804-4; Phillips DM, 1998, AIDS RES HUM RETROV, V14, pS67; Pierson TC, 2003, CURR TOP MICROBIOL, V281, P1; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Qureshi M N, 1997, Oral Dis, V3 Suppl 1, pS73; QURESHI MN, 1995, J INFECT DIS, V171, P190, DOI 10.1093/infdis/171.1.190; RODERIQUEZ G, 1995, J VIROL, V69, P2233, DOI 10.1128/JVI.69.4.2233-2239.1995; Rodriguez-Inigo E, 2005, J MED VIROL, V77, P17, DOI [10.1002/jmv.20409, 10.1002/JMV.20409]; Rothenberg RB, 1998, AIDS, V12, P2095, DOI 10.1097/00002030-199816000-00004; Schaller M, 2006, NAT PROTOC, V1, P2767, DOI 10.1038/nprot.2006.474; Shen RZ, 2011, AM J REPROD IMMUNOL, V65, P261, DOI 10.1111/j.1600-0897.2010.00939.x; Shen R, 2009, J VIROL, V83, P3258, DOI 10.1128/JVI.01796-08; Soda Y, 1999, BIOCHEM BIOPH RES CO, V258, P313, DOI 10.1006/bbrc.1999.0633; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Spira AI, 1996, J EXP MED, V183, P215, DOI 10.1084/jem.183.1.215; Strus M., 2001, Medycyna Doswiadczalna i Mikrobiologia, V53, P253; TAN X, 1993, J VIROL, V67, P6447, DOI 10.1128/JVI.67.11.6447-6452.1993; Tugizov SM, 2012, J VIROL, V86, P2556, DOI 10.1128/JVI.06578-11; Tugizov SM, 2011, VIROLOGY, V409, P211, DOI 10.1016/j.virol.2010.10.004; Vacharaksa A, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-66; Van Herrewege Y, 2007, ANTIVIR RES, V74, P111, DOI 10.1016/j.antiviral.2006.10.010; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; Velarde G, 1999, TOXICOL IN VITRO, V13, P723, DOI 10.1016/S0887-2333(99)00048-X; WALSH LJ, 1990, J ORAL PATHOL MED, V19, P177, DOI 10.1111/j.1600-0714.1990.tb00820.x; Weinberg A, 2011, Adv Dent Res, V23, P122, DOI 10.1177/0022034511399917; Wilkinson J, 2006, CURR DRUG TARGETS, V7, P1563, DOI 10.2174/138945006779025482; Wu ZW, 2003, J INFECT DIS, V188, P1473, DOI 10.1086/379248; Yeaman GR, 2004, IMMUNOLOGY, V113, P524, DOI 10.1111/j.1365-2567.2004.01990.x; Yeaman GR, 1998, AIDS RES HUM RETROV, V14, pS57; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	104	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98077	10.1371/journal.pone.0098077	http://dx.doi.org/10.1371/journal.pone.0098077			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24857971	Green Published, Green Submitted, gold			2022-12-25	WOS:000336839400037
J	Takae, S; Kawamura, K; Sato, Y; Nishijima, C; Yoshioka, N; Sugishita, Y; Horage, Y; Tanaka, M; Ishizuka, B; Suzuki, N				Takae, Seido; Kawamura, Kazuhiro; Sato, Yorino; Nishijima, Chie; Yoshioka, Nobuhito; Sugishita, Yodo; Horage, Yuki; Tanaka, Mamoru; Ishizuka, Bunpei; Suzuki, Nao			Analysis of Late-Onset Ovarian Insufficiency after Ovarian Surgery: Retrospective Study with 75 Patients of Post-Surgical Ovarian Insufficiency	PLOS ONE			English	Article							LAPAROSCOPIC EXCISION; BILATERAL ENDOMETRIOMAS; FAILURE; CYSTS	The primary objectives of the present study are to determine the period of onset of ovarian insufficiency after surgery and to confirm potential risk factors for ovarian insufficiency after surgery for the removal of benign ovarian cysts. Data were obtained from 75 patients who underwent surgery for benign ovarian cysts prior to the onset of ovarian insufficiency. Our analysis included 835 ovarian insufficiency patients who were referred to our institution from July 2003 to July 2013. Several epidemiological parameters of ovarian insufficiency after surgery (age at operation, period of onset of ovarian insufficiency, operation procedure, and pathological diagnosis) were investigated. Of the 835 patients who had ovarian insufficiency, 75 patients (9.0%) underwent ovarian surgery before the onset of ovarian insufficiency. Of those 75 patients, 66 patients (88.0%) underwent cystectomy. For the majority of the 75 patients the surgical indication was the presence of endometriotic cysts (57 patients; 76.0%). Twelve patients (16.0%) underwent multiple surgeries (all bilateral cystectomies). The mean age of the patients at the time of surgery was 27.8 +/- 5.5 years-old, and the mean period of onset of ovarian insufficiency was 5.8 +/- 3.8 years. In patients with cystectomy, the patient's age at the time of surgery and period of onset of ovarian insufficiency was well-correlated (coefficient of correlation; hemilateral endometriotic cystectomy: -0.64, bilateral endometriotic cystectomy: -0.61, and multiple endimetriotic cystectomy: -0.40). We found that cystectomy of endometriotic cysts is the potential risk factor for ovarian insufficiency after surgery, at times, the onset of ovarian insufficiency long after cystectomy. Therefore, it is important to monitor ovarian reserve for an extended period of time after ovarian surgery. It is particularly important to monitor ovarian reserve long-term for patients who wish to conceive in the future and to suggest a variety of infertility treatments appropriate for their ovarian reserve.	[Takae, Seido; Kawamura, Kazuhiro; Sato, Yorino; Nishijima, Chie; Yoshioka, Nobuhito; Sugishita, Yodo; Horage, Yuki; Tanaka, Mamoru; Suzuki, Nao] St Marianna Univ, Sch Med, Dept Obstet & Gynecol, Kawasaki, Kanagawa, Japan; [Ishizuka, Bunpei] St Marianna Univ, Sch Med, Dept Adv Reprod Med, Kawasaki, Kanagawa, Japan	Saint Marianna University; Saint Marianna University	Kawamura, K (corresponding author), St Marianna Univ, Sch Med, Dept Obstet & Gynecol, Kawasaki, Kanagawa, Japan.	kawamurak@marianna-u.ac.jp		Sugishita, Yodo/0000-0003-4315-1370				Benaglia L, 2010, HUM REPROD, V25, P678, DOI 10.1093/humrep/dep464; Brosens IA, 1996, FERTIL STERIL, V66, P517, DOI 10.1016/S0015-0282(16)58561-6; Busacca M, 2006, AM J OBSTET GYNECOL, V195, P421, DOI 10.1016/j.ajog.2006.03.064; Coccia ME, 2011, HUM REPROD, V26, P3000, DOI 10.1093/humrep/der286; De Vos M, 2010, LANCET, V376, P911, DOI 10.1016/S0140-6736(10)60355-8; Di Prospero F, 2009, REPROD BIOMED ONLINE, V18, P167, DOI 10.1016/S1472-6483(10)60251-9; Dogan E, 2011, INT J GYNECOL OBSTET, V114, P124, DOI 10.1016/j.ijgo.2011.04.002; Donnez J, 1996, HUM REPROD, V11, P641, DOI 10.1093/HUMREP/11.3.641; Iwase A, 2010, FERTIL STERIL, V94, P2846, DOI 10.1016/j.fertnstert.2010.06.010; Kitajima M, 2011, FERTIL STERIL, V96, P685, DOI 10.1016/j.fertnstert.2011.06.064; Lemos NA, 2008, FERTIL STERIL, V89, P1064, DOI 10.1016/j.fertnstert.2007.04.048; Li CZ, 2009, FERTIL STERIL, V92, P1428, DOI 10.1016/j.fertnstert.2008.08.071; Muzii L, 2002, FERTIL STERIL, V77, P609, DOI 10.1016/S0015-0282(01)03203-4; Welt CK, 2008, CLIN ENDOCRINOL, V68, P499, DOI 10.1111/j.1365-2265.2007.03073.x	14	11	13	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98174	10.1371/journal.pone.0098174	http://dx.doi.org/10.1371/journal.pone.0098174			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858999	Green Submitted, Green Published, gold			2022-12-25	WOS:000336839400049
J	Ghosh, A; Birngruber, T; Sattler, W; Kroath, T; Ratzer, M; Sinner, F; Pieber, TR				Ghosh, Arijit; Birngruber, Thomas; Sattler, Wolfgang; Kroath, Thomas; Ratzer, Maria; Sinner, Frank; Pieber, Thomas R.			Assessment of Blood-Brain Barrier Function and the Neuroinflammatory Response in the Rat Brain by Using Cerebral Open Flow Microperfusion (cOFM)	PLOS ONE			English	Article							TNF-ALPHA; IN-VIVO; NEURODEGENERATIVE DISORDERS; ENDOTHELIAL-CELLS; LIPOPOLYSACCHARIDE; CYTOKINE; TRANSPORT; INFLAMMATION; EXPRESSION; MICRODIALYSIS	Blood-brain barrier (BBB) impairment in systemic inflammation leads to neuroinflammation. Several factors including cytokines, chemokines and signal transduction molecules are implicated in BBB dysfunction in response to systemic inflammation. Here, we have adopted a novel in vivo technique; namely, cerebral open flow microperfusion (cOFM), to perform time-dependent cytokine analysis (TNF-alpha, IL-6 and IL-10) in the frontal cortex of the rat brain in response to a single peripheral administration of lipopolysaccharide (LPS). In parallel, we monitored BBB function using sodium fluorescein as low molecular weight reporter in the cOFM sample. In response to the systemic LPS administration, we observed a rapid increase of TNF-alpha in the serum and brain, which coincides with the BBB disruption. Brain IL-6 and IL-10 synthesis was delayed by approximately 1 h. Our data demonstrate that cOFM can be used to monitor changes in brain cytokine levels and BBB disruption in a rat sepsis model.	[Ghosh, Arijit; Sinner, Frank; Pieber, Thomas R.] Med Univ Graz, Div Endocrinol & Metab, Graz, Austria; [Birngruber, Thomas; Kroath, Thomas; Ratzer, Maria; Sinner, Frank; Pieber, Thomas R.] Joanneum Res, HEALTH, Inst Biomed & Hlth Sci, Graz, Austria; [Sattler, Wolfgang] Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria	Medical University of Graz; Medical University of Graz	Sinner, F (corresponding author), Med Univ Graz, Div Endocrinol & Metab, Graz, Austria.	ca.health@joanneum.at		Pieber, Thomas/0000-0003-3554-0405	Austrian Science Fund FWF [F 3007] Funding Source: Medline; Austrian Science Fund (FWF) [F 3007] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		Acarin L, 2000, EUR J NEUROSCI, V12, P3505, DOI 10.1046/j.1460-9568.2000.00226.x; Lopez-Ramirez MA, 2012, J IMMUNOL, V189, P3130, DOI 10.4049/jimmunol.1103460; Alexander JJ, 2008, NEUROCHEM INT, V52, P447, DOI 10.1016/j.neuint.2007.08.006; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Asai S, 1996, ANAL BIOCHEM, V237, P182, DOI 10.1006/abio.1996.0226; Banks WA, 1999, J NEUROVIROL, V5, P538, DOI 10.3109/13550289909021284; Banks WA, 2010, BRAIN BEHAV IMMUN, V24, P102, DOI 10.1016/j.bbi.2009.09.001; Birngruber T, 2013, CLIN EXP PHARMACOL P, V40, P864, DOI 10.1111/1440-1681.12174; Chakravarty S, 2005, J NEUROSCI, V25, P1788, DOI 10.1523/jneurosci.4268-04.2005; Denes A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-164; Deng YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087420; Dohgu S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-167; Erickson MA, 2011, BRAIN BEHAV IMMUN, V25, P1637, DOI 10.1016/j.bbi.2011.06.006; FABRY Z, 1993, J NEUROIMMUNOL, V47, P23, DOI 10.1016/0165-5728(93)90281-3; Fannin RD, 2005, PHYSIOL GENOMICS, V21, P92, DOI 10.1152/physiolgenomics.00190.2004; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; Ghezzi P, 2000, CYTOKINE, V12, P1205, DOI 10.1006/cyto.2000.0697; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Godbout JP, 2004, J NEUROIMMUNOL, V147, P141, DOI 10.1016/j.jneuroim.2003.10.031; Harden LM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-22; He F, 2011, NEUROSCIENCE, V188, P35, DOI 10.1016/j.neuroscience.2011.04.025; Henry CJ, 2009, BRAIN BEHAV IMMUN, V23, P309, DOI 10.1016/j.bbi.2008.09.002; Jacob A, 2011, NEUROCHEM INT, V58, P472, DOI 10.1016/j.neuint.2011.01.004; Jaeger LB, 2009, BRAIN BEHAV IMMUN, V23, P507, DOI 10.1016/j.bbi.2009.01.017; Jancalek R, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-11; Jin L, 2013, ANTIMICROB AGENTS CH, V57, P4336, DOI 10.1128/AAC.00765-13; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; KENDRICK KM, 1990, J NEUROSCI METH, V34, P35, DOI 10.1016/0165-0270(90)90040-M; LI L, 1994, J IMMUNOL, V153, P3967; Lord R, 2001, CYTOKINE, V13, P155, DOI 10.1006/cyto.2000.0815; McNay EC, 2004, J NEUROSCI METH, V132, P35, DOI 10.1016/j.jneumeth.2003.08.014; Nagyoszi P, 2010, NEUROCHEM INT, V57, P556, DOI 10.1016/j.neuint.2010.07.002; Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240; Nonaka N, 2004, BRAIN RES, V1016, P58, DOI 10.1016/j.brainres.2004.04.066; Osburg B, 2002, AM J PHYSIOL-ENDOC M, V283, pE899, DOI 10.1152/ajpendo.00436.2001; Pan W, 2001, Arch Physiol Biochem, V109, P350, DOI 10.1076/apab.109.4.350.4238; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Reyes TM, 1999, BRAIN RES, V851, P215, DOI 10.1016/S0006-8993(99)02189-7; Riese Jutta, 2003, Surg Infect (Larchmt), V4, P11, DOI 10.1089/109629603764655236; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; ROSENBERG GA, 1993, NEUROSCI LETT, V160, P117, DOI 10.1016/0304-3940(93)90927-D; Sawada M, 1999, J NEUROCHEM, V72, P1466, DOI 10.1046/j.1471-4159.1999.721466.x; Schreibelt G, 2007, FASEB J, V21, P3666, DOI 10.1096/fj.07-8329com; Semmler A, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-38; Sjogren S, 2002, BRIT J DERMATOL, V146, P375, DOI 10.1046/j.1365-2133.2002.04621.x; Sopasakis VR, 2004, OBES RES, V12, P454, DOI 10.1038/oby.2004.51; Stamatovic SM, 2008, CURR NEUROPHARMACOL, V6, P179, DOI 10.2174/157015908785777210; Steiner AA, 2006, BLOOD, V107, P4000, DOI 10.1182/blood-2005-11-4743; Tsao N, 2001, J MED MICROBIOL, V50, P812, DOI 10.1099/0022-1317-50-9-812; Ullen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064034; Verma S, 2006, BRAIN BEHAV IMMUN, V20, P449, DOI 10.1016/j.bbi.2005.10.005; Wang X, 2008, CYTOKINE, V43, P15, DOI 10.1016/j.cyto.2008.04.009; WATKINS LR, 1995, LIFE SCI, V57, P1011, DOI 10.1016/0024-3205(95)02047-M; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Wilson JX, 2003, CAN J NEUROL SCI, V30, P98, DOI 10.1017/S031716710005335X; Winter CD, 2002, J NEUROSCI METH, V119, P45, DOI 10.1016/S0165-0270(02)00153-X; Wisniewski N, 2001, J BIOMED MATER RES, V57, P513, DOI 10.1002/1097-4636(20011215)57:4<513::AID-JBM1197>3.0.CO;2-E; Xaio HP, 2001, BRAIN RES, V896, P36, DOI 10.1016/S0006-8993(00)03247-9; Zhao CH, 2007, NEUROBIOL DIS, V26, P36, DOI 10.1016/j.nbd.2006.11.012; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	60	44	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98143	10.1371/journal.pone.0098143	http://dx.doi.org/10.1371/journal.pone.0098143			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852285	Green Submitted, gold, Green Published			2022-12-25	WOS:000338323200049
J	Goo, YK; Ji, SY; Shin, HI; Moon, JH; Cho, SH; Lee, WJ; Kim, JY				Goo, Youn-Kyoung; Ji, So-Young; Shin, Hyun-Il; Moon, Jun-Hye; Cho, Shin-Hyung; Lee, Won-Ja; Kim, Jung-Yeon			First Evaluation of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency in Vivax Malaria Endemic Regions in the Republic of Korea	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; POPULATIONS; VARIANTS; SENSITIVITY; RESISTANCE; PRIMAQUINE; MUTATIONS; SELECTION	Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzyme defect and affects more than 400 million people worldwide. This deficiency is believed to protect against malaria because its global distribution is similar. However, this genetic disorder may be associated with potential hemolytic anemia after treatment with anti-malarials, primaquine or other 8-aminoquinolines. Although primaquine is used for malaria prevention, no study has previously investigated the prevalence of G6PD variants and G6PD deficiency in the Republic of Korea (ROK). Methods: Two commercialized test kits (Trinity G-6-PDH and CareStart G6PD test) were used for G6PD deficiency screening. The seven common G6PD variants were investigated by DiaPlexC kit in blood samples obtained living in vivax malaria endemic regions in the ROK. Results: Of 1,044 blood samples tested using the CareStart G6PD test, none were positive for G6PD deficiency. However, a slightly elevated level of G6PD activity was observed in 14 of 1,031 samples tested with the Trinity G-6-PDH test. Forty-nine of the 298 samples with non-specific amplification by DiaPlexC kit were confirmed by sequencing to be negative for the G6PD variants. Conclusions: No G6PD deficiency was observed using phenotypic- or genetic-based tests in individuals residing in vivax malaria endemic regions in the ROK. Because massive chemoprophylaxis using primaquine has been performed in the ROK military to kill hypnozoites responsible for relapse and latent stage vivax malaria, further regular monitoring is essential for the safe administration of primaquine.	[Goo, Youn-Kyoung; Ji, So-Young; Shin, Hyun-Il; Moon, Jun-Hye; Cho, Shin-Hyung; Lee, Won-Ja; Kim, Jung-Yeon] Osong Hlth Technol Adm, Korea CDC, NIH, Div Malaria & Parasit Dis, Osong, South Korea; [Goo, Youn-Kyoung] Kyungpook Natl Univ, Sch Med, Dept Parasitol & Trop Med, Taegu, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Kyungpook National University	Kim, JY (corresponding author), Osong Hlth Technol Adm, Korea CDC, NIH, Div Malaria & Parasit Dis, Osong Saeng Myeong 2 Ro, Osong, South Korea.	jykim-malaria@nih.go.kr			Asia Pacific Malaria Elimination Network (APMEN) [107-05]; Korea National Institute of Health [4837-302-210-13]	Asia Pacific Malaria Elimination Network (APMEN); Korea National Institute of Health	This study was supported by the extramural fund of the Asia Pacific Malaria Elimination Network (APMEN; project number 107-05) and the intramural fund of the Korea National Institute of Health (Grant no. 4837-302-210-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird JK, 2011, TRENDS PARASITOL, V27, P11, DOI 10.1016/j.pt.2010.08.005; BEUTLER E, 1995, BLOOD CELL MOL DIS, V21, P64, DOI 10.1006/bcmd.1995.0010; BLACKWELL RQ, 1968, VOX SANG, V14, P299, DOI 10.1111/j.1423-0410.1968.tb04628.x; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; DERN RJ, 1981, J LAB CLIN MED, V97, P750; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Hill DR, 2006, AM J TROP MED HYG, V75, P402, DOI 10.4269/ajtmh.2006.75.402; Howes RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001339; Huang YX, 2008, MOL GENET METAB, V93, P44, DOI 10.1016/j.ymgme.2007.08.122; Jiang WY, 2006, HUM GENET, V119, P463, DOI 10.1007/s00439-005-0126-5; Khim N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-171; KIM M K, 1992, Journal of Korean Medical Science, V7, P71; Kim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028357; KROTOSKI WA, 1985, T ROY SOC TROP MED H, V79, P1, DOI 10.1016/0035-9203(85)90221-4; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; LaMonte G, 2012, CELL HOST MICROBE, V12, P187, DOI 10.1016/j.chom.2012.06.007; LIVINGSTONE FB, 1984, HUM BIOL, V56, P413; Louicharoen C, 2009, SCIENCE, V326, P1546, DOI 10.1126/science.1178849; Nuchprayoon I, 2002, Hum Mutat, V19, P185, DOI 10.1002/humu.9010; Phompradit P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-368; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Silao CL, 1999, PEDIATR INT, V41, P138, DOI 10.1046/j.1442-200X.1999.4121035.x; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Than AM, 2005, INT J HEMATOL, V82, P119, DOI 10.1532/IJH97.05028; von Seidlein L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-112; Wagner G, 1996, HUM BIOL, V68, P383	27	19	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97390	10.1371/journal.pone.0097390	http://dx.doi.org/10.1371/journal.pone.0097390			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853873	Green Published, gold, Green Submitted			2022-12-25	WOS:000338323200021
J	Xie, XZ; Kagawa, T; Takano, M				Xie, Xianzhi; Kagawa, Takatoshi; Takano, Makoto			The Phytochrome B/Phytochrome C Heterodimer Is Necessary for Phytochrome C-Mediated Responses in Rice Seedlings	PLOS ONE			English	Article							RED-LIGHT; SIGNALING MECHANISMS; RESONANCE RAMAN; GENE FAMILY; ARABIDOPSIS; EXPRESSION; PHOTORECEPTORS; AGROBACTERIUM; CHROMOPHORE; SEQUENCES	Background: PhyC levels have been observed to be markedly lower in phyB mutants than in Arabidopsis or rice wild type etiolated seedlings, but the mechanism of this phenomenon has not been fully elucidated. Results: In the present study, we investigated the mechanism by which phyB affects the protein concentration and photo-sensing abilities of phyC and demonstrated that rice phyC exists predominantly as phyB/phyC heterodimers in etiolated seedlings. PHYC-GFP protein was detected when expressed in phyA phyC mutants, but not in phyA phyB mutants, suggesting that phyC requires phyB for its photo-sensing abilities. Interestingly, when a mutant PHYB gene that has no chromophore binding site, PHYB(C364A), was introduced into phyB mutants, the phyC level was restored. Moreover, when PHYB(C364A) was introduced into phyA phyB mutants, the seedlings exhibited de-etiolation under both far-red light (FR) and red light (R) conditions, while the phyA phyB mutants were blind to both FR and R. These results are the first direct evidence that phyC is responsible for regulating seedling de-etiolation under both FR and R. These findings also suggest that phyB is indispensable for the expression and function of phyC, which depends on the formation of phyB/phyC heterodimers. Significance: The present report clearly demonstrates the similarities and differences in the properties of phyC between Arabidopsis and rice and will advance our understanding of phytochrome functions in monocots and dicots.	[Xie, Xianzhi; Kagawa, Takatoshi; Takano, Makoto] Natl Inst Agrobiol Sci, Photobiol & Photosynthesis Res Unit, Tsukuba, Ibaraki, Japan; [Xie, Xianzhi] Shandong Acad Agr Sci, Shandong Rice Res Inst, Jinan, Shandong, Peoples R China	National Institute of Agrobiological Sciences - Japan; Shandong Academy of Agricultural Sciences	Takano, M (corresponding author), Natl Inst Agrobiol Sci, GMO Res Ctr, Tsukuba, Ibaraki, Japan.	mtakano@affrc.go.jp			Ministry of Agriculture, Forestry, and Fisheries; Rice Genome Programs [IP1006, SY1108]; Genomics for Agricultural Innovation [GPN0003]	Ministry of Agriculture, Forestry, and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan); Rice Genome Programs; Genomics for Agricultural Innovation	This work was supported by grants from the Ministry of Agriculture, Forestry, and Fisheries, the Rice Genome Programs IP1006 and SY1108, and the Genomics for Agricultural Innovation GPN0003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba R, 2000, MOL BIOL EVOL, V17, P362, DOI 10.1093/oxfordjournals.molbev.a026316; Andel F, 1996, BIOCHEMISTRY-US, V35, P15997, DOI 10.1021/bi962175k; Basu D, 2000, PLANT MOL BIOL, V44, P27, DOI 10.1023/A:1006488119301; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen M, 2011, TRENDS CELL BIOL, V21, P664, DOI 10.1016/j.tcb.2011.07.002; CLACK T, 1994, PLANT MOL BIOL, V25, P413, DOI 10.1007/BF00043870; Clack T, 2009, PLANT CELL, V21, P786, DOI 10.1105/tpc.108.065227; Clough RC, 1997, PLANT CELL ENVIRON, V20, P713, DOI 10.1046/j.1365-3040.1997.d01-107.x; Clough RC, 1999, PLANT J, V17, P155, DOI 10.1046/j.1365-313X.1999.00360.x; Debrieux D, 2010, PLANT MOL BIOL, V73, P687, DOI 10.1007/s11103-010-9649-9; DEHESH K, 1991, MOL GEN GENET, V225, P305, DOI 10.1007/BF00269863; Eichenberg K, 2000, FEBS LETT, V470, P107, DOI 10.1016/S0014-5793(00)01301-6; Franklin KA, 2003, PLANT CELL, V15, P1981, DOI 10.1105/tpc.015164; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Fuse T., 2001, PLANT BIOTECHNOL, V18, P219, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.18.219; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hennig L, 2001, J BIOL CHEM, V276, P7913, DOI 10.1074/jbc.M009793200; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hirschfeld M, 1998, GENETICS, V149, P523; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; JONES AM, 1986, BIOCHEMISTRY-US, V25, P2987, DOI 10.1021/bi00358a038; Kagawa T, 2007, FEBS LETT, V581, P368, DOI 10.1016/j.febslet.2006.12.041; KAY SA, 1989, NUCLEIC ACIDS RES, V17, P2865, DOI 10.1093/nar/17.7.2865; Kim JI, 2005, LIGHT SENSING IN PLANTS, P57, DOI 10.1007/4-431-27092-2_6; Kiyota S, 2012, PLANT PHYSIOL BIOCH, V51, P10, DOI 10.1016/j.plaphy.2011.10.002; LAGARIAS JC, 1985, J BIOL CHEM, V260, P2415; Mathews S, 1996, MOL BIOL EVOL, V13, P1141, DOI 10.1093/oxfordjournals.molbev.a025677; Matsushita T, 2003, NATURE, V424, P571, DOI 10.1038/nature01837; Monte E, 2003, PLANT CELL, V15, P1962, DOI 10.1105/tpc.012971; Mroginski MA, 2007, ACCOUNTS CHEM RES, V40, P258, DOI 10.1021/ar6000523; Nagatani A, 2010, CURR OPIN PLANT BIOL, V13, P565, DOI 10.1016/j.pbi.2010.07.002; NAKAZAWA M, 1991, PLANT CELL PHYSIOL, V32, P1187; Neff MM, 2000, GENE DEV, V14, P257; Osugi A, 2011, PLANT PHYSIOL, V157, P1128, DOI 10.1104/pp.111.181792; Palecanda L, 2001, PLANT MOL BIOL, V46, P89, DOI 10.1023/A:1010686805488; Quail PH, 2002, CURR OPIN CELL BIOL, V14, P180, DOI 10.1016/S0955-0674(02)00309-5; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Seo HS, 2004, GENE DEV, V18, P617, DOI 10.1101/gad.1187804; Sharrock RA, 2004, P NATL ACAD SCI USA, V101, P11500, DOI 10.1073/pnas.0404286101; SHARROCK RA, 1989, GENE DEV, V3, P1745, DOI 10.1101/gad.3.11.1745; Smith Harry, 1994, Seminars in Cell Biology, V5, P315, DOI 10.1006/scel.1994.1038; Tahir M, 1998, PLANT PHYSIOL, V118, P1535; Takano M, 2005, PLANT CELL, V17, P3311, DOI 10.1105/tpc.105.035899; Takano M, 2001, PLANT CELL, V13, P521, DOI 10.1105/tpc.13.3.521; Takano M, 2009, P NATL ACAD SCI USA, V106, P14705, DOI 10.1073/pnas.0907378106; Trupkin SA, 2007, PLANT MOL BIOL, V63, P669, DOI 10.1007/s11103-006-9115-x; Ulijasz AT, 2011, CURR OPIN PLANT BIOL, V14, P498, DOI 10.1016/j.pbi.2011.06.002; Wagner D, 1996, PLANT CELL, V8, P859, DOI 10.1105/tpc.8.5.859; Wang HY, 2005, CURR TOP DEV BIOL, V68, P227, DOI 10.1016/S0070-2153(05)68008-8; Wolf I, 2011, PLANT CELL PHYSIOL, V52, P361, DOI 10.1093/pcp/pcq194; Yamaguchi R, 1999, J CELL BIOL, V145, P437, DOI 10.1083/jcb.145.3.437	52	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97264	10.1371/journal.pone.0097264	http://dx.doi.org/10.1371/journal.pone.0097264			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853557	Green Published, Green Submitted, gold			2022-12-25	WOS:000338323200019
J	Olson, MA; Lee, MS				Olson, Mark A.; Lee, Michael S.			Evaluation of Unrestrained Replica-Exchange Simulations Using Dynamic Walkers in Temperature Space for Protein Structure Refinement	PLOS ONE			English	Article							GUIDED LANGEVIN DYNAMICS; MOLECULAR-DYNAMICS; STRUCTURE SELECTION; I-TASSER; PREDICTION; FORCE	A central problem of computational structural biology is the refinement of modeled protein structures taken from either comparative modeling or knowledge-based methods. Simulations are commonly used to achieve higher resolution of the structures at the all-atom level, yet methodologies that consistently yield accurate results remain elusive. In this work, we provide an assessment of an adaptive temperature-based replica exchange simulation method where the temperature clients dynamically walk in temperature space to enrich their population and exchanges near steep energetic barriers. This approach is compared to earlier work of applying the conventional method of static temperature clients to refine a dataset of conformational decoys. Our results show that, while an adaptive method has many theoretical advantages over a static distribution of client temperatures, only limited improvement was gained from this strategy in excursions of the downhill refinement regime leading to an increase in the fraction of native contacts. To illustrate the sampling differences between the two simulation methods, energy landscapes are presented along with their temperature client profiles.	[Olson, Mark A.] USAMRIID, Dept Cell Biol & Biochem Mol & Translat Sci, Frederick, MD USA; [Olson, Mark A.] Johns Hopkins Univ, Zanvyl Krieger Sch Arts & Sci, Adv Acad Programs, Baltimore, MD USA; [Lee, Michael S.] US Army Res Lab, Computat Sci Div, Aberdeen Proving Ground, MD USA	United States Army Medical Research Institute of Infectious Diseases; Johns Hopkins University; United States Department of Defense; United States Army; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL)	Olson, MA (corresponding author), USAMRIID, Dept Cell Biol & Biochem Mol & Translat Sci, Frederick, MD USA.	molson@compbiophys.org			U.S. Department of Defense Threat Reduction Agency [CBCALL12-LS6-2-0036]; Army Research Lab	U.S. Department of Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Army Research Lab(United States Department of DefenseUS Army Research Laboratory (ARL))	Funding of this research was provided by the U.S. Department of Defense Threat Reduction Agency Grant CBCALL12-LS6-2-0036 to MAO and the Army Research Lab to MSL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya D, 2013, PROTEINS, V81, P119, DOI 10.1002/prot.24167; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chaudhury S, 2012, J CHEM THEORY COMPUT, V8, P677, DOI 10.1021/ct200529b; Chen JH, 2007, PROTEINS, V67, P922, DOI 10.1002/prot.21345; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Ishikawa Y, 2001, CHEM PHYS LETT, V333, P199, DOI 10.1016/S0009-2614(00)01342-7; Katzgraber G, 2006, J STAT MECH-THEORY E; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Larsen AB, 2013, J CHEM INF MODEL; Lee MS, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3603964; Lee MS, 2010, J CHEM THEORY COMPUT, V6, P2477, DOI 10.1021/ct100062b; Lee MS, 2003, J COMPUT CHEM, V24, P1348, DOI 10.1002/jcc.10272; MacCallum JL, 2011, PROTEINS, V79, P74, DOI 10.1002/prot.23131; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mirjalili V, 2014, PROTEINS, V82, P196, DOI 10.1002/prot.24336; Mirjalili V, 2013, J CHEM THEORY COMPUT, V9, P1294, DOI 10.1021/ct300962x; Nugent T, 2013, PROTEINS; Olson MA, 2013, J COMPUT CHEM, V34, P1785, DOI 10.1002/jcc.23325; Olson MA, 2013, PROTEINS, V81, P469, DOI 10.1002/prot.24204; Olson MA, 2011, J COMPUT CHEM, V32, P3014, DOI 10.1002/jcc.21883; Predescu C, 2004, J CHEM PHYS, V120, P4119, DOI 10.1063/1.1644093; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Raval A, 2012, PROTEINS, V80, P2071, DOI 10.1002/prot.24098; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Spill YG, 2013, J COMPUT CHEM, V34, P132, DOI 10.1002/jcc.23113; Trebst S, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2186639; Wu XW, 2003, CHEM PHYS LETT, V381, P512, DOI 10.1016/j.cplett.2003.10.013; Xu D, 2011, PROTEINS, V79, P147, DOI 10.1002/prot.23111; Yeh IC, 2008, J PHYS CHEM B, V112, P15064, DOI 10.1021/jp802469g; Zhang J, 2011, STRUCTURE, V19, P1784, DOI 10.1016/j.str.2011.09.022; Zhang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015386; Zhang WH, 2013, J CHEM THEORY COMPUT, V9, P2849, DOI 10.1021/ct400191b; Zhou HY, 2011, BIOPHYS J, V101, P2043, DOI 10.1016/j.bpj.2011.09.012; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002; Zhou RH, 2002, P NATL ACAD SCI USA, V99, P12777, DOI 10.1073/pnas.142430099	37	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e96638	10.1371/journal.pone.0096638	http://dx.doi.org/10.1371/journal.pone.0096638			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848767	Green Submitted, Green Published, gold			2022-12-25	WOS:000336730600014
J	Otaki, Y; Watanabe, T; Takahashi, H; Hirayama, A; Narumi, T; Kadowaki, S; Honda, Y; Arimoto, T; Shishido, T; Miyamoto, T; Konta, T; Shibata, Y; Fukao, A; Daimon, M; Ueno, Y; Kato, T; Kayama, T; Kubota, I				Otaki, Yoichiro; Watanabe, Tetsu; Takahashi, Hiroki; Hirayama, Atushi; Narumi, Taro; Kadowaki, Shinpei; Honda, Yuki; Arimoto, Takanori; Shishido, Tetsuro; Miyamoto, Takuya; Konta, Tsuneo; Shibata, Yoko; Fukao, Akira; Daimon, Makoto; Ueno, Yoshiyuki; Kato, Takeo; Kayama, Takamasa; Kubota, Isao			Association of Heart-Type Fatty Acid-Binding Protein with Cardiovascular Risk Factors and All-Cause Mortality in the General Population: The Takahata Study	PLOS ONE			English	Article							HIGHLY SENSITIVE ASSAY; CARDIAC TROPONIN-T; ONGOING MYOCARDIAL DAMAGE; BRAIN NATRIURETIC PEPTIDE; INSULIN-RESISTANCE; PROGNOSTIC VALUE; I LEVELS; FAILURE; CANCER; MECHANISMS	Background: Despite many recent advances in medicine, preventing the development of cardiovascular diseases remains a challenge. Heart-type fatty acid-binding protein (H-FABP) is a marker of ongoing myocardial damage and has been reported to be a useful indicator for future cardiovascular events. However, it remains to be determined whether H-FABP can predict all-cause and cardiovascular deaths in the general population. Methods and Results: This longitudinal cohort study included 3,503 subjects who participated in a community-based health checkup with a 7-year follow-up. Serum H-FABP was measured in registered subjects. The results demonstrated that higher H-FABP levels were associated with increasing numbers of cardiovascular risk factors, including hypertension, diabetes mellitus, obesity, and metabolic syndrome. There were 158 deaths during the follow-up period, including 50 cardiovascular deaths. Deceased subjects had higher H-FABP levels compared to surviving subjects. Multivariate Cox proportional hazard regression analysis revealed that H-FABP is an independent predictor of all-cause and cardiovascular deaths after adjustments for confounding factors. Subjects were divided into four quartiles according to H-FABP level, and Kaplan-Meier analysis demonstrated that the highest H-FABP quartile was associated with the greatest risks for all-cause and cardiovascular deaths. Net reclassification index and integrated discrimination index were significantly increased by addition of H-FABP to cardiovascular risk factors. Conclusions: H-FABP level was increased in association with greater numbers of cardiovascular risk factors and was an independent risk factor for all-cause and cardiovascular deaths. H-FABP could be a useful indicator for the early identification of high-risk subjects in the general population.	[Otaki, Yoichiro; Watanabe, Tetsu; Takahashi, Hiroki; Hirayama, Atushi; Narumi, Taro; Kadowaki, Shinpei; Honda, Yuki; Arimoto, Takanori; Shishido, Tetsuro; Miyamoto, Takuya; Konta, Tsuneo; Shibata, Yoko; Kubota, Isao] Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 99023, Japan; [Fukao, Akira; Ueno, Yoshiyuki; Kato, Takeo; Kayama, Takamasa] Yamagata Univ, Sch Med, Global Ctr Excellence Program Study Grp, Yamagata 99023, Japan; [Daimon, Makoto] Hirosaki Univ, Grad Sch Med, Dept Endocrinol & Metab, Aomori, Japan	Yamagata University; Yamagata University; Hirosaki University	Watanabe, T (corresponding author), Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 99023, Japan.	tewatana@med.id.yamagata-u.ac.jp	Daimon, Makoto/AAY-1289-2020; Ueno, Yoshiyuki/R-9242-2019; Konta, Tsuneo/AAO-9286-2021	Daimon, Makoto/0000-0002-3775-1719; Ueno, Yoshiyuki/0000-0001-5623-4250; Narumi, Taro/0000-0001-6466-9457	21st 9 Century Center of Excellence (COE); Global COE program of the Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [25460737] Funding Source: KAKEN	21st 9 Century Center of Excellence (COE)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE program of the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant-in-aid from the 21st 9 Century Center of Excellence (COE) and the Global COE program of the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad T, 2012, NAT REV CARDIOL, V9, P347, DOI 10.1038/nrcardio.2012.37; Arimoto T, 2005, J CARD FAIL, V11, P56, DOI 10.1016/j.cardfail.2004.03.005; Arimoto T, 2007, J CARD FAIL, V13, P34, DOI 10.1016/j.cardfail.2006.09.002; Braga JR, 2013, CIRC-HEART FAIL, V6, P193, DOI 10.1161/CIRCHEARTFAILURE.112.000075; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; Chiu YT, 2005, INT J CARDIOL, V100, P401, DOI 10.1016/j.ijcard.2004.08.026; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Daidoji H, 2012, J CARD FAIL, V18, P556, DOI 10.1016/j.cardfail.2012.04.006; de Antonio M, 2012, AM HEART J, V163, P821, DOI 10.1016/j.ahj.2012.03.004; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; deFilippi CR, 2010, JAMA-J AM MED ASSOC, V304, P2494, DOI 10.1001/jama.2010.1708; Eckardt KU, 2009, AM J KIDNEY DIS, V53, P915, DOI 10.1053/j.ajkd.2009.04.001; Eggers KM, 2008, EUR HEART J, V29, P2252, DOI 10.1093/eurheartj/ehn327; Eggers KM, 2013, J AM COLL CARDIOL, V61, P1906, DOI 10.1016/j.jacc.2012.12.048; George AJ, 2010, NAT REV CANCER, V10, P745, DOI 10.1038/nrc2945; GLATZ JFC, 1985, CHEM PHYS LIPIDS, V38, P115, DOI 10.1016/0009-3084(85)90061-1; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hernandez AF, 2012, JAMA-J AM MED ASSOC, V308, P2097, DOI 10.1001/jama.2012.14795; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Jee SH, 2005, YONSEI MED J, V46, P449, DOI 10.3349/ymj.2005.46.4.449; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; Leistner DM, 2012, CLIN CHEM, V58, P200, DOI 10.1373/clinchem.2011.174292; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; Mann J, 1999, HEART, V82, P265, DOI 10.1136/hrt.82.3.265; Matsumoto S, 2013, CIRC J, V77, P1026, DOI 10.1253/circj.CJ-12-0999; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meng XZ, 2006, FORENSIC SCI INT, V160, P11, DOI 10.1016/j.forsciint.2005.08.008; Mervaala E, 2000, HYPERTENSION, V35, P360, DOI 10.1161/01.HYP.35.1.360; Narumi T, 2012, EXP DIABETES RES, DOI 10.1155/2012/815098; Niizeki T, 2005, CIRC J, V69, P922, DOI 10.1253/circj.69.922; Niizeki T, 2007, J CARD FAIL, V13, P120, DOI 10.1016/j.cardfail.2006.10.014; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Omland T, 2013, J AM COLL CARDIOL, V61, P1240, DOI 10.1016/j.jacc.2012.12.026; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Sakata Y, 2013, CIRC J, V77, P2209, DOI 10.1253/circj.CJ-13-0971; Saunders JT, 2011, CIRCULATION, V123, P1367, DOI 10.1161/CIRCULATIONAHA.110.005264; Shiba N, 2011, CIRC J, V75, P823, DOI 10.1253/circj.CJ-11-0135; Stengel B, 2010, J NEPHROL, V23, P253; Tsutamoto T, 1997, CIRCULATION, V96, P509; Ueshima H, 2006, CIRC J, V70, P1249; Viswanathan K, 2010, J AM COLL CARDIOL, V55, P2590, DOI 10.1016/j.jacc.2009.12.062; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865	45	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e94834	10.1371/journal.pone.0094834	http://dx.doi.org/10.1371/journal.pone.0094834			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847804	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600005
J	Zager, RA; Johnson, ACM; Frostad, KB				Zager, Richard A.; Johnson, Ali C. M.; Frostad, Kirsten B.			Rapid Renal Alpha-1 Antitrypsin Gene Induction in Experimental and Clinical Acute Kidney Injury	PLOS ONE			English	Article							HUMAN MONOCYTES; ALPHA(1)-ANTITRYPSIN; EXPRESSION; BIOMARKER; ACCUMULATION; DISEASE; PROTEIN; LIVER	Alpha-1-antitrypsin (AAT) is a hepatic stress protein with protease inhibitor activity. Recent evidence indicates that ischemic or toxic injury can evoke selective changes within kidney that resemble a hepatic phenotype. Hence, we tested the following: i) Does acute kidney injury (AKI) up-regulate the normally renal silent AAT gene? ii) Does rapid urinary AAT excretion result? And iii) Can AAT's anti-protease/anti-neutrophil elastase (NE) activity protect injured proximal tubule cells? CD-1 mice were subjected to ischemic or nephrotoxic (glycerol, maleate, cisplatin) AKI. Renal functional and biochemical assessments were made 4-72 hrs later. Rapidly following injury, 5-10 fold renal cortical and isolated proximal tubule AAT mRNA and protein increases occurred. These were paralleled by rapid (>100 fold) increases in urinary AAT excretion. AKI also induced marked increases in renal cortical/isolated proximal tubule NE mRNA. However, sharp NE protein levels declines resulted, which strikingly correlated (r, -0.94) with rising AAT protein levels (reflecting NE complexing by AAT/destruction). NE addition to HK-2 cells evoked similar to 95% cell death. AAT completely blocked this NE toxicity, as well as Fe induced oxidant HK-2 cell attack. Translational relevance of experimental AAT gene induction was indicated by similar to 100-1000 fold urinary AAT increases in 22 AKI patients (matching urine NGAL increases). We conclude: i) AKI rapidly up-regulates the renal cortical/proximal tubule AAT gene; ii) NE gene induction also results; iii) AAT can confer cytoprotection, potentially by blocking/reducing cytotoxic NE accumulation; and iv) marked increases in urinary AAT excretion in AKI patients implies clinical relevance of the AKI-AAT induction pathway.	[Zager, Richard A.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Univ Washington, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Zager, RA (corresponding author), Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.	dzager@fhcrc.org			National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonventre JV, 2008, SCAND J CLIN LAB INV, V68, P78, DOI 10.1080/00365510802145059; Bonventre JV, 2010, CURR OPIN CRIT CARE, V16, P556, DOI 10.1097/MCC.0b013e32834008d3; Churg A, 2001, LAB INVEST, V81, P1119, DOI 10.1038/labinvest.3780324; Daemen MARC, 2000, CIRCULATION, V102, P1420, DOI 10.1161/01.CIR.102.12.1420; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Goldstein S, 2012, EXPERT REV CLIN IMMU, V8, P397, DOI [10.1586/eci.12.33, 10.1586/ECI.12.33]; Hu CB, 2002, AM J PHYSIOL-LUNG C, V282, pL757, DOI 10.1152/ajplung.00271.2001; Hunt JM, 2012, CURR MOL MED, V12, P827; Janciauskiene SM, 2007, J BIOL CHEM, V282, P8573, DOI 10.1074/jbc.M607976200; Kaushal GP, 2013, AM J PHYSIOL-RENAL, V304, pF1150, DOI 10.1152/ajprenal.00014.2013; Makris K, 2012, CLIN CHEM LAB MED, V50, P1519, DOI 10.1515/cclm-2012-0227; McCullough PA, 2013, CONTRIB NEPHROL, V182, P13, DOI 10.1159/000349963; McLean C, 2009, BIOL-TARGETS THER, V3, P63; MILLAND J, 1990, AM J PHYSIOL, V259, pG340, DOI 10.1152/ajpgi.1990.259.3.G340; MOLMENTI EP, 1993, J CLIN INVEST, V92, P2022, DOI 10.1172/JCI116797; Munshi R, 2011, J AM SOC NEPHROL, V22, P165, DOI 10.1681/ASN.2010060641; Negishi K, 2009, AM J PATHOL, V174, P1154, DOI 10.2353/ajpath.2009.080644; Nita IM, 2007, INT J BIOCHEM CELL B, V39, P1165, DOI 10.1016/j.biocel.2007.02.017; Noiri E, 2009, AM J PHYSIOL-RENAL, V296, pF669, DOI 10.1152/ajprenal.90513.2008; Petrache I, 2006, AM J PATHOL, V169, P1155, DOI 10.2353/ajpath.2006.060058; Petrache L, 2006, AM J RESP CRIT CARE, V173, P1222, DOI 10.1164/rccm.200512-1842OC; ROGERS J, 1983, BIOCHEM BIOPH RES CO, V116, P375, DOI 10.1016/0006-291X(83)90532-6; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; SCHREIBER G, 1989, ANN NY ACAD SCI, V557, P61; Tawara I, 2012, P NATL ACAD SCI USA, V109, P564, DOI 10.1073/pnas.1117665109; Ware LB, 2011, AM J PHYSIOL-RENAL, V300, pF628, DOI 10.1152/ajprenal.00654.2010; ZAGER RA, 1994, KIDNEY INT, V45, P1760, DOI 10.1038/ki.1994.229; Zager RA, 1998, J AM SOC NEPHROL, V9, P1670; ZAGER RA, 1993, CIRC RES, V72, P837, DOI 10.1161/01.RES.72.4.837; Zager RA, 2012, AM J PHYSIOL-RENAL, V303, pF1460, DOI 10.1152/ajprenal.00426.2012; Zager RA, 2012, AM J PHYSIOL-RENAL, V303, pF139, DOI 10.1152/ajprenal.00168.2012; Zager RA, 2012, J AM SOC NEPHROL, V23, P1048, DOI 10.1681/ASN.2011121147	32	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98380	10.1371/journal.pone.0098380	http://dx.doi.org/10.1371/journal.pone.0098380			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848503	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600112
J	Murciano-Calles, J; Marin-Argany, M; Cobos, ES; Villegas, S; Martinez, JC				Murciano-Calles, Javier; Marin-Argany, Marta; Cobos, Eva S.; Villegas, Sandra; Martinez, Jose C.			The Impact of Extra-Domain Structures and Post-Translational Modifications in the Folding/Misfolding Behaviour of the Third PDZ Domain of MAGUK Neuronal Protein PSD-95	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PROTEIN; TIGHT JUNCTION PROTEIN; BETA-SHEET; SUPERTERTIARY STRUCTURE; AMYLOID FIBRILS; IN-VITRO; ZO-1; DIMERIZATION; CLAUDINS; KINASES	The modulation of binding affinities and specificities by post-translational modifications located out from the binding pocket of the third PDZ domain of PSD-95 (PDZ3) has been reported recently. It is achieved through an intra-domain electrostatic network involving some charged residues in the beta 2-beta 3 loop (were a succinimide modification occurs), the alpha 3 helix (an extra-structural element that links the PDZ3 domain with the following SH3 domain in PSD-95, and contains the phosphorylation target Tyr397), and the ligand peptide. Here, we have investigated the main structural and thermodynamic aspects that these structural elements and their related post-translational modifications display in the folding/misfolding pathway of PDZ3 by means of site-directed mutagenesis combined with calorimetry and spectroscopy. We have found that, although all the assayed mutations generate proteins more prone to aggregation than the wild-type PDZ3, those directly affecting the alpha 3 helix, like the E401R substitution or the truncation of the whole alpha 3 helix, increase the population of the DSC-detected intermediate state and the misfolding kinetics, by organizing the supramacromolecular structures at the expense of the two beta-sheets present in the PDZ3 fold. However, those mutations affecting the beta 2-beta 3 loop, included into the prone-to-aggregation region composed by a single beta-sheet comprising beta 2 to beta 4 chains, stabilize the trimeric intermediate previously shown in the wild-type PDZ3 and slow-down aggregation, also making it partly reversible. These results strongly suggest that the alpha 3 helix protects to some extent the PDZ3 domain core from misfolding. This might well constitute the first example where an extra-element, intended to link the PDZ3 domain to the following SH3 in PSD-95 and in other members of the MAGUK family, not only regulates the binding abilities of this domain but it also protects PDZ3 from misfolding and aggregation. The influence of the post-translational modifications in this regulatory mechanism is also discussed.	[Murciano-Calles, Javier; Cobos, Eva S.; Martinez, Jose C.] Univ Granada, Dept Quim Fis, Granada, Spain; [Murciano-Calles, Javier; Cobos, Eva S.; Martinez, Jose C.] Univ Granada, Inst Biotecnol, Fac Ciencias, Granada, Spain; [Marin-Argany, Marta; Villegas, Sandra] Univ Autonoma Barcelona, Fac Biociencies, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain	University of Granada; University of Granada; Autonomous University of Barcelona	Villegas, S (corresponding author), Univ Autonoma Barcelona, Fac Biociencies, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain.	sandra.villegas@uab.cat; jcmh@ugr.es	S. Cobos, Eva/H-7703-2015; Martinez, Jose C./J-8721-2012; Murciano-Calles, Javier/J-8897-2012; Villegas, Sandra/D-8789-2011; Villegas, Sandra/ABF-8206-2021	S. Cobos, Eva/0000-0002-4622-8698; Martinez, Jose C./0000-0003-2657-2456; Murciano-Calles, Javier/0000-0002-8667-1651; Villegas, Sandra/0000-0001-8644-4304; Villegas, Sandra/0000-0001-8644-4304; Argany, Meysam/0000-0001-6577-4443	Andalusian Regional Government [CVI-05915]; Spanish Ministry of Science and Education [BIO2009-13261-C02, BIO2012-39922-C02]; FEDER; Instituto de Salud Carlos III [PI13-01330]; Generalitat de Catalunya [SGR09-0761]; Spanish Ministry of Science and Education; PIF (UAB) fellowship	Andalusian Regional Government; Spanish Ministry of Science and Education(Spanish Government); FEDER(European Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Generalitat de Catalunya(Generalitat de Catalunya); Spanish Ministry of Science and Education(Spanish Government); PIF (UAB) fellowship	This research was supported by grants CVI-05915, from the Andalusian Regional Government; BIO2009-13261-C02 and BIO2012-39922-C02, from the Spanish Ministry of Science and Education and FEDER; PI13-01330 from Instituto de Salud Carlos III and SGR09-0761 from the Generalitat de Catalunya. J.M-C. received a postdoctoral contract from the Spanish Ministry of Science and Education. M. M-A. was supported by a PIF (UAB) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JM, 1995, BIOCHEM SOC T, V23, P470, DOI 10.1042/bst0230470; Camara-Artigas A, 2010, J STRUCT BIOL, V170, P565, DOI 10.1016/j.jsb.2010.03.005; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; Hasty J, 2001, NATURE, V411, P30, DOI 10.1038/35075182; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Jahn TR, 2008, J BIOL CHEM, V283, P17279, DOI 10.1074/jbc.M710351200; JESAITIS LA, 1994, J CELL BIOL, V124, P949, DOI 10.1083/jcb.124.6.949; Kad NM, 2003, J MOL BIOL, V330, P785, DOI 10.1016/S0022-2836(03)00583-7; Kalia LV, 2003, NEUROPHARMACOLOGY, V45, P720, DOI 10.1016/S0028-3908(03)00313-7; Kardos J, 2004, J BIOL CHEM, V279, P55308, DOI 10.1074/jbc.M409677200; KIM SK, 1995, CURR OPIN CELL BIOL, V7, P641, DOI 10.1016/0955-0674(95)80105-7; Korkin D, 2006, PLOS COMPUT BIOL, V2, P1365, DOI 10.1371/journal.pcbi.0020153; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; Marin-Argany M, 2012, BIOPHYS J, V103, P738, DOI 10.1016/j.bpj.2012.07.029; Murciano-Calles J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090030; Murciano-Calles J, 2014, BIOPHYS CHEM, V185, P1, DOI 10.1016/j.bpc.2013.10.005; Murciano-Calles J, 2011, BIOPHYS CHEM, V158, P104, DOI 10.1016/j.bpc.2011.05.018; Murciano-Calles J, 2010, BIOPHYS J, V99, P263, DOI 10.1016/j.bpj.2010.04.003; Orpiszewski J, 1999, J MOL BIOL, V289, P413, DOI 10.1006/jmbi.1999.2768; Sainlos M, 2011, NAT CHEM BIOL, V7, P81, DOI 10.1038/NCHEMBIO.498; Shimizu T, 2005, BIOL PHARM BULL, V28, P1590, DOI 10.1248/bpb.28.1590; Smith A, 2006, AGENDA, V42, P9; Takemoto L, 2001, EXP EYE RES, V72, P559, DOI 10.1006/exer.2001.0983; Tompa P, 2012, NAT CHEM BIOL, V8, P597, DOI 10.1038/nchembio.1009; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Utepbergenov DI, 2006, J BIOL CHEM, V281, P24671, DOI 10.1074/jbc.M512820200; Villegas V, 2000, PROTEIN SCI, V9, P1700, DOI 10.1110/ps.9.9.1700; WILLOTT E, 1993, P NATL ACAD SCI USA, V90, P7834, DOI 10.1073/pnas.90.16.7834; WOODS DF, 1993, MECH DEVELOP, V44, P85, DOI 10.1016/0925-4773(93)90059-7; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195; Wu JW, 2007, J BIOL CHEM, V282, P35988, DOI 10.1074/jbc.M703826200; Zhang J, 2013, STRUCTURE, V21, P402, DOI 10.1016/j.str.2012.12.014; Zhang J, 2011, J BIOL CHEM, V286, P41776, DOI 10.1074/jbc.M111.272583	34	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98124	10.1371/journal.pone.0098124	http://dx.doi.org/10.1371/journal.pone.0098124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845085	Green Published, Green Submitted, gold			2022-12-25	WOS:000339563400099
J	Quinnan, GV; Onabajo, O; Zhang, PF; Yan, LY; Mattapallil, JJ; Zhang, ZQ; Dong, M; Lu, M; Montefiori, D; LaBranche, C; Broder, CC				Quinnan, Gerald V., Jr.; Onabajo, Olusegun; Zhang, Pengfei; Yan, Lianying; Mattapallil, Joseph J.; Zhang, Zhiqiang; Dong, Ming; Lu, Min; Montefiori, David; LaBranche, Celia; Broder, Christopher C.			Immunization of Rabbits with Highly Purified, Soluble, Trimeric Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Induces a Vigorous B Cell Response and Broadly Cross-Reactive Neutralization	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; CORECEPTOR-BINDING-SITE; HIV-1 INFECTION; ENV CLONES; VACCINE; GP120; EPITOPES; POTENT; EXPRESSION; COMPLEX	Previously we described induction of cross-reactive HIV-1 neutralizing antibody responses in rabbits using a soluble HIV-1 gp140 envelope glycoprotein (Env) in an adjuvant containing monophosphoryl lipid A (MPL) and QS21 (AS02(A)). Here, we compared different forms of the same HIV-1 strain R2 Env for antigenic and biophysical characteristics, and in rabbits characterized the extent of B cell induction for specific antibody expression and secretion and neutralizing responses. The forms of this Env that were produced in and purified from stably transformed 293T cells included a primarily dimeric gp140, a trimeric gp140 appended to a GCN4 trimerization domain (gp140-GCN4), gp140-GCN4 with a 15 amino acid flexible linker between the gp120 and gp41 ectodomain (gp140-GCN4-L), also trimeric, and a gp140 with the flexible linker purified from cell culture supernatants as either dimer (gp140-L(D)) or monomer (gp140-L(M)). Multimeric states of the Env proteins were assessed by native gel electrophoresis and analytical ultracentrifugation. The different forms of gp140 bound broadly cross-reactive neutralizing (BCN) human monoclonal antibodies (mAbs) similarly in ELISA and immunoprecipitation assays. All Envs bound CD4i mAbs in the presence and absence of sCD4, as reported for the R2 Env. Weak neutralization of some strains of HIV-1 was seen after two additional doses in AS02A. Rabbits that were given a seventh dose of gp140-GCN4-L developed BCN responses that were weak to moderate, similar to our previous report. The specificity of these responses did not appear similar to that of any of the known BCN human mAbs. Induction of spleen B cell and plasma cells producing immunoglobulins that bound trimeric gp140-GCN4-L was vigorous, based on ELISpot and flow cytometry analyses. The results demonstrate that highly purified gp140-GCN4-L trimer in adjuvant elicits BCN responses in rabbits accompanied by vigorous B cell induction.	[Quinnan, Gerald V., Jr.; Zhang, Pengfei; Zhang, Zhiqiang; Dong, Ming] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA; [Onabajo, Olusegun; Yan, Lianying; Mattapallil, Joseph J.; Broder, Christopher C.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD USA; [Lu, Min] Univ Med & Dent New Jersey, New Jersey Med Sch, Publ Hlth Res Inst, Dept Microbiol & Mol Genet, Newark, NJ 07103 USA; [Montefiori, David; LaBranche, Celia] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; Rutgers State University New Brunswick; Rutgers State University Medical Center; Duke University	Quinnan, GV (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA.	gerald.quinnan@usuhs.edu	Broder, Christopher/E-1169-2013	Mattapallil, Joseph/0000-0002-7412-9507	National Institutes of Health [AI078412]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI078412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by National Institutes of Health Grant AI078412; website: http://grants.nih.gov/grants/oer.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Chan YP, 2012, J VIROL, V86, P11457, DOI 10.1128/JVI.01318-12; Chow YH, 2002, BIOCHEMISTRY-US, V41, P7176, DOI 10.1021/bi025646d; Davenport TM, 2011, J VIROL, V85, P7095, DOI 10.1128/JVI.00411-11; Decker JM, 2005, J EXP MED, V201, P1407, DOI 10.1084/jem.20042510; Dong M, 2003, J VIROL, V77, P3119, DOI 10.1128/JVI.77.5.3119-3130.2003; GERSHONI JM, 1993, FASEB J, V7, P1185, DOI 10.1096/fasebj.7.12.7690724; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Kim JH, 2010, CURR OPIN HIV AIDS, V5, P428, DOI 10.1097/COH.0b013e32833d17ac; Kwong PD, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17407; Lee S, 1997, J VIROL, V71, P6037, DOI 10.1128/JVI.71.8.6037-6043.1997; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Lynch RM, 2012, J VIROL, V86, P7588, DOI 10.1128/JVI.00734-12; Mirzabekov T, 1999, J BIOL CHEM, V274, P28745, DOI 10.1074/jbc.274.40.28745; Ohagen A, 2000, AIDS RES HUM RETROV, V16, P27, DOI 10.1089/088922200309575; Pallister J, 2011, VACCINE, V29, P5623, DOI 10.1016/j.vaccine.2011.06.015; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; Quinnan GV, 2005, J VIROL, V79, P3358, DOI 10.1128/JVI.79.6.3358-3369.2005; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Selvarajah S, 2008, AIDS RES HUM RETROV, V24, P301, DOI 10.1089/aid.2007.0158; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; WYATT R, 1995, J VIROL, V69, P5723, DOI 10.1128/JVI.69.9.5723-5733.1995; Xiang SH, 2002, AIDS RES HUM RETROV, V18, P1207, DOI 10.1089/08892220260387959; Yang XZ, 2000, J VIROL, V74, P4746, DOI 10.1128/JVI.74.10.4746-4754.2000; Zhang MY, 2010, MABS-AUSTIN, V2, P266, DOI 10.4161/mabs.2.3.11416; Zhang MY, 2009, VACCINE, V27, P857, DOI 10.1016/j.vaccine.2008.11.083; Zhang MY, 2004, J VIROL, V78, P9233, DOI 10.1128/JVI.78.17.9233-9242.2004; Zhang PF, 2007, P NATL ACAD SCI USA, V104, P10193, DOI 10.1073/pnas.0608635104; Zhang PF, 2002, J VIROL, V76, P644, DOI 10.1128/JVI.76.2.644-655.2002	37	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98060	10.1371/journal.pone.0098060	http://dx.doi.org/10.1371/journal.pone.0098060			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846288	gold, Green Submitted, Green Published			2022-12-25	WOS:000339563400089
J	Manconi, A; Orro, A; Manca, E; Armano, G; Milanesi, L				Manconi, Andrea; Orro, Alessandro; Manca, Emanuele; Armano, Giuliano; Milanesi, Luciano			GPU-BSM: A GPU-Based Tool to Map Bisulfite-Treated Reads	PLOS ONE			English	Article							DNA METHYLATION; ALIGNMENT TOOL; ACCURATE; EFFICIENT; ALIGNER; ULTRAFAST	Cytosine DNA methylation is an epigenetic mark implicated in several biological processes. Bisulfite treatment of DNA is acknowledged as the gold standard technique to study methylation. This technique introduces changes in the genomic DNA by converting cytosines to uracils while 5-methylcytosines remain nonreactive. During PCR amplification 5-methylcytosines are amplified as cytosine, whereas uracils and thymines as thymine. To detect the methylation levels, reads treated with the bisulfite must be aligned against a reference genome. Mapping these reads to a reference genome represents a significant computational challenge mainly due to the increased search space and the loss of information introduced by the treatment. To deal with this computational challenge we devised GPU-BSM, a tool based on modern Graphics Processing Units. Graphics Processing Units are hardware accelerators that are increasingly being used successfully to accelerate general-purpose scientific applications. GPU-BSM is a tool able to map bisulfite-treated reads from whole genome bisulfite sequencing and reduced representation bisulfite sequencing, and to estimate methylation levels, with the goal of detecting methylation. Due to the massive parallelization obtained by exploiting graphics cards, GPU-BSM aligns bisulfite-treated reads faster than other cutting-edge solutions, while outperforming most of them in terms of unique mapped reads.	[Manconi, Andrea; Orro, Alessandro; Milanesi, Luciano] CNR, Inst Biomed Technol, Segrate, Mi, Italy; [Manca, Emanuele; Armano, Giuliano] Univ Cagliari, Dept Elect & Elect Engn, Cagliari, Ca, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Cagliari	Manconi, A (corresponding author), CNR, Inst Biomed Technol, Segrate, Mi, Italy.	andrea.manconi@itb.cnr.it	Armano, Giuliano/AAA-9145-2022; Milanesi, Luciano/AAE-7230-2019; Orro, Alessandro/ABA-3542-2020	Armano, Giuliano/0000-0002-8597-1433; Milanesi, Luciano/0000-0002-1201-3939; 	MIUR [PB05]; MIUR HIRMA [RBAP11YS7K]; EU; Sardinia Region	MIUR(Ministry of Education, Universities and Research (MIUR)); MIUR HIRMA(Ministry of Education, Universities and Research (MIUR)); EU(European Commission); Sardinia Region(Regione Sardegna)	This work was supported by the MIUR (PB05) "InterOmics''; MIUR HIRMA (RBAP11YS7K); EU FP7 "MIMOMICS'' and the Sardinia Region "PAIN'' Projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SY, 2011, J HUM GENET, V56, P406, DOI 10.1038/jhg.2011.43; Chen PY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-203; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Dean J, 2004, USENIX ASSOCIATION PROCEEDINGS OF THE SIXTH SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION (OSDE '04), P137; Esteller M, 2002, J PATHOL, V196, P1, DOI 10.1002/path.1024; Ferragina P, 2000, ANN IEEE SYMP FOUND, P390, DOI 10.1109/SFCS.2000.892127; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Guo WL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-774; Harris EY, 2012, BIOINFORMATICS, V28, P1795, DOI 10.1093/bioinformatics/bts264; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jelinek J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022110; Klus Petr, 2012, BMC Res Notes, V5, P27, DOI 10.1186/1756-0500-5-27; Krueger F, 2012, NAT METHODS, V9, P145, DOI [10.1038/NMETH.1828, 10.1038/nmeth.1828]; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu CM, 2012, BIOINFORMATICS, V28, P878, DOI 10.1093/bioinformatics/bts061; Liu YC, 2012, BIOINFORMATICS, V28, P1830, DOI 10.1093/bioinformatics/bts276; Liu Yongchao, 2010, BMC Res Notes, V3, P93, DOI 10.1186/1756-0500-3-93; Luo RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065632; Manavski SA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S10; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Mu JC, 2012, BIOINFORMATICS, V28, P2366, DOI 10.1093/bioinformatics/bts450; Otto C, 2012, BIOINFORMATICS, V28, P1698, DOI 10.1093/bioinformatics/bts254; Robertson KD, 2000, CARCINOGENESIS, V21, P461, DOI 10.1093/carcin/21.3.461; Ruffalo M, 2011, BIOINFORMATICS, V27, P2790, DOI 10.1093/bioinformatics/btr477; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Schatz MC, 2009, BIOINFORMATICS, V25, P1363, DOI 10.1093/bioinformatics/btp236; Sharma MD, 2013, IMMUNITY, V38, P998, DOI 10.1016/j.immuni.2013.01.013; Shi HX, 2010, PROCEDIA COMPUT SCI, V1, P1123, DOI 10.1016/j.procs.2010.04.125; Smith AD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-128; Smith AD, 2009, BIOINFORMATICS, V25, P2841, DOI 10.1093/bioinformatics/btp533; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; White T., 2012, HADOOP DEFINITIVE GU; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Xi YX, 2012, BIOINFORMATICS, V28, P430, DOI 10.1093/bioinformatics/btr668; Yung LS, 2011, BIOINFORMATICS, V27, P1309, DOI 10.1093/bioinformatics/btr114	44	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97277	10.1371/journal.pone.0097277	http://dx.doi.org/10.1371/journal.pone.0097277			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842718	Green Published, gold, Green Submitted			2022-12-25	WOS:000340948600021
J	Vieira, HGS; Grynberg, P; Bitar, M; Pires, SD; Hilario, HO; Macedo, AM; Machado, CR; de Andrade, HM; Franco, GR				Santos Vieira, Helaine Graziele; Grynberg, Priscila; Bitar, Maina; Pires, Simone da Fonseca; Hilario, Heron Oliveira; Macedo, Andrea Mara; Machado, Carlos Renato; de Andrade, Helida Monteiro; Franco, Gloria Regina			Proteomic Analysis of Trypanosoma cruzi Response to Ionizing Radiation Stress	PLOS ONE			English	Article							MESSENGER-RNA; GLUTAMATE-DEHYDROGENASE; PROTEIN ABUNDANCE; GENE-EXPRESSION; AU-RICH; MECHANISMS; OXIDATION; ELEMENTS; REVEALS; DAMAGE	Trypanosoma cruzi, the causative agent of Chagas disease, is extremely resistant to ionizing radiation, enduring up to 1.5 kGy of gamma rays. Ionizing radiation can damage the DNA molecule both directly, resulting in double-strand breaks, and indirectly, as a consequence of reactive oxygen species production. After a dose of 500 Gy of gamma rays, the parasite genome is fragmented, but the chromosomal bands are restored within 48 hours. Under such conditions, cell growth arrests for up to 120 hours and the parasites resume normal growth after this period. To better understand the parasite response to ionizing radiation, we analyzed the proteome of irradiated (4, 24, and 96 hours after irradiation) and non-irradiated T. cruzi using two-dimensional differential gel electrophoresis followed by mass spectrometry for protein identification. A total of 543 spots were found to be differentially expressed, from which 215 were identified. These identified protein spots represent different isoforms of only 53 proteins. We observed a tendency for overexpression of proteins with molecular weights below predicted, indicating that these may be processed, yielding shorter polypeptides. The presence of shorter protein isoforms after irradiation suggests the occurrence of post-translational modifications and/or processing in response to gamma radiation stress. Our results also indicate that active translation is essential for the recovery of parasites from ionizing radiation damage. This study therefore reveals the peculiar response of T. cruzi to ionizing radiation, raising questions about how this organism can change its protein expression to survive such a harmful stress.	[Santos Vieira, Helaine Graziele; Grynberg, Priscila; Bitar, Maina; Hilario, Heron Oliveira; Macedo, Andrea Mara; Machado, Carlos Renato; Franco, Gloria Regina] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Pires, Simone da Fonseca; de Andrade, Helida Monteiro] Univ Fed Minas Gerais, Dept Parasitol, Belo Horizonte, MG, Brazil; [Grynberg, Priscila] Embrapa Recursos Genet & Biotecnol Brasilia, Brasilia, DF, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Franco, GR (corresponding author), Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.	gfrancoufmg@gmail.com	Grynberg, Priscila/AAX-3019-2020; Machado, Carlos Renato/H-1043-2015; MACHADO, CARLOS/AAW-1492-2020; Macedo, Andréa M/C-1506-2013; SANTOS VIEIRA, HELAINE GRAZIELE/AAE-7564-2022; Santos Vieira, Helaine Graziele/S-3236-2018	Grynberg, Priscila/0000-0003-4009-9538; Machado, Carlos Renato/0000-0002-8724-3165; SANTOS VIEIRA, HELAINE GRAZIELE/0000-0002-1114-9439; Santos Vieira, Helaine Graziele/0000-0002-1114-9439; Hilario, Heron/0000-0002-2548-1053	CNPq; FAPEMIG; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Brazilian governmental funding agencies: CNPq, FAPEMIG and CAPES. The student HGSV received a scholarship from CNPq during the course of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa RPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061795; Anitori RP, 2012, IONIZING RAD RESISTA, P25; Appukuttan D, 2006, APPL ENVIRON MICROB, V72, P7873, DOI 10.1128/AEM.01362-06; Barderi P, 1998, BIOCHEM J, V330, P951, DOI 10.1042/bj3300951; Basu B, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011734; BENACHENHOULAHFA N, 1993, J MOL EVOL, V36, P335; BRENER Z, 1963, Rev Inst Med Trop Sao Paulo, V5, P220; Buckner Frederick S, 2010, Curr Opin Infect Dis, V23, P609, DOI 10.1097/QCO.0b013e3283402956; Butter F, 2013, MOL CELL PROTEOMICS, V12, P172, DOI 10.1074/mcp.M112.019224; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Clayton J, 2010, NATURE, V465, pS12, DOI 10.1038/nature09224; Conte L, 2003, MOL BIOL CELL, V14, P3529, DOI 10.1091/mbc.E03-04-0228; D'Orso I, 2001, J BIOL CHEM, V276, P15783, DOI 10.1074/jbc.M010959200; Daly Michael J, 2007, PLoS Biol, V5, pe92; Daly MJ, 2012, DNA REPAIR, V11, P12, DOI 10.1016/j.dnarep.2011.10.024; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Di Noia JM, 2000, J BIOL CHEM, V275, P10218, DOI 10.1074/jbc.275.14.10218; Diniz LD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002367; Ezkurdia I, 2012, MOL BIOL EVOL, V29, P2265, DOI 10.1093/molbev/mss100; Foth BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r177; Grynberg P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029596; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; HUTCHINSON F, 1985, PROG NUCLEIC ACID RE, V32, P115, DOI 10.1016/S0079-6603(08)60347-5; Jager AV, 2007, P NATL ACAD SCI USA, V104, P2035, DOI 10.1073/pnas.0611125104; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Krisko A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012765; Krisko A, 2012, P NATL ACAD SCI USA, V109, P2354, DOI 10.1073/pnas.1119762109; Krisko A, 2010, P NATL ACAD SCI USA, V107, P14373, DOI 10.1073/pnas.1009312107; Machado FS, 2012, CARDIOL REV, V20, P53, DOI 10.1097/CRD.0b013e31823efde2; Marchini FK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025381; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; Martinez-Calvillo S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/525241; MATTHEWS KR, 1994, GENE DEV, V8, P491, DOI 10.1101/gad.8.4.491; Michaeli S, 2011, FUTURE MICROBIOL, V6, P459, DOI [10.2217/fmb.11.20, 10.2217/FMB.11.20]; Nagajyothi F, 2012, CELL MICROBIOL, V14, P634, DOI 10.1111/j.1462-5822.2012.01764.x; Nie L, 2006, BIOCHEM BIOPH RES CO, V339, P603, DOI 10.1016/j.bbrc.2005.11.055; Ning K, 2012, J PROTEOME RES, V11, P2261, DOI 10.1021/pr201052x; Parodi-Talice A, 2007, J MASS SPECTROM, V42, P1422, DOI 10.1002/jms.1267; Passos-Silva DG, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/840768; Regis-Da-Silva CG, 2006, MOL BIOCHEM PARASIT, V149, P191, DOI 10.1016/j.molbiopara.2006.05.012; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Robinson CK, 2011, J BACTERIOL, V193, P1653, DOI 10.1128/JB.01310-10; Sghaier H, 2013, ANN MICROBIOL, V63, P1483, DOI 10.1007/s13213-013-0612-2; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; Washburn MP, 2003, P NATL ACAD SCI USA, V100, P3107, DOI 10.1073/pnas.0634629100; Zhang CC, 2005, PROTEOMICS, V5, P138, DOI 10.1002/pmic.200300875; Zinoviev A, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/813718	48	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97526	10.1371/journal.pone.0097526	http://dx.doi.org/10.1371/journal.pone.0097526			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842666	Green Published, gold			2022-12-25	WOS:000340948600040
J	Havel, LS; Kline, ER; Salgueiro, AM; Marcus, AI				Havel, L. S.; Kline, E. R.; Salgueiro, A. M.; Marcus, A. I.			Vimentin regulates lung cancer cell adhesion through a VAV2-Rac1 pathway to control focal adhesion kinase activity	ONCOGENE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; EPITHELIAL-MESENCHYMAL TRANSITIONS; ACTIN STRESS FIBERS; ENDOTHELIAL-CELLS; MATRIX ADHESION; GROWTH-FACTOR; INTERMEDIATE-FILAMENTS; CARCINOMA METASTASIS; PROSTATE-CANCER; RAC1 ACTIVATION	Vimentin is an intermediate filament protein whose expression correlates with increased metastatic disease, reduced patient survival and poor prognosis across multiple tumor types. Despite these well-characterized correlations, the molecular role of vimentin in cancer cell motility remains undefined. To approach this, we used an unbiased phosphoproteomics screen in lung cancer cell lines to discover cell motility proteins that show significant changes in phosphorylation upon vimentin depletion. We identified the guanine nucleotide exchange factor (GEF), VAV2, as having the greatest loss of phosphorylation owing to vimentin depletion. Since VAV2 serves as a GEF for the small Rho GTPase Rac1, a key player in cell motility and adhesion, we explored the vimentin-VAV2 pathway as a potential novel regulator of lung cancer cell motility. We show that VAV2 localizes to vimentin-positive focal adhesions (FAs) in lung cancer cells and complexes with vimentin and FA kinase (FAK). Vimentin loss impairs both pY142-VAV2 and downstream pY397-FAK activity showing that vimentin is critical for maintaining VAV2 and FAK activity. Importantly, vimentin depletion reduces the activity of the VAV2 target, Rac1, and a constitutively active Rac1 rescues defects in FAK and cell adhesion when vimentin or VAV2 is compromised. Based upon this data, we propose a model whereby vimentin promotes FAK stabilization through VAV2-mediated Rac1 activation. This model may explain why vimentin expressing metastatic lung cancer cells are more motile and invasive.	[Havel, L. S.; Kline, E. R.; Salgueiro, A. M.; Marcus, A. I.] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	Emory University	Marcus, AI (corresponding author), Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, 1365C Clifton Rd,NE Room C4092, Atlanta, GA 30322 USA.	aimarcu@emory.edu			National Cancer Institute [1R01CA1428580]; Ruth L Kirschstein National Research Service Award [1F32CA168112-01]; Winship and Emory Integrated Cellular Imaging Core; NIH/NCI [P30CA138292]; NATIONAL CANCER INSTITUTE [P30CA138292, R01CA142858, F32CA168112] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ruth L Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Winship and Emory Integrated Cellular Imaging Core; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (1R01CA1428580) awarded to AIM and through a Ruth L Kirschstein National Research Service Award (1F32CA168112-01) awarded to LSH Research reported in this publication was supported in part by the Winship and Emory Integrated Cellular Imaging Core and NIH/NCI under award number P30CA138292. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We would like to thank the Custom Cloning Core at Emory University for generating the mutant FAK constructs and Doris Powell in the laboratory of Paula Vertino for her technical assistance with the quantitative RT-PCR experiments. We would also like to thank Anthea Hammond for reviewing this manuscript. In addition, we thank Keith Burridge at the University of North Carolina for generously supplying us with the VAV2 plasmids.	Abe K, 2000, J BIOL CHEM, V275, P10141, DOI 10.1074/jbc.275.14.10141; Ahn J, 2013, MOL CANCER RES, V11, P952, DOI 10.1158/1541-7786.MCR-13-0003-T; Al-Saad S, 2008, BRIT J CANCER, V99, P1476, DOI 10.1038/sj.bjc.6604713; Baylin SB, 2001, HUM MOL GENET, V10, P687, DOI 10.1093/hmg/10.7.687; BERSHADSKY AD, 1987, CELL MOTIL CYTOSKEL, V8, P274, DOI 10.1002/cm.970080308; Bhattacharya R, 2009, J CELL SCI, V122, P1390, DOI 10.1242/jcs.043042; Burgstaller G, 2010, MOL BIOL CELL, V21, P3362, DOI 10.1091/mbc.E10-02-0094; Carr HS, 2013, MOL CELL BIOL, V33, P622, DOI 10.1128/MCB.00980-12; Chan KT, 2010, J BIOL CHEM, V285, P11418, DOI 10.1074/jbc.M109.090746; Chang FM, 2007, MOL BIOL CELL, V18, P253, DOI 10.1091/mbc.E06-03-0207; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Charrasse S, 2007, MOL BIOL CELL, V18, P1734, DOI 10.1091/mbc.E06-08-0766; Choma DP, 2007, J INVEST DERMATOL, V127, P31, DOI 10.1038/sj.jid.5700505; Citterio C, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002962; Dauphin M, 2013, LUNG CANCER, V81, P117, DOI 10.1016/j.lungcan.2013.03.011; Deakin NO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037990; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Gonzales M, 2001, MOL BIOL CELL, V12, P85, DOI 10.1091/mbc.12.1.85; GREENBURG G, 1982, J CELL BIOL, V95, P333, DOI 10.1083/jcb.95.1.333; Helfand BT, 2011, MOL BIOL CELL, V22, P1274, DOI 10.1091/mbc.E10-08-0699; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hu L, 2004, ONCOGENE, V23, P298, DOI 10.1038/sj.onc.1206483; Ivaska J, 2005, EMBO J, V24, P3834, DOI 10.1038/sj.emboj.7600847; Kallergi G, 2007, CELL PHYSIOL BIOCHEM, V20, P977, DOI 10.1159/000110458; Kreis S, 2005, EXP CELL RES, V305, P110, DOI 10.1016/j.yexcr.2004.12.023; Lai SY, 2008, ORAL ONCOL, V44, P683, DOI 10.1016/j.oraloncology.2007.08.017; Li QF, 2006, J BIOL CHEM, V281, P34716, DOI 10.1074/jbc.M607715200; Lim JA, 2012, FEBS J, V279, P3573, DOI 10.1111/j.1742-4658.2012.08715.x; Liu BP, 2000, MOL CELL BIOL, V20, P7160, DOI 10.1128/MCB.20.19.7160-7169.2000; Liu LK, 2010, MODERN PATHOL, V23, P213, DOI 10.1038/modpathol.2009.160; Liu ZD, 1997, BIOCHEM BIOPH RES CO, V231, P283, DOI 10.1006/bbrc.1997.6083; Marignani PA, 2001, J CELL BIOL, V154, P177, DOI 10.1083/jcb.200103134; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; MILLER SD, 2007, ONCOGENE, V31, P26; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Patz EF, 2004, J CLIN ONCOL, V22, P2202, DOI 10.1200/JCO.2004.12.046; Pisters KMW, 2005, J CLIN ONCOL, V23, P3270, DOI 10.1200/JCO.2005.11.478; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Schuebel KE, 1998, EMBO J, V17, P6608, DOI 10.1093/emboj/17.22.6608; Schuebel KE, 1996, ONCOGENE, V13, P363; SEIFERT GJ, 1992, EUR J CELL BIOL, V59, P138; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Singh GK, 2002, JNCI-J NATL CANCER I, V94, P916, DOI 10.1093/jnci/94.12.916; Singh S, 2003, CANCER RES, V63, P2306; Soltermann A, 2008, CLIN CANCER RES, V14, P7430, DOI 10.1158/1078-0432.CCR-08-0935; STOKER M, 1985, J CELL SCI, V77, P209; Tamas P, 2003, J BIOL CHEM, V278, P5163, DOI 10.1074/jbc.M207555200; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tsuruta D, 2003, J CELL SCI, V116, P4977, DOI 10.1242/jcs.00823; Wang JW, 2009, CANCER LETT, V281, P71, DOI 10.1016/j.canlet.2009.02.020; Wei JC, 2008, ANTICANCER RES, V28, P327; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; Yamauchi J, 2005, P NATL ACAD SCI USA, V102, P14889, DOI 10.1073/pnas.0507125102; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhu QS, 2011, ONCOGENE, V30, P457, DOI 10.1038/onc.2010.421	56	108	112	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 9	2015	34	15					1979	1990		10.1038/onc.2014.123	http://dx.doi.org/10.1038/onc.2014.123			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CF7GY	24858039	Green Accepted			2022-12-25	WOS:000352725600012
J	Hudson, BD; Shimpukade, B; Milligan, G; Ulven, T				Hudson, Brian D.; Shimpukade, Bharat; Milligan, Graeme; Ulven, Trond			The Molecular Basis of Ligand Interaction at Free Fatty Acid Receptor 4 (FFA4/GPR120)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; AGONIST RECOGNITION; CRYSTAL-STRUCTURE; GPR120; GPR40; IDENTIFICATION; POTENT; GPCRS; ANTAGONIST; CHALLENGES	The long-chain fatty acid receptor FFA4 (previously GPR120) is receiving substantial interest as a novel target for the treatment of metabolic and inflammatory disease. This study examines for the first time the detailed mode of binding of both long-chain fatty acid and synthetic agonist ligands at FFA4 by integrating molecular modeling, receptor mutagenesis, and ligand structure-activity relationship approaches in an iterative format. In doing so, residues required for binding of fatty acid and synthetic agonists to FFA4 have been identified. This has allowed for the refinement of a well validated model of the mode of ligand-FFA4 interaction that will be invaluable in the identification of novel ligands and the future development of this receptor as a therapeutic target. The model reliably predicted the effects of substituent variations on agonist potency, and it was also able to predict the qualitative effect of binding site mutations in the majority of cases.	[Hudson, Brian D.; Milligan, Graeme] Univ Glasgow, Mol Pharmacol Grp, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Shimpukade, Bharat; Ulven, Trond] Univ Southern Denmark, Dept Phys Chem & Pharm, DK-5230 Odense M, Denmark	University of Glasgow; University of Southern Denmark	Milligan, G (corresponding author), Univ Glasgow, Wolfson Link Bldg 253, Glasgow G12 8QQ, Lanark, Scotland.	Graeme.Milligan@glasgow.ac.uk; ulven@sdu.dk	Ulven, Trond/H-5500-2015; Hudson, B. D./H-4845-2013	Ulven, Trond/0000-0002-8135-1755; Hudson, B. D./0000-0001-7059-0091; Shimpukade, Bharat/0000-0001-7468-2348	Danish Council for Strategic Research Grant [11-116196]; Biotechnology and Biosciences Research Council [BB/K019864/1]; Canadian Institutes of Health Research; BBSRC [BB/K019864/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K019864/1] Funding Source: researchfish	Danish Council for Strategic Research Grant(Danske Strategiske Forskningsrad (DSF)); Biotechnology and Biosciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Danish Council for Strategic Research Grant 11-116196 (to T. U. and G. M.), the Biotechnology and Biosciences Research Council Grant BB/K019864/1 (to G. M.), and the Canadian Institutes of Health Research fellowship (to B. D. H.).	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Butcher AJ, 2014, J BIOL CHEM, V289, P18451, DOI 10.1074/jbc.M114.568816; Congreve M, 2011, ADV PHARMACOL, V62, P1, DOI 10.1016/B978-0-12-385952-5.00011-7; Correll C. C., 2014, J MED CHEM, DOI 10.1021/jm401677g; Dranse HJ, 2013, BRIT J PHARMACOL, V170, P696, DOI 10.1111/bph.12327; Engelstoft MS, 2013, MOL METAB, V2, P376, DOI 10.1016/j.molmet.2013.08.006; Genheden S, 2012, J CHEM INF MODEL, V52, P3013, DOI [10.1021/ci300349a, 10.1021/ci300349s]; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1215904, 10.1126/science.1244693]; Hara T, 2009, N-S ARCH PHARMACOL, V380, P247, DOI 10.1007/s00210-009-0425-9; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Holliday Nicholas D, 2011, Front Endocrinol (Lausanne), V2, P112, DOI 10.3389/fendo.2011.00112; Hudson BD, 2011, ADV PHARMACOL, V62, P175, DOI 10.1016/B978-0-12-385952-5.00006-3; Hudson BD, 2013, MOL PHARMACOL, V84, P710, DOI 10.1124/mol.113.087783; Hudson BD, 2013, CURR TOP MED CHEM, V13, P14; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Michino M, 2009, NAT REV DRUG DISCOV, V8, P455, DOI 10.1038/nrd2877; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Schrodinger, 2013, LIGPREP VERSION 2 6; Schrodinger L, 2013, SCHRODINGER SUITE 20; Schrodinger LLC, 2012, MACROMODEL VERSION 9; Schrodinger LLC, 2013, PRIME VERSION 3 2; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Shimpukade B, 2012, J MED CHEM, V55, P4511, DOI 10.1021/jm300215x; Shoichet BK, 2012, TRENDS PHARMACOL SCI, V33, P268, DOI 10.1016/j.tips.2012.03.007; Stoddart LA, 2008, J BIOL CHEM, V283, P32913, DOI 10.1074/jbc.M805601200; Sum CS, 2007, J BIOL CHEM, V282, P29248, DOI 10.1074/jbc.M705077200; Sun Q, 2010, MOL PHARMACOL, V78, P804, DOI 10.1124/mol.110.066324; Suzuki T, 2008, J MED CHEM, V51, P7640, DOI 10.1021/jm800970b; Taneera J, 2012, CELL METAB, V16, P122, DOI 10.1016/j.cmet.2012.06.006; Tikhonova IG, 2007, J MED CHEM, V50, P2981, DOI 10.1021/jm0614782; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Watson SJ, 2012, MOL PHARMACOL, V81, P631, DOI 10.1124/mol.111.077388; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004	39	51	52	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20345	20358		10.1074/jbc.M114.561449	http://dx.doi.org/10.1074/jbc.M114.561449			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24860101	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000339395200045
J	Gautrey, HE; van Otterdijk, SD; Cordell, HJ; Mathers, JC; Strathdee, G				Gautrey, Hannah E.; van Otterdijk, Sanne D.; Cordell, Heather J.; Mathers, John C.; Strathdee, Gordon		Newcastle 85 Study Core Team	DNA methylation abnormalities at gene promoters are extensive and variable in the elderly and phenocopy cancer cells	FASEB JOURNAL			English	Article						epigenetics; aging; CpG island; cell type specific	ACUTE LYMPHOBLASTIC-LEUKEMIA; CPG-ISLAND METHYLATION; ACUTE MYELOID-LEUKEMIA; TUMOR-SUPPRESSOR; STEM-CELLS; AGE; HYPERMETHYLATION; GENDER; PROLIFERATION; INACTIVATION	Abnormal patterns of DNA methylation are one of the hallmarks of cancer cells. The process of aging has also been associated with similar, albeit less dramatic, changes in methylation patterns, leading to the hypothesis that age-related changes in DNA methylation may partially underlie the increased risk of cancer in the elderly. Here we studied 377 participants aged 85 yr from the Newcastle 85+ Study to investigate the extent of, and interindividual variation in, age-related changes in DNA methylation at specific CpG islands. Using highly quantitative pyrosequencing analysis, we found extensive and highly variable methylation of promoter-associated CpG islands with levels ranging from 4% to 35%, even at known tumor suppressor genes such as TWIST2. Furthermore, the interindividual differences in methylation seen across this elderly population phenocopies multiple features of the altered methylation patterns seen in cancer cells. Both aging-and cancer-related methylation can occur at similar sets of genes, both result in the formation of densely methylated, and likely transcriptionally repressed, alleles, and both exhibit coordinate methylation across multiple loci. In addition, high methylation levels were associated with subsequent diagnosis of leukemia or lymphoma during a 3-yr follow-up period (P = 0.00008). These data suggest that the accumulation of age-related changes in promoter-associated CpG islands may contribute to the increased cancer risk seen during aging.	[Gautrey, Hannah E.; van Otterdijk, Sanne D.; Strathdee, Gordon] Newcastle Univ, Northern Inst Canc Res, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Cordell, Heather J.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Mathers, John C.] Newcastle Univ, Inst Ageing & Hlth, Human Nutr Res Ctr, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Strathdee, G (corresponding author), Newcastle Univ, Royal Victoria Infirm, Northern Inst Canc Res, Sir James Spence Inst, 5th Floor,Queen Victoria Rd, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	gordon.strathdee@ncl.ac.uk		Robinson, Louise/0000-0003-0209-2503; Jagger, Carol/0000-0002-6377-9926; Strathdee, Gordon/0000-0001-9681-8429; Davies, Karen/0000-0002-2820-9397; Mathers, John/0000-0003-3406-3002; Cordell, Heather/0000-0002-1879-5572	U.K. Medical Research Council; Biotechnology and Biological Sciences Research Council [G0500997]; Newcastle Healthcare Charity; Dunhill Medical Trust; National Institute for Health Research Newcastle Biomedical Research Centre; Rank Prize Funds; Biotechnology and Biological Sciences Research Council; MRC [G0500997, G0700718] Funding Source: UKRI; Medical Research Council [G0700718, G0500997] Funding Source: researchfish; NIHR Newcastle Biomedical Research Centre [BH111030] Funding Source: researchfish	U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Newcastle Healthcare Charity; Dunhill Medical Trust(Dunhill Medical Trust); National Institute for Health Research Newcastle Biomedical Research Centre; Rank Prize Funds; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NIHR Newcastle Biomedical Research Centre	Thanks are especially due to the 85-yr-olds of Newcastle and North Tyneside and their families and care givers, for the generous donation of their time and personal information to make the study possible. In addition we thank the research nurses (Brenda Balderson, Sally Barker, Julie Burrows, June Edwards, Julie Ferguson, Gill Hedley, Joan Hughes, Judith Hunt, Julie Kimber, and Victoria Raynor), biomarker technicians (Sam Jameson, Claire Kolenda, Craig Parker, and Anna Tang), data manager (Pauline Potts), project secretary (Lucy Farfort), and North of England Commissioning Support Unit (formerly NHS North of Tyne, working on behalf of Newcastle PCT, North Tyneside PCT, and Northumberland Care Trust), and local general practices. The baseline phase of the Newcastle 85+ Study was funded by a combined grant from the U.K. Medical Research Council and the Biotechnology and Biological Sciences Research Council (G0500997) and a grant from the Newcastle Healthcare Charity. The research was also supported by the Dunhill Medical Trust and by National Institute for Health Research Newcastle Biomedical Research Centre, based at Newcastle on Tyne Hospitals NHS Foundation Trust and Newcastle University. The Rank Prize Funds supported purchase of the pyrosequencer. H.E.G. was funded by a Ph.D. studentship from the Biotechnology and Biological Sciences Research Council, and S.D.v.O. was funded by a Ph.D. studentship from the National Institute for Health Research Newcastle Biomedical Research Centre.	Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Brennan K, 2012, CANCER RES, V72, P2304, DOI 10.1158/0008-5472.CAN-11-3157; Chase DS, 1998, J MED GENET, V35, P413, DOI 10.1136/jmg.35.5.413; Collerton Joanna, 2007, BMC Geriatr, V7, P14, DOI 10.1186/1471-2318-7-14; Collerton J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4904; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Costello JF, 2001, J MED GENET, V38, P285, DOI 10.1136/jmg.38.5.285; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Di Gioia S, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-89; Fahrner JA, 2002, CANCER RES, V62, P7213; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Ferguson S, 2011, PEDIATR BLOOD CANCER, V56, P349, DOI 10.1002/pbc.22679; Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008; Gemma C, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r43; Herman JG, 1996, CANCER RES, V56, P722; Hughes LAE, 2013, CANCER RES, V73, P5858, DOI 10.1158/0008-5472.CAN-12-4306; Issa JP, 1999, CRIT REV ONCOL HEMAT, V32, P31, DOI 10.1016/S1040-8428(99)00019-0; Jacinto FV, 2007, MUTAGENESIS, V22, P247, DOI 10.1093/mutage/gem009; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Kanaya T, 2003, ONCOGENE, V22, P2352, DOI 10.1038/sj.onc.1206365; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Kuang SQ, 2010, BLOOD, V115, P2412, DOI 10.1182/blood-2009-05-222208; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Kwabi-Addo B, 2007, CLIN CANCER RES, V13, P3796, DOI 10.1158/1078-0432.CCR-07-0085; Martin-Ruiz C, 2011, MECH AGEING DEV, V132, P496, DOI 10.1016/j.mad.2011.08.001; McKay JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033290; Pearce MS, 2009, INT J EPIDEMIOL, V38, P932, DOI 10.1093/ije/dyn184; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Potter C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076506; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Raval A, 2005, J CLIN ONCOL, V23, P3877, DOI 10.1200/JCO.2005.02.196; Scholz C, 2005, ANN HEMATOL, V84, P236, DOI 10.1007/s00277-004-0969-1; Strathdee G, 2007, CARCINOGENESIS, V28, P299, DOI 10.1093/carcin/bgl133; Sullivan MJ, 1999, ONCOGENE, V18, P7527, DOI 10.1038/sj.onc.1203096; Tamura G, 2004, HISTOL HISTOPATHOL, V19, P221, DOI 10.14670/HH-19.221; Tapp HS, 2013, AGING CELL, V12, P148, DOI 10.1111/acel.12030; Teschendorff AE, 2013, HUM MOL GENET, V22, pR7, DOI 10.1093/hmg/ddt375; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Thathia SH, 2012, HAEMATOL-HEMATOL J, V97, P371, DOI 10.3324/haematol.2011.049593; Tong Wei-Gang, 2010, Epigenetics, V5, P499; Toyota M, 1999, SEMIN CANCER BIOL, V9, P349, DOI 10.1006/scbi.1999.0135; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Wikby A, 2008, BIOGERONTOLOGY, V9, P299, DOI 10.1007/s10522-008-9138-6; Yu CE, 2013, HUM MOL GENET, V22, P5036, DOI 10.1093/hmg/ddt354; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005	51	23	23	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					3261	3272		10.1096/fj.13-246173	http://dx.doi.org/10.1096/fj.13-246173			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24858281	Green Submitted			2022-12-25	WOS:000337949400045
J	Davidson, JO; Drury, PP; Green, CR; Nicholson, LF; Bennet, L; Gunn, AJ				Davidson, Joanne O.; Drury, Paul P.; Green, Colin R.; Nicholson, Louise F.; Bennet, Laura; Gunn, Alistair J.			Connexin Hemichannel Blockade Is Neuroprotective after Asphyxia in Preterm Fetal Sheep	PLOS ONE			English	Article							WHITE-MATTER INJURY; GAP-JUNCTIONAL HEMICHANNELS; SEVERE HYPOXIA; CELL-DEATH; CEREBRAL HYPOTHERMIA; CORTICAL ASTROCYTES; PERINATAL ASPHYXIA; NERVOUS-SYSTEM; CORD OCCLUSION; ISCHEMIA	Asphyxia around the time of preterm birth is associated with neurodevelopmental disability. In this study, we tested the hypothesis that blockade of connexin hemichannels would improve recovery of brain activity and reduce cell loss after asphyxia in preterm fetal sheep. Asphyxia was induced by 25 min of complete umbilical cord occlusion in preterm fetal sheep (103-104 d gestational age). Connexin hemichannels were blocked by intracerebroventricular infusion of mimetic peptide starting 90 min after asphyxia at a concentration of 50 mu M/h for one hour followed by 50 mM/24 hour for 24 hours (occlusion-peptide group, n = 6) or vehicle infusion for controls (occlusion-vehicle group, n = 7). Peptide infusion was associated with earlier recovery of electroencephalographic power after asphyxia compared to occlusion-vehicle (p<0.05), with reduced neuronal loss in the caudate and putamen (p<0.05), but not in the hippocampus. In the intragyral and periventricular white matter, peptide administration was associated with an increase in total oligodendrocyte numbers (p<0.05) and immature/mature oligodendrocytes compared to occlusion-vehicle (p<0.05), with a significant increase in proliferation (p<0.05). Connexin hemichannel blockade was neuroprotective and reduced oligodendrocyte death and improved recovery of oligodendrocyte maturation in preterm fetuses after asphyxia.	[Davidson, Joanne O.; Drury, Paul P.; Bennet, Laura; Gunn, Alistair J.] Univ Auckland, Dept Physiol, Auckland, New Zealand; [Green, Colin R.] Univ Auckland, Dept Ophthalmol, Auckland 1, New Zealand; [Nicholson, Louise F.] Univ Auckland, Dept Anat Radiol, Auckland 1, New Zealand	University of Auckland; University of Auckland; University of Auckland	Gunn, AJ (corresponding author), Univ Auckland, Dept Physiol, Auckland, New Zealand.	aj.gunn@auckland.ac.nz	Davidson, Joanne/ABD-1694-2021; Green, Colin R/B-5663-2012	Green, Colin R/0000-0003-3459-6298; Nicholson, Louise/0000-0003-1737-7624; Gunn, Alistair/0000-0003-0656-7035; Davidson, Joanne/0000-0002-6781-4258; Bennet, Laura/0000-0002-4336-7596	Health Research Council of New Zealand; Lottery Health Board of New Zealand	Health Research Council of New Zealand(Health Research Council of New Zealand); Lottery Health Board of New Zealand	This study was funded by the Health Research Council of New Zealand and the Lottery Health Board of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andiman SE, 2010, BRAIN PATHOL, V20, P803, DOI 10.1111/j.1750-3639.2010.00380.x; Back SA, 2006, J CHILD NEUROL, V21, P582, DOI 10.1177/08830738060210070101; Back SA, 2012, NEUROTHERAPEUTICS, V9, P359, DOI 10.1007/s13311-012-0108-y; BARKOVICH AJ, 1990, AM J NEURORADIOL, V11, P1087; BARLOW RM, 1969, J COMP NEUROL, V135, P249, DOI 10.1002/cne.901350302; Barrett RD, 2012, BRAIN RES, V1469, P35, DOI 10.1016/j.brainres.2012.06.018; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Behrman RE, 2007, PRETERM BIRTH CAUSES; Bennet L, 2007, J PHYSIOL-LONDON, V578, P491, DOI 10.1113/jphysiol.2006.119602; Bennet L, 2007, J NEUROPHYSIOL, V97, P572, DOI 10.1152/jn.00957.2006; Bennet L, 1999, J PHYSIOL-LONDON, V517, P247, DOI 10.1111/j.1469-7793.1999.0247z.x; Buser JR, 2012, ANN NEUROL, V71, P93, DOI 10.1002/ana.22627; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Danesh-Meyer HV, 2012, BRAIN, V135, P506, DOI 10.1093/brain/awr338; Davidson JO, 2013, EXP NEUROL, V248, P301, DOI 10.1016/j.expneurol.2013.06.026; Davidson JO, 2012, INT J MOL SCI, V13, P6303, DOI 10.3390/ijms13056303; Davidson JO, 2012, ANN NEUROL, V71, P121, DOI 10.1002/ana.22654; Decrock E, 2009, CELL DEATH DIFFER, V16, P151, DOI 10.1038/cdd.2008.138; Gajda Z, 2003, EPILEPSIA, V44, P1596, DOI 10.1111/j.0013-9580.2003.25803.x; Gajda Z, 2006, EPILEPSIA, V47, P1009, DOI 10.1111/j.1528-1167.2006.00573.x; Gomez-Gonzalo M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000352; GUNN AJ, 1992, PEDIATR RES, V31, P486, DOI 10.1203/00006450-199205000-00016; Hunter CJ, 2003, STROKE, V34, P2240, DOI 10.1161/01.STR.0000083623.77327.CE; Jakovcevski I, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.005.2009; Kang J, 2008, J NEUROSCI, V28, P4702, DOI 10.1523/JNEUROSCI.5048-07.2008; Keogh MJ, 2012, PEDIATR RES, V71, P345, DOI 10.1038/pr.2011.80; Kondo RP, 2000, J MOL CELL CARDIOL, V32, P1859, DOI 10.1006/jmcc.2000.1220; Li HY, 1996, J CELL BIOL, V134, P1019, DOI 10.1083/jcb.134.4.1019; MCINTOSH GH, 1979, NEUROPATH APPL NEURO, V5, P103, DOI 10.1111/j.1365-2990.1979.tb00664.x; Murray DM, 2009, PEDIATRICS, V124, pE459, DOI 10.1542/peds.2008-2190; O'Carroll SJ, 2008, CELL COMMUN ADHES, V15, P27, DOI 10.1080/15419060802014164; Orellana JA, 2010, GLIA, V58, P329, DOI 10.1002/glia.20926; Quaedackers JS, 2004, AM J PHYSIOL-REG I, V286, pR576, DOI 10.1152/ajpregu.00592.2003; Quist AP, 2000, J CELL BIOL, V148, P1063, DOI 10.1083/jcb.148.5.1063; Riddle A, 2011, ANN NEUROL, V70, P493, DOI 10.1002/ana.22501; Rodriguez-Sinovas A, 2007, PROG BIOPHYS MOL BIO, V94, P219, DOI 10.1016/j.pbiomolbio.2007.03.003; Sabir H, 2012, STROKE, V43, P3364, DOI 10.1161/STROKEAHA.112.674481; Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359; van Rooij LGM, 2005, ARCH DIS CHILD-FETAL, V90, P245, DOI 10.1136/adc.2004.064964; Volpe JJ, 2005, PEDIATRICS, V116, P221, DOI 10.1542/peds.2005-0191; Wang XY, 2013, CELL MOL NEUROBIOL, V33, P401, DOI 10.1007/s10571-013-9906-y; Wibbens B, 2005, AM J OBSTET GYNECOL, V193, P803, DOI 10.1016/j.ajog.2005.01.058; WILLIAMS CE, 1992, ANN NEUROL, V31, P14, DOI 10.1002/ana.410310104; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003	44	63	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e96558	10.1371/journal.pone.0096558	http://dx.doi.org/10.1371/journal.pone.0096558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865217	Green Published, gold, Green Submitted			2022-12-25	WOS:000336914100007
J	Heude, E; Shaikho, S; Ekker, M				Heude, Eglantine; Shaikho, Sarah; Ekker, Marc			The dlx5a/dlx6a Genes Play Essential Roles in the Early Development of Zebrafish Median Fin and Pectoral Structures	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; LATE-STAGE ZEBRAFISH; HOMEOBOX GENES; DANIO-RERIO; PAIRED FINS; DISTAL-LESS; DLX GENES; LIMB DEVELOPMENT; NEURAL-TUBE; EXPRESSION PATTERNS	The Dlx5 and Dlx6 genes encode homeodomain transcription factors essential for the proper development of limbs in mammalian species. However, the role of their teleost counterparts in fin development has received little attention. Here, we show that dlx5a is an early marker of apical ectodermal cells of the pectoral fin buds and of the median fin fold, but also of cleithrum precursor cells during pectoral girdle development. We propose that early median fin fold establishment results from the medial convergence of dlx5a-expressing cells at the lateral edges of the neural keel. Expression analysis also shows involvement of dlx5a during appendage skeletogenesis. Using morpholino-mediated knock down, we demonstrate that disrupted dlx5a/6a function results in pectoral fin agenesis associated with misexpression of bmp4, fgf8a, and1 and msx genes. In contrast, the median fin fold presents defects in mesenchymal cell migration and actinotrichia formation, whereas the initial specification seems to occur normally. Our results demonstrate that the dlx5a/6a genes are essential for the induction of pectoral fin outgrowth, but are not required during median fin fold specification. The dlx5a/6a knock down also causes a failure of cleithrum formation associated with a drastic loss of runx2b and col10a1 expression. The data indicate distinct requirements for dlx5a/6a during median and pectoral fin development suggesting that initiation of unpaired and paired fin formation are not directed through the same molecular mechanisms. Our results refocus arguments on the mechanistic basis of paired appendage genesis during vertebrate evolution.	[Heude, Eglantine; Shaikho, Sarah; Ekker, Marc] Univ Ottawa, Dept Biol, Ctr Adv Res Environm Genom, Ottawa, ON, Canada	University of Ottawa	Ekker, M (corresponding author), Museum Natl Hist Nat, CNRS, UMR 7221, Paris, France.	mekker@uottawa.ca	Heude, Eglantine/AAR-4334-2020	Heude, Eglantine/0000-0003-0563-9607	CIHR [MOP14460]; government of Canada	CIHR(Canadian Institutes of Health Research (CIHR)); government of Canada(CGIAR)	This work was supported by CIHR grant MOP14460. EH was a recipient of a postdoctoral fellowship from the government of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe G, 2007, DEV BIOL, V304, P355, DOI 10.1016/j.ydbio.2006.12.040; Acampora D, 1999, DEVELOPMENT, V126, P3795; Ahn D, 2008, DEV BIOL, V322, P220, DOI 10.1016/j.ydbio.2008.06.032; Ahn DG, 2002, NATURE, V417, P754, DOI 10.1038/nature00814; AKIMENKO MA, 1995, DEVELOPMENT, V121, P347; AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Avaron F, 2006, DEV DYNAM, V235, P478, DOI 10.1002/dvdy.20619; Bendall AJ, 2003, INT J DEV BIOL, V47, P335; Beverdam A, 2002, GENESIS, V34, P221, DOI 10.1002/gene.10156; Birnbaum RY, 2012, HUM MOL GENET, V21, P4930, DOI 10.1093/hmg/dds336; Capdevila J, 2001, ANNU REV CELL DEV BI, V17, P87, DOI 10.1146/annurev.cellbio.17.1.87; Choo BG, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-5; COATES MI, 1994, DEVELOPMENT, P169; COHEN SM, 1989, NATURE, V338, P432, DOI 10.1038/338432a0; Crotwell PL, 2007, DEV DYNAM, V236, P3111, DOI 10.1002/dvdy.21352; Crotwell PL, 2001, DEV GENES EVOL, V211, P555, DOI 10.1007/s00427-001-0186-z; DANE PJ, 1985, J EMBRYOL EXP MORPH, V87, P145; Debiais-Thibaud M, 2008, EVOL DEV, V10, P464, DOI 10.1111/j.1525-142X.2008.00257.x; Depew MJ, 2002, SCIENCE, V298, P381, DOI 10.1126/science.1075703; Depew MJ, 1999, DEVELOPMENT, V126, P3831; Depew MJ, 2005, J ANAT, V207, P501, DOI 10.1111/j.1469-7580.2005.00487.x; Ellies DL, 1997, GENOMICS, V45, P580, DOI 10.1006/geno.1997.4978; Esterberg R, 2009, DEV BIOL, V325, P189, DOI 10.1016/j.ydbio.2008.10.017; Ferrari D, 2006, INT J DEV BIOL, V50, P709, DOI 10.1387/ijdb.062180df; Finckbeiner S, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-32; Fischer S, 2003, DEVELOPMENT, V130, P3515, DOI 10.1242/dev.00537; Freitas R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000754; Freitas R, 2006, NATURE, V442, P1033, DOI 10.1038/nature04984; Garrity DM, 2002, DEVELOPMENT, V129, P4635; Gibert Y, 2006, DEVELOPMENT, V133, P2649, DOI 10.1242/dev.02438; Grandel H, 2002, DEVELOPMENT, V129, P2851; Grandel H, 1998, MECH DEVELOP, V79, P99, DOI 10.1016/S0925-4773(98)00176-2; Grandel H, 2000, DEVELOPMENT, V127, P4169; Harrington MJ, 2010, DEV DYNAM, V239, P747, DOI 10.1002/dvdy.22184; He XJ, 2011, DEV BIOL, V357, P463, DOI 10.1016/j.ydbio.2011.07.014; Heude E, 2010, P NATL ACAD SCI USA, V107, P11441, DOI 10.1073/pnas.1001582107; Johanson Z, 2010, J EXP ZOOL PART B, V314B, P347, DOI 10.1002/jez.b.21343; Kague E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047394; Kouwenhoven EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001065; Kraus P, 2006, AM J MED GENET A, V140A, P1366, DOI 10.1002/ajmg.a.31252; Li N, 2009, DEV DYNAM, V238, P459, DOI 10.1002/dvdy.21838; Lo Iacono N, 2008, DEVELOPMENT, V135, P1377, DOI 10.1242/dev.011759; Lowery LA, 2004, MECH DEVELOP, V121, P1189, DOI 10.1016/j.mod.2004.04.022; Mabee PM, 2002, J EXP ZOOL, V294, P77, DOI 10.1002/JEZ.10076; MacDonald RB, 2013, DEV BIOL, V381, P276, DOI 10.1016/j.ydbio.2013.05.025; MacDonald RB, 2010, DEV DYNAM, V239, P2298, DOI 10.1002/dvdy.22365; MacDonald RB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-157; Matsuoka T, 2005, NATURE, V436, P347, DOI 10.1038/nature03837; Merlo GR, 2002, GENESIS, V33, P97, DOI 10.1002/gene.10098; Norton WHJ, 2005, DEVELOPMENT, V132, P4963, DOI 10.1242/dev.02084; Padhi BK, 2004, DEV DYNAM, V231, P527, DOI 10.1002/dvdy.20153; Panganiban G, 2002, DEVELOPMENT, V129, P4371; QIU MS, 1995, GENE DEV, V9, P2523, DOI 10.1101/gad.9.20.2523; Qiu MS, 1997, DEV BIOL, V185, P165, DOI 10.1006/dbio.1997.8556; Quint E, 2000, J EXP ZOOL, V288, P235, DOI 10.1002/1097-010X(20001015)288:3&lt;235::AID-JEZ4&gt;3.0.CO;2-J; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Robledo RF, 2002, GENE DEV, V16, P1089, DOI 10.1101/gad.988402; Ruvinsky I, 2000, DEVELOPMENT, V127, P5233; Shearman RM, 2005, J MORPHOL, V264, P94, DOI 10.1002/jmor.10322; SIMEONE A, 1994, P NATL ACAD SCI USA, V91, P2250, DOI 10.1073/pnas.91.6.2250; Sleptsova-Friedrich I, 2001, MECH DEVELOP, V102, P213, DOI 10.1016/S0925-4773(01)00280-5; Smith A, 2008, DEV DYNAM, V237, P417, DOI 10.1002/dvdy.21417; Smith A, 2006, DEV BIOL, V299, P438, DOI 10.1016/j.ydbio.2006.08.016; Stock DW, 1996, P NATL ACAD SCI USA, V93, P10858, DOI 10.1073/pnas.93.20.10858; Talbot JC, 2010, DEVELOPMENT, V137, P2506, DOI 10.1242/dev.049700; Tanaka M, 2012, EVOL DEV, V14, P412, DOI 10.1111/j.1525-142X.2012.00561.x; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tulenko FJ, 2013, P NATL ACAD SCI USA, V110, P11899, DOI 10.1073/pnas.1304210110; vanEeden FJM, 1996, DEVELOPMENT, V123, P255; Verreijdt L, 2006, DEV DYNAM, V235, P1371, DOI 10.1002/dvdy.20734; Vieux-Rochas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051700; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yang L, 1998, J NEUROSCI, V18, P8322; Yano T, 2012, DEVELOPMENT, V139, P2916, DOI 10.1242/dev.075572; Yonei-Tamura S, 2008, EVOL DEV, V10, P737, DOI 10.1111/j.1525-142X.2008.00288.x; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zerucha T, 2000, BIOCHEM CELL BIOL, V78, P593, DOI 10.1139/bcb-78-5-593; Zhang J, 2010, NATURE, V466, P234, DOI 10.1038/nature09137; Zhu H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008097	80	15	15	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98505	10.1371/journal.pone.0098505	http://dx.doi.org/10.1371/journal.pone.0098505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858471	Green Published, gold, Green Submitted			2022-12-25	WOS:000336839400079
J	Makino, K; Jinnin, M; Aoi, J; Kajihara, I; Makino, T; Fukushima, S; Sakai, K; Nakayama, K; Emoto, N; Yanagisawa, M; Ihn, H				Makino, Katsunari; Jinnin, Masatoshi; Aoi, Jun; Kajihara, Ikko; Makino, Takamitsu; Fukushima, Satoshi; Sakai, Keisuke; Nakayama, Kazuhiko; Emoto, Noriaki; Yanagisawa, Masashi; Ihn, Hironobu			Knockout of Endothelial Cell-Derived Endothelin-1 Attenuates Skin Fibrosis but Accelerates Cutaneous Wound Healing	PLOS ONE			English	Article							BLEOMYCIN-INDUCED SCLERODERMA; GROWTH-FACTOR-BETA; SYSTEMIC-SCLEROSIS; BOSENTAN TREATMENT; BLOOD-PRESSURE; ANIMAL-MODEL; MICE; COLLAGEN; REGENERATION; REPAIR	Endothelin (ET)-1 is known for the most potent vasoconstrictive peptide that is released mainly from endothelial cells. Several studies have reported ET-1 signaling is involved in the process of wound healing or fibrosis as well as vasodilation. However, little is known about the role of ET-1 in these processes. To clarify its mechanism, we compared skin fibrogenesis and wound repair between vascular endothelial cell-specific ET-1 knockout mice and their wild-type littermates. Bleomycin-injected fibrotic skin of the knockout mice showed significantly decreased skin thickness and collagen content compared to that of wild-type mice, indicating that bleomycin-induced skin fibrosis is attenuated in the knockout mice. The mRNA levels of transforming growth factor (TGF)-beta were decreased in the bleomycin-treated skin of ET-1 knockout mice. On the other hand, skin wound healing was accelerated in ET-1 knockout mice, which was indicated by earlier granulation tissue reduction and re-epithelialization in these mice. The mRNA levels of TGF-beta, tumor necrosis factor (TNF)-alpha and connective tissue growth factor (CTGF) were reduced in the wound of ET-1 knockout mice. In endothelial ET-1 knockout mouse, the expression of TNF-alpha, CTGF and TGF-beta was down-regulated. Bosentan, an antagonist of dual ET receptors, is known to attenuate skin fibrosis and accelerate wound healing in systemic sclerosis, and such contradictory effect may be mediated by above molecules. The endothelial cell-derived ET-1 is the potent therapeutic target in fibrosis or wound healing, and investigations of the overall regulatory mechanisms of these pathological conditions by ET-1 may lead to a new therapeutic approach.	[Makino, Katsunari; Jinnin, Masatoshi; Aoi, Jun; Kajihara, Ikko; Makino, Takamitsu; Fukushima, Satoshi; Sakai, Keisuke; Ihn, Hironobu] Kumamoto Univ, Fac Life Sci, Dept Dermatol & Plast Surg, Kumamoto, Japan; [Nakayama, Kazuhiko; Emoto, Noriaki] Kobe Pharmaceut Univ, Kobe, Hyogo 658, Japan; [Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Yanagisawa, Masashi] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki, Japan; [Yanagisawa, Masashi] Univ Tsukuba, Ctr Behav Mol Genet, Tsukuba, Ibaraki, Japan	Kumamoto University; Kobe Pharmaceutical University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Tsukuba; University of Tsukuba	Makino, K (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Dermatol & Plast Surg, Kumamoto, Japan.	mjin@kumamoto-u.ac.jp		Fukushima, Satoshi/0000-0002-0622-7682; Emoto, Noriaki/0000-0001-6673-2616	Japanese Ministry of Education, Science, Sports and Culture; Japanese Ministry of Health, Labour and Welfare	Japanese Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by a grant for scientific research from the Japanese Ministry of Education, Science, Sports and Culture, and by project research on intractable diseases from the Japanese Ministry of Health, Labour and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anggrahini DW, 2009, CARDIOVASC RES, V82, P143, DOI 10.1093/cvr/cvp026; Ashcroft GS, 2012, WOUND REPAIR REGEN, V20, P38, DOI 10.1111/j.1524-475X.2011.00748.x; Avraham T, 2010, AM J PATHOL, V177, P3202, DOI 10.2353/ajpath.2010.100594; Barton M, 2008, CAN J PHYSIOL PHARM, V86, P485, DOI 10.1139/Y08-059; BORDER WA, 1992, J CLIN INVEST, V90, P1, DOI 10.1172/JCI115821; Bullard KM, 2003, WORLD J SURG, V27, P54, DOI 10.1007/s00268-002-6737-2; Ernst C, 2006, J NEUROSCI METH, V150, P138, DOI 10.1016/j.jneumeth.2005.06.018; Ferguson MWJ, 2004, PHILOS T R SOC B, V359, P839, DOI 10.1098/rstb.2004.1475; Giordano N, 2010, INT J IMMUNOPATH PH, V23, P1185, DOI 10.1177/039463201002300422; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Han GW, 2011, AM J PATHOL, V179, P1768, DOI 10.1016/j.ajpath.2011.06.003; Horstmeyer A, 2005, FEBS J, V272, P6297, DOI 10.1111/j.1742-4658.2005.05016.x; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; Kisanuki YY, 2010, HYPERTENSION, V56, P121, DOI 10.1161/HYPERTENSIONAHA.109.138701; Koch RM, 2000, WOUND REPAIR REGEN, V8, P179, DOI 10.1046/j.1524-475x.2000.00179.x; KOMURO I, 1988, FEBS LETT, V238, P249, DOI 10.1016/0014-5793(88)80489-7; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; LOPEZDELEON A, 1985, J HISTOCHEM CYTOCHEM, V33, P737, DOI 10.1177/33.8.2410480; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Matucci-Cerinic M, 2011, ANN RHEUM DIS, V70, P32, DOI 10.1136/ard.2010.130658; Mori R, 2002, FASEB J, V16, P963, DOI 10.1096/fj.01-0776com; Nishida M, 2007, J BIOL CHEM, V282, P23117, DOI 10.1074/jbc.M611780200; Peng HM, 2012, PFLUG ARCH EUR J PHY, V464, P415, DOI 10.1007/s00424-012-1150-7; Rho SS, 2011, BIOCHEM BIOPH RES CO, V404, P103, DOI 10.1016/j.bbrc.2010.11.075; Rodriguez-Pascual F, 2003, CIRC RES, V92, P1288, DOI 10.1161/01.RES.0000078491.79697.7F; Sauter G, 2004, J CARDIOVASC PHARM, V44, pS165, DOI 10.1097/01.fjc.0000166245.28368.ae; SHAH M, 1994, J CELL SCI, V107, P1137; Simonson MS, 2011, J BIOL CHEM, V286, P11003, DOI 10.1074/jbc.M110.190793; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Siqueira MF, 2010, DIABETOLOGIA, V53, P378, DOI 10.1007/s00125-009-1529-y; Tanaka C, 2010, ARTHRITIS RHEUM-US, V62, P1723, DOI 10.1002/art.27428; Watts SW, 2010, AM J PHYSIOL-REG I, V298, pR254, DOI 10.1152/ajpregu.00584.2009; Xu SW, 2007, ARTHRITIS RHEUM-US, V56, P4189, DOI 10.1002/art.23134; Yamamoto T, 2006, ARCH DERMATOL RES, V297, P333, DOI 10.1007/s00403-005-0635-z; Yamamoto T, 1999, J INVEST DERMATOL, V112, P456, DOI 10.1046/j.1523-1747.1999.00528.x; Yamamoto T, 2000, ARCH DERMATOL RES, V292, P535, DOI 10.1007/s004030000183	36	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97972	10.1371/journal.pone.0097972	http://dx.doi.org/10.1371/journal.pone.0097972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853267	Green Published, gold, Green Submitted			2022-12-25	WOS:000338323200036
J	Hombrebueno, JR; Chen, M; Penalva, RG; Xu, HP				Hombrebueno, Jose R.; Chen, Mei; Penalva, Rosana G.; Xu, Heping			Loss of Synaptic Connectivity, Particularly in Second Order Neurons Is a Key Feature of Diabetic Retinal Neuropathy in the Ins2(Akita) Mouse	PLOS ONE			English	Article							AMACRINE CELLS; OSCILLATORY POTENTIALS; RAT; RETINOPATHY; MODEL; NEURODEGENERATION; ABNORMALITIES; INFLAMMATION; THRESHOLD; PATHOLOGY	Retinal neurodegeneration is a key component of diabetic retinopathy (DR), although the detailed neuronal damage remains ill-defined. Recent evidence suggests that in addition to amacrine and ganglion cell, diabetes may also impact on other retinal neurons. In this study, we examined retinal degenerative changes in Ins2(Akita) diabetic mice. In scotopic electroretinograms (ERG), b-wave and oscillatory potentials were severely impaired in 9-month old Ins2(Akita) mice. Despite no obvious pathology in fundoscopic examination, optical coherence tomography (OCT) revealed a progressive thinning of the retina from 3 months onwards. Cone but not rod photoreceptor loss was observed in 3-month-old diabetic mice. Severe impairment of synaptic connectivity at the outer plexiform layer (OPL) was detected in 9-month old Ins2(Akita) mice. Specifically, photoreceptor presynaptic ribbons were reduced by 25% and postsynaptic boutons by 70%, although the density of horizontal, rod- and cone-bipolar cells remained similar to non-diabetic controls. Significant reductions in GABAergic and glycinergic amacrine cells and Brn3a(+) retinal ganglion cells were also observed in 9-month old Ins2(Akita) mice. In conclusion, the Ins2(Akita) mouse develops cone photoreceptor degeneration and the impairment of synaptic connectivity at the OPL, predominately resulting from the loss of postsynaptic terminal boutons. Our findings suggest that the Ins2(Akita) mouse is a good model to study diabetic retinal neuropathy.	[Hombrebueno, Jose R.; Chen, Mei; Penalva, Rosana G.; Xu, Heping] Queens Univ, Ctr Med Expt, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland	Queens University Belfast	Xu, HP (corresponding author), Queens Univ, Ctr Med Expt, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland.	heping.xu@qub.ac.uk	Xu, Heping/A-4430-2008	Xu, Heping/0000-0003-4000-931X; Romero Hombrebueno, Jose/0000-0003-1094-2977	Diabetes UK [11/0004230]	Diabetes UK(Diabetes UK)	This work was supported by Diabetes UK (11/0004230). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonetti D A, 1999, Semin Ophthalmol, V14, P240, DOI 10.3109/08820539909069543; Barber AJ, 2005, INVEST OPHTH VIS SCI, V46, P2210, DOI 10.1167/iovs.04-1340; Barber AJ, 2003, PROG NEURO-PSYCHOPH, V27, P283, DOI 10.1016/S0278-5846(03)00023-X; Barber AJ, 2011, INVEST OPHTH VIS SCI, V52, P1156, DOI 10.1167/iovs.10-6293; BLOODWORTH JMB, 1962, DIABETES, V11, P1; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P263, DOI 10.1002/cne.901880205; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chen HL, 2008, DOC OPHTHALMOL, V117, P129, DOI 10.1007/s10633-008-9114-0; Chen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061381; Gao W, 2011, J BIOMED SCI ENG, V4, P657, DOI [DOI 10.4236/JBISE.2011.410082, 10.4236/jbise.2011.410082]; Gardner TW, 2002, SURV OPHTHALMOL, V47, pS253, DOI 10.1016/S0039-6257(02)00387-9; Gastinger MJ, 2008, INVEST OPHTH VIS SCI, V49, P2635, DOI 10.1167/iovs.07-0683; Gastinger MJ, 2006, INVEST OPHTH VIS SCI, V47, P3143, DOI 10.1167/iovs.05-1376; Han ZC, 2013, INVEST OPHTH VIS SCI, V54, P574, DOI 10.1167/iovs.12-10959; Hombrebueno JR, 2014, TRANSL VIS SCI TECHN, V3, DOI 10.1167/tvst.3.2.3; Hombrebueno JR, 2010, BRAIN RES, V1321, P60, DOI 10.1016/j.brainres.2010.01.051; Ishikawa A, 1996, CURR EYE RES, V15, P63, DOI 10.3109/02713689609017612; Kamal A, 2005, BRAIN RES, V1053, P126, DOI 10.1016/j.brainres.2005.06.036; Klein BEK, 2007, OPHTHAL EPIDEMIOL, V14, P179, DOI 10.1080/09286580701396720; Knott EJ, 2011, EXP EYE RES, V92, P155, DOI 10.1016/j.exer.2010.10.009; Kowluru RA, 2007, EXP DIABETES RES, DOI 10.1155/2007/43603; Kurtenbach A, 2006, VISUAL NEUROSCI, P23651; Leal EC, 2007, INVEST OPHTH VIS SCI, V48, P5257, DOI 10.1167/iovs.07-0112; Lieth E, 2000, CLIN EXP OPHTHALMOL, V28, P3, DOI 10.1046/j.1442-9071.2000.00222.x; McLenachan S, 2013, CLIN EXP OPHTHALMOL, V41, P582, DOI 10.1111/ceo.12084; Murray AR, 2013, INVEST OPHTH VIS SCI, V54, P1689, DOI 10.1167/iovs.12-10921; Ozawa Yoko, 2011, Exp Diabetes Res, V2011, P108328, DOI 10.1155/2011/108328; Paques M, 2007, INVEST OPHTH VIS SCI, V48, P2769, DOI 10.1167/iovs.06-1099; Park SH, 2003, DIABETOLOGIA, V46, P1260, DOI 10.1007/s00125-003-1177-6; Preet A, 2006, MOL CELL BIOCHEM, V289, P137, DOI 10.1007/s11010-006-9156-0; Ramsey DJ, 2006, INVEST OPHTH VIS SCI, V47, P5116, DOI 10.1167/iovs.06-0364; Rice DS, 2000, J COMP NEUROL, V424, P327, DOI 10.1002/1096-9861(20000821)424:2<327::AID-CNE10>3.0.CO;2-6; ROY MS, 1986, ARCH OPHTHALMOL-CHIC, V104, P225; Seki M, 2004, DIABETES, V53, P2412, DOI 10.2337/diabetes.53.9.2412; Smith SB, 2008, INVEST OPHTH VIS SCI, V49, P4154, DOI 10.1167/iovs.08-1824; Szabadfi K, 2012, CELL TISSUE RES, V348, P37, DOI 10.1007/s00441-012-1349-0; Tregear SJ, 1997, EYE, V11, P537, DOI 10.1038/eye.1997.140; TRICK GL, 1988, OPHTHALMOLOGY, V95, P693; Tzekov R, 1999, SURV OPHTHALMOL, V44, P53, DOI 10.1016/S0039-6257(99)00063-6; Vagaja NN, 2013, BRIT J OPHTHALMOL, V97, P1343, DOI 10.1136/bjophthalmol-2013-303201; VANEY DI, 1988, BRAIN RES, V438, P369, DOI 10.1016/0006-8993(88)91366-2; VanGuilder HD, 2008, EUR J NEUROSCI, V28, P1, DOI 10.1111/j.1460-9568.2008.06322.x; WACHTMEISTER L, 1978, INVEST OPHTH VIS SCI, V17, P1176; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; WOLTER JR, 1961, AM J OPHTHALMOL, V51, P1123; Xu HP, 2008, EXP EYE RES, V87, P319, DOI 10.1016/j.exer.2008.06.012; Yamato T, 2004, DIABETES NUTR METAB, V17, P128; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887	48	61	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97970	10.1371/journal.pone.0097970	http://dx.doi.org/10.1371/journal.pone.0097970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848689	Green Published, Green Submitted, gold			2022-12-25	WOS:000336730600073
J	Kaminski, R; Wollebo, HS; Datta, PK; White, MK; Amini, S; Khalili, K				Kaminski, Rafal; Wollebo, Hassen S.; Datta, Prasun K.; White, Martyn K.; Amini, Shohreh; Khalili, Kamel			Interplay of Rad51 with NF-kappa B Pathway Stimulates Expression of HIV-1	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HOMOLOGOUS RECOMBINATION; TRANSCRIPTION FACTOR; DNA-DAMAGE; BINDING PROTEIN; GENE-EXPRESSION; REL DOMAIN; IN-VITRO; ACTIVATION; CELLS	Transcription from the HIV-1 promoter is controlled by a series of ubiquitous and inducible cellular proteins with the ability to enter the nucleus and interact with the promoter. A DNA sequence spanning nucleotides -120 to -80, which supports the association of the inducible NF-kappa B transcription factor, has received much attention. Here we demonstrate that the interplay between Rad51, a key regulator of the homologous recombination pathway of DNA repair and whose level is induced upon HIV-1 infection, with the NF-kappa B pathway, augments transcription of the viral promoter. Evidently, stimulation of the NF-kappa B pathway by PMA and/or TSA promotes association of Rad51 with the LTR DNA sequence and that the p65 subunit of NF-kappa B is important for this event. Our results also demonstrate that, similar to p65, Rad51 utilizes the NF-kappa B pathway to position itself in the nucleus as ectopic expression of an I kappa B mutant impedes its nuclear appearance and transcriptional activity upon the HIV-1 LTR. Treatment of peripheral blood mononuclear cells with small molecules that inhibit Rad51 activity results in greater than 50% decrease in the HIV-1 infection of cells. These observations provide evidence for the involvement of DNA repair factors in control of HIV-1 gene activation and offer a new avenue for the development of anti-viral therapeutics that affect viral gene transcription in latently infected cells.	[Kaminski, Rafal; Wollebo, Hassen S.; Datta, Prasun K.; White, Martyn K.; Amini, Shohreh; Khalili, Kamel] Temple Univ Sch Med, Dept Neurosci, Ctr Neurovirol, Philadelphia, PA 19140 USA; [Amini, Shohreh] Temple Univ, Dept Biol, Coll Sci & Technol, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Khalili, K (corresponding author), Temple Univ Sch Med, Dept Neurosci, Ctr Neurovirol, Philadelphia, PA 19140 USA.	kamel.khalili@temple.edu	Kaminski, Rafal/V-3516-2018	Kaminski, Rafal/0000-0001-8827-6658; Wollebo, Hassen/0000-0003-2285-3496; Datta, Prasun/0000-0001-5133-253X	National Institutes of Health (NIH) [R01 MH092371]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH092177, R01MH093271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033213] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grant number R01 MH092371 awarded by the National Institutes of Health (NIH) to KK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aymard F, 2014, NAT STRUCT MOL BIOL, V21, P366, DOI 10.1038/nsmb.2796; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Benezra M, 2003, J BIOL CHEM, V278, P26333, DOI 10.1074/jbc.M303076200; Brack-Werner R, 1999, AIDS, V13, P1, DOI 10.1097/00002030-199901140-00003; Budke B, 2012, NUCLEIC ACIDS RES, V40, P7347, DOI 10.1093/nar/gks353; Calao M, 2008, TRENDS BIOCHEM SCI, V33, P339, DOI 10.1016/j.tibs.2008.04.015; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Chipitsyna G, 2006, J CELL PHYSIOL, V207, P605, DOI 10.1002/jcp.20612; Chipitsyna G, 2004, ONCOGENE, V23, P2664, DOI 10.1038/sj.onc.1207417; Churchill M, 2013, CURR OPIN HIV AIDS, V8, P165, DOI 10.1097/COH.0b013e32835fc601; Cole Ruth, 1997, P117; Cooper A, 2013, NATURE, V498, P376, DOI 10.1038/nature12274; Cosnefroy O, 2012, J VIROL, V86, P513, DOI 10.1128/JVI.05425-11; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Featherstone C, 1999, CURR BIOL, V9, pR759, DOI 10.1016/S0960-9822(00)80005-6; Feldman I, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.033; Flygare J, 1996, BBA-MOL CELL RES, V1312, P231, DOI 10.1016/0167-4889(96)00040-7; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; Gorrill TS, 2005, VIROLOGY, V335, P1, DOI 10.1016/j.virol.2005.02.006; Habraken Y, 2006, BIOCHEM PHARMACOL, V72, P1132, DOI 10.1016/j.bcp.2006.07.015; Harte MT, 2013, ONCOGENE IN PRESS; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Huang F, 2012, J MED CHEM, V55, P3011, DOI 10.1021/jm201173g; Jayathilaka K, 2008, P NATL ACAD SCI USA, V105, P15848, DOI 10.1073/pnas.0808046105; Lau A, 2005, NAT CELL BIOL, V7, P493, DOI 10.1038/ncb1250; Mbonye U, 2011, CURR HIV RES, V9, P554, DOI 10.2174/157016211798998736; McCool KW, 2012, IMMUNOL REV, V246, P311, DOI 10.1111/j.1600-065X.2012.01101.x; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Pereira LA, 2000, NUCLEIC ACIDS RES, V28, P663, DOI 10.1093/nar/28.3.663; PHARES W, 1992, J VIROL, V66, P7490, DOI 10.1128/JVI.66.12.7490-7498.1992; Quivy V, 2004, BIOCHEM PHARMACOL, V68, P1221, DOI 10.1016/j.bcp.2004.05.039; Raj GV, 1996, J VIROL, V70, P5944, DOI 10.1128/JVI.70.9.5944-5953.1996; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; REDDY EP, 1992, PATHOBIOLOGY, V60, P219; Rom I, 2010, CELL CYCLE, V9, P3715, DOI 10.4161/cc.9.18.12930; ROULSTON A, 1995, MICROBIOL REV, V59, P481, DOI 10.1128/MMBR.59.3.481-505.1995; SCHMITZ ML, 1995, J BIOL CHEM, V270, P7219, DOI 10.1074/jbc.270.13.7219; STEIN B, 1989, MOL CELL BIOL, V9, P5169, DOI 10.1128/MCB.9.11.5169; STEIN B, 1993, MOL CELL BIOL, V13, P3964, DOI 10.1128/MCB.13.7.3964; Sweet T, 2003, J CELL BIOCHEM, V90, P884, DOI 10.1002/jcb.10701; Takahashi K, 1996, ANN NEUROL, V39, P705, DOI 10.1002/ana.410390606; Tarsounas M, 2004, PHILOS T R SOC B, V359, P87, DOI 10.1098/rstb.2003.1368; TAYLOR JP, 1992, EMBO J, V11, P3395, DOI 10.1002/j.1460-2075.1992.tb05418.x; TAYLOR JP, 1994, ADV NEUROIMMUNOL, V4, P291, DOI 10.1016/S0960-5428(06)80270-6; Trillo-Pazos G, 2003, BRAIN PATHOL, V13, P144; VALERIE K, 1988, NATURE, V333, P78, DOI 10.1038/333078a0; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Volcic M, 2012, NUCLEIC ACIDS RES, V40, P181, DOI 10.1093/nar/gkr687; WALLACE BM, 1992, SCIENCE, V257, P1211, DOI 10.1126/science.1519057; Wollebo HS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-264; Wu LX, 2013, RADIAT RES, V179, P160, DOI 10.1667/RR3034.1; Wu Yuntao, 2004, Retrovirology, V1, P13, DOI 10.1186/1742-4690-1-13; Yong VW, 1997, PROTOCOLS NEURAL CEL, P117	55	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98304	10.1371/journal.pone.0098304	http://dx.doi.org/10.1371/journal.pone.0098304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847939	Green Submitted, Green Published, gold			2022-12-25	WOS:000336730600107
J	Mann, AJ; Noulin, N; Catchpole, A; Stittelaar, KJ; de Waal, L; Kroeze, EJBV; Hinchcliffe, M; Smith, A; Montomoli, E; Piccirella, S; Osterhaus, ADME; Knight, A; Oxford, JS; Lapini, G; Cox, R; Lambkin-Williams, R				Mann, Alex J.; Noulin, Nicolas; Catchpole, Andrew; Stittelaar, Koert J.; de Waal, Leon; Kroeze, Edwin J. B. Veldhuis; Hinchcliffe, Michael; Smith, Alan; Montomoli, Emanuele; Piccirella, Simona; Osterhaus, Albert D. M. E.; Knight, Alastair; Oxford, John S.; Lapini, Giulia; Cox, Rebecca; Lambkin-Williams, Rob			Intranasal H5N1 Vaccines, Adjuvanted with Chitosan Derivatives, Protect Ferrets against Highly Pathogenic Influenza Intranasal and Intratracheal Challenge	PLOS ONE			English	Article							IMMUNE-RESPONSES; VIRUS-INFECTION; ANIMAL-MODELS; EFFICACY; TRANSMISSION; IMMUNIZATION; IMMUNOGENICITY; HEMAGGLUTININ; PROSPECTS; MUCOSAL	We investigated the protective efficacy of two intranasal chitosan (CSN and TM-CSN) adjuvanted H5N1 Influenza vaccines against highly pathogenic avian Influenza (HPAI) intratracheal and intranasal challenge in a ferret model. Six groups of 6 ferrets were intranasally vaccinated twice, 21 days apart, with either placebo, antigen alone, CSN adjuvanted antigen, or TMCSN adjuvanted antigen. Homologous and intra-subtypic antibody cross-reacting responses were assessed. Ferrets were inoculated intratracheally (all treatments) or intranasally (CSN adjuvanted and placebo treatments only) with clade 1 HPAI A/Vietnam/1194/2004 (H5N1) virus 28 days after the second vaccination and subsequently monitored for morbidity and mortality outcomes. Clinical signs were assessed and nasal as well as throat swabs were taken daily for virology. Samples of lung tissue, nasal turbinates, brain, and olfactory bulb were analysed for the presence of virus and examined for histolopathological findings. In contrast to animals vaccinated with antigen alone, the CSN and TM-CSN adjuvanted vaccines induced high levels of antibodies, protected ferrets from death, reduced viral replication and abrogated disease after intratracheal challenge, and in the case of CSN after intranasal challenge. In particular, the TM-CSN adjuvanted vaccine was highly effective at eliciting protective immunity from intratracheal challenge; serologically, protective titres were demonstrable after one vaccination. The 2-dose schedule with TM-CSN vaccine also induced cross-reactive antibodies to clade 2.1 and 2.2 H5N1 viruses. Furthermore ferrets immunised with TM-CSN had no detectable virus in the respiratory tract or brain, whereas there were signs of virus in the throat and lungs, albeit at significantly reduced levels, in CSN vaccinated animals. This study demonstrated for the first time that CSN and in particular TM-CSN adjuvanted intranasal vaccines have the potential to protect against significant mortality and morbidity arising from infection with HPAI H5N1 virus.	[Mann, Alex J.; Noulin, Nicolas; Catchpole, Andrew; Oxford, John S.; Lambkin-Williams, Rob] Retroscreen Virol, London, England; [Stittelaar, Koert J.; de Waal, Leon; Kroeze, Edwin J. B. Veldhuis; Osterhaus, Albert D. M. E.] Viroclin Biosci BV, Rotterdam, Netherlands; [Hinchcliffe, Michael; Smith, Alan] Archimedes Dev Ltd, Nottingham, England; [Montomoli, Emanuele; Lapini, Giulia] Univ Siena, I-53100 Siena, Italy; [Montomoli, Emanuele; Piccirella, Simona] VisMederi LifeSci Srl, Siena, Italy; [Osterhaus, Albert D. M. E.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Knight, Alastair] Evicom, Teddington, Middx, England; [Cox, Rebecca] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Cox, Rebecca] Haukeland Hosp, Dept Res & Dev, N-5021 Bergen, Norway	University of Siena; Erasmus University Rotterdam; Erasmus MC; University of Bergen; University of Bergen; Haukeland University Hospital	Mann, AJ (corresponding author), Retroscreen Virol, London, England.	a.mann@retroscreen.com	MONTOMOLI, EMANUELE/Q-2122-2015; Lambkin-Williams, Rob/L-2397-2019; Lambkin-Williams, Robert/P-5963-2016	MONTOMOLI, EMANUELE/0000-0001-7595-4974; Lambkin-Williams, Rob/0000-0003-2107-0174; Lambkin-Williams, Robert/0000-0003-2107-0174; Cox, Rebecca Jane/0000-0002-8341-4078; Mann, Alexander/0000-0002-3744-4604	FP7 EU grant [202083]	FP7 EU grant	This work was supported by an FP7 EU grant (Grant Agreement number 202083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baras B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001401; Bodewes R, 2011, CLIN VACCINE IMMUNOL, V18, P469, DOI 10.1128/CVI.00396-10; Bodewes R, 2010, J VIROL, V84, P7943, DOI 10.1128/JVI.00549-10; Bodewes R, 2011, AM J PATHOL, V179, P30, DOI 10.1016/j.ajpath.2011.03.026; Bodewes R, 2010, EXPERT REV VACCINES, V9, P59, DOI [10.1586/erv.09.148, 10.1586/ERV.09.148]; Brown IH, 2009, INFLUENZA OTHER RESP, V3, P59, DOI 10.1111/j.1750-2659.2009.00078.x; Buchy P, 2007, J CLIN VIROL, V39, P164, DOI 10.1016/j.jcv.2007.04.010; Buricchi F, 2012, EUR J IMMUNOL; CHMP, 1997, CHMPBWP21496 EMEA; Chowell G, 2008, EPIDEMIOL INFECT, V136, P852, DOI 10.1017/S0950268807009144; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; EMEA, 2007, GUID INFL VACC PREP; Forrest HL, 2009, VACCINE, V27, P4187, DOI 10.1016/j.vaccine.2009.04.050; Govorkova EA, 2006, J INFECT DIS, V194, P159, DOI 10.1086/505225; Gustin KM, 2011, J INFECT DIS, V204, P1491, DOI 10.1093/infdis/jir596; Heffernan MJ, 2011, BIOMATERIALS, V32, P926, DOI 10.1016/j.biomaterials.2010.09.058; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jabbal-Gill I, 2012, EXPERT OPIN DRUG DEL, V9, P1051, DOI 10.1517/17425247.2012.697455; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; Kuiken T, 2010, VET PATHOL, V47, P893, DOI 10.1177/0300985810378651; Lipatov AS, 2006, J INFECT DIS, V194, P1040, DOI 10.1086/507709; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Mann A, 2006, VACCINE, V24, P4290, DOI 10.1016/j.vaccine.2006.03.004; de Jong MD, 2008, PEDIATR INFECT DIS J, V27, pS54, DOI 10.1097/INF.0b013e3181684d2d; Middleton D, 2009, J VIROL, V83, P7770, DOI 10.1128/JVI.00241-09; Palmer DF, 1975, IMMUNOLOGY SERIES, V6, P25; Rao SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009812; Rockman S, 2010, HUM VACCINES, V6, P792, DOI 10.4161/hv.6.10.12915; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Sahni JK, 2008, J PHARM PHARMACOL, V60, P1111, DOI 10.1211/jpp.60.9.0001; SCHILD GC, 1975, B WORLD HEALTH ORGAN, V52, P43; Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x; Stittelaar KJ, 2011, VACCINE, V29, P9265, DOI 10.1016/j.vaccine.2011.09.049; Suguitan AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021942; Svindland SC, 2012, INFLUENZA OTHER RESP, V6, P90, DOI 10.1111/j.1750-2659.2011.00271.x; van den Brand JMA, 2012, VET PATHOL, V49, P562, DOI 10.1177/0300985811429812; van der Laan JW, 2008, EXPERT REV VACCINES, V7, P783, DOI 10.1586/14760584.7.6.783; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; WHO, 2012, INFL HUM AN INT; WHO/PED, 2003, CUM NUMB CONF HUM CA	41	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e93761	10.1371/journal.pone.0093761	http://dx.doi.org/10.1371/journal.pone.0093761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24850536	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600003
J	Abeysekara, NS; Bhattacharyya, MK				Abeysekara, Nilwala S.; Bhattacharyya, Madan K.			Analyses of the Xylem Sap Proteomes Identified Candidate Fusarium virguliforme Proteinacious Toxins	PLOS ONE			English	Article							SUDDEN-DEATH SYNDROME; CERATO-PLATANIN; RICH PROTEINS; GLYCINE-MAX; 1ST MEMBER; SOLANI; DEFENSE; EXPRESSION; FAMILY; PURIFICATION	Background: Sudden death syndrome (SDS) caused by the ascomycete fungus, Fusarium virguliforme, exhibits root necrosis and leaf scorch or foliar SDS. The pathogen has never been identified from the above ground diseased foliar tissues. Foliar SDS is believed to be caused by host selective toxins, including FvTox1, secreted by the fungus. This study investigated if the xylem sap of F. virguliforme-infected soybean plants contains secreted F. virguliforme-proteins, some of which could cause foliar SDS development. Results: Xylem sap samples were collected from five biological replications of F. virguliforme-infected and uninfected soybean plants under controlled conditions. We identified five F. virguliforme proteins from the xylem sap of the F. virguliforme-infected soybean plants by conducting LC-ESI-MS/MS analysis. These five proteins were also present in the excreted proteome of the pathogen in culture filtrates. One of these proteins showed high sequence identity to ceratoplatanin, a phytotoxin produced by Ceratocystis fimbriata f. sp. platani to cause canker stain disease in the plane tree. Of over 500 soybean proteins identified in this study, 112 were present in at least 80% of the sap samples collected from F. virguliforme-infected and - uninfected control plants. We have identified four soybean defense proteins from the xylem sap of F. virguliforme-infected soybean plants. The data have been deposited to the ProteomeXchange with identifier PXD000873. Conclusion: This study confirms that a few F. virguliforme proteins travel through the xylem, some of which could be involved in foliar SDS development. We have identified five candidate proteinaceous toxins, one of which showed high similarity to a previously characterized phytotoxin. We have also shown the presence of four soybean defense proteins in the xylem sap of F. virguliforme-infected soybean plants. This study laid the foundation for studying the molecular basis of foliar SDS development in soybean and possible defense mechanisms that may be involved in conferring immunity against F. virguliforme and other soybean pathogens.	[Abeysekara, Nilwala S.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA; [Abeysekara, Nilwala S.; Bhattacharyya, Madan K.] Iowa State Univ, Dept Agron, Ames, IA 50011 USA	Iowa State University; Iowa State University	Bhattacharyya, MK (corresponding author), Iowa State Univ, Dept Agron, Ames, IA 50011 USA.	mbhattac@iastate.edu			United Soybean Board (USB)	United Soybean Board (USB)	The authors are thankful to United Soybean Board (USB) for funding this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki T, 2008, PLANT CELL PHYSIOL, V49, P767, DOI 10.1093/pcp/pcn049; Alvarez S, 2006, J PROTEOME RES, V5, P963, DOI 10.1021/pr050471q; Anderson TR, 1998, PLANT DIS, V82, P448, DOI 10.1094/PDIS.1998.82.4.448D; Aoki T, 2003, MYCOLOGIA, V95, P660, DOI 10.2307/3761942; Aoki Takayuki, 2005, Mycoscience, V46, P162, DOI 10.1007/s10267-005-0235-y; Babadoost M, 1997, 512 RPD; Bernardi R, 2011, FOREST PATHOL, V41, P255, DOI 10.1111/j.1439-0329.2010.00668.x; BILES CL, 1991, PLANT PHYSIOL, V96, P597, DOI 10.1104/pp.96.2.597; Brar HK, 2012, MOL PLANT MICROBE IN, V25, P817, DOI 10.1094/MPMI-12-11-0317; Brar HK, 2011, MOL PLANT MICROBE IN, V24, P1179, DOI 10.1094/MPMI-12-10-0285; Butzen S, 2010, CROP INSIGHTS, V19, P1; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa A, 2009, BLAST2GO TUTORIAL; Dafoe NJ, 2009, PHYTOCHEMISTRY, V70, P856, DOI 10.1016/j.phytochem.2009.04.016; de Oliveira AL, 2011, J BIOL CHEM, V286, P17560, DOI 10.1074/jbc.M111.223644; Djordjevic MA, 2007, J PROTEOME RES, V6, P3771, DOI 10.1021/pr0606833; Fontana F, 2008, J PLANT PATHOL, V90, P295; Hartman GL, 1997, PLANT DIS, V81, P515, DOI 10.1094/PDIS.1997.81.5.515; Houterman PM, 2007, MOL PLANT PATHOL, V8, P215, DOI 10.1111/J.1364-3703.2007.00384.X; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Ji J, 2006, PLANT BIOLOGY, V8, P597, DOI 10.1055/s-2006-924175; Jin H, 1996, PHYTOPATHOLOGY, V86, P277, DOI 10.1094/Phyto-86-277; Kav Nat N. V., 2007, Current Proteomics, V4, P28; Kehr J, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-11; Kim ST, 2004, PROTEOMICS, V4, P3569, DOI 10.1002/pmic.200400999; Krishnan HB, 2011, PLANTA, V233, P921, DOI 10.1007/s00425-011-1352-9; Lee J, 2006, MOL PLANT PATHOL, V7, P405, DOI 10.1111/j.1364-3703.2006.00350.x; Li S, 1999, PLANT CELL REP, V18, P375, DOI 10.1007/s002990050589; Li SX, 2000, PLANT PHYSIOL BIOCH, V38, P803, DOI 10.1016/S0981-9428(00)01180-3; Ligat L, 2011, PROTEOMICS, V11, P1798, DOI 10.1002/pmic.201000781; LIGHTFOOT DA, 2007, Patent No. 7288386; Mehta A, 2008, FEBS J, V275, P3731, DOI 10.1111/j.1742-4658.2008.06528.x; Nakajima T, 1996, JARQ-JPN AGR RES Q, V30, P31; Pazzagli L, 1999, J BIOL CHEM, V274, P24959, DOI 10.1074/jbc.274.35.24959; Pazzagli L, 2006, CELL BIOCHEM BIOPHYS, V44, P512, DOI 10.1385/CBB:44:3:512; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ploper LD, 1993, AVANCE AGROINDUSTRIA; Pos Veronika, 2005, Acta Biologica Szegediensis, V49, P31; Pudake RN, 2013, CURR GENET, DOI 10-1007/s00294-013-0392-z; Rep M, 2003, FEBS LETT, V534, P82, DOI 10.1016/S0014-5793(02)03788-2; Rep M, 2002, PLANT PHYSIOL, V130, P904, DOI 10.1104/pp.007427; ROY KW, 1989, PHYTOPATHOLOGY, V79, P191, DOI 10.1094/Phyto-79-191; RUPE JC, 1989, PLANT DIS, V73, P581, DOI 10.1094/PD-73-0581; Sakuta C, 2000, PLANT CELL PHYSIOL, V41, P627, DOI 10.1093/pcp/41.5.627; Scala A, 2004, J PLANT PATHOL, V86, P27; SCHAAF J, 1995, PLANT PHYSIOL, V108, P949, DOI 10.1104/pp.108.3.949; SELABUURLAGE MB, 1993, PLANT PHYSIOL, V101, P857, DOI 10.1104/pp.101.3.857; SIMMONS CR, 1994, CRIT REV PLANT SCI, V13, P325, DOI 10.1080/07352680490484569; Srivastava SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081832; STINTZI A, 1993, BIOCHIMIE, V75, P687, DOI 10.1016/0300-9084(93)90100-7; Subramanian S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-119; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; WOLOSHUK CP, 1991, PLANT CELL, V3, P619, DOI 10.1105/tpc.3.6.619; Wrather JA, 2006, J NEMATOL, V38, P173; Wrather JA, 2011, SOYBEAN DIS LOSS EST; Zhou WC, 2006, PROTEOMICS, V6, P4599, DOI 10.1002/pmic.200600052	56	38	39	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e93667	10.1371/journal.pone.0093667	http://dx.doi.org/10.1371/journal.pone.0093667			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845418	gold, Green Submitted, Green Published			2022-12-25	WOS:000339563400001
J	Luo, HJ; Deng, WQ; Zou, K				Luo, Hua-Jun; Deng, Wei-Qiao; Zou, Kun			Protonated Form: The Potent Form of Potassium-Competitive Acid Blockers	PLOS ONE			English	Article							GASTRIC H,K ATPASE; PUMP INHIBITORS; H,K-ATPASE; MECHANISM; VESICLES; GENERATION; MANAGEMENT; SORAPRAZAN; TRANSPORT; TAK-438	Potassium-competitive acid blockers (P-CABs) are highly safe and active drugs targeting H+,K+-ATPase to cure acid-related gastric diseases. In this study, we for the first time investigate the interaction mechanism between the protonated form of P-CABs and human H+,K+-ATPase using homology modeling, molecular docking, molecular dynamics and binding free energy calculation methods. The results explain why P-CABs have higher activities with higher pKa values or at lower pH. With positive charge, the protonated forms of P-CABs have more competitive advantage to block potassium ion into luminal channel and to bind with H+,K+-ATPase via electrostatic interactions. The binding affinity of the protonated form is more favorable than that of the neutral P-CABs. In particular, Asp139 should be a very important binding site for the protonated form of P-CABs through hydrogen bonds and electrostatic interactions. These findings could promote the rational design of novel P-CABs.	[Luo, Hua-Jun; Deng, Wei-Qiao; Zou, Kun] China Three Gorges Univ, Coll Chem & Life Sci, Hubei Key Lab Nat Prod Res & Dev, Yichang, Hubei, Peoples R China; [Deng, Wei-Qiao] Chinese Acad Sci, Dalian Inst Chem Phys, Dalian, Liaoning, Peoples R China	China Three Gorges University; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS	Zou, K (corresponding author), China Three Gorges Univ, Coll Chem & Life Sci, Hubei Key Lab Nat Prod Res & Dev, Yichang, Hubei, Peoples R China.	kzou_ctgu@163.com	Deng, Wei-Qiao/AAB-6502-2020	Deng, Wei-Qiao/0000-0002-3671-5951				Abe K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1154; Abe K, 2009, EMBO J, V28, P1637, DOI 10.1038/emboj.2009.102; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson K, 2005, PHARMACOL THERAPEUT, V108, P294, DOI 10.1016/j.pharmthera.2005.05.005; [Anonymous], 2013, ACD I LAB VERS 12 01; [Anonymous], 2012, DESM MOL DYN SYST VE; [Anonymous], 2010, GLID VERS 5 6; [Anonymous], 2012, MAESTR VERS 9 3; [Anonymous], 2010, LIGPREP VERS 2 4; Arikawa Y, 2012, J MED CHEM, V55, P4446, DOI 10.1021/jm300318t; Asano S, 1997, J BIOL CHEM, V272, P17668, DOI 10.1074/jbc.272.28.17668; BEIL W, 1986, BRIT J PHARMACOL, V88, P19, DOI 10.1111/j.1476-5381.1986.tb09466.x; BELL NJV, 1992, DIGESTION, V51, P59, DOI 10.1159/000200917; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bytzer P, 2003, AM J GASTROENTEROL, V98, pS31, DOI 10.1016/S0002-9270(03)00013-3; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Dent J, 2008, AM J GASTROENTEROL, V103, P20, DOI 10.1111/j.1572-0241.2007.01544.x; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gedda K, 2007, BIOCHEM PHARMACOL, V73, P198, DOI 10.1016/j.bcp.2006.09.020; HALL K, 1990, BIOCHEMISTRY-US, V29, P701, DOI 10.1021/bi00455a016; Hori Y, 2010, J PHARMACOL EXP THER, V335, P231, DOI 10.1124/jpet.110.170274; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jain KS, 2007, BIOORGAN MED CHEM, V15, P1181, DOI 10.1016/j.bmc.2006.07.068; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE J, 1974, BIOCHEM BIOPH RES CO, V60, P825, DOI 10.1016/0006-291X(74)90315-5; Lee JW, 1998, Pyrimidine derivatives and processes for the preparation thereof, Patent No. [US005750531A, 005750531]; Li H, 2013, EXPERT OPIN THER PAT, V23, P99, DOI 10.1517/13543776.2013.741121; Li W, 2011, INT J PHARMACEUT, V408, P157, DOI 10.1016/j.ijpharm.2011.01.059; MAEDA M, 1990, J BIOL CHEM, V265, P9027; MAEDA M, 1988, BIOCHEM BIOPH RES CO, V157, P203, DOI 10.1016/S0006-291X(88)80033-0; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; Matsukawa J, 2011, BIOCHEM PHARMACOL, V81, P1145, DOI 10.1016/j.bcp.2011.02.009; MUNSON KB, 1991, J BIOL CHEM, V266, P18976; Munson K, 2007, BIOCHEMISTRY-US, V46, P5398, DOI 10.1021/bi062305h; Murphy RB, 2000, J COMPUT CHEM, V21, P1442, DOI 10.1002/1096-987X(200012)21:16<1442::AID-JCC3>3.0.CO;2-O; Philipp DM, 1999, J COMPUT CHEM, V20, P1468, DOI 10.1002/(SICI)1096-987X(19991115)20:14<1468::AID-JCC2>3.0.CO;2-0; Robinson M, 2002, PHARM THER J, V27, P202; Sachs G, 2006, ALIMENT PHARM THERAP, V23, P2, DOI 10.1111/j.1365-2036.2006.02943.x; Sachs G, 2007, J CLIN GASTROENTEROL, V41, pS226, DOI 10.1097/MCG.0b013e31803233b7; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scarpignato C., 2007, DRUG DISCOV TODAY, V4, P155; Scarpignato C, 2008, CURR OPIN PHARMACOL, V8, P677, DOI 10.1016/j.coph.2008.09.004; Schrodinger LLC, 2012, PYMOL MOL GRAPH SYST; Schrodinger LLC, 2010, MACROMODEL VERS 9 8; SCOTT CK, 1987, BIOCHEM PHARMACOL, V36, P97, DOI 10.1016/0006-2952(87)90386-8; Senn-Bilfinger J, 2006, TETRAHEDRON LETT, V47, P3321, DOI 10.1016/j.tetlet.2006.02.156; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Shin JM, 2006, DIGEST DIS SCI, V51, P823, DOI 10.1007/s10620-005-9042-8; Shin JM, 2011, J PHARMACOL EXP THER, V339, P412, DOI 10.1124/jpet.111.185314; Shin JM, 2009, PFLUG ARCH EUR J PHY, V457, P609, DOI 10.1007/s00424-008-0495-4; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b; Simon WA, 2007, J PHARMACOL EXP THER, V321, P866, DOI 10.1124/jpet.107.120428; Vagin O, 2002, BIOCHEMISTRY-US, V41, P12755, DOI 10.1021/bi025921w; Vagin O, 2001, BIOCHEMISTRY-US, V40, P7480, DOI 10.1021/bi0105328; WOLOSIN JM, 1985, AM J PHYSIOL, V248, pG595, DOI 10.1152/ajpgi.1985.248.6.G595; Yoon YA, 2010, BIOORG MED CHEM LETT, V20, P5735, DOI 10.1016/j.bmcl.2010.08.007	60	9	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97688	10.1371/journal.pone.0097688	http://dx.doi.org/10.1371/journal.pone.0097688			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845980	Green Published, gold, Green Submitted			2022-12-25	WOS:000339563400044
J	Paul, P; Simm, S; Mirus, O; Scharf, KD; Fragkostefanakis, S; Schleiff, E				Paul, Puneet; Simm, Stefan; Mirus, Oliver; Scharf, Klaus-Dieter; Fragkostefanakis, Sotirios; Schleiff, Enrico			The Complexity of Vesicle Transport Factors in Plants Examined by Orthology Search	PLOS ONE			English	Article							ADP-RIBOSYLATION FACTOR; GTP-BINDING PROTEIN; CLATHRIN-ASSOCIATED PROTEINS; ARABIDOPSIS POLLEN TUBES; PLASMA-MEMBRANE PROTEINS; AP-3 ADAPTER COMPLEX; RING FINGER PROTEIN; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; GOLGI-APPARATUS	Vesicle transport is a central process to ensure protein and lipid distribution in eukaryotic cells. The current knowledge on the molecular components and mechanisms of this process is majorly based on studies in Saccharomyces cerevisiae and Arabidopsis thaliana, which revealed 240 different proteinaceous factors either experimentally proven or predicted to be involved in vesicle transport. In here, we performed an orthologue search using two different algorithms to identify the components of the secretory pathway in yeast and 14 plant genomes by using the 'core-set' of 240 factors as bait. We identified 4021 orthologues and (co-) orthologues in the discussed plant species accounting for components of COP-II, COP-I, Clathrin Coated Vesicles, Retromers and ESCRTs, Rab GTPases, Tethering factors and SNAREs. In plants, we observed a significantly higher number of (co-) orthologues than yeast, while only 8 tethering factors from yeast seem to be absent in the analyzed plant genomes. To link the identified (co-) orthologues to vesicle transport, the domain architecture of the proteins from yeast, genetic model plant A. thaliana and agriculturally relevant crop Solanum lycopersicum has been inspected. For the orthologous groups containing (co-) orthologues from yeast, A. thaliana and S. lycopersicum, we observed the same domain architecture for 79% (416/527) of the (co-) orthologues, which documents a very high conservation of this process. Further, publically available tissue-specific expression profiles for a subset of (co-) orthologues found in A. thaliana and S. lycopersicum suggest that some (co-) orthologues are involved in tissue-specific functions. Inspection of localization of the (co-) orthologues based on available proteome data or localization predictions lead to the assignment of plastid-as well as mitochondrial localized (co-) orthologues of vesicle transport factors and the relevance of this is discussed.	[Paul, Puneet; Simm, Stefan; Mirus, Oliver; Scharf, Klaus-Dieter; Fragkostefanakis, Sotirios; Schleiff, Enrico] Goethe Univ Frankfurt, Dept Biosci Mol Cell Biol Plants, D-60054 Frankfurt, Germany; [Schleiff, Enrico] Goethe Univ Frankfurt, Cluster Excellence Frankfurt, D-60054 Frankfurt, Germany; [Schleiff, Enrico] Goethe Univ Frankfurt, Ctr Membrane Prote, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Schleiff, E (corresponding author), Goethe Univ Frankfurt, Dept Biosci Mol Cell Biol Plants, D-60054 Frankfurt, Germany.	Schleiff@bio.uni-frankfurt.de	Schleiff, Enrico/C-5105-2017; Simm, Stefan/AAX-4991-2020; Fragkostefanakis, Sotirios/AFR-5656-2022; Paul, Puneet/ABC-6326-2020	Schleiff, Enrico/0000-0002-0518-3489; Fragkostefanakis, Sotirios/0000-0001-5311-7868; Paul, Puneet/0000-0001-8220-8021	Deutsche Forschungsgemeinschaft [SFB807-P17]; SPOT-ITN/Marie Curie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); SPOT-ITN/Marie Curie	The work was supported by grants from the Deutsche Forschungsgemeinschaft SFB807-P17 to ES and from SPOT-ITN/Marie Curie to ES and KDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; ACHSTETTER T, 1988, J BIOL CHEM, V263, P11711; Aker J, 2006, J STRUCT BIOL, V156, P62, DOI 10.1016/j.jsb.2006.03.004; Alexander L, 2002, J EXP BOT, V53, P2039, DOI 10.1093/jxb/erf072; ANAI T, 1991, GENE, V108, P259, DOI 10.1016/0378-1119(91)90442-E; Andag U, 2001, J BIOL CHEM, V276, P39150, DOI 10.1074/jbc.M105833200; Anders N, 2008, PLANT CELL, V20, P142, DOI 10.1105/tpc.107.056515; Andersson MX, 2007, J BIOL CHEM, V282, P1170, DOI 10.1074/jbc.M608124200; Andersson MX, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-40; Andrade-Navarro MA, 2009, CURR OPIN CELL BIOL, V21, P560, DOI 10.1016/j.ceb.2009.04.005; Angers CG, 2011, SEMIN CELL DEV BIOL, V22, P18, DOI 10.1016/j.semcdb.2010.07.003; Antonny B, 1997, J BIOL CHEM, V272, P30848, DOI 10.1074/jbc.272.49.30848; ANUNTALABHOCHAI S, 1991, PLANT J, V1, P167, DOI 10.1111/j.1365-313X.1991.00167.x; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; Asaoka R., 2012, PLANT J; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; BANFIELD DK, 1995, NATURE, V375, P806, DOI 10.1038/375806a0; BARLOWE C, 1993, J BIOL CHEM, V268, P873; Barlowe C, 1997, J CELL BIOL, V139, P1097, DOI 10.1083/jcb.139.5.1097; BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; BarPeled M, 1997, PLANT PHYSIOL, V114, P315, DOI 10.1104/pp.114.1.315; BARPELED M, 1995, PLANT CELL, V7, P667, DOI 10.1105/tpc.7.6.667; Barth M, 2004, J CELL SCI, V117, P2051, DOI 10.1242/jcs.01062; Bassham DC, 1998, PLANT PHYSIOL, V117, P407, DOI 10.1104/pp.117.2.407; BASSHAM DC, 1995, P NATL ACAD SCI USA, V92, P7262, DOI 10.1073/pnas.92.16.7262; Bassham Diane C, 2008, Arabidopsis Book, V6, pe0116, DOI 10.1199/tab.0116; Batoko H, 2001, CURR BIOL, V11, pR423, DOI 10.1016/S0960-9822(01)00251-2; Beck R, 2009, FEBS LETT, V583, P2701, DOI 10.1016/j.febslet.2009.07.032; Belles-Boix E, 2000, J EXP BOT, V51, P1761, DOI 10.1093/jexbot/51.351.1761; Ben-Menachem R, 2011, PROTEOMICS, V11, P4468, DOI 10.1002/pmic.201100199; Bergmann DC, 2001, TRENDS PLANT SCI, V6, P235, DOI 10.1016/S1360-1385(01)01959-8; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Borghese R, 2004, APPL ENVIRON MICROB, V70, P6595, DOI 10.1128/AEM.70.11.6595-6602.2004; Briesemeister S, 2010, NUCLEIC ACIDS RES, V38, pW497, DOI 10.1093/nar/gkq477; Brodsky FM, 2012, ANNU REV CELL DEV BI, V28, P309, DOI 10.1146/annurev-cellbio-101011-155716; Cai Y, 2012, TRAFFIC, V13, P1023, DOI 10.1111/j.1600-0854.2012.01360.x; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; Carter C, 2004, PLANT CELL, V16, P3285, DOI 10.1105/tpc.104.027078; Chatre L, 2005, PLANT PHYSIOL, V139, P1244, DOI 10.1104/pp.105.067447; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Chen X, 2011, CURR OPIN PLANT BIOL, V14, P674, DOI 10.1016/j.pbi.2011.08.006; Chen Y, 2005, J MOL BIOL, V350, P92, DOI 10.1016/j.jmb.2005.04.061; Chong YT, 2010, NEW PHYTOL, V185, P401, DOI 10.1111/j.1469-8137.2009.03070.x; Chow CM, 2008, PLANT CELL, V20, P101, DOI 10.1105/tpc.107.052001; Coe JGS, 1999, MOL BIOL CELL, V10, P2407, DOI 10.1091/mbc.10.7.2407; Conibear E, 2003, MOL BIOL CELL, V14, P1610, DOI 10.1091/mbc.E02-10-0654; Connerly PL, 2005, CURR BIOL, V15, P1439, DOI 10.1016/j.cub.2005.06.065; Cosson P, 1996, EMBO J, V15, P1792, DOI 10.1002/j.1460-2075.1996.tb00528.x; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; Dong QF, 2004, NUCLEIC ACIDS RES, V32, pD354, DOI 10.1093/nar/gkh046; Du SY, 2012, PLANT MOL BIOL, V80, P519, DOI 10.1007/s11103-012-9965-3; DUDEN R, 1994, J BIOL CHEM, V269, P24486; Duden R, 1998, EMBO J, V17, P985, DOI 10.1093/emboj/17.4.985; EAKLE KA, 1988, MOL CELL BIOL, V8, P4098, DOI 10.1128/MCB.8.10.4098; Ebersberger I, 2013, NUCL ACIDS RES; Ebine K, 2008, PLANT CELL, V20, P3006, DOI 10.1105/tpc.107.057711; Edgar R, 2006, NAT BIOTECHNOL, V24, P1471, DOI 10.1038/nbt1206-1471; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Enami K, 2009, PLANT CELL PHYSIOL, V50, P280, DOI 10.1093/pcp/pcn197; ESPENSHADE P, 1995, J CELL BIOL, V131, P311, DOI 10.1083/jcb.131.2.311; Faso C, 2009, PLANT CELL, V21, P3655, DOI 10.1105/tpc.109.068262; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Feraru E, 2012, PLANT CELL, V24, P3074, DOI 10.1105/tpc.112.098152; Feraru E, 2010, PLANT CELL, V22, P2812, DOI 10.1105/tpc.110.075424; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; FRANCO M, 1995, J BIOL CHEM, V270, P1337, DOI 10.1074/jbc.270.3.1337; Franco-Zorrilla JM, 2002, PLANT PHYSIOL, V128, P418, DOI 10.1104/pp.010323; Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; Froehlich JE, 2003, J PROTEOME RES, V2, P413, DOI 10.1021/pr034025j; Garcia C, 2010, PLANT J, V63, P73, DOI 10.1111/j.1365-313X.2010.04225.x; Gaut BS, 1997, P NATL ACAD SCI USA, V94, P6809, DOI 10.1073/pnas.94.13.6809; Gebbie LK, 2005, J EXP BOT, V56, P1079, DOI 10.1093/jxb/eri099; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Gerhardt B, 1998, J BIOL CHEM, V273, P15818, DOI 10.1074/jbc.273.25.15818; GERICH B, 1995, P NATL ACAD SCI USA, V92, P3229, DOI 10.1073/pnas.92.8.3229; Gillingham AK, 2004, J CELL BIOL, V167, P281, DOI 10.1083/jcb.200407088; Gillingham AK, 2003, BBA-MOL CELL RES, V1641, P71, DOI 10.1016/S0167-4889(03)00088-0; Gillingham AK, 2002, MOL BIOL CELL, V13, P3761, DOI 10.1091/mbc.E02-06-0349; GIMENO RE, 1995, J CELL BIOL, V131, P325, DOI 10.1083/jcb.131.2.325; GRIFF IC, 1992, J BIOL CHEM, V267, P12106; Grosshans BL, 2006, J CELL BIOL, V172, P55, DOI 10.1083/jcb.200510016; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Guda C, 2004, BIOINFORMATICS, V20, P1785, DOI 10.1093/bioinformatics/bth171; Guermonprez H, 2008, J EXP BOT, V59, P3087, DOI 10.1093/jxb/ern162; Guo W, 1999, J BIOL CHEM, V274, P23558, DOI 10.1074/jbc.274.33.23558; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Haffani YZ, 2006, PLANT SIGNAL BEHAV, V1, P251, DOI 10.4161/psb.1.5.3324; Hala M, 2008, PLANT CELL, V20, P1330, DOI 10.1105/tpc.108.059105; Halachmi N, 1996, J NEUROCHEM, V66, P889; Hanson PI, 2000, NAT STRUCT BIOL, V7, P347, DOI 10.1038/75103; Hanton SL, 2008, PLANT MOL BIOL, V67, P283, DOI 10.1007/s11103-008-9317-5; Happel N, 2004, PLANT J, V37, P678, DOI 10.1111/j.1365-313X.2003.01995.x; HARDWICK KG, 1992, J CELL BIOL, V119, P513, DOI 10.1083/jcb.119.3.513; Hashiguchi Y, 2010, PLANT CELL, V22, P159, DOI 10.1105/tpc.109.069294; Hashimoto K, 2008, J EXP BOT, V59, P3523, DOI 10.1093/jxb/ern202; Heazlewood JL, 2004, PLANT CELL, V16, P241, DOI 10.1105/tpc.016055; Hettema EH, 2003, EMBO J, V22, P548, DOI 10.1093/emboj/cdg062; Hierro A, 2004, NATURE, V431, P221, DOI 10.1038/nature02914; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; Horazdovsky BF, 1996, J BIOL CHEM, V271, P33607, DOI 10.1074/jbc.271.52.33607; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hu JP, 2012, PLANT CELL, V24, P2279, DOI 10.1105/tpc.112.096586; Huang CF, 1999, J BIOL CHEM, V274, P3819, DOI 10.1074/jbc.274.6.3819; Hummel M, 2012, PROTEOMICS, V12, P1024, DOI 10.1002/pmic.201100413; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Hwang I, 2009, CURR OPIN PLANT BIOL, V12, P660, DOI 10.1016/j.pbi.2009.09.012; Ibl V, 2012, J PROTEOME RES, V11, P397, DOI 10.1021/pr200845n; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishikawa T, 2005, J GEN APPL MICROBIOL, V51, P73, DOI 10.2323/jgam.51.73; Ito J, 2011, J PROTEOME RES, V10, P1571, DOI 10.1021/pr1009433; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jaillais Y, 2007, CELL, V130, P1057, DOI 10.1016/j.cell.2007.08.040; Jaillais Y, 2006, NATURE, V443, P106, DOI 10.1038/nature05046; Jedd G, 1997, J CELL BIOL, V137, P563, DOI 10.1083/jcb.137.3.563; Jensen D, 2011, J CELL SCI, V124, P1, DOI 10.1242/jcs.069773; Jia DJ, 2009, J INTEGR PLANT BIOL, V51, P762, DOI 10.1111/j.1744-7909.2009.00858.x; Jiang DH, 2009, PLANT CELL, V21, P1733, DOI 10.1105/tpc.109.067967; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Johansen JN, 2009, J EXP BOT, V60, P3179, DOI 10.1093/jxb/erp153; Kamena F, 2004, SCIENCE, V304, P286, DOI 10.1126/science.1095049; Kato N, 2010, PLANT PHYSIOL, V152, P590, DOI 10.1104/pp.109.148700; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Khan NZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059898; Kirasak K, 2010, PROTOPLASMA, V241, P51, DOI 10.1007/s00709-010-0105-0; KIRCHHAUSEN T, 1991, J BIOL CHEM, V266, P11153; Kitakura S, 2011, PLANT CELL, V23, P1920, DOI 10.1105/tpc.111.083030; Kjer-Nielsen L, 1999, CURR BIOL, V9, P385, DOI 10.1016/S0960-9822(99)80168-7; Kleffmann T, 2004, CURR BIOL, V14, P354, DOI 10.1016/j.cub.2004.02.039; Kleine-Vehn J, 2009, PLANT CELL, V21, P3839, DOI 10.1105/tpc.109.071639; Koh EJ, 2009, PLANT MOL BIOL, V70, P113, DOI 10.1007/s11103-009-9460-7; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Kosodo Y, 2003, BIOSCI BIOTECH BIOCH, V67, P448, DOI 10.1271/bbb.67.448; Kwon C, 2008, NATURE, V451, P835, DOI 10.1038/nature06545; Kwon SI, 2010, PLANT J, V64, P151, DOI 10.1111/j.1365-313X.2010.04315.x; Lam SK, 2011, P NATL ACAD SCI USA, V108, pE51, DOI 10.1073/pnas.1103526108; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Latijnhouwers M, 2005, CURR OPIN PLANT BIOL, V8, P632, DOI 10.1016/j.pbi.2005.09.014; Latijnhouwers M, 2007, J EXP BOT, V58, P4373, DOI 10.1093/jxb/erm304; LEBAS M, 1994, PLANT PHYSIOL, V106, P809, DOI 10.1104/pp.106.2.809; Lee FJS, 1997, J BIOL CHEM, V272, P30998, DOI 10.1074/jbc.272.49.30998; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; LEMMON SK, 1987, SCIENCE, V238, P504, DOI 10.1126/science.3116672; Leshem Y, 2010, J EXP BOT, V61, P2615, DOI 10.1093/jxb/erq099; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Li BJ, 1996, J BIOL CHEM, V271, P16813, DOI 10.1074/jbc.271.28.16813; Li LX, 2013, PLANT J, V76, P781, DOI 10.1111/tpj.12347; Lipka V, 2007, ANNU REV CELL DEV BI, V23, P147, DOI 10.1146/annurev.cellbio.23.090506.123529; Lobstein E, 2004, PLANT PHYSIOL, V135, P1480, DOI 10.1104/pp.103.037747; Lockstone HE, 2011, BRIEF BIOINFORM, V12, P634, DOI 10.1093/bib/bbq086; Luo YJ, 2013, PLANT J, V75, P377, DOI 10.1111/tpj.12207; Lupas A, 1997, CURR OPIN STRUC BIOL, V7, P388, DOI 10.1016/S0959-440X(97)80056-5; Lupashin VV, 1997, MOL BIOL CELL, V8, P2659, DOI 10.1091/mbc.8.12.2659; Maldonado-Mendoza IE, 1997, PLANT MOL BIOL, V35, P865, DOI 10.1023/A:1005923829224; Mannella CA, 2001, IUBMB LIFE, V52, P93, DOI 10.1080/15216540152845885; McNew JA, 1998, FEBS LETT, V435, P89, DOI 10.1016/S0014-5793(98)01044-8; McNew JA, 1997, J BIOL CHEM, V272, P17776, DOI 10.1074/jbc.272.28.17776; Mehrshahi P, 2013, P NATL ACAD SCI USA, V110, P12126, DOI 10.1073/pnas.1306331110; Meiling-Wesse K, 2005, J BIOL CHEM, V280, P33669, DOI 10.1074/jbc.M501701200; Meyer D, 2009, PLANT J, V57, P986, DOI 10.1111/j.1365-313X.2008.03743.x; Miller E, 2002, EMBO J, V21, P6105, DOI 10.1093/emboj/cdf605; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Mitra SK, 2009, J PROTEOME RES, V8, P2752, DOI 10.1021/pr801044y; Morsomme P, 2002, DEV CELL, V2, P307, DOI 10.1016/S1534-5807(02)00133-8; Mulkidjanian AY, 2005, BIOCHEMISTRY-MOSCOW+, V70, P251, DOI 10.1007/s10541-005-0108-1; NAKAJIMA H, 1991, J CELL BIOL, V113, P245, DOI 10.1083/jcb.113.2.245; Nakamura N, 1997, J BIOL CHEM, V272, P11344; NAKANO A, 1988, J CELL BIOL, V107, P851, DOI 10.1083/jcb.107.3.851; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; Nakano RT, 2009, PLANT CELL, V21, P3672, DOI 10.1105/tpc.109.068270; NAKAYAMA Y, 1991, EUR J BIOCHEM, V202, P569, DOI 10.1111/j.1432-1033.1991.tb16409.x; Nebenfuhr A, 2000, PLANT PHYSIOL, V124, P135, DOI 10.1104/pp.124.1.135; NEHRBASS U, 1990, CELL, V61, P979, DOI 10.1016/0092-8674(90)90063-K; Niihama M, 2005, CURR BIOL, V15, P555, DOI 10.1016/j.cub.2005.02.021; Nodzynski T, 2013, MOL PLANT, V6, P1849, DOI 10.1093/mp/sst044; Nothwehr SF, 1997, J CELL SCI, V110, P1063; ODonnell PJ, 1996, SCIENCE, V274, P1914, DOI 10.1126/science.274.5294.1914; Olinares PDB, 2010, MOL CELL PROTEOMICS, V9, P1594, DOI 10.1074/mcp.M000038-MCP201; Orci L, 2000, P NATL ACAD SCI USA, V97, P10400, DOI 10.1073/pnas.190292497; Orci L, 1997, CELL, V90, P335, DOI 10.1016/S0092-8674(00)80341-4; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Panek HR, 1997, EMBO J, V16, P4194, DOI 10.1093/emboj/16.14.4194; Paul P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-189; Peng JL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-25; Peng RW, 2000, J BIOL CHEM, V275, P11521, DOI 10.1074/jbc.275.15.11521; PHAN HL, 1994, EMBO J, V13, P1706, DOI 10.1002/j.1460-2075.1994.tb06435.x; PIPER RC, 1994, EUR J CELL BIOL, V65, P305; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; Popoff V, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005231; Preuss ML, 2004, PLANT CELL, V16, P1589, DOI 10.1105/tpc.021634; PROTOPOPOV V, 1993, CELL, V74, P855, DOI 10.1016/0092-8674(93)90465-3; PRYER NK, 1993, J CELL BIOL, V120, P865, DOI 10.1083/jcb.120.4.865; RAD MR, 1995, J CELL SCI, V108, P1605; Ram RJ, 2002, MOL BIOL CELL, V13, P1484, DOI 10.1091/mbc.01-10-0495; Raturi A, 2013, BBA-MOL CELL RES, V1833, P213, DOI 10.1016/j.bbamcr.2012.04.013; RAYMOND CK, 1990, J CELL BIOL, V111, P877, DOI 10.1083/jcb.111.3.877; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Renna L, 2005, PLANT MOL BIOL, V58, P109, DOI 10.1007/s11103-005-4618-4; Reyes FC, 2011, CURR OPIN PLANT BIOL, V14, P666, DOI 10.1016/j.pbi.2011.07.009; Richter S, 2007, NATURE, V448, P488, DOI 10.1038/nature05967; Rieder SE, 1997, MOL BIOL CELL, V8, P2307, DOI 10.1091/mbc.8.11.2307; Robinson DG, 2007, CRIT REV PLANT SCI, V26, P199, DOI 10.1080/07352680701495820; Robinson DG, 2011, PLANT CELL, V23, P846, DOI 10.1105/tpc.110.082099; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Rojo E, 2003, MOL BIOL CELL, V14, P361, DOI 10.1091/mbc.E02-08-0509; Rojo E, 2001, DEV CELL, V1, P303, DOI 10.1016/S1534-5807(01)00024-7; ROSSI G, 1995, MOL BIOL CELL, V6, P1769, DOI 10.1091/mbc.6.12.1769; Sacher M, 2000, EUR J CELL BIOL, V79, P71, DOI 10.1078/S0171-9335(04)70009-6; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; Salama NR, 1997, MOL BIOL CELL, V8, P205, DOI 10.1091/mbc.8.2.205; Sanderfoot AA, 2000, PLANT PHYSIOL, V124, P1558, DOI 10.1104/pp.124.4.1558; Sanderfoot AA, 1998, P NATL ACAD SCI USA, V95, P9920, DOI 10.1073/pnas.95.17.9920; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Sato TK, 1998, MOL CELL BIOL, V18, P5308, DOI 10.1128/MCB.18.9.5308; Scheele U, 2002, FEBS LETT, V514, P355, DOI 10.1016/S0014-5793(02)02439-0; Scheuring D, 2011, PLANT CELL, V23, P3463, DOI 10.1105/tpc.111.086918; Schiller M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-123; SCHIMMOLLER F, 1993, J CELL SCI, V106, P823; Schlueter JA, 2008, J HERED, V99, P390, DOI 10.1093/jhered/esn010; Schlueter SD, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r111; Schmitt HD, 2010, TRENDS CELL BIOL, V20, P257, DOI 10.1016/j.tcb.2010.02.001; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Shirakawa M, 2010, PLANT J, V64, P924, DOI 10.1111/j.1365-313X.2010.04394.x; SINGERKRUGER B, 1994, J CELL BIOL, V125, P283, DOI 10.1083/jcb.125.2.283; Sjolander K, 2011, BRIEF BIOINFORM, V12, P413, DOI 10.1093/bib/bbr036; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Smith AC, 2009, MOL CELL PROTEOMICS, V8, P1324, DOI 10.1074/mcp.M800373-MCP200; Soldatova O, 2005, MOL GENET GENOMICS, V273, P311, DOI 10.1007/s00438-005-1129-6; Song J, 2006, PLANT CELL, V18, P2258, DOI 10.1105/tpc.105.039123; Sonnhammer ELL, 2002, TRENDS GENET, V18, P619, DOI 10.1016/S0168-9525(02)02793-2; Spang A, 2008, CELL MOL LIFE SCI, V65, P2781, DOI 10.1007/s00018-008-8349-y; Spang A, 2001, MOL BIOL CELL, V12, P1035, DOI 10.1091/mbc.12.4.1035; Spitzer C, 2006, DEVELOPMENT, V133, P4679, DOI 10.1242/dev.02654; Spitzer C, 2009, PLANT CELL, V21, P749, DOI 10.1105/tpc.108.064865; Srivastava A, 2000, GENETICS, V156, P105; Stachowiak JC, 2013, NAT CELL BIOL, V15, P1019, DOI 10.1038/ncb2832; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; STEARNS T, 1990, MOL CELL BIOL, V10, P6690, DOI 10.1128/MCB.10.12.6690; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; Supek F, 2002, J CELL BIOL, V158, P1029, DOI 10.1083/jcb.200207053; Sutter JU, 2006, TRAFFIC, V7, P627, DOI 10.1111/j.1600-0854.2006.00414.x; Swaminathan K, 2008, TRENDS PLANT SCI, V13, P647, DOI 10.1016/j.tplants.2008.09.006; Synek L, 2006, PLANT J, V48, P54, DOI 10.1111/j.1365-313X.2006.02854.x; Sztul E, 2006, AM J PHYSIOL-CELL PH, V290, pC11, DOI 10.1152/ajpcell.00293.2005; Szumlanski AL, 2009, PLANT CELL, V21, P526, DOI 10.1105/tpc.108.060277; Tai WCS, 2001, FEBS LETT, V500, P177, DOI 10.1016/S0014-5793(01)02599-6; Takagi J, 2013, PLANT CELL, V25, P4658, DOI 10.1105/tpc.113.118158; Takahashi H, 2010, PLANT CELL PHYSIOL, V51, P1777, DOI 10.1093/pcp/pcq137; Takatsu H, 2001, BIOCHEM BIOPH RES CO, V284, P1083, DOI 10.1006/bbrc.2001.5081; Tamura K, 2010, PLANT CELL, V22, P4084, DOI 10.1105/tpc.110.079947; Tanaka H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003540; Tanz SK, 2013, NUCLEIC ACIDS RES, V41, pD1185, DOI 10.1093/nar/gks1151; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Thellmann M, 2010, PLANT PHYSIOL, V154, P720, DOI 10.1104/pp.110.154286; Tian GW, 2004, PLANT PHYSIOL, V135, P25, DOI 10.1104/pp.104.040139; Traub LM, 1999, P NATL ACAD SCI USA, V96, P8907, DOI 10.1073/pnas.96.16.8907; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Tyrrell M, 2007, PLANT J, V51, P1099, DOI 10.1111/j.1365-313X.2007.03206.x; Uemura T, 2004, CELL STRUCT FUNCT, V29, P49, DOI 10.1247/csf.29.49; Uemura T, 2012, P NATL ACAD SCI USA, V109, P1784, DOI 10.1073/pnas.1115146109; Uemura T, 2010, PLANT J, V64, P864, DOI 10.1111/j.1365-313X.2010.04372.x; Vanoosthuyse V, 2003, PLANT PHYSIOL, V133, P919, DOI 10.1104/pp.103.023846; Vernoud V, 2003, PLANT PHYSIOL, V131, P1191, DOI 10.1104/pp.013052; Villarejo A, 2005, NAT CELL BIOL, V7, P1224, DOI 10.1038/ncb1330; Wadskog I, 2004, MOL BIOL CELL, V15, P1436, DOI 10.1091/mbc.E03-02-0114; Weber T, 2000, J CELL BIOL, V149, P1063, DOI 10.1083/jcb.149.5.1063; Whyte JRC, 2002, J CELL SCI, V115, P2627; Winter V, 2006, TRENDS PLANT SCI, V11, P115, DOI 10.1016/j.tplants.2006.01.008; Wishart MJ, 2001, CELL, V105, P817, DOI 10.1016/S0092-8674(01)00414-7; Woollard AAD, 2008, CURR OPIN PLANT BIOL, V11, P610, DOI 10.1016/j.pbi.2008.09.010; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Xu WJ, 2004, MOL BIOL CELL, V15, P5528, DOI 10.1091/mbc.E04-08-0666; Yamazaki M, 2008, PLANT CELL PHYSIOL, V49, P142, DOI 10.1093/pcp/pcn006; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327; Zhang Y, 2010, PLANT PHYSIOL, V152, P2200, DOI 10.1104/pp.109.142349; Zhang Y, 2013, NEW PHYTOL, V199, P74, DOI 10.1111/nph.12236; Zhang ZJ, 2011, PROTEOMICS, V11, P1780, DOI 10.1002/pmic.201000648; Zhao YB, 2012, BIOINFORMATICS, V28, P416, DOI 10.1093/bioinformatics/btr655; Zheng HQ, 2005, PLANT CELL, V17, P2020, DOI 10.1105/tpc.105.031112; Zheng HY, 2002, PLANT PHYSIOL, V129, P530, DOI 10.1104/pp.003970; Zhu JH, 2002, PLANT CELL, V14, P3009, DOI 10.1105/tpc.006981; Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013; Zwiewka M, 2011, CELL RES, V21, P1711, DOI 10.1038/cr.2011.99; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	293	28	28	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97745	10.1371/journal.pone.0097745	http://dx.doi.org/10.1371/journal.pone.0097745			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844592	Green Published, Green Submitted, gold			2022-12-25	WOS:000339563400055
J	Johns, DJ; Lindroos, AK; Jebb, SA; Sjostrom, L; Carlsson, LMS; Ambrosini, GL				Johns, David J.; Lindroos, Anna Karin; Jebb, Susan A.; Sjostrom, Lars; Carlsson, Lena M. S.; Ambrosini, Gina L.			Tracking of a Dietary Pattern and Its Components over 10-Years in the Severely Obese	PLOS ONE			English	Article							PHYSICAL-ACTIVITY INTERVENTIONS; CARDIOVASCULAR RISK-FACTORS; BODY-MASS INDEX; LIFE-STYLE; AMSTERDAM-GROWTH; CHILDHOOD; ENERGY; ADOLESCENCE; CONSUMPTION; STABILITY	Understanding how dietary intake changes over time is important for studies of diet and disease and may inform interventions to improve dietary intakes. We investigated how a dietary pattern (DP) tracked over 10-years in the Swedish Obese Subjects (SOS) study control group. Dietary intake was assessed at multiple time-points in 2037 severely obese individuals (BMI 4164 kg/m(2)). Reduced rank regression was used to derive a dietary pattern using dietary energy density (kJ/g), saturated fat (%) and fibre density (mg/kJ) as response variables and score respondents at each follow-up. Tracking coefficients for the DP, its key foods and macronutrient response variables and corrected for time-dependent and time-independent covariates were calculated using generalised estimating equations to take into account all available data. The DP tracking coefficient was moderate for women (0.40; 95% CI: 0.38-0.42) and men (0.38; 95% CI: 0.35-0.41). Of the eleven foods key to this DP, fruit and vegetable intakes had the strongest tracking coefficient for both sexes. Fast food and candy had the lowest tracking coefficients for women and men respectively. Scores for an energy dense, high saturated fat, low fibre density DP appear moderately stable over a 10-year period in this severely obese population. Furthermore, some food groups appear more amenable to change while others, often the most healthful, appear more stable and may require intervention before adulthood.	[Johns, David J.; Jebb, Susan A.; Ambrosini, Gina L.] Med Res Council Human Nutr Res, Elsie Widdowson Lab, Cambridge, England; [Sjostrom, Lars; Carlsson, Lena M. S.] Univ Gothenburg, Inst Med, Gothenburg, Sweden; [Lindroos, Anna Karin] Natl Food Adm Toxicol Lab, Uppsala, Sweden	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Cambridge; University of Gothenburg	Johns, DJ (corresponding author), Med Res Council Human Nutr Res, Elsie Widdowson Lab, Cambridge, England.	david.johns@mrc-hnr.cam.ac.uk	Ambrosini, Gina/E-7107-2010; Carlsson, Lena/F-7570-2018	Ambrosini, Gina/0000-0003-1001-4265; Carlsson, Lena/0000-0003-4145-6242; Jebb, Susan/0000-0001-9190-2920	UK Medical Research Council [U105960389]; MRC PhD studentship; MRC [MC_U105960389] Funding Source: UKRI; Medical Research Council [MC_U105960389] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC PhD studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a programme grant from the UK Medical Research Council (U105960389 Nutrition and Health) and a MRC PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini GL, 2013, OBESITY; Borland SE, 2008, EUR J CLIN NUTR, V62, P119, DOI 10.1038/sj.ejcn.1602684; Collins CE, 2011, PUBLIC HEALTH NUTR, V14, P168, DOI 10.1017/S1368980010001916; Crozier SR, 2009, J NUTR, V139, P1956, DOI 10.3945/jn.109.109579; Demory-Luce D, 2004, J AM DIET ASSOC, V104, P1684, DOI 10.1016/j.jada.2004.07.026; Gondoni LA, 2011, JAMA-J AM MED ASSOC, V305, P563, DOI 10.1001/jama.2011.82; Goodpaster BH, 2010, JAMA-J AM MED ASSOC, V304, P1795, DOI 10.1001/jama.2010.1505; Hemmingsson E, 2011, JAMA-J AM MED ASSOC, V305, P563, DOI 10.1001/jama.2011.83; Hjartaker A, 2001, EUR J PUBLIC HEALTH, V11, P141, DOI 10.1093/eurpub/11.2.141; Hoffmann K, 2004, AM J EPIDEMIOL, V159, P935, DOI 10.1093/aje/kwh134; Imamura F, 2009, AM J CLIN NUTR, V90, P1075, DOI 10.3945/ajcn.2009.28009; Johnson L, 2008, AM J CLIN NUTR, V87, P846, DOI 10.1093/ajcn/87.4.846; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; Li J, 2008, J NUTR, V138, P94, DOI 10.1093/jn/138.1.94; Lien N, 2001, PREV MED, V33, P217, DOI 10.1006/pmed.2001.0874; Lindroos AK, 1999, EUR J CLIN NUTR, V53, P375, DOI 10.1038/sj.ejcn.1600732; LINDROOS AK, 1993, EUR J CLIN NUTR, V47, P461; Mikkilae V, 2007, BRIT J NUTR, V98, P218, DOI 10.1017/S0007114507691831; Mishra GD, 2006, BRIT J NUTR, V96, P735, DOI 10.1079/BJN20061871; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Northstone K, 2008, BRIT J NUTR, V99, P1099, DOI 10.1017/S0007114507842802; Pearson N, 2011, PREV MED, V53, P268, DOI 10.1016/j.ypmed.2011.07.014; Post GB, 2001, BRIT J NUTR, V85, P375, DOI 10.1079/BJN2000249; Prevost AT, 1997, BRIT J NUTR, V78, P873, DOI 10.1079/BJN19970206; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; SJOSTROM L, 1987, INT J OBESITY, V11, P87; te Velde SJ, 2007, BRIT J NUTR, V98, P431, DOI 10.1017/S0007114507721451; Totland TH, 2013, PUBLIC HEALTH NUTR, V16, P673, DOI 10.1017/S1368980012003060; Twisk J, 2009, APPL LONGITUDINAL DA; Twisk JWR, 1996, ANN EPIDEMIOL, V6, P246, DOI 10.1016/1047-2797(96)00003-8; Twisk JWR, 1997, AM J EPIDEMIOL, V145, P888, DOI 10.1093/oxfordjournals.aje.a009048; Wang YF, 2002, J NUTR, V132, P430, DOI 10.1093/jn/132.3.430; Weismayer C, 2006, J NUTR, V136, P1582, DOI 10.1093/jn/136.6.1582	33	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97457	10.1371/journal.pone.0097457	http://dx.doi.org/10.1371/journal.pone.0097457			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841709	Green Submitted, Green Published, gold			2022-12-25	WOS:000340948600034
J	Kristensen, LJ; Birkebaek, NH; Mose, AH; Hohwu, L; Thastum, M				Kristensen, Lene J.; Birkebaek, Niels H.; Mose, Anne H.; Hohwu, Lena; Thastum, Mikael			Symptoms of Emotional, Behavioral, and Social Difficulties in the Danish Population of Children and Adolescents with Type 1 Diabetes - Results of a National Survey	PLOS ONE			English	Article							QUALITY-OF-LIFE; CHRONICALLY ILL CHILDREN; CHRONIC PHYSICAL ILLNESS; DEPRESSIVE SYMPTOMS; METABOLIC-CONTROL; MENTAL-DISORDERS; GLYCEMIC CONTROL; YOUNG ADULTHOOD; ADAPTIVE STYLE; HEALTH	Objective: To assess the prevalence of psychological difficulties in Danish children and adolescents with type 1 diabetes using both child/adolescent and caregiver reports, and to investigate associations between these symptoms and metabolic control, adherence, and quality of life. Research Design and Method:: A total of 786 children and adolescents (8-17 years) recruited through the Danish Registry of Childhood Diabetes completed subscales of the Beck's Youth Inventories (BYI-Y), while 910 caregivers completed the Strength and Difficulties Questionnaire (SDQ). The participants also completed questionnaires assessing adherence and quality of life. BYI-Y and SDQ responses were compared with results from normative samples. Results: Children with diabetes generally reported a lower level of symptoms of depression and anxiety, while older adolescents in most cases were comparable to the normative samples. However, the numbers of patients with elevated scores were similar to normative groups, especially regarding the proportion of participants with 'Extremely elevated' scores. Caregivers of children and adolescents with diabetes generally reported the prevalence of elevated scores on the SDQ to exceed the prevalence observed in the norm sample - particularly with regard to older boys. Both BYI-Y and SDQ responses were significantly correlated with HbA(1c), adherence, and quality of life. Conclusions: This study finds Danish children and adolescents with diabetes to report lower or comparable levels of emotional difficulties compared to norms, while caregiver reports are less positive. The results therefore support the value of a multi-informant approach to the assessment of symptoms of psychological difficulty in girls and boys with diabetes.	[Kristensen, Lene J.; Thastum, Mikael] Aarhus Univ, Dept Psychol & Behav Sci, Aarhus, Denmark; [Birkebaek, Niels H.; Mose, Anne H.] Aarhus Univ Hosp, Dept Pediat, DK-8000 Aarhus N, Denmark; [Hohwu, Lena] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Kristensen, LJ (corresponding author), Aarhus Univ, Dept Psychol & Behav Sci, Aarhus, Denmark.	lenej@psy.au.dk	Thastum, Mikael/A-3443-2008	Thastum, Mikael/0000-0001-8582-5682; Birkebaek, Niels/0000-0001-6268-6464; Hohwu, Lena/0000-0002-9887-7745; Kristensen, Lene Juel/0000-0003-1364-3737	Novo Nordisk A/S [494887]	Novo Nordisk A/S(Novo Nordisk)	Novo Nordisk A/S supported the work ('Psychosocial aspects of diabetes - Grant number: 494887). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbas S, 2009, J ENDOCRINOL INVEST, V32, P325, DOI 10.1007/BF03345721; Armstrong B, 2011, J PEDIATR PSYCHOL, V36, P1052, DOI 10.1093/jpepsy/jsr039; Beck J. S., 2012, BECK YOUTH INVENTORI, V2nd; Bryden KS, 2001, DIABETES CARE, V24, P1536, DOI 10.2337/diacare.24.9.1536; CANNING EH, 1994, PSYCHOSOM MED, V56, P104, DOI 10.1097/00006842-199403000-00005; CANNING EH, 1992, PEDIATRICS, V90, P692; CANNING EH, 1992, J AM ACAD CHILD PSY, V31, P1120, DOI 10.1097/00004583-199211000-00021; Cohen J., 1988, STAT POWER ANAL BEHA; Dantzer C, 2003, CLIN PSYCHOL REV, V23, P787, DOI 10.1016/S0272-7358(03)00069-2; de Wit M, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-10; de Wit M, 2011, PEDIATR DIABETES, V12, P172, DOI 10.1111/j.1399-5448.2010.00673.x; Duke DC, 2008, J PEDIATR PSYCHOL, V33, P719, DOI 10.1093/jpepsy/jsn012; Eiser C, 2001, QUAL LIFE RES, V10, P347, DOI 10.1023/A:1012253723272; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Grey M, 2002, J PSYCHOSOM RES, V53, P907, DOI 10.1016/S0022-3999(02)00312-4; Grey M, 1994, Pediatr Nurs, V20, P17; Helgeson VS, 2007, J PEDIATR PSYCHOL, V32, P794, DOI 10.1093/jpepsy/jsm020; Helgeson VS, 2009, J PEDIATR PSYCHOL, V34, P254, DOI 10.1093/jpepsy/jsn079; Herzer M, 2010, J PEDIATR PSYCHOL, V35, P415, DOI 10.1093/jpepsy/jsp063; Hohwu L, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2595; Hood KK, 2006, DIABETES CARE, V29, P1389, DOI 10.2337/dc06-0087; Horsch A, 2007, J TRAUMA STRESS, V20, P881, DOI 10.1002/jts.20247; Hysing M, 2007, J CHILD PSYCHOL PSYC, V48, P785, DOI 10.1111/j.1469-7610.2007.01755.x; Insabella G, 2007, PEDIATR DIABETES, V8, P228, DOI 10.1111/j.1399-5448.2007.00266.x; Johnson B, 2013, DIABETIC MED, V30, P199, DOI 10.1111/j.1464-5491.2012.03721.x; Kohler L, 2001, AR BRA MEN KAN BLI A; Kovacs M, 1997, DIABETES CARE, V20, P36, DOI 10.2337/diacare.20.1.36; Kristensen LJ, 2012, DIABETES CARE, V35, P2161, DOI 10.2337/dc11-2342; Lawrence JM, 2012, J PEDIATR-US, V161, P201, DOI 10.1016/j.jpeds.2012.01.016; Leonard Barbara J, 2002, J Pediatr Nurs, V17, P28, DOI 10.1053/jpdn.2002.30931; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Niclasen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032025; Nielsen A., 2001, BORN BORNEFAMILIERS; Northam EA, 2005, DIABETIC MED, V22, P152, DOI 10.1111/j.1464-5491.2004.01370.x; Obel C, 2004, EUR CHILD ADOLES PSY, V13, P32, DOI 10.1007/s00787-004-2006-2; Peyrot M, 2009, PEDIATR DIABETES, V10, P37, DOI 10.1111/j.1399-5448.2009.00612.x; Phipps S, 2002, PSYCHOSOM MED, V64, P34, DOI 10.1097/00006842-200201000-00006; Pinquart M, 2011, J PEDIATR PSYCHOL, V36, P375, DOI 10.1093/jpepsy/jsq104; Rewers A, 2002, JAMA-J AM MED ASSOC, V287, P2511, DOI 10.1001/jama.287.19.2511; Reynolds KA, 2011, ANN BEHAV MED, V42, P29, DOI 10.1007/s12160-011-9262-4; Stewart SM, 2005, PEDIATRICS, V115, P1315, DOI 10.1542/peds.2004-1717; Thastum M, 2009, SCAND J PSYCHOL, V50, P47, DOI 10.1111/j.1467-9450.2008.00690.x; Upton P, 2008, QUAL LIFE RES, V17, P895, DOI 10.1007/s11136-008-9350-5; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2003, DIABETES CARE, V26, P631, DOI 10.2337/diacare.26.3.631; Whittemore Robin, 2002, Pediatr Diabetes, V3, P135, DOI 10.1034/j.1399-5448.2002.30303.x	47	21	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97543	10.1371/journal.pone.0097543	http://dx.doi.org/10.1371/journal.pone.0097543			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9SK	24842772	Green Published, Green Submitted, gold			2022-12-25	WOS:000340948600041
J	Sharma, N; Jung, CH; Bhalla, PL; Singh, MB				Sharma, Niharika; Jung, Chol-Hee; Bhalla, Prem L.; Singh, Mohan B.			RNA Sequencing Analysis of the Gametophyte Transcriptome from the Liverwort, Marchantia polymorpha	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; DE-NOVO CHARACTERIZATION; GENE ORGANIZATION; ROOT TRANSCRIPTOME; NONCODING RNA; LAND PLANTS; GENOME; DNA; EVOLUTION; REVEALS	The liverwort Marchantia polymorpha is a member of the most basal lineage of land plants (embryophytes) and likely retains many ancestral morphological, physiological and molecular characteristics. Despite its phylogenetic importance and the availability of previous EST studies, M. polymorpha's lack of economic importance limits accessible genomic resources for this species. We employed Illumina RNA-Seq technology to sequence the gametophyte transcriptome of M. polymorpha. cDNA libraries from 6 different male and female developmental tissues were sequenced to delineate a global view of the M. polymorpha transcriptome. Approximately 80 million short reads were obtained and assembled into a non-redundant set of 46,533 transcripts (>= 200 bp) from 46,070 loci. The average length and the N50 length of the transcripts were 757 bp and 471 bp, respectively. Sequence comparison of assembled transcripts with non-redundant proteins from embryophytes resulted in the annotation of 43% of the transcripts. The transcripts were also compared with M. polymorpha expressed sequence tags (ESTs), and approximately 69.5% of the transcripts appeared to be novel. Twenty-one percent of the transcripts were assigned GO terms to improve annotation. In addition, 6,112 simple sequence repeats (SSRs) were identified as potential molecular markers, which may be useful in studies of genetic diversity. A comparative genomics approach revealed that a substantial proportion of the genes (35.5%) expressed in M. polymorpha were conserved across phylogenetically related species, such as Selaginella and Physcomitrella, and identified 580 genes that are potentially unique to liverworts. Our study presents an extensive amount of novel sequence information for M. polymorpha. This information will serve as a valuable genomics resource for further molecular, developmental and comparative evolutionary studies, as well as for the isolation and characterization of functional genes that are involved in sex differentiation and sexual reproduction in this liverwort.	[Sharma, Niharika; Bhalla, Prem L.; Singh, Mohan B.] Univ Melbourne, Plant Mol Biol & Biotechnol Lab, Melbourne Sch Land & Environm, Parkville, Vic 3052, Australia; [Jung, Chol-Hee] Univ Melbourne, Victorian Life Sci Computat Initiat, Carlton, Vic 3053, Australia	University of Melbourne; University of Melbourne	Singh, MB (corresponding author), Univ Melbourne, Plant Mol Biol & Biotechnol Lab, Melbourne Sch Land & Environm, Parkville, Vic 3052, Australia.	mohan@unimelb.edu.au	Jung, Cholhee/S-8670-2019; Sharma, Niharika/AAE-7843-2019	Singh, Mohan/0000-0001-9427-8975; Sharma, Niharika/0000-0001-6707-4467; Bhalla, Prem/0000-0002-2910-0393	Australian Research Council [ARC DP0988972, ARCDP1097262]	Australian Research Council(Australian Research Council)	Financial support from the Australian Research Council in the form of the ARC Discovery grants ARC DP0988972 and ARCDP1097262 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowman JL, 2007, CELL, V129, P229, DOI 10.1016/j.cell.2007.04.004; Chiyoda S, 2008, PLANT CELL REP, V27, P1467, DOI 10.1007/s00299-008-0570-5; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Der JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-99; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Fan HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059997; Fischer Steve, 2011, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0612s35; Fujisawa M, 2001, GENETICS, V159, P981; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Gordo SMC, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-168; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; He SM, 2008, NUCLEIC ACIDS RES, V36, pD170, DOI 10.1093/nar/gkm1011; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Ishizaki K, 2008, PLANT CELL PHYSIOL, V49, P1084, DOI 10.1093/pcp/pcn085; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kohchi T, 2010, PLANT AN GEN 18 C; Kozik A, 2008, PLANT AN GEN 16 C; Kubota A, 2013, BIOSCI BIOTECH BIOCH, V77, P167, DOI 10.1271/bbb.120700; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin HN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-41; Lister R, 2009, CURR OPIN PLANT BIOL, V12, P107, DOI 10.1016/j.pbi.2008.11.004; Marquez Y, 2012, GENOME RES, V22, P1184, DOI 10.1101/gr.134106.111; Mattick JS, 2005, SCIENCE, V309, P1527, DOI 10.1126/science.1117806; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagai J, 1999, DNA Res, V6, P1, DOI 10.1093/dnares/6.1.1; Nagalakshmi Ugrappa, 2010, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0411s89; Nakasugi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059534; Nishiyama R, 2000, DNA RES, V7, P165, DOI 10.1093/dnares/7.3.165; ODA K, 1992, J MOL BIOL, V223, P1, DOI 10.1016/0022-2836(92)90708-R; OHYAMA K, 1986, NATURE, V322, P572, DOI 10.1038/322572a0; Pires ND, 2013, P NATL ACAD SCI USA, V110, P9571, DOI 10.1073/pnas.1305457110; Pires ND, 2012, PHILOS T R SOC B, V367, P508, DOI 10.1098/rstb.2011.0252; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Sharma N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-915; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Vinogradov AE, 2003, NUCLEIC ACIDS RES, V31, P1838, DOI 10.1093/nar/gkg296; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang L, 2010, BRIEF FUNCT GENOMICS, V9, P118, DOI 10.1093/bfgp/elp057; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yamato KT, 2007, P NATL ACAD SCI USA, V104, P6472, DOI 10.1073/pnas.0609054104; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang LG, 2004, P NATL ACAD SCI USA, V101, P16855, DOI 10.1073/pnas.0407821101; Zhao ZG, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-222	53	17	17	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97497	10.1371/journal.pone.0097497	http://dx.doi.org/10.1371/journal.pone.0097497			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841988	Green Published, gold			2022-12-25	WOS:000340948600036
J	Yun, HM; Park, MH; Kim, DH; Ahn, YJ; Park, KR; Kim, TM; Yun, NY; Jung, YS; Hwang, DY; Yoon, DY; Han, SB; Hong, JT				Yun, H-M; Park, M. H.; Kim, D. H.; Ahn, Y. J.; Park, K-R; Kim, T. M.; Yun, N. Y.; Jung, Y. S.; Hwang, D. Y.; Yoon, D. Y.; Han, S. B.; Hong, J. T.			Loss of presenilin 2 is associated with increased iPLA2 activity and lung tumor development	ONCOGENE			English	Article							AMYLOID PRECURSOR PROTEIN; E-CADHERIN CLEAVAGE; GAMMA-SECRETASE; ALZHEIMERS-DISEASE; PEROXIREDOXIN 6; CANCER-CELLS; INDUCED APOPTOSIS; BRAIN; IDENTIFICATION; TUMORIGENESIS	Presenilins are the enzymatic components of gamma-secretase complex that cleaves amyloid precursor protein, Notch and beta-catenin, which has critical roles in the development of Alzheimer's disease and cancer cell growth. Therefore, in the present study, we studied the effects and mechanisms of PS2 knockout on lung cancer development and possible mechanisms as a key regulator of lung tumor development. We compared carcinogen-induced tumor growth between PS2 knockout mice and wild-type mice. PS2 knockout mice showed increased urethane (1 mg/g)-induced lung tumor incidence when compared with that of wild-type mice with decreased activity of gamma-secretase in the lung tumor tissues. Consequently, iPLA2 activities in lung tumor tissues of PS2 knockout mice were much higher than in tumor tissues of wild-type mice. Furthermore, knockdown of PS2 using PS2 siRNA decreased gamma-secretase activity with increased iPLA2 activity in the lung cancer cells (A549 and NCI-H460), leading to increased lung cancer cell growth. PS2 knockout mice and PS2 knockdown lung cancer cells showed increased DNA-binding activities of nuclear factor kappa-beta, signal transducer and activator of transcription 3 (STAT3) and AP-1 which are critical transcriptional factors of iPLA2 than those of PS2 wild-type mice and control lung cancer cells. Taken together, these results suggest that the loss of PS2 could have a critical role in lung tumor development through the upregulation of iPLA2 activity by reducing gamma-secretase.	[Yun, H-M; Park, M. H.; Kim, D. H.; Ahn, Y. J.; Park, K-R; Yun, N. Y.; Han, S. B.; Hong, J. T.] Chungbuk Natl Univ, Coll Pharm, Cheongju 361763, Chungbuk, South Korea; [Yun, H-M; Park, M. H.; Kim, D. H.; Ahn, Y. J.; Park, K-R; Yun, N. Y.; Han, S. B.; Hong, J. T.] Chungbuk Natl Univ, Med Res Ctr, Cheongju 361763, Chungbuk, South Korea; [Kim, T. M.] Chungbuk Natl Univ, Coll Vet Med, Cheongju 361763, Chungbuk, South Korea; [Jung, Y. S.] Pusan Natl Univ, Coll Pharm, Pusan, South Korea; [Hwang, D. Y.] Pusan Natl Univ, Dept Biomat Sci, Miryang, Kyungnam, South Korea; [Yoon, D. Y.] Konkuk Univ, Bio Mol Informat Ctr, Dept Biosci & Biotechnol, Seoul, South Korea	Chungbuk National University; Chungbuk National University; Chungbuk National University; Pusan National University; Pusan National University; Konkuk University	Hong, JT (corresponding author), Chungbuk Natl Univ, Coll Pharm, 48 Gaeshin Dong, Cheongju 361763, Chungbuk, South Korea.	jinthong@chungbuk.ac.kr			National Research Foundation of Korea (NRF) - Korea Government (MSIP) [MRC, 2008-0062275]	National Research Foundation of Korea (NRF) - Korea Government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea Government (MSIP) (No; MRC, 2008-0062275).	Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Borgegard T, 2012, J BIOL CHEM, V287, P11810, DOI 10.1074/jbc.M111.305227; Boulton ME, 2008, J CELL MOL MED, V12, P781, DOI 10.1111/j.1582-4934.2008.00274.x; Chatterjee S, 2011, J BIOL CHEM, V286, P11696, DOI 10.1074/jbc.M110.206623; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Chhunchha B, 2013, AM J PHYSIOL-CELL PH, V304, pC636, DOI 10.1152/ajpcell.00345.2012; Conti A, 2011, AM J PATHOL, V178, P88, DOI 10.1016/j.ajpath.2010.11.035; Das I, 2004, J BIOL CHEM, V279, P30771, DOI 10.1074/jbc.M309252200; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Granville CA, 2005, AM J RESP CELL MOL, V32, P169, DOI 10.1165/rcmb.F290; Jo M, 2013, FREE RADICAL BIO MED, V61, P453, DOI 10.1016/j.freeradbiomed.2013.04.032; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4; Kim SY, 2011, CELL DEATH DIFFER, V18, P1573, DOI 10.1038/cdd.2011.21; Kovacs DM, 1996, NAT MED, V2, P224, DOI 10.1038/nm0296-224; Kovacs DM, 1999, J NEUROCHEM, V73, P2278, DOI 10.1046/j.1471-4159.1999.0732278.x; Lehtonen ST, 2004, INT J CANCER, V111, P514, DOI 10.1002/ijc.20294; Liu B, 2012, NEURO-ONCOLOGY, V14, P994, DOI 10.1093/neuonc/nos138; Liu Hai-yan, 2013, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V35, P19, DOI 10.3881/j.issn.1000-503X.2013.01.004; Liu Y, 2004, J PROTEOME RES, V3, P728, DOI 10.1021/pr034127+; McHowat J, 2011, AM J PHYSIOL-CELL PH, V300, pC825, DOI 10.1152/ajpcell.00502.2010; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Murakami D, 2003, ONCOGENE, V22, P1511, DOI 10.1038/sj.onc.1206298; Oh S, 2010, BIOCHEM BIOPH RES CO, V399, P91, DOI 10.1016/j.bbrc.2010.07.047; Olahova M, 2008, P NATL ACAD SCI USA, V105, P19839, DOI 10.1073/pnas.0805507105; Park CS, 2008, TOXICOL SCI, V106, P413, DOI 10.1093/toxsci/kfn197; Rahimi N, 2009, CANCER RES, V69, P2607, DOI 10.1158/0008-5472.CAN-08-2905; Rocher-Ros V, 2010, ONCOGENE, V29, P2950, DOI 10.1038/onc.2010.57; Roe CM, 2005, NEUROLOGY, V64, P895, DOI 10.1212/01.WNL.0000152889.94785.51; Sagi SA, 2011, J BIOL CHEM, V286, P39794, DOI 10.1074/jbc.M111.277228; Schremmer Bruno, 2007, V44, P317; Serrano J, 2010, ONCOGENE, V29, P2165, DOI 10.1038/onc.2009.503; Song X, 2012, HEAD NECK ONCOL, V4, P47; Takahashi T, 2002, ONCOGENE, V21, P6868, DOI 10.1038/sj.onc.1205830; Tanii H, 2000, NEUROSCIENCE, V95, P593; Tarassishin L, 2004, P NATL ACAD SCI USA, V101, P17050, DOI 10.1073/pnas.0408007101; Thun MJ, 2008, PLOS MED, V5, P1357, DOI 10.1371/journal.pmed.0050185; To MD, 2006, ONCOGENE, V25, P3557, DOI 10.1038/sj.onc.1209397; Cespedes MV, 2010, AM J PATHOL, V177, P2067, DOI 10.2353/ajpath.2010.100079; Wakabayashi T, 2008, PHYSIOLOGY, V23, P194, DOI 10.1152/physiol.00009.2008; Wang L, 2008, MOL PHARMACOL, V73, P119, DOI 10.1124/mol.107.040873; Wood WJL, 2003, J COMB CHEM, V5, P869, DOI 10.1021/cc034008r; Xia XF, 2001, P NATL ACAD SCI USA, V98, P10863, DOI 10.1073/pnas.191284198; Yan Ke-xia, 2004, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V22, P331; Yun HM, 2014, FREE RADICAL BIO MED, V69, P367, DOI 10.1016/j.freeradbiomed.2014.02.001; Zhang WP, 2007, MOL CARCINOGEN, V46, P372, DOI 10.1002/mc.20285; Zhang XZ, 2009, CANCER SCI, V100, P2396, DOI 10.1111/j.1349-7006.2009.01314.x	49	24	26	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 30	2014	33	44					5193	5200		10.1038/onc.2014.128	http://dx.doi.org/10.1038/onc.2014.128			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR9RZ	24858037	hybrid, Green Published			2022-12-25	WOS:000343914900006
J	Aman, TK; Maki, BA; Ruffino, TJ; Kasperek, EM; Popescu, GK				Aman, Teresa K.; Maki, Bruce A.; Ruffino, Thomas J.; Kasperek, Eileen M.; Popescu, Gabriela K.			Separate Intramolecular Targets for Protein Kinase A Control N-Methyl-D-aspartate Receptor Gating and Ca2+ Permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMDA RECEPTORS; CALCIUM PERMEABILITY; HIPPOCAMPAL-NEURONS; PHOSPHORYLATION; DESENSITIZATION; INACTIVATION; CHANNELS; NR2A; PLASTICITY; INHIBITOR	Protein kinase A (PKA) enhances synaptic plasticity in the central nervous system by increasing NMDA receptor current amplitude and Ca2+ flux in an isoform-dependent yet poorly understood manner. PKA phosphorylates multiple residues on GluN1, GluN2A, and GluN2B subunits in vivo, but the functional significance of this multiplicity is unknown. We examined gating and permeation properties of recombinant NMDA receptor isoforms and of receptors with altered C-terminal domain (CTDs) prior to and after pharmacological inhibition of PKA. We found that PKA inhibition decreased GluN1/GluN2B but not GluN1/GluN2A gating; this effect was due to slower rates for receptor activation and resensitization and was mediated exclusively by the GluN2B CTD. In contrast, PKA inhibition reduced NMDA receptor-relative Ca2+ permeability (PCa/PNa) regardless of the GluN2 isoform and required the GluN1 CTD; this effect was due primarily to decreased unitary Ca2+ conductance, because neither Na+ conductance nor Ca2+- dependent block was altered substantially. Finally, we show that both the gating and permeation effects can be reproduced by changing the phosphorylation state of a single residue: GluN2B Ser-1166 and GluN1 Ser-897, respectively. We conclude that PKA effects on NMDA receptor gating and Ca2+ permeability rely on distinct phosphorylation sites located on the CTD of GluN2B and GluN1 subunits. This separate control of NMDA receptor properties by PKA may account for the specific effects of PKA on plasticity during synaptic development and may lead to drugs targeted to alter NMDA receptor gating or Ca2+ permeability.	[Aman, Teresa K.; Maki, Bruce A.; Ruffino, Thomas J.; Kasperek, Eileen M.; Popescu, Gabriela K.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA; [Maki, Bruce A.; Popescu, Gabriela K.] SUNY Buffalo, Sch Med & Biomed Sci, Neurosci Program, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Popescu, GK (corresponding author), SUNY Buffalo, Dept Biochem, 140 Farber Hall, Buffalo, NY 14214 USA.	popescu@buffalo.edu	popescu, gabriela k/AAB-6155-2022	popescu, gabriela k/0000-0003-4658-2002; Maki, Bruce/0000-0002-6760-375X	National Institutes of Health Grants [R01052669, F32NS077622]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS077622, R01NS052669] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01052669 (to G. K. P.) and F32NS077622 (to T. K. A.).	Amico-Ruvio SA, 2011, BIOPHYS J, V100, P1910, DOI 10.1016/j.bpj.2011.02.042; Amico-Ruvio SA, 2010, BIOPHYS J, V98, P1160, DOI 10.1016/j.bpj.2009.12.4276; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; Bird GC, 2005, J PHYSIOL-LONDON, V564, P907, DOI 10.1113/jphysiol.2005.084780; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Borschel WF, 2012, J NEUROPHYSIOL, V108, P3105, DOI 10.1152/jn.00551.2012; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; CERNE R, 1993, NEUROSCI LETT, V161, P124, DOI 10.1016/0304-3940(93)90275-P; Chalifoux JR, 2010, NEURON, V66, P101, DOI 10.1016/j.neuron.2010.03.012; Chatterjea D, 2010, J NEUROPHYSIOL, V104, P2203, DOI 10.1152/jn.01081.2009; Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; CHOI DW, 1994, ANN NY ACAD SCI, V747, P162; Dalton GD, 2006, NEUROPEPTIDES, V40, P23, DOI 10.1016/j.npep.2005.10.002; Foster KA, 2010, J NEUROSCI, V30, P2676, DOI 10.1523/JNEUROSCI.4022-09.2010; Gambrill AC, 2011, J NEUROPHYSIOL, V105, P162, DOI 10.1152/jn.00457.2010; Higley MJ, 2010, NAT NEUROSCI, V13, P958, DOI 10.1038/nn.2592; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Krupp JJ, 2002, NEUROPHARMACOLOGY, V42, P593, DOI 10.1016/S0028-3908(02)00031-X; Krupp JJ, 1996, MOL PHARMACOL, V50, P1680; Kussius CL, 2009, J NEUROSCI, V29, P6819, DOI 10.1523/JNEUROSCI.0281-09.2009; Lau CG, 2009, BIOCHEM SOC T, V37, P1369, DOI 10.1042/BST0371369; LEGENDRE P, 1993, J NEUROSCI, V13, P674; Leonard AS, 1997, J BIOL CHEM, V272, P12107, DOI 10.1074/jbc.272.18.12107; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; Li B, 2009, J NEUROSCI, V29, P11965, DOI 10.1523/JNEUROSCI.2109-09.2009; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; Maki BA, 2013, CHANNELS, V7, P126, DOI 10.4161/chan.23968; Maki BA, 2012, J BIOL CHEM, V287, P36071, DOI 10.1074/jbc.M112.390013; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Murphy JA, 2014, J NEUROSCI, V34, P869, DOI 10.1523/JNEUROSCI.4538-13.2014; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Popescu G, 2003, NAT NEUROSCI, V6, P476, DOI 10.1038/nn1044; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Raman IM, 1996, NEURON, V16, P415, DOI 10.1016/S0896-6273(00)80059-8; ROSENMUND C, 1993, J PHYSIOL-LONDON, V470, P705, DOI 10.1113/jphysiol.1993.sp019884; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Skeberdis VA, 2006, NAT NEUROSCI, V9, P501, DOI 10.1038/nn1664; Sobczyk A, 2007, NEURON, V53, P17, DOI 10.1016/j.neuron.2006.11.016; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; TASH JS, 1980, CELL, V21, P57, DOI 10.1016/0092-8674(80)90114-2; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; Townsend M, 2004, J NEUROSCI, V24, P11098, DOI 10.1523/JNEUROSCI.1207-04.2004; Watanabe J, 2002, J NEUROSCI, V22, P10209; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Xu MF, 2011, ALCOHOL, V45, P373, DOI 10.1016/j.alcohol.2010.08.015	48	27	29	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18805	18817		10.1074/jbc.M113.537282	http://dx.doi.org/10.1074/jbc.M113.537282			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24847051	hybrid, Green Published			2022-12-25	WOS:000339062900016
J	Robins, JH; Tintinger, V; Aplin, KP; Hingston, M; Matisoo-Smith, E; Penny, D; Lavery, SD				Robins, Judith H.; Tintinger, Vernon; Aplin, Ken P.; Hingston, Melanie; Matisoo-Smith, Elizabeth; Penny, David; Lavery, Shane D.			Phylogenetic Species Identification in Rattus Highlights Rapid Radiation and Morphological Similarity of New Guinean Species	PLOS ONE			English	Article							ANCIENT DNA; CHROMOSOME EVOLUTION; BLACK RATS; MITOCHONDRIAL; DELIMITATION; SEQUENCE; REVEALS; EXTRACTION; SPECIATION; DIVERSITY	The genus Rattus is highly speciose, the taxonomy is complex, and individuals are often difficult to identify to the species level. Previous studies have demonstrated the usefulness of phylogenetic approaches to identification in Rattus but some species, especially among the endemics of the New Guinean region, showed poor resolution. Possible reasons for this are simple misidentification, incomplete gene lineage sorting, hybridization, and phylogenetically distinct lineages that are unrecognised taxonomically. To assess these explanations we analysed 217 samples, representing nominally 25 Rattus species, collected in New Guinea, Asia, Australia and the Pacific. To reduce misidentification problems we sequenced museum specimens from earlier morphological studies and recently collected tissues from samples with associated voucher specimens. We also reassessed vouchers from previously sequenced specimens. We inferred combined and separate phylogenies from two mitochondrial DNA regions comprising 550 base pair D-loop sequences and both long (655 base pair) and short (150 base pair) cytochrome oxidase I sequences. Our phylogenetic species identification for 17 species was consistent with morphological designations and current taxonomy thus reinforcing the usefulness of this approach. We reduced misidentifications and consequently the number of polyphyletic species in our phylogenies but the New Guinean Rattus clades still exhibited considerable complexity. Only three of our eight New Guinean species were monophyletic. We found good evidence for either incomplete mitochondrial lineage sorting or hybridization between species within two pairs, R. leucopus/R. cf. verecundus and R. steini/R. praetor. Additionally, our results showed that R. praetor, R. niobe and R. verecundus each likely encompass more than one species. Our study clearly points to the need for a revised taxonomy of the rats of New Guinea, based on broader sampling and informed by both morphology and phylogenetics. The remaining taxonomic complexity highlights the recent and rapid radiation of Rattus in the Australo-Papuan region.	[Robins, Judith H.; Hingston, Melanie; Lavery, Shane D.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Robins, Judith H.; Tintinger, Vernon] Univ Auckland, Dept Anthropol, Auckland 1, New Zealand; [Aplin, Ken P.] Smithsonian Inst, Natl Museum Nat Hist, Div Mammals, Washington, DC 20560 USA; [Matisoo-Smith, Elizabeth] Univ Otago, Dept Anat, Dunedin, New Zealand; [Penny, David] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand; [Lavery, Shane D.] Univ Auckland, Inst Marine Sci, Auckland 1, New Zealand	University of Auckland; University of Auckland; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Otago; Massey University; University of Auckland	Robins, JH (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	j.robins@auckland.ac.nz	Lavery, Shane/AFX-7929-2022	Lavery, Shane/0000-0003-3038-292X; Hingston, Melanie/0000-0002-2960-6212; Matisoo-Smith, Elizabeth/0000-0002-3500-8307	University of Auckland; Marsden Fund of New Zealand [UOA510]	University of Auckland; Marsden Fund of New Zealand(Royal Society of New ZealandMarsden Fund (NZ))	The University of Auckland and the Marsden Fund of New Zealand, Project Number UOA510. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin Ken P., 2003, ACIAR Monograph Series, V100, P1; Aplin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026357; Aplin KP, 2011, RAP B BIOL ASSESSMEN, V60; Atkinson I.A.E., 1985, International Council for Bird Preservation Technical Publication, P35; Balakirev Alexander E., 2012, Russian Journal of Theriology, V11, P33; Bastos AD, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-26; BAVERSTOCK PR, 1983, GENETICA, V60, P93, DOI 10.1007/BF00127495; BAVERSTOCK PR, 1986, GENETICA, V71, P11, DOI 10.1007/BF00123228; BAVERSTOCK PR, 1977, CHROMOSOMA, V61, P227, DOI 10.1007/BF00292807; Chaimanee Y, 2000, HIST BIOL, V15, P181, DOI DOI 10.1080/10292380109380590; CLARK DA, 1981, BIOTROPICA, V13, P182, DOI 10.2307/2388123; Conroy CJ, 2013, BIOL INVASIONS, V15, P741, DOI 10.1007/s10530-012-0323-9; Cooper A, 2000, SCIENCE, V289, P1139; DENNIS E, 1978, AUST J ZOOL, V26, P197, DOI 10.1071/ZO9780197; FLANNERY T F, 1990, Records of the Australian Museum, V42, P173; Flannery TF, 1995, MAMMALS NEW GUINEA; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Galan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048374; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Homer E., 1965, CSIRO Wildlife Research, V10, P101; HOSS M, 1993, NUCLEIC ACIDS RES, V21, P3913, DOI 10.1093/nar/21.16.3913; Huynen L, 2010, P NATL ACAD SCI USA, V107, P16201, DOI 10.1073/pnas.0914096107; Innes J.G., 1990, P206; Jansa SA, 2006, SYST BIOL, V55, P73, DOI 10.1080/10635150500431254; Knowles LL, 2007, SYST BIOL, V56, P887, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Lack JB, 2012, MOL ECOL, V21, P3545, DOI 10.1111/j.1365-294X.2012.05620.x; Lecompte E, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-199; Matisoo-Smith E, 1998, P NATL ACAD SCI USA, V95, P15145, DOI 10.1073/pnas.95.25.15145; MatisooSmith E, 1997, ELECTROPHORESIS, V18, P1534, DOI 10.1002/elps.1150180908; Musser GG, 2005, MAMMAL SPECIES WORLD, P894; Musser Guy G., 1993, P501; Nilsson MA, 2003, J MOL EVOL, V57, pS3, DOI 10.1007/s00239-003-0001-8; Pages M, 2013, MOL ECOL, V22, P1019, DOI 10.1111/mec.12149; Pages M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-184; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2007, TRACER V1 5; Robins JH, 2007, MOL ECOL NOTES, V7, P717, DOI 10.1111/j.1471-8286.2007.01752.x; Robins JH, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-375; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ross HA, 2003, J HERED, V94, P111, DOI 10.1093/jhered/esg027; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Rowe KC, 2011, SYST BIOL, V60, P188, DOI 10.1093/sysbio/syq092; Sambrook J., 1989, MOL CLONING LAB MANU; Simmons MP, 2014, MOL PHYLOGENET EVOL, V74, P1, DOI 10.1016/j.ympev.2014.01.030; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; TAYLOR J M, 1973, Bulletin of the American Museum of Natural History, V150, P1; TAYLOR JM, 1983, J MAMMAL, V64, P463, DOI 10.2307/1380359; Taylor JM, 1982, B AM MUS NAT HIST, V173, P177; Verneau O, 1998, P NATL ACAD SCI USA, V95, P11284, DOI 10.1073/pnas.95.19.11284; WATTS CHS, 1994, AUST J ZOOL, V42, P711, DOI 10.1071/ZO9940711; Wyatt KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003602; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107	57	16	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98002	10.1371/journal.pone.0098002	http://dx.doi.org/10.1371/journal.pone.0098002			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865350	Green Published, Green Submitted, gold			2022-12-25	WOS:000336914100028
J	Guitart, M; Osorio-Conles, O; Pentinat, T; Cebria, J; Garcia-Villoria, J; Sala, D; Sebastian, D; Zorzano, A; Ribes, A; Jimenez-Chillaron, JC; Garcia-Martinez, C; Gomez-Foix, AM				Guitart, Maria; Osorio-Conles, Oscar; Pentinat, Thais; Cebria, Judith; Garcia-Villoria, Judit; Sala, David; Sebastian, David; Zorzano, Antonio; Ribes, Antonia; Jimenez-Chillaron, Josep C.; Garcia-Martinez, Celia; Gomez-Foix, Anna M.			Fatty Acid Transport Protein 1 (FATP1) Localizes in Mitochondria in Mouse Skeletal Muscle and Regulates Lipid and Ketone Body Disposal	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; IN-VIVO; EXPRESSION; CELLS; METABOLISM; OXIDATION; MEMBRANE; GLUCOSE; LIVER; MICE	FATP1 mediates skeletal muscle cell fatty acid import, yet its intracellular localization and metabolic control role are not completely defined. Here, we examine FATP1 localization and metabolic effects of its overexpression in mouse skeletal muscle. The FATP1 protein was detected in mitochondrial and plasma membrane fractions, obtained by differential centrifugation, of mouse gastrocnemius muscle. FATP1 was most abundant in purified mitochondria, and in the outer membrane and soluble intermembrane, but not in the inner membrane plus matrix, enriched subfractions of purified mitochondria. Immunogold electron microscopy localized FATP1-GFP in mitochondria of transfected C2C12 myotubes. FATP1 was overexpressed in gastrocnemius mouse muscle, by adenovirus-mediated delivery of the gene into hindlimb muscles of newborn mice, fed after weaning a chow or high-fat diet. Compared to GFP delivery, FATP1 did not alter body weight, serum fed glucose, insulin and triglyceride levels, and whole-body glucose tolerance, in either diet. However, fatty acid levels were lower and beta-hydroxybutyrate levels were higher in FATP1-than GFP-mice, irrespective of diet. Moreover, intramuscular triglyceride content was lower in FATP1-versus GFP-mice regardless of diet, and beta-hydroxybutyrate content was unchanged in high-fat-fed mice. Electroporation-mediated FATP1 overexpression enhanced palmitate oxidation to CO2, but not to acid-soluble intermediate metabolites, while CO2 production from beta-hydroxybutyrate was inhibited and that from glucose unchanged, in isolated mouse gastrocnemius strips. In summary, FATP1 was localized in mitochondria, in the outer membrane and intermembrane parts, of mouse skeletal muscle, what may be crucial for its metabolic effects. Overexpressed FATP1 enhanced disposal of both systemic fatty acids and intramuscular triglycerides. Consistently, it did not contribute to the high-fat diet-induced metabolic dysregulation. However, FATP1 lead to hyperketonemia, likely secondary to the sparing of ketone body oxidation by the enhanced oxidation of fatty acids.	[Guitart, Maria; Osorio-Conles, Oscar; Sala, David; Sebastian, David; Zorzano, Antonio; Gomez-Foix, Anna M.] Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Inst Biomed, Barcelona, Spain; [Pentinat, Thais; Cebria, Judith; Jimenez-Chillaron, Josep C.] Hosp St Joan de Deu, Barcelona, Spain; [Garcia-Villoria, Judit; Ribes, Antonia] Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer, Serv Bioquim & Genet Mol, Secc Errores Congenitos Metab IBC, Barcelona, Spain; [Garcia-Villoria, Judit; Ribes, Antonia] Inst Salud Carlos III, CIBERER, Madrid, Spain; [Sala, David; Sebastian, David; Zorzano, Antonio] Inst Res Biomed, Barcelona, Spain; [Osorio-Conles, Oscar; Sala, David; Sebastian, David; Zorzano, Antonio; Gomez-Foix, Anna M.] Inst Salud Carlos III, CIBER Diabet & Enfermedades Metab Asociadas CIBER, Madrid, Spain; [Garcia-Martinez, Celia] Univ Barcelona, Dept Patol & Terapeut Expt, Barcelona, Spain	University of Barcelona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; University of Barcelona	Guitart, M (corresponding author), Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Inst Biomed, Barcelona, Spain.	maguita022002@yahoo.es	Osorio-Conles, Óscar/B-2064-2017; Martinez, Celia Garcia/G-9536-2017; Garcia, Judit/AAN-1753-2021; Zorzano, Antonio/R-5479-2018; Sebastián, David/ABH-1574-2020; Osorio-Conles, Óscar/ABC-7346-2021	Osorio-Conles, Óscar/0000-0002-0285-5526; Martinez, Celia Garcia/0000-0002-5267-0191; Osorio-Conles, Óscar/0000-0002-0285-5526; Ribes Rubio, Antonia/0000-0002-2249-246X; Garcia Villoria, Judit/0000-0003-2132-4138; Sebastian, David/0000-0002-7260-3869	Spanish Ministerio de Ciencia e Innovacion (MCI) [SAF2009-07559, SAF2012-37480]; CIBERDEM de Diabetes y Enfermedades Metabolicas Asociadas [PI 08/0733, PI08/1195, CB07/08/0012]	Spanish Ministerio de Ciencia e Innovacion (MCI)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CIBERDEM de Diabetes y Enfermedades Metabolicas Asociadas	This study was supported by the following grants: SAF2009-07559 and SAF2012-37480 from the Spanish Ministerio de Ciencia e Innovacion (MCI); and PI 08/0733, PI08/1195, CIBERDEM de Diabetes y Enfermedades Metabolicas Asociadas (CB07/08/0012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chiu HC, 2005, CIRC RES, V96, P225, DOI 10.1161/01.RES.0000154079.20681.B9; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; Cotter DG, 2013, AM J PHYSIOL-HEART C, V304, pH1060, DOI 10.1152/ajpheart.00646.2012; Cotter DG, 2013, AM J PHYSIOL-ENDOC M, V304, pE363, DOI 10.1152/ajpendo.00547.2012; CRETTAZ M, 1980, BIOCHEM J, V186, P525, DOI 10.1042/bj1860525; De Pinto V, 2010, FEBS LETT, V584, P1793, DOI 10.1016/j.febslet.2010.02.049; FINK G, 1988, J BIOL CHEM, V263, P18036; Garcia-Martinez C, 2005, AM J PHYSIOL-CELL PH, V288, pC1264, DOI 10.1152/ajpcell.00271.2004; Guitart M, 2009, MITOCHONDRION, V9, P266, DOI 10.1016/j.mito.2009.03.007; Hall AM, 2005, J BIOL CHEM, V280, P11948, DOI 10.1074/jbc.M412629200; Hatch GM, 2002, J LIPID RES, V43, P1380, DOI 10.1194/jlr.M200130-JLR200; Hayasaki H, 2001, CELL MOL BIOL NOISY, V47; Holloway GP, 2011, DIABETOLOGIA, V54, P1457, DOI 10.1007/s00125-011-2114-8; Holness MJ, 2000, DIABETES, V49, P775, DOI 10.2337/diabetes.49.5.775; HUARD J, 1995, GENE THER, V2, P107; Jeong JY, 2012, DIABETES METAB J, V36, P328, DOI 10.4093/dmj.2012.36.5.328; Jeoung NH, 2008, AM J PHYSIOL-ENDOC M, V295, pE46, DOI 10.1152/ajpendo.00536.2007; Jimenez-Chillaron JC, 2002, METABOLISM, V51, P121, DOI 10.1053/meta.2002.29028; Jimenez-Chillaron JC, 1999, FASEB J, V13, P2153, DOI 10.1096/fasebj.13.15.2153; Johnson M, 2006, HUM GENE THER, V17, P1262, DOI 10.1089/hum.2006.17.1262; Kazantzis M, 2012, BBA-MOL CELL BIOL L, V1821, P852, DOI 10.1016/j.bbalip.2011.09.010; Kim JK, 2004, J CLIN INVEST, V113, P756, DOI 10.1172/JCI200418917; KOCH DD, 1987, CLIN CHEM, V33, P1761; Lanni A, 1996, INT J BIOCHEM CELL B, V28, P337, DOI 10.1016/1357-2725(95)00137-9; Lewis SE, 2001, J BIOL CHEM, V276, P37042, DOI 10.1074/jbc.M105556200; Lobo S, 2007, J LIPID RES, V48, P609, DOI 10.1194/jlr.M600441-JLR200; Marotta M, 2004, METABOLISM, V53, P1032, DOI 10.1016/j.metabol.2004.03.011; MASCARO C, 1995, ARCH BIOCHEM BIOPHYS, V317, P385, DOI 10.1006/abbi.1995.1178; Mashek DG, 2006, CURR OPIN LIPIDOL, V17, P274, DOI 10.1097/01.mol.0000226119.20307.2b; Matsufuji T, 2012, BIOORG MED CHEM LETT, V22, P5067, DOI 10.1016/j.bmcl.2012.05.130; Muoio DM, 2010, BBA-MOL CELL BIOL L, V1801, P281, DOI 10.1016/j.bbalip.2009.11.007; OKAMOTO H, 1970, J BIOL CHEM, V245, P3603; Peters SJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE1151, DOI 10.1152/ajpendo.2001.281.6.E1151; Pilegaard H, 2006, DIABETES, V55, P3020, DOI 10.2337/db06-0152; Puisac B, 2012, MOL BIOL REP, V39, P4777, DOI 10.1007/s11033-011-1270-8; QUANTIN B, 1992, P NATL ACAD SCI USA, V89, P2581, DOI 10.1073/pnas.89.7.2581; RIBES A, 1992, J INHERIT METAB DIS, V15, P367, DOI 10.1007/BF02435978; RODRIGUEZ JC, 1994, J BIOL CHEM, V269, P18767; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; SCHNAITMAN C, 1967, J CELL BIOL, V32, P719, DOI 10.1083/jcb.32.3.719; Schwenk RW, 2010, PROSTAG LEUKOTR ESS, V82, P149, DOI 10.1016/j.plefa.2010.02.029; Sebastian D, 2009, J LIPID RES, V50, P1789, DOI 10.1194/jlr.M800535-JLR200; Seifert EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009834; Stahl A, 2002, DEV CELL, V2, P477, DOI 10.1016/S1534-5807(02)00143-0; Stefanyk LE, 2012, METABOLISM, V61, P1518, DOI 10.1016/j.metabol.2012.04.002; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; VANLAACK HLJM, 1988, CLIN CHIM ACTA, V171, P109; Walter G, 2000, P NATL ACAD SCI USA, V97, P5151, DOI 10.1073/pnas.97.10.5151; Wang YB, 2000, DRUG DISCOV TODAY, V5, P10, DOI 10.1016/S1359-6446(99)01433-6; WEIDEMANN MJ, 1969, BIOCHEM J, V112, P149, DOI 10.1042/bj1120149; Wentz AE, 2010, J BIOL CHEM, V285, P24447, DOI 10.1074/jbc.M110.100651; Wiczer BM, 2009, J LIPID RES, V50, P2502, DOI 10.1194/jlr.M900218-JLR200; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zhan TZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045087	59	19	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98109	10.1371/journal.pone.0098109	http://dx.doi.org/10.1371/journal.pone.0098109			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858472	Green Published, gold, Green Submitted			2022-12-25	WOS:000336839400041
J	Rajput, NA; Zhang, MX; Ru, YY; Liu, TL; Xu, J; Liu, L; Mafurah, JJ; Dou, DL				Rajput, Nasir Ahmed; Zhang, Meixiang; Ru, Yanyan; Liu, Tingli; Xu, Jing; Liu, Li; Mafurah, Joseph Juma; Dou, Daolong			Phytophthora sojae Effector PsCRN70 Suppresses Plant Defenses in Nicotiana benthamiana	PLOS ONE			English	Article							CELL-DEATH; HYPERSENSITIVE RESPONSE; PROTEIN; LOCALIZATION; ACCUMULATION; EXPRESSION; INFESTANS	Phytophthora sojae, an oomycete pathogen, produces a large number of effector proteins that enter into host cells. The Crinklers (Crinkling and Necrosis, CRN) are cytoplasmic effectors that are conserved in oomycete pathogens and their encoding genes are highly expressed at the infective stages in P. sojae. However, their roles in pathogenesis are largely unknown. Here, we functionally characterized an effector PsCRN70 by transiently and stably overexpressing it in Nicotiana benthamiana. We demonstrated that PsCRN70 was localized to the plant cell nucleus and suppressed cell death elicited by all the tested cell death-inducing proteins, including BAX, PsAvh241, PsCRN63, PsojNIP and R3a/Avr3a. Overexpression of the PsCRN70 gene in N. benthamiana enhanced susceptibility to P. parasitica. The H2O2 accumulation in the PsCRN70-transgenic plants was reduced compared to the GFP-lines. The transcriptional levels of the defense-associated genes, including PR1b, PR2b, ERF1 and LOX, were also down-regulated in the PsCRN70-transgenic lines. Our results suggest that PsCRN70 may function as a universal suppressor of the cell death induced by many elicitors, the host H2O2 accumulation and the expression of defense-associated genes, and therefore promotes pathogen infection.	[Rajput, Nasir Ahmed; Zhang, Meixiang; Ru, Yanyan; Liu, Tingli; Xu, Jing; Liu, Li; Mafurah, Joseph Juma; Dou, Daolong] Nanjing Agr Univ, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Dou, DL (corresponding author), Nanjing Agr Univ, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China.	ddou@njau.edu.cn	Dou, Daolong/AAW-1678-2021	Dou, Daolong/0000-0001-5226-6642	NSF of Jiangsu Province [BK2012027]; NSFC [31301613]; Youth Science and Technology Innovation Fund of NJAU [KJ2013005]	NSF of Jiangsu Province; NSFC(National Natural Science Foundation of China (NSFC)); Youth Science and Technology Innovation Fund of NJAU	NSF of Jiangsu Province (BK2012027); NSFC(31301613); Youth Science and Technology Innovation Fund of NJAU (KJ2013005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Bozkurt TO, 2011, P NATL ACAD SCI USA, V108, P20832, DOI 10.1073/pnas.1112708109; Dou DL, 2008, PLANT CELL, V20, P1930, DOI 10.1105/tpc.107.056093; Dou DL, 2012, CELL HOST MICROBE, V12, P484, DOI 10.1016/j.chom.2012.09.003; Gallois P, 1995, Methods Mol Biol, V49, P39; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hann DR, 2010, CURR OPIN PLANT BIOL, V13, P388, DOI 10.1016/j.pbi.2010.04.003; Hemetsberger C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002684; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kelley BS, 2010, PLANT J, V62, P357, DOI 10.1111/j.1365-313X.2010.04160.x; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P13142, DOI 10.1073/pnas.0907506106; Lacomme C, 1999, P NATL ACAD SCI USA, V96, P7956, DOI 10.1073/pnas.96.14.7956; Lamour KH, 2012, MOL PLANT MICROBE IN, V25, P1350, DOI 10.1094/MPMI-02-12-0028-R; Lee S, 2013, PEERJ, V1, DOI 10.7717/peerj.34; Liu TL, 2011, PLANT PHYSIOL, V155, P490, DOI 10.1104/pp.110.166470; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Lu R, 2003, EMBO J, V22, P5690, DOI 10.1093/emboj/cdg546; McLellan H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003670; Petrov VD, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls014; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; Rafiqi M, 2012, CURR OPIN PLANT BIOL, V15, P477, DOI 10.1016/j.pbi.2012.05.003; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Shen DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070036; Song TQ, 2013, MOL PLANT MICROBE IN, V26, P711, DOI 10.1094/MPMI-12-12-0289-R; Stam R, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00387; Stam R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059517; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Tyler BM, 2001, TRENDS GENET, V17, P611, DOI 10.1016/S0168-9525(01)02517-3; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van Damme M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002875; Wang CX, 2000, PLANT CELL, V12, P2237, DOI 10.1105/tpc.12.11.2237; Wang QQ, 2011, PLANT CELL, V23, P2064, DOI 10.1105/tpc.111.086082; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Yu XL, 2012, NEW PHYTOL, V196, P247, DOI 10.1111/j.1469-8137.2012.04241.x; Zhang MX, 2012, FUNGAL BIOL-UK, V116, P1013, DOI 10.1016/j.funbio.2012.07.006	37	35	41	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98114	10.1371/journal.pone.0098114	http://dx.doi.org/10.1371/journal.pone.0098114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858571	Green Published, gold, Green Submitted			2022-12-25	WOS:000336839400042
J	Xiong, Y; Zhang, LS; Kebebew, E				Xiong, Yin; Zhang, Lisa; Kebebew, Electron			MiR-20a Is Upregulated in Anaplastic Thyroid Cancer and Targets LIMK1	PLOS ONE			English	Article							BREAST-CANCER; MIR-17-92 CLUSTER; TUMOR-METASTASIS; PROSTATE-CANCER; CELL-LINE; MICRORNA; INVASION; EXPRESSION; KINASE; PROLIFERATION	Background: There have been conflicting reports regarding the function of miR-20a in a variety of cancer types and we previously found it to be dysregulated in sporadic versus familial papillary thyroid cancer. In this study, we studied the expression of miR-20a in normal, benign and malignant thyroid samples, and its effect on thyroid cancer cells in vitro and in vivo. Methodology/Principal Findings: The expression of miR-20a in normal, benign and malignant thyroid tissue was determined by quantitative RT-PCR. Thyroid cancer cells were transfected with miR-20a and the effect on cellular proliferation, tumor spheroid formation, and invasion was evaluated. Target genes of miR-20 were determined by genome-wide mRNA expression analysis with miR-20a overexpression in thyroid cancer cells and target prediction database. Target genes were validated by quantitative PCR and immunoblotting, and luciferase assays. MiR-20a expression was significantly higher in anaplastic thyroid cancer than in differentiated thyroid cancer, and benign and normal thyroid tissues. MiR-20a significantly inhibited thyroid cancer cell proliferation in vitro (p<0.01) and in vivo (p<0.01), tumor spheroid formation (p<0.05) and invasion (p<0.05) in multiple thyroid cancer cell lines. We found that LIMK1 was a target of miR-20a in thyroid cancer cell lines and direct knockdown of LIMK1 recapitulated the effect of miR-20a in thyroid cancer cells. Conclusions/Significance: To our knowledge, this is the first study to demonstrate that miR-20a plays a role as a tumor suppressor in thyroid cancer cells and targets LIMK1. Our findings suggest the upregulated expression of miR-20a in anaplastic thyroid cancer counteracts thyroid cancer progression and may have therapeutic potential.	[Xiong, Yin; Zhang, Lisa; Kebebew, Electron] NCI, Endocrine Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kebebew, E (corresponding author), NCI, Endocrine Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA.	kebebewe@mail.nih.gov			National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC011275] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Institutes of Health, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagheri-Yarmand R, 2006, INT J CANCER, V118, P2703, DOI 10.1002/ijc.21650; Bernard O, 2007, INT J BIOCHEM CELL B, V39, P1071, DOI 10.1016/j.biocel.2006.11.011; Carraro G, 2009, DEV BIOL, V333, P238, DOI 10.1016/j.ydbio.2009.06.020; Chen AY, 2009, CANCER-AM CANCER SOC, V115, P3801, DOI 10.1002/cncr.24416; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r127; Davila M, 2003, J BIOL CHEM, V278, P36868, DOI 10.1074/jbc.M306196200; Davila M, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-40; Ding YM, 2008, MOL CELL BIOL, V28, P3742, DOI 10.1128/MCB.01832-07; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fan XX, 2010, ACTA BIOCH BIOPH SIN, V42, P318, DOI 10.1093/abbs/gmq026; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hu QL, 2013, BIOMATERIALS, V34, P2265, DOI 10.1016/j.biomaterials.2012.12.016; Huang GX, 2012, CANCER RES, V72, P908, DOI 10.1158/0008-5472.CAN-11-1460; Huang XM, 2013, CLIN CANCER RES, V19, P2355, DOI 10.1158/1078-0432.CCR-12-3191; Institute NC, 2011, THYR CANC; Kang HW, 2012, FEBS LETT, V586, P897, DOI 10.1016/j.febslet.2012.02.020; Kebebew E, 2008, WORLD J SURG, V32, P678, DOI 10.1007/s00268-007-9312-z; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Takakura S, 2008, CANCER SCI, V99, P1147, DOI 10.1111/j.1349-7006.2008.00800.x; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Vriens MR, 2009, THYROID, V19, P1343, DOI 10.1089/thy.2009.1607; Weber F, 2006, J CLIN ENDOCR METAB, V91, P3584, DOI 10.1210/jc.2006-0693; Xiong Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024717; Ye WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001719; Yoshioka K, 2003, P NATL ACAD SCI USA, V100, P7247, DOI 10.1073/pnas.1232344100; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Yu ZR, 2010, P NATL ACAD SCI USA, V107, P8231, DOI 10.1073/pnas.1002080107; Zielke A, 1998, THYROID, V8, P475, DOI 10.1089/thy.1998.8.475	34	114	118	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e96103	10.1371/journal.pone.0096103	http://dx.doi.org/10.1371/journal.pone.0096103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858712	Green Submitted, gold, Green Published			2022-12-25	WOS:000336839400001
J	Ozdemir, K; Acar, S				Ozdemir, Kerem; Acar, Sumeyra			Plasmid Profile and Pulsed-Field Gel Electrophoresis Analysis of Salmonella enterica Isolates from Humans in Turkey	PLOS ONE			English	Article							ENTERITIDIS; RESISTANCE; TYPHIMURIUM; DIVERSITY	This study was conducted for typing Salmonella enterica subspecies enterica strains in Turkey using pulsed-field gel electrophoresis (PFGE) and plasmid DNA profile analysis. Fourty-two strains were isolated from clinical samples obtained from unrelated patients with acute diarrhea. The samples were collected from state hospitals and public health laboratories located at seven provinces in different regions of Turkey at different times between 2004 and 2010. The strains were determined to belong to 4 different serovars. The Salmonella enterica strains belonged to the serovars Salmonella Enteritidis (n = 23), Salmonella Infantis (n = 14), Salmonella Munchen (n = 2), and Salmonella Typhi (n = 3). Forty-two Salmonella enterica strains were typed with PFGE methods using XbaI restriction enzyme and plasmid analysis. At the end of typing, 11 different PFGE band profiles were obtained. Four different PFGE profiles (type 1, 4, 9, and 10) were found among serotype S. Enteritidis species, 3 different PFGE profiles (type 3, 5, 6) were found among S. Infantis species, 2 different PFGE profiles were found among S. Typhi species (type 2 and 11), and 2 different PFGE profiles were found among S. Munchen species (type 7, 8). The UPGMA dendrogram was built on the PFGE profiles. In this study, it was determined that 4 strains of 42 Salmonella enterica strains possess no plasmid, while the isolates have 1-3 plasmids ranging from 5.0 to 150 kb and making 12 different plasmid profiles (P1-P12). In this study, we have applied the analysis of the PFGE patterns and used bioinformatics methods to identify both inter and intra serotype relationships of 4 frequently encountered serotypes for the first time in Turkey.	[Ozdemir, Kerem] Yuzuncu Yil Univ, Fac Sci, Dept Biol, Van, Turkey; [Acar, Sumeyra] Publ Hlth Inst Turkey, Ankara, Turkey	Yuzuncu Yil University; Refik Saydam Hifzissihha Merkezi Baskanligi	Ozdemir, K (corresponding author), Yuzuncu Yil Univ, Fac Sci, Dept Biol, Van, Turkey.	kerem@yyu.edu.tr						Abbassi-Ghozzi I, 2011, PATHOL BIOL, V59, P207, DOI 10.1016/j.patbio.2010.06.001; Adesiyun A, 2000, Rev Panam Salud Publica, V8, P342, DOI 10.1590/S1020-49892000001000004; Aksoycan N, 1974, MIKROBIYOL BUL, V8, P153; Aktas Z, 2007, INT J ANTIMICROB AG, V30, P541, DOI 10.1016/j.ijantimicag.2007.06.034; Allard MW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-32; Ammari S, 2009, J INFECT DEV COUNTR, V3, P41; Bayramova M, 2007, THESIS ANKARA U TURK; Ben Aissa R, 2008, EPIDEMIOL INFECT, V136, P468, DOI 10.1017/S0950268807008916; Boxrud D, 2007, J CLIN MICROBIOL, V45, P536, DOI 10.1128/JCM.01595-06; Cardinale E, 2005, J APPL MICROBIOL, V99, P968, DOI 10.1111/j.1365-2672.2005.02618.x; Centers for Disease Control and Prevention, 2005, MMWR-MORBID MORTAL W, V52, P10; Erdem Birsel, 2004, Mikrobiyoloji Bulteni, V38, P173; Fonseca EL, 2006, J CLIN MICROBIOL, V44, P2767, DOI 10.1128/JCM.01916-05; Fontana J, 2003, EMERG INFECT DIS, V9, P496, DOI 10.3201/eid0904.020423; Gatto A. J., 2006, EPIDEMIOL INFECT, V25, P1; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kerouanton A, 2007, FOODBORNE PATHOG DIS, V4, P293, DOI 10.1089/fpd.2007.0090; Kilic A, 2010, INTERNAL MED, V49, P31, DOI 10.2169/internalmedicine.49.2743; Koort JMK, 2002, J CLIN MICROBIOL, V40, P3497, DOI 10.1128/JCM.40.9.3497-3498.2002; Kubota K, 2005, J CLIN MICROBIOL, V43, P1205, DOI 10.1128/JCM.43.3.1205-1209.2005; Levent B, 2010, 34 TURK MICR C 7 11, P234; LINTON AH, 1981, J APPL BACTERIOL, V50, P115, DOI 10.1111/j.1365-2672.1981.tb00876.x; Merino Luis A., 2003, Rev. Inst. Med. trop. S. Paulo, V45, P119, DOI 10.1590/S0036-46652003000300001; OLSEN JE, 1994, J MED MICROBIOL, V40, P15, DOI 10.1099/00222615-40-1-15; Onyango MD, 2009, J INFECT DEV COUNTR, V3, P685; Otgun SN, 2011, EUR J CLIN MICROBIOL, V30, P1229, DOI 10.1007/s10096-011-1217-y; Parker CT, 2010, APPL ENVIRON MICROB, V76, P3723, DOI 10.1128/AEM.03053-09; Ridley AM, 1998, J CLIN MICROBIOL, V36, P2314, DOI 10.1128/JCM.36.8.2314-2321.1998; Seno M, 2004, J INFECTION, V49, P291, DOI 10.1016/j.jinf.2003.09.002; Soyer Y, 2010, FOODBORNE PATHOG DIS, V7, P707, DOI 10.1089/fpd.2009.0424; Taban B, 2007, THESIS HACETTEPE U A; Tekeli A, 2006, NEW MICROBIOL, V29, P251; Us E, 2011, MIKROBIYOL BUL, V45, P210; Wattiau P, 2011, APPL ENVIRON MICROB, V77, P7877, DOI 10.1128/AEM.05527-11; Wu W, 2010, BMC MICROBIOL, V10, P1471; Zou W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059224	36	24	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e95976	10.1371/journal.pone.0095976	http://dx.doi.org/10.1371/journal.pone.0095976			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852084	gold, Green Submitted, Green Published			2022-12-25	WOS:000338323200008
J	Smits, EJ; Tolonen, AJ; Cluitmans, L; van Gils, M; Conway, BA; Zietsma, RC; Leenders, KL; Maurits, NM				Smits, Esther J.; Tolonen, Antti J.; Cluitmans, Luc; van Gils, Mark; Conway, Bernard A.; Zietsma, Rutger C.; Leenders, Klaus L.; Maurits, Natasha M.			Standardized Handwriting to Assess Bradykinesia, Micrographia and Tremor in Parkinson's Disease	PLOS ONE			English	Article							COORDINATION; DIAGNOSIS; IMPAIRMENT; MOVEMENTS; ACCURACY; WRIST; HAND; ARM	Objective: To assess whether standardized handwriting can provide quantitative measures to distinguish patients diagnosed with Parkinson's disease from age- and gender-matched healthy control participants. Design: Exploratory study. Pen tip trajectories were recorded during circle, spiral and line drawing and repeated character 'elelelel' and sentence writing, performed by Parkinson patients and healthy control participants. Parkinson patients were tested after overnight withdrawal of anti-Parkinsonian medication. Setting: University Medical Center Groningen, tertiary care, the Netherlands. Participants: Patients with Parkinson's disease (n = 10; mean age 69.0 years; 6 male) and healthy controls (n = 10; mean age 68.1 years; 6 male). Interventions: Not applicable. Main Outcome Measures: Movement time and velocity to detect bradykinesia and the size of writing to detect micrographia. A rest recording to investigate the presence of a rest-tremor, by frequency analysis. Results: Mean disease duration in the Parkinson group was 4.4 years and the patients were in modified Hoehn-Yahr stages 1-2.5. In general, Parkinson patients were slower than healthy control participants. Median time per repetition, median velocity and median acceleration of the sentence task and median velocity of the elel task differed significantly between Parkinson patients and healthy control participants (all p < 0.0014). Parkinson patients also wrote smaller than healthy control participants and the width of the 'e' in the elel task was significantly smaller in Parkinson patients compared to healthy control participants (p < 0.0014). A rest-tremor was detected in the three patients who were clinically assessed as having rest-tremor. Conclusions: This study shows that standardized handwriting can provide objective measures for bradykinesia, tremor and micrographia to distinguish Parkinson patients from healthy control participants.	[Smits, Esther J.; Leenders, Klaus L.; Maurits, Natasha M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Tolonen, Antti J.; Cluitmans, Luc; van Gils, Mark] VTT Tech Res Ctr Finland, Tampere, Finland; [Conway, Bernard A.] Univ Strathclyde, Dept Biomed Engn, Glasgow, Lanark, Scotland; [Zietsma, Rutger C.] Manus Neurodynam Ltd, Newcastle, NSW, Australia	University of Groningen; VTT Technical Research Center Finland; University of Strathclyde	Smits, EJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.	e.j.smits@umcg.nl	Smits, Esther/F-9651-2018; Conway, Bernard/A-9625-2016	Smits, Esther/0000-0002-1356-7255; Conway, Bernard/0000-0002-0069-0131; van Gils, Mark/0000-0002-0029-1771; Maurits, Natasha/0000-0001-6231-7044	EC [262291]; Manus Neurodynamica Ltd, Newcastle, United Kingdom	EC(European CommissionEuropean Commission Joint Research Centre); Manus Neurodynamica Ltd, Newcastle, United Kingdom	This study is part of the DiPAR project for which funding was received from the EC in the FP7-SME-201001 programme (grant agreement 262291). VTT and UMCG collaborated as subcontracted RTD performers. Manus Neurodynamica Ltd, Newcastle, United Kingdom provided support in the form of salaries for author RZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alty JE, 2012, MOVEMENT DISORD, V27, pS91; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Bajaj NPS, 2012, J NEUROL, V259, P2335, DOI 10.1007/s00415-012-6495-5; Broderick MP, 2009, EXP BRAIN RES, V197, P223, DOI 10.1007/s00221-009-1925-z; de Jong BM, 1999, COGNITIVE BRAIN RES, V8, P45, DOI 10.1016/S0926-6410(99)00005-1; Dounskaia N, 2009, NEUROPSYCHOLOGIA, V47, P2504, DOI 10.1016/j.neuropsychologia.2009.04.020; Eshuis SA, 2009, EUR J NUCL MED MOL I, V36, P454, DOI 10.1007/s00259-008-0989-5; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Grosset DG, 2008, J NEUROL NEUROSUR PS, V79, P615, DOI 10.1136/jnnp.2008.144741; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Inlu A, 2006, ISBMDA LECT NOTES CO, V4345, P441; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Keresztenyi Z, 2009, INT J REHABIL RES, V32, P53, DOI 10.1097/MRR.0b013e32830d369c; Massano J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008870; MCLENNAN JE, 1972, J NEUROL SCI, V15, P141, DOI 10.1016/0022-510X(72)90002-0; Moroney R, 2008, J COMPUT NEUROSCI, V25, P501, DOI 10.1007/s10827-008-0091-9; Ondo WG, 2007, MOVEMENT DISORD, V22, P2130, DOI 10.1002/mds.21733; Ponsen MM, 2008, PARKINSONISM RELAT D, V14, P199, DOI 10.1016/j.parkreldis.2007.07.019; Ramaker C, 2002, MOVEMENT DISORD, V17, P867, DOI 10.1002/mds.10248; Rosenblum S, 2013, J NEUROL, V260, P2357, DOI 10.1007/s00415-013-6996-x; Saunders-Pullman R, 2008, MOVEMENT DISORD, V23, P531, DOI 10.1002/mds.21874; Scanlon BK, 2013, J CLIN NEUROSCI, V20, P827, DOI 10.1016/j.jocn.2012.06.015; Shukla AW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000628; Stanley K, 2010, PARKINSONISM RELAT D, V16, P233, DOI 10.1016/j.parkreldis.2009.12.007; Teulings HL, 1997, EXP NEUROL, V146, P159, DOI 10.1006/exnr.1997.6507; Van Gemmert AWA, 2001, BRAIN COGNITION, V47, P504, DOI 10.1006/brcg.2001.1328; Zietsma RC, 2010, THESIS U STRATHCLYDE	28	74	77	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97614	10.1371/journal.pone.0097614	http://dx.doi.org/10.1371/journal.pone.0097614			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24854199	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000338323200023
J	Suld, K; Valdmann, H; Laurimaa, L; Soe, E; Davison, J; Saarma, U				Sueld, Karmen; Valdmann, Harri; Laurimaa, Leidi; Soe, Egle; Davison, John; Saarma, Urmas			An Invasive Vector of Zoonotic Disease Sustained by Anthropogenic Resources: The Raccoon Dog in Northern Europe	PLOS ONE			English	Article							WOLF CANIS-LUPUS; NYCTEREUTES-PROCYONOIDES; ESTONIA; MAMMALS; IMPACT; DIET	The raccoon dog (Nyctereutes procyonoides) is an introduced species in Europe with a continually expanding range. Since the species is capable of affecting local ecosystems and is a vector for a number of severe zoonotic diseases, it is important to understand its food habits. Raccoon dog diet was studied in Estonia by examining the contents of 223 stomach samples collected during the coldest period of the year, August to March, in 2010-2012. The most frequently consumed food categories were anthropogenic plants (e.g. cereals, fruits; FO = 56.1%) and carrion (e.g. carcasses of artiodactyls and carnivores; FO = 48.4%). Carrion was also the only food category that was consumed significantly more frequently by raccoon dogs exhibiting symptoms of sarcoptic mange than by uninfected animals. Small mammals, which represent intermediate hosts for the zoonotic tapeworm Echinococcus multilocularis, were more commonly recorded in samples also containing anthropogenic plants than expected by chance. Comparison of raccoon dog and red fox (Vulpes vulpes) diet in Estonia revealed higher overlap than found elsewhere in Europe, with 'carrion' and 'anthropogenic plants' making up the bulk of both species' diet; however, raccoon dogs were more omnivorous than red foxes. Our results suggest that while the use of most food categories reflects the phenology of natural food sources, 'anthropogenic plants' and 'carrion' provide an essential resource for raccoon dogs during the coldest period of the year, with the latter resource especially important for individuals infected with sarcoptic mange. Since both of these food categories and small mammals are often found at supplementary feeding sites for wild boar (Sus scrofa), this game management practice may facilitate high densities of mesocarnivores and promote the spread of some severe zoonotic diseases, including alveolar echinococcosis, trichinellosis, rabies and sarcoptic mange.	[Sueld, Karmen; Valdmann, Harri; Laurimaa, Leidi; Soe, Egle; Davison, John; Saarma, Urmas] Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, EE-50090 Tartu, Estonia	University of Tartu; Tartu University Institute of Ecology & Earth Sciences	Saarma, U (corresponding author), Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, Ulikooli 18, EE-50090 Tartu, Estonia.	Urmas.Saarma@ut.ee	Saarma, Urmas/AAC-9813-2019; Saarma, Urmas/J-6448-2015	Saarma, Urmas/0000-0002-3222-571X; Saarma, Urmas/0000-0002-3222-571X	Estonian Research Council [IUT 20-32, ESF 8793]; European Union through the European Regional Development Fund (Centre of Excellence FIBIR); Estonian Doctoral School of Ecology and Environmental Sciences	Estonian Research Council(Estonian Research Council); European Union through the European Regional Development Fund (Centre of Excellence FIBIR)(European Commission); Estonian Doctoral School of Ecology and Environmental Sciences	This work was supported by grants from the Estonian Research Council (grants IUT 20-32 and ESF 8793), from the European Union through the European Regional Development Fund (Centre of Excellence FIBIR), and from the Estonian Doctoral School of Ecology and Environmental Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aul J, 1957, EESTI NSV IMETAJAD, P256; Baltrunaite Laima, 2006, Acta Zoologica Lituanica, V16, P46, DOI 10.1080/13921657.2006.10512709; Baltrunaite Laima, 2002, Acta Zoologica Lituanica, V12, P362; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bornstein Set, 2001, P107, DOI 10.1002/9780470377000.ch5; Davidson RK, 2012, TRENDS PARASITOL, V28, P239, DOI 10.1016/j.pt.2012.03.004; Eckert J., 2001, WHO OIE MANUAL ECHIN; ERLICH PR, 1989, BIOL INVASIONS GLOBA, P315; Genovesi P, 2012, INTEGR ZOOL, V7, P247, DOI 10.1111/j.1749-4877.2012.00309.x; HELLE E, 1995, J MAMMAL, V76, P1036, DOI 10.2307/1382597; Jedrzejewska B., 1998, PREDATION VERTEBRATE, V135; Kaal M, 1981, EESTI IMETAJATE MAAR; KAUHALA K, 1993, Z SAUGETIERKD, V58, P129; Kauhala K, 2011, CURR ZOOL, V57, P584, DOI 10.1093/czoolo/57.5.584; Kauhala K, 1996, WILDLIFE BIOL, V2, P197, DOI 10.2981/wlb.1996.019; Krebs C. J., 1999, ECOLOGICAL METHODOLO; Kubarsepp Marko, 2003, Acta Zoologica Lituanica, V13, P28; Laanetu N., 1986, Eesti Ulukid, V4, P15; Miller I, 2004, WILD ANIMAL TRICHINE, P174; Moks E, 2006, J WILDLIFE DIS, V42, P359, DOI 10.7589/0090-3558-42.2.359; Moks E, 2005, EMERG INFECT DIS, V11, P1973, DOI 10.3201/eid1112.050339; Naaber J., 1971, EESTI LODUS, V14, P449; Naaber J., 1974, EESTI NSV JAHIMEESTE, P102; Neronov VM, 2008, INTEGR ZOOL, V3, P83, DOI 10.1111/j.1749-4877.2008.00084.x; Newman TJ, 2002, CAN J ZOOL, V80, P154, DOI [10.1139/z01-216, 10.1139/Z01-216]; Niin E, 2008, VACCINE, V26, P3556, DOI 10.1016/j.vaccine.2008.04.056; Oja R, 2011, THESIS U TARTU; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Partel A, 2013, B OIE, V3, P58; Planka E.R., 1973, Annual Rev Ecol Syst, V4, P53; POZIO E, 1995, INT J PARASITOL, V25, P1247, DOI 10.1016/0020-7519(95)00042-Z; Ratsepp M, 2005, THESIS U TARTU; Remonti L, 2005, PARASITOL RES, V97, P431, DOI 10.1007/s00436-005-1481-9; Sato Y, 2000, WILDLIFE SOC B, V28, P311; Selva N, 2005, CAN J ZOOL, V83, P1590, DOI 10.1139/Z05-158; Sidorovich VE, 2011, ANAL VERTEBRATE PRED, P429; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; Sutor A, 2010, ACTA THERIOL, V55, P165, DOI 10.4098/j.at.0001-7051.035.2009; Teerink BJ, 1991, HAIR W EUROPEAN MAMM, P223; Tumanov I. L., 2003, BIOL CHARACTERISTICS; Valdmann H, 2005, ACTA THERIOL, V50, P521, DOI 10.1007/BF03192645; Vulla E, 2009, ANN ZOOL FENN, V46, P395, DOI 10.5735/086.046.0601; XIAO YJ, 1995, ACTA AGR SCAND A-AN, V45, P186, DOI 10.1080/09064709509415850	43	37	37	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e96358	10.1371/journal.pone.0096358	http://dx.doi.org/10.1371/journal.pone.0096358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852942	Green Published, gold, Green Submitted			2022-12-25	WOS:000338323200013
J	Dehury, B; Patra, MC; Maharana, J; Sahu, J; Sen, P; Modi, MK; Choudhury, MD; Barooah, M				Dehury, Budheswar; Patra, Mahesh Chandra; Maharana, Jitendra; Sahu, Jagajjit; Sen, Priyabrata; Modi, Mahendra Kumar; Choudhury, Manabendra Dutta; Barooah, Madhumita			Structure-Based Computational Study of Two Disease Resistance Gene Homologues (Hm1 and Hm2) in Maize (Zea mays L.) with Implications in Plant-Pathogen Interactions	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; CRYSTAL-STRUCTURE; RECOGNITION; SERVER; EVOLUTION; REDUCTASE; WEB; PLATFORM; MODELS; ORIGIN	The NADPH-dependent HC-toxin reductases (HCTR1 and 2) encoded by enzymatic class of disease resistance homologous genes (Hm1 and Hm2) protect maize by detoxifying a cyclic tetrapeptide, HC-toxin, secreted by the fungus Cochliobolus carbonum race 1(CCR1). Unlike the other classes' resistance (R) genes, HCTR-mediated disease resistance is an inimitable mechanism where the avirulence (Avr) component from CCR1 is not involved in toxin degradation. In this study, we attempted to decipher cofactor (NADPH) recognition and mode of HC-toxin binding to HCTRs through molecular docking molecular dynamics (MD) simulations and binding free energy calculation methods. The rationality and the stability of docked complexes were validated by 30-ns MD simulation. The binding free energy decomposition of enzyme-cofactor complex was calculated to find the driving force behind cofactor recognition. The overall binding free energies of HCTR1-NADPH and HCTR2-NADPH were found to be -616.989 and -16.9749 kJ mol(-1) respectively. The binding free energy decomposition revealed that the binding of NADPH to the HCTR1 is mainly governed by van der Waals and nonpolar interactions, whereas electrostatic terms play dominant role in stabilizing the binding mode between HCTR2 and NADPH. Further, docking analysis of HC-toxin with HCTR-NADPH complexes showed a distinct mode of binding and the complexes were stabilized by a strong network of hydrogen bond and hydrophobic interactions. This study is the first in silico attempt to unravel the biophysical and biochemical basis of cofactor recognition in enzymatic class of R genes in cereal crop maize.	[Dehury, Budheswar; Sahu, Jagajjit; Sen, Priyabrata; Modi, Mahendra Kumar; Barooah, Madhumita] Assam Agr Univ, Dept Agr Biotechnol, Jorhat, Assam, India; [Dehury, Budheswar; Choudhury, Manabendra Dutta] Assam Univ, Dept Life Sci & Bioinformat, Silchar, Assam, India; [Patra, Mahesh Chandra; Maharana, Jitendra] Orissa Univ Agr & Technol, Dept Bioinformat, BIF Ctr, Bhubaneswar 751003, Orissa, India; [Patra, Mahesh Chandra] Natl Dairy Res Inst, Anim Biotechnol Ctr, Anim Genom Lab, Karnal 132001, Haryana, India; [Maharana, Jitendra] Cent Inland Fisheries Res Inst, Biotechnol Lab, Kolkata, W Bengal, India	Assam Agricultural University; Assam University; Orissa University of Agriculture & Technology; Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Central Inland Fisheries Research Institute	Barooah, M (corresponding author), Assam Agr Univ, Dept Agr Biotechnol, Jorhat, Assam, India.	m17barooah@yahoo.co.in	Choudhury, Manabendra/AAP-1817-2021; DEHURY, BUDHESWAR/G-9330-2017; Maharana, Jitendra/B-5210-2014; Sen, Priyabrata/AAD-8490-2019; Sahu, Jagajjit/J-6696-2019; Patra, Mahesh/I-9746-2014	DEHURY, BUDHESWAR/0000-0002-9726-8454; Maharana, Jitendra/0000-0003-4628-5956; Sahu, Jagajjit/0000-0001-7468-5696; Modi, Mahendra Kumar/0000-0001-5509-4612; Barooah, Madhumita/0000-0002-3768-5336; Patra, Mahesh/0000-0003-0471-6236; Dutta Choudhury, Manabendra/0000-0002-9472-0572	Bioinformatics Initiative Division, Department of Electronics and Information Technology (DeitY), Ministry of Communications & Information Technology, Government of India; Biotechnology Information System Network (BTISNET), Department of Biotechnology, Government of India	Bioinformatics Initiative Division, Department of Electronics and Information Technology (DeitY), Ministry of Communications & Information Technology, Government of India; Biotechnology Information System Network (BTISNET), Department of Biotechnology, Government of India	The authors acknowledge the financial support from Bioinformatics Initiative Division, Department of Electronics and Information Technology (DeitY), Ministry of Communications & Information Technology, Government of India as well as Biotechnology Information System Network (BTISNET), Department of Biotechnology, Government of India. The authors are also grateful to Assam Agricultural University for providing necessary infrastructure to carry out this research work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Balint-Kurti Peter J., 2009, P229, DOI 10.1007/978-0-387-79418-1_12; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bishop JG, 2000, P NATL ACAD SCI USA, V97, P5322, DOI 10.1073/pnas.97.10.5322; Biswas D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045525; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Bottoms CA, 2002, PROTEIN SCI, V11, P2125, DOI 10.1110/ps.0213502; Chen CC, 2006, NUCLEIC ACIDS RES, V34, pW152, DOI 10.1093/nar/gkl187; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chintamanani S, 2008, MOL PLANT MICROBE IN, V21, P79, DOI 10.1094/MPMI-21-1-0079; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Dehury B, 2013, J MOL GRAPH MODEL, V45, P50, DOI 10.1016/j.jmgm.2013.08.011; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Gargouri M, 2009, ACTA CRYSTALLOGR D, V65, P989, DOI 10.1107/S0907444909025013; Han F, 1997, MOL PLANT MICROBE IN, V10, P234, DOI 10.1094/MPMI.1997.10.2.234; JOHAL GS, 1992, SCIENCE, V258, P985, DOI 10.1126/science.1359642; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Ko J, 2012, NUCLEIC ACIDS RES, V40, pW294, DOI 10.1093/nar/gks493; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Malde AK, 2011, J CHEM THEORY COMPUT, V7, P4026, DOI 10.1021/ct200196m; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; McGuffin LJ, 2013, NUCLEIC ACIDS RES, V41, pW368, DOI 10.1093/nar/gkt294; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Multani DS, 1998, P NATL ACAD SCI USA, V95, P1686, DOI 10.1073/pnas.95.4.1686; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Petit P, 2007, J MOL BIOL, V368, P1345, DOI 10.1016/j.jmb.2007.02.088; Pontius J, 1996, J MOL BIOL, V264, P121, DOI 10.1006/jmbi.1996.0628; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shao H, 2007, J MOL BIOL, V369, P265, DOI 10.1016/j.jmb.2007.03.040; Sindhu A, 2008, P NATL ACAD SCI USA, V105, P1762, DOI 10.1073/pnas.0711406105; Sparla F, 2004, J MOL BIOL, V340, P1025, DOI 10.1016/j.jmb.2004.06.005; Spiliotopoulos D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046902; Tiffin P, 2006, TRENDS GENET, V22, P662, DOI 10.1016/j.tig.2006.09.011; Ullstrup AJ, 1941, PHYTOPATHOLOGY, V31, P508; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Walton JD, 2006, PHYTOCHEMISTRY, V67, P1406, DOI 10.1016/j.phytochem.2006.05.033; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Yang YD, 2011, BIOINFORMATICS, V27, P2076, DOI 10.1093/bioinformatics/btr350; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang LQ, 2002, GENETICS, V162, P851	53	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97852	10.1371/journal.pone.0097852	http://dx.doi.org/10.1371/journal.pone.0097852			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847713	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600064
J	Enlund, E; Fischer, S; Handrick, R; Otte, K; Debatin, KM; Wabitsch, M; Fischer-Posovszky, P				Enlund, Eveliina; Fischer, Simon; Handrick, Rene; Otte, Kerstin; Debatin, Klaus-Michael; Wabitsch, Martin; Fischer-Posovszky, Pamela			Establishment of Lipofection for Studying miRNA Function in Human Adipocytes	PLOS ONE			English	Article							MICRORNAS; DELIVERY	miRNA dysregulation has recently been linked to human obesity and its related complications such as type 2 diabetes. In order to study miRNA function in human adipocytes, we aimed for the modulation of mature miRNA concentration in these cells. Adipocytes, however, tend to be resistant to transfection and there is often a need to resort to viral transduction or electroporation. Our objective therefore was to identify an efficient, non-viral transfection reagent capable of delivering small RNAs into these cells. To achieve this, we compared the efficiencies of three transfection agents, Lipofectamine 2000, ScreenFect A and BPEI 1.2 k in delivering fluorescent-labelled siRNA into human Simpson-Golabi-Behmel syndrome (SGBS) preadipocytes and adipocytes. Downregulation of a specific target gene in response to miRNA mimic overexpression was assayed in SGBS cells and also in ex vivo differentiated primary human adipocytes. Our results demonstrated that while all three transfection agents were able to internalize the oligos, only lipofection resulted in the efficient downregulation of a specific target gene both in SGBS cells and in primary human adipocytes. Lipofectamine 2000 outperformed ScreenFect A in preadipocytes, but in adipocytes the two reagents gave comparable results making ScreenFect A a notable new alternative for the gold standard Lipofectamine 2000.	[Enlund, Eveliina; Wabitsch, Martin; Fischer-Posovszky, Pamela] Univ Ulm, Med Ctr, Dept Pediat & Adolescent Med, Div Pediat Endocrinol & Diabet, D-89069 Ulm, Germany; [Fischer, Simon; Handrick, Rene; Otte, Kerstin] Univ Appl Sci Biberach, Inst Appl Biotechnol, Biberach, Germany; [Debatin, Klaus-Michael] Univ Ulm, Med Ctr, Dept Pediat & Adolescent Med, D-89069 Ulm, Germany	Ulm University; Ulm University	Fischer-Posovszky, P (corresponding author), Univ Ulm, Med Ctr, Dept Pediat & Adolescent Med, Div Pediat Endocrinol & Diabet, D-89069 Ulm, Germany.	pamela.fischer@uniklinik-ulm.de	Debatin, Klaus-Michael/J-9704-2014	Debatin, Klaus-Michael/0000-0002-8397-1886; Fischer-Posovszky, Pamela/0000-0003-3402-9840	European Society for Paediatric Endocrinology (ESPE-Research Unit Grant); Ministry of Science, Research and Arts Baden-Wuerttemberg; European Social Fund Baden-Wuerttemberg; International Graduate School in Molecular Medicine Ulm; "Cooperative Research Training Group Pharmaceutical Biotechnology" stated by the Postgraduate Scholarships Act of the Ministry for Science, Research and Arts of the federal state government of Baden-Wuerttemberg, Germany	European Society for Paediatric Endocrinology (ESPE-Research Unit Grant); Ministry of Science, Research and Arts Baden-Wuerttemberg; European Social Fund Baden-Wuerttemberg(European Social Fund (ESF)); International Graduate School in Molecular Medicine Ulm; "Cooperative Research Training Group Pharmaceutical Biotechnology" stated by the Postgraduate Scholarships Act of the Ministry for Science, Research and Arts of the federal state government of Baden-Wuerttemberg, Germany	This project was supported by the European Society for Paediatric Endocrinology (ESPE-Research Unit Grant). PFP was also funded by the Ministry of Science, Research and Arts Baden-Wuerttemberg and the European Social Fund Baden-Wuerttemberg. EE was financed by the International Graduate School in Molecular Medicine Ulm. SF was funded by "Cooperative Research Training Group Pharmaceutical Biotechnology" stated by the Postgraduate Scholarships Act of the Ministry for Science, Research and Arts of the federal state government of Baden-Wuerttemberg, Germany. SF was a member of the International Graduate School in Molecular Medicine Ulm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen J, 2009, MACROMOL BIOSCI, V9, P1247, DOI 10.1002/mabi.200900249; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Fischer S, 2013, J BIOTECHNOL, V168, P589, DOI 10.1016/j.jbiotec.2013.08.027; Fischer-Posovszky P, 2012, MOL CELL ENDOCRINOL, V358, P135, DOI 10.1016/j.mce.2012.03.018; Fischer-Posovszky P, 2008, OBESITY FACTS, V1, P184, DOI 10.1159/000145784; Grayson ACR, 2006, PHARM RES-DORDR, V23, P1868, DOI 10.1007/s11095-006-9009-2; Hauner H, 2000, METH MOL B, V155, P239; Iwata T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033402; Li Q, 2010, J CELL SCI, V123, P2444, DOI 10.1242/jcs.067165; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Martinelli R, 2010, OBESITY, V18, P2170, DOI 10.1038/oby.2009.474; Meerson A, 2013, DIABETOLOGIA, V56, P1971, DOI 10.1007/s00125-013-2950-9; Mittal V, 2004, NAT REV GENET, V5, P355, DOI 10.1038/nrg1323; Rong Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073272; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schweiger M, 2012, J LIPID RES, V53, P2307, DOI 10.1194/jlr.M027409; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357	18	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98023	10.1371/journal.pone.0098023	http://dx.doi.org/10.1371/journal.pone.0098023			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849298	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600078
J	Huntelmann, B; Staab, J; Herrmann-Lingen, C; Meyer, T				Huentelmann, Bettina; Staab, Julia; Herrmann-Lingen, Christoph; Meyer, Thomas			A Conserved Motif in the Linker Domain of STAT1 Transcription Factor Is Required for Both Recognition and Release from High-Affinity DNA-Binding Sites	PLOS ONE			English	Article							TYROSINE PHOSPHORYLATION; NUCLEAR IMPORT; SIGNAL-TRANSDUCTION; IFN-GAMMA; ACTIVATION; INACTIVATION; DETERMINES; DIMERS; ALPHA; DEPHOSPHORYLATION	Binding to specific palindromic sequences termed gamma-activated sites (GAS) is a hallmark of gene activation by members of the STAT (signal transducer and activator of transcription) family of cytokine-inducible transcription factors. However, the precise molecular mechanisms involved in the signal-dependent finding of target genes by STAT dimers have not yet been very well studied. In this study, we have characterized a sequence motif in the STAT1 linker domain which is highly conserved among the seven human STAT proteins and includes surface-exposed residues in close proximity to the bound DNA. Using site-directed mutagenesis, we have demonstrated that a lysine residue in position 567 of the full-length molecule is required for GAS recognition. The substitution of alanine for this residue completely abolished both binding to high-affinity GAS elements and transcriptional activation of endogenous target genes in cells stimulated with interferon-c (IFN gamma), while the time course of transient nuclear accumulation and tyrosine phosphorylation were virtually unchanged. In contrast, two glutamic acid residues (E559 and E563) on each monomer are important for the dissociation of dimeric STAT1 from DNA and, when mutated to alanine, result in elevated levels of tyrosine-phosphorylated STAT1 as well as prolonged IFN gamma-stimulated nuclear accumulation. In conclusion, our data indicate that the kinetics of signal-dependent GAS binding is determined by an array of glutamic acid residues located at the interior surface of the STAT1 dimer. These negatively charged residues appear to align the long axis of the STAT1 dimer in a position perpendicular to the DNA, thereby facilitating the interaction between lysine 567 and the phosphodiester backbone of a bound GAS element, which is a prerequisite for transient gene induction.	[Huentelmann, Bettina; Staab, Julia; Herrmann-Lingen, Christoph; Meyer, Thomas] Univ Gottingen, Klin Psychosomat Med & Psychotherapie, D-37073 Gottingen, Germany	University of Gottingen	Meyer, T (corresponding author), Univ Gottingen, Klin Psychosomat Med & Psychotherapie, D-37073 Gottingen, Germany.	thomas.meyer@med.uni-goettingen.de	Herrmann-Lingen, Christoph/ABC-9496-2021		Deutsche Forschungsgemeinschaft [TM1648]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The research on this subject was funded by a grant from the Deutsche Forschungsgemeinschaft to TM (TM1648). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Begitt A, 2000, P NATL ACAD SCI USA, V97, P10418, DOI 10.1073/pnas.190318397; Begitt A, 2014, NAT IMMUNOL, V15, P168, DOI 10.1038/ni.2794; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Decker T, 1997, J INTERF CYTOK RES, V17, P121, DOI 10.1089/jir.1997.17.121; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Fagerlund R, 2002, J BIOL CHEM, V277, P30072, DOI 10.1074/jbc.M202943200; GREENLUND AC, 1995, IMMUNITY, V2, P677, DOI 10.1016/1074-7613(95)90012-8; Haspel RL, 1999, P NATL ACAD SCI USA, V96, P10188, DOI 10.1073/pnas.96.18.10188; Haspel RL, 1996, EMBO J, V15, P6262, DOI 10.1002/j.1460-2075.1996.tb01016.x; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; Koch V, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-22; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lodige I, 2005, J BIOL CHEM, V280, P43087, DOI 10.1074/jbc.M509180200; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; Marg A, 2004, J CELL BIOL, V165, P823, DOI 10.1083/jcb.200403057; McBride KM, 2002, EMBO J, V21, P1754, DOI 10.1093/emboj/21.7.1754; Melen K, 2003, J BIOL CHEM, V278, P28193, DOI 10.1074/jbc.M303571200; Mertens C, 2006, GENE DEV, V20, P3372, DOI 10.1101/gad.1485406; Meyer T, 2004, J BIOL CHEM, V279, P18998, DOI 10.1074/jbc.M400766200; Meyer T, 2002, EMBO J, V21, P344, DOI 10.1093/emboj/21.3.344; Meyer T, 2003, GENE DEV, V17, P1992, DOI 10.1101/gad.268003; Meyer T, 2010, METHODS MOL BIOL, V647, P139, DOI 10.1007/978-1-60761-738-9_8; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; Nardozzi J, 2010, J MOL BIOL, V402, P83, DOI 10.1016/j.jmb.2010.07.013; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; Sehgal PB, 2008, SEMIN CELL DEV BIOL, V19, P329, DOI 10.1016/j.semcdb.2008.07.003; Sekimoto T, 1997, EMBO J, V16, P7067, DOI 10.1093/emboj/16.23.7067; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; Speil J, 2011, BIOPHYS J, V101, P2592, DOI 10.1016/j.bpj.2011.10.006; Staab J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069903; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Vinkemeier U, 1996, EMBO J, V15, P5616, DOI 10.1002/j.1460-2075.1996.tb00946.x; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wenta N, 2008, P NATL ACAD SCI USA, V105, P9238, DOI 10.1073/pnas.0802130105; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yang E, 2002, J BIOL CHEM, V277, P13455, DOI 10.1074/jbc.M112038200; Zhong MH, 2005, P NATL ACAD SCI USA, V102, P3966, DOI 10.1073/pnas.0501063102	45	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97633	10.1371/journal.pone.0097633	http://dx.doi.org/10.1371/journal.pone.0097633			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847715	gold, Green Published, Green Submitted			2022-12-25	WOS:000336730600044
J	Sui, XB; Xu, YH; Yang, J; Fang, Y; Lou, HZ; Han, WD; Zhang, ML; Chen, W; Wang, KF; Li, D; Jin, W; Lou, F; Zheng, Y; Hu, H; Gong, L; Zhou, XY; Pan, Q; Pan, HM; Wang, X; He, C				Sui, Xinbing; Xu, Yinghua; Yang, Jie; Fang, Yong; Lou, Haizhou; Han, Weidong; Zhang, Maolin; Chen, Wei; Wang, Kaifeng; Li, Da; Jin, Wei; Lou, Fang; Zheng, Yu; Hu, Hong; Gong, Liu; Zhou, Xiaoyun; Pan, Qin; Pan, Hongming; Wang, Xian; He, Chao			Use of Metformin Alone Is Not Associated with Survival Outcomes of Colorectal Cancer Cell but AMPK Activator AICAR Sensitizes Anticancer Effect of 5-Fluorouracil through AMPK Activation	PLOS ONE			English	Article							LKB1-AMPK PATHWAY; PROTEIN-KINASE; LEUKEMIA; GROWTH; LIVER; RISK; TRANSFORMATION; PROLIFERATION; METABOLISM; INDUCTION	Colorectal cancer (CRC) is still the third most common cancer and the second most common causes of cancer-related death around the world. Metformin, a biguanide, which is widely used for treating diabetes mellitus, has recently been shown to have a suppressive effect on CRC risk and mortality, but not all laboratory studies suggest that metformin has antineoplastic activity. Here, we investigated the effect of metformin and AMPK activator AICAR on CRC cells proliferation. As a result, metformin did not inhibit cell proliferation or induce apoptosis for CRC cell lines in vitro and in vivo. Different from metformin, AICAR emerged antitumor activity and sensitized anticancer effect of 5-FU on CRC cells in vitro and in vivo. In further analysis, we show that AMPK activation may be a key molecular mechanism for the additive effect of AICAR. Taken together, our results suggest that metformin has not antineoplastic activity for CRC cells as a single agent but AMPK activator AICAR can induce apoptosis and enhance the cytotoxic effect of 5-FU through AMPK activation.	[Sui, Xinbing; Xu, Yinghua; Yang, Jie; Fang, Yong; Lou, Haizhou; Han, Weidong; Chen, Wei; Wang, Kaifeng; Li, Da; Jin, Wei; Lou, Fang; Zheng, Yu; Hu, Hong; Gong, Liu; Zhou, Xiaoyun; Pan, Qin; Pan, Hongming; Wang, Xian] Zhejiang Univ, Dept Med Oncol, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Sui, Xinbing; Xu, Yinghua; Fang, Yong; Lou, Haizhou; Han, Weidong; Zhang, Maolin; Pan, Hongming; Wang, Xian; He, Chao] Biomed Res Ctr, Hangzhou, Zhejiang, Peoples R China; [Sui, Xinbing; Xu, Yinghua; Fang, Yong; Lou, Haizhou; Han, Weidong; Zhang, Maolin; Pan, Hongming; Wang, Xian; He, Chao] Key Lab Biotherapy Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Zhang, Maolin; He, Chao] Zhejiang Univ, Dept Colorectal Surg, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Pan, HM (corresponding author), Zhejiang Univ, Dept Med Oncol, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China.	drpanhm@aliyun.com; wangxzju@163.com; drhechao@yahoo.com.cn			National Natural Science Foundation of China [81301891, 81272593]; Zhejiang Provincial Natural Science Foundation of China [LQ13H160008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This study is supported by grants from National Natural Science Foundation of China (grant No. 81301891 and 81272593) and Zhejiang Provincial Natural Science Foundation of China (grant No. LQ13H160008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayraktar S, 2012, CANCER-AM CANCER SOC, V118, P1202, DOI 10.1002/cncr.26439; Berstein LM, 2013, CELL CYCLE, V12, P3681, DOI 10.4161/cc.26868; Bodmer M, 2012, LUNG CANCER, V78, P133, DOI 10.1016/j.lungcan.2012.08.010; Bodmer M, 2012, CANCER EPIDEM BIOMAR, V21, P280, DOI 10.1158/1055-9965.EPI-11-0992-T; Bonanni B, 2012, J CLIN ONCOL, V30, P2593, DOI 10.1200/JCO.2011.39.3769; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Campas C, 2003, BLOOD, V101, P3674, DOI 10.1182/blood-2002-07-2339; Chae HD, 2012, STEM CELLS, V30, P140, DOI 10.1002/stem.778; Cossor FI, 2012, J CLIN ONCOL S, V30; Cufi S, 2013, ONCOTARGET, V4, P1484, DOI 10.18632/oncotarget.1234; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Franciosi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071583; Guo DL, 2009, P NATL ACAD SCI USA, V106, P12932, DOI 10.1073/pnas.0906606106; Harris D, 2013, CURR ONCOL, V20, pE532, DOI 10.3747/co.20.1499; Herszenyi L, 2010, EUR REV MED PHARMACO, V14, P249; Hirsch HA, 2013, P NATL ACAD SCI USA, V110, P972, DOI 10.1073/pnas.1221055110; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Iliopoulos D, 2011, CANCER RES, V71, P3196, DOI 10.1158/0008-5472.CAN-10-3471; Karpinski P, 2008, J APPL GENET, V49, P1, DOI 10.1007/BF03195243; Lee JH, 2012, INT J CANCER, V131, P752, DOI 10.1002/ijc.26421; Lee MS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-20; Lo AKF, 2013, J PATHOL, V230, P336, DOI 10.1002/path.4201; Luo ZJ, 2010, FUTURE ONCOL, V6, P457, DOI 10.2217/FON.09.174; Martelli AM, 2012, EXPERT OPIN THER TAR, V16, P729, DOI 10.1517/14728222.2012.694869; Martin MJ, 2012, CANCER DISCOV, V2, P344, DOI 10.1158/2159-8290.CD-11-0280; Morgillo F, 2013, CLIN CANCER RES, V19, P3508, DOI 10.1158/1078-0432.CCR-12-2777; Nangia-Makker P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084369; Noto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033411; Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256; Phoenix KN, 2009, BREAST CANCER RES TR, V113, P101, DOI 10.1007/s10549-008-9916-5; Robert G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007889; Ryu JH, 2008, BIOCHEM BIOPH RES CO, V366, P438, DOI 10.1016/j.bbrc.2007.11.134; Santidrian AF, 2010, BLOOD, V116, P3023, DOI 10.1182/blood-2010-05-283960; Sengupta TK, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-46; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Soranna D, 2012, ONCOLOGIST, V17, P813, DOI 10.1634/theoncologist.2011-0462; Spillane S, 2014, CANCER EPIDEMIOL, pS1877; Takahashi H, 2013, J GASTROEN HEPATOL, V28, P41, DOI 10.1111/jgh.12240; Theodoropoulou S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052852; Theodoropoulou S, 2010, FASEB J, V24, P2620, DOI 10.1096/fj.09-152546; Vakana E, 2011, ONCOTARGET, V2, P1322; Vakana E, 2011, BLOOD, V118, P6399, DOI 10.1182/blood-2011-01-332783; Zang Y, 2009, J BIOL CHEM, V284, P6175, DOI 10.1074/jbc.M806887200; Zhang YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081264	45	38	40	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97781	10.1371/journal.pone.0097781	http://dx.doi.org/10.1371/journal.pone.0097781			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849329	gold, Green Submitted, Green Published			2022-12-25	WOS:000336730600059
J	Kiba, A; Galis, I; Hojo, Y; Ohnishi, K; Yoshioka, H; Hikichi, Y				Kiba, Akinori; Galis, Ivan; Hojo, Yuko; Ohnishi, Kouhei; Yoshioka, Hirofumi; Hikichi, Yasufumi			SEC14 Phospholipid Transfer Protein Is Involved in Lipid Signaling-Mediated Plant Immune Responses in Nicotiana benthamiana	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL TRANSFER PROTEIN; PHOSPHATIDIC-ACID ACCUMULATION; NITRIC-OXIDE; POLYPHOSPHOINOSITIDE METABOLISM; DISEASE RESISTANCE; EFFECTOR MOLECULES; DEFENSE RESPONSES; INNATE IMMUNITY; RAPID TURNOVER; PATHOGEN	We previously identified a gene related to the SEC14-gene phospholipid transfer protein superfamily that is induced in Nicotiana benthamiana (NbSEC14) in response to infection with Ralstonia solanacearum. We here report that NbSEC14 plays a role in plant immune responses via phospholipid-turnover. NbSEC14-silencing compromised expression of defense-related PR-4 and accumulation of jasmonic acid (JA) and its derivative JA-Ile. Transient expression of NbSEC14 induced PR-4 gene expression. Activities of diacylglycerol kinase, phospholipase C and D, and the synthesis of diacylglycerol and phosphatidic acid elicited by avirulent R. solanacearum were reduced in NbSEC14-silenced plants. Accumulation of signaling lipids and activation of diacylglycerol kinase and phospholipases were enhanced by transient expression of NbSEC14. These results suggest that the NbSEC14 protein plays a role at the interface between lipid signaling-metabolism and plant innate immune responses.	[Kiba, Akinori; Hikichi, Yasufumi] Kochi Univ, Fac Agr, Lab Plant Pathol & Biotechnol, Nankoku, Kochi 783, Japan; [Galis, Ivan; Hojo, Yuko] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan; [Ohnishi, Kouhei] Kochi Univ, Res Inst Mol Genet, Nankoku, Kochi, Japan; [Yoshioka, Hirofumi] Nagoya Univ, Grad Sch Bioagr Sci, Lab Def Plant Pathogen Interact, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Kochi University; Okayama University; Kochi University; Nagoya University	Kiba, A (corresponding author), Kochi Univ, Fac Agr, Lab Plant Pathol & Biotechnol, Nankoku, Kochi 783, Japan.	akiba@kochi-u.ac.jp	Galis, Ivan/F-5734-2011; Ohnishi, Kouhei/AAN-9527-2020	Galis, Ivan/0000-0001-9840-8845	Ministry of Education, Culture, Sports, Science and Technology, Japan [16780031, 18780029, 15028214, 16380037]; Asahi Glass Foundation; Agricultural Chemical Foundation	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Asahi Glass Foundation; Agricultural Chemical Foundation	This work was supported by Grants in Aid for Scientific Research to AK (16780031 and 18780029) and YH (15028214 and 16380037) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. AK is also grateful for financial support from the Asahi Glass Foundation, and Agricultural Chemical Foundation. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Asai S, 2008, PLANT CELL, V20, P1390, DOI 10.1105/tpc.107.055855; Asai S, 2009, MOL PLANT MICROBE IN, V22, P619, DOI 10.1094/MPMI-22-6-0619; BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; Bankaitis VA, 2007, ADV ENZYME REGUL, V47, P27, DOI 10.1016/j.advenzreg.2006.12.007; Bankaitis VA, 2010, TRENDS BIOCHEM SCI, V35, P150, DOI 10.1016/j.tibs.2009.10.008; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; de Jong CF, 2004, PLANT J, V39, P1, DOI 10.1111/j.1365-313X.2004.02110.x; DROBAK BK, 1994, PLANT J, V6, P389, DOI 10.1046/j.1365-313X.1994.06030389.x; Ekengren SK, 2003, PLANT J, V36, P905, DOI 10.1046/j.1365-313X.2003.01944.x; Fukumoto K, 2013, J INTEGR PLANT BIOL, V55, P775, DOI 10.1111/jipb.12057; Gechev TS, 2005, J CELL BIOL, V168, P17, DOI 10.1083/jcb.200409170; Gohre V, 2008, ANNU REV PHYTOPATHOL, V46, P189, DOI 10.1146/annurev.phyto.46.120407.110050; Helling D, 2006, PLANT CELL, V18, P3519, DOI 10.1105/tpc.106.047373; Huitema E, 2005, MOL PLANT MICROBE IN, V18, P183, DOI 10.1094/MPMI-18-0183; Jin HL, 2003, PLANT J, V33, P719, DOI 10.1046/j.1365-313X.2003.01664.x; Jones DA, 2004, CURR OPIN IMMUNOL, V16, P48, DOI 10.1016/j.coi.2003.11.016; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Katou Shinpei, 2003, Journal of General Plant Pathology, V69, P161; Kiba A, 2012, J PLANT PHYSIOL, V169, P1017, DOI 10.1016/j.jplph.2012.04.002; Kobayashi M, 2007, PLANT CELL, V19, P1065, DOI 10.1105/tpc.106.048884; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Laxalt AM, 2001, PLANT J, V26, P237, DOI 10.1046/j.1365-313X.2001.01023.x; Laxalt AM, 2007, J BIOL CHEM, V282, P21160, DOI 10.1074/jbc.M701212200; Maimbo M, 2007, PLANT PHYSIOL, V145, P1588, DOI 10.1104/pp.107.105353; Maimbo M, 2010, PLANT PHYSIOL, V152, P2023, DOI 10.1104/pp.109.148189; Monks DE, 2001, PLANT CELL, V13, P1205, DOI 10.1105/tpc.13.5.1205; Munnik T, 2000, PLANT J, V22, P147, DOI 10.1046/j.1365-313x.2000.00725.x; Munnik T, 1998, PLANTA, V207, P133, DOI 10.1007/s004250050465; MUNNIK T, 1994, BIOCHEM J, V298, P269, DOI 10.1042/bj2980269; MUNNIK T, 1994, PLANTA, V193, P89, DOI 10.1007/BF00191611; Munnik T, 2001, TRENDS PLANT SCI, V6, P227, DOI 10.1016/S1360-1385(01)01918-5; Munnik T, 2009, J LIPID RES, V50, pS260, DOI 10.1194/jlr.R800098-JLR200; Nakano M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075124; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; OHASHI M, 1995, NATURE, V377, P544, DOI 10.1038/377544a0; Pedley KF, 2005, CURR OPIN PLANT BIOL, V8, P541, DOI 10.1016/j.pbi.2005.07.006; Pejchar P, 2010, NEW PHYTOL, V188, P150, DOI 10.1111/j.1469-8137.2010.03349.x; Peterman TK, 2004, PLANT PHYSIOL, V136, P3080, DOI 10.1104/pp.104.045369; Phillips SE, 2006, CRIT REV BIOCHEM MOL, V41, P21, DOI 10.1080/10409230500519573; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Robert-Seilaniantz A, 2007, CURR OPIN PLANT BIOL, V10, P372, DOI 10.1016/j.pbi.2007.06.003; Schaaf G, 2008, MOL CELL, V29, P191, DOI 10.1016/j.molcel.2007.11.026; Simon JP, 1998, P NATL ACAD SCI USA, V95, P11181, DOI 10.1073/pnas.95.19.11181; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Testerink C, 2007, J EXP BOT, V58, P3905, DOI 10.1093/jxb/erm243; TOYODA K, 1993, PLANT CELL PHYSIOL, V34, P729, DOI 10.1093/oxfordjournals.pcp.a078476; TOYODA K, 1992, PLANT CELL PHYSIOL, V33, P445; van der Luit AH, 2000, PLANT PHYSIOL, V123, P1507, DOI 10.1104/pp.123.4.1507; Vincent P, 2005, J CELL BIOL, V168, P801, DOI 10.1083/jcb.200412074; Vossen JH, 2010, PLANT J, V62, P224, DOI 10.1111/j.1365-313X.2010.04136.x; Wang CX, 2000, PLANT CELL, V12, P2237, DOI 10.1105/tpc.12.11.2237; Wimalasekera R, 2010, MOL PLANT, V3, P610, DOI 10.1093/mp/ssq005; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Yamaguchi T, 2005, PLANT CELL PHYSIOL, V46, P579, DOI 10.1093/pcp/pci065; Yoshioka H, 2003, PLANT CELL, V15, P706, DOI 10.1105/tpc.008680; Yoshioka H, 2009, MOL CELLS, V28, P321, DOI 10.1007/s10059-009-0156-2; Young SA, 1996, PLANT CELL, V8, P1079, DOI 10.1105/tpc.8.6.1079; Zhang WH, 2004, P NATL ACAD SCI USA, V101, P9508, DOI 10.1073/pnas.0402112101; Zhang YY, 2009, PLANT CELL, V21, P2357, DOI 10.1105/tpc.108.062992; Zien CA, 2001, BBA-MOL CELL BIOL L, V1530, P236, DOI 10.1016/S1388-1981(01)00091-9; Zipfel C, 2008, CURR OPIN IMMUNOL, V20, P10, DOI 10.1016/j.coi.2007.11.003	63	30	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98150	10.1371/journal.pone.0098150	http://dx.doi.org/10.1371/journal.pone.0098150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845602	gold, Green Submitted, Green Published			2022-12-25	WOS:000339563400102
J	Peh, KSH; Sonke, B; Sene, O; Djuikouo, MNK; Nguembou, CK; Taedoumg, H; Begne, SK; Lewis, SL				Peh, Kelvin S. -H.; Sonke, Bonaventure; Sene, Olivier; Djuikouo, Marie-Noel K.; Nguembou, Charlemagne K.; Taedoumg, Hermann; Begne, Serge K.; Lewis, Simon L.			Mixed-Forest Species Establishment in a Monodominant Forest in Central Africa: Implications for Tropical Forest Invasibility	PLOS ONE			English	Article							RAIN-FOREST; WOOD DENSITY; DIVERSITY; BIOMASS; EXTINCTION; RICHNESS; HISTORY; BIRDS; TREES; BIODIVERSITY	Background: Traits of non-dominant mixed-forest tree species and their synergies for successful co-occurrence in monodominant Gilbertiodendron dewevrei forest have not yet been investigated. Here we compared the tree species diversity of the monodominant forest with its adjacent mixed forest and then determined which fitness proxies and life history traits of the mixed-forest tree species were most associated with successful co-existence in the monodominant forest. Methodology/Principal Findings: We sampled all trees (diameter in breast height [dbh]>= 10 cm) within 661 ha topographically homogenous areas of intact central African forest in SE Cameroon, three independent patches of G. dewevrei-dominated forest and three adjacent areas (450-800 m apart). Monodominant G. dewevrei forest had lower sample-controlled species richness, species density and population density than its adjacent mixed forest in terms of stems with dbh >= 10 cm. Analysis of a suite of population-level characteristics, such as relative abundance and geographical distribution, and traits such as wood density, height, diameter at breast height, fruit/seed dispersal mechanism and light requirement-revealed after controlling for phylogeny, species that co-occur with G. dewevrei tend to have higher abundance in adjacent mixed forest, higher wood density and a lower light requirement. Conclusions/Significance: Our results suggest that certain traits (wood density and light requirement) and population-level characteristics (relative abundance) may increase the invasibility of a tree species into a tropical closed-canopy system. Such knowledge may assist in the pre-emptive identification of invasive tree species.	[Peh, Kelvin S. -H.] Univ Southampton, Inst Life Sci, Southampton, Hants, England; [Peh, Kelvin S. -H.; Begne, Serge K.; Lewis, Simon L.] Univ Leeds, Sch Geog, Ecol & Global Change Grp, Leeds LS2 9JT, W Yorkshire, England; [Peh, Kelvin S. -H.] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England; [Sonke, Bonaventure; Taedoumg, Hermann] Univ Yaounde I, Higher Teachers Training Coll, Plant Systemat & Ecol Lab, Yaounde, Cameroon; [Sene, Olivier] Inst Agr Res Dev, Yaounde, Cameroon; [Djuikouo, Marie-Noel K.] Univ Buea, Dept Bot & Plant Physiol, Buea, Cameroon; [Nguembou, Charlemagne K.] African Forest Forum, Nairobi, Kenya; [Begne, Serge K.] Cameroon Biodivers Conservat Soc, Yaounde, Cameroon; [Lewis, Simon L.] UCL, Dept Geog, London, England	University of Southampton; University of Leeds; University of Cambridge; University of Yaounde I; University of London; University College London	Peh, KSH (corresponding author), Univ Southampton, Inst Life Sci, Southampton, Hants, England.	kelvin.peh@gmail.com	Peh, Kelvin/C-3408-2013	Peh, Kelvin/0000-0002-2921-1341; Lewis, Simon/0000-0002-8066-6851	European Union; AXA Fellowship; Southampton University's IFLS Fellowship; Royal Society University Research Fellowship; T-Forces project - European Research Council; EU program GEOCARBON; Phillip Leverhulme Prize; Natural Environment Research Council [NE/D000300/1] Funding Source: researchfish	European Union(European Commission); AXA Fellowship(AXA Research Fund); Southampton University's IFLS Fellowship; Royal Society University Research Fellowship(Royal Society of London); T-Forces project - European Research Council; EU program GEOCARBON; Phillip Leverhulme Prize; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	KSHP was supported by the European Union Marie Curie EST Fellowship, AXA Fellowship and Southampton University's IFLS Fellowship. SLL was supported by a Royal Society University Research Fellowship, T-Forces project funded by the European Research Council, the EU program GEOCARBON, and a Phillip Leverhulme Prize. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; Banasiak SE, 2009, BIOL INVASIONS, V11, P215, DOI 10.1007/s10530-008-9226-1; Brown S, 1997, ESTIMATING BIOMASS B; Burnham K. P., 1998, MODEL SELECTION INFE; Cassey P, 2008, WILDLIFE RES, V35, P193, DOI 10.1071/WR07109; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Colwell RK, 2007, ESTIMATES STAT ESTIM; Condit R, 1998, TROPICAL FOREST CENS; CONNELL JH, 1989, AM NAT, V134, P88, DOI 10.1086/284967; Conway D, 1992, THESIS U ABERDEEN AB; Djuikouo MNK, 2010, AFR J ECOL, V48, P1053, DOI 10.1111/j.1365-2028.2010.01212.x; Fearnside PM, 1997, FOREST ECOL MANAG, V90, P59, DOI 10.1016/S0378-1127(96)03840-6; GARTNER BL, 1989, BIOTROPICA, V21, P303, DOI 10.2307/2388280; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Harcourt AH, 2002, J BIOGEOGR, V29, P445, DOI 10.1046/j.1365-2699.2002.00685.x; HART TB, 1989, AM NAT, V133, P613, DOI 10.1086/284941; Hart TB, 1985, THESIS MICHIGAN STAT; Hubbell SP, 1986, CONSERVATION BIOL SC, P205; JABLONSKI D, 1991, SCIENCE, V253, P754, DOI 10.1126/science.253.5021.754; Kyereh B, 1999, J ECOL, V87, P772, DOI 10.1046/j.1365-2745.1999.00386.x; Letcher SG, 2009, BIOTROPICA, V41, P608, DOI 10.1111/j.1744-7429.2009.00517.x; Lewis SL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0295; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Lozon Joseph D., 1997, Environmental Reviews, V5, P131, DOI 10.1139/er-5-2-131; Makana JR, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P492; Makana JR, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P159; Marcon E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090289; Marcon E, 2012, OIKOS, V121, P516, DOI 10.1111/j.1600-0706.2011.19267.x; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McGinley M, 2008, ENCY EARTH; Menard S, 2002, SAGE U PAPERS SERIES; Muller-Landau HC, 2004, BIOTROPICA, V36, P20, DOI 10.1111/j.1744-7429.2004.tb00292.x; Parmentier I, 2007, J ECOL, V95, P1058, DOI 10.1111/j.1365-2745.2007.01273.x; Peh KSH, 2012, J VEG SCI, V23, P223, DOI 10.1111/j.1654-1103.2011.01352.x; Peh KSH, 2011, J ECOL, V99, P891, DOI 10.1111/j.1365-2745.2011.01827.x; Peh KSH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016996; Peh KSH, 2010, BIODIVERS CONSERV, V19, P1083, DOI 10.1007/s10531-009-9755-7; Phillips O, 2002, FIELD MANUAL PLOT ES, DOI [10.13140/RG.2.1.1735.7202, DOI 10.13140/RG.2.1.1735.7202]; Poorter L, 2005, J ECOL, V93, P256, DOI 10.1111/j.1365-2745.2004.00956.x; Poorter L, 2012, PLANT ECOL, V213, P707, DOI 10.1007/s11258-012-0032-6; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; R Development Core Team, 2010, LANG ENV STAT COMP; Read J, 2000, J BIOGEOGR, V27, P233, DOI 10.1046/j.1365-2699.2000.00407.x; Richards PW, 1996, TROPICAL RAIN FOREST, V2; RICHARDSON DM, 1990, J VEG SCI, V1, P629, DOI 10.2307/3235569; Sonke B, 2004, SCRIPTA BOT BELGICA, V32; SWAINE MD, 1988, VEGETATIO, V75, P81, DOI 10.1007/BF00044629; Tanentzap AJ, 2009, OIKOS, V118, P300, DOI 10.1111/j.1600-0706.2008.17069.x; Torti SD, 2001, AM NAT, V157, P141, DOI 10.1086/318629; van Gelder HA, 2006, NEW PHYTOL, V171, P367, DOI 10.1111/j.1469-8137.2006.01757.x; van Gemerden BS, 2003, J BIOGEOGR, V30, P1381, DOI 10.1046/j.1365-2699.2003.00937.x; VanderMeer PJ, 1996, J ECOL, V84, P19, DOI 10.2307/2261696; Veltman CJ, 1996, AM NAT, V147, P542, DOI 10.1086/285865; Walther BA, 1998, PARASITOLOGY, V116, P395, DOI 10.1017/S0031182097002230	58	19	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97585	10.1371/journal.pone.0097585	http://dx.doi.org/10.1371/journal.pone.0097585			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844914	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000339563400037
J	Wang, HQ; Tu, MF; Fu, R; Wu, YH; Liu, H; Xing, LM; Shao, ZH				Wang, Huaquan; Tu, Meifeng; Fu, Rong; Wu, Yuhong; Liu, Hong; Xing, Limin; Shao, Zonghong			The Clinical and Immune Characteristics of Patients with Hepatitis-Associated Aplastic Anemia in China	PLOS ONE			English	Article							VIRAL-HEPATITIS; EPIDEMIOLOGY; VIRUS; CELLS	Hepatitis-associated aplastic anemia (HAAA) is a variant of severe aplastic anemia (SAA) in which bone marrow failure follows an acute attack of hepatitis. Its pathogenesis is poorly understood. We investigated the prevalence of HAAA among cases of newly diagnosed SAA presenting to our hospital between January 1998 and February 2013, and analyzed the clinical and immune characteristics of HAAA and non-hepatitis-associated SAA (non-HASAA) patients. The prevalence of HAAA among cases of SAA was 3.8% (36/949), and the majority of patients (33/36) were seronegative for a known hepatitis virus. Compared with non-HASAA patients, HAAA patients had a larger proportion of CD8+ T cells, a lower ratio of CD4+/CD8+ T cells, and a smaller proportion of CD4+CD25+ regulatory T cells. There was no significant difference in peripheral blood count, bone marrow cellularity, or the number of blood transfusions received between HAAA and non-HASAA patients. HAAA patients had a higher early infection rate and more infection-related mortality in the first 2 years after diagnosis than non-HASAA patients, and their 2-year survival rate was lower. The results demonstrate that HAAA patients have a more severe T cell imbalance and a poorer prognosis than non-HASAA patients.	[Wang, Huaquan; Fu, Rong; Wu, Yuhong; Liu, Hong; Xing, Limin; Shao, Zonghong] Tianjin Med Univ, Gen Hosp, Dept Hematol, Tianjin, Peoples R China; [Tu, Meifeng] Peking Univ, Sch Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Lymphoma,Beijing Canc Hosp & Ins, Beijing 100871, Peoples R China	Tianjin Medical University; Peking University	Shao, ZH (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Hematol, Tianjin, Peoples R China.	shaozonghong@sina.com	Wang, Huaquan/AAN-6917-2021		Natural Science Foundation of China [30971286, 30971285, 81170472, 81370607]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project is partly supported by Natural Science Foundation of China (No. 30971286, 30971285, 81170472, 81370607). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	BAUMELOU E, 1993, BLOOD, V81, P1471; Brown KE, 1997, NEW ENGL J MED, V336, P1059, DOI 10.1056/NEJM199704103361504; Cengiz C, 2007, DIGEST DIS SCI, V52, P2438, DOI 10.1007/s10620-006-9280-4; Gonzalez-Casas R, 2009, ALIMENT PHARM THER, V30, P436, DOI 10.1111/j.1365-2036.2009.04060.x; HAGLER L, 1975, MEDICINE, V54, P139, DOI 10.1097/00005792-197554020-00003; HIBBS JR, 1992, JAMA-J AM MED ASSOC, V267, P2051; Ikawa Y, 2013, BRIT J HAEMATOL, V161, P599, DOI 10.1111/bjh.12259; Ikeda T, 2012, J PEDIAT HEMATOL ONC, V34, P375, DOI 10.1097/MPH.0b013e31822bf699; Locasciulli A, 2010, BRIT J HAEMATOL, V149, P890, DOI 10.1111/j.1365-2141.2010.08194.x; Lu J, 2004, BLOOD, V103, P4588, DOI 10.1182/blood-2003-11-3959; Osugi Y, 2007, HAEMATOLOGICA, V92, P1687, DOI 10.3324/haematol.11359; Pardi DS, 1998, AM J GASTROENTEROL, V93, P468, DOI 10.1111/j.1572-0241.1998.468_1.x; Rauff B, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-87; Safadi R, 2001, BONE MARROW TRANSPL, V27, P183, DOI 10.1038/sj.bmt.1702749; Shi J, 2012, BLOOD, V120, P1624, DOI 10.1182/blood-2011-11-390708; Xu BY, 2013, P NATL ACAD SCI USA, V110, P10264, DOI 10.1073/pnas.1303744110	16	23	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98142	10.1371/journal.pone.0098142	http://dx.doi.org/10.1371/journal.pone.0098142			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845454	Green Published, gold, Green Submitted			2022-12-25	WOS:000339563400101
J	Andrew, EVW; Pell, C; Angwin, A; Auwun, A; Daniels, J; Mueller, I; Phuanukoonnon, S; Pool, R				Andrew, Erin V. W.; Pell, Christopher; Angwin, Angeline; Auwun, Alma; Daniels, Job; Mueller, Ivo; Phuanukoonnon, Suparat; Pool, Robert			Factors Affecting Attendance at and Timing of Formal Antenatal Care: Results from a Qualitative Study in Madang, Papua New Guinea	PLOS ONE			English	Article							PREGNANT-WOMEN; SULFADOXINE-PYRIMETHAMINE; MATERNAL MORTALITY; RURAL MALAWI; SOUTH-AFRICA; MALARIA; HEALTH; PERCEPTIONS; SERVICES; PERSPECTIVES	Background: Appropriate antenatal care (ANC) is key for the health of mother and child. However, in Papua New Guinea (PNG), only a third of women receive any ANC during pregnancy. Drawing on qualitative research, this paper explores the influences on ANC attendance and timing of first visit in the Madang region of Papua New Guinea. Methods: Data were collected in three sites utilizing several qualitative methods: free-listing and sorting of terms and definitions, focus group discussions, in-depth interviews, observation in health care facilities and case studies of pregnant women. Respondents included pregnant women, their relatives, biomedical and traditional health providers, opinion leaders and community members. Results: Although generally reported to be important, respondents' understanding of the procedures involved in ANC was limited. Factors influencing attendance fell into three main categories: accessibility, attitudes to ANC, and interpersonal issues. Although women saw accessibility (distance and cost) as a barrier, those who lived close to health facilities and could easily afford ANC also demonstrated poor attendance. Attitudes were shaped by previous experiences of ANC, such as waiting times, quality of care, and perceptions of preventative care and medical interventions during pregnancy. Interpersonal factors included relationships with healthcare providers, pregnancy disclosure, and family conflict. A desire to avoid repeat clinic visits, ideas about the strength of the fetus and parity were particularly relevant to the timing of first ANC visit. Conclusions: This long-term in-depth study (the first of its kind in Madang, PNG) shows how socio-cultural and economic factors influence ANC attendance. These factors must be addressed to encourage timely ANC visits: interventions could focus on ANC delivery in health facilities, for example, by addressing healthcare staff's attitudes towards pregnant women.	[Andrew, Erin V. W.; Pell, Christopher; Mueller, Ivo; Pool, Robert] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Pell, Christopher; Pool, Robert] Univ Amsterdam, Ctr Social Sci & Global Hlth, Amsterdam, Netherlands; [Angwin, Angeline; Auwun, Alma; Daniels, Job; Mueller, Ivo; Phuanukoonnon, Suparat] Papua New Guinea Inst Med Res, Madang, Papua N Guinea; [Mueller, Ivo] Royal Melbourne Hosp, Walter & Eliza Hall Inst, Infect & Immun Div, Parkville, Vic 3050, Australia	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; University of Amsterdam; PNG Institute Of Medical Research; Royal Melbourne Hospital; Walter & Eliza Hall Institute	Andrew, EVW (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain.	erinvwandrew@gmail.com		Pell, Christopher/0000-0001-9405-5851	Malaria in Pregnancy (MiP) Consortium - Bill and Melinda Gates Foundation [OPP46099]	Malaria in Pregnancy (MiP) Consortium - Bill and Melinda Gates Foundation	This research was supported and endorsed by the Malaria in Pregnancy (MiP) Consortium, which is funded by a grant from the Bill and Melinda Gates Foundation (www.gatesfoundation.org), Grant OPP46099. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams N, 2001, J MIDWIFERY WOM HEAL, V46, P240, DOI 10.1016/S1526-9523(01)00138-6; Adetunji JA, 1996, SOC SCI MED, V43, P1561, DOI 10.1016/S0277-9536(96)00052-4; Ager A, 2005, HEALTH POLICY PLANN, V20, P176, DOI 10.1093/heapol/czi021; [Anonymous], 2008, WORLDWIDE PREVALENCE; Atuyambe L, 2008, COPING RESPONSES PRE; Atuyambe L, 2009, J ADOLESCENCE, V32, P781, DOI 10.1016/j.adolescence.2008.10.012; Bloom SS, 1999, HEALTH POLICY PLANN, V14, P38, DOI 10.1093/heapol/14.1.38; BMJ Evidence Centre, 2011, BEST PRACT ROUT ANT; BRABIN BJ, 1990, ANN TROP MED PARASIT, V84, P1; Campbell J., 2011, STATE WORLDS MIDWIFE; Carroli G, 2001, PAEDIATR PERINAT EP, V15, P1; Chapman RR, 2006, MED ANTHROPOL Q, V20, P487, DOI 10.1525/maq.2006.20.4.487; Chapman Rachel R, 2004, Med Anthropol, V23, P229, DOI 10.1080/01459740490487107; Chapman RR, 2003, SOC SCI MED, V57, P355, DOI 10.1016/S0277-9536(02)00363-5; Choudhury N, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-15; Davis-Floyd Robbie E., 1997, CHILDBIRTH AUTHORITA, P55; Davy C, 2009, PRIMARY HLTH CARE KN; Davy CP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-268; Dowswell T, 2010, COCHRANE DATABASE SY, P10; Duke T, 1999, LANCET, V354, P1291, DOI 10.1016/S0140-6736(99)00335-9; Finlayson K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001373; Garner P., 1990, Health Policy and Planning, V5, P49, DOI 10.1093/heapol/5.1.49; Government of Papua New Guinea, 2010, NAT HLTH PLAN 2011 2; Griffiths P, 2001, J BIOSOC SCI, V33, P339, DOI 10.1017/S002193200100339X; Grossmann-Kendall F, 2001, REPROD HEALTH MATTER, V9, P90, DOI 10.1016/S0968-8080(01)90095-3; Hill Z, 2007, PUBLIC HEALTH NUTR, V10, P827, DOI 10.1017/S1368980007382554; Hinton R, 2010, WOMEN STUD INT FORUM, V33, P180, DOI 10.1016/j.wsif.2009.12.006; Kabakian-Khasholian T, 2000, SOC SCI MED, V51, P103, DOI 10.1016/S0277-9536(99)00443-8; Karel HS, 1999, PACIFIC HLTH DIALOG, V6, P326; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; Klufio C, 1993, POPULATION FAMILY HL; Kyomuhendo GB, 2003, REPROD HEALTH MATTER, V11, P16, DOI 10.1016/S0968-8080(03)02176-1; Larsen Gail L., 2004, Papua New Guinea Medical Journal, V47, P202; Launiala A, 2007, T ROY SOC TROP MED H, V101, P980, DOI 10.1016/j.trstmh.2007.04.005; Launiala A, 2006, ACTA TROP, V98, P111, DOI 10.1016/j.actatropica.2005.12.008; MARSHALL LB, 1985, SOC SCI MED, V21, P341, DOI 10.1016/0277-9536(85)90111-X; Mathole T, 2004, MIDWIFERY, V20, P122, DOI 10.1016/j.midw.2003.10.003; Matsuoka S, 2010, HEALTH POLICY, V95, P255, DOI 10.1016/j.healthpol.2009.12.011; Mbonye AK, 2006, HEALTH POLICY, V77, P279, DOI 10.1016/j.healthpol.2005.07.020; Menendez C, 2007, LANCET INFECT DIS, V7, P126, DOI 10.1016/S1473-3099(07)70024-5; Mrisho M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-10; Mubyazi GM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-54; Mueller Ivo, 2008, Papua New Guinea Medical Journal, V51, P12; Mumtaz Z, 2007, SOCIOL HEALTH ILL, V29, P1, DOI 10.1111/j.1467-9566.2007.00519.x; Myer L, 2003, J MIDWIFERY WOM HEAL, V48, P268, DOI 10.1016/S1526-9523(02)00421-X; Ndyomugyenyi R, 1998, HEALTH POLICY PLANN, V13, P94, DOI 10.1093/heapol/13.1.94; Pell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022452; Regmi K., 2009, BR J MIDWIFERY, V17, P382, DOI [10.12968/bjom.2009.17.6.42608, DOI 10.12968/BJOM.2009.17.6.42608, DOI 10.12968/BJ0M.2009.17.6.42608]; Ribera JM, 2007, PLOS MED, V4, P631, DOI 10.1371/journal.pmed.0040092; Rogerson SJ, 2000, T ROY SOC TROP MED H, V94, P549, DOI 10.1016/S0035-9203(00)90083-X; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Sanga K, 2010, AUST NZ J OBSTET GYN, V50, P21, DOI 10.1111/j.1479-828X.2009.01116.x; SHARP PT, 1982, PAPUA NEW GUINEA MED, V25, P108; Simkhada B, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-34; Stokes E, 2008, BJOG-INT J OBSTET GY, V115, P1641, DOI 10.1111/j.1471-0528.2008.01950.x; Strauss A., 1997, GROUNDED THEORY PRAC; Tautz S, 2000, SOC SCI MED, V50, P689, DOI 10.1016/S0277-9536(99)00321-4; Tinoco-Ojanguren R, 2008, SOC SCI MED, V66, P1057, DOI 10.1016/j.socscimed.2007.11.006; Tolhurst R, 2008, MIDWIFERY, V24, P83, DOI 10.1016/j.midw.2006.09.003; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X; Waiswa Peter, 2008, BMC Pregnancy Childbirth, V8, P21, DOI 10.1186/1471-2393-8-21; Wardlow H, 2004, SIGNS J WOMEN CULTUR, V29; World Bank, 2011, REPR HLTH GLANC PAP; World Health Organization, 2010, COUNTR COOP STRAT PN; World Health Organization, 2002, ANT CAR RAND TRIAL M	65	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e93025	10.1371/journal.pone.0093025	http://dx.doi.org/10.1371/journal.pone.0093025			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9SK	24842484	Green Published, gold			2022-12-25	WOS:000340948600002
J	Fioresi, M; Simoes, MR; Furieri, LB; Broseghini, GB; Vescovi, MVA; Stefanon, I; Vassallo, DV				Fioresi, Mirian; Simoes, Maylla Ronacher; Furieri, Lorena Barros; Broseghini-Filho, Gilson Bras; Vescovi, Marcos Vinicius A.; Stefanon, Ivanita; Vassallo, Dalton Valentim			Chronic Lead Exposure Increases Blood Pressure and Myocardial Contractility in Rats	PLOS ONE			English	Article							SOLUBLE GUANYLATE-CYCLASE; NITRIC-OXIDE; INDUCED HYPERTENSION; REST CONTRACTIONS; ATPASE ACTIVITY; AORTA; SYSTEM; PB2+; CA2+	We investigated the cardiovascular effects of lead exposure, emphasising its direct action on myocardial contractility. Male Wistar rats were sorted randomly into two groups: control (Ct) and treatment with 100 ppm of lead (Pb) in the drinking water. Blood pressure (BP) was measured weekly. At the end of the treatment period, the animals were anaesthetised and haemodynamic parameters and contractility of the left ventricular papillary muscles were recorded. Blood and tissue samples were properly stored for further biochemical investigations. Statistical analyses were considered to be significant at p < 0.05. The lead concentrations in the blood reached approximately 13 mu g/dL, while the bone was the site of the highest deposition of this metal. BP in the Pb-treated group was higher from the first week of lead exposure and remained at the same level over the next four weeks. Haemodynamic evaluations revealed increases in systolic (Ct: 96 +/- 3.79 vs. Pb: 116 +/- 1.37 mmHg) and diastolic blood pressure (Ct: 60 +/- 2.93 vs. Pb: 70 +/- 3.38 mmHg), left ventricular systolic pressure (Ct: 104 +/- 5.85 vs. Pb: 120 +/- 2.51 mmHg) and heart rate (Ct: 307 +/- 10 vs. Pb: 348 +/- 16 bpm). Lead treatment did not alter the force and time derivatives of the force of left ventricular papillary muscles that were contracting isometrically. However, our results are suggestive of changes in the kinetics of calcium (Ca++) in cardiomyocytes increased transarcolemmal Ca++ influx, low Ca++ uptake by the sarcoplasmic reticulum and high extrusion by the sarcolemma. Altogether, these results show that despite the increased Ca++ influx that was induced by lead exposure, the myocytes had regulatory mechanisms that prevented increases in force, as evidenced in vivo by the increased systolic ventricular pressure.	[Fioresi, Mirian; Simoes, Maylla Ronacher; Furieri, Lorena Barros; Broseghini-Filho, Gilson Bras; Stefanon, Ivanita; Vassallo, Dalton Valentim] Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, ES, Brazil; [Fioresi, Mirian; Furieri, Lorena Barros] Univ Fed Espirito Santo, Dept Nursing, Vitoria, ES, Brazil; [Vassallo, Dalton Valentim] Hlth Sci Ctr Vitoria EMESCAM, Vitoria, ES, Brazil; [Vescovi, Marcos Vinicius A.] Univ Fed Espirito Santo, Dept Chem, Vitoria, ES, Brazil	Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria; Universidade Federal do Espirito Santo	Fioresi, M (corresponding author), Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, ES, Brazil.	mirianfioresi@hotmail.com	Fioresi, Mirian/O-6625-2019; Stefanon, Ivanita/J-4729-2014; Vassallo, Dalton/K-8289-2016	Vassallo, Dalton/0000-0002-4463-4174; Stefanon, Ivanita/0000-0003-2638-5183	Capes; FAPESp; CNPq	Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Our study received financial support from Capes, FAPESp CNPq. (http://www.capes.gov.br/; http://www.cnpq.br/; http://www.fapes.es.gov.br/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Toxic Substances and Disease Registry (ATSDR), 2007, TOX PROF LEAD; Berry RG, 2007, CARDIOVASC RES, V73, P92, DOI 10.1016/j.cardiores.2006.11.006; BOSCOLO P, 1988, ENVIRON HEALTH PERSP, V78, P101, DOI 10.2307/3430508; Carmignani M, 2000, LIFE SCI, V68, P401, DOI 10.1016/S0024-3205(00)00954-1; Carmignani M, 1999, IMMUNOPHARMACOLOGY, V44, P105, DOI 10.1016/S0162-3109(99)00115-0; Courtois E, 2003, J AM SOC NEPHROL, V14, P1464, DOI 10.1097/01.ASN.0000064947.14997.69; Den HE, 2006, J HUM HYPERTENS, V16, P563; Farmand F, 2005, ENVIRON RES, V98, P33, DOI 10.1016/j.envres.2004.05.016; Fioresi M, 2013, BRAZ J MED BIOL RES, V46, P178, DOI 10.1590/1414-431X20122190; Fiorim J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017117; Grizzo LT, 2008, TOXICOL SCI, V103, P207, DOI 10.1093/toxsci/kfn018; Heydari A, 2006, TOXICOL LETT, V166, P88, DOI 10.1016/j.toxlet.2006.05.014; KHALILMANESH F, 1993, AM J HYPERTENS, V6, P723, DOI 10.1093/ajh/6.9.723; KoreckovaSysalova J, 1997, BIOL TRACE ELEM RES, V56, P321, DOI 10.1007/BF02785303; Lee DI, 2009, MOL PHARMACOL, V75, P774, DOI 10.1124/mol.108.052597; LEITE CM, 1995, CAN J PHYSIOL PHARM, V73, P638, DOI 10.1139/y95-081; LEITE CM, 1988, BRAZ J MED BIOL RES, V21, P859; Marques M, 2001, J AM SOC NEPHROL, V12, P2594, DOI 10.1681/ASN.V12122594; Ministerio da saude Brasil, 2006, AT SAUD TRAB EXP CHU; Navas-Acien A, 2007, ENVIRON HEALTH PERSP, V115, P472, DOI 10.1289/ehp.9785; Okoshi M P, 1994, Arq Bras Cardiol, V63, P501; Oliveira EM, 2000, BRAZ J MED BIOL RES, V33, P755, DOI 10.1590/S0100-879X2000000700005; PIRKLE JL, 1985, AM J EPIDEMIOL, V121, P246, DOI 10.1093/oxfordjournals.aje.a113995; Prasad AM, 2007, AM J PHYSIOL-CELL PH, V292, pC2269, DOI 10.1152/ajpcell.00441.2006; Qi M, 1997, AM J PHYSIOL-HEART C, V272, pH2416, DOI 10.1152/ajpheart.1997.272.5.H2416; Quintanar-Escorza MA, 2007, TOXICOL APPL PHARM, V220, P1, DOI 10.1016/j.taap.2006.10.016; Quintanar-Escorza MA, 2010, TOXICOL IN VITRO, V24, P1338, DOI 10.1016/j.tiv.2010.05.002; Raeymaekers L, 2011, BIOPHYS J, V100, P1216, DOI 10.1016/j.bpj.2011.01.024; Roncal C, 2007, AM J PHYSIOL-RENAL, V293, pF1391, DOI 10.1152/ajprenal.00216.2007; Ryall JG, 2008, AM J PHYSIOL-HEART C, V294, pH2587, DOI 10.1152/ajpheart.00985.2007; Sharifi AM, 2004, TOXICOL LETT, V153, P233, DOI 10.1016/j.toxlet.2004.04.013; Silveira EA, 2010, BRAZ J MED BIOL RES, V43, P492, DOI 10.1590/S0100-879X2010007500027; Simoes MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018730; Stefanon I, 2009, BRAZ J MED BIOL RES, V42, P902, DOI 10.1590/S0100-879X2009005000015; Stokke MK, 2010, CARDIOVASC RES, V86, P63, DOI 10.1093/cvr/cvp401; Sun HW, 2009, ENVIRON TECHNOL, V30, P1051, DOI 10.1080/09593330903055643; Valencia I, 2001, PHARMACOL TOXICOL, V89, P177, DOI 10.1111/j.0901-9928.2001.890406.x; Vassallo DV, 2008, BRAZ J MED BIOL RES, V41, P789, DOI 10.1590/S0100-879X2008000900008; VASSALLO DV, 1988, ACTA PHYSIOL PHARM L, V38, P87; Vassallo DV, 1988, ACTA PHYSL PHARM LAT, V29, P131; Vaziri ND, 1997, KIDNEY INT, V52, P1042, DOI 10.1038/ki.1997.426; Vaziri ND, 1999, KIDNEY INT, V56, P1492, DOI 10.1046/j.1523-1755.1999.00670.x; Vupputuri S, 2003, HYPERTENSION, V41, P463, DOI 10.1161/01.HYP.0000055015.39788.29; World Health Organization, 2011, CARD DIS; Zhang LF, 2007, TOXICOL LETT, V170, P104, DOI 10.1016/j.toxlet.2007.02.004; Zhang LF, 2005, TOXICOL LETT, V159, P71, DOI 10.1016/j.toxlet.2005.04.009	46	31	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e96900	10.1371/journal.pone.0096900	http://dx.doi.org/10.1371/journal.pone.0096900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841481	Green Submitted, gold, Green Published			2022-12-25	WOS:000340948600013
J	Senol, O; Schaaij-Visser, TBM; Erkan, EP; Dorfer, C; Lewandrowski, G; Pham, TV; Piersma, SR; Peerdeman, M; Strobel, T; Tannous, B; Saydam, N; Slavc, I; Knosp, E; Jimenez, CR; Saydam, O				Senol, O.; Schaaij-Visser, T. B. M.; Erkan, E. P.; Dorfer, C.; Lewandrowski, G.; Pham, T. V.; Piersma, S. R.; Peerdeman, M.; Stroebel, T.; Tannous, B.; Saydam, N.; Slavc, I.; Knosp, E.; Jimenez, C. R.; Saydam, O.			miR-200a-mediated suppression of non-muscle heavy chain IIb inhibits meningioma cell migration and tumor growth in vivo	ONCOGENE			English	Article							MYOSIN-II; MESENCHYMAL TRANSITION; INVASION	miR-200a has been implicated in the pathogenesis of meningiomas, one of the most common central nervous system tumors in humans. To identify how miR-200a contributes to meningioma pathogenesis at the molecular level, we used a comparative protein profiling approach using Gel-nanoLC-MS/MS and identified approximately 130 dysregulated proteins in miR-200a-overexpressing meningioma cells. Following the bioinformatic analysis to identify potential genes targeted by miR-200a, we focused on the nonmuscle heavy chain IIb (NMHCIIb), and showed that miR-200a directly targeted NMHCIIb. Considering the key roles of NMHCIIb in cell division and cell migration, we aimed to identify whether miR-200a regulated these processes through NMHCIIb. We found that NMHCIIb overexpression partially rescued miR-200a-mediated inhibition of cell migration, as well as cell growth in vitro and in vivo. Moreover, siRNA-mediated silencing of NMHCIIb expression resulted in a similar migration phenotype in these cells and inhibited meningioma tumor growth in mice. Taken together, these results suggest that NMHCIIb might serve as a novel therapeutic target in meningiomas.	[Senol, O.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol & Radiol, Boston, MA USA; [Schaaij-Visser, T. B. M.; Pham, T. V.; Piersma, S. R.; Jimenez, C. R.] Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, OncoProte Lab, Amsterdam, Netherlands; [Erkan, E. P.; Saydam, N.; Slavc, I.; Saydam, O.] Med Univ Vienna, Dept Pediat, Mol Neurooncol Res Unit, A-1090 Vienna, Austria; [Dorfer, C.; Knosp, E.] Med Univ Vienna, Dept Neurosurg, A-1090 Vienna, Austria; [Lewandrowski, G.; Tannous, B.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Expt Therapeut & Mol Imaging Lab, Boston, MA USA; [Peerdeman, M.] Vrije Univ Amsterdam Med Ctr, Dept Neurosurg, Amsterdam, Netherlands; [Stroebel, T.] Med Univ Vienna, Inst Neurol, A-1090 Vienna, Austria	Harvard University; Harvard Medical School; Massachusetts General Hospital; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Medical University of Vienna; Medical University of Vienna; Harvard University; Harvard Medical School; Massachusetts General Hospital; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Medical University of Vienna	Saydam, O (corresponding author), Med Univ Vienna, Dept Pediat, Mol Neurooncol Res Unit, A-1090 Vienna, Austria.	okay.saydam@meduniwien.ac.at	Erkan, Erdogan Pekcan/GQR-2513-2022; Jimenez, Connie/AAI-3763-2020; Dorfer, Christian/AAP-1990-2020; Erkan, Erdogan Pekcan/ABI-6822-2020; Saydam, Okay/HDM-4999-2022	Erkan, Erdogan Pekcan/0000-0001-9287-4773; Jimenez, Connie R/0000-0002-3103-4508; Dorfer, Christian/0000-0002-1843-7732	Forschungsgesellschaft for Brain Tumors; EU-FP7-PEOPLE-CIG; Association for Conduct of Scientific Research in the Field of Neonatology and Pediatric Intensive Care: 'Unser Kind'	Forschungsgesellschaft for Brain Tumors; EU-FP7-PEOPLE-CIG; Association for Conduct of Scientific Research in the Field of Neonatology and Pediatric Intensive Care: 'Unser Kind'	Support for this work was provided, in part, by Forschungsgesellschaft for Brain Tumors (to OS, NS), EU-FP7-PEOPLE-2011-CIG (to OS) and Association for Conduct of Scientific Research in the Field of Neonatology and Pediatric Intensive Care: 'Unser Kind' (to OS). We thank Dr Marianne F James for providing us with AC030 cells.	Ahmad A, 2011, CANCER RES, V71, P3400, DOI 10.1158/0008-5472.CAN-10-0965; Badr CE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000571; Beach JR, 2011, P NATL ACAD SCI USA, V108, P17991, DOI 10.1073/pnas.1106499108; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; Eades G, 2011, J BIOL CHEM, V286, P25992, DOI 10.1074/jbc.M111.229401; Elson-Schwab I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013176; Figueroa BE, 1999, BRIT J RADIOL, V72, P513, DOI 10.1259/bjr.72.857.10505022; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hu XX, 2009, GYNECOL ONCOL, V114, P457, DOI 10.1016/j.ygyno.2009.05.022; Jacobs K, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-255; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; Mawrin C, 2010, J NEURO-ONCOL, V99, P379, DOI 10.1007/s11060-010-0342-2; Pham MH, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.2.FOCUS1117; Pramesh CS, 2003, JPN J CLIN ONCOL, V33, P86, DOI 10.1093/jjco/hyg022; Ragel Brian, 2003, Cancer Control, V10, P148; Ragel BT, 2008, SURG NEUROL, V70, P295, DOI 10.1016/j.surneu.2007.06.031; Ragel BT, 2010, J NEURO-ONCOL, V99, P315, DOI 10.1007/s11060-010-0381-8; Sandquist JC, 2006, J BIOL CHEM, V281, P35873, DOI 10.1074/jbc.M605343200; Saydam O, 2011, CANCER RES, V71, P852, DOI 10.1158/0008-5472.CAN-10-1219; Saydam O, 2010, J PROTEOME RES, V9, P485, DOI 10.1021/pr900834h; Saydam O, 2009, MOL CELL BIOL, V29, P5923, DOI 10.1128/MCB.00332-09; Sureban SM, 2011, CANCER RES, V71, P2328, DOI 10.1158/0008-5472.CAN-10-2738; Takeda K, 2003, CIRC RES, V93, P330, DOI 10.1161/01.RES.0000089256.00309.CB; Tullio AN, 1997, P NATL ACAD SCI USA, V94, P12407, DOI 10.1073/pnas.94.23.12407; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wilisch-Neumann A, 2013, CLIN CANCER RES, V19, P5402, DOI 10.1158/1078-0432.CCR-12-0299; Wu QH, 2011, GYNECOL ONCOL, V122, P149, DOI 10.1016/j.ygyno.2011.03.026; Xia HP, 2010, BIOCHEM BIOPH RES CO, V391, P535, DOI 10.1016/j.bbrc.2009.11.093	29	27	27	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 2	2015	34	14					1790	1798		10.1038/onc.2014.120	http://dx.doi.org/10.1038/onc.2014.120			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CE9IQ	24858044				2022-12-25	WOS:000352158000006
J	Bracey, NA; Gershkovich, B; Chun, J; Vilaysane, A; Meijndert, HC; Wright, JR; Fedak, PW; Beck, PL; Muruve, DA; Duff, HJ				Bracey, Nathan A.; Gershkovich, Benjamin; Chun, Justin; Vilaysane, Akosua; Meijndert, H. Christopher; Wright, James R., Jr.; Fedak, Paul W.; Beck, Paul L.; Muruve, Daniel A.; Duff, Henry J.			Mitochondrial NLRP3 Protein Induces Reactive Oxygen Species to Promote Smad Protein Signaling and Fibrosis Independent from the Inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA RECEPTOR; ANGIOTENSIN-II; MYOFIBROBLAST DIFFERENTIATION; MYOCARDIAL-INFARCTION; CARDIAC FIBROBLASTS; ACTIVATION; PATHWAYS; DYSFUNCTION; MECHANISM; INJURY	Nucleotide-binding domain and leucine-rich repeat containing PYD-3 (NLRP3) is a pattern recognition receptor that is implicated in the pathogenesis of inflammation and chronic diseases. Although much is known regarding the NLRP3 inflammasome that regulates proinflammatory cytokine production in innate immune cells, the role of NLRP3 in non-professional immune cells is unclear. Here we report that NLRP3 is expressed in cardiac fibroblasts and increased during TGF beta stimulation. NLRP3-deficient cardiac fibroblasts displayed impaired differentiation and R-Smad activation in response to TGF beta. Only the central nucleotide binding domain of NLRP3 was required to augment R-Smad signaling because the N-terminal Pyrin or C-terminal leucine- rich repeat domains were dispensable. Interestingly, NLRP3 regulation of myofibroblast differentiation proceeded independently from the inflammasome, IL-1 beta /IL-18, or caspase 1. Instead, mitochondrially localized NLRP3 potentiated reactive oxygen species to augment R-Smad activation. In vivo, NLRP3-deficient mice were protected against angiotensin II-induced cardiac fibrosis with preserved cardiac architecture and reduced collagen 1. Together, these results support a distinct role for NLRP3 in non-professional immune cells independent from the inflammasome to regulate differential aspects of wound healing and chronic disease.	[Bracey, Nathan A.; Gershkovich, Benjamin; Meijndert, H. Christopher; Fedak, Paul W.; Duff, Henry J.] Univ Calgary, Libin Cardiovasc Inst, Calgary, AB T2N 4N1, Canada; [Chun, Justin; Vilaysane, Akosua; Beck, Paul L.; Muruve, Daniel A.] Univ Calgary, Dept Med, Calgary, AB T2N 4N1, Canada; [Wright, James R., Jr.] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB T2N 4N1, Canada	Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Calgary; University of Calgary	Duff, HJ (corresponding author), Univ Calgary, Libin Cardiovasc Inst, HRIC, GAC 72,3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	hduff@ucalgary.ca	Chun, Justin/R-8487-2019	Fedak, Paul/0000-0003-0658-9381; Chun, Justin/0000-0002-3820-7192	Alberta Heart and Stroke Foundation; Canadian Institutes for Health Research; Alberta HEART Initiative; Alberta Innovates Health Solutions	Alberta Heart and Stroke Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta HEART Initiative; Alberta Innovates Health Solutions	This work was supported by operating grants from the Alberta Heart and Stroke Foundation and Canadian Institutes for Health Research.; Supported in part by a studentship award from the Alberta HEART Initiative and an MD/PhD studentship from Alberta Innovates Health Solutions.; Holder of a Tier II Canada Research Chair in Inflammation and Kidney Disease and recipient of a Clinical Senior Scholar award from Alberta Innovates Health Solutions.	Arnoult D, 2009, J CELL SCI, V122, P3161, DOI 10.1242/jcs.051193; Artlett CM, 2011, ARTHRITIS RHEUM-US, V63, P3563, DOI 10.1002/art.30568; Bracey NA, 2013, EXP PHYSIOL, V98, P462, DOI 10.1113/expphysiol.2012.068338; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Fedak PWM, 2012, CIRC-HEART FAIL, V5, P349, DOI 10.1161/CIRCHEARTFAILURE.111.965889; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Koitabashi N, 2011, J CLIN INVEST, V121, P2301, DOI 10.1172/JCI44824; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Matsui Y, 2011, CIRC RES, V108, P1328, DOI 10.1161/CIRCRESAHA.110.235689; Mezzaroma E, 2011, P NATL ACAD SCI USA, V108, P19725, DOI 10.1073/pnas.1108586108; Petrov VV, 2002, HYPERTENSION, V39, P258, DOI 10.1161/hy0202.103268; Sandanger O, 2013, CARDIOVASC RES, V99, P164, DOI 10.1093/cvr/cvt091; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Shigeoka AA, 2010, J IMMUNOL, V185, P6277, DOI 10.4049/jimmunol.1002330; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143; Wang W, 2013, J IMMUNOL, V190, P1239, DOI 10.4049/jimmunol.1201959; Wang WS, 2006, CIRC RES, V98, P1032, DOI 10.1161/01.RES.0000218782.52610.dc; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Xu L, 2000, NAT CELL BIOL, V2, P559, DOI 10.1038/35019649; Yang FY, 2010, J PATHOL, V221, P390, DOI 10.1002/path.2721; Zhang GX, 2007, CARDIOVASC RES, V76, P204, DOI 10.1016/j.cardiores.2007.07.014; Zhang HY, 1997, J IMMUNOL, V158, P1392; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zimmerman MC, 2002, CIRC RES, V91, P1038, DOI 10.1161/01.RES.0000043501.47934.FA; Zuurbier CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040643	37	106	111	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19571	19584		10.1074/jbc.M114.550624	http://dx.doi.org/10.1074/jbc.M114.550624			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24841199	Green Published, hybrid			2022-12-25	WOS:000339326800031
J	Chan, CY; Parra, KJ				Chan, Chun-Yuan; Parra, Karlett J.			Yeast Phosphofructokinase-1 Subunit Pfk2p Is Necessary for pH Homeostasis and Glucose-dependent Vacuolar ATPase Reassembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; H+-ATPASE; V-ATPASE; SACCHAROMYCES-CEREVISIAE; GLYCOLYTIC OSCILLATIONS; CYTOSOLIC PH; PROTON PUMPS; V-0 SUBUNIT; CELLULAR PH; ALDOLASE	V-ATPases are conserved ATP-driven proton pumps that acidify organelles. Yeast V-ATPase assembly and activity are glucose-dependent. Glucose depletion causes V-ATPase disassembly and its inactivation. Glucose readdition triggers reassembly and resumes proton transport and organelle acidification. We investigated the roles of the yeast phosphofructokinase-1 subunits Pfk1p and Pfk2p for V-ATPase function. The pfk1 Delta and pfk2 Delta mutants grew on glucose and assembled wild-type levels of V-ATPase pumps at the membrane. Both phosphofructokinase-1 subunits co-immunoprecipitated with V-ATPase in wild-type cells; upon deletion of one subunit, the other subunit retained binding to V-ATPase. The pfk2 Delta cells exhibited a partialvmagrowth phenotype. In vitro ATP hydrolysis and proton transport were reduced by 35% in pfk2 Delta membrane fractions; they were normal in pfk1 Delta. In vivo, the pfk1 Delta and pfk2 Delta vacuoles were alkalinized and the cytosol acidified, suggestive of impaired V-ATPase proton transport. Overall the pH alterations were more dramatic in pfk2 Delta than pfk1 Delta at steady state and after readdition of glucose to glucose-deprived cells. Glucose-dependent reassembly was 50% reduced in pfk2 Delta, and the vacuolar lumen was not acidified after reassembly. RAVE-assisted glucose-dependent reassembly and/or glucose signals were disturbed in pfk2 Delta. Binding of disassembled V-ATPase (V-1 domain) to its assembly factor RAVE (subunit Rav1p) was 5-fold enhanced, indicating that Pfk2p is necessary for V-ATPase regulation by glucose. Because Pfk1p and Pfk2p are necessary for V-ATPase proton transport at the vacuole in vivo, a role for glycolysis at regulating V-ATPase proton transport is discussed.	[Chan, Chun-Yuan; Parra, Karlett J.] Univ New Mexico, Dept Biochem & Mol Biol, Sch Med, Hlth Sci Ctr, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center	Parra, KJ (corresponding author), Univ New Mexico, Dept Biochem & Mol Biol, MSC08 4670, Albuquerque, NM 87131 USA.	kjparra@salud.unm.edu	Chan, Chun Yuan/F-5811-2010		National Institutes of Health [R01GM086495]; American Heart Association [0855228F, 14PRE19020015]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM086495 (to K. J. P.). This work was also supported by American Heart Association Grants 0855228F (to K. J. P.) and 14PRE19020015 (to C.-Y. C.).	ARVANITIDIS A, 1994, J BIOL CHEM, V269, P8911; Avnet S, 2013, BBA-MOL BASIS DIS, V1832, P1105, DOI 10.1016/j.bbadis.2013.04.003; Banaszak K, 2011, J MOL BIOL, V407, P284, DOI 10.1016/j.jmb.2011.01.019; BAUERLE C, 1993, J BIOL CHEM, V268, P12749; Bond S, 2008, J BIOL CHEM, V283, P36513, DOI 10.1074/jbc.M805232200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breton S, 2013, PHYSIOLOGY, V28, P318, DOI 10.1152/physiol.00007.2013; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Chan CY, 2012, J BIOL CHEM, V287, P10236, DOI 10.1074/jbc.M111.321133; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; Dhar-Chowdhury P, 2005, J BIOL CHEM, V280, P38464, DOI 10.1074/jbc.M508744200; Diakov Theodore T, 2010, J Biol Chem, V285, P23771, DOI 10.1074/jbc.M110.110122; DOHERTY RD, 1993, J BIOL CHEM, V268, P16845; Ediger B, 2009, J BIOL CHEM, V284, P19522, DOI 10.1074/jbc.M109.013375; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Fogarty FM, 2014, ONCOGENE, V33, P4653, DOI 10.1038/onc.2013.403; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; HEINISCH J, 1986, CURR GENET, V11, P227, DOI 10.1007/BF00420611; HSU SC, 1991, J BIOL CHEM, V266, P21745; Ikemoto A, 2003, J BIOL CHEM, V278, P5929, DOI 10.1074/jbc.M211617200; Johnson RM, 2010, ANAL BIOCHEM, V398, P203, DOI 10.1016/j.ab.2009.12.020; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2003, J BIOENERG BIOMEMBR, V35, P313, DOI 10.1023/A:1025724814656; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kane PM, 2000, J EXP BIOL, V203, P81; Klinder A, 1998, YEAST, V14, P323, DOI 10.1002/(SICI)1097-0061(19980315)14:4<323::AID-YEA223>3.0.CO;2-W; Kohio HP, 2013, VIROLOGY, V444, P301, DOI 10.1016/j.virol.2013.06.026; Konishi H, 2004, PLANT MOL BIOL, V56, P839, DOI 10.1007/s11103-004-5920-2; Liberman R, 2014, J BIOL CHEM, V289, P1355, DOI 10.1074/jbc.M113.524561; Lu M, 2004, J BIOL CHEM, V279, P8732, DOI 10.1074/jbc.M303871200; Lu M, 2001, J BIOL CHEM, V276, P30407, DOI 10.1074/jbc.M008768200; Lu M, 2007, J BIOL CHEM, V282, P24495, DOI 10.1074/jbc.M702598200; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; Merkulova M, 2011, AM J PHYSIOL-CELL PH, V300, pC1442, DOI 10.1152/ajpcell.00076.2010; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Muller S, 1997, MICROBIOL-UK, V143, P3055, DOI 10.1099/00221287-143-9-3055; Oot RA, 2012, STRUCTURE, V20, P1881, DOI 10.1016/j.str.2012.08.020; Owegi MA, 2005, J BIOL CHEM, V280, P18393, DOI 10.1074/jbc.M412567200; Parra KJ, 2014, EUKARYOT CELL, V13, P706, DOI 10.1128/EC.00050-14; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Schroder TD, 2013, FEBS J, V280, P6033, DOI 10.1111/febs.12522; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; Smardon AM, 2002, J BIOL CHEM, V277, P13831, DOI 10.1074/jbc.M200682200; Smardon AM, 2007, J BIOL CHEM, V282, P26185, DOI 10.1074/jbc.M703627200; Smardon AM, 2014, MOL BIOL CELL, V25, P356, DOI 10.1091/mbc.E13-05-0231; Sobacchi C, 2001, HUM MOL GENET, V10, P1767, DOI 10.1093/hmg/10.17.1767; Stewart AG, 2012, STRUCTURE, V20, P1799, DOI 10.1016/j.str.2012.10.003; Su Y, 2003, J BIOL CHEM, V278, P20013, DOI 10.1074/jbc.M210077200; Su Y, 2008, AM J PHYSIOL-RENAL, V295, pF950, DOI 10.1152/ajprenal.90258.2008; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Sun-Wada GH, 2003, J BIOENERG BIOMEMBR, V35, P347, DOI 10.1023/A:1025780932403; Tarsio M, 2011, J BIOL CHEM, V286, P28089, DOI 10.1074/jbc.M111.251363; Tiburcy F, 2013, J EXP BIOL, V216, P881, DOI 10.1242/jeb.078360; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; WEISS JN, 1987, SCIENCE, V238, P67, DOI 10.1126/science.2443972; Williamson T, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-108	59	20	21	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19448	19457		10.1074/jbc.M114.569855	http://dx.doi.org/10.1074/jbc.M114.569855			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24860096	Green Published, hybrid			2022-12-25	WOS:000339326800020
J	Haerteis, S; Krappitz, A; Krappitz, M; Murphy, JE; Bertog, M; Krueger, B; Nacken, R; Chung, H; Hollenberg, MD; Knecht, W; Bunnett, NW; Korbmacher, C				Haerteis, Silke; Krappitz, Annabel; Krappitz, Matteus; Murphy, Jane E.; Bertog, Marko; Krueger, Bettina; Nacken, Regina; Chung, Hyunjae; Hollenberg, Morley D.; Knecht, Wolfgang; Bunnett, Nigel W.; Korbmacher, Christoph			Proteolytic Activation of the Human Epithelial Sodium Channel by Trypsin IV and Trypsin I Involves Distinct Cleavage Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SUBUNIT; NA+ TRANSPORT; HUMAN MESOTRYPSIN; SERINE PROTEASES; PROSTATE-CANCER; HUMAN BRAIN; ENAC; EXPRESSION; CELLS; RECEPTOR-2	Proteolytic activation is a unique feature of the epithelial sodium channel (ENaC). However, the underlying molecular mechanisms and the physiologically relevant proteases remain to be identified. The serine protease trypsin I can activate ENaC in vitro but is unlikely to be the physiologically relevant activating protease in ENaC-expressing tissues in vivo. Herein, we investigated whether human trypsin IV, a form of trypsin that is co-expressed in several extrapancreatic epithelial cells with ENaC, can activate human ENaC. In Xenopus laevis oocytes, we monitored proteolytic activation of ENaC currents and the appearance of gamma ENaC cleavage products at the cell surface. We demonstrated that trypsin IV and trypsin I can stimulate ENaC heterologously expressed in oocytes. ENaC cleavage and activation by trypsin IV but not by trypsin I required a critical cleavage site (Lys-189) in the extracellular domain of the gamma-subunit. In contrast, channel activation by trypsin I was prevented by mutating three putative cleavage sites (Lys-168, Lys-170, and Arg-172) in addition to mutating previously described prostasin (RKRK178), plasmin (Lys-189), and neutrophil elastase (Val-182 and Val-193) sites. Moreover, we found that trypsin IV is expressed in human renal epithelial cells and can increase ENaC-mediated sodium transport in cultured human airway epithelial cells. Thus, trypsin IV may regulate ENaC function in epithelial tissues. Our results show, for the first time, that trypsin IV can stimulate ENaC and that trypsin IV and trypsin I activate ENaC by cleavage at distinct sites. The presence of distinct cleavage sites may be important for ENaC regulation by tissue-specific proteases.	[Haerteis, Silke; Krappitz, Annabel; Krappitz, Matteus; Bertog, Marko; Krueger, Bettina; Nacken, Regina; Korbmacher, Christoph] Friedrich Alexander Univ Erlangen Nurnberg FAU, Inst Zellulare & Mol Physiol, D-91054 Erlangen, Germany; [Murphy, Jane E.] Univ Calif San Francisco, Dept Surg, Ctr Neurobiol Digest Dis, San Francisco, CA USA; [Chung, Hyunjae; Hollenberg, Morley D.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada; [Knecht, Wolfgang] AstraZeneca Res & Dev, CVGI iMed, Biosci, S-43181 Molndal, Sweden; [Bunnett, Nigel W.] Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Bunnett, Nigel W.] Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia	University of Erlangen Nuremberg; University of California System; University of California San Francisco; University of Calgary; AstraZeneca; University of Melbourne	Korbmacher, C (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Inst Zellulare & Mol Physiol, Waldstr 6, D-91054 Erlangen, Germany.	christoph.korbmacher@fau.de	Haerteis, Silke/AGS-5314-2022; Hollenberg, Morley/AFV-6966-2022	Bunnett, Nigel W./0000-0003-3367-0644; Bertog, Marko/0000-0002-1504-9582; Haerteis, Silke/0000-0002-9440-3307	National Institutes of Health [DK43207, DK57840]; Interdisziplinares Zentrum fur Klinische Forschung (IZKF); Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsfoerderung (ELAN) program of the Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU); National Health and Medical Research Council [63303, 1049682, 1031886]; Monash University; Prostate Cancer Canada; Canadian Institutes of Health Research (CIHR); Biomedical Research Technology Program of the National Institutes of Health, NCRR [P41RR001614, 1S10RR014606]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057840, R01DK043207, R56DK043207] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Interdisziplinares Zentrum fur Klinische Forschung (IZKF); Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsfoerderung (ELAN) program of the Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Monash University(Monash University); Prostate Cancer Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Biomedical Research Technology Program of the National Institutes of Health, NCRR; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK43207 and DK57840 (to N. W. B.). This work was also supported by grants from the Interdisziplinares Zentrum fur Klinische Forschung (IZKF) (to S. H. and M. K.) and the Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsfoerderung (ELAN) program of the Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) (to S. H.), by National Health and Medical Research Council Grants 63303, 1049682, 1031886 and Monash University (to N. W. B.), and by grants from Prostate Cancer Canada and the Canadian Institutes of Health Research (CIHR) (to M. D. H.). The Bio-Organic Biomedical Mass Spectrometry Resource at the University of California, San Francisco, is supported by the Biomedical Research Technology Program of the National Institutes of Health, NCRR, Grants P41RR001614 and 1S10RR014606.	Adebamiro A, 2007, J GEN PHYSIOL, V130, P611, DOI 10.1085/jgp.200709781; Bertog M, 1999, J PHYSIOL-LONDON, V521, P3, DOI 10.1111/j.1469-7793.1999.00003.x; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Cattaruzza F, 2014, BRIT J PHARMACOL, V171, P3814, DOI 10.1111/bph.12738; Ceppa EP, 2011, AM J PHYSIOL-GASTR L, V300, pG1033, DOI 10.1152/ajpgi.00305.2010; Chen J. M., 2012, HDB PROTEOLYTIC ENZY, P2600; Chung H, 2013, J BIOL CHEM, V288, P37319, DOI 10.1074/jbc.M113.492793; Cottrell GS, 2004, J BIOL CHEM, V279, P13532, DOI 10.1074/jbc.M312090200; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; Diederichs S, 2004, CANCER RES, V64, P5564, DOI 10.1158/0008-5472.CAN-04-2004; Eaton DC, 2009, ANNU REV PHYSIOL, V71, P403, DOI 10.1146/annurev.physiol.010908.163250; EMI M, 1986, GENE, V41, P305; Gallatz Katalin, 2007, Ideggyogy Sz, V60, P118; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Ghilardi C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-201; Haerteis S, 2009, J BIOL CHEM, V284, P29024, DOI 10.1074/jbc.M109.018945; Haerteis S, 2012, J GEN PHYSIOL, V140, P375, DOI 10.1085/jgp.201110763; Haerteis S, 2012, PFLUG ARCH EUR J PHY, V464, P353, DOI 10.1007/s00424-012-1138-3; Hockla A, 2012, MOL CANCER RES, V10, P1555, DOI 10.1158/1541-7786.MCR-12-0314; Hummler E, 2010, CELL PHYSIOL BIOCHEM, V25, P63, DOI 10.1159/000272051; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Ji HL, 2006, J BIOL CHEM, V281, P8233, DOI 10.1074/jbc.M512293200; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Knecht W, 2007, J BIOL CHEM, V282, P26089, DOI 10.1074/jbc.M703840200; Koshikawa N, 1998, AM J PATHOL, V153, P937, DOI 10.1016/S0002-9440(10)65635-0; Krueger B, 2012, INVEST OPHTH VIS SCI, V53, P596, DOI 10.1167/iovs.11-8581; Lazrak A, 2003, AM J PHYSIOL-LUNG C, V285, pL443, DOI 10.1152/ajplung.00412.2002; Navarrete M, 2013, CLIN PROTEOM, V10, DOI 10.1186/1559-0275-10-17; Nesterov V, 2008, AM J PHYSIOL-RENAL, V295, pF1052, DOI 10.1152/ajprenal.00031.2008; Nyaruhucha CNM, 1997, J BIOL CHEM, V272, P10573; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Patel AB, 2012, AM J PHYSIOL-RENAL, V303, pF540, DOI 10.1152/ajprenal.00133.2012; Radisky ES, 2013, ASIAN J ANDROL, V15, P439, DOI 10.1038/aja.2013.14; Rauh R, 2010, J PHYSIOL-LONDON, V588, P1211, DOI 10.1113/jphysiol.2009.180224; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Sahin-Toth M, 2005, PROTEIN PEPTIDE LETT, V12, P457, DOI 10.2174/0929866054395356; Stewart AP, 2011, J BIOL CHEM, V286, P31944, DOI 10.1074/jbc.M111.275289; Stockand JD, 2008, IUBMB LIFE, V60, P620, DOI 10.1002/iub.89; Svenningsen P, 2009, J AM SOC NEPHROL, V20, P299, DOI 10.1681/ASN.2008040364; Szmola R, 2003, J BIOL CHEM, V278, P48580, DOI 10.1074/jbc.M310301200; Tan CD, 2011, PFLUG ARCH EUR J PHY, V462, P431, DOI 10.1007/s00424-011-0982-x; Toth J, 2007, NEUROCHEM RES, V32, P1423, DOI 10.1007/s11064-007-9327-8; Volk T, 2004, PFLUG ARCH EUR J PHY, V447, P884, DOI 10.1007/s00424-003-1193-x; WIEGAND U, 1993, GENE, V136, P167, DOI 10.1016/0378-1119(93)90460-K; Woollhead AM, 2005, J PHYSIOL-LONDON, V566, P781, DOI 10.1113/jphysiol.2005.088674; Zeissig S, 2008, GASTROENTEROLOGY, V134, P1436, DOI 10.1053/j.gastro.2008.02.030	47	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19067	19078		10.1074/jbc.M113.538470	http://dx.doi.org/10.1074/jbc.M113.538470			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24841206	Green Published, hybrid			2022-12-25	WOS:000339062900037
J	Kawai, T; Katayama, Y; Guo, LJ; Liu, DS; Suzuki, T; Hayakawa, K; Lee, JM; Nagamine, T; Hull, JJ; Matsumoto, S; Nagasawa, H; Tanokura, M; Nagata, K				Kawai, Takeshi; Katayama, Yukie; Guo, Linjun; Liu, Desheng; Suzuki, Tatsuya; Hayakawa, Kou; Lee, Jae Min; Nagamine, Toshihiro; Hull, J. Joe; Matsumoto, Shogo; Nagasawa, Hiromichi; Tanokura, Masaru; Nagata, Koji			Identification of Functionally Important Residues of the Silkmoth Pheromone Biosynthesis-activating Neuropeptide Receptor, an Insect Ortholog of the Vertebrate Neuromedin U Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; A(2A) ADENOSINE RECEPTOR; BOMBYX-MORI; SEX-PHEROMONE; PBAN RECEPTOR; LEPIDOPTERA-NOCTUIDAE; CARBOXYL-TERMINUS; CRYSTAL-STRUCTURE; SILKWORM MOTH; PEPTIDES	The biosynthesis of sex pheromone components in many lepidopteran insects is regulated by the interaction between pheromone biosynthesis-activating neuropeptide (PBAN) and the PBAN receptor (PBANR), a class A G-protein-coupled receptor. To identify functionally important amino acid residues in the silkmoth PBANR, a series of 27 alanine substitutions was generated using a PBANR chimera C-terminally fused with enhanced GFP. The PBANR mutants were expressed in Sf9 insect cells, and their ability to bind and be activated by a core PBAN fragment (C10PBAN(R2K)) was monitored. Among the 27 mutants, 23 localized to the cell surface of transfected Sf9 cells, whereas the other four remained intracellular. Reduced binding relative to wild type was observed with 17 mutants, and decreased Ca2+ mobilization responses were observed with 12 mutants. Ala substitution of Glu-95, Glu-120, Asn-124, Val-195, Phe-276, Trp-280, Phe-283, Arg-287, Tyr-307, Thr-311, and Phe-319 affected both binding and Ca2+ mobilization. The most pronounced effects were observed with the E120A mutation. A molecular model of PBANR indicated that the functionally important PBANR residues map to the 2nd, 3rd, 6th, and 7th transmembrane helices, implying that the same general region of class A G-protein-coupled receptors recognizes both peptidic and nonpeptidic ligands. Docking simulations suggest similar ligand-receptor recognition interactions for PBAN-PBANR and the orthologous vertebrate pair, neuromedin U (NMU) and NMU receptor (NMUR). The simulations highlight the importance of two glutamate residues, Glu-95 and Glu-120, in silkmoth PBANR and Glu-117 and Glu-142 in human NMUR1, in the recognition of the most functionally critical region of the ligands, the C-terminal residue and amide.	[Kawai, Takeshi; Katayama, Yukie; Guo, Linjun; Liu, Desheng; Suzuki, Tatsuya; Hayakawa, Kou; Nagasawa, Hiromichi; Tanokura, Masaru; Nagata, Koji] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Lee, Jae Min; Nagamine, Toshihiro; Matsumoto, Shogo] RIKEN, Mol Entomol Lab, Adv Sci Inst, Wako, Saitama 3510198, Japan; [Hull, J. Joe] USDA, Arid Land Agr Res Ctr, Maricopa, AZ 85138 USA	University of Tokyo; RIKEN; United States Department of Agriculture (USDA)	Tanokura, M (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amtanok@mail.ecc.u-tokyo.ac.jp; aknagata@mail.ecc.u-tokyo.ac.jp	Hayakawa, Kou/AAC-9018-2022	Nagata, Koji/0000-0002-4704-0603; Tanokura, Masaru/0000-0001-5072-2480	Targeted Proteins Research Project; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science [17681026]	Targeted Proteins Research Project; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the Targeted Proteins Research Project and the Platform for Drug Discovery, Informatics, and Structural Life Science of the Ministry of Education, Culture, Sports, Science, and Technology of Japan and a Grant-in-aid for Young Scientists (A) 17681026 from the Japan Society for the Promotion of Science. Mention of trade names or commercial products in this article is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the United States Department of Agriculture. United States Department of Agriculture is an equal opportunity provider and employer.	ANDO T, 1988, AGR BIOL CHEM TOKYO, V52, P141; ANDO T, 1988, AGR BIOL CHEM TOKYO, V52, P473; Brighton PJ, 2004, PHARMACOL REV, V56, P231, DOI 10.1124/pr.56.2.3; Bylund David B, 2004, Methods Mol Biol, V259, P1; Cazzamali G, 2005, BIOCHEM BIOPH RES CO, V335, P14, DOI 10.1016/j.bbrc.2005.07.038; Cheng YX, 2010, ARCH INSECT BIOCHEM, V75, P13, DOI 10.1002/arch.20379; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Choi MY, 2007, INSECT BIOCHEM MOLEC, V37, P296, DOI 10.1016/j.ibmb.2006.12.004; Choi MY, 2010, FEBS LETT, V584, P1212, DOI 10.1016/j.febslet.2010.02.033; Choi MY, 2003, P NATL ACAD SCI USA, V100, P9721, DOI 10.1073/pnas.1632485100; Clark BA, 1996, INT J PEPT PROT RES, V47, P361; Congreve M, 2011, J MED CHEM, V54, P4283, DOI 10.1021/jm200371q; COOK LL, 1988, J BIOL CHEM, V263, P13991; DeLano W. L., 2002, CCP4 NEWSLETT PROTEI, V40, P44; Fonagy A, 2001, ARTHROPOD STRUCT DEV, V30, P113, DOI 10.1016/S1467-8039(01)00027-5; Fujii R, 2000, J BIOL CHEM, V275, P21068, DOI 10.1074/jbc.M001546200; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Holst B, 2010, J BIOL CHEM, V285, P3973, DOI 10.1074/jbc.M109.064725; Homma T, 2006, BIOCHEM BIOPH RES CO, V344, P386, DOI 10.1016/j.bbrc.2006.03.085; Hosoya M, 2000, J BIOL CHEM, V275, P29528, DOI 10.1074/jbc.M004261200; Howard AD, 2000, NATURE, V406, P70, DOI 10.1038/35017610; Hull JJ, 2011, INSECT MOL BIOL, V20, P801, DOI 10.1111/j.1365-2583.2011.01110.x; Hull JJ, 2007, BIOSCI BIOTECH BIOCH, V71, P1993, DOI 10.1271/bbb.70175; Hull JJ, 2005, BIOCHEM BIOPH RES CO, V334, P69, DOI 10.1016/j.bbrc.2005.06.050; Hull JJ, 2004, J BIOL CHEM, V279, P51500, DOI 10.1074/jbc.M408142200; IMAI K, 1991, P JPN ACAD B-PHYS, V67, P98, DOI 10.2183/pjab.67.98; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Jurenka R, 2011, INSECT MOL BIOL, V20, P323, DOI 10.1111/j.1365-2583.2010.01065.x; Kawai T., 2011, P SCI, P126; Kawai Takeshi, 2012, Front Endocrinol (Lausanne), V3, P42, DOI 10.3389/fendo.2012.00042; KAWANO T, 1992, BIOCHEM BIOPH RES CO, V189, P221, DOI 10.1016/0006-291X(92)91547-4; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim YJ, 2008, PEPTIDES, V29, P268, DOI 10.1016/j.peptides.2007.12.001; KITAMURA A, 1989, BIOCHEM BIOPH RES CO, V163, P520, DOI 10.1016/0006-291X(89)92168-2; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUNIYOSHI H, 1992, BIOSCI BIOTECH BIOCH, V56, P167, DOI 10.1271/bbb.56.167; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee DW, 2011, INSECT BIOCHEM MOLEC, V41, P236, DOI 10.1016/j.ibmb.2011.01.001; Lee Jae Min, 2012, Front Endocrinol (Lausanne), V3, P6, DOI 10.3389/fendo.2012.00006; Matsumoto S., 1990, J INSECT PHYSL, V53, P752; MINAMINO N, 1985, BIOCHEM BIOPH RES CO, V130, P1078, DOI 10.1016/0006-291X(85)91726-7; Mobarec JC, 2009, J MED CHEM, V52, P5207, DOI 10.1021/jm9005252; Mori K, 2005, EMBO J, V24, P325, DOI 10.1038/sj.emboj.7600526; Moto K, 2004, P NATL ACAD SCI USA, V101, P8631, DOI 10.1073/pnas.0402056101; Moto K, 2003, P NATL ACAD SCI USA, V100, P9156, DOI 10.1073/pnas.1531993100; NACHMAN RJ, 1986, BIOCHEM BIOPH RES CO, V137, P936, DOI 10.1016/0006-291X(86)90315-3; NACHMAN RJ, 1993, BIOCHEM BIOPH RES CO, V193, P661, DOI 10.1006/bbrc.1993.1675; Nagata K., 2009, P 21 AM PEPT S, P345; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Nusawardani T, 2013, INSECT MOL BIOL, V22, P331, DOI 10.1111/imb.12025; Park Y, 2002, P NATL ACAD SCI USA, V99, P11423, DOI 10.1073/pnas.162276199; Predel R, 2006, CELL MOL LIFE SCI, V63, P2477, DOI 10.1007/s00018-006-6187-3; Rafaeli A, 2007, INSECT MOL BIOL, V16, P287, DOI 10.1111/j.1365-2583.2007.00725.x; Rafaeli A, 2009, GEN COMP ENDOCR, V162, P69, DOI 10.1016/j.ygcen.2008.04.004; RAINA AK, 1989, SCIENCE, V244, P796, DOI 10.1126/science.244.4906.796; ROELOFS W, 1984, BIOORG CHEM, V12, P279, DOI 10.1016/0045-2068(84)90011-7; Roelofs WL, 2003, P NATL ACAD SCI USA, V100, P9179, DOI 10.1073/pnas.1233767100a; Rosenkilde C, 2003, BIOCHEM BIOPH RES CO, V309, P485, DOI 10.1016/j.bbrc.2003.08.022; Sabio M, 2008, BIOORG MED CHEM LETT, V18, P5391, DOI 10.1016/j.bmcl.2008.09.046; SCHOOFS L, 1992, INSECT BIOCHEM MOLEC, V22, P447, DOI 10.1016/0965-1748(92)90140-A; SMITH GE, 1985, P NATL ACAD SCI USA, V82, P8404, DOI 10.1073/pnas.82.24.8404; Stern PS, 2007, J INSECT PHYSIOL, V53, P803, DOI 10.1016/j.jinsphys.2007.03.012; Szekeres PG, 2000, J BIOL CHEM, V275, P20247, DOI 10.1074/jbc.C000244200; Thomas CJ, 1998, J VIROL, V72, P10207, DOI 10.1128/JVI.72.12.10207-10212.1998; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Watanabe K, 2007, MOL CELL ENDOCRINOL, V273, P51, DOI 10.1016/j.mce.2007.05.008; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Zdarek J, 1998, EUR J ENTOMOL, V95, P9; Zheng L, 2007, GENE, V393, P20, DOI 10.1016/j.gene.2006.12.025	79	13	13	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19150	19163		10.1074/jbc.M113.488999	http://dx.doi.org/10.1074/jbc.M113.488999			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24847080	Green Published, hybrid			2022-12-25	WOS:000339062900044
J	Pan, GD; Cao, J; Yang, NL; Ding, KH; Fan, C; Xiong, WC; Hamrick, M; Isales, CM; Shi, XM				Pan, Guodong; Cao, Jay; Yang, Nianlan; Ding, Kehong; Fan, Cheng; Xiong, Wen-Cheng; Hamrick, Mark; Isales, Carlos M.; Shi, Xing-Ming			Role of Glucocorticoid-induced Leucine Zipper (GILZ) in Bone Acquisition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2; ACTIVATED PROTEIN-KINASE; OSTEOBLAST DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; CELL-DIFFERENTIATION; GENE-TRANSCRIPTION; ADDISONS-DISEASE; BINDING-PROTEINS; TRANSGENIC MICE	Glucocorticoids (GCs) have both anabolic and catabolic effects on bone. However, no GC anabolic effect mediator has been identified to date. Here we show that targeted expression of glucocorticoid-induced leucine zipper (GILZ), a GC anti-inflammatory effect mediator, enhances bone acquisition in mice. Transgenic mice, in which the expression of GILZ is under the control of a 3.6-kb rat type I collagen promoter, exhibited a high bone mass phenotype with significantly increased bone formation rate and osteoblast numbers. The increased osteoblast activity correlates with enhanced osteogenic differentiation and decreased adipogenic differentiation of bone marrow stromal cell cultures in vitro. In line with these changes, the mRNA levels of key osteogenic regulators (Runx2 and Osx) increased, and the level of adipogenic regulator peroxisome proliferator-activated receptor (PPAR) gamma 2 decreased significantly. We also found that GILZ physically interacts with C/EBPs and disrupts C/EBP-mediated PPAR gamma gene transcription. In conclusion, our results showed that GILZ is capable of increasing bone acquisition in vivo, and this action is mediated via a mechanism involving the inhibition of PPAR gamma gene transcription and shifting of bone marrow MSC/progenitor cell lineage commitment in favor of the osteoblast pathway.	[Pan, Guodong; Yang, Nianlan; Ding, Kehong; Fan, Cheng; Xiong, Wen-Cheng; Isales, Carlos M.; Shi, Xing-Ming] Georgia Regents Univ, Dept Neurosci & Regenerat Med, Augusta, GA 30912 USA; [Hamrick, Mark] Georgia Regents Univ, Dept Cellular Biol & Anat, Augusta, GA 30912 USA; [Isales, Carlos M.; Shi, Xing-Ming] Georgia Regents Univ, Dept Orthopaed Surg, Augusta, GA 30912 USA; [Pan, Guodong] Wuhan Univ, Wuhan 430072, Peoples R China; [Cao, Jay] ARS, Grand Forks Human Nutr Res Ctr, USDA, Grand Forks, ND 58203 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Wuhan University; United States Department of Agriculture (USDA)	Shi, XM (corresponding author), Georgia Regents Univ, Dept Neurosci & Regenerat Med, 1120 15th St,CA-2003, Augusta, GA 30912 USA.	xshi@gru.edu	pan, guodong/F-3794-2017; Isales, Carlos/J-9902-2013	Isales, Carlos/0000-0002-4480-3484	National Institutes of Health [R01DK76045, R01AG046248, P01AG036675]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG046248, P01AG036675] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK76045, R01AG046248, and P01AG036675.	Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Beaulieu E, 2010, ARTHRITIS RHEUM-US, V62, P2651, DOI 10.1002/art.27566; Cannarile L, 2001, CELL DEATH DIFFER, V8, P201, DOI 10.1038/sj.cdd.4400798; Cao JJ, 2009, BONE, V44, P1097, DOI 10.1016/j.bone.2009.02.017; Clarke SL, 1997, BIOCHEM BIOPH RES CO, V240, P99, DOI 10.1006/bbrc.1997.7627; Clowes JA, 2001, CURR OPIN RHEUMATOL, V13, P326, DOI 10.1097/00002281-200107000-00015; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; Elberg G, 2000, J BIOL CHEM, V275, P27815; Gimble JM, 2009, OBES REV, V10, P46, DOI 10.1111/j.1467-789X.2009.00661.x; Hamm JK, 2001, J BIOL CHEM, V276, P18464, DOI 10.1074/jbc.M100797200; He LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031717; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Kassem M, 2000, EUR J CLIN INVEST, V30, P429; Mittelstadt PR, 2001, J BIOL CHEM, V276, P29603, DOI 10.1074/jbc.M101522200; MORRISON N, 1993, J BONE MINER RES, V8, P969; Nishimura J, 2000, J BONE MINER METAB, V18, P350, DOI 10.1007/s007740070008; Park OJ, 2010, J BIOL CHEM, V285, P3568, DOI 10.1074/jbc.M109.055053; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rauch A, 2010, CELL METAB, V11, P517, DOI 10.1016/j.cmet.2010.05.005; Rutter MM, 2005, BONE, V36, P224, DOI 10.1016/j.bone.2004.10.005; Sher LB, 2006, CALCIFIED TISSUE INT, V79, P118, DOI 10.1007/s00223-005-0297-z; Sher LB, 2004, ENDOCRINOLOGY, V145, P922, DOI 10.1210/en.2003-0655; Shi XM, 2001, J BIOL CHEM, V276, P850, DOI 10.1074/jbc.M005955200; Shi XM, 2000, J CELL BIOCHEM, V76, P518, DOI 10.1002/(SICI)1097-4644(20000301)76:3<518::AID-JCB18>3.0.CO;2-M; Shi XM, 2003, EMBO REP, V4, P374, DOI 10.1038/sj.embor.embor805; Song CZ, 1999, P NATL ACAD SCI USA, V96, P11776, DOI 10.1073/pnas.96.21.11776; Soule S, 1999, CLIN ENDOCRINOL, V50, P115, DOI 10.1046/j.1365-2265.1999.00625.x; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; VALERO MA, 1994, BONE MINER, V26, P9, DOI 10.1016/S0169-6009(08)80158-4; Woitge HW, 2001, ENDOCRINOLOGY, V142, P1341, DOI 10.1210/en.142.3.1341; Xia WF, 2013, J BONE MINER RES, V28, P2122, DOI 10.1002/jbmr.1954; Yang MB, 2010, BONE, V47, P573, DOI 10.1016/j.bone.2010.06.002; Yang NL, 2008, J CELL BIOCHEM, V103, P1760, DOI 10.1002/jcb.21562; Yao W, 2008, ARTHRITIS RHEUM, V58, P1674, DOI 10.1002/art.23454; Zhang W, 2008, J BONE MINER RES, V23, P1118, DOI 10.1359/JBMR.080304; Zhang WX, 2008, J BIOL CHEM, V283, P4723, DOI 10.1074/jbc.M704147200	38	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19373	19382		10.1074/jbc.M113.535237	http://dx.doi.org/10.1074/jbc.M113.535237			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24860090	Green Published, hybrid			2022-12-25	WOS:000339326800014
J	Alvarez, CL; Schachter, J; Pinheiro, AAD; Silva, LD; Verstraeten, SV; Persechini, PM; Schwarzbaum, PJ				Alvarez, Cora Lilia; Schachter, Julieta; de Sa Pinheiro, Ana Acacia; Silva, Leandro de Souza; Viviana Verstraeten, Sandra; Persechini, Pedro Muanis; Julio Schwarzbaum, Pablo			Regulation of Extracellular ATP in Human Erythrocytes Infected with Plasmodium falciparum	PLOS ONE			English	Article							RED-BLOOD-CELLS; SIGNAL-TRANSDUCTION PATHWAY; PANNEXIN 1 CHANNELS; G-PROTEIN; NITRIC-OXIDE; MEMBRANE-PERMEABILITY; MALARIA; RELEASE; CAMP; NUCLEOTIDES	In human erythrocytes (h-RBCs) various stimuli induce increases in [cAMP] that trigger ATP release. The resulting pattern of extracellular ATP accumulation (ATPe kinetics) depends on both ATP release and ATPe degradation by ectoATPase activity. In this study we evaluated ATPe kinetics from primary cultures of h-RBCs infected with P. falciparum at various stages of infection (ring, trophozoite and schizont stages). A "3V'' mixture containing isoproterenol (beta-adrenergic agonist), forskolin (adenylate kinase activator) and papaverine (phosphodiesterase inhibitor) was used to induce cAMP-dependent ATP release. ATPe kinetics of r-RBCs (ring-infected RBCs), t-RBCs (trophozoite-infected RBCs) and s-RBCs (schizont-infected RBCs) showed [ATPe] to peak acutely to a maximum value followed by a slower time dependent decrease. In all intraerythrocytic stages, values of Delta ATP(1) (difference between [ATPe] measured 1 min post-stimulus and basal [ATPe]) increased nonlinearly with parasitemia (from 2 to 12.5%). Under 3V exposure, t-RBCs at parasitemia 94% (t94-RBCs) showed 3.8-fold higher Delta ATP(1) values than in h-RBCs, indicative of upregulated ATP release. Pre-exposure to either 100 mu M carbenoxolone, 100 nM mefloquine or 100 mM NPPB reduced Delta ATP(1) to 83-87% for h-RBCs and 63-74% for t94-RBCs. EctoATPase activity, assayed at both low nM concentrations (300-900 nM) and 500 mM exogenous ATPe concentrations increased approx. 400-fold in t94-RBCs, as compared to h-RBCs, while intracellular ATP concentrations of t94-RBCs were 65% that of h-RBCs. In t94-RBCs, production of nitric oxide (NO) was approx. 7-fold higher than in h-RBCs, and was partially inhibited by L-NAME pretreatment. In media with L-NAME, Delta ATP(1) values were 2.7-times higher in h-RBCs and 4.2-times higher in t94-RBCs, than without L-NAME. Results suggest that P. falciparum infection of h-RBCs strongly activates ATP release via Pannexin 1 in these cells. Several processes partially counteracted ATPe accumulation: an upregulated ATPe degradation, an enhanced NO production, and a decreased intracellular ATP concentration.	[Alvarez, Cora Lilia; Viviana Verstraeten, Sandra; Julio Schwarzbaum, Pablo] Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fis Quim Biol, RA-1113 Buenos Aires, DF, Argentina; [Alvarez, Cora Lilia; Schachter, Julieta; de Sa Pinheiro, Ana Acacia; Silva, Leandro de Souza; Persechini, Pedro Muanis] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Alvarez, Cora Lilia; Schachter, Julieta; Persechini, Pedro Muanis] INPeTAm Inst Nacl Ciencia & Tecnol Pesquisa Trans, Rio De Janeiro, Brazil	University of Buenos Aires; Universidade Federal do Rio de Janeiro	Schwarzbaum, PJ (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fis Quim Biol, RA-1113 Buenos Aires, DF, Argentina.	pjs@qb.ffyb.uba.ar	Verstraeten, Sandra/H-7612-2019; Sila, Leandro/B-1381-2018; Persechini, Pedro/A-9477-2009; Schachter, Julieta/GLR-1361-2022	Verstraeten, Sandra/0000-0001-5760-6271; Sila, Leandro/0000-0001-8720-0088; Persechini, Pedro/0000-0002-3278-1951; Schachter, Julieta/0000-0001-7704-4958; schwarzbaum, pablo/0000-0002-5176-089X; Pinheiro, Ana Acacia/0000-0002-3894-1645	CAPES-MINCYT [197/11]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 639]; Secretaria de Ciencia y Tecnica, Universidad de Buenos Aires [20020100100090]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior (CAPES); Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina [0151]; Instituto Nacional para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (INCT-INPeTAm/CNPq/MCT) of Brasil	CAPES-MINCYT(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Secretaria de Ciencia y Tecnica, Universidad de Buenos Aires(University of Buenos AiresSecretaria de Ciencia y Tecnologia (SECYT)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina(ANPCyT); Instituto Nacional para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (INCT-INPeTAm/CNPq/MCT) of Brasil	This work was supported by the following agencies and organisations: CAPES-MINCYT (197/11), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) Grant PIP 639, Secretaria de Ciencia y Tecnica, Universidad de Buenos Aires Grant 20020100100090, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior (CAPES), Agencia Nacional de Promocion Cientifica y Tecnologica Grant 0151 of Argentina and Instituto Nacional para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (INCT-INPeTAm/CNPq/MCT) of Brasil. CLA, SVV, PJS are career researchers from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkaya C, 2009, PFLUG ARCH EUR J PHY, V457, P1035, DOI 10.1007/s00424-008-0572-8; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Baumeister S, 2006, MOL MICROBIOL, V60, P493, DOI 10.1111/j.1365-2958.2006.05112.x; Bencic DC, 1997, PHYSIOL ZOOL, V70, P621, DOI 10.1086/515873; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Brown A., 1982, ATP ATPASE DETERMINA, P223; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Cerutti C, 1999, J INFECT DIS, V180, P2077, DOI 10.1086/315141; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; COADE SB, 1989, CIRC RES, V65, P531, DOI 10.1161/01.RES.65.3.531; Dahl G, 2012, BRAIN RES, V1487, P150, DOI 10.1016/j.brainres.2012.04.058; Dondorp AM, 2008, J INFECT DIS, V197, P79, DOI 10.1086/523762; Dondorp AM, 2000, PARASITOL TODAY, V16, P228, DOI 10.1016/S0169-4758(00)01666-5; Dubyak GR, 2009, AM J PHYSIOL-CELL PH, V296, pC235, DOI 10.1152/ajpcell.00639.2008; Egee S, 2002, J PHYSIOL-LONDON, V542, P795, DOI 10.1113/jphysiol.2002.022970; Ellsworth ML, 2009, PHYSIOLOGY, V24, P107, DOI 10.1152/physiol.00038.2008; Essien EM, 1998, THROMB HAEMOSTASIS, V80, P867; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GHIGO D, 1995, J EXP MED, V182, P677, DOI 10.1084/jem.182.3.677; Glenister FK, 2009, BLOOD, V113, P919, DOI 10.1182/blood-2008-05-157735; Glushakova S, 2005, CURR BIOL, V15, P1645, DOI 10.1016/j.cub.2005.07.067; Gorman MW, 2007, CLIN CHEM, V53, P318, DOI 10.1373/clinchem.2006.076364; Griess P., 1879, BER DTSCH CHEM GES, V12, P426, DOI DOI 10.1002/CBER.187901201117; Haldar K, 2007, CURR OPIN HEMATOL, V14, P203, DOI 10.1097/MOH.0b013e3280f31b2d; Hanson MS, 2010, EXP BIOL MED, V235, P256, DOI 10.1258/ebm.2009.009206; Harrison T, 2003, SCIENCE, V301, P1734, DOI 10.1126/science.1089324; Huber SM, 2004, J BIOL CHEM, V279, P41444, DOI 10.1074/jbc.M407618200; Huber SM, 2002, EMBO J, V21, P22, DOI 10.1093/emboj/21.1.22; Iglesias R, 2009, CELL COMMUN ADHES, V16, P131, DOI 10.3109/15419061003642618; Kitchen LW, 2006, CLIN INFECT DIS, V43, P67, DOI 10.1086/504873; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Koka S, 2008, CELL PHYSIOL BIOCHEM, V21, P481, DOI 10.1159/000129641; Kukulski F, 2005, Purinergic Signal, V1, P193, DOI 10.1007/s11302-005-6217-x; KUTNER S, 1982, BIOCHIM BIOPHYS ACTA, V687, P113, DOI 10.1016/0005-2736(82)90178-X; KWANT W O, 1970, Journal of General Physiology, V55, P208, DOI 10.1085/jgp.55.2.208; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lazarowski ER, 2012, PURINERG SIGNAL, V8, P359, DOI 10.1007/s11302-012-9304-9; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Denis MFL, 2013, BBA-GEN SUBJECTS, V1830, P4692, DOI 10.1016/j.bbagen.2013.05.033; Levano-Garcia J, 2010, PURINERG SIGNAL, V6, P365, DOI 10.1007/s11302-010-9202-y; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; Maia J.C., 1983, GENES ANTIGENS PARAS, P144; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Mehta M, 2005, FEBS LETT, V579, P6151, DOI 10.1016/j.febslet.2005.09.088; Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9; Miles AM, 1996, METHOD ENZYMOL, V268, P105; Montalbetti N, 2011, J BIOL CHEM, V286, P38397, DOI 10.1074/jbc.M111.221713; Murphy SC, 2006, PLOS MED, V3, P2403, DOI 10.1371/journal.pmed.0030528; Nicolay JP, 2008, PFLUG ARCH EUR J PHY, V456, P293, DOI 10.1007/s00424-007-0393-1; Olearczyk JJ, 2004, AM J PHYSIOL-HEART C, V286, pH940, DOI 10.1152/ajpheart.00677.2003; Pafundo DE, 2008, AM J PHYSIOL-REG I, V294, pR220, DOI 10.1152/ajpregu.00522.2007; Park YK, 2008, P NATL ACAD SCI USA, V105, P13730, DOI 10.1073/pnas.0806100105; PLESNER L, 1995, INT REV CYTOL, V158, P141; Raththagala M, 2010, EUR J PHARMACOL, V645, P32, DOI 10.1016/j.ejphar.2010.07.012; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Saraiva VB, 2011, PLOS ONE, V18, P1; SCHWARZBAUM PJ, 1995, BBA-BIOMEMBRANES, V1233, P33, DOI 10.1016/0005-2736(94)00229-I; Sevigny J, 2002, BLOOD, V99, P2801, DOI 10.1182/blood.V99.8.2801; Sherman IW, 2003, MICROBES INFECT, V5, P897, DOI 10.1016/S1286-4579(03)00162-X; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Sprague RS, 2006, DIABETES, V55, P3588, DOI 10.2337/db06-0555; Sprague RS, 2002, J PHYSIOL PHARMACOL, V53, P667; Sprague RS, 2001, AM J PHYSIOL-CELL PH, V281, pC1158, DOI 10.1152/ajpcell.2001.281.4.C1158; Sprague RS, 1998, AM J PHYSIOL-HEART C, V275, pH1726, DOI 10.1152/ajpheart.1998.275.5.H1726; Sridharan M, 2012, AM J PHYSIOL-HEART C, V302, pH553, DOI 10.1152/ajpheart.00998.2011; Strehler B L, 1968, Methods Biochem Anal, V16, P99, DOI 10.1002/9780470110348.ch2; Tanneur V, 2005, FASEB J, V19, P133, DOI 10.1096/fj.04-3371fje; Taruno A, 2013, NATURE, V495, P223, DOI 10.1038/nature11906; Uhlemann A.-C., 2000, MACS MORE, V4, P7; WHO, 2013, WORLD MALARIA REPORT 2013, P1	71	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e96216	10.1371/journal.pone.0096216	http://dx.doi.org/10.1371/journal.pone.0096216			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858837	Green Submitted, Green Published, gold			2022-12-25	WOS:000336839400003
J	Arunasri, K; Adil, M; Khan, PAA; Shivaji, S				Arunasri, Kotakonda; Adil, Mohammed; Khan, Pathan Akbar Ali; Shivaji, Sisinthy			Global Gene Expression Analysis of Long-Term Stationary Phase Effects in E. coli K12 MG1655	PLOS ONE			English	Article							RIBOSOME MODULATION FACTOR; ESCHERICHIA-COLI; PROTEIN-SYNTHESIS; GROWTH; RNA; PHYSIOLOGY; EVOLUTION; CELL; IDENTIFICATION; CHANNELS	Global gene expression was monitored in long-term stationary phase (LSP) cells of E. coli K12 MG1655 and compared with stationary phase (SP) cells that were sub-cultured without prolonged delay to get an insight into the survival strategies of LSP cells. The experiments were carried out using both LB medium and LB supplemented with 10% of glycerol. In both the media the LSP cells showed decreased growth rate compared to SP cells. DNA microarray analysis of LSP cells in both the media resulted in the up-and down-regulation of several genes in LSP cells compared to their respective SP cells in the corresponding media. In LSP cells grown in LB 204 genes whereas cells grown in LB plus glycerol 321 genes were differentially regulated compared to the SP cells. Comparison of these differentially regulated genes indicated that irrespective of the medium used for growth in LSP cells expression of 95 genes (22 genes up-regulated and 73 down-regulated) were differentially regulated. These 95 genes could be associated with LSP status of the cells and are likely to influence survival and growth characteristics of LSP cells. This is indeed so since the up-and down-regulated genes include genes that protect E. coli LSP cells from stationary phase stress and genes that would help to recover from stress when transferred into fresh medium. The growth phenotype in LSP cells could be attributed to up-regulation of genes coding for insertion sequences that confer beneficial effects during starvation, genes coding for putative transposases and simultaneous down-regulation of genes coding for ribosomal protein synthesis, transport-related genes, non-coding RNA genes and metabolic genes. As yet we still do not know the role of several unknown genes and genes coding for hypothetical proteins which are either up-or down-regulated in LSP cells compared to SP cells.	[Arunasri, Kotakonda; Adil, Mohammed; Khan, Pathan Akbar Ali; Shivaji, Sisinthy] CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Shivaji, S (corresponding author), LV Prasad Eye Inst, Jhaveri Microbiol Ctr, LV Prasad Marg,Banjara Hills, Hyderabad, Andhra Pradesh, India.	shivas@ccmb.res.in	PATHAN, AKBAR ALI KHAN/ABC-8189-2021	PATHAN, AKBAR ALI KHAN/0000-0002-6516-7587; Kotakonda, Arunasri/0000-0001-6870-2541; shivaji, sisinthy/0000-0003-0376-4658	ISRO, India	ISRO, India	The authors would also like to state that this project was funded by ISRO, India up to March 2012 and the authors do not have any current funding sources for this study for paying the publication charges. Further the authors would also like to state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnio V, 2014, COMP BIOCHEM PHYS D, V9, P40, DOI 10.1016/j.cbd.2013.12.001; ANTONUCCI T K, 1986, Proteins Structure Function and Genetics, V1, P125, DOI 10.1002/prot.340010204; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Arunasri K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057860; Berthoumieux S, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.70; BOYLE SM, 1984, GENE, V30, P129, DOI 10.1016/0378-1119(84)90113-6; Bremer H, 1996, ESCHERICHIA COLI SAL; Brinkkotter A, 2000, MOL MICROBIOL, V37, P125, DOI 10.1046/j.1365-2958.2000.01969.x; BROWN S, 1984, J MOL BIOL, V178, P533, DOI 10.1016/0022-2836(84)90237-7; Bury-Mone S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000651; Bylund GO, 1998, J BACTERIOL, V180, P73, DOI 10.1128/JB.180.1.73-82.1998; Calhoun LN., 2011, INT J MICROBIOL RES, V3, P136, DOI [10.9735/0975-5276.3.3.136-147, DOI 10.9735/0975-5276.3.3.136-147]; Campbell JW, 2001, ANNU REV MICROBIOL, V55, P305, DOI 10.1146/annurev.micro.55.1.305; CONDON C, 1995, J BACTERIOL, V177, P4152, DOI 10.1128/jb.177.14.4152-4156.1995; de Visser JAGM, 2004, GENETICS, V168, P1145, DOI 10.1534/genetics.104.032136; Dhavan GM, 2002, J MOL BIOL, V315, P1027, DOI 10.1006/jmbi.2001.5303; Ekaza E, 2000, MICROBIOL-UK, V146, P1605, DOI 10.1099/00221287-146-7-1605; El-Sharoud Walid M., 2004, Science Progress, V87, P137, DOI 10.3184/003685004783238517; Feng Y, 2001, J BIOL CHEM, V276, P31651, DOI 10.1074/jbc.M102855200; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Finkel SE, 1999, P NATL ACAD SCI USA, V96, P4023, DOI 10.1073/pnas.96.7.4023; FREUNDLICH M, 1992, MOL MICROBIOL, V6, P2557, DOI 10.1111/j.1365-2958.1992.tb01432.x; Gajiwala KS, 2000, J MOL BIOL, V295, P605, DOI 10.1006/jmbi.1999.3347; HEYDE M, 1988, FEMS MICROBIOL LETT, V52, P59; HOGARTH BG, 1983, J BACTERIOL, V153, P1548, DOI 10.1128/JB.153.3.1548-1551.1983; HSU D, 1994, J BACTERIOL, V176, P4761, DOI 10.1128/JB.176.15.4761-4765.1994; IKENAKA K, 1986, J BIOL CHEM, V261, P9316; John E, 1968, J BACTERIOL, V95, P2054; Jonas K, 2009, FEMS MICROBIOL LETT, V297, P80, DOI 10.1111/j.1574-6968.2009.01661.x; Kaji A, 2001, COLD SPRING HARB SYM, V66, P515, DOI 10.1101/sqb.2001.66.515; Kalinin A, 2002, J BIOMOL NMR, V23, P335, DOI 10.1023/A:1020279728394; Kinne RKH, 2001, AM ZOOL, V41, P728, DOI 10.1668/0003-1569(2001)041[0728:OOCITR]2.0.CO;2; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Korea CG, 2010, ENVIRON MICROBIOL, V12, P1957, DOI 10.1111/j.1462-2920.2010.02202.x; LANGE R, 1991, J BACTERIOL, V173, P4474, DOI 10.1128/JB.173.14.4474-4481.1991; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Maaloe O., 1979, BIOL REGUL DEV, P487; MCCARTHY BJ, 1960, BIOCHIM BIOPHYS ACTA, V39, P563, DOI 10.1016/0006-3002(60)90221-3; Llorens JMN, 2010, FEMS MICROBIOL REV, V34, P476, DOI 10.1111/j.1574-6976.2010.00213.x; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Pin C, 2008, APPL ENVIRON MICROB, V74, P2534, DOI 10.1128/AEM.02402-07; PRAMANIK A, 1986, J BACTERIOL, V168, P746, DOI 10.1128/jb.168.2.746-751.1986; RAK B, 1984, EMBO J, V3, P807, DOI 10.1002/j.1460-2075.1984.tb01889.x; Repoila F, 2009, BIOL CELL, V101, P117, DOI 10.1042/BC20070137; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; SCHEPS R, 1972, EUR J BIOCHEM, V29, P319, DOI 10.1111/j.1432-1033.1972.tb01991.x; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; SIEGELE DA, 1992, J BACTERIOL, V174, P345, DOI 10.1128/jb.174.2.345-348.1992; SQUIRES C, 1992, J BACTERIOL, V174, P1081, DOI 10.1128/jb.174.4.1081-1085.1992; Swinger KK, 2004, CURR OPIN STRUC BIOL, V14, P28, DOI 10.1016/j.sbi.2003.12.003; THOMAS AD, 1992, J GEN MICROBIOL, V138, P1829, DOI 10.1099/00221287-138-9-1829; Towle DW, 2001, AM ZOOL, V41, P770, DOI 10.1668/0003-1569(2001)041[0770:OBGOEC]2.0.CO;2; WADA A, 1990, P NATL ACAD SCI USA, V87, P2657, DOI 10.1073/pnas.87.7.2657; Wassarman KM, 2000, CELL, V101, P613, DOI 10.1016/S0092-8674(00)80873-9; Waters LS, 2011, J BACTERIOL, V193, P5887, DOI 10.1128/JB.05872-11; Wawrzynow A, 1996, MOL MICROBIOL, V21, P895, DOI 10.1046/j.1365-2958.1996.421404.x; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Weerasinghe JP, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-14; YAMAGISHI M, 1993, EMBO J, V12, P625, DOI 10.1002/j.1460-2075.1993.tb05695.x; YANG WP, 1993, P NATL ACAD SCI USA, V90, P5796, DOI 10.1073/pnas.90.12.5796; ZAMBRANO MM, 1993, SCIENCE, V259, P1757, DOI 10.1126/science.7681219; Zambrano MM, 1996, CELL, V86, P181, DOI 10.1016/S0092-8674(00)80089-6; Zinser ER, 2004, RES MICROBIOL, V155, P328, DOI 10.1016/j.resmic.2004.01.014	64	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e96701	10.1371/journal.pone.0096701	http://dx.doi.org/10.1371/journal.pone.0096701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858919	Green Published, gold, Green Submitted			2022-12-25	WOS:000336839400006
J	Keller, J; Sanchez-Dalmau, BF; Villoslada, P				Keller, Johannes; Sanchez-Dalmau, Bernardo F.; Villoslada, Pablo			Lesions in the Posterior Visual Pathway Promote Trans-Synaptic Degeneration of Retinal Ganglion Cells	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; TRANSNEURONAL RETROGRADE DEGENERATION; NERVE-FIBER LAYER; DAMAGE; SYSTEM	Objective: Retrograde trans-synaptic degeneration of retinal ganglion cell layer (GCL) has been proposed as one of the mechanisms contributing to permanent disability after visual pathway damage. We set out to test this mechanism taking advantage of the new methods for imaging the macula with high resolution by optical coherence tomography (OCT) in patients with lesions in the posterior visual pathway. Additionally, we explored the association between thinning of GCL as an imaging marker of visual impairment such as visual field defects. Methods: Retrospective case note review of patients with retrogeniculate lesions studied by spectral domain OCT of the macula and quadrant pattern deviation (PD) of the visual fields. Results: We analysed 8 patients with either hemianopia or quadrantanopia due to brain lesions (stroke = 5; surgery = 2; infection = 1). We found significant thinning of the GCL in the projecting sector of the retina mapping to the brain lesion. Second, we found strong correlation between the PD of the visual field quadrant and the corresponding macular GCL sector for the right (R = 0.792, p<0.001) and left eyes (R = 0.674, p<0.001). Conclusions: The mapping between lesions in the posterior visual pathway and their projection in the macula GCL sector corroborates retrograde trans-synaptic neuronal degeneration after brain injury as a mechanism of damage with functional consequences. This finding supports the use of GCL thickness as an imaging marker of trans-synaptic degeneration in the visual pathway after brain lesions.	[Villoslada, Pablo] Hosp Clin Barcelona, Inst Ophthalmol, Barcelona, Spain; Hosp Clin Barcelona, Ctr Neuroimmunol, Inst Biomed Res August Pi Sunyer IDIBAPS, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Villoslada, P (corresponding author), Hosp Clin Barcelona, Inst Ophthalmol, Barcelona, Spain.	pvilloslada@clinic.ub.es	Villoslada, Pablo/AAF-9547-2019	Keller, Johannes/0000-0003-0367-2227; Sanchez-Dalmau, Bernardo F./0000-0001-8950-9759	Instituto de Salud Carlos III, Spain [PS09/00259, RD12/0032/0001]	Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III)	This work was supported by grants from the Instituto de Salud Carlos III, Spain (FIS program PS09/00259, and RETICS program RD12/0032/0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balk LJ, 2014, J NEUROL NEUROSURG P; Gabilondo I, 2014, ANN NEUROL, V75, P98, DOI 10.1002/ana.24030; Gabilondo I, 2013, J NEUROL NEUROSUR PS, V84, P824, DOI 10.1136/jnnp-2012-304854; Hood DC, 2008, J GLAUCOMA, V17, P519, DOI 10.1097/IJG.0b013e3181629a02; Hood DC, 2007, PROG RETIN EYE RES, V26, P688, DOI 10.1016/j.preteyeres.2007.08.001; HOYT WF, 1972, BRIT J OPHTHALMOL, V56, P537, DOI 10.1136/bjo.56.7.537; Jacob M, 2009, AM J OPHTHALMOL, V147, P64, DOI 10.1016/j.ajo.2008.07.016; Jindahra P, 2012, NEURO-OPHTHALMOLOGY, V36, P79, DOI 10.3109/01658107.2012.674615; Jindahra P, 2012, BRAIN, V135, P534, DOI 10.1093/brain/awr324; Jindahra P, 2009, BRAIN, V132, P628, DOI 10.1093/brain/awp001; Johnson H, 2000, EXP BRAIN RES, V132, P269, DOI 10.1007/s002210000384; Kardon RH, 2011, J NEURO-OPHTHALMOL, V31, P353, DOI 10.1097/WNO.0b013e318238b9cb; Mehta JS, 2005, AM J OPHTHALMOL, V140, P727, DOI 10.1016/j.ajo.2005.03.059; MILLER NR, 1981, ARCH OPHTHALMOL-CHIC, V99, P1654; Ohkubo S, 2012, JPN J OPHTHALMOL, V56, P68, DOI 10.1007/s10384-011-0093-4; Park HYL, 2013, OPHTHALMOLOGY, V120, P1292, DOI 10.1016/j.ophtha.2012.11.021; VANBUREN JM, 1963, J NEUROL NEUROSUR PS, V26, P402	17	50	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97444	10.1371/journal.pone.0097444	http://dx.doi.org/10.1371/journal.pone.0097444			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24857938	Green Submitted, Green Published, gold			2022-12-25	WOS:000336839400016
J	Kohler, D; Devanathan, V; Franz, CBD; Eldh, T; Novakovic, A; Roth, JM; Granja, T; Birnbaumer, L; Rosenberger, P; Beer-Hammer, S; Nurnberg, B				Koehler, David; Devanathan, Vasudharani; Franz, Claudia Bernardo de Oliveira; Eldh, Therese; Novakovic, Ana; Roth, Judith M.; Granja, Tiago; Birnbaumer, Lutz; Rosenberger, Peter; Beer-Hammer, Sandra; Nuernberg, Bernd			G alpha(i2)- and G alpha(i3)- Deficient Mice Display Opposite Severity of Myocardial Ischemia Reperfusion Injury	PLOS ONE			English	Article							G-PROTEIN; PERTUSSIS TOXIN; INHIBITION; MIGRATION; CYCLASE	G-protein-coupled receptors (GPCRs) are the most abundant receptors in the heart and therefore are common targets for cardiovascular therapeutics. The activated GPCRs transduce their signals via heterotrimeric G-proteins. The four major families of G-proteins identified so far are specified through their alpha-subunit: G alpha(i), G alpha(s), G alpha(q) and G(12/13). G alpha(i)-proteins have been reported to protect hearts from ischemia reperfusion injury. However, determining the individual impact of G alpha(i2) or G alpha(i3) on myocardial ischemia injury has not been clarified yet. Here, we first investigated expression of G alpha(i2) and G alpha(i3) on transcriptional level by quantitative PCR and on protein level by immunoblot analysis as well as by immunofluorescence in cardiac tissues of wild-type, G alpha(i2), and G alpha(i3)-deficient mice. G alpha(i2) was expressed at higher levels than G alpha(i3) in murine hearts, and irrespective of the isoform being knocked out we observed an up regulation of the remaining G alpha i-protein. Myocardial ischemia promptly regulated cardiac mRNA and with a slight delay protein levels of both G alpha(i2) and G alpha(i3), indicating important roles for both G alpha(i) isoforms. Furthermore, ischemia reperfusion injury in G alpha(i2)- and G alpha(i3)-deficient mice exhibited opposite outcomes. Whereas the absence of G alpha(i2) significantly increased the infarct size in the heart, the absence of G alpha(i3) or the concomitant upregulation of G alpha(i2) dramatically reduced cardiac infarction. In conclusion, we demonstrate for the first time that the genetic ablation of G alpha(i) proteins has protective or deleterious effects on cardiac ischemia reperfusion injury depending on the isoform being absent.	[Koehler, David; Franz, Claudia Bernardo de Oliveira; Roth, Judith M.; Granja, Tiago; Rosenberger, Peter] Eberhard Karls Univ Hosp & Clin, Dept Anesthesiol & Intens Care Med, Inst Expt & Clin Pharmacol & Toxicol, Tubingen, Germany; [Koehler, David; Devanathan, Vasudharani; Franz, Claudia Bernardo de Oliveira; Eldh, Therese; Novakovic, Ana; Roth, Judith M.; Granja, Tiago; Rosenberger, Peter; Beer-Hammer, Sandra; Nuernberg, Bernd] Interfac Ctr Pharmacogen & Drug Res, Tubingen, Germany; [Devanathan, Vasudharani; Eldh, Therese; Novakovic, Ana; Beer-Hammer, Sandra; Nuernberg, Bernd] Eberhard Karls Univ Hosp & Clin, Inst Expt & Clin Pharmacol & Toxicol, Dept Pharmacol & Expt Therapy, Tubingen, Germany; [Birnbaumer, Lutz] NIEHS, Neurobiol Lab, Div Intramural Res, NIH,Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Beer-Hammer, S (corresponding author), Eberhard Karls Univ Hosp & Clin, Inst Expt & Clin Pharmacol & Toxicol, Dept Pharmacol & Expt Therapy, Tubingen, Germany.	sandra.beer-hammer@uni-tuebingen.de; bernd.nuernberg@uni-tuebingen.de	Beer-Hammer, Sandra/AAK-4516-2020; Granja, Tiago/O-2597-2019; Granja, Tiago/D-8426-2014	Beer-Hammer, Sandra/0000-0001-6049-0257; Granja, Tiago/0000-0002-8137-1449; Granja, Tiago/0000-0002-8137-1449; Nurnberg, Bernd/0000-0002-5995-6555	Deutsche Forschungsgemeinschaft [SFB 612, MO2252/1]; Tuebingen University; NIH [Z01-ES-101643]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101643, Z01ES101643] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tuebingen University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants of the Deutsche Forschungsgemeinschaft (SFB 612 to B.N. and MO2252/1 to D. K.), the Open Access Publishing Fund of Tuebingen University and the Intramural Research Program of the NIH (project Z01-ES-101643 to L. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarran-Juarez J, 2009, J PHARMACOL EXP THER, V331, P35, DOI 10.1124/jpet.109.157230; DeGeorge BR, 2008, CIRCULATION, V117, P1378, DOI 10.1161/CIRCULATIONAHA.107.752618; DeWire SM, 2011, CIRC RES, V109, P205, DOI 10.1161/CIRCRESAHA.110.231308; Dizayee S, 2013, PLOS ONE, V8, DOI [10.1371/annotation/7be097c0-9075-41ae-91e9-d2209de952cc, DOI 10.1371/ANNOTATION/7BE097C0-9075-41AE-91E9-D2209DE952CC]; Eckle T, 2006, AM J PHYSIOL-HEART C, V291, pH2533, DOI 10.1152/ajpheart.00472.2006; Eisen A, 2004, ATHEROSCLEROSIS, V172, P201, DOI 10.1016/S0021-9150(03)00238-7; Exner T, 1999, P NATL ACAD SCI USA, V96, P1327, DOI 10.1073/pnas.96.4.1327; Ezan J, 2013, NAT CELL BIOL, V15, P1107, DOI 10.1038/ncb2819; FISHBEIN MC, 1981, AM HEART J, V101, P593, DOI 10.1016/0002-8703(81)90226-X; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Gohla A, 2007, P NATL ACAD SCI USA, V104, P3003, DOI 10.1073/pnas.0611434104; Hippe HJ, 2013, N-S ARCH PHARMACOL, V386, P459, DOI 10.1007/s00210-013-0876-x; Huang XY, 2006, MOL CELL BIOL, V26, P6870, DOI 10.1128/MCB.00314-06; Jantzen HM, 2001, J CLIN INVEST, V108, P477; Jin YZ, 2008, EUR J IMMUNOL, V38, P1988, DOI 10.1002/eji.200737738; Kamakura S, 2013, DEV CELL, V26, P292, DOI 10.1016/j.devcel.2013.06.008; Leopoldt D, 1997, N-S ARCH PHARMACOL, V356, P216, DOI 10.1007/PL00005044; Minetti GC, 2014, MOL CELL BIOL, V34, P619, DOI 10.1128/MCB.00957-13; MURAYAMA T, 1983, J BIOL CHEM, V258, P3319; Nagata K, 2000, CIRC RES, V87, P903, DOI 10.1161/01.RES.87.10.903; Plummer NW, 2012, P NATL ACAD SCI USA, V109, P21366, DOI 10.1073/pnas.1219810110; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; Salazar NC, 2007, BBA-BIOMEMBRANES, V1768, P1006, DOI 10.1016/j.bbamem.2007.02.010; Schultz JE, 1998, AM J PHYSIOL-HEART C, V275, pH495, DOI 10.1152/ajpheart.1998.275.2.H495; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Waterson RE, 2011, CARDIOVASC RES, V91, P45, DOI 10.1093/cvr/cvr054; Wiege K, 2013, J IMMUNOL, V190, P324, DOI 10.4049/jimmunol.1201398; Wiege K, 2012, J IMMUNOL, V189, P980, DOI 10.4049/jimmunol.1200891; Yellon D.M, 2007, NEW ENGL J MED, V357, P1121, DOI [10.1056/NEJMra071667, DOI 10.1056/NEJMRA071667]	29	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98325	10.1371/journal.pone.0098325	http://dx.doi.org/10.1371/journal.pone.0098325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858945	Green Published, Green Submitted, gold			2022-12-25	WOS:000336839400066
J	Liang, S; Varrecchia, M; Ishida, K; Jolly, ER				Liang, Shuang; Varrecchia, Melissa; Ishida, Kenji; Jolly, Emmitt R.			Evaluation of Schistosome Promoter Expression for Transgenesis and Genetic Analysis	PLOS ONE			English	Article							RNA INTERFERENCE; CMV PROMOTER; CYCLIN B1; BLOOD FLUKE; MANSONI; OVEREXPRESSION; APOPTOSIS; ACTIN; DNA; TRANSFECTION	Schistosome worms of the genus Schistosoma are the causative agents of schistosomiasis, a devastating parasitic disease affecting more than 240 million people worldwide. Schistosomes have complex life cycles, and have been challenging to manipulate genetically due to the dearth of molecular tools. Although the use of gene overexpression, gene knockouts or knockdowns are straight-forward genetic tools applied in many model systems, gene misexpression and genetic manipulation of schistosome genes in vivo has been exceptionally challenging, and plasmid based transfection inducing gene expression is limited. We recently reported the use of polyethyleneimine (PEI) as a simple and effective method for schistosome transfection and gene expression. Here, we use PEI-mediated schistosome plasmid transgenesis to define and compare gene expression profiles from endogenous and nonendogenous promoters in the schistosomula stage of schistosomes that are potentially useful to misexpress (underexpress or overexpress) gene product levels. In addition, we overexpress schistosome genes in vivo using a strong promoter and show plasmid-based misregulation of genes in schistosomes, producing a clear and distinct phenotype-death. These data focus on the schistosomula stage, but they foreshadow strong potential for genetic characterization of schistosome molecular pathways, and potential for use in overexpression screens and drug resistance studies in schistosomes using plasmid-based gene expression.	[Liang, Shuang; Varrecchia, Melissa; Ishida, Kenji; Jolly, Emmitt R.] Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA	Case Western Reserve University	Jolly, ER (corresponding author), Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA.	emmitt.jolly@case.edu	Jolly, Emmitt R/I-6646-2012	Jolly, Emmitt R/0000-0002-7141-2307	Case Western Reserve University; NIH-NIAID [1 R21 AI107147 01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI107147] Funding Source: NIH RePORTER	Case Western Reserve University; NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by Case Western Reserve University startup funds provided to ERJ and in part by NIH-NIAID grant 1 R21 AI107147 01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abruzzese Ronald V, 2002, Methods Mol Med, V69, P109; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Alrefaei YN, 2011, MEM I OSWALDO CRUZ, V106, P785, DOI 10.1590/S0074-02762011000700002; BASCH PF, 1981, J PARASITOL, V67, P179, DOI 10.2307/3280632; Beckmann S, 2007, EXP PARASITOL, V117, P292, DOI 10.1016/j.exppara.2007.04.007; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Bhardwaj R, 2011, METHODS MOL BIOL, V764, P223, DOI 10.1007/978-1-61779-188-8_15; Blazeck J, 2012, BIOTECHNOL BIOENG, V109, P2884, DOI 10.1002/bit.24552; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Brandeis M, 1998, P NATL ACAD SCI USA, V95, P4344, DOI 10.1073/pnas.95.8.4344; Brooks AR, 2004, J GENE MED, V6, P395, DOI 10.1002/jgm.516; Chang BD, 2000, ONCOGENE, V19, P2165, DOI 10.1038/sj.onc.1203573; Correnti JA, 2005, MOL BIOCHEM PARASIT, V143, P209, DOI 10.1016/j.molbiopara.2005.06.007; Correnti JM, 2007, INT J PARASITOL, V37, P1107, DOI 10.1016/j.ijpara.2007.02.011; Cursio R, 1999, FASEB J, V13, P253, DOI 10.1096/fasebj.13.2.253; Davis RE, 1999, P NATL ACAD SCI USA, V96, P8687, DOI 10.1073/pnas.96.15.8687; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Dubois F, 2009, MOL BIOCHEM PARASIT, V168, P7, DOI 10.1016/j.molbiopara.2009.06.001; Gobert GN, 2006, EXP PARASITOL, V114, P160, DOI 10.1016/j.exppara.2006.03.003; Gomez LA, 2007, MOL CANCER THER, V6, P1534, DOI 10.1158/1535-7163.MCT-06-0727; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Han HX, 2013, PARASITOL INT, V62, P100, DOI 10.1016/j.parint.2012.09.008; He SJ, 2010, PARASITOL RES, V107, P955, DOI 10.1007/s00436-010-1960-5; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; Heyers O, 2003, EXP PARASITOL, V105, P174, DOI 10.1016/j.exppara.2003.11.001; HOLLAND JP, 1980, J BIOL CHEM, V255, P2596; Jin P, 1998, J CELL BIOL, V141, P875, DOI 10.1083/jcb.141.4.875; Jolly ER, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r65; Kalinna BH, 2007, TRENDS PARASITOL, V23, P197, DOI 10.1016/j.pt.2007.03.007; Kerr LE, 2004, CELL DEATH DIFFER, V11, P1102, DOI 10.1038/sj.cdd.4401449; Kines KJ, 2006, EXP PARASITOL, V112, P209, DOI 10.1016/j.exppara.2006.02.003; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; KOSTER B, 1994, ARCH BIOCHEM BIOPHYS, V310, P108, DOI 10.1006/abbi.1994.1146; Lamkanfi M, 2010, INT J BIOCHEM CELL B, V42, P21, DOI 10.1016/j.biocel.2009.09.013; LEE KW, 1995, EXP PARASITOL, V80, P155, DOI 10.1006/expr.1995.1018; Liang S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002332; LIU HP, 1992, GENETICS, V132, P665; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LLOYD C, 1992, J CELL BIOL, V117, P787, DOI 10.1083/jcb.117.4.787; Lu CF, 2007, APPL ENVIRON MICROB, V73, P6072, DOI 10.1128/AEM.00955-07; MACGREGOR AN, 1990, INT J PARASITOL, V20, P279, DOI 10.1016/0020-7519(90)90141-9; Marcelli M, 2000, J UROLOGY, V164, P518, DOI 10.1016/S0022-5347(05)67416-2; Mecozzi B, 2000, MOL BIOCHEM PARASIT, V110, P333, DOI 10.1016/S0166-6851(00)00287-5; Meilinger D, 2009, EMBO REP, V10, P1259, DOI 10.1038/embor.2009.201; Milligan JN, 2011, JOVE-J VIS EXP, DOI 10.3791/3191; Morales ME, 2007, FASEB J, V21, P3479, DOI 10.1096/fj.07-8726com; Norden C, 2004, MOL MICROBIOL, V53, P469, DOI 10.1111/j.1365-2958.2004.04148.x; Osman A, 2006, PLOS PATHOG, V2, P536, DOI 10.1371/journal.ppat.0020054; Peak E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000759; Peckham M, 2001, J CELL SCI, V114, P1367; Prelich G, 2012, GENETICS, V190, P841, DOI 10.1534/genetics.111.136911; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; REIFENBERGER E, 1995, MOL MICROBIOL, V16, P157, DOI 10.1111/j.1365-2958.1995.tb02400.x; Rinaldi G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002820; Rossi A, 2003, MOL BIOCHEM PARASIT, V130, P133, DOI 10.1016/S0166-6851(03)00158-0; Skelly PJ, 2003, INT J PARASITOL, V33, P363, DOI 10.1016/S0020-7519(03)00030-4; Song YM, 2008, CARCINOGENESIS, V29, P307, DOI 10.1093/carcin/bgm269; Stevenson LF, 2001, P NATL ACAD SCI USA, V98, P3946, DOI 10.1073/pnas.051013498; Sun J, 2012, BIOTECHNOL BIOENG, V109, P2082, DOI 10.1002/bit.24481; Tchoubrieva EB, 2010, CELL MOL LIFE SCI, V67, P3739, DOI 10.1007/s00018-010-0345-3; Teschendorf C, 2002, ANTICANCER RES, V22, P3325; WALFRIDSSON M, 1995, APPL ENVIRON MICROB, V61, P4184, DOI 10.1128/AEM.61.12.4184-4190.1995; Wang J, 2000, J CELL SCI, V113, P753; Wippersteg V, 2002, INT J PARASITOL, V32, P1219, DOI 10.1016/S0020-7519(02)00092-9; Wippersteg V, 2002, MOL BIOCHEM PARASIT, V120, P141, DOI 10.1016/S0166-6851(01)00446-7; Wippersteg V, 2005, INT J PARASITOL, V35, P583, DOI 10.1016/j.ijpara.2005.02.002; Zhou XY, 2002, CANCER RES, V62, P1598	67	6	7	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98302	10.1371/journal.pone.0098302	http://dx.doi.org/10.1371/journal.pone.0098302			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858918	gold, Green Published, Green Submitted			2022-12-25	WOS:000336839400064
J	Salojin, KV; Hamman, BD; Chang, WC; Jhaver, KG; Al-Shami, A; Crisostomo, J; Wilkins, C; Digeorge-Foushee, AM; Allen, J; Patel, N; Gopinathan, S; Zhou, J; Nouraldeen, A; Jessop, TC; Bagdanoff, JT; Augeri, DJ; Read, R; Vogel, P; Wilson, SA; Platt, KA; Carson, KG; Main, A; Zambrowicz, BP; Oravecz, T				Salojin, Konstantin V.; Hamman, Brian D.; Chang, Wei Chun; Jhaver, Kanchan G.; Al-Shami, Amin; Crisostomo, Jeannette; Wilkins, Carrie; Digeorge-Foushee, Ann Marie; Allen, Jason; Patel, Nita; Gopinathan, Suma; Zhou, Julia; Nouraldeen, Amr; Jessop, Theodore C.; Bagdanoff, Jeffrey T.; Augeri, David J.; Read, Robert; Vogel, Peter; Wilson, Swaffield Alan; Platt, Kenneth A.; Carson, Kenneth G.; Main, Alan; Zambrowicz, Brian P.; Oravecz, Tamas			Genetic Deletion of Mst1 Alters T Cell Function and Protects against Autoimmunity	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; TRANSCRIPTION FACTOR; SIGNALING PATHWAY; IMMUNE-RESPONSES; ACTIVATION; APOPTOSIS; MICE; KINASE; ENCEPHALOMYELITIS; DEATH	Mammalian sterile 20-like kinase 1 (Mst1) is a MAPK kinase kinase kinase which is involved in a wide range of cellular responses, including apoptosis, lymphocyte adhesion and trafficking. The contribution of Mst1 to Ag-specific immune responses and autoimmunity has not been well defined. In this study, we provide evidence for the essential role of Mst1 in T cell differentiation and autoimmunity, using both genetic and pharmacologic approaches. Absence of Mst1 in mice reduced T cell proliferation and IL-2 production in vitro, blocked cell cycle progression, and elevated activation-induced cell death in Th1 cells. Mst1 deficiency led to a CD4(+) T cell development path that was biased toward Th2 and immunoregulatory cytokine production with suppressed Th1 responses. In addition, Mst1(-/-) B cells showed decreased stimulation to B cell mitogens in vitro and deficient Ag-specific Ig production in vivo. Consistent with altered lymphocyte function, deletion of Mst1 reduced the severity of experimental autoimmune encephalomyelitis (EAE) and protected against collagen-induced arthritis development. Mst1(-/-) CD4(+) T cells displayed an intrinsic defect in their ability to respond to encephalitogenic antigens and deletion of Mst1 in the CD4(+) T cell compartment was sufficient to alleviate CNS inflammation during EAE. These findings have prompted the discovery of novel compounds that are potent inhibitors of Mst1 and exhibit desirable pharmacokinetic properties. In conclusion, this report implicates Mst1 as a critical regulator of adaptive immune responses, Th1/Th2-dependent cytokine production, and as a potential therapeutic target for immune disorders.	[Salojin, Konstantin V.; Hamman, Brian D.; Chang, Wei Chun; Jhaver, Kanchan G.; Al-Shami, Amin; Crisostomo, Jeannette; Wilkins, Carrie; Digeorge-Foushee, Ann Marie; Allen, Jason; Patel, Nita; Gopinathan, Suma; Zhou, Julia; Nouraldeen, Amr; Jessop, Theodore C.; Bagdanoff, Jeffrey T.; Augeri, David J.; Read, Robert; Vogel, Peter; Wilson, Swaffield Alan; Platt, Kenneth A.; Carson, Kenneth G.; Main, Alan; Zambrowicz, Brian P.; Oravecz, Tamas] Lexicon Pharmaceut Inc, The Woodlands, TX 77381 USA	Lexicon Pharmaceuticals	Salojin, KV (corresponding author), Lexicon Pharmaceut Inc, The Woodlands, TX 77381 USA.	ksalojin@gmail.com	Vogel, Peter/N-2490-2018	Vogel, Peter/0000-0002-7535-0545; Gopinathan, Suma/0000-0001-5261-1901	Lexicon Pharmaceuticals, Inc.	Lexicon Pharmaceuticals, Inc.	The work described in this paper was funded by Lexicon Pharmaceuticals, Inc. The authors designed the study, conducted data collection and analysis, and prepared the manuscript. Lexicon Pharmaceuticals approved the decision to publish this manuscript.	Abdollahpour H, 2012, BLOOD, V119, P3450, DOI 10.1182/blood-2011-09-378158; Augeri D.J., 2012, US Pat, Patent No. [US 2012/0225857A1, 20120225857]; Avruch J, 2012, SEMIN CELL DEV BIOL, V23, P770, DOI 10.1016/j.semcdb.2012.07.002; Baird AM, 1998, J LEUKOCYTE BIOL, V63, P669, DOI 10.1002/jlb.63.6.669; Bettelli E, 1998, J IMMUNOL, V161, P3299; Brand DD, 2003, SPRINGER SEMIN IMMUN, V25, P3, DOI 10.1007/s00281-003-0127-1; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; CAMBIAGGI C, 1992, IMMUNOGENETICS, V36, P117, DOI 10.1007/BF00215288; Campbell IK, 2000, EUR J IMMUNOL, V30, P1568, DOI 10.1002/1521-4141(200006)30:6<1568::AID-IMMU1568>3.0.CO;2-R; Chen DW, 2001, J IMMUNOL, V166, P5889, DOI 10.4049/jimmunol.166.10.5889; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Choi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008011; CREASY CL, 1995, J BIOL CHEM, V270, P21695, DOI 10.1074/jbc.270.37.21695; de Souza PM, 2004, BIOCHEM SOC T, V32, P485, DOI 10.1042/BST0320485; Densham RM, 2009, MOL CELL BIOL, V29, P6380, DOI 10.1128/MCB.00116-09; Dong YL, 2009, J IMMUNOL, V183, P3865, DOI 10.4049/jimmunol.0900678; Fleming KK, 2005, J NEUROIMMUNOL, V170, P71, DOI 10.1016/j.jneuroim.2005.08.020; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Fujii K, 2001, J IMMUNOL, V167, P1198, DOI 10.4049/jimmunol.167.3.1198; Fuller KG, 2004, METH MOLEC MED, V102, P339; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Hildeman D, 2007, CURR OPIN IMMUNOL, V19, P516, DOI 10.1016/j.coi.2007.05.005; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Kandula S, 2004, J IMMUNOL, V173, P4443, DOI 10.4049/jimmunol.173.7.4443; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Katagiri K, 2009, EMBO J, V28, P1319, DOI 10.1038/emboj.2009.82; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Lin JL, 2001, ONCOGENE, V20, P6559, DOI 10.1038/sj.onc.1204818; Lin YS, 2002, J BIOL CHEM, V277, P47991, DOI 10.1074/jbc.M202630200; Ling P, 2008, CELL SIGNAL, V20, P1237, DOI 10.1016/j.cellsig.2007.12.019; Liu L, 2005, J EXP MED, V202, P1341, DOI 10.1084/jem.20051359; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; McKallip RJ, 2002, INT IMMUNOL, V14, P1015, DOI 10.1093/intimm/dxf068; Monaco Claudia, 2004, Current Drug Targets - Inflammation and Allergy, V3, P35, DOI 10.2174/1568010043483881; Mou F, 2012, J EXP MED, V209, P741, DOI 10.1084/jem.20111692; Nakano K, 2007, APOPTOSIS, V12, P45, DOI 10.1007/s10495-006-0488-8; Nehme NT, 2012, BLOOD, V119, P3458, DOI 10.1182/blood-2011-09-378364; Okamoto K, NATURE, V464, P1381; Pino PA, 2011, J VIS EXP FEB, V2, P2348; Rao P, 2004, METH MOLEC MED, V102, P363; Saijo K, 1997, J EXP MED, V185, P351, DOI 10.1084/jem.185.2.351; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Steinman L, 2001, J EXP MED, V194, pF27, DOI 10.1084/jem.194.5.F27; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suzuki K, 2000, INT IMMUNOL, V12, P123, DOI 10.1093/intimm/12.2.123; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tan CY, 2011, CELL IMMUNOL, V271, P210, DOI 10.1016/j.cellimm.2011.08.006; Vogel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004112; Wang Y, 2009, J BIOL CHEM, V284, P12645, DOI 10.1074/jbc.M807207200; Wang Yanming, 2004, Novartis Found Symp, V259, P3; Wattler S, 1999, BIOTECHNIQUES, V26, P1150, DOI 10.2144/99266rr02; Wehrens EJ, 2013, NAT REV RHEUMATOL, V9, P34, DOI 10.1038/nrrheum.2012.149; Zambrowicz BP, 2003, NAT REV DRUG DISCOV, V2, P38, DOI 10.1038/nrd987; Zhang J, 2001, J IMMUNOL, V166, P4981, DOI 10.4049/jimmunol.166.8.4981; Zhang XH, 1997, J EXP MED, V185, P1837, DOI 10.1084/jem.185.10.1837; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou DW, 2008, P NATL ACAD SCI USA, V105, P20321, DOI 10.1073/pnas.0810773105	61	35	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98151	10.1371/journal.pone.0098151	http://dx.doi.org/10.1371/journal.pone.0098151			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852423	gold, Green Published, Green Submitted			2022-12-25	WOS:000338323200050
J	Xie, BQ; Wang, W; Zhang, WQ; Guo, XH; Yang, MF; Wang, L; He, ZX; Tian, YQ				Xie, Bo-Qia; Wang, Wei; Zhang, Wen-Qian; Guo, Xin-Hua; Yang, Min-Fu; Wang, Li; He, Zuo-Xiang; Tian, Yue-Qin			Ventilation/Perfusion Scintigraphy in Children with Post-Infectious Bronchiolitis Obliterans: A Pilot Study	PLOS ONE			English	Article							HIGH-RESOLUTION CT; PULMONARY-FUNCTION; PERFUSION; SPECT	Purpose: Childhood post-infectious bronchiolitis obliterans (BO) is an infrequent lung disease leading to narrowing and/or complete obliteration of small airways. Ventilation and perfusion (V/Q) scan can provide both regional and global pulmonary information. However, only few retrospective researches investigating post-infectious BO involved V/Q scan, the clinical value of this method is unknown. This preliminary prospective study was aimed to evaluate the correlation of V/Q scan with disease severity, pulmonary function test results, and prognosis in children with post-infectious BO. Methods: Twenty-five post-infectious BO children (18 boys and 7 girls; mean age, 41 months) underwent V/Q scan and pulmonary function tests. Patients were followed after their inclusion. Ventilation index and perfusion index obtained from V/Q scan were used to measure pulmonary abnormalities. Spearman's rank correlation test of ventilation index and perfusion index on disease severity, lung function tests indices, and follow-up results were performed. Results: The median follow-up period was 4.6 years (range, 2.2 to 5.0 years). Ventilation index and perfusion index were both correlated with disease severity (r = 0.72, p<0.01 and r = 0.73, p<0.01), but only ventilation index was related to pulmonary function tests results (all p<0.05). In addition, Spearman test yielded significant correlations between perfusion index and prognosis (r = 0.77, p<0.01), and ventilation index and prognosis (r = 0.63, p = 0.01). Conclusions: For children with post-infectious BO, the present study preliminarily indicated that the degree of ventilation and perfusion abnormalities evaluated by V/Q scan may be used to assess disease severity, and may be predictive of patient's outcome.	[Xie, Bo-Qia] Capital Med Univ, Chaoyang Hosp, Dept Cardiol, Beijing, Peoples R China; [Wang, Wei] Capital Med Univ, Beijing Childrens Hosp, Dept Resp, Beijing, Peoples R China; [Zhang, Wen-Qian] Capital Med Univ, Chaoyang Hosp, Inst Resp Dis, Dept Thorac Surg, Beijing, Peoples R China; [Xie, Bo-Qia; Guo, Xin-Hua; Wang, Li; He, Zuo-Xiang; Tian, Yue-Qin] Chinese Acad Med Sci, Fu Wai Hosp, Natl Ctr Cardiovascular Dis, Dept Nucl Med,State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Xie, Bo-Qia; Guo, Xin-Hua; Wang, Li; He, Zuo-Xiang; Tian, Yue-Qin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Yang, Min-Fu] Capital Med Univ, Chaoyang Hosp, Dept Nucl Med, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University	Tian, YQ (corresponding author), Chinese Acad Med Sci, Fu Wai Hosp, Natl Ctr Cardiovascular Dis, Dept Nucl Med,State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China.	dr.yueqintian@gmail.com						[Anonymous], 1950, THORAX, V5, P222; Chan P W, 2000, Respirology, V5, P369, DOI 10.1046/j.1440-1843.2000.00277.x; Colom AJ, 2009, PEDIATR PULM, V44, P1065, DOI 10.1002/ppul.21080; Donnelly LF, 1997, PEDIATR RADIOL, V27, P920, DOI 10.1007/s002470050272; Frey U, 2010, EUROPEAN RESP MONOGR, V47; Hansell DM, 1997, RADIOLOGY, V203, P721, DOI 10.1148/radiology.203.3.9169694; HOSHINO Y, 1994, AM J PHYSIOL, V267, pL120, DOI 10.1152/ajplung.1994.267.2.L120; Katier N, 2005, CHEST, V128, P1822, DOI 10.1378/chest.128.3.1822; King GG, 2010, SEMIN NUCL MED, V40, P467, DOI 10.1053/j.semnuclmed.2010.07.006; Kurland G, 2005, PEDIATR PULM, V39, P193, DOI 10.1002/ppul.20145; Moonnumakal SP, 2008, CURR OPIN PEDIATR, V20, P272, DOI 10.1097/MOP.0b013e3282ff62e9; Navalkissoor S, 2010, NUCL MED COMMUN, V31, P896, DOI 10.1097/MNM.0b013e32833dad0c; PADLEY SPG, 1993, CLIN RADIOL, V47, P236, DOI 10.1016/S0009-9260(05)81129-8; Parker JA, 2012, J NUCL MED TECHNOL, V40, P57, DOI 10.2967/jnmt.111.101386; Subspecialty Group of Respiratory Diseases The Society of Pediatrics Chinese Medical Association, 2012, CHINESE J PEDIAT, V50, P743; Washko GR, 2012, RESPIROLOGY, V17, P432, DOI 10.1111/j.1440-1843.2011.02117.x; Yang CF, 1997, AM J ROENTGENOL, V168, P1045, DOI 10.2214/ajr.168.4.9124113; Yilmaz O, 2009, RESPIROLOGY, V14, P295, DOI 10.1111/j.1440-1843.2008.01456.x; Yuksel H, 2009, TUBERK TORAK, V57, P376; [郑劲平 Zheng Jinping], 2002, [中华儿科杂志, Chinese Journal of Pediatrics], V40, P103; Zophel K, 2009, ANN NUCL MED, V23, P1, DOI 10.1007/s12149-008-0187-3	21	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98381	10.1371/journal.pone.0098381	http://dx.doi.org/10.1371/journal.pone.0098381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852165	Green Published, Green Submitted, gold			2022-12-25	WOS:000338323200068
J	Lee, Y; Lee, JJ; Kim, S; Lee, SC; Han, J; Heu, W; Park, K; Kim, HJ; Cheong, HK; Kim, D; Kim, HS; Lee, KW				Lee, Yuno; Lee, Joong-jae; Kim, Songmi; Lee, Sang-Chul; Han, Jieun; Heu, Woosung; Park, Keunwan; Kim, Hyun Jung; Cheong, Hae-Kap; Kim, Dongsup; Kim, Hak-Sung; Lee, Keun Woo			Dissecting the Critical Factors for Thermodynamic Stability of Modular Proteins Using Molecular Modeling Approach	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; FORCE-FIELD; FREE-ENERGY; BINDING; DENATURATION; SOLVATION; RECEPTORS; DESIGN; UREA	Repeat proteins have recently attracted much attention as alternative scaffolds to immunoglobulin antibodies due to their unique structural and biophysical features. In particular, repeat proteins show high stability against temperature and chaotic agents. Despite many studies, structural features for the stability of repeat proteins remain poorly understood. Here we present an interesting result from in silico analyses pursuing the factors which affect the stability of repeat proteins. Previously developed repebody structure based on variable lymphocytes receptors (VLRs) which consists of leucine-rich repeat (LRR) modules was used as initial structure for the present study. We constructed extra six repebody structures with varying numbers of repeat modules and those structures were used for molecular dynamics simulations. For the structures, the intramolecular interactions including backbone H-bonds, van der Waals energy, and hydrophobicity were investigated and then the radius of gyration, solvent-accessible surface area, ratio of secondary structure, and hydration free energy were also calculated to find out the relationship between the number of LRR modules and stability of the protein. Our results show that the intramolecular interactions lead to more compact structure and smaller surface area of the repebodies, which are critical for the stability of repeat proteins. The other features were also well compatible with the experimental results. Based on our observations, the repebody-5 was proposed as the best structure from the all repebodies in structure optimization process. The present study successfully demonstrated that our computer-based molecular modeling approach can significantly contribute to the experiment-based protein engineering challenge.	[Lee, Yuno; Kim, Songmi; Lee, Keun Woo] GNU, RINS, Div Appl Life Sci, SSAC,PMBBRC,Program BK21, Jinju, South Korea; [Lee, Joong-jae; Lee, Sang-Chul; Han, Jieun; Heu, Woosung; Kim, Hak-Sung] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon, South Korea; [Park, Keunwan; Kim, Dongsup] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Kim, Hyun Jung; Cheong, Hae-Kap] Korea Basic Sci Inst, Div Magnet Resonance Res, Cheongwon, Chungbuk, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Basic Science Institute (KBSI)	Kim, HS (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon, South Korea.	hskim76@kaist.ac.kr; kwlee@gnu.ac.kr	Kim, Dongsup/C-1612-2011; Kim, Hak-Sung/C-1929-2011	Lee, Joong-jae/0000-0002-3121-1420; LEE, Sangchul/0000-0002-7002-1179	National Research Foundation of Korea (NRF) - Korean Government; Pioneer Research Center Program [2009-0081539]; Management of Climate Change Program through the NRF - Ministry of Education, Science and Technology (MEST) of Republic of Korea [2010-0029084]; Next-Generation BioGreen 21 Program from Rural Development Administration (RDA) of Republic of Korea [PJ009486]	National Research Foundation of Korea (NRF) - Korean Government; Pioneer Research Center Program; Management of Climate Change Program through the NRF - Ministry of Education, Science and Technology (MEST) of Republic of Korea; Next-Generation BioGreen 21 Program from Rural Development Administration (RDA) of Republic of Korea	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean Government (NRF-2012-Fostering Core Leaders of the Future Basic Science Program). This research was supported by Pioneer Research Center Program (2009-0081539) and Management of Climate Change Program (2010-0029084) through the NRF funded by the Ministry of Education, Science and Technology (MEST) of Republic of Korea. This work was also supported by the Next-Generation BioGreen 21 Program (PJ009486) from Rural Development Administration (RDA) of Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksel T, 2009, METHOD ENZYMOL, V455, P95, DOI 10.1016/S0076-6879(08)04204-3; Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Bennion BJ, 2003, P NATL ACAD SCI USA, V100, P5142, DOI 10.1073/pnas.0930122100; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Boersma YL, 2011, CURR OPIN BIOTECH, V22, P849, DOI 10.1016/j.copbio.2011.06.004; Botos I, 2011, STRUCTURE, V19, P447, DOI 10.1016/j.str.2011.02.004; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; CHAN MK, 1995, SCIENCE, V267, P1463, DOI 10.1126/science.7878465; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Grove TZ, 2008, CURR OPIN STRUC BIOL, V18, P507, DOI 10.1016/j.sbi.2008.05.008; Harvey S.C., 1988, DYNAMICS PROTEINS NU; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hua L, 2008, P NATL ACAD SCI USA, V105, P16928, DOI 10.1073/pnas.0808427105; Ivankov DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006476; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karino Y, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3535560; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004; Lee SC, 2012, P NATL ACAD SCI USA, V109, P3299, DOI 10.1073/pnas.1113193109; Low C, 2008, P NATL ACAD SCI USA, V105, P3779, DOI 10.1073/pnas.0710657105; Main ERG, 2005, CURR OPIN STRUC BIOL, V15, P464, DOI 10.1016/j.sbi.2005.07.003; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Stumpe MC, 2007, J AM CHEM SOC, V129, P16126, DOI 10.1021/ja076216j; Van der Spoel D, 2006, GROMACS USER MANUAL, V4, P9747; Villa A, 2002, J COMPUT CHEM, V23, P548, DOI 10.1002/jcc.10052; Yang C, 2011, BIOCHEMISTRY	32	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98243	10.1371/journal.pone.0098243	http://dx.doi.org/10.1371/journal.pone.0098243			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849801	Green Published, Green Submitted, gold			2022-12-25	WOS:000336730600102
J	Duan, P; Sun, SL; Li, B; Huang, CT; Xu, Y; Han, XF; Xing, Y; Yan, WH				Duan, Ping; Sun, Shiling; Li, Bo; Huang, Chuntian; Xu, Yan; Han, Xuefei; Xing, Ying; Yan, Wenhai			miR-29a Modulates Neuronal Differentiation through Targeting REST in Mesenchymal Stem Cells	PLOS ONE			English	Article							ADULT BONE-MARROW; PROGENITOR CELLS; STROMAL CELLS; NEURAL PRECURSORS; SILENCING FACTOR; IN-VITRO; GENES; MICRORNAS; PLASTICITY; SPECIFICATION	Objective: To investigate the modulation of microRNAs (miRNAs) upon the neuronal differentiation of mesenchymal stem cells (MSCs) through targeting RE-1 Silencing Factor (REST), a mature neuronal gene suppressor in neuronal and unneuronal cells. Methods: Rat bone marrow derived-MSCs were induced into neuron-like cells (MSC-NCs) by DMSO and BHA in vitro. The expression of neuron specific enolase (NSE), microtubule-associated protein tau (Tau), REST and its target genes, including synaptosomal-associated protein 25 (SNAP25) and L1 cell adhesion molecular (L1CAM), were detected in MSCs and MSC-NCs. miRNA array analysis was conducted to screen for the upregulated miRNAs after neuronal differentiation. TargetScan was used to predict the relationship between these miRNAs and REST gene, and dual luciferase reporter assay was applied to validate it. Gain and loss of function experiments were used to study the role of miR-29a upon neuronal differentiation of MSCs. The knockdown of REST was conducted to show that miR-29a affected this process through targeting REST. Results: MSCs were induced into neuron-like cells which presented neuronal cell shape and expressed NSE and Tau. The expression of REST declined and the expression of SNAP25 and L1CAM increased upon the neuronal differentiation of MSCs. Among 14 upregulated miRNAs, miR-29a was validated to target REST gene. During the neuronal differentiation of MSCs, miR-29a inhibition blocked the downregulation of REST, as well as the upregulation of SNAP25, L1CAM, NSE and Tau. REST knockdown rescued the effect of miR-29a inhibition on the expression of NSE and Tau. Meanwhile, miR-29a knockin significantly decreased the expression of REST and increased the expression of SNAP25 and L1CMA in MSCs, but did not significantly affect the expression of NSE and Tau. Conclusion: miR-29a regulates neurogenic markers through targeting REST in mesenchymal stem cells, which provides advances in neuronal differentiation research and stem cell therapy for neurodegenerative diseases.	[Duan, Ping; Li, Bo; Huang, Chuntian; Xu, Yan; Han, Xuefei; Yan, Wenhai] Zhengzhou Univ, Inst Basic Med, Zhengzhou 450052, Henan, Peoples R China; [Sun, Shiling] Henan Univ Tradit Chinese Med, Affiliated Hosp 1, Dept Hematol, Zhengzhou, Henan, Peoples R China; [Xing, Ying] Xinxiang Med Univ, Dept Physiol, Xinxiang, Henan, Peoples R China	Zhengzhou University; Henan University of Traditional Chinese Medicine; Xinxiang Medical University	Xing, Y (corresponding author), Xinxiang Med Univ, Dept Physiol, Xinxiang, Henan, Peoples R China.	xingy@zzu.edu.cn; yanwhzzu@163.com			National Natural Science Foundation of China [81171250, 31100790]; Zhengzhou University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhengzhou University	This work was supported by a grant from National Natural Science Foundation of China (Grant number: 81171250, 31100790) and a grant from Zhengzhou University 211 project-phase II'-the basic and clinical research of Stem Cells. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernardo ME, 2009, ANN NY ACAD SCI, V1176, P101, DOI 10.1111/j.1749-6632.2009.04607.x; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Chang SJ, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-65; de Boer J, 2004, BONE, V34, P818, DOI 10.1016/j.bone.2004.01.016; Duan P, 2012, IN VITRO CELL DEV-AN, V48, P251, DOI 10.1007/s11626-012-9494-z; Dykxhoorn DM, 2010, CANCER RES, V70, P6401, DOI 10.1158/0008-5472.CAN-10-1346; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Glenn MJ, 2008, BRAIN RES, V1237, P110, DOI 10.1016/j.brainres.2008.08.049; Greco SJ, 2007, P NATL ACAD SCI USA, V104, P15484, DOI 10.1073/pnas.0703037104; Han R, 2012, NEUROSCI LETT, V515, P147, DOI 10.1016/j.neulet.2012.03.032; Hung SC, 2002, STEM CELLS, V20, P522, DOI 10.1634/stemcells.20-6-522; Jiang YH, 2003, P NATL ACAD SCI USA, V100, P11854, DOI 10.1073/pnas.1834196100; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kabos P, 2002, EXP NEUROL, V178, P288, DOI 10.1006/exnr.2002.8039; Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137; Kapinas K, 2009, J CELL BIOCHEM, V108, P216, DOI 10.1002/jcb.22243; Li XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057621; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Liu Bin, 2009, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V31, P702, DOI 10.3881/j.issn.1000-503X.2009.06.009; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Majumder S, 2006, CELL CYCLE, V5, P1929, DOI 10.4161/cc.5.17.2982; Mareschi K, 2009, CYTOTHERAPY, V11, P534, DOI 10.1080/14653240902974024; Paratore S, 2006, GENES BRAIN BEHAV, V5, P209, DOI 10.1111/j.1601-183X.2005.00159.x; Ratnayake U, 2012, BRAIN BEHAV IMMUN, V26, P1288, DOI 10.1016/j.bbi.2012.08.011; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Schmitt MJ, 2013, CURR MOL MED, V13, P572; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Shu SY, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-9; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Trzaska KA, 2008, MOL CELL NEUROSCI, V39, P285, DOI 10.1016/j.mcn.2008.07.006; Van Damme An, 2002, Current Gene Therapy, V2, P195; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Wislet-Gendebien S, 2005, STEM CELLS, V23, P392, DOI 10.1634/stemcells.2004-0149; Woodbury D, 2002, J NEUROSCI RES, V69, P908, DOI 10.1002/jnr.10365; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Yang YX, 2008, EXP CELL RES, V314, P2257, DOI 10.1016/j.yexcr.2008.04.008	42	27	28	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97684	10.1371/journal.pone.0097684	http://dx.doi.org/10.1371/journal.pone.0097684			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841827	Green Submitted, gold, Green Published			2022-12-25	WOS:000340948600055
J	Huang, Y; Zhang, XJ; Du, Q; Wang, FY; Zhao, XM; Zhang, WL; Tong, DW				Huang, Yong; Zhang, Xiujuan; Du, Qian; Wang, Fengyu; Zhao, Xiaomin; Zhang, Wenlong; Tong, Dewen			Preclinical Detection of Porcine Circovirus Type 2 Infection Using an Ultrasensitive Nanoparticle DNA Probe-Based PCR Assay	PLOS ONE			English	Article							REAL-TIME PCR; MONOCLONAL-ANTIBODIES; PIGS; PCV2; QUANTIFICATION; AMPLIFICATION; EPITOPES; STRAINS; SERUM; FIELD	Porcine circovirus type 2 (PCV2) has emerged as one of the most important pathogens affecting swine production globally. Preclinical identification of PCV2 is very important for effective prophylaxis of PCV2-associated diseases. In this study, we developed an ultrasensitive nanoparticle DNA probe-based PCR assay (UNDP-PCR) for PCV2 detection. Magnetic microparticles coated with PCV2 specific DNA probes were used to enrich PCV2 DNA from samples, then gold nanoparticles coated with PCV2 specific oligonucleotides were added to form a sandwich nucleic acid-complex. After the complex was formed, the oligonucleotides were released and characterized by PCR. This assay exhibited about 500-fold more sensitive than conventional PCR, with a detection limit of 2 copies of purified PCV2 genomic DNA and 10 viral copies of PCV2 in serum. The assay has a wide detection range for all of PCV2 genotypes with reliable reproducibility. No cross-reactivity was observed from the samples of other related viruses including porcine circovirus type 1, porcine parvovirus, porcine pseudorabies virus, porcine reproductive and respiratory syndrome virus and classical swine fever virus. The positive detection rate of PCV2 specific UNDP-PCR in 40 preclinical field samples was 27.5%, which appeared greater than that by conventional and real-time PCR and appeared application potency in evaluation of the viral loads levels of preclinical infection samples. The UNDP-PCR assay reported here can reliably rule out false negative results from antibody-based assays, provide a nucleic acid extraction free, specific, ultrasensitive, economic and rapid diagnosis method for preclinical PCV2 infection in field, which may help prevent large-scale outbreaks.	[Huang, Yong; Zhang, Xiujuan; Du, Qian; Wang, Fengyu; Zhao, Xiaomin; Zhang, Wenlong; Tong, Dewen] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Tong, DW (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.	dwtong@nwsuaf.edu.cn	du, qian/GYJ-7090-2022; Huang, Yong/G-9365-2011		scientific and technological project in Shaanxi province [2012K02-05]; international science and technology cooperation fund of Northwest AF University [A213021310]; national training programs of innovation and entrepreneurship for undergraduates [1210712038]; scientific research program of Northwest AF University [QN2011064, ZD2013009, Z111021103]	scientific and technological project in Shaanxi province; international science and technology cooperation fund of Northwest AF University; national training programs of innovation and entrepreneurship for undergraduates; scientific research program of Northwest AF University	This study was funded by grants from the scientific and technological project in Shaanxi province (Grant No. 2012K02-05), international science and technology cooperation fund of Northwest A&F University (Grant No. A213021310), and national training programs of innovation and entrepreneurship for undergraduates (Grant No. 1210712038), and the scientific research program of Northwest A&F University (No. QN2011064 & ZD2013009 & Z111021103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan GM, 2000, J VET DIAGN INVEST, V12, P3, DOI 10.1177/104063870001200102; Chen HT, 2008, J VIROL METHODS, V149, P264, DOI 10.1016/j.jviromet.2008.01.023; de Boisseson C, 2004, J GEN VIROL, V85, P293, DOI 10.1099/vir.0.19536-0; Ellis J, 2004, VET MICROBIOL, V98, P159, DOI 10.1016/j.vetmic.2003.10.008; Finsterbusch T, 2009, VIRUS RES, V143, P177, DOI 10.1016/j.virusres.2009.02.009; Huang Y, 2013, VIRUS RES, V175, P78, DOI 10.1016/j.virusres.2013.03.014; Khayat R, 2011, J VIROL, V85, P7856, DOI 10.1128/JVI.00737-11; Kim EY, 2008, NANOMEDICINE-UK, V3, P293, DOI 10.2217/17435889.3.3.293; Kim Jin H, 2002, J Vet Sci, V3, P31; Lefebvre DJ, 2008, J GEN VIROL, V89, P177, DOI 10.1099/vir.0.83280-0; Mahe D, 2000, J GEN VIROL, V81, P1815, DOI 10.1099/0022-1317-81-7-1815; McIntosh KA, 2009, VET MICROBIOL, V133, P23, DOI 10.1016/j.vetmic.2008.06.010; Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755; Niemeyer CM, 2007, NAT PROTOC, V2, P1918, DOI 10.1038/nprot.2007.267; Opriessnig T, 2006, CLIN VACCINE IMMUNOL, V13, P923, DOI 10.1128/CVI.00074-06; Opriessnig T, 2007, J VET DIAGN INVEST, V19, P591, DOI 10.1177/104063870701900601; Saha D, 2012, VET MICROBIOL, V157, P13, DOI 10.1016/j.vetmic.2011.11.030; Segales J, 2005, VET MICROBIOL, V111, P223, DOI 10.1016/j.vetmic.2005.10.008; SEHGAL D, 1994, ANAL BIOCHEM, V218, P87, DOI 10.1006/abio.1994.1144; Shao Meng, 2013, Journal of Northwest A & F University - Natural Science Edition, V41, P19; [时乐 Shi Le], 2012, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V21, P6; Shuai J, 2007, VIRUS GENES, V35, P619, DOI 10.1007/s11262-007-0121-0; Vlasakova M, 2012, J VIROL METHODS, V179, P311, DOI 10.1016/j.jviromet.2011.11.014; Xu XG, 2012, J VIROL METHODS, V183, P69, DOI 10.1016/j.jviromet.2012.03.034; Xu XR, 2008, ANTIVIR RES, V78, P188, DOI 10.1016/j.antiviral.2007.12.012; Zhao Xiao-jie, 2010, Journal of Fisheries of China, V34, P1, DOI 10.3724/SP.J.1231.2010.06155	26	17	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97869	10.1371/journal.pone.0097869	http://dx.doi.org/10.1371/journal.pone.0097869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842840	Green Published, Green Submitted, gold			2022-12-25	WOS:000340948600083
J	Wu, J; Han, YR; Xu, J; Lu, Y; Cong, HL; Zheng, JY; Sun, H				Wu, Jing; Han, Yuerong; Xu, Judy; Lu, Yang; Cong, Hongliang; Zheng, Junyi; Sun, He			Chronic Stable Angina Is Associated with Lower Health-Related Quality of Life: Evidence from Chinese Patients	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; HEART-DISEASE; FOLLOW-UP; PECTORIS; POPULATION; SYMPTOMS; EUROQOL; STATES; FRAMINGHAM; TRIAL	Objectives: To compare health-related quality of life (HRQoL) between patients with stable angina and the general population in China and to examine factors associated with HRQoL among patients with stable angina. Methods: A cross-sectional HRQoL survey of stable angina patients recruited from 4 hospitals (n = 411) and the general population recruited from 3 Physical Examination Centers (n = 549) was conducted from July to December, 2011 in two large cities, Tianjin and Chengdu. HRQoL was assessed using the EQ-5D, EQ-VAS, and SF-6D instruments. The health status specific to patients with stable angina was assessed using the Seattle Angina Questionnaire (SAQ). Information on socio-demographic, clinical, and lifestyle factors were also collected. Nested regressions were performed to explore how these factors were associated with HRQoL in patients with stable angina. Results: Compared with the general population (44.2 +/- 10 years, 49.9% females), stable angina patients (68.1 +/- 12 years, 50.4% females) had significantly lower HRQoL scores in EQ-5D utility index (0.75 +/- 0.19 vs. 0.90 +/- 0.20, p < 0.05), SF-6D utility index (0.68 +/- 0.12 vs. 0.85 +/- 0.11, p < 0.05), and EQ-VAS (71.2 +/- 12.3 vs. 83.9 +/- 10.9, p < 0.05). The differences remained (-0.05 for EQ-5D, -9.27 for EQ-VAS and -0.13 for SF-6D) after controlling for socio-economic characteristics. SAQ scores showed that stable angina patients experienced impaired disease-specific health status, especially in angina stability (40.5 +/- 34.6). Nested regressions indicated stable angina-specific health status explained most of the variation in HRQoL, among which disease perception, physical limitation, and angina stability were the strongest predictors. More physical exercise and better sleep were positively related with HRQoL. Conclusions: Compared to the general population, stable angina patients were associated with lower HRQoL and lower health utility scores, which were largely impacted by clinical symptoms. Further studies are needed to characterize the influence of geographic and cultural factors on the variations of health-related utility in stable angina patients.	[Wu, Jing; Han, Yuerong; Sun, He] Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin 300072, Peoples R China; [Xu, Judy] Southwest Univ Finance & Econ, Sch Publ Adm, Chengdu, Peoples R China; [Lu, Yang] Harbor UCLA Med Ctr, Torrance, CA 90509 USA; [Cong, Hongliang; Zheng, Junyi] Tianjin Chest Hosp, Tianjin, Peoples R China	Tianjin University; Southwestern University of Finance & Economics - China; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Wu, J (corresponding author), Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin 300072, Peoples R China.	jingwu@tju.edu.cn; henrysunusa@gmail.com		Lu, Yang/0000-0003-2905-7302; Wu, Jing/0000-0002-6012-2785	Innovation Research Fund of Tianjin University, China	Innovation Research Fund of Tianjin University, China	This study was supported by Innovation Research Fund of Tianjin University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australia Pharmaceutical Benefits Advisory Committee, 2006, GUID PREP SUBM PBAC; Beltrame JF, 2009, ARCH INTERN MED, V169, P1491, DOI 10.1001/archinternmed.2009.295; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Canadian Agency for Drugs and Technologies in Health (CADTH), 2017, GUID EC EV HLTH TECH; Center for Health Statistics and Information Ministry of Health, 2009, ANAL REPORT NATL HLT; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; ELVEBACK LR, 1986, MAYO CLIN PROC, V61, P896, DOI 10.1016/S0025-6196(12)62612-3; Gandjour A, 1999, PHARMACOECONOMICS, V16, P141, DOI 10.2165/00019053-199916020-00003; Gardner AW, 2011, ANGIOLOGY, V62, P461, DOI 10.1177/0003319711399897; GIBBONS RJ, 2002, ACC AHA 2002 GUIDELI; Goldsmith KA, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-96; Hemingway H, 2008, CIRCULATION, V117, P1526, DOI 10.1161/CIRCULATIONAHA.107.720953; Jin H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041550; KANNEL WB, 1972, AM J CARDIOL, V29, P154, DOI 10.1016/0002-9149(72)90624-8; Kardas P, 2007, VASC HEALTH RISK MAN, V3, P235, DOI 10.2147/vhrm.2007.3.2.235; Kiessling A, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-13; Kimble LP, 2011, J ADV NURS, V67, P1000, DOI 10.1111/j.1365-2648.2010.05564.x; Kimble LP, 2003, PAIN, V101, P45, DOI 10.1016/S0304-3959(02)00319-6; Lam CLK, 2008, VALUE HEALTH, V11, P295, DOI 10.1111/j.1524-4733.2007.00233.x; Le Grande MR, 2012, PSYCHOL HEALTH MED, V17, P709, DOI 10.1080/13548506.2012.661865; LERNER DJ, 1986, AM HEART J, V111, P383, DOI 10.1016/0002-8703(86)90155-9; Li MH, 2010, CHINESE PHARM EC, V3, P22; Liu SH, 2003, THESIS TIANJIN MED U; Liu XT, 1997, CHINESE J ERGONOMICS, V2, P49; Luo Nan, 2003, Health Qual Life Outcomes, V1, P7, DOI 10.1186/1477-7525-1-7; McGillion M, 2008, CURR CARDIOL REV, V4, P1, DOI 10.2174/157340308783565393; Miklaucich M, 1998, J ADV NURS, V28, P1207, DOI 10.1046/j.1365-2648.1998.00828.x; National Bureau of Statistics of China, NAT DAT SEARCH; National Institute for Clinical Excellence, 2008, GUID METH HLTH TECHN; National Institute for Health and Clinical Excellence, 2012, MAN STABL ANG; Pocock SJ, 1996, CIRCULATION, V94, P135, DOI 10.1161/01.CIR.94.2.135; SPERTUS JA, 1994, AM J CARDIOL, V74, P1240, DOI 10.1016/0002-9149(94)90555-X; SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9; Sullivan PW, 2005, MED CARE, V43, P736, DOI 10.1097/01.mlr.0000172050.67085.4f; The Task Force on the Management of stable angina pectoris of the European Society of Cardiology European Society of Cardiology (ESC), 2006, GUID MAN STABL ANG P; Vicari RM, 2005, J AM COLL CARDIOL, V46, P1803, DOI 10.1016/j.jacc.2005.07.047; Walters Stephen J, 2003, Health Qual Life Outcomes, V1, P4, DOI 10.1186/1477-7525-1-4; Wang H, 2005, QUAL LIFE RES, V14, P119, DOI 10.1007/s11136-004-0612-6; Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771; Werdan K, 2012, CLIN RES CARDIOL, V101, P365, DOI 10.1007/s00392-011-0402-4; WIKLUND I, 1991, CLIN CARDIOL, V14, P204, DOI 10.1002/clc.4960140306; Zhao FL, 2010, QUAL LIFE RES, V19, P1273, DOI 10.1007/s11136-010-9697-2; Zhao FL, 2010, VALUE HEALTH, V13, P649, DOI 10.1111/j.1524-4733.2010.00728.x	43	12	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97294	10.1371/journal.pone.0097294	http://dx.doi.org/10.1371/journal.pone.0097294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9SK	24842793	Green Published, gold, Green Submitted			2022-12-25	WOS:000340948600022
J	Li, SH; Izumi, T; Hu, J; Jin, HH; Siddiqui, AAA; Jacobson, SG; Bok, D; Jin, MH				Li, Songhua; Izumi, Tadahide; Hu, Jane; Jin, Heather H.; Siddiqui, Ahmed-Abdul A.; Jacobson, Samuel G.; Bok, Dean; Jin, Minghao			Rescue of Enzymatic Function for Disease-associated RPE65 Proteins Containing Various Missense Mutations in Non-active Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINAL-PIGMENT EPITHELIUM; LEBER CONGENITAL AMAUROSIS; 2 POINT MUTATIONS; ISOMEROHYDROLASE ACTIVITY; VISUAL CYCLE; GENE-THERAPY; RETINITIS-PIGMENTOSA; BINDING PROTEIN; ER-STRESS; MUTANT MYOCILINS	Over 70 different missense mutations, including a dominant mutation, in RPE65 retinoid isomerase are associated with distinct forms of retinal degeneration; however, the disease mechanisms for most of these mutations have not been studied. Although some mutations have been shown to abolish enzyme activity, the molecular mechanisms leading to the loss of enzymatic function and retinal degeneration remain poorly understood. Here we show that the 26 S proteasome non-ATPase regulatory subunit 13 (PSMD13), a newly identified negative regulator of RPE65, plays a critical role in regulating pathogenicity of three mutations (L22P, T101I, and L408P) by mediating rapid degradation of mutated RPE65s via a ubiquitinationand proteasome-dependent non-lysosomal pathway. These mutant RPE65s were misfolded and formed aggregates or high molecular complexes via disulfide bonds. Interaction of PSMD13 with mutant RPE65s promoted degradation of misfolded but not properly folded mutant RPE65s. Many mutations, including L22P, T101I, and L408P, were mapped on non-active sites. Although their activities were very low, these mutant RPE65s were catalytically active and could be significantly rescued at low temperature, whereas mutant RPE65s with a distinct active site mutation could not be rescued under the same conditions. Sodium 4-phenylbutyrate and glycerol displayed a significant synergistic effect on the low temperature rescue of the mutant RPE65s by promoting proper folding, reducing aggregation, and increasing membrane association. Our results suggest that a low temperature eye mask and sodium 4-phenylbutyrate, a United States Food and Drug Administration- approved oral medicine, may provide a promising "protein repair therapy" that can enhance the efficacy of gene therapy by reducing the cytotoxic effect of misfolded mutant RPE65s.	[Li, Songhua; Jin, Minghao] Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, New Orleans, LA 70112 USA; [Li, Songhua; Jin, Minghao] Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr, New Orleans, LA 70112 USA; [Izumi, Tadahide] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Hu, Jane; Bok, Dean] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Hu, Jane; Bok, Dean] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; [Jin, Heather H.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Siddiqui, Ahmed-Abdul A.] Tulane Univ, Dept Neurosci, New Orleans, LA 70118 USA; [Jacobson, Samuel G.] Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Kentucky; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Washington University (WUSTL); Tulane University; University of Pennsylvania; Pennsylvania Medicine	Jin, MH (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, 2020 Gravier St, New Orleans, LA 70112 USA.	mjin@lsuhsc.edu		Jacobson, Samuel/0000-0003-2122-169X	National Institutes of Health [EY021208, CA098664, EY017280, P30-GM103340]; Macula Vision Research Foundation; Research to Prevent Blindness; NATIONAL CANCER INSTITUTE [R01CA098664, R56CA098664] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021208, U10EY017280] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103340] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Macula Vision Research Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY021208 (to M. J.), CA098664 (to T. I.), EY017280 (to S. G. J.), and P30-GM103340 (to Louisiana State University Neuroscience Center of Biomedical Research Excellence core facility). This work was also supported by a Macula Vision Research Foundation grant (to D. B.) and a Research to Prevent Blindness grant (to Louisiana State University Department of Ophthalmology).	Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bonapace G, 2004, P NATL ACAD SCI USA, V101, P12300, DOI 10.1073/pnas.0404764101; Bowne SJ, 2011, EUR J HUM GENET, V19, P1074, DOI 10.1038/ejhg.2011.86; Busso CS, 2009, ONCOGENE, V28, P1616, DOI 10.1038/onc.2009.5; Carlson A, 1999, INVEST OPHTH VIS SCI, V40, P533; CARLSON A, 1992, BIOCHEMISTRY-US, V31, P9056, DOI 10.1021/bi00152a049; Chen Y, 2006, FEBS LETT, V580, P4200, DOI 10.1016/j.febslet.2006.06.078; Cideciyan AV, 2013, P NATL ACAD SCI USA, V110, pE517, DOI 10.1073/pnas.1218933110; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Duricka DL, 2012, BIOCHEM J, V441, P685, DOI 10.1042/BJ20111004; Golczak M, 2010, J BIOL CHEM, V285, P9667, DOI 10.1074/jbc.M109.063941; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; HAMEL CP, 1993, J BIOL CHEM, V268, P15751; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Hu J, 2001, MOL VIS, V7, P14; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Jin MH, 2007, J BIOL CHEM, V282, P20915, DOI 10.1074/jbc.M701432200; Jin MH, 2009, J NEUROSCI, V29, P1486, DOI 10.1523/JNEUROSCI.3882-08.2009; Joe MK, 2003, BIOCHEM BIOPH RES CO, V312, P592, DOI 10.1016/j.bbrc.2003.10.162; Kiser PD, 2012, P NATL ACAD SCI USA, V109, pE2747, DOI 10.1073/pnas.1212025109; Kiser PD, 2009, P NATL ACAD SCI USA, V106, P17325, DOI 10.1073/pnas.0906600106; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Li SH, 2013, J BIOL CHEM, V288, P11395, DOI 10.1074/jbc.M112.418251; Li SH, 2013, J NEUROSCI, V33, P3178, DOI 10.1523/JNEUROSCI.2428-12.2013; Liao JL, 2010, HUM MOL GENET, V19, P4229, DOI 10.1093/hmg/ddq341; Lobanova ES, 2013, P NATL ACAD SCI USA, V110, P9986, DOI 10.1073/pnas.1305521110; Lotery AJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P538; MAESTRI NE, 1991, J PEDIATR-US, V119, P923, DOI 10.1016/S0022-3476(05)83044-6; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Moiseyev G, 2003, BIOCHEMISTRY-US, V42, P2229, DOI 10.1021/bi026911y; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Nikolaeva O, 2010, BIOCHEM BIOPH RES CO, V391, P1757, DOI 10.1016/j.bbrc.2009.12.149; Nikolaeva O, 2009, FEBS J, V276, P3020, DOI 10.1111/j.1742-4658.2009.07021.x; Pang JJ, 2005, MOL VIS, V11, P152; Philpa AR, 2009, HUM MUTAT, V30, P1183, DOI 10.1002/humu.21033; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Rubenstein RC, 1998, AM J RESP CRIT CARE, V157, P484, DOI 10.1164/ajrccm.157.2.9706088; Rubenstein Ronald C., 1998, Current Opinion in Pediatrics, V10, P250, DOI 10.1097/00008480-199806000-00005; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; Samardzija M, 2008, HUM MOL GENET, V17, P281, DOI 10.1093/hmg/ddm304; Sato K, 2013, J NEUROSCI, V33, P17458, DOI 10.1523/JNEUROSCI.1380-13.2013; Shang F, 2012, PROG MOL BIOL TRANSL, V109, P347, DOI 10.1016/B978-0-12-397863-9.00010-9; SHIRASAWA H, 1994, VIROLOGY, V203, P36, DOI 10.1006/viro.1994.1452; Takahashi Y, 2005, FEBS LETT, V579, P5414, DOI 10.1016/j.febslet.2005.09.002; Takahashi Y, 2006, J BIOL CHEM, V281, P21820, DOI 10.1074/jbc.M603725200; Takahashi Y, 2009, J BIOL CHEM, V284, P3211, DOI 10.1074/jbc.M807248200; Takeuchi J, 1999, MOL CELL BIOL, V19, P6575; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; Vollrath D, 2006, EXP EYE RES, V82, P1030, DOI 10.1016/j.exer.2005.10.007; WILKINSON KD, 1980, J BIOL CHEM, V255, P7529; Winston A, 1998, BIOCHEMISTRY-US, V37, P2044, DOI 10.1021/bi971908d; Won JY, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/391384; Wright CB, 2014, INVEST OPHTH VIS SCI, V55, P2500, DOI 10.1167/iovs.13-13574; Wright CB, 2013, INVEST OPHTH VIS SCI, V54, P5111, DOI 10.1167/iovs.13-12336; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Zode GS, 2011, J CLIN INVEST, V121, P3542, DOI 10.1172/JCI58183	63	31	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18943	18956		10.1074/jbc.M114.552117	http://dx.doi.org/10.1074/jbc.M114.552117			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24849605	hybrid, Green Published			2022-12-25	WOS:000339062900027
J	Dorland, A; Rytwinski, T; Fahrig, L				Dorland, Alexandra; Rytwinski, Trina; Fahrig, Lenore			Do Roads Reduce Painted Turtle (Chrysemys picta) Populations?	PLOS ONE			English	Article							FRESH-WATER TURTLES; LANDSCAPE COMPOSITION; EMYDOIDEA-BLANDINGII; GOPHERUS-AGASSIZII; PSEUDEMYS-SCRIPTA; HABITAT FEATURES; SPATIAL SCALES; SEX-RATIO; MORTALITY; PREDATION	Road mortality is thought to be a leading cause of turtle population decline. However, empirical evidence of the direct negative effects of road mortality on turtle population abundance is lacking. The purpose of this study was to provide a strong test of the prediction that roads reduce turtle population abundance. While controlling for potentially confounding variables, we compared relative abundance of painted turtles (Chrysemys picta) in 20 ponds in Eastern Ontario, 10 as close as possible to high traffic roads (Road sites) and 10 as far as possible from any major roads (No Road sites). There was no significant effect of roads on painted turtle relative abundance. Furthermore, our data do not support other predictions of the road mortality hypothesis; we observed neither a higher relative frequency of males to females at Road sites than at No Road sites, nor a lower average body size of turtles at Road than at No Road sites. We speculate that, although roads can cause substantial adult mortality in turtles, other factors, such as release from predation on adults and/or nests close to roads counter the negative effect of road mortality in some populations. We suggest that road mitigation for painted turtles can be limited to locations where turtles are forced to migrate across high traffic roads due, for example, to destruction of local nesting habitat or seasonal drying of ponds. This conclusion should not be extrapolated to other species of turtles, where road mortality could have a larger population-level effect than on painted turtles.	[Dorland, Alexandra; Rytwinski, Trina; Fahrig, Lenore] Carleton Univ, Dept Biol, Geomat & Landscape Ecol Res Lab, Ottawa, ON K1S 5B6, Canada	Carleton University	Rytwinski, T (corresponding author), Carleton Univ, Dept Biol, Geomat & Landscape Ecol Res Lab, Ottawa, ON K1S 5B6, Canada.	trytwinski@hotmail.com	Fahrig, Lenore/C-6494-2012	Fahrig, Lenore/0000-0002-3841-0342	Natural Sciences and Engineering Research Council of Canada [OGP197309]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was funded by the Natural Sciences and Engineering Research Council of Canada (Grant #:OGP197309). http://www.nserc-crsng.gc.ca/index_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aresco MJ, 2005, BIOL CONSERV, V123, P37, DOI 10.1016/j.biocon.2004.10.006; Aresco MJ, 2004, J HERPETOL, V38, P249, DOI 10.1670/169-03A; Aresco MJ, 2003, N CAR STAT U RAL P I, P433; Ashley EP, 1996, CAN FIELD NAT, V110, P403; Baldwin EA, 2004, NORTHEAST NAT, V11, P41, DOI 10.1656/1092-6194(2004)011[0041:THUBNP]2.0.CO;2; Beaudry F, 2008, BIOL CONSERV, V141, P2550, DOI 10.1016/j.biocon.2008.07.016; Boarman WI, 2006, J ARID ENVIRON, V65, P94, DOI 10.1016/j.jaridenv.2005.06.020; Bowne DR, 2004, ANIM BEHAV, V68, P1401, DOI 10.1016/j.anbehav.2004.01.018; Bulte G, 2010, AQUAT CONSERV, V20, P31, DOI [10.1002/aqc.1063, 10.1002/aqc.1089]; Bulte G, 2009, ECOSCIENCE, V16, P175, DOI 10.2980/16-2-3243; Burke VJ, 1995, CONSERV BIOL, V9, P1365, DOI 10.1046/j.1523-1739.1995.09061365.x; Bury RB, 2011, J WILDLIFE MANAGE, V75, P3, DOI 10.1002/jwmg.31; Caldwell IR, 2006, CAN J ZOOL, V84, P1129, DOI 10.1139/Z06-102; Carr LW, 2001, CONSERV BIOL, V15, P1071, DOI 10.1046/j.1523-1739.2001.0150041071.x; CHRISTENS E, 1987, HERPETOLOGICA, V43, P55; Congdon JD, 2003, EXP GERONTOL, V38, P765, DOI 10.1016/S0531-5565(03)00106-2; Congdon Justin D., 1996, P137, DOI 10.1016/B978-012178075-3/50007-6; Crawford BA, 2014, J APPL ECOL, V51, P359, DOI 10.1111/1365-2664.12194; Dorcas ME, 2007, BIOL CONSERV, V137, P334, DOI 10.1016/j.biocon.2007.02.014; Eigenbrod F, 2008, BIOL CONSERV, V141, P35, DOI 10.1016/j.biocon.2007.08.025; Ernst CH, 2009, TURTLES US CANADA; Fahrig L, 2009, ECOL SOC, V14; Findlay CS, 1997, CONSERV BIOL, V11, P1000, DOI 10.1046/j.1523-1739.1997.96144.x; Findlay CS, 2000, CONSERV BIOL, V14, P86, DOI 10.1046/j.1523-1739.2000.99086.x; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Fowle SC, 1996, THESIS U MONTANA MIS, P55; FRAZER NB, 1993, AM MIDL NAT, V130, P314, DOI 10.2307/2426130; Galois P, 2007, CHELONIAN CONSERV BI, V6, P288, DOI 10.2744/1071-8443(2007)6[288:TIIESS]2.0.CO;2; GARBER SD, 1995, ECOL APPL, V5, P1151, DOI 10.2307/2269362; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Gibbs JP, 2005, CONSERV BIOL, V19, P552, DOI 10.1111/j.1523-1739.2005.000155.x; Gibbs JP, 2002, CONSERV BIOL, V16, P1647, DOI 10.1046/j.1523-1739.2002.01215.x; Janzen FJ, 2001, ANIM BEHAV, V62, P73, DOI 10.1006/anbe.2000.1732; Jones MT, 2012, HERPETOL CONSERV BIO, V7, P89; Kolbe JJ, 2002, OIKOS, V99, P538, DOI 10.1034/j.1600-0706.2002.11853.x; Langen TA, 2009, AM05405 MOU NEW YORK; Larocque SM, 2012, ANIM CONSERV, V15, P53, DOI 10.1111/j.1469-1795.2011.00487.x; MAHMOUD I Y, 1968, Herpetologica, V24, P158; Marchand MA, 2002, WILDLIFE SOC B, V30, P1092; Marchand MN, 2004, CONSERV BIOL, V18, P758, DOI 10.1111/j.1523-1739.2004.00019.x; Marchand MN, 2004, BIOL CONSERV, V117, P243, DOI 10.1016/j.biocon.2003.07.003; MITCHELL J.C, 1988, HERPETOL MONOGR, V2, P40, DOI DOI 10.2307/1467026; MOLL E O, 1973, Herpetologica, V29, P307; MORREALE SJ, 1984, CAN J ZOOL, V62, P1038, DOI 10.1139/z84-148; Nafus MG, 2013, BIOL CONSERV, V162, P100, DOI 10.1016/j.biocon.2013.04.009; PARKER WS, 1984, AM MIDL NAT, V112, P280, DOI 10.2307/2425435; Patrick DA, 2010, LANDSCAPE ECOL, V25, P791, DOI 10.1007/s10980-010-9459-0; Proulx CL, 2014, J HERPETOL, V48, P267, DOI 10.1670/12-176; Refsnider JM, 2012, HERPETOL CONSERV BIO, V7, P185; Roe JH, 2011, J WILDLIFE MANAGE, V75, P1544, DOI 10.1002/jwmg.219; Rowe JW, 2003, J HERPETOL, V37, P342, DOI 10.1670/0022-1511(2003)037[0342:AAMOMP]2.0.CO;2; Rytwinski T, 2013, OECOLOGIA, V173, P1143, DOI 10.1007/s00442-013-2684-x; Rytwinski T, 2012, BIOL CONSERV, V147, P87, DOI 10.1016/j.biocon.2011.11.023; Rytwinski T, 2011, ECOL APPL, V21, P589, DOI 10.1890/10-0968.1; Schlaepfer MA, 2005, BIOSCIENCE, V55, P256, DOI 10.1641/0006-3568(2005)055[0256:CIETIO]2.0.CO;2; SHINE R, 1995, OIKOS, V72, P343, DOI 10.2307/3546119; Steen DA, 2006, ANIM CONSERV, V9, P269, DOI 10.1111/j.1469-1795.2006.00032.x; Steen DA, 2004, CONSERV BIOL, V18, P1143, DOI 10.1111/j.1523-1739.2004.00240.x; TEMPLE SA, 1987, COPEIA, P250, DOI 10.2307/1446069; TINKLE DW, 1981, ECOLOGY, V62, P1426, DOI 10.2307/1941498; WILBUR HM, 1975, ECOLOGY, V56, P64, DOI 10.2307/1935300; Wood RC, 1997, P CONSERVATION RESTO, V1, P46	62	15	16	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98414	10.1371/journal.pone.0098414	http://dx.doi.org/10.1371/journal.pone.0098414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858065	Green Published, gold			2022-12-25	WOS:000336839400076
J	Laurent, VM; Duperray, A; Rajan, VS; Verdier, C				Laurent, Valerie M.; Duperray, Alain; Rajan, Vinoth Sundar; Verdier, Claude			Atomic Force Microscopy Reveals a Role for Endothelial Cell ICAM-1 Expression in Bladder Cancer Cell Adherence	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; N-CADHERIN; SPECTROSCOPY; STRENGTH; MIGRATION; BONDS; EXTRAVASATION; METASTASIS; CARCINOMA; SELECTIN	Cancer metastasis is a complex process involving cell-cell interactions mediated by cell adhesive molecules. In this study we determine the adhesion strength between an endothelial cell monolayer and tumor cells of different metastatic potentials using Atomic Force Microscopy. We show that the rupture forces of receptor-ligand bonds increase with retraction speed and range between 20 and 70 pN. It is shown that the most invasive cell lines (T24, J82) form the strongest bonds with endothelial cells. Using ICAM-1 coated substrates and a monoclonal antibody specific for ICAM-1, we demonstrate that ICAM-1 serves as a key receptor on endothelial cells and that its interactions with ligands expressed by tumor cells are correlated with the rupture forces obtained with the most invasive cancer cells (T24, J82). For the less invasive cancer cells (RT112), endothelial ICAM-1 does not seem to play any role in the adhesion process. Moreover, a detailed analysis of the distribution of rupture forces suggests that ICAM-1 interacts preferentially with one ligand on T24 cancer cells and with two ligands on J82 cancer cells. Possible counter receptors for these interactions are CD43 and MUC1, two known ligands for ICAM-1 which are expressed by these cancer cells.	[Laurent, Valerie M.; Verdier, Claude] Univ Grenoble Alpes, LIPHY, F-38000 Grenoble, France; [Laurent, Valerie M.; Verdier, Claude] CNRS, LIPHY, F-38000 Grenoble, France; [Duperray, Alain; Rajan, Vinoth Sundar] INSERM, IAB, F-38000 Grenoble, France; [Duperray, Alain; Rajan, Vinoth Sundar] Univ Grenoble Alpes, IAB, F-38000 Grenoble, France; [Duperray, Alain; Rajan, Vinoth Sundar] CHU Grenoble, IAB, F-38000 Grenoble, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Laurent, VM (corresponding author), Univ Grenoble Alpes, LIPHY, F-38000 Grenoble, France.	valerie.laurent@ujf-grenoble.fr	Verdier, Claude/C-1419-2008; Duperray, Alain/E-8428-2012; Laurent, Valerie M./K-6506-2015	Verdier, Claude/0000-0003-3706-7148; Duperray, Alain/0000-0002-2719-252X; 	Nanosciences Foundation; ANR Transmig; La Ligue contre le cancer; LabeX Tec21	Nanosciences Foundation; ANR Transmig(French National Research Agency (ANR)); La Ligue contre le cancer(Ligue nationale contre le cancer); LabeX Tec21	The sources of funding that have supported the work are Nanosciences Foundation, ANR Transmig, La Ligue contre le cancer, LabeX Tec21. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Benoit M, 2000, NAT CELL BIOL, V2, P313, DOI 10.1038/35014000; Buitrago D, 2012, ANN SURG ONCOL, V19, P973, DOI 10.1245/s10434-011-2029-0; Canetta E, 2005, BIORHEOLOGY, V42, P321; CARPEN O, 1992, J CELL BIOL, V118, P1223, DOI 10.1083/jcb.118.5.1223; Champelovier P, 2003, CLIN CANCER RES, V9, P4562; Chotard-Ghodsnia R, 2007, J BIOMECH, V40, P335, DOI 10.1016/j.jbiomech.2006.01.001; Chu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064187; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Geng Y, 2012, FRONT ONCOL, V2, P1, DOI 10.2389/fonc.2012.00076; Geng Y, 2012, ANN BIOMED ENG, V40, P790, DOI 10.1007/s10439-011-0463-6; Haddad O, 2010, EXP CELL RES, V316, P615, DOI 10.1016/j.yexcr.2009.11.015; Hanley WD, 2004, J CELL SCI, V117, P2503, DOI 10.1242/jcs.01088; Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999; Heyder C, 2005, CLIN EXP METASTAS, V22, P99, DOI 10.1007/s10585-005-4335-z; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; Klemke M, 2007, J CELL PHYSIOL, V212, P368, DOI 10.1002/jcp.21029; Laidler P, 2000, ACTA BIOCHIM POL, V47, P1159, DOI 10.18388/abp.2000_3968; Lascombe I, 2006, CLIN CANCER RES, V12, P2780, DOI 10.1158/1078-0432.CCR-05-2387; Lekka M, 2011, J MOL RECOGNIT, V24, P833, DOI 10.1002/jmr.1123; Li FY, 2003, BIOPHYS J, V84, P1252, DOI 10.1016/S0006-3495(03)74940-6; Litvinov RI, 2002, P NATL ACAD SCI USA, V99, P7426, DOI 10.1073/pnas.112194999; Miles FL, 2008, CLIN EXP METASTAS, V25, P305, DOI 10.1007/s10585-007-9098-2; Panorchan P, 2006, J CELL SCI, V119, P66, DOI 10.1242/jcs.02719; Pincet F, 2005, BIOPHYS J, V89, P4374, DOI 10.1529/biophysj.105.067769; Pittet P, 2008, J CELL SCI, V121, P877, DOI 10.1242/jcs.024877; Puech PH, 2006, ULTRAMICROSCOPY, V106, P637, DOI 10.1016/j.ultramic.2005.08.003; Regimbald LH, 1996, CANCER RES, V56, P4244; Roche Y, 2003, THROMB HAEMOSTASIS, V89, P1089, DOI 10.1055/s-0037-1613412; ROSENSTEIN Y, 1991, NATURE, V354, P233, DOI 10.1038/354233a0; Sans E, 2001, J IMMUNOL, V166, P544, DOI 10.4049/jimmunol.166.1.544; Santamaria M, 1996, CANCER RES, V56, P3526; Schroder C, 2011, J CANCER RES CLIN, V137, P1193, DOI 10.1007/s00432-011-0984-2; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Strell C, 2008, CELL COMMUN SIGNAL, V6, P1; van Buul JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011336; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Wojcikiewicz E, 2003, BIOL P, V6, P1; Wojcikiewicz EP, 2006, BIOMACROMOLECULES, V7, P3188, DOI 10.1021/bm060559c; Yamada M, 2006, CLIN EXP IMMUNOL, V143, P216, DOI 10.1111/j.1365-2249.2005.02989.x; Zhang XH, 2004, AM J PHYSIOL-HEART C, V286, pH359, DOI 10.1152/ajpheart.00491.2003; Zhang XH, 2002, BIOPHYS J, V83, P2270, DOI 10.1016/S0006-3495(02)73987-8; Zhang XH, 2006, EXP BIOL MED, V231, P1306, DOI 10.1177/153537020623100804	44	38	38	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98034	10.1371/journal.pone.0098034	http://dx.doi.org/10.1371/journal.pone.0098034			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24857933	Green Submitted, gold, Green Published			2022-12-25	WOS:000336839400035
J	Queiroz, EAIF; Puukila, S; Eichler, R; Sampaio, SC; Forsyth, HL; Lees, SJ; Barbosa, AM; Dekker, RFH; Fortes, ZB; Khaper, N				Queiroz, Eveline A. I. F.; Puukila, Stephanie; Eichler, Rosangela; Sampaio, Sandra C.; Forsyth, Heidi L.; Lees, Simon J.; Barbosa, Aneli M.; Dekker, Robert F. H.; Fortes, Zuleica B.; Khaper, Neelam			Metformin Induces Apoptosis and Cell Cycle Arrest Mediated by Oxidative Stress, AMPK and FOXO3a in MCF-7 Breast Cancer Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; IN-VIVO; INSULIN-RESISTANCE; TUMOR SUPPRESSORS; GROWTH; INHIBITION; OBESITY; AUTOPHAGY; PROSTATE; AKT	Recent studies have demonstrated that the anti-diabetic drug, metformin, can exhibit direct antitumoral effects, or can indirectly decrease tumor proliferation by improving insulin sensitivity. Despite these recent advances, the underlying molecular mechanisms involved in decreasing tumor formation are not well understood. In this study, we examined the antiproliferative role and mechanism of action of metformin in MCF-7 cancer cells treated with 10 mM of metformin for 24, 48, and 72 hours. Using BrdU and the MTT assay, it was found that metformin demonstrated an antiproliferative effect in MCF-7 cells that occurred in a time-and concentration-dependent manner. Flow cytometry was used to analyze markers of cell cycle, apoptosis, necrosis and oxidative stress. Exposure to metformin induced cell cycle arrest in G(0)-G(1) phase and increased cell apoptosis and necrosis, which were associated with increased oxidative stress. Gene and protein expression were determined in MCF-7 cells by real time RT-PCR and western blotting, respectively. In MCF-7 cells metformin decreased the activation of IRb, Akt and ERK1/2, increased p-AMPK, FOXO3a, p27, Bax and cleaved caspase-3, and decreased phosphorylation of p70S6K and Bcl-2 protein expression. Co-treatment with metformin and H2O2 increased oxidative stress which was associated with reduced cell number. In the presence of metformin, treating with SOD and catalase improved cell viability. Treatment with metformin resulted in an increase in p-p38 MAPK, catalase, MnSOD and Cu/Zn SOD protein expression. These results show that metformin has an antiproliferative effect associated with cell cycle arrest and apoptosis, which is mediated by oxidative stress, as well as AMPK and FOXO3a activation. Our study further reinforces the potential benefit of metformin in cancer treatment and provides novel mechanistic insight into its antiproliferative role.	[Queiroz, Eveline A. I. F.; Eichler, Rosangela; Sampaio, Sandra C.; Fortes, Zuleica B.] Univ Sao Paulo, Dept Pharmacol, Inst Biomed Sci, Sao Paulo, Brazil; [Queiroz, Eveline A. I. F.] Univ Estadual Londrina, Dept Physiol Sci, Londrina, Parana, Brazil; [Barbosa, Aneli M.; Dekker, Robert F. H.] Lakehead Univ, Biorefining Res Inst, Thunder Bay, ON P7B 5E1, Canada; [Forsyth, Heidi L.; Lees, Simon J.; Khaper, Neelam] Lakehead Univ, Northern Ontario Sch Med, Thunder Bay, ON P7B 5E1, Canada; [Puukila, Stephanie; Lees, Simon J.; Khaper, Neelam] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada	Universidade de Sao Paulo; Universidade Estadual de Londrina; Lakehead University; Lakehead University; Northern Ontario School of Medicine; Lakehead University	Fortes, ZB (corresponding author), Univ Sao Paulo, Dept Pharmacol, Inst Biomed Sci, Sao Paulo, Brazil.	zbfortes@icb.usp.br; nkhaper@nosm.ca	Sampaio, Sandra/D-1585-2012; Vessoni, Sandra/AAA-5380-2021; Barbosa-Dekker, Aneli/F-9936-2013; Eichler, Rosangela/Q-4967-2019; Dekker, Robert/AAM-1597-2020	Vessoni, Sandra/0000-0001-6257-3531; Barbosa-Dekker, Aneli/0000-0002-2339-8985; Eichler, Rosangela/0000-0002-7629-0089; Dekker, Robert F. H./0000-0002-3787-6917; Isquierdo Fonseca de Queiroz, Eveline Aparecida/0000-0002-8094-1585	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Sao Paulo (Brazil); NSERC-Research Capacity Development - Canada; NOSM	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Sao Paulo (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NSERC-Research Capacity Development - Canada; NOSM	E.A.I.F. Queiroz is grateful to Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; Z.B. Fortes) Sao Paulo (Brazil) for a doctoral scholarship at USP (Brazil), and to study in Canada at Lakehead University. This project was conducted by E. A. I. F. Queiroz while a Visiting Scholar at the Biorefining Research Institute (BRI) and Northern Ontario School of Medicine (NOSM) under the supervision of N. Khaper, and funded by a grant from NSERC-Research Capacity Development - Canada (R. F. H. Dekker) and NOSM (N. Khaper). The authors are grateful to the BRI and NOSM for the conduct of this work and Dr. S. Gupta for critical reading of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Algire C, 2008, ENDOCR-RELAT CANCER, V15, P833, DOI 10.1677/ERC-08-0038; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; [Anonymous], 2008, GLOBOCAN DATABASE; Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Ben Sahra I, 2010, CANCER RES, V70, P2465, DOI 10.1158/0008-5472.CAN-09-2782; Berstein LM, 2011, BREAST CANCER RES TR, V128, P109, DOI 10.1007/s10549-010-1072-z; Borkhardt A, 1997, ONCOGENE, V14, P195, DOI 10.1038/sj.onc.1200814; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Cantrell LA, 2010, GYNECOL ONCOL, V116, P92, DOI 10.1016/j.ygyno.2009.09.024; Chen Y, 1998, ONCOGENE, V16, P1913, DOI 10.1038/sj.onc.1201719; Chiacchiera F, 2009, CELL DEATH DIFFER, V16, P1203, DOI 10.1038/cdd.2009.36; Chiacchiera F, 2009, AUTOPHAGY, V5, P1030, DOI 10.4161/auto.5.7.9252; Cuvillier O, 2001, CELL DEATH DIFFER, V8, P162, DOI 10.1038/sj.cdd.4400793; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; DiPaola RS, 2008, PROSTATE, V68, P1743, DOI 10.1002/pros.20837; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; de Mattos SF, 2008, MOL CANCER THER, V7, P3237, DOI 10.1158/1535-7163.MCT-08-0398; Franciosi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071583; Fuchs-Tarlovsky V, 2013, NUTRITION, V29, P15, DOI 10.1016/j.nut.2012.02.014; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Giannarelli R, 2003, DIABETES METAB, V29, pS28; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Greer EL, 2009, ANN NY ACAD SCI, V1170, P688, DOI 10.1111/j.1749-6632.2009.04019.x; Gruning NM, 2011, NATURE, V480, P190, DOI 10.1038/480190a; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Han J, 1999, NAT CELL BIOL, V1, pE39, DOI 10.1038/10032; Ho KK, 2008, ONCOGENE, V27, P2300, DOI 10.1038/onc.2008.23; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; HULL RN, 1953, SCIENCE, V117, P223, DOI 10.1126/science.117.3035.223; Hundal RS, 2003, DRUGS, V63, P1879, DOI 10.2165/00003495-200363180-00001; Hursting SD, 2012, ARTERIOSCL THROM VAS, V32, P1766, DOI 10.1161/ATVBAHA.111.241927; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Fonseca EAI, 2011, LIFE SCI, V88, P846, DOI 10.1016/j.lfs.2011.03.005; Jagani Z, 2008, BBA-REV CANCER, V1785, P63, DOI 10.1016/j.bbcan.2007.10.003; Kaaks R, 2002, CANCER EPIDEM BIOMAR, V11, P1531; Kaaks R, 1996, CANCER CAUSE CONTROL, V7, P605, DOI 10.1007/BF00051703; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lees SJ, 2008, CELL PROLIFERAT, V41, P193, DOI 10.1111/j.1365-2184.2008.00512.x; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Osorio-Costa F, 2009, ARQ BRAS ENDOCRINOL, V53, P213, DOI 10.1590/S0004-27302009000200013; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; PICK E, 1981, J IMMUNOL METHODS, V46, P211, DOI 10.1016/0022-1759(81)90138-1; PICK E, 1980, J IMMUNOL METHODS, V38, P161, DOI 10.1016/0022-1759(80)90340-3; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Pollak M, 2013, J CLIN INVEST, V123, P3693, DOI 10.1172/JCI67232; Pollak MN, 2007, AM J CLIN NUTR, V86, p820S, DOI 10.1093/ajcn/86.3.820S; Raisova M, 2001, J INVEST DERMATOL, V117, P333, DOI 10.1046/j.0022-202x.2001.01409.x; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; Rena G, 2013, DIABETOLOGIA, V56, P1898, DOI 10.1007/s00125-013-2991-0; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Rocha GZ, 2011, CLIN CANCER RES, V17, P3993, DOI 10.1158/1078-0432.CCR-10-2243; Ropelle ER, 2007, ENDOCRINOLOGY, V148, P5220, DOI 10.1210/en.2007-0381; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Seufert J, 2004, CLIN THER, V26, P805, DOI 10.1016/S0149-2918(04)90125-7; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Youle RJ, 2008, NATURE REV, V9, P4759; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Zakikhani M, 2008, CANCER PREV RES, V1, P369, DOI 10.1158/1940-6207.CAPR-08-0081; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010; Zhuang YX, 2011, MOL CANCER RES, V9, P603, DOI 10.1158/1541-7786.MCR-10-0343	74	182	194	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98207	10.1371/journal.pone.0098207	http://dx.doi.org/10.1371/journal.pone.0098207			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858012	Green Published, Green Submitted, gold			2022-12-25	WOS:000336839400055
J	Reybroeck, W; De Vleeschouwer, M; Marchand, S; Sinnaeve, D; Heylen, K; De Block, J; Madder, A; Martins, JC; Heyndrickx, M				Reybroeck, Wim; De Vleeschouwer, Matthias; Marchand, Sophie; Sinnaeve, Davy; Heylen, Kim; De Block, Jan; Madder, Annemieke; Martins, Jose C.; Heyndrickx, Marc			Cyclic Lipodepsipeptides Produced by Pseudomonas spp. Naturally Present in Raw Milk Induce Inhibitory Effects on Microbiological Inhibitor Assays for Antibiotic Residue Screening	PLOS ONE			English	Article							BIOLOGICAL-PROPERTIES; INDIVIDUAL COWS; PSYCHROTROPHIC BACTERIA; SPECIFICITY RATES; PSEUDOPHOMIN-B; TESTS; TOLAASII; SAMPLES; FLUORESCENS; MASTITIS	Two Pseudomonas strains, identified as closely related to Pseudomonas tolaasii, were isolated from milk of a farm with frequent false-positive Delvotest results for screening putative antibiotic residues in raw milk executed as part of the regulatory quality programme. Growth at 5 to 7 degrees C of these isolates in milk resulted in high lipolysis and the production of bacterial inhibitors. The two main bacterial inhibitors have a molecular weight of 1168.7 and 1140.7 Da respectively, are heat-tolerant and inhibit Geobacillus stearothermophilus var. calidolactis, the test strain of most of the commercially available microbiological inhibitor tests for screening of antibiotic residues in milk. Furthermore, these bacterial inhibitors show antimicrobial activity against Staphylococcus aureus, Bacillus cereus and B. subtilis and also interfere negatively with yoghurt production. Following their isolation and purification with RP-HPLC, the inhibitors were identified by NMR analysis as cyclic lipodepsipeptides of the viscosin group. Our findings bring to light a new challenge for quality control in the dairy industry. By prolonging the refrigerated storage of raw milk, the keeping quality of milk is influenced by growth and metabolic activities of psychrotrophic bacteria such as pseudomonads. Besides an increased risk of possible spoilage of long shelf-life milk, the production at low temperature of natural bacterial inhibitors may also result in false-positive results for antibiotic residue screening tests based on microbial inhibitor assays thus leading to undue production loss.	[Reybroeck, Wim; Marchand, Sophie; De Block, Jan; Heyndrickx, Marc] Inst Agr & Fisheries Res ILVO, Technol & Food Sci Unit, Melle, Belgium; [De Vleeschouwer, Matthias; Sinnaeve, Davy; Martins, Jose C.] Univ Ghent, UGent, Dept Organ Chem, NMR & Struct Anal Unit, B-9000 Ghent, Belgium; [De Vleeschouwer, Matthias; Madder, Annemieke] Univ Ghent, UGent, Dept Organ Chem, Organ & Biomimet Chem Res Unit, B-9000 Ghent, Belgium; [Heylen, Kim] Univ Ghent, UGent, Dept Biochem & Microbiol, Microbiol Lab, B-9000 Ghent, Belgium; [Heyndrickx, Marc] Univ Ghent, UGent, Dept Pathol Bacteriol & Poultry Dis, Merelbeke, Belgium	Institute For Agricultural & Fisheries Research; Ghent University; Ghent University; Ghent University; Ghent University	Reybroeck, W (corresponding author), Inst Agr & Fisheries Res ILVO, Technol & Food Sci Unit, Melle, Belgium.	Wim.Reybroeck@ilvo.vlaanderen.be	Martins, José C/A-3495-2008; Sinnaeve, Davy/F-2293-2013; Heyndrickx, Marc/AAM-1353-2020; Heylen, Kim/G-4085-2011	Sinnaeve, Davy/0000-0003-2556-5895; Heyndrickx, Marc/0000-0002-2913-2686; Madder, Annemieke/0000-0003-0179-7608; De Vleeschouwer, Matthias/0000-0001-6889-1928; Martins, Jose/0000-0001-7350-2253	Fund for Scientific Research Flanders (FWO-Vlaanderen) [G.0901.10, G.0422.13]; FFEU-ZWAP initiative of the Flemish Government; Hercules foundation	Fund for Scientific Research Flanders (FWO-Vlaanderen)(FWO); FFEU-ZWAP initiative of the Flemish Government; Hercules foundation	The Fund for Scientific Research Flanders (FWO-Vlaanderen) is funding the Ph.D. fellowship of Matthias De Vleeschouwer and the postdoctoral mandate of Davy Sinnaeve and joint research projects to Annemieke Madder and Jose C. Martins (G.0901.10 and G.0422.13). The FFEU-ZWAP initiative of the Flemish Government and the Hercules foundation were funding the 700 MHz and 500 MHz high-field NMR equipment respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew SM, 1997, J DAIRY SCI, V80, P3050, DOI 10.3168/jds.S0022-0302(97)76272-6; Andrew SM, 2001, J DAIRY SCI, V84, P100, DOI 10.3168/jds.S0022-0302(01)74457-8; Andrew SM, 2000, J DAIRY SCI, V83, P2992, DOI 10.3168/jds.S0022-0302(00)75200-3; [Anonymous], 1991, BULLETIN, V265, P26; [Anonymous], 2005, 6730 ISO; [Anonymous], 2002, OFF J EUR COMM L, V221, P8; [Anonymous], 2004, 7932 ISO; [Anonymous], 1997, 96593 AOAC; [Anonymous], 2006, 4832 ISO; [Anonymous], 1986, VOORSCHRIFTEN CHEM F; [Anonymous], 1989, 6B INT DAIR FED; Bassarello C, 2004, J NAT PROD, V67, P811, DOI 10.1021/np0303557; Both PT, 1999, MICROBIOLOGIE VOEDIN, P216; CARLSSON A, 1989, J DAIRY SCI, V72, P3166, DOI 10.3168/jds.S0022-0302(89)79475-3; CARLSSON A, 1992, J FOOD PROTECT, V55, P374, DOI 10.4315/0362-028X-55.5.374; Carlsson A, 1991, THESIS U AGR SCI UPP; Carlsson A, 1987, MILCHWISSENSCHAFT, V42, P283; Chan V, 2002, J EXP MICROBIOL IMMU, V2, P130; Commission E., 2004, OFF J EUR UNION, V139, P55; Coraiola M, 2006, BBA-BIOMEMBRANES, V1758, P1713, DOI 10.1016/j.bbamem.2006.06.023; CULLOR JS, 1992, VET MED-US, V87, P477; De Jonghe V, 2010, THESIS GHENT U GENT; Deeth H. C., 1983, Developments in Dairy Chemistry, V2, P195; Desbois AP, 2010, APPL MICROBIOL BIOT, V85, P1629, DOI 10.1007/s00253-009-2355-3; DRIESSEN FM, 1977, NETH MILK DAIRY J, V31, P40; DUTHIE AH, 1976, J MILK FOOD TECHNOL, V39, P774, DOI 10.4315/0022-2747-39.11.774; EC (European Commission), 2004, OFF J EUR UNION L, VL226, P22; EGAN J, 1984, IRISH J FOOD SCI TEC, V8, P115; Emanuele MC, 1998, FEBS LETT, V433, P317, DOI 10.1016/S0014-5793(98)00933-8; Gerard J, 1997, J NAT PROD, V60, P223, DOI 10.1021/np9606456; GINN RE, 1982, J FOOD PROTECT, V45, P571, DOI 10.4315/0362-028X-45.6.571; GOUDSWAARD J, 1978, TIJDSCHR DIERGENEESK, V103, P445; GRIFFITHS MW, 1981, J APPL BACTERIOL, V50, P289, DOI 10.1111/j.1365-2672.1981.tb00894.x; Halbert RW, 1996, J FOOD PROTECT, V59, P886; Hillerton JE, 1999, J DAIRY SCI, V82, P704, DOI 10.3168/jds.S0022-0302(99)75287-2; Kang JH, 2005, J DAIRY SCI, V88, P908, DOI 10.3168/jds.S0022-0302(05)72757-0; Kang JH, 2001, J FOOD PROTECT, V64, P1211, DOI 10.4315/0362-028X-64.8.1211; KITCHEN BJ, 1981, J DAIRY RES, V48, P167, DOI 10.1017/S0022029900021580; Korhonen H, 1995, BOVINE UDDER MASTITI, P76; KOSIKOWSKI FV, 1963, J DAIRY SCI, V46, P89, DOI 10.3168/jds.S0022-0302(63)88979-1; Lavermicocca P, 1997, PHYSIOL MOL PLANT P, V50, P129, DOI 10.1006/pmpp.1996.0078; Li W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062946; Lo Cantore P, 2006, MOL PLANT MICROBE IN, V19, P1113, DOI 10.1094/MPMI-19-1113; Marchand S, 2009, ENVIRON MICROBIOL, V11, P467, DOI 10.1111/j.1462-2920.2008.01785.x; Mayra-Makinen A, 1990, SCAND DAIRY INF, V2, P38; McPhee J.D., 2002, ENCY DAIRY SCI, V4, P2340; MORTISHIRESMITH RJ, 1991, TETRAHEDRON, V47, P3645, DOI 10.1016/S0040-4020(01)80877-2; Mullan W.M.A., 2003, MAJOR ANTIMICROBIAL; Mullan WMA, 2003, INHIBITORS MILK; Munsch P, 2002, MICROBIOL RES, V157, P311, DOI 10.1078/0944-5013-00159; Munsch-Alatossava P, 2006, MICROBIOL RES, V161, P334, DOI 10.1016/j.micres.2005.12.004; Naser S, 2005, J CLIN MICROBIOL, V43, P2224, DOI 10.1128/JCM.43.5.2224-2230.2005; Nielsen TH, 2002, APPL ENVIRON MICROB, V68, P3416, DOI 10.1128/AEM.68.7.3416-3423.2002; NUTKINS JC, 1991, J AM CHEM SOC, V113, P2621, DOI 10.1021/ja00007a040; Okada Y., 1986, Journal of the Japan Veterinary Medical Association, V39, P97; Pan Y, 2007, AUST J DAIRY TECHNOL, V62, P31; Pedras MSC, 2003, PHYTOCHEMISTRY, V62, P1105, DOI 10.1016/S0031-9422(02)00617-9; Peng JT, 1986, THESIS U LEEDS LEEDS; POLYCHRONIADOU A, 1988, J DAIRY RES, V55, P585, DOI 10.1017/S0022029900033379; Quail JW, 2002, ACTA CRYSTALLOGR C, V58, po268, DOI 10.1107/S0108270102004432; Raaijmakers JM, 2006, MOL PLANT MICROBE IN, V19, P699, DOI 10.1094/MPMI-19-0699; Raaijmakers JM, 2010, FEMS MICROBIOL REV, V34, P1037, DOI 10.1111/j.1574-6976.2010.00221.x; Rademaker JLW, 2009, A VANLEEUWENHOEK S, V95, P125, DOI [10.1007/s10482-009-9328-5, DOI 10.1007/S10482-009-9328-5]; RAINEY PB, 1991, PHYSIOL MOL PLANT P, V39, P57, DOI 10.1016/0885-5765(91)90031-C; Reybroeck W, 1997, MONOGRAPH RESIDUES C, P109; Reybroeck W., 2012, P EURORESIDUE 7 C RE, P197; Rokni-Zadeh H, 2012, APPL ENVIRON MICROB, V78, P4826, DOI 10.1128/AEM.00335-12; Rombaut R, 2006, INT DAIRY J, V16, P1362, DOI 10.1016/j.idairyj.2006.06.011; Romnee JM, 1999, LAIT, V79, P341, DOI 10.1051/lait:1999329; Ron EZ, 2001, ENVIRON MICROBIOL, V3, P229, DOI 10.1046/j.1462-2920.2001.00190.x; Rossignol G, 2009, RES MICROBIOL, V160, P337, DOI 10.1016/j.resmic.2009.04.004; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Scaloni A, 2004, BIOCHEM J, V384, P25, DOI 10.1042/BJ20040422; SCHIFFMANN AP, 1992, MILCHWISSENSCHAFT, V47, P770; Sinnaeve D, 2012, CHEM SCI, V3, P1284, DOI 10.1039/c2sc01088g; Sinnaeve D, 2009, CHEM-EUR J, V15, P12653, DOI 10.1002/chem.200901885; Sinnaeve D, 2009, TETRAHEDRON, V65, P4173, DOI 10.1016/j.tet.2009.03.045; STADHOUDERS J, 1963, NED MELK ZUI, V17, P96; Suhren G, 1995, SYMPOSIUM ON RESIDUES OF ANTIMICROBIAL DRUGS AND OTHER INHIBITORS IN MILK, P159; Tayeb LA, 2005, RES MICROBIOL, V156, P763, DOI 10.1016/j.resmic.2005.02.009; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tran H, 2007, NEW PHYTOL, V175, P731, DOI 10.1111/j.1469-8137.2007.02138.x; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; VANEENENNAAM AL, 1993, J DAIRY SCI, V76, P3041, DOI 10.3168/jds.S0022-0302(93)77644-4; WOLIN AG, 1958, J DAIRY SCI, V41, P34, DOI 10.3168/jds.S0022-0302(58)90863-4; Zvirdauskiene R, 2007, FOOD CONTROL, V18, P541, DOI 10.1016/j.foodcont.2006.01.003; 2003, 4833 ISO	87	10	10	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98266	10.1371/journal.pone.0098266	http://dx.doi.org/10.1371/journal.pone.0098266			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853676	Green Published, gold, Green Submitted			2022-12-25	WOS:000338323200058
J	Kraitsy, K; Uecal, M; Grossauer, S; Bruckmann, L; Pfleger, F; Ropele, S; Fazekas, F; Gruenbacher, G; Patz, S; Absenger, M; Porubsky, C; Smolle-Juettner, F; Tezer, I; Molcanyi, M; Fasching, U; Schaefer, U				Kraitsy, Klaus; Uecal, Muammer; Grossauer, Stefan; Bruckmann, Lukas; Pfleger, Florentina; Ropele, Stefan; Fazekas, Franz; Gruenbacher, Gerda; Patz, Silke; Absenger, Markus; Porubsky, Christian; Smolle-Juettner, Freyja; Tezer, Irem; Molcanyi, Marek; Fasching, Ulrike; Schaefer, Ute			Repetitive Long-Term Hyperbaric Oxygen Treatment (HBOT) Administered after Experimental Traumatic Brain Injury in Rats Induces Significant Remyelination and a Recovery of Sensorimotor Function	PLOS ONE			English	Article							MYELIN BASIC-PROTEIN; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; SOMATOSENSORY-EVOKED POTENTIALS; ISCHEMIA-REPERFUSION INJURY; FLUID-PERCUSSION INJURY; MITOCHONDRIAL-FUNCTION; CEREBRAL-ISCHEMIA; HEAD-INJURY; THERAPY; MODEL	Cells in the central nervous system rely almost exclusively on aerobic metabolism. Oxygen deprivation, such as injury-associated ischemia, results in detrimental apoptotic and necrotic cell loss. There is evidence that repetitive hyperbaric oxygen therapy (HBOT) improves outcomes in traumatic brain-injured patients. However, there are no experimental studies investigating the mechanism of repetitive long-term HBOT treatment-associated protective effects. We have therefore analysed the effect of long-term repetitive HBOT treatment on brain trauma-associated cerebral modulations using the lateral fluid percussion model for rats. Trauma-associated neurological impairment regressed significantly in the group of HBO-treated animals within three weeks post trauma. Evaluation of somatosensory-evoked potentials indicated a possible remyelination of neurons in the injured hemisphere following HBOT. This presumption was confirmed by a pronounced increase in myelin basic protein isoforms, PLP expression as well as an increase in myelin following three weeks of repetitive HBO treatment. Our results indicate that protective long-term HBOT effects following brain injury is mediated by a pronounced remyelination in the ipsilateral injured cortex as substantiated by the associated recovery of sensorimotor function.	[Kraitsy, Klaus; Uecal, Muammer; Pfleger, Florentina; Gruenbacher, Gerda; Patz, Silke; Fasching, Ulrike; Schaefer, Ute] Med Univ Graz, Res Unit Expt Neurotraumatol, Graz, Austria; [Grossauer, Stefan; Bruckmann, Lukas] Med Univ Graz, Dept Neurosurg, Graz, Austria; [Ropele, Stefan; Fazekas, Franz] Med Univ Graz, Clin Div Gen Neurol, Graz, Austria; [Absenger, Markus] Med Univ Graz, Med Res Ctr, Core Facil Microscopy, Graz, Austria; [Porubsky, Christian; Smolle-Juettner, Freyja; Tezer, Irem] Med Univ Graz, Dept Surg, Div Thorac & Hyperbar Surg, Graz, Austria; [Molcanyi, Marek] Univ Cologne, Dept Neurosurg, D-50931 Cologne, Germany; [Molcanyi, Marek] Univ Cologne, Inst Neurophysiol, D-50931 Cologne, Germany	Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; University of Cologne; University of Cologne	Schaefer, U (corresponding author), Med Univ Graz, Res Unit Expt Neurotraumatol, Graz, Austria.	ute.schaefer@medunigraz.at						Adamides AA, 2009, ACTA NEUROCHIR, V151, P1399, DOI 10.1007/s00701-009-0398-y; Amantini A, 2008, EUR J ANAESTH, V25, P196, DOI 10.1017/S0265021507003183; Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; Asou Hiroaki, 1995, Keio Journal of Medicine, V44, P47; Barrett KF, 2004, UNDERSEA HYPERBAR M, V31, P395; Bentz K, 2010, CELL PHYSIOL BIOCHEM, V26, P821, DOI 10.1159/000323991; Beynon C, 2012, J NEUROTRAUM, V29, P2109, DOI 10.1089/neu.2012.2365; Brkic P, 2012, BRAIN INJ; Butt AM, 1997, J NEUROSCI RES, V48, P588; Calvert JW, 2002, BRAIN RES, V951, P1, DOI 10.1016/S0006-8993(02)03094-9; Campbell J.N., 2011, J NEUROTRAUMA; Capello E, 1997, ANN NEUROL, V41, P797, DOI 10.1002/ana.410410616; Chang CF, 2000, EXP NEUROL, V166, P298, DOI 10.1006/exnr.2000.7506; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; CONTRERAS FL, 1988, J NEUROSURG, V68, P137, DOI 10.3171/jns.1988.68.1.0137; Crawford AH, 2013, J COMP PATHOL, V149, P242, DOI 10.1016/j.jcpa.2013.05.004; Cummins FJ, 2010, J CARDIOVASC TRANSL, V3, P683, DOI 10.1007/s12265-010-9221-7; Daugherty WP, 2004, J NEUROSURG, V101, P499, DOI 10.3171/jns.2004.101.3.0499; DeBruin LS, 2006, BIOCHEM CELL BIOL, V84, P993, DOI 10.1139/O06-180; Dell'Acqua ML, 2012, NEUROPATH APPL NEURO, V38, P454, DOI 10.1111/j.1365-2990.2011.01228.x; DEROSBO NK, 1991, DEV NEUROSCI-BASEL, V13, P34; Eovaldi B, 2010, NEUROPSYCH DIS TREAT, V6, P785, DOI 10.2147/NDT.S16071; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Freund P, 2012, J NEUROL NEUROSUR PS, V83, P629, DOI 10.1136/jnnp-2011-301875; Furlonger A J, 2000, Crit Care Resusc, V2, P246; Gambi D, 1996, ITAL J NEUROL SCI, V17, P23, DOI 10.1007/BF01995706; Golden Z, 2006, DISABIL REHABIL, V28, P1379, DOI 10.1080/09638280600638364; Golden ZL, 2002, INT J NEUROSCI, V112, P119, DOI 10.1080/00207450212027; Grin'kina NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053775; Harauz G, 2013, J NEUROCHEM, V125, P334, DOI 10.1111/jnc.12195; Harch PG, 2007, BRAIN RES, V1174, P120, DOI 10.1016/j.brainres.2007.06.105; Hardy P, 2007, J NEUROL SCI, V253, P94, DOI 10.1016/j.jns.2006.12.005; HOMAN RW, 1987, ELECTROEN CLIN NEURO, V66, P376, DOI 10.1016/0013-4694(87)90206-9; Huchzermeyer C, 2013, J CEREBR BLOOD F MET, V33, P263, DOI 10.1038/jcbfm.2012.165; Hyder F, 2006, J CEREBR BLOOD F MET, V26, P865, DOI 10.1038/sj.jcbfm.9600263; IULIANO BA, 1994, J NEUROL SCI, V123, P186, DOI 10.1016/0022-510X(94)90222-4; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Kao HK, 2009, PULM PHARMACOL THER, V22, P473, DOI 10.1016/j.pupt.2009.04.006; KEREN O, 1991, Brain Injury, V5, P233, DOI 10.3109/02699059109008094; Koch JD, 2008, J CEREBR BLOOD F MET, V28, P1294, DOI 10.1038/jcbfm.2008.15; Lee LC, 2012, AM J PHYS MED REHAB, V91, P528, DOI 10.1097/PHM.0b013e31824ad556; Li JS, 2009, NEUROSCIENCE, V159, P1309, DOI 10.1016/j.neuroscience.2009.01.011; Li JS, 2008, BRAIN RES, V1210, P223, DOI 10.1016/j.brainres.2008.03.007; Liu ZJ, 2008, ANTIOXID REDOX SIGN, V10, P1869, DOI 10.1089/ars.2008.2121; Maegele M, 2008, MINIM INVASIV THER, V17, P119, DOI 10.1080/13645700801970087; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; Mattiasson GJ, 2000, J NEUROSCI METH, V95, P75, DOI 10.1016/S0165-0270(99)00162-4; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; Michalski D, 2009, BRAIN RES, V1303, P161, DOI 10.1016/j.brainres.2009.09.038; Miljkovic-Lolic M, 2003, BRAIN RES, V971, P90, DOI 10.1016/S0006-8993(03)02364-3; MINK RB, 1995, STROKE, V26, P2307, DOI 10.1161/01.STR.26.12.2307; Molcanyi M, 2007, J NEUROTRAUM, V24, P625, DOI 10.1089/neu.2006.0180; MONDELLI M, 1989, ITAL J NEUROL SCI, V10, P433, DOI 10.1007/BF02334949; Morelli A, 2011, CELL BIOCHEM BIOPHYS, V61, P179, DOI 10.1007/s12013-011-9174-8; Murtie JC, 2005, NEUROBIOL DIS, V19, P171, DOI 10.1016/j.nbd.2004.12.006; NEUBAUER RA, 1992, CLIN NUCL MED, V17, P477, DOI 10.1097/00003072-199206000-00010; NEUBAUER RA, 1993, J NEUROSURG, V78, P687; NEUBAUER RA, 1994, SOUTHERN MED J, V87, P933, DOI 10.1097/00007611-199409000-00015; Niklas A, 2004, J NEUROL SCI, V219, P77, DOI 10.1016/j.jns.2003.12.013; Ohguri T, 2007, INT J RADIAT ONCOL, V67, P248, DOI 10.1016/j.ijrobp.2006.08.009; Ostrowski RP, 2006, STROKE, V37, P1314, DOI 10.1161/01.STR.0000217310.88450.c3; Ostrowski RP, 2005, J CEREBR BLOOD F MET, V25, P554, DOI 10.1038/sj.jcbfm.9600048; Palzur E, 2004, J NEUROTRAUM, V21, P41, DOI 10.1089/089771504772695931; Palzur E, 2008, BRAIN RES, V1221, P126, DOI 10.1016/j.brainres.2008.04.078; Prakash A, 2012, J PEDIATR NEUROSCI, V7, P4, DOI 10.4103/1817-1745.97610; Puri V, 2005, MUSCLE NERVE, V32, P230, DOI 10.1002/mus.20316; Raible DJ, 2012, J NEUROTRAUM, V29, P2548, DOI 10.1089/neu.2012.2483; Ren HJ, 2001, CHINESE MED J-PEKING, V114, P387; Riess P, 2007, J NEUROTRAUM, V24, P216, DOI 10.1089/neu.2006.0141; ROBERTSON A, 1993, ACTA NEUROPATHOL, V86, P163, DOI 10.1007/BF00334883; ROCKSWOLD GL, 1992, J NEUROSURG, V76, P929, DOI 10.3171/jns.1992.76.6.0929; Rockswold SB, 2007, NEUROL RES, V29, P162, DOI 10.1179/016164107X181798; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Rogatsky GG, 2005, BRAIN RES, V1047, P131, DOI 10.1016/j.brainres.2005.02.049; SHIBASAKI H, 1982, ANN NEUROL, V12, P355, DOI 10.1002/ana.410120407; Sleigh JW, 1999, J NEUROSURG, V91, P577, DOI 10.3171/jns.1999.91.4.0577; Smith G, 2012, BALLET REV, V40, P18; Soustiel JF, 2008, NEUROPATH APPL NEURO, V34, P412, DOI 10.1111/j.1365-2990.2007.00906.x; STANLEY GP, 1991, BRAIN, V114, P1827, DOI 10.1093/brain/114.4.1827; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Vlodavsky E, 2005, ACTA NEUROPATHOL, V110, P120, DOI 10.1007/s00401-004-0946-8; Wang GH, 2010, J NEUROTRAUM, V27, P1733, DOI 10.1089/neu.2009.1175; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yi JH, 2007, BRAIN RES, V1154, P200, DOI 10.1016/j.brainres.2007.04.011; Zhang K, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00005; Zhou ZW, 2007, J NEUROSURG, V106, P687, DOI 10.3171/jns.2007.106.4.687	89	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97750	10.1371/journal.pone.0097750	http://dx.doi.org/10.1371/journal.pone.0097750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848795	Green Published, Green Submitted, gold			2022-12-25	WOS:000336730600054
J	Moll, J; Weingartner, JH; Bado, P; Basilio, R; Sato, JR; Melo, BR; Bramati, IE; de Oliveira-Souza, R; Zahn, R				Moll, Jorge; Weingartner, Julie H.; Bado, Patricia; Basilio, Rodrigo; Sato, Joao R.; Melo, Bruno R.; Bramati, Ivanei E.; de Oliveira-Souza, Ricardo; Zahn, Roland			Voluntary Enhancement of Neural Signatures of Affiliative Emotion Using fMRI Neurofeedback	PLOS ONE			English	Article							HUMAN BRAIN ACTIVITY; REAL-TIME FMRI; FUNCTIONAL MRI; INDIVIDUAL-DIFFERENCES; NATURAL IMAGES; ACTIVATION; SELF; CLASSIFICATION; COOPERATION; OXYTOCIN	In Ridley Scott's film "Blade Runner", empathy-detection devices are employed to measure affiliative emotions. Despite recent neurocomputational advances, it is unknown whether brain signatures of affiliative emotions, such as tenderness/affection, can be decoded and voluntarily modulated. Here, we employed multivariate voxel pattern analysis and real-time fMRI to address this question. We found that participants were able to use visual feedback based on decoded fMRI patterns as a neurofeedback signal to increase brain activation characteristic of tenderness/affection relative to pride, an equally complex control emotion. Such improvement was not observed in a control group performing the same fMRI task without neurofeedback. Furthermore, the neurofeedback-driven enhancement of tenderness/affection-related distributed patterns was associated with local fMRI responses in the septohypothalamic area and frontopolar cortex, regions previously implicated in affiliative emotion. This demonstrates that humans can voluntarily enhance brain signatures of tenderness/affection, unlocking new possibilities for promoting prosocial emotions and countering antisocial behavior.	[Moll, Jorge; Weingartner, Julie H.; Bado, Patricia; Basilio, Rodrigo; Sato, Joao R.; Melo, Bruno R.; Bramati, Ivanei E.; de Oliveira-Souza, Ricardo; Zahn, Roland] DOr Inst Res & Educ IDOR, Cognit & Behav Neurosci Unit, Rio De Janeiro, Brazil; [Moll, Jorge; Weingartner, Julie H.; Bado, Patricia; Basilio, Rodrigo; Sato, Joao R.; Melo, Bruno R.; Bramati, Ivanei E.; de Oliveira-Souza, Ricardo; Zahn, Roland] DOr Inst Res & Educ IDOR, Neuroinformat Workgrp, Rio De Janeiro, Brazil; [Bado, Patricia] Univ Fed Rio de Janeiro, ICB, Rio De Janeiro, Brazil; [Sato, Joao R.] Univ Fed ABC, Ctr Math Computat & Cognit, Santo Andre, Brazil; [de Oliveira-Souza, Ricardo] Fed Univ State Rio de Janeiro, Gaffree & Guinle Univ Hosp, Rio De Janeiro, Brazil; [Zahn, Roland] Kings Coll London, Inst Psychiat, Ctr Affect Disorders, London WC2R 2LS, England	IDOR - Instituto D'Or de Ensino e Pesquisa; IDOR - Instituto D'Or de Ensino e Pesquisa; Universidade Federal do Rio de Janeiro; Universidade Federal do ABC (UFABC); University of London; King's College London	Moll, J (corresponding author), DOr Inst Res & Educ IDOR, Cognit & Behav Neurosci Unit, Rio De Janeiro, Brazil.	jorge.moll@idor.org	Moll, Jorge/AAF-8388-2021; Zahn, Roland/O-8944-2019; BADO, PATRICIA/AAF-6217-2021; Zahn, Roland/C-4665-2008	Moll, Jorge/0000-0002-4297-591X; Zahn, Roland/0000-0002-8447-1453; BADO, PATRICIA/0000-0001-8543-2547; Zahn, Roland/0000-0002-8447-1453; Sato, Joao Ricardo/0000-0002-7503-9781	FAPERJ Sediadas grant; INNT grant; CAPES; CNPq; IDOR; MRC [G0902304]; FAPESP, Brazil [2013/10498-6]; Medical Research Council [G0902304] Funding Source: researchfish	FAPERJ Sediadas grant(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); INNT grant; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); IDOR; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FAPESP, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by FAPERJ Sediadas and INNT grants, CAPES, CNPq and by intramural grants from IDOR; R.Z. was supported by an MRC clinician scientist award (G0902304). J.R.S. was supported by FAPESP (grant number 2013/10498-6), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman J, 2002, NEUROSCIENTIST, V8, P335, DOI 10.1177/107385840200800409; Andari E, 2010, P NATL ACAD SCI USA, V107, P4389, DOI 10.1073/pnas.0910249107; Avenanti A, 2010, CURR BIOL, V20, P1018, DOI 10.1016/j.cub.2010.03.071; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; BISHOP MP, 1963, SCIENCE, V140, P394, DOI 10.1126/science.140.3565.394; Bodurka J, 2007, NEUROIMAGE, V34, P542, DOI 10.1016/j.neuroimage.2006.09.039; Chu C, 2012, NEUROIMAGE, V60, P59, DOI 10.1016/j.neuroimage.2011.11.066; Coricelli G, 2005, NAT NEUROSCI, V8, P1255, DOI 10.1038/nn1514; COX RW, 1995, MAGNET RESON MED, V33, P230, DOI 10.1002/mrm.1910330213; De Oliveira-Souza R, 2008, CRIM JUSTICE BEHAV, V35, P427, DOI 10.1177/0093854807310853; Decety J, 2004, NEUROIMAGE, V23, P744, DOI 10.1016/j.neuroimage.2004.05.025; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102; Depue RA, 2005, BEHAV BRAIN SCI, V28, P313; Eslinger PJ, 1998, EUR NEUROL, V39, P193, DOI 10.1159/000007933; Fan Y, 2011, NEUROSCI BIOBEHAV R, V35, P903, DOI 10.1016/j.neubiorev.2010.10.009; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; FRISTON KJ, 1995, NEUROIMAGE, V2, P157, DOI 10.1006/nimg.1995.1018; GORMAN DG, 1992, ARCH NEUROL-CHICAGO, V49, P308, DOI 10.1001/archneur.1992.00530270128029; Green AE, 2006, BRAIN RES, V1096, P125, DOI 10.1016/j.brainres.2006.04.024; Green S, 2012, ARCH GEN PSYCHIAT, V69, P1014, DOI 10.1001/archgenpsychiatry.2012.135; Harmelech T, 2013, J NEUROSCI, V33, P9488, DOI 10.1523/JNEUROSCI.5911-12.2013; Hein G, 2010, NEURON, V68, P149, DOI 10.1016/j.neuron.2010.09.003; Hsu M, 2008, SCIENCE, V320, P1092, DOI 10.1126/science.1153651; Hyman SE, 2007, AM J BIOETHICS, V7, P8, DOI 10.1080/15265160601063969; Hyman SE, 2011, NEURON, V69, P595, DOI 10.1016/j.neuron.2011.02.012; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; IRVIN RW, 1990, PHYSIOL BEHAV, V48, P693, DOI 10.1016/0031-9384(90)90213-N; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Krueger F, 2007, P NATL ACAD SCI USA, V104, P20084, DOI 10.1073/pnas.0710103104; LaConte SM, 2007, HUM BRAIN MAPP, V28, P1033, DOI 10.1002/hbm.20326; MILLER NE, 1978, ANNU REV PSYCHOL, V29, P373, DOI 10.1146/annurev.ps.29.020178.002105; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Moll J, 2012, J NEUROSCI, V32, P12499, DOI 10.1523/JNEUROSCI.6508-11.2012; Moll J, 2011, NEUROIMAGE, V54, P1735, DOI 10.1016/j.neuroimage.2010.08.026; Morey RA, 2012, NEUROIMAGE, V60, P683, DOI 10.1016/j.neuroimage.2011.12.069; Morrone-Strupinsky JV, 2007, PERS INDIV DIFFER, V42, P1267, DOI 10.1016/j.paid.2006.10.005; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; Naselaris T, 2009, NEURON, V63, P902, DOI 10.1016/j.neuron.2009.09.006; Nelson EE, 1998, NEUROSCI BIOBEHAV R, V22, P437, DOI 10.1016/S0149-7634(97)00052-3; Panksepp J, 2011, SCIENCE, V334, P1358, DOI 10.1126/science.1216480; Papageorgiou TD, 2013, P NATL ACAD SCI USA, V110, P13630, DOI 10.1073/pnas.1210738110; Phan KL, 2004, NEUROREPORT, V15, P527, DOI 10.1097/00001756-200403010-00029; Posse S, 2003, NEUROIMAGE, V18, P760, DOI 10.1016/S1053-8119(03)00004-1; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Ruiz S, 2013, HUM BRAIN MAPP, V34, P200, DOI 10.1002/hbm.21427; Sato JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081658; Sato JR, 2008, NEUROIMAGE, V42, P1473, DOI 10.1016/j.neuroimage.2008.06.024; Scheinost D, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.24; Schweizer S, 2013, J NEUROSCI, V33, P5301, DOI 10.1523/JNEUROSCI.2593-12.2013; Sitaram R, 2011, NEUROIMAGE, V56, P753, DOI 10.1016/j.neuroimage.2010.08.007; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Takahashi H, 2004, NEUROIMAGE, V23, P967, DOI 10.1016/j.neuroimage.2004.07.054; Takahashi H, 2008, CEREB CORTEX, V18, P898, DOI 10.1093/cercor/bhm120; Vapnik V. N., 1998, NATURE STAT LEARNING; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Weiskopf N, 2003, NEUROIMAGE, V19, P577, DOI 10.1016/S1053-8119(03)00145-9; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Zaborszky L, 2008, NEUROIMAGE, V42, P1127, DOI 10.1016/j.neuroimage.2008.05.055; Zahn R, 2009, NEUROSCI LETT, V457, P107, DOI 10.1016/j.neulet.2009.03.090; Zahn R, 2009, CEREB CORTEX, V19, P276, DOI 10.1093/cercor/bhn080; Zarahn E, 1997, NEUROIMAGE, V457, P107; Zotev V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024522	66	31	32	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97343	10.1371/journal.pone.0097343	http://dx.doi.org/10.1371/journal.pone.0097343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847819	Green Published, Green Submitted, gold			2022-12-25	WOS:000336730600025
J	Schutte, HJ; Jansen, S; Schafroth, MU; Goslings, JC; van der Velde, N; de Rooij, SEJA				Schutte, Hermien Janneke; Jansen, Sofie; Schafroth, Matthias U.; Goslings, J. Carel; van der Velde, Nathalie; de Rooij, Sophia E. J. A.			SSRIs Increase Risk of Blood Transfusion in Patients Admitted for Hip Surgery	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ANTIDEPRESSANTS; ASSOCIATION; MORTALITY	Background: Recent studies have shown that an increased bleeding tendency can be caused by Selective Serotonin Reuptake Inhibitors (SSRI) use. We aimed to investigate the occurrence and risk of blood transfusion in SSRI users compared to non-SSRI users in a cohort of patients admitted for hip-surgery. Methods: We conducted a retrospective cohort study of patients who underwent planned or emergency hip surgery from 1996 to 2011 in the Academic Medical Center in Amsterdam. Primary outcome measure was risk of blood transfusion. Secondary outcome measures were pre- and postoperative hemoglobin level. Multivariate logistic regression was used to adjust for potential confounders. Results: One-hundred and fourteen SSRI users were compared to 1773 non-SSRI users. Risk of blood transfusion during admission was increased for SSRI users in multivariate analyses (OR 1.7 [95% CI 1.1-2.5]). Also, pre-operative hemoglobin levels were lower in SSRI users (7.8 +/- 1.0 mmol/L) compared to non-SSRI users (8.0 +/- 1.0 mmol/L) (p=0.042)), as were postoperative hemoglobin levels (6.2 +/- 1.0 mmol/L vs. 6.4 +/- 1.0 mmol/L respectively) (p=0.017)). Conclusions: SSRI users undergoing hip surgery have an increased risk for blood transfusion during admission, potentially explained by a lower hemoglobin level before surgery. SSRI use should be considered as a potential risk indicator for increased blood loss in patients admitted for hip surgery. These results need to be confirmed in a prospective study.	[Schutte, Hermien Janneke; Jansen, Sofie; van der Velde, Nathalie; de Rooij, Sophia E. J. A.] Univ Amsterdam, Acad Med Ctr, Dept Med, Geriatr Med Sect, NL-1105 AZ Amsterdam, Netherlands; [Schafroth, Matthias U.] Univ Amsterdam, Acad Med Ctr, Dept Orthoped Surg, NL-1105 AZ Amsterdam, Netherlands; [Goslings, J. Carel] Univ Amsterdam, Acad Med Ctr, Trauma Unit, Dept Surg, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	de Rooij, SEJA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med, Geriatr Med Sect, NL-1105 AZ Amsterdam, Netherlands.	s.e.derooij@amc.uva.nl		van der Velde, Nathalie/0000-0002-6477-6209				Andrade C, 2010, J CLIN PSYCHIAT, V71, P1565, DOI 10.4088/JCP.09r05786blu; Auerbach AD, 2013, JAMA INTERN MED, V173, P1075, DOI 10.1001/jamainternmed.2013.714; Carvajal A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019819; Centraal Begeleidings Orgaan, 2011, BLOOD TRANSF GUID; Centraal Begeleidings Orgaan, 2004, BLOOD TRANSF GUID; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cobain TJ, 2007, TRANSFUSION MED, V17, P1, DOI 10.1111/j.1365-3148.2006.00709.x; College van zorgverzekeringen, 2012, AANT GEBR 2007 2011; COOK EH, 1994, J NEUROCHEM, V63, P465; de Abajo FJ, 2008, ARCH GEN PSYCHIAT, V65, P795, DOI 10.1001/archpsyc.65.7.795; Gardarsdottir H, 2007, J AFFECT DISORDERS, V98, P109, DOI 10.1016/j.jad.2006.07.003; Jansen S, 2012, EUROPEAN GERIATRIC M, V3, pS2; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Morel-Kopp MC, 2009, J THROMB HAEMOST, V7, P573, DOI 10.1111/j.1538-7836.2009.03278.x; Movig KLL, 2003, ARCH INTERN MED, V163, P2354, DOI 10.1001/archinte.163.19.2354; NARANJO CA, 1995, DRUG AGING, V7, P184, DOI 10.2165/00002512-199507030-00004; OWENS WD, 1978, ANESTHESIOLOGY, V49, P239, DOI 10.1097/00000542-197810000-00003; Radovanovic I, 2012, ACTA ORTHOP BELG, V78, P187; Rogers MAM, 2007, J WOMENS HEALTH, V16, P1412, DOI 10.1089/jwh.2007.0397; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Shander A, 2009, SURG INFECT, V10, P277, DOI 10.1089/sur.2007.055; Takeuchi K, 2011, J PHARMACOL EXP THER, V338, P850, DOI 10.1124/jpet.111.183293; Targownik LE, 2009, AM J GASTROENTEROL, V104, P1475, DOI 10.1038/ajg.2009.128; van Haelst IMM, 2010, ANESTHESIOLOGY, V112, P631, DOI 10.1097/ALN.0b013e3181cf8fdf; Vidal X, 2008, DRUG SAFETY, V31, P159, DOI 10.2165/00002018-200831020-00005; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wu WC, 2012, ANN SURG, V255, P708, DOI 10.1097/SLA.0b013e31824a55b9; Ziegelstein RC, 2009, INTERN MED J, V39, P38, DOI 10.1111/j.1445-5994.2008.01794.x	28	15	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e95906	10.1371/journal.pone.0095906	http://dx.doi.org/10.1371/journal.pone.0095906			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848000	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600008
J	Durinovic-Bello, I; Gersuk, VH; Ni, C; Wu, R; Thorpe, J; Jospe, N; Sanda, S; Greenbaum, CJ; Nepom, GT				Durinovic-Bello, Ivana; Gersuk, Vivian H.; Ni, Chester; Wu, Rebecca; Thorpe, Jerill; Jospe, Nicholas; Sanda, Srinath; Greenbaum, Carla J.; Nepom, Gerald T.			Avidity-Dependent Programming of Autoreactive T Cells in T1D	PLOS ONE			English	Article							CLASS-II TETRAMERS; INSULIN GENE; THYMOCYTE SELECTION; HUMAN THYMUS; IN-VIVO; LOCUS; SUSCEPTIBILITY; PROINSULIN; EXPRESSION; TOLERANCE	Fate determination for autoreactive T cells relies on a series of avidity-dependent interactions during T cell selection, represented by two general types of signals, one based on antigen expression and density during T cell development, and one based on genes that interpret the avidity of TCR interaction to guide developmental outcome. We used proinsulin-specific HLA class II tetramers to purify and determine transcriptional signatures for autoreactive T cells under differential selection in type 1 diabetes (T1D), in which insulin (INS) genotypes consist of protective and susceptible alleles that regulate the level of proinsulin expression in the thymus. Upregulation of steroid nuclear receptor family 4A (NR4A) and early growth response family genes in proinsulin-specific T cells was observed in individuals with susceptible INS-VNTR genotypes, suggesting a mechanism for avidity-dependent fate determination of the T cell repertoire in T1D. The NR4A genes act as translators of TCR signal strength that guide central and peripheral T cell fate decisions through transcriptional modification. We propose that maintenance of an NR4A-guided program in low avidity autoreactive T cells in T1D reflects their prior developmental experience influenced by proinsulin expression, identifying a pathway permissive for autoimmunity.	[Durinovic-Bello, Ivana; Gersuk, Vivian H.; Ni, Chester; Wu, Rebecca; Thorpe, Jerill; Sanda, Srinath; Greenbaum, Carla J.; Nepom, Gerald T.] Benaroya Res Inst Virginia Mason, Seattle, WA 98101 USA; [Jospe, Nicholas] Univ Rochester, Sch Med, Rochester, NY USA; [Nepom, Gerald T.] Univ Washington, Sch Med, Seattle, WA USA	Benaroya Research Institute; Virginia Mason Medical Center; University of Rochester; University of Washington; University of Washington Seattle	Durinovic-Bello, I (corresponding author), Benaroya Res Inst Virginia Mason, Seattle, WA 98101 USA.	ivanadbello@gmail.com; jnepom@benaroyaresearch.org		Nepom, Gerald/0000-0002-8063-1464	Juvenile Diabetes Research Foundation, JDRF-BRI Center for Translational Research [4-2007-1058]; Life Sciences Discovery Fund, Program in Autoimmune Disease Intervention [2087550]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation, JDRF-BRI Center for Translational Research; Life Sciences Discovery Fund, Program in Autoimmune Disease Intervention; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work has the following funding sources: Juvenile Diabetes Research Foundation, JDRF-BRI Center for Translational Research [4-2007-1058; (completed); www.jdrf.org]; Life Sciences Discovery Fund, Program in Autoimmune Disease Intervention [2087550; (completed); www.lsdfa.org]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; Baldwin TA, 2007, J IMMUNOL, V179, P837, DOI 10.4049/jimmunol.179.2.837; Barratt BJ, 2004, DIABETES, V53, P1884, DOI 10.2337/diabetes.53.7.1884; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Collins S, 2008, EUR J IMMUNOL, V38, P528, DOI 10.1002/eji.200737157; Danke NA, 2005, J AUTOIMMUN, V25, P303, DOI 10.1016/j.jaut.2005.08.007; Durinovic-Bello I, 2002, J AUTOIMMUN, V18, P55, DOI 10.1006/jaut.2001.0566; Durinovic-Bello I, 2010, GENES IMMUN, V11, P188, DOI 10.1038/gene.2009.108; Durinovic-Bello I, 2006, P NATL ACAD SCI USA, V103, P11683, DOI 10.1073/pnas.0603682103; DurinovicBello I, 1996, DIABETES, V45, P795, DOI 10.2337/diabetes.45.6.795; Fukui Y, 1997, IMMUNITY, V6, P401, DOI 10.1016/S1074-7613(00)80283-6; Gebe JA, 2009, J IMMUNOL, V183, P59, DOI 10.4049/jimmunol.0804046; Gersuk VH, 2006, J IMMUNOL METHODS, V317, P64, DOI 10.1016/j.jim.2006.09.003; James EA, 2009, J VIS EXP, V6, P1167; James EA, 2008, DIABETES, V57, P1788, DOI 10.2337/db08-0530; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; McDavid A, 2013, BIOINFORMATICS, V29, P461, DOI 10.1093/bioinformatics/bts714; Monti P, 2007, J IMMUNOL, V179, P5785, DOI 10.4049/jimmunol.179.9.5785; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Nepom GT, 2012, J IMMUNOL, V188, P2477, DOI 10.4049/jimmunol.1102398; Novak EJ, 1999, J CLIN INVEST, V104, pR63, DOI 10.1172/JCI8476; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; Sekiya T, 2013, NAT IMMUNOL, V14, P230, DOI 10.1038/ni.2520; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stead JDH, 2000, HUM MOL GENET, V9, P2929, DOI 10.1093/hmg/9.20.2929; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; Yang JB, 2008, J AUTOIMMUN, V31, P30, DOI 10.1016/j.jaut.2008.02.001; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009	31	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98074	10.1371/journal.pone.0098074	http://dx.doi.org/10.1371/journal.pone.0098074			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844227	gold, Green Published, Green Submitted			2022-12-25	WOS:000339563400091
J	Yang, DH; Lee, JW; Lee, J; Moon, EY				Yang, Dong-Hee; Lee, Jae-Wook; Lee, Jiyoung; Moon, Eun-Yi			Dynamic Rearrangement of F-Actin Is Required to Maintain the Antitumor Effect of Trichostatin A	PLOS ONE			English	Article							CANCER-CHEMOTHERAPY; INDUCED APOPTOSIS; CYTOSKELETON; RESISTANCE; DEPOLYMERIZATION; REORGANIZATION; GELSOLIN	Actin plays a role in various processes in eukaryotic cells, including cell growth and death. We investigated whether the antitumor effect of trichostatin A (TSA) is associated with the dynamic rearrangement of F-actin. TSA is an antitumor drug that induces hyper-acetylation of histones by inhibiting histone deacetylase. HeLa human cervical cancer cells were used to measure the antitumor effect of TSA. The percent cell survival was determined by an MTT assay. Hypodiploid cell formation was assessed by flow cytometry. Collapse of the mitochondrial membrane potential (MMP) was identified by a decrease in the percentage of cells with red MitoProbe J-aggregate (JC-1) fluorescence. Cell survival was reduced by treatment with TSA, as judged by an MTT assay and staining with propidium iodide, FITC-labeled annexin V, or 49,6-diamidino-2-phenylindole (DAPI). TSA also induced an MMP collapse, as judged by the measurement of intracellular red JC-1 fluorescence. In addition, the F-actin depolymerizers cytochalasin D (CytoD) and latrunculin B (LatB) induced an MMP collapse and increased apoptotic cell death in HeLa cells. However, our data show that apoptotic cell death and the MMP collapse induced by TSA were decreased by the co-treatment of cells with CytoD and LatB. These findings demonstrate that the dynamic rearrangement of F-actin might be necessary for TSA-induced HeLa cell apoptosis involving a TSA-induced MMP collapse. They also suggest that actin cytoskeleton dynamics play an important role in maintaining the therapeutic effects of antitumor agents in tumor cells. They further suggest that maintaining the MMP could be a novel strategy for increasing drug sensitivity in TSA-treated tumors.	[Yang, Dong-Hee; Lee, Jae-Wook; Lee, Jiyoung; Moon, Eun-Yi] Sejong Univ, Dept Biosci & Biotechnol, Seoul, South Korea	Sejong University	Moon, EY (corresponding author), Sejong Univ, Dept Biosci & Biotechnol, Seoul, South Korea.	eunyimoon@sejong.ac.kr			Mid-career Researcher Program through National Research Foundation of Korea (NRF) [2012-R1A2A2A01005449]; National Nuclear R&D Program through National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology (MEST), Korea [2010-00018545, 2012-M2B2A9A03051296]	Mid-career Researcher Program through National Research Foundation of Korea (NRF); National Nuclear R&D Program through National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology (MEST), Korea	This work was supported by grants from Mid-career Researcher Program (#2012-R1A2A2A01005449) and National Nuclear R&D Program (#2010-00018545 and #2012-M2B2A9A03051296) through National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST), Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JS, 2003, ANN NY ACAD SCI, V1010, P493, DOI 10.1196/annals.1299.090; Baumeister P, 2009, MOL CANCER THER, V8, P1086, DOI 10.1158/1535-7163.MCT-08-1166; Boldogh IR, 2006, BBA-MOL CELL RES, V1763, P450, DOI 10.1016/j.bbamcr.2006.02.014; Cicchillitti L, 2008, MOL CANCER THER, V7, P2070, DOI 10.1158/1535-7163.MCT-07-2370; Croft DR, 2005, J CELL BIOL, V168, P245, DOI 10.1083/jcb.200409049; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Emmenegger U, 2010, NATURE, V468, P637, DOI 10.1038/468637a; Genesca M, 2006, APOPTOSIS, V11, P563, DOI 10.1007/s10495-006-4937-1; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Harms C, 2004, MOL CELL NEUROSCI, V25, P69, DOI 10.1016/j.mcn.2003.09.012; Jordan MA, 1998, CURR OPIN CELL BIOL, V10, P123, DOI 10.1016/S0955-0674(98)80095-1; Kotiadis VN, 2012, J CELL SCI, V125, P2288, DOI 10.1242/jcs.099390; Levee MG, 1996, AM J PHYSIOL-CELL PH, V271, pC1981, DOI 10.1152/ajpcell.1996.271.6.C1981; Moon EY, 2004, EUR J IMMUNOL, V34, P2119, DOI 10.1002/eji.200424962; Odaka C, 2000, CLIN DIAGN LAB IMMUN, V7, P947, DOI 10.1128/CDLI.7.6.947-952.2000; Ouyang YB, 2011, MITOCHONDRION, V11, P279, DOI 10.1016/j.mito.2011.09.001; Posey SC, 1999, J BIOL CHEM, V274, P4259, DOI 10.1074/jbc.274.7.4259; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; Spector I, 1999, MICROSC RES TECHNIQ, V47, P18, DOI 10.1002/(SICI)1097-0029(19991001)47:1<18::AID-JEMT3>3.0.CO;2-E; Torgerson RR, 1998, J CELL SCI, V111, P2911; Tsai JC, 2005, LASER SURG MED, V36, P398, DOI 10.1002/lsm.20179; van der Heijden M, 2008, APOPTOSIS, V13, P404, DOI 10.1007/s10495-007-0173-6; Yamazaki Y, 2000, EXP CELL RES, V259, P64, DOI 10.1006/excr.2000.4970	23	24	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97352	10.1371/journal.pone.0097352	http://dx.doi.org/10.1371/journal.pone.0097352			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846135	Green Submitted, gold, Green Published			2022-12-25	WOS:000339563400025
J	Schroder-Braunstein, J; Gras, J; Brors, B; Schwarz, S; Szikszai, T; Lasitschka, F; Wabnitz, G; Heidtmann, A; Lee, YS; Schiessling, S; Leowardi, C; Al-Saeedi, M; Ulrich, A; Engelke, A; Winter, J; Samstag, Y; Giese, T; Meuer, S				Schroeder-Braunstein, Jutta; Gras, Judith; Brors, Benedikt; Schwarz, Sonja; Szikszai, Timea; Lasitschka, Felix; Wabnitz, Guido; Heidtmann, Antje; Lee, Young-Seon; Schiessling, Serin; Leowardi, Christine; Al-Saeedi, Mohammed; Ulrich, Alexis; Engelke, Antonia; Winter, Johannes; Samstag, Yvonne; Giese, Thomas; Meuer, Stefan			Initiation of an Inflammatory Response in Resident Intestinal Lamina Propria Cells - Use of a Human Organ Culture Model	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; NF-KAPPA-B; BOWEL-DISEASE; ULCERATIVE-COLITIS; EPITHELIAL-CELLS; CROHNS-DISEASE; T-LYMPHOCYTES; HUMAN GUT; MACROPHAGES; MUCOSAL	Resident human lamina propria immune cells serve as powerful effectors in host defense. Molecular events associated with the initiation of an intestinal inflammatory response in these cells are largely unknown. Here, we aimed to characterize phenotypic and functional changes induced in these cells at the onset of intestinal inflammation using a human intestinal organ culture model. In this model, healthy human colonic mucosa was depleted of epithelial cells by EDTA treatment. Following loss of the epithelial layer, expression of the inflammatory mediators IL1B, IL6, IL8, IL23A, TNFA, CXCL2, and the surface receptors CD14, TLR2, CD86, CD54 was rapidly induced in resident lamina propria cells in situ as determined by qRT-PCR and immunohistology. Gene microarray analysis of lamina propria cells obtained by laser-capture microdissection provided an overview of global changes in gene expression occurring during the initiation of an intestinal inflammatory response in these cells. Bioinformatic analysis gave insight into signalling pathways mediating this inflammatory response. Furthermore, comparison with published microarray datasets of inflamed mucosa in vivo (ulcerative colitis) revealed a significant overlap of differentially regulated genes underlining the in vivo relevance of the organ culture model. Furthermore, genes never been previously associated with intestinal inflammation were identified using this model. The organ culture model characterized may be useful to study molecular mechanisms underlying the initiation of an intestinal inflammatory response in normal mucosa as well as potential alterations of this response in inflammatory bowel disease.	[Schroeder-Braunstein, Jutta; Gras, Judith; Schwarz, Sonja; Szikszai, Timea; Wabnitz, Guido; Heidtmann, Antje; Lee, Young-Seon; Schiessling, Serin; Samstag, Yvonne; Giese, Thomas; Meuer, Stefan] Univ Heidelberg Hosp, Inst Immunol, Heidelberg, Germany; [Brors, Benedikt] German Canc Res Ctr, Div Theoret Bioinformat, Heidelberg, Germany; [Lasitschka, Felix] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany; [Schiessling, Serin; Leowardi, Christine; Al-Saeedi, Mohammed; Ulrich, Alexis] Univ Heidelberg Hosp, Dept Surg, Heidelberg, Germany; [Szikszai, Timea] Univ Heidelberg Hosp, Dept Anesthesiol, Heidelberg, Germany; [Engelke, Antonia] Salem Hosp, Dept Surg, Heidelberg, Germany; [Winter, Johannes] St Vincentius Hosp, Dept Surg, Speyer, Germany; [Lee, Young-Seon] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Hannover Medical School	Schroder-Braunstein, J (corresponding author), Univ Heidelberg Hosp, Inst Immunol, Heidelberg, Germany.	jutta.schroeder-braunstein@urz.uni-heidelberg.de	Brors, Benedikt/E-5620-2013	Brors, Benedikt/0000-0001-5940-3101; Wabnitz, Guido/0000-0001-5101-9885	Deutsche Forschungsgemeinschaft [SFB 938]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (SFB 938, project O, M, and Z2) (www.dkfz.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autschbach F, 1998, AM J PATHOL, V153, P121, DOI 10.1016/S0002-9440(10)65552-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BULL DM, 1977, J CLIN INVEST, V59, P966, DOI 10.1172/JCI108719; Carrasco A, 2013, J IMMUNOL METHODS, V389, P29, DOI 10.1016/j.jim.2012.12.006; Chen C, 2004, J BIOL CHEM, V279, P27948, DOI 10.1074/jbc.M313920200; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Clark PM, 2012, INFLAMM BOWEL DIS, V18, P2315, DOI 10.1002/ibd.22958; Coron E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004713; Danese S, 2012, GUT, V61, P918, DOI 10.1136/gutjnl-2011-300904; DEMARIA R, 1993, EUR J IMMUNOL, V23, P3104, DOI 10.1002/eji.1830231209; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Faubion WA, 2013, AM J GASTROENTEROL, V108, P1891, DOI 10.1038/ajg.2013.354; Fiocchi C, 2011, CURR OPIN GASTROEN, V27, P317, DOI 10.1097/MOG.0b013e3283483986; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Granlund AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056818; Halin C, 2008, METHOD ENZYMOL, V445, P1, DOI 10.1016/S0076-6879(08)03001-2; Hausmann M, 2002, GASTROENTEROLOGY, V122, P1987, DOI 10.1053/gast.2002.33662; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Iliev ID, 2009, MUCOSAL IMMUNOL, V2, P340, DOI 10.1038/mi.2009.13; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Lorrot M, 2007, ARCH PEDIATRIE, V14, pS145, DOI 10.1016/S0929-693X(07)80018-2; Mahida YR, 1997, CLIN EXP IMMUNOL, V109, P377, DOI 10.1046/j.1365-2249.1997.4481346.x; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Moresco EMY, 2011, CURR BIOL, V21, pR488, DOI 10.1016/j.cub.2011.05.039; MORISE K, 1994, J GASTROENTEROL, V29, P257, DOI 10.1007/BF02358363; Oberhuber G, 1997, SCAND J GASTROENTERO, V32, P48, DOI 10.3109/00365529709025062; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Ordas I, 2012, LANCET, V380, P1606, DOI 10.1016/S0140-6736(12)60150-0; Phalipon A, 2003, CRIT REV IMMUNOL, V23, P371, DOI 10.1615/CritRevImmunol.v23.i56.20; PIRZER UC, 1990, EUR J IMMUNOL, V20, P2339, DOI 10.1002/eji.1830201025; QIAO L, 1993, GASTROENTEROLOGY, V105, P814, DOI 10.1016/0016-5085(93)90899-N; QIAO L, 1991, GASTROENTEROLOGY, V101, P1529, DOI 10.1016/0016-5085(91)90388-2; Qiao L, 1996, EUR J IMMUNOL, V26, P922, DOI 10.1002/eji.1830260430; RIEGLER M, 1995, J CLIN INVEST, V95, P2004, DOI 10.1172/JCI117885; Rogler G, 1998, CLIN EXP IMMUNOL, V112, P205; ROHAN PJ, 1993, SCIENCE, V259, P1763, DOI 10.1126/science.7681221; Rugtveit J, 1997, CLIN EXP IMMUNOL, V110, P104, DOI 10.1046/j.1365-2249.1997.5071404.x; RYAN GB, 1977, AM J PATHOL, V86, P183; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shkoda A, 2007, GASTROENTEROLOGY, V132, P190, DOI 10.1053/j.gastro.2006.10.030; Sido B, 2000, J EXP MED, V192, P907, DOI 10.1084/jem.192.6.907; Sido B, 2008, GASTROENTEROLOGY, V134, P179, DOI 10.1053/j.gastro.2007.11.001; Smith PD, 1997, J IMMUNOL METHODS, V202, P1, DOI 10.1016/S0022-1759(96)00204-9; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Smythies LE, 2010, J BIOL CHEM, V285, P19593, DOI 10.1074/jbc.M109.069955; Stallmach Andreas, 2004, Int J Colorectal Dis, V19, P308, DOI 10.1007/s00384-003-0554-4; Takada Y, 2010, J IMMUNOL, V184, P1014, DOI 10.4049/jimmunol.0901196; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Team RC, 2013, R LANGUAGE ENV STAT; VANSPREEUWEL JP, 1985, GUT, V26, P945, DOI 10.1136/gut.26.9.945; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Zahn A, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-13	59	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97780	10.1371/journal.pone.0097780	http://dx.doi.org/10.1371/journal.pone.0097780			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841635	Green Submitted, Green Published, gold			2022-12-25	WOS:000340948600074
J	Valiathan, R; Miguez, MJ; Patel, B; Arheart, KL; Asthana, D				Valiathan, Ranjini; Miguez, Maria J.; Patel, Bijal; Arheart, Kristopher L.; Asthana, Deshratn			Tobacco Smoking Increases Immune Activation and Impairs T-Cell Function in HIV Infected Patients on Antiretrovirals: A Cross-Sectional Pilot Study	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; CIGARETTE-SMOKING; MICROBIAL TRANSLOCATION; PERIPHERAL-BLOOD; LYMPHOCYTE SUBSETS; FLOW-CYTOMETRY; PLASMA-LEVELS; INDIVIDUALS; POPULATION; BIOMARKERS	Background: The influence of tobacco smoking on the immune system of HIV infected individuals is largely unknown. We investigated the impact of tobacco smoking on immune activation, microbial translocation, immune exhaustion and T-cell function in HIV infected individuals. Method: HIV infected smokers and non-smokers (n = 25 each) with documented viral suppression on combination antiretroviral therapy and HIV uninfected smokers and non-smokers (n = 15 each) were enrolled. Markers of immune activation (CD38 and HLA-DR) and immune exhaustion (PD1, Tim3 and CTLA4) were analyzed in peripheral blood mononuclear cells (PBMCs) by flow cytometry. Plasma markers of microbial translocation (soluble-CD14 - sCD14 and lipopolysaccharide - LPS) were measured. Antigen specific functions of CD4+ and CD8+ T-cells were measured, by flow cytometry, in PBMCs after 6 hours stimulation with Cytomegalovirus, Epstein-Barr virus and Influenza Virus (CEF) peptide pool. Results: Compared to non-smokers, smokers of HIV infected and uninfected groups showed significantly higher CD4+ and CD8+ T-cell activation with increased frequencies of CD38+ HLA-DR+ cells with a higher magnitude in HIV infected smokers. Expressions of immune exhaustion markers (PD1, Tim3 and CTLA4) either alone or in combinations were significantly higher in smokers, especially on CD4+ T-cells. Compared to HIV uninfected non-smokers, microbial translocation (sCD14 and LPS) was higher in smokers of both groups and directly correlated with CD4+ and CD8+ T-cell activation. Antigen specific T-cell function showed significantly lower cytokine response of CD4+ and CD8+ T-cells to CEF peptide-pool stimulation in smokers of both HIV infected and uninfected groups. Conclusions: Our results suggest that smoking and HIV infection independently influence T-cell immune activation and function and together they present the worst immune profile. Since smoking is widespread among HIV infected individuals, studies are warranted to further evaluate the cumulative effect of smoking on impairment of the immune system and accelerated disease progression.	[Valiathan, Ranjini; Asthana, Deshratn] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA; [Asthana, Deshratn] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; [Valiathan, Ranjini; Patel, Bijal; Asthana, Deshratn] Univ Miami, Miller Sch Med, Lab Clin & Biol Studies, Miami, FL 33136 USA; [Miguez, Maria J.] Florida Int Univ, Sch Integrated Sci & Humanities, Miami, FL 33199 USA; [Arheart, Kristopher L.] Univ Miami, Miller Sch Med, Div Biostat, Dept Publ Hlth Sci, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; State University System of Florida; Florida International University; University of Miami	Asthana, D (corresponding author), Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA.	DAsthan@med.miami.edu			Laboratory for Clinical and Biological Studies at the University of Miami; Florida Department of Health; James and Esther King Biomedical Research Program [10KG-10]	Laboratory for Clinical and Biological Studies at the University of Miami; Florida Department of Health; James and Esther King Biomedical Research Program	This study was supported by the research and training funds of the Laboratory for Clinical and Biological Studies at the University of Miami. The authors would also like to acknowledge the support received from the Florida Department of Health and the James and Esther King Biomedical Research Program (grant 10KG-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Qouzi A, 2002, CLIN DIAGN LAB IMMUN, V9, P279, DOI 10.1128/CDLI.9.2.279-281.2002; Allen JN, 1996, J ALLERGY CLIN IMMUN, V97, P1366, DOI 10.1016/S0091-6749(96)70206-3; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Ashman M, 2007, CYTOM PART B-CLIN CY, V72B, P380, DOI 10.1002/cyto.b.20178; Baroncelli S, 2009, J CLIN VIROL, V46, P367, DOI 10.1016/j.jcv.2009.09.011; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; CAIAFFA WT, 1994, AM J RESP CRIT CARE, V150, P1493, DOI 10.1164/ajrccm.150.6.7952605; Charlesworth JC, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-29; Chng WJ, 2004, CLIN DIAGN LAB IMMUN, V11, P168, DOI 10.1128/CDLI.11.1.168-173.2004; CHOONG ML, 1995, ANN CLIN BIOCHEM, V32, P532, DOI 10.1177/000456329503200603; Conley LJ, 1996, AIDS, V10, P1121, DOI 10.1097/00002030-199609000-00010; de Heens GLT, 2009, CYTOKINE, V47, P157, DOI 10.1016/j.cyto.2009.05.006; Freiberg MS, 2010, ALCOHOL RES HEALTH, V33, P237; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Helleberg M, 2013, CLIN INFECT DIS, V56, P727, DOI 10.1093/cid/cis933; HOLT PG, 1987, THORAX, V42, P241, DOI 10.1136/thx.42.4.241; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kassu A, 2010, J IMMUNOL, V185, P3007, DOI 10.4049/jimmunol.1000156; Kedzierska Katherine, 2001, Antiviral Chemistry and Chemotherapy, V12, P133; Khaitan Alka, 2011, Curr HIV/AIDS Rep, V8, P4, DOI 10.1007/s11904-010-0066-0; Kim Victor, 2008, Proc Am Thorac Soc, V5, P478, DOI 10.1513/pats.200802-014ET; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Kuschner WG, 1996, EUR RESPIR J, V9, P1989, DOI 10.1183/09031936.96.09101989; Lichtfuss GF, 2011, BIOMARK MED, V5, P171, DOI [10.2217/bmm.11.15, 10.2217/BMM.11.15]; Maecker HT, 2006, CYTOM PART A, V69A, P1037, DOI 10.1002/cyto.a.20333; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Nakanjako D, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-43; Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002; Patel RR, 2008, DRUGS, V68, P1511, DOI 10.2165/00003495-200868110-00004; Perfetto SP, 2006, NAT PROTOC, V1, P1522, DOI 10.1038/nprot.2006.250; Pilakka-Kanthikeel S, 2012, PEDIATR INFECT DIS J, V31, P583, DOI 10.1097/INF.0b013e31824da0f5; Reguleiro V, 2009, EUR RESPIR J, V33, P273, DOI 10.1183/09031936.00087708; Reynolds NR, 2009, AIDS EDUC PREV, V21, P106, DOI 10.1521/aeap.2009.21.3_supp.106; Rodger AJ, 2009, J INFECT DIS, V200, P973, DOI 10.1086/605447; Salazar-Gonzalez JF, 1998, J INFECT DIS, V178, P423, DOI 10.1086/515629; Sandler NG, 2012, NAT REV MICROBIOL, V10, P655, DOI 10.1038/nrmicro2848; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Sopori ML, 1998, J NEUROIMMUNOL, V83, P148, DOI 10.1016/S0165-5728(97)00231-2; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tewari AK, 2011, PROTEOMICS, V11, P2051, DOI 10.1002/pmic.201000159; TOLLERUD DJ, 1989, AM REV RESPIR DIS, V139, P1446, DOI 10.1164/ajrccm/139.6.1446; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Zeidel A, 2002, ACTA ANAESTH SCAND, V46, P959, DOI 10.1034/j.1399-6576.2002.460806.x	45	69	70	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97698	10.1371/journal.pone.0097698	http://dx.doi.org/10.1371/journal.pone.0097698			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842313	gold, Green Published			2022-12-25	WOS:000340948600058
J	Itahana, Y; Han, R; Barbier, S; Lei, Z; Rozen, S; Itahana, K				Itahana, Y.; Han, R.; Barbier, S.; Lei, Z.; Rozen, S.; Itahana, K.			The uric acid transporter SLC2A9 is a direct target gene of the tumor suppressor p53 contributing to antioxidant defense	ONCOGENE			English	Article							URATE OXIDASE; IDENTIFICATION; GLUT9; INACTIVATION; REGULATOR; ARREST; FAMILY; CANCER; DAMAGE; RISK	Only humans and higher primates have high uric acid blood levels. Although high uric acid causes gout, it has been linked with human longevity because of its hypothetical antioxidant function. Recent studies reveal that p53 has significant roles in cellular metabolism. One example of this is an antioxidant function that potentially contributes to tumor suppression. Here, we reported a first beneficial link between p53 and uric acid. We identified the uric acid transporter SLC2A9 (also known as GLUT9) as a direct p53 target gene and a key downstream effector in the reduction of reactive oxygen species (ROS) through transporting uric acid as a source of antioxidant. Oxidative stress induced SLC2A9 expression in a p53-dependent manner, and inhibition of SLC2A9 by small interfering RNA (siRNA) or anti-gout drugs such as probenecid significantly increased ROS levels in an uric acid-dependent manner and greatly sensitized cancer cells to chemotherapeutic drugs. Conversely, expression of SLC2A9 reduced ROS and protected against DNA damage and cell death, suggesting its antioxidant function. The increased production of ROS because of p53 loss was rescued by SLC2A9 expression. Furthermore, decreased SLC2A9 expression was observed in several cancer types and was associated with a poorer prognosis. Our findings suggest that the p53-SLC2A9 pathway is a novel antioxidant mechanism that uses uric acid to maintain ROS homeostasis and prevent accumulation of ROS-associated damage that potentially contributes to cancer development.	[Itahana, Y.; Han, R.; Lei, Z.; Rozen, S.; Itahana, K.] Duke NUS Grad Med Sch Singapore, Canc & Stem Cell Biol Program, Singapore 169857, Singapore; [Barbier, S.] Duke NUS Grad Med Sch Singapore, Ctr Quantitat Med, Off Clin Sci, Singapore 169857, Singapore; [Lei, Z.; Rozen, S.] Duke NUS Grad Med Sch Singapore, Ctr Computat Biol, Singapore 169857, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Itahana, K (corresponding author), Duke NUS Grad Med Sch Singapore, Canc & Stem Cell Biol Program, Room 07-18,Level 7,8 Coll Rd, Singapore 169857, Singapore.	koji.itahana@duke-nus.edu.sg	Rozen, Steven G./J-5939-2013; Itahana, Koji/J-5505-2013	Rozen, Steven G./0000-0002-4288-0056; Itahana, Koji/0000-0002-7241-2894	Singapore Ministry of Education AcRF Tier 2 fund [MOE2013-T2-1-123]; Duke-NUS core grant	Singapore Ministry of Education AcRF Tier 2 fund(Ministry of Education, Singapore); Duke-NUS core grant	We acknowledge funding from the Singapore Ministry of Education AcRF Tier 2 fund (MOE2013-T2-1-123) and the Duke-NUS core grant. We thank Dr Gerald Evan for providing Mdm2<SUP>+/+</SUP>; p53<SUP>ER/-</SUP> and Mdm2<SUP>-/-</SUP>; p53<SUP>ER/-</SUP> MEFs, Dr. Bert Vogelstein for HCT116 (p53<SUP>+/+</SUP>) and HCT116 (p53<SUP>-/-</SUP>) cell lines, Dr Yanping Zhang for p53 and green-fluorescent protein adenoviruses. We also thank Drs David Virshup, Patrick Casey, Kanaga Sabapathy and Paul Yen for critical reading of the manuscript. We thank Lee Guan Hwee Bernard for technical assistance.	AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Anzai N, 2008, J BIOL CHEM, V283, P26834, DOI 10.1074/jbc.C800156200; Augustin R, 2004, J BIOL CHEM, V279, P16229, DOI 10.1074/jbc.M312226200; Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bibert S, 2009, AM J PHYSIOL-RENAL, V297, pF612, DOI 10.1152/ajprenal.00139.2009; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Campos-Arroyo D, 2012, CANCER CHEMOTH PHARM, V69, P495, DOI 10.1007/s00280-011-1725-6; Caulfield MJ, 2008, PLOS MED, V5, P1509, DOI 10.1371/journal.pmed.0050197; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Clegg HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038212; CUTLER RG, 1991, AM J CLIN NUTR, V53, pS373, DOI 10.1093/ajcn/53.1.373S; de Lau LML, 2005, ANN NEUROL, V58, P797, DOI 10.1002/ana.20663; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Gottlieb E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001040; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; Hooper DC, 1997, P NATL ACAD SCI USA, V94, P2528, DOI 10.1073/pnas.94.6.2528; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Itahana K, 2008, CANCER CELL, V13, P542, DOI 10.1016/j.ccr.2008.04.002; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Itahana Y, 2012, CURR DRUG TARGETS, V13, P1633, DOI 10.2174/138945012803529992; Jackson AL, 2001, MUTAT RES-FUND MOL M, V477, P7, DOI 10.1016/S0027-5107(01)00091-4; KELLOGG EW, 1977, J BIOL CHEM, V252, P6721; Kim TS, 2006, INT J GERIATR PSYCH, V21, P344, DOI 10.1002/gps.1469; Lei ZD, 2013, GASTROENTEROLOGY, V145, P554, DOI 10.1053/j.gastro.2013.05.010; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Liu JW, 2005, ONCOGENE, V24, P2020, DOI 10.1038/sj.onc.1208385; Macip S, 2003, MOL CELL BIOL, V23, P8576, DOI 10.1128/MCB.23.23.8576-8585.2003; Maddocks ODK, 2011, J MOL MED, V89, P237, DOI 10.1007/s00109-011-0735-5; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Matsuo H, 2008, AM J HUM GENET, V83, P744, DOI 10.1016/j.ajhg.2008.11.001; Oda M, 2002, MOL BIOL EVOL, V19, P640, DOI 10.1093/oxfordjournals.molbev.a004123; Phay JE, 2000, GENOMICS, V66, P217, DOI 10.1006/geno.2000.6195; Pietraforte D, 2006, FREE RADICAL BIO MED, V41, P1753, DOI 10.1016/j.freeradbiomed.2006.08.014; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Preitner F, 2009, P NATL ACAD SCI USA, V106, P15501, DOI 10.1073/pnas.0904411106; Ringshausen I, 2006, CANCER CELL, V10, P501, DOI 10.1016/j.ccr.2006.10.010; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; So A, 2010, J CLIN INVEST, V120, P1791, DOI 10.1172/JCI42344; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; WU XW, 1992, J MOL EVOL, V34, P78, DOI 10.1007/BF00163854; Yoon KA, 2004, J HUM GENET, V49, P134, DOI 10.1007/s10038-003-0122-3	50	61	67	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 2	2015	34	14					1799	1810		10.1038/onc.2014.119	http://dx.doi.org/10.1038/onc.2014.119			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CE9IQ	24858040				2022-12-25	WOS:000352158000007
J	Jin, J; Colin, P; Staropoli, I; Lima-Fernandes, E; Ferret, C; Demir, A; Rogee, S; Hartley, O; Randriamampita, C; Scott, MGH; Marullo, S; Sauvonnet, N; Arenzana-Seisdedos, F; Lagane, B; Brelot, A				Jin, Jun; Colin, Philippe; Staropoli, Isabelle; Lima-Fernandes, Evelyne; Ferret, Cecile; Demir, Arzu; Rogee, Sophie; Hartley, Oliver; Randriamampita, Clotilde; Scott, Mark G. H.; Marullo, Stefano; Sauvonnet, Nathalie; Arenzana-Seisdedos, Fernando; Lagane, Bernard; Brelot, Anne			Targeting Spare CC Chemokine Receptor 5 (CCR5) as a Principle to Inhibit HIV-1 Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROTEIN-COUPLED RECEPTORS; N-TERMINAL MODIFICATIONS; HIGHLY POTENT; BETA(2)-ADRENERGIC RECEPTOR; ANTI-HIV-1 ACTIVITY; RANTES; ENDOCYTOSIS; ANTAGONIST; INFECTION	CCR5 binds the chemokines CCL3, CCL4, and CCL5 and is the major coreceptor for HIV-1 entry into target cells. Chemokines are supposed to form a natural barrier against human immunodeficiency virus, type 1 (HIV-1) infection. However, we showed that their antiviral activity is limited by CCR5 adopting low-chemokine affinity conformations at the cell surface. Here, we investigated whether a pool of CCR5 that is not stabilized by chemokines could represent a target for inhibiting HIV infection. We exploited the characteristics of the chemokine analog PSC-RANTES (N-alpha-(n-nonanoyl)- des-Ser(1)-[ L-thioprolyl(2), L-cyclohexylglycyl(3)]RANTES( 4-68)), which displays potent anti-HIV-1 activity. We show that native chemokines fail to prevent high-affinity binding of PSC-RANTES, analog-mediated calcium release (in desensitization assays), and analog-mediated CCR5 internalization. These results indicate that a pool of spare CCR5 may bind PSC-RANTES but not native chemokines. Improved recognition of CCR5 by PSC-RANTES may explain why the analog promotes higher amounts of beta-arrestin2 .CCR5 complexes, thereby increasing CCR5 down-regulation and HIV-1inhibition. Together, these results highlight that spare CCR5, which might permit HIV-1 to escape from chemokines, should be targeted for efficient viral blockade.	[Jin, Jun; Colin, Philippe; Staropoli, Isabelle; Ferret, Cecile; Demir, Arzu; Arenzana-Seisdedos, Fernando; Lagane, Bernard; Brelot, Anne] Inst Pasteur, INSERM U1108, Viral Pathogenesis Unit, Dept Virol, F-75724 Paris 15, France; [Colin, Philippe] Univ Paris Diderot, Sorbonne Paris Cite, F-75015 Paris, France; [Lima-Fernandes, Evelyne; Rogee, Sophie; Randriamampita, Clotilde; Scott, Mark G. H.; Marullo, Stefano] Univ Paris 05, Inst Cochin, CNRS UMR 8104, INSERM U1016, F-75014 Paris, France; [Hartley, Oliver] Univ Geneva, Dept Pathol & Immunol, CH-1211 Geneva 4, Switzerland; [Sauvonnet, Nathalie] Inst Pasteur, Unite Biol Interact Cellulaires, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Geneva; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Brelot, A (corresponding author), Inst Pasteur, 28 Rue Docteur Roux, F-75724 Paris 15, France.	anne.brelot@pasteur.fr	Colin, Philippe/AAM-3923-2020; Marullo, Stefano/C-6142-2008; Lagane, Bernard/K-8446-2016; Lagane, Bernard/AAA-2205-2019; Brelot, Anne/P-4129-2017; Arenzana-Seisdedos, Fernando/E-5835-2016; Scott, Mark/R-3521-2019	Colin, Philippe/0000-0002-5552-8908; Marullo, Stefano/0000-0001-9604-9973; Lagane, Bernard/0000-0002-3459-7867; Brelot, Anne/0000-0002-8095-4909; sauvonnet, nathalie/0000-0003-0306-3376; Lima Fernandes, Evelyne/0000-0002-3628-9745; Scott, Mark G.H./0000-0002-1557-1856; Randriamampita, Clotilde/0000-0001-8594-7831	Agence Nationale de Recherche sur le SIDA (ANRS); Fondation ARC; Fondation pour la Recherche Medicale (FRM); SIDACTION; INSERM; Institut Pasteur; Swiss National Science Foundation; China Scholarship Council;  [ANR-10-LabEx-62-IBEID]	Agence Nationale de Recherche sur le SIDA (ANRS)(ANRSFrench National Research Agency (ANR)); Fondation ARC; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); SIDACTION; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Pasteur(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); China Scholarship Council(China Scholarship Council); 	This work was supported by Agence Nationale de Recherche sur le SIDA (ANRS), Fondation ARC, Fondation pour la Recherche Medicale (FRM), SIDACTION, INSERM, Institut Pasteur, the Swiss National Science Foundation, and by Grant ANR-10-LabEx-62-IBEID.; Supported by a fellowship from the China Scholarship Council.	Abrol R, 2013, METHOD ENZYMOL, V520, P31, DOI 10.1016/B978-0-12-391861-1.00002-2; Achour L, 2011, METHODS MOL BIOL, V756, P183, DOI 10.1007/978-1-61779-160-4_9; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Barretina J, 2000, TRANSFUSION, V40, P461, DOI 10.1046/j.1537-2995.2000.40040461.x; Basquin C, 2013, J CELL SCI, V126, P1099, DOI 10.1242/jcs.110932; Benmerah A, 1999, J CELL SCI, V112, P1303; Berro R, 2013, J VIROL, V87, P6569, DOI 10.1128/JVI.00099-13; Berro R, 2011, J VIROL, V85, P8227, DOI 10.1128/JVI.00767-11; Blanpain C, 2003, J BIOL CHEM, V278, P5179, DOI 10.1074/jbc.M205684200; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chabre M, 2009, TRENDS PHARMACOL SCI, V30, P182, DOI 10.1016/j.tips.2009.01.003; Choi WT, 2012, J VIROL, V86, P10218, DOI 10.1128/JVI.00353-12; Colin P, 2013, P NATL ACAD SCI USA, V110, P9475, DOI 10.1073/pnas.1222205110; Conche C, 2009, IMMUNITY, V30, P33, DOI 10.1016/j.immuni.2008.10.020; Delhaye M, 2007, MOL PHARMACOL, V72, P1497, DOI 10.1124/mol.107.038422; Escola JM, 2010, J BIOL CHEM, V285, P41772, DOI 10.1074/jbc.M110.153460; Fish Kenneth N, 2009, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1218s50; Gaertner H, 2008, PROTEIN ENG DES SEL, V21, P65, DOI 10.1093/protein/gzm079; Gaertner H, 2008, P NATL ACAD SCI USA, V105, P17706, DOI 10.1073/pnas.0805098105; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Haqqani AA, 2013, ANTIVIR RES, V98, P158, DOI 10.1016/j.antiviral.2013.03.017; Hartley O, 2004, P NATL ACAD SCI USA, V101, P16460, DOI 10.1073/pnas.0404802101; Issafras H, 2002, J BIOL CHEM, V277, P34666, DOI 10.1074/jbc.M202386200; Jacquin L, 2013, FEBS OPEN BIO, V3, P1, DOI 10.1016/j.fob.2012.11.004; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Kuhmann SE, 2000, J VIROL, V74, P7005, DOI 10.1128/JVI.74.15.7005-7015.2000; Lagane B, 2005, MOL PHARMACOL, V67, P1966, DOI 10.1124/mol.104.009779; Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288; Molla-Herman A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003728; Mueller A, 2006, BIOCHEM PHARMACOL, V72, P739, DOI 10.1016/j.bcp.2006.06.001; Nakajima T, 2008, CYTOGENET GENOME RES, V123, P156, DOI 10.1159/000184703; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Oppermann M, 2004, CELL SIGNAL, V16, P1201, DOI 10.1016/j.cellsig.2004.04.007; Pastore C, 2003, ANTIMICROB AGENTS CH, V47, P509, DOI 10.1128/AAC.47.2.509-517.2003; Rajagopal S, 2013, J BIOL CHEM, V288, P35039, DOI 10.1074/jbc.M113.479113; Randriamampita C, 2003, EUR J IMMUNOL, V33, P1215, DOI 10.1002/eji.200323844; Ray Neelanjana, 2009, Drug Des Devel Ther, V2, P151; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Schols D, 1998, ANTIVIR RES, V39, P175, DOI 10.1016/S0166-3542(98)00039-4; Simmons G, 1997, SCIENCE, V276, P276, DOI 10.1126/science.276.5310.276; Storez H, 2005, J BIOL CHEM, V280, P40210, DOI 10.1074/jbc.M508001200; Tarancon Diez L., 2014, HISTOCHEM C IN PRESS; Watson C, 2005, MOL PHARMACOL, V67, P1268, DOI 10.1124/mol.104.008565	45	26	27	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19042	19052		10.1074/jbc.M114.559831	http://dx.doi.org/10.1074/jbc.M114.559831			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24855645	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000339062900035
J	Kawano, Y; Fujiwara, T; Yao, A; Housen, Y; Hayashi, K; Shimamoto, K				Kawano, Yoji; Fujiwara, Tadashi; Yao, Ai; Housen, Yusuke; Hayashi, Keiko; Shimamoto, Ko			Palmitoylation-dependent Membrane Localization of the Rice Resistance Protein Pit Is Critical for the Activation of the Small GTPase OsRac1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-RESISTANCE; PLASMA-MEMBRANE; INNATE IMMUNITY; NADPH OXIDASE; HYPERSENSITIVE RESPONSE; ARABIDOPSIS EDS1; EFFECTOR AVRRPT2; RAC GTPASE; RECEPTOR; DEFENSE	Nucleotide binding domain and leucine-rich repeat (NLR)-containing family proteins function as intracellular immune sensors in both plants and animals. In plants, the downstream components activated by NLR family proteins and the immune response mechanisms induced by these downstream molecules are largely unknown. We have previously found that the small GTPase OsRac1, which acts as a molecular switch in rice immunity, is activated by Pit, an NLR-type resistance (R) protein to rice blast fungus, and this activation plays critical roles in Pit-mediated immunity. However, the sites and mechanisms of activation of Pit in vivo remain unknown. To clarify the mechanisms involved in the localization of Pit, we searched for consensus sequences in Pit that specify membrane localization and found a pair of potential palmitoylation sites in the N-terminal coiled-coil region. Although wild-type Pit was localized mainly to the plasma membrane, this membrane localization was compromised in a palmitoylation-deficient mutant of Pit. The palmitoylation- deficient Pit displayed significantly lower affinity for OsRac1 on the plasma membrane, thereby resulting in failures of the Pit-mediated cell death, the production of reactive oxygen species, and disease resistance to rice blast fungus. These results indicate that palmitoylation-dependent membrane localization of Pit is required for the interaction with and the activation of OsRac1 and that OsRac1 activation by Pit is vital for Pit-mediated disease resistance to rice blast fungus.	[Kawano, Yoji; Fujiwara, Tadashi; Yao, Ai; Housen, Yusuke; Shimamoto, Ko] Nara Inst Sci & Technol, Plant Mol Genet Lab, Nara 6300101, Japan; [Hayashi, Keiko] Natl Agr & Food Res Org, Natl Agr Res Ctr, Tsukuba, Ibaraki 3058666, Japan	Nara Institute of Science & Technology; National Agriculture & Food Research Organization - Japan	Kawano, Y (corresponding author), Nara Inst Sci & Technol, Plant Mol Genet Lab, 8916-5 Takayama, Nara 6300101, Japan.	y-kawano@bs.naist.jp	Kawano, Yoji/C-7484-2011	Kawano, Yoji/0000-0003-0687-2777	MAFF Genomics for Agricultural Innovation [PMI0007]; Japan Society for the Promotion of Science KAKENHI [19108005, 2377044, 24113515, 26113712, 26450055]	MAFF Genomics for Agricultural Innovation; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MAFF Genomics for Agricultural Innovation Grant PMI0007 (to K. S.) and by Japan Society for the Promotion of Science KAKENHI Grants 19108005 (to K. S.) and 2377044, 24113515, 26113712, and 26450055 (to Y. K.).	Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Berken A, 2006, CELL MOL LIFE SCI, V63, P2446, DOI 10.1007/s00018-006-6197-1; Berruyer R, 2006, PHYTOPATHOLOGY, V96, P346, DOI 10.1094/PHYTO-96-0346; Bhattacharjee S, 2011, SCIENCE, V334, P1405, DOI 10.1126/science.1211592; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; Chen LT, 2010, CELL HOST MICROBE, V7, P185, DOI 10.1016/j.chom.2010.02.008; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Gao ZY, 2011, P NATL ACAD SCI USA, V108, P7619, DOI 10.1073/pnas.1104410108; Hayashi K, 2009, PLANT J, V57, P413, DOI 10.1111/j.1365-313X.2008.03694.x; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Heidrich K, 2011, SCIENCE, V334, P1401, DOI 10.1126/science.1211641; Hemsley PA, 2009, MOL MEMBR BIOL, V26, P114, DOI 10.1080/09687680802680090; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Jones MA, 2007, J EXP BOT, V58, P1261, DOI 10.1093/jxb/erl279; Kakita M, 2007, PLANT CELL, V19, P3961, DOI 10.1105/tpc.106.049999; Kawano Y, 2013, CURR OPIN PLANT BIOL, V16, P496, DOI 10.1016/j.pbi.2013.07.004; Kawano Y, 2010, RICE, V3, P112, DOI 10.1007/s12284-010-9049-4; Kawano Y, 2010, CELL HOST MICROBE, V7, P362, DOI 10.1016/j.chom.2010.04.010; Kawasaki T, 2006, P NATL ACAD SCI USA, V103, P230, DOI 10.1073/pnas.0509875103; Kawasaki T, 1999, P NATL ACAD SCI USA, V96, P10922, DOI 10.1073/pnas.96.19.10922; Kim HS, 2005, P NATL ACAD SCI USA, V102, P6496, DOI 10.1073/pnas.0500792102; Kobayashi M, 2007, PLANT CELL, V19, P1065, DOI 10.1105/tpc.106.048884; Lee YJ, 2008, CURR OPIN PLANT BIOL, V11, P662, DOI 10.1016/j.pbi.2008.10.002; Lieberherr D, 2005, PLANT PHYSIOL, V138, P1644, DOI 10.1104/pp.104.057414; Lukasik E, 2009, CURR OPIN PLANT BIOL, V12, P427, DOI 10.1016/j.pbi.2009.03.001; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Moeder W, 2005, MOL PLANT MICROBE IN, V18, P116, DOI 10.1094/MPMI-18-0116; Monaghan J, 2012, CURR OPIN PLANT BIOL, V15, P349, DOI 10.1016/j.pbi.2012.05.006; Nakashima A, 2008, PLANT CELL, V20, P2265, DOI 10.1105/tpc.107.054395; Ono E, 2001, P NATL ACAD SCI USA, V98, P759, DOI 10.1073/pnas.021273498; Purwestri YA, 2009, PLANT CELL PHYSIOL, V50, P429, DOI 10.1093/pcp/pcp012; Qi D, 2012, PLANT PHYSIOL, V158, P1819, DOI 10.1104/pp.112.194035; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Slootweg E, 2010, PLANT CELL, V22, P4195, DOI 10.1105/tpc.110.077537; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Thao NP, 2007, PLANT CELL, V19, P4035, DOI 10.1105/tpc.107.055517; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wirthmueller L, 2007, CURR BIOL, V17, P2023, DOI 10.1016/j.cub.2007.10.042; Wong HL, 2007, PLANT CELL, V19, P4022, DOI 10.1105/tpc.107.055624; Wong HL, 2004, PLANT PHYSIOL, V135, P1447, DOI 10.1104/pp.103.036384	46	24	24	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19079	19088		10.1074/jbc.M114.569756	http://dx.doi.org/10.1074/jbc.M114.569756			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24841201	Green Published, hybrid			2022-12-25	WOS:000339062900038
J	Koch, B; Schmidt, C; Ploier, B; Daum, G				Koch, Barbara; Schmidt, Claudia; Ploier, Birgit; Daum, Guenther			Modifications of the C terminus Affect Functionality and Stability of Yeast Triacylglycerol Lipase Tgl3p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; LIPID PARTICLES; ENDOPLASMIC-RETICULUM; PROTEINS; DROPLETS; IDENTIFICATION; PURIFICATION; MITOCHONDRIA; MEMBRANES; ENCODES	Lipid droplets are specific organelles for the storage of triacylglycerols and steryl esters. They are surrounded by a phospholipid monolayer with a small but specific set of proteins embedded. Assembly and insertion of proteins into this surface membrane is an intriguing question of lipid droplet biology. To address this question we studied the topology of Tgl3p, the major triacylglycerol lipase of the yeast Saccharomyces cerevisiae, on lipid droplets. Employing the method of limited proteolysis of lipid droplet surface proteins, we found that the C terminus of Tgl3p faces the inside of the organelle, whereas the N terminus is exposed at the cytosolic side of lipid droplets. Detailed analysis of the C terminus revealed a stretch of seven amino acids that are critical for protein stability and functionality. The negative charge of two aspartate residues within this stretch is crucial for lipase activity of Tgl3p. A portion of Tgl3p, which is located to the endoplasmic reticulum, exhibits a different topology. In the phospholipid bilayer of the endoplasmic reticulum the C terminus faces the cytosol, which results in instability of the protein. Thus, the topology of Tgl3p is important for its function and strongly dependent on the membrane environment.	[Koch, Barbara; Schmidt, Claudia; Ploier, Birgit; Daum, Guenther] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria	Graz University of Technology	Daum, G (corresponding author), Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria.	guenther.daum@tugraz.at			Austrian Science Fund (FWF) [P23029, W901]; Austrian Science Fund (FWF) [P 23029] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund (FWF) projects P23029 and W901 DK Molecular Enzymology (to G. D.).	Abell BM, 1997, PLANT CELL, V9, P1481, DOI 10.1105/tpc.9.8.1481; Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Athenstaedt K, 2000, J BIOL CHEM, V275, P235, DOI 10.1074/jbc.275.1.235; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; Czabany T, 2008, J BIOL CHEM, V283, P17065, DOI 10.1074/jbc.M800401200; FOLCH J, 1957, J BIOL CHEM, V226, P497; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Grillitsch K, 2011, BBA-MOL CELL BIOL L, V1811, P1165, DOI 10.1016/j.bbalip.2011.07.015; HAID A, 1983, METHOD ENZYMOL, V96, P192; Ham HJ, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.046946; HEESEN ST, 1991, EUR J CELL BIOL, V56, P8; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leber R, 1998, MOL BIOL CELL, V9, P375, DOI 10.1091/mbc.9.2.375; LEBER R, 1994, YEAST, V10, P1421, DOI 10.1002/yea.320101105; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mullner H, 2004, BBA-BIOMEMBRANES, V1663, P9, DOI 10.1016/S0005-2736(04)00079-3; Ploier B, 2013, J BIOL CHEM, V288, P36061, DOI 10.1074/jbc.M113.509927; Pu J, 2011, PROTEIN CELL, V2, P487, DOI 10.1007/s13238-011-1061-y; Rajakumari S, 2010, J BIOL CHEM, V285, P15769, DOI 10.1074/jbc.M109.076331; Rajakumari S, 2010, MOL BIOL CELL, V21, P501, DOI 10.1091/mbc.E09-09-0775; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Schmidt C, 2013, J BIOL CHEM, V288, P19939, DOI 10.1074/jbc.M113.459610; SIKORSKI RS, 1989, GENETICS, V122, P19; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; ZINSER E, 1993, J BACTERIOL, V175, P2853, DOI 10.1128/JB.175.10.2853-2858.1993; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	32	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19306	19316		10.1074/jbc.M114.556944	http://dx.doi.org/10.1074/jbc.M114.556944			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24847060	Green Published, hybrid			2022-12-25	WOS:000339326800008
J	Paoletta, S; Tosh, DK; Salvemini, D; Jacobson, KA				Paoletta, Silvia; Tosh, Dilip K.; Salvemini, Daniela; Jacobson, Kenneth A.			Structural Probing of Off-Target G Protein-Coupled Receptor Activities within a Series of Adenosine/Adenine Congeners	PLOS ONE			English	Article							SEROTONIN RECEPTORS; DRUG DESIGN; NUCLEOSIDES; AGONISTS; 2-ARYLETHYNYL; SUBSTITUTIONS; PROMISCUITY; SELECTIVITY; ANTAGONISTS; ACTIVATION	We studied patterns of off-target receptor interactions, mostly at G protein-coupled receptors (GPCRs) in the mu M range, of nucleoside derivatives that are highly engineered for nM interaction with adenosine receptors (ARs). Because of the considerable interest of using AR ligands for treating diseases of the CNS, we used the Psychoactive Drug Screening Program (PDSP) for probing promiscuity of these adenosine/adenine congeners at 41 diverse receptors, channels and a transporter. The step-wise truncation of rigidified, trisubstituted (at N degrees, C2, and 5' positions) nucleosides revealed unanticipated interactions mainly with biogenic amine receptors, such as adrenergic receptors and serotonergic receptors, with affinities as high as 61 nM. The unmasking of consistent sets of structure activity relationship (SAR) at novel sites suggested similarities between receptor families in molecular recognition. Extensive molecular modeling of the GPCRs affected suggested binding modes of the ligands that supported the patterns of SAR at individual receptors. In some cases, the ligand docking mode closely resembled AR binding and in other cases the ligand assumed different orientations. The recognition patterns for different GPCRs were clustered according to which substituent groups were tolerated and explained in light of the complementarity with the receptor binding site. Thus, some likely off-target interactions, a concern for secondary drug effects, can be predicted for analogues of this set of substructures, aiding the design of additional structural analogues that either eliminate or accentuate certain off-target activities. Moreover, similar analyses could be performed for unrelated structural families for other GPCRs.	[Paoletta, Silvia; Tosh, Dilip K.; Jacobson, Kenneth A.] NIDDK, Mol Recognit Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA; [Salvemini, Daniela] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Saint Louis University	Jacobson, KA (corresponding author), NIDDK, Mol Recognit Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA.	kajacobs@helix.nih.gov	Jacobson, Kenneth Alan/A-1530-2009	Jacobson, Kenneth Alan/0000-0001-8104-1493	National Institutes of Health (Intramural Research Program of the NIDDK); National Institutes of Health [R01HL077707]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031126, ZIADK031115, ZIADK031117] Funding Source: NIH RePORTER	National Institutes of Health (Intramural Research Program of the NIDDK); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the National Institutes of Health (Intramural Research Program of the NIDDK and R01HL077707). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 2011, ANNU REV PHARMACOL, V51, P117, DOI 10.1146/annurev-pharmtox-010510-100553; [Anonymous], MOL OP ENV MOE VERS; [Anonymous], 2012, SCHROD SUIT 2012; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chen JF, 2013, NAT REV DRUG DISCOV, V12, P265, DOI 10.1038/nrd3955; Chen ZM, 2012, FASEB J, V26, P1855, DOI 10.1096/fj.11-201541; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Costanzi S., 2007, FRONT DRUG DES DISCO, V3, P63; Dimova D, 2012, J MED CHEM, V55, P10220, DOI 10.1021/jm301292a; Fishman P, 2012, DRUG DISCOV TODAY, V17, P359, DOI 10.1016/j.drudis.2011.10.007; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; GALLORODRIGUEZ C, 1994, J MED CHEM, V37, P636, DOI 10.1021/jm00031a014; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Haupt VJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065894, 10.1371/journal.pone.0059937]; Hopkins AL, 2006, CURR OPIN STRUC BIOL, V16, P127, DOI 10.1016/j.sbi.2006.01.013; Huggins DJ, 2012, J MED CHEM, V55, P1424, DOI 10.1021/jm2010332; Jensen NH, 2008, COMB CHEM HIGH T SCR, V11, P420, DOI 10.2174/138620708784911483; Jiang QL, 1997, J MED CHEM, V40, P2588, DOI 10.1021/jm970084v; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Klotz KN, 2003, N-S ARCH PHARMACOL, V367, P629, DOI 10.1007/s00210-003-0749-9; Kolb P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049910; Lin H, 2013, NAT METHODS, V10, P140, DOI [10.1038/NMETH.2324, 10.1038/nmeth.2324]; Melman A, 2008, BIOORGAN MED CHEM, V16, P8546, DOI 10.1016/j.bmc.2008.08.007; Peprah K, 2012, BIOORGAN MED CHEM, V20, P1291, DOI 10.1016/j.bmc.2011.12.019; Peters JU, 2012, DRUG DISCOV TODAY, V17, P325, DOI 10.1016/j.drudis.2012.01.001; Pinna A, 2010, NEUROPHARMACOLOGY, V58, P613, DOI 10.1016/j.neuropharm.2009.11.012; Tosh DK, 2012, J MED CHEM, V55, P8075, DOI 10.1021/jm300965a; Tosh DK, 2012, ACS MED CHEM LETT, V3, P596, DOI 10.1021/ml300107e; Tosh DK, 2012, J MED CHEM, V55, P4847, DOI 10.1021/jm300396n; Triggle DJ, 2003, CELL MOL NEUROBIOL, V23, P293, DOI 10.1023/A:1023632419813; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807; Warne T, 2012, STRUCTURE, V20, P841, DOI 10.1016/j.str.2012.03.014; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Zhu CB, 2011, MOL PHARMACOL, V80, P458, DOI 10.1124/mol.111.071399	40	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97858	10.1371/journal.pone.0097858	http://dx.doi.org/10.1371/journal.pone.0097858			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859150	Green Submitted, gold, Green Published			2022-12-25	WOS:000336839400028
J	van Gestel, MA; Boender, AJ; de Vrind, VAJ; Garner, KM; Luijendijk, MCM; Adan, RAH				van Gestel, Margriet A.; Boender, Arjen J.; de Vrind, Veronne A. J.; Garner, Keith M.; Luijendijk, Mieneke C. M.; Adan, Roger A. H.			Recombinant Adeno-Associated Virus: Efficient Transduction of the Rat VMH and Clearance from Blood	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; GENE-TRANSFER; NONHUMAN-PRIMATES; SIALIC-ACID; DELIVERY; TYPE-2; EXPRESSION; NEURONS; HYPOTHALAMUS; CORECEPTOR	To promote the efficient and safe application of adeno-associated virus (AAV) vectors as a gene transfer tool in the central nervous system (CNS), transduction efficiency and clearance were studied for serotypes commonly used to transfect distinct areas of the brain. As AAV2 was shown to transduce only small volumes in several brain regions, this study compares the transduction efficiency of three AAV pseudotyped vectors, namely AAV2/1, AAV2/5 and AAV2/8, in the ventromedial nucleus of the hypothalamus (VMH). No difference was found between AAV2/1 and AAV2/5 in transduction efficiency. Both AAV2/1 and AAV2/5 achieved a higher transduction rate than AAV2/8. One hour after virus administration to the brain, no viral particles could be traced in blood, indicating that no or negligible numbers of virions crossed the blood-brain barrier. In order to investigate survival of AAV in blood, clearance was determined following systemic AAV administration. The half-life of AAV2/1, AAV2/2, AAV2/5 and AAV2/8 was calculated by determining virus clearance rates from blood after systemic injection. The half-life of AAV2/2 was 4.2 minutes, which was significantly lower than the half-lives of AAV2/1, AAV2/5 and AAV2/8. With a half-life of more than 11 hours, AAV2/8 particles remained detectable in blood significantly longer than AAV2/5. We conclude that application of AAV in the CNS is relatively safe as no AAV particles are detectable in blood after injection into the brain. With a half-life of 1.67 hours of AAV2/5, a systemic injection with 1x10(9) genomic copies of AAV would be fully cleared from blood after 2 days.	[van Gestel, Margriet A.; Boender, Arjen J.; de Vrind, Veronne A. J.; Garner, Keith M.; Luijendijk, Mieneke C. M.; Adan, Roger A. H.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Translat Neurosci, Brain Ctr Rudolf Magnus, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Adan, RAH (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Dept Translat Neurosci, Brain Ctr Rudolf Magnus, Utrecht, Netherlands.	r.a.h.adan@umcutrecht.nl		Boender, Arjen/0000-0002-6018-3588	TI Pharma [T5-210-1]	TI Pharma	This work was supported by TI Pharma, project T5-210-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Alemany R, 2000, J GEN VIROL, V81, P2605, DOI 10.1099/0022-1317-81-11-2605; Blits B, 2010, J NEUROSCI METH, V185, P257, DOI 10.1016/j.jneumeth.2009.10.009; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Chen SF, 2005, HUM GENE THER, V16, P235, DOI 10.1089/hum.2005.16.235; Ciron C, 2009, HUM GENE THER, V20, P350, DOI 10.1089/hum.2008.155; Colle MA, 2010, HUM MOL GENET, V19, P147, DOI 10.1093/hmg/ddp475; Cunningham J, 2008, MOL THER, V16, P1267, DOI 10.1038/mt.2008.111; de Backer MWA, 2010, J MOL ENDOCRINOL, V45, P341, DOI 10.1677/JME-10-0057; de Backer MWA, 2010, HUM GENE THER, V21, P673, DOI 10.1089/hum.2009.169; Di Pasquale G, 2006, MOL THER, V13, P506, DOI 10.1016/j.ymthe.2005.11.007; Di Pasquale G, 2003, NAT MED, V9, P1306, DOI 10.1038/nm929; Ferrari FK, 1996, J VIROL, V70, P3227, DOI 10.1128/JVI.70.5.3227-3234.1996; Fitzsimons HL, 2010, J GENE MED, V12, P385, DOI 10.1002/jgm.1449; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Hauck B, 2004, J VIROL, V78, P13678, DOI 10.1128/JVI.78.24.13678-13686.2004; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Kaludov N, 2001, J VIROL, V75, P6884, DOI 10.1128/JVI.75.15.6884-6893.2001; KAPLITT MG, 1994, NAT GENET, V8, P148, DOI 10.1038/ng1094-148; Kashiwakura Y, 2005, J VIROL, V79, P609, DOI 10.1128/JVI.79.1.609-614.2005; Klein RL, 2006, MOL THER, V13, P517, DOI 10.1016/j.ymthe.2005.10.008; Klein RL, 2008, MOL THER, V16, P89, DOI 10.1038/sj.mt.6300331; Kotchey NM, 2011, MOL THER, V19, P1079, DOI 10.1038/mt.2011.3; MATHEWS D, 1977, HORM BEHAV, V8, P40, DOI 10.1016/0018-506X(77)90019-8; McCown TJ, 1996, BRAIN RES, V713, P99, DOI 10.1016/0006-8993(95)01488-8; McFarland NR, 2009, J NEUROCHEM, V109, P838, DOI 10.1111/j.1471-4159.2009.06010.x; Miyake N, 2011, BRAIN RES, V1389, P19, DOI 10.1016/j.brainres.2011.03.014; Negishi A, 2004, GLYCOBIOLOGY, V14, P969, DOI 10.1093/glycob/cwh118; Qing K, 1999, NAT MED, V5, P71, DOI 10.1038/4758; Rabinowitz JE, 2002, J VIROL, V76, P791, DOI 10.1128/JVI.76.2.791-801.2002; Reimsnider S, 2007, MOL THER, V15, P1504, DOI 10.1038/sj.mt.6300227; Satoh N, 1997, ENDOCRINOLOGY, V138, P947, DOI 10.1210/en.138.3.947; Summerford C, 1999, NAT MED, V5, P78, DOI 10.1038/4768; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Thomas CE, 2004, J VIROL, V78, P3110, DOI 10.1128/JVI.78.6.3110-3122.2004; Trogrlic L, 2011, LEARN MEMORY, V18, P678, DOI 10.1101/lm.2314311; Walters RW, 2001, J BIOL CHEM, V276, P20610, DOI 10.1074/jbc.M101559200; Wu ZJ, 2006, J VIROL, V80, P9093, DOI 10.1128/JVI.00895-06; Zhang HW, 2011, MOL THER, V19, P1440, DOI 10.1038/mt.2011.98; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	40	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97639	10.1371/journal.pone.0097639	http://dx.doi.org/10.1371/journal.pone.0097639			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858547	Green Published, Green Submitted, gold			2022-12-25	WOS:000336839400022
J	Wang, SX; Wu, MQ; Yao, G; Zhang, JJ; Zhou, J				Wang, Shixuan; Wu, Maoqing; Yao, Gang; Zhang, Jingjing; Zhou, Jing			The Cytoplasmic Tail of FPC Antagonizes the Full-Length Protein in the Regulation of mTOR Pathway	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; PRIMARY CILIA; CELL-GROWTH; RAG GTPASES; GENE; FIBROCYSTIN; COMPLEX; PKHD1; PHOSPHORYLATION; RAPTOR	FPC (fibrocystin or polyductin) is a single transmembrane receptor-like protein, responsible for the human autosomal recessive polycystic kidney disease (ARPKD). It was recently proposed that FPC undergoes a Notch-like cleavage and subsequently the cleaved carboxy(C)-terminal fragment translocates to the nucleus. To study the functions of the isolated C-tail, we expressed the intracellular domain of human FPC (hICD) in renal epithelial cells. By 3-dimensional (3D) tubulogenesis assay, we found that in contrast to tubule-like structures formed from control cells, hICD-expressing cells exclusively formed cyst-like structures. By western blotting, we showed that the Akt/mTOR pathway, indicated by increased phosphorylation of Akt at serine 473 and S6 kinase 1 at threonine 389, was constitutively activated in hICD-expressing cells, similar to that in FPC knockdown cells and ARPKD kidneys. Moreover, application of mTOR inhibitor rapamycin reduced the size of the cyst-like structures formed by hICD-expressing cells. Application of either LY294002 or wortmannin inhibited the activation of both S6K1 and Akt. Expression of full-length FPC inhibited the activation of S6 and S6 kinase whereas co-expression of hICD with full-length FPC antagonized the inhibitory effect of full-length FPC on mTOR. Taken together, we propose that FPC modulates the PI3K/Akt/mTOR pathway and the cleaved C-tail regulates the function of the full-length protein.	[Wang, Shixuan] Brigham & Womens Hosp, Dept Med & Ctr Polycyst Kidney Dis, Div Renal, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Wang, SX (corresponding author), Brigham & Womens Hosp, Dept Med & Ctr Polycyst Kidney Dis, Div Renal, 75 Francis St, Boston, MA 02115 USA.	shwang@gru.edu; jzhou@partners.org		Wang, Shixuan/0000-0002-3088-0745	National Institutes of Health [P50DK074030]; March of Dimes [1-FY12-527]; Young Investigator Career Development Award from the Polycystic Kidney Disease Foundation [03YI08c]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK074030] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Young Investigator Career Development Award from the Polycystic Kidney Disease Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding sources: the National Institutes of Health (P50DK074030) and March of Dimes (1-FY12-527) to JZ, the Young Investigator Career Development Award from the Polycystic Kidney Disease Foundation (03YI08c) to SW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castedo M, 2002, CELL DEATH DIFFER, V9, P99, DOI 10.1038/sj/cdd/4400978; Edelstein CL, 2005, CELL CYCLE, V4, P1550, DOI 10.4161/cc.4.11.2185; Follit JA, 2010, J CELL BIOL, V188, P21, DOI 10.1083/jcb.200910096; Goilav B, 2008, PEDIATR NEPHROL, V23, P1473, DOI 10.1007/s00467-008-0851-9; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hiesberger T, 2006, J BIOL CHEM, V281, P34357, DOI 10.1074/jbc.M606740200; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kaimori JY, 2007, HUM MOL GENET, V16, P942, DOI 10.1093/hmg/ddm039; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073173; Mai WY, 2005, MOL BIOL CELL, V16, P4398, DOI 10.1091/mbc.E04-11-1019; Menezes LFC, 2004, KIDNEY INT, V66, P1345, DOI 10.1111/j.1523-1755.2004.00844.x; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Onuchic LF, 2002, AM J HUM GENET, V70, P1305, DOI 10.1086/340448; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Walz G, 2010, NEW ENGL J MED, V363, P830, DOI 10.1056/NEJMoa1003491; Wang SX, 2007, MOL CELL BIOL, V27, P3241, DOI 10.1128/MCB.00072-07; Wang SX, 2004, J AM SOC NEPHROL, V15, P592, DOI 10.1097/01.ASN.0000113793.12558.1D; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; Ward CJ, 2003, HUM MOL GENET, V12, P2703, DOI 10.1093/hmg/ddg274; Xiong HQ, 2002, GENOMICS, V80, P96, DOI 10.1006/geno.2002.6802; Yao G, 2014, HUM MOL GENET; Yao G, 2013, KIDNEY INT, V83, P426, DOI 10.1038/ki.2012.379; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Zhang JJ, 2010, HUM MOL GENET, V19, P3306, DOI 10.1093/hmg/ddq233; Zhang MZ, 2004, P NATL ACAD SCI USA, V101, P2311, DOI 10.1073/pnas.0400073101; Zhou J, 2008, AUTOSOMAL DOMINANT P; Zhou J, 2009, ANNU REV PHYSIOL, V71, P83, DOI 10.1146/annurev.physiol.70.113006.100621	34	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e95630	10.1371/journal.pone.0095630	http://dx.doi.org/10.1371/journal.pone.0095630			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24851866	Green Published, Green Submitted, gold			2022-12-25	WOS:000338323200005
J	Wernike, K; Holsteg, M; Schirrmeier, H; Hoffmann, B; Beer, M				Wernike, Kerstin; Holsteg, Mark; Schirrmeier, Horst; Hoffmann, Bernd; Beer, Martin			Natural Infection of Pregnant Cows with Schmallenberg Virus - A Follow-Up Study	PLOS ONE			English	Article							AKABANE VIRUS; CONGENITAL-ABNORMALITIES; CATTLE; ORTHOBUNYAVIRUS; ARTHROGRYPOSIS; NETHERLANDS; INOCULATION; ANTIBODIES; BELGIUM; BOVINE	Schmallenberg virus (SBV), an orthobunyavirus discovered in European livestock in late 2011 for the first time, causes premature or stillbirth and severe fetal malformation when cows and ewes are infected during pregnancy. Therefore, cattle of two holdings in the initially most affected area in Germany were closely monitored to describe the consequence for fetuses and newborn calves. Seventy-one calves whose mothers were naturally infected during the first five months of pregnancy were clinically, virologically, and serologically examined. One calve showed typical malformation, another one, born without visible abnormalities, was dead. Two cows aborted during the studied period; spleen and brain samples or meconium swabs were tested by real-time PCR, in none of the fetuses SBV-specific RNA was detectable and the tested fetal sera were negative in a commercially available antibody ELISA. In contrast, in nine clinically healthy calves high SBV-antibody titers were measurable before colostrum intake, and in meconium swabs of six of these animals viral RNA was present as well. The mothers of all nine seropositive calves were presumably infected between days 47 and 162 of gestation, which is within the critical timeframe for fetal infection suggested for SBV and related viruses.	[Wernike, Kerstin; Schirrmeier, Horst; Hoffmann, Bernd; Beer, Martin] FLI, Inst Diagnost Virol, Greifswald, Germany; [Holsteg, Mark] Chamber Agr North Rhine Westphalia, Bovine Hlth Serv, Bonn, Germany	Friedrich Loeffler Institute	Beer, M (corresponding author), FLI, Inst Diagnost Virol, Greifswald, Germany.	martin.beer@fli.bund.de			Germany Federal Ministry of Food, Agriculture and consumer protection; European Union [2012/349/EU]	Germany Federal Ministry of Food, Agriculture and consumer protection; European Union(European Commission)	This study was supported by the Germany Federal Ministry of Food, Agriculture and consumer protection and the European Union as outlined in Council Decision 2012/349/EU concerning a financial contribution by the Union for studies on Schmallenberg virus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, VET REC, V170, P217; Bilk S, 2012, VET MICROBIOL, V159, P236, DOI 10.1016/j.vetmic.2012.03.035; Bouwstra RJ, 2013, VET MICROBIOL, V165, P102, DOI 10.1016/j.vetmic.2013.03.004; Breard E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053446; Conraths FJ, 2013, NEW ZEAL VET J, V61, P63, DOI 10.1080/00480169.2012.738403; De Regge N, 2013, VET MICROBIOL, V162, P595, DOI 10.1016/j.vetmic.2012.11.029; Dominguez M, 2012, VET REC, V171, DOI 10.1136/vr.100883; Elbers ARW, 2012, EMERG INFECT DIS, V18, P1065, DOI 10.3201/eid1807.120323; European Food Safety Authority, 2012, EFSA J, V10, P2768, DOI DOI 10.2903/J.EFSA.2012.2768; Garigliany MM, 2012, EMERG INFECT DIS, V18, P1512, DOI 10.3201/eid1809.120716; Garigliany MM, 2012, EMERG INFECT DIS, V18, P1005, DOI 10.3201/eid1806.120104; HARTLEY WJ, 1977, AUST VET J, V53, P319, DOI 10.1111/j.1751-0813.1977.tb00240.x; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; KIRKLAND PD, 1988, VET REC, V122, P582, DOI 10.1136/vr.122.24.582; KONNO S, 1982, VET PATHOL, V19, P246, DOI 10.1177/030098588201900304; KUROGI H, 1975, ARCH VIROL, V47, P71, DOI 10.1007/BF01315594; KUROGI H, 1977, INFECT IMMUN, V17, P338, DOI 10.1128/IAI.17.2.338-343.1977; Meroc E, 2012, TRANSBOUND EMERG DIS; Meroc E., 2013, TRANSBOUND EMERG DIS; PARSONSON IM, 1975, AUST VET J, V51, P585, DOI 10.1111/j.1751-0813.1975.tb09398.x; St George T. D., 2004, Infectious diseases of livestock. Volume Two, P1029; van Maanen C, 2012, VET REC, V171, P299, DOI 10.1136/vr.101061; Veldhuis A.M., 2013, VET MICROBIOL; Wernike K, 2014, PREV VET MED; Wernike K., 2013, EPIDEMIOL INFECT, P1	25	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98223	10.1371/journal.pone.0098223	http://dx.doi.org/10.1371/journal.pone.0098223			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853555	Green Published, Green Submitted, gold			2022-12-25	WOS:000338323200057
J	Chen, CC; Chien, WF; Lin, NC; Yeh, KC				Chen, Chyi-chuann; Chien, Wei-Fu; Lin, Nai-Chun; Yeh, Kuo-Chen			Alternative Functions of Arabidopsis YELLOW STRIPE-LIKE3: From Metal Translocation to Pathogen Defense	PLOS ONE			English	Article							SALICYLIC-ACID; YELLOW-STRIPE; CROSS-TALK; PHYTOSIDEROPHORE TRANSPORTER; IRON PHYTOSIDEROPHORES; SIGNALING PATHWAYS; ION HOMEOSTASIS; ARABIDOPSIS; NICOTIANAMINE; PLANTS	YELLOW STRIPE-LIKE1 (YSL1) and YSL3 are involved in iron (Fe) and copper (Cu) translocation. Previously, we reported that upregulation of YSL1 and YSL3 under excess Cu caused high accumulation of Cu in the siz1 mutant, impaired in small ubiquitin-like modifier (SUMO) E3 ligase. Interestingly, the siz1 mutant contains high levels of salicylic acid (SA), involved in plant defense against biotrophic pathogens. In this study, we found that YSL1 and YSL3 were upregulated by SA. SA-regulated YSL3 but not YSL1 depended on NONEXPRESSOR OF PR1 (NPR1). Susceptibility to the pathogen Pseudomonas syringe pv. tomato (Pst) DC3000 was greater for ysl3 than the wild type. Also, during Pst DC3000 infection, YSL3 was positively regulated by SA signaling through NPR1 and the upregulation was enhanced in the coi1 mutant that defective in the jasmonic acid (JA) receptor, CORONATINE INSENSITIVE1. This line of evidence indicates that the regulation of YSL3 is downstream of SA signaling and interplays with JA signaling for involvement in pathogen-induced defense. We provide new insights into the biological function of the metal transporter YSL3 in plant pathogen defense.	[Chen, Chyi-chuann; Chien, Wei-Fu; Yeh, Kuo-Chen] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Lin, Nai-Chun] Natl Taiwan Univ, Dept Agr Chem, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Yeh, KC (corresponding author), Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan.	kcyeh@gate.sinica.edu.tw	Yeh, Kuo-Chen/AAG-4485-2021	Yeh, Kuo-Chen/0000-0002-3791-3423; LIN, NAI-CHUN/0000-0002-6485-9776	Academia Sinica; National Science Council, Taiwan [NSC 97-2311-B-001-008-MY3, NSC 101-2311-B-001-014-MY3]	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Academia Sinica and the National Science Council, Taiwan (NSC 97-2311-B-001-008-MY3 and NSC 101-2311-B-001-014-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernal M, 2012, PLANT CELL, V24, P738, DOI 10.1105/tpc.111.090431; Blanco F, 2009, PLANT MOL BIOL, V70, P79, DOI 10.1007/s11103-009-9458-1; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chen CC, 2011, PLANT PHYSIOL, V156, P2225, DOI 10.1104/pp.111.178996; Chu HH, 2010, PLANT PHYSIOL, V154, P197, DOI 10.1104/pp.110.159103; Colangelo EP, 2006, CURR OPIN PLANT BIOL, V9, P322, DOI 10.1016/j.pbi.2006.03.015; Conte SS, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00283; Conte SS, 2012, CURR TOP MEMBR, V69, P295, DOI 10.1016/B978-0-12-394390-3.00011-2; Curie C, 2001, NATURE, V409, P346, DOI 10.1038/35053080; Curie C, 2009, ANN BOT-LONDON, V103, P1, DOI 10.1093/aob/mcn207; DiDonato RJ, 2004, PLANT J, V39, P403, DOI 10.1111/j.1365-313X.2004.02128.x; Divol F, 2013, PLANT CELL, V25, P1040, DOI 10.1105/tpc.112.107672; Dong XN, 2004, CURR OPIN PLANT BIOL, V7, P547, DOI 10.1016/j.pbi.2004.07.005; Ellis C, 2002, PLANTA, V215, P549, DOI 10.1007/s00425-002-0787-4; Gendre D, 2007, PLANT J, V49, P1, DOI 10.1111/j.1365-313X.2006.02937.x; Harada E, 2007, FEBS LETT, V581, P4298, DOI 10.1016/j.febslet.2007.08.011; Higuchi K, 1999, PLANT PHYSIOL, V119, P471, DOI 10.1104/pp.119.2.471; Jaquinod M, 2007, MOL CELL PROTEOMICS, V6, P394, DOI 10.1074/mcp.M600250-MCP200; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; KING EO, 1954, J LAB CLIN MED, V44, P301; Kloek AP, 2001, PLANT J, V26, P509, DOI 10.1046/j.1365-313x.2001.01050.x; Kobayashi T, 2012, ANNU REV PLANT BIOL, V63, P131, DOI 10.1146/annurev-arplant-042811-105522; Koike S, 2004, PLANT J, V39, P415, DOI 10.1111/j.1365-313X.2004.02146.x; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Le Jean M, 2005, PLANT J, V44, P769, DOI 10.1111/j.1365-313X.2005.02569.x; Lee J, 2007, PLANT J, V49, P79, DOI 10.1111/j.1365-313X.2006.02947.x; Lin NC, 2005, MOL PLANT MICROBE IN, V18, P43, DOI 10.1094/MPMI-18-0043; Murata Y, 2006, PLANT J, V46, P563, DOI 10.1111/j.1365-313X.2006.02714.x; Roberts LA, 2004, PLANT PHYSIOL, V135, P112, DOI 10.1104/pp.103.037572; ROMHELD V, 1986, PLANT PHYSIOL, V80, P175, DOI 10.1104/pp.80.1.175; Schaaf G, 2005, PLANT CELL PHYSIOL, V46, P762, DOI 10.1093/pcp/pci081; Schaaf G, 2004, J BIOL CHEM, V279, P9091, DOI 10.1074/jbc.M311799200; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; TAKAGI S, 1984, J PLANT NUTR, V7, P469, DOI 10.1080/01904168409363213; Victoria FD, 2012, GENOME, V55, P883, DOI 10.1139/gen-2012-0064; VONWIREN N, 1994, PLANT PHYSIOL, V106, P71, DOI 10.1104/pp.106.1.71; WALTER A, 1995, J PLANT NUTR, V18, P1577, DOI 10.1080/01904169509365005; Waters BM, 2006, PLANT PHYSIOL, V141, P1446, DOI 10.1104/pp.106.082586; Wu Y, 2012, CELL REPORTS, V1, P639, DOI 10.1016/j.celrep.2012.05.008; Xin XF, 2013, ANN REV PHYTOPATHOL; Yamasaki H, 2009, PLANT CELL, V21, P347, DOI 10.1105/tpc.108.060137; Yan JB, 2009, PLANT CELL, V21, P2220, DOI 10.1105/tpc.109.065730; Yen MR, 2001, MICROBIOL-SGM, V147, P2881, DOI 10.1099/00221287-147-11-2881; Yoo CY, 2006, PLANT PHYSIOL, V142, P1548, DOI 10.1104/pp.106.088831; Zheng XY, 2012, CELL HOST MICROBE, V11, P587, DOI 10.1016/j.chom.2012.04.014	46	18	19	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98008	10.1371/journal.pone.0098008	http://dx.doi.org/10.1371/journal.pone.0098008			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845074	Green Published, gold, Green Submitted			2022-12-25	WOS:000339563400079
J	Figley, SA; Liu, Y; Karadimas, SK; Satkunendrarajah, K; Fettes, P; Spratt, SK; Lee, G; Ando, D; Surosky, R; Giedlin, M; Fehlings, MG				Figley, Sarah A.; Liu, Yang; Karadimas, Spyridon K.; Satkunendrarajah, Kajana; Fettes, Peter; Spratt, S. Kaye; Lee, Gary; Ando, Dale; Surosky, Richard; Giedlin, Martin; Fehlings, Michael G.			Delayed Administration of a Bio-Engineered Zinc-Finger VEGF-A Gene Therapy Is Neuroprotective and Attenuates Allodynia Following Traumatic Spinal Cord Injury	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; EXPERIMENTAL DIABETIC-NEUROPATHY; TRANSCRIPTION FACTOR; FUNCTIONAL RECOVERY; CHRONIC PAIN; INTRASPINAL INJECTION; NEUROLOGICAL FUNCTION; RECEPTOR EXPRESSION; CONTUSION INJURY; BLOOD-FLOW	Following spinal cord injury (SCI) there are drastic changes that occur in the spinal microvasculature, including ischemia, hemorrhage, endothelial cell death and blood-spinal cord barrier disruption. Vascular endothelial growth factor-A (VEGF-A) is a pleiotropic factor recognized for its pro-angiogenic properties; however, VEGF has recently been shown to provide neuroprotection. We hypothesized that delivery of AdV-ZFP-VEGF - an adenovirally delivered bio-engineered zinc-finger transcription factor that promotes endogenous VEGF-A expression - would result in angiogenesis, neuroprotection and functional recovery following SCI. This novel VEGF gene therapy induces the endogenous production of multiple VEGF-A isoforms; a critical factor for proper vascular development and repair. Briefly, female Wistar rats - under cyclosporin immunosuppression - received a 35 g clip-compression injury and were administered AdV-ZFP-VEGF or AdV-eGFP at 24 hours post-SCI. qRT-PCR and Western Blot analysis of VEGF-A mRNA and protein, showed significant increases in VEGF-A expression in AdV-ZFP-VEGF treated animals (p<0.001 and p<0.05, respectively). Analysis of NF200, TUNEL, and RECA-1 indicated that AdV-ZFP-VEGF increased axonal preservation (p<0.05), reduced cell death (p<0.01), and increased blood vessels (p<0.01), respectively. Moreover, AdV-ZFP-VEGF resulted in a 10% increase in blood vessel proliferation (p<0.001). Catwalk (TM) analysis showed AdV-ZFP-VEGF treatment dramatically improves hindlimb weight support (p<0.05) and increases hindlimb swing speed (p<0.02) when compared to control animals. Finally, AdV-ZFP-VEGF administration provided a significant reduction in allodynia (p<0.01). Overall, the results of this study indicate that AdV-ZFP-VEGF administration can be delivered in a clinically relevant time-window following SCI (24 hours) and provide significant molecular and functional benefits.	[Figley, Sarah A.; Liu, Yang; Karadimas, Spyridon K.; Satkunendrarajah, Kajana; Fettes, Peter; Fehlings, Michael G.] Univ Hlth Network, Dept Genet & Dev, Toronto Western Res Inst, Toronto, ON, Canada; [Figley, Sarah A.; Liu, Yang; Karadimas, Spyridon K.; Satkunendrarajah, Kajana; Fettes, Peter; Fehlings, Michael G.] Univ Hlth Network, Spinal Program, Krembil Neurosci Ctr, Toronto, ON, Canada; [Figley, Sarah A.; Karadimas, Spyridon K.; Giedlin, Martin; Fehlings, Michael G.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Spratt, S. Kaye; Lee, Gary; Ando, Dale; Surosky, Richard] Sangamo BioSci, Dept Therapeut Dev, Pt Richmond, CA USA; [Fehlings, Michael G.] Univ Toronto, Dept Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Sangamo Therapeutics, Inc.; University of Toronto	Fehlings, MG (corresponding author), Univ Hlth Network, Dept Genet & Dev, Toronto Western Res Inst, Toronto, ON, Canada.	michael.fehlings@uhn.on.ca		Fehlings, Michael/0000-0002-5722-6364	Sangamo BioSciences; Krembil Chair in Neural Repair and Regeneration	Sangamo BioSciences; Krembil Chair in Neural Repair and Regeneration	This study was supported by Sangamo BioSciences and the Krembil Chair in Neural Repair and Regeneration (held by Dr. Michael G. Fehlings). The funders had no role in data collection, data analysis, or decision to publish; however, they did participate in some aspects of study design and reviewed the manuscript prior to publication.	Azzouz M, 2000, HUM MOL GENET, V9, P803, DOI 10.1093/hmg/9.5.803; Ballermann M, 2006, EUR J NEUROSCI, V23, P1988, DOI 10.1111/j.1460-9568.2006.04726.x; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bearden SE, 2004, MICROCIRCULATION, V11, P633, DOI 10.1080/10739680490517659; Beattie MS, 2004, TRENDS MOL MED, V10, P580, DOI 10.1016/j.molmed.2004.10.006; Benton RL, 2008, J COMP NEUROL, V507, P1031, DOI 10.1002/cne.21570; Benton RL, 2003, NEUROCHEM RES, V28, P1693, DOI 10.1023/A:1026013106016; Bruce JC, 2002, EXP NEUROL, V178, P33, DOI 10.1006/exnr.2002.8026; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8; Choi BH, 2007, J NEUROSURG-SPINE, V7, P54, DOI 10.3171/SPI-07/07/054; Dai QS, 2004, CIRCULATION, V110, P2467, DOI 10.1161/01.CIR.0000145139.53840.49; Defrin R, 2001, PAIN, V89, P253, DOI 10.1016/S0304-3959(00)00369-9; Dijkers M, 2009, J REHABIL RES DEV, V46, P13, DOI 10.1682/JRRD.2008.04.0053; Facchiano F, 2002, J NEUROSURG, V97, P161, DOI 10.3171/jns.2002.97.1.0161; FEHLINGS MG, 1995, EXP NEUROL, V132, P220, DOI 10.1016/0014-4886(95)90027-6; FEHLINGS MG, 1989, ELECTROEN CLIN NEURO, V74, P241, DOI 10.1016/0168-5597(89)90055-5; Flynn JR, 2011, NEUROPHARMACOLOGY, V60, P809, DOI 10.1016/j.neuropharm.2011.01.016; Gensel JC, 2006, J NEUROTRAUM, V23, P36, DOI 10.1089/neu.2006.23.36; Glantz S. A., 2005, PRIMER BIOSTATISTICS; Glaser J, 2006, J NEUROSCI RES, V84, P724, DOI 10.1002/jnr.20982; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Grossman SD, 2001, EXP NEUROL, V168, P273, DOI 10.1006/exnr.2001.7628; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Hobson MI, 2000, J ANAT, V197, P591, DOI 10.1046/j.1469-7580.2000.19740591.x; Hoheisel U, 2003, BRAIN RES, V974, P134, DOI 10.1016/S0006-8993(03)02571-X; HOLM S, 1979, SCAND J STAT, V6, P65; Jin KL, 2000, NEUROSCIENCE, V99, P577, DOI 10.1016/S0306-4522(00)00207-4; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Kaneko S, 2006, NAT MED, V12, P1380, DOI 10.1038/nm1505; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Karimi-Abdolrezaee S, 2004, EUR J NEUROSCI, V19, P577, DOI 10.1111/j.0953-816X.2004.03164.x; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Koopmans GC, 2005, J NEUROTRAUM, V22, P214, DOI 10.1089/neu.2005.22.214; Krum JM, 1999, EXP NEUROL, V160, P348, DOI 10.1006/exnr.1999.7222; Krum JM, 1998, EXP NEUROL, V154, P57, DOI 10.1006/exnr.1998.6930; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Leypold BG, 2007, SPINE, V32, P373, DOI 10.1097/01.brs.0000253964.10701.00; Ling X, 2007, J NEUROSCI RES, V85, P2175, DOI 10.1002/jnr.21362; Liu PQ, 2001, J BIOL CHEM, V276, P11323, DOI 10.1074/jbc.M011172200; Liu XZ, 1997, J NEUROSCI, V17, P5395; Liu Y, 2010, NEUROBIOL DIS, V37, P384, DOI 10.1016/j.nbd.2009.10.018; Loy DN, 2002, J COMP NEUROL, V445, P308, DOI 10.1002/cne.10168; Mabon PJ, 2000, EXP NEUROL, V166, P52, DOI 10.1006/exnr.2000.7488; Naldini Antonella, 2005, Current Drug Targets - Inflammation and Allergy, V4, P3, DOI 10.2174/1568010053622830; Nesic O, 2010, J NEUROTRAUM, V27, P1793, DOI 10.1089/neu.2010.1351; Neufeld G, 2002, TRENDS CARDIOVAS MED, V12, P13, DOI 10.1016/S1050-1738(01)00140-2; Neufeld G, 2003, INTERACTION NEUROPIL, P81; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Osterberg A, 2010, EUR J PAIN, V14, P104, DOI 10.1016/j.ejpain.2009.03.003; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; PETERS KG, 1993, P NATL ACAD SCI USA, V90, P8915, DOI 10.1073/pnas.90.19.8915; Price SA, 2006, DIABETES, V55, P1847, DOI 10.2337/db05-1060; Raab S, 2007, ACTA NEUROPATHOL, V113, P607, DOI 10.1007/s00401-007-0228-3; Rebar EJ, 2002, NAT MED, V8, P1427, DOI 10.1038/nm795; Schratzberger P, 2001, J CLIN INVEST, V107, P1083, DOI 10.1172/JCI12188; Schumacher PA, 2000, J NEUROCHEM, V74, P1646, DOI 10.1046/j.1471-4159.2000.0741646.x; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Tsao MN, 1999, J NEUROPATH EXP NEUR, V58, P1051, DOI 10.1097/00005072-199910000-00003; Vierck CJ, 2000, PAIN, V89, P1, DOI 10.1016/S0304-3959(00)00463-2; Waxman SG, 1999, MUSCLE NERVE, V22, P1177, DOI 10.1002/(SICI)1097-4598(199909)22:9<1177::AID-MUS3>3.3.CO;2-G; Werhagen L, 2004, SPINAL CORD, V42, P665, DOI 10.1038/sj.sc.3101641; Widenfalk J, 2003, NEUROSCIENCE, V120, P951, DOI 10.1016/S0306-4522(03)00399-3; Yezierski RP, 1996, J CEREBR BLOOD F MET, V16, P996, DOI 10.1097/00004647-199609000-00025; Yoshihara T, 2007, J NEUROTRAUM, V24, P1026, DOI 10.1089/neu.2007.132R; Yu J, 2006, FASEB J, V20, P479, DOI 10.1096/fj.04-3670fje	71	21	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e96137	10.1371/journal.pone.0096137	http://dx.doi.org/10.1371/journal.pone.0096137			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846143	gold, Green Published, Green Submitted			2022-12-25	WOS:000339563400005
J	Hu, LW; Yen, JH; Shen, YT; Wu, KY; Wu, MJ				Hu, Ling-Wei; Yen, Jui-Hung; Shen, Yi-Ting; Wu, Kuan-Yi; Wu, Ming-Jiuan			Luteolin Modulates 6-Hydroxydopamine-Induced Transcriptional Changes of Stress Response Pathways in PC12 Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; HEME OXYGENASE-1 EXPRESSION; OXIDATIVE STRESS; ER STRESS; DNA-DAMAGE; LIPID-PEROXIDATION; GENE-EXPRESSION; CELLULAR-MODEL; DEATH	The neurotoxin 6-hydroxydopamine (6-OHDA), which causes transcriptional changes associated with oxidative and proteotoxic stress, has been widely used to generate an experimental model of Parkinson's disease. The food-derived compound luteolin has multi-target actions including antioxidant, anti-inflammatory and neurotrophic activities. The aim of this study is to investigate how luteolin affects 6-OHDA-mediated stress response pathways. The results showed that when PC12 cells were pre-treated with luteolin (20 mu M) 30 min prior to 6-OHDA (100 mu M) exposure, 6-OHDA-induced ROS overproduction, cytotoxicity, caspase-3 activation, and mRNA expression of BIM, TRB3 and GADD34 were significantly attenuated. Moreover, 6-OHDA-mediated cell cycle arrest and transcription of p53 target genes, p21, GADD45 alpha and PUMA, were reduced by luteolin. Luteolin also significantly down-regulated 6-OHDA-mediated unfolded protein response (UPR), leading to decreases in phospho-eIF2 alpha, ATF4, GRP78 and CHOP. In addition, luteolin attenuated 6-OHDA-induced Nrf2-mediated HO-1 and GCLC. Taken together, these results suggest that diminishing intracellular ROS formation and down-regulation of p53, UPR and Nrf2-ARE pathways may be involved in the neuroprotective effect of luteolin.	[Hu, Ling-Wei; Wu, Kuan-Yi; Wu, Ming-Jiuan] Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan, Taiwan; [Yen, Jui-Hung] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Shen, Yi-Ting] Chia Nan Univ Pharm & Sci, Dept Pharm, Tainan, Taiwan	Chia Nan University of Pharmacy & Science; Tzu Chi University; Chia Nan University of Pharmacy & Science	Wu, MJ (corresponding author), Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan, Taiwan.	imwu@mail.chna.edu.tw			National Science Council, Taiwan, ROC [NSC-99-2320-B-041-005-MY3, NSC 102-2320-B-041-003-MY3]	National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This study was supported by grants NSC-99-2320-B-041-005-MY3 and NSC 102-2320-B-041-003-MY3 from the National Science Council, Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa YO, 2010, FREE RADICAL RES, V44, P410, DOI 10.3109/10715760903536349; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Bellucci A, 2011, J NEUROCHEM, V116, P588, DOI 10.1111/j.1471-4159.2010.07143.x; Bernstein AI, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-2; Biswas SC, 2005, NEUROCHEM RES, V30, P839, DOI 10.1007/s11064-005-6877-5; Blum D, 2000, NEUROSCI LETT, V283, P193, DOI 10.1016/S0304-3940(00)00948-4; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; Bowers AJ, 2003, ONCOGENE, V22, P2823, DOI 10.1038/sj.onc.1206367; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Cai QY, 1997, CANCER LETT, V119, P99, DOI 10.1016/S0304-3835(97)00261-9; Calabrese V, 2010, ANTIOXID REDOX SIGN, V13, P1763, DOI 10.1089/ars.2009.3074; CARMICHAEL J, 1987, CANCER RES, V47, P936; Cheng HY, 2010, PHYTOTHER RES, V24, pS102, DOI 10.1002/ptr.2940; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Cullinan SB, 2006, INT J BIOCHEM CELL B, V38, P317, DOI 10.1016/j.biocel.2005.09.018; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; De Araujo DP, 2011, INT J NEUROSCI, V121, P51, DOI 10.3109/00207454.2010.535934; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Dirscherl K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-3; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Gelinas S, 2004, NEUROTOX RES, V6, P141, DOI 10.1007/BF03033216; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Griffith OW, 1999, ADV ENZYMOL RAMB, V73, P209, DOI 10.1002/9780470123195.ch7; Guo DJ, 2013, PHARM BIOL, V51, P190, DOI 10.3109/13880209.2012.716852; Gupta S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000410; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Holtz WA, 2005, ANTIOXID REDOX SIGN, V7, P639, DOI 10.1089/ars.2005.7.639; Holtz WA, 2003, J BIOL CHEM, V278, P19367, DOI 10.1074/jbc.M211821200; Hoozemans JJM, 2007, BIOCHEM BIOPH RES CO, V354, P707, DOI 10.1016/j.bbrc.2007.01.043; Hoozemans JJM, 2012, INT J BIOCHEM CELL B, V44, P1295, DOI 10.1016/j.biocel.2012.04.023; Hoozemans Jeroen J. N., 2009, V7, P111, DOI 10.1007/978-1-4020-9434-7_5; Hughes KJ, 2009, J BIOL CHEM, V284, P27402, DOI 10.1074/jbc.M109.046912; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Jennings P, 2013, ARCH TOXICOL, V87, P49, DOI 10.1007/s00204-012-0919-y; Kensler TW, 2010, CARCINOGENESIS, V31, P90, DOI 10.1093/carcin/bgp231; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lee C, 2011, TOXICOLOGY, V283, P118, DOI 10.1016/j.tox.2011.03.004; Liebermann Dan A, 2008, J Mol Signal, V3, P15, DOI 10.1186/1750-2187-3-15; Lin CW, 2010, J AGR FOOD CHEM, V58, P4477, DOI 10.1021/jf904061x; Lin LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043304; Lin MH, 2014, TOXICOLOGY, V315, P24, DOI 10.1016/j.tox.2013.11.007; Lin YP, 2012, PHYTOCHEMISTRY, V84, P102, DOI 10.1016/j.phytochem.2012.07.020; Liu R, 2009, NEUROSCIENCE, V162, P1232, DOI 10.1016/j.neuroscience.2009.05.009; Lopez-Lazaro M, 2009, MINI-REV MED CHEM, V9, P31, DOI 10.2174/138955709787001712; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Magesh S, 2012, MED RES REV, V32, P687, DOI 10.1002/med.21257; Maher J, 2010, TOXICOL APPL PHARM, V244, P4, DOI 10.1016/j.taap.2010.01.011; Martin D, 2004, J BIOL CHEM, V279, P8919, DOI 10.1074/jbc.M309660200; Morse E, 2010, AM J PHYSIOL-RENAL, V299, pF965, DOI 10.1152/ajprenal.00236.2010; Ord D, 2007, EXP CELL RES, V313, P3556, DOI 10.1016/j.yexcr.2007.07.017; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Pavlica S, 2010, LIFE SCI, V86, P79, DOI 10.1016/j.lfs.2009.10.017; Pedrosa R, 2002, BRIT J PHARMACOL, V137, P1305, DOI 10.1038/sj.bjp.0704982; Pereira C, 2013, ISRN CELL BIOL, V2013, P22, DOI DOI 10.1155/2013/256404; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Rasheva VI, 2009, APOPTOSIS, V14, P996, DOI 10.1007/s10495-009-0341-y; Reisman D, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/808934; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Ryu EJ, 2005, NEUROBIOL DIS, V18, P54, DOI 10.1016/j.nbd.2004.08.016; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Saito Y, 2007, FREE RADICAL BIO MED, V42, P675, DOI 10.1016/j.freeradbiomed.2006.12.004; Sato M, 2006, P NATL ACAD SCI USA, V103, P797, DOI 10.1073/pnas.0507467103; Schipper HM, 2000, EXP GERONTOL, V35, P821, DOI 10.1016/S0531-5565(00)00148-0; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shay KP, 2008, IUBMB LIFE, V60, P362, DOI 10.1002/iub.40; Spencer JPE, 2010, P NUTR SOC, V69, P244, DOI 10.1017/S0029665110000054; Su JD, 2012, FREE RADICAL BIO MED, V52, P126, DOI 10.1016/j.freeradbiomed.2011.10.002; Sun XT, 2013, J NEUROSCI, V33, P2398, DOI 10.1523/JNEUROSCI.2292-12.2013; Taylor JM, 2013, NEUROCHEM INT, V62, P803, DOI 10.1016/j.neuint.2012.12.016; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Tsai FS, 2007, LIFE SCI, V80, P1692, DOI 10.1016/j.lfs.2007.01.055; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Wang XH, 2006, P NATL ACAD SCI USA, V103, P3604, DOI 10.1073/pnas.0510962103; West JD, 2012, CHEM RES TOXICOL, V25, P2036, DOI 10.1021/tx300264x; Wu MJ, 2005, J AGR FOOD CHEM, V53, P6305, DOI 10.1021/jf050511a; Xu XH, 2001, J BIOL CHEM, V276, P43221, DOI 10.1074/jbc.M104446200; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yamamuro A, 2006, NEUROCHEM RES, V31, P657, DOI 10.1007/s11064-006-9062-6; Yang MH, 2011, BREAST CANCER RES TR, V129, P983, DOI 10.1007/s10549-011-1604-1; Zenkov NK, 2013, BIOCHEMISTRY-MOSCOW+, V78, P19, DOI 10.1134/S0006297913010033; Zhang LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041226; Zou CG, 2009, ENDOCRINOLOGY, V150, P277, DOI 10.1210/en.2008-0794	84	42	44	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97880	10.1371/journal.pone.0097880	http://dx.doi.org/10.1371/journal.pone.0097880			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846311	Green Published, gold, Green Submitted			2022-12-25	WOS:000339563400069
J	Silva, FD; Ramos, RN; de Almeida, DC; Bassi, EJ; Gonzales, RP; Miyagi, SPH; Maranduba, CP; Sant'Anna, OABE; Marques, MM; Barbuto, JAM; Camara, NOS; Maranduba, CMD				Silva, Fernando de Sa; Ramos, Rodrigo Nalio; de Almeida, Danilo Candido; Bassi, Enio Jose; Gonzales, Roberto Pereira; Harumi Miyagi, Sueli Patricia; Maranduba, Claudineia Pereira; Brazil Esteves Sant'Anna, Osvaldo Augusto; Marques, Marcia Martins; Marzagao Barbuto, Jose Alexandre; Saraiva Camara, Niels Olsen; da Costa Maranduba, Carlos Magno			Mesenchymal Stem Cells Derived from Human Exfoliated Deciduous Teeth (SHEDs) Induce Immune Modulatory Profile in Monocyte-Derived Dendritic Cells	PLOS ONE			English	Article							IN-VITRO; MATURATION; RESPONSES	Background: Mesenchymal stem cells have prominent immune modulatory properties, which may have clinical applications; however their major source, bone marrow, is of limited availability. On the other hand, mesenchymal stem cells derived from human exfoliated deciduous teeth (SHEDs) are readily accessible, but their immune regulatory properties have not been completely investigated. This study was designed, therefore, to evaluate the SHEDs influence on DCs differentiation, maturation, ability to activate T cells and to expand CD4(+)Foxp3(+) T cells. Methodology/Principal Findings: The experiments were based in cellular co-culture during differentiation and maturation of monocyte derived-DCs (moDCs), with, or not, presence of SHEDs. After co-culture with SHEDs, (moDCs) presented lower expression of BDCA-1 and CD11c, in comparison to DC cultivated without SHEDs. CD40, CD80, CD83 and CD86 levels were also decreased in mature DCs (mDCs) after co-cultivation with SHEDs. To assess the ability of SHEDs-exposed moDCs to modulate T cell responses, the former were separated from SHEDs, and co-cultured with peripheral blood lymphocytes. After 5 days, the proliferation of CD4(+) and CD8(+) T cells was evaluated and found to be lower than that induced by moDCs cultivated without SHEDs. In addition, an increase in the proportion of CD4(+)Foxp3(+)IL-10(+) T cells was observed among cells stimulated by mature moDCs that were previously cultivated with SHEDs. Soluble factors released during co-cultures also showed a reduction in the pro-inflammatory cytokines (IL-2, TNF-alpha and IFN-gamma), and an increase in the anti-inflammatory molecule IL-10. Conclusion/Significance: This study shows that SHEDs induce an immune regulatory phenotype in moDCs cells, evidenced by changes in maturation and differentiation rates, inhibition of lymphocyte stimulation and ability to expand CD4(+)Foxp3(+) T cells. Further characterization and validation of this phenomenon could support the use of SHEDs, directly or indirectly for immune modulation in the clinical practice.	[Silva, Fernando de Sa; Ramos, Rodrigo Nalio; de Almeida, Danilo Candido; Bassi, Enio Jose; Gonzales, Roberto Pereira; Marzagao Barbuto, Jose Alexandre; Saraiva Camara, Niels Olsen] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil; [Silva, Fernando de Sa; Harumi Miyagi, Sueli Patricia] Univ Sao Paulo, Dept Dent, Sao Paulo, Brazil; [Marques, Marcia Martins] Butantan Inst, Immunochem Lab, Sao Paulo, Brazil; [Silva, Fernando de Sa; Maranduba, Claudineia Pereira; Brazil Esteves Sant'Anna, Osvaldo Augusto; da Costa Maranduba, Carlos Magno] Univ Juiz Fora, Inst Biomed Sci, Juiz De Fora, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Butantan; Universidade Federal de Juiz de Fora	Silva, FD (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil.	fernando.silva@ufjf.edu.br	de Almeida, Danilo/AAK-2399-2021; Barbuto, Jose A. M./H-5299-2011; Bassi, Ênio José/P-9937-2019; Marques, Márcia M/F-3780-2012; Camara, Niels OS/G-8336-2011; camara, niels olsen saraiva/AAX-3269-2020; de Almeida, Danilo Candido/R-2646-2019; Bassi, Ênio José/I-3616-2016; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; Ramos, Rodrigo N/K-3553-2012; Silva, Fernando/D-7736-2012	Barbuto, Jose A. M./0000-0001-9526-6781; Bassi, Ênio José/0000-0002-7956-5746; Marques, Márcia M/0000-0002-9398-1252; Camara, Niels OS/0000-0001-5436-1248; camara, niels olsen saraiva/0000-0001-5436-1248; de Almeida, Danilo Candido/0000-0003-3661-2124; Bassi, Ênio José/0000-0002-7956-5746; Ramos, Rodrigo N/0000-0003-1249-4733; Silva, Fernando/0000-0003-0821-5535	Agency of the Sao Paulo Research Foundation (FAPESP) [02/02270-2, 10/09491-9]; CNPq	Agency of the Sao Paulo Research Foundation (FAPESP); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work has received financial support from the Agency of the Sao Paulo Research Foundation (FAPESP, grant numbers: 02/02270-2 and 10/09491-9) and from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Alipour R, 2013, IRAN J ALLERGY ASTHM, V12, P331; Angelot F, 2009, HAEMATOL-HEMATOL J, V94, P1502, DOI 10.3324/haematol.2009.010934; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Bassi EJ, 2012, DIABETES, V61, P2534, DOI 10.2337/db11-0844; Beissert S, 2006, J INVEST DERMATOL, V126, P15, DOI 10.1038/sj.jid.5700004; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Choi YS, 2012, IMMUNOL INVEST, V41, P214, DOI 10.3109/08820139.2011.619022; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; English K, 2009, CLIN EXP IMMUNOL, V156, P149, DOI 10.1111/j.1365-2249.2009.03874.x; Ferrari D, 2000, FASEB J, V14, P2466, DOI 10.1096/fj.00-0031com; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Kota DJ, 2013, DIABETES, V62, P2048, DOI 10.2337/db12-0931; Krampera M, 2007, STEM CELLS DEV, V16, P797, DOI 10.1089/scd.2007.0024; Lai HY, 2010, TISSUE ENG PT A, V16, P2987, DOI 10.1089/ten.tea.2009.0731; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Oliveira BL, 2009, CELL IMMUNOL, V258, P107, DOI 10.1016/j.cellimm.2009.03.019; Pierdomenico L, 2005, TRANSPLANTATION, V80, P836, DOI 10.1097/01.tp.0000173794.72151.88; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ramos RN, 2012, J LEUKOCYTE BIOL, V92, P673, DOI 10.1189/jlb.0112048; Roncarolo MG, 2001, IMMUNOL REV, V182, P68, DOI 10.1034/j.1600-065X.2001.1820105.x; Ryan JM, 2007, CLIN EXP IMMUNOL, V149, P353, DOI 10.1111/j.1365-2249.2007.03422.x; Silva FD, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/758102; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762; Yamaza T, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt5; Zhang W, 2004, STEM CELLS DEV, V13, P263, DOI 10.1089/154732804323099190; Zhao ZG, 2012, IMMUNOL INVEST, V41, P183, DOI 10.3109/08820139.2011.607877; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	31	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98050	10.1371/journal.pone.0098050	http://dx.doi.org/10.1371/journal.pone.0098050			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846008	Green Published, Green Submitted, gold			2022-12-25	WOS:000339563400084
J	Naugler, WE				Naugler, Willscott E.			Bile Acid Flux Is Necessary for Normal Liver Regeneration	PLOS ONE			English	Article							EXTERNAL BILIARY DRAINAGE; C-JUN; RAT-LIVER; PARTIAL-HEPATECTOMY; MESSENGER-RNA; KINASE; HOMEOSTASIS; EXPRESSION; RECEPTOR; MICE	Background & Aims: Many signals governing liver regeneration (LR) following 2/3 partial hepatectomy (PH) are recognized, but the primary signal(s) remains unknown. The aim of the study was to confirm that the remnant liver after PH lacks capacity to secrete the BA pool returning via the enterohepatic ciruculation (EHC), which may in turn stimulate LR. Methods: After standard PH, BA flux was documented and BA signaling (Fgf15) and synthesis (Cyp7a) determined by qPCR. Rat biliary fistula (BF) and Asbt knockout mouse models interrupted the EHC prior to PH, and standard assays for LR employed along with complete RNA sequencing. CCl4 intoxication after BF tested the hypothesis in an alternate injury model. Results: BA rise in systemic blood immediately following PH, confirming that the remnant liver cannot handle the BA returning via portal circulation. When the BA pool is drained prior to PH in the rat BF model, LR is markedly attenuated, a phenomenon reversed with duodenal BA replacement. Hepatocyte proliferation is similarly attenuated after PH in the Asbt knockout mouse as well as after CCl4(4) intoxication in rats with BF. Complete RNA sequencing in the rat PH model shows that early c-jun and AP-1 gene expression pathways are down regulated in the absence of BA, coincident with attenuated LR. Conclusions: Absent BA return to the liver after PH or CCl4 injury markedly attenuates LR, though hepatocyte proliferation still occurs, inferring that BA flux and signaling are not the sole signals governing LR. Transcriptional networks involving c-jun and AP-1 are involved in the BA-specific effects on hepatocyte proliferation.	[Naugler, Willscott E.] Oregon Hlth & Sci Ctr, Dept Med, Div GI & Hepatol, Portland, OR 97239 USA; [Naugler, Willscott E.] Oregon Hlth & Sci Ctr, Oregon Stem Cell Ctr, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University	Naugler, WE (corresponding author), Oregon Hlth & Sci Ctr, Dept Med, Div GI & Hepatol, Portland, OR 97239 USA.	nauglers@ohsu.edu			National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), "Role of Bile Acids in the Initiation of Liver Regeneration" [DK083507]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK083507] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), "Role of Bile Acids in the Initiation of Liver Regeneration"; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The author and study were funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK; DK083507), "Role of Bile Acids in the Initiation of Liver Regeneration.'' The author would like to thank the NIH for funding this research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte U, 2009, HEPATOLOGY, V50, P844, DOI 10.1002/hep.23059; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Campbell JS, 2006, J IMMUNOL, V176, P2522, DOI 10.4049/jimmunol.176.4.2522; Dawson PA, 2003, J BIOL CHEM, V278, P33920, DOI 10.1074/jbc.M306370200; DIEHL AM, 1994, AM J PHYSIOL-GASTR L, V267, pG552, DOI 10.1152/ajpgi.1994.267.4.G552; Doignon I, 2011, J HEPATOL, V54, P481, DOI 10.1016/j.jhep.2010.07.012; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dong XS, 2010, J HUAZHONG U SCI-MED, V30, P55, DOI 10.1007/s11596-010-0110-8; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Gerloff T, 1999, GASTROENTEROLOGY, V117, P1408, DOI 10.1016/S0016-5085(99)70291-X; Graf D, 2002, GASTROENTEROLOGY, V122, P1411, DOI 10.1053/gast.2002.32976; Greene AK, 2003, J INVEST SURG, V16, P99, DOI 10.1080/08941930390194424; Gupta S, 2001, J BIOL CHEM, V276, P15816, DOI 10.1074/jbc.M010878200; HARDISON WGM, 1981, AM J PHYSIOL, V241, pG337, DOI 10.1152/ajpgi.1981.241.4.G337; Higgins GM, 1931, ARCH PATHOL, V12, P186; Huang J, 2013, AM J PATHOL; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; IYOMASA S, 1992, EUR SURG RES, V24, P265, DOI 10.1159/000129215; KUIPERS F, 1985, GASTROENTEROLOGY, V88, P403, DOI 10.1016/0016-5085(85)90499-8; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Michalopoulos GK, 2013, COMPR PHYSIOL, V3, P485, DOI 10.1002/cphy.c120014; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; MOOLTEN FL, 1967, SCIENCE, V158, P272, DOI 10.1126/science.158.3798.272; Otao R, 2012, BRIT J SURG, V99, P1569, DOI 10.1002/bjs.8906; PANDAK WM, 1991, J BIOL CHEM, V266, P3416; Paranjpe S, 2007, HEPATOLOGY; Pean N, 2013, HEPATOLOGY, V58, P1451, DOI 10.1002/hep.26463; Schwabe RF, 2003, HEPATOLOGY, V37, P824, DOI 10.1053/jhep.2003.50135; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; SUZUKI H, 1994, HEPATOLOGY, V20, P1318, DOI 10.1016/0270-9139(94)90774-9; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; TSUDA H, 1990, LIVER, V10, P28; Uriarte I, 2013, GUT; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Wuestefeld T, 2013, CELL, V153, P389, DOI 10.1016/j.cell.2013.03.026; Yu CD, 2005, J BIOL CHEM, V280, P17707, DOI 10.1074/jbc.M411771200; Zhang LS, 2012, HEPATOLOGY, V56, P2336, DOI 10.1002/hep.25905; Zhang LS, 2009, MOL ENDOCRINOL, V23, P137, DOI 10.1210/me.2008-0198	41	39	39	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97426	10.1371/journal.pone.0097426	http://dx.doi.org/10.1371/journal.pone.0097426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841254	Green Published, gold, Green Submitted			2022-12-25	WOS:000340948600031
J	Tu, CF; Tsao, KC; Lee, SJ; Yang, RB				Tu, Cheng-Fen; Tsao, Ku-Chi; Lee, Shyh-Jye; Yang, Ruey-Bing			SCUBE3 (Signal Peptide-CUB-EGF Domain-containing Protein 3) Modulates Fibroblast Growth Factor Signaling during Fast Muscle Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE GLYCOPROTEIN; IN-VIVO; EMBRYONIC-DEVELOPMENT; CRYSTAL-STRUCTURE; ZEBRAFISH; EXPRESSION; FGF8; DIFFERENTIATION; GENE; IDENTIFICATION	SCUBE3 (signal peptide CUB-EGF-like domain-containing protein 3) belongs to a newly identified secreted and cell membrane- associated SCUBE family, which is evolutionarily conserved in vertebrates. Scube3 is predominantly expressed in a variety of developing tissues in mice such as somites, neural tubes, and limb buds. However, its function during development remains unclear. In this study, we first showed that knockdown of SCUBE3 in C2C12 myoblasts inhibited FGF receptor 4 expression and FGF signaling, thus resulting in reduced myogenic differentiation. Furthermore, knockdown of zebrafish scube3 by antisense morpholino oligonucleotides specifically suppressed the expression of the myogenic marker myod1 within the lateral fast muscle precursors, whereas its expression in the adaxial slow muscle precursors was largely unaffected. Consistent with these findings, immunofluorescent staining of fast but not slow muscle myosin was markedly decreased in scube3 morphants. Further genetic studies identified fgf8 as a key regulator in scube3-mediated fast muscle differentiation in zebrafish. Biochemical and molecular analysis showed that SCUBE3 acts as a FGF co-receptor to augment FGF8 signaling. Scube3 may be a critical upstream regulator of fast fiber myogenesis by modulating fgf8 signaling during zebrafish embryogenesis.	[Tu, Cheng-Fen; Tsao, Ku-Chi; Yang, Ruey-Bing] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Tu, Cheng-Fen; Tsao, Ku-Chi; Yang, Ruey-Bing] Acad Sinica, Taipei 11529, Taiwan; [Tu, Cheng-Fen; Yang, Ruey-Bing] Acad Sinica, Inst Biomed Sci, Program Mol Med, Taiwan Int Grad Program, Taipei 11529, Taiwan; [Tu, Cheng-Fen; Yang, Ruey-Bing] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 11221, Taiwan; [Yang, Ruey-Bing] Natl Yang Ming Univ, Inst Pharmacol, Taipei 11221, Taiwan; [Lee, Shyh-Jye] Natl Taiwan Univ, Dept Life Sci, Taipei 10617, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taiwan University	Yang, RB (corresponding author), Acad Sinica, Inst Biomed Sci, 128 Acad Rd,Sec 2, Taipei 11529, Taiwan.	rbyang@ibms.sinica.edu.tw	Lee, Shyh-Jye/C-6092-2008; Yang, Ruey-Bing/O-1494-2018	Lee, Shyh-Jye/0000-0001-8452-9152; Yang, Ruey-Bing/0000-0003-3017-3714; Tu, Cheng-Fen/0000-0003-3624-7884	United States NICHD, National Institutes of Health	United States NICHD, National Institutes of Health	We thank the Taiwan Zebrafish Core Facility at Academia Sinica for providing zebrafish and some ISH probes used in this study. RNAi reagents were obtained from the National RNAi Core Facility located at the Institute of Molecular Biology/Genomic Research Center of Academia Sinica. The F59, F310, and MF20 monoclonal antibodies developed by F. E. Stockdale and D. A. Fischman were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the United States NICHD, National Institutes of Health and maintained by the Department of Biology of the University of Iowa (Iowa City, IA).	Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; CADENA DL, 1992, FASEB J, V6, P2332, DOI 10.1096/fasebj.6.6.1312047; Cheng CJ, 2009, CANCER RES, V69, P3634, DOI 10.1158/0008-5472.CAN-08-3615; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Feng XS, 2006, DEV BIOL, V300, P736, DOI 10.1016/j.ydbio.2006.08.056; Grimmond S, 2000, GENOMICS, V70, P74, DOI 10.1006/geno.2000.6370; Groves JA, 2005, DEVELOPMENT, V132, P4211, DOI 10.1242/dev.01958; Gutierrez J, 2010, MOL CELL BIOL, V30, P1634, DOI 10.1128/MCB.01164-09; Hamade A, 2006, DEV BIOL, V289, P127, DOI 10.1016/j.ydbio.2005.10.019; Hammond CL, 2007, DEV BIOL, V302, P504, DOI 10.1016/j.ydbio.2006.10.009; Haworth K, 2007, GENE EXPR PATTERNS, V7, P630, DOI 10.1016/j.modgep.2006.12.004; Hughes SM, 1999, CURR OPIN NEUROBIOL, V9, P54, DOI 10.1016/S0959-4388(99)80007-5; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Johnson JLFA, 2012, DEV BIOL, V368, P193, DOI 10.1016/j.ydbio.2012.05.007; Kawakami A, 2005, CURR BIOL, V15, P480, DOI 10.1016/j.cub.2005.02.018; Kim GY, 2012, MOL CELL BIOL, V32, P4482, DOI 10.1128/MCB.00872-12; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kwiatkowski BA, 2008, J CELL PHYSIOL, V215, P803, DOI 10.1002/jcp.21365; Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621; Lin YC, 2011, J BIOL CHEM, V286, P27039, DOI 10.1074/jbc.M111.244418; Marics I, 2002, DEVELOPMENT, V129, P4559; Ochi H, 2007, DEV GROWTH DIFFER, V49, P1, DOI 10.1111/j.1440-169x.2007.00905.x; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Reifers F, 1998, DEVELOPMENT, V125, P2381; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Scata KA, 1999, EXP CELL RES, V250, P10, DOI 10.1006/excr.1999.4506; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Stickney HL, 2000, DEV DYNAM, V219, P287; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tsai MT, 2009, BIOCHEM J, V422, P119, DOI 10.1042/BJ20090341; Tsao KC, 2013, J BIOL CHEM, V288, P5017, DOI 10.1074/jbc.M112.375196; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Wu BT, 2004, J BIOL CHEM, V279, P37485, DOI 10.1074/jbc.M405912200; Wu YY, 2011, ONCOGENE, V30, P3682, DOI 10.1038/onc.2011.85; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Xavier GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055274; Xavier GM, 2011, J MOL HISTOL, V42, P383, DOI 10.1007/s10735-011-9341-7; Yang HY, 2007, CARDIOVASC RES, V75, P139, DOI 10.1016/j.cardiores.2007.03.014; Yang RB, 2002, J BIOL CHEM, V277, P46364, DOI 10.1074/jbc.M207410200; Yang RB, 2003, J BIOL CHEM, V278, P33232, DOI 10.1074/jbc.M305022200; Zhao P, 2006, J BIOL CHEM, V281, P429, DOI 10.1074/jbc.M507440200	43	16	16	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18928	18942		10.1074/jbc.M114.551929	http://dx.doi.org/10.1074/jbc.M114.551929			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24849601	Green Published, hybrid			2022-12-25	WOS:000339062900026
J	Budiharjo, A; Chowdhury, SP; Dietel, K; Beator, B; Dolgova, O; Fan, B; Bleiss, W; Ziegler, J; Schmid, M; Hartmann, A; Borriss, R				Budiharjo, Anto; Chowdhury, Soumitra Paul; Dietel, Kristin; Beator, Barbara; Dolgova, Olga; Fan, Ben; Bleiss, Wilfrid; Ziegler, Joerg; Schmid, Michael; Hartmann, Anton; Borriss, Rainer			Transposon Mutagenesis of the Plant-Associated Bacillus amyloliquefaciens ssp plantarum FZB42 Revealed That the nfrA and RBAM17410 Genes Are Involved in Plant-Microbe-Interactions	PLOS ONE			English	Article							RESPONSE REGULATOR DEGU; ROOT COLONIZATION; BIOFILM FORMATION; SUBTILIS; GROWTH; BIOCONTROL; EXPRESSION; STRESS; TRANSCRIPTOME; LEVEL	Bacillus amyloliquefaciens ssp. plantarum FZB42 represents the prototype of Gram-positive plant growth promoting and biocontrol bacteria. In this study, we applied transposon mutagenesis to generate a transposon library, which was screened for genes involved in multicellular behavior and biofilm formation on roots as a prerequisite of plant growth promoting activity. Transposon insertion sites were determined by rescue-cloning followed by DNA sequencing. As in B. subtilis, the global transcriptional regulator DegU was identified as an activator of genes necessary for swarming and biofilm formation, and the DegU-mutant of FZB42 was found impaired in efficient root colonization. Direct screening of 3,000 transposon insertion mutants for plant-growth-promotion revealed the gene products of nfrA and RBAM_017140 to be essential for beneficial effects exerted by FZB42 on plants. We analyzed the performance of GFP-labeled wild-type and transposon mutants in the colonization of lettuce roots using confocal laser scanning microscopy. While the wild-type strain heavily colonized root surfaces, the nfrA mutant did not colonize lettuce roots, although it was not impaired in growth in laboratory cultures, biofilm formation and swarming motility on agar plates. The RBAM17410 gene, occurring in only a few members of the B. subtilis species complex, was directly involved in plant growth promotion. None of the mutant strains were affected in producing the plant growth hormone auxin. We hypothesize that the nfrA gene product is essential for overcoming the stress caused by plant response towards bacterial root colonization.	[Budiharjo, Anto; Beator, Barbara; Fan, Ben; Bleiss, Wilfrid; Borriss, Rainer] Humboldt Univ, Inst Biol, D-10099 Berlin, Germany; [Chowdhury, Soumitra Paul; Schmid, Michael; Hartmann, Anton] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Res Unit Microbe Plant Interact, Neuherberg, Germany; [Dietel, Kristin; Dolgova, Olga; Borriss, Rainer] ABiTEP GmbH, Berlin, Germany; [Ziegler, Joerg] Leibniz Inst Pflanzenbiochem, Abt Mol Signalverarbeitung, Halle, Germany	Humboldt University of Berlin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Leibniz Institut fur Pflanzenbiochemie	Borriss, R (corresponding author), Humboldt Univ, Inst Biol, D-10099 Berlin, Germany.	rainer.borriss@rz.hu-berlin.de	Budiharjo, Anto/GRY-3134-2022; Hartmann, Anton/D-8070-2013; Borriss, Rainer/C-5026-2012; Chowdhury, Soumitra Paul/AAA-5346-2020; Hartmann, Anton/AAN-8922-2020; Schmid, Michael/D-7105-2013; Ziegler, Jörg/W-7645-2019	Borriss, Rainer/0000-0003-3726-1004; Chowdhury, Soumitra Paul/0000-0002-8576-8857; Budiharjo, Anto/0000-0002-4815-5138	German Ministry for Education and Research [PATHCONTROL 0315654A, PATHCONTROL 0315654C]; European Union [312117]; ABiTEP GmbH	German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); ABiTEP GmbH	German Ministry for Education and Research (PATHCONTROL 0315654A and C) to RB and AH (http://www.genomik-transfer.de/index.php?section = verbund&fkz = 0315654). European Union's Seventh Framework Programme (FP/2007-2013) under Grant agreement n o312117 to RB (http://www.biofector.info/). ABiTEP GmbH provided support in the form of salaries for authors KD, OD & RB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Borriss R, 2011, BACTERIA IN AGROBIOLOGY: PLANT GROWTH RESPONSES, P41, DOI 10.1007/978-3-642-20332-9_3; Borriss R, 2011, INT J SYST EVOL MICR, V61, P1786, DOI 10.1099/ijs.0.023267-0; Branda SS, 2004, J BACTERIOL, V186, P3970, DOI 10.1128/JB.186.12.3970-3979.2004; Burroughs AM, 2011, MOL BIOSYST, V7, P2261, DOI 10.1039/c1mb05061c; Calvio C, 2008, J BACTERIOL, V190, P5720, DOI 10.1128/JB.00455-08; Chen XH, 2009, J BIOTECHNOL, V140, P38, DOI 10.1016/j.jbiotec.2008.10.015; Chen XH, 2007, NAT BIOTECHNOL, V25, P1007, DOI 10.1038/nbt1325; Chen Y, 2013, ENVIRON MICROBIOL, V15, P848, DOI 10.1111/j.1462-2920.2012.02860.x; Chin-A-Woeng TFC, 2000, MOL PLANT MICROBE IN, V13, P1340, DOI 10.1094/MPMI.2000.13.12.1340; Chowdhury SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068818; Dietel K, 2013, PLANT PATHOLOGY J, V29, P59, DOI 10.5423/PPJ.OA.10.2012.0155; DUBNAU D, 1994, RES MICROBIOL, V145, P403, DOI 10.1016/0923-2508(94)90088-4; Fan B, 2012, J MICROBIOL, V50, P38, DOI 10.1007/s12275-012-1439-4; Fan B, 2011, J BIOTECHNOL, V151, P303, DOI 10.1016/j.jbiotec.2010.12.022; Idris EE, 2007, MOL PLANT MICROBE IN, V20, P619, DOI 10.1094/MPMI-20-6-0619; Idriss EE, 2002, MICROBIOL-SGM, V148, P2097, DOI 10.1099/00221287-148-7-2097; Kearns DB, 2004, MOL MICROBIOL, V52, P357, DOI 10.1111/j.1365-2958.2004.03996.x; Koumoutsi A, 2004, J BACTERIOL, V186, P1084, DOI 10.1128/JB.186.4.1084-1096.2004; Koumoutsi A, 2007, APPL ENVIRON MICROB, V73, P6953, DOI 10.1128/AEM.00565-07; KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995; Le Breton Y, 2006, APPL ENVIRON MICROB, V72, P327, DOI 10.1128/AEM.72.1.327-333.2006; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Mariappan A, 2012, J MOL MICROB BIOTECH, V22, P114, DOI 10.1159/000338804; Moch C, 2000, J BACTERIOL, V182, P4384, DOI 10.1128/JB.182.16.4384-4393.2000; Mostertz J, 2004, MICROBIOL-SGM, V150, P497, DOI 10.1099/mic.0.26665-0; MSADEK T, 1990, J BACTERIOL, V172, P824, DOI 10.1128/jb.172.2.824-834.1990; Murray EJ, 2009, MICROBIOL-SGM, V155, P1, DOI 10.1099/mic.0.023903-0; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Ollinger J, 2006, J BACTERIOL, V188, P3664, DOI 10.1128/JB.188.10.3664-3673.2006; Ostrowski A, 2011, J BACTERIOL, V193, P4821, DOI 10.1128/JB.00223-11; PIRSON A, 1950, PLANTA, V38, P431, DOI 10.1007/BF01928941; Rudrappa T, 2007, PLANTA, V226, P283, DOI 10.1007/s00425-007-0480-8; Ryu CM, 2003, P NATL ACAD SCI USA, V100, P4927, DOI 10.1073/pnas.0730845100; Schadt HS, 2009, J AM CHEM SOC, V131, P3481, DOI 10.1021/ja809283u; Stanley NR, 2005, MOL MICROBIOL, V57, P1143, DOI 10.1111/j.1365-2958.2005.04746.x; Streker K, 2005, J BACTERIOL, V187, P2249, DOI 10.1128/JB.187.7.2249-2256.2005; Verhamme DT, 2007, MOL MICROBIOL, V65, P554, DOI 10.1111/j.1365-2958.2007.05810.x; WELLER DM, 1988, ANNU REV PHYTOPATHOL, V26, P379, DOI 10.1146/annurev.py.26.090188.002115; Weng J, 2013, APPL MICROBIOL BIOT, V97, P8823, DOI 10.1007/s00253-012-4572-4	39	16	20	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98267	10.1371/journal.pone.0098267	http://dx.doi.org/10.1371/journal.pone.0098267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847778	Green Published, gold			2022-12-25	WOS:000336730600105
J	Song, Y; Zhu, LA; Wang, SL; Leng, L; Bucala, R; Lu, LJ				Song, Yang; Zhu, Li-an; Wang, Su-li; Leng, Lin; Bucala, Richard; Lu, Liang-Jing			Multi-Dimensional Health Assessment Questionnaire in China: Reliability, Validity and Clinical Value in Patients with Rheumatoid Arthritis	PLOS ONE			English	Article							DISEASE-ACTIVITY SCORE; QUALITY-OF-LIFE; RAPID3 ROUTINE ASSESSMENT; WORK DISABILITY; INDEX DATA; FUNCTIONAL STATUS; REVISED CRITERIA; SWEDISH VERSION; MDHAQ; SCALE	Objective: To evaluate the psychometric properties and clinical utility of Chinese Multidimensional Health Assessment Questionnaire (MDHAQ-C) in patients with rheumatoid arthritis (RA) in China. Methods: 162 RA patients were recruited in the evaluation process. The reliability of the questionnaire was tested by internal consistency and item analysis. Convergent validity was assessed by correlations of MDHAQ-C with Health Assessment Questionnaire (HAQ), the 36-item Short-Form Health Survey (SF-36) and the Hospital anxiety and depression scales (HAD). Discriminant validity was tested in groups of patients with varied disease activities and functional classes. To evaluate the clinical values, correlations were calculated between MDHAQ-C and indices of clinical relevance and disease activity. Agreement with the Disease Activity Score (DAS28) and Clinical Disease Activity Index (CDAI) was estimated. Results: The Cronbach's alpha was 0.944 in the Function scale (FN) and 0.768 in the scale of psychological status (PS). The item analysis indicated all the items of FN and PS are correlated at an acceptable level. MDHAQ-C correlated with the questionnaires significantly in most scales and scores of scales differed significantly in groups of different disease activity and functional status. MDHAQ-C has moderate to high correlation with most clinical indices and high correlation with a spearman coefficient of 0.701 for DAS 28 and 0.843 for CDAI. The overall agreement of categories was satisfying. Conclusion: MDHAQ-C is a reliable, valid instrument for functional measurement and a feasible, informative quantitative index for busy clinical settings in Chinese RA patients.	[Song, Yang; Wang, Su-li; Lu, Liang-Jing] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Rheumatol, Shanghai 200030, Peoples R China; [Zhu, Li-an; Leng, Lin; Bucala, Richard] Yale Univ, Sch Med, Dept Med, Rheumatol Sect, New Haven, CT 06510 USA	Shanghai Jiao Tong University; Yale University	Lu, LJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Rheumatol, Shanghai 200030, Peoples R China.	lianzhu20032003@hotmail.com; lu_liangjing@medmail.com.cn		Lu, Liangjing/0000-0001-9116-6038	National Natural Sciences Foundation of China [81373209, 30671946, 81072469]; Shanghai Natural Sciences Foundation [09ZR1417600]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Sciences Foundation(Natural Science Foundation of Shanghai)	This work was supported by grants from National Natural Sciences Foundation of China (No. 81373209; No. 30671946; No. 81072469) and Shanghai Natural Sciences Foundation (No. 09ZR1417600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkela-Kautiainen M, 2005, J RHEUMATOL, V32, P1426; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Chiou CF, 2004, ARTHRIT RHEUM-ARTHR, V51, P358, DOI 10.1002/art.20400; Chung CP, 2006, ANN RHEUM DIS, V65, P1653, DOI 10.1136/ard.2005.048439; Ehrlich-Jones L, 2011, ARTHRIT CARE RES, V63, P1700, DOI 10.1002/acr.20616; Ekback M, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-168; FELSON DT, 1993, ARTHRITIS RHEUM-US, V36, P729, DOI 10.1002/art.1780360601; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; HOCHBERG MC, 1992, ARTHRITIS RHEUM, V35, P498, DOI 10.1002/art.1780350502; Josefsson KA, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-178; KATZ JN, 1992, MED CARE, V30, P917, DOI 10.1097/00005650-199210000-00004; Krishnan E, 2005, ANN RHEUM DIS, V64, P1350, DOI 10.1136/ard.2005.037903; Kwoh CK, 2001, ARTHRIT RHEUM-ARTHR, V45, P372, DOI 10.1002/1529-0131(200108)45:4<372::AID-ART350>3.0.CO;2-D; Lee J, 2012, ARTHRIT CARE RES, V64, P488, DOI 10.1002/acr.21582; Leung C M, 1993, Int J Psychosom, V40, P29; Li Lu, 2002, Zhonghua Yufang Yixue Zazhi, V36, P109; Li R, 2012, RHEUMATOLOGY, V51, P721, DOI 10.1093/rheumatology/ker370; Lillegraven S, 2007, BEST PRACT RES CL RH, V21, P827, DOI 10.1016/j.berh.2007.05.004; Maska L, 2011, ARTHRIT CARE RES, V63, pS4, DOI 10.1002/acr.20620; PINCUS T, 1984, ARTHRITIS RHEUM-US, V27, P864, DOI 10.1002/art.1780270805; Pincus T, 2008, RHEUMATOLOGY, V47, P345, DOI 10.1093/rheumatology/kem364; Pincus T, 2006, J RHEUMATOL, V33, P834; Pincus T, 2005, J RHEUMATOL, V32, P1432; Pincus T, 2003, BEST PRACT RES CL RH, V17, P753, DOI 10.1016/S1521-6942(03)00077-9; PINCUS T, 1993, RHEUM DIS CLIN N AM, V19, P123; Pincus T, 2008, J RHEUMATOL, V35, P2136, DOI 10.3899/jrheum.080182; Pincus T, 2007, BULL HOSP JT DIS, V65, P150; Pincus T, 2012, BULL HOSP JT DIS, V70, pS30; Pincus T, 2010, ARTHRIT CARE RES, V62, P181, DOI 10.1002/acr.20066; Pioro Mathilde H., 1996, Current Opinion in Rheumatology, V8, P101, DOI 10.1097/00002281-199603000-00003; Pollard L, 2005, CLIN EXP RHEUMATOL, V23, pS43; Power M, 2005, QUAL LIFE RES, V14, P2197, DOI 10.1007/s11136-005-7380-9; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Sokka T, 2001, J RHEUMATOL, V28, P1718; Wagner E, 2007, RHEUMATOL INT, V27, P1041, DOI 10.1007/s00296-007-0343-4; Wu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047373; Yazici Y, 2008, J RHEUMATOL, V35, P603; YELIN E, 1980, ANN INTERN MED, V93, P551, DOI 10.7326/0003-4819-93-4-551	41	3	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97952	10.1371/journal.pone.0097952	http://dx.doi.org/10.1371/journal.pone.0097952			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848431	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600071
J	Yaqoob, U; Jagavelu, K; Shergill, U; de Assuncao, T; Cao, S; Shah, VH				Yaqoob, Usman; Jagavelu, Kumaravelu; Shergill, Uday; de Assuncao, Thiago; Cao, Sheng; Shah, Vijay H.			FGF21 Promotes Endothelial Cell Angiogenesis through a Dynamin-2 and Rab5 Dependent Pathway	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; FATTY LIVER-DISEASE; FACTOR RECEPTOR; INTRACELLULAR TRAFFICKING; ENDOCYTOSIS; ACTIVATION; PROTEINS; PHOSPHORYLATION; INTERNALIZATION; PERMEABILITY	Binding of angiogenic molecules with cognate receptor tyrosine kinases (RTK) is required for angiogenesis however the precise link between RTK binding, endocytosis, and signaling requires further investigation. Here, we use FGFR1 as a model to test the effects of the large GTPase and endocytosis regulatory molecule dynamin-2 on angiogenic signaling in context of distinct FGF ligands. In vitro, overexpression of dominant negative dynamin-2 (DynK44A) attenuates FGFR1 activation of Erk and tubulogenesis by FGF2. Furthermore, we identify FGF21, a non-classical, FGF ligand implicated in diverse human pathologies as an angiogenic molecule acting through FGFR1 and beta-Klotho coreceptor. Disruption of FGFR1 activation of ERK by FGF21 is achieved by perturbation of the function of both dynamin-2 and Rab5 GTPase. In vivo, mice harboring endothelial selective overexpression of DynK44A, show impaired angiogenesis in response to FGF21. In conclusion, dynamin dependent endocytosis of FGFR1 is required for in vitro and in vivo angiogenesis in response to FGF2 and the non-classical FGF ligand, FGF21. These studies extend our understanding of the relationships between RTK binding, internalization, endosomal targeting, and angiogenic signaling.	[Yaqoob, Usman; Jagavelu, Kumaravelu; Shergill, Uday; de Assuncao, Thiago; Cao, Sheng; Shah, Vijay H.] Mayo Clin, Gastroenterol Res Unit, Rochester, MN 55905 USA	Mayo Clinic	Cao, S (corresponding author), Mayo Clin, Gastroenterol Res Unit, Rochester, MN 55905 USA.	cao.sheng@mayo.edu; shah.vijay@mayo.edu	Jagavelu, Kumaravelu/L-8053-2019	Jagavelu, Kumaravelu/0000-0002-9235-0600	NIH [DK59615, DK084567]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK059615, R01DK059615, P30DK084567] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants to VS (DK59615, DK084567-Clinical Core and Cell Biology Core). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bache KG, 2004, EMBO J, V23, P2707, DOI 10.1038/sj.emboj.7600292; Bauer PM, 2005, P NATL ACAD SCI USA, V102, P204, DOI 10.1073/pnas.0406092102; Bhattacharya R, 2005, FASEB J, V19, P1692, DOI 10.1096/fj.05-3889fje; Brodsky FM, 2012, ANNU REV CELL DEV BI, V28, P309, DOI 10.1146/annurev-cellbio-101011-155716; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Cao S, 2010, J CLIN INVEST, V120, P2379, DOI 10.1172/JCI41203; Cariello M, 2014, HEPTAOLOGY; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Carracedo J, 2012, MECH AGEING DEV, V133, P647, DOI 10.1016/j.mad.2012.09.002; Chen Y, 2013, SMALL GTPASES, V4; Chu HH, 2011, P NATL ACAD SCI USA, V108, P13444, DOI 10.1073/pnas.1110121108; Citores L, 1999, MOL BIOL CELL, V10, P3835, DOI 10.1091/mbc.10.11.3835; Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681; Echarri A, 2007, SEMIN CELL DEV BIOL, V18, P627, DOI 10.1016/j.semcdb.2007.08.004; Elfenbein A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002495; Fan GH, 2003, BLOOD, V101, P2115, DOI 10.1182/blood-2002-07-1965; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Gaengel K, 2013, NAT CELL BIOL, V15, P233, DOI 10.1038/ncb2705; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gourlaouen M, 2013, J BIOL CHEM, V288, P7467, DOI 10.1074/jbc.M112.446401; Harris KP, 2011, CURR BIOL, V21, pR841, DOI 10.1016/j.cub.2011.08.061; Haugsten EM, 2008, MOL BIOL CELL, V19, P3390, DOI 10.1091/mbc.E07-12-1219; Hausott B, 2011, NEUROSCIENCE, V188, P13, DOI 10.1016/j.neuroscience.2011.04.064; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Huebert RC, 2011, AM J PATHOL, V179, P1851, DOI 10.1016/j.ajpath.2011.06.045; Hyndman KA, 2011, AM J PHYSIOL-RENAL, V301, pF118, DOI 10.1152/ajprenal.00534.2010; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Jagavelu K, 2010, HEPATOLOGY, V52, P590, DOI 10.1002/hep.23739; Jean S, 2010, DEV CELL, V19, P426, DOI 10.1016/j.devcel.2010.08.007; Kang-Decker N, 2007, J CELL SCI, V120, P492, DOI 10.1242/jcs.03361; Lee JS, 2007, HEPATOLOGY, V45, P817, DOI 10.1002/hep.21564; Lee MY, 2014, DEVELOPMENT, V141, P1465, DOI 10.1242/dev.104539; LI GP, 1993, J BIOL CHEM, V268, P24475; Li HT, 2010, J HEPATOL, V53, P934, DOI 10.1016/j.jhep.2010.05.018; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mohammadi M., 2013, COLD SPRING HARB PER, V5; Mukherjee S, 2006, CIRC RES, V98, P743, DOI 10.1161/01.RES.0000214545.99387.e3; Nakatsu MN, 2008, METHOD ENZYMOL, V443, P65, DOI 10.1016/S0076-6879(08)02004-1; Nakayama M, 2013, NAT CELL BIOL, V15, P249, DOI 10.1038/ncb2679; Park RJ, 2013, J CELL SCI, V126, P5305, DOI 10.1242/jcs.138578; Pellegrini L, 2001, CURR OPIN STRUC BIOL, V11, P629, DOI 10.1016/S0959-440X(00)00258-X; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Ridyard MS, 2003, J BIOL CHEM, V278, P13803, DOI 10.1074/jbc.M210245200; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; Shajahan AN, 2004, J BIOL CHEM, V279, P20392, DOI 10.1074/jbc.M308710200; Shilo BZ, 2011, EMBO J, V30, P3516, DOI 10.1038/emboj.2011.269; SOROKIN A, 1994, J BIOL CHEM, V269, P17056; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Wang ZM, 2011, J CELL BIOL, V192, P101, DOI 10.1083/jcb.201003027; Yaqoob U, 2012, CANCER RES, V72, P4047, DOI 10.1158/0008-5472.CAN-11-3907; Yie JM, 2009, FEBS LETT, V583, P19, DOI 10.1016/j.febslet.2008.11.023; Yilmaz Y, 2010, EUR J CLIN INVEST, V40, P887, DOI 10.1111/j.1365-2362.2010.02338.x; Zern BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011017; Zou L, 2012, J BIOL CHEM, V287, P7190, DOI 10.1074/jbc.M111.304972	57	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98130	10.1371/journal.pone.0098130	http://dx.doi.org/10.1371/journal.pone.0098130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848261	Green Submitted, Green Published, gold			2022-12-25	WOS:000336730600089
J	Dumont, C; Irenge, LM; Magazani, EK; Garin, D; Muyembe, JJT; Bentahir, M; Gala, JL				Dumont, Catherine; Irenge, Leonid M.; Magazani, Edmond K.; Garin, Daniel; Muyembe, Jean-Jacques T.; Bentahir, Mostafa; Gala, Jean-Luc			Simple Technique for in Field Samples Collection in the Cases of Skin Rash Illness and Subsequent PCR Detection of Orthopoxviruses and Varicella Zoster Virus	PLOS ONE			English	Article							REAL-TIME PCR; HUMAN MONKEYPOX; WEST-AFRICAN; CONGO BASIN; SMALLPOX; ASSAY; IDENTIFICATION; INFECTION; VARIOLA; DIFFERENTIATION	Background: In case of outbreak of rash illness in remote areas, clinically discriminating monkeypox (MPX) from severe form of chickenpox and from smallpox remains a concern for first responders. Objective: The goal of the study was therefore to use MPX and chickenpox outbreaks in Democratic Republic of Congo (DRC) as a test case for establishing a rapid and specific diagnosis in affected remote areas. Methods: In 2008 and 2009, successive outbreaks of presumed MPX skin rash were reported in Bena Tshiadi, Yangala and Ndesha healthcare districts of the West Kasai province (DRC). Specimens consisting of liquid vesicle dried on filter papers or crusted scabs from healing patients were sampled by first responders. A field analytical facility was deployed nearby in order to carry out a real-time PCR (qPCR) assay using genus consensus primers, consensus orthopoxvirus (OPV) and smallpox-specific probes spanning over the 14 kD fusion protein encoding gene. A PCR-restriction fragment length polymorphism was used on-site as backup method to confirm the presence of monkeypox virus (MPXV) in samples. To complete the differential diagnosis of skin rash, chickenpox was tested in parallel using a commercial qPCR assay. In a post-deployment step, a MPXV-specific pyrosequencing was carried out on all biotinylated amplicons generated on-site in order to confirm the on-site results. Results: Whereas MPXV proved to be the agent causing the rash illness outbreak in the Bena Tshiadi, VZV was the causative agent of the disease in Yangala and Ndesha districts. In addition, each on-site result was later confirmed by MPXV-specific pyrosequencing analysis without any discrepancy. Conclusion: This experience of rapid on-site dual use DNA-based differential diagnosis of rash illnesses demonstrates the potential of combining tests specifically identifying bioterrorism agents and agents causing natural outbreaks. This opens the way to rapid on-site DNA-based identification of a broad spectrum of causative agents in remote areas.	[Dumont, Catherine] Royal Mil Acad, Brussels, Belgium; [Irenge, Leonid M.; Bentahir, Mostafa; Gala, Jean-Luc] Belgian Armed Forces, ACOS Ops&Trg, Def Labs Dept, Peutie, Belgium; [Dumont, Catherine; Irenge, Leonid M.; Bentahir, Mostafa; Gala, Jean-Luc] Catholic Univ Louvain, Inst Rech Expt & Clin, Ctr Appl Mol Technol, B-1200 Brussels, Belgium; [Magazani, Edmond K.] Minist Sante Publ, Gombe, DEM REP CONGO; [Garin, Daniel] Serv Sante Armees, Inst Rech Biomed Armees, Bretigny Sur Orge, France; [Muyembe, Jean-Jacques T.] Inst Natl Rech Biomed, Lab Natl Sante Publ, Kinshasa, DEM REP CONGO	Universite Catholique Louvain; Institute Nacional de Recherche Biomedical	Gala, JL (corresponding author), Belgian Armed Forces, ACOS Ops&Trg, Def Labs Dept, Peutie, Belgium.	jean-luc.gala@uclouvain.be			Department Management of Scientific and Technological Research of Defense IRSD/RSTD [MED 05, MED 08]	Department Management of Scientific and Technological Research of Defense IRSD/RSTD	This work was funded by the Department Management of Scientific and Technological Research of Defense IRSD/RSTD (grants MED 05 and MED 08),http://www.irsd.be/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitichou M, 2008, J VIROL METHODS, V153, P190, DOI 10.1016/j.jviromet.2008.07.018; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambroise J, 2013, BIOINFORMATICS, V29, P1963, DOI 10.1093/bioinformatics/btt339; [Anonymous], 1984, Bull World Health Organ, V62, P703; Berche P, 2001, TRENDS MICROBIOL, V9, P15, DOI 10.1016/S0966-842X(00)01855-2; Bray M, 2009, AM J TROP MED HYG, V80, P499, DOI 10.4269/ajtmh.2009.80.499; Cann JA, 2013, J COMP PATHOL, V148, P6, DOI 10.1016/j.jcpa.2012.06.007; De Benedictis P, 2011, J CLIN MICROBIOL, V49, P1932, DOI 10.1128/JCM.02015-10; Deng YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023400; Di Giulio DB, 2004, LANCET INFECT DIS, V4, P15, DOI 10.1016/S1473-3099(03)00856-9; Diven DG, 2001, J AM ACAD DERMATOL, V44, P1, DOI 10.1067/mjd.2001.109302; DOWNIE AW, 1947, LANCET, V252, P550; Durant JF, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-288; Eshoo MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006342; FOSTER SO, 1972, B WORLD HEALTH ORGAN, V46, P569; Gala JLIL, 2011, MED BIOD C MUN; Heymann DL, 1998, BRIT MED BULL, V54, P693, DOI 10.1093/oxfordjournals.bmb.a011720; Irenge LM, 2010, APPL MICROBIOL BIOT, V88, P1179, DOI 10.1007/s00253-010-2848-0; JEZEK Z, 1987, J INFECT DIS, V156, P293, DOI 10.1093/infdis/156.2.293; JEZEK Z, 1988, ACTA TROP, V45, P297; Klietmann WF, 2001, CLIN MICROBIOL REV, V14, P364, DOI 10.1128/CMR.14.2.364-381.2001; Kulesh DA, 2004, J CLIN MICROBIOL, V42, P601, DOI 10.1128/JCM.42.2.601-609.2004; Li Y, 2010, J VIROL METHODS, V169, P223, DOI 10.1016/j.jviromet.2010.07.012; MacNeil A, 2009, CLIN INFECT DIS, V48, pE6, DOI 10.1086/595552; MacNeil A, 2009, AM J TROP MED HYG, V80, P503, DOI 10.4269/ajtmh.2009.80.503; Meyer H, 2002, J CLIN MICROBIOL, V40, P2919, DOI 10.1128/JCM.40.8.2919-2921.2002; Nalca A, 2005, CLIN INFECT DIS, V41, P1765, DOI 10.1086/498155; Putkuri N, 2009, J MED VIROL, V81, P146, DOI 10.1002/jmv.21385; Reynolds MG, 2012, TRENDS MICROBIOL, V20, P80, DOI 10.1016/j.tim.2011.12.001; Rimoin AW, 2007, EMERG INFECT DIS, V13, P934, DOI 10.3201/eid1306.061540; Roberts KL, 2008, TRENDS MICROBIOL, V16, P472, DOI 10.1016/j.tim.2008.07.009; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Saijo M, 2008, JPN J INFECT DIS, V61, P140; Scaramozzino N, 2007, CLIN CHEM, V53, P606, DOI 10.1373/clinchem.2006.068635; Shchelkunov SN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003756; Shchelkunov SN, 2011, J VIROL METHODS, V175, P163, DOI 10.1016/j.jviromet.2011.05.002; STAGLES MJ, 1985, T ROY SOC TROP MED H, V79, P192, DOI 10.1016/0035-9203(85)90333-5; Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06	38	10	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e96930	10.1371/journal.pone.0096930	http://dx.doi.org/10.1371/journal.pone.0096930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841633	Green Published, Green Submitted, gold			2022-12-25	WOS:000340948600014
J	Kukutla, P; Lindberg, BG; Pei, D; Rayl, M; Yu, WQ; Steritz, M; Faye, I; Xu, JN				Kukutla, Phanidhar; Lindberg, Bo G.; Pei, Dong; Rayl, Melanie; Yu, Wanqin; Steritz, Matthew; Faye, Ingrid; Xu, Jiannong			Insights from the Genome Annotation of Elizabethkingia anophelis from the Malaria Vector Anopheles gambiae	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; TONB-DEPENDENT TRANSPORTERS; CARBOHYDRATE-ACTIVE ENZYMES; MULTIDRUG EFFLUX PUMPS; ANTIBIOTIC-RESISTANCE; CHRYSEOBACTERIUM-MENINGOSEPTICUM; PATHOGEN FLAVOBACTERIUM; ISOPRENOID BIOSYNTHESIS; BACTEROIDES-FRAGILIS; DIPTERA-CULICIDAE	Elizabethkingia anophelis is a dominant bacterial species in the gut ecosystem of the malaria vector mosquito Anopheles gambiae. We recently sequenced the genomes of two strains of E. anophelis, R26(T) and Ag1, isolated from different strains of A. gambiae. The two bacterial strains are identical with a few exceptions. Phylogenetically, Elizabethkingia is closer to Chryseobacterium and Riemerella than to Flavobacterium. In line with other Bacteroidetes known to utilize various polymers in their ecological niches, the E. anophelis genome contains numerous TonB dependent transporters with various substrate specificities. In addition, several genes belonging to the polysaccharide utilization system and the glycoside hydrolase family were identified that could potentially be of benefit for the mosquito carbohydrate metabolism. In agreement with previous reports of broad antibiotic resistance in E. anophelis, a large number of genes encoding efflux pumps and blactamases are present in the genome. The component genes of resistance-nodulation-division type efflux pumps were found to be syntenic and conserved in different taxa of Bacteroidetes. The bacterium also displays hemolytic activity and encodes several hemolysins that may participate in the digestion of erythrocytes in the mosquito gut. At the same time, the OxyR regulon and antioxidant genes could provide defense against the oxidative stress that is associated with blood digestion. The genome annotation and comparative genomic analysis revealed functional characteristics associated with the symbiotic relationship with the mosquito host.	[Kukutla, Phanidhar; Pei, Dong; Yu, Wanqin; Steritz, Matthew; Xu, Jiannong] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Lindberg, Bo G.; Rayl, Melanie; Faye, Ingrid] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden	New Mexico State University; Stockholm University	Faye, I (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden.	ingrid.faye@su.se; jxu@nmsu.edu	Xu, Jiannong/N-1583-2019	Xu, Jiannong/0000-0001-7332-4370; KUKUTLA, PHANIDHAR/0000-0002-4790-386X	National Institute of General Medical Sciences; National Institutes of Health [1SC2GM092789, 1SC1AI112786]; National Science Foundation [DMS-1222592]; NMSU Howard Hughes Medical Institute (HHMI) research scholars program; Research Infrastructure - Integrating Activity project - European Community (INFRAVEC) FP7 Infrastructures [228421]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI112786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM092789] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NMSU Howard Hughes Medical Institute (HHMI) research scholars program; Research Infrastructure - Integrating Activity project - European Community (INFRAVEC) FP7 Infrastructures; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JX was supported by grants from the National Institute of General Medical Sciences, the National Institutes of Health (1SC2GM092789, 1SC1AI112786) and National Science Foundation (DMS-1222592). MS was an undergraduate research scholar supported by the NMSU Howard Hughes Medical Institute (HHMI) research scholars program. IF was supported by a grant from the Research Infrastructure - Integrating Activity project supported by the European Community (INFRAVEC) FP7 Infrastructures (grant agreement number: 228421). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez C, 2012, J BACTERIOL, V194, P5449, DOI 10.1128/JB.01173-12; Alvarez-Ortega C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00007; Amer MZ, 2011, J INFECT DEV COUNTR, V5, P745, DOI 10.3855/jidc.1570; Andreassi JL, 2004, BIOCHEMISTRY-US, V43, P14594, DOI 10.1021/bi048963o; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; BILLINGSLEY PF, 1991, J MED ENTOMOL, V28, P865, DOI 10.1093/jmedent/28.6.865; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Blanvillain S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000224; Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742; Bolam DN, 2012, CURR OPIN STRUC BIOL, V22, P563, DOI 10.1016/j.sbi.2012.06.006; Brown SD, 2012, J BACTERIOL, V194, P5991, DOI 10.1128/JB.01243-12; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Clark SE, 2009, VET RES, V40, DOI 10.1051/vetres/2009038; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Di Pentima MC, 1998, CLIN INFECT DIS, V26, P1169, DOI 10.1086/520309; Dietrich LEP, 2008, SCIENCE, V321, P1203, DOI 10.1126/science.1160619; Dong YM, 2009, J BIOL CHEM, V284, P9835, DOI 10.1074/jbc.M807084200; Fernandez-Gomez B, 2013, ISME J, V7, P1026, DOI 10.1038/ismej.2012.169; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Frank T, 2013, LANCET, V381, P1876, DOI 10.1016/S0140-6736(13)60318-9; Gaio Analiz de O, 2011, Parasit Vectors, V4, P105, DOI 10.1186/1756-3305-4-105; Gary RE, 2004, MED VET ENTOMOL, V18, P102, DOI 10.1111/j.0269-283X.2004.00483.x; Gonzalez LJ, 2012, ANTIMICROB AGENTS CH, V56, P1686, DOI 10.1128/AAC.05835-11; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Gusmao DS, 2010, ACTA TROP, V115, P275, DOI 10.1016/j.actatropica.2010.04.011; Heuston S, 2012, MICROBIOL-SGM, V158, P1389, DOI 10.1099/mic.0.051599-0; Hillyer JF, 2010, DEV COMP IMMUNOL, V34, P141, DOI 10.1016/j.dci.2009.08.014; Hogfors-Ronnholm E, 2010, MICROB PATHOGENESIS, V49, P369, DOI 10.1016/j.micpath.2010.08.002; Horsfall LE, 2011, FEBS J, V278, P1252, DOI 10.1111/j.1742-4658.2011.08046.x; HULTMARK D, 1982, EUR J BIOCHEM, V127, P207, DOI 10.1111/j.1432-1033.1982.tb06857.x; Impoinvil DE, 2004, MED VET ENTOMOL, V18, P108, DOI 10.1111/j.0269-283X.2004.00484.x; Jakes KS, 2012, ANNU REV GENET, V46, P209, DOI 10.1146/annurev-genet-110711-155427; Jiang JJ, 2012, J BACTERIOL, V194, P5481, DOI 10.1128/JB.01275-12; Junnila A, 2010, ACTA TROP, V115, P227, DOI 10.1016/j.actatropica.2010.04.002; Kampfer P, 2011, INT J SYST EVOL MICR, V61, P2670, DOI 10.1099/ijs.0.026393-0; KAWAI Y, 1988, EUR J BIOCHEM, V171, P73, DOI 10.1111/j.1432-1033.1988.tb13760.x; Kim KK, 2005, INT J SYST EVOL MICR, V55, P1287, DOI 10.1099/ijs.0.63541-0; Kolton M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076704; Krewulak KD, 2011, BIOCHEM CELL BIOL, V89, P87, DOI [10.1139/o10-141, 10.1139/O10-141]; Kukutla P, 2013, GENOME ANNOUNC, V1; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Lee M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040460; Lin XH, 2012, INT J ANTIMICROB AG, V40, P186, DOI 10.1016/j.ijantimicag.2012.03.020; Lindh JM, 2008, ACTA TROP, V107, P242, DOI 10.1016/j.actatropica.2008.06.008; Liu MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037630; Lombard J, 2011, MOL BIOL EVOL, V28, P87, DOI 10.1093/molbev/msq177; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luckhart S, 1998, P NATL ACAD SCI USA, V95, P5700, DOI 10.1073/pnas.95.10.5700; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Matyi SA, 2013, GENOME ANNOUNC, V1; McBride MJ, 2009, APPL ENVIRON MICROB, V75, P6864, DOI 10.1128/AEM.01495-09; Meister S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000542; Michel C, 2005, J APPL MICROBIOL, V99, P323, DOI 10.1111/j.1365-2672.2005.02592.x; Mirus O, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-68; Miziorko HM, 2011, ARCH BIOCHEM BIOPHYS, V505, P131, DOI 10.1016/j.abb.2010.09.028; Monier JM, 2011, CURR OPIN MICROBIOL, V14, P229, DOI 10.1016/j.mib.2011.04.010; Moran-Barrio J, 2007, J BIOL CHEM, V282, P18286, DOI 10.1074/jbc.M700467200; Muller G, 2005, MED VET ENTOMOL, V19, P413, DOI 10.1111/j.1365-2915.2005.00590.x; Neuner EA, 2012, J ANTIMICROB CHEMOTH, V67, P1558, DOI 10.1093/jac/dks053; Ngwa CJ, 2013, J MED ENTOMOL, V50, P404, DOI 10.1603/ME12180; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Pimenta AL, 2005, J BACTERIOL, V187, P7471, DOI 10.1128/JB.187.21.7471-7480.2005; Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96; REDDY D, 1983, SCIENCE, V221, P769, DOI 10.1126/science.6308761; Rocha ER, 2003, ANAEROBE, V9, P165, DOI 10.1016/S1075-9964(03)00118-5; Rossolini GM, 2001, ANTIMICROB AGENTS CH, V45, P837, DOI 10.1128/AAC.45.3.837-844.2001; Saavedra MJ, 2003, ANTIMICROB AGENTS CH, V47, P2330, DOI 10.1128/AAC.47.7.2330-2333.2003; Saidijam M, 2006, CURR DRUG TARGETS, V7, P793, DOI 10.2174/138945006777709575; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012; SCHLEIN Y, 1995, J MED ENTOMOL, V32, P882, DOI 10.1093/jmedent/32.6.882; Schmieder R, 2012, FUTURE MICROBIOL, V7, P73, DOI [10.2217/fmb.11.135, 10.2217/FMB.11.135]; Simm AM, 2001, FEBS LETT, V509, P350, DOI 10.1016/S0014-5793(01)03152-0; Sommer MOA, 2010, VIRULENCE, V1, P299, DOI 10.4161/viru.1.4.12010; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Souza JA, 2007, COMP BIOCHEM PHYS A, V147, P993, DOI 10.1016/j.cbpa.2007.03.008; Stoczko M, 2006, ANTIMICROB AGENTS CH, V50, P1973, DOI 10.1128/AAC.01551-05; Sund CJ, 2008, MOL MICROBIOL, V67, P129, DOI 10.1111/j.1365-2958.2007.06031.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041204; Teo J, 2013, LANCET, V382, P855, DOI 10.1016/S0140-6736(13)61858-9; Terenius O, 2012, FEMS MICROBIOL ECOL, V80, P556, DOI 10.1111/j.1574-6941.2012.01317.x; Touchon M, 2011, APPL ENVIRON MICROB, V77, P7656, DOI 10.1128/AEM.05625-11; Vinella D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000497; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; Wexler HM, 2012, ANAEROBE, V18, P200, DOI 10.1016/j.anaerobe.2011.12.017; Wong K, 2014, TRENDS BIOCHEM SCI, V39, P8, DOI 10.1016/j.tibs.2013.11.002; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Yum JH, 2010, J MICROBIOL, V48, P358, DOI 10.1007/s12275-010-9308-5; Zheng M, 2000, BIOCHEM PHARMACOL, V59, P1, DOI 10.1016/S0006-2952(99)00289-0	97	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97715	10.1371/journal.pone.0097715	http://dx.doi.org/10.1371/journal.pone.0097715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842809	gold, Green Submitted, Green Published			2022-12-25	WOS:000340948600062
J	Miow, QH; Tan, TZ; Ye, J; Lau, JA; Yokomizo, T; Thiery, JP; Mori, S				Miow, Q. H.; Tan, T. Z.; Ye, J.; Lau, J. A.; Yokomizo, T.; Thiery, J-P; Mori, S.			Epithelial-mesenchymal status renders differential responses to cisplatin in ovarian cancer	ONCOGENE			English	Article							NF-KAPPA-B; PLATINUM-BASED CHEMOTHERAPY; GERM-CELL TUMORS; TRANSCRIPTION FACTORS SNAIL; BREAST-CANCER; DRUG-RESISTANCE; MOLECULAR SUBTYPES; CYCLE PROGRESSION; INDUCED APOPTOSIS; OXIDATIVE STRESS	Chemoresistance to platinums, such as cisplatin, is of critical concern in the treatment of ovarian cancer. Recent evidence has linked epithelial-mesenchymal transition (EMT) as a contributing mechanism. The current study explored the connection between cellular responses to cisplatin and EMT in ovarian cancer. Expression microarrays were utilized to estimate the EMT status as a binary phenotype, and the transcriptional responses of 46 ovarian cancer cell lines to cisplatin were measured at dosages equivalent to 50% growth inhibition. Phenotypic responses to cisplatin were quantified with respect to cell number, proliferation rate and apoptosis, and then compared with the epithelial or mesenchymal status. Ovarian cancer cell lines with an epithelial status exhibited higher resistance to cisplatin treatment in the MTS assay than those with a mesenchymal status. Pathway analyses revealed the induction of G1/S- and S-phase genes (P = 0.001) and the activation of multiple NF-kappa B (nuclear factor kappa-light-chain-enhancer of activated B cells) downstream genes (P = 0.0016) by cisplatin selectively in epithelial-like cell lines. BrdU incorporation and Caspase-3/7 release assays confirmed impaired apoptosis in epithelial-like ovarian cancer cells. In clinical samples, we observed resistance to single platinum treatment and the selective activation of the NF-kappa B pathway by platinum in ovarian cancers with an epithelial status. Overall, our results suggest that, in epithelial-like ovarian cancer cells, NF-kappa B activation by cisplatin may lead to defective apoptosis, preferential proliferation arrest and a consequential decreased sensitivity to cisplatin.	[Miow, Q. H.; Tan, T. Z.; Lau, J. A.; Thiery, J-P; Mori, S.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Miow, Q. H.] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore, Singapore; [Ye, J.] Natl Univ Singapore, Yong Loo Lin Sch Med, Deans Off, Singapore, Singapore; [Yokomizo, T.; Mori, S.] Japanese Fdn Canc Res, Inst Canc, Div Canc Genom, Tokyo 1358550, Japan; [Thiery, J-P] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Thiery, J-P] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; Japanese Foundation for Cancer Research; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Mori, S (corresponding author), Japanese Fdn Canc Res, Inst Canc, Div Canc Genom, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	seiichi.mori@jfcr.or.jp	Tan, Tuan Zea/I-9227-2019; Thiery, Jean Paul/M-9387-2019; Thiery, Jean Paul/H-1550-2011	Tan, Tuan Zea/0000-0001-6624-1593; Miow, Qing Hao/0000-0001-8029-8238; Thiery, Jean Paul/0000-0003-0478-5020; Ye, Jieru/0000-0002-5776-9385	Cancer Science Institute of Singapore; Institute of Molecular and Cell Biology at A*STAR, Singapore; Vehicle Racing Commemorative Foundation in Japan; Princess Takamatsu Cancer Research Fund	Cancer Science Institute of Singapore; Institute of Molecular and Cell Biology at A*STAR, Singapore; Vehicle Racing Commemorative Foundation in Japan; Princess Takamatsu Cancer Research Fund	We thank Drs K Yamaguchi, N Matsumura and S Murphy for kindly providing us with a panel of ovarian cancer cell lines. We thank Dr R Jackson for her careful editing of the English language. This work was supported in part through a grant from the Cancer Science Institute of Singapore, the Institute of Molecular and Cell Biology at A*STAR, Singapore, the Vehicle Racing Commemorative Foundation in Japan and the Princess Takamatsu Cancer Research Fund.	Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Ahmed AA, 2007, CANCER CELL, V12, P514, DOI 10.1016/j.ccr.2007.11.014; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bentires-Alj M, 2003, ONCOGENE, V22, P90, DOI 10.1038/sj.onc.1206056; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bremmer F, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-19; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Coleman RL, 2013, NAT REV CLIN ONCOL, V10, P211, DOI 10.1038/nrclinonc.2013.5; Davidson B, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00033; DEMARCQ C, 1994, CELL GROWTH DIFFER, V5, P983; Du FF, 2013, ONCOL REP, V30, P1113, DOI 10.3892/or.2013.2567; Escarcega RO, 2007, CLIN ONCOL-UK, V19, P154, DOI 10.1016/j.clon.2006.11.013; Gatti L, 2002, CELL DEATH DIFFER, V9, P1352, DOI 10.1038/sj.cdd.4401109; Godwin P, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00120; Gupta N, 2013, GYNECOL ONCOL, V130, P200, DOI 10.1016/j.ygyno.2013.03.019; Haslehurst AM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-91; Helleman J, 2010, GYNECOL ONCOL, V117, P170, DOI 10.1016/j.ygyno.2010.01.010; Huang RYJ, 2012, CURR DRUG TARGETS, V13, P1649; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Kajiyama H, 2007, INT J ONCOL, V31, P277; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kang J, 2012, JNCI-J NATL CANCER I, V104, P670, DOI 10.1093/jnci/djs177; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kondoh E, 2010, INT J CANCER, V126, P2448, DOI 10.1002/ijc.24919; Kurrey NK, 2005, GYNECOL ONCOL, V97, P155, DOI 10.1016/j.ygyno.2004.12.043; Latifi A, 2011, J CELL BIOCHEM, V112, P2850, DOI 10.1002/jcb.23199; Leitao MM, 2009, SEMIN ONCOL, V36, P106, DOI 10.1053/j.seminoncol.2008.12.002; Li QQ, 2009, CLIN CANCER RES, V15, P2657, DOI 10.1158/1078-0432.CCR-08-2372; Lin-Chao S., 1994, J Biomed Sci, V1, P131, DOI 10.1007/BF02257987; Liu GH, 2006, INT J GYNECOL CANCER, V16, P1777, DOI 10.1111/j.1525-1438.2006.00652.x; Mabuchi S, 2004, J BIOL CHEM, V279, P23477, DOI 10.1074/jbc.M313709200; Marchini S, 2013, EUR J CANCER, V49, P520, DOI 10.1016/j.ejca.2012.06.026; Masters JRW, 2003, NAT REV CANCER, V3, P517, DOI 10.1038/nrc1120; Matsumura N, 2011, GENOME RES, V21, P74, DOI 10.1101/gr.108803.110; MIETTINEN M, 1985, AM J PATHOL, V120, P402; Mizuno H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-137; Mueller S, 2006, INT J ONCOL, V29, P471; Nakamura Y, 2004, CANCER SCI, V95, P7, DOI 10.1111/j.1349-7006.2004.tb03163.x; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; OSTROW S, 1980, CANCER CLIN TRIALS, V3, P23; Parajuli B, 2013, CANCER EPIDEMIOL, V37, P512, DOI 10.1016/j.canep.2013.02.008; PARKER RJ, 1991, J CLIN INVEST, V87, P772, DOI 10.1172/JCI115080; Perez RP, 1998, EUR J CANCER, V34, P1535, DOI 10.1016/S0959-8049(98)00227-5; Qin LF, 2002, CANCER LETT, V175, P27, DOI 10.1016/S0304-3835(01)00720-0; Rosano L, 2011, CLIN CANCER RES, V17, P2350, DOI 10.1158/1078-0432.CCR-10-2325; Rustin GJS, 2006, J CLIN ONCOL, V24, P45, DOI 10.1200/JCO.2005.01.2757; Samanta AK, 2004, J BIOL CHEM, V279, P7576, DOI 10.1074/jbc.M311659200; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Shah MA, 2001, CLIN CANCER RES, V7, P2168; Shen DW, 2012, PHARMACOL REV, V64, P706, DOI 10.1124/pr.111.005637; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Silver DP, 2010, J CLIN ONCOL, V28, P1145, DOI 10.1200/JCO.2009.22.4725; Simons AL, 2007, CANCER RES, V67, P3364, DOI 10.1158/0008-5472.CAN-06-3717; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Solomon LA, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-9; SORENSON CM, 1988, CANCER RES, V48, P4484; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan TZ, 2013, EMBO MOL MED, V5, P1051, DOI 10.1002/emmm.201201823; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tomaskovic-Crook E, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2416; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Troester MA, 2004, CANCER RES, V64, P4218, DOI 10.1158/0008-5472.CAN-04-0107; Verhaak RGW, 2013, J CLIN INVEST, V123, P517, DOI 10.1172/JCI65833; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Weir NM, 2007, CANCER BIOL THER, V6, P178, DOI 10.4161/cbt.6.2.3577; Wintzell M, 2012, CANCER BIOL THER, V13, P1454, DOI 10.4161/cbt.22007; Xiao GT, 2011, AM J CANCER RES, V1, P192; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038; Yang D, 2013, CANCER CELL, V23, P186, DOI 10.1016/j.ccr.2012.12.020; Yip HT, 2006, ARCH OTOLARYNGOL, V132, P317, DOI 10.1001/archotol.132.3.317; Yue P, 2012, ONCOGENE, V31, P2309, DOI 10.1038/onc.2011.409	76	84	87	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 9	2015	34	15					1899	1907		10.1038/onc.2014.136	http://dx.doi.org/10.1038/onc.2014.136			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CF7GY	24858042				2022-12-25	WOS:000352725600004
J	Lee, CW; Yang, FC; Chang, HY; Chou, HY; Tan, BCM; Lee, SC				Lee, Chia-Wei; Yang, Fu-Chia; Chang, Hsin-Yun; Chou, Hanyi; Tan, Bertrand Chin-Ming; Lee, Sheng-Chung			Interaction between Salt-inducible Kinase 2 and Protein Phosphatase 2A Regulates the Activity of Calcium/Calmodulin-dependent Protein Kinase I and Protein Phosphatase Methylesterase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE CARBOXYL METHYLTRANSFERASE; TUMOR-SUPPRESSOR PP2A; HISTONE DEACETYLASE-5; CATALYTIC SUBUNIT; COACTIVATOR TORC2; DOWN-REGULATION; B-SUBUNITS; SIK2; PHOSPHORYLATION; METHYLATION	Salt-inducible kinase 2 (SIK2) is the only AMP-activated kinase (AMPK) family member known to interact with protein phosphatase 2 (PP2A). However, the functional aspects of this complex are largely unknown. Here we report that the SIK2 center dot PP2A complex preserves both kinase and phosphatase activities. In this capacity, SIK2 attenuates the association of the PP2A repressor, the protein phosphatase methylesterase-1 (PME-1), thus preserving the methylation status of the PP2A catalytic subunit. Furthermore, the SIK2 center dot PP2A holoenzyme complex dephosphorylates and inactivates Ca2+/calmodulin-dependent protein kinase I (CaMKI), an upstream kinase for phosphorylating PME-1/Ser(15). The functionally antagonistic SIK2 center dot PP2A and CaMKI and PME-1 networks thus constitute a negative feedback loop that modulates the phosphatase activity of PP2A. Depletion of SIK2 led to disruption of the SIK2 center dot PP2A complex, activation of CaMKI, and downstream effects, including phosphorylation of HDAC5/Ser259, sequestration of HDAC5 in the cytoplasm, and activation of myocyte-specific enhancer factor 2C (MEF2C)-mediated gene expression. These results suggest that the SIK2 center dot PP2A complex functions in the regulation of MEF2C-dependent transcription. Furthermore, this study suggests that the tightly linked regulatory loop comprised of the SIK2 center dot PP2A and CaMKI and PME-1 networks may function in fine-tuning cell proliferation and stress response.	[Lee, Chia-Wei; Yang, Fu-Chia; Chang, Hsin-Yun; Lee, Sheng-Chung] Natl Taiwan Univ, Inst Mol Med, Taipei 10051, Taiwan; [Chou, Hanyi] Natl Taiwan Univ, Inst Oral Biol, Taipei 10051, Taiwan; [Tan, Bertrand Chin-Ming] Chang Gung Univ, Dept Biomed Sci, Tao Yuan 33302, Taiwan; [Lee, Sheng-Chung] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan	National Taiwan University; National Taiwan University; Chang Gung University; Academia Sinica - Taiwan	Lee, SC (corresponding author), Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 10051, Taiwan.	slee@ntu.edu.tw		Lee, Chia-Wei/0000-0002-8925-7421; Tan, Bertrand/0000-0002-2218-7115	Department of Medical Research, National Taiwan University Hospital	Department of Medical Research, National Taiwan University Hospital	We thank Dr. Mitsuhiro Okamoto for the GST-Syntide construct and Dr. Sheng-Liang Chen for the 3xMEF2-Luc reporter and pcDNA-MEF2C expression vector. We are indebted to Yi-Li Liu and I-Ching Huang for technical assistance with DNA sequencing, supported in part by the Department of Medical Research, National Taiwan University Hospital.	Ahmed AA, 2010, CANCER CELL, V18, P109, DOI 10.1016/j.ccr.2010.06.018; Al-Hakim AK, 2005, J CELL SCI, V118, P5661, DOI 10.1242/jcs.02670; Anderson KA, 2004, J BIOL CHEM, V279, P31708, DOI 10.1074/jbc.M404523200; Arnold HK, 2008, CANCER METAST REV, V27, P147, DOI 10.1007/s10555-008-9128-9; Bachovchin DA, 2011, J MED CHEM, V54, P5229, DOI 10.1021/jm200502u; Bassik MC, 2004, EMBO J, V23, P1207, DOI 10.1038/sj.emboj.7600104; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; De Baere I, 1999, BIOCHEMISTRY-US, V38, P16539, DOI 10.1021/bi991646a; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Du HJ, 2013, J BIOL CHEM, V288, P21341, DOI 10.1074/jbc.M113.481093; Finsterwald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054545; Horike N, 2003, J BIOL CHEM, V278, P18440, DOI 10.1074/jbc.M211770200; Horike N, 2010, PIGM CELL MELANOMA R, V23, P809, DOI 10.1111/j.1755-148X.2010.00760.x; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; LeNoue-Newton M, 2011, J BIOL CHEM, V286, P17665, DOI 10.1074/jbc.M111.222414; Leulliot N, 2004, J BIOL CHEM, V279, P8351, DOI 10.1074/jbc.M311484200; Li XH, 2002, EUR J BIOCHEM, V269, P546, DOI 10.1046/j.0014-2956.2001.02680.x; Li XH, 2002, MOL CELL BIOL, V22, P3674, DOI 10.1128/MCB.22.11.3674-3684.2002; Liu EB, 2011, P NATL ACAD SCI USA, V108, P8680, DOI 10.1073/pnas.1100131108; Longin S, 2007, J BIOL CHEM, V282, P26971, DOI 10.1074/jbc.M704059200; Mcgee SL, 2008, DIABETES, V57, P860, DOI 10.2337/db07-0843; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Muraoka M, 2009, AM J PHYSIOL-ENDOC M, V296, pE1430, DOI 10.1152/ajpendo.00024.2009; Ogris E, 1999, J VIROL, V73, P7390, DOI 10.1128/JVI.73.9.7390-7398.1999; Ogris E, 1999, J BIOL CHEM, V274, P14382, DOI 10.1074/jbc.274.20.14382; Ortega-Gutierrez S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002486; Puustinen P, 2009, CANCER RES, V69, P2870, DOI 10.1158/0008-5472.CAN-08-2760; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Sasaki T, 2011, NEURON, V69, P106, DOI 10.1016/j.neuron.2010.12.004; Schoenthal Axel H., 1998, Frontiers in Bioscience, V3, pD1262; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Sjostrom M, 2007, P NATL ACAD SCI USA, V104, P16922, DOI 10.1073/pnas.0706838104; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P1080, DOI 10.1093/jnen/63.10.1080; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; Walkinshaw DR, 2013, J BIOL CHEM, V288, P9345, DOI 10.1074/jbc.M113.456996; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; Xing YN, 2008, CELL, V133, P154, DOI 10.1016/j.cell.2008.02.041; Yang FC, 2013, J BIOL CHEM, V288, P33861, DOI 10.1074/jbc.M113.492199; Yang FC, 2013, J BIOL CHEM, V288, P6227, DOI 10.1074/jbc.M112.431239	49	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21108	21119		10.1074/jbc.M113.540229	http://dx.doi.org/10.1074/jbc.M113.540229			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24841198	Green Published, hybrid			2022-12-25	WOS:000339396600061
J	Tomita, T; Yasui-Furukori, N; Nakagami, T; Tsuchimine, S; Ishioka, M; Kaneda, A; Sugawara, N; Kaneko, S				Tomita, Tetsu; Yasui-Furukori, Norio; Nakagami, Taku; Tsuchimine, Shoko; Ishioka, Masamichi; Kaneda, Ayako; Sugawara, Norio; Kaneko, Sunao			The Influence of 5-HTTLPR Genotype on the Association between the Plasma Concentration and Therapeutic Effect of Paroxetine in Patients with Major Depressive Disorder	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; CLINICAL PHARMACOKINETICS; TRICYCLIC ANTIDEPRESSANTS; SERUM CONCENTRATIONS; REUPTAKE INHIBITORS; TREATMENT RESPONSE; POLYMORPHISM; PROMOTER; EFFICACY; PHARMACOGENETICS	Introduction: The efficacy of treatment with selective serotonin reuptake inhibitors in patients with major depressive disorder (MDD) can differ depending on the patient's serotonin transporter-linked polymorphic region (5-HTTLPR) genotype, and the effects of varying plasma concentrations of drugs can also vary. We investigated the association between the paroxetine plasma concentration and clinical response in patients with different 5-HTTLPR genotypes. Methods: Fifty-one patients were enrolled in this study. The Montgomery-Asberg Depression Rating Scale (MADRS) was used to evaluate patients at 0, 1, 2, 4, and 6 weeks. The patients' paroxetine plasma concentrations at week 6 were measured using high-performance liquid chromatography. Additionally, their 5-HTTLPR polymorphisms (alleles S and L) were analyzed using a polymerase chain reaction with specific primers. We divided the participants into two groups based on their L haplotype: the SS group and the SL and LL group. We performed single and multiple regression analyses to investigate the associations between MADRS improvement and paroxetine plasma concentrations or other covariates for each group. Results: There were no significant differences between the two groups with regard to demographic or clinical data. In the SS group, the paroxetine plasma concentration was significantly negatively correlated with improvement in MADRS at week 6. In the SL and LL group, the paroxetine plasma concentration was significantly positively correlated with improvement in MADRS at week 6 according to the results of the single regression analysis; however, it was not significantly correlated with improvement in MADRS at week 6 according to the results of the multiple regression analysis. Conclusion: Among patients with MDD who do not respond to paroxetine, a lower plasma concentration or a lower oral dose of paroxetine might be more effective in those with the SS genotype, and a higher plasma concentration might be more effective in those with the SL or LL genotype.	[Tomita, Tetsu; Yasui-Furukori, Norio; Nakagami, Taku; Tsuchimine, Shoko; Ishioka, Masamichi; Kaneda, Ayako; Sugawara, Norio; Kaneko, Sunao] Hirosaki Univ, Grad Sch Med, Dept Neuropsychiat, Hirosaki, Aomori, Japan	Hirosaki University	Yasui-Furukori, N (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Neuropsychiat, Hirosaki, Aomori, Japan.	yasufuru@cc.hirosaki-u.ac.jp	Tomita, Tetsu/G-4806-2014		Japan Society for the Promotion of Research (JSPS) [24590652]; Mitsubishi Pharma Research Foundation	Japan Society for the Promotion of Research (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mitsubishi Pharma Research Foundation	This study was funded by a Grant-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Research (JSPS, #24590652) and Mitsubishi Pharma Research Foundation. The funding sources played no role in the study design, in the collection, analysis, or interpretation of data, in the writing of the report, or in the decision to submit the paper for publication.	Abela JRZ, 2005, J PERS DISORD, V19, P68, DOI 10.1521/pedi.19.1.68.62177; AMDISEN A, 1980, THER DRUG MONIT, V2, P73, DOI 10.1097/00007691-198001000-00009; AMDISEN A, 1977, CLIN PHARMACOKINET, V2, P73, DOI 10.2165/00003088-197702020-00001; AMSTERDAM J, 1980, AM J PSYCHIAT, V137, P653; Andersen B, 1990, J AFFECT DISORDERS, V18, P289; Antonijevic IA, 2006, PSYCHONEUROENDOCRINO, V31, P1, DOI 10.1016/j.psyneuen.2005.04.004; Arias B, 2001, MOL PSYCHIATR, V6, P239, DOI 10.1038/sj.mp.4000818; Baffa A, 2010, NEUROPSYCHOBIOLOGY, V62, P121, DOI 10.1159/000317285; Bonvicini C, 2010, PROG NEURO-PSYCHOPH, V34, P934, DOI 10.1016/j.pnpbp.2010.04.020; BROWNE TR, 1978, AM J HOSP PHARM, V35, P1048, DOI 10.1093/ajhp/35.9.1048; BURROWS GD, 1988, J CLIN PSYCHIAT, V49, P18; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; David SP, 2005, J NEUROSCI, V25, P2586, DOI 10.1523/JNEUROSCI.3769-04.2005; Dreimuller N, 2012, PHARMACOPSYCHIATRY, V45, P108, DOI 10.1055/s-0031-1291347; Eggart V, 2011, PSYCHOPHARMACOLOGY, V217, P297, DOI 10.1007/s00213-011-2319-z; Freeman DJ, 1997, CLIN PHARMACOKINET, V32, P93, DOI 10.2165/00003088-199732020-00001; Gex-Fabry M, 2007, PROG NEURO-PSYCHOPH, V31, P892, DOI 10.1016/j.pnpbp.2007.02.003; Gilles M, 2005, PHARMACOPSYCHIATRY, V38, P118, DOI 10.1055/s-2005-864121; GLASSMAN AH, 1985, AM J PSYCHIAT, V142, P155; Gonda X, 2009, EUR ARCH PSY CLIN N, V259, P106, DOI 10.1007/s00406-008-0842-7; Gunasekara NS, 1998, DRUGS, V55, P85, DOI 10.2165/00003495-199855010-00007; HADDOCK RE, 1989, ACTA PSYCHIAT SCAND, V80, P24, DOI 10.1111/j.1600-0447.1989.tb07163.x; Heils A, 1996, J NEUROCHEM, V66, P2621; Heils A, 1997, J NEURAL TRANSM, V104, P1005, DOI 10.1007/BF01273314; Hiemke C, 2011, PHARMACOPSYCHIATRY, V44, P195, DOI 10.1055/s-0031-1286287; Hranilovic D, 2004, BIOL PSYCHIAT, V55, P1090, DOI 10.1016/j.biopsych.2004.01.029; Huezo-Diaz P, 2009, BRIT J PSYCHIAT, V195, P30, DOI 10.1192/bjp.bp.108.062521; Illi A, 2011, EUR ARCH PSY CLIN N, V261, P95, DOI 10.1007/s00406-010-0126-x; KAYE CM, 1989, ACTA PSYCHIAT SCAND, V80, P60, DOI 10.1111/j.1600-0447.1989.tb07176.x; Kunugi H, 1997, MOL PSYCHIATR, V2, P457, DOI 10.1038/sj.mp.4000334; Laje G, 2009, PSYCHIAT SERV, V60, P1446, DOI 10.1176/appi.ps.60.11.1446; Lamers F, 2010, J CLIN PSYCHIAT, V71, P1582, DOI 10.4088/JCP.09m05398blu; LESCH KP, 1994, J NEURAL TRANSM-GEN, V95, P157, DOI 10.1007/BF01276434; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lieberman R, 1996, THER DRUG MONIT, V18, P423, DOI 10.1097/00007691-199608000-00019; LIEBERMAN R, 1993, THER DRUG MONIT, V15, P498, DOI 10.1097/00007691-199312000-00008; Lingjaerde O, 1987, Acta Psychiatr Scand Suppl, V334, P1; Lundmark J, 2000, ACTA PSYCHIAT SCAND, V101, P354, DOI 10.1034/j.1600-0447.2000.101005354.x; Maron E, 2009, EUR NEUROPSYCHOPHARM, V19, P451, DOI 10.1016/j.euroneuro.2009.01.010; Min WJ, 2009, PSYCHOPHARMACOLOGY, V205, P409, DOI 10.1007/s00213-009-1550-3; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Muller MJ, 2003, PHARMACOPSYCHIATRY, V36, P98; Murphy DL, 2004, MOL INTERV, V4, P109, DOI 10.1124/mi.4.2.8; Niitsu T, 2013, PROG NEURO-PSYCHOPH, V45, P183, DOI 10.1016/j.pnpbp.2013.05.011; Normann C, 2004, PHARMACOPSYCHIATRY, V37, P123, DOI 10.1055/s-2004-818990; PERRY PJ, 1987, CLIN PHARMACOKINET, V13, P381, DOI 10.2165/00003088-198713060-00003; PERRY PJ, 1994, J CLIN PSYCHOPHARM, V14, P230; Pfuhlmann B, 2007, J NEURAL TRANSM-SUPP, P287; RODIGHIERO V, 1989, CLIN PHARMACOKINET, V16, P27, DOI 10.2165/00003088-198916010-00002; Serretti A, 2007, MOL PSYCHIATR, V12, P247, DOI 10.1038/sj.mp.4001926; Smeraldi E, 1998, MOL PSYCHIATR, V3, P508, DOI 10.1038/sj.mp.4000425; Takahashi N, 2004, HUM PSYCHOPHARM CLIN, V19, P187, DOI 10.1002/hup.576; TASKER TCG, 1989, ACTA PSYCHIAT SCAND, V80, P152, DOI 10.1111/j.1600-0447.1989.tb07201.x; Umene-Nakano W, 2010, J PSYCHOPHARMACOL, V24, P1764, DOI 10.1177/0269881109106899; van Praag HM, 2008, EUR ARCH PSY CLIN N, V258, P29, DOI 10.1007/s00406-008-2006-1; VANHARTEN J, 1993, CLIN PHARMACOKINET, V24, P203, DOI 10.2165/00003088-199324030-00003; Wilkie MJV, 2009, PHARMACOGENOMICS J, V9, P61, DOI 10.1038/sj.tpj.6500491; Won ES, 2012, NEUROPSYCHOBIOLOGY, V66, P221, DOI 10.1159/000341876; Yasui-Furukori N, 2007, THER DRUG MONIT, V29, P45, DOI 10.1097/FTD.0b013e31802bb20d; Yasui-Furukori N, 2007, EUR J CLIN PHARMACOL, V63, P51, DOI 10.1007/s00228-006-0217-9; Yasui-Furukori N, 2011, HUM PSYCHOPHARM CLIN, V26, P602, DOI 10.1002/hup.1252	61	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98099	10.1371/journal.pone.0098099	http://dx.doi.org/10.1371/journal.pone.0098099			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858363	Green Published, gold, Green Submitted			2022-12-25	WOS:000336839400040
J	Vallejo, G; La Greca, AD; Tarifa-Reischle, IC; Mestre-Citrinovitz, AC; Ballare, C; Beato, M; Saragueta, P				Vallejo, Griselda; La Greca, Alejandro D.; Tarifa-Reischle, Inti C.; Mestre-Citrinovitz, Ana C.; Ballare, Cecilia; Beato, Miguel; Saragueeta, Patricia			CDC2 Mediates Progestin Initiated Endometrial Stromal Cell Proliferation: A PR Signaling to Gene Expression Independently of Its Binding to Chromatin	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; CYCLIN D1; STEROID-HORMONES; CROSS-TALK; IN-VIVO; ACTIVATION; PROMOTER; RAT; ESTRADIOL; KINASES	Although non-genomic steroid receptor pathways have been studied over the past decade, little is known about the direct gene expression changes that take place as a consequence of their activation. Progesterone controls proliferation of rat endometrial stromal cells during the peri-implantation phase of pregnancy. We showed that picomolar concentration of progestin R5020 mimics this control in UIII endometrial stromal cells via ERK1-2 and AKT activation mediated by interaction of Progesterone Receptor (PR) with Estrogen Receptor beta (ERb) and without transcriptional activity of endogenous PR and ER. Here we identify early downstream targets of cytoplasmic PR signaling and their possible role in endometrial stromal cell proliferation. Microarray analysis of global gene expression changes in UIII cells treated for 45 min with progestin identified 97 up-and 341 down-regulated genes. The most over-represented molecular functions were transcription factors and regulatory factors associated with cell proliferation and cell cycle, a large fraction of which were repressors down-regulated by hormone. Further analysis verified that progestins regulate Ccnd1, JunD, Usf1, Gfi1, Cyr61, and Cdkn1b through PR-mediated activation of ligand-free ER, ERK1-2 or AKT, in the absence of genomic PR binding. ChIP experiments show that progestin promoted the interaction of USF1 with the proximal promoter of the Cdc2 gene. Usf1 knockdown abolished Cdc2 progestin-dependent transcriptional regulation and cell proliferation, which also blocked Cdc2 knockdown. We conclude that progestin-induced proliferation of endometrial stromal cells is mediated by ERK1-2 and AKT dependent early regulation of USF1, which directly induces Cdc2. To our knowledge, this is the first description of early target genes of progestin-activated classical PR via crosstalk with protein kinases and independently of hormone receptor binding to the genomic targets.	[Vallejo, Griselda; La Greca, Alejandro D.; Tarifa-Reischle, Inti C.; Mestre-Citrinovitz, Ana C.; Saragueeta, Patricia] IByME Conicet, Inst Biol & Med Expt, Buenos Aires, DF, Argentina; [Ballare, Cecilia; Beato, Miguel] CRG, Barcelona, Spain; [Beato, Miguel] UPF, Barcelona, Spain	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University	Saragueta, P (corresponding author), IByME Conicet, Inst Biol & Med Expt, Buenos Aires, DF, Argentina.	sarag@dna.uba.ar	Beato, Miguel/B-5564-2015; Ballare, Cecilia/F-2593-2016	Beato, Miguel/0000-0002-2878-2222; Ballare, Cecilia/0000-0002-9442-807X; Mestre, Ana Cecilia/0000-0001-8027-3487	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina [PICT 5-34086, PID 88]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP); Ministerio de Educacion y Ciencia (MEC) [BMC 2003-02902]; Consolider [CSD2006-00049]	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Ministerio de Educacion y Ciencia (MEC)(Spanish Government); Consolider(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants to P. S. from Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 5-34086 and PID 88) Argentina and Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 2005-2006); and to M. B. from the Ministerio de Educacion y Ciencia (MEC) BMC 2003-02902, Consolider (CSD2006-00049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Ballare C, 2013, MOL CELL, V49, P67, DOI 10.1016/j.molcel.2012.10.019; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Boonyaratanakornkit V, 2001, MOL CELL, V8, P269, DOI 10.1016/S1097-2765(01)00304-5; Breitkreutz BJ, 2001, GENOME BIOL, V2; Castoria G, 1999, EMBO J, V18, P2500, DOI 10.1093/emboj/18.9.2500; Cicatiello L, 2004, MOL CELL BIOL, V24, P7260, DOI 10.1128/MCB.24.16.7260-7274.2004; Clarkl DE, 2001, EMBO J, V20, P3484, DOI 10.1093/emboj/20.13.3484; COGSWELL JP, 1995, MOL CELL BIOL, V15, P2782; COHEN H, 1993, EUR J CELL BIOL, V61, P116; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Duan ZJ, 2003, P NATL ACAD SCI USA, V100, P5932, DOI 10.1073/pnas.1031694100; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Gazel A, 2008, J CELL PHYSIOL, V215, P292, DOI 10.1002/jcp.21394; Gerstein M, 2012, NATURE, V489, P208, DOI 10.1038/489208b; Groshong SD, 1997, MOL ENDOCRINOL, V11, P1593, DOI 10.1210/me.11.11.1593; GRUMMER R, 1994, BIOL REPROD, V51, P1109, DOI 10.1095/biolreprod51.6.1109; Hu X, 2011, CELL PROLIFERAT, V44, P205, DOI 10.1111/j.1365-2184.2011.00753.x; HUETHUDSON YM, 1989, ENDOCRINOLOGY, V125, P1683, DOI 10.1210/endo-125-3-1683; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Lindqvist A, 2007, PLOS BIOL, V5, P1127, DOI 10.1371/journal.pbio.0050123; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Migliaccio A, 1996, EMBO J, V15, P1292, DOI 10.1002/j.1460-2075.1996.tb00471.x; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Migliaccio A, 1998, EMBO J, V17, P2008, DOI 10.1093/emboj/17.7.2008; North S, 1999, ONCOGENE, V18, P1945, DOI 10.1038/sj.onc.1202506; PARR MB, 1989, J REPROD FERTIL, V85, P105, DOI 10.1530/jrf.0.0850105; Psychoyos A, 1973, Vitam Horm, V31, P201; REISMAN D, 1993, NUCLEIC ACIDS RES, V21, P345, DOI 10.1093/nar/21.2.345; Said TK, 1997, ENDOCRINOLOGY, V138, P3933, DOI 10.1210/en.138.9.3933; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Strutt H, 1999, METH MOL B, V119, P455; Vallejo G, 2005, MOL ENDOCRINOL, V19, P3023, DOI 10.1210/me.2005-0016; Vallejo G, 2010, J CELL PHYSIOL, V222, P127, DOI 10.1002/jcp.21929; Vicent GP, 2006, MOL CELL, V24, P367, DOI 10.1016/j.molcel.2006.10.011; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16; ZHANG ZM, 1994, ENDOCRINOLOGY, V135, P1256, DOI 10.1210/en.135.3.1256	38	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97311	10.1371/journal.pone.0097311	http://dx.doi.org/10.1371/journal.pone.0097311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859236	Green Published, gold, Green Submitted			2022-12-25	WOS:000336839400012
J	Rocha, KSO; Martins, JH; Martins, MA; Tinoca, IDF; Saraz, JAO; Lacerda, AF; Fernandes, LHM				Oliveira Rocha, Keller Sullivan; Martins, Jose Helvecio; Martins, Marcio Aredes; Ferrei Tinoca, Ilda De Fatima; Osorio Saraz, Jairo Alexander; Lacerda Filho, Adilio Flauzino; Martins Fernandes, Luiz Henrique			Modeling and Simulation of the Transient Response of Temperature and Relative Humidity Sensors with and without Protective Housing	PLOS ONE			English	Article							MASS-TRANSFER; CFD; ACCURACY; HEAT; FLOW	Based on the necessity for enclosure protection of temperature and relative humidity sensors installed in a hostile environment, a wind tunnel was used to quantify the time that the sensors take to reach equilibrium in the environmental conditions to which they are exposed. Two treatments were used: (1) sensors with polyvinyl chloride (PVC) enclosure protection, and (2) sensors with no enclosure protection. The primary objective of this study was to develop and validate a 3-D computational fluid dynamics (CFD) model for analyzing the temperature and relative humidity distribution in a wind tunnel using sensors with PVC enclosure protection and sensors with no enclosure protection. A CFD simulation model was developed to describe the temperature distribution and the physics of mass transfer related to the airflow relative humidity. The first results demonstrate the applicability of the simulation. For verification, a sensor device was successfully assembled and tested in an environment that was optimized to ensure fast change conditions. The quantification setup presented in this paper is thus considered to be adequate for testing different materials and morphologies for enclosure protection. The results show that the boundary layer flow regime has a significant impact on the heat flux distribution. The results indicate that the CFD technique is a powerful tool which provides a detailed description of the flow and temperature fields as well as the time that the relative humidity takes to reach equilibrium with the environment in which the sensors are inserted.	[Oliveira Rocha, Keller Sullivan; Martins, Jose Helvecio; Martins, Marcio Aredes; Ferrei Tinoca, Ilda De Fatima; Lacerda Filho, Adilio Flauzino; Martins Fernandes, Luiz Henrique] Univ Fed Vicosa, Dept Engn Agr, Vicosa, MG, Brazil; [Osorio Saraz, Jairo Alexander] Univ Nacl Colombia, Dept Ingn Alimentos, Medellin, Colombia	Universidade Federal de Vicosa; Universidad Nacional de Colombia	Rocha, KSO (corresponding author), Univ Fed Vicosa, Dept Engn Agr, Vicosa, MG, Brazil.	kellersullivan@yahoo.com.br	Saraz, Jairo Alexander Osorio/AAV-4900-2020; Martins, Marcio Arêdes/M-4671-2019; Martins, Marcio A/C-1105-2017	Martins, Marcio Arêdes/0000-0001-5705-9431; Martins, Marcio A/0000-0001-5705-9431; Martins, Jose Helvecio/0000-0002-4841-8970; FerreiraTinoco, Ilda de Fatima/0000-0002-4557-8071	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES; Simon Luke Elliot/PROEX; AUX [CAPES/PROEX 1534/2013]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Simon Luke Elliot/PROEX; AUX; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES, Simon Luke Elliot/PROEX, AUX CAPES/PROEX 1534/2013, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambaw A, 2012, COMPUTERS ELECT AGR; Awtrey D, 2002, DALLAS SEMICONDUCTOR; Awtrey D, 1997, DALLAS SEMICONDUCTOR; Bird R.B., 2006, TRANSPORT PHENOMENA, DOI 10.1002/aic.690070245; Bjerg B, 2002, COMPUT ELECTRON AGR, V34, P223, DOI 10.1016/S0168-1699(01)00189-2; Monte JE, 2008, ACTA SCI-AGRON, V30, P307, DOI 10.4025/actasciagron.v30i3.3499; Celik HK, 2011, VIRTUAL PHYS PROTOTY, V6, P47, DOI 10.1080/17452759.2010.525215; HUNTER AJ, 1987, J AGR ENG RES, V37, P93, DOI 10.1016/0021-8634(87)90085-0; Katz A, 2011, J COMPUT PHYS, V230, P7670, DOI 10.1016/j.jcp.2011.06.023; Lee IB, 2007, JARQ-JPN AGR RES Q, V41, P53, DOI 10.6090/jarq.41.53; Liu SX, 2005, COMPUT ELECTRON AGR, V49, P309, DOI 10.1016/j.compag.2005.05.003; Lopes Daniela de Carvalho, 2007, Acta Scientiarum Agronomy, V29, P157; Martins MA, 2010, REV FACULDADE MINAS; Norton T, 2010, COMPUT ELECTRON AGR, V73, P17, DOI 10.1016/j.compag.2010.04.002; Rocha KSO, 2013, DRYING TECHNOLOGY; Rocha KSO, 2008, 8 INT LIV ENV S ILES, P1001; Sitompul JP, 2003, DRY TECHNOL, V21, P217, DOI 10.1081/DRT-120017744; Steidle Neto AJ, 2005, ENGENHARIA AGRICOLA, V25, P29; Tu J, 2008, COMPUTATIONAL FLUID DYNAMICS: A PRACTICAL APPROACH, P1; Vaz J, 2011, ENERG BUILDINGS, V43, P2476, DOI 10.1016/j.enbuild.2011.06.003; Wass JA, 2009, SCI COMPUT, V26, P21; Xia B, 2002, COMPUT ELECTRON AGR, V34, P5, DOI 10.1016/S0168-1699(01)00177-6; Younsi R, 2010, DRY TECHNOL, V28, P1148, DOI 10.1080/07373937.2010.483049	23	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e95874	10.1371/journal.pone.0095874	http://dx.doi.org/10.1371/journal.pone.0095874			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24851994	gold, Green Submitted, Green Published			2022-12-25	WOS:000338323200007
J	Perucci, LO; Gomes, KB; Freitas, LG; Godoi, LC; Alpoim, PN; Pinheiro, MB; Miranda, AS; Teixeria, AL; Dusse, LM; Sousa, LP				Perucci, Luiza O.; Gomes, Karina B.; Freitas, Leticia G.; Godoi, Lara C.; Alpoim, Patricia N.; Pinheiro, Melina B.; Miranda, Aline S.; Teixeria, Antonio L.; Dusse, Luci M.; Sousa, Lirlandia P.			Soluble Endoglin, Transforming Growth Factor-Beta 1 and Soluble Tumor Necrosis Factor Alpha Receptors in Different Clinical Manifestations of Preeclampsia	PLOS ONE			English	Article							CIRCULATING ANTIANGIOGENIC FACTORS; NITRIC-OXIDE; NORMAL-PREGNANCY; PLASMA-LEVELS; SERUM; INFLAMMATION; CYTOKINES; ADHESION; WOMEN; FETAL	Background: Despite intensive research, the etiopathogenesis of preeclampsia (PE) remains uncertain. Inflammatory and angiogenic factors are thought to play considerable roles in this disease. The objective of this study was to investigate the association between soluble endoglin (sEng), transforming growth factor beta-1 (TGF-beta 1) and tumor necrosis factor alpha soluble receptors (sTNF-Rs) and the clinical manifestations of PE. Methods: Plasma levels of sEng, TGF-beta 1 and sTNF-Rs were determined by ELISA in 23 non-pregnant, 21 normotensive pregnant and 43 PE women. PE women were stratified into subgroups according to the severity [mild (n = 12) and severe (n = 31)] and onset-time of the disease [ early (n = 19) and late (n = 24)]. Results: Pregnancy was associated with higher levels of sEng, sTNF-R1 and sTNF-R2 than the non-pregnant state. Moreover, PE women had higher levels of sEng and sTNF-R1 than normotensive pregnant women. No difference was found in TGF-beta 1 levels, comparing the three study groups. Late PE had higher levels of sTNF-R1 and sTNF-R2 than early PE. No significant differences were found in sEng and TGF-beta 1 comparing early and late PE. sEng levels were higher in severe PE than in mild PE and no difference was found for TGF-beta 1, sTNF-R1 and sTNF-R2 levels. There was a positive correlation among sEng, TNF-R1 and sTNF-2 levels. Logistic regression analysis revealed that primiparity and sEng levels are independently associated with the development of PE. Furthermore, sEng levels are independently associated with the disease severity. Conclusions: These results suggest that pregnancy is a condition associated with higher levels of anti-angiogenic and pro-inflammatory factors than the non-pregnant state and that PE is associated with an imbalance of these factors in the maternal circulation.	[Perucci, Luiza O.; Gomes, Karina B.; Freitas, Leticia G.; Godoi, Lara C.; Alpoim, Patricia N.; Dusse, Luci M.; Sousa, Lirlandia P.] Univ Fed Minas Gerais, Fac Farm, Dept Anal Clin & Toxicol, Belo Horizonte, MG, Brazil; [Perucci, Luiza O.; Gomes, Karina B.; Dusse, Luci M.; Sousa, Lirlandia P.] Univ Fed Minas Gerais, Fac Farm, Programa Grad Anal Clin & Toxicol, Belo Horizonte, MG, Brazil; [Freitas, Leticia G.; Godoi, Lara C.; Alpoim, Patricia N.; Pinheiro, Melina B.; Dusse, Luci M.; Sousa, Lirlandia P.] Univ Fed Minas Gerais, Fac Farm, Programa Grad Ciencias Farmaceut, Belo Horizonte, MG, Brazil; [Pinheiro, Melina B.] Univ Fed Sao Joa Del Rei, Fac Med, Sao Joao Del Rei, MG, Brazil; [Miranda, Aline S.; Teixeria, Antonio L.] Univ Fed Minas Gerais, Fac Med, Lab Interdisciplinar Invest Med, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Sousa, LP (corresponding author), Univ Fed Minas Gerais, Fac Farm, Dept Anal Clin & Toxicol, Belo Horizonte, MG, Brazil.	lipsousa72@gmail.com	Miranda, Aline Silva de/AFM-2106-2022; Teixeira, Antonio L/N-3315-2014	Miranda, Aline Silva de/0000-0003-2811-7924; Teixeira, Antonio L/0000-0002-9621-5422; Sousa, Lirlandia/0000-0002-1042-9762; Dusse, Luci/0000-0002-7484-1684	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG, Brazil [APQ00588-11]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Brazil; Pro-Reitoria de Pesquisa da UFMG -PRPq UFMG - Programa de Auxilio a Pesquisa de Doutores Recem-Contratados, Brazil	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG, Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Pro-Reitoria de Pesquisa da UFMG -PRPq UFMG - Programa de Auxilio a Pesquisa de Doutores Recem-Contratados, Brazil	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG, Brazil (APQ00588-11, http://www.fapemig.br/), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Brazil (http://www.cnpq.br/), and Pro-Reitoria de Pesquisa da UFMG -PRPq UFMG - Programa de Auxilio a Pesquisa de Doutores Recem-Contratados, Brazil (https://www.ufmg.br/prpq/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson HDI, 2004, J BIOL CHEM, V279, P963, DOI 10.1074/jbc.M309552200; ARNTZEN KJ, 1995, AM J REPROD IMMUNOL, V34, P163, DOI 10.1111/j.1600-0897.1995.tb00933.x; AUSTGULEN R, 1993, PEDIATR RES, V33, P82, DOI 10.1203/00006450-199301000-00017; Ayatollahi M, 2005, TRANSPL P, V37, P4603, DOI 10.1016/j.transproceed.2005.11.023; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Blanco JCG, 2004, J INTERF CYTOK RES, V24, P21, DOI 10.1089/107999004772719873; Burtis CA, 2006, TIETZ TXB CLIN CHEM; Chaiworapongsa T, 2010, ULTRASOUND OBST GYN, V35, P155, DOI 10.1002/uog.7491; De Vivo A, 2008, ACTA OBSTET GYN SCAN, V87, P837, DOI 10.1080/00016340802253759; DEKKER GA, 1995, AM J OBSTET GYNECOL, V173, P1042, DOI 10.1016/0002-9378(95)91324-6; Eiland E, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/586578; Feizollahzadeh S, 2012, J REPROD IMMUNOL, V94, P216, DOI 10.1016/j.jri.2012.02.006; Gil-Villa AM, 2012, PROSTAG LEUKOTR ESS, V87, P127, DOI 10.1016/j.plefa.2012.08.003; Halim A, 1996, GYNECOL OBSTET INVES, V41, P106, DOI 10.1159/000292053; Hertig A, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.006; Hupuczi P, 2007, HYPERTENS PREGNANCY, V26, P389, DOI 10.1080/10641950701521221; Jerkic M, 2004, FASEB J, V18, P609, DOI 10.1096/fj.03-0197fje; Kim YN, 2009, PRENATAL DIAG, V29, P464, DOI 10.1002/pd.2203; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; LASTRES P, 1992, EUR J IMMUNOL, V22, P393, DOI 10.1002/eji.1830220216; Lau SY, 2013, AM J REPROD IMMUNOL, V70, P412, DOI 10.1111/aji.12138; Leal AM, 2009, ULTRASOUND OBST GYN, V33, P135, DOI 10.1002/uog.6275; Lev PR, 2007, PLATELETS, V18, P35, DOI 10.1080/09537100600800743; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Li CG, 2003, J CELL SCI, V116, P2677, DOI 10.1242/jcs.00470; Luft FC, 2006, NEPHROL DIAL TRANSPL, V21, P3052, DOI 10.1093/ndt/gfl439; Madazli R, 2003, ACTA OBSTET GYN SCAN, V82, P797, DOI 10.1034/j.1600-0412.2003.00206.x; Marques FK, 2012, CLIN CHIM ACTA, V414, P253, DOI 10.1016/j.cca.2012.09.023; Masuyama H, 2010, BJOG-INT J OBSTET GY, V117, P314, DOI 10.1111/j.1471-0528.2009.02453.x; Masuyama H, 2007, J CLIN ENDOCR METAB, V92, P2672, DOI 10.1210/jc.2006-2349; OPSJON SL, 1995, J REPROD IMMUNOL, V29, P119, DOI 10.1016/0165-0378(95)00940-M; Parrish MR, 2010, AM J HYPERTENS, V23, P911, DOI 10.1038/ajh.2010.70; Pinheiro MB, 2013, CYTOKINE, V62, P165, DOI 10.1016/j.cyto.2013.02.027; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Reuvekamp A, 1999, BRIT J OBSTET GYNAEC, V106, P1019, DOI 10.1111/j.1471-0528.1999.tb08107.x; Robinson CJ, 2007, AM J OBSTET GYNECOL, V197; Rossi E, 2013, BLOOD, V121, P403, DOI 10.1182/blood-2012-06-435347; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Scharpfenecker M, 2012, RADIOTHER ONCOL, V105, P313, DOI 10.1016/j.radonc.2012.08.021; Schroeder BM, 2002, AM FAM PHYSICIAN, V66, P330; Peracoli MTS, 2008, J REPROD IMMUNOL, V79, P79, DOI 10.1016/j.jri.2008.08.001; Sibai B, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.033; Sibai BM, 2008, HYPERTENSION, V52, P805, DOI 10.1161/HYPERTENSIONAHA.108.119115; SLUNGAARD A, 1990, J EXP MED, V171, P2025, DOI 10.1084/jem.171.6.2025; Staff AC, 2009, EUR J OBSTET GYN R B, V143, P29, DOI 10.1016/j.ejogrb.2008.11.003; Szarka A, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-59; Tjwa M, 2003, CELL TISSUE RES, V314, P5, DOI 10.1007/s00441-003-0776-3; Torsney E, 2002, INFLAMM RES, V51, P464, DOI 10.1007/PL00012413; TRACEY KJ, 1993, CRIT CARE MED, V21, pS415; Troisi R, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.030; VANZEE KJ, 1992, P NATL ACAD SCI USA, V89, P4845, DOI 10.1073/pnas.89.11.4845; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; VINCE GS, 1995, BRIT J OBSTET GYNAEC, V102, P20, DOI 10.1111/j.1471-0528.1995.tb09020.x; Zhang Li-jun, 2010, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V22, P371	54	43	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97632	10.1371/journal.pone.0097632	http://dx.doi.org/10.1371/journal.pone.0097632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24851923	Green Submitted, Green Published, gold			2022-12-25	WOS:000338323200026
J	Stevanovic, DM; Grefhorst, A; Themmen, APN; Popovic, V; Holstege, J; Haasdijk, E; Trajkovic, V; van der Lely, AJ; Delhanty, PJD				Stevanovic, Darko M.; Grefhorst, Aldo; Themmen, Axel P. N.; Popovic, Vera; Holstege, Joan; Haasdijk, Elize; Trajkovic, Vladimir; van der Lely, Aart-Jan; Delhanty, Patric J. D.			Unacylated Ghrelin Suppresses Ghrelin-Induced Neuronal Activity in the Hypothalamus and Brainstem of Male Rats	PLOS ONE			English	Article							DES-ACYL GHRELIN; FOOD-INTAKE; CONSCIOUS RATS; ENERGY-BALANCE; SOLITARY TRACT; PROMOTE SURVIVAL; DESACYL GHRELIN; ARCUATE NUCLEUS; FOS EXPRESSION; RECEPTOR	Ghrelin, the endogenous growth hormone secretagogue, has an important role in metabolic homeostasis. It exists in two major molecular forms: acylated (AG) and unacylated (UAG). Many studies suggest different roles for these two forms of ghrelin in energy balance regulation. In the present study, we compared the effects of acute intracerebroventricular administration of AG, UAG and their combination (AG+UAG) to young adult Wistar rats on food intake and central melanocortin system modulation. Although UAG did not affect food intake it significantly increased the number of c-Fos positive neurons in the arcuate (ARC), paraventricular (PVN) and solitary tract (NTS) nuclei. In contrast, UAG suppressed AG-induced neuronal activity in PVN and NTS. Central UAG also modulated hypothalamic expression of Mc4r and Bmp8b, which were increased and Mc3r, Pomc, Agrp and Ucp2, which were decreased. Finally, UAG, AG and combination treatments caused activation of c-Fos in POMC expressing neurons in the arcuate, substantiating a physiologic effect of these peptides on the central melanocortin system. Together, these results demonstrate that UAG can act directly to increase neuronal activity in the hypothalamus and is able to counteract AG-induced neuronal activity in the PVN and NTS. UAG also modulates expression of members of the melanocortin signaling system in the hypothalamus. In the absence of an effect on energy intake, these findings indicate that UAG could affect energy homeostasis by modulation of the central melanocortin system.	[Stevanovic, Darko M.; Grefhorst, Aldo; Themmen, Axel P. N.; van der Lely, Aart-Jan; Delhanty, Patric J. D.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Stevanovic, Darko M.] Univ Belgrade, Sch Med, Inst Med Physiol, Belgrade, Serbia; [Popovic, Vera] Univ Belgrade, Sch Med, Inst Endocrinol Diabet & Dis Metab, Belgrade, Serbia; [Holstege, Joan; Haasdijk, Elize] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Trajkovic, Vladimir] Univ Belgrade, Sch Med, Inst Microbiol & Immunol, Belgrade, Serbia	Erasmus University Rotterdam; Erasmus MC; University of Belgrade; University of Belgrade; Erasmus University Rotterdam; Erasmus MC; University of Belgrade	Stevanovic, DM (corresponding author), Erasmus MC, Dept Internal Med, Rotterdam, Netherlands.	dstevano@bidmc.harvard.edu; p.delhanty@erasmusmc.nl		Trajkovic, Vladimir/0000-0002-8061-2968	European Society of Endocrinology; Serbian Ministry of Science and Technological Development [III 41025]	European Society of Endocrinology; Serbian Ministry of Science and Technological Development(Ministry of Education, Science & Technological Development, Serbia)	This work was assisted by the ENDO/ESE International Endocrine Scholars Program Fellowship 2011 (DS) supported by the European Society of Endocrinology, and Serbian Ministry of Science and Technological Development proj. no. III 41025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Asakawa A, 2005, GUT, V54, P18, DOI 10.1136/gut.2004.038737; Chen AS, 2000, NAT GENET, V26, P97, DOI 10.1038/79254; Chen CY, 2005, GASTROENTEROLOGY, V129, P8, DOI 10.1053/j.gastro.2005.04.015; Chen CY, 2005, INT J MOL MED, V16, P695; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; De Jonghe BC, 2011, CELL MOL LIFE SCI, V68, P2569, DOI 10.1007/s00018-011-0707-5; Delhanty PJD, 2013, FASEB J, V27, P1690, DOI 10.1096/fj.12-221143; Delhanty PJD, 2012, EUR J ENDOCRINOL, V167, P601, DOI 10.1530/EJE-12-0456; Delhanty PJD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011749; Diano S, 2012, TRENDS MOL MED, V18, P52, DOI 10.1016/j.molmed.2011.08.003; Ellacott KLJ, 2006, ENDOCRINOLOGY, V147, P3190, DOI 10.1210/en.2005-0877; Faulconbridge LF, 2008, BRAIN RES, V1218, P151, DOI 10.1016/j.brainres.2008.04.068; Favaro E, 2012, DIABETOLOGIA, V55, P1058, DOI 10.1007/s00125-011-2423-y; Fong TM, 1997, BIOCHEM BIOPH RES CO, V237, P629, DOI 10.1006/bbrc.1997.7200; Fujimiya M, 2008, WORLD J GASTROENTERO, V14, P6318, DOI 10.3748/wjg.14.6318; Granata R, 2012, J MED CHEM, V55, P2585, DOI 10.1021/jm201223m; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Hayes MR, 2010, CELL METAB, V11, P77, DOI 10.1016/j.cmet.2009.10.009; Heijboer AC, 2006, J NEUROENDOCRINOL, V18, P883, DOI 10.1111/j.1365-2826.2006.01492.x; Huo LH, 2006, DIABETES, V55, P567, DOI 10.2337/diabetes.55.03.06.db05-1143; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Inhoff T, 2008, PEPTIDES, V29, P2159, DOI 10.1016/j.peptides.2008.09.014; Inhoff T, 2009, PEPTIDES, V30, P991, DOI 10.1016/j.peptides.2009.01.019; Kirchner Henriette, 2012, Handb Exp Pharmacol, P161, DOI 10.1007/978-3-642-24716-3_7; Kobelt P, 2008, BRAIN RES, V1204, P77, DOI 10.1016/j.brainres.2008.01.054; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lawrence CB, 2002, ENDOCRINOLOGY, V143, P155, DOI 10.1210/en.143.1.155; Li G, 2007, AM J PHYSIOL-ENDOC M, V293, pE252, DOI 10.1152/ajpendo.00451.2006; Matsuda K, 2006, PEPTIDES, V27, P2321, DOI 10.1016/j.peptides.2006.03.028; Muccioli G, 2007, NEUROENDOCRINOLOGY, V86, P147, DOI 10.1159/000105141; Neary NM, 2006, GUT, V55, P135; Paxinos G., 2004, RAT BRAIN STEREOTAXI; Pritchard LE, 2007, ENDOCRINOLOGY, V148, P4201, DOI 10.1210/en.2006-1686; ROSELLIREHFUSS L, 1993, P NATL ACAD SCI USA, V90, P8856, DOI 10.1073/pnas.90.19.8856; Silva RM, 2001, J PHARMACOL EXP THER, V297, P590; Skibicka KP, 2009, ENDOCRINOLOGY, V150, P5351, DOI 10.1210/en.2009-0804; Skibicka KP, 2009, ENDOCRINOLOGY, V150, P1705, DOI 10.1210/en.2008-1316; STARCEVIC VP, 1988, BRAIN RES, V462, P112, DOI 10.1016/0006-8993(88)90592-6; Takayama K, 2007, NEUROSCI LETT, V417, P292, DOI 10.1016/j.neulet.2007.02.089; Togliatto G, 2010, DIABETES, V59, P1016, DOI 10.2337/db09-0858; Toshinai K, 2006, ENDOCRINOLOGY, V147, P2306, DOI 10.1210/en.2005-1357; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Wu Q, 2011, EUR J PHARMACOL, V660, P21, DOI 10.1016/j.ejphar.2010.10.110; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Zhang Y, 2010, NEUROSCIENCE, V169, P1662, DOI 10.1016/j.neuroscience.2010.06.001	50	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98180	10.1371/journal.pone.0098180	http://dx.doi.org/10.1371/journal.pone.0098180			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852945	Green Submitted, Green Published, gold			2022-12-25	WOS:000338323200053
J	Dautova, Y; Kozlova, D; Skepper, JN; Epple, M; Bootman, MD; Proudfoot, D				Dautova, Yana; Kozlova, Diana; Skepper, Jeremy N.; Epple, Matthias; Bootman, Martin D.; Proudfoot, Diane			Fetuin-A and Albumin Alter Cytotoxic Effects of Calcium Phosphate Nanoparticles on Human Vascular Smooth Muscle Cells	PLOS ONE			English	Article							CONTAINING CALCIPROTEIN PARTICLES; CRYSTAL-INDUCED INFLAMMATION; HYDROXYAPATITE NANOPARTICLES; POTENTIAL MECHANISM; CALCIFIED MATRIX; PLASMA-PROTEIN; CALCIFICATION; SERUM; PLAQUE; ATHEROSCLEROSIS	Calcification is a detrimental process in vascular ageing and in diseases such as atherosclerosis and arthritis. In particular, small calcium phosphate (CaP) crystal deposits are associated with inflammation and atherosclerotic plaque de-stabilisation. We previously reported that CaP particles caused human vascular smooth muscle cell (VSMC) death and that serum reduced the toxic effects of the particles. Here, we found that the serum proteins fetuin-A and albumin (>= 1 mu M) reduced intracellular Ca2+ elevations and cell death in VSMCs in response to CaP particles. In addition, CaP particles functionalised with fetuin-A, but not albumin, were less toxic than naked CaP particles. Electron microscopic studies revealed that CaP particles were internalised in different ways; via macropinocytosis, membrane invagination or plasma membrane damage, which occurred within 10 minutes of exposure to particles. However, cell death did not occur until approximately 30 minutes, suggesting that plasma membrane repair and survival mechanisms were activated. In the presence of fetuin-A, CaP particle-induced damage was inhibited and CaP/plasma membrane interactions and particle uptake were delayed. Fetuin-A also reduced dissolution of CaP particles under acidic conditions, which may contribute to its cytoprotective effects after CaP particle exposure to VSMCs. These studies are particularly relevant to the calcification observed in blood vessels in patients with kidney disease, where circulating levels of fetuin-A and albumin are low, and in pathological situations where CaP crystal formation outweighs calcification-inhibitory mechanisms.	[Dautova, Yana; Proudfoot, Diane] Babraham Inst, Signalling ISP, Cambridge, England; [Kozlova, Diana; Epple, Matthias] Univ Duisburg Essen, Essen, Germany; [Kozlova, Diana; Epple, Matthias] Univ Duisburg Essen, Ctr Nanointegrat Duisburg Essen CeNIDE, Essen, Germany; [Skepper, Jeremy N.] Univ Cambridge, Cambridge Adv Imaging Ctr, Cambridge, England; [Bootman, Martin D.] Open Univ, Dept Life Hlth & Chem Sci, Milton Keynes MK7 6AA, Bucks, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Duisburg Essen; University of Duisburg Essen; University of Cambridge; Open University - UK	Proudfoot, D (corresponding author), Babraham Inst, Signalling ISP, Cambridge, England.	diane.proudfoot@babraham.ac.uk	Bootman, Martin/AAB-3330-2019; Epple, Matthias/AAX-9694-2020	Bootman, Martin/0000-0002-6447-3451; Epple, Matthias/0000-0002-1641-7068	British Heart Foundation [FS/11/21/28691]; BBSRC [BBS/E/B/0000H330] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a British Heart Foundation Career Re-entry Fellowship (FS/11/21/28691, to Diane Proudfoot). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa E, 2007, CIRCULATION, V116, P2841, DOI 10.1161/CIRCULATIONAHA.107.732867; Barros LF, 2003, CELL DEATH DIFFER, V10, P687, DOI 10.1038/sj.cdd.4401236; Bootman Martin D, 2013, Cold Spring Harb Protoc, V2013, P126, DOI 10.1101/pdb.prot072827; BURT HM, 1991, SCANNING MICROSCOPY, V5, P273; DENGLER WA, 1995, ANTI-CANCER DRUG, V6, P522, DOI 10.1097/00001813-199508000-00005; Dietzel E, 2013, DEV CELL, V25, P106, DOI 10.1016/j.devcel.2013.03.001; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Dweck MR, 2012, J AM COLL CARDIOL, V59, P1539, DOI 10.1016/j.jacc.2011.12.037; Ea HK, 2008, ANN RHEUM DIS, V67, P1617, DOI 10.1136/ard.2008.087718; Ehara S, 2004, CIRCULATION, V110, P3424, DOI 10.1161/01.CIR.0000148131.41425.E9; Ewence AE, 2008, CIRC RES, V103, pE28, DOI 10.1161/CIRCRESAHA.108.181305; Heiss A, 2007, BIOINTERPHASES, V2, P16, DOI 10.1116/1.2714924; Herrmann M, 2012, CIRC RES, V111, P575, DOI 10.1161/CIRCRESAHA.111.261479; Jahnen-Dechent W, 2011, CIRC RES, V108, P1494, DOI 10.1161/CIRCRESAHA.110.234260; KEELEY FW, 1985, ATHEROSCLEROSIS, V55, P63, DOI 10.1016/0021-9150(85)90166-2; KEELEY FW, 1983, ATHEROSCLEROSIS, V46, P29, DOI 10.1016/0021-9150(83)90161-2; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; MCCARTHY GM, 1991, ARTHRITIS RHEUM-US, V34, P1021, DOI 10.1002/art.1780340812; Moe SM, 2005, KIDNEY INT, V67, P2295, DOI 10.1111/j.1523-1755.2005.00333.x; Molloy ES, 2006, RHEUM DIS CLIN N AM, V32, P383, DOI 10.1016/j.rdc.2006.02.001; Motskin M, 2011, BIOMATERIALS, V32, P9470, DOI 10.1016/j.biomaterials.2011.08.060; Muller KH, 2014, BIOMATERIALS, V35, P1074, DOI 10.1016/j.biomaterials.2013.10.041; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Neumann S, 2009, BIOMATERIALS, V30, P6794, DOI 10.1016/j.biomaterials.2009.08.043; Potez S, 2011, J BIOL CHEM, V286, P17982, DOI 10.1074/jbc.M110.187625; Proudfoot D, 2002, CIRCULATION, V106, P3044, DOI 10.1161/01.CIR.0000041429.83465.41; Proudfoot D, 2000, CIRC RES, V87, P1055, DOI 10.1161/01.RES.87.11.1055; Proudfoot D, 2001, HERZ, V26, P245, DOI 10.1007/PL00002027; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Reynolds JL, 2005, J AM SOC NEPHROL, V16, P2920, DOI 10.1681/ASN.2004100895; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Smith ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060904; Smith ER, 2013, NEPHROLOGY, V18, P215, DOI 10.1111/nep.12021; Sokolova V, 2013, ACTA BIOMATER, V9, P7527, DOI 10.1016/j.actbio.2013.02.034; TERKELTAUB R, 1983, ARTHRITIS RHEUM, V26, P775, DOI 10.1002/art.1780260612; TERKELTAUB RA, 1988, ARTHRITIS RHEUM, V31, P1081, DOI 10.1002/art.1780310901; Vengrenyuk Y, 2006, P NATL ACAD SCI USA, V103, P14678, DOI 10.1073/pnas.0606310103; Virmani Renu, 2003, J Interv Cardiol, V16, P267, DOI 10.1034/j.1600-0854.2003.8042.x; Visser M, 2005, AM J CLIN NUTR, V82, P531; Wang AYM, 2005, NEPHROL DIAL TRANSPL, V20, P1676, DOI 10.1093/ndt/gfh891; Wang FJ, 2013, NANOMED-NANOTECHNOL, V9, P1159, DOI 10.1016/j.nano.2013.04.010; WOOLF AD, 1987, BRIT MED BULL, V43, P429, DOI 10.1093/oxfordjournals.bmb.a072192	43	47	50	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97565	10.1371/journal.pone.0097565	http://dx.doi.org/10.1371/journal.pone.0097565			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849210	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000336730600036
J	Li, RK; Tan, JL; Chen, LT; Feng, JS; Liang, WX; Guo, XJ; Liu, P; Chen, Z; Sha, JH; Wang, YF; Chen, SJ				Li, Ren-Ke; Tan, Jue-Ling; Chen, Li-Ting; Feng, Jing-Sheng; Liang, Wen-Xue; Guo, Xue-Jiang; Liu, Ping; Chen, Zhu; Sha, Jia-Hao; Wang, Yi-Fei; Chen, Sai-Juan			Iqcg Is Essential for Sperm Flagellum Formation in Mice	PLOS ONE			English	Article							SEMINIFEROUS EPITHELIUM; ACROSOME FORMATION; MALE-INFERTILITY; MOUSE MODELS; CALMODULIN; SPERMATOGENESIS; GENE; MANCHETTE; DEFICIENT; DEFECTS	Mammalian spermatogenesis comprises three successive phases: mitosis phase, meiosis phase, and spermiogenesis. During spermiogenesis, round spermatid undergoes dramatic morphogenesis to give rise to mature spermatozoon, including the condensation and elongation of nucleus, development of acrosome, formation of flagellum, and removal of excessive cytoplasm. Although these transformations are well defined at the morphological level, the mechanisms underlying these intricate processes are largely unknown. Here, we report that Iqcg, which was previously characterized to be involved in a chromosome translocation of human leukemia, is highly expressed in the spermatogenesis of mice and localized to the manchette in developing spermatids. Iqcg knockout causes male infertility, due to severe defects of spermiogenesis and resultant total immobility of spermatozoa. The axoneme in the Iqcg knockout sperm flagellum is disorganized and hardly any typical ("9+2") pattern of microtubule arrangement could be found in Iqcg knockout spermatids. Iqcg interacts with calmodulin in a calcium dependent manner in the testis, suggesting that Iqcg may play a role through calcium signaling. Furthermore, cilia structures in the trachea and oviduct, as well as histological appearances of other major tissues, remain unchanged in the Iqcg knockout mice, suggesting that Iqcg is specifically required for spermiogenesis in mammals. These results might also provide new insights into the genetic causes of human infertility.	[Li, Ren-Ke; Tan, Jue-Ling; Chen, Li-Ting; Liu, Ping; Chen, Zhu; Chen, Sai-Juan] Chinese Acad Sci, Inst Hlth Sci, State Key Lab Med Genom, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Li, Ren-Ke; Tan, Jue-Ling; Chen, Li-Ting; Liu, Ping; Chen, Zhu; Chen, Sai-Juan] Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China; [Li, Ren-Ke; Tan, Jue-Ling; Chen, Li-Ting; Liu, Ping; Chen, Zhu; Chen, Sai-Juan] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Shanghai Inst Hematol, Shanghai 200030, Peoples R China; [Feng, Jing-Sheng; Wang, Yi-Fei] Shanghai Jiao Tong Univ, Sch Med, Dept Histol & Embryol, Shanghai 200030, Peoples R China; [Guo, Xue-Jiang; Sha, Jia-Hao] Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, Nanjing, Jiangsu Provinc, Peoples R China; [Liang, Wen-Xue] Lianyungang First Peoples Hosp, Cent Lab, Lianyungang, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Nanjing Medical University	Sha, JH (corresponding author), Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, Nanjing, Jiangsu Provinc, Peoples R China.	shajh@njmu.edu.cn; wangyf@shsmu.edu.cn; sjchen@stn.sh.cn	Guo, Xuejiang/J-9600-2014	Guo, Xuejiang/0000-0002-0475-5705	Chinese National Key Basic Research Project [973: 2013CB966800]; MOH [201202003]; Mega-projects of Scientific Research for the 12th Five-Year Plan [2013ZX09303302]; State Key Laboratories Project of Excellence [81123005]	Chinese National Key Basic Research Project(National Basic Research Program of China); MOH; Mega-projects of Scientific Research for the 12th Five-Year Plan; State Key Laboratories Project of Excellence	This work was supported by the Chinese National Key Basic Research Project (973: 2013CB966800, http://www.973.gov.cn/English/Index.aspx), the Special Grant of MOH (201202003), the Mega-projects of Scientific Research for the 12th Five-Year Plan (2013ZX09303302), the State Key Laboratories Project of Excellence (81123005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSTEIN RS, 1982, CELL, V30, P349, DOI 10.1016/0092-8674(82)90232-X; Ahmed EA, 2009, METHODS MOL BIOL, V558, P263, DOI 10.1007/978-1-60761-103-5_16; Baccetti B, 2001, HUM REPROD, V16, P1365, DOI 10.1093/humrep/16.7.1365; BACCETTI B, 1993, ANDROLOGIA, V25, P331; Berrios J, 1998, BIOL CELL, V90, P391, DOI 10.1016/S0248-4900(98)80088-9; Borg CL, 2010, HUM REPROD UPDATE, V16, P205, DOI 10.1093/humupd/dmp032; Cao WL, 2006, MOL CELL PROTEOMICS, V5, P801, DOI 10.1074/mcp.M500322-MCP200; Cho C, 2001, NAT GENET, V28, P82, DOI 10.1038/ng0501-82; Cho C, 2003, BIOL REPROD, V69, P211, DOI 10.1095/biolreprod.102.015115; CLERMONT Y, 1972, PHYSIOL REV, V52, P198, DOI 10.1152/physrev.1972.52.1.198; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; Darszon A, 2011, PHYSIOL REV, V91, P1305, DOI 10.1152/physrev.00028.2010; Escalier D, 2003, MOL REPROD DEV, V66, P190, DOI 10.1002/mrd.10346; Escalier D, 2006, HUM REPROD UPDATE, V12, P449, DOI 10.1093/humupd/dml013; Fath MA, 2005, HUM MOL GENET, V14, P1109, DOI 10.1093/hmg/ddi123; Garcia-Gonzalo FR, 2012, J CELL BIOL, V197, P697, DOI 10.1083/jcb.201111146; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Hammer John A 3rd, 2011, Nat Rev Mol Cell Biol, V13, P13, DOI 10.1038/nrm3248; Harris TP, 2013, IQ MOTIF CONTAINING; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; JONES HP, 1980, P NATL ACAD SCI-BIOL, V77, P2772, DOI 10.1073/pnas.77.5.2772; Kang-Decker N, 2001, SCIENCE, V294, P1531, DOI 10.1126/science.1063665; KANN ML, 1991, ANAT REC, V230, P481, DOI 10.1002/ar.1092300407; KEITH CH, 1986, ANN NY ACAD SCI, V466, P375, DOI 10.1111/j.1749-6632.1986.tb38407.x; Kierszenbaum Abraham L, 2011, Spermatogenesis, V1, P221; Kierszenbaum AL, 2011, DEV DYNAM, V240, P723, DOI 10.1002/dvdy.22563; Kierszenbaum AL, 2003, CYTOGENET GENOME RES, V103, P337, DOI 10.1159/000076822; Kierszenbaum AL, 2002, MOL REPROD DEV, V63, P1, DOI 10.1002/mrd.10179; Kierszenbaum AL, 2001, MOL REPROD DEV, V59, P347, DOI 10.1002/mrd.1040; Kotaja N, 2004, NAT METHODS, V1, P249, DOI 10.1038/nmeth1204-249; Lehti MS, 2013, MOL CELL ENDOCRINOL, V377, P44, DOI 10.1016/j.mce.2013.06.030; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Lorenzetti D, 2004, P NATL ACAD SCI USA, V101, P8402, DOI 10.1073/pnas.0401832101; MEANS AR, 1982, ANN NY ACAD SCI, V383, P69, DOI 10.1111/j.1749-6632.1982.tb23162.x; Mendoza-Lujambio I, 2002, HUM MOL GENET, V11, P1647, DOI 10.1093/hmg/11.14.1647; Miki K, 2002, DEV BIOL, V248, P331, DOI 10.1006/dbio.2002.0728; Nishimura DY, 2004, P NATL ACAD SCI USA, V101, P16588, DOI 10.1073/pnas.0405496101; Oh EC, 2012, DEVELOPMENT, V139, P443, DOI 10.1242/dev.050054; Pan Q, 2008, ONCOGENE, V27, P3414, DOI 10.1038/sj.onc.1210999; SANO M, 1987, J EXP ZOOL, V241, P51, DOI 10.1002/jez.1402410107; SLAUGHTER GR, 1987, BIOL REPROD, V37, P1259, DOI 10.1095/biolreprod37.5.1259; SLAUGHTER GR, 1989, BIOL REPROD, V40, P395, DOI 10.1095/biolreprod40.2.395; Sperry AO, 2012, BIOL CELL, V104, P297, DOI 10.1111/boc.201100102; Tanaka H, 2004, MOL CELL BIOL, V24, P7958, DOI 10.1128/MCB.24.18.7958-7964.2004; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; WEINMAN S, 1986, J HISTOCHEM CYTOCHEM, V34, P1181, DOI 10.1177/34.9.3734420; WOLOSEWICK JJ, 1977, AM J ANAT, V150, P301, DOI 10.1002/aja.1001500206; Yan W, 2009, MOL CELL ENDOCRINOL, V306, P24, DOI 10.1016/j.mce.2009.03.003; Yao RJ, 2002, P NATL ACAD SCI USA, V99, P11211, DOI 10.1073/pnas.162027899; Yu YE, 2000, P NATL ACAD SCI USA, V97, P4683, DOI 10.1073/pnas.97.9.4683; Zhang ZB, 2009, P NATL ACAD SCI USA, V106, P17055, DOI 10.1073/pnas.0906414106; Zhao M, 2004, GENESIS, V38, P200, DOI 10.1002/gene.20019; Zhou J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002516; Zhou J, 2009, DEVELOPMENT, V136, P373, DOI 10.1242/dev.030858	55	26	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98053	10.1371/journal.pone.0098053	http://dx.doi.org/10.1371/journal.pone.0098053			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849454	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600080
J	Li, W; Li, YJ; Li, WZ; Yang, JP; Song, MX; Diao, RN; Jia, HL; Lu, YX; Zheng, J; Zhang, XC; Xiao, LH				Li, Wei; Li, Yijing; Li, Weizhi; Yang, Jinping; Song, Mingxin; Diao, Ruinan; Jia, Honglin; Lu, Yixin; Zheng, Jun; Zhang, Xichen; Xiao, Lihua			Genotypes of Enterocytozoon bieneusi in Livestock in China: High Prevalence and Zoonotic Potential	PLOS ONE			English	Article							VIRUS-INFECTED PATIENTS; MICROSPORIDIOSIS; IDENTIFICATION; EPIDEMIOLOGY; ANIMALS; SAMPLES; LIMA	Despite many recent advances in genotype characterization of Enterocytozoon bieneusi worldwide and the exploration of the extent of cross-species transmission of microsporidiosis between humans and animals, the epidemiology of this neglected disease in China is poorly understood. In this study, a very high prevalence (60.3%; 94/156) of E. bieneusi infections in farmed pigs in Jilin province was detected by PCR of the ribosomal internal transcribed spacer (ITS). DNA sequence analysis of 88 E. bieneusi-positive specimens identified 12 distinct genotypes (11 known: CHN7, CS-1, CS-4, CS-6, EbpA, EbpB, EbpC, EbpD, EBITS3, G, and Henan-I; one novel: CS-9). Frequent appearance of mixed genotype infections was seen in the study animals. Weaned (74.6%; 53/71) or pre-weaned (68.8%; 22/32) pigs have infection rates significantly higher than growing pigs (35.8%; 19/53) (p<0.01). Likewise, E. bieneusi was detected in 2 of 45 sheep fecal specimens (4.4%) in Heilongjiang province, belonging to the known genotype BEB6. Genotypes EbpA, EbpC, EbpD, and Henan-I examined herein have been documented in the cases of human infections and BEB6, EbpA, EbpC, and EbpD in wastewater in central China. Infections of EbpA and EbpC in humans were also reported in other areas of the world. The other known genotypes (CHN7, CS-1, CS-4, CS-6, EBITS3, EbpB, and G) and the new genotype CS-9 were genetically clustered into a group of existing E. bieneusi genotypes with zoonotic potential. Thus, pigs could be a potential source of human E. bieneusi infections in China.	[Li, Wei; Jia, Honglin; Zheng, Jun] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Heilongjiang, Peoples R China; [Li, Wei; Li, Yijing; Yang, Jinping; Song, Mingxin; Diao, Ruinan; Lu, Yixin] Northeast Agr Univ, Coll Vet Med, Harbin, Heilongjiang, Peoples R China; [Li, Weizhi; Zhang, Xichen] Jilin Univ, Coll Vet Med, Minist Educ, Key Lab Zoonosis Res, Changchun 130023, Jilin, Peoples R China; [Xiao, Lihua] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Northeast Agricultural University - China; Jilin University; Centers for Disease Control & Prevention - USA	Zhang, XC (corresponding author), Jilin Univ, Coll Vet Med, Minist Educ, Key Lab Zoonosis Res, Changchun 130023, Jilin, Peoples R China.	xczhang@jlu.edu.cn; lax0@cdc.gov	Xiao, Lihua/B-1704-2013; Li, Wei/H-7214-2013	Xiao, Lihua/0000-0001-8532-2727; Li, Wei/0000-0002-4264-1864	State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute [SKLVBF201307]; National Natural Science Foundation of China [31302081]; Natural Science Foundation of Heilongjiang Province [QC2013C015]; 54th Postdoctoral Scientific Foundation of China [2013M540266]; Heilongjiang Postdoctoral Research Fund [LBH-Z13024]	State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); 54th Postdoctoral Scientific Foundation of China; Heilongjiang Postdoctoral Research Fund	This study was supported by the State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute (SKLVBF201307), the National Natural Science Foundation of China (No. 31302081), the Natural Science Foundation of Heilongjiang Province (No. QC2013C015), the 54th Postdoctoral Scientific Foundation of China (No. 2013M540266), and the Heilongjiang Postdoctoral Research Fund (No. LBH-Z13024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinbo FO, 2012, AM J TROP MED HYG, V86, P441, DOI 10.4269/ajtmh.2012.11-0548; Anane S, 2010, GASTROEN CLIN BIOL, V34, P450, DOI 10.1016/j.gcb.2010.07.003; Bern C, 2005, J INFECT DIS, V191, P1658, DOI 10.1086/429674; Breitenmoser AC, 1999, PARASITOLOGY, V118, P447, DOI 10.1017/S0031182099004229; Cama VA, 2007, J CLIN MICROBIOL, V45, P2708, DOI 10.1128/JCM.00725-07; Didier ES, 2006, CURR OPIN INFECT DIS, V19, P485, DOI 10.1097/01.qco.0000244055.46382.23; Didier ES, 2005, ACTA TROP, V94, P61, DOI 10.1016/j.actatropica.2005.01.010; Espern A, 2007, J CLIN MICROBIOL, V45, P2999, DOI 10.1128/JCM.00684-07; Fayer R, 2007, PARASITOL RES, V102, P15, DOI 10.1007/s00436-007-0746-x; Kasickova D, 2009, VET PARASITOL, V165, P125, DOI 10.1016/j.vetpar.2009.06.033; Leelayoova S, 2006, J CLIN MICROBIOL, V44, P3001, DOI 10.1128/JCM.00945-06; Li N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001809; Li W, 2013, INFECT GENET EVOL, V14, P111, DOI 10.1016/j.meegid.2012.11.021; Li W, 2012, INT J PARASITOL, V42, P287, DOI 10.1016/j.ijpara.2012.01.003; Li W, 2011, J CLIN MICROBIOL, V49, P4326, DOI 10.1128/JCM.05051-11; Lores B, 2002, MEM I OSWALDO CRUZ, V97, P941, DOI 10.1590/S0074-02762002000700003; Mathis A, 2005, CLIN MICROBIOL REV, V18, P423, DOI 10.1128/CMR.18.3.423-445.2005; Matos Olga, 2012, J Parasitol Res, V2012, P981424, DOI 10.1155/2012/981424; Nemejc K, 2014, PARASITOL RES, V113, P761, DOI 10.1007/s00436-013-3707-6; Sak B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001162; Sak B, 2011, VET PARASITOL, V178, P246, DOI 10.1016/j.vetpar.2010.12.044; Sak B, 2011, J CLIN MICROBIOL, V49, P1064, DOI 10.1128/JCM.01147-10; Sak B, 2008, VET PARASITOL, V153, P220, DOI 10.1016/j.vetpar.2008.01.043; Santin M, 2011, RES VET SCI, V90, P363, DOI 10.1016/j.rvsc.2010.07.014; Sulaiman IM, 2003, J EUKARYOT MICROBIOL, V50, P591, DOI 10.1111/j.1550-7408.2003.tb00642.x; Thellier M, 2008, PARASITE, V15, P349, DOI 10.1051/parasite/2008153349; Wagnerova P, 2012, VET PARASITOL, V190, P573, DOI 10.1016/j.vetpar.2012.07.013; Wang L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002437; Wang L, 2013, J CLIN MICROBIOL, V51, P557, DOI 10.1128/JCM.02758-12; Ye JB, 2012, EMERG INFECT DIS, V18, P1640, DOI 10.3201/eid1810.120653; Zhang X, 2011, J CLIN MICROBIOL, V49, P2006, DOI 10.1128/JCM.00372-11	31	48	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97623	10.1371/journal.pone.0097623	http://dx.doi.org/10.1371/journal.pone.0097623			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845247	Green Published, Green Submitted, gold			2022-12-25	WOS:000339563400040
J	Reddy, PBJ; Sehrawat, S; Suryawanshi, A; Rajasagi, NK; Khatri, M; Rouse, BT				Reddy, Pradeep B. J.; Sehrawat, Sharvan; Suryawanshi, Amol; Rajasagi, Naveen K.; Khatri, Madhu; Rouse, Barry T.			An Approach to Control Relapse of Inflammatory Lesions after Discontinuation of Primary Therapy	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-1; REGULATORY T-CELLS; MULTIPLE-SCLEROSIS; SPHINGOSINE 1-PHOSPHATE; IMMUNOPATHOLOGY; FINGOLIMOD; FTY720; T(H)17; DIFFERENTIATION; STABILIZATION	Long-term treatment with the fungal metabolite drug FTY720 (Fingolimod) was shown to be highly effective in controlling viral immunopathological lesions. However, in this report we show that the anti-inflammatory effect of FTY720 in herpes simplex virus-1 (HSV-1) induced ocular inflammation is lost upon the discontinuation of treatment and lesions rapidly recurred. The lesions that developed after FTY720 treatment withdrawal involved mainly Th17 cells rather than Th1 cells explained in part by differential expression of surface CD103, an integrin that permits migration of effector cells to inflammatory sites. The expression of IL-6, a proinflammatory cytokine involved in the generation of Th17 cells, was found to be increased in FTY treated mice as compared to controls and this effect could be abrogated upon administration of neutralizing antibody to IL-6. Furthermore, IL-17RKO mice failed to show the recurrence of stromal keratitis (SK) lesions upon FTY720 withdrawal. These results indicate that approaches such as neutralization of proinflammatory cytokines might be considered along with FTY720 treatment if interruption of drug therapy becomes necessary.	[Reddy, Pradeep B. J.; Sehrawat, Sharvan; Suryawanshi, Amol; Rajasagi, Naveen K.; Khatri, Madhu; Rouse, Barry T.] Univ Tennessee, Coll Vet Med, Dept Pathobiol, Knoxville, TN 37901 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Rouse, BT (corresponding author), Univ Tennessee, Coll Vet Med, Dept Pathobiol, Knoxville, TN 37901 USA.	btr@utk.edu	Suryawanshi, Amol/J-3787-2019	Suryawanshi, Amol/0000-0001-5031-5818	National Institute of Allergy and Infectious Diseases [AI 063365]; National Eye Institute [EY 005093]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063365] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergy and Infectious Diseases Grant AI 063365 and National Eye Institute Grant EY 005093 to BTR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Fujimoto M, 2008, ARTHRITIS RHEUM-US, V58, P3710, DOI 10.1002/art.24126; Garris CS, 2013, NAT IMMUNOL, V14, P1166, DOI 10.1038/ni.2730; Halford WP, 1996, J IMMUNOL, V157, P3542; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hayashi K, 2006, J GEN VIROL, V87, P2161, DOI 10.1099/vir.0.81772-0; HENDRICKS RL, 1992, J IMMUNOL, V149, P3023; Ingwersen J, 2012, CLIN IMMUNOL, V142, P15, DOI [10.1016/j.clim.2011.05.005, 10.1016/j.clim.2011.10.008]; Kanangat S, 1996, VIROLOGY, V219, P295, DOI 10.1006/viro.1996.0250; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Liu GW, 2010, NAT IMMUNOL, V11, P1047, DOI 10.1038/ni.1939; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; NIEMIALTOWSKI MG, 1992, J IMMUNOL, V149, P3035; NIEMIALTOWSKI MG, 1992, J IMMUNOL, V148, P1864; Penaranda C, 2010, DIABETES, V59, P1461, DOI 10.2337/db09-1129; Rajasagi NK, 2011, J IMMUNOL, V186, P1735, DOI 10.4049/jimmunol.1003456; Reddy PBJ, 2012, J VIROL, V86, P10606, DOI 10.1128/JVI.01391-12; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Rowe AM, 2013, PROG RETIN EYE RES, V32, P88, DOI 10.1016/j.preteyeres.2012.08.002; Sehrawat S, 2008, J VIROL, V82, P6838, DOI 10.1128/JVI.00697-08; Sehrawat S, 2008, J IMMUNOL, V180, P7636, DOI 10.4049/jimmunol.180.11.7636; Suryawanshi A, 2011, J IMMUNOL, V187, P1919, DOI 10.4049/jimmunol.1100736; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; van Loosdregt J, 2013, IMMUNITY, V39, P259, DOI 10.1016/j.immuni.2013.05.018; Veiga-Parga T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002427; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Yoshida Y, 2011, BIOL PHARM BULL, V34, P933, DOI 10.1248/bpb.34.933; Zhao ZS, 1998, SCIENCE, V279, P1344, DOI 10.1126/science.279.5355.1344	34	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98051	10.1371/journal.pone.0098051	http://dx.doi.org/10.1371/journal.pone.0098051			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846129	Green Submitted, Green Published, gold			2022-12-25	WOS:000339563400085
J	Yamashita, Y; Ueyama, T; Nishi, T; Yamamoto, Y; Kawakoshi, A; Sunami, S; Iguchi, M; Tamai, H; Ueda, K; Ito, T; Tsuruo, Y; Ichinose, M				Yamashita, Yasunobu; Ueyama, Takashi; Nishi, Toshio; Yamamoto, Yuta; Kawakoshi, Akatsuki; Sunami, Shogo; Iguchi, Mikitaka; Tamai, Hideyuki; Ueda, Kazuki; Ito, Takao; Tsuruo, Yoshihiro; Ichinose, Masao			Nrf2-Inducing Anti-Oxidation Stress Response in the Rat Liver - New Beneficial Effect of Lansoprazole	PLOS ONE			English	Article							PROTON PUMP INHIBITORS; DRUG-METABOLIZING-ENZYMES; CANCER CHEMOPREVENTION; OXIDATIVE STRESS; SIGNALING SYSTEM; HEME OXYGENASE-1; GENE-EXPRESSION; PHASE-I; PATHWAY; INDUCTION	Lansoprazole is a potent anti-gastric ulcer drug that inhibits gastric proton pump activity. We identified a novel function for lansoprazole, as an inducer of anti-oxidative stress responses in the liver. Gastric administration of lansoprazole (10-100 mg/kg) to male Wistar rats produced a dose-dependent increase in hepatic mRNA levels of nuclear factor, erythroid-derived 2, - like 2 (Nrf2), a redox-sensitive transcription factor, at 3 h and Nrf2 immunoreactivity (IR) in whole hepatic lysates at 6 h. Conversely, the levels of Kelch-like ECH-associated protein (Keap1), which sequesters Nrf2 in the cytoplasm under un-stimulated conditions, were unchanged. Translocation of Nrf2 into the nuclei of hepatocytes was observed using western blotting and immunohistochemistry. Expression of mRNAs for Nrf2-dependent antioxidant and phase II enzymes, such as heme oxygenase 1 (HO-1), NAD (P) H dehydrogenase, quinone 1 (Nqo1), glutathione S-transferase A2 (Gsta2), UDP glucuronosyltransferase 1 family polypeptide A6 (Ugt1a6), were dose-dependently up-regulated at 3 h. Furthermore, the levels of HO-1 IR were dose-dependently increased in hepatocytes at 6 h. Subcutaneous administration of lansoprazole (30 mg/kg/day) for 7 successive days resulted in up-regulation and nuclear translocation of Nrf2 IR in hepatocytes and up-regulation of HO-1 IR in the liver. Pretreatment with lansoprazole attenuated thioacetamide (500 mg/kg)-induced acute hepatic damage via both HO-1-dependent and -independent pathways. Up-stream networks related to Nrf2 expression were investigated using microarray analysis, followed by data mining with Ingenuity Pathway Analysis. Up-regulation of the aryl hydrocarbon receptor (AhR)-cytochrome P450, family 1, subfamily a, polypeptide 1 (Cyp1a1) pathway was associated with up-regulation of Nrf2 mRNA. In conclusion, lansoprazole might have an alternative indication in the prevention and treatment of oxidative hepatic damage through the induction of both phase I and phase II drug-metabolizing systems, i.e. the AhR/Cyp1a1/Nrf2 pathway in hepatocytes.	[Yamashita, Yasunobu; Iguchi, Mikitaka; Tamai, Hideyuki; Ueda, Kazuki; Ichinose, Masao] Wakayama Med Univ, Grad Sch Med, Dept Internal Med 2, Wakayama, Japan; [Ueyama, Takashi; Nishi, Toshio; Yamamoto, Yuta; Kawakoshi, Akatsuki; Sunami, Shogo; Ito, Takao; Tsuruo, Yoshihiro] Wakayama Med Univ, Grad Sch Med, Dept Anat & Cell Biol, Wakayama, Japan	Wakayama Medical University; Wakayama Medical University	Ueyama, T (corresponding author), Wakayama Med Univ, Grad Sch Med, Dept Anat & Cell Biol, Wakayama, Japan.	tueyama@wakayama-med.ac.jp	Ichinose, Masao/HAB-1645-2022; Yamamoto, Yuta/R-1143-2019	Yamamoto, Yuta/0000-0001-5225-6989	Japan Society for the Promotion of Science (JSPS KAKENHI) [23592229]; Grants-in-Aid for Scientific Research [24590895, 26462316] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	1) The paper was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS KAKENHI Grant Number 23592229) 2) The paper was also supported by annual research expenses provided by Wakayama Medical University 3) Lansoprazole used in this study was supplied by Takeda Pharmaceutical Co. Ltd. No other supports was received from Takeda Pharmaceutical Co. Ltd. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker JC, 2006, BIOCHEM BIOPH RES CO, V345, P1014, DOI 10.1016/j.bbrc.2006.04.170; Bown RL, 2002, INT J CLIN PRACT, V56, P132; Copple IM, 2012, ADV PHARMACOL, V63, P43, DOI 10.1016/B978-0-12-398339-8.00002-1; CURIPEDROSA R, 1994, J PHARMACOL EXP THER, V269, P384; Eggler AL, 2008, MOL NUTR FOOD RES, V52, pS84, DOI 10.1002/mnfr.200700249; Hayes JD, 2001, CANCER LETT, V174, P103, DOI 10.1016/S0304-3835(01)00695-4; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Inatomi N, 1997, JPN PHARMACOL THER, V25, P2445; Kawai H, 2009, J TOXICOL SCI, V34, P27, DOI 10.2131/jts.34.27; Keum YS, 2011, ANN NY ACAD SCI, V1229, P184, DOI 10.1111/j.1749-6632.2011.06092.x; Masubuchi N, 1997, DRUG METAB DISPOS, V25, P584; Miao WM, 2005, J BIOL CHEM, V280, P20340, DOI 10.1074/jbc.M412081200; Murakami I, 1996, JPN J PHARMACOL, V72, P137, DOI 10.1254/jjp.72.137; Numazawa S, 2003, AM J PHYSIOL-CELL PH, V285, pC334, DOI 10.1152/ajpcell.00043.2003; Otterbein LE, 2000, AM J PHYSIOL-LUNG C, V279, pL1029, DOI 10.1152/ajplung.2000.279.6.L1029; Pearce RE, 1996, J PHARMACOL EXP THER, V277, P805; Rushmore TH, 2002, CURR DRUG METAB, V3, P481, DOI 10.2174/1389200023337171; Sanderson LM, 2010, PHYSIOL GENOMICS, V41, P42, DOI 10.1152/physiolgenomics.00127.2009; Satoh H, 2013, CURR PHARM DESIGN, V19, P67; Shay KP, 2009, BBA-GEN SUBJECTS, V1790, P1149, DOI 10.1016/j.bbagen.2009.07.026; Shin S, 2007, MOL CELL BIOL, V27, P7188, DOI 10.1128/MCB.00915-07; Stedman CAM, 2000, ALIMENT PHARM THERAP, V14, P963, DOI 10.1046/j.1365-2036.2000.00788.x; Takagi T, 2009, J PHARMACOL EXP THER, V331, P255, DOI 10.1124/jpet.109.152702; Tkachev VO, 2011, BIOCHEMISTRY-MOSCOW+, V76, P407, DOI 10.1134/S0006297911040031; Ueda K, 2008, AM J PHYSIOL-GASTR L, V295, pG460, DOI 10.1152/ajpgi.00204.2007; Ueda K, 2009, J PHARMACOL SCI, V110, P285, DOI 10.1254/jphs.09056FP; Ueyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065685; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; WHITLOCK JP, 1990, ANNU REV PHARMACOL, V30, P251; Yamamoto Y, 2009, PHYSIOL GENOMICS, V39, P227, DOI 10.1152/physiolgenomics.00082.2009; Yeager RL, 2009, TOXICOL SCI, V111, P238, DOI 10.1093/toxsci/kfp115; Yoda Y, 2010, J PHYSIOL PHARMACOL, V61, P287; Yoshinari K, 2008, BIOCHEM PHARMACOL, V76, P139, DOI 10.1016/j.bcp.2008.04.005; Zenkov NK, 2013, BIOCHEMISTRY-MOSCOW+, V78, P19, DOI 10.1134/S0006297913010033	34	28	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97419	10.1371/journal.pone.0097419	http://dx.doi.org/10.1371/journal.pone.0097419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846271	Green Published, gold, Green Submitted			2022-12-25	WOS:000339563400028
J	Mayer, MC; Kaden, D; Schauenburg, L; Hancock, MA; Voigt, P; Roeser, D; Barucker, C; Than, ME; Schaefer, M; Multhaup, G				Mayer, Magnus C.; Kaden, Daniela; Schauenburg, Linda; Hancock, Mark A.; Voigt, Philipp; Roeser, Dirk; Barucker, Christian; Than, Manuel E.; Schaefer, Michael; Multhaup, Gerhard			Novel Zinc-binding Site in the E2 Domain Regulates Amyloid Precursor-like Protein 1 (APLP1) Oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; APP FAMILY-MEMBERS; ALZHEIMERS-DISEASE; POSTSYNAPTIC DENSITY; HEPARIN; MICE; DIMERIZATION; COPPER; MOUSE; SYNAPTOGENESIS	The amyloid precursor protein (APP) and the APP-like proteins 1 and 2 (APLP1 and APLP2) are a family of multidomain transmembrane proteins possessing homo-and heterotypic contact sites in their ectodomains. We previously reported that divalent metal ions dictate the conformation of the extracellular APP E2 domain (Dahms, S. O., Konnig, I., Roeser, D., G hrs, K.-H., Mayer, M. C., Kaden, D., Multhaup, G., and Than, M. E. (2012) J. Mol. Biol. 416, 438-452), but unresolved is the nature and functional importance of metal ion binding to APLP1 and APLP2. We found here that zinc ions bound to APP and APLP1 E2 domains and mediated their oligomerization, whereas the APLP2 E2 domain interacted more weakly with zinc possessing a less surface-exposed zinc-binding site, and stayed monomeric. Copper ions bound to E2 domains of all three proteins. Fluorescence resonance energy transfer (FRET) analyses examined the effect of metal ion binding to APP and APLPs in the cellular context in real time. Zinc ions specifically induced APP and APLP1 oligomerization and forced APLP1 into multimeric clusters at the plasma membrane consistent with zinc concentrations in the blood and brain. The observed effects were mediated by a novel zinc-binding site within the APLP1 E2 domain as APLP1 deletion mutants revealed. Based upon its cellular localization and its dominant response to zinc ions, APLP1 is mainly affected by extracellular zinc among the APP family proteins. We conclude that zinc binding and APP/APLP oligomerization are intimately linked, and we propose that this represents a novel mechanism for regulating APP/APLP protein function at the molecular level.	[Mayer, Magnus C.; Kaden, Daniela; Schauenburg, Linda; Multhaup, Gerhard] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Hancock, Mark A.; Barucker, Christian; Multhaup, Gerhard] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Voigt, Philipp] Charite, Neurowissenschaftliches Forschungszentrum, D-14195 Berlin, Germany; [Roeser, Dirk; Than, Manuel E.] Fritz Lipmann Inst, Leibniz Inst Age Res, Prot Crystallog Grp, D-07745 Jena, Germany; [Schaefer, Michael] Univ Leipzig, Rudolf Boehm Inst Pharmakol & Toxikol, Fak Med, D-04107 Leipzig, Germany	Free University of Berlin; McGill University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Leipzig University	Multhaup, G (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, 3655 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada.	gerhard.multhaup@mcgill.ca	Than, Manuel/F-7536-2015	Than, Manuel/0000-0002-4707-9225; Voigt, Philipp/0000-0003-4366-0490	Deutsche Forschungsgemeinschaft [MU901, SFB740, GRK1123, Exc 257 NeuroCure]; German Federal Ministry of Education and Research through the Kompetenznetz Degenerative Demenzen Forderkennzeichen [01 GI 1004G]; Canadian Institute of Health Research [MOP-133411]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research through the Kompetenznetz Degenerative Demenzen Forderkennzeichen; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Deutsche Forschungsgemeinschaft Grants MU901, SFB740, GRK1123, and Exc 257 NeuroCure, German Federal Ministry of Education and Research through the Kompetenznetz Degenerative Demenzen Forderkennzeichen 01 GI 1004G, and Canadian Institute of Health Research Grant MOP-133411 (to G. M.).	Akatsu H, 2012, BIOMETALS, V25, P337, DOI 10.1007/s10534-011-9504-8; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Ball LJ, 2002, FEBS LETT, V513, P45, DOI 10.1016/S0014-5793(01)03291-4; Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Baumkotter F, 2012, EXP BRAIN RES, V217, P389, DOI 10.1007/s00221-011-2878-6; Bayer TA, 1997, ACTA NEUROPATHOL, V94, P519, DOI 10.1007/s004010050745; Brocca S, 1998, PROTEIN SCI, V7, P1415, DOI 10.1002/pro.5560070618; BUSH AI, 1994, J BIOL CHEM, V269, P26618; BUSH AI, 1993, J BIOL CHEM, V268, P16109; Coburger I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081926; Coulson EJ, 2000, NEUROCHEM INT, V36, P175, DOI 10.1016/S0197-0186(99)00125-4; Dahms SO, 2012, J MOL BIOL, V416, P438, DOI 10.1016/j.jmb.2011.12.057; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Dugan TA, 2003, J BIOL CHEM, V278, P13655, DOI 10.1074/jbc.M300171200; Eggert S, 2004, J BIOL CHEM, V279, P18146, DOI 10.1074/jbc.M311601200; Frederickson CJ, 2006, EXP NEUROL, V198, P285, DOI 10.1016/j.expneurol.2005.08.030; Gaier ED, 2013, J NEUROSCI RES, V91, P2, DOI 10.1002/jnr.23143; Grabrucker AM, 2011, EMBO J, V30, P569, DOI 10.1038/emboj.2010.336; Graille M, 2010, STRUCTURE, V18, P710, DOI 10.1016/j.str.2010.03.012; Gu CG, 1999, ANAL CHIM ACTA, V397, P247, DOI 10.1016/S0003-2670(99)00409-2; Guo QX, 2012, J BIOL CHEM, V287, P2437, DOI 10.1074/jbc.M111.315051; Hansson MD, 2008, ANAL BIOCHEM, V375, P373, DOI 10.1016/j.ab.2007.12.005; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heber S, 2000, J NEUROSCI, V20, P7951; HEMDAN ES, 1989, P NATL ACAD SCI USA, V86, P1811, DOI 10.1073/pnas.86.6.1811; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; HESSE L, 1994, FEBS LETT, V349, P109, DOI 10.1016/0014-5793(94)00658-X; Hoe HS, 2009, J BIOL CHEM, V284, P8495, DOI 10.1074/jbc.M900141200; Isbert S, 2012, CELL MOL LIFE SCI, V69, P1353, DOI 10.1007/s00018-011-0882-4; Jansen J, 2012, J NUTR BIOCHEM, V23, P1458, DOI 10.1016/j.jnutbio.2011.09.008; Kaden D, 2012, EUR J CELL BIOL, V91, P234, DOI 10.1016/j.ejcb.2011.01.017; Kaden D, 2009, J CELL SCI, V122, P368, DOI 10.1242/jcs.034058; KIM TW, 1995, MOL BRAIN RES, V32, P36, DOI 10.1016/0169-328X(95)00328-P; Kuhn PH, 2012, EMBO J, V31, P3157, DOI 10.1038/emboj.2012.173; Lee S, 2011, BIOCHEMISTRY-US, V50, P5453, DOI 10.1021/bi101846x; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; LORENT K, 1995, NEUROSCIENCE, V65, P1009, DOI 10.1016/0306-4522(94)00555-J; Lyckman AW, 1998, J BIOL CHEM, V273, P11100, DOI 10.1074/jbc.273.18.11100; MULTHAUP G, 1994, BIOCHIMIE, V76, P304, DOI 10.1016/0300-9084(94)90163-5; MULTHAUP G, 1995, J MOL RECOGNIT, V8, P247; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; PARR RM, 1964, BIOCHEM J, V91, P424, DOI 10.1042/bj0910424; Que EL, 2008, CHEM REV, V108, P1517, DOI 10.1021/cr078203u; SEGREST JP, 1973, ARCH BIOCHEM BIOPHYS, V155, P167, DOI 10.1016/S0003-9861(73)80019-0; Sensi SL, 2011, J NEUROSCI, V31, P16076, DOI 10.1523/JNEUROSCI.3454-11.2011; Shariati SAM, 2013, J CELL SCI, V126, P1268, DOI 10.1242/jcs.122440; Shen C, 2008, PROTEINS, V71, P1744, DOI 10.1002/prot.21857; Sindreu C, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00068; SMALL DH, 1994, J NEUROSCI, V14, P2117; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0; Tamano H, 2011, METALLOMICS, V3, P656, DOI 10.1039/c1mt00008j; THINAKARAN G, 1995, J NEUROSCI, V15, P6314; Tyan SH, 2012, MOL CELL NEUROSCI, V51, P43, DOI 10.1016/j.mcn.2012.07.009; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; Wang ZL, 2009, J NEUROSCI, V29, P10788, DOI 10.1523/JNEUROSCI.2132-09.2009; Wattenberg A, 2002, J AM SOC MASS SPECTR, V13, P772, DOI 10.1016/S1044-0305(02)00414-2; Weyer SW, 2011, EMBO J, V30, P2266, DOI 10.1038/emboj.2011.119; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1; Xue Y, 2011, P NATL ACAD SCI USA, V108, P16229, DOI 10.1073/pnas.1103407108; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	68	20	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19019	19030		10.1074/jbc.M114.570382	http://dx.doi.org/10.1074/jbc.M114.570382			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24855651	Green Published, hybrid			2022-12-25	WOS:000339062900033
J	Rai, R; Tate, JJ; Shanmuganatham, K; Howe, MM; Cooper, TG				Rai, Rajendra; Tate, Jennifer J.; Shanmuganatham, Karthik; Howe, Martha M.; Cooper, Terrance G.			A Domain in the Transcription Activator Gln3 Specifically Required for Rapamycin Responsiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITROGEN CATABOLITE REPRESSION; NUCLEAR-LOCALIZATION; STRUCTURE PREDICTION; SACCHAROMYCES-CEREVISIAE; CARBON STARVATION; CONTROLS TORC1; URE2P; PHOSPHORYLATION; PHOSPHATASE; LIMITATION	Nitrogen-responsive control of Gln3 localization is implemented through TorC1-dependent (rapamycin-responsive) and TorC1-independent (nitrogen catabolite repression-sensitive and methionine sulfoximine (Msx)-responsive) regulatory pathways. W epreviously demonstrated amino acid substitutions in a putative Gln3 alpha-helix(656-666), which are required for a two-hybrid Gln3-Tor1 interaction, also abolished rapamycin responsiveness of Gln3 localization and partially abrogated cytoplasmic Gln3 sequestration in cells cultured under nitrogen-repressive conditions. Here, we demonstrate these three characteristics are not inextricably linked together. A second distinct Gln3 region (Gln3(510-589)) is specifically required for rapamycin responsiveness of Gln3 localization, but not for cytoplasmic Gln3 sequestration under repressive growth conditions or relocation to the nucleus following Msx addition. Aspartate or alanine substitution mutations throughout this region uniformly abolish rapamycin responsiveness. Contained within this region is a sequence with a predicted propensity to form an alpha-helix(583-591), one side of which consists of three hydrophobic amino acids flanked by serine residues. Substitution of aspartate for even one of these serines abolishes rapamycin responsiveness and increases rapamycin resistance without affecting either of the other two Gln3 localization responses. In contrast, alanine substitutions decrease rapamycin resistance. Together, these data suggest that targets in the C-terminal portion of Gln3 required for the Gln3-Tor1 interaction, cytoplasmic Gln3 sequestration, and Gln3 responsiveness to Msx addition and growth in poor nitrogen sources are distinct from those needed for rapamycin responsiveness.	[Rai, Rajendra; Tate, Jennifer J.; Howe, Martha M.; Cooper, Terrance G.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Shanmuganatham, Karthik] St Jude Childrens Res Hosp, Div Virol, Dept Infect Dis, Memphis, TN 38105 USA	University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital	Cooper, TG (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA.	tcooper@uthsc.edu		Cooper, Terrance G./0000-0002-7651-9963	National Institutes of Health from NIGMS [GM-35642]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035642] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-35642 from the NIGMS.	Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; Binda M, 2010, CELL CYCLE, V9, P221, DOI 10.4161/cc.9.2.10585; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Blinder D, 1996, J BACTERIOL, V178, P4734, DOI 10.1128/jb.178.15.4734-4736.1996; Bonfils G, 2012, MOL CELL, V46, P105, DOI 10.1016/j.molcel.2012.02.009; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Carvalho J, 2003, J BIOL CHEM, V278, P16878, DOI 10.1074/jbc.M300429200; CHISHOLM G, 1982, MOL CELL BIOL, V2, P1088, DOI 10.1128/MCB.2.9.1088; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Cooper T., 1982, MOL BIOL YEAST SACCH, P39, DOI DOI 10.1101/087969180.11B.39; Cooper TG, 2004, TOP CURR GENET, V7, P225; Cox KH, 2004, J BIOL CHEM, V279, P19294, DOI 10.1074/jbc.M309240200; Cox KH, 2004, J BIOL CHEM, V279, P10270, DOI 10.1074/jbc.M312023200; Cox KH, 2002, J BIOL CHEM, V277, P37559, DOI 10.1074/jbc.M204879200; Crespo JL, 2004, J BIOL CHEM, V279, P37512, DOI 10.1074/jbc.M407372200; Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599; Cunningham TS, 2000, J BIOL CHEM, V275, P14408, DOI 10.1074/jbc.275.19.14408; Georis I, 2008, J BIOL CHEM, V283, P8919, DOI 10.1074/jbc.M708811200; Georis I, 2011, J BIOL CHEM, V286, P44897, DOI 10.1074/jbc.M111.290577; Georis I, 2011, MOL CELL BIOL, V31, P92, DOI 10.1128/MCB.00482-10; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Hofman-Bang J, 1999, MOL BIOTECHNOL, V12, P35, DOI 10.1385/MB:12:1:35; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Lorberg A, 2003, CURR TOP MICROBIOL, V279, P1; Magasanik B, 2005, P NATL ACAD SCI USA, V102, P16537, DOI 10.1073/pnas.0507116102; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Maupetit J, 2010, J COMPUT CHEM, V31, P726, DOI 10.1002/jcc.21365; Panchaud N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004112; Powers T, 2007, CELL METAB, V6, P1, DOI 10.1016/j.cmet.2007.06.009; Puria R, 2008, P NATL ACAD SCI USA, V105, P7194, DOI 10.1073/pnas.0801087105; Rai R, 2013, J BIOL CHEM, V288, P2789, DOI 10.1074/jbc.M112.421826; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; Smets B, 2010, CURR GENET, V56, P1, DOI 10.1007/s00294-009-0287-1; Tate JJ, 2007, J BIOL CHEM, V282, P18467, DOI 10.1074/jbc.M609550200; Tate JJ, 2006, J BIOL CHEM, V281, P37980, DOI 10.1074/jbc.M606973200; Tate JJ, 2013, J BIOL CHEM, V288, P27243, DOI 10.1074/jbc.M113.484386; Tate JJ, 2010, J BIOL CHEM, V285, P17880, DOI 10.1074/jbc.M109.085712; Tate JJ, 2009, J BIOL CHEM, V284, P2522, DOI 10.1074/jbc.M806162200; Tate JJ, 2005, J BIOL CHEM, V280, P27195, DOI 10.1074/jbc.M504052200; Thevenet P, 2012, NUCLEIC ACIDS RES, V40, pW288, DOI 10.1093/nar/gks419; Wang HM, 2003, MOL BIOL CELL, V14, P4342, DOI 10.1091/mbc.E03-02-0072; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yan GH, 2006, EMBO J, V25, P3546, DOI 10.1038/sj.emboj.7601239; Zhang TL, 2012, STRUCTURE, V20, P2151, DOI 10.1016/j.str.2012.09.019	49	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18999	19018		10.1074/jbc.M114.563668	http://dx.doi.org/10.1074/jbc.M114.563668			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24847055	Green Published, hybrid			2022-12-25	WOS:000339062900032
J	Plaza-Diaz, J; Gomez-Llorente, C; Abadia-Molina, F; Saez-Lara, MJ; Campana-Martin, L; Munoz-Quezada, S; Romero, F; Gil, A; Fontana, L				Plaza-Diaz, Julio; Gomez-Llorente, Carolina; Abadia-Molina, Francisco; Jose Saez-Lara, Maria; Campana-Martin, Laura; Munoz-Quezada, Sergio; Romero, Fernando; Gil, Angel; Fontana, Luis			Effects of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 on Hepatic Steatosis in Zucker Rats	PLOS ONE			English	Article							FATTY LIVER-DISEASE; HIGH-CHOLESTEROL DIET; INSULIN-RESISTANCE; METABOLIC SYNDROME; GUT MICROBIOTA; INTESTINAL MICROBIOTA; PROBIOTIC STRAINS; LIPID-METABOLISM; OBESITY; CELLS	We have previously described the safety and immunomodulatory effects of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 in healthy volunteers. The scope of this work was to evaluate the effects of these probiotic strains on the hepatic steatosis of obese rats. We used the Zucker rat as a genetic model of obesity. Zucker-Lepr(fa/fa) rats received one of three probiotic strains, a mixture of L. paracasei CNCM I-4034 and B. breve CNCM I-4035, or a placebo for 30 days. An additional group of Zucker-lean(+/fa) rats received a placebo for 30 days. No alterations in intestinal histology, in the epithelial, lamina propria, muscular layers of the ileal or colonic mucosa, or the submucosae, were observed in any of the experimental groups. Triacylglycerol content decreased in the liver of Zucker-Lepr(fa/fa) rats that were fed L. rhamnosus, B. breve, or the mixture of B. breve and L. paracasei. Likewise, the area corresponding to neutral lipids was significantly smaller in the liver of all four groups of Zucker-Lepr(fa/fa) rats that received probiotics than in rats fed the placebo. Zucker-Lepr(fa/fa) rats exhibited significantly greater serum LPS levels than Zuckerlean(+/fa) rats upon administration of placebo for 30 days. In contrast, all four groups of obese Zucker-Lepr(fa/fa) rats that received LAB strains exhibited serum LPS concentrations similar to those of Zucker-lean(+/fa) rats. Serum TNF-alpha levels decreased in the Zucker-Lepr(fa/fa) rats that received B. breve, L. rhamnosus, or the mixture, whereas L. paracasei feeding decreased IL-6 levels in the serum of Zucker-Lepr(fa/fa) rats. In conclusion, the probiotic strains reduced hepatic steatosis in part by lowering serum LPS, and had an anti-inflammatory effect in obese Zucker rats.	[Plaza-Diaz, Julio; Gomez-Llorente, Carolina; Munoz-Quezada, Sergio; Gil, Angel; Fontana, Luis] Univ Granada, Sch Pharm, Dept Biochem & Mol Biol II, Granada, Spain; [Plaza-Diaz, Julio; Gomez-Llorente, Carolina; Campana-Martin, Laura; Munoz-Quezada, Sergio; Gil, Angel; Fontana, Luis] Univ Granada, Biomed Res Ctr, Inst Nutr & Food Technol Jose Mataix, Granada, Spain; [Abadia-Molina, Francisco] Univ Granada, Sch Sci, Dept Cell Biol, Granada, Spain; [Jose Saez-Lara, Maria] Univ Granada, Sch Sci, Dept Biochem & Mol Biol I, Granada, Spain; [Romero, Fernando] Hero Global Technol Ctr, Murcia, Spain	University of Granada; University of Granada; University of Granada; University of Granada	Fontana, L (corresponding author), Univ Granada, Sch Pharm, Dept Biochem & Mol Biol II, Granada, Spain.	fontana@ugr.es	Gil, Angel/ABA-7621-2020; Plaza-Diaz, Julio/C-8094-2016; Llorente, Carolina Gomez/K-7484-2015; Fontana, Luis/K-5528-2015; Gil, Angel/L-2275-2014	Gil, Angel/0000-0001-7663-0939; Plaza-Diaz, Julio/0000-0002-5171-9408; Llorente, Carolina Gomez/0000-0003-3948-1473; Fontana, Luis/0000-0001-8395-8393; Gil, Angel/0000-0001-7663-0939	Hero Spain, S.A. [3545]	Hero Spain, S.A.	Part of the research currently in progress in the authors' laboratory is funded by the company Hero Spain, S.A. through the grant #3545 managed by the Fundacion General Empresa-Universidad de Granada. No additional external funding was received for this study. The funders played a role in the study design, but had no role in the decision to publish or preparation of the manuscript.	ADACHI Y, 1995, GASTROENTEROLOGY, V108, P218, DOI 10.1016/0016-5085(95)90027-6; Awaisheh SS, 2013, J DAIRY SCI, V96, P9, DOI 10.3168/jds.2012-5442; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bermudez-Brito M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059370; Bermudez-Brito M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043197; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2009, CURR OPIN PHARMACOL, V9, P737, DOI 10.1016/j.coph.2009.06.016; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Collins JK, 1998, INT DAIRY J, V8, P487, DOI 10.1016/S0958-6946(98)00073-9; D'Angelo G, 2006, HYPERTENSION, V48, P1109, DOI 10.1161/01.HYP.0000247306.53547.d4; Delzenne NM, 2011, ANNU REV NUTR, V31, P15, DOI 10.1146/annurev-nutr-072610-145146; Dokken BB, 2006, AM J PHYSIOL-ENDOC M, V291, pE207, DOI 10.1152/ajpendo.00628.2005; Erdos B, 2004, DIABETES, V53, P1352, DOI 10.2337/diabetes.53.5.1352; Esposito E, 2009, J NUTR, V139, P905, DOI 10.3945/jn.108.101808; Farhadi A, 2008, LIVER INT, V28, P1026, DOI 10.1111/j.1478-3231.2008.01723.x; Food and Agriculture Organization of the United Nations; World Health Organization, 2002, GUID EV PROB FOOD RE; Frick JS, 2007, INFLAMM BOWEL DIS, V13, P83, DOI 10.1002/ibd.20009; Gourbeyre P, 2011, J LEUKOCYTE BIOL, V89, P685, DOI 10.1189/jlb.1109753; Harte AL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-15; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Knaapen M, 2013, CLIN MICROBIOL INFEC, V19, P331, DOI 10.1111/1469-0691.12170; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lanthier N, 2010, AM J PHYSIOL-GASTR L, V298, pG107, DOI 10.1152/ajpgi.00391.2009; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li ZP, 2003, HEPATOLOGY, V37, P343, DOI 10.1053/jhep.2003.50048; Ma X, 2008, J HEPATOL, V49, P821, DOI 10.1016/j.jhep.2008.05.025; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Munoz-Quezada S, 2013, BRIT J NUTR, V109, pS51, DOI 10.1017/S0007114512005211; NANJI AA, 1994, P SOC EXP BIOL MED, V205, P243; Neyrinck AM, 2009, BIOCHEM BIOPH RES CO, V385, P351, DOI 10.1016/j.bbrc.2009.05.070; Nolan J P, 1978, Gastroenterology, V75, P765; NOLAN JP, 1979, YALE J BIOL MED, V52, P127; Obeid OA, 2000, INT J OBESITY, V24, P508, DOI 10.1038/sj.ijo.0801189; Ouwehand AC, 2002, ANTON LEEUW INT J G, V82, P279, DOI 10.1023/A:1020620607611; Paik HD, 2005, BIOL PHARM BULL, V28, P1270, DOI 10.1248/bpb.28.1270; Plaza-Diaz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078111; Power SE, 2014, BRIT J NUTR, V111, P387, DOI 10.1017/S0007114513002560; Reaven G, 2004, ENDOCRIN METAB CLIN, V33, P283, DOI 10.1016/j.ecl.2004.03.002; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Serkova NJ, 2006, J HEPATOL, V44, P956, DOI 10.1016/j.jhep.2005.07.009; Singh R, 2009, HEPATOLOGY, V49, P87, DOI 10.1002/hep.22578; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Thuy S, 2008, J NUTR, V138, P1452, DOI 10.1093/jn/138.8.1452; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Verdam FJ, 2011, J CLIN GASTROENTEROL, V45, P149, DOI 10.1097/MCG.0b013e3181e12c24; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Xie N, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-53; Yadav H, 2008, J DAIRY RES, V75, P189, DOI 10.1017/S0022029908003129; Yoo SR, 2013, OBESITY, V21, P2571, DOI 10.1002/oby.20428	53	49	50	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98401	10.1371/journal.pone.0098401	http://dx.doi.org/10.1371/journal.pone.0098401			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852284	Green Submitted, Green Published, gold			2022-12-25	WOS:000338323200069
J	Bergs, JW; Neuendorff, N; van der Heijden, G; Wassenaar, E; Rexin, P; Elsasser, HP; Moll, R; Baarends, WM; Brehm, A				Bergs, Judith W.; Neuendorff, Nina; van der Heijden, Godfried; Wassenaar, Evelyne; Rexin, Peter; Elsaesser, Hans-Peter; Moll, Roland; Baarends, Willy M.; Brehm, Alexander			Differential Expression and Sex Chromosome Association of CHD3/4 and CHD5 during Spermatogenesis	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; PSEUDOAUTOSOMAL REGION; MI-2/NURD COMPLEX; MALE MEIOSIS; PHD FINGERS; CHROMATIN; MOUSE; RECOMBINATION; ATPASE; GENE	ATP-dependent nucleosome remodelers of the CHD family play important roles in chromatin regulation during development and differentiation. The ubiquitously expressed CHD3 and CHD4 proteins are essential for stem cell function and serve to orchestrate gene expression in different developmental settings. By contrast, the closely related CHD5 is predominantly expressed in neural tissue and its role is believed to be restricted to neural differentiation. Indeed, loss of CHD5 contributes to neuroblastoma. In this study, we first demonstrate that CHD5 is a nucleosome-stimulated ATPase. We then compare CHD3/4 and CHD5 expression in mouse brain and show that CHD5 expression is restricted to a subset of cortical and hippocampal neurons whereas CHD3/4 expression is more widespread. We also uncover high levels of CHD5 expression in testis. CHD5 is transiently expressed in differentiating germ cells. Expression is first detected in nuclei of postmeiotic round spermatids, reaches a maximum in stage VIII spermatids and then falls to undetectable levels in stage IX spermatids. Surprisingly, CHD3/4 and CHD5 show complementary expression patterns during spermatogenesis with CHD3/4 levels progressively decreasing as CHD5 expression increases. In spermatocytes, CHD3/4 localizes to the pseudoautosomal region, the X centromeric region and then spreads into the XY body chromatin. In postmeiotic cells, CHD5 colocalises with macroH2A1.2 in association with centromeres and part of the Y chromosome. The subnuclear localisations of CHD4 and CHD5 suggest specific roles in regulation of sex chromosome chromatin and pericentromeric chromatin structure prior to the histone-protamine switch.	[Bergs, Judith W.; Neuendorff, Nina; Brehm, Alexander] Univ Marburg, Inst Mol Biol & Tumor Res IMT, Marburg, Germany; [van der Heijden, Godfried; Wassenaar, Evelyne; Baarends, Willy M.] Erasmus MC Univ Med Ctr, Dept Reprod & Dev, Rotterdam, Netherlands; [Rexin, Peter; Moll, Roland] Univ Marburg, Inst Pathol, Marburg, Germany; [Elsaesser, Hans-Peter] Univ Marburg, Inst Zytobiol & Zytopathol, Marburg, Germany	Philipps University Marburg; Erasmus University Rotterdam; Erasmus MC; Philipps University Marburg; Philipps University Marburg	Baarends, WM (corresponding author), Erasmus MC Univ Med Ctr, Dept Reprod & Dev, Rotterdam, Netherlands.	w.baarends@erasmusmc.nl; brehm@imt.uni-marburg.de	van der Heijden, Godfried/ABC-5623-2021	van der Heijden, Godfried/0000-0001-5894-7027; Bergs, Judith/0000-0003-2497-3248; Bergs, Judith/0000-0002-6859-5202	LOEWE Schwerpunkt "Tumor und Entzundung";  [Transregio 17];  [TRR81]	LOEWE Schwerpunkt "Tumor und Entzundung"; ; 	J.B, N.N, P. R, R. M, H.-P. E. and A. B. acknowledge support from Transregio 17, TRR81 and LOEWE Schwerpunkt "Tumor und Entzundung". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHLEY T, 1995, CHROMOSOMA, V104, P19, DOI 10.1007/BF00352222; Baarends WM, 2005, MOL CELL BIOL, V25, P1041, DOI 10.1128/MCB.25.3.1041-1053.2005; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Barchi M, 2005, MOL CELL BIOL, V25, P7203, DOI 10.1128/MCB.25.16.7203-7215.2005; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Bellani MA, 2005, J CELL SCI, V118, P3233, DOI 10.1242/jcs.02466; Brehm A, 2000, EMBO J, V19, P4332, DOI 10.1093/emboj/19.16.4332; Carofiglio F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003538; Cole F, 2012, NAT CELL BIOL, V14, P424, DOI 10.1038/ncb2451; Corona DFV, 1999, MOL CELL, V3, P239, DOI 10.1016/S1097-2765(00)80314-7; Dantzer F, 2006, P NATL ACAD SCI USA, V103, P14854, DOI 10.1073/pnas.0604252103; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Eberl HC, 2013, MOL CELL, V49, P368, DOI 10.1016/j.molcel.2012.10.026; Fujita T, 2008, JNCI-J NATL CANCER I, V100, P940, DOI 10.1093/jnci/djn176; Garcia I, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-277; Gaucher J, 2012, EMBO J, V31, P3809, DOI 10.1038/emboj.2012.233; Gaucher J, 2010, FEBS J, V277, P599, DOI 10.1111/j.1742-4658.2009.07504.x; Gotoh H, 1999, ANN NY ACAD SCI, V870, P351, DOI 10.1111/j.1749-6632.1999.tb08901.x; Hall JA, 2007, BIOCHEM CELL BIOL, V85, P463, DOI 10.1139/O07-063; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Hauk G, 2010, MOL CELL, V39, P711, DOI 10.1016/j.molcel.2010.08.012; Kauppi L, 2011, SCIENCE, V331, P916, DOI 10.1126/science.1195774; Koyama H, 2012, CLIN CANCER RES, V18, P1588, DOI 10.1158/1078-0432.CCR-11-2644; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Larsen DH, 2010, J CELL BIOL, V190, P731, DOI 10.1083/jcb.200912135; Le Gallo M, 2012, NAT GENET, V44, P1310, DOI 10.1038/ng.2455; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Mallette FA, 2012, CELL REP, V2, P1233, DOI 10.1016/j.celrep.2012.09.033; Mansfield RE, 2011, J BIOL CHEM, V286, P11779, DOI 10.1074/jbc.M110.208207; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Moens PB, 2002, J CELL SCI, V115, P1611; MONESI V, 1965, CHROMOSOMA, V17, P11, DOI 10.1007/BF00285153; Montellier E, 2013, GENE DEV, V27, P1680, DOI 10.1101/gad.220095.113; Morra R, 2012, FEBS LETT, V586, P2513, DOI 10.1016/j.febslet.2012.06.017; Murawska M, 2012, TRANSCRIPTION, V2, P244; Musselman CA, 2012, P NATL ACAD SCI USA, V109, P787, DOI 10.1073/pnas.1113655109; Musselman CA, 2009, BIOCHEM J, V423, P179, DOI 10.1042/BJ20090870; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; Oliver SS, 2012, BIOCHEMISTRY-US, V51, P6534, DOI 10.1021/bi3006972; PALMER DK, 1990, CHROMOSOMA, V100, P32, DOI 10.1007/BF00337600; Paul S, 2013, CELL REP, V3, P92, DOI 10.1016/j.celrep.2012.12.009; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; Potts RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024515; Rathke C., 2013, BIOCHIM BIOPHYS ACTA, V1839, P155; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Sims JK, 2011, MOL BIOL CELL, V22, P3094, DOI 10.1091/mbc.E11-03-0258; Smagulova F, 2011, NATURE, V472, P375, DOI 10.1038/nature09869; Smeenk G, 2010, J CELL BIOL, V190, P741, DOI 10.1083/jcb.201001048; SODERSTROM KO, 1976, MOL CELL ENDOCRINOL, V5, P181, DOI 10.1016/0303-7207(76)90082-4; Thompson PM, 2003, ONCOGENE, V22, P1002, DOI 10.1038/sj.onc.1206211; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Turner JMA, 2006, DEV CELL, V10, P521, DOI 10.1016/j.devcel.2006.02.009; Turner JMA, 2001, J CELL SCI, V114, P3367; Van Den Tweel ERW, 2006, PEDIATR RES, V59, P232, DOI 10.1203/01.pdr.0000196807.10122.5f; van der Heijden GW, 2007, NAT GENET, V39, P251, DOI 10.1038/ng1949; Wang HB, 2001, NUCLEIC ACIDS RES, V29, P2517, DOI 10.1093/nar/29.12.2517; Watson AA, 2012, J MOL BIOL, V422, P3, DOI 10.1016/j.jmb.2012.04.031; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; Zhuang T, 2013, MECH DEVELOP, V131, P652	60	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98203	10.1371/journal.pone.0098203	http://dx.doi.org/10.1371/journal.pone.0098203			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849318	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600098
J	Bucardo, F; Reyes, Y; Svensson, L; Nordgren, J				Bucardo, Filemon; Reyes, Yaoska; Svensson, Lennart; Nordgren, Johan			Predominance of Norovirus and Sapovirus in Nicaragua after Implementation of Universal Rotavirus Vaccination	PLOS ONE			English	Article							SAPPORO-VIRUS GASTROENTERITIS; GENETIC DIVERSITY; CHILDREN; DIARRHEA; INFECTIONS; PCR; IMMUNIZATION; ASSOCIATION; POPULATION; SPECIMENS	Background: Despite significant reduction of rotavirus (RV) infections following implementation of RotaTeq vaccination in Nicaragua, a large burden of patients with diarrhea persists. Methods: We conducted a community-and hospital-based study of the burden of RV, norovirus (NV) and sapovirus (SV) infections as cause of sporadic acute gastroenteritis (GE) among 330 children <= 5 years of age between September 2009 and October 2010 in two major cities of Nicaragua with a RotaTeq coverage rate of 95%. Results: We found that NV, SV and RV infections altogether accounted for 45% of cases of GE. Notably, NV was found in 24% (79/330) of the children, followed by SV (17%, 57/330) and RV (8%, 25/330). The detection rate in the hospital setting was 27%, 15% and 14% for NV, SV and RV respectively, whereas in the community setting the detection rate of RV was < 1%. Among each of the investigated viruses one particular genogroup or genotype was dominant; GII.4 (82%) for NV, GI (46%) for SV and G1P[8] (64%) in RV. These variants were also found in higher proportions in the hospital setting compared to the community setting. The GII.4.2006 Minerva strain circulating globally since 2006 was the most common among genotyped NV in this study, with the GII.4-2010 New Orleans emerging in 2010. Conclusions: This study shows that NV has become the leading viral cause of gastroenteritis at hospital and community settings in Nicaragua after implementation of RV vaccination.	[Bucardo, Filemon; Reyes, Yaoska] Univ Leon UNAN Leon, Dept Microbiol, Leon, Nicaragua; [Svensson, Lennart; Nordgren, Johan] Linkoping Univ, Div Mol Virol, Dept Clin & Expt Med, Linkoping, Sweden	Linkoping University	Nordgren, J (corresponding author), Linkoping Univ, Div Mol Virol, Dept Clin & Expt Med, Linkoping, Sweden.	johan.nordgren@liu.se	svensson, lennart/K-6163-2019; Bucardo, Filemon/AFK-4817-2022	Bucardo, Filemon/0000-0002-9819-870X	Network for Research and Training in Tropical Diseases in Central America (NeTropica) [05-N-2010]; Swedish Research Council [10392, 348-2011-7420]	Network for Research and Training in Tropical Diseases in Central America (NeTropica); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by grants from the Network for Research and Training in Tropical Diseases in Central America (NeTropica, Grant:05-N-2010) and Swedish Research Council (grants 10392 and 348-2011-7420). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker-Dreps S, 2013, AM J TROP MED HYG, V89, P246, DOI 10.4269/ajtmh.13-0026; Becker-Dreps S, 2011, AM J TROP MED HYG, V85, P957, DOI 10.4269/ajtmh.2011.11-0401; Becker-Dreps S, 2011, PEDIATR INFECT DIS J, V30, P243, DOI 10.1097/INF.0b013e3181f87ffe; Bucardo F, 2008, J CLIN MICROBIOL, V46, P2573, DOI 10.1128/JCM.00505-08; Bucardo F, 2012, EMERG INFECT DIS, V18, P1875, DOI 10.3201/eid1811.111581; Bucardo F, 2012, INFECT GENET EVOL, V12, P1282, DOI 10.1016/j.meegid.2012.03.007; Bucardo F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025962; Bucardo F, 2010, PEDIATR INFECT DIS J, V29, P934, DOI 10.1097/INF.0b013e3181ed9f2f; Chan MCW, 2006, J VIROL METHODS, V134, P146, DOI 10.1016/j.jviromet.2005.12.013; Desai R, 2012, CLIN INFECT DIS, V55, P189, DOI 10.1093/cid/cis372; GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Hemming M, 2013, EUR J PEDIATR, V172, P739, DOI 10.1007/s00431-013-1945-3; Hu LY, 2012, NATURE, V485, P256, DOI 10.1038/nature10996; Iturriza-Gomara M, 2004, J CLIN VIROL, V31, P259, DOI 10.1016/j.jcv.2004.04.009; Johnsen CK, 2009, J CLIN VIROL, V46, P265, DOI 10.1016/j.jcv.2009.07.008; Khamrin P, 2007, J MED VIROL, V79, P1921, DOI 10.1002/jmv.21004; Khawaja S, 2012, HUM VACC IMMUNOTHER, V8, P777, DOI 10.4161/hv.19757; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Koo Hoonmo L, 2013, J Pediatric Infect Dis Soc, V2, P57, DOI 10.1093/jpids/pis070; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Moreno-Espinosa Sarbelio, 2004, Semin Pediatr Infect Dis, V15, P237, DOI 10.1053/j.spid.2004.07.004; Nordgren J, 2008, J CLIN MICROBIOL, V46, P164, DOI 10.1128/JCM.01316-07; Okada M, 2006, ARCH VIROL, V151, P2503, DOI 10.1007/s00705-006-0820-1; Pang XL, 2001, PEDIATR INFECT DIS J, V20, P295, DOI 10.1097/00006454-200103000-00015; Pang XL, 1999, J PEDIATR GASTR NUTR, V29, P366, DOI 10.1097/00005176-199909000-00026; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Patel M, 2009, JAMA-J AM MED ASSOC, V301, P2243, DOI 10.1001/jama.2009.756; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Podkolzin AT, 2009, J INFECT DIS, V200, pS228, DOI 10.1086/605054; Sakai Y, 2001, PEDIATR INFECT DIS J, V20, P849, DOI 10.1097/00006454-200109000-00005; Samajdar S, 2006, J CLIN VIROL, V36, P183, DOI 10.1016/j.jcv.2006.03.006; Simpson R, 2003, J MED VIROL, V70, P258, DOI 10.1002/jmv.10386; Soares-Weiser K, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008521.pub3; Tam CC, 2012, CLIN INFECT DIS, V54, P1275, DOI 10.1093/cid/cis028; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Vesikari T, 2010, EUR J PEDIATR, V169, P1379, DOI 10.1007/s00431-010-1242-3; Vinje J, 2000, J CLIN MICROBIOL, V38, P530; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6; Zeng SQ, 2010, SCAND J INFECT DIS, V42, P540, DOI 10.3109/00365541003652556; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	44	125	127	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98201	10.1371/journal.pone.0098201	http://dx.doi.org/10.1371/journal.pone.0098201			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849288	Green Published, Green Submitted, gold			2022-12-25	WOS:000336730600097
J	Ishizu-Higashi, S; Seno, H; Nishi, E; Matsumoto, Y; Ikuta, K; Tsuda, M; Kimura, Y; Takada, Y; Kimura, Y; Nakanishi, Y; Kanda, K; Komekado, H; Chiba, T				Ishizu-Higashi, Shoko; Seno, Hiroshi; Nishi, Eiichiro; Matsumoto, Yoshihide; Ikuta, Kozo; Tsuda, Motoyuki; Kimura, Yoshito; Takada, Yutaka; Kimura, Yuto; Nakanishi, Yuki; Kanda, Keitaro; Komekado, Hideyuki; Chiba, Tsutomu			Deletion of Nardilysin Prevents the Development of Steatohepatitis and Liver Fibrotic Changes	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; GROWTH-FACTOR; TNF-ALPHA; ACTIVATION; INFLIXIMAB; OBESITY	Nonalcoholic steatohepatitis (NASH) is an inflammatory form of nonalcoholic fatty liver disease that progresses to liver cirrhosis. It is still unknown how only limited patients with fatty liver develop NASH. Tumor necrosis factor (TNF)-alpha is one of the key molecules in initiating the vicious circle of inflammations. Nardilysin (N-arginine dibasic convertase; Nrd1), a zinc metalloendopeptidase of the M16 family, enhances ectodomain shedding of TNF-alpha, resulting in the activation of inflammatory responses. In this study, we aimed to examine the role of Nrd1 in the development of NASH. Nrd1(+/+) and Nrd1(-/-) mice were fed a control choline-supplemented amino acid-defined (CSAA) diet or a choline-deficient amino acid-defined (CDAA) diet. Fatty deposits were accumulated in the livers of both Nrd1(+/+) and Nrd1(-/-) mice by the administration of the CSAA or CDAA diets, although the amount of liver triglyceride in Nrd1(-/-) mice was lower than that in Nrd1(+/+) mice. Serum alanine aminotransferase levels were increased in Nrd1(+/+) mice but not in Nrd1(-/-) mice fed the CDAA diet. mRNA expression of inflammatory cytokines were decreased in Nrd1(-/-) mice than in Nrd1(+/+) mice fed the CDAA diet. While TNF-alpha protein was detected in both Nrd1(+/+) and Nrd1(-/-) mouse livers fed the CDAA diet, secretion of TNF-alpha in Nrd1(-/-) mice was significantly less than that in Nrd1(+/+) mice, indicating the decreased TNF-alpha shedding in Nrd1(-/-) mouse liver. Notably, fibrotic changes of the liver, accompanied by the increase of fibrogenic markers, were observed in Nrd1(+/+) mice but not in Nrd1(-/-) mice fed the CDAA diet. Similar to the CDAA diet, fibrotic changes were not observed in Nrd1(-/-) mice fed a high-fat diet. Thus, deletion of nardilysin prevents the development of diet-induced steatohepatitis and liver fibrogenesis. Nardilysin could be an attractive target for anti-inflammatory therapy against NASH.	[Ishizu-Higashi, Shoko; Seno, Hiroshi; Matsumoto, Yoshihide; Ikuta, Kozo; Tsuda, Motoyuki; Kimura, Yoshito; Takada, Yutaka; Kimura, Yuto; Nakanishi, Yuki; Kanda, Keitaro; Komekado, Hideyuki; Chiba, Tsutomu] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan; [Nishi, Eiichiro] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan	Kyoto University; Kyoto University	Seno, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan.	seno@kuhp.kyoto-u.ac.jp; nishi@kuhp.kyoto-u.ac.jp	Nishi, Eiichiro/A-8246-2019	Nishi, Eiichiro/0000-0002-8188-8026; Seno, Hiroshi/0000-0002-8509-8128	Japan Society for the Promotion of Science (JSPS) KAKENHI [21229009, 23300117, 23590937, 24229005, 24590914, 24590916, 24659363, 25112707, 25130706, 25461021, 25860533, 26293173]; Research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Health and Labour Sciences Research Grants for Research on Intractable Diseases, Hepatitis; Funding Program for Next-Generation World-leading Researchers [LS075]; Ministry of Education, Culture, Science, Sports and Technology of Japan; Kobayashi Foundation for Cancer Research; Naito Foundation; Princess Takamatsu Cancer Research Foundation [13-24514]; Grants-in-Aid for Scientific Research [26670139, 26116715, 26293173] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Health and Labour Sciences Research Grants for Research on Intractable Diseases, Hepatitis; Funding Program for Next-Generation World-leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Science, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kobayashi Foundation for Cancer Research(Kobayashi Foundation for Cancer Research); Naito Foundation(Naito Memorial Foundation); Princess Takamatsu Cancer Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI 21229009, 23300117, 23590937, 24229005, 24590914, 24590916, 24659363, 25112707, 25130706, 25461021, 25860533, and 26293173; Research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Health and Labour Sciences Research Grants for Research on Intractable Diseases, Hepatitis, and The innovative development and the practical application of new drugs for hepatitis B from the Ministry of Health, Labour and Welfare, Japan; the Funding Program for Next-Generation World-leading Researchers (LS075), Grants-in Aid from the Ministry of Education, Culture, Science, Sports and Technology of Japan; Kobayashi Foundation for Cancer Research; The Naito Foundation; and Princess Takamatsu Cancer Research Foundation (13-24514). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Fujita K, 2008, GUT, V57, P1583, DOI 10.1136/gut.2007.144550; Hiraoka Y, 2008, BIOCHEM BIOPH RES CO, V370, P154, DOI 10.1016/j.bbrc.2008.03.050; Imajo K, 2012, CELL METAB, V16, P44, DOI 10.1016/j.cmet.2012.05.012; Ito M, 2006, HEPATOL RES, V34, P92, DOI 10.1016/j.hepres.2005.12.001; Kanda K, 2012, EMBO MOL MED, V4, P396, DOI 10.1002/emmm.201200216; Kodama Y, 2009, GASTROENTEROLOGY, V137, P1467, DOI 10.1053/j.gastro.2009.06.045; Kudo H, 2009, J HEPATOL, V51, P168, DOI 10.1016/j.jhep.2009.02.032; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Mallat A, 2013, AM J PHYSIOL-CELL PH, V305, pC789, DOI 10.1152/ajpcell.00230.2013; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Nishi E, 2001, EMBO J, V20, P3342, DOI 10.1093/emboj/20.13.3342; Nishi E, 2006, J BIOL CHEM, V281, P31164, DOI 10.1074/jbc.M601316200; Ohno M, 2009, NAT NEUROSCI, V12, P1506, DOI 10.1038/nn.2438; Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Tomita K, 2006, GUT, V55, P415, DOI 10.1136/gut.2005.071118; Younossi ZM, 2008, ALIMENT PHARM THER, V28, P2, DOI 10.1111/j.1365-2036.2008.03710.x	22	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98017	10.1371/journal.pone.0098017	http://dx.doi.org/10.1371/journal.pone.0098017			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849253	Green Published, Green Submitted, gold			2022-12-25	WOS:000336730600077
J	Yu, CJ; Kancha, RK; Duyster, J				Yu, Chuanjiang; Kancha, Rama Krishna; Duyster, Justus			Targeting Oncoprotein Stability Overcomes Drug Resistance Caused by FLT3 Kinase Domain Mutations	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; CLINICAL RESISTANCE; TANDEM DUPLICATION; INHIBITOR PKC412; SENSITIVITY; IDENTIFICATION; SORAFENIB; SUNITINIB; CELLS	FLT3 is the most frequently mutated kinase in acute myeloid leukemia (AML). Internal tandem duplications (ITDs) in the juxta-membrane region constitute the majority of activating FLT3 mutations. Several FLT3 kinase inhibitors were developed and tested in the clinic with significant success. However, recent studies have reported the development of secondary drug resistance in patients treated with FLT3 inhibitors. Since FLT3-ITD is an HSP90 client kinase, we here explored if targeting the stability of drug-resistant FLT3 mutant protein could be a potential therapeutic option. We observed that HSP90 inhibitor treatment resulted in the degradation of inhibitor-resistant FLT3-ITD mutants and selectively induced toxicity in cells expressing FLT3-ITD mutants. Thus, HSP90 inhibitors provide a potential therapeutic choice to overcome secondary drug resistance following TKI treatment in FLT3-ITD positive AML.	[Yu, Chuanjiang; Kancha, Rama Krishna; Duyster, Justus] Univ Med Ctr Freiburg, Dept Med 1, Freiburg, Germany	University of Freiburg	Duyster, J (corresponding author), Univ Med Ctr Freiburg, Dept Med 1, Freiburg, Germany.	direktion-med1@uniklinik-freiburg.de	Kancha, Rama Krishna/B-5992-2009	Kancha, Rama Krishna/0000-0001-8146-1551	Jose Carreras Leukamie-Stiftung	Jose Carreras Leukamie-Stiftung	JD is supported by a grant from the Jose Carreras Leukamie-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers C, 2013, LEUKEMIA, V27, P1416, DOI 10.1038/leu.2013.14; Cools J, 2004, CANCER RES, V64, P6385, DOI 10.1158/0008-5472.CAN-04-2148; George P, 2004, CANCER RES, V64, P3645, DOI 10.1158/0008-5472.CAN-04-0006; Heidel F, 2006, BLOOD, V107, P293, DOI 10.1182/blood-2005-06-2469; Kancha RK, 2007, EXP HEMATOL, V35, P1522, DOI 10.1016/j.exphem.2007.07.008; Knapper S, 2006, BLOOD, V108, P3262, DOI 10.1182/blood-2006-04-015560; Lierman E, 2007, HAEMATOL-HEMATOL J, V92, P27, DOI 10.3324/haematol.10692; Minami Y, 2002, LEUKEMIA, V16, P1535, DOI 10.1038/sj.leu.2402558; Moore AS, 2012, LEUKEMIA, V26, P1462, DOI 10.1038/leu.2012.52; Pauwels D, 2012, HAEMATOLOGICA, V35, P1522; Smith CC, 2013, BLOOD, V121, P3165, DOI 10.1182/blood-2012-07-442871; Smith CC, 2012, NATURE, V485, P260, DOI 10.1038/nature11016; Stone RM, 2005, BLOOD, V105, P54, DOI 10.1182/blood-2004-03-0891; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; von Bubnoff N, 2010, LEUKEMIA, V24, P1523, DOI 10.1038/leu.2010.122; von Bubnoff N, 2009, CANCER RES, V69, P3032, DOI 10.1158/0008-5472.CAN-08-2923; Wagner K, 2011, HAEMATOL-HEMATOL J, V96, P681, DOI 10.3324/haematol.2010.034074; Williams AB, 2013, LEUKEMIA, V27, P48, DOI 10.1038/leu.2012.191; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Yao Q, 2005, LEUKEMIA, V19, P1605, DOI 10.1038/sj.leu.2403881; Yao Q, 2003, CLIN CANCER RES, V9, P4483; Zhang WG, 2008, JNCI-J NATL CANCER I, V100, P184, DOI 10.1093/jnci/djm328	24	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97116	10.1371/journal.pone.0097116	http://dx.doi.org/10.1371/journal.pone.0097116			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849514	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600021
J	Eguchi, T; Yoshizawa, A; Kawakami, S; Kumeda, H; Umesaki, T; Agatsuma, H; Sakaizawa, T; Tominaga, Y; Toishi, M; Hashizume, M; Shiina, T; Yoshida, K; Asaka, S; Matsushita, M; Koizumi, T				Eguchi, Takashi; Yoshizawa, Akihiko; Kawakami, Satoshi; Kumeda, Hirotaka; Umesaki, Tetsuya; Agatsuma, Hiroyuki; Sakaizawa, Takao; Tominaga, Yoshiaki; Toishi, Masayuki; Hashizume, Masahiro; Shiina, Takayuki; Yoshida, Kazuo; Asaka, Shiho; Matsushita, Mina; Koizumi, Tomonobu			Tumor Size and Computed Tomography Attenuation of Pulmonary Pure Ground-Glass Nodules Are Useful for Predicting Pathological Invasiveness	PLOS ONE			English	Article							HIGH-RESOLUTION CT; THIN-SECTION CT; LUNG-CANCER; FLEISCHNER-SOCIETY; FOLLOW-UP; ADENOCARCINOMA; OPACITY; CLASSIFICATION; EFFICACY; SCREEN	Objectives: Pulmonary ground-glass nodules (GGNs) are occasionally diagnosed as invasive adenocarcinomas. This study aimed to evaluate the clinicopathological features of patients with pulmonary GGNs to identify factors predictive of pathological invasion. Methods: We retrospectively evaluated 101 pulmonary GGNs resected between July 2006 and November 2013 and pathologically classified them as adenocarcinoma in situ (AIS; n = 47), minimally invasive adenocarcinoma (MIA; n = 30), or invasive adenocarcinoma (I-ADC; n = 24). The age, sex, smoking history, tumor size, and computed tomography (CT) attenuation of the 3 groups were compared. Receiver operating characteristic (ROC) curve analyses were performed to identify factors that could predict the presence of pathologically invasive adenocarcinomas. Results: Tumor size was significantly larger in the MIA and I-ADC groups than in the AIS group. CT attenuation was significantly greater in the I-ADC group than in the AIS and MIA groups. In ROC curve analyses, the sensitivity and specificity of tumor size (cutoff, 11 mm) were 95.8% and 46.8%, respectively, and those for CT attenuation (cutoff, -680 HU) were 95.8% and 35.1%, respectively; the areas under the curve (AUC) were 0.75 and 0.77, respectively. A combination of tumor size and CT attenuation (cutoffs of 11 mm and -680 HU for tumor size and CT attenuation, respectively) yielded in a sensitivity and specificity of 91.7% and 71.4%, respectively, with an AUC of 0.82. Conclusions: Tumor size and CT attenuation were predictive factors of pathological invasiveness for pulmonary GGNs. Use of a combination of tumor size and CT attenuation facilitated more accurate prediction of invasive adenocarcinoma than the use of these factors independently.	[Eguchi, Takashi; Kumeda, Hirotaka; Umesaki, Tetsuya; Agatsuma, Hiroyuki; Sakaizawa, Takao; Tominaga, Yoshiaki; Toishi, Masayuki; Hashizume, Masahiro; Shiina, Takayuki; Yoshida, Kazuo] Shinshu Univ, Dept Surg, Div Thorac Surg, Matsumoto, Nagano 390, Japan; [Yoshizawa, Akihiko; Asaka, Shiho] Shinshu Univ, Dept Pathol, Matsumoto, Nagano 390, Japan; [Kawakami, Satoshi; Matsushita, Mina] Shinshu Univ, Dept Radiol, Matsumoto, Nagano 390, Japan; [Koizumi, Tomonobu] Shinshu Univ, Ctr Comprehens Canc, Matsumoto, Nagano 390, Japan	Shinshu University; Shinshu University; Shinshu University; Shinshu University	Eguchi, T (corresponding author), Shinshu Univ, Dept Surg, Div Thorac Surg, Matsumoto, Nagano 390, Japan.	tks1976@shinshu-u.ac.jp	Asaka, Shiho/W-2061-2018; Yoshizawa, Akihiko/AAM-9519-2020; Eguchi, Takashi/AAS-9215-2021	Asaka, Shiho/0000-0003-2697-114X; Eguchi, Takashi/0000-0001-9460-0696				Chang B, 2013, CHEST, V143, P172, DOI 10.1378/chest.11-2501; Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Kondo R, 2011, LUNG CANCER, V74, P433, DOI 10.1016/j.lungcan.2011.05.007; Kondo R, 2011, LUNG CANCER, V74, P426, DOI 10.1016/j.lungcan.2011.05.006; Lee HJ, 2007, KOREAN J RADIOL, V8, P22, DOI 10.3348/kjr.2007.8.1.22; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; Nakajima R, 2002, J COMPUT ASSIST TOMO, V26, P323, DOI 10.1097/00004728-200205000-00001; Noguchi M, 2010, CANCER METAST REV, V29, P15, DOI 10.1007/s10555-010-9210-y; Okada M, 2006, J THORAC CARDIOV SUR, V132, P769, DOI 10.1016/j.jtcvs.2006.02.063; Park CM, 2007, RADIOGRAPHICS, V27, P391, DOI 10.1148/rg.272065061; Suzuki K, 2000, ANN THORAC SURG, V69, P893, DOI 10.1016/S0003-4975(99)01331-4; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Yang ZG, 2001, AM J ROENTGENOL, V176, P1399, DOI 10.2214/ajr.176.6.1761399; Yoshizawa A, 2011, MODERN PATHOL, V24, P653, DOI 10.1038/modpathol.2010.232	15	47	66	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97867	10.1371/journal.pone.0097867	http://dx.doi.org/10.1371/journal.pone.0097867			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846292	Green Published, gold, Green Submitted			2022-12-25	WOS:000339563400068
J	Oh-oka, K; Kono, H; Ishimaru, K; Miyake, K; Kubota, T; Ogawa, H; Okumura, K; Shibata, S; Nakao, A				Oh-oka, Kyoko; Kono, Hiroshi; Ishimaru, Kayoko; Miyake, Kunio; Kubota, Takeo; Ogawa, Hideoki; Okumura, Ko; Shibata, Shigenobu; Nakao, Atsuhito			Expressions of Tight Junction Proteins Occludin and Claudin-1 Are under the Circadian Control in the Mouse Large Intestine: Implications in Intestinal Permeability and Susceptibility to Colitis	PLOS ONE			English	Article							DIRECT ASSOCIATION; EPITHELIAL-CELLS; BARRIER FUNCTION; GENE-EXPRESSION; DISEASE; CLOCK; MICE; LIVER; COMPONENT; REVEALS	Background & Aims: The circadian clock drives daily rhythms in behavior and physiology. A recent study suggests that intestinal permeability is also under control of the circadian clock. However, the precise mechanisms remain largely unknown. Because intestinal permeability depends on tight junction (TJ) that regulates the epithelial paracellular pathway, this study investigated whether the circadian clock regulates the expression levels of TJ proteins in the intestine. Methods: The expression levels of TJ proteins in the large intestinal epithelium and colonic permeability were analyzed every 4, 6, or 12 hours between wild-type mice and mice with a mutation of a key clock gene Period2 (Per2; mPer2(m/m)). In addition, the susceptibility to dextran sodium sulfate (DSS)-induced colitis was compared between wild-type mice and mPer2(m/m) mice. Results: The mRNA and protein expression levels of Occludin and Claudin-1 exhibited daily variations in the colonic epithelium in wild-type mice, whereas they were constitutively high in mPer2(m/m) mice. Colonic permeability in wild-type mice exhibited daily variations, which was inversely associated with the expression levels of Occludin and Claudin-1 proteins, whereas it was constitutively low in mPer2(m/m) mice. mPer2(m/m) mice were more resistant to the colonic injury induced by DSS than wild-type mice. Conclusions: Occludin and Claudin-1 expressions in the large intestine are under the circadian control, which is associated with temporal regulation of colonic permeability and also susceptibility to colitis.	[Oh-oka, Kyoko; Ishimaru, Kayoko; Nakao, Atsuhito] Univ Yamanashi, Fac Med, Dept Immunol, Yamanashi, Japan; [Kono, Hiroshi] Univ Yamanashi, Fac Med, Dept Surg 1, Yamanashi, Japan; [Miyake, Kunio; Kubota, Takeo] Univ Yamanashi, Fac Med, Dept Epigenet Med, Yamanashi, Japan; [Ogawa, Hideoki; Okumura, Ko; Nakao, Atsuhito] Juntendo Univ, Sch Med, Atopy Res Ctr, Tokyo 113, Japan; [Shibata, Shigenobu] Waseda Univ, Sch Adv Sci & Engn, Dept Physiol & Pharmacol, Tokyo, Japan	University of Yamanashi; University of Yamanashi; University of Yamanashi; Juntendo University; Waseda University	Nakao, A (corresponding author), Univ Yamanashi, Fac Med, Dept Immunol, Yamanashi, Japan.	anakao@yamanashi.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [H25]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (H25). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop BL, 2010, BIOCHEM BIOPH RES CO, V394, P254, DOI 10.1016/j.bbrc.2010.02.091; COOPER HS, 1993, LAB INVEST, V69, P238; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Henderson P, 2011, INFLAMM BOWEL DIS, V17, P382, DOI 10.1002/ibd.21379; Hogenesch JB, 2011, NAT REV GENET, V12, P407, DOI 10.1038/nrg2972; Hoogerwerf Willemijntje A, 2006, Curr Gastroenterol Rep, V8, P353, DOI 10.1007/s11894-006-0019-3; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; KOMANO H, 1995, P NATL ACAD SCI USA, V92, P6147, DOI 10.1073/pnas.92.13.6147; Kono H, 2003, ANN SURG, V237, P246, DOI 10.1097/00000658-200302000-00014; Kovalenko OV, 2007, MOL CELL PROTEOMICS, V6, P1855, DOI 10.1074/mcp.M700183-MCP200; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; Mennigen R, 2009, AM J PHYSIOL-GASTR L, V296, pG1140, DOI 10.1152/ajpgi.90534.2008; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Pan XY, 2013, J BIOL CHEM, V288, P20464, DOI 10.1074/jbc.M113.473454; Ramirez SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055972; Saitou M, 1998, J CELL BIOL, V141, P397, DOI 10.1083/jcb.141.2.397; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Summa KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067102; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Takamura T, 2010, IMMUNOL CELL BIOL, V88, P685, DOI 10.1038/icb.2010.35; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	32	73	78	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98016	10.1371/journal.pone.0098016	http://dx.doi.org/10.1371/journal.pone.0098016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845399	Green Published, gold, Green Submitted			2022-12-25	WOS:000339563400081
J	Walia, RR; Xue, LC; Wilkins, K; El-Manzalawy, Y; Dobbs, D; Honavar, V				Walia, Rasna R.; Xue, Li C.; Wilkins, Katherine; El-Manzalawy, Yasser; Dobbs, Drena; Honavar, Vasant			RNABindRPlus: A Predictor that Combines Machine Learning and Sequence Homology-Based Methods to Improve the Reliability of Predicted RNA-Binding Residues in Proteins	PLOS ONE			English	Article							LONG NONCODING RNAS; CD-HIT; SITES; INTERFACE; TRANSLATION; SERVER; IDENTIFICATION; INFORMATION; PROPENSITY; GENERATION	Protein-RNA interactions are central to essential cellular processes such as protein synthesis and regulation of gene expression and play roles in human infectious and genetic diseases. Reliable identification of protein-RNA interfaces is critical for understanding the structural bases and functional implications of such interactions and for developing effective approaches to rational drug design. Sequence-based computational methods offer a viable, cost-effective way to identify putative RNA-binding residues in RNA-binding proteins. Here we report two novel approaches: (i) HomPRIP, a sequence homology-based method for predicting RNA-binding sites in proteins; (ii) RNABindRPlus, a new method that combines predictions from HomPRIP with those from an optimized Support Vector Machine (SVM) classifier trained on a benchmark dataset of 198 RNA-binding proteins. Although highly reliable, HomPRIP cannot make predictions for the unaligned parts of query proteins and its coverage is limited by the availability of close sequence homologs of the query protein with experimentally determined RNA-binding sites. RNABindRPlus overcomes these limitations. We compared the performance of HomPRIP and RNABindRPlus with that of several state-of-the-art predictors on two test sets, RB44 and RB111. On a subset of proteins for which homologs with experimentally determined interfaces could be reliably identified, HomPRIP outperformed all other methods achieving an MCC of 0.63 on RB44 and 0.83 on RB111. RNABindRPlus was able to predict RNA-binding residues of all proteins in both test sets, achieving an MCC of 0.55 and 0.37, respectively, and outperforming all other methods, including those that make use of structure-derived features of proteins. More importantly, RNABindRPlus outperforms all other methods for any choice of tradeoff between precision and recall. An important advantage of both HomPRIP and RNABindRPlus is that they rely on readily available sequence and sequence-derived features of RNA-binding proteins. A webserver implementation of both methods is freely available at http://einstein.cs.iastate.edu/RNABindRPlus/.	[Walia, Rasna R.; Dobbs, Drena] Iowa State Univ, Bioinformat & Computat Biol Program, Ames, IA 50011 USA; [Walia, Rasna R.] Iowa State Univ, Dept Comp Sci, Ames, IA USA; [Xue, Li C.; Honavar, Vasant] Penn State Univ, Coll Informat Sci & Technol, University Pk, PA 16802 USA; [Wilkins, Katherine] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY USA; [Wilkins, Katherine] Cornell Univ, Grad Field Computat Biol, Ithaca, NY USA; [El-Manzalawy, Yasser] Al Azhar Univ, Dept Syst & Comp Engn, Cairo, Egypt; [Dobbs, Drena] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA USA; [Honavar, Vasant] Penn State Univ, Bioinformat & Genom Grad Program, University Pk, PA 16802 USA; [Honavar, Vasant] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA	Iowa State University; Iowa State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Cornell University; Cornell University; Egyptian Knowledge Bank (EKB); Al Azhar University; Iowa State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Walia, RR (corresponding author), Iowa State Univ, Bioinformat & Computat Biol Program, Ames, IA 50011 USA.	rwalia@iastate.edu	Xue, LI C./ABG-4802-2021; Honavar, Vasant G/K-9835-2015; El-Manzalawy, Yasser/ABE-3489-2020	Xue, LI C./0000-0002-2613-538X; Honavar, Vasant G/0000-0001-5399-3489; Walia, Rasna/0000-0001-7088-5535; Dobbs, Drena/0000-0003-4404-9554	National Institutes of Health [GM066387]; Iowa State University Center for Computational Intelligence, Learning, and Discovery; National Science Foundation [DGE 0504304]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM066387, R33GM066387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Iowa State University Center for Computational Intelligence, Learning, and Discovery; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by the National Institutes of Health grant GM066387 to VH and DD and by a research assistantship to RRW and LCX funded by the Iowa State University Center for Computational Intelligence, Learning, and Discovery. This research was also supported in part by an Integrative Graduate Education and Research Training (IGERT) fellowship to KW, provided by the National Science Foundation grant (DGE 0504304). The research of VH, while working at the National Science Foundation (during 2010-2013) was supported by the Foundation, and at Pennsylvania State University by the Edward Frymoyer Chair of Information Sciences and Technology. Any opinions, findings, and conclusions contained in this article are those of the authors and do not necessarily reflect the views of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrade MA, 1999, ISMB, P28; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Caragea C, 2007, PROCEEDINGS OF THE 7TH IEEE INTERNATIONAL SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, VOLS I AND II, P320; Carson MB, 2010, NUCLEIC ACIDS RES, V38, pW431, DOI 10.1093/nar/gkq361; Cheetham SW, 2013, BRIT J CANCER, V108, P2419, DOI 10.1038/bjc.2013.233; Cheng CW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S6; Denison MR, 2008, PLOS BIOL, V6, P2098, DOI 10.1371/journal.pbio.0060270; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Galicia-Vazquez G, 2009, ANAL BIOCHEM, V384, P180, DOI 10.1016/j.ab.2008.09.037; Grigull J, 2004, MOL CELL BIOL, V24, P5534, DOI 10.1128/MCB.24.12.5534-5547.2004; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Iwasaki A, 2012, ANNU REV MICROBIOL, V66, P177, DOI 10.1146/annurev-micro-092611-150203; Jeong EN, 2006, LECT NOTES COMPUT SC, V3939, P123; Jeong Euna, 2004, Genome Inform, V15, P105; Jordan RA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-41; Kauffman C, 2009, BIOINFORMATICS, V25, P3099, DOI 10.1093/bioinformatics/btp561; Ke A, 2004, METHODS, V34, P408, DOI 10.1016/j.ymeth.2004.03.027; Kechavarzi B, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r14; Khalil AM, 2011, SEMIN CELL DEV BIOL, V22, P359, DOI 10.1016/j.semcdb.2011.02.016; Kim OTP, 2006, NUCLEIC ACIDS RES, V34, P6450, DOI 10.1093/nar/gkl819; Konc J, 2010, BIOINFORMATICS, V26, P1160, DOI 10.1093/bioinformatics/btq100; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; Leung DW, 2012, TRENDS MICROBIOL, V20, P139, DOI 10.1016/j.tim.2011.12.005; Lewis BA, 2011, NUCLEIC ACIDS RES, V39, pD277, DOI 10.1093/nar/gkq1108; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Ma X, 2011, PROTEINS, V79, P1230, DOI 10.1002/prot.22958; Maetschke SR, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-341; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Mitra Sheetal A., 2012, Frontiers in Genetics, V3, P17, DOI 10.3389/fgene.2012.00017; Muers M, 2008, NAT REV GENET, V9, DOI 10.1038/nrg2494; Mukherjee S, 2011, STRUCTURE, V19, P955, DOI 10.1016/j.str.2011.04.006; Murakami Y, 2010, NUCLEIC ACIDS RES, V38, pW412, DOI 10.1093/nar/gkq474; Nagy PD, 2012, NAT REV MICROBIOL, V10, P137, DOI 10.1038/nrmicro2692; Perez-Cano L, 2010, PROTEINS, V78, P25, DOI 10.1002/prot.22527; Puton T, 2012, J STRUCT BIOL, V179, P261, DOI 10.1016/j.jsb.2011.10.001; Schonrock N, 2012, CELL MOL LIFE SCI, V69, P3543, DOI 10.1007/s00018-012-1125-z; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Spriggs RV, 2009, BIOINFORMATICS, V25, P1492, DOI 10.1093/bioinformatics/btp257; Spriggs RV, 2009, COMPUT BIOL CHEM, V33, P397, DOI 10.1016/j.compbiolchem.2009.07.012; STANDART N, 1994, BIOCHIMIE, V76, P867, DOI 10.1016/0300-9084(94)90189-9; Tadros W, 2007, DEV CELL, V12, P143, DOI 10.1016/j.devcel.2006.10.005; Tan L, 2013, MOL NEUROBIOL, V47, P382, DOI 10.1007/s12035-012-8359-5; Terribilini M, 2007, NUCLEIC ACIDS RES, V35, pW578, DOI 10.1093/nar/gkm294; Terribilini M, 2006, RNA, V12, P1450, DOI 10.1261/rna.2197306; Towfic F, 2010, INT J DATA MIN BIOIN, V4, P21, DOI 10.1504/IJDMB.2010.030965; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Van Roosbroeck K, 2013, EXPERT REV MOL DIAGN, V13, P183, DOI [10.1586/ERM.12.134, 10.1586/erm.12.134]; Walia RR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-89; Wang CC, 2011, AMINO ACIDS, V40, P239, DOI 10.1007/s00726-010-0639-7; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; WANG L, 2006, C P IEEE ENG MED BIO, V1, P5830, DOI DOI 10.1109/IEMBS.2006.260025; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; Wang LJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S3; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Wu HH, 2005, METHOD ENZYMOL, V394, P525, DOI 10.1016/S0076-6879(05)94022-6; Xue LC, 2014, PROTEINS, V82, P250, DOI 10.1002/prot.24370; Xue LC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-244; Zehetner G, 2003, NUCLEIC ACIDS RES, V31, P3799, DOI 10.1093/nar/gkg555; Zhang QC, 2011, NUCLEIC ACIDS RES, V39, pW283, DOI 10.1093/nar/gkr311; Zhang QC, 2010, P NATL ACAD SCI USA, V107, P10896, DOI 10.1073/pnas.1005894107; Zhao HY, 2011, NUCLEIC ACIDS RES, V39, P3017, DOI 10.1093/nar/gkq1266	70	69	70	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97725	10.1371/journal.pone.0097725	http://dx.doi.org/10.1371/journal.pone.0097725			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846307	Green Published, Green Submitted, gold			2022-12-25	WOS:000339563400050
J	Wu, SQ; Tao, AZ; Jiang, H; Xu, Z; Perez, V; Wang, JH				Wu, Shuangqing; Tao, Aizhu; Jiang, Hong; Xu, Zhe; Perez, Victor; Wang, Jianhua			Vertical and Horizontal Corneal Epithelial Thickness Profile Using Ultra-High Resolution and Long Scan Depth Optical Coherence Tomography	PLOS ONE			English	Article							FREQUENCY DIGITAL ULTRASOUND; IN-VIVO; BOWMANS LAYER; TOPOGRAPHICAL THICKNESS; HIGH-SPEED; REPEATABILITY; EYES; ARTEMIS; MYOPIA; WEAR	Purpose: To determine the vertical and horizontal thickness profiles of the corneal epithelium in vivo using ultra-long scan depth and ultra-high resolution spectral domain optical coherence tomography (SD-OCT). Methods: A SD-OCT was developed with an axial resolution of similar to 3.3 mu m in tissue and an extended scan depth. Forty-two eyes of 21 subjects were imaged twice. The entire horizontal and vertical corneal epithelial thickness profiles were evaluated. The coefficient of repeatability (CoR) and intraclass correlation (ICC) of the tests and interobserver variability were analyzed. Results: The full width of the horizontal epithelium was detected, whereas part of the superior epithelium was not shown for the covered super eyelid. The mean central epithelial corneal thickness was 52.0 +/- 3.2 mu m for the first measurement and 52.36 +/- 3.4 mu m for the second measurement (P>.05). In the central zone (0-3.0 mm), the paracentral zones (3.0-6.0 mm) and the peripheral zones (6.0-10.0 mm), the mean epithelial thickness ranged from 51 to 53 mu m, 52 to 57 mu m, and 58 to 72 mu m, respectively. There was no difference between the two tests at both meridians and in the right and left eyes (P>.05). The ICCs of the two tests ranged from 0.70 to 0.97 and the CoRs ranged from 2.5 mu m to 7.8 mu m from the center to the periphery, corresponding to 5.6% to 10.6% (CoR%). The ICCs of the two observers ranged from 0.72 to 0.93 and the CoRs ranged from 4.5 mu m to 10.4 mu m from the center to the periphery, corresponding to 8.7% to 15.2% (CoR%). Conclusions: This study demonstrated good repeatability of ultra-high resolution and long scan depth SD-OCT to evaluate the entire thickness profiles of the corneal epithelium. The epithelial thickness increases from the center toward the limbus.	[Wu, Shuangqing] Red Cross Hosp, Dept Ophthalmol, Hangzhou, Zhejiang, Peoples R China; [Wu, Shuangqing; Tao, Aizhu; Jiang, Hong; Xu, Zhe; Perez, Victor; Wang, Jianhua] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Tao, Aizhu; Xu, Zhe] Wenzhou Med Coll, Sch Ophthalmol & Optometry, Wenzhou, Peoples R China	Bascom Palmer Eye Institute; University of Miami; Wenzhou Medical University	Wang, JH (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	jwang3@med.miami.edu	Perez, Victor L./AAY-8633-2020		NIH [EY021012, EY021336, EY020607S]; NIH Center [P30 EY014801]; Research to Prevent Blindness (RPB); Hangzhou Red-Cross Hospital, Hangzhou, China; NATIONAL EYE INSTITUTE [P30EY014801, R21EY021012, R21EY021336] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); Hangzhou Red-Cross Hospital, Hangzhou, China; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by research grants in part from the NIH EY021012, EY021336 and EY020607S, NIH Center Grant P30 EY014801, Research to Prevent Blindness (RPB). A visiting scholar award for Dr. Shuangqing Wu was provided by the Hangzhou Red-Cross Hospital, Hangzhou, China. The funding organizations had no role in the design or conduct of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen WL, 2011, INVEST OPHTH VIS SCI, V52, P3640, DOI 10.1167/iovs.10-6390; Du CX, 2012, CORNEA, V31, P1036, DOI 10.1097/ICO.0b013e31823f8d56; Feng YW, 2001, CORNEA, V20, P480, DOI 10.1097/00003226-200107000-00008; Francoz M, 2011, INVEST OPHTH VIS SCI, V52, P9116, DOI 10.1167/iovs.11-7988; Ge LL, 2013, INVEST OPHTH VIS SCI, V54, P746, DOI 10.1167/iovs.11-9308; Haque S, 2008, OPTOMETRY VISION SCI, V85, P963, DOI 10.1097/OPX.0b013e318188892c; Hutchings N, 2010, INVEST OPHTH VIS SCI, V51, P4579, DOI 10.1167/iovs.09-4676; IZATT JA, 1994, ARCH OPHTHALMOL-CHIC, V112, P1584, DOI 10.1001/archopht.1994.01090240090031; Kanellopoulos AJ, 2014, AM J OPHTHALMOL, V157, P63, DOI 10.1016/j.ajo.2013.08.025; Li Y, 2012, OPHTHALMOLOGY, V119, P2425, DOI 10.1016/j.ophtha.2012.06.023; Lian Y, 2013, INVEST OPHTH VIS SCI, V54, P691, DOI 10.1167/iovs.12-10263; Lohmann CP, 1999, J CATARACT REFR SURG, V25, P712, DOI 10.1016/S0886-3350(99)00014-0; Ma XJ, 2013, CORNEA, V32, P1544, DOI 10.1097/ICO.0b013e3182a7f39d; Maldonado MJ, 2000, OPHTHALMOLOGY, V107, P81, DOI 10.1016/S0161-6420(99)00022-6; Prakash G, 2012, INVEST OPHTH VIS SCI, V53, P2580, DOI 10.1167/iovs.11-8981; Reinstein DZ, 2008, J REFRACT SURG, V24, P571, DOI 10.3928/1081597X-20080601-05; Reinstein DZ, 2010, J REFRACT SURG, V26, P646, DOI 10.3928/1081597X-20091105-01; Rocha KM, 2013, J REFRACT SURG, V29, P173, DOI 10.3928/1081597X-20130129-08; Schmoll T, 2012, OPTOMETRY VISION SCI, V89, pE795, DOI 10.1097/OPX.0b013e3182504346; Shen MX, 2010, EYE CONTACT LENS, V36, P73, DOI 10.1097/ICL.0b013e3181d0423e; Sin S, 2006, OPTOMETRY VISION SCI, V83, P360, DOI 10.1097/01.opx.0000221388.26031.23; Tao AZ, 2013, EYE CONTACT LENS, V39, P329, DOI 10.1097/ICL.0b013e31829fae00; Tao AZ, 2013, CLIN OPHTHALMOL, V7, P1623, DOI 10.2147/OPTH.S45122; Tao AZ, 2011, INVEST OPHTH VIS SCI, V52, P3901, DOI 10.1167/iovs.09-4748; Wang JH, 2003, INVEST OPHTH VIS SCI, V44, P4742, DOI 10.1167/iovs.03-0239; Wang JH, 2003, INVEST OPHTH VIS SCI, V44, P1070, DOI 10.1167/iovs.02-0343; Wang JH, 2002, AM J OPHTHALMOL, V133, P315, DOI 10.1016/S0002-9394(01)01382-4; Westphal V, 2002, OPT EXPRESS, V10, P397, DOI 10.1364/OE.10.000397; WILSON G, 1980, INVEST OPHTH VIS SCI, V19, P414	29	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97962	10.1371/journal.pone.0097962	http://dx.doi.org/10.1371/journal.pone.0097962			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844566	Green Published, Green Submitted, gold			2022-12-25	WOS:000339563400075
J	Chen, Q; Zhang, XB; Zhao, YL; Zhou, X; Sun, LN; Zeng, SJ; Zuo, MX; Zhang, XW				Chen, Qiong; Zhang, Xuebo; Zhao, Yueliu; Zhou, Xin; Sun, Lina; Zeng, Shaoju; Zuo, Mingxue; Zhang, Xinwen			Sexual Differences in Cell Proliferation in the Ventricular Zone, Cell Migration and Differentiation in the HVC of Juvenile Bengalese Finch	PLOS ONE			English	Article							SONG-CONTROL NUCLEUS; ZEBRA FINCH; NEUROTROPHIC FACTOR; NEURONS BORN; DIMORPHIC EXPRESSION; GANGLIONIC EMINENCE; BRAIN; ESTROGEN; BDNF; SYSTEM	Song control nuclei have distinct sexual differences and thus are an ideal model to address how brain areas are sexually differentiated. Through a combination of histological analysis and electrical lesions, we first identified the ventricle site for HVC progenitor cells. We then found that there were significant sex differences in the cellular proliferation activity in the ventricular zone of the HVC, the number of migrating cells along the radial cells (positive immunoreactions to vimentin) and differentiation towards neurons. Through co-culturing of male and female slices containing the developing HVC in the same well, we found that the male slices could produce diffusible substances to masculinize the female HVC. By adding estrogen, an estrogen antagonist, brain-derived neurotrophic factor (BDNF) or its antibody into the culture medium, separately or in combination, we found that these diffusible substances may include estrogen and BDNF. Finally, we found that 1) estrogen-induced BDNF upregulation could be detected 48 hr after estrogen treatment and could not be blocked by a vascular endothelial growth factor (VEGF) receptor inhibitor and 2) the amount of VEGF mRNA expressed in the developing HVC and its adjacent area did not display any significant sex differences, as did the distribution of VEGF and laminin-expressing endothelial cells in the developing HVC. Because these findings are largely different from previous reports on the adult female HVC, it is suggested that our estrogen-induced BDNF up-regulation and the resultant sexual differentiation might not be mediated by VEGF and endothelial cells, but instead, may result from the direct effects of estrogen on BDNF.	[Chen, Qiong; Zhang, Xuebo; Zhao, Yueliu; Zhou, Xin; Sun, Lina; Zeng, Shaoju; Zuo, Mingxue] Beijing Normal Univ, Beijing Key Lab Gene Resource & Mol Dev, Beijing 100875, Peoples R China; [Zhang, Xuebo; Zhang, Xinwen] Hainan Normal Univ, Coll Life Sci, Haikou, Peoples R China; [Chen, Qiong] Guangzhou Med Univ, Affiliated Hosp 3, Dept Lab Med, Guangzhou, Guangdong, Peoples R China	Beijing Normal University; Hainan Normal University; Guangzhou Medical University	Zeng, SJ (corresponding author), Beijing Normal Univ, Beijing Key Lab Gene Resource & Mol Dev, Beijing 100875, Peoples R China.	sjzeng@bnu.edu.cn; mxzuo@bnu.edu.cn			National Natural Science Foundation of China [31172082, 31372200, 31160205, 31360517, 31360243, 37212310]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [85032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by the National Natural Science Foundation of China to SJ Zeng (No: 31172082 and 31372200), XW Zhang (No: 31160205 and 31360517), XB Zhang (No: 31360243), and MX Zuo (No: 37212310), and by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry to SJ Zeng (No: 85032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADKINSREGAN E, 1994, J NEUROBIOL, V25, P865, DOI 10.1002/neu.480250710; Akutagawa E, 1998, P NATL ACAD SCI USA, V95, P11429, DOI 10.1073/pnas.95.19.11429; ALVAREZBUYLLA A, 1988, NATURE, V335, P353, DOI 10.1038/335353a0; ALVAREZBUYLLA A, 1990, NEURON, V5, P101, DOI 10.1016/0896-6273(90)90038-H; ALVAREZBUYLLA A, 1994, J COMP NEUROL, V347, P233, DOI 10.1002/cne.903470207; AlvarezBuylla A, 1997, J NEUROBIOL, V33, P585, DOI 10.1002/(SICI)1097-4695(19971105)33:5<585::AID-NEU7>3.0.CO;2-0; Arnold AP, 2012, TRENDS GENET, V28, P55, DOI 10.1016/j.tig.2011.10.004; BALABAN E, 1988, SCIENCE, V241, P1339, DOI 10.1126/science.3413496; BREEDLOVE SM, 2002, BEHAV ENDOCRINOLOGY, P75; BROWN SD, 1993, J NEUROSCI, V13, P2024; BUREK MJ, 1995, DEV BRAIN RES, V85, P220, DOI 10.1016/0165-3806(94)00215-L; Burek MJ, 1997, J NEUROBIOL, V33, P61; BUREK MJ, 1994, DEV BRAIN RES, V78, P57, DOI 10.1016/0165-3806(94)90009-4; Chen XQ, 2005, P NATL ACAD SCI USA, V102, P7730, DOI 10.1073/pnas.0408350102; Chue J, 2011, FEBS J, V278, P1027, DOI 10.1111/j.1742-4658.2011.08032.x; Cobos I, 2001, DEV BIOL, V239, P30, DOI 10.1006/dbio.2001.0422; Cooke B, 1998, FRONT NEUROENDOCRIN, V19, P323, DOI 10.1006/frne.1998.0171; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; DeWulf V, 2005, J COMP NEUROL, V481, P70, DOI 10.1002/cne.20352; DeWulf V, 2002, J NEUROSCI, V22, P4080, DOI 10.1523/JNEUROSCI.22-10-04080.2002; Dittrich F, 1999, P NATL ACAD SCI USA, V96, P8241, DOI 10.1073/pnas.96.14.8241; Fridolfsson AK, 1998, P NATL ACAD SCI USA, V95, P8147, DOI 10.1073/pnas.95.14.8147; Gahr M, 1999, J NEUROSCI, V19, P2628; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; GRISHAM W, 1995, J NEUROBIOL, V26, P163, DOI 10.1002/neu.480260202; Hartog TE, 2009, J NEUROSCI, V29, P15511, DOI 10.1523/JNEUROSCI.2564-09.2009; Holloway CC, 2001, NAT NEUROSCI, V4, P170, DOI 10.1038/84001; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Jiang JW, 1998, J NEUROBIOL, V36, P1, DOI 10.1002/(SICI)1097-4695(199807)36:1<1::AID-NEU1>3.0.CO;2-6; Kalman M, 1998, ANAT EMBRYOL, V198, P213, DOI 10.1007/s004290050179; Kashimada K, 2010, DEVELOPMENT, V137, P3921, DOI 10.1242/dev.048983; Kirn JR, 1999, J COMP NEUROL, V411, P487; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Lindholm D, 1996, EUR J NEUROSCI, V8, P1452, DOI 10.1111/j.1460-9568.1996.tb01607.x; Linnarsson S, 2000, MOL BRAIN RES, V75, P61, DOI 10.1016/S0169-328X(99)00295-8; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Mahadevaiah SK, 1998, HUM MOL GENET, V7, P715, DOI 10.1093/hmg/7.4.715; MIRANDA RC, 1993, P NATL ACAD SCI USA, V90, P6439, DOI 10.1073/pnas.90.14.6439; MOONEY R, 1994, J NEUROSCI, V14, P6532; Nixdorf-Bergweiler BE., 2007, STEREOTAXIC ATLAS BR; NORDEEN EJ, 1989, DEV BRAIN RES, V49, P27, DOI 10.1016/0165-3806(89)90056-4; NORDEEN EJ, 1988, J NEUROSCI, V8, P2869; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; Peng Z, 2012, BRAIN RES BULL, V89, P211, DOI 10.1016/j.brainresbull.2012.09.004; Rasika S, 1999, NEURON, V22, P53, DOI 10.1016/S0896-6273(00)80678-9; Scott BB, 2007, J COMP NEUROL, V502, P202, DOI 10.1002/cne.21296; SIMPSON HB, 1991, J NEUROBIOL, V22, P777, DOI 10.1002/neu.480220711; SOHRABJI F, 1995, P NATL ACAD SCI USA, V92, P11110, DOI 10.1073/pnas.92.24.11110; Sohrabji F, 2006, FRONT NEUROENDOCRIN, V27, P404, DOI 10.1016/j.yfrne.2006.09.003; Striedter GF, 1998, J NEUROSCI, V18, P5839; Tang YP, 2012, PLOS ONE, V7, pe4368; Tobari Y, 2005, ZOOL SCI, V22, P1089, DOI 10.2108/zsj.22.1089; Vellema M, 2010, J COMP NEUROL, V518, P1442, DOI 10.1002/cne.22281; Wade J, 2000, J CHEM NEUROANAT, V19, P33, DOI 10.1016/S0891-0618(00)00051-X; Wang Q, 1998, J NEUROSCI, V18, P4973; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wu H, 2004, J NEUROSCI RES, V76, P76, DOI 10.1002/jnr.20060; Zeng SJ, 2007, NEUROSCI RES, V58, P207, DOI 10.1016/j.neures.2007.02.001; Zeng Shao-Ju, 2001, Zoological Research, V22, P51; Zeng SJ, 2001, ACTA ZOOLOGICAL SINI, V47, P552; Zheng G.M, 2002, CHECKLIST CLASSIFICA, P214	64	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97403	10.1371/journal.pone.0097403	http://dx.doi.org/10.1371/journal.pone.0097403			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841082	Green Published, Green Submitted, gold			2022-12-25	WOS:000340948600030
J	Wu, NC; De La Cruz, J; Al-Mawsawi, LQ; Olson, CA; Qi, HF; Luan, HH; Nguyen, N; Du, YS; Le, S; Wu, TT; Li, XM; Lewis, MJ; Yang, OO; Sun, R				Wu, Nicholas C.; De La Cruz, Justin; Al-Mawsawi, Laith Q.; Olson, C. Anders; Qi, Hangfei; Luan, Harding H.; Nguyen, Nguyen; Du, Yushen; Le, Shuai; Wu, Ting-Ting; Li, Xinmin; Lewis, Martha J.; Yang, Otto O.; Sun, Ren			HIV-1 Quasispecies Delineation by Tag Linkage Deep Sequencing	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; COMPENSATORY MUTATIONS; GENETIC DIVERSITY; RESISTANT HIV-1; RECOMBINATION; EPISTASIS; EVOLUTION; FITNESS; RECONSTRUCTION; REPLICATION	Trade-offs between throughput, read length, and error rates in high-throughput sequencing limit certain applications such as monitoring viral quasispecies. Here, we describe a molecular-based tag linkage method that allows assemblage of short sequence reads into long DNA fragments. It enables haplotype phasing with high accuracy and sensitivity to interrogate individual viral sequences in a quasispecies. This approach is demonstrated to deduce similar to 2000 unique 1.3 kb viral sequences from HIV-1 quasispecies in vivo and after passaging ex vivo with a detection limit of similar to 0.005% to similar to 0.001%. Reproducibility of the method is validated quantitatively and qualitatively by a technical replicate. This approach can improve monitoring of the genetic architecture and evolution dynamics in any quasispecies population.	[Wu, Nicholas C.; Al-Mawsawi, Laith Q.; Olson, C. Anders; Qi, Hangfei; Luan, Harding H.; Nguyen, Nguyen; Du, Yushen; Wu, Ting-Ting; Sun, Ren] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Wu, Nicholas C.; Sun, Ren] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [De La Cruz, Justin; Yang, Otto O.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Le, Shuai] Third Mil Med Univ, Dept Microbiol, Chongqing, Peoples R China; [Li, Xinmin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Lewis, Martha J.; Yang, Otto O.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90095 USA; [Lewis, Martha J.; Yang, Otto O.; Sun, Ren] Univ Calif Los Angeles, AIDS Inst, Los Angeles, CA 90095 USA; [Yang, Otto O.] AIDS Healthcare Fdn, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Army Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Sun, R (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	RSun@mednet.ucla.edu	Wu, Nicholas/H-3822-2015	Wu, Nicholas/0000-0002-9078-6697; Le, Shuai/0000-0003-3748-5454	UCLA Molecular Biology Whitcome Fellowship; National Institutes of Health [R01 AI043203]; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043203] Funding Source: NIH RePORTER	UCLA Molecular Biology Whitcome Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by UCLA Molecular Biology Whitcome Fellowship (N.C.W.), National Institutes of Health R01 AI043203 (O.O.Y). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astrovskaya I, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S6-S1; Baird HA, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-91; Beerenwinkel N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00329; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Bonhoeffer S, 2004, SCIENCE, V306, P1547, DOI 10.1126/science.1101786; Brockman MA, 2007, J VIROL, V81, P12608, DOI 10.1128/JVI.01369-07; Charpentier C, 2006, J VIROL, V80, P2472, DOI 10.1128/JVI.80.5.2472-2482.2006; Clotet B, 2004, AIDS REV, V6, P123; da Silva J, 2010, GENETICS, V185, P293, DOI 10.1534/genetics.109.112458; Dam E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000345; Delaney WE, 2003, J VIROL, V77, P11833, DOI 10.1128/JVI.77.21.11833-11841.2003; Eriksson N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000074; Froissart R, 2005, PLOS BIOL, V3, P389, DOI 10.1371/journal.pbio.0030089; Fumero E, 2003, CLIN MICROBIOL INFEC, V9, P1077, DOI 10.1046/j.1469-0691.2003.00730.x; Gong LI, 2013, ELIFE, V2, DOI 10.7554/eLife.00631; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; Janini M, 2001, J VIROL, V75, P7973, DOI 10.1128/JVI.75.17.7973-7986.2001; Jetzt AE, 2000, J VIROL, V74, P1234, DOI 10.1128/JVI.74.3.1234-1240.2000; Johnson JA, 2005, J INFECT DIS, V192, P16, DOI 10.1086/430741; Judo MSB, 1998, NUCLEIC ACIDS RES, V26, P1819, DOI 10.1093/nar/26.7.1819; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Lahr DJG, 2009, BIOTECHNIQUES, V47, P857, DOI 10.2144/000113219; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Lewis MJ, 2012, J VIROL, V86, P7459, DOI 10.1128/JVI.06724-11; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liu J, 2011, ANTIMICROB AGENTS CH, V55, P1114, DOI 10.1128/AAC.01492-10; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Martinez-Picado J, 2008, VIRUS RES, V134, P104, DOI 10.1016/j.virusres.2007.12.021; Michalakis Y, 2004, SCIENCE, V306, P1492, DOI 10.1126/science.1106677; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Neher RA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000660; Nowak MA, 1996, SCIENCE, V272, P74, DOI 10.1126/science.272.5258.74; Palmer S, 2006, AIDS, V20, P701, DOI 10.1097/01.aids.0000216370.69066.7f; Piana S, 2002, PROTEIN SCI, V11, P2393, DOI 10.1110/ps.0206702; Prosperi MCF, 2012, BIOINFORMATICS, V28, P132, DOI 10.1093/bioinformatics/btr627; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P15376, DOI 10.1073/pnas.0404125101; Shriner D, 2004, GENETICS, V167, P1573, DOI 10.1534/genetics.103.023382; Simon-Loriere E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000418; Skums P, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S9-S2; Topfer A, 2013, J COMPUT BIOL, V20, P113, DOI 10.1089/cmb.2012.0232; Verheyen J, 2006, ANTIVIR THER, V11, P879; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569; WONG JT, 1987, J IMMUNOL, V139, P1369; Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535; Wu NC, 2013, J VIROL, V87, P1193, DOI 10.1128/JVI.01658-12; Yim HJ, 2006, HEPATOLOGY, V44, P703, DOI 10.1002/hep.21290; Zagordi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047046; Zagordi O, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-119; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655; Zhang J, 2010, P NATL ACAD SCI USA, V107, P1321, DOI 10.1073/pnas.0907304107; Zhuang JL, 2002, J VIROL, V76, P11273, DOI 10.1128/JVI.76.22.11273-11282.2002	56	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97505	10.1371/journal.pone.0097505	http://dx.doi.org/10.1371/journal.pone.0097505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842159	Green Published, Green Submitted, gold			2022-12-25	WOS:000340948600037
J	Cheney, JA; Ton, D; Konow, N; Riskin, DK; Breuer, KS; Swartz, SM				Cheney, Jorn A.; Ton, Daniel; Konow, Nicolai; Riskin, Daniel K.; Breuer, Kenneth S.; Swartz, Sharon M.			Hindlimb Motion during Steady Flight of the Lesser Dog-Faced Fruit Bat, Cynopterus brachyotis	PLOS ONE			English	Article							MEMBRANE WINGS; KINEMATICS; BIOMECHANICS; CHIROPTERA; STRENGTH	In bats, the wing membrane is anchored not only to the body and forelimb, but also to the hindlimb. This attachment configuration gives bats the potential to modulate wing shape by moving the hindlimb, such as by joint movement at the hip or knee. Such movements could modulate lift, drag, or the pitching moment. In this study we address: 1) how the ankle translates through space during the wingbeat cycle; 2) whether amplitude of ankle motion is dependent upon flight speed; 3) how tension in the wing membrane pulls the ankle; and 4) whether wing membrane tension is responsible for driving ankle motion. We flew five individuals of the lesser dog-faced fruit bat, Cynopterus brachyotis (Family: Pteropodidae), in a wind tunnel and documented kinematics of the forelimb, hip, ankle, and trailing edge of the wing membrane. Based on kinematic analysis of hindlimb and forelimb movements, we found that: 1) during downstroke, the ankle moved ventrally and during upstroke the ankle moved dorsally; 2) there was considerable variation in amplitude of ankle motion, but amplitude did not correlate significantly with flight speed; 3) during downstroke, tension generated by the wing membrane acted to pull the ankle dorsally, and during upstroke, the wing membrane pulled laterally when taut and dorsally when relatively slack; and 4) wing membrane tension generally opposed dorsoventral ankle motion. We conclude that during forward flight in C. brachyotis, wing membrane tension does not power hindlimb motion; instead, we propose that hindlimb movements arise from muscle activity and/or inertial effects.	[Cheney, Jorn A.; Ton, Daniel; Konow, Nicolai; Riskin, Daniel K.; Breuer, Kenneth S.; Swartz, Sharon M.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Breuer, Kenneth S.; Swartz, Sharon M.] Brown Univ, Sch Engn, Providence, RI 02912 USA	Brown University; Brown University	Cheney, JA (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	Jorn_Cheney@Brown.edu	Breuer, Kenneth/P-7753-2016; Swartz, Sharon/B-9309-2011	Breuer, Kenneth/0000-0002-5122-2231; Swartz, Sharon/0000-0001-5762-7435; Riskin, Daniel K./0000-0001-8742-8509; Cheney, Jorn/0000-0002-9952-2612	National Science Foundation [IOS-0723392, IOS-1145549]; Air Force Office of Scientific Research [F49620-01-1-0335, FA9550-12-1-0301]; Direct For Biological Sciences [1145549] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (IOS-0723392, IOS-1145549) and the Air Force Office of Scientific Research (F49620-01-1-0335, FA9550-12-1-0301) monitored by W. Larkin, D. Smith, and P. Bradshaw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott I., 1959, THEORY WING SECTIONS; Abdel-Aziz Y. I., 1971, P ASP UI S CLOS RANG, P1, DOI [DOI 10.1080/10671188.1967.10616517, 10.14358/PERS.81.2.103]; Adams RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032074; CROWLEY GV, 1994, AUST J ZOOL, V42, P215, DOI 10.1071/ZO9940215; Gardiner JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018214; Hedrick TL, 2002, J EXP BIOL, V205, P1389; HOEVE CAJ, 1959, J AM CHEM SOC, V80, P6523, DOI 10.1021/ja01557a016; HOLBROOK KA, 1978, J ANAT, V126, P21; HOWELL DJ, 1977, J THEOR BIOL, V69, P625, DOI 10.1016/0022-5193(77)90371-X; Hubner JP, 2011, AEROSP SCI TECHNOL, V15, P670, DOI 10.1016/j.ast.2011.01.004; Leishman J. G., 2005, PRINCIPLES HELICOPTE; Lillie MA, 2002, INT J BIOL MACROMOL, V30, P119, DOI 10.1016/S0141-8130(02)00008-9; NORBERG U M, 1970, Bijdragen tot de Dierkunde, V40, P62; Norberg UML, 2006, J EXP BIOL, V209, P3887, DOI 10.1242/jeb.02446; Riskin DK, 2008, J THEOR BIOL, V254, P604, DOI 10.1016/j.jtbi.2008.06.011; Riskin DK, 2010, J EXP BIOL, V213, P4110, DOI 10.1242/jeb.043091; Riskin DK, 2009, J EXP BIOL, V212, P945, DOI 10.1242/jeb.026161; Riskin DK, 2005, J EXP BIOL, V208, P1309, DOI 10.1242/jeb.01522; Simmons Nancy B., 1994, American Museum Novitates, V3103, P1; Song A, 2008, AIAA J, V46, P2096, DOI 10.2514/1.36694; Stanford B, 2008, PROG AEROSP SCI, V44, P258, DOI 10.1016/j.paerosci.2008.03.001; Swartz SM, 2008, CELLS TISSUES ORGANS, V187, P59, DOI 10.1159/000109964; Swartz SM, 1996, J ZOOL, V239, P357, DOI 10.1111/j.1469-7998.1996.tb05455.x; von Busse R, 2012, BIOL OPEN, V1, P1226, DOI 10.1242/bio.20122964; Waldman R M, 2013, P 43 AIAA FLUID DYN, P1; Wolf M, 2010, J EXP BIOL, V213, P2142, DOI 10.1242/jeb.029777	26	12	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98093	10.1371/journal.pone.0098093	http://dx.doi.org/10.1371/journal.pone.0098093			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858194	gold, Green Submitted, Green Published			2022-12-25	WOS:000336839400039
J	Consonni, SV; Brouwer, PM; van Slobbe, ES; Bos, JL				Consonni, Sarah V.; Brouwer, Patricia M.; van Slobbe, Eleonora S.; Bos, Johannes L.			The PDZ Domain of the Guanine Nucleotide Exchange Factor PDZGEF Directs Binding to Phosphatidic Acid during Brush Border Formation	PLOS ONE			English	Article							RAP1; POLARIZATION; ACTIVATION; PROTEINS; EZRIN; PAR-3; GEFS	PDZGEF is a guanine nucleotide exchange factor for the small G protein Rap. It was recently found that PDZGEF contributes to establishment of intestinal epithelial polarity downstream of the kinase Lkb1. By binding to phosphatidic acid enriched at the apical membrane, PDZGEF locally activates Rap2a resulting in induction of brush border formation via a pathway that includes the polarity players TNIK, Mst4 and Ezrin. Here we show that the PDZ domain of PDZGEF is essential and sufficient for targeting PDZGEF to the apical membrane of polarized intestinal epithelial cells. Inhibition of PLD and consequently production of phosphatidic acid inhibitis targeting of PDZGEF to the plasma membrane. Furthermore, localization requires specific positively charged residues within the PDZ domain. We conclude that local accumulation of PDZGEF at the apical membrane during establishment of epithelial polarity is mediated by electrostatic interactions between positively charged side chains in the PDZ domain and negatively charged phosphatidic acid.	[Consonni, Sarah V.; Brouwer, Patricia M.; van Slobbe, Eleonora S.; Bos, Johannes L.] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Mol Canc Res, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Bos, JL (corresponding author), Univ Med Ctr Utrecht, Ctr Mol Med, Dept Mol Canc Res, Utrecht, Netherlands.	j.l.bos@umcutrecht.nl			Chemical Sciences and the Netherlands Genomics Initiative of the Netherlands Organization for Scientific Research (NWO)	Chemical Sciences and the Netherlands Genomics Initiative of the Netherlands Organization for Scientific Research (NWO)	This work is supported by Chemical Sciences (S. V. C.) and the Netherlands Genomics Initiative (J.L.B.) of the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Chen J, 2008, EMBO J, V27, P2113, DOI 10.1038/emboj.2008.138; de Rooij J, 1999, J BIOL CHEM, V274, P38125, DOI 10.1074/jbc.274.53.38125; Gallardo R, 2010, CHEMBIOCHEM, V11, P456, DOI 10.1002/cbic.200900616; Gloerich M, 2012, NAT CELL BIOL, V14, P793, DOI 10.1038/ncb2537; Hodgkin MN, 2000, CURR BIOL, V10, P43, DOI 10.1016/S0960-9822(99)00264-X; Kooijman EE, 2007, J BIOL CHEM, V282, P11356, DOI 10.1074/jbc.M609737200; Kuiperij HB, 2003, BBA-MOL CELL RES, V1593, P141, DOI 10.1016/S0167-4889(02)00365-8; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Mauceri D, 2007, J NEUROCHEM, V100, P1032, DOI 10.1111/j.1471-4159.2006.04267.x; Mishra P, 2007, CELL, V131, P80, DOI 10.1016/j.cell.2007.07.037; Pannekoek WJ, 2011, CELL SIGNAL, V23, P2056, DOI 10.1016/j.cellsig.2011.07.022; Post A, 2013, P NATL ACAD SCI USA, V110, P11427, DOI 10.1073/pnas.1306595110; Ross SH, 2011, J CELL SCI, V124, P1808, DOI 10.1242/jcs.079830; Sciorra VA, 1999, EMBO J, V18, P5911, DOI 10.1093/emboj/18.21.5911; ten Klooster JP, 2009, DEV CELL, V16, P551, DOI 10.1016/j.devcel.2009.01.016; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Wu H, 2007, MOL CELL, V28, P886, DOI 10.1016/j.molcel.2007.10.028; Yu CG, 2012, MOL BIOL CELL, V23, P3743, DOI 10.1091/mbc.E12-03-0196; Zimmermann P, 2002, MOL CELL, V9, P1215, DOI 10.1016/S1097-2765(02)00549-X	22	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98253	10.1371/journal.pone.0098253	http://dx.doi.org/10.1371/journal.pone.0098253			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858808	gold, Green Submitted, Green Published			2022-12-25	WOS:000336839400061
J	Meng, FQ; Olesen, JE; Sun, XP; Wu, WL				Meng, Fanqiao; Olesen, Jorgen E.; Sun, Xiangping; Wu, Wenliang			Inorganic Nitrogen Leaching from Organic and Conventional Rice Production on a Newly Claimed Calciustoll in Central Asia	PLOS ONE			English	Article							USE-EFFICIENCY; SOIL-WATER; NITRATE; DENITRIFICATION; NITRIFICATION; DYNAMICS; LOSSES; MINERALIZATION; IRRIGATION; MANAGEMENT	Characterizing the dynamics of nitrogen (N) leaching from organic and conventional paddy fields is necessary to optimize fertilization and to evaluate the impact of these contrasting farming systems on water bodies. We assessed N leaching in organic versus conventional rice production systems of the Ili River Valley, a representative aquatic ecosystem of Central Asia. The N leaching and overall performance of these systems were measured during 2009, using a randomized block experiment with five treatments. PVC pipes were installed at soil depths of 50 and 180 cm to collect percolation water from flooded organic and conventional paddies, and inorganic N (NH4-N+NO3-N) was analyzed. Two high-concentration peaks of NH4-N were observed in all treatments: one during early tillering and a second during flowering. A third peak at the mid-tillering stage was observed only under conventional fertilization. NO3-N concentrations were highest at transplant and then declined until harvest. At the 50 cm soil depth, NO3-N concentration was 21-42% higher than NH4-N in percolation water from organic paddies, while NH4-N and NO3-N concentrations were similar for the conventional and control treatments. At the depth of 180 cm, NH4-N and NO3-N were the predominant inorganic N for organic and conventional paddies, respectively. Inorganic N concentrations decreased with soil depth, but this attenuation was more marked in organic than in conventional paddies. Conventional paddies leached a higher percentage of applied N (0.78%) than did organic treatments (0.32-0.60%), but the two farming systems leached a similar amount of inorganic N per unit yield (0.21-0.34 kg N Mg-1 rice grains). Conventional production showed higher N utilization efficiency compared to fertilized organic treatments. These results suggest that organic rice production in the Ili River Valley is unlikely to reduce inorganic N leaching, if high crop yields similar to conventional rice production are to be maintained.	[Meng, Fanqiao; Sun, Xiangping; Wu, Wenliang] China Agr Univ, Coll Resources & Environm Sci, Beijing 100094, Peoples R China; [Olesen, Jorgen E.] Aarhus Univ, Fac Agr Sci, Dept Agroecol & Environm, Tjele, Denmark	China Agricultural University; Aarhus University	Meng, FQ (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Beijing 100094, Peoples R China.	mengfq@cau.edu.cn	Olesen, Jørgen/Y-2857-2019; Olesen, Jørgen E/C-2905-2016; MENG, Fanqiao/J-1514-2014	Olesen, Jørgen/0000-0002-6639-1273; Olesen, Jørgen E/0000-0002-6639-1273; MENG, Fanqiao/0000-0002-0172-7776	National Natural Science Foundation of China [30970533]; National Key Science and Technology Project-Organic Farming Development in the Ili River Valley [2007BAC15B05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Science and Technology Project-Organic Farming Development in the Ili River Valley	The study was funded by National Natural Science Foundation of China (No. 30970533) and the National Key Science and Technology Project-Organic Farming Development in the Ili River Valley (No. 2007BAC15B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askegaard M, 2011, AGR ECOSYST ENVIRON, V142, P149, DOI 10.1016/j.agee.2011.04.014; BAUDER JW, 1980, AGRON J, V72, P593, DOI 10.2134/agronj1980.00021962007200040005x; BIJAYSINGH, 1991, FERT RES, V28, P179, DOI 10.1007/BF01049748; Cassman KG, 1998, FIELD CROP RES, V56, P7, DOI 10.1016/S0378-4290(97)00140-8; Chhabra A, 2010, INT J APPL EARTH OBS, V12, P190, DOI 10.1016/j.jag.2010.02.007; Chowdary VM, 2004, AGR ECOSYST ENVIRON, V103, P425, DOI 10.1016/j.agee.2003.12.001; Devkota KP, 2013, EUR J AGRON, V47, P65, DOI 10.1016/j.eja.2013.01.009; Gao JS, 2002, TILLAGE CULTIVATION, V2, P31; GEORGE T, 1993, SOIL SCI SOC AM J, V57, P1526, DOI 10.2136/sssaj1993.03615995005700060022x; Ghosh BC, 1998, ENVIRON POLLUT, V102, P123, DOI 10.1016/S0269-7491(98)80024-9; Guan J., 2009, CHINESE AGR SCI B, V25, P88; Hansen B, 2000, EUR J AGRON, V13, P65, DOI 10.1016/S1161-0301(00)00060-5; Islam MM, 1998, COMMUN SOIL SCI PLAN, V29, P971, DOI 10.1080/00103629809370000; JEMISON JM, 1994, J ENVIRON QUAL, V23, P337, DOI 10.2134/jeq1994.00472425002300020018x; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; KEENEY DR, 1986, FERT RES, V9, P15, DOI 10.1007/BF01048694; Kirchmann H, 2001, COMMUN SOIL SCI PLAN, V32, P997, DOI 10.1081/CSS-100104101; Kirchmann Holger, 2008, P89, DOI 10.1007/978-1-4020-9316-6_5; Li CF, 2008, PLANT SOIL, V307, P207, DOI 10.1007/s11104-008-9597-1; Li FD, 2008, ENVIRON GEOL, V55, P1109, DOI 10.1007/s00254-007-1059-1; Li X, 2010, HUNAN AGR SCI, V5, P64; Luo LG, 1999, CHINESE J APPL ECOLO, V10, P301; Luo LG, 2011, ENVIRON MONIT ASSESS, V177, P141, DOI 10.1007/s10661-010-1624-z; Ma JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051894; Ou YangHong, 2009, Jiangsu Journal of Agricultural Sciences, V25, P106; Qian C, 2007, PLANT SOIL, V300, P197, DOI 10.1007/s11104-007-9404-4; REDDY KR, 1986, FERT RES, V9, P99, DOI 10.1007/BF01048697; REDDY KR, 1989, LIMNOL OCEANOGR, V34, P1004, DOI 10.4319/lo.1989.34.6.1004; Rodrigues MA, 2006, EUR J AGRON, V25, P328, DOI 10.1016/j.eja.2006.07.002; STANFORD G, 1972, SOIL SCI SOC AM PRO, V36, P465, DOI 10.2136/sssaj1972.03615995003600030029x; Sun XP, 2011, T CSAE, V27, P158; Tian YH, 2007, PEDOSPHERE, V17, P445, DOI 10.1016/S1002-0160(07)60054-X; UHEL C, 1989, PLANT SOIL, V116, P197, DOI 10.1007/BF02214548; Wang XT, 2011, PLANT SOIL, V343, P195, DOI 10.1007/s11104-010-0648-z; WEIER KL, 1993, SOIL SCI SOC AM J, V57, P66, DOI 10.2136/sssaj1993.03615995005700010013x; Xi YunGuan, 2007, Acta Agriculturae Shanghai, V23, P28; Xing GX, 2001, SCI CHINA SER B, V44, P304, DOI 10.1007/BF02879621; Xiong ZQ, 2010, PEDOSPHERE, V20, P209, DOI 10.1016/S1002-0160(10)60008-2; Yang L, 2008, WATER SAVING IRRIGAT, V3, P34; Zhou S, 2011, ECOL ENG, V37, P685, DOI 10.1016/j.ecoleng.2010.04.032; Zhu JG, 2000, NUTR CYCL AGROECOSYS, V57, P75, DOI 10.1023/A:1009712404335	41	35	39	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98138	10.1371/journal.pone.0098138	http://dx.doi.org/10.1371/journal.pone.0098138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858826	gold, Green Submitted, Green Published			2022-12-25	WOS:000336839400045
J	Astorino, TA; Schubert, MM				Astorino, Todd A.; Schubert, Matthew M.			Individual Responses to Completion of Short-Term and Chronic Interval Training: A Retrospective Study	PLOS ONE			English	Article							MAXIMAL FAT OXIDATION; METABOLIC ADAPTATIONS; SKELETAL-MUSCLE; OXYGEN-UPTAKE; EXERCISE; CAPACITY; SEDENTARY; FITNESS; VO2MAX; VOLUME	Alterations in maximal oxygen uptake (VO(2)max), heart rate (HR), and fat oxidation occur in response to chronic endurance training. However, many studies report frequent incidence of "non-responders'' who do not adapt to continuous moderate exercise. Whether this is the case in response to high intensity interval training (HIT), which elicits similar adaptations as endurance training, is unknown. The aim of this retrospective study was to examine individual responses to two paradigms of interval training. In the first study (study 1), twenty active men and women (age and baseline VO(2)max=24.0 +/- 4.6 yr and 42.8 +/- 4.8 mL/kg/min) performed 6 d of sprint interval training (SIT) consisting of 4-6 Wingate tests per day, while in a separate study (study 2), 20 sedentary women (age and baseline VO(2)max=23.7 +/- 6.2 yr and 30.0 +/- 4.9 mL/kg/min) performed 12 wk of high-volume HIT at workloads ranging from 60-90% maximal workload. Individual changes in VO(2)max, HR, and fat oxidation were examined in each study, and multiple regression analysis was used to identify predictors of training adaptations to SIT and HIT. Data showed high frequency of increased VO(2)max (95%) and attenuated exercise HR (85%) in response to HIT, and low frequency of response for VO(2)max (65%) and exercise HR (55%) via SIT. Frequency of improved fat oxidation was similar (60-65%) across regimens. Only one participant across both interventions showed non-response for all variables. Baseline values of VO(2)max, exercise HR, respiratory exchange ratio, and body fat were significant predictors of adaptations to interval training. Frequency of positive responses to interval training seems to be greater in response to prolonged, higher volume interval training compared to similar durations of endurance training.	[Astorino, Todd A.] Calif State Univ San Marcos, Dept Kinesiol, San Marcos, CA 92078 USA; [Schubert, Matthew M.] Griffith Univ, Sch Allied Hlth Sci, Gold Coast, Qld, Australia	California State University System; California State University San Marcos; Griffith University	Astorino, TA (corresponding author), Calif State Univ San Marcos, Dept Kinesiol, San Marcos, CA 92078 USA.	astorino@csusm.edu	Schubert, Matthew/A-9799-2017	Schubert, Matthew/0000-0002-0994-8805				[Anonymous], 1994, AM J HEALTH PROMOT, DOI DOI 10.4278/0890-1171-8.4.279; Astorino T.A., 2004, J EXERC PHYSL, V7, P1; Astorino TA, 2013, MED SCI SPORT EXER, V45, P1878, DOI 10.1249/MSS.0b013e3182936261; Astorino TA, 2013, EUR J APPL PHYSIOL, V113, P2361, DOI 10.1007/s00421-013-2672-1; Astorino TA, 2009, CLIN PHYSIOL FUNCT I, V29, P60, DOI 10.1111/j.1475-097X.2008.00835.x; Astorino TA, 2011, EUR J APPL PHYSIOL, V111, P1279, DOI 10.1007/s00421-010-1741-y; Bacon AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073182; Bailey SJ, 2009, J APPL PHYSIOL, V106, P1875, DOI 10.1152/japplphysiol.00144.2009; Bartlett JD, 2011, J SPORT SCI, V29, P547, DOI 10.1080/02640414.2010.545427; Blaak EE, 2004, P NUTR SOC, V63, P323, DOI 10.1079/PNS2004361; Bouchard C, 1999, J APPL PHYSIOL, V87, P1003, DOI 10.1152/jappl.1999.87.3.1003; Bouchard C, 2001, MED SCI SPORT EXER, V33, pS446, DOI 10.1097/00005768-200106001-00013; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Corpeleijn E, 2009, OBES REV, V10, P178, DOI 10.1111/j.1467-789X.2008.00544.x; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Gibala MJ, 2008, EXERC SPORT SCI REV, V36, P58, DOI 10.1097/JES.0b013e318168ec1f; Gist NH, 2013, SPORTS MED IN PRESS; Goedecke JH, 2000, AM J PHYSIOL-ENDOC M, V279, pE1325, DOI 10.1152/ajpendo.2000.279.6.E1325; Hazell TJ, 2010, EUR J APPL PHYSIOL, V110, P153, DOI 10.1007/s00421-010-1474-y; Helgerud J, 2007, MED SCI SPORT EXER, V39, P665, DOI 10.1249/mss.0b013e3180304570; HEYWARD VH, 2006, ADV FITNESS ASSESSME, P202; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; KOHRT WM, 1991, J APPL PHYSIOL, V71, P2004, DOI 10.1152/jappl.1991.71.5.2004; Little JP, 2011, J APPL PHYSIOL, V111, P1554, DOI 10.1152/japplphysiol.00921.2011; LORTIE G, 1984, INT J SPORTS MED, V5, P232, DOI 10.1055/s-2008-1025911; Macpherson REK, 2011, MED SCI SPORT EXER, V43, P115, DOI 10.1249/MSS.0b013e3181e5eacd; Midgley AW, 2006, APPL PHYSIOL NUTR ME, V31, P541, DOI 10.1139/H06-023; Moholdt TT, 2009, AM HEART J, V158, P1031, DOI 10.1016/j.ahj.2009.10.003; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Nybo L, 2010, MED SCI SPORT EXER, V42, P1951, DOI 10.1249/MSS.0b013e3181d99203; Rankinen T, 2012, J APPL PHYSIOL, V112, P892, DOI 10.1152/japplphysiol.01287.2011; Saltin B, 2010, COMPR PHYSIOL, P555; Scharhag-Rosenberger F, 2012, SCAND J MED SCI SPOR, V22, P113, DOI 10.1111/j.1600-0838.2010.01139.x; Sisson SB, 2009, MED SCI SPORT EXER, V41, P539, DOI 10.1249/MSS.0b013e3181896c4e; Skinner JS, 2001, J APPL PHYSIOL, V90, P1770, DOI 10.1152/jappl.2001.90.5.1770; Stisen AB, 2006, EUR J APPL PHYSIOL, V98, P497, DOI 10.1007/s00421-006-0290-x; Talanian JL, 2007, J APPL PHYSIOL, V102, P1439, DOI 10.1152/japplphysiol.01098.2006; Wang L, 2009, MED SCI SPORT EXER, V41, P2136, DOI 10.1249/MSS.0b013e3181abc1ec; Whyte LJ, 2010, METABOLISM, V59, P1421, DOI 10.1016/j.metabol.2010.01.002; Wilmore JH, 2011, MED SCI SPORTS EXERC, V33, P107	40	51	51	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97638	10.1371/journal.pone.0097638	http://dx.doi.org/10.1371/journal.pone.0097638			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847797	gold, Green Published			2022-12-25	WOS:000336730600045
J	Chen, KC; Yang, TY; Wu, CC; Cheng, CC; Hsu, SL; Hung, HW; Chen, JW; Chang, GC				Chen, Kun-Chieh; Yang, Tsung-Ying; Wu, Chun-Chi; Cheng, Chi-Chih; Hsu, Shih-Lan; Hung, Hsiao-Wen; Chen, Jian-Wei; Chang, Gee-Chen			Pemetrexed Induces S-Phase Arrest and Apoptosis via a Deregulated Activation of Akt Signaling Pathway	PLOS ONE			English	Article							CELL LUNG-CANCER; KINASE-C-DELTA; MULTITARGETED ANTIFOLATE LY231514; HUMAN TUMOR XENOGRAFTS; DNA-DAMAGE; SYNERGISTIC INTERACTION; CYCLIN-A; THYMIDYLATE SYNTHASE; HEMATOPOIETIC-CELLS; UP-REGULATION	Pemetrexed is approved for first-line and maintenance treatment of patients with advanced or metastatic non-small-cell lung cancer (NSCLC). The protein kinase Akt/protein kinase B is a well-known regulator of cell survival which is activated by pemetrexed, but its role in pemetrexed-mediated cell death and its molecular mechanisms are unclear. This study showed that stimulation with pemetrexed induced S-phase arrest and cell apoptosis and a parallel increase in sustained Akt phosphorylation and nuclear accumulation in the NSCLC A549 cell line. Inhibition of Akt expression by Akt specific siRNA blocked S-phase arrest and protected cells from apoptosis, indicating an unexpected proapoptotic role of Akt in the pemetrexed-mediated toxicity. Treatment of A549 cells with pharmacological inhibitors of phosphatidylinositol 3-kinase (PI3K), wortmannin and Ly294002, similarly inhibited pemetrexed-induced S-phase arrest and apoptosis and Akt phosphorylation, indicating that PI3K is an upstream mediator of Akt and is involved in pemetrexed-mediated cell death. Previously, we identified cyclin A-associated cyclin-dependent kinase 2 (Cdk2) as the principal kinase that was required for pemetrexed-induced S-phase arrest and apoptosis. The current study showed that inhibition of Akt function and expression by pharmacological inhibitors as well as Akt siRNA drastically inhibited cyclin A/Cdk2 activation. These pemetrexed-mediated biological and molecular events were also observed in a H1299 cell line. Overall, our results indicate that, in contrast to its normal prosurvival role, the activated Akt plays a proapoptotic role in pemetrexed-mediated S-phase arrest and cell death through a mechanism that involves Cdk2/cyclin A activation.	[Chen, Kun-Chieh; Yang, Tsung-Ying; Chang, Gee-Chen] Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan; [Chen, Kun-Chieh; Chen, Jian-Wei; Chang, Gee-Chen] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Wu, Chun-Chi] Chung Shang Med Univ, Inst Med, Taichung, Taiwan; [Wu, Chun-Chi; Hsu, Shih-Lan] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Cheng, Chi-Chih; Hsu, Shih-Lan; Hung, Hsiao-Wen] Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan; [Hsu, Shih-Lan] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Chang, Gee-Chen] Natl Yang Ming Univ, Dept Med, Sch Med, Taipei 112, Taiwan	Taichung Veterans General Hospital; National Chung Hsing University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Taichung Veterans General Hospital; National Chung Hsing University; National Yang Ming Chiao Tung University	Chen, JW (corresponding author), Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan.	jwchen@dragon.nchu.edu.tw; august@vghtc.gov.tw		Chen, Jeremy J.W./0000-0003-1049-3825	Taichung Veterans General Hospital [TCVGH1003205D, TCVGH-1007322D, TCVGH-NCNU1017901]	Taichung Veterans General Hospital	This work was supported in part by grants from the Taichung Veterans General Hospital (TCVGH1003205D) to Dr. Gee-Chen Chang; and Taichung Veterans General Hospital (TCVGH-1007322D) and TCVGH-NCNU1017901 to Dr. Shih-Lan Hsu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2001, CIRC RES, V88, P408, DOI 10.1161/01.res.88.4.408; Aki T, 2003, ONCOGENE, V22, P8529, DOI 10.1038/sj.onc.1207197; Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Bischof M, 2004, INT J RADIAT ONCOL, V60, P1220, DOI 10.1016/j.ijrobp.2004.07.689; Britten CD, 1999, CANCER CHEMOTH PHARM, V44, P105, DOI 10.1007/s002800050953; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Choi JS, 2007, APOPTOSIS, V12, P1229, DOI 10.1007/s10495-006-0047-3; Dai Y, 2003, CURR OPIN PHARMACOL, V3, P362, DOI 10.1016/S1471-4892(03)00079-1; DeVries-Seimon TA, 2007, J BIOL CHEM, V282, P22307, DOI 10.1074/jbc.M703661200; Ding HM, 2008, INT J CANCER, V123, P2931, DOI 10.1002/ijc.23895; Eapen AK, 2001, MOL CELL BIOL, V21, P6113, DOI 10.1128/MCB.21.18.6113-6121.2001; Edelman MJ, 2012, J THORAC ONCOL, V7, P1331, DOI 10.1097/JTO.0b013e3182629e37; Eitel K, 2003, DIABETES, V52, P991, DOI 10.2337/diabetes.52.4.991; Gadgeel SM, 2013, CLIN LUNG CANCER, V14, P322, DOI 10.1016/j.cllc.2012.12.001; Giovannetti E, 2005, MOL PHARMACOL, V68, P110, DOI 10.1124/mol.104.009373; Giovannetti E, 2011, BRIT J CANCER, V105, P1542, DOI 10.1038/bjc.2011.400; Gonen N, 2012, DRUG RESIST UPDATE, V15, P183, DOI 10.1016/j.drup.2012.07.002; GRANA X, 1995, ONCOGENE, V11, P211; Greenhalgh J, 2010, HEALTH TECHNOL ASSES, V14, P33, DOI 10.3310/hta14suppl2/05; Huang XD, 2011, MOL CELL, V42, P511, DOI 10.1016/j.molcel.2011.03.027; JACKSON RC, 1984, PHARMACOL THERAPEUT, V25, P61, DOI 10.1016/0163-7258(84)90024-X; Jin YH, 2000, J BIOL CHEM, V275, P30256, DOI 10.1074/jbc.M001902200; Jin YH, 2003, BIOCHEM BIOPH RES CO, V305, P974, DOI 10.1016/S0006-291X(03)00870-2; Khan KH, 2013, CHIN J CANCER, V32, P253, DOI 10.5732/cjc.013.10057; Lee YC, 2002, J THORAC CARDIOV SUR, V123, P502, DOI 10.1067/mtc.2002.119334; Li TH, 2007, CLIN CANCER RES, V13, P3413, DOI 10.1158/1078-0432.CCR-06-2923; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Lu B, 2006, J IMMUNOL, V176, P6785, DOI 10.4049/jimmunol.176.11.6785; Ma X, 2013, CURR MED CHEM, V20, P2991, DOI 10.2174/09298673113209990124; Maddika S, 2007, CELL PROLIFERAT, V40, P835, DOI 10.1111/j.1365-2184.2007.00475.x; Maddika S, 2008, J CELL SCI, V121, P979, DOI 10.1242/jcs.009530; Maddika S, 2009, MOL CELL BIOL, V29, P1235, DOI 10.1128/MCB.00668-08; Narayan RS, 2013, CURR PHARM DESIGN, V19, P951; Neganova I, 2011, STEM CELLS, V29, P651, DOI 10.1002/stem.620; Nimbalkar D, 2003, CANCER RES, V63, P1034; Raina D, 2006, EMBO J, V25, P3774, DOI 10.1038/sj.emboj.7601263; Ramalingam S, 2008, ONCOLOGIST, V13, P5, DOI 10.1634/theoncologist.13-S1-5; Schuurbiers OCJ, 2009, J THORAC ONCOL, V4, P761, DOI 10.1097/JTO.0b013e3181a1084f; Shack S, 2003, MOL CELL BIOL, V23, P2407, DOI 10.1128/MCB.23.7.2407-2414.2003; Stiles BL, 2009, ADV DRUG DELIVER REV, V61, P1276, DOI 10.1016/j.addr.2009.07.017; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Takezawa K, 2011, BRIT J CANCER, V104, P1594, DOI 10.1038/bjc.2011.129; Teicher BA, 1999, SEMIN ONCOL, V26, P55; Teicher BA, 2000, CLIN CANCER RES, V6, P1016; Tekle C, 2008, BRIT J CANCER, V99, P750, DOI 10.1038/sj.bjc.6604566; Tonkinson JL, 1997, CANCER CHEMOTH PHARM, V39, P521, DOI 10.1007/s002800050608; Tonkinson JL, 1999, CANCER RES, V59, P3671; Vadlakonda L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00165; Vadlakondalf L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00085; van Gorp AGM, 2006, CANCER RES, V66, P10760, DOI 10.1158/0008-5472.CAN-06-1111; Volm M, 1998, BRIT J CANCER, V77, P663, DOI 10.1038/bjc.1998.106; Wakelee H, 2005, ONCOLOGIST, V10, P1, DOI 10.1634/theoncologist.10-90003-1; Welker ME, 2013, BIOORGAN MED CHEM, V21, P4063, DOI 10.1016/j.bmc.2013.04.083; Welsh SJ, 2000, CLIN CANCER RES, V6, P2538; Yam CH, 2002, CELL MOL LIFE SCI, V59, P1317, DOI 10.1007/s00018-002-8510-y; Yang TY, 2013, MOL CARCINOGEN, V52, P183, DOI 10.1002/mc.21842; Yang TY, 2011, EUR J PHARMACOL, V663, P17, DOI 10.1016/j.ejphar.2011.04.057; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Yoshida K, 2003, EMBO J, V22, P1431, DOI 10.1093/emboj/cdg134; Zhan Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044923	60	31	32	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97888	10.1371/journal.pone.0097888	http://dx.doi.org/10.1371/journal.pone.0097888			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847863	Green Submitted, Green Published, gold			2022-12-25	WOS:000336730600066
J	Liao, P; Wang, H; Wang, MF; Hsiao, AS; Bach, TJ; Chye, ML				Liao, Pan; Wang, Hui; Wang, Mingfu; Hsiao, An-Shan; Bach, Thomas J.; Chye, Mee-Len			Transgenic Tobacco Overexpressing Brassica juncea HMG-CoA Synthase 1 Shows Increased Plant Growth, Pod Size and Seed Yield	PLOS ONE			English	Article							METHYLGLUTARYL COENZYME-A; ISOPENTENYL DIPHOSPHATE ISOMERASES; ISOPRENOID BIOSYNTHESIS; SQUALENE SYNTHASE; BINDING PROTEIN; STEROL BIOSYNTHESIS; MEVALONATE PATHWAY; MOLECULAR CHARACTERIZATION; METHYLTRANSFERASE TYPE-1; REDUCTASE-ACTIVITY	Seeds are very important not only in the life cycle of the plant but they represent food sources for man and animals. We report herein a mutant of 3-hydroxy-3-methylglutaryl-coenzyme A synthase (HMGS), the second enzyme in the mevalonate (MVA) pathway that can improve seed yield when overexpressed in a phylogenetically distant species. In Brassica juncea, the characterisation of four isogenes encoding HMGS has been previously reported. Enzyme kinetics on recombinant wild-type (wt) and mutant BjHMGS1 had revealed that S359A displayed a 10-fold higher enzyme activity. The overexpression of wt and mutant (S359A) BjHMGS1 in Arabidopsis had up-regulated several genes in sterol biosynthesis, increasing sterol content. To quickly assess the effects of BjHMGS1 overexpression in a phylogenetically more distant species beyond the Brassicaceae, wt and mutant (S359A) BjHMGS1 were expressed in tobacco (Nicotiana tabacum L. cv. Xanthi) of the family Solanaceae. New observations on tobacco OEs not previously reported for Arabidopsis OEs included: (i) phenotypic changes in enhanced plant growth, pod size and seed yield (more significant in OE-S359A than OE-wtBjHMGS1) in comparison to vector-transformed tobacco, (ii) higher NtSQS expression and sterol content in OE-S359A than OE-wtBjHMGS1 corresponding to greater increase in growth and seed yield, and (iii) induction of NtIPPI2 and NtGGPPS2 and downregulation of NtIPPI1, NtGGPPS1, NtGGPPS3 and NtGGPPS4. Resembling Arabidopsis HMGS-OEs, tobacco HMGS-OEs displayed an enhanced expression of NtHMGR1, NtSMT1-2, NtSMT2-1, NtSMT2-2 and NtCYP85A1. Overall, increased growth, pod size and seed yield in tobacco HMGS-OEs were attributed to the up-regulation of native NtHMGR1, NtIPPI2, NtSQS, NtSMT1-2, NtSMT2-1, NtSMT2-2 and NtCYP85A1. Hence, S359A has potential in agriculture not only in improving phytosterol content but also seed yield, which may be desirable in food crops. This work further demonstrates HMGS function in plant reproduction that is reminiscent to reduced fertility of hmgs RNAi lines in let-7 mutants of Caenorhabditis elegans.	[Liao, Pan; Wang, Hui; Wang, Mingfu; Hsiao, An-Shan; Chye, Mee-Len] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Bach, Thomas J.] CNRS, Inst Biol Mol Plantes, UPR 2357, F-67084 Strasbourg, France	University of Hong Kong; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Chye, ML (corresponding author), Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China.	mlchye@hkucc.hku.hk	LIAO, Pan/AAV-8138-2020; Wang, Mingfu/AAT-3292-2021; Liao, Pan/GSM-8793-2022; Chye, Mee Len/A-2740-2010	Wang, Mingfu/0000-0003-1469-3963; Liao, Pan/0000-0002-1156-8916; Chye, Mee Len/0000-0003-3505-3674	Wilson and Amelia Wong Endowment Fund; University of Hong Kong [CRCG 10400945, CRCG 104001061]	Wilson and Amelia Wong Endowment Fund; University of Hong Kong(University of Hong Kong)	This work was supported by the Wilson and Amelia Wong Endowment Fund and the University of Hong Kong (CRCG 10400945, CRCG 104001061, University Postgraduate Fellowship (PL) and studentships (HW and ASH)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE I, 1993, CHEM REV, V93, P2189, DOI 10.1021/cr00022a009; Ahumada I, 2008, FUNCT PLANT BIOL, V35, P1100, DOI 10.1071/FP08012; Alex D, 2000, PLANT J, V22, P415, DOI 10.1046/j.1365-313X.2000.00751.x; Babiychuk E, 2008, P NATL ACAD SCI USA, V105, P3163, DOI 10.1073/pnas.0712190105; BACH TJ, 1986, LIPIDS, V21, P82, DOI 10.1007/BF02534307; BACH TJ, 1983, PHYSIOL PLANTARUM, V59, P50, DOI 10.1111/j.1399-3054.1983.tb06570.x; BACH TJ, 1995, LIPIDS, V30, P191, DOI 10.1007/BF02537822; Bae H, 2009, MOL CELLS, V28, P57, DOI 10.1007/s10059-009-0101-4; BALASUBRAMANIAM S, 1977, P NATL ACAD SCI USA, V74, P1421, DOI 10.1073/pnas.74.4.1421; Bouvier-Nave P, 1998, EUR J BIOCHEM, V256, P88, DOI 10.1046/j.1432-1327.1998.2560088.x; BouvierNave P, 1997, EUR J BIOCHEM, V246, P518, DOI 10.1111/j.1432-1033.1997.t01-1-00518.x; Bradford PG, 2007, MOL NUTR FOOD RES, V51, P161, DOI 10.1002/mnfr.200600164; Briskin DP, 2000, PLANT PHYSIOL, V124, P507, DOI 10.1104/pp.124.2.507; Brodersen P, 2012, P NATL ACAD SCI USA, V109, P1778, DOI 10.1073/pnas.1112500109; BUSH PB, 1972, PLANT PHYSIOL, V50, P69, DOI 10.1104/pp.50.1.69; CHAPPELL J, 1991, PLANT PHYSIOL, V97, P693, DOI 10.1104/pp.97.2.693; CHAPPELL J, 1995, PLANT PHYSIOL, V109, P1337, DOI 10.1104/pp.109.4.1337; Chen QF, 2008, PLANT PHYSIOL, V148, P304, DOI 10.1104/pp.108.123331; Choe S, 2000, PLANT J, V21, P431, DOI 10.1046/j.1365-313x.2000.00693.x; Choe S, 2001, PLANT J, V26, P573, DOI 10.1046/j.1365-313x.2001.01055.x; Chye ML, 1999, PLANT J, V18, P205, DOI 10.1046/j.1365-313X.1999.00443.x; Closa M, 2010, PLANT J, V63, P512, DOI 10.1111/j.1365-313X.2010.04253.x; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Cunillera N, 1996, J BIOL CHEM, V271, P7774, DOI 10.1074/jbc.271.13.7774; DemmigAdams B, 1996, TRENDS PLANT SCI, V1, P21, DOI 10.1016/S1360-1385(96)80019-7; Devarenne TP, 2002, PLANT PHYSIOL, V129, P1095, DOI 10.1104/pp.001438; Devarenne TP, 1998, ARCH BIOCHEM BIOPHYS, V349, P205, DOI 10.1006/abbi.1997.0463; Dooley KA, 1998, J BIOL CHEM, V273, P1349, DOI 10.1074/jbc.273.3.1349; Dudareva N, 2013, NEW PHYTOL, V198, P16, DOI 10.1111/nph.12145; Durek P, 2010, NUCLEIC ACIDS RES, V38, pD828, DOI 10.1093/nar/gkp810; Eisenreich W, 2001, TRENDS PLANT SCI, V6, P78, DOI 10.1016/S1360-1385(00)01812-4; Fang ZM, 2013, PLANT BIOTECHNOL J, V11, P446, DOI 10.1111/pbi.12031; FERGUSON JJ, 1959, J BIOL CHEM, V234, P1072; FONTENEAU P, 1977, PLANT SCI LETT, V10, P147, DOI 10.1016/0304-4211(77)90122-5; Gevaudant F, 2007, PLANT PHYSIOL, V144, P1763, DOI 10.1104/pp.107.103762; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; GROVE MD, 1979, NATURE, V281, P216, DOI 10.1038/281216a0; He JX, 2003, PLANT PHYSIOL, V131, P1258, DOI 10.1104/pp.014605; Hedden P, 1997, ANNU REV PLANT PHYS, V48, P431, DOI 10.1146/annurev.arplant.48.1.431; Hemmerlin A, 2000, PLANT PHYSIOL, V123, P1257, DOI 10.1104/pp.123.4.1257; Hemmerlin A, 2004, LIPIDS, V39, P723, DOI 10.1007/s11745-004-1289-0; Hemmerlin A, 2003, J BIOL CHEM, V278, P32132, DOI 10.1074/jbc.M213045200; Hemmerlin A, 2003, J BIOL CHEM, V278, P26666, DOI 10.1074/jbc.M302526200; Hemmerlin A, 2013, PLANT SCI, V203, P41, DOI 10.1016/j.plantsci.2012.12.008; Hemmerlin A, 2012, PROG LIPID RES, V51, P95, DOI 10.1016/j.plipres.2011.12.001; Holmberg N, 2003, PLANT J, V36, P12, DOI 10.1046/j.1365-313X.2003.01851.x; Holmberg N, 2002, PLANT PHYSIOL, V130, P303, DOI 10.1104/pp.004226; Horsch R., 1989, PLANT MOL BIOL MANUA, P63, DOI DOI 10.1007/978-94-009-0951-9_5; Huchelmann A, 2014, PLANT PHYSIOL, V164, P935, DOI 10.1104/pp.113.232546; Perez-Espana VH, 2011, PLANT SIGNAL BEHAV, V6, P321, DOI 10.4161/psb.6.3.13206; Ishiguro S, 2010, PLANT CELL PHYSIOL, V51, P896, DOI 10.1093/pcp/pcq068; Jin HN, 2012, PLANT J, V70, P1015, DOI 10.1111/j.1365-313X.2012.04942.x; Laule O, 2003, P NATL ACAD SCI USA, V100, P6866, DOI 10.1073/pnas.1031755100; Lee MH, 2004, PLANT CELL PHYSIOL, V45, P976, DOI 10.1093/pcp/pch126; Li D, 2009, PLANT BIOTECHNOL J, V7, P791, DOI 10.1111/j.1467-7652.2009.00444.x; Li FL, 2007, PLANT PHYSIOL, V145, P87, DOI 10.1104/pp.107.100560; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; LYNEN F., 1967, PURE APPL CHEM, V14, P137, DOI 10.1351/pac196714010137; Masferrer A, 2002, PLANT J, V30, P123, DOI 10.1046/j.1365-313X.2002.01273.x; Merret R, 2007, FEBS LETT, V581, P5295, DOI 10.1016/j.febslet.2007.10.023; Montoya T, 2005, PLANT J, V42, P262, DOI 10.1111/j.1365-313X.2005.02376.x; Moreau RA, 2002, PROG LIPID RES, V41, P457, DOI 10.1016/S0163-7827(02)00006-1; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Murray JAH, 2012, PLANT CELL, V24, P3907, DOI 10.1105/tpc.112.102194; Nagegowda DA, 2005, PLANTA, V221, P844, DOI 10.1007/s00425-005-1497-5; Nagegowda DA, 2004, BIOCHEM J, V383, P517, DOI 10.1042/BJ20040721; Nakamura A, 2001, FEBS LETT, V506, P61, DOI 10.1016/S0014-5793(01)02870-8; Nguyen HTM, 2013, PLANT PHYSIOL BIOCH, V73, P23, DOI 10.1016/j.plaphy.2013.07.018; Nomura T, 2005, J BIOL CHEM, V280, P17873, DOI 10.1074/jbc.M414592200; Okada K, 2008, PLANT CELL PHYSIOL, V49, P604, DOI 10.1093/pcp/pcn032; Orlova I, 2009, PLANT CELL, V21, P4002, DOI 10.1105/tpc.109.071282; Pojer F, 2006, P NATL ACAD SCI USA, V103, P11491, DOI 10.1073/pnas.0604935103; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Rohmer M, 1999, NAT PROD REP, V16, P565, DOI 10.1039/a709175c; RUDNEY H, 1959, J BIOL CHEM, V234, P1076; Sacchettini JC, 1997, SCIENCE, V277, P1788, DOI 10.1126/science.277.5333.1788; Schaller H, 1998, PLANT PHYSIOL, V118, P461, DOI 10.1104/pp.118.2.461; SCHALLER H, 1995, PLANT PHYSIOL, V109, P761, DOI 10.1104/pp.109.3.761; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seo JW, 2005, PHYTOCHEMISTRY, V66, P869, DOI 10.1016/j.phytochem.2005.02.016; Shani E, 2010, PLANT CELL, V22, P3206, DOI 10.1105/tpc.110.078253; Shi Z, 2012, P NATL ACAD SCI USA, V109, P4568, DOI 10.1073/pnas.1202421109; Sitbon F, 2001, PLANTA, V212, P568, DOI 10.1007/s004250000417; Southern E, 2006, NAT PROTOC, V1, P518, DOI 10.1038/nprot.2006.73; STEWART PR, 1966, J BIOL CHEM, V241, P1222; Sun F, 2012, NEW PHYTOL, V194, P206, DOI 10.1111/j.1469-8137.2011.04026.x; Suwanmanee P, 2013, ISOPRENOID SYNTHESIS, P315; Suzuki M, 2004, PLANT J, V37, P750, DOI 10.1111/j.1365-313X.2004.02003.x; Suzuki M, 2009, J EXP BOT, V60, P2055, DOI 10.1093/jxb/erp073; Vriet C, 2012, PLANT CELL, V24, P842, DOI 10.1105/tpc.111.094912; Wang H, 2012, PLANT BIOTECHNOL J, V10, P31, DOI 10.1111/j.1467-7652.2011.00631.x; Wentzinger L, 2013, ISOPRENOID SYNTHESIS, P347; Woyengo TA, 2009, EUR J CLIN NUTR, V63, P813, DOI 10.1038/ejcn.2009.29; Xiao S, 2008, PLANT MOL BIOL, V68, P571, DOI 10.1007/s11103-008-9392-7; Xiao S, 2010, PLANT CELL, V22, P1463, DOI 10.1105/tpc.110.075333; Zhang YJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-19	97	26	27	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98264	10.1371/journal.pone.0098264	http://dx.doi.org/10.1371/journal.pone.0098264			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847714	gold, Green Published, Green Submitted			2022-12-25	WOS:000336730600104
J	Meng, FC; Zhang, JH; Yao, FM; Hao, C				Meng, Fanchao; Zhang, Jiahua; Yao, Fengmei; Hao, Cui			Interactive Effects of Elevated CO2 Concentration and Irrigation on Photosynthetic Parameters and Yield of Maize in Northeast China	PLOS ONE			English	Article							WATER-USE EFFICIENCY; CARBON-DIOXIDE CONCENTRATION; OPEN-AIR ELEVATION; ACUTE HEAT-STRESS; ATMOSPHERIC CO2; STOMATAL CONDUCTANCE; GAS-EXCHANGE; NET PHOTOSYNTHESIS; RISING CO2; GROWTH	Maize is one of the major cultivated crops of China, having a central role in ensuring the food security of the country. There has been a significant increase in studies of maize under interactive effects of elevated CO2 concentration ([CO2]) and other factors, yet the interactive effects of elevated [CO2] and increasing precipitation on maize has remained unclear. In this study, a manipulative experiment in Jinzhou, Liaoning province, Northeast China was performed so as to obtain reliable results concerning the later effects. The Open Top Chambers (OTCs) experiment was designed to control contrasting [CO2] i.e., 390, 450 and 550 mu mol.mol(-1), and the experiment with 15% increasing precipitation levels was also set based on the average monthly precipitation of 5-9 month from 1981 to 2010 and controlled by irrigation. Thus, six treatments, i.e. C550W+15%, C550(W0), C450(W+15%), C450(W0), C390(W+15%) and C-390W0 were included in this study. The results showed that the irrigation under elevated [CO2] levels increased the leaf net photosynthetic rate (P-n) and intercellular CO2 concentration (C-i) of maize. Similarly, the stomatal conductance (G(s)) and transpiration rate (T-r) decreased with elevated [CO2], but irrigation have a positive effect on increased of them at each [CO2] level, resulting in the water use efficiency (WUE) higher in natural precipitation treatment than irrigation treatment at elevated [CO2] levels. Irradiance-response parameters, e.g., maximum net photosynthetic rate (P-nmax) and light saturation points (LSP) were increased under elevated [CO2] and irrigation, and dark respiration (R-d) was increased as well. The growth characteristics, e.g., plant height, leaf area and aboveground biomass were enhanced, resulting in an improved of yield and ear characteristics except axle diameter. The study concluded by reporting that, future elevated [CO2] may favor to maize when coupled with increasing amount of precipitation in Northeast China.	[Meng, Fanchao; Zhang, Jiahua; Hao, Cui] Chinese Acad Meteorol Sci, Inst Ecoenvironm & Agrometeorol, Beijing, Peoples R China; [Meng, Fanchao] Nanjing Univ Informat Sci & Technol, Coll Atmospher Sci, Nanjing, Jiangsu, Peoples R China; [Zhang, Jiahua] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Key Lab Digital Earth Sci, Beijing, Peoples R China; [Yao, Fengmei] Chinese Acad Sci, Key Lab Computat Geodynam, Beijing, Peoples R China	Chinese Academy of Meteorological Sciences (CAMS); Nanjing University of Information Science & Technology; Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; Chinese Academy of Sciences	Zhang, JH (corresponding author), Chinese Acad Meteorol Sci, Inst Ecoenvironm & Agrometeorol, Beijing, Peoples R China.	jhzhang@ceode.ac.cn			Global Change Research Key Project of MOST 973 Program [2010CB951302]; Hundred Talents Program of CAS [Y24002101A]; Social Commonweal Meteorological Research Project [GYHY201106027]; CAS-RADI [Y3ZZ15101A]; CAS-TWAS	Global Change Research Key Project of MOST 973 Program; Hundred Talents Program of CAS(Chinese Academy of Sciences); Social Commonweal Meteorological Research Project; CAS-RADI; CAS-TWAS(Chinese Academy of Sciences)	This work was supported by Global Change Research Key Project of MOST 973 Program (No. 2010CB951302), the Hundred Talents Program of CAS (Y24002101A), the Social Commonweal Meteorological Research Project (No. GYHY201106027), 1-3-5 Innovation Project of CAS-RADI (Y3ZZ15101A) and CAS-TWAS project for drought monitoring and assessment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Ainsworth EA, 2008, GLOBAL CHANGE BIOL, V14, P1642, DOI 10.1111/j.1365-2486.2008.01594.x; Ainsworth EA, 2008, PLANT PHYSIOL, V147, P13, DOI 10.1104/pp.108.117101; Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; Allen LH, 2011, J PLANT PHYSIOL, V168, P1909, DOI 10.1016/j.jplph.2011.05.005; ALLEN SG, 1990, AGR ECOSYST ENVIRON, V30, P81, DOI 10.1016/0167-8809(90)90185-G; AMTHOR JS, 1994, NEW PHYTOL, V128, P443, DOI 10.1111/j.1469-8137.1994.tb02990.x; [Anonymous], 2013, SUMM POL MAK IMPL NE; [白向历 BAI Xiang-li], 2009, [玉米科学, Maize Science], V17, P60; Bernacchi CJ, 2007, PLANT PHYSIOL, V143, P134, DOI 10.1104/pp.106.089557; Burkart S, 2004, EUR J AGRON, V21, P401, DOI 10.1016/j.eja.2004.07.003; CURE JD, 1986, AGR FOREST METEOROL, V38, P127, DOI 10.1016/0168-1923(86)90054-7; Curtis PS, 1998, OECOLOGIA, V113, P299, DOI 10.1007/s004420050381; Easterling DR, 2000, B AM METEOROL SOC, V81, P417, DOI 10.1175/1520-0477(2000)081<0417:OVATIE>2.3.CO;2; ELLIS RH, 1995, ANN BOT-LONDON, V75, P193, DOI 10.1006/anbo.1995.1012; Geissler N, 2009, ENVIRON EXP BOT, V65, P220, DOI 10.1016/j.envexpbot.2008.11.001; Ghannoum O, 2000, PLANT CELL ENVIRON, V23, P931, DOI 10.1046/j.1365-3040.2000.00609.x; Guo JP, 2003, RESPONSES MAINLY PLA; Hamilton EW, 2008, J INTEGR PLANT BIOL, V50, P1375, DOI 10.1111/j.1744-7909.2008.00747.x; Han GX, 2007, PLANT SOIL, V291, P15, DOI 10.1007/s11104-006-9170-8; [韩瑞锋 Han Ruifeng], 2012, [生态学报, Acta Ecologica Sinica], V32, P1471; Hattenschwiler S, 2006, OECOLOGIA, V147, P47, DOI 10.1007/s00442-005-0255-5; Houghton RA, 2001, CLIMATIC CHANGE, V48, P525, DOI 10.1023/A:1005658316062; Hu G, 2007, CATENA, V71, P321, DOI 10.1016/j.catena.2007.02.004; Hulme M, 1998, GEOPHYS RES LETT, V25, P3379, DOI 10.1029/98GL02562; IDSO SB, 1993, ENVIRON EXP BOT, V33, P367, DOI 10.1016/0098-8472(93)90038-H; IPCC Apndice, 2007, AR4 CLIMATE CHANGE 2; Jones PD, 1996, INT J CLIMATOL, V16, P361, DOI [10.1002/(SICI)1097-0088(199604)16:4<361::AID-JOC53>3.0.CO;2-F, 10.1002/(SICI)1097-0088(199604)16:4&lt;361::AID-JOC53&gt;3.0.CO;2-F]; Kang ShaoZhong, 1999, Acta Agronomica Sinica, V25, P55; Kang SZ, 2002, PLANT SOIL, V238, P69, DOI 10.1023/A:1014244413067; Kim HY, 2001, NEW PHYTOL, V150, P223, DOI 10.1046/j.1469-8137.2001.00111.x; Kim HY, 2003, FIELD CROP RES, V83, P261, DOI 10.1016/S0378-4290(03)00076-5; Kim SH, 2007, ENVIRON EXP BOT, V61, P224, DOI 10.1016/j.envexpbot.2007.06.005; Kirschbaum MUF, 2011, PLANT PHYSIOL, V155, P117, DOI 10.1104/pp.110.166819; LEADLEY PW, 1993, VEGETATIO, V104, P3, DOI 10.1007/BF00048141; Leakey ADB, 2006, PLANT PHYSIOL, V140, P779, DOI 10.1104/pp.105.073957; Leakey ADB, 2009, J EXP BOT, V60, P2859, DOI 10.1093/jxb/erp096; Lee JS, 2011, AGR ECOSYST ENVIRON, V140, P484, DOI 10.1016/j.agee.2011.01.013; Liang NS, 1995, ENVIRON EXP BOT, V35, P353, DOI 10.1016/0098-8472(95)00009-8; Liu JL, 2008, ANHUI AGR SCI B, V14, P126; Liu X, 1998, SCI GEOGRAPHICA SINI, V18, P18; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; Long SP, 2006, SCIENCE, V312, P1918, DOI 10.1126/science.1114722; [马树庆 MA ShuQing], 2008, [生态学报, Acta Ecologica Sinica], V28, P2131; Manderscheid R, 2014, EUR J AGRON, V52, P11, DOI 10.1016/j.eja.2011.12.007; MARC J, 1984, CAN J BOT, V62, P9, DOI 10.1139/b84-002; Markelz RJC, 2011, J EXP BOT, V62, P3235, DOI 10.1093/jxb/err056; Maroco JP, 1999, PLANTA, V210, P115, DOI 10.1007/s004250050660; Mason TG, 1928, ANN BOT-LONDON, V42, P571, DOI 10.1093/oxfordjournals.aob.a090131; MAUNEY JR, 1978, CROP SCI, V18, P259, DOI 10.2135/cropsci1978.0011183X001800020016x; Milcu A, 2011, BASIC APPL ECOL, V12, P600, DOI 10.1016/j.baae.2011.08.004; MURRAY DR, 1995, AM J BOT, V82, P690, DOI 10.2307/2445426; Newton PCD, 1996, J EXP BOT, V47, P771, DOI 10.1093/jxb/47.6.771; Olszyk DM, 1997, AGR ECOSYST ENVIRON, V66, P1, DOI 10.1016/S0167-8809(97)00085-6; Olszyk DM, 2001, ENVIRON POLLUT, V115, P447, DOI 10.1016/S0269-7491(01)00234-2; Onoda Y, 2007, ECOL RES, V22, P475, DOI 10.1007/s11284-006-0030-z; Reddy AR, 2010, CURR SCI INDIA, V99, P46; Reddy KR, 2005, FIELD CROP RES, V94, P201, DOI 10.1016/j.fcr.2005.01.004; REEVES DW, 1994, J PLANT NUTR, V17, P1939, DOI 10.1080/01904169409364856; Robredo A, 2007, ENVIRON EXP BOT, V59, P252, DOI 10.1016/j.envexpbot.2006.01.001; Roden JS, 1996, PLANT PHYSIOL, V111, P909, DOI 10.1104/pp.111.3.909; Rogers A, 2009, PLANT PHYSIOL, V151, P1009, DOI 10.1104/pp.109.144113; SAMARAKOON AB, 1995, AUST J PLANT PHYSIOL, V22, P33, DOI 10.1071/PP9950033; Samarakoon AB, 1995, J BIOGEOGR, V22, P193, DOI 10.2307/2845910; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; [石耀辉 Shi Yaohui], 2013, [生态学报, Acta Ecologica Sinica], V33, P4478; Temperton VM, 2003, GLOBAL CHANGE BIOL, V9, P286, DOI 10.1046/j.1365-2486.2003.00568.x; Wall GW, 2011, AGR ECOSYST ENVIRON, V144, P390, DOI 10.1016/j.agee.2011.07.006; Wall GW, 2001, NEW PHYTOL, V152, P231, DOI 10.1046/j.0028-646X.2001.00260.x; Wallace JS, 2000, AGR ECOSYST ENVIRON, V82, P105, DOI 10.1016/S0167-8809(00)00220-6; Wang Chunyi, 1996, ACTA SCIENTICE CIRCU, V16, P331; Wang D, 2008, AM J BOT, V95, P165, DOI 10.3732/ajb.95.2.165; Wang Hui, 2012, Chinese Journal of Plant Ecology, V36, P597, DOI 10.3724/SP.J.1258.2012.00597; Wang Jian-Lin, 2012, Chinese Journal of Plant Ecology, V36, P438, DOI 10.3724/SP.J.1258.2012.00438; [王润佳 Wang Runjia], 2010, [干旱地区农业研究, Agricultural Research in the Arid Areas], V28, P32; Wang XL, 1998, SCI AGR SIN, V31, P55; Wigley TML, 2001, SCIENCE, V293, P451, DOI 10.1126/science.1061604; Wu J-D, 2000, RESOURCES SCI, V22, P36; Xu Ling, 2008, Journal of Triticeae Crops, V28, P867; Xu ZZ, 2014, PLANTA, V239, P421, DOI 10.1007/s00425-013-1987-9; Yang J, 2003, CHIN AGR SCI B, V19, P28; Ye ZP, 2007, PHOTOSYNTHETICA, V45, P637, DOI 10.1007/s11099-007-0110-5; Ye ZP, 2008, PHOTOSYNTHETICA, V46, P637, DOI 10.1007/s11099-008-0110-0; Zhang Q, 2006, GBT204812006 PEOPL R; Zhou HQ, 2006, J NE AGR U, V4, P5; Ziska L, 2013, WEED RES, V53, P140, DOI 10.1111/wre.12005; Ziska LH, 1997, PHOTOSYNTH RES, V54, P199, DOI 10.1023/A:1005947802161; Ziska LH, 1999, PHYSIOL PLANTARUM, V105, P74, DOI 10.1034/j.1399-3054.1999.105112.x; Zong YZ, 2014, PHOTOSYNTHETICA, V52, P63, DOI 10.1007/s11099-014-0009-x	89	28	31	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98318	10.1371/journal.pone.0098318	http://dx.doi.org/10.1371/journal.pone.0098318			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848097	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600109
J	Barnett, C; Bril, V; Kapral, M; Kulkarni, A; Davis, AM				Barnett, Carolina; Bril, Vera; Kapral, Moira; Kulkarni, Abhaya; Davis, Aileen M.			A Conceptual Framework for Evaluating Impairments in Myasthenia Gravis	PLOS ONE			English	Article							RELIABILITY; DISABILITY	Background: Myasthenia gravis is characterized by weakness and fatigability of different muscle groups, including ocular, bulbar and the limbs. Therefore, a measure of disease severity at the impairment level in myasthenia needs to reflect all the relevant impairments, as well as their variations with activity and fatigue. We conducted a qualitative study of patients with myasthenia, to explore their experiences and related impairments, aimed at developing a conceptual framework of disease severity at the impairment level in myasthenia gravis. Methods: Twenty patients representing the spectrum of disease participated in semi-structured interviews. Interviews were recorded and the transcripts were analyzed by content analysis using an inductive approach with line-by-line open coding. Themes were generated from these codes. Results: Two main themes were identified: the severity of the impairments and fatigability (i.e., triggering or worsening of an impairment with activity). The impairments were further classified within body regions (ocular, bulbar and axial/limbs). Fatigability was described as a phenomenon affecting the whole body but also affecting specific impairments, and was associated with fluctuation of the symptoms. Patients were concerned that clinical examination at a single point in time might not reflect their true clinical state due to fatigability and fluctuations in severity. Conclusions: This conceptual framework reflects the relevance of both severity and fatigability in understanding impairment-based disease severity in myasthenia. This framework could inform the development of impairment measures in myasthenia gravis.	[Barnett, Carolina; Bril, Vera] Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada; [Barnett, Carolina; Bril, Vera; Kapral, Moira] Univ Hlth Network, Toronto, ON, Canada; [Barnett, Carolina; Kapral, Moira; Kulkarni, Abhaya; Davis, Aileen M.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Kapral, Moira] Univ Toronto, Dept Med, Toronto, ON, Canada; [Kulkarni, Abhaya] Hosp Sick Children, Dept Neurosurg, Toronto, ON M5G 1X8, Canada; [Davis, Aileen M.] Univ Hlth Network, Toronto Western Res Inst, Div Hlth Care & Outcomes Res, Toronto, ON, Canada; [Davis, Aileen M.] Univ Toronto, Dept Phys Therapy, Toronto, ON, Canada; [Davis, Aileen M.] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Barnett, C (corresponding author), Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada.	c.barnetttapia@utoronto.ca	BRIL, vera/ABA-6509-2020; Barnett, Carolina/AFM-9470-2022	Barnett, Carolina/0000-0001-5546-0221; Davis, Aileen/0000-0002-9903-9399	AAN; American Brain foundation; Grifols; CSL; Bionevia; Lilly; Pfizer; Dainippon Sumitomo; Eisai	AAN; American Brain foundation; Grifols; CSL; Bionevia; Lilly(Eli Lilly); Pfizer(Pfizer); Dainippon Sumitomo(Dainippon Sumitomo Pharma Co., Ltd.); Eisai(Eisai Co Ltd)	1. Dr. Barnett holds a clinical research fellowship award by the AAN and American Brain foundation. 2. Dr. Bril has acted as consultant for Grifols, CSL, Bionevia, Lilly, Pfizer, Dainippon Sumitomo, Eisai, and has received research grant support from all of these. 3. Dr. Kapral has no disclosures. 4. Dr. Kulkarni has no disclosures. 5. Dr. Davis has no disclosures. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Barnett TC, 2013, NEUROMUSCULAR DISORD, V23, P413, DOI 10.1016/j.nmd.2013.02.008; Barohn RJ, 1998, ANN NY ACAD SCI, V841, P769, DOI 10.1111/j.1749-6632.1998.tb11015.x; BESINGER UA, 1983, NEUROLOGY, V33, P1316, DOI 10.1212/WNL.33.10.1316; Burns TM, 2008, MUSCLE NERVE, V38, P1553, DOI 10.1002/mus.21185; Coyne IT, 1997, J ADV NURS, V26, P623, DOI 10.1046/j.1365-2648.1997.t01-25-00999.x; de Vet HC, 2011, MEASUREMENT MED, P30; Dobkin BH, 2008, NEUROREHAB NEURAL RE, V22, P105, DOI 10.1177/1545968308315046; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; FDA Ctr Drug Evaluation Res, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-79; Fossey E, 2002, AUST NZ J PSYCHIAT, V36, P717, DOI 10.1046/j.1440-1614.2002.01100.x; GAJDOS P, 1983, PRESSE MED, V12, P939; Gajdos P, 2003, ANN NY ACAD SCI, V998, P445, DOI 10.1196/annals.1254.058; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Howard JF, 2012, MYASTHENIA GRAVIS MY, P108; Jaretzki A, 2000, NEUROLOGY, V55, P16, DOI 10.1212/WNL.55.1.16; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; Kuks JMB, 2009, MYASTHENIA GRAVIS RE, P93; Lashley D, 2010, NEUROLOGY, V74, P1517, DOI 10.1212/WNL.0b013e3181dd43bf; Leonardi M, 2009, DISABIL REHABIL, V31, P2041, DOI 10.3109/09638280902893634; Leonardi M, 2009, INT J REHABIL RES, V32, P167, DOI 10.1097/MRR.0b013e32831e4587; MANTEGAZZA R, 1988, J NEUROL, V235, P449, DOI 10.1007/BF00314245; Mokkink LB, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-22; Okochi Jiro, 2005, Health Qual Life Outcomes, V3, P46, DOI 10.1186/1477-7525-3-46; Romani A, 2002, FUNCT NEUROL, V17, P137; Sanders DB, 2003, ANN NY ACAD SCI, V998, P440, DOI 10.1196/annals.1254.057; Sharshar T, 2000, J NEUROL, V247, P286, DOI 10.1007/s004150050585; TINDALL RSA, 1987, NEW ENGL J MED, V316, P719, DOI 10.1056/NEJM198703193161205; Twork S, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-129; WHO, 2001, WHO INT CLASS FUNCT; Zhang Y, 2009, QUALITATIVE ANAL CON, DOI DOI 10.1002/HBM.20661	30	17	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98089	10.1371/journal.pone.0098089	http://dx.doi.org/10.1371/journal.pone.0098089			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0UW	24844418	Green Published, Green Submitted, gold			2022-12-25	WOS:000339563400094
J	Carvalho, RS; Abreu, RBV; Velkova, A; Marsillac, S; Rodarte, RS; Suarez-Kurtz, G; Iversen, ES; Monteiro, ANA; Carvalho, MA				Carvalho, Renato S.; Abreu, Renata B. V.; Velkova, Aneliya; Marsillac, Sylvia; Rodarte, Renato S.; Suarez-Kurtz, Guilherme; Iversen, Edwin S.; Monteiro, Alvaro N. A.; Carvalho, Marcelo A.			Probing Structure-Function Relationships in Missense Variants in the Carboxy-Terminal Region of BRCA1	PLOS ONE			English	Article							GERM-LINE BRCA1; TRANSCRIPTIONAL ACTIVATION; BREAST; MUTATIONS; PHOSPHORYLATION; CLASSIFICATION; SUSCEPTIBILITY; INDIVIDUALS; ALLELE; ASSAY	Germline inactivating variants in BRCA1 lead to a significantly increased risk of breast and ovarian cancers in carriers. While the functional effect of many variants can be inferred from the DNA sequence, determining the effect of missense variants present a significant challenge. A series of biochemical and cell biological assays have been successfully used to explore the impact of these variants on the function of BRCA1, which contribute to assessing their likelihood of pathogenicity. It has been determined that variants that co-localize with structural or functional motifs are more likely to disrupt the stability and function of BRCA1. Here we assess the functional impact of 37 variants chosen to probe the functional impact of variants in phosphorylation sites and in the BRCT domains. In addition, we perform a meta-analysis of 170 unique variants tested by the transcription activation assays in the carboxy-terminal domain of BRCA1 using a recently developed computation model to provide assessment for functional impact and their likelihood of pathogenicity.	[Carvalho, Renato S.; Velkova, Aneliya; Marsillac, Sylvia; Monteiro, Alvaro N. A.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Canc Epidemiol Program, Tampa, FL 33612 USA; [Carvalho, Renato S.; Abreu, Renata B. V.; Suarez-Kurtz, Guilherme; Carvalho, Marcelo A.] Inst Nacl Canc, Programa Farmacol, Rio De Janeiro, RJ, Brazil; [Rodarte, Renato S.] Univ Fed Alagoas, Maceio, AL, Brazil; [Iversen, Edwin S.] Duke Univ, Dept Stat Sci, Durham, NC USA; [Carvalho, Marcelo A.] Inst Fed Educ Ciencia & Tecnol Rio de Janeiro, Rio De Janeiro, RJ, Brazil	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; National Cancer Institute (Inca); Universidade Federal de Alagoas; Duke University; Instituto Federal do Rio de Janeiro (IFRJ)	Monteiro, ANA (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Canc Epidemiol Program, Tampa, FL 33612 USA.	alvaro.monteiro@moffitt.org; marcelo.carvalho@ifrj.edu.br	Suarez-Kurtz, Guilherme/P-4620-2019; Carvalho, Renato/AAK-3890-2020; Barbosa Vahia de Abreu, Renata/V-5594-2018; Carvalho, Marcelo/T-2014-2019; Carvalho, Marcelo A/J-7144-2012; Suarez-Kurtz, Guilherme/J-6648-2012; Monteiro, Alvaro N. A./A-7566-2009	Suarez-Kurtz, Guilherme/0000-0002-1115-8319; Barbosa Vahia de Abreu, Renata/0000-0002-3183-1195; Carvalho, Marcelo A/0000-0002-7053-0053; Suarez-Kurtz, Guilherme/0000-0002-1115-8319; Monteiro, Alvaro N. A./0000-0002-8448-4801	National Institutes of Health [CA116167]; Florida Breast Cancer Foundation; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); INCT para o Controle do Cancer (CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); Department of Defense [W81XWH-08-1-0509]; NATIONAL CANCER INSTITUTE [U01CA116167, P30CA076292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Breast Cancer Foundation; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); INCT para o Controle do Cancer (CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Institutes of Health award CA116167, and grants from the Florida Breast Cancer Foundation, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), and INCT para o Controle do Cancer (CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico). A.V. was the recipient of a predoctoral fellowship from the Department of Defense Breast Cancer Research Program (W81XWH-08-1-0509). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abkevich V, 2004, J MED GENET, V41, P492, DOI 10.1136/jmg.2003.015867; Carvalho MA, 2007, CANCER RES, V67, P1494, DOI 10.1158/0008-5472.CAN-06-3297; Carvalho MA, 2007, INT J BIOCHEM CELL B, V39, P298, DOI 10.1016/j.biocel.2006.08.002; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Chen SN, 2006, J CLIN ONCOL, V24, P863, DOI 10.1200/JCO.2005.03.6772; Concolino P, 2014, CLIN CHEM LAB MED, V52, P1119, DOI 10.1515/cclm-2013-1114; Couch FJ, 2014, SCIENCE, V343, P1466, DOI 10.1126/science.1251827; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; Evans DG, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-155; Frank TS, 1998, J CLIN ONCOL, V16, P2417, DOI 10.1200/JCO.1998.16.7.2417; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; Gatei M, 2000, CANCER RES, V60, P3299; Goldgar DE, 2008, HUM MUTAT, V29, P1265, DOI 10.1002/humu.20897; Hayes F, 2000, CANCER RES, V60, P2411; Iversen ES, 2011, CANCER EPIDEM BIOMAR, V20, P1078, DOI 10.1158/1055-9965.EPI-10-1214; Jackson SA, 2014, CANCER-AM CANCER SOC, V120, P1557, DOI 10.1002/cncr.28577; JOHNSON DH, 2003, PCR PRACTICAL APPROA; Lee MS, 2010, CANCER RES, V70, P4880, DOI 10.1158/0008-5472.CAN-09-4563; Malander S, 2004, EUR J CANCER, V40, P422, DOI 10.1016/j.ejca.2003.09.016; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mavaddat N, 2010, MOL ONCOL, V4, P174, DOI 10.1016/j.molonc.2010.04.011; Millot GA, 2012, HUM MUTAT, V33, P1526, DOI 10.1002/humu.22150; Mirkovic N, 2004, CANCER RES, V64, P3790, DOI 10.1158/0008-5472.CAN-03-3009; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Okada S, 2003, J BIOL CHEM, V278, P2015, DOI 10.1074/jbc.M208685200; Ouchi T, 2006, CANCER BIOL THER, V5, P470, DOI 10.4161/cbt.5.5.2845; Phelan CM, 2005, J MED GENET, V42, P138, DOI 10.1136/jmg.2004.024711; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; Spurdle AB, 2011, HUM MUTAT; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Tavtigian SV, 2008, HUM MUTAT, V29, P1342, DOI 10.1002/humu.20896; Tomlinson GE, 1998, CANCER RES, V58, P3237; Tram E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062468; Vallon-Christersson J, 2001, HUM MOL GENET, V10, P353, DOI 10.1093/hmg/10.4.353; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Worley T, 2002, CANCER BIOL THER, V1, P497, DOI 10.4161/cbt.1.5.164	37	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97766	10.1371/journal.pone.0097766	http://dx.doi.org/10.1371/journal.pone.0097766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845084	Green Published, Green Submitted, gold			2022-12-25	WOS:000339563400059
J	Castelli, MP; Madeddu, C; Casti, A; Casu, A; Casti, P; Scherma, M; Fattore, L; Fadda, P; Ennas, MG				Castelli, M. Paola; Madeddu, Camilla; Casti, Alberto; Casu, Angelo; Casti, Paola; Scherma, Maria; Fattore, Liana; Fadda, Paola; Ennas, M. Grazia			Delta 9-Tetrahydrocannabinol Prevents Methamphetamine-Induced Neurotoxicity	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; INDUCED DOPAMINERGIC NEUROTOXICITY; FOCAL CEREBRAL-ISCHEMIA; ENDOCANNABINOID SYSTEM; MICROGLIAL ACTIVATION; N-ACYLETHANOLAMINES; CANNABINOID CB1; MENTAL-HEALTH; BRAIN-DAMAGE; MDMA ECSTASY	Methamphetamine (METH) is a potent psychostimulant with neurotoxic properties. Heavy use increases the activation of neuronal nitric oxide synthase (nNOS), production of peroxynitrites, microglia stimulation, and induces hyperthermia and anorectic effects. Most METH recreational users also consume cannabis. Preclinical studies have shown that natural (Delta 9-tetrahydrocannabinol, Delta 9-THC) and synthetic cannabinoid CB1 and CB2 receptor agonists exert neuroprotective effects on different models of cerebral damage. Here, we investigated the neuroprotective effect of Delta 9-THC on METH-induced neurotoxicity by examining its ability to reduce astrocyte activation and nNOS overexpression in selected brain areas. Rats exposed to a METH neurotoxic regimen (4x10 mg/kg, 2 hours apart) were pre- or post-treated with Delta 9-THC (1 or 3 mg/kg) and sacrificed 3 days after the last METH administration. Semi-quantitative immunohistochemistry was performed using antibodies against nNOS and Glial Fibrillary Acidic Protein (GFAP). Results showed that, as compared to corresponding controls (i) METH-induced nNOS overexpression in the caudate-putamen (CPu) was significantly attenuated by pre- and post-treatment with both doses of Delta 9-THC (219% and 228% for 1 mg/kg pre- and post-treated animals; 225% and 221% for 3 mg/kg pre- and post-treated animals); (ii) METH-induced GFAP-immunoreactivity (IR) was significantly reduced in the CPu by post-treatment with 1 mg/kg Delta 9-THC1 (250%) and by pre-treatment with 3 mg/kg Delta 9-THC (253%); (iii) METH-induced GFAP-IR was significantly decreased in the prefrontal cortex (PFC) by pre- and post-treatment with both doses of Delta 9-THC (234% and 247% for 1 mg/kg pre- and post-treated animals; 237% and 229% for 3 mg/kg pre- and post-treated animals). The cannabinoid CB1 receptor antagonist SR141716A attenuated METH-induced nNOS overexpression in the CPu, but failed to counteract the Delta 9-THC-mediated reduction of METH-induced GFAP-IR both in the PFC and CPu. Our results indicate that Delta 9-THC reduces METH-induced brain damage via inhibition of nNOS expression and astrocyte activation through CB1-dependent and independent mechanisms, respectively.	[Castelli, M. Paola; Madeddu, Camilla; Casti, Alberto; Casu, Angelo; Casti, Paola; Scherma, Maria; Fadda, Paola; Ennas, M. Grazia] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [Castelli, M. Paola; Fadda, Paola] Univ Cagliari, Ctr Excellence Neurobiol Addict, Cagliari, Italy; [Fadda, Paola] Univ Cagliari, Natl Inst Neurosci INN, Cagliari, Italy; [Fattore, Liana] Cittadella Univ Monserrato, Natl Res Council Italy, CNR Inst Neurosci Cagliari, Cagliari, Italy	University of Cagliari; University of Cagliari; University of Cagliari; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); University of Cagliari	Castelli, MP (corresponding author), Univ Cagliari, Dept Biomed Sci, Cagliari, Italy.	castelli@unica.it	Scherma, Maria/AAJ-7294-2020; Castelli, Maria Paola/F-9295-2012; Fattore, Liana/AAC-6996-2021	Castelli, Maria Paola/0000-0003-3249-4706; Ennas, Maria Grazia/0000-0002-9448-715X; FADDA, PAOLA/0000-0002-0642-6710; FATTORE, LIANA/0000-0002-2663-666X	Fondazione Banco di Sardegna	Fondazione Banco di Sardegna(Fondazione Banco di Sardegna)	This work was partially supported by Grant to MPC from Fondazione Banco di Sardegna. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amantea D, 2007, FEBS J, V274, P4464, DOI 10.1111/j.1742-4658.2007.05975.x; Anderson KL, 2006, ANN NY ACAD SCI, V1074, P225, DOI 10.1196/annals.1369.021; Asanuma M, 2003, NEUROSCI LETT, V352, P13, DOI 10.1016/j.neulet.2003.08.015; Ayata C, 1997, J NEUROSCI, V17, P6908; Baker D, 2008, CURR PHARM DESIGN, V14, P2326, DOI 10.2174/138161208785740036; Berger C, 2004, J NEUROCHEM, V88, P1159, DOI 10.1046/j.1471-4159.2003.02244.x; Bisogno T, 2008, CURR PHARM DESIGN, V14, P2299, DOI 10.2174/138161208785740027; Blackshaw S, 2003, NEUROSCIENCE, V119, P979, DOI 10.1016/S0306-4522(03)00217-3; Bortolato M, 2010, J PSYCHIATR RES, V44, P944, DOI 10.1016/j.jpsychires.2010.03.002; Bortolato M, 2009, NEUROTOX RES, V15, P232, DOI 10.1007/s12640-009-9024-2; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Callahan BT, 1998, NEUROREPORT, V9, P2691, DOI 10.1097/00001756-199808240-00001; Cernak I, 2004, J CEREBR BLOOD F MET, V24, P564, DOI 10.1097/00004647-200405000-00011; Churchwell JC, 2012, DEV NEUROSCI-BASEL, V34, P310, DOI 10.1159/000337724; Cohen M, 2012, INT J NEUROPSYCHOPH, V15, P297, DOI 10.1017/S146114571100068X; Davidson C, 2001, BRAIN RES REV, V36, P1, DOI 10.1016/S0165-0173(01)00054-6; De Petrocellis L, 2001, FEBS LETT, V506, P253, DOI 10.1016/S0014-5793(01)02934-9; Deng XL, 1999, BRAIN RES, V851, P254, DOI 10.1016/S0006-8993(99)02087-9; El-Remessy AB, 2003, AM J PATHOL, V163, P1997, DOI 10.1016/S0002-9440(10)63558-4; Fernandez-Ruiz J, 2008, MOL CELL ENDOCRINOL, V286, pS91, DOI 10.1016/j.mce.2008.01.001; Fernandez-Ruiz J, 2010, EXPERT OPIN THER TAR, V14, P387, DOI 10.1517/14728221003709792; Fishbein M, 2012, EXP BRAIN RES, V221, P437, DOI 10.1007/s00221-012-3186-5; Fowler CJ, 2010, EXP NEUROL, V224, P37, DOI 10.1016/j.expneurol.2010.03.021; Garcia-Arencibia M, 2009, CNS NEUROL DISORD-DR, V8, P432, DOI 10.2174/187152709789824642; Goncalves J, 2010, EUR J NEUROSCI, V31, P315, DOI 10.1111/j.1460-9568.2009.07059.x; Gonzalez R, 2004, DRUG ALCOHOL DEPEN, V76, P181, DOI 10.1016/j.drugalcdep.2004.04.014; Gruber SA, 2009, DRUG ALCOHOL DEPEN, V105, P139, DOI 10.1016/j.drugalcdep.2009.06.019; Hampson AJ, 2001, EUR J NEUROSCI, V13, P1529, DOI 10.1046/j.0953-816x.2001.01536.x; Hansen HH, 2002, J NEUROCHEM, V82, P154, DOI 10.1046/j.1471-4159.2002.00961.x; Hansen HS, 1998, BIOCHEM PHARMACOL, V55, P719, DOI 10.1016/S0006-2952(97)00396-1; Imam SZ, 2001, J NEUROCHEM, V76, P745, DOI 10.1046/j.1471-4159.2001.00029.x; Itzhak Y, 2000, NEUROREPORT, V11, P2943, DOI 10.1097/00001756-200009110-00022; Kim SH, 2006, MOL PHARMACOL, V69, P691, DOI 10.1124/mol.105.016428; Kim SH, 2006, J PHARMACOL EXP THER, V319, P150, DOI 10.1124/jpet.106.107698; Kofalvi A, 2003, EUR J NEUROSCI, V18, P1973, DOI 10.1046/j.1460-9568.2003.02897.x; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; Landa L, 2006, NEUROENDOCRINOL LETT, V27, P63; LaVoie MJ, 2004, EXP NEUROL, V187, P47, DOI 10.1016/j.expneurol.2004.01.010; Lawston J, 2000, BRAIN RES, V877, P407, DOI 10.1016/S0006-8993(00)02739-6; Marinelli S, 2002, J PHYSIOL-LONDON, V543, P531, DOI 10.1113/jphysiol.2002.022863; Marshall JF, 2012, TRENDS NEUROSCI, V35, P536, DOI 10.1016/j.tins.2012.05.006; Marsicano G, 2002, J NEUROCHEM, V80, P448, DOI 10.1046/j.0022-3042.2001.00716.x; Massi P, 2008, CURR PHARM DESIGN, V14, P2289, DOI 10.2174/138161208785740135; Maxwell JC, 2011, ADDICT BEHAV, V36, P1168, DOI 10.1016/j.addbeh.2011.07.017; Mechoulam R, 2007, MOL NEUROBIOL, V36, P68, DOI 10.1007/s12035-007-8008-6; Morley KC, 2004, NEUROPHARMACOLOGY, V46, P954, DOI 10.1016/j.neuropharm.2004.01.002; Muthian S, 2004, NEUROSCIENCE, V129, P743, DOI 10.1016/j.neuroscience.2004.08.044; Nagayama T, 1999, J NEUROSCI, V19, P2987; O'Shea M, 2006, J PSYCHOPHARMACOL, V20, P611, DOI 10.1177/0269881106065188; Oddi S, 2012, J MOL MED, V90, P371, DOI 10.1007/s00109-011-0846-z; Ortega-Gutierrez S, 2005, GLIA, V52, P163, DOI 10.1002/glia.20229; Pacher P, 2011, PROG LIPID RES, V50, P193, DOI 10.1016/j.plipres.2011.01.001; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Patton GC, 2002, BMJ-BRIT MED J, V325, P1195, DOI 10.1136/bmj.325.7374.1195; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pegorini S, 2006, BRIT J PHARMACOL, V147, P552, DOI 10.1038/sj.bjp.0706656; Pellegrini-Giampietro DE, 2009, FEBS J, V276, P2, DOI 10.1111/j.1742-4658.2008.06765.x; Pope C, 2010, NEUROTOXICOLOGY, V31, P562, DOI 10.1016/j.neuro.2009.12.002; Rubino T, 2009, NEUROTOX RES, V15, P291, DOI 10.1007/s12640-009-9031-3; Sarne Y, 2011, BRIT J PHARMACOL, V163, P1391, DOI 10.1111/j.1476-5381.2011.01280.x; Scott LA, 2012, ADDICT BEHAV, V37, P1058, DOI 10.1016/j.addbeh.2012.04.012; Simon SL, 2002, J ADDICT DIS, V21, P61; Solowij N, 2011, PSYCHOL MED, V41, P2349, DOI 10.1017/S003329171100050X; Sung YH, 2013, BEHAV BRAIN RES, V246, P154, DOI 10.1016/j.bbr.2013.02.028; Thomas DM, 2004, NEUROSCI LETT, V367, P349, DOI 10.1016/j.neulet.2004.06.065; Torres E, 2010, J NEUROCHEM, V113, P67, DOI 10.1111/j.1471-4159.2010.06578.x; Tourino C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009143; United Nations Office on Drugs and Crime (UNODC), 2013, WORLD DRUG REP 2013; Valdeolivas S, 2012, ACS CHEM NEUROSCI, V3, P400, DOI 10.1021/cn200114w; Voytek B, 2005, SYNAPSE, V57, P113, DOI 10.1002/syn.20155; Wang J, 2011, BRAIN RES, V1369, P131, DOI 10.1016/j.brainres.2010.11.017; Yamamoto BK, 2010, ANN NY ACAD SCI, V1187, P101, DOI 10.1111/j.1749-6632.2009.05141.x	72	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98079	10.1371/journal.pone.0098079	http://dx.doi.org/10.1371/journal.pone.0098079			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844285	Green Published, gold, Green Submitted			2022-12-25	WOS:000339563400092
J	Hill, JM; Egan, JF; Stauffer, GE; Diefenbach, DR				Hill, Jason M.; Egan, J. Franklin; Stauffer, Glenn E.; Diefenbach, Duane R.			Habitat Availability Is a More Plausible Explanation than Insecticide Acute Toxicity for US Grassland Bird Species Declines	PLOS ONE			English	Article							LAND-USE; AGRICULTURAL LANDSCAPES; BREEDING BIRDS; FARMLAND BIRDS; CONSERVATION; POPULATIONS; SONGBIRDS; ABUNDANCE; CONSEQUENCES; MANAGEMENT	Grassland bird species have experienced substantial declines in North America. These declines have been largely attributed to habitat loss and degradation, especially from agricultural practices and intensification (the habitat-availability hypothesis). A recent analysis of North American Breeding Bird Survey (BBS) "grassland breeding'' bird trends reported the surprising conclusion that insecticide acute toxicity was a better correlate of grassland bird declines in North America from 1980-2003 (the insecticide-acute-toxicity hypothesis) than was habitat loss through agricultural intensification. In this paper we reached the opposite conclusion. We used an alternative statistical approach with additional habitat covariates to analyze the same grassland bird trends over the same time frame. Grassland bird trends were positively associated with increases in area of Conservation Reserve Program (CRP) lands and cropland used as pasture, whereas the effect of insecticide acute toxicity on bird trends was uncertain. Our models suggested that acute insecticide risk potentially has a detrimental effect on grassland bird trends, but models representing the habitat-availability hypothesis were 1.3-21.0 times better supported than models representing the insecticide-acute-toxicity hypothesis. Based on point estimates of effect sizes, CRP area and agricultural intensification had approximately 3.6 and 1.6 times more effect on grassland bird trends than lethal insecticide risk, respectively. Our findings suggest that preserving remaining grasslands is crucial to conserving grassland bird populations. The amount of grassland that has been lost in North America since 1980 is well documented, continuing, and staggering whereas insecticide use greatly declined prior to the 1990s. Grassland birds will likely benefit from the de-intensification of agricultural practices and the interspersion of pastures, Conservation Reserve Program lands, rangelands and other grassland habitats into existing agricultural landscapes.	[Hill, Jason M.; Stauffer, Glenn E.] Penn State Univ, Penn Cooperat Fish & Wildlife Res Unit, University Pk, PA 16802 USA; [Egan, J. Franklin] ARS, USDA, Pasture Syst & Watershed Management Res Unit, University Pk, PA USA; [Diefenbach, Duane R.] Penn State Univ, Penn Cooperat Fish & Wildlife Res Unit, US Geol Survey, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Agriculture (USDA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of the Interior; United States Geological Survey	Hill, JM (corresponding author), Penn State Univ, Penn Cooperat Fish & Wildlife Res Unit, University Pk, PA 16802 USA.	jmh656@psu.edu			ARS [ARS-0424215] Funding Source: Federal RePORTER	ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)		[Anonymous], 2008, REV INDIRECT EFFECTS; [Anonymous], 2013, NY TIMES; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Askins Robert A., 2007, Ornithological Monographs, V64, pi; Atwell RC, 2011, ECOL SOC, V16; Barton K., 2013, MUMIN MULTIMODEL INF; BEST LB, 1995, AM MIDL NAT, V134, P1, DOI 10.2307/2426479; Boody G, 2005, BIOSCIENCE, V55, P27, DOI 10.1641/0006-3568(2005)055[0027:MAITUS]2.0.CO;2; Brennan LA, 2005, J WILDLIFE MANAGE, V69, P1, DOI 10.2193/0022-541X(2005)069&lt;0001:NAGBAU&gt;2.0.CO;2; Briggs JM, 2005, BIOSCIENCE, V55, P243, DOI 10.1641/0006-3568(2005)055[0243:AEITCA]2.0.CO;2; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.2307/3802723, DOI 10.2307/3802723]; Carson R., 2002, SILENT SPRING; Coppedge BR, 2001, ECOL APPL, V11, P47, DOI 10.1890/1051-0761(2001)011[0047:ARTLCI]2.0.CO;2; Dale BC, 1997, WILDLIFE SOC B, V25, P616; Daugherty AB, 1995, MAJOR USES LAND US 1; Davis SK, 2004, AUK, V121, P1130, DOI 10.1642/0004-8038(2004)121[1130:ASIGPE]2.0.CO;2; Davis SK, 2006, AUK, V123, P807, DOI 10.1642/0004-8038(2006)123[807:MPPEWA]2.0.CO;2; DECHANT J. A., 2003, EFFECTS MANAGEMENT P; Dechant JA, 2003, EFFECTS MANAGMEMENT; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Frey HT, 1982, MAJOR USES LAND US 1; Fry JA, 2011, PHOTOGRAMM ENG REM S, V77, P859; Geiger F, 2010, AGR ECOSYST ENVIRON, V139, P571, DOI 10.1016/j.agee.2010.09.018; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Helzer CJ, 1999, ECOL APPL, V9, P1448; Herkert J. R., 1996, MANAGEMENT MIDWESTER; Herkert JR, 2009, CONSERV BIOL, V23, P1036, DOI 10.1111/j.1523-1739.2009.01234.x; Hiron M, 2013, AGR ECOSYST ENVIRON, V176, P9, DOI 10.1016/j.agee.2013.05.013; Johnson DH, 1995, WILSON BULL, V107, P709; Johnson Douglas H., 1996, U S Forest Service General Technical Report NC, V187, P53; Jordan N, 2010, BIOSCIENCE, V60, P60, DOI 10.1525/bio.2010.60.1.10; Kohler HR, 2013, SCIENCE, V341, P759, DOI 10.1126/science.1237591; Koford Rolf R., 1996, U S Forest Service General Technical Report NC, V187, P68; Lazic SE, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-5; Link WA, 1998, ECOL APPL, V8, P258, DOI 10.1890/1051-0761(1998)008[0258:EPCFCD]2.0.CO;2; Link WA, 1997, BIOMETRICS, V53, P488, DOI 10.2307/2533952; Link WA, 1996, ECOLOGY, V77, P1633, DOI 10.2307/2265557; Lubowski RN, 2006, MAJOR USES LAND US 2; MANSFIELD ER, 1982, AM STAT, V36, P158, DOI 10.2307/2683167; MCEWEN LC, 1972, J RANGE MANAGE, V25, P188, DOI 10.2307/3897053; Mela CF, 2002, APPL ECON, V34, P667, DOI 10.1080/00036840110058482; Mineau P, 2005, ECOSCIENCE, V12, P267, DOI 10.2980/i1195-6860-12-2-267.1; Mineau P, 2002, ENVIRON TOXICOL CHEM, V21, P1497, DOI 10.1897/1551-5028(2002)021&lt;1497:ETPOBM&gt;2.0.CO;2; Mineau P, 1999, POISONING RAPTORS OR; Mineau P, 2006, ENVIRON TOXICOL CHEM, V25, P1214, DOI 10.1897/05-035R.1; Mineau P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057457; Murphy MT, 2003, AUK, V120, P20, DOI 10.1642/0004-8038(2003)120[0020:APTWTE]2.0.CO;2; Newton I, 2004, IBIS, V146, P579, DOI 10.1111/j.1474-919X.2004.00375.x; Nickerson C., 2012, EC INFORM B; Nickerson C, 2011, MAJOR LAND USES US 2; North American Bird Conservation Initiative U.S. Committee, 2011, US FISH WILDL PUBL, V48; Osteen CD, 2013, PEST MANAG SCI, V69, P1001, DOI 10.1002/ps.3529; Pabian SE, 2013, J WILDLIFE MANAGE, V77, P616, DOI 10.1002/jwmg.514; Perlut NG, 2008, ECOLOGY, V89, P1941, DOI 10.1890/07-0900.1; Perlut NG, 2006, ECOL APPL, V16, P2235, DOI 10.1890/1051-0761(2006)016[2235:GSIADM]2.0.CO;2; Perlut NG, 2014, WILDLIFE SOC B, V38, P574, DOI 10.1002/wsb.415; Perlut NG, 2008, BIOL CONSERV, V141, P3139, DOI 10.1016/j.biocon.2008.09.011; Piha M, 2007, BIOL CONSERV, V140, P50, DOI 10.1016/j.biocon.2007.07.021; Powell AFLA, 2006, AUK, V123, P183, DOI 10.1642/0004-8038(2006)123[0183:EOPBAB]2.0.CO;2; R Core Team, 2021, R LANG ENV STAT COMP; Renfrew RB, 2005, AUK, V122, P618, DOI 10.1642/0004-8038(2005)122[0618:EABNGB]2.0.CO;2; Riffell Sam, 2010, Open Ornithology Journal, V3, P112, DOI 10.2174/1874453201003010112; Risebrough R.W., 1986, Current Ornithology, V3, P397; Robertson GP, 2014, BIOSCIENCE, V64, P404, DOI 10.1093/biosci/biu037; Samson F.B., 2004, GREAT PLAINS ECOSYST; Sauer JR, 2012, N AM BREEDING BIRD S; Scherr SJ, 2003, ECOAGRICULTURE STRAT, P115; Smith AC, 2009, LANDSCAPE ECOL, V24, P1271, DOI 10.1007/s10980-009-9383-3; Smith C. R., 1997, GRASSLANDS NE N AM, P171; Smith HG, 2010, OECOLOGIA, V162, P1071, DOI 10.1007/s00442-010-1588-2; U.S. Department of Agriculture, 2009, SUMM REP 2007 NAT RE; U.S. Department of Agriculture, 2004, 2002 CENS AGR US SUM; U.S. Department of Commerce, 1981, 1978 CENS AGR US SUM; USDA Farm Service Agency, 2007, CONS RES PROGR SUMM; USDA Farm Service Agency, 2013, CONS RES PROGR NOV 2; Veech JA, 2006, CONSERV BIOL, V20, P1422, DOI 10.1111/j.1523-1739.2006.00487.x; Vickery PD, 1999, STUD AVIAN BIOL, P2; VICKERY PD, 1994, CONSERV BIOL, V8, P1087, DOI 10.1046/j.1523-1739.1994.08041087.x; Virkkala R, 2004, ECOGRAPHY, V27, P273, DOI 10.1111/j.0906-7590.2004.03810.x; Walk JW, 2000, BIOL CONSERV, V94, P165, DOI 10.1016/S0006-3207(99)00182-2; Wretenberg J, 2010, BIOL CONSERV, V143, P375, DOI 10.1016/j.biocon.2009.11.001; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110	82	38	38	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98064	10.1371/journal.pone.0098064	http://dx.doi.org/10.1371/journal.pone.0098064			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846309	Green Published, Green Submitted, gold			2022-12-25	WOS:000339563400090
J	Yasser, M; Shaikh, R; Chilakapati, MK; Teni, T				Yasser, Mohd; Shaikh, Rubina; Chilakapati, Murali Krishna; Teni, Tanuja			Raman Spectroscopic Study of Radioresistant Oral Cancer Sublines Established by Fractionated Ionizing Radiation	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; IN-VITRO; INCREASED EXPRESSION; ANTIOXIDANT ENZYMES; OPTICAL PATHOLOGY; APOPTOSIS; TUMOR; RADIOTHERAPY; RESISTANCE; PHENOTYPE	Radiotherapy is an important treatment modality for oral cancer. However, development of radioresistance is a major hurdle in the efficacy of radiotherapy in oral cancer patients. Identifying predictors of radioresistance is a challenging task and has met with little success. The aim of the present study was to explore the differential spectral profiles of the established radioresistant sublines and parental oral cancer cell lines by Raman spectroscopy. We have established radioresistant sublines namely, 50Gy-UPCI:SCC029B and 70Gy-UPCI:SCC029B from its parental UPCI:SCC029B cell line, by using clinically admissible 2Gy fractionated ionizing radiation (FIR). The developed radioresistant character was validated by clonogenic cell survival assay and known radioresistance-related protein markers like Mcl-1, Bcl-2, Cox-2 and Survivin. Altered cellular morphology with significant increase (p < 0.001) in the number of filopodia in radioresistant cells with respect to parental cells was observed. The Raman spectra of parental UPCI:SCC029B, 50Gy-UPCI:SCC029B and 70Gy-UPCI:SCC029B cells were acquired and spectral features indicate possible differences in biomolecules like proteins, lipids and nucleic acids. Principal component analysis (PCA) provided three clusters corresponding to radioresistant 50Gy, 70Gy-UPCI:SCC029B sublines and parental UPCI: SCC029B cell line with minor overlap, which suggest altered molecular profile acquired by the radioresistant cells due to multiple doses of irradiation. The findings of this study support the potential of Raman spectroscopy in prediction of radioresistance and possibly contribute to better prognosis of oral cancer.	[Yasser, Mohd; Teni, Tanuja] Tata Mem Hosp, ACTREC, Teni Lab, Kharghar Node, Navi Mumbai, India; [Shaikh, Rubina; Chilakapati, Murali Krishna] Tata Mem Hosp, ACTREC, Chilakapati Lab, Kharghar Node, Navi Mumbai, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital	Chilakapati, MK (corresponding author), Tata Mem Hosp, ACTREC, Chilakapati Lab, KS-04, Kharghar Node, Navi Mumbai, India.	mchilakapati@actrec.gov.in; tteni@actrec.gov.in	shaikh, rubina/AAS-2776-2020	Multhoff, Gabriele/0000-0002-2616-3137; Shaikh, Dr Rubina/0000-0003-4184-8254; C, Murali Krishna/0000-0002-4974-8533	Department of Biotechnology, Government of India [BT/PRI11282/MED/32/83/2008]; University Grants Commission (UGC) - India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); University Grants Commission (UGC) - India(University Grants Commission, India)	The Raman spectrometer employed in the study was procured from DBT project BT/PRI11282/MED/32/83/2008, entitled "Development of in vivo laser Raman spectroscopy methods for diagnosis of oral precancerous and cancerous conditions," Department of Biotechnology, Government of India. Mohd Yasser is funded by a fellowship from the University Grants Commission (UGC) - India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Bates S, 1996, CURR OPIN GENET DEV, V6, P12, DOI 10.1016/S0959-437X(96)90004-0; Bessell A, 2011, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD006205.PUB3; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Bucci B, 2006, ANTICANCER RES, V26, P4549; Chapman JD, 1998, RADIOTHER ONCOL, V46, P229, DOI 10.1016/S0167-8140(97)00186-2; CHEN JD, 1995, MOL MED, V1, P142, DOI 10.1007/BF03401562; De Veld DCG, 2005, ORAL ONCOL, V41, P117, DOI 10.1016/j.oraloncology.2004.07.007; Dikshit R, 2012, LANCET, V379, P1807, DOI 10.1016/S0140-6736(12)60358-4; Fenton RG, 2011, HARRISONS PRINCIPLES, P294; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferreira DS, 2010, IEEE ENG MED BIO, P1210, DOI 10.1109/IEMBS.2010.5626448; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Ghanate AD, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3548303; Huang SH, 2013, MED ORAL PATOL ORAL, V18, pE233, DOI 10.4317/medoral.18772; Ishigami T, 2007, INT J CANCER, V120, P2262, DOI 10.1002/ijc.22561; John-Aryankalayil M, 2010, RADIAT RES, V174, P446, DOI 10.1667/RR2105.1; Kitada S, 1993, Antisense Res Dev, V3, P157; Koljenovic S, 2002, LAB INVEST, V82, P1265, DOI 10.1097/01.LAB.0000032545.96931.B8; Krishna CM, 2006, BIOPOLYMERS, V82, P462, DOI 10.1002/bip.20485; Krishna CM, 2005, BBA-GEN SUBJECTS, V1726, P160, DOI 10.1016/j.bbagen.2005.08.006; Krishna CM, 2004, APPL SPECTROSC, V58, P1128, DOI 10.1366/0003702041959460; Lee HC, 2004, INT J MOL MED, V13, P883; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malini R, 2006, BIOPOLYMERS, V81, P179, DOI 10.1002/bip.20398; Mallick S, 2009, J PATHOL, V217, P398, DOI 10.1002/path.2459; Martin CL, 2008, ORAL ONCOL, V44, P369, DOI 10.1016/j.oraloncology.2007.05.003; Carrillo MM, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-103; Matthews Q, 2011, PHYS MED BIOL, V56, P6839, DOI 10.1088/0031-9155/56/21/006; Matthews Q, 2011, PHYS MED BIOL, V56, P19, DOI 10.1088/0031-9155/56/1/002; Moosmann B, 2000, EUR J BIOCHEM, V267, P5687, DOI 10.1046/j.1432-1327.2000.01658.x; Nijssen A, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2750287; Nijsssen A, 2009, J BIOPHOTONICS, V2, P29, DOI 10.1002/jbio.200810055; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Palve VC, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-135; Rajendran R., 2009, SHAFERS TXB ORAL PAT; Rubina S, 2013, VIB SPECTROSC, V68, P115, DOI 10.1016/j.vibspec.2013.06.002; Rubina S, 2013, J INNOV OPT HEAL SCI, V6, DOI 10.1142/S1793545813500144; Sahu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078921; Sahu A, 2013, ANALYST, V138, P4161, DOI 10.1039/c3an00308f; Shannan B, 2006, J MOL HISTOL, V37, P183, DOI 10.1007/s10735-006-9052-7; SINGH AD, 1966, AMER J ROENTGENOL RA, V96, P6, DOI 10.2214/ajr.96.1.6; Singh SP, 2013, ANALYST, V138, P4175, DOI 10.1039/c3an36761d; Singh SP, 2012, J CANCER RES THER, V8, P126, DOI 10.4103/0973-1482.92227; Singh SP, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.10.105002; SKLAR MD, 1991, MOL CELL BIOL, V11, P3699, DOI 10.1128/MCB.11.7.3699; Skvara H, 2005, ANTICANCER RES, V25, P2697; Sun J, 1998, FREE RADICAL BIO MED, V24, P586, DOI 10.1016/S0891-5849(97)00291-8; Terakado N, 2004, ORAL ONCOL, V40, P383, DOI 10.1016/j.oraloncology.2003.09.005; Valko M, 2004, MOL CELL BIOCHEM, V266, P37, DOI 10.1023/B:MCBI.0000049134.69131.89; Venkatakrishna K, 2001, CURR SCI INDIA, V80, P665; Wang B, 2014, CELL DEATH DIFFER, V21, P1160, DOI 10.1038/cdd.2014.42; Wu JG, 2001, BIOPOLYMERS, V62, P185, DOI 10.1002/bip.1013; Yamamori T, 2012, FREE RADICAL BIO MED, V53, P260, DOI 10.1016/j.freeradbiomed.2012.04.033; Yasuda H, 2008, NITRIC OXIDE-BIOL CH, V19, P205, DOI 10.1016/j.niox.2008.04.026	55	36	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97777	10.1371/journal.pone.0097777	http://dx.doi.org/10.1371/journal.pone.0097777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841281	gold, Green Submitted, Green Published			2022-12-25	WOS:000340948600072
J	Li, PC; Wei, XC; Guan, YJ; Chen, Q; Zhao, TC; Sun, CQ; Wei, L				Li, Pengcui; Wei, Xiaochun; Guan, Yingjie; Chen, Qian; Zhao, Tingcun; Sun, Changqi; Wei, Lei			MicroRNA-1 regulates chondrocyte phenotype by repressing histone deacetylase 4 during growth plate development	FASEB JOURNAL			English	Article						differentiation; HDAC4; Runx2; collagen X	INDIAN HEDGEHOG; RUNX2 CONTRIBUTES; GENE-REGULATION; DIFFERENTIATION; PROLIFERATION; HYPERTROPHY; EXPRESSION; TARGET; DYSREGULATION; MATURATION	MicroRNAs (miRs) are noncoding RNAs (17-25 nt) that control translation and/or mRNA degradation. Using Northern blot analysis, we identified that miR-1 is specifically expressed in growth plate cartilage in addition to muscle tissue, but not in brain, intestine, liver, or lung. We obtained the first evidence that miR-1 is highly expressed in the hypertrophic zone of the growth plate, with an 8-fold increase compared with the proliferation zone; this location coincides with the Ihh and Col X expression regions in vivo. MiR-1 significantly induces chondrocyte proliferation and differentiation. We further identified histone deacetylase 4 (HDAC4) as a target of miR-1. HDAC4 negatively regulates chondrocyte hypertrophy by inhibiting Runx2, a critical transcription factor for chondrocyte hypertrophy. MiR-1 inhibits both endogenous HDAC4 protein by 2.2-fold and the activity of a reporter gene bearing the 3'-untranslated region (UTR) of HDAC4 by 3.3-fold. Conversely, knockdown of endogenous miR-1 relieves the repression of HDAC4. Deletion of the miR-1 binding site in HDAC4 3'-UTR or mutated miR-1 abolishes miR-1-mediated inhibition of the reporter gene activity. Overexpression of HDAC4 reverses miR-1 induction of chondrocyte differentiation markers Col X and Ihh. HDAC4 inhibits Runx2 promoter activity in a dosage-dependent manner. Thus, miR-1 plays an important role in the regulation of the chondrocyte phenotype during the growth plate development via direct targeting of HDAC4.	[Li, Pengcui; Wei, Xiaochun; Wei, Lei] Shanxi Med Univ, Hosp 2, Dept Orthopaed, Shanxi Key Lab Bone & Soft Tissue Injury Repair, Taiyuan, Peoples R China; [Guan, Yingjie; Chen, Qian; Sun, Changqi; Wei, Lei] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Orthopaed, Providence, RI 02903 USA; [Zhao, Tingcun] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Surg, Providence, RI 02903 USA	Shanxi Medical University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Wei, L (corresponding author), Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Orthopaed, Corp Off West,Suite 402H,1 Hoppin St, Providence, RI 02903 USA.	lei_wei@brown.edu	Chen, Qian/C-4354-2011	Chen, Qian/0000-0003-4406-5618	U.S. National Insitutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR059142]; NIH/National Institute of General Medical Sciences [P20GM104937]; National Science Foundation of China [81071495, 81171676, 31271033]; SXNSF [2011011042]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104937] Funding Source: NIH RePORTER	U.S. National Insitutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases; NIH/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); SXNSF; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project was supported by grants R01AR059142 from U.S. National Insitutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases and P20GM104937 from NIH/National Institute of General Medical Sciences, National Science Foundation of China grants 81071495, 81171676 and 31271033, SXNSF 2011011042. The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH. The authors gratefully acknowledge Dr. Ericka M. Bueno for help with the manuscript preparation and editorial services.	Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Beier F, 1999, J BIOL CHEM, V274, P30273, DOI 10.1074/jbc.274.42.30273; Beier F, 1999, P NATL ACAD SCI USA, V96, P1433, DOI 10.1073/pnas.96.4.1433; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Correa D, 2010, DEV CELL, V19, P533, DOI 10.1016/j.devcel.2010.09.008; Emiliani S, 1998, P NATL ACAD SCI USA, V95, P2795, DOI 10.1073/pnas.95.6.2795; Eulalio A, 2007, GENE DEV, V21, P2558, DOI 10.1101/gad.443107; Grozinger CM, 2002, CHEM BIOL, V9, P3, DOI 10.1016/S1074-5521(02)00092-3; Guan YJ, 2011, FASEB J, V25, P4457, DOI 10.1096/fj.11-185132; Guan YJ, 2012, AM J PHYSIOL-CELL PH, V303, pC33, DOI 10.1152/ajpcell.00348.2011; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Lai LP, 2005, J CELL BIOCHEM, V96, P1163, DOI 10.1002/jcb.20635; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Li FF, 2011, J BONE MINER RES, V26, P2899, DOI 10.1002/jbmr.504; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Liu XL, 2011, CELL PHYSIOL BIOCHEM, V27, P391, DOI 10.1159/000327966; Qu DZ, 2011, ANAL BIOCHEM, V417, P112, DOI 10.1016/j.ab.2011.05.037; Redfern AD, 2013, P NATL ACAD SCI USA, V110, P6536, DOI 10.1073/pnas.1301620110; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Wang Y, 2008, CLIN GENET, V74, P307, DOI 10.1111/j.1399-0004.2008.01075.x; Wei F, 2012, OSTEOARTHR CARTILAGE, V20, P755, DOI 10.1016/j.joca.2012.03.010; Wei L, 2010, J ORTHOP RES, V28, P900, DOI 10.1002/jor.21093; Wei L, 2010, DEV BIOL, V341, P236, DOI 10.1016/j.ydbio.2010.02.033; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Zhang Y, 2000, J BIOL CHEM, V275, P32628, DOI 10.1074/jbc.M002594200; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089	35	35	41	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2014	28	9					3930	3941		10.1096/fj.13-249318	http://dx.doi.org/10.1096/fj.13-249318			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN8HU	24858276	Green Published			2022-12-25	WOS:000340845900011
J	Chang, HY; Chou, CC; Hsu, MF; Wang, AHJ				Chang, Hsin-Yang; Chou, Chia-Cheng; Hsu, Min-Feng; Wang, Andrew H. J.			Proposed Carrier Lipid-binding Site of Undecaprenyl Pyrophosphate Phosphatase from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FARNESYL-DIPHOSPHATE SYNTHASE; P-LOOP MOTIF; CRYSTAL-STRUCTURE; ENDOPLASMIC-RETICULUM; ACTIVE-SITE; BACILLUS-STEAROTHERMOPHILUS; DIRECTED MUTAGENESIS; RECA PROTEIN; BACA GENE; METAL-ION	Undecaprenyl pyrophosphate phosphatase (UppP), an integral membrane protein, catalyzes the dephosphorylation of undecaprenyl pyrophosphate to undecaprenyl phosphate, which is an essential carrier lipid in the bacterial cell wall synthesis. Sequence alignment reveals two consensus regions, containing glutamate-rich (E/Q)XXXE plus PGXSRSXXT motifs and a histidine residue, specific to the bacterial UppP enzymes. The predicted topological model suggests that both of these regions are localized near the aqueous interface of UppP and face the periplasm, implicating that its enzymatic function is on the outer side of the plasma membrane. The mutagenesis analysis demonstrates that most of the mutations (E17A/E21A, H30A, S173A, R174A, and T178A) within the consensus regions are completely inactive, indicating that the catalytic site of UppP is constituted by these two regions. Enzymatic analysis also shows an absolute requirement of magnesium or calcium ions in enzyme activity. The three-dimensional structural model and molecular dynamics simulation studies have shown a plausible structure of the catalytic site of UppP and thus provides insights into the molecular basis of the enzyme-substrate interaction in membrane bilayers.	[Chang, Hsin-Yang; Chou, Chia-Cheng; Hsu, Min-Feng; Wang, Andrew H. J.] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Chou, Chia-Cheng; Hsu, Min-Feng; Wang, Andrew H. J.] Acad Sinica, Core Facil Prot Struct Anal, Taipei 11529, Taiwan; [Wang, Andrew H. J.] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Translat Med, Taipei 11529, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Taipei Medical University	Wang, AHJ (corresponding author), Acad Sinica, Inst Biol Chem, 128 Acad Rd,Sect 2, Taipei 11529, Taiwan.	ahjwang@gate.sinica.edu.tw		Chou, Chia-Cheng/0000-0002-0467-1755	 [NSC 10102325-B-492-001]		We thank the National Research Program for Biopharmaceuticals (supported by Grant NSC 10102325-B-492-001) and the National Center for High Performance Computing, National Applied Research Laboratories of Taiwan, for providing computing resources.	Apfel CM, 1999, J BACTERIOL, V181, P483, DOI 10.1128/JB.181.2.483-492.1999; Barreteau H, 2009, J CHROMATOGR B, V877, P213, DOI 10.1016/j.jchromb.2008.12.010; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Bickford JS, 2013, MICROBIOL-SGM, V159, P2444, DOI 10.1099/mic.0.070474-0; CAIN BD, 1993, J BACTERIOL, V175, P3784, DOI 10.1128/JB.175.12.3784-3789.1993; Chang SY, 2004, PROTEIN SCI, V13, P971, DOI 10.1110/ps.03519904; Chang SY, 2003, J BIOL CHEM, V278, P29298, DOI 10.1074/jbc.M302687200; Chung BC, 2013, SCIENCE, V341, P1012, DOI 10.1126/science.1236501; Economou NJ, 2013, P NATL ACAD SCI USA, V110, P14207, DOI 10.1073/pnas.1308268110; El Ghachi M, 2005, J BIOL CHEM, V280, P18689, DOI 10.1074/jbc.M412277200; El Ghachi M, 2004, J BIOL CHEM, V279, P30106, DOI 10.1074/jbc.M401701200; Fernandez F, 2001, J BIOL CHEM, V276, P41455, DOI 10.1074/jbc.M105544200; Fothergill-Gilmore L. A., 1989, ADV ENZYMOLOGY RELAT, V62, P227; Fujihashi M, 2001, P NATL ACAD SCI USA, V98, P4337, DOI 10.1073/pnas.071514398; Ghosh A, 2002, J BIOL CHEM, V277, P32837, DOI 10.1074/jbc.M201853200; Guo RT, 2005, J BIOL CHEM, V280, P20762, DOI 10.1074/jbc.M502121200; Guo RT, 2004, J BIOL CHEM, V279, P4903, DOI 10.1074/jbc.M310161200; Hsu MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056363; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ishikawa K, 2000, EMBO J, V19, P2412, DOI 10.1093/emboj/19.11.2412; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; JOLY A, 1993, J BIOL CHEM, V268, P26983; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kellosalo J, 2012, SCIENCE, V337, P473, DOI 10.1126/science.1222505; Kinoshita K, 1999, PROTEIN ENG, V12, P11, DOI 10.1093/protein/12.1.11; KONOLA JT, 1994, J MOL BIOL, V237, P20, DOI 10.1006/jmbi.1994.1206; Koyama T, 1996, BIOCHEMISTRY-US, V35, P9533, DOI 10.1021/bi960137v; LASKOVICS FM, 1981, BIOCHEMISTRY-US, V20, P1893, DOI 10.1021/bi00510a027; Lin SM, 2012, NATURE, V484, P399, DOI 10.1038/nature10963; LOGAN KM, 1993, J MOL BIOL, V232, P1048, DOI 10.1006/jmbi.1993.1459; Makde RD, 2007, BIOCHEMISTRY-US, V46, P2079, DOI 10.1021/bi062180g; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; Ogino T, 1998, MOL MICROBIOL, V27, P573, DOI 10.1046/j.1365-2958.1998.00703.x; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PILKIS SJ, 1987, J BIOL CHEM, V262, P12672; Pojer F, 2003, P NATL ACAD SCI USA, V100, P2316, DOI 10.1073/pnas.0337708100; Renirie R, 2000, J BIOL CHEM, V275, P11650, DOI 10.1074/jbc.275.16.11650; Rigden DJ, 2001, PROTEIN SCI, V10, P1835, DOI 10.1110/ps.15701; Rush JS, 2002, J BIOL CHEM, V277, P45226, DOI 10.1074/jbc.M207076200; Segel I. H., 1993, ENZYME KINETICS BEHA, P100; Shimizu N, 1998, J BIOL CHEM, V273, P19476, DOI 10.1074/jbc.273.31.19476; SONG LS, 1994, P NATL ACAD SCI USA, V91, P3044, DOI 10.1073/pnas.91.8.3044; STONE KJ, 1971, P NATL ACAD SCI USA, V68, P3223, DOI 10.1073/pnas.68.12.3223; Stukey J, 1997, PROTEIN SCI, V6, P469; Tatar LD, 2007, MICROBIOL-SGM, V153, P2518, DOI 10.1099/mic.0.2007/006312-0; Touze T, 2008, J BIOL CHEM, V283, P16573, DOI 10.1074/jbc.M800394200; van Berkel MAA, 1999, GLYCOBIOLOGY, V9, P243, DOI 10.1093/glycob/9.3.243; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang QX, 2000, BIOCHEM J, V345, P181, DOI 10.1042/0264-6021:3450181	54	29	29	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18719	18735		10.1074/jbc.M114.575076	http://dx.doi.org/10.1074/jbc.M114.575076			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24855653	Green Published, hybrid			2022-12-25	WOS:000339062900010
J	McTernan, PM; Chandrayan, SK; Wu, CH; Vaccaro, BJ; Lancaster, WA; Yang, QY; Fu, D; Hura, GL; Tainer, JA; Adams, MWW				McTernan, Patrick M.; Chandrayan, Sanjeev K.; Wu, Chang-Hao; Vaccaro, Brian J.; Lancaster, W. Andrew; Yang, Qingyuan; Fu, Dax; Hura, Greg L.; Tainer, John A.; Adams, Michael W. W.			Intact Functional Fourteen-subunit Respiratory Membrane-bound [NiFe]-Hydrogenase Complex of the Hyperthermophilic Archaeon Pyrococcus furiosus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONVERTING NIFE HYDROGENASES; SMALL-ANGLE SCATTERING; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; METHANOSARCINA-BARKERI; CATALYTIC-PROPERTIES; BIOLOGICAL FUNCTION; ATP SYNTHASE; ACTIVE-SITE; PURIFICATION	The archaeon Pyrococcus furiosus grows optimally at 100 degrees C by converting carbohydrates to acetate, CO2, and H-2, obtaining energy from a respiratory membrane-bound hydrogenase (MBH). This conserves energy by coupling H-2 production to oxidation of reduced ferredoxin with generation of a sodium ion gradient. MBH is encoded by a 14-gene operon with both hydrogenase and Na+/H+ antiporter modules. Herein a His-tagged MBH was expressed in P. furiosus and the detergent-solubilized complex purified under anaerobic conditions by affinity chromatography. Purified MBH contains all 14 subunits by electrophoretic analysis (13 subunits were also identified by mass spectrometry) and had a measured iron: nickel ratio of 15:1, resembling the predicted value of 13:1. The as-purified enzyme exhibited a rhombic EPR signal characteristic of the ready nickel-boron state. The purified and membrane-bound forms of MBH both preferentially evolved H-2 with the physiological donor (reduced ferredoxin) as well as with standard dyes. The O-2 sensitivities of the two forms were similar (half-lives of similar to 15 h in air), but the purified enzyme was more thermolabile (half-lives at 90 degrees C of 1 and 25 h, respectively). Structural analysis of purified MBH by small angle x-ray scattering indicated a Z-shaped structure with a mass of 310 kDa, resembling the predicted value (298 kDa). The angle x-ray scattering analyses reinforce and extend the conserved sequence relationships of group 4 enzymes and complex I (NADH quinone oxidoreductase). This is the first report on the properties of a solubilized form of an intact respiratory MBH complex that is proposed to evolve H-2 and pump Na+ ions.	[McTernan, Patrick M.; Chandrayan, Sanjeev K.; Wu, Chang-Hao; Vaccaro, Brian J.; Lancaster, W. Andrew; Adams, Michael W. W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Yang, Qingyuan; Fu, Dax] Johns Hopkins Univ, Dept Physiol, Sch Med, Baltimore, MD 21205 USA; [Hura, Greg L.; Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University System of Georgia; University of Georgia; Johns Hopkins University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Adams, MWW (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	adams@bmb.uga.edu	McTernan, Patrick/HGV-0762-2022; Vaccaro, Brian/F-8526-2017; CHANDRAYAN, SANJEEV/M-1662-2016; Tainer, John/GWQ-4878-2022	CHANDRAYAN, SANJEEV/0000-0003-2219-4654; Tainer, John/0000-0003-1659-2429; Adams, Michael/0000-0002-9796-5014; Fu, Dax/0000-0002-2663-1316; Hura, Greg/0000-0003-0501-8464	National Institutes of Health [GM105404]; Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the Department of Energy [DE-FG05-95ER20175]; Department of Energy project Integrated Diffraction Analysis Technologies; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the Department of Energy; Department of Energy project Integrated Diffraction Analysis Technologies(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM105404 (to J. A. T.). This work was also supported by Grant DE-FG05-95ER20175 (to M. W. W. A.) from the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the Department of Energy. SAXS analyses were supported by Department of Energy project Integrated Diffraction Analysis Technologies.	Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; BOHM R, 1990, MOL MICROBIOL, V4, P231, DOI 10.1111/j.1365-2958.1990.tb00590.x; Brereton PS, 1998, BIOCHEMISTRY-US, V37, P7351, DOI 10.1021/bi972864b; Chandrayan SK, 2012, J BIOL CHEM, V287, P3257, DOI 10.1074/jbc.M111.290916; Classen S, 2013, J APPL CRYSTALLOGR, V46, P1, DOI 10.1107/S0021889812048698; Cvetkovic A, 2010, NATURE, V466, P779, DOI 10.1038/nature09265; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; FIALA G, 1986, ARCH MICROBIOL, V145, P56, DOI 10.1007/BF00413027; Foerster S, 2003, J AM CHEM SOC, V125, P83, DOI 10.1021/ja027522u; Fontecilla-Camps Juan C., 2009, V6, P151, DOI [10.1039/9781847559159-00151, 10.1039/BK9781847559159-00151]; Friedrich B, 2011, CURR OPIN BIOTECH, V22, P358, DOI 10.1016/j.copbio.2011.01.006; Hedderich R, 2005, J MOL MICROB BIOTECH, V10, P92, DOI 10.1159/000091557; Hedderich R, 2004, J BIOENERG BIOMEMBR, V36, P65, DOI 10.1023/B:JOBB.0000019599.43969.33; Hopkins RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026569; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Kim MS, 2013, APPL ENVIRON MICROB, V79, P2048, DOI 10.1128/AEM.03298-12; Kurkin S, 2002, EUR J BIOCHEM, V269, P6101, DOI 10.1046/j.1432-1033.2002.03328.x; Lee HS, 2010, TRENDS BIOTECHNOL, V28, P262, DOI 10.1016/j.tibtech.2010.01.007; Lipscomb GL, 2014, J BIOL CHEM, V289, P2873, DOI 10.1074/jbc.M113.530725; Lipscomb GL, 2011, APPL ENVIRON MICROB, V77, P2232, DOI 10.1128/AEM.02624-10; Marreiros BC, 2013, BBA-BIOENERGETICS, V1827, P198, DOI 10.1016/j.bbabio.2012.09.012; Meuer J, 1999, EUR J BIOCHEM, V265, P325, DOI 10.1046/j.1432-1327.1999.00738.x; Pisa KY, 2007, FEBS J, V274, P3928, DOI 10.1111/j.1742-4658.2007.05925.x; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Sapra R, 2000, J BACTERIOL, V182, P3423, DOI 10.1128/JB.182.12.3423-3428.2000; Sapra R, 2003, P NATL ACAD SCI USA, V100, P7545, DOI 10.1073/pnas.1331436100; SAUTER M, 1992, MOL MICROBIOL, V6, P1523, DOI 10.1111/j.1365-2958.1992.tb00873.x; Schut GJ, 2013, FEMS MICROBIOL REV, V37, P182, DOI 10.1111/j.1574-6976.2012.00346.x; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shafaat HS, 2013, BBA-BIOENERGETICS, V1827, P986, DOI 10.1016/j.bbabio.2013.01.015; Silva PJ, 2000, EUR J BIOCHEM, V267, P6541, DOI 10.1046/j.1432-1327.2000.01745.x; Singer SW, 2006, BBA-BIOENERGETICS, V1757, P1582, DOI 10.1016/j.bbabio.2006.10.003; Soboh B, 2002, EUR J BIOCHEM, V269, P5712, DOI 10.1046/j.1432-1033.2002.03282.x; Soboh B, 2004, MICROBIOL-SGM, V150, P2451, DOI 10.1099/mic.0.27159-0; STULTS LW, 1986, J BACTERIOL, V166, P795, DOI 10.1128/jb.166.3.795-800.1986; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Swartz TH, 2005, EXTREMOPHILES, V9, P345, DOI 10.1007/s00792-005-0451-6; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Volbeda A, 2013, STRUCTURE, V21, P184, DOI 10.1016/j.str.2012.11.010; Vonck J, 2009, J BIOL CHEM, V284, P10110, DOI 10.1074/jbc.M808498200	44	30	35	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19364	19372		10.1074/jbc.M114.567255	http://dx.doi.org/10.1074/jbc.M114.567255			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24860091	Green Published, hybrid			2022-12-25	WOS:000339326800013
J	Yang, XM; Hegde, VL; Rao, R; Zhang, JJ; Nagarkatti, PS; Nagarkatti, M				Yang, Xiaoming; Hegde, Venkatesh L.; Rao, Roshni; Zhang, Jiajia; Nagarkatti, Prakash S.; Nagarkatti, Mitzi			Histone Modifications Are Associated with Delta 9-Tetrahydrocannabinol-mediated Alterations in Antigen-specific T Cell Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANNABINOID-RECEPTOR; DEVELOPMENTAL REGULATORS; LEGIONELLA-PNEUMOPHILA; SUPPRESSOR-CELLS; DELTA(9)-TETRAHYDROCANNABINOL; METHYLATION; ACETYLATION; ACTIVATION; GENE; APOPTOSIS	Marijuana is one of the most abused drugs due to its psychotropic effects. Interestingly, it is also used for medicinal purposes. The main psychotropic component in marijuana, Delta 9-tetrahydrocannabinol (THC), has also been shown to mediate potent anti-inflammatory properties. Whether the immunomodulatory activity of THC is mediated by epigenetic regulation has not been investigated previously. In this study, we employed ChIP-Seq technology to examine the in vivo effect of THC on global histone methylation in lymph node cells of mice immunized with a superantigen, staphylococcal enterotoxin B. We compared genome-wide histone H3 Lys-4, Lys-27, Lys-9, and Lys-36 trimethylation and histone H3 Lys-9 acetylation patterns in such cells exposed to THC or vehicle. Our results showed that THC treatment leads to the association of active histone modification signals to Th2 cytokine genes and suppressive modification signals to Th1 cytokine genes, indicating that such a mechanism may play a critical role in the THC-mediated switch from Th1 to Th2. At the global level, a significant portion of histone methylation and acetylation regions were altered by THC. However, the overall distribution of these histone methylation signals among the genomic features was not altered significantly by THC, suggesting that THC activates the expression of a subset of genes while suppressing the expression of another subset of genes through histone modification. Functional classification of these histone marker-associated genes showed that these differentially associated genes were involved in various cellular functions, from cell cycle regulation to metabolism, suggesting that THC had a pleiotropic effect on gene expression in immune cells. Altogether, the current study demonstrates for the first time that THC may modulate immune response through epigenetic regulation involving histone modifications.	[Yang, Xiaoming; Hegde, Venkatesh L.; Rao, Roshni; Nagarkatti, Prakash S.; Nagarkatti, Mitzi] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29209 USA; [Zhang, Jiajia] Univ S Carolina, Sch Publ Hlth, Columbia, SC 29209 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Nagarkatti, M (corresponding author), Univ S Carolina, Sch Med, 6439 Garners Ferry Rd, Columbia, SC 29209 USA.	Mitzi.Nagarkatti@uscmed.sc.edu	; Hegde, Venkatesh/E-8519-2014	Nagarkatti, Prakash/0000-0003-2663-0759; Hegde, Venkatesh/0000-0002-0949-919X; Nagarkatti, Mitzi/0000-0002-5977-5615	National Institutes of Health Grants [P01AT003961, R01AT006888, R01ES019313, R01MH094755, P20GM103641]; Veterans Affairs Merit Award [BX001357]; National Center for Complementary & Integrative Health [P01AT003961, R01AT006888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094755] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001357] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants P01AT003961, R01AT006888, R01ES019313, R01MH094755, and P20GM103641. This work was also supported by Veterans Affairs Merit Award BX001357.	Aguado T, 2007, J BIOL CHEM, V282, P6854, DOI 10.1074/jbc.M608900200; Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; BOUABOULA M, 1993, EUR J BIOCHEM, V214, P173, DOI 10.1111/j.1432-1033.1993.tb17910.x; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bronte V, 2000, BLOOD, V96, P3838, DOI 10.1182/blood.V96.12.3838.h8003838_3838_3846; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chioccarelli T, 2010, ENDOCRINOLOGY, V151, P5017, DOI 10.1210/en.2010-0133; Cinti Sandro, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P342, DOI 10.1177/1545109709351167; Do Y, 2004, J IMMUNOL, V173, P2373, DOI 10.4049/jimmunol.173.4.2373; Ellert-Miklaszewska A, 2005, CELL SIGNAL, V17, P25, DOI 10.1016/j.cellsig.2004.05.011; Fraser JD, 2008, IMMUNOL REV, V225, P226, DOI 10.1111/j.1600-065X.2008.00681.x; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Greenhough A, 2007, INT J CANCER, V121, P2172, DOI 10.1002/ijc.22917; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Guenther MG, 2003, METHOD ENZYMOL, V364, P246; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; Hegde VL, 2008, MOL PHARMACOL, V74, P20, DOI 10.1124/mol.108.047035; Hegde VL, 2013, J BIOL CHEM, V288, P36810, DOI 10.1074/jbc.M113.503037; Hegde VL, 2010, EUR J IMMUNOL, V40, P3358, DOI 10.1002/eji.201040667; Incoronato M, 2010, CANCER RES, V70, P3638, DOI 10.1158/0008-5472.CAN-09-3341; Karmaus PWF, 2013, TOXICOL SCI, V131, P419, DOI 10.1093/toxsci/kfs315; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Kawazu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017830; Khare M, 2006, MOL HUM REPROD, V12, P321, DOI 10.1093/molehr/gal036; Klein TW, 2000, J IMMUNOL, V164, P6461, DOI 10.4049/jimmunol.164.12.6461; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Kozela E, 2013, J NEUROIMMUNE PHARM, V8, P1265, DOI 10.1007/s11481-013-9493-1; Kumar P, 2014, BIOCHEM BIOPH RES CO, V443, P144, DOI 10.1016/j.bbrc.2013.11.071; Kusmartsev SA, 2000, J IMMUNOL, V165, P779, DOI 10.4049/jimmunol.165.2.779; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lim PS, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r107; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Liu Y, 2013, FEBS LETT, V587, P847, DOI 10.1016/j.febslet.2013.02.023; Lombard C, 2011, J PHARMACOL EXP THER, V339, P607, DOI 10.1124/jpet.111.181206; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Morinobu A, 2004, J BIOL CHEM, V279, P40640, DOI 10.1074/jbc.M407576200; Nagarkatti P, 2009, FUTURE MED CHEM, V1, P1333, DOI 10.4155/FMC.09.93; NEWTON CA, 1994, INFECT IMMUN, V62, P4015, DOI 10.1128/IAI.62.9.4015-4020.1994; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Ozaita A, 2007, J NEUROCHEM, V102, P1105, DOI 10.1111/j.1471-4159.2007.04642.x; Pandey R, 2011, J PHARMACOL EXP THER, V338, P819, DOI 10.1124/jpet.111.182717; Paradisi A, 2008, J BIOL CHEM, V283, P6005, DOI 10.1074/jbc.M707964200; Prather PL, 2013, BIOCHEM BIOPH RES CO, V441, P339, DOI 10.1016/j.bbrc.2013.10.057; Rao GK, 2004, J LEUKOCYTE BIOL, V75, P884, DOI 10.1189/jlb.1203638; Remenyi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062509; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Roh TY, 2007, GENOME RES, V17, P74, DOI 10.1101/gr.5767907; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Sadri-Vakili G, 2007, HUM MOL GENET, V16, P1293, DOI 10.1093/hmg/ddm078; SAUER MA, 1983, J PHARMACOL EXP THER, V224, P404; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shaked I, 2009, IMMUNITY, V31, P965, DOI 10.1016/j.immuni.2009.09.019; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Substance Abuse and Mental Health Services Administration, 2010, RES 2009 NAT SURV DR; Tam W, 2001, GENE, V274, P157, DOI 10.1016/S0378-1119(01)00612-6; Terlou A, 2012, J INVEST DERMATOL, V132, P658, DOI 10.1038/jid.2011.369; Todaro B, 2012, J NATL COMPR CANC NE, V10, P487, DOI 10.6004/jnccn.2012.0048; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Vastenhouw NL, 2012, CURR OPIN CELL BIOL, V24, P374, DOI 10.1016/j.ceb.2012.03.009; von Bueren AO, 2008, ANTICANCER RES, V28, P85; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Yuan M, 2002, J NEUROIMMUNOL, V133, P124, DOI 10.1016/S0165-5728(02)00370-3; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhu LX, 2000, J IMMUNOL, V165, P373, DOI 10.4049/jimmunol.165.1.373; Zhu WG, 1998, J PHARMACOL EXP THER, V286, P1103; Zuo T, 2011, CANCER RES, V71, P1752, DOI 10.1158/0008-5472.CAN-10-3573	77	52	53	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18707	18718		10.1074/jbc.M113.545210	http://dx.doi.org/10.1074/jbc.M113.545210			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24841204	Green Published, hybrid			2022-12-25	WOS:000339062900009
J	Yamane, K; Indalao, IL; Chida, J; Yamamoto, Y; Hanawa, M; Kido, H				Yamane, Kazuhiko; Indalao, Irene L.; Chida, Junji; Yamamoto, Yoshikazu; Hanawa, Masaaki; Kido, Hiroshi			Diisopropylamine Dichloroacetate, a Novel Pyruvate Dehydrogenase Kinase 4 Inhibitor, as a Potential Therapeutic Agent for Metabolic Disorders and Multiorgan Failure in Severe Influenza	PLOS ONE			English	Article							CARNITINE PALMITOYLTRANSFERASE-II; PROLIFERATOR-ACTIVATED RECEPTOR; BLOOD-BRAIN-BARRIER; GENE-EXPRESSION; TRYPSIN-I; A VIRUS; PROTEIN-KINASE; RAT LUNGS; IDENTIFICATION; INFLAMMATION	Severe influenza is characterized by cytokine storm and multiorgan failure with metabolic energy disorders and vascular hyperpermeability. In the regulation of energy homeostasis, the pyruvate dehydrogenase (PDH) complex plays an important role by catalyzing oxidative decarboxylation of pyruvate, linking glycolysis to the tricarboxylic acid cycle and fatty acid synthesis, and thus its activity is linked to energy homeostasis. The present study tested the effects of diisopropylamine dichloroacetate (DADA), a new PDH kinase 4 (PDK4) inhibitor, in mice with severe influenza. Infection of mice with influenza A PR/8/34(H1N1) virus resulted in marked down-regulation of PDH activity and ATP level, with selective up-regulation of PDK4 in the skeletal muscles, heart, liver and lungs. Oral administration of DADA at 12-h intervals for 14 days starting immediately after infection significantly restored PDH activity and ATP level in various organs, and ameliorated disorders of glucose and lipid metabolism in the blood, together with marked improvement of survival and suppression of cytokine storm, trypsin up-regulation and viral replication. These results indicate that through PDK4 inhibition, DADA effectively suppresses the host metabolic disorder-cytokine cycle, which is closely linked to the influenza virus-cytokine-trypsin cycle, resulting in prevention of multiorgan failure in severe influenza.	[Yamane, Kazuhiko; Indalao, Irene L.; Chida, Junji; Kido, Hiroshi] Univ Tokushima, Inst Enzyme Res, Div Enzyme Chem, Tokushima 770, Japan; [Yamamoto, Yoshikazu; Hanawa, Masaaki] Daiichi Sankyo Healthcare Co Ltd, R&D Dept, Tokyo, Japan	Tokushima University; Daiichi Sankyo Company Limited	Kido, H (corresponding author), Univ Tokushima, Inst Enzyme Res, Div Enzyme Chem, Tokushima 770, Japan.	kido@ier.tokushima-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24249059]; Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan [12103307]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan	This research was funded in part by Grants-in-Aid (#24249059) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; by Health and Labor Sciences Research Grants (Grant #12103307) from the Ministry of Health, Labor and Welfare of Japan. The funding agencies have no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basler Christopher F., 2007, Infectious Disorders - Drug Targets, V7, P282, DOI 10.2174/187152607783018745; Bersin RM, 1997, AM HEART J, V134, P841, DOI 10.1016/S0002-8703(97)80007-5; Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; Chen Y, 2005, FEBS LETT, V579, P2040, DOI 10.1016/j.febslet.2005.02.050; Chida J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060561; Chida J, 2012, ANAL CHIM ACTA, V727, P8, DOI 10.1016/j.aca.2012.03.022; Chowell G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041069; Close TE, 2013, MICROCIRCULATION, V20, P534, DOI 10.1111/micc.12053; da Rocha  LF, 2013, PPAR RES, V2013, DOI 10.1155/2013/519724; Dagher Z, 2001, CIRC RES, V88, P1276, DOI 10.1161/hh1201.092998; DELORME L, 1979, AM J DIS CHILD, V133, P822, DOI 10.1001/archpedi.1979.02130080062011; Denker BM, 1998, AM J PHYSIOL-RENAL, V274, pF1, DOI 10.1152/ajprenal.1998.274.1.F1; Fedson DS, 2009, INFLUENZA OTHER RESP, V3, P129, DOI 10.1111/j.1750-2659.2009.00090.x; Gallagher D, 1998, AM J PHYSIOL-ENDOC M, V275, pE249, DOI 10.1152/ajpendo.1998.275.2.E249; Hardaway AL, 2013, FUTURE MED CHEM, V5, P1089, DOI [10.4155/FMC.13.90, 10.4155/fmc.13.90]; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Henderson GN, 1997, BIOCHEM BIOPH RES CO, V235, P695, DOI 10.1006/bbrc.1997.6868; HERBERT V, 1979, AM J CLIN NUTR, V32, P1534, DOI 10.1093/ajcn/32.7.1534; Hunt JM, 2012, CURR MOL MED, V12, P827; Jeong JY, 2012, DIABETES METAB J, V36, P328, DOI 10.4093/dmj.2012.36.5.328; Kato M, 2007, STRUCTURE, V15, P992, DOI 10.1016/j.str.2007.07.001; Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27; Kelly DP, 2003, CIRC RES, V92, P482, DOI 10.1161/01.RES.0000064382.46274.95; Kido H, 2012, BBA-PROTEINS PROTEOM, V1824, P186, DOI 10.1016/j.bbapap.2011.07.001; KIM HW, 1979, AM J EPIDEMIOL, V109, P464, DOI 10.1093/oxfordjournals.aje.a112704; Kim YD, 2012, DIABETES, V61, P2484, DOI 10.2337/db11-1665; Kitagawa D, 2013, GENES CELLS, V18, P110, DOI 10.1111/gtc.12022; Koshiba T, 2013, BBA-MOL CELL RES, V1833, P225, DOI 10.1016/j.bbamcr.2012.03.005; Le TQ, 2006, BIOL CHEM, V387, P467, DOI 10.1515/BC.2006.062; Lee H, 2013, PEDIATR GASTROENTERO, V16, P143, DOI 10.5223/pghn.2013.16.3.143; Lipatov AS, 2004, J VIROL, V78, P8951, DOI 10.1128/JVI.78.17.8951-8959.2004; Lu Lun Geng, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P92; Mariappan N, 2009, FREE RADICAL BIO MED, V46, P462, DOI 10.1016/j.freeradbiomed.2008.10.049; McAinch AJ, 2009, DIABETES OBES METAB, V11, P721, DOI 10.1111/j.1463-1326.2009.01042.x; Mizuguchi M, 2007, ACTA NEUROL SCAND, V115, P45, DOI 10.1111/j.1600-0404.2007.00809.x; Moseley CE, 2010, INFLUENZA OTHER RESP, V4, P307, DOI 10.1111/j.1750-2659.2010.00155.x; NAITO E, 1989, BRAIN DEV-JPN, V11, P195, DOI 10.1016/S0387-7604(89)80098-1; Nakamura MT, 2014, PROG LIPID RES, V53, P124, DOI 10.1016/j.plipres.2013.12.001; OLDENDORF WH, 1977, ANN NEUROL, V1, P409, DOI 10.1002/ana.410010502; Pan HY, 2011, J MED INVESTIG, V58, P19, DOI 10.2152/jmi.58.19; Perkins LEL, 2001, VET PATHOL, V38, P149, DOI 10.1354/vp.38-2-149; Planavila A, 2005, BBA-MOL CELL BIOL L, V1736, P120, DOI 10.1016/j.bbalip.2005.08.001; PLATEEL M, 1995, J NEUROCHEM, V65, P2138; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Stacpoole PW, 2006, PEDIATRICS, V117, P1519, DOI 10.1542/peds.2005-1226; Stacpoole PW, 2003, J CLIN PHARMACOL, V43, P683, DOI 10.1177/0091270003254637; STACPOOLE PW, 1989, METABOLISM, V38, P1124, DOI 10.1016/0026-0495(89)90051-6; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Sutendra G, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00038; Towatari T, 2002, EUR J BIOCHEM, V269, P2613, DOI 10.1046/j.1432-1033.2002.02937.x; Ushikai M, 2011, MOL GENET METAB, V102, P349, DOI 10.1016/j.ymgme.2010.11.167; Wang SY, 2010, J INFECT DIS, V202, P991, DOI 10.1086/656044; Way JM, 2001, ENDOCRINOLOGY, V142, P1269, DOI 10.1210/en.142.3.1269; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; WHITEHOUSE S, 1974, BIOCHEM J, V141, P761, DOI 10.1042/bj1410761; Witt KA, 2003, AM J PHYSIOL-HEART C, V285, pH2820, DOI 10.1152/ajpheart.00589.2003; Yamada H, 2006, ARCH VIROL, V151, P2529, DOI 10.1007/s00705-006-0807-y; Yang B, 2002, EUR RESPIR J, V19, P952, DOI 10.1183/09031936.02.00253302; Yao DB, 2008, HUM MUTAT, V29, P718, DOI 10.1002/humu.20717; Yao DB, 2011, J MED INVESTIG, V58, P210, DOI 10.2152/jmi.58.210; Yao M, 2011, MOL GENET METAB, V104, P265, DOI 10.1016/j.ymgme.2011.07.009	61	42	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98032	10.1371/journal.pone.0098032	http://dx.doi.org/10.1371/journal.pone.0098032			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865588	Green Published, gold, Green Submitted			2022-12-25	WOS:000336914100030
J	Franklin, MT; Myers, JH; Cory, JS				Franklin, Michelle T.; Myers, Judith H.; Cory, Jenny S.			Genetic Similarity of Island Populations of Tent Caterpillars during Successive Outbreaks	PLOS ONE			English	Article							HARE LEPUS-AMERICANUS; CYCLIC POPULATIONS; WINTER MOTH; SIZE; FLOW; LEPIDOPTERA; VARIABILITY; DIVERSITY; MIGRATION; PROGRAM	Cyclic or fluctuating populations experience regular periods of low population density. Genetic bottlenecks during these periods could give rise to temporal or spatial genetic differentiation of populations. High levels of movement among increasing populations, however, could ameliorate any differences and could also synchronize the dynamics of geographically separated populations. We use microsatellite markers to investigate the genetic differentiation of four island and one mainland population of western tent caterpillars, Malacosoma californicum pluviale, in two periods of peak or pre-peak density separated by 8 years. Populations showed high levels of genetic variation and little genetic differentiation either temporally between peaks or spatially among sites. Mitochondrial haplotypes were also shared between one island population and one mainland population in the two years studied. An isolation-by-distance analysis showed the F-ST values of the two geographically closest populations to have the highest level of differentiation in both years. We conclude that high levels of dispersal among populations maintain both synchrony of population dynamics and override potential genetic differentiation that might occur during population troughs. As far we are aware, this is the first time that genetic similarity between temporally separated population outbreaks in insects has been investigated. A review of genetic data for both vertebrate and invertebrate species of cyclic animals shows that a lack of spatial genetic differentiation is typical, and may result from high levels of dispersal associated with fluctuating dynamics.	[Franklin, Michelle T.; Cory, Jenny S.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Franklin, Michelle T.; Myers, Judith H.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Franklin, Michelle T.; Myers, Judith H.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada	Simon Fraser University; University of British Columbia; University of British Columbia	Cory, JS (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	jsc21@sfu.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Financial support was provided by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grants to JSC and JHM. Additional support was provided by a President's Research Start-up Grant to JSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthier K, 2006, MOL ECOL, V15, P2665, DOI 10.1111/j.1365-294X.2006.02959.x; BROWN CE, 1965, CAN ENTOMOL, V97, P1073, DOI 10.4039/Ent971073-10; Burton C, 2002, MOL ECOL, V11, P1689, DOI 10.1046/j.1365-294X.2002.01566.x; Chapuis MP, 2011, P ROY SOC B-BIOL SCI, V278, P3152, DOI 10.1098/rspb.2010.2605; Chapuis MP, 2009, MOL ECOL, V18, P792, DOI 10.1111/j.1365-294X.2008.04072.x; Chitty D, 1971, NATURAL REGULATION A, P136; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cory JS, 2009, J ANIM ECOL, V78, P646, DOI 10.1111/j.1365-2656.2008.01519.x; COSTA JT, 1994, EVOLUTION, V48, P1158, DOI 10.1111/j.1558-5646.1994.tb05302.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ebert D, 2002, SCIENCE, V295, P485, DOI 10.1126/science.1067485; Ehrich D, 2005, J MAMMAL, V86, P380, DOI 10.1644/BER-126.1; Elton CS, 1924, BR J EXP BIOL, V2, P119; EMELIANOV I, 1995, HEREDITY, V75, P416, DOI 10.1038/hdy.1995.154; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Franklin MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037472; Franklin MT, 2010, MOL ECOL, V19, P1122, DOI 10.1111/j.1365-294X.2010.04548.x; Garant D, 2007, FUNCT ECOL, V21, P434, DOI 10.1111/j.1365-2435.2006.01228.x; Gilbert KJ, 2012, MOL ECOL, V21, P4925, DOI 10.1111/j.1365-294X.2012.05754.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Ingvarsson PK, 2000, P ROY SOC B-BIOL SCI, V267, P1321, DOI 10.1098/rspb.2000.1145; Jakobsson M, 2007, CLUMPP CLUSTER MATCH; Jorde PE, 2007, GENETICS, V177, P927, DOI 10.1534/genetics.107.075481; Krebs CJ, 2013, CAN J ZOOL, V91, P562, DOI 10.1139/cjz-2013-0012; Larsson LC, 2010, HEREDITY, V104, P40, DOI 10.1038/hdy.2009.98; Leggett HC, 2011, ECOL ENTOMOL, V36, P318, DOI 10.1111/j.1365-2311.2011.01275.x; Liebhold AM, 2012, INSECT OUTBREAKS REV, P114; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Myers JH, 2000, POPUL ECOL, V42, P231, DOI 10.1007/PL00012002; Myers JH, 2013, ANNU REV ECOL EVOL S, V44, P565, DOI 10.1146/annurev-ecolsys-110512-135858; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; NEI M, 1981, GENETICS, V98, P625; Noren K, 2013, BIOL REV; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pilot M, 2010, MOL ECOL, V19, P2800, DOI 10.1111/j.1365-294X.2010.04692.x; Pritchard JK, 2000, GENETICS, V155, P945; Rikalainen K, 2012, ECOL EVOL, V2, P1491, DOI 10.1002/ece3.277; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Salvato P, 2002, MOL ECOL, V11, P2435, DOI 10.1046/j.1365-294X.2002.01631.x; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Tenow O, 2013, J ANIM ECOL, V82, P84, DOI 10.1111/j.1365-2656.2012.02023.x; Van Dongen S, 1998, HEREDITY, V80, P92, DOI 10.1046/j.1365-2540.1998.00278.x; Waite TA, 1997, EVOLUTION, V51, P620, DOI 10.1111/j.1558-5646.1997.tb02450.x; Wang JL, 2001, GENET RES, V78, P243, DOI 10.1017/S0016672301005286; Wang JL, 2003, GENETICS, V163, P429; WELLINGTON W. G., 1960, CANADIAN JOUR ZOOL, V38, P289, DOI 10.1139/z60-036; Wheat CW, 2011, MOL ECOL, V20, P1813, DOI 10.1111/j.1365-294X.2011.05062.x	48	12	12	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e96679	10.1371/journal.pone.0096679	http://dx.doi.org/10.1371/journal.pone.0096679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858905	Green Submitted, Green Published, gold			2022-12-25	WOS:000336839400005
J	Gomes-Santos, IL; Fernandes, T; Couto, GK; Ferreira, JCA; Salemi, VMC; Fernandes, FB; Casarini, DE; Brum, PC; Rossoni, LV; de Oliveira, EM; Negrao, CE				Gomes-Santos, Igor Lucas; Fernandes, Tiago; Couto, Gisele Kruger; Ayres Ferreira-Filho, Julio Cesar; Cury Salemi, Vera Maria; Fernandes, Fernanda Barrinha; Casarini, Dulce Elena; Brum, Patricia Chakur; Rossoni, Luciana Venturini; de Oliveira, Edilamar Menezes; Negrao, Carlos Eduardo			Effects of Exercise Training on Circulating and Skeletal Muscle Renin-Angiotensin System in Chronic Heart Failure Rats	PLOS ONE			English	Article							ENZYME-RELATED CARBOXYPEPTIDASE; CONVERTING ENZYME; MYOCARDIAL-INFARCTION; BAROREFLEX SENSITIVITY; DEPENDENT MECHANISM; RECEPTOR BLOCKER; IN-VIVO; ANG-II; ACTIVATION; ACE2	Background: Accumulated evidence shows that the ACE-AngII-AT1 axis of the renin-angiotensin system (RAS) is markedly activated in chronic heart failure (CHF). Recent studies provide information that Angiotensin (Ang)-(1-7), a metabolite of AngII, counteracts the effects of AngII. However, this balance between AngII and Ang-(1-7) is still little understood in CHF. We investigated the effects of exercise training on circulating and skeletal muscle RAS in the ischemic model of CHF. Methods/Main Results: Male Wistar rats underwent left coronary artery ligation or a Sham operation. They were divided into four groups: 1) Sedentary Sham (Sham-S), 2) exercise-trained Sham (Sham-Ex), sedentary CHF (CHF-S), and exercise-trained CHF (CHF-Ex). Angiotensin concentrations and ACE and ACE2 activity in the circulation and skeletal muscle (soleus and plantaris) were quantified. Skeletal muscle ACE and ACE2 protein expression, and AT1, AT2, and Mas receptor gene expression were also evaluated. CHF reduced ACE2 serum activity. Exercise training restored ACE2 and reduced ACE activity in CHF. Exercise training reduced plasma AngII concentration in both Sham and CHF rats and increased the Ang-(1-7)/AngII ratio in CHF rats. CHF and exercise training did not change skeletal muscle ACE and ACE2 activity and protein expression. CHF increased AngII levels in both soleus and plantaris muscle, and exercise training normalized them. Exercise training increased Ang-(1-7) in the plantaris muscle of CHF rats. The AT1 receptor was only increased in the soleus muscle of CHF rats, and exercise training normalized it. Exercise training increased the expression of the Mas receptor in the soleus muscle of both exercise-trained groups, and normalized it in plantaris muscle. Conclusions: Exercise training causes a shift in RAS towards the Ang-(1-7)-Mas axis in skeletal muscle, which can be influenced by skeletal muscle metabolic characteristics. The changes in RAS circulation do not necessarily reflect the changes occurring in the RAS of skeletal muscle.	[Gomes-Santos, Igor Lucas; Ayres Ferreira-Filho, Julio Cesar; Cury Salemi, Vera Maria; Negrao, Carlos Eduardo] Univ Sao Paulo, Sch Med, Heart Inst InCor HCFMUSP, Sao Paulo, Brazil; [Fernandes, Tiago; Brum, Patricia Chakur; de Oliveira, Edilamar Menezes; Negrao, Carlos Eduardo] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Couto, Gisele Kruger; Rossoni, Luciana Venturini] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil; [Fernandes, Fernanda Barrinha; Casarini, Dulce Elena] Univ Fed Sao Paulo, Kidney & Hypertens Hosp, Div Nephrol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Negrao, CE (corresponding author), Univ Sao Paulo, Sch Med, Heart Inst InCor HCFMUSP, Sao Paulo, Brazil.	cndnegrao@incor.usp.br	Salemi, Vera MC/C-9104-2013; Negrao, Carlos E/C-4281-2012; Brum, Patricia C/E-6605-2011; Oliveira, Edilamar M/AAG-1082-2019; Fernandes, Tiago/I-7891-2014; Salemi, Vera/AAY-5024-2020; Ferreira, Julio/L-4687-2019; Rossoni, Luciana Venturini/AFR-0021-2022; Gomes dos Santos, Igor Lucas/H-3706-2013; Fernandes, Fernanda B/N-8202-2013; Rossoni, Luciana Venturini/C-7226-2012	Salemi, Vera MC/0000-0002-7152-1810; Brum, Patricia C/0000-0002-4750-6506; Oliveira, Edilamar M/0000-0002-7101-312X; Fernandes, Tiago/0000-0002-9057-3878; Gomes dos Santos, Igor Lucas/0000-0001-5946-8300; Fernandes, Fernanda B/0000-0002-7919-6098; Rossoni, Luciana Venturini/0000-0002-0944-9483; Casarini, Dulce/0000-0003-1912-4292; Negrao, Carlos Eduardo/0000-0003-4652-1226	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP-2010/50048-1]; Fundacao Zerbini; Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao Zerbini; Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-2010/50048-1) and, in part, by Fundacao Zerbini. IL Gomes-Santos was supported by Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). PC Brum, DE Casarini, LV Rossoni, EM Oliveira and CE Negrao are research fellows at Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abassi ZA, 1997, CIRCULATION, V96, P3655; Agata J, 2006, HYPERTENS RES, V29, P865, DOI 10.1291/hypres.29.865; Akasu M, 1998, HYPERTENSION, V32, P514, DOI 10.1161/01.HYP.32.3.514; Barretto ACP, 2009, INT J CARDIOL, V135, P302, DOI 10.1016/j.ijcard.2008.03.056; Braith RW, 1999, J AM COLL CARDIOL, V34, P1170, DOI 10.1016/S0735-1097(99)00339-3; BROOKS GA, 1978, J APPL PHYSIOL, V45, P1009, DOI 10.1152/jappl.1978.45.6.1009; Burniston JG, 2005, EXP PHYSIOL, V90, P755, DOI 10.1113/expphysiol.2005.030908; Dalla Libera L, 2001, CIRCULATION, V103, P2195; Franco FGD, 2006, EUR J HEART FAIL, V8, P851, DOI 10.1016/j.ejheart.2006.02.009; Dimitrijevic I, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-40; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Epelman S, 2008, J AM COLL CARDIOL, V52, P750, DOI 10.1016/j.jacc.2008.02.088; Fernandes T, 2010, BRAZ J MED BIOL RES, V43, P837, DOI 10.1590/S0100-879X2010000900005; Fernandes T, 2011, HYPERTENSION, V58, P182, DOI 10.1161/HYPERTENSIONAHA.110.168252; Ferrario CM, 2011, CURR OPIN NEPHROL HY, V20, P1, DOI 10.1097/MNH.0b013e3283406f57; Ferreira JCB, 2008, AM J PHYSIOL-REG I, V294, pR26, DOI 10.1152/ajpregu.00424.2007; Filho AG, 2008, EXP PHYSIOL, V93, P589, DOI 10.1113/expphysiol.2007.014293; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Johnston APW, 2011, J RENIN-ANGIO-ALDO S, V12, P75, DOI 10.1177/1470320310381795; Kar S, 2010, J APPL PHYSIOL, V108, P923, DOI 10.1152/japplphysiol.00840.2009; Kato M, 1996, J Card Fail, V2, P103, DOI 10.1016/S1071-9164(96)80028-5; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Liu JL, 2000, CIRCULATION, V102, P1854; Malendowicz SL, 2000, CIRCULATION, V102, P2210; Mariappan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046568; Mousa TM, 2008, J APPL PHYSIOL, V104, P616, DOI 10.1152/japplphysiol.00601.2007; Munoz MC, 2012, REGUL PEPTIDES, V177, P1, DOI 10.1016/j.regpep.2012.04.001; Negrao CE, 2008, HEART FAIL REV, V13, P51, DOI 10.1007/s10741-007-9057-7; Ocaranza MP, 2006, HYPERTENSION, V48, P572, DOI 10.1161/01.HYP.0000237862.94083.45; OSTERZIEL KJ, 1995, BRIT HEART J, V73, P517; Patel VB, 2014, J MOL CELL CARDIOL, V66, P167, DOI 10.1016/j.yjmcc.2013.11.017; PFEFFER JM, 1985, CIRC RES, V57, P84, DOI 10.1161/01.RES.57.1.84; PFEFFER MA, 1985, CIRCULATION, V72, P406, DOI 10.1161/01.CIR.72.2.406; Prasannarong M, 2012, BIOCHEM BIOPH RES CO, V426, P369, DOI 10.1016/j.bbrc.2012.08.093; Roig E, 2000, EUR HEART J, V21, P53, DOI 10.1053/euhj.1999.1740; Rondon E, 2006, AM J PHYSIOL-HEART C, V291, pH2801, DOI 10.1152/ajpheart.01352.2005; Roveda F, 2003, J AM COLL CARDIOL, V42, P854, DOI 10.1016/S0735-1097(03)00831-3; Russell ST, 2007, CELL SIGNAL, V19, P1797, DOI 10.1016/j.cellsig.2007.04.003; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Santos RAS, 2013, J ENDOCRINOL, V216, pR1, DOI 10.1530/JOE-12-0341; SCHUNKERT H, 1992, J CLIN INVEST, V90, P1523, DOI 10.1172/JCI116020; Semprun-Prieto LC, 2011, BIOCHEM BIOPH RES CO, V409, P217, DOI 10.1016/j.bbrc.2011.04.122; SIGURDSSON A, 1993, AM HEART J, V126, P1068, DOI 10.1016/0002-8703(93)90656-T; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Uehara Y, 2013, CURR PHARM DESIGN, V19, P3054; vanKats JP, 1997, HYPERTENSION, V30, P42, DOI 10.1161/01.HYP.30.1.42; Vescovo G, 2000, HEART, V84, P431, DOI 10.1136/heart.84.4.431; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; WARD PE, 1995, PEPTIDES, V16, P1073, DOI 10.1016/0196-9781(95)00082-U; Xu XH, 2008, CARDIOVASC RES, V78, P523, DOI 10.1093/cvr/cvn028; Zhang GX, 2007, J MOL CELL CARDIOL, V42, P804, DOI 10.1016/j.yjmcc.2007.01.012	51	55	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98012	10.1371/journal.pone.0098012	http://dx.doi.org/10.1371/journal.pone.0098012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859374	Green Submitted, Green Published, gold			2022-12-25	WOS:000336839400034
J	Caito, S; Zeng, H; Aschner, JL; Aschner, M				Caito, Samuel; Zeng, Heng; Aschner, Judy L.; Aschner, Michael			Methylmercury Alters the Activities of Hsp90 Client Proteins, Prostaglandin E Synthase/p23 (PGES/23) and nNOS	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; HEAT-SHOCK-PROTEIN; PHOSPHOLIPASE A(2) EXPRESSION; ARACHIDONIC-ACID RELEASE; CULTURED ASTROCYTES; EXCITOTOXIC LESION; OXIDATIVE STRESS; E-2 SYNTHASE; GLUTAMATE; MERCURY	Methylmercury (MeHg) is a persistent pollutant with known neurotoxic effects. We have previously shown that astrocytes accumulate MeHg and play a prominent role in mediating MeHg toxicity in the central nervous system (CNS) by altering glutamate signaling, generating oxidative stress, depleting glutathione (GSH) and initiating lipid peroxidation. Interestingly, all of these pathways can be regulated by the constitutively expressed, 90-kDa heat shock protein, Hsp90. As Hsp90 function is regulated by oxidative stress, we hypothesized that MeHg disrupts Hsp90-client protein functions. Astrocytes were treated with MeHg and expression of Hsp90, as well as the abundance of complexes of Hsp90-neuronal nitric oxide synthase (nNOS) and Hsp90-prostaglandin E synthase/p23 (PGES/p23) were assessed. MeHg exposure decreased Hsp90 protein expression following 12 h of treatment while shorter exposures had no effect on Hsp90 protein expression. Interestingly, following 1 or 6 h of MeHg exposure, Hsp90 binding to PGES/p23 or nNOS was significantly increased, resulting in increased prostaglandin E-2 (PGE(2)) synthesis from MeHg-treated astrocytes. These effects were attenuated by the Hsp90 antagonist, geldanmycin. NOS activity was increased following MeHg treatment while cGMP formation was decreased. This was accompanied by an increase in center dot O-2(-) and H2O2 levels, suggesting that MeHg uncouples NO formation from NO-dependent signaling and increases oxidative stress. Altogether, our data demonstrates that Hsp90 interactions with client proteins are increased following MeHg exposure, but over time Hsp90 levels decline, contributing to oxidative stress and MeHg-dependent excitotoxicity.	[Caito, Samuel; Aschner, Michael] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Zeng, Heng; Aschner, Michael] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [Aschner, Judy L.; Aschner, Michael] Yeshiva Univ, Albert Einstein Coll Med, Dept Pediat & Obstet & Gynecol, Bronx, NY USA; [Aschner, Michael] Albert Einstein Coll Med, Kennedy Ctr, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Vanderbilt University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Aschner, M (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA.	michael.aschner@einstein.yu.edu			NIEHS [R01 ES007331]; Vanderbilt University Center in Molecular Toxicology [P30 ES000267]; Vanderbilt University Training Program in Environmental Toxicology [5T32 ES007028]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028, R01ES007331, P30ES000267] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Vanderbilt University Center in Molecular Toxicology; Vanderbilt University Training Program in Environmental Toxicology; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by NIEHS R01 ES007331, the Vanderbilt University Center in Molecular Toxicology (P30 ES000267), and the Vanderbilt University Training Program in Environmental Toxicology (5T32 ES007028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JW, 2001, BRAIN RES, V902, P92, DOI 10.1016/S0006-8993(01)02375-7; ASCHNER M, 1993, BRAIN RES, V602, P181, DOI 10.1016/0006-8993(93)90680-L; Aschner M, 2000, NEUROCHEM INT, V37, P199, DOI 10.1016/S0197-0186(00)00023-1; Aschner M, 1998, BRAIN RES, V811, P133, DOI 10.1016/S0006-8993(98)00629-5; ASCHNER M, 1990, BRAIN RES, V530, P245, DOI 10.1016/0006-8993(90)91290-W; Beck R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040795; Beck R, 2009, BIOCHEM PHARMACOL, V77, P375, DOI 10.1016/j.bcp.2008.10.019; Bender AT, 1999, J BIOL CHEM, V274, P1472, DOI 10.1074/jbc.274.3.1472; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; BOLANOS JP, 1995, J NEUROCHEM, V64, P1965; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; BROOKES N, 1992, TOXICOLOGY, V76, P245, DOI 10.1016/0300-483X(92)90193-I; BROOKES N, 1989, J NEUROCHEM, V53, P1228, DOI 10.1111/j.1471-4159.1989.tb07419.x; Caplan AJ, 1999, TRENDS CELL BIOL, V9, P262, DOI 10.1016/S0962-8924(99)01580-9; Carvalho CML, 2008, J BIOL CHEM, V283, P11913, DOI 10.1074/jbc.M710133200; Charleston JS, 1996, NEUROTOXICOLOGY, V17, P127; Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619; Ekino S, 2007, J NEUROL SCI, V262, P131, DOI 10.1016/j.jns.2007.06.036; Farina M, 2011, TOXICOL APPL PHARM, V256, P405, DOI 10.1016/j.taap.2011.05.001; Farina M, 2009, TOXICOL SCI, V112, P416, DOI 10.1093/toxsci/kfp219; GARMAN RH, 1975, ACTA NEUROPATHOL, V32, P61, DOI 10.1007/BF00686067; Giffard RG, 2004, J EXP BIOL, V207, P3213, DOI 10.1242/jeb.01034; Goering PL, 2000, TOXICOL SCI, V53, P447, DOI 10.1093/toxsci/53.2.447; Golde S, 2002, J NEUROCHEM, V82, P269, DOI 10.1046/j.1471-4159.2002.00973.x; Grandjean P, 2010, ENVIRON HEALTH PERSP, V118, P1137, DOI 10.1289/ehp.0901757; Heales SJR, 1999, BBA-BIOENERGETICS, V1410, P215, DOI 10.1016/S0005-2728(98)00168-6; Helmcke KJ, 2010, TOXICOL APPL PHARM, V248, P156, DOI 10.1016/j.taap.2010.07.023; Herculano AM, 2006, BRAZ J MED BIOL RES, V39, P415, DOI 10.1590/S0100-879X2006000300013; Horn TFW, 2002, FASEB J, V16, P1611, DOI 10.1096/fj.02-0126com; Ikeda M, 1999, J NEUROSCI RES, V55, P352, DOI 10.1002/(SICI)1097-4547(19990201)55:3<352::AID-JNR10>3.0.CO;2-3; Jeon GS, 2004, GLIA, V48, P250, DOI 10.1002/glia.20075; Lecanu L, 1998, BRIT J PHARMACOL, V125, P584, DOI 10.1038/sj.bjp.0702119; Lee M, 2001, ARIEL-REV INT ENGL, V32, P90; Lee MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014123; Luo WJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-24; MAILHOS C, 1994, J NEUROCHEM, V63, P1787; Mori N, 2007, ARCH TOXICOL, V81, P769, DOI 10.1007/s00204-007-0209-2; Morken TS, 2005, TOXICOL SCI, V87, P169, DOI 10.1093/toxsci/kfi227; MULLANEY KJ, 1994, BRAIN RES, V641, P1, DOI 10.1016/0006-8993(94)91808-2; Mutkus L, 2005, BIOL TRACE ELEM RES, V107, P231, DOI 10.1385/BTER:107:3:231; Nardai G, 2000, ARCH BIOCHEM BIOPHYS, V384, P59, DOI 10.1006/abbi.2000.2075; Ni Mingwei, 2010, Curr Protoc Toxicol, VChapter 12, DOI 10.1002/0471140856.tx1217s43; Ni MW, 2011, GLIA, V59, P810, DOI 10.1002/glia.21153; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Papaconstantinou AD, 2003, BIRTH DEFECTS RES B, V68, P456, DOI 10.1002/bdrb.10044; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Rameau GA, 2003, NEUROBIOL AGING, V24, P1123, DOI 10.1016/j.neurobiolaging.2003.07.002; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Segnitz B, 1997, J BIOL CHEM, V272, P18694, DOI 10.1074/jbc.272.30.18694; Shanker G, 2004, MOL BRAIN RES, V128, P48, DOI 10.1016/j.molbrainres.2004.05.022; Shanker G, 2004, NEUROTOXICOLOGY, V25, P399, DOI 10.1016/j.neuro.2003.08.008; Shanker G, 2003, MOL BRAIN RES, V110, P85, DOI 10.1016/S0169-328X(02)00642-3; Shanker G, 2002, MOL BRAIN RES, V106, P1, DOI 10.1016/S0169-328X(02)00403-5; Shanker G, 2001, J NEUROSCI RES, V66, P998, DOI 10.1002/jnr.10066; Shen HY, 2005, J BIOL CHEM, V280, P39962, DOI 10.1074/jbc.M505524200; Song Y, 2001, BIOCHEM J, V355, P357, DOI 10.1042/0264-6021:3550357; Sullivan JC, 2006, CIRC RES, V98, P717, DOI 10.1161/01.RES.0000217594.97174.c2; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tani M, 1996, AM J PATHOL, V148, P889; Tanioka T, 2003, BIOCHEM BIOPH RES CO, V303, P1018, DOI 10.1016/S0006-291X(03)00470-4; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Wormser U, 2012, NEUROTOXICOLOGY, V33, P763, DOI 10.1016/j.neuro.2011.12.004; Xia Y, 2007, ANTIOXID REDOX SIGN, V9, P1773, DOI 10.1089/ars.2007.1733; Yao SY, 2010, J NEUROIMMUNOL, V229, P146, DOI 10.1016/j.jneuroim.2010.07.023; YU ACH, 1987, J NEUROSCI RES, V17, P424, DOI 10.1002/jnr.490170414; Zemolin APP, 2012, TOXICOLOGY, V302, P60, DOI 10.1016/j.tox.2012.07.013	68	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98161	10.1371/journal.pone.0098161	http://dx.doi.org/10.1371/journal.pone.0098161			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852575	Green Submitted, gold, Green Published			2022-12-25	WOS:000338323200051
J	Kato, T; Kawai, K; Egami, Y; Kakehi, Y; Araki, N				Kato, Takuma; Kawai, Katsuhisa; Egami, Youhei; Kakehi, Yoshiyuki; Araki, Nobukazu			Rac1-Dependent Lamellipodial Motility in Prostate Cancer PC-3 Cells Revealed by Optogenetic Control of Rac1 Activity	PLOS ONE			English	Article							SMALL GTPASES; RHO-GTPASE; MIGRATION; ACTIVATION; MACROPINOCYTOSIS; FIBROBLASTS; METASTASIS; COMPLETION; EXPRESSION; INHIBITOR	The lamellipodium, an essential structure for cell migration, plays an important role in the invasion and metastasis of cancer cells. Although Rac1 recognized as a key player in the formation of lamellipodia, the molecular mechanisms underlying lamellipodial motility are not fully understood. Optogenetic technology enabled us to spatiotemporally control the activity of photoactivatable Rac1 (PA-Rac1) in living cells. Using this system, we revealed the role of phosphatidylinositol 3-kinase (PI3K) in Rac1-dependent lamellipodial motility in PC-3 prostate cancer cells. Through local blue laser irradiation of PA-Rac1-expressing cells, lamellipodial motility was reversibly induced. First, outward extension of a lamellipodium parallel to the substratum was observed. The extended lamellipodium then showed ruffling activity at the periphery. Notably, PI(3,4,5)P-3 and WAVE2 were localized in the extending lamellipodium in a PI3K-dependent manner. We confirmed that the inhibition of PI3K activity greatly suppressed lamellipodial extension, while the ruffling activity was less affected. These results suggest that Rac1-induced lamellipodial motility consists of two distinct activities, PI3K-dependent outward extension and PI3K-independent ruffling.	[Kato, Takuma; Kakehi, Yoshiyuki] Kagawa Univ, Sch Med, Dept Urol, Miki, Kagawa, Japan; [Kawai, Katsuhisa; Egami, Youhei; Araki, Nobukazu] Kagawa Univ, Sch Med, Dept Histol & Cell Biol, Miki, Kagawa, Japan	Kagawa University; Kagawa University	Araki, N (corresponding author), Kagawa Univ, Sch Med, Dept Histol & Cell Biol, Miki, Kagawa, Japan.	naraki@med.kagawa-u.ac.jp		Araki, Nobukazu/0000-0001-6160-210X	Japan Society for the Promotion of Science (JSPS) KAKENHI [25861427, 24659087, 23390039, 26860136, 24890154, 25860142, 24390369]; Grants-in-Aid for Scientific Research [23390039, 26860136] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI (http://www.jsps.go.jp/english/e-grants/index.html) 25861427 to TK; 24659087 and 23390039 to NA; 26860136 and 24890154 to KK; 25860142 to YE; 24390369 to YK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1970, EXP CELL RES, V60, P437, DOI 10.1016/0014-4827(70)90537-9; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Araki N, 2007, EXP CELL RES, V313, P1496, DOI 10.1016/j.yexcr.2007.02.012; Araki N, 2014, MICROSCOPY-JPN, V63, P255, DOI 10.1093/jmicro/dfu003; Claesson-Welsh Lena, 1994, Progress in Growth Factor Research, V5, P37, DOI 10.1016/0955-2235(94)90016-7; Costa C, 2010, THESCIENTIFICWORLDJO, V10, P1826, DOI 10.1100/tsw.2010.178; Frankenberry KA, 2004, AM J SURG, V188, P560, DOI 10.1016/j.amjsurg.2004.07.031; Fujii M, 2013, CHEM PHYS, V419, P1, DOI 10.1016/j.chemphys.2013.04.003; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Goc A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040594; Inoue T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003068; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Knight-Krajewski S, 2004, ONCOGENE, V23, P5513, DOI 10.1038/sj.onc.1207708; Kobayashi T, 2010, MOL ENDOCRINOL, V24, P722, DOI 10.1210/me.2009-0326; Kurisu S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-226; Lebensohn AM, 2009, MOL CELL, V36, P512, DOI 10.1016/j.molcel.2009.10.024; Lin KT, 2012, CANCER RES, V72, P3000, DOI 10.1158/0008-5472.CAN-11-2502; Maekawa M, 2014, P NATL ACAD SCI USA, V111, pE978, DOI 10.1073/pnas.1311029111; Monet M, 2009, BBA-MOL CELL RES, V1793, P528, DOI 10.1016/j.bbamcr.2009.01.003; Oda A, 2013, SEMIN CELL DEV BIOL, V24, P308, DOI 10.1016/j.semcdb.2013.03.002; Qin J, 2009, ONCOGENE, V28, P1853, DOI 10.1038/onc.2009.30; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Rikitake Y, 2011, INT REV CEL MOL BIO, V287, P97, DOI 10.1016/B978-0-12-386043-9.00003-7; Spiering D, 2011, CELL ADHES MIGR, V5, P170, DOI 10.4161/cam.5.2.14403; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Suetsugu S, 2006, J CELL BIOL, V173, P571, DOI 10.1083/jcb.200509067; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Welf ES, 2012, J CELL BIOL, V197, P105, DOI 10.1083/jcb.201108152; Wu YI, 2011, METHOD ENZYMOL, V497, P393, DOI 10.1016/B978-0-12-385075-1.00016-0; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yoo SK, 2010, DEV CELL, V18, P226, DOI 10.1016/j.devcel.2009.11.015; Yu HM, 2004, MOL CARCINOGEN, V41, P85, DOI 10.1002/mc.20041	34	27	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97749	10.1371/journal.pone.0097749	http://dx.doi.org/10.1371/journal.pone.0097749			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848679	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600053
J	Neill, DR; Saint, GL; Bricio-Moreno, L; Fothergill, JL; Southern, KW; Winstanley, C; Christmas, SE; Slupsky, JR; McNamara, PS; Kadioglu, A; Flanagan, BF				Neill, Daniel R.; Saint, Gemma L.; Bricio-Moreno, Laura; Fothergill, Joanne L.; Southern, Kevin W.; Winstanley, Craig; Christmas, Stephen E.; Slupsky, Joseph R.; McNamara, Paul S.; Kadioglu, Aras; Flanagan, Brian F.			The B Lymphocyte Differentiation Factor (BAFF) Is Expressed in the Airways of Children with CF and in Lungs of Mice Infected with Pseudomonas aeruginosa	PLOS ONE			English	Article							CELL-ACTIVATING FACTOR; CYSTIC-FIBROSIS; EPITHELIAL-CELLS; INDUCTION; IMMUNITY; VACCINE	Background: Chronic lung infection with Pseudomonas aeruginosa remains a major cause of mortality and morbidity among individuals with CF. Expression of mediators promoting recruitment and differentiation of B cells, or supporting antibody production is poorly understood yet could be key to controlling infection. Methods: BAFF was measured in BAL from children with CF, both with and without P. aeruginosa, and controls. Mice were intra-nasally infected with P. aeruginosa strain LESB65 for up to 7 days. Cellular infiltration and expression of B cell chemoattractants and B cell differentiation factor, BAFF were measured in lung tissue. Results: BAFF expression was elevated in both P. aeruginosa negative and positive CF patients and in P. aeruginosa infected mice post infection. Expression of the B cell chemoattractants CXCL13, CCL19 and CCL21 increased progressively post infection. Conclusions: In a mouse model, infection with P. aeruginosa was associated with elevated expression of BAFF and other B cell chemoattractants suggesting a role for airway B cell recruitment and differentiation in the local adaptive immune response to P. aeruginosa. The paediatric CF airway, irrespective of pseudomonal infection, was found to be associated with an elevated level of BAFF implying that BAFF expression is not specific to pseudomonas infection and may be a feature of the CF airway. Despite the observed presence of a potent B cell activator, chronic colonisation is common suggesting that this response is ineffective.	[Neill, Daniel R.; Bricio-Moreno, Laura; Fothergill, Joanne L.; Winstanley, Craig; Christmas, Stephen E.; Kadioglu, Aras] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool L69 3BX, Merseyside, England; [Saint, Gemma L.; Southern, Kevin W.; McNamara, Paul S.; Flanagan, Brian F.] Univ Liverpool, Alder Hey Childrens NHS Fdn Trust Hosp, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England; [Slupsky, Joseph R.] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England	University of Liverpool; Alder Hey Children's NHS Foundation Trust; University of Liverpool; University of Liverpool	Flanagan, BF (corresponding author), Univ Liverpool, Alder Hey Childrens NHS Fdn Trust Hosp, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England.	fla1@liverpool.ac.uk	Bricio-Moreno, Laura/AAD-2781-2019; Slupsky, Joseph/H-2843-2019; Neill, Daniel/Q-6290-2019; Neill, Daniel/E-1403-2012; Fothergill, Joanne L/B-8284-2011	Slupsky, Joseph/0000-0002-7410-9004; Neill, Daniel/0000-0002-7911-8153; Neill, Daniel/0000-0002-7911-8153; Fothergill, Joanne L/0000-0002-7012-1508; Bricio Moreno, Laura/0000-0002-4956-7142; Winstanley, Craig/0000-0002-2662-8053; Christmas, Steve/0000-0001-8925-3204; kadioglu, aras/0000-0003-1137-6321; Saint, Gemma/0000-0003-4031-4939; McNamara, Paul/0000-0002-7055-6034; Christmas, Stephen/0000-0001-5909-0280	Liverpool Cancer Research UK Centre	Liverpool Cancer Research UK Centre	This work was supported in part by Research Development Funding from the Liverpool Cancer Research UK Centre. The authors would also like to acknowledge Alder Hey charitable funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann U, 2004, VACCINE, V22, P840, DOI 10.1016/j.vaccine.2003.11.029; Carter MEK, 2010, J INFECT DIS, V202, P935, DOI 10.1086/655781; Eddens T, 2012, CURR OPIN IMMUNOL, V24, P424, DOI 10.1016/j.coi.2012.07.005; Eppert BL, 2010, INFECT IMMUN, V78, P2099, DOI 10.1128/IAI.00962-09; Foo SY, 2010, MUCOSAL IMMUNOL, V3, P537, DOI 10.1038/mi.2010.52; Hart CA, 2002, BRIT MED BULL, V61, P81, DOI 10.1093/bmb/61.1.81; Hartl D, 2006, J ALLERGY CLIN IMMUN, V117, P204, DOI 10.1016/j.jaci.2005.09.023; Kadioglu A, 2000, INFECT IMMUN, V68, P492, DOI 10.1128/IAI.68.2.492-501.2000; Kamei A, 2011, INFECT IMMUN, V79, P1289, DOI 10.1128/IAI.01139-10; Kato A, 2006, J IMMUNOL, V177, P7164, DOI 10.4049/jimmunol.177.10.7164; Liu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038429; McNamara PS, 2013, THORAX, V68, P76, DOI 10.1136/thoraxjnl-2012-202288; McNamara PS, 2003, ARCH DIS CHILD, V88, P922, DOI 10.1136/adc.88.10.922; Moser C, 2002, CLIN EXP IMMUNOL, V127, P206, DOI 10.1046/j.1365-2249.2002.01731.x; Neill DR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002660; Parker D, 2012, AM J RESP CELL MOL, V46, P6, DOI 10.1165/rcmb.2011-0080OC; Rangel-Moreno J, 2007, P NATL ACAD SCI USA, V104, P10577, DOI 10.1073/pnas.0700591104; Stein JV, 2005, IMMUNOLOGY, V116, P1, DOI 10.1111/j.1365-2567.2005.02183.x; Tan HL, 2013, THORAX, V68, P788, DOI 10.1136/thoraxjnl-2013-203307; Tertilt C, 2009, INFECT IMMUN, V77, P3044, DOI 10.1128/IAI.00927-08; Vareille M, 2012, THORAX, V67, P517, DOI 10.1136/thoraxjnl-2011-200405; Williams BJ, 2010, RESPIROLOGY, V15, P1037, DOI 10.1111/j.1440-1843.2010.01819.x; Wu WH, 2012, AM J RESP CRIT CARE, V186, P420, DOI 10.1164/rccm.201202-0182OC	23	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e95892	10.1371/journal.pone.0095892	http://dx.doi.org/10.1371/journal.pone.0095892			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847941	gold, Green Published, Green Submitted			2022-12-25	WOS:000336730600007
J	Xiang, Y; Eyers, F; Young, IG; Rosenberg, HF; Foster, PS; Yang, M				Xiang, Yang; Eyers, Fiona; Young, Ian G.; Rosenberg, Helene F.; Foster, Paul S.; Yang, Ming			Identification of MicroRNAs Regulating the Developmental Pathways of Bone Marrow Derived Mast Cells	PLOS ONE			English	Article							C-KIT LIGAND; IMMUNE-RESPONSES; EXPRESSION; MURINE; DISEASE; MASTOCYTOSIS; ACTIVATION; LINEAGES; DECREASE; SURVIVAL	Background: MicroRNAs (miRNAs) play important roles in leukocyte differentiation, although those utilised for specific programs and key functions remain incompletely characterised. As a global approach to gain insights into the potential regulatory role of miRNA in mast cell differentiation we characterised expression in BM cultures from the initiation of differentiation. In cultures enriched in differentiating mast cells we characterised miRNA expression and identified miRNA targeting the mRNA of putative factors involved in differentiation pathways and cellular identity. Detailed pathway analysis identified a unique miRNA network that is intimately linked to the mast cell differentiation program. Methodology/Principal Findings: We identified 86 unique miRNAs with expression patterns that were up-or downregulated at 5-fold or more during bone marrow derived mast cells (BMMC) development. By employing TargetScan and MeSH databases, we identified 524 transcripts involved in 30 canonical pathways as potentially regulated by these specific 86 miRNAs. Furthermore, by applying miRanda and IPA analyses, we predict that 7 specific miRNAs of this group are directly associated with the expression of c-Kit and Fc epsilon RI alpha and likewise, that 18 miRNAs promote expression of Mitf, GATA1 and c/EBP alpha three core transcription factors that direct mast cell differentiation. Furthermore, we have identified 11 miRNAs that may regulate the expression of STATs-3, -5a/b, GATA2 and GATA3 during differentiation, along with 13 miRNAs that target transcripts encoding Ndst2, mMCP4 and mMCP6 and thus may regulate biosynthesis of mast cell secretory mediators. Conclusions/Significance: This investigation characterises changes in miRNA expression in whole BM cultures during the differentiation of mast cells and predicts functional links between miRNAs and their target mRNAs for the regulation of development. This information provides an important resource for further investigations of the contributions of miRNAs to mast cell differentiation and function.	[Xiang, Yang; Eyers, Fiona; Foster, Paul S.; Yang, Ming] Univ Newcastle, Fac Hlth, Sch Biomed Sci & Pharm, Ctr Asthma & Resp Dis, Callaghan, NSW 2308, Australia; [Xiang, Yang; Eyers, Fiona; Foster, Paul S.; Yang, Ming] Hunter Med Res Inst, Callaghan, NSW, Australia; [Xiang, Yang] Cent S Univ, Xiangya Sch Med, Dept Physiol, Changsha, Hunan, Peoples R China; [Young, Ian G.] Australian Natl Univ, John Curtin Sch Med Res, Dept Mol Biosci, Canberra, ACT 2601, Australia; [Rosenberg, Helene F.] NIAID, Inflammat Immunobiol Sect, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; Central South University; Australian National University; John Curtin School of Medical Research; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Foster, PS (corresponding author), Univ Newcastle, Fac Hlth, Sch Biomed Sci & Pharm, Ctr Asthma & Resp Dis, Callaghan, NSW 2308, Australia.	Paul.Foster@newcastle.edu.au; Ming.Yang@newcastle.edu.au	Foster, Paul/G-5057-2013	, Paul/0000-0002-0827-8299	National Health and Medical Research Council of Australia; Australian Research Council; Cooperative Research Centre for Asthma and Airways; National Institute of Allergy and Infectious Diseases Division of Intramural Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000941] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Cooperative Research Centre for Asthma and Airways(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); National Institute of Allergy and Infectious Diseases Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors are supported by the National Health and Medical Research Council of Australia, the Australian Research Council, the Cooperative Research Centre for Asthma and Airways and National Institute of Allergy and Infectious Diseases Division of Intramural Research. The funding bodies had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Alvarez-Twose I, 2010, J ALLERGY CLIN IMMUN, V125, P1269, DOI 10.1016/j.jaci.2010.02.019; Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Dawicki W, 2007, CURR OPIN IMMUNOL, V19, P31, DOI 10.1016/j.coi.2006.11.006; Duelli A, 2009, J IMMUNOL, V183, P7073, DOI 10.4049/jimmunol.0900309; Foster PS, 2013, IMMUNOL REV, V253, P198, DOI 10.1111/imr.12058; Furumoto Y, 2011, BLOOD, V118, P5466, DOI 10.1182/blood-2010-09-309955; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Garcia-Montero AC, 2006, BLOOD, V108, P2366, DOI 10.1182/blood-2006-04-015545; Gerrits A, 2012, BLOOD, V119, P377, DOI 10.1182/blood-2011-01-331686; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; GURISH MF, 1992, J EXP MED, V175, P1003, DOI 10.1084/jem.175.4.1003; Hofmann AM, 2009, CURR OPIN IMMUNOL, V21, P679, DOI 10.1016/j.coi.2009.09.007; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; KITAMURA Y, 1978, BLOOD, V52, P447; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; Larsen MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058454; Lee ST, 2011, EXP NEUROL, V227, P172, DOI 10.1016/j.expneurol.2010.10.012; Lee YN, 2011, BLOOD, V117, P3629, DOI 10.1182/blood-2010-07-293548; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Ma F, 2010, J IMMUNOL, V184, P6053, DOI 10.4049/jimmunol.0902308; Ma PL, 2011, BLOOD, V118, P3459, DOI 10.1182/blood-2011-04-351809; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; Maruotti N, 2007, CLIN RHEUMATOL, V26, P1, DOI 10.1007/s10067-006-0305-3; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; Mayoral RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026133; Mayoral RJ, 2009, J IMMUNOL, V182, P433, DOI 10.4049/jimmunol.182.1.433; Merkerova MD, 2011, EUR J HUM GENET, V19, P313, DOI 10.1038/ejhg.2010.209; MITSUI H, 1993, P NATL ACAD SCI USA, V90, P735, DOI 10.1073/pnas.90.2.735; Molnar V, 2012, CELL MOL LIFE SCI, V69, P793, DOI 10.1007/s00018-011-0786-3; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; Rusca N, 2012, MOL CELL BIOL, V32, P4432, DOI 10.1128/MCB.00824-12; Sakai H, 1999, ARCH DERMATOL RES, V291, P224, DOI 10.1007/s004030050398; Shin J, 2012, BLOOD, V119, P3306, DOI 10.1182/blood-2011-05-353342; Siemens H, 2013, ONCOTARGET, V4, P1399, DOI 10.18632/oncotarget.1202; Takemoto CM, 2008, BLOOD CELL MOL DIS, V41, P82, DOI 10.1016/j.bcmd.2008.02.005; TRAVIS WD, 1985, AM J CLIN PATHOL, V84, P710, DOI 10.1093/ajcp/84.6.710; TSUJI K, 1991, J CELL PHYSIOL, V148, P362, DOI 10.1002/jcp.1041480306; Yang M, 2008, PHARMACOL THERAPEUT, V117, P94, DOI 10.1016/j.pharmthera.2007.08.004	47	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98139	10.1371/journal.pone.0098139	http://dx.doi.org/10.1371/journal.pone.0098139			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848502	Green Published, Green Submitted, gold			2022-12-25	WOS:000336730600091
J	Chan, TC; Chiang, PH; Su, MD; Wang, HW; Liu, MSY				Chan, Ta-Chien; Chiang, Po-Huang; Su, Ming-Daw; Wang, Hsuan-Wen; Liu, Michael Shi-yung			Geographic Disparity in Chronic Obstructive Pulmonary Disease (COPD) Mortality Rates among the Taiwan Population	PLOS ONE			English	Article							AIR-POLLUTION; HOSPITAL ADMISSIONS; LIFE EXPECTANCY; RISK; TUBERCULOSIS; OUTDOOR; HEALTH; CITY	Chronic obstructive pulmonary disease (COPD) causes a high disease burden among the elderly worldwide. In Taiwan, the long-term temporal trend of COPD mortality is declining, but the geographical disparity of the disease is not yet known. Nationwide COPD age-adjusted mortality at the township level during 1999-2007 is used for elucidating the geographical distribution of the disease. With an ordinary least squares (OLS) model and geographically weighted regression (GWR), the ecologic risk factors such as smoking rate, area deprivation index, tuberculosis exposure, percentage of aborigines, density of health care facilities, air pollution and altitude are all considered in both models to evaluate their effects on mortality. Global and local Moran's I are used for examining their spatial autocorrelation and identifying clusters. During the study period, the COPD age-adjusted mortality rates in males declined from 26.83 to 19.67 per 100,000 population, and those in females declined from 8.98 to 5.70 per 100,000 population. Overall, males' COPD mortality rate was around three times higher than females'. In the results of GWR, the median coefficients of smoking rate, the percentage of aborigines, PM10 and the altitude are positively correlated with COPD mortality in males and females. The median value of density of health care facilities is negatively correlated with COPD mortality. The overall adjusted R-squares are about 20% higher in the GWR model than in the OLS model. The local Moran's I of the GWR's residuals reflected the consistent high-high cluster in southern Taiwan. The findings indicate that geographical disparities in COPD mortality exist. Future epidemiological investigation is required to understand the specific risk factors within the clustering areas.	[Chan, Ta-Chien; Liu, Michael Shi-yung] Acad Sinica, Res Ctr Humanities & Social Sci, Taipei 115, Taiwan; [Chiang, Po-Huang] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan; [Su, Ming-Daw] Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan; [Wang, Hsuan-Wen] Natl Taiwan Univ, Sch Publ Hlth, Master Publ Hlth Program, Taipei 10764, Taiwan; [Wang, Hsuan-Wen] Fangliao Gen Hosp, Div Family Med, Pingtung, Taiwan; [Liu, Michael Shi-yung] Acad Sinica, Inst Taiwan Hist, Taipei 115, Taiwan	Academia Sinica - Taiwan; National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan	Liu, MSY (corresponding author), Acad Sinica, Res Ctr Humanities & Social Sci, Taipei 115, Taiwan.	liumike@gate.sinica.edu.tw	Chiang, Po-Huang/E-3996-2010	SU, MING-DAW/0000-0001-5555-9598	National Science Council, R.O.C. [NSC-102-2627-M-001-006, NSC-102-2627-M-001-007]	National Science Council, R.O.C.(Ministry of Science and Technology, Taiwan)	This research was supported by grants from the National Science Council, R.O.C. (NSC-102-2627-M-001-006 and NSC-102-2627-M-001-007). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentayeb M, 2012, INT J TUBERC LUNG D, V16, P1149, DOI 10.5588/ijtld.11.0666; Berry SD, 2010, J AM GERIATR SOC, V58, P783, DOI 10.1111/j.1532-5415.2010.02767.x; Brown D. W., 2008, Morbidity and Mortality Weekly Report, V57, P1229; Centers for Disease Control R.O.C. (Taiwan), 2012, TAIW TUB CONTR REP 2; Chakrabarti Biswajit, 2007, Int J Chron Obstruct Pulmon Dis, V2, P263; Chan Ta-Chien, 2010, INFECT DIS INFORM BI, P208; Chiang CH, 2008, RESPIROLOGY, V13, P689, DOI 10.1111/j.1440-1843.2008.01308.x; Chiang CY, 2005, INT J TUBERC LUNG D, V9, P1006; Dijkstra A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072730; Ezzati M, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.112938; Forey BA, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-36; Foster Talia S, 2006, COPD, V3, P211, DOI 10.1080/15412550601009396; Fotheringham AS, 1999, GEOGR ANAL, V31, P340; Gershon AS, 2012, COPD, V9, P216, DOI 10.3109/15412555.2011.648030; Health Promotion Administration Ministry of Health and Welfare, 2013, SURV AD SMOK BEH; Holt JB, 2011, INT J CHRONIC OBSTR, V6, P321, DOI 10.2147/COPD.S19945; Hu GP, 2010, CHEST, V138, P20, DOI 10.1378/chest.08-2114; Ko FWS, 2012, RESPIROLOGY, V17, P395, DOI 10.1111/j.1440-1843.2011.02112.x; Kuo LC, 2005, J FORMOS MED ASSOC, V104, P89; Lee CH, 2012, PLOS ONE, V7, DOI DOI 10.1371/journal.pone.0037978; Lee IM, 2007, INHAL TOXICOL, V19, P393, DOI 10.1080/08958370601174818; Lee YC, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-225; Lin HC, 2001, AREA DEPRIVATION MOR; Liu Y, 2008, INT J TUBERC LUNG D, V12, P115; Mannino David M, 2006, Int J Chron Obstruct Pulmon Dis, V1, P219; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Nakaya T, 2005, STAT MED, V24, P2695, DOI 10.1002/sim.2129; Pilz J, 2008, STOCH ENV RES RISK A, V22, P621, DOI 10.1007/s00477-007-0165-7; Reilly KH, 2008, AM J EPIDEMIOL, V167, P998, DOI 10.1093/aje/kwm393; Rycroft CE, 2012, INT J CHRONIC OBSTR, V7, P457, DOI 10.2147/COPD.S32330; Schikowski T, 2014, EUR RESPIR J, V43, P250, DOI 10.1183/09031936.00100112; Sun YC, 2013, CHINESE MED J-PEKING, V126, P2203, DOI 10.3760/cma.j.issn.0366-6999.20131159; Tachikawa T, 2011, NASA LAND PROCESSES; Tan WC, 2003, RESPIROLOGY, V8, P192; The Ministry of Health and Welfare of the Republic of China, 2009, CAUS DEATHS; van Durme YMTA, 2009, CHEST, V135, P368, DOI 10.1378/chest.08-0684; Wang SC, 2009, J PUBLIC HEALTH-UK, V31, P406, DOI 10.1093/pubmed/fdp052; Wen CP, 2004, INT J EPIDEMIOL, V33, P320, DOI 10.1093/ije/dyh009; World Health Organization, 2008, CAUS DEATH GLOB BU 2; Yang CY, 2007, J TOXICOL ENV HEAL A, V70, P1214, DOI 10.1080/15287390701380880	40	12	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98170	10.1371/journal.pone.0098170	http://dx.doi.org/10.1371/journal.pone.0098170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845852	Green Submitted, Green Published, gold			2022-12-25	WOS:000339563400103
J	Mangalam, M; Desai, N; Singh, M				Mangalam, Madhur; Desai, Nisarg; Singh, Mewa			Do Right-Handed Monkeys Use the Right Cheek Pouch before the Left?	PLOS ONE			English	Article							CAPUCHIN MONKEYS; BEHAVIORAL LATERALITY; FACIAL EXPRESSION; ASYMMETRIES; METAANALYSIS; EVOLUTION; MOUTH	There can be several factors that are likely to have played a role in the evolution of hand preference in humans and non-human primates, which the existing theories do not consider. There exists a possibility that hand preference in non-human primates evolved from the pre-existing lateralities in more elementary brain functions and behavior, or alternatively, the two coevolved. A basic example can be a hand-mouth command system that could have evolved in the context of ingestion. In the present study, we examined the relationship between lateralities in prehension and mastication processes, that is, hand and cheek pouch usage, in free-ranging bonnet macaques, Macaca radiata. The macaques preferentially used one hand-the 'preferred' hand, to pick up the bananas lying on the ground. Lateralities in hand and cheek pouch usage (for both filling and emptying) were positively related with each other, that is, the macaques used the cheek pouch corresponding to the preferred hand predominantly and before the other. Moreover, when the macaques used the non-preferred hand to pick up the bananas, the frequency of contralateral cheek pouch usage was higher than the frequency of ipsilateral cheek pouch usage, that is, the combined structure of hand, mouth, and food did not influence the relationship between laterality in hand usage and laterality in cheek pouch usage. These findings demonstrate laterality in a relatively more involuntary function than those explored previously in any non-human primate species (e. g., facial expressions and manual gestures).	[Mangalam, Madhur; Singh, Mewa] Univ Mysore, Biopsychol Lab, Mysore, Karnataka, India; [Desai, Nisarg] Indian Inst Sci Educ & Res Pune, Pune, Maharashtra, India; [Singh, Mewa] Jawaharlal Nehru Ctr Adv Sci Res, Evolutionary & Organismal Biol Unit, Bangalore, Karnataka, India	University of Mysore; Indian Institute of Science Education & Research (IISER) Pune; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Singh, M (corresponding author), Univ Mysore, Biopsychol Lab, Mysore, Karnataka, India.	mewasinghltm@gmail.com						Anfora G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018903; Annett M., 1985, LEFT RIGHT HAND BRAI; Bradshaw JL., 1993, EVOLUTION LATERAL AS; Cashmore L, 2008, J ANTHROPOL SCI, V86, P7; Corballis MC, 2003, BEHAV BRAIN SCI, V26, P199, DOI 10.1017/S0140525X03000062; Corballis MC, 2002, HAND MOUTH ORIGINS L; DECASTRO JMB, 1988, J HUM EVOL, V17, P403, DOI 10.1016/0047-2484(88)90029-2; FAGOT J, 1991, PSYCHOL BULL, V109, P76, DOI 10.1037/0033-2909.109.1.76; Fernandez-Carriba S, 2002, NEUROPSYCHOLOGIA, V40, P1523, DOI 10.1016/S0028-3932(02)00028-3; Frasnelli E, 2012, NEUROSCI BIOBEHAV R, V36, P1273, DOI 10.1016/j.neubiorev.2012.02.006; Gentilucci M, 2006, NEUROSCI BIOBEHAV R, V30, P949, DOI 10.1016/j.neubiorev.2006.02.004; HAUSER MD, 1993, SCIENCE, V261, P475, DOI 10.1126/science.8332914; Hauser MD, 2001, ANIM BEHAV, V61, P391, DOI 10.1006/anbe.2000.1588; Hook-Costigan MA, 1998, NEUROPSYCHOLOGIA, V36, P1265, DOI 10.1016/S0028-3932(98)00037-2; HOPKINS WD, 1993, J COMP PSYCHOL, V107, P403, DOI 10.1037/0735-7036.107.4.403; Hopkins WD, 2000, NEUROPSYCHOLOGIA, V38, P493, DOI 10.1016/S0028-3932(99)00090-1; Hopkins WD, 2003, DEVELOPMENTAL SCI, V6, P55, DOI 10.1111/1467-7687.00254; Hopkins WD, 1998, J COMP PSYCHOL, V112, P95, DOI 10.1037/0735-7036.112.1.95; HOPKINS WD, 1995, INT J PRIMATOL, V16, P261, DOI 10.1007/BF02735481; Letzkus P, 2006, CURR BIOL, V16, P1471, DOI 10.1016/j.cub.2006.05.060; MACNEILAGE PF, 1987, BEHAV BRAIN SCI, V10, P247, DOI 10.1017/S0140525X00047695; Mangalam M, 2014, AM J PRIMATOL, V76, P576, DOI 10.1002/ajp.22250; Martinez-Gomis J, 2009, ARCH ORAL BIOL, V54, P101, DOI 10.1016/j.archoralbio.2008.09.006; McGrew WC, 1997, YEARB PHYS ANTHROPOL, V40, P201; Meguerditchian A, 2006, BEHAV BRAIN RES, V171, P170, DOI 10.1016/j.bbr.2006.03.018; Nissan J, 2004, J ORAL REHABIL, V31, P412, DOI 10.1111/j.1365-2842.2004.01256.x; Papademetriou E, 2005, J COMP PSYCHOL, V119, P33, DOI 10.1037/0735-7036.119.1.33; Phillips KA, 2005, BEHAV NEUROSCI, V119, P1701, DOI 10.1037/0735-7044.119.6.1701; Phillips KA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000792; Phillips KA, 2007, NEUROPSYCHOLOGIA, V45, P2398, DOI 10.1016/j.neuropsychologia.2007.02.021; Raymond M, 2004, LATERALITY, V9, P35, DOI 10.1080/13576500244000274; Rogers LJ., 2002, COMP VERTEBRATE LATE; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105	33	1	1	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97971	10.1371/journal.pone.0097971	http://dx.doi.org/10.1371/journal.pone.0097971			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844660	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000339563400076
J	Matsui, S; Yamane, T; Kobayashi-Hattori, K; Oishi, Y				Matsui, Sho; Yamane, Takumi; Kobayashi-Hattori, Kazuo; Oishi, Yuichi			Ultraviolet B Irradiation Reduces the Expression of Adiponectin in Ovarial Adipose Tissues through Endocrine Actions of Calcitonin Gene-Related Peptide-Induced Serum Amyloid A	PLOS ONE			English	Article							INSULIN SENSITIVITY; FAT DIET; PROTEIN; RADIATION; HYALURONAN; ACTIVATION; RESISTANCE; INCREASES; ALPHA; RNA	Ultraviolet (UV) B irradiation decreases blood adiponectin levels, but the mechanism is not well understood. This study investigated how UVB irradiation reduces adiponectin expression in ovarial adipose tissues. Female Hos:HR-1 hairless mice were exposed to UVB (1.6 J/cm(2)) irradiation and were killed 24 h later. UVB irradiation decreased the adiponectin protein level in the serum and the adiponectin mRNA level in ovarial adipose tissues. UVB irradiation also decreased the mRNA levels of peroxisome proliferator-activated receptor (PPAR) gamma, CCAAT/enhancer binding protein (C/EBP) alpha, C/EBP beta, and fatty acid binding protein 4 (aP2) in ovarial adipose tissues. In contrast, UVB irradiation increased the mRNA levels of interleukin (IL)-6 and monocyte chemoattractant protein (MCP)-1 in ovarial adipose tissues. In the serum and liver, the levels of serum amyloid A (SAA), involved in PPAR gamma, C/EBP alpha, C/EBP beta, aP2, IL-6, and MCP-1 regulation, increased after UVB irradiation. The SAA gene is regulated by IL-1 beta, IL-6, and tumor necrosis factor-alpha, but only IL-6 expression increased in the liver after UVB irradiation. Additionally, in the liver, hypothalamus, and epidermis, UVB irradiation increased the expression of calcitonin gene-related peptide (CGRP), which upregulates SAA in the liver. Collectively, our results suggest that the CGRP signal induced by skin exposure to UVB transfers to the liver, possibly through the brain, and increases SAA production via IL-6 in the liver. In turn, serum SAA acts in an endocrine manner to decreases the serum adiponectin level by downregulating factors that regulate adiponectin expression in adipose tissues.	[Matsui, Sho; Yamane, Takumi; Kobayashi-Hattori, Kazuo; Oishi, Yuichi] Tokyo Univ Agr, Fac Appl Biosci, Dept Nutrit Sci, Tokyo, Japan	Tokyo University of Agriculture	Oishi, Y (corresponding author), Tokyo Univ Agr, Fac Appl Biosci, Dept Nutrit Sci, Tokyo, Japan.	y3oishi@nodai.ac.jp	Yamane, Takumi/N-7442-2019	, Kazuo/0000-0002-0921-2128	JSPS KAKENHI [24580199]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (grant numbers 24580199). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa Y, 2011, CONNECT TISSUE RES, V52, P322, DOI 10.3109/03008207.2010.528566; AMARA SG, 1982, NATURE, V298, P240, DOI 10.1038/298240a0; Arita Y, 2012, BIOCHEM BIOPH RES CO, V425, P560, DOI 10.1016/j.bbrc.2012.08.024; Brain SD, 2004, PHYSIOL REV, V84, P903, DOI 10.1152/physrev.00037.2003; Duivenvoorde LP, 2014, J GERONTOL A; Ezure T, 2010, EXP DERMATOL, V19, P878, DOI 10.1111/j.1600-0625.2009.00970.x; Ezure T, 2007, BIOFACTORS, V31, P229, DOI 10.1002/biof.5520310310; Faty A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034031; Gruys E, 2005, J Zhejiang Univ Sci B, V6, P1045, DOI 10.1631/jzus.2005.B1045; Gustafson B, 2003, BIOCHEM BIOPH RES CO, V308, P933, DOI 10.1016/S0006-291X(03)01518-3; Harada N, 2007, NEUROPHARMACOLOGY, V52, P1303, DOI 10.1016/j.neuropharm.2007.01.016; Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kim EJ, 2011, J INVEST DERMATOL, V131, P1720, DOI 10.1038/jid.2011.106; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Malle E, 1996, EUR J CLIN INVEST, V26, P427, DOI 10.1046/j.1365-2362.1996.159291.x; Matsui S, 2013, BIOSCI BIOTECH BIOCH, V77, P2151, DOI 10.1271/bbb.130450; Mayer JM, 2002, BRIT J SURG, V89, P163, DOI 10.1046/j.1365-2168.2002.01972.x; Meeran SM, 2009, TOXICOL APPL PHARM, V241, P303, DOI 10.1016/j.taap.2009.09.003; Polefka TG, 2012, J COSMET DERMATOL-US, V11, P134, DOI 10.1111/j.1473-2165.2012.00614.x; Qiao LP, 2005, DIABETES, V54, P1744, DOI 10.2337/diabetes.54.6.1744; Ruan H, 2004, CURR OPIN LIPIDOL, V15, P297, DOI 10.1097/00041433-200406000-00009; Ryo M, 2004, CIRC J, V68, P975, DOI 10.1253/circj.68.975; Salma N, 2006, J MOL ENDOCRINOL, V36, P139, DOI 10.1677/jme.1.01918; Sleijffers A, 2003, J PHOTOCH PHOTOBIO B, V69, P149, DOI 10.1016/S1011-1344(03)00002-2; SPIEGELMAN BM, 1993, J BIOL CHEM, V268, P6823; Terra XM, 2011, EUR J ENDOCRINOL, V164, P539, DOI 10.1530/EJE-10-1195; Tran MT, 2000, J IMMUNOL, V164, P4307, DOI 10.4049/jimmunol.164.8.4307; Trost A, 2007, EXP DERMATOL, V16, P185, DOI 10.1111/j.1600-0625.2006.00534.x; Vieira VJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE1164, DOI 10.1152/ajpendo.00054.2009; Yamamoto Y, 2004, J CLIN ENDOCR METAB, V89, P87, DOI 10.1210/jc.2003-031163; Yamane T, 2011, BIOCHEM BIOPH RES CO, V415, P235, DOI 10.1016/j.bbrc.2011.09.151; Yamane T, 2010, MOL NUTR FOOD RES, V54, pS53, DOI 10.1002/mnfr.201000022; Yatagai T, 2003, METABOLISM, V52, P1274, DOI 10.1016/S0026-0495(03)00195-1; Young Antony R, 2006, Prog Biophys Mol Biol, V92, P80, DOI 10.1016/j.pbiomolbio.2006.02.005; Zhang J, 2012, INVEST OPHTH VIS SCI, V53, P7276, DOI 10.1167/iovs.12-10482; Zoico E, 2009, INT J MOL MED, V24, P847, DOI 10.3892/ijmm_00000302	38	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98040	10.1371/journal.pone.0098040	http://dx.doi.org/10.1371/journal.pone.0098040			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845824	Green Published, Green Submitted, gold			2022-12-25	WOS:000339563400083
J	Milner, JJ; Wang, J; Sheridan, PA; Ebbels, T; Beck, MA; Saric, J				Milner, J. Justin; Wang, Jue; Sheridan, Patricia A.; Ebbels, Tim; Beck, Melinda A.; Saric, Jasmina			H-1 NMR-Based Profiling Reveals Differential Immune-Metabolic Networks during Influenza Virus Infection in Obese Mice	PLOS ONE			English	Article							DIET-INDUCED OBESITY; OXIDATIVE STRESS; H1N1 INFLUENZA; RISK-FACTOR; MOUSE; RESPONSES; MODEL; CHEMOMETRICS; MORTALITY; IMPACT	Obese individuals are at greater risk for death from influenza virus infection. Paralleling human evidence, obese mice are also more susceptible to influenza infection mortality. However, the underlying mechanisms driving greater influenza severity in the obese remain unclear. Metabolic profiling has been utilized in infectious disease models to enhance prognostic or diagnostic methods, and to gain insight into disease pathogenesis by providing a more global picture of dynamic infection responses. Herein, metabolic profiling was used to develop a deeper understanding of the complex processes contributing to impaired influenza protection in obese mice and to facilitate generation of new explanatory hypotheses. Diet-induced obese and lean mice were infected with influenza A/Puerto Rico/8/34. H-1 nuclear magnetic resonance-based metabolic profiling of urine, feces, lung, liver, mesenteric white adipose tissue, bronchoalveolar lavage fluid and serum revealed distinct metabolic signatures in infected obese mice, including perturbations in nucleotide, vitamin, ketone body, amino acid, carbohydrate, choline and lipid metabolic pathways. Further, metabolic data was integrated with immune analyses to obtain a more comprehensive understanding of potential immune-metabolic interactions. Of interest, uncovered metabolic signatures in urine and feces allowed for discrimination of infection status in both lean and obese mice at an early influenza time point, which holds prognostic and diagnostic implications for this methodology. These results confirm that obesity causes distinct metabolic perturbations during influenza infection and provide a basis for generation of new hypotheses and use of this methodology in detection of putative biomarkers and metabolic patterns to predict influenza infection outcome.	[Milner, J. Justin; Sheridan, Patricia A.; Beck, Melinda A.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC 27514 USA; [Wang, Jue; Ebbels, Tim; Saric, Jasmina] Univ London Imperial Coll Sci Technol & Med, Sect Computat & Syst Med, Dept Surg & Canc, Fac Med, London, England	University of North Carolina; University of North Carolina Chapel Hill; Imperial College London	Beck, MA (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC 27514 USA.	Melinda_beck@med.unc.edu; jasmina.saric05@imperial.ac.uk	Ebbels, Tim/ABB-2627-2021; , UNC Flow Cytometry Core/AGU-9839-2022	Ebbels, Tim/0000-0002-3372-8423; 	National Institutes of Health [DK56350]; Faculty of Medicine at Imperial College; National Cancer Institute at the National Institutes of Health Center Core Support Grant [P30CA06086]; NIH Tetramer Core Facility [HHSN272201300006C]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Faculty of Medicine at Imperial College; National Cancer Institute at the National Institutes of Health Center Core Support Grant; NIH Tetramer Core Facility(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health supported Nutrition Obesity Research Center [DK56350]. The Faculty of Medicine at Imperial College provided financial support for the Mres studentship funds for JW. Flow Cytometry was performed in the Flow Cytometer Core Facility at the University of North Carolina at Chapel Hill. The UNC Flow Cytometry Core Facility is supported in part by the National Cancer Institute at the National Institutes of Health Center Core Support Grant [P30CA06086] to the UNC Lineberger Comprehensive Cancer Center. The authors acknowledge the NIH Tetramer Core Facility (contract HHSN272201300006C) for provision of MHCI restricted DbNP366-74 and DbPA224-233 tetramers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Bindels LB, 2012, BRIT J CANCER, V107, P1337, DOI 10.1038/bjc.2012.409; Caballero B, 2007, EPIDEMIOL REV, V29, P1, DOI 10.1093/epirev/mxm012; Campitelli MA, 2014, INT J OBESITY, V38, P113, DOI 10.1038/ijo.2013.57; Chen LJ, 2014, BIOMED CHROMATOGR, V28, P468, DOI 10.1002/bmc.3055; Choi AMK, 1996, AM J PHYSIOL-LUNG C, V271, pL383, DOI 10.1152/ajplung.1996.271.3.L383; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; Corpe CP, 2010, J CLIN INVEST, V120, P1069, DOI 10.1172/JCI39191; De Tullio Mario C, 2012, Subcell Biochem, V56, P49, DOI 10.1007/978-94-007-2199-9_4; Easterbrook JD, 2011, INFLUENZA OTHER RESP, V5, P418, DOI 10.1111/j.1750-2659.2011.00254.x; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Eriksson L, 2004, ANAL BIOANAL CHEM, V380, P419, DOI 10.1007/s00216-004-2783-y; Fanos V, 2013, EARLY HUM DEV, V89, pS58, DOI 10.1016/S0378-3782(13)70017-3; Ferrannini E, 2011, DIABETES, V60, P695, DOI 10.2337/db10-1667; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Glasser SW, 2009, AM J PHYSIOL-LUNG C, V297, pL64, DOI 10.1152/ajplung.90640.2008; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Harrison FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035623; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Jackson JA, 2005, J ORTHOMOL MED, V20, P259; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Johnson AR, 2012, IMMUNOL REV, V249, P218, DOI 10.1111/j.1600-065X.2012.01151.x; Jung JY, 2012, BMB REP, V45, P419, DOI 10.5483/BMBRep.2012.45.7.248; Karasawa H, 2009, METABOLISM, V58, P296, DOI 10.1016/j.metabol.2008.09.028; Karisson EA, 2010, J IMMUNOL, V184, P3127, DOI 10.4049/jimmunol.0903220; Karlsson EA, 2010, J NUTR, V140, P1691, DOI 10.3945/jn.110.123653; Kennedy AJ, 2010, DIS MODEL MECH, V3, P156, DOI 10.1242/dmm.003467; Kim Yejin, 2013, Immune Netw, V13, P70, DOI 10.4110/in.2013.13.2.70; Kim YH, 2012, J INFECT DIS, V205, P244, DOI 10.1093/infdis/jir731; Kwong JC, 2011, CLIN INFECT DIS, V53, P413, DOI 10.1093/cid/cir442; Li JV, 2009, INT J PARASITOL, V39, P547, DOI 10.1016/j.ijpara.2008.10.010; Li W, 2006, J NUTR, V136, P2611, DOI 10.1093/jn/136.10.2611; Louie JK, 2011, CLIN INFECT DIS, V52, P301, DOI 10.1093/cid/ciq152; Mertz D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5061; Milner JJ, 2013, J IMMUNOL, V191, P2474, DOI 10.4049/jimmunol.1202429; Milner JJ, 2012, P NUTR SOC, V71, P298, DOI 10.1017/S0029665112000158; Morgan OW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009694; NISHIKIMI M, 1994, J BIOL CHEM, V269, P13685; O'Brien KB, 2012, J INFECT DIS, V205, P252, DOI 10.1093/infdis/jir729; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Poirier P, 2006, ARTERIOSCL THROM VAS, V26, P968, DOI 10.1161/01.ATV.0000216787.85457.f3; Ren YY, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-149; Saric J, 2010, PARASITOLOGY, V137, P1451, DOI 10.1017/S0031182010000697; Saric J, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000254; Saric J, 2008, J PROTEOME RES, V7, P352, DOI 10.1021/pr070340k; Saric J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.49; Saric J, 2010, J PROTEOME RES, V9, P2255, DOI 10.1021/pr901019z; Shearer J, 2008, DIABETES OBES METAB, V10, P950, DOI 10.1111/j.1463-1326.2007.00837.x; Sheetz MJ, 2002, JAMA-J AM MED ASSOC, V288, P2579, DOI 10.1001/jama.288.20.2579; Sheridan PA, 2012, INT J OBESITY, V36, P1072, DOI 10.1038/ijo.2011.208; Smith AG, 2007, J NUTR, V137, P1236, DOI 10.1093/jn/137.5.1236; Smith AG, 2009, IMMUNOLOGY, V126, P268, DOI 10.1111/j.1365-2567.2008.02895.x; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Veselkov KA, 2011, ANAL CHEM, V83, P5864, DOI 10.1021/ac201065j; Wang XJ, 2012, MOL CELL PROTEOMICS, V11, P370, DOI 10.1074/mcp.M111.016006; Wang YL, 2008, P NATL ACAD SCI USA, V105, P6127, DOI 10.1073/pnas.0801777105; Wang YL, 2010, ADV PARASIT, V73, P373, DOI 10.1016/S0065-308X(10)73012-8; World Health Organization, INFL SEAS; World Health Organization, OB OV; Wortham BW, 2012, J IMMUNOL, V188, P4468, DOI 10.4049/jimmunol.1102643; Zhang AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064381; Zhang AJX, 2013, J INFECT DIS, V207, P1270, DOI 10.1093/infdis/jit031	63	22	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97238	10.1371/journal.pone.0097238	http://dx.doi.org/10.1371/journal.pone.0097238			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844920	Green Published, Green Submitted, gold			2022-12-25	WOS:000339563400017
J	Riess, TH; Achieng', MM; Bailey, RC				Riess, Thomas H.; Achieng', Maryline M.; Bailey, Robert C.			Women's Beliefs about Male Circumcision, HIV Prevention, and Sexual Behaviors in Kisumu, Kenya	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; SUB-SAHARAN AFRICA; RANDOMIZED-TRIAL; NEGATIVE MEN; NYANZA PROVINCE; RAKAI; RISK; ACCEPTABILITY; TRANSMISSION; IMPACT	It is important to understand how women's sexual practices may be influenced by male circumcision (MC) as an HIV prevention effort. Women's beliefs about MC and sexual behaviour will likely influence the scale-up and uptake of medical MC. We conducted qualitative interviews with 30 sexually active women in Kisumu, Kenya. Women discussed MC related to perceived health benefits, condom use, sexual behaviour, knowledge of susceptibility to HIV and sexually transmitted infections (STIs), circumcision preference, and influence on circumcision uptake. Respondents had a good understanding of the partial protection of MC for acquisition of HIV for men. Women perceived circumcised men as cleaner, carrying fewer diseases, and taking more time to reach ejaculation. Male's circumcision status is a salient factor for women's sexual decision making, including partner choice, and condom use. It will be important that educational information affirms that MC provides only partial protection against female to male transmission of HIV and some STIs; that other HIV and STI prevention methods such as condoms need to be used in conjunction with MC; that MC does not preclude a man from having HIV; and that couples should develop plans for not having sex while the man is healing.	[Riess, Thomas H.; Bailey, Robert C.] Univ Illinois, Sch Publ Hlth, Chicago, IL 60607 USA; [Achieng', Maryline M.] Liverpool VCT Care & Treatment, Res & Policy Dept, Nairobi, Kenya	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Riess, TH (corresponding author), Univ Illinois, Sch Publ Hlth, Chicago, IL 60607 USA.	vonriess@yahoo.com			Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) [AI50440]; U.S. Centers for Disease Control and Prevention [2 T01 CD000189-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI050440] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, CENTERS FOR DISEASE CONTROL &PREVENTION [T01CD000189] Funding Source: NIH RePORTER	Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, CENTERS FOR DISEASE CONTROL &PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was supported in part by Grant No. AI50440 from the Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). THR was supported in part by the U.S. Centers for Disease Control and Prevention Training Program Grant #2 T01 CD000189-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SS, 1993, CANCER, V72, P166; [Anonymous], 2008, ATLAS TI VERS 5 2 CO; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2009, J INFECT DIS, V199, P14, DOI 10.1086/595566; Baeten JM, 2010, AIDS, V24, P737, DOI 10.1097/QAD.0b013e32833616e0; Baeten JM, 2009, LANCET, V374, P182, DOI 10.1016/S0140-6736(09)61311-8; Bailey RC, 2002, AIDS CARE, V14, P27, DOI 10.1080/09540120220097919; Bailey RC, 1999, 13 M INT SOC SEX TRA; Bailey RC, 2007, LANCET, V369, P1; Boeije H, 2002, QUAL QUANT, V36, P391, DOI 10.1023/A:1020909529486; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; Drain PK, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-172; Feuer C., 2010, ALQ MUJERES AIDS JUL; Glaser B, 1978, DISCOV GROUNDED THEO; Gostin LO, 2008, JAMA-J AM MED ASSOC, V300, P2539, DOI 10.1001/jama.2008.752; Gray RH, 2000, AIDS, V14, P2371, DOI 10.1097/00002030-200010200-00019; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gray RH, 2010, J INFECT DIS, V201, P1455, DOI 10.1086/652184; Gray RH, 2009, J INFECT DIS, V199, P1, DOI 10.1086/595568; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; Hallett TB, 2011, SEX TRANSM INFECT, V87, P88, DOI 10.1136/sti.2010.043372; Hankins C, 2007, REPROD HEALTH MATTER, V15, P62, DOI 10.1016/S0968-8080(07)29311-5; Herman-Roloff A, 2011, 16 INT C AIDS STIS A; Kenya National Bureau of Statistics, 2010, KEN DEM HLTH SURV 20; Kigozi G, 2009, BJU INT, V104, P1698, DOI 10.1111/j.1464-410X.2009.08683.x; Krieger JN, 2008, J SEX MED, V5, P2610, DOI 10.1111/j.1743-6109.2008.00979.x; Lagarde E, 2003, AIDS, V17, P89, DOI 10.1097/00002030-200301030-00012; Layer EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074391; Mattson CL, 2005, AIDS CARE, V17, P182, DOI 10.1080/09540120512331325671; Miles M. B., 2019, QUALITATIVE DATA ANA, V4th; Mugo N, 2011, SEX TRANSM DIS, V38, P1059, DOI 10.1097/OLQ.0b013e31822e60b6; Nagelkerke NJD, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-16; National AIDS and STI Control Programme, 2013, KEN AIDS IND SURV 20; Nielson CM, 2009, J INFECT DIS, V199, P7, DOI 10.1086/595567; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Obure A, 2011, GLOBAL J COMMUNITY P, V1, P1; Odoyo-June E, 2013, JAIDS-J ACQ IMM DEF, V62, P465, DOI [10.1097/QAI.0b013e3182800710, 10.1097/QAI.]; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Rain-Taljaard RC, 2003, AIDS CARE, V15, P315, DOI 10.1080/0954012031000105379; Riess TH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012366; Sobngwi-Tambekou J, 2009, J INFECT DIS, V199, P958, DOI 10.1086/597208; Strauss AL, 1998, BASICS QUALITATIVE R, V2nd; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; UNAIDS, 2010, GLOB REP UNAIDS REP; Waldinger MD, 2009, J SEX MED, V6, P2888, DOI 10.1111/j.1743-6109.2009.01392.x; Waldinger MD, 2005, J SEX MED, V2, P492, DOI 10.1111/j.1743-6109.2005.00070.x; Wawer MJ, 2011, LANCET, V377, P209, DOI 10.1016/S0140-6736(10)61967-8; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; Westercamp M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015552; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; White RG, 2008, JAIDS-J ACQ IMM DEF, V47, P346, DOI 10.1097/QAI.0b013e318160d56a	53	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97748	10.1371/journal.pone.0097748	http://dx.doi.org/10.1371/journal.pone.0097748			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0UW	24844845	Green Published, gold			2022-12-25	WOS:000339563400057
J	Takashima, T; Sanai, T; Miyazono, M; Fukuda, M; Kishi, T; Nonaka, Y; Yoshizaki, M; Sato, S; Ikeda, Y				Takashima, Tsuyoshi; Sanai, Toru; Miyazono, Motoaki; Fukuda, Makoto; Kishi, Tomoya; Nonaka, Yasunori; Yoshizaki, Mai; Sato, Sae; Ikeda, Yuji			A Comparison of the Long-Term Effects of Lanthanum Carbonate and Calcium Carbonate on the Course of Chronic Renal Failure in Rats with Adriamycin-Induced Nephropathy	PLOS ONE			English	Article							PHOSPHATE-BINDER; MAINTENANCE HEMODIALYSIS; DISEASE; EFFICACY; TOLERABILITY; PROGRESSION; THERAPY; SAFETY; BONE; HYPERPHOSPHATEMIA	Lanthanum carbonate (LA) is an effective phosphate binder. Previous study showed the phosphate-binding potency of LA was twice that of calcium carbonate (CA). No study in which LA and CA were given at an equivalent phosphate-binding potency to rats or humans with chronic renal failure for a long period has been reported to date. The objective of this study was to compare the phosphate level in serum and urine and suppression of renal deterioration during long-term LA and CA treatment when they were given at an equivalent phosphate-binding potency in rats with adriamycin (ADR)-induced nephropathy. Rats were divided into three groups: an untreated group (ADR group), a CA-treated (ADR-CA) group and a LA-treated (ADR-LA) group. The daily oral dose of LA was 1.0 g/kg/day and CA was 2.0 g/kg/day for 24 weeks. The serum phosphate was lower in the ADR-CA or ADR-LA group than in the ADR group and significantly lower in the ADR-CA group than in the ADR group at each point, but there were no significant differences between the ADR and ADR-LA groups. The serum phosphate was also lower in the ADR-CA group than in the ADR-LA group, and there was significant difference at week 8. The urinary phosphate was significantly lower in the ADR-CA group than in the ADR or ADR-LA group at each point. The urinary phosphate was also lower in the ADR-LA group than in the ADR group at each point, and significant difference at week 8. There were no significant differences in the serum creatinine or blood urea nitrogen among the three groups. In conclusion, this study indicated the phosphate-binding potency of LA isn't twice as strong as CA, and neither LA nor CA suppressed the progression of chronic renal failure in the serum creatinine and blood urea nitrogen, compared to the untreated group.	[Takashima, Tsuyoshi; Miyazono, Motoaki; Fukuda, Makoto; Kishi, Tomoya; Yoshizaki, Mai; Sato, Sae; Ikeda, Yuji] Saga Univ, Fac Med, Dept Nephrol, Saga 840, Japan; [Sanai, Toru] Fukumitsu Hosp, Dept Nephrol, Fukuoka, Japan; [Nonaka, Yasunori] Ureshino Med Ctr, Dept Nephrol, Ureshino, Japan	Saga University	Takashima, T (corresponding author), Saga Univ, Fac Med, Dept Nephrol, Saga 840, Japan.	takashim@cc.saga-u.ac.jp			Bayer Yakuhin, Ltd. (Osaka, Japan)	Bayer Yakuhin, Ltd. (Osaka, Japan)	This study was supported by a grant from Bayer Yakuhin, Ltd. (Osaka, Japan). The funder had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Behets GJ, 2004, J AM SOC NEPHROL, V15, P2219, DOI 10.1097/01.ASN.0000133022.32912.95; BERTANI T, 1986, KIDNEY INT, V30, P488, DOI 10.1038/ki.1986.212; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Burke SK, 1997, NEPHROL DIAL TRANSPL, V12, P1640, DOI 10.1093/ndt/12.8.1640; Chiang SS, 2005, CLIN NEPHROL, V63, P461; D'Haese PC, 2003, KIDNEY INT, V63, pS73, DOI 10.1046/j.1523-1755.63.s85.18.x; Damment SJP, 2011, RENAL FAILURE, V33, P217, DOI 10.3109/0886022X.2011.552821; Danese MD, 2008, CLIN J AM SOC NEPHRO, V3, P1423, DOI 10.2215/CJN.01060308; Daugirdas JT, 2011, SEMIN DIALYSIS, V24, P41, DOI 10.1111/j.1525-139X.2011.00849.x; Finn WF, 2006, CLIN NEPHROL, V65, P191; GIMENEZ LF, 1987, KIDNEY INT, V31, P93, DOI 10.1038/ki.1987.14; Gonzalez-Parra E, 2011, NEPHROL DIAL TRANSPL, V26, P2567, DOI 10.1093/ndt/gfr144; Hutchison AJ, 2006, NEPHRON CLIN PRACT, V102, P61, DOI 10.1159/000088932; Hutchison AJ, 2005, NEPHRON CLIN PRACT, V100, pC8, DOI 10.1159/000084653; Hutchison AJ, 2004, NEPHROL DIAL TRANSPL, V19, pI19, DOI 10.1093/ndt/gfh1004; Hutchison AJ, 2008, NEPHRON CLIN PRACT, V110, pC15, DOI 10.1159/000149239; IBELS LS, 1978, NEW ENGL J MED, V298, P122, DOI 10.1056/NEJM197801192980302; ISRAEL Y, 1975, J PHARMACOL EXP THER, V192, P565; KARLINSKY ML, 1980, KIDNEY INT, V17, P293, DOI 10.1038/ki.1980.35; KATZ AI, 1968, NEW ENGL J MED, V278, P253, DOI 10.1056/NEJM196802012780506; KLAHR S, 1983, KIDNEY INT, V24, P579, DOI 10.1038/ki.1983.197; LAOUARI D, 1982, CLIN SCI, V63, P539, DOI 10.1042/cs0630539; LINS LE, 1978, ACTA MED SCAND, V203, P309; LUMLERTGUL D, 1986, KIDNEY INT, V29, P658, DOI 10.1038/ki.1986.49; OKUDA S, 1986, KIDNEY INT, V29, P502, DOI 10.1038/ki.1986.28; Pennick M, 2012, RENAL FAILURE, V34, P263, DOI 10.3109/0886022X.2011.649657; Persy VP, 2006, SEMIN DIALYSIS, V19, P195, DOI 10.1111/j.1525-139X.2006.00169.x; Russo D, 2007, KIDNEY INT, V72, P1255, DOI 10.1038/sj.ki.5002518; SANAI T, 1989, NEPHRON, V51, P530, DOI 10.1159/000185388; SERROS ER, 1981, AM J PHYSIOL, V241, pF224, DOI 10.1152/ajprenal.1981.241.3.F224; Spasovski Goce, 2008, Recent Pat Cardiovasc Drug Discov, V3, P222, DOI 10.2174/157489008786263961; Sprague SM, 2009, CLIN J AM SOC NEPHRO, V4, P178, DOI 10.2215/CJN.02830608; WALSER M, 1979, CLIN NEPHROL, V11, P66	33	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97859	10.1371/journal.pone.0097859	http://dx.doi.org/10.1371/journal.pone.0097859			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846276	gold, Green Published, Green Submitted			2022-12-25	WOS:000339563400067
J	Ang, M; Ng, X; Wong, C; Yan, P; Chee, SP; Venkatraman, SS; Wong, TT				Ang, Marcus; Ng, Xuwen; Wong, Cheewai; Yan, Peng; Chee, Soon-Phaik; Venkatraman, Subbu S.; Wong, Tina T.			Evaluation of a Prednisolone Acetate-Loaded Subconjunctival Implant for the Treatment of Recurrent Uveitis in a Rabbit Model	PLOS ONE			English	Article							DEXAMETHASONE INTRAVITREAL IMPLANT; SUSTAINED-RELEASE; POSTERIOR UVEITIS; DRUG-DELIVERY; ANIMAL-MODEL; INTERMEDIATE; PENETRATION; SURGERY	Aim: To assess the efficacy of a biodegradable, prednisolone acetate implant in a rabbit uveitis model. Methods: Randomized, controlled study of biodegradable microfilms preloaded with prednisolone acetate (PA) in a rabbit uveitis model. Experimental uveitis was induced by unilateral intravitreal injection of Mycobacterium tuberculosis H37Ra antigen (50 ug; 1 ug/uL) in preimmunized rabbits. PA-loaded poly[d,l-lactide-co-epsilon-caprolactone] (PLC) microfilms (n = 10) and blank microfilms (n = 6) were implanted subconjunctivally. An estimate of PA release in vivo was calculated from measured residual PA amounts in microfilms after the rabbits were sacrificed. The eyes were clinically monitored for ocular inflammation for 28 days. Histopathological examination of the enucleated eyes was performed at the end of the study period. Results: In vitro studies revealed that sandwich PA-loaded microfilm formulations exhibited higher release kinetic compared to homogenous PA-loaded microfilms. The 60-40-60% microfilm released an average of 0.034 mg/day of PA over the period of 60 days in vitro; and we found that approximately 0.12 mg/day PA was released in vivo. Animals implanted with the PA-loaded microfilms exhibited significantly lowered median inflammatory scores when compared against the control group in this model for recurrent uveitis (P < 0.001). The implants were clinically well tolerated by all the animals. Histology results showed no significant scarring or inflammation around the PA-loaded microfilms. Conclusion: Our pilot study demonstrated that a subconjunctival PA-loaded implant is effective in suppressing inflammation in the rabbit model of uveitis, by providing therapeutic levels of PA that attenuated the inflammatory response even after a rechallenge. Longer term studies are now needed to establish the therapeutic potential of such a delivery system for treatment of ocular inflammation.	[Ang, Marcus; Wong, Cheewai; Chee, Soon-Phaik; Wong, Tina T.] Singapore Natl Eye Ctr, Singapore, Singapore; [Ang, Marcus; Wong, Cheewai; Chee, Soon-Phaik; Wong, Tina T.] Singapore Eye Res Inst, Singapore, Singapore; [Ng, Xuwen; Yan, Peng; Venkatraman, Subbu S.; Wong, Tina T.] Nanyang Technol Univ, Singapore 639798, Singapore	Singapore National Eye Center; National University of Singapore; Singapore National Eye Center; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Venkatraman, SS (corresponding author), Nanyang Technol Univ, Singapore 639798, Singapore.	ASSubbu@ntu.edu.sg; tina.wong.t.l@snec.com.sg	Venkatraman, Subramanian/A-2228-2011	Venkatraman, Subramanian/0000-0002-8693-1070	National Medical Research Council/Early Development Grant (Singapore) [0064/2010]	National Medical Research Council/Early Development Grant (Singapore)	The authors report funding from the National Medical Research Council/Early Development Grant/ 0064/2010 (Singapore). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang M, 2011, CURR EYE RES, V36, P1123, DOI 10.3109/02713683.2011.627489; Awan MA, 2009, BRIT J OPHTHALMOL, V93, P708, DOI 10.1136/bjo.2008.154906; BLOCHMICHEL E, 1987, AM J OPHTHALMOL, V103, P234, DOI 10.1016/S0002-9394(14)74235-7; Chang-Lin JE, 2011, INVEST OPHTH VIS SCI, V52, P80, DOI 10.1167/iovs.10-5285; CHENG CK, 1995, INVEST OPHTH VIS SCI, V36, P442; Dandona L, 2000, BRIT J OPHTHALMOL, V84, P706, DOI 10.1136/bjo.84.7.706; Eperon S, 2013, INT J PHARMACEUT, V443, P254, DOI 10.1016/j.ijpharm.2012.12.033; Ghosn CR, 2011, INVEST OPHTH VIS SCI, V52, P2917, DOI 10.1167/iovs.10-5939; Gutteridge IF, 2007, CLIN EXP OPTOM, V90, P70, DOI 10.1111/j.1444-0938.2006.00128.x; Haghjou Nahid, 2011, J Ophthalmic Vis Res, V6, P317; HYNDIUK RA, 1969, ARCH OPHTHALMOL-CHIC, V82, P259, DOI 10.1001/archopht.1969.00990020261021; Lao LL, 2008, EUR J PHARM BIOPHARM, V70, P796, DOI 10.1016/j.ejpb.2008.05.024; Liu YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070419; Liu YC, 2013, INVEST OPHTH VIS SCI, V54, P2607, DOI 10.1167/iovs.12-11466; Lowder C, 2011, ARCH OPHTHALMOL-CHIC, V129, P545, DOI 10.1001/archophthalmol.2010.339; NUSSENBLATT RB, 1985, OPHTHALMOLOGY, V92, P467; Paivonsalo-Hietanen T, 1997, ACTA OPHTHALMOL SCAN, V75, P76; Peng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022507; Siddique SS, 2011, EXPERT OPIN INV DRUG, V20, P1497, DOI 10.1517/13543784.2011.617741	19	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97555	10.1371/journal.pone.0097555	http://dx.doi.org/10.1371/journal.pone.0097555			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842851	Green Published, gold			2022-12-25	WOS:000340948600043
J	Coogan, SCP; Raubenheimer, D; Stenhouse, GB; Nielsen, SE				Coogan, Sean C. P.; Raubenheimer, David; Stenhouse, Gordon B.; Nielsen, Scott E.			Macronutrient Optimization and Seasonal Diet Mixing in a Large Omnivore, the Grizzly Bear: A Geometric Analysis	PLOS ONE			English	Article							NUTRITIONAL ECOLOGY; BODY-COMPOSITION; ENERGY; FOOD; MASS; HIBERNATION; REPRODUCTION; CONSERVATION; CONSTRAINTS; SELECTION	Nutrient balance is a strong determinant of animal fitness and demography. It is therefore important to understand how the compositions of available foods relate to required balance of nutrients and habitat suitability for animals in the wild. These relationships are, however, complex, particularly for omnivores that often need to compose balanced diets by combining their intake from diverse nutritionally complementary foods. Here we apply geometric models to understand how the nutritional compositions of foods available to an omnivorous member of the order Carnivora, the grizzly bear (Ursus arctos L.), relate to optimal macronutrient intake, and assess the seasonal nutritional constraints on the study population in west-central Alberta, Canada. The models examined the proportion of macronutrients that bears could consume by mixing their diet from food available in each season, and assessed the extent to which bears could consume the ratio of protein to nonprotein energy previously demonstrated using captive bears to optimize mass gain. We found that non-selective feeding on ungulate carcasses provided a non-optimal macronutrient balance with surplus protein relative to fat and carbohydrate, reflecting adaptation to an omnivorous lifestyle, and that optimization through feeding selectively on different tissues of ungulate carcasses is unlikely. Bears were, however, able to dilute protein intake to an optimal ratio by mixing their otherwise high-protein diet with carbohydrate-rich fruit. Some individual food items were close to optimally balanced in protein to non-protein energy (e. g. Hedysarum alpinum roots), which may help explain their dietary prevalence. Ants may be consumed particularly as a source of lipids. Overall, our analysis showed that most food available to bears in the study area were high in protein relative to lipid or carbohydrate, suggesting the lack of non-protein energy limits the fitness (e. g. body size and reproduction) and population density of grizzly bears in this ecosystem.	[Coogan, Sean C. P.; Nielsen, Scott E.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Raubenheimer, David] Univ Sydney, Fac Vet Sci, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Raubenheimer, David] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Stenhouse, Gordon B.] Foothills Res Inst, Grizzly Bear Program, Hinton, AB, Canada	University of Alberta; University of Sydney; University of Sydney	Coogan, SCP (corresponding author), Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada.	scoogan@ualberta.ca	Nielsen, Scott/O-7482-2019; Nielsen, Scott/C-2842-2013	Nielsen, Scott/0000-0002-9754-0630; Nielsen, Scott/0000-0002-9754-0630; Coogan, Sean/0000-0003-2694-8468; Raubenheimer, David/0000-0001-9050-1447	Foothills Research Institute Grizzly Bear Program; Natural Sciences and Engineering Research Council (NSERC) of Canada; Alberta Innovates - Bio Solutions; Applied Conservation Ecology lab	Foothills Research Institute Grizzly Bear Program; Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates - Bio Solutions; Applied Conservation Ecology lab	Funding for S. C. P. Coogan was provided by the Foothills Research Institute Grizzly Bear Program, Natural Sciences and Engineering Research Council (NSERC) of Canada, Alberta Innovates - Bio Solutions, and the Applied Conservation Ecology lab (http://www.ace-lab.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberta Grizzly Bear Inventory Team, 2005, 2004 POP INV DENS ES; Alberta Sustainable Resource Development Alberta Conservation Association, 2010, 37 ALB SUST RES DEV; [Anonymous], 2013, USDA NAT NUTR DAT ST; [Anonymous], 1987, BEARS BIOL MANAG; Beckingham J. D., 1996, FIELD GUIDE ECOSITES; Bojarska K, 2012, MAMMAL REV, V42, P120, DOI 10.1111/j.1365-2907.2011.00192.x; Clements KD, 2009, FUNCT ECOL, V23, P79, DOI 10.1111/j.1365-2435.2008.01524.x; Coogan Sean C.P., 2012, ISRN Ecology, P1; Cotter SC, 2011, FUNCT ECOL, V25, P186, DOI 10.1111/j.1365-2435.2010.01766.x; Cristescu B, 2013, THESIS U ALBERTA EDM; DELGIUDICE GD, 1990, J WILDLIFE MANAGE, V54, P539, DOI 10.2307/3809347; Edwards MA, 2011, OECOLOGIA, V165, P877, DOI 10.1007/s00442-010-1869-9; Erlenbach JA, 2014, J MAMMAL, V95, P160, DOI 10.1644/13-MAMM-A-161; Farley SD, 1995, CAN J ZOOL, V73, P2216, DOI 10.1139/z95-262; Felton AM, 2009, BEHAV ECOL, V20, P685, DOI 10.1093/beheco/arp021; Gende SM, 2001, OECOLOGIA, V127, P372, DOI 10.1007/s004420000590; Hawlena D, 2010, P NATL ACAD SCI USA, V107, P15503, DOI 10.1073/pnas.1009300107; Hewson-Hughes AK, 2013, J COMP PHYSIOL B, V183, P525, DOI 10.1007/s00360-012-0727-y; Hewson-Hughes AK, 2013, BEHAV ECOL, V24, P293, DOI 10.1093/beheco/ars168; Hilderbrand GV, 2000, J WILDLIFE MANAGE, V64, P178, DOI 10.2307/3802988; Hilderbrand GV, 1999, CAN J ZOOL, V77, P132, DOI 10.1139/cjz-77-1-132; Hilderbrand GV, 1999, CAN J ZOOL, V77, P1623, DOI 10.1139/cjz-77-10-1623; Hundertmark K. J., 1997, ESTIMATION BODY COMP; Jensen K, 2012, P ROY SOC B-BIOL SCI, V279, P2212, DOI 10.1098/rspb.2011.2410; Johnson CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070383; Kearney M, 2010, PHILOS T R SOC B, V365, P3469, DOI 10.1098/rstb.2010.0034; KUHNLEIN H V, 1990, Journal of Food Composition and Analysis, V3, P38, DOI 10.1016/0889-1575(90)90007-9; Kuipers RS, 2010, BRIT J NUTR, V104, P1666, DOI 10.1017/S0007114510002679; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Lopez-Alfaro C, 2013, ECOL MODEL, V270, P1, DOI 10.1016/j.ecolmode1.2013.09.002; Maklakov AA, 2008, CURR BIOL, V18, P1062, DOI 10.1016/j.cub.2008.06.059; MATTSON DJ, 1991, CAN J ZOOL, V69, P1619, DOI 10.1139/z91-226; Mayntz D, 2009, ANIM BEHAV, V77, P349, DOI 10.1016/j.anbehav.2008.09.036; MCCULLOUGH DR, 1983, J WILDLIFE MANAGE, V47, P430, DOI 10.2307/3808516; McLellan BN, 2011, CAN J ZOOL, V89, P546, DOI 10.1139/Z11-026; MCLELLAN BN, 1995, CAN J ZOOL, V73, P704, DOI 10.1139/z95-082; Merrill AL, 1973, AGR HDB, V74, P105; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; Nielsen SE, 2010, BIOL CONSERV, V143, P1623, DOI 10.1016/j.biocon.2010.04.007; Piper MDW, 2011, CELL METAB, V14, P154, DOI 10.1016/j.cmet.2011.06.013; PRITCHARD GT, 1990, CAN J ZOOL, V68, P1645, DOI 10.1139/z90-244; Raubenheimer D, 2004, ECOLOGY, V85, P1203, DOI 10.1890/02-0248; Raubenheimer D, 1997, NUTR RES REV, V10, P151, DOI 10.1079/NRR19970009; Raubenheimer D, 2006, ANIM BEHAV, V71, P1253, DOI 10.1016/j.anbehav.2005.07.024; Raubenheimer D, 2005, ECOLOGY, V86, P2601, DOI 10.1890/04-1472; Raubenheimer D, 2013, ANNU REV ENTOMOL, V58, P141, DOI 10.1146/annurev-ento-120710-100713; Raubenheimer D, 2012, PHILOS T R SOC B, V367, P1628, DOI 10.1098/rstb.2012.0007; Raubenheimer D, 2011, ECOL MONOGR, V81, P407, DOI 10.1890/10-1707.1; Raubenheimer D, 2009, FUNCT ECOL, V23, P4, DOI 10.1111/j.1365-2435.2009.01522.x; REDFORD KH, 1984, J ZOOL, V203, P385, DOI 10.1111/j.1469-7998.1984.tb02339.x; Robbins CT, 2007, OIKOS, V116, P1675, DOI 10.1111/j.0030-1299.2007.16140.x; Rode KD, 2006, ECOLOGY, V87, P2636, DOI 10.1890/0012-9658(2006)87[2636:SDRSAH]2.0.CO;2; Rode KD, 2001, OECOLOGIA, V128, P62, DOI 10.1007/s004420100637; Rothman JM, 2011, BIOL LETTERS, V7, P847, DOI 10.1098/rsbl.2011.0321; Simpson SJ, 2005, OBES REV, V6, P133, DOI 10.1111/j.1467-789X.2005.00178.x; Simpson SJ, 2004, ANIM BEHAV, V68, P1299, DOI 10.1016/j.anbehav.2004.03.003; Simpson SJ, 2012, NATURE NUTR UNIFYING; Wehi PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084641; Welch CA, 1997, ECOLOGY, V78, P1105, DOI 10.2307/2265862; WORDEN KA, 1995, CAN J ZOOL, V73, P452, DOI 10.1139/z95-052	60	53	53	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97968	10.1371/journal.pone.0097968	http://dx.doi.org/10.1371/journal.pone.0097968			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841821	Green Published, gold, Green Submitted			2022-12-25	WOS:000340948600095
J	Iovino, F; Molema, G; Bijlsma, JJE				Iovino, Federico; Molema, Grietje; Bijlsma, Jetta J. E.			Streptococcus pneumoniae Interacts with pIgR Expressed by the Brain Microvascular Endothelium but Does Not Co-Localize with PAF Receptor	PLOS ONE			English	Article							POLYMERIC IMMUNOGLOBULIN RECEPTOR; ACTIVATING-FACTOR-RECEPTOR; CULTURED HIPPOCAMPAL; EPITHELIAL-CELLS; PROTEIN; TRANSCYTOSIS; INVASION; BINDING; PATHOPHYSIOLOGY; PATHOGENESIS	Streptococcus pneumoniae is thought to adhere to the blood-brain barrier (BBB) endothelium prior to causing meningitis. The platelet activating factor receptor (PAFR) has been implicated in this adhesion but there is a paucity of data demonstrating direct binding of the bacteria to PAFR. Additionally, studies that inhibit PAFR strongly suggest that alternative receptors for pneumococci are present on the endothelium. Therefore, we studied the roles of PAFR and pIgR, an established epithelial pneumococcal receptor, in pneumococcal adhesion to brain endothelial cells in vivo. Mice were intravenously infected with pneumococci and sacrificed at various time points before meningitis onset. Co-localization of bacteria with PAFR and pIgR was investigated using immunofluorescent analysis of the brain tissue. In vitro blocking with antibodies and incubation of pneumococci with endothelial cell lysates were used to further probe bacteria-receptor interaction. In vivo as well as in vitro pneumococci did not co-localize with PAFR. On the other hand the majority of S. pneumoniae co-localized with endothelial pIgR and pIgR blocking reduced pneumococcal adhesion to endothelial cells. Pneumococci physically interacted with pIgR in endothelial cell lysates. In conclusion, bacteria did not associate with PAFR, indicating an indirect role of PAFR in pneumococcal adhesion to endothelial cells. In contrast, pIgR on the BBB endothelium may represent a novel pneumococcal adhesion receptor.	[Iovino, Federico; Bijlsma, Jetta J. E.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Molema, Grietje] Univ Groningen, Univ Med Ctr Groningen, Med Biol Sect, Dept Pathol & Med Biol, Groningen, Netherlands	University of Groningen; University of Groningen	Bijlsma, JJE (corresponding author), MSD Anim Hlth, Intervet Int BV, Boxmeer, Netherlands.	bijlsmajje@gmail.com	Iovino, Federico/R-2721-2017; Iovino, Federico/AGW-9968-2022	Iovino, Federico/0000-0001-5249-9120; Iovino, Federico/0000-0001-5249-9120; Molema, Grietje/0000-0002-4147-6676				Adamou JE, 1998, INFECT IMMUN, V66, P820, DOI 10.1128/IAI.66.2.820-822.1998; Agarwal V, 2010, J BIOL CHEM, V285, P35615, DOI 10.1074/jbc.M110.172999; Agarwal V, 2009, J BIOL CHEM, V284, P19427, DOI 10.1074/jbc.M109.003442; Asgeirsdottir SA, 2010, J CONTROL RELEASE, V141, P241, DOI 10.1016/j.jconrel.2009.09.008; BITO H, 1994, EUR J BIOCHEM, V221, P211, DOI 10.1111/j.1432-1033.1994.tb18731.x; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; DEHOOP M, 1995, J CELL BIOL, V130, P1447, DOI 10.1083/jcb.130.6.1447; Elm C, 2004, J BIOL CHEM, V279, P6296, DOI 10.1074/jbc.M310528200; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Gradstedt H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065626; Hammerschmidt S, 2000, MOL MICROBIOL, V36, P726, DOI 10.1046/j.1365-2958.2000.01897.x; Hemar A, 1997, J NEUROSCI, V17, P9026; IKONEN E, 1993, CURR BIOL, V3, P635, DOI 10.1016/0960-9822(93)90061-R; Iovino F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068408; Iovino F, 2013, CELL MICROBIOL, V15, P870, DOI 10.1111/cmi.12129; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; Jen FEC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003377; Kim KJ, 2003, AM J PHYSIOL-LUNG C, V284, pL247, DOI 10.1152/ajplung.00235.2002; Koedel U, 2002, LANCET INFECT DIS, V2, P721, DOI 10.1016/S1473-3099(02)00450-4; Lu L, 2003, J BIOL CHEM, V278, P48178, DOI 10.1074/jbc.M306906200; Luo RS, 2005, EMBO J, V24, P34, DOI 10.1038/sj.emboj.7600490; Mook-Kanamori BB, 2011, CLIN MICROBIOL REV, V24, P557, DOI 10.1128/CMR.00008-11; Orihuela CJ, 2009, J CLIN INVEST, V119, P1638, DOI 10.1172/JCI36759; Orihuela CJ, 2004, J INFECT DIS, V190, P1661, DOI 10.1086/424596; Radin JN, 2005, INFECT IMMUN, V73, P7827, DOI 10.1128/IAI.73.12.7827-7835.2005; Ring A, 1998, J CLIN INVEST, V102, P347, DOI 10.1172/JCI2406; Romero-Steiner S, 2006, VACCINE, V24, P3224, DOI 10.1016/j.vaccine.2006.01.042; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406; Woehrl B, 2011, EXPERT REV ANTI-INFE, V9, P1053, DOI [10.1586/ERI.11.129, 10.1586/eri.11.129]; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4	32	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97914	10.1371/journal.pone.0097914	http://dx.doi.org/10.1371/journal.pone.0097914			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841255	Green Published, gold, Green Submitted			2022-12-25	WOS:000340948600092
J	Modulevsky, DJ; Lefebvre, C; Haase, K; Al-Rekabi, Z; Pelling, AE				Modulevsky, Daniel J.; Lefebvre, Cory; Haase, Kristina; Al-Rekabi, Zeinab; Pelling, Andrew E.			Apple Derived Cellulose Scaffolds for 3D Mammalian Cell Culture	PLOS ONE			English	Article							BACTERIAL CELLULOSE; DECELLULARIZED MATRIX; POTENTIAL SCAFFOLD; IN-VIVO; TISSUE; CHONDROCYTES; MEMBRANE; POLYMER; MICROENVIRONMENTS; DIFFERENTIATION	There are numerous approaches for producing natural and synthetic 3D scaffolds that support the proliferation of mammalian cells. 3D scaffolds better represent the natural cellular microenvironment and have many potential applications in vitro and in vivo. Here, we demonstrate that 3D cellulose scaffolds produced by decellularizing apple hypanthium tissue can be employed for in vitro 3D culture of NIH3T3 fibroblasts, mouse C2C12 muscle myoblasts and human HeLa epithelial cells. We show that these cells can adhere, invade and proliferate in the cellulose scaffolds. In addition, biochemical functionalization or chemical cross-linking can be employed to control the surface biochemistry and/or mechanical properties of the scaffold. The cells retain high viability even after 12 continuous weeks of culture and can achieve cell densities comparable with other natural and synthetic scaffold materials. Apple derived cellulose scaffolds are easily produced, inexpensive and originate from a renewable source. Taken together, these results demonstrate that naturally derived cellulose scaffolds offer a complementary approach to existing techniques for the in vitro culture of mammalian cells in a 3D environment.	[Modulevsky, Daniel J.; Lefebvre, Cory; Haase, Kristina; Al-Rekabi, Zeinab; Pelling, Andrew E.] Univ Ottawa, Ctr Interdisciplinary NanoPhys, Ottawa, ON, Canada; [Modulevsky, Daniel J.; Pelling, Andrew E.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Haase, Kristina; Al-Rekabi, Zeinab; Pelling, Andrew E.] Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada; [Pelling, Andrew E.] Univ Ottawa, Inst Sci Soc & Policy, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa	Pelling, AE (corresponding author), Univ Ottawa, Ctr Interdisciplinary NanoPhys, Ottawa, ON, Canada.	a@pellinglab.net		Pelling, Andrew/0000-0003-3732-7472; Haase, Kristina/0000-0003-3321-4286	University of Ottawa; Natural Science and Engineering Research Council (NSERC); NSERC; NSERC-CREATE Training Program in Quantitative; Canada Research Chairs Program; Province of Ontario Early Researcher Award	University of Ottawa; Natural Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC-CREATE Training Program in Quantitative; Canada Research Chairs Program(Canada Research Chairs); Province of Ontario Early Researcher Award(Ministry of Research and Innovation, Ontario)	This work was made possible by support from the University of Ottawa and a Natural Science and Engineering Research Council (NSERC) Discovery Grant. C. L. was supported by an NSERC Undergraduate Student Research Award, Z.A.R. was supported by a graduate fellowship from the NSERC-CREATE Training Program in Quantitative. A. E. P. acknowledges generous support from the Canada Research Chairs Program and a Province of Ontario Early Researcher Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade FK, 2013, J BIOACT COMPAT POL, V28, P97, DOI 10.1177/0883911512467643; Andrade FK, 2011, J BIOMED MATER RES A, V98A, P554, DOI 10.1002/jbm.a.33148; [Anonymous], 1985, BIOCH PLANT CELL WAL; Arenas-Herrera JE, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014106; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; ATALA A, 1992, J UROLOGY, V148, P658, DOI 10.1016/S0022-5347(17)36685-5; Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026; Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; Bancroft G. N., 2003, TISSUE ENG, V9; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; Bourgine PE, 2013, BIOMATERIALS, V34, P6099, DOI 10.1016/j.biomaterials.2013.04.058; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Carl P, 2001, P NATL ACAD SCI USA, V98, P1565, DOI 10.1073/pnas.031409698; Chang HI, 2011, REGENERATIVE MEDICINE AND TISSUE ENGINEERING - CELLS AND BIOMATERIALS, P569; Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d; Derda R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018940; Derda R, 2009, P NATL ACAD SCI USA, V106, P18457, DOI 10.1073/pnas.0910666106; Dorothee K, 2011, TISSUE ENG REGEN MED, DOI [10.5772/21197, DOI 10.5772/21197]; Entcheva E, 2004, BIOMATERIALS, V25, P5753, DOI 10.1016/j.biomaterials.2004.01.024; Esau K, 1965, PLANT ANANTOMY; Fennema E, 2013, TRENDS BIOTECHNOL, V31, P108, DOI 10.1016/j.tibtech.2012.12.003; Fong ELS, 2013, P NATL ACAD SCI USA, V110, P6500, DOI 10.1073/pnas.1221403110; FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104; FREED LE, 1994, J BIOMED MATER RES, V28, P891, DOI 10.1002/jbm.820280808; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Gillies AR, 2011, TISSUE ENG PART C-ME, V17, P383, DOI [10.1089/ten.tec.2010.0438, 10.1089/ten.TEC.2010.0438]; Gratzer PF, 2006, TISSUE ENG, V12, P2975, DOI 10.1089/ten.2006.12.2975; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Grotte M, 2002, INT J FOOD PROP, V5, P333, DOI 10.1081/JFP-120005789; Guolla L, 2012, J CELL SCI, V125, P603, DOI 10.1242/jcs.088302; Haase K, 2013, CYTOSKELETON, V70, P494, DOI 10.1002/cm.21129; Hansen P, 2009, CONNECT TISSUE RES, V50, P211, DOI 10.1080/03008200802610040; Haycock JW, 2011, METHODS MOL BIOL, V695, P1, DOI 10.1007/978-1-60761-984-0_1; Hirayama K, 2013, BIOMATERIALS, V34, P2421, DOI 10.1016/j.biomaterials.2012.12.013; Hulbary RL, 1944, AM J BOT, V31, P561, DOI 10.2307/2437380; Hutter JL, 2005, J MICROSC-OXFORD, V219, P61, DOI 10.1111/j.1365-2818.2005.01497.x; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; ISHIHARA K, 1995, J BIOMED MATER RES, V29, P181, DOI 10.1002/jbm.820290207; Kasimir MT, 2003, INT J ARTIF ORGANS, V26, P421, DOI 10.1177/039139880302600508; Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587; Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1; Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j; Levy R, 2002, NANOTECHNOLOGY, V13, P33, DOI 10.1088/0957-4484/13/1/307; Lu TY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3307; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Manduca A, 2001, MED IMAGE ANAL, V5, P237, DOI 10.1016/S1361-8415(00)00039-6; Masoudi H., 2007, Canadian Biosystems Engineering, V49; McBane JE, 2011, BIOMATERIALS, V32, P6034, DOI 10.1016/j.biomaterials.2011.04.048; McBane JE, 2011, ACTA BIOMATER, V7, P115, DOI 10.1016/j.actbio.2010.08.014; Milotti E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013942; Modulevsky DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045329; Nakayama KH, 2010, TISSUE ENG PT A, V16, P2207, DOI [10.1089/ten.tea.2009.0602, 10.1089/ten.TEA.2009.0602]; Nilsen Timothy W, 2013, Cold Spring Harb Protoc, V2013, P579, DOI 10.1101/pdb.prot075176; Orlando G, 2011, TRANSPLANTATION, V91, P1310, DOI 10.1097/TP.0b013e318219ebb5; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Ou KL, 2011, J MECH BEHAV BIOMED, V4, P618, DOI 10.1016/j.jmbbm.2011.02.001; Owen SC, 2010, J BIOMED MATER RES A, V94A, P1321, DOI 10.1002/jbm.a.32834; Page H, 2013, CELL TISSUE RES, V352, P123, DOI 10.1007/s00441-012-1441-5; Pelling AE, 2009, CELL MOTIL CYTOSKEL, V66, P409, DOI 10.1002/cm.20391; Peng R, 2012, BIOMATERIALS, V33, P6008, DOI 10.1016/j.biomaterials.2012.05.010; Pertile RAN, 2012, J BIOMAT SCI-POLYM E, V23, P1339, DOI 10.1163/092050611X581516; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Puschmann TB, 2013, GLIA, V61, P432, DOI 10.1002/glia.22446; Rai R, 2011, MAT SCI ENG R, V72, P29, DOI 10.1016/j.mser.2010.11.002; Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017; Ross EA, 2009, J AM SOC NEPHROL, V20, P2338, DOI 10.1681/ASN.2008111196; Schaffner JH, 1916, OHIO J SCI, V16, P360; Schaner PJ, 2004, J VASC SURG, V40, P146, DOI 10.1016/j.jvs.2004.03.033; Schumann DA, 2009, CELLULOSE, V16, P877, DOI 10.1007/s10570-008-9264-y; Soares CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038147; Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005; Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049; Tee SY, 2011, BIOPHYS J, V100, pL25, DOI 10.1016/j.bpj.2010.12.3744; TERRY RA, 1969, J SCI FOOD AGR, V20, P317, DOI 10.1002/jsfa.2740200514; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Truernit E, 2008, PLANT CELL, V20, P1494, DOI 10.1105/tpc.107.056069; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; Versaevel M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1668; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; WATANABE K, 1993, CYTOTECHNOLOGY, V13, P107, DOI 10.1007/BF00749937; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Zdunek A, 2013, INS S	84	102	106	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97835	10.1371/journal.pone.0097835	http://dx.doi.org/10.1371/journal.pone.0097835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842603	gold, Green Submitted, Green Published			2022-12-25	WOS:000340948600080
J	El Ghamrasni, S; Cardoso, R; Halaby, MJ; Zeegers, D; Harding, S; Kumareswaran, R; Yavorska, T; Chami, N; Jurisicova, A; Sanchez, O; Hande, MP; Bristow, R; Hakem, R; Hakem, A				El Ghamrasni, S.; Cardoso, R.; Halaby, M. J.; Zeegers, D.; Harding, S.; Kumareswaran, R.; Yavorska, T.; Chami, N.; Jurisicova, A.; Sanchez, O.; Hande, M. P.; Bristow, R.; Hakem, R.; Hakem, A.			Cooperation of Blm and Mus81 in development, fertility, genomic integrity and cancer suppression	ONCOGENE			English	Article							DNA-DAMAGE; HOMOLOGOUS RECOMBINATION; DOWN-REGULATION; RECQ HELICASES; S-PHASE; ENDONUCLEASE; REPLICATION; REPAIR; PROMOTE; MEIOSIS	BLM is a DNA helicase important for the restart of stalled replication forks and for homologous recombination (HR) repair. Mutations of BLM lead to Bloom Syndrome, a rare autosomal recessive disorder characterized by elevated levels of sister chromatid exchanges (SCEs), dwarfism, immunodeficiency, infertility and increased cancer predisposition. BLM physically interacts with MUS81, an endonuclease involved in the restart of stalled replication forks and HR repair. Herein we report that loss of Mus81 in Blm hypomorph mutant mice leads to infertility, and growth and developmental defects that are not observed in single mutants. Double mutant cells and mice were hypersensitive to Mitomycin C and gamma-irradiation (IR) compared with controls and their repair of DNA double-strand breaks (DSBs) mediated by HR pathway was significantly defective, whereas their non-homologous-end-joining repair was elevated compared with controls. We also demonstrate the importance of the loss of the nuclease activity of Mus81 in the defects observed in Mus81(-/-) and double mutant cells. Exacerbated IR-induced chromosomal aberration was observed in double mutant mice and despite their reduced SCE levels, these mutants showed increased tumorigenesis risks. Our data highlight the importance of Mus81 and Blm in DNA DSB repair pathways, fertility, development and cancer.	[El Ghamrasni, S.; Cardoso, R.; Halaby, M. J.; Harding, S.; Kumareswaran, R.; Bristow, R.; Hakem, R.; Hakem, A.] Univ Toronto, Univ Hlth Network, Ontario Canc Inst, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [El Ghamrasni, S.; Chami, N.] Univ SMBA, Fac Sci DHEM, Lab Biotechnol, Fes, Morocco; [Zeegers, D.; Hande, M. P.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117548, Singapore; [Zeegers, D.; Hande, M. P.] Natl Univ Singapore, Tembusu Coll, Singapore 117548, Singapore; [Yavorska, T.; Jurisicova, A.] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Obstet & Gynecol & Physiol, Toronto, ON M5G 2M9, Canada; [Sanchez, O.] Univ Ontario, Inst Technol, Dept Pathol, Oshawa, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Sidi Mohamed Ben Abdellah University of Fez; National University of Singapore; National University of Singapore; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Ontario Tech University	Hakem, R (corresponding author), Univ Toronto, Univ Hlth Network, Ontario Canc Inst, Dept Med Biophys, 610 Univ Ave,10th Floor Room 622, Toronto, ON M5G 2M9, Canada.	rhakem@uhnres.utoronto.ca; ahakem@uhnres.utoronto.ca	Jurisicova, Andrea/E-4580-2013; Harding, Shane M/N-2377-2017; El Ghamrasni, Samah/AAA-1350-2022; Hande, M. Prakash/B-1645-2008	Harding, Shane M/0000-0002-5524-3566; El Ghamrasni, Samah/0000-0003-4346-1360; Hande, M. Prakash/0000-0002-4511-6256; Hakem, Razqallah/0000-0001-5948-7931; Bristow, Robert/0000-0002-8553-9544	Canadian Institute of Health Research	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	We thank G Brown, P McPherson, R Hill and A Koch for reviewing the manuscript and for their valuable comments and suggestions. This study was supported by the Canadian Institute of Health Research (R Hakem).	Boddy MN, 2000, MOL CELL BIOL, V20, P8758, DOI 10.1128/MCB.20.23.8758-8766.2000; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Bohgaki Toshiyuki, 2010, Genome Integr, V1, P15, DOI 10.1186/2041-9414-1-15; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chen XB, 2001, MOL CELL, V8, P1117, DOI 10.1016/S1097-2765(01)00375-6; Chester N, 2006, MOL CELL BIOL, V26, P6713, DOI 10.1128/MCB.00296-06; Chu WK, 2010, ONCOGENE, V29, P4705, DOI 10.1038/onc.2010.214; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; de los Santos T, 2003, GENETICS, V164, P81; de los Santos T, 2001, GENETICS, V159, P1511; De Muyt A, 2012, MOL CELL, V46, P43, DOI 10.1016/j.molcel.2012.02.020; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Dendouga N, 2005, MOL CELL BIOL, V25, P7569, DOI 10.1128/MCB.25.17.7569-7579.2005; El Ghamrasni S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001385; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Higgins JD, 2008, PLANT J, V54, P152, DOI 10.1111/j.1365-313X.2008.03403.x; Hiyama T, 2006, NUCLEIC ACIDS RES, V34, P880, DOI 10.1093/nar/gkj495; Hoadley KA, 2012, P NATL ACAD SCI USA, V109, P4437, DOI 10.1073/pnas.1117279109; Holloway JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000186; Interthal H, 2000, MOL GEN GENET, V263, P812, DOI 10.1007/s004380000241; Klein HL, 2012, CELL, V149, P257, DOI 10.1016/j.cell.2012.03.020; LaRocque JR, 2010, MOL CELL BIOL, V30, P1887, DOI 10.1128/MCB.01553-09; Loizidou MA, BREAST CANC RES TREA, V121, P147; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Mao ZY, 2009, NEOPLASIA, V11, P683, DOI 10.1593/neo.09312; Matulova P, 2009, J BIOL CHEM, V284, P7733, DOI 10.1074/jbc.M806192200; Mazina OM, 2008, P NATL ACAD SCI USA, V105, P18249, DOI 10.1073/pnas.0807016105; McPherson JP, 2004, SCIENCE, V304, P1822, DOI 10.1126/science.1094557; McPherson JP, 2004, EMBO J, V23, P3677, DOI 10.1038/sj.emboj.7600371; Mullen JR, 2001, GENETICS, V157, P103; Munoz-Galvan S, 2012, MOL CELL BIOL, V32, P1592, DOI 10.1128/MCB.00111-12; Naim V, 2013, NAT CELL BIOL, V15, P1008, DOI 10.1038/ncb2793; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Oh SD, 2008, MOL CELL, V31, P324, DOI 10.1016/j.molcel.2008.07.006; Ouyang KJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000252; Pamidi A, 2007, CANCER RES, V67, P8527, DOI 10.1158/0008-5472.CAN-07-1161; Sengupta S, 2004, J CELL BIOL, V166, P801, DOI 10.1083/jcb.200405128; Shimura T, 2008, J MOL BIOL, V375, P1152, DOI 10.1016/j.jmb.2007.11.006; Singh DK, 2009, BIOGERONTOLOGY, V10, P235, DOI 10.1007/s10522-008-9205-z; Smith GR, 2003, GENETICS, V165, P2289; So S, 2004, J BIOL CHEM, V279, P55433, DOI 10.1074/jbc.M409827200; Szakal B, 2013, EMBO J, V32, P1155, DOI 10.1038/emboj.2013.67; Taylor ER, 2008, P NATL ACAD SCI USA, V105, P3757, DOI 10.1073/pnas.0710291105; Theunissen JWF, 2006, METHOD ENZYMOL, V409, P251, DOI 10.1016/S0076-6879(05)09015-4; Tripathi V, 2008, CARCINOGENESIS, V29, P52, DOI 10.1093/carcin/bgm238; Trowbridge K, 2007, GENETICS, V176, P1993, DOI 10.1534/genetics.106.070060; Wechsler T, 2011, NATURE, V471, P642, DOI 10.1038/nature09790; Wu F, 2008, CANCER-AM CANCER SOC, V112, P2002, DOI 10.1002/cncr.23396; Wu F, 2011, CANCER SCI, V102, P472, DOI 10.1111/j.1349-7006.2010.01790.x; Wu F, 2010, ANTICANCER RES, V30, P5011; Ying SM, 2013, NAT CELL BIOL, V15, P1001, DOI 10.1038/ncb2773; Zakharyevich K, 2012, CELL, V149, P334, DOI 10.1016/j.cell.2012.03.023; Zhang R, 2005, CANCER RES, V65, P2526, DOI 10.1158/0008-5472.CAN-04-2421	56	12	12	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 2	2015	34	14					1780	1789		10.1038/onc.2014.121	http://dx.doi.org/10.1038/onc.2014.121			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CE9IQ	24858046				2022-12-25	WOS:000352158000005
J	Altamirano, F; Eltit, JM; Robin, G; Linares, N; Ding, XD; Pessah, IN; Allen, PD; Lopez, JR				Altamirano, Francisco; Eltit, Jose M.; Robin, Gaelle; Linares, Nancy; Ding, Xudong; Pessah, Isaac N.; Allen, Paul D.; Lopez, Jose R.			Ca2+ Influx via the Na+/Ca2+ Exchanger Is Enhanced in Malignant Hyperthermia Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGE; TRANSVERSE TUBULES; EXTERNAL SODIUM; FROG; FIBERS; RYR1; ATPASE; CONTRACTION; DEPRIVATION; INHIBITOR	Malignant hyperthermia (MH) is potentially fatal pharmacogenetic disorder of skeletal muscle caused by intracellular Ca2+ dysregulation. NCX is a bidirectional transporter that effluxes (forward mode) or influxes (reverse mode) Ca2+ depending on cellular activity. Resting intracellular calcium ([Ca2+](r)) and sodium ([Na+](r)) concentrations are elevated in MH susceptible (MHS) swine and murine muscles compared with their normal (MHN) counterparts, although the contribution of NCX is unclear. Lowering [Na+](e) elevates [Ca2+](r) in both MHN and MHS swine muscle fibers and it is prevented by removal of extracellular Ca2+ or reduced by t-tubule disruption, in both genotypes. KB-R7943, a nonselective NCX3 blocker, reduced [Ca2+](r) in both swine and murine MHN and MHS muscle fibers at rest and decreased the magnitude of the elevation of [Ca2+](r) observed in MHS fibers after exposure to halothane. YM-244769, a high affinity reverse mode NCX3 blocker, reduces [Ca2+](r) in MHS muscle fibers and decreases the amplitude of [Ca2+](r) rise triggered by halothane, but had no effect on [Ca2+](r) in MHN muscle. In addition, YM-244769 reduced the peak and area under the curve of the Ca2+ transient elicited by high [K+](e) and increased its rate of decay in MHS muscle fibers. siRNA knockdown of NCX3 in MHS myotubes reduced [Ca2+](r) and the Ca2+ transient area induced by high [K+](e). These results demonstrate a functional NCX3 in skeletal muscle whose activity is enhanced in MHS. Moreover reverse mode NCX3 contributes to the Ca2+ transients associated with K+-induced depolarization and the halothane-triggered MH episode in MHS muscle fibers.	[Altamirano, Francisco; Robin, Gaelle; Pessah, Isaac N.; Allen, Paul D.; Lopez, Jose R.] Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA; [Linares, Nancy; Lopez, Jose R.] Inst Venezolano Invest Cient, Ctr Biofis & Bioquim, Caracas 1020A, Venezuela; [Eltit, Jose M.; Ding, Xudong; Allen, Paul D.; Lopez, Jose R.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Eltit, Jose M.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23298 USA	University of California System; University of California Davis; Venezuelan Institute Science Research; Harvard University; Brigham & Women's Hospital; Virginia Commonwealth University	Lopez, JR (corresponding author), Univ Calif Davis, Dept Mol Biosci, 1089 Vet Med Dr, Davis, CA 95616 USA.	jrlopez@ucdavis.edu	Pessah, Isaac N/K-7985-2017; Altamirano, Francisco/I-1928-2013	Pessah, Isaac N/0000-0002-8149-588X; Altamirano, Francisco/0000-0002-1612-2729	National Institutes of Health [AR43140, AR052534, 4P42 ES04699]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR052354, R01AR043140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR43140 (to P. D. A., J. R. L., and I. N. P.), AR052534 (to P. D. A. and J. R. L.), and 4P42 ES04699 (to I. N. P.).	Akabas MH, 2004, MOL PHARMACOL, V66, P8, DOI 10.1124/mol.104.000232.; ARMSTRONG CM, 1972, BIOCHIM BIOPHYS ACTA, V267, P605, DOI 10.1016/0005-2728(72)90194-6; Barrientos G, 2009, MOL PHARMACOL, V76, P560, DOI 10.1124/mol.109.057265; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; BLINKS JR, 1965, J PHYSIOL-LONDON, V177, P42, DOI 10.1113/jphysiol.1965.sp007574; BOLANOS P, 1986, J PHYSIOL-LONDON, V370, P39, DOI 10.1113/jphysiol.1986.sp015921; CAPUTO C, 1978, J MEMBRANE BIOL, V41, P1, DOI 10.1007/BF01873337; CAPUTO C, 1967, J GEN PHYSIOL, V50, P2177, DOI 10.1085/jgp.50.9.2177; CASTILLO E, 1991, ANN NY ACAD SCI, V639, P554, DOI 10.1111/j.1749-6632.1991.tb17349.x; Cifuentes F, 2000, AM J PHYSIOL-CELL PH, V279, pC89, DOI 10.1152/ajpcell.2000.279.1.C89; COTA G, 1981, J PHYSIOL-LONDON, V317, P303, DOI 10.1113/jphysiol.1981.sp013826; DAVEY DF, 1980, J MEMBRANE BIOL, V53, P223, DOI 10.1007/BF01868828; Despa S, 2003, BIOPHYS J, V85, P3388, DOI 10.1016/S0006-3495(03)74758-4; Deval E, 2002, NEUROMUSCULAR DISORD, V12, P665, DOI 10.1016/S0960-8966(02)00022-6; DONOSO P, 1989, BIOCHIM BIOPHYS ACTA, V978, P8, DOI 10.1016/0005-2736(89)90491-4; EDMAN KAP, 1982, J PHYSIOL-LONDON, V329, P1; EISENBERG B, 1968, SCIENCE, V160, P1243, DOI 10.1126/science.160.3833.1243; Eltit JM, 2013, FASEB J, V27, P991, DOI 10.1096/fj.12-218354; Eltit JM, 2012, P NATL ACAD SCI USA, V109, P7923, DOI 10.1073/pnas.1119207109; Esteve E, 2010, J GEN PHYSIOL, V135, P619, DOI 10.1085/jgp.200910328; EVERTS ME, 1992, MUSCLE NERVE, V15, P162, DOI 10.1002/mus.880150206; FORD LE, 1972, J PHYSIOL-LONDON, V223, P21, DOI 10.1113/jphysiol.1972.sp009831; Fraysse B, 2001, AM J PHYSIOL-CELL PH, V280, pC146, DOI 10.1152/ajpcell.2001.280.1.C146; GARCIA MC, 1992, J MUSCLE RES CELL M, V13, P354, DOI 10.1007/BF01766463; GILBERT JR, 1982, J MEMBRANE BIOL, V69, P77, DOI 10.1007/BF01871244; GODT RE, 1974, J GEN PHYSIOL, V63, P722, DOI 10.1085/jgp.63.6.722; GonzalezSerratos H, 1996, ANN NY ACAD SCI, V779, P556, DOI 10.1111/j.1749-6632.1996.tb44837.x; HIDALGO C, 1991, ANN NY ACAD SCI, V639, P483; HODGKIN AL, 1957, J PHYSIOL-LONDON, V137, pP30; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hurst RS, 1998, FEBS LETT, V422, P333, DOI 10.1016/S0014-5793(98)00035-0; IAIZZO PA, 1988, PFLUG ARCH EUR J PHY, V411, P648, DOI 10.1007/BF00580861; Iwamoto T, 1996, J BIOL CHEM, V271, P22391, DOI 10.1074/jbc.271.37.22391; Iwamoto T, 2006, MOL PHARMACOL, V70, P2075, DOI 10.1124/mol.106.028464; JUEL C, 1995, BBA-MOL CELL RES, V1265, P127, DOI 10.1016/0167-4889(94)00209-W; Jurkat-Rott K, 2000, MUSCLE NERVE, V23, P4, DOI 10.1002/(SICI)1097-4598(200001)23:1<4::AID-MUS3>3.0.CO;2-D; KAWATA H, 1990, JPN J PHYSIOL, V40, P243, DOI 10.2170/jjphysiol.40.243; Kraft R, 2007, BIOCHEM BIOPH RES CO, V361, P230, DOI 10.1016/j.bbrc.2007.07.019; LI ZP, 1994, J BIOL CHEM, V269, P17434; LOPEZ JR, 1988, MUSCLE NERVE, V11, P82; LOPEZ JR, 1985, MUSCLE NERVE, V8, P355, DOI 10.1002/mus.880080502; LOPEZ JR, 1983, BIOPHYS J, V43, P1, DOI 10.1016/S0006-3495(83)84316-1; LUTTGAU HC, 1979, J PHYSIOL-LONDON, V296, P411; Mackiewicz U, 2009, CARDIOVASC RES, V81, P546, DOI 10.1093/cvr/cvn285; Manno C, 2013, J PHYSIOL-LONDON, V591, P4439, DOI 10.1113/jphysiol.2013.259572; Meme W, 1999, PFLUG ARCH EUR J PHY, V438, P851, DOI 10.1007/s004240051115; MIURA Y, 1989, J GEN PHYSIOL, V93, P1129, DOI 10.1085/jgp.93.6.1129; Monnier N, 1997, AM J HUM GENET, V60, P1316, DOI 10.1086/515454; MUNIZ J, 1991, ANN NY ACAD SCI, V639, P573, DOI 10.1111/j.1749-6632.1991.tb17354.x; NAKAMURA H, 1992, J BIOCHEM, V112, P750, DOI 10.1093/oxfordjournals.jbchem.a123970; Nelson Thomas E., 2002, Current Molecular Medicine (Hilversum), V2, P347, DOI 10.2174/1566524023362429; Nicoll DA, 1996, J BIOL CHEM, V271, P24914, DOI 10.1074/jbc.271.40.24914; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Sacchetto R, 1996, EUR J BIOCHEM, V237, P483, DOI 10.1111/j.1432-1033.1996.0483k.x; VOGELI P, 1994, ANIM GENET, V25, P59, DOI 10.1111/j.1365-2052.1994.tb00404.x; Wanaverbecq N, 2003, J PHYSIOL-LONDON, V550, P83, DOI 10.1113/jphysiol.2002.035782; Watano T, 1996, BRIT J PHARMACOL, V119, P555, DOI 10.1111/j.1476-5381.1996.tb15708.x; WICTOME M, 1992, FEBS LETT, V304, P109, DOI 10.1016/0014-5793(92)80599-C; WUYTACK F, 1992, ANN NY ACAD SCI, V671, P82, DOI 10.1111/j.1749-6632.1992.tb43786.x; Yang TZ, 2006, ANESTHESIOLOGY, V105, P1164, DOI 10.1097/00000542-200612000-00016; Yang T, 2007, J BIOL CHEM, V282, P37471, DOI 10.1074/jbc.M701379200; Yang TZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1591, DOI 10.1152/ajpcell.00133.2006; YU ASL, 1992, AM J PHYSIOL, V263, pF680, DOI 10.1152/ajprenal.1992.263.4.F680	64	22	23	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19180	19190		10.1074/jbc.M114.550764	http://dx.doi.org/10.1074/jbc.M114.550764			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24847052	Green Published, hybrid			2022-12-25	WOS:000339062900046
J	Fiebig, T; Freiberger, F; Pinto, V; Romano, MR; Black, A; Litschko, C; Bethe, A; Yashunsky, D; Adamo, R; Nikolaev, A; Berti, F; Gerardy-Schahn, R				Fiebig, Timm; Freiberger, Friedrich; Pinto, Vittoria; Romano, Maria Rosaria; Black, Alan; Litschko, Christa; Bethe, Andrea; Yashunsky, Dmitry; Adamo, Roberto; Nikolaev, Andrei; Berti, Francesco; Gerardy-Schahn, Rita			Molecular Cloning and Functional Characterization of Components of the Capsule Biosynthesis Complex of Neisseria meningitidis Serogroup A TOWARD IN VITRO VACCINE PRODUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C MENINGOCOCCAL POLYSACCHARIDES; CONJUGATE VACCINE; BIOCHEMICAL-CHARACTERIZATION; GLYCOCONJUGATE VACCINES; ESCHERICHIA-COLI; GENE RECOGNITION; HUMAN IMMUNITY; O-ACETYLATION; ACETYLTRANSFERASE; AFRICA	The human pathogen Neisseria meningitidis (Nm) is a leading cause of bacterial meningitis and sepsis globally. A major virulence factor of Nm is the capsular polysaccharide (CPS), which in Nm serogroup A consists of N-acetyl-mannosamine-1-phosphate units linked together by phosphodiester linkages [-> 6)-alpha-D-ManNAc-(1 -> OPO3-->](n). Acetylation in O-3 (to a minor extent in O-4) position results in immunologically active polymer. In the capsule gene cluster (cps) of Nm, region A contains the genetic information for CPSA biosynthesis. Thereby the open reading frames csaA, -B, and -C are thought to encode the UDP-N-acetyl-D-glucosamine-2-epimerase, poly-ManNAc-1-phosphate- transferase, and O-acetyltransferase, respectively. With the aim to use a minimal number of recombinant enzymes to produce immunologically active CPSA, we cloned the genes csaA, csaB, and csaC and functionally characterized the purified recombinant proteins. If recombinant CsaA and CsaB were combined in one reaction tube, priming CPSA-oligosaccharides were efficiently elongated with UDP-GlcNAc as the donor substrate, confirming that CsaA is the functional UDP-N-acetyl-D-glucosamine-2-epimerase and CsaB the functional poly-ManNAc-1-phosphate-transferase. Subsequently, CsaB was shown to transfer ManNAc-1P onto O-6 of the non-reducing end sugar of priming oligosaccharides, to prefer non-O-acetylated over O-acetylated primers, and to efficiently elongate the dimer of ManNAc-1-phosphate. The in vitro synthesized CPSA was purified, O-acetylated with recombinant CsaC, and proven to be identical to the natural CPSA by H-1 NMR, P-31 NMR, and immunoblotting. If all three enzymes and their substrates were combined in a one-pot reaction, nature identical CPSA was obtained. These data provide the basis for the development of novel vaccine production protocols.	[Fiebig, Timm; Freiberger, Friedrich; Litschko, Christa; Bethe, Andrea; Gerardy-Schahn, Rita] Hannover Med Sch, Inst Cellular Chem, D-30625 Hannover, Germany; [Pinto, Vittoria; Romano, Maria Rosaria; Adamo, Roberto; Berti, Francesco] Novartis Vaccines, Res, I-53100 Siena, Italy; [Black, Alan; Nikolaev, Andrei] Univ Dundee, Coll Life Sci, Dundee DD1 5EH, Scotland; [Yashunsky, Dmitry] Russian Acad Med Sci, Inst Biomed Chem, Moscow 119832, Russia	Hannover Medical School; Novartis; University of Dundee; Russian Academy of Medical Sciences; Institute of Biomedical Chemistry	Berti, F (corresponding author), Novartis Vaccines, Res, Via Fiorentina 1, I-53100 Siena, Italy.	francesco.berti@novartis.com; gerardy-schahn.rita@mh-hannover.de	Adamo, Roberto/Q-9284-2017	Adamo, Roberto/0000-0001-5228-6088; Fiebig, Timm/0000-0002-2021-7296; Litschko, Christa/0000-0001-9114-4832	Deutsche Forschungsgemeinschaft (DFG) [Ge801/10-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) in the framework of DFG Research Unit 548 (Ge801/10-1).	Bardotti A, 2008, VACCINE, V26, P2284, DOI 10.1016/j.vaccine.2008.01.022; Bergfeld AK, 2007, J BIOL CHEM, V282, P22217, DOI 10.1074/jbc.M703044200; Bergfeld AK, 2009, J BIOL CHEM, V284, P6, DOI 10.1074/jbc.M807518200; Berry DS, 2002, INFECT IMMUN, V70, P3707, DOI 10.1128/IAI.70.7.3707-3713.2002; Berti F, 2012, VACCINE, V30, P6409, DOI 10.1016/j.vaccine.2012.08.021; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Black A., 2010, 4 BALT M MICR CARB S, P56; Black A., 2011, 16 EUR CARB S JUL 3, P61; BORODOVSKY M, 1993, COMPUT CHEM, V17, P123, DOI 10.1016/0097-8485(93)85004-V; BUNDLE DR, 1974, J BIOL CHEM, V249, P2275; Caini S, 2013, VACCINE, V31, P1597, DOI 10.1016/j.vaccine.2013.01.015; Chang R, 2004, CARBOHYD RES, V339, P1531, DOI 10.1016/j.carres.2004.03.014; Costantino P, 2011, EXPERT OPIN DRUG DIS, V6, P1045, DOI 10.1517/17460441.2011.609554; Djingarey MH, 2012, VACCINE, V30, pB40, DOI 10.1016/j.vaccine.2011.12.073; Fiebig T, 2014, GLYCOBIOLOGY, V24, P150, DOI 10.1093/glycob/cwt102; Frasch CE, 2012, HUM VACC IMMUNOTHER, V8, P715, DOI 10.4161/hv.19619; Freiberger F, 2007, MOL MICROBIOL, V65, P1258, DOI 10.1111/j.1365-2958.2007.05862.x; GOTSCHLICH EC, 1969, J EXP MED, V129, P1349, DOI 10.1084/jem.129.6.1349; GOTSCHLICH EC, 1969, J EXP MED, V129, P1367, DOI 10.1084/jem.129.6.1367; Gudlavalleti SK, 2004, J BIOL CHEM, V279, P42765, DOI 10.1074/jbc.M313552200; Harrison OB, 2013, EMERG INFECT DIS, V19, P566, DOI 10.3201/eid1904.111799; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Keys TG, 2012, ANAL BIOCHEM, V427, P107, DOI 10.1016/j.ab.2012.05.011; Kristiansen PA, 2013, CLIN INFECT DIS, V56, P354, DOI 10.1093/cid/cis892; LaForce FM, 2011, HEALTH AFFAIR, V30, P1049, DOI 10.1377/hlthaff.2011.0328; LAI ECK, 1994, BIOCHEMISTRY-US, V33, P14743, DOI 10.1021/bi00253a012; Lemercinier X, 1996, CARBOHYD RES, V296, P83, DOI 10.1016/S0008-6215(96)00253-4; LIU TY, 1971, J BIOL CHEM, V246, P2849; McCarthy PC, 2013, GLYCOCONJUGATE J, V30, P857, DOI 10.1007/s10719-013-9490-x; MIN H, 1986, ANAL BIOCHEM, V155, P275, DOI 10.1016/0003-2697(86)90437-9; Muindi KM, 2014, GLYCOBIOLOGY, V24, P139, DOI 10.1093/glycob/cwt091; Nikolaev A. V., 2011, CARB GORD RES C JUN, P4; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Peterson DC, 2011, J BACTERIOL, V193, P1576, DOI 10.1128/JB.00924-10; Ravenscroft N, 1999, VACCINE, V17, P2802, DOI 10.1016/S0264-410X(99)00092-4; Roberts L, 2010, SCIENCE, V330, P1466, DOI 10.1126/science.330.6010.1466; Romanow A, 2013, J BIOL CHEM, V288, P11718, DOI 10.1074/jbc.M113.452276; Sala RF, 1996, J AM CHEM SOC, V118, P3033, DOI 10.1021/ja960266z; Schwarzer D, 2009, J BIOL CHEM, V284, P9465, DOI 10.1074/jbc.M808475200; Sperisen P, 2005, PLOS COMPUT BIOL, V1, P492, DOI 10.1371/journal.pcbi.0010063; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Stephens DS, 2009, VACCINE, V27, pB71, DOI 10.1016/j.vaccine.2009.04.070; Swartley JS, 1998, J BACTERIOL, V180, P1533, DOI 10.1128/JB.180.6.1533-1539.1998; Villalobos A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-285; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002	45	32	32	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19395	19407		10.1074/jbc.M114.575142	http://dx.doi.org/10.1074/jbc.M114.575142			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24849599	Green Published, hybrid			2022-12-25	WOS:000339326800016
J	Kalamajski, S; Liu, CP; Tillgren, V; Rubin, K; Oldberg, A; Rai, J; Weis, M; Eyre, DR				Kalamajski, Sebastian; Liu, Cuiping; Tillgren, Viveka; Rubin, Kristofer; Oldberg, Ake; Rai, Jyoti; Weis, MaryAnn; Eyre, David R.			Increased C-telopeptide Cross-linking of Tendon Type I Collagen in Fibromodulin-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUMICAN-NULL MICE; TARGETED DISRUPTION; DECORIN; FIBRILLOGENESIS; BINDING; FIBRILS; PROTEOGLYCAN; MUTATIONS; KERATOCAN; BIGLYCAN	The controlled assembly of collagen monomers into fibrils, with accompanying intermolecular cross-linking by lysyl oxidase-mediated bonds, is vital to the structural and mechanical integrity of connective tissues. This process is influenced by collagen-associated proteins, including small leucine-rich proteins (SLRPs), but the regulatory mechanisms are not well understood. Deficiency in fibromodulin, an SLRP, causes abnormal collagen fibril ultrastructure and decreased mechanical strength in mouse tendons. In this study, fibromodulin deficiency rendered tendon collagen more resistant to nonproteolytic extraction. The collagen had an increased and altered cross-linking pattern at an early stage of fibril formation. Collagen extracts contained a higher proportion of stably crosslinked alpha 1(I) chains as a result of their C-telopeptide lysines being more completely oxidized to aldehydes. The findings suggest that fibromodulin selectively affects the extent and pattern of lysyl oxidase-mediated collagen cross-linking by sterically hindering access of the enzyme to telopeptides, presumably through binding to the collagen. Such activity implies a broader role for SLRP family members	[Kalamajski, Sebastian; Tillgren, Viveka] Lund Univ, Dept Clin Sci, SE-22184 Lund, Sweden; [Liu, Cuiping; Rubin, Kristofer; Oldberg, Ake] Lund Univ, Dept Expt Med Sci, S-22184 Lund, Sweden; [Rubin, Kristofer] Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Rai, Jyoti; Weis, MaryAnn; Eyre, David R.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA	Lund University; Lund University; Uppsala University; University of Washington; University of Washington Seattle	Kalamajski, S (corresponding author), Lund Univ, Dept Clin Sci, BMC C12,Klinikgatan 28, S-22184 Lund, Sweden.	Sebastian.Kalamajski@med.lu.se	Rubin, Kristofer/AAC-1810-2020	Rubin, Kristofer/0000-0003-2789-6276; Kalamajski, Sebastian/0000-0002-6600-9302	National Institutes of Health Grants [AR036794, AR037318]; Swedish Research Council; Swedish Cancer Foundation; Crafoord Foundation; King Gustaf V's 80th Anniversary Fund; Magnus Bergvall Foundation; Ake Wiberg Foundation; Greta and Johan Kock's Foundation; Alfred Osterlund's Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR037318, R01AR036794, R37AR037318, R37AR036794] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Crafoord Foundation; King Gustaf V's 80th Anniversary Fund; Magnus Bergvall Foundation; Ake Wiberg Foundation; Greta and Johan Kock's Foundation; Alfred Osterlund's Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR036794 and AR037318 (to D. R. E.). This work was also supported by grants from the Swedish Research Council, Swedish Cancer Foundation, Crafoord Foundation, King Gustaf V's 80th Anniversary Fund, Magnus Bergvall Foundation, Ake Wiberg Foundation, Greta and Johan Kock's Foundation, and Alfred Osterlund's Foundation.	Chakravarti S, 2000, INVEST OPHTH VIS SCI, V41, P3365; CUTRONEO KR, 1975, MOL PHARMACOL, V11, P632; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Eyre DR, 2011, J BIOL CHEM, V286, P7732, DOI 10.1074/jbc.C110.195768; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; FLANDIN F, 1984, BIOCHIM BIOPHYS ACTA, V791, P205, DOI 10.1016/0167-4838(84)90010-4; Font B, 1998, EUR J BIOCHEM, V254, P580, DOI 10.1046/j.1432-1327.1998.2540580.x; Fust A, 2005, AM J PHYSIOL-LUNG C, V288, pL159, DOI 10.1152/ajplung.00089.2004; Gill MR, 2002, OSTEOARTHR CARTILAGE, V10, P751, DOI 10.1053/joca.2002.0527; Hanson DA, 1996, J BIOL CHEM, V271, P26508, DOI 10.1074/jbc.271.43.26508; HEDBOM E, 1989, J BIOL CHEM, V264, P6898; HORGAN DJ, 1990, ARCH BIOCHEM BIOPHYS, V281, P21, DOI 10.1016/0003-9861(90)90407-P; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; Kalamajski S, 2007, J BIOL CHEM, V282, P26740, DOI 10.1074/jbc.M704026200; Kalamajski S, 2007, J BIOL CHEM, V282, P16062, DOI 10.1074/jbc.M700073200; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Kalamajski S, 2009, BIOCHEM J, V423, P53, DOI 10.1042/BJ20090542; Kalamajski S, 2009, J BIOL CHEM, V284, P534, DOI 10.1074/jbc.M805721200; Koyama H, 1996, CELL, V87, P1069, DOI 10.1016/S0092-8674(00)81801-2; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Liu CY, 2003, J BIOL CHEM, V278, P21672, DOI 10.1074/jbc.M301169200; MILLER EJ, 1982, METHOD ENZYMOL, V82, P33; Oldberg A, 2007, P NATL ACAD SCI USA, V104, P13966, DOI 10.1073/pnas.0702014104; Pellegata NS, 2000, NAT GENET, V25, P91, DOI 10.1038/75664; Schlessinger J, 1997, CELL, V91, P869, DOI 10.1016/S0092-8674(00)80477-8; Schwarze U, 2013, HUM MOL GENET, V22, P1, DOI 10.1093/hmg/dds371; Sini P, 1997, GLYCOCONJUGATE J, V14, P871, DOI 10.1023/A:1018550307649; Stamov DR, 2013, J STRUCT BIOL, V183, P394, DOI 10.1016/j.jsb.2013.05.022; Svensson L, 2000, FEBS LETT, V470, P178, DOI 10.1016/S0014-5793(00)01314-4; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; WU JJ, 1992, J BIOL CHEM, V267, P23007; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746; Yeh JT, 2010, BRIT J DERMATOL, V163, P1174, DOI 10.1111/j.1365-2133.2010.10008.x; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776; Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200	37	46	46	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18873	18879		10.1074/jbc.M114.572941	http://dx.doi.org/10.1074/jbc.M114.572941			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24849606	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000339062900021
J	Porsch, H; Mehic, M; Olofsson, B; Heldin, P; Heldin, CH				Porsch, Helena; Mehic, Merima; Olofsson, Berit; Heldin, Paraskevi; Heldin, Carl-Henrik			Platelet-derived Growth Factor beta-Receptor, Transforming Growth Factor beta Type I Receptor, and CD44 Protein Modulate Each Other's Signaling and Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; EPITHELIAL-CELLS; TUMOR-CELLS; PROXIMITY LIGATION; CARCINOMA-CELLS; BREAST-CANCER; PDGF; ACTIVATION; INTEGRIN; PROLIFERATION	Growth factors, such as platelet-derived growth factor BB (PDGF-BB) and transforming growth factor beta(TGF beta), are key regulators of cellular functions, including proliferation, migration, and differentiation. Growth factor signaling is modulated by context-dependent cross-talk between different signaling pathways. We demonstrate in this study that PDGF-BB induces phosphorylation of Smad2, a downstream mediator of the canonical TGF beta pathway, in primary dermal fibroblasts. The PDGF-BB-mediated Smad2 phosphorylation was dependent on the kinase activities of both TGF beta type I receptor (T beta RI) and PDGF beta-receptor (PDGFR beta), and it was prevented by inhibitory antibodies against TGF beta. Inhibition of the activity of the T beta RI kinase greatly reduced the PDGF-BB-dependent migration in dermal fibroblasts. Moreover, we demonstrate that the receptors for PDGF-BB and TGF beta interact physically in primary dermal fibroblasts and that stimulation with PDGF-BB induces internalization not only of PDGFR beta but also of T beta RI. In addition, silencing of PDGFR beta by siRNA decreased the stability of T beta RI and delayed TGF beta-induced signaling. We further show that the hyaluronan receptor CD44 interacts with both PDGFR beta and T beta RI. Depletion of CD44 by siRNA increased signaling via PDGFR beta and T beta RI by stabilizing the receptor proteins. Our data suggest that cross-talk between PDGFR beta and T beta RI occurs in dermal fibroblasts and that CD44 negatively modulates signaling via these receptors.	[Porsch, Helena; Mehic, Merima; Olofsson, Berit; Heldin, Paraskevi; Heldin, Carl-Henrik] Uppsala Univ, Ludwig Inst Canc Res, Biomed Ctr, Sci Life Lab, SE-75124 Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University	Heldin, P (corresponding author), Uppsala Univ, Ludwig Inst Canc Res, Biomed Ctr, Sci Life Lab, Box 595, SE-75124 Uppsala, Sweden.	Evi.Heldin@LICR.uu.se; C-H.Heldin@LICR.uu.se		Mehic, Merima/0000-0001-8249-5526	Swedish Cancer Society; Agnes and Mac Rudberg Foundation; Gurli and Edward Brunnberg Foundation	Swedish Cancer Society(Swedish Cancer Society); Agnes and Mac Rudberg Foundation; Gurli and Edward Brunnberg Foundation	This work was supported in part by grants from the Swedish Cancer Society, the Agnes and Mac Rudberg Foundation, and the Gurli and Edward Brunnberg Foundation.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; BATTEGAY EJ, 1990, CELL, V63, P515, DOI 10.1016/0092-8674(90)90448-N; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Ding Q, 2003, J BIOL CHEM, V278, P39882, DOI 10.1074/jbc.M304685200; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Gotzmann J, 2006, ONCOGENE, V25, P3170, DOI 10.1038/sj.onc.1209083; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hellberg C, 2009, MOL BIOL CELL, V20, P2856, DOI 10.1091/mbc.E08-12-1228; Ishigaki T, 2011, J CELL PHYSIOL, V226, P2617, DOI 10.1002/jcp.22614; Ito T, 2004, J BIOL CHEM, V279, P25326, DOI 10.1074/jbc.M403135200; Ito T, 2004, AM J PATHOL, V164, P1979, DOI 10.1016/S0002-9440(10)63758-3; JALKANEN S, 1987, J CELL BIOL, V105, P983, DOI 10.1083/jcb.105.2.983; Jarvius M, 2007, MOL CELL PROTEOMICS, V6, P1500, DOI 10.1074/mcp.M700166-MCP200; Jechlinger M, 2003, ONCOGENE, V22, P7155, DOI 10.1038/sj.onc.1206887; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; Karlsson S, 2006, MOL BIOL CELL, V17, P4846, DOI 10.1091/mbc.E06-04-0306; Kim Y, 2008, J BIOL CHEM, V283, P22513, DOI 10.1074/jbc.M708319200; Kovalenko M, 2000, J BIOL CHEM, V275, P16219, DOI 10.1074/jbc.275.21.16219; Lammich S, 2002, J BIOL CHEM, V277, P44754, DOI 10.1074/jbc.M206872200; Lee JL, 2009, J CELL BIOL, V185, P949, DOI 10.1083/jcb.200812060; Li LL, 2006, J BIOL CHEM, V281, P26512, DOI 10.1074/jbc.M605607200; Ludbrook SB, 2003, BIOCHEM J, V369, P311, DOI 10.1042/BJ20020809; LYONS RM, 1988, J CELL BIOL, V106, P1659, DOI 10.1083/jcb.106.5.1659; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Moustakas A, 2014, BBA-GEN SUBJECTS, V1840, P2621, DOI 10.1016/j.bbagen.2014.02.004; MURRAYRUST J, 1993, STRUCTURE, V1, P153, DOI 10.1016/0969-2126(93)90029-G; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Piek E, 1999, J CELL SCI, V112, P4557; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; SEYMOUR L, 1993, BREAST CANCER RES TR, V26, P247, DOI 10.1007/BF00665802; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SHIBANAKA Y, 1994, BIOCHEM BIOPH RES CO, V198, P613, DOI 10.1006/bbrc.1994.1089; Skandalis SS, 2010, IUBMB LIFE, V62, P833, DOI 10.1002/iub.392; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Steller EJA, 2013, NEOPLASIA, V15, P204, DOI 10.1593/neo.121726; Toole BP, 2009, CLIN CANCER RES, V15, P7462, DOI 10.1158/1078-0432.CCR-09-0479; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Wakahara K, 2005, J CELL BIOCHEM, V94, P995, DOI 10.1002/jcb.20364; Woodard AS, 1998, J CELL SCI, V111, P469; Yao DY, 2002, MOL BIOL CELL, V13, P4001, DOI 10.1091/mbc.02-07-0104; Yu Q, 2004, CLIN EXP METASTAS, V21, P235, DOI 10.1023/B:CLIN.0000037705.25256.d3; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Yu Q, 2000, GENE DEV, V14, P163; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	58	47	47	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19747	19757		10.1074/jbc.M114.547273	http://dx.doi.org/10.1074/jbc.M114.547273			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24860093	Green Published, hybrid			2022-12-25	WOS:000339326800046
J	Samarelli, AV; Riccitelli, E; Bizzozero, L; Silveira, TN; Seano, G; Pergolizzi, M; Vitagliano, G; Cascone, I; Carpentier, G; Bottos, A; Primo, L; Bussolino, F; Arese, M				Samarelli, Anna Valeria; Riccitelli, Elena; Bizzozero, Laura; Silveira, Tatiana Nunes; Seano, Giorgio; Pergolizzi, Margherita; Vitagliano, Grazia; Cascone, Ilaria; Carpentier, Gilles; Bottos, Alessia; Primo, Luca; Bussolino, Federico; Arese, Marco			Neuroligin 1 Induces Blood Vessel Maturation by Cooperating with the alpha 6 Integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; TUMOR ANGIOGENESIS; BASEMENT-MEMBRANE; ENDOTHELIAL-CELLS; EXPRESSION; VASCULATURE; NEUREXINS; JUNCTIONS; LAMININ; MICE	The synaptic protein Neuroligin 1 (NLGN1), a cell adhesion molecule, is critical for the formation and consolidation of synaptic connectivity and is involved in vascular development. The mechanism through which NLGN1 acts, especially in vascular cells, is unknown. Here, we aimed at deepening our knowledge on the cellular activities and molecular pathways exploited by endothelial NLGN1 both in vitro and in vivo. We analyzed the phenotypic consequences of NLGN1 expression modulation in endothelial cells through in vitro angiogenesis assays and the mouse postnatal retinal angiogenesis model. We demonstrate that NLGN1, whereas not affecting endothelial cell proliferation or migration, modulates cell adhesion to the vessel stabilizing protein laminin through cooperation with the alpha 6 integrin, a specific laminin receptor. Finally, we show that in vivo, NLGN1 and alpha 6 integrin preferentially colocalize in the mature retinal vessels, whereas NLGN1 deletion causes an aberrant VE-cadherin, laminin and alpha 6 integrin distribution in vessels, along with significant structural defects in the vascular tree.	[Samarelli, Anna Valeria; Riccitelli, Elena; Bizzozero, Laura; Silveira, Tatiana Nunes; Seano, Giorgio; Pergolizzi, Margherita; Vitagliano, Grazia; Bottos, Alessia; Primo, Luca; Bussolino, Federico; Arese, Marco] Univ Turin, Sch Med, Dept Oncol, I-10060 Candiolo, TO, Italy; [Samarelli, Anna Valeria; Riccitelli, Elena; Bizzozero, Laura; Silveira, Tatiana Nunes; Pergolizzi, Margherita; Vitagliano, Grazia; Bottos, Alessia; Arese, Marco] Candiolo Canc Inst, Lab Neurovasc Biol, I-10060 Turin, Italy; [Seano, Giorgio; Primo, Luca] Candiolo Canc Inst, I-10060 Turin, Italy; [Cascone, Ilaria; Carpentier, Gilles] Univ Paris Est Creteil Val de Marne, Lab CRRET, Fac Sci & Technol, F-94010 Creteil, France	University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; IRCCS Fondazione del Piemonte per l'Oncologia; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Arese, M (corresponding author), Candiolo Canc Inst, Lab Neurovasc Biol, Str Prov 142 Km 3,95, I-10060 Turin, Italy.	marco.arese@unito.it	Bussolino, Federico/AES-3951-2022; Cascone, Ilaria/Q-7844-2018; Seano, Giorgio/R-6611-2016; arese, marco/J-6119-2013; Bussolino, Federico/K-2500-2016	Cascone, Ilaria/0000-0003-4903-8926; Seano, Giorgio/0000-0002-7294-302X; arese, marco/0000-0002-7384-9406; Bizzozero, Laura/0000-0003-2038-7356; Carpentier, Gilles/0000-0002-3730-7263; Pergolizzi, Margherita/0000-0002-8486-1478; Bussolino, Federico/0000-0002-5348-1341; PRIMO, Luca/0000-0002-1294-0441	Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 11503, 10133]; AIRC [12182]; Fondazione Umberto Veronesi; Young Investigator Grant; Regione Piemonte: Ricerca Sanitaria Finalizzata; Converging Technologies Program grant "Photonic Biosensors for Early Cancer Diagnostics," Industrial Research; Fondo Investimenti per la Ricerca di Base [RBAP11BYNP]; University of Torino-Compagnia di San Paolo Grant RETHE; Grant GeneRNet; FP7-ICT Biloba [318035]; Consiglio Nazionale delle Ricerche grant "Personalized Medicine"	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); AIRC(Fondazione AIRC per la ricerca sul cancro); Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); Young Investigator Grant; Regione Piemonte: Ricerca Sanitaria Finalizzata(Regione Piemonte); Converging Technologies Program grant "Photonic Biosensors for Early Cancer Diagnostics," Industrial Research; Fondo Investimenti per la Ricerca di Base(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); University of Torino-Compagnia di San Paolo Grant RETHE; Grant GeneRNet; FP7-ICT Biloba; Consiglio Nazionale delle Ricerche grant "Personalized Medicine"	This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC) investigator Grants IG 11503 (to M. A.), 10133 (to F. B.), AIRC 5 x 1000 (code 12182), Fondazione Umberto Veronesi, Young Investigator Grant 2014 (to M. A.), Regione Piemonte: Ricerca Sanitaria Finalizzata, 2008, Converging Technologies Program grant "Photonic Biosensors for Early Cancer Diagnostics," Industrial Research 2009 (Grant BANP) Fondo Investimenti per la Ricerca di Base RBAP11BYNP (Newton) (to F. B.), and University of Torino-Compagnia di San Paolo Grant RETHE (to F. B.), Grant GeneRNet (to M. A.), FP7-ICT-2011-8 Biloba (contract 318035), and Consiglio Nazionale delle Ricerche grant "Personalized Medicine" (to F. B.).	Bedell VM, 2012, ARTERIOSCL THROM VAS, V32, P1546, DOI 10.1161/ATVBAHA.112.251272; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bottos A, 2009, P NATL ACAD SCI USA, V106, P20782, DOI 10.1073/pnas.0809510106; Carpentier G, 2012, 4 IMAGEJ US DEV C P, P198; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Dejana E, 1996, J CLIN INVEST, V98, P1949, DOI 10.1172/JCI118997; Estrach S, 2011, CIRC RES, V109, P172, DOI 10.1161/CIRCRESAHA.111.240622; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; GeorgesLabouesse E, 1996, NAT GENET, V13, P370, DOI 10.1038/ng0796-370; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Germain M, 2010, J PATHOL, V220, P370, DOI 10.1002/path.2654; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; KENNEL SJ, 1990, HYBRIDOMA, V9, P243, DOI 10.1089/hyb.1990.9.243; Nikolopoulos SN, 2004, CANCER CELL, V6, P471, DOI 10.1016/j.ccr.2004.09.029; Primo L, 2010, CANCER RES, V70, P5759, DOI 10.1158/0008-5472.CAN-10-0507; Ribatti D, 2012, DEV BIOL, V372, P157, DOI 10.1016/j.ydbio.2012.09.018; Rissone A, 2012, ARTERIOSCL THROM VAS, V32, P1563, DOI 10.1161/ATVBAHA.111.243006; Rudenko G, 2001, TRENDS BIOCHEM SCI, V26, P363, DOI 10.1016/S0968-0004(01)01832-1; Sawamiphak S, 2010, NAT PROTOC, V5, P1659, DOI 10.1038/nprot.2010.130; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; Stenzel D, 2011, EMBO REP, V12, P1135, DOI 10.1038/embor.2011.194; TSAI WH, 1985, COMPUT VISION GRAPH, V29, P377, DOI 10.1016/0734-189X(85)90133-1; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Yanez-Mo M, 1998, J CELL BIOL, V141, P791, DOI 10.1083/jcb.141.3.791	28	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19466	19476		10.1074/jbc.M113.530972	http://dx.doi.org/10.1074/jbc.M113.530972			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24860089	Green Published, hybrid			2022-12-25	WOS:000339326800022
J	Contreras, H; Joens, MS; McMath, LM; Le, VP; Tullius, MV; Kimmey, JM; Bionghi, N; Horwitz, MA; Fitzpatrick, JAJ; Goulding, CW				Contreras, Heidi; Joens, Matthew S.; McMath, Lisa M.; Le, Vincent P.; Tullius, Michael V.; Kimmey, Jaqueline M.; Bionghi, Neda; Horwitz, Marcus A.; Fitzpatrick, James A. J.; Goulding, Celia W.			Characterization of a Mycobacterium tuberculosis Nanocompartment and Its Potential Cargo Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOCOCCUS-JOSTII RHA1; CRYSTAL-STRUCTURE; HYPOXIC RESPONSE; PEROXIDASE; HEME; IDENTIFICATION; ORGANELLES; PURIFICATION; MECHANISMS; EXOSOMES	Mycobacterium tuberculosis has evolved various mechanisms by which the bacterium can maintain homeostasis under numerous environmental assaults generated by the host immune response. M. tuberculosis harbors enzymes involved in the oxidative stress response that aid in survival during the production of reactive oxygen species in activated macrophages. Previous studies have shown that a dye-decolorizing peroxidase (DyP) is encapsulated by a bacterial nanocompartment, encapsulin (Enc), whereby packaged DyP interacts with Enc via a unique C-terminal extension. M. tuberculosis also harbors an encapsulin homolog (CFP-29, Mt-Enc), within an operon with M. tuberculosis DyP (Mt-DyP), which contains a C-terminal extension. Together these observations suggest that Mt-DyP interacts with Mt-Enc. Furthermore, it has been suggested that DyPs may function as either a heme-dependent peroxidase or a deferrochelatase. Like Mt-DyP, M. tuberculosis iron storage ferritin protein, Mt-BfrB, and an M. tuberculosis protein involved in folate biosynthesis, 7,8-dihydroneopterin aldolase (Mt-FolB), have C-terminal tails that could also interact with Mt-Enc. For the first time, we show by co-purification and electron microscopy that mycobacteria via Mt-Enc can encapsulate Mt-DyP, Mt-BfrB, and Mt-FolB. Functional studies of free or encapsulated proteins demonstrate that they retain their enzymatic activity within the Mt-Enc nanocompartment. Mt-DyP, Mt-FolB, and Mt-BfrB all have antioxidant properties, suggesting that if these proteins are encapsulated by Mt-Enc, then this nanocage may play a role in the M. tuberculosis oxidative stress response. This report provides initial structural and biochemical clues regarding the molecular mechanisms that utilize compartmentalization by which the mycobacterial cell may aid in detoxification of the local environment to ensure long term survival.	[Contreras, Heidi; McMath, Lisa M.; Le, Vincent P.; Goulding, Celia W.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Goulding, Celia W.] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA; [Joens, Matthew S.; Fitzpatrick, James A. J.] Salk Inst Biol Studies, Waitt Adv Biophoton Ctr, La Jolla, CA 92037 USA; [Tullius, Michael V.; Kimmey, Jaqueline M.; Bionghi, Neda; Horwitz, Marcus A.] Univ Calif Los Angeles, Div Infect Dis, Dept Med, Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Salk Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Goulding, CW (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	celia.goulding@uci.edu	Kimmey, Jacqueline/GXV-9323-2022	Kimmey, Jacqueline M/0000-0003-1330-8525	National Institutes of Health [AI081161, GM101945, AI078691, AI095208, AI068413]; Waitt Advanced Biophotonics Center; W. M. Keck Foundation; NCI, National Institutes of Health [CA014195-40]; NINDS, National Institutes of Health [NS072031-03A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI078691, P01AI095208, R01AI068413, R01AI081161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM101945] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Waitt Advanced Biophotonics Center; W. M. Keck Foundation(W.M. Keck Foundation); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI081161 (to C. W. G.), GM101945 (to H. C.), AI078691 (to L. M. M.), AI095208 (to C. W. G.), and AI068413 (to M. A. H.).; Supported by the Waitt Advanced Biophotonics Center, W. M. Keck Foundation, NCI, National Institutes of Health, P30 Cancer Support Grant CA014195-40, and NINDS, National Institutes of Health, P30 Neuroscience Center Core Grant NS072031-03A1.	Ahmad M, 2011, BIOCHEMISTRY-US, V50, P5096, DOI 10.1021/bi101892z; Akita F, 2007, J MOL BIOL, V368, P1469, DOI 10.1016/j.jmb.2007.02.075; Bannantine JP, 2001, J MED MICROBIOL, V50, P795, DOI 10.1099/0022-1317-50-9-795; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown ME, 2012, ACS CHEM BIOL, V7, P2074, DOI 10.1021/cb300383y; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; Chiancone E, 2004, BIOMETALS, V17, P197, DOI 10.1023/B:BIOM.0000027692.24395.76; Chim N, 2010, J MOL BIOL, V395, P595, DOI 10.1016/j.jmb.2009.11.025; Choudhary S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033342; Corchero JL, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-92; Czekster CM, 2012, J AM CHEM SOC, V134, P19758, DOI 10.1021/ja308350f; Dailey HA, 2011, MBIO, V2, DOI 10.1128/mBio.00248-11; Dantola ML, 2008, HELV CHIM ACTA, V91, P411, DOI 10.1002/hlca.200890046; Dawson R. M. C., 1986, DATA BIOCH RES, V3rd; Dunford H. B., 1999, HEME PEROXIDASES, P15; Fan CG, 2010, P NATL ACAD SCI USA, V107, P7509, DOI 10.1073/pnas.0913199107; Garbe TR, 1999, INFECT IMMUN, V67, P460, DOI 10.1128/IAI.67.1.460-465.1999; Giri PK, 2010, PROTEOMICS, V10, P3190, DOI 10.1002/pmic.200900840; Goulding CW, 2005, J MOL BIOL, V349, P61, DOI 10.1016/j.jmb.2005.03.023; Gupta V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008028; Jones CM, 2011, J BACTERIOL, V193, P1767, DOI 10.1128/JB.01312-10; Jorda J, 2013, PROTEIN SCI, V22, P179, DOI 10.1002/pro.2196; Kaur A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.50; Kerfeld CA, 2010, ANNU REV MICROBIOL, V64, P391, DOI 10.1146/annurev.micro.112408.134211; Khare G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018570; Kim SJ, 1999, APPL ENVIRON MICROB, V65, P1029; KODURI RS, 1995, J BIOL CHEM, V270, P22254, DOI 10.1074/jbc.270.38.22254; Lassila JK, 2014, J MOL BIOL, V426, P2217, DOI 10.1016/j.jmb.2014.02.025; LEE BY, 1992, INFECT IMMUN, V60, P2066, DOI 10.1128/IAI.60.5.2066-2074.1992; Letoffe S, 2009, P NATL ACAD SCI USA, V106, P11719, DOI 10.1073/pnas.0903842106; Liu XF, 2004, P NATL ACAD SCI USA, V101, P8557, DOI 10.1073/pnas.0401146101; Liu XH, 2011, J BIOL CHEM, V286, P14922, DOI 10.1074/jbc.M110.197780; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manca C, 1999, INFECT IMMUN, V67, P74, DOI 10.1128/IAI.67.1.74-79.1999; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; McMath LM, 2010, ACTA CRYSTALLOGR F, V66, P1657, DOI 10.1107/S1744309110042958; McMath LM, 2013, J PORPHYR PHTHALOCYA, V17, P229, DOI 10.1142/S1088424613500211; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; Nambu S, 2013, J BIOL CHEM, V288, P10101, DOI 10.1074/jbc.M112.448399; Ogola HJO, 2009, APPL ENVIRON MICROB, V75, P7509, DOI 10.1128/AEM.01121-09; Ohno S, 2013, ADV DRUG DELIVER REV, V65, P398, DOI 10.1016/j.addr.2012.07.019; Owens CP, 2012, BIOCHEMISTRY-US, V51, P1518, DOI 10.1021/bi2018305; Pandey R, 2012, INFECT IMMUN, V80, P3650, DOI 10.1128/IAI.00229-12; Rahmanpour R, 2013, FEBS J, V280, P2097, DOI 10.1111/febs.12234; Roberts JN, 2011, BIOCHEMISTRY-US, V50, P5108, DOI 10.1021/bi200427h; Rosenkrands I, 1998, INFECT IMMUN, V66, P2728, DOI 10.1128/IAI.66.6.2728-2735.1998; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schobersberger W, 1996, FEBS LETT, V397, P263, DOI 10.1016/S0014-5793(96)01194-5; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shin KS, 2000, ARCH BIOCHEM BIOPHYS, V384, P109, DOI 10.1006/abbi.2000.2083; Sil S, 2004, J BIOSCIENCES, V29, P281, DOI 10.1007/BF02702610; Singh R, 2012, J BIOL CHEM, V287, P10623, DOI 10.1074/jbc.M111.332171; Sutter M, 2008, NAT STRUCT MOL BIOL, V15, P939, DOI 10.1038/nsmb.1473; Tetta C, 2013, ENDOCRINE, V44, P11, DOI 10.1007/s12020-012-9839-0; Tullius MV, 2011, P NATL ACAD SCI USA, V108, P5051, DOI 10.1073/pnas.1009516108; Turlin E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056529; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; Yeates TO, 2010, ANNU REV BIOPHYS, V39, P185, DOI 10.1146/annurev.biophys.093008.131418	62	59	61	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18279	18289		10.1074/jbc.M114.570119	http://dx.doi.org/10.1074/jbc.M114.570119			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24855650	hybrid, Green Published			2022-12-25	WOS:000338042000028
J	Garderes, J; Henry, J; Bernay, B; Ritter, A; Zatylny-Gaudin, C; Wiens, M; Muller, WEG; Le Pennec, G				Garderes, Johan; Henry, Joel; Bernay, Benoit; Ritter, Andres; Zatylny-Gaudin, Celine; Wiens, Matthias; Mueller, Werner E. G.; Le Pennec, Gael			Cellular Effects of Bacterial N-3-Oxo-Dodecanoyl-(L)-Homoserine Lactone on the Sponge Suberites domuncula (Olivi, 1792): Insights into an Intimate Inter-Kingdom Dialogue	PLOS ONE			English	Article							INNATE IMMUNE DEFENSE; N-3-OXODODECANOYL HOMOSERINE LACTONE; SENSING SIGNAL MOLECULE; N-(3-OXODODECANOYL)-L-HOMOSERINE LACTONE; RETINA COGNIN; QUORUM; COFILIN; EXPRESSION; INDUCTION; EVOLUTION	Sponges and bacteria have lived together in complex consortia for 700 million years. As filter feeders, sponges prey on bacteria. Nevertheless, some bacteria are associated with sponges in symbiotic relationships. To enable this association, sponges and bacteria are likely to have developed molecular communication systems. These may include molecules such as N-acyl-(L)-homoserine lactones, produced by Gram-negative bacteria also within sponges. In this study, we examined the role of N-3-oxododecanoyl-(L)-homoserine lactone (3-oxo-C-12-HSL) on the expression of immune and apoptotic genes of the host sponge Suberites domuncula. This molecule seemed to inhibit the sponge innate immune system through a decrease of the expression of genes coding for proteins sensing the bacterial membrane: a Toll-Like Receptor and a Toll-like Receptor Associated Factor 6 and for an anti-bacterial perforin-like molecule. The expression of the pro-apoptotic caspase-like 3/7 gene decreased as well, whereas the level of mRNA of anti-apoptotic genes Bcl-2 Homolog Proteins did not change. Then, we demonstrated the differential expression of proteins in presence of this 3-oxo-C-12-HSL using 3D sponge cell cultures. Proteins involved in the first steps of the endocytosis process were highlighted using the 2D electrophoresis protein separation and the MALDI-TOF/TOF protein characterization: alpha and beta subunits of the lysosomal ATPase, a cognin, cofilins-related proteins and cytoskeleton proteins actin, alpha tubulin and alpha actinin. The genetic expression of some of these proteins was subsequently followed. We propose that the 3-oxo-C-12-HSL may participate in the tolerance of the sponge apoptotic and immune systems towards the presence of bacteria. Besides, the sponge may sense the 3-oxo-C-12-HSL as a molecular evidence of the bacterial presence and/or density in order to regulate the populations of symbiotic bacteria in the sponge. This study is the first report of a bacterial secreted molecule acting on sponge cells and regulating the symbiotic relationship.	[Garderes, Johan; Le Pennec, Gael] Univ Bretagne Sud, Lab Biotechnol & Chim Marines, EA 3884, Inst Univ Europeen Mer, Lorient, France; [Henry, Joel; Zatylny-Gaudin, Celine] Univ Caen Basse Normandie, CNRS INEE FRE 3484, Lab Mollusques Marins & Ecosyst Associes, Caen, France; [Bernay, Benoit] Univ Caen Basse Normandie, SF ICORE 4206, Post Genom Platform PROTEOGEN, Caen, France; [Ritter, Andres] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Santiago, Chile; [Wiens, Matthias; Mueller, Werner E. G.] Johannes Gutenberg Univ Mainz, Inst Physiol Chem, Univ Med Ctr, European Res Council Adv Investigator Grant Res G, D-55122 Mainz, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Caen Normandie; Universite de Caen Normandie; Pontificia Universidad Catolica de Chile; Johannes Gutenberg University of Mainz	Le Pennec, G (corresponding author), Univ Bretagne Sud, Lab Biotechnol & Chim Marines, EA 3884, Inst Univ Europeen Mer, Lorient, France.	gael.le-pennec@univ-ubs.fr	Müller, W. E. G./AAR-8651-2020	Müller, W. E. G./0000-0002-8223-3689; Wiens, Matthias/0000-0001-9219-0478; Zatylny-Gaudin, Celine/0000-0001-9258-9876; Ritter, Andres/0000-0001-7011-6824; GARDERES, Johan/0000-0002-0934-8041	Ministere de la Recherche et de l'Enseignement Superieur, France; Axis 1 (Genomics and Blue Chemistry) of the GIS Europole Mer; Region Bretagne; European FEDER	Ministere de la Recherche et de l'Enseignement Superieur, France; Axis 1 (Genomics and Blue Chemistry) of the GIS Europole Mer; Region Bretagne(Region Bretagne); European FEDER(European Commission)	JG was the recipient of a PhD fellowship from the Ministere de la Recherche et de l'Enseignement Superieur, France. This project was funded by the Axis 1 (Genomics and Blue Chemistry) of the GIS Europole Mer. The LBCM is supported by the Region Bretagne and European FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa H, 1997, J CELL SCI, V110, P2333; Allen LAH, 1996, CURR OPIN IMMUNOL, V8, P36, DOI 10.1016/S0952-7915(96)80102-6; Bamburg JR, 2011, MOL MICROBIOL, V81, P851, DOI 10.1111/j.1365-2958.2011.07759.x; Bohm M, 2001, MAR BIOL, V139, P1037; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; Bryan A, 2010, MICROBES INFECT, V12, P1042, DOI 10.1016/j.micinf.2010.07.006; Chantzoura E, 2010, BIOCHEM BIOPH RES CO, V403, P335, DOI 10.1016/j.bbrc.2010.11.029; de Bary HA, 1879, ERSCHEINUNG SYMBIOSE; Fu Q, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-600; Garderes J, 2012, MAR BIOL, V159, P1685, DOI 10.1007/s00227-012-1956-z; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Hooi DSW, 2004, INFECT IMMUN, V72, P6463, DOI 10.1128/IAI.72.11.6463-6470.2004; Jacobi CA, 2009, INT J MED MICROBIOL, V299, P509, DOI 10.1016/j.ijmm.2009.03.005; Landstrom M, 2010, INT J BIOCHEM CELL B, V42, P585, DOI 10.1016/j.biocel.2009.12.023; Lawrence RN, 1999, BRIT J PHARMACOL, V128, P845, DOI 10.1038/sj.bjp.0702870; Le Pennec G, 2003, J BIOTECHNOL, V100, P93, DOI 10.1016/S0168-1656(02)00259-6; Mathesius U, 2003, P NATL ACAD SCI USA, V100, P1444, DOI 10.1073/pnas.262672599; May RC, 2001, J CELL SCI, V114, P1061; MCFALLNGAI M, 1990, BIOL BULL, V179, P332, DOI 10.2307/1542325; Mohamed NM, 2008, ENVIRON MICROBIOL, V10, P75, DOI 10.1111/j.1462-2920.2007.01431.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mueller Werner E. G., 2009, V47, P55, DOI 10.1007/978-3-540-88552-8_3; Muller WEG, 2004, PROG MOL SUBCELL BIO, V34, P103; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; Pariser HP, 1998, DEV BRAIN RES, V111, P1, DOI 10.1016/S0165-3806(98)00113-8; Pariser HP, 2000, EXP CELL RES, V258, P42, DOI 10.1006/excr.2000.4931; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reading NC, 2006, FEMS MICROBIOL LETT, V254, P1, DOI 10.1111/j.1574-6968.2005.00001.x; Ritchie AJ, 2005, INFECT IMMUN, V73, P1648, DOI 10.1128/IAI.73.3.1648-1655.2005; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Siegl A, 2011, ISME J, V5, P61, DOI 10.1038/ismej.2010.95; Smith RS, 2002, J BACTERIOL, V184, P1132, DOI 10.1128/jb.184.4.1132-1139.2002; Smith RS, 2001, J IMMUNOL, V167, P366, DOI 10.4049/jimmunol.167.1.366; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Sun-Wada GH, 2009, J CELL SCI, V122, P2504, DOI 10.1242/jcs.050443; Sun-Wada GH, 2003, CELL STRUCT FUNCT, V28, P455, DOI 10.1247/csf.28.455; Tang L, 2011, ARCH ORAL BIOL, V56, P1064, DOI 10.1016/j.archoralbio.2011.02.020; Taylor MW, 2004, APPL ENVIRON MICROB, V70, P4387, DOI 10.1128/AEM.70.7.4387-4389.2004; Telford G, 1998, INFECT IMMUN, V66, P36, DOI 10.1128/IAI.66.1.36-42.1998; Thakur NL, 2005, MAR BIOL, V146, P271, DOI 10.1007/s00227-004-1438-z; Thomas T, 2010, ISME J, V4, P1557, DOI 10.1038/ismej.2010.74; Vikstrom E, 2005, MICROBES INFECT, V7, P1512, DOI 10.1016/j.micinf.2005.05.012; Vikstrom E, 2006, FEBS LETT, V580, P6921, DOI 10.1016/j.febslet.2006.11.057; Wagner C, 2007, ANAL BIOANAL CHEM, V387, P481, DOI 10.1007/s00216-006-0698-5; Wiens M, 2005, J BIOL CHEM, V280, P27949, DOI 10.1074/jbc.M504049200; Wiens M, 2004, IMMUNOGENETICS, V56, P597, DOI 10.1007/s00251-004-0718-6; Wiens M, 2007, MOL BIOL EVOL, V24, P792, DOI 10.1093/molbev/msl208; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Zan JD, 2012, MOL MICROBIOL, V85, P916, DOI 10.1111/j.1365-2958.2012.08149.x; ZHANG LH, 1993, NATURE, V362, P446, DOI 10.1038/362446a0; Zhang XY, 2004, BIOTECHNOL PROGR, V20, P151, DOI 10.1021/bp0341601	51	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97662	10.1371/journal.pone.0097662	http://dx.doi.org/10.1371/journal.pone.0097662			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858701	gold, Green Published, Green Submitted			2022-12-25	WOS:000336839400023
J	Boubaker, G; Gottstein, B; Hemphill, A; Babba, H; Spiliotis, M				Boubaker, Ghalia; Gottstein, Bruno; Hemphill, Andrew; Babba, Hamouda; Spiliotis, Markus			Echinococcus P29 Antigen: Molecular Characterization and Implication on Post-Surgery Follow-Up of CE Patients Infected with Different Species of the Echinococcus granulosus Complex	PLOS ONE			English	Article							CYSTIC ECHINOCOCCOSIS; RECOMBINANT ANTIGENS; BREEDING SYSTEMS; MESSENGER-RNA; STRAINS; VACCINE; GENE; MULTILOCULARIS; G6; FERTILIZATION	The protein P29 is a potential serological marker for post-treatment monitoring of cystic echinococcosis (CE) especially in young patients. We now have demonstrated that P29 is encoded in the Echinococcus genus by a single gene consisting of 7 exons spanning 1.2 kb of DNA. Variability of the p29 gene at inter- and intra-species level was assessed with 50 cDNA and 280 genomic DNA clones isolated from different E. granulosus s. l. isolates (E. granulosus sensu stricto (G1), E. equinus (G4), E. ortleppi (G5), E. canadensis (G6), E. canadensis (G7) and E. canadensis (G10)) as well as four E. multilocularis isolates. Scarce interspecies polymorphism at the p29 locus was observed and affected predominantly E. granulosus s. s. (G1), where we identified two alleles (A1 and A2) coding for identical P29 proteins and yielding in three genotypes (A1/A1, A2/A2 and A1/A2). Genotypic frequencies expected under Hardy-Weinberg equilibrium revealed a high rate of heterozygosity (47%) that strongly supports the hypothesis that E. granulosus s. s. (G1) is predominantly outbreeding. Comparative sequence analyses of the complete p29 gene showed that phylogenetic relationships within the genus Echinococcus were in agreement with those of previous nuclear gene studies. At the protein level, the deduced P29 amino acid (AA) sequences exhibited a high level of conservation, ranging from 97.9% AA sequence identity among the whole E. granulosus s. l. group to 99.58% identity among E. multilocularis isolates. We showed that P29 proteins of these two species differ by three AA substitutions without implication for antigenicity. In Western-blot analyses, serum antibodies from a human CE patient infected with E. canadensis (G6) strongly reacted with recombinant P29 from E. granulosus s. s. (G1) (recEg(G1)P29). In the same line, human anti-Eg(G1) P29 antibodies bound to recEcnd(G6)P29. Thus, minor AA sequence variations appear not to impair the prognostic serological use of P29.	[Boubaker, Ghalia; Gottstein, Bruno; Hemphill, Andrew; Spiliotis, Markus] Univ Bern, Inst Parasitol, Bern, Switzerland; [Boubaker, Ghalia] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Boubaker, Ghalia; Babba, Hamouda] Univ Monastir, Dept Clin Biol B, Lab Parasitol & Mycol, Monastir, Tunisia	University of Bern; University of Bern; Universite de Monastir	Gottstein, B (corresponding author), Univ Bern, Inst Parasitol, Bern, Switzerland.	bruno.gottstein@vetsuisse.unibe.ch		Hemphill, Andrew/0000-0002-0622-2128	Swiss National Science Foundation [31003A_141039/1]; UNESCO-L'OREAL international "For women in science" Fellowships	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); UNESCO-L'OREAL international "For women in science" Fellowships	This work was supported by the Swiss National Science Foundation (grant no. 31003A_141039/1) and the UNESCO-L'OREAL international "For women in science" Fellowships (http://www.unesco.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix B, 2012, NUCLEIC ACIDS RES, V40, pW573, DOI 10.1093/nar/gks485; Alvarez Rojas CA, 2012, MOL BIOCHEM PARASIT, V183, P115, DOI 10.1016/j.molbiopara.2012.02.005; Arend AC, 2004, EXP PARASITOL, V108, P76, DOI 10.1016/j.exppara.2004.07.009; Ben Nouir N, 2008, J CLIN MICROBIOL, V46, P1631, DOI 10.1128/JCM.01689-07; Ben Nouir N, 2009, T ROY SOC TROP MED H, V103, P355, DOI 10.1016/j.trstmh.2008.09.020; Boubaker G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002017; BREATHNACH R, 1978, P NATL ACAD SCI USA, V75, P4853, DOI 10.1073/pnas.75.10.4853; Brehm K, 2000, J BIOL CHEM, V275, P38311, DOI 10.1074/jbc.M006091200; Brehm K, 2010, PARASITOLOGY, V137, P537, DOI 10.1017/S0031182009991727; Brunetti E, 2010, ACTA TROP, V114, P1, DOI 10.1016/j.actatropica.2009.11.001; Chemale G, 2001, MOL BIOCHEM PARASIT, V116, P233, DOI 10.1016/S0166-6851(01)00316-4; Chojnowski JL, 2008, GENE, V410, P89, DOI 10.1016/j.gene.2007.11.016; Chow C, 2001, MOL BIOCHEM PARASIT, V118, P83, DOI 10.1016/S0166-6851(01)00373-5; Chow C, 2008, EXP PARASITOL, V119, P499, DOI 10.1016/j.exppara.2008.01.004; Eckert J, 2004, CLIN MICROBIOL REV, V17, P107, DOI 10.1128/CMR.17.1.107-135.2004; El Malki HO, 2010, J GASTROINTEST SURG, V14, P1121, DOI 10.1007/s11605-010-1220-0; Fernandez V, 1996, MOL BIOCHEM PARASIT, V77, P247, DOI 10.1016/0166-6851(96)02602-3; FROSCH P, 1994, MOL BIOCHEM PARASIT, V64, P171, DOI 10.1016/0166-6851(94)90145-7; Galitza Z, 2006, T ROY SOC TROP MED H, V100, P126, DOI 10.1016/j.trstmh.2005.05.014; Gonzalez G, 2000, MOL BIOCHEM PARASIT, V105, P177, DOI 10.1016/S0166-6851(99)00166-8; Gonzalez LM, 2011, MOL BIOCHEM PARASIT, V176, P131, DOI 10.1016/j.molbiopara.2010.12.014; Haag KL, 2006, INFECT GENET EVOL, V6, P251, DOI 10.1016/j.meegid.2005.07.003; Haag KL, 2011, PARASITOLOGY, V138, P298, DOI 10.1017/S0031182010001307; Haag KL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005362; Haag KL, 1999, PARASITOLOGY, V118, P63, DOI 10.1017/S0031182098003485; Haag KL, 2004, GENE, V333, P157, DOI 10.1016/j.gene.2004.02.027; Haag KL, 1998, MEM I OSWALDO CRUZ, V93, P695, DOI 10.1590/S0074-02761998000500024; Hernandez-Gonzalez A, 2008, CLIN VACCINE IMMUNOL, V15, P147, DOI 10.1128/CVI.00363-07; Kamenetzky L, 2005, PARASITOLOGY, V131, P805, DOI 10.1017/S0031182005008474; Kamenetzky L, 2002, INFECT GENET EVOL, V2, P129, DOI 10.1016/S1567-1348(02)00131-4; Knapp J, 2011, MOL PHYLOGENET EVOL, V61, P628, DOI 10.1016/j.ympev.2011.07.022; Lightowlers MW, 1999, INT J PARASITOL, V29, P531, DOI 10.1016/S0020-7519(99)00003-X; LIGHTOWLERS MW, 1990, INT J PARASITOL, V20, P471, DOI 10.1016/0020-7519(90)90194-R; Lymbery AJ, 1997, EVOLUTION, V51, P289, DOI [10.2307/2410983, 10.1111/j.1558-5646.1997.tb02411.x]; LYMBERY AJ, 1990, PARASITOLOGY, V101, P283, DOI 10.1017/S0031182000063344; Maass DR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000597; Maillard S, 2011, VET PARASITOL, V175, P80, DOI 10.1016/j.vetpar.2010.09.014; Mamuti W, 2006, EXP PARASITOL, V113, P75, DOI 10.1016/j.exppara.2005.12.007; Meinecke M, 2013, J BIOL CHEM, V288, P6651, DOI 10.1074/jbc.M112.444869; Nakao M, 2007, PARASITOLOGY, V134, P713, DOI 10.1017/S0031182006001934; Rigano R, 2001, INFECT IMMUN, V69, P288, DOI 10.1128/IAI.69.1.288-296.2001; Rigano R, 2007, INFECT IMMUN, V75, P1667, DOI 10.1128/IAI.01156-06; Rojas CAA, 2013, PARASITE IMMUNOL, V35, P99, DOI 10.1111/pim.12009; Saarma U, 2009, PARASITOLOGY, V136, P317, DOI 10.1017/S0031182008005453; Sambrook J, 1989, MOL CLONING LAB MANU; Siles-Lucas M, 2001, PARASITOLOGY, V122, P281, DOI 10.1017/S0031182001007405; Stojkovic M, 2009, PLOS NEGLECT TROP D, V3, P1; Tsai IJ, 2013, NATURE, V496, P57, DOI 10.1038/nature12031; Verani JR, 2009, AM J TROP MED HYG, V80, P410; Virginio VG, 2003, CLIN EXP IMMUNOL, V132, P309, DOI 10.1046/j.1365-2249.2003.02123.x; WHO Informal Working Group on Echinococcosis, 1996, B WORLD HEALTH ORGAN, P74231; Wulamu M, 2007, PARASITOL INT, V56, P313, DOI 10.1016/j.parint.2007.06.003; Zhang WB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001166	53	24	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98357	10.1371/journal.pone.0098357	http://dx.doi.org/10.1371/journal.pone.0098357			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24851904	Green Published, Green Submitted, gold			2022-12-25	WOS:000338323200066
J	Parkinson, E; Skipp, P; Aleksic, M; Garrow, A; Dadd, T; Hughes, M; Clough, G; O'Connor, CD				Parkinson, Erika; Skipp, Paul; Aleksic, Maja; Garrow, Andrew; Dadd, Tony; Hughes, Michael; Clough, Geraldine; O'Connor, C. David			Proteomic Analysis of the Human Skin Proteome after In Vivo Treatment with Sodium Dodecyl Sulphate	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; HUMAN SERUM-ALBUMIN; LAURYL SULFATE; BICINCHONINIC ACID; P-PHENYLENEDIAMINE; IDENTIFICATION; BINDING; MODEL; SENSITIZATION; IRRITATION	Background: Skin has a variety of functions that are incompletely understood at the molecular level. As the most accessible tissue in the body it often reveals the first signs of inflammation or infection and also represents a potentially valuable source of biomarkers for several diseases. In this study we surveyed the skin proteome qualitatively using gel electrophoresis, liquid chromatography tandem mass spectrometry (GeLC-MS/MS) and quantitatively using an isobaric tagging strategy (iTRAQ) to characterise the response of human skin following exposure to sodium dodecyl sulphate (SDS). Results: A total of 653 skin proteins were assigned, 159 of which were identified using GeLC-MS/MS and 616 using iTRAQ, representing the most comprehensive proteomic study in human skin tissue. Statistical analysis of the available iTRAQ data did not reveal any significant differences in the measured skin proteome after 4 hours exposure to the model irritant SDS. Conclusions: This study represents the first step in defining the critical response to an irritant at the level of the proteome and provides a valuable resource for further studies at the later stages of irritant exposure.	[Parkinson, Erika; Skipp, Paul; O'Connor, C. David] Univ Southampton, Ctr Biol Sci, Southampton, Hants, England; [Parkinson, Erika; Skipp, Paul; O'Connor, C. David] Univ Southampton, Inst Life Sci, Ctr Prote Res, Southampton, Hants, England; [Aleksic, Maja; Garrow, Andrew; Hughes, Michael] Unilever, Safety & Environm Assurance Ctr, Sharnbrook, Beds, England; [Dadd, Tony] Unilever Res, Unilever Clin, Sharnbrook, Beds, England; [Clough, Geraldine] Univ Southampton, Sch Med, Inst Dev Sci, Southampton, Hants, England	University of Southampton; University of Southampton; Unilever; Unilever; University of Southampton	Parkinson, E (corresponding author), Univ Southampton, Ctr Biol Sci, Southampton, Hants, England.	epp@soton.ac.uk	Parkinson, Erika/AAG-5798-2019	Parkinson, Erika/0000-0002-3130-2445	SEAC, Unilever plc. [KOM060136]	SEAC, Unilever plc.	This study was funded by SEAC, Unilever plc. study KOM060136. The funder provided support in the form of salaries for authors EP, MA, AG, TS and MW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Aleksic M, 2008, TOXICOL IN VITRO, V22, P1169, DOI 10.1016/j.tiv.2008.03.006; Aleksic M, 2007, TOXICOL IN VITRO, V21, P723, DOI 10.1016/j.tiv.2007.01.008; Aleksic M, 2009, TOXICOL SCI, V108, P401, DOI 10.1093/toxsci/kfp030; Alvarez-Sanchez R, 2004, CHEM RES TOXICOL, V17, P1280, DOI 10.1021/tx049935+; Basketter D, 1997, CONTACT DERMATITIS, V37, P218, DOI 10.1111/j.1600-0536.1997.tb02438.x; Boxman ILA, 2002, BRIT J DERMATOL, V146, P777, DOI 10.1046/j.1365-2133.2002.04714.x; Broccardo CJ, 2011, J ALLERGY CLIN IMMUN, V127, P186, DOI 10.1016/j.jaci.2010.10.033; Broccardo CJ, 2009, J ALLERGY CLIN IMMUN, V124, P1113, DOI 10.1016/j.jaci.2009.07.057; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Cedano J, 1997, J MOL BIOL, V266, P594, DOI 10.1006/jmbi.1996.0804; Celis JE, 1998, FEBS LETT, V430, P64, DOI 10.1016/S0014-5793(98)00527-4; Delattre C, 2012, EXP DERMATOL, V21, P205, DOI 10.1111/j.1600-0625.2011.01434.x; Denecker G, 2008, J CELL BIOL, V180, P451, DOI 10.1083/jcb.200709098; Divkovic M, 2005, CONTACT DERMATITIS, V53, P189, DOI 10.1111/j.0105-1873.2005.00683.x; Fletcher ST, 2006, TOXICOL IN VITRO, V20, P975, DOI 10.1016/j.tiv.2005.12.007; Hill EG, 2008, J PROTEOME RES, V7, P3091, DOI 10.1021/pr070520u; Hoste E, 2011, J INVEST DERMATOL, V131, P2233, DOI 10.1038/jid.2011.153; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Jansen Bastiaan J. H., 2003, Briefings in Functional Genomics & Proteomics, V1, P326, DOI 10.1093/bfgp/1.4.326; Jenkinson C, 2010, J INVEST DERMATOL, V130, P732, DOI 10.1038/jid.2009.271; Jenkinson C, 2009, CHEM RES TOXICOL, V22, P1172, DOI 10.1021/tx900095r; Landsteiner K, 1935, J EXP MED, V61, P643, DOI 10.1084/jem.61.5.643; Lepoittevin JP, 1998, HAPTEN PROTEIN INTER, P82; Masaki H, 2010, J DERMATOL SCI, V58, P85, DOI 10.1016/j.jdermsci.2010.03.003; Oberg AL, 2008, J PROTEOME RES, V7, P225, DOI 10.1021/pr700734f; Proksch E, 2006, J DERMATOL SCI, V43, P159, DOI 10.1016/j.jdermsci.2006.06.003; Roosterman D, 2006, PHYSIOL REV, V86, P1309, DOI 10.1152/physrev.00026.2005; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schirle M, 2003, MOL CELL PROTEOMICS, V2, P1297, DOI 10.1074/mcp.M300087-MCP200; Schwarz T, 2003, BRIT J DERMATOL, V149, P2, DOI 10.1046/j.0366-077X.2003.05624.x; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Skipp P, 2005, PROTEOMICS, V5, P1558, DOI 10.1002/pmic.200401044; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Torma H, 2008, J INVEST DERMATOL, V128, P1212, DOI 10.1038/sj.jid.5701170; White GM, 2007, COLOUR ATLAS DERMATO; WIECHELMAN KJ, 1988, ANAL BIOCHEM, V175, P231, DOI 10.1016/0003-2697(88)90383-1; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104; Zhang QH, 2011, J APPL TOXICOL, V31, P762, DOI 10.1002/jat.1630	40	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97772	10.1371/journal.pone.0097772	http://dx.doi.org/10.1371/journal.pone.0097772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849295	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000336730600058
J	Peng, XJ; Teng, LH; Wang, XM; Wang, YC; Shen, SH				Peng Xianjun; Teng Linhong; Wang Xiaoman; Wang Yucheng; Shen Shihua			De Novo Assembly of Expressed Transcripts and Global Transcriptomic Analysis from Seedlings of the Paper Mulberry (Broussonetia kazinoki x Broussonetia papyifera)	PLOS ONE			English	Article							LIGNIN BIOSYNTHESIS; PAPYRIFERA; ANTIOXIDANT; RESPONSES; GROWTH	The paper mulberry is one of the multifunctional tree species in agroforestry systems and is also commonly utilized in traditional medicine in China and other Asian countries. However, little is known about its molecular genetics, which hinders research on and exploitation of this valuable resource. To discern the correlation between gene expression and the essential properties of the paper mulberry, we performed a transcriptomics analysis, assembling a total of 37,725 unigenes from 54,638,676 reads generated by RNA-seq. Among these, 22,692 unigenes showed greater than 60% similarity with genes from other species. The lengths of 13,566 annotated unigenes were longer than 1,000 bp. Functional clustering analysis with COG (Cluster of Orthologous Groups) revealed that 17,184 unigenes are primarily involved in transcription, translation, signal transduction, carbohydrate metabolism, secondary metabolism, and energy metabolism. GO (Gene Ontology) annotation suggests enrichment of genes encoding antioxidant activity, transporter activity, biosynthesis, metabolism and stress response, with a total of 30,659 unigenes falling in these categories. KEGG (Kyoto Encyclopedia of Genes and Genomes) metabolic pathway analysis showed that 7,199 unigenes are associated with 119 metabolic pathways. In addition to the basic metabolism, these genes are enriched for plant pathogen interaction, flavonoid metabolism and other secondary metabolic processes. Furthermore, differences in the transcriptomes of leaf, stem and root tissues were analyzed and 7,233 specifically expressed unigenes were identified. This global expression analysis provided novel insights about the molecular mechanisms of the biosynthesis of flavonoid, lignin and cellulose, as well as on the response to biotic and abiotic stresses including the remediation of contaminated soil by the paper mulberry.	[Peng Xianjun; Teng Linhong; Wang Xiaoman; Wang Yucheng; Shen Shihua] Chinese Acad Sci, Key Lab Plant Resources, Inst Bot, Beijing, Peoples R China; [Teng Linhong; Wang Xiaoman; Wang Yucheng] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Shen, SH (corresponding author), Chinese Acad Sci, Key Lab Plant Resources, Inst Bot, Beijing, Peoples R China.	shshen@ibcas.ac.cn	wang, xiaoman/GQH-0836-2022		foundation of the knowledge innovation project in the Chinese academy [KZCX2-YW-359-2]; National Natural Science Foundation of China [31270653]	foundation of the knowledge innovation project in the Chinese academy; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by foundation of the knowledge innovation project in the Chinese academy (KZCX2-YW-359-2) and the National Natural Science Foundation of China (31270653). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonawitz ND, 2010, ANNU REV GENET, V44, P337, DOI 10.1146/annurev-genet-102209-163508; Bosu PP, 2013, AFR J ECOL, V51, P528, DOI 10.1111/aje.12063; Cheng ZJ, 2001, BIOCHEM PHARMACOL, V61, P939, DOI 10.1016/S0006-2952(01)00543-3; Endler A, 2011, MOL PLANT, V4, P199, DOI 10.1093/mp/ssq079; Endo A, 2012, PLANT CELL PHYSIOL, V53, P16, DOI 10.1093/pcp/pcr171; Fridlender ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031524; Gandotra N, 2013, PLANT J, V74, P48, DOI 10.1111/tpj.12100; Ge G., 2011, PLOS ONE, V6, DOI DOI 10.1371/JOURNAL.PONE.0021220; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo FJ, 2013, PHYTOCHEM LETT, V6, P331, DOI 10.1016/j.phytol.2013.03.017; Gupta D.K., 2013, HEAVY METAL STRESS P, P73, DOI DOI 10.1007/978-3-642-38469-1_4; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; He L, 2001, J GUANGXI U NATL, V7, P121; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Jia GQ, 2013, NAT GENET, V45, P957, DOI 10.1038/ng.2673; Jiang L, 2007, J SW FORESTRY COLL, V7, P71; Kampa A, 2013, P NATL ACAD SCI USA, V110, pE3129, DOI 10.1073/pnas.1305867110; Khraiwesh B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060774; Ko HH, 2008, J NAT PROD, V71, P1930, DOI 10.1021/np800564z; Ko HJ, 2013, BIOMOL THER, V21, P66, DOI 10.4062/biomolther.2012.081; Kuang Y.W., 2012, OPEN J FOR, V2, P71, DOI [DOI 10.4236/OJF.2012.22010, 10.4236/ojf.2012.22010]; Li GY, 2011, B ENVIRON CONTAM TOX, V86, P646, DOI 10.1007/s00128-011-0291-2; Liu ZhaoGang, 2009, Scientia Silvae Sinicae, V45, P54; Matas AJ, 2011, PLANT CELL, V23, P3893, DOI 10.1105/tpc.111.091173; Morgan EC, 2004, WILDLAND WEEDS PAPER; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagpal UMK, 2011, WATER AIR SOIL POLL, V215, P177, DOI 10.1007/s11270-010-0468-z; Ryu HW, 2012, FOOD CHEM, V132, P1244, DOI 10.1016/j.foodchem.2011.11.093; Ryu HW, 2010, J AGR FOOD CHEM, V58, P202, DOI 10.1021/jf903068k; Saito K, 2009, AGROFOREST SYST, V76, P525, DOI 10.1007/s10457-009-9206-1; Skipper M, 2013, NAT REV GENET, V14, DOI 10.1038/nrg3518; Slavov GT, 2012, NEW PHYTOL, V196, P713, DOI 10.1111/j.1469-8137.2012.04258.x; Sohn HY, 2004, PHYTOMEDICINE, V11, P666, DOI 10.1016/j.phymed.2003.09.005; Stanton-Geddes J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065688; Sun XL, 2013, J PLANT PHYSIOL, V170, P505, DOI 10.1016/j.jplph.2012.11.017; Thaiutsa B, 2001, PAPER MULBERRY ALTER, P19; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Vanholme R, 2013, SCIENCE, V341, P1103, DOI 10.1126/science.1241602; Wang LianJun, 2012, African Journal of Biotechnology, V11, P8196, DOI 10.5897/AJB11.243; Wang ZW, 2012, PLANT J, V72, P461, DOI 10.1111/j.1365-313X.2012.05093.x; Wei Hui, 2005, Yingyong Shengtai Xuebao, V16, P1086; Weng JK, 2010, PLANT J, V64, P898, DOI 10.1111/j.1365-313X.2010.04391.x; Xiang XZ, 2007, PROGR TEXTILE SCI TE, V5, P1; Xu ZY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S11-S3; Xue CY, 2006, CHINA PULP PAPER; Yan J, 2011, PLANT DIS, V95, P880, DOI 10.1094/PDIS-03-11-0186; Zhai X., 2012, J NE FORESTRY U, V11; Zhang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048183; Zhang Y.M., 2008, FEED IND, V29, P54; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005	50	23	24	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97487	10.1371/journal.pone.0097487	http://dx.doi.org/10.1371/journal.pone.0097487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848504	Green Submitted, Green Published, gold			2022-12-25	WOS:000336730600031
J	Suda, M; Brooks, SJ; Giampietro, V; Uher, R; Mataix-Cols, D; Brammer, MJ; Williams, SCR; Treasure, J; Campbell, IC				Suda, Masashi; Brooks, Samantha J.; Giampietro, Vincent; Uher, Rudolf; Mataix-Cols, David; Brammer, Michael J.; Williams, Steven C. R.; Treasure, Janet; Campbell, Iain C.			Provocation of Symmetry/Ordering Symptoms in Anorexia nervosa: A Functional Neuroimaging Study	PLOS ONE			English	Article							EATING-DISORDERS; BODY-IMAGE; BULIMIA-NERVOSA; BRAIN; STIMULI; FOOD; VOXEL; VALIDATION; DIMENSIONS; SATIETY	Anorexia nervosa (AN), obsessive-compulsive disorder (OCD), and obsessive-compulsive personality disorder (OCPD) are often co-morbid; however, the aetiology of such co-morbidity has not been well investigated. This study examined brain activation in women with AN and in healthy control (HC) women during the provocation of symmetry/ordering-related anxiety. During provocation, patients with AN showed more anxiety compared to HCs, which was correlated with the severity of symmetry/ordering symptoms. Activation in the right parietal lobe and right prefrontal cortex (rPFC) in response to provocation was reduced in the AN group compared with the HC group. The reduced right parietal activation observed in the AN group is consistent with parietal lobe involvement in visuospatial cognition and with studies of OCD reporting an association between structural abnormalities in this region and the severity of 'ordering' symptoms. Reduced rPFC activation in response to symmetry/ordering provocation has similarities with some, but not all, data collected from patients with AN who were exposed to images of food and bodies. Furthermore, the combination of data from the AN and HC groups showed that rPFC activation during symptom provocation was inversely correlated with the severity of symmetry/ordering symptoms. These data suggest that individuals with AN have a diminished ability to cognitively deal with illness-associated symptoms of provocation. Furthermore, our data also suggest that symptom provocation can progressively overload attempts by the rPFC to exert cognitive control. These findings are discussed in the context of the current neurobiological models of AN.	[Suda, Masashi; Uher, Rudolf; Treasure, Janet; Campbell, Iain C.] Kings Coll London, Inst Psychiat, Sect Eating Disorders, London WC2R 2LS, England; [Brooks, Samantha J.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Giampietro, Vincent; Brammer, Michael J.; Williams, Steven C. R.] Kings Coll London, Inst Psychiat, Ctr Neuroimaging Studies, London WC2R 2LS, England; [Mataix-Cols, David] Kings Coll London, Dept Psychosis Studies, London WC2R 2LS, England; [Mataix-Cols, David] Kings Coll London, Inst Psychiat, Dept Psychol, London WC2R 2LS, England	University of London; King's College London; Uppsala University; University of London; King's College London; University of London; King's College London; University of London; King's College London	Suda, M (corresponding author), Kings Coll London, Inst Psychiat, Sect Eating Disorders, London WC2R 2LS, England.	sudamasashi7@gmail.com	Giampietro, Vincent P/D-1279-2011; Brooks, Samantha/AAJ-2159-2020; Williams, Steve C/D-6979-2011; Uher, Rudolf/A-5477-2008; Mataix-Cols, David/AAF-3347-2021; Mataix-Cols, David/G-3843-2010	Giampietro, Vincent P/0000-0002-9381-8201; Williams, Steve C/0000-0003-4299-1941; Uher, Rudolf/0000-0002-2998-0546; Mataix-Cols, David/0000-0002-4545-0924; Mataix-Cols, David/0000-0002-4545-0924; Brooks, Samantha/0000-0002-9146-6257; Treasure, Janet/0000-0003-0871-4596; opoku, anita/0000-0001-7243-8157	Canon Foundation in Europe Fellowship; Nina Jackson Fellowship (Research Into Eating Disorders)	Canon Foundation in Europe Fellowship; Nina Jackson Fellowship (Research Into Eating Disorders)	Masashi Suda was financially supported by Canon Foundation in Europe Fellowship, and Samantha J. Brooks was financially supported by the Nina Jackson Fellowship (Research Into Eating Disorders). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartholdy S, 2013, EUR EAT DIS IN PRESS; Boghi A, 2011, PSYCHIAT RES-NEUROIM, V192, P154, DOI 10.1016/j.pscychresns.2010.12.008; Brammer MJ, 1997, MAGN RESON IMAGING, V15, P763, DOI 10.1016/S0730-725X(97)00135-5; Brooks SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022259; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Castellini G, 2013, EUR PSYCHIAT, V28, P427, DOI 10.1016/j.eurpsy.2012.06.006; Castro-Fornieles J, 2010, PROG NEURO-PSYCHOPH, V34, P1049, DOI 10.1016/j.pnpbp.2010.05.020; de Vries FE, 2013, CNS SPECTRUMS, V1, P1; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; Favaro A, 2012, BIOL PSYCHIAT, V72, P864, DOI 10.1016/j.biopsych.2012.04.025; First M. B., 1997, STRUCTURED CLIN INTE; Foa EB, 2002, PSYCHOL ASSESSMENT, V14, P485, DOI 10.1037//1040-3590.14.4.485; Frank GKW, 2012, NEUROPSYCHOPHARMACOL, V37, P2031, DOI 10.1038/npp.2012.51; Friederich HC, 2010, NEUROPSYCHOLOGIA, V48, P2878, DOI 10.1016/j.neuropsychologia.2010.04.036; Frieling H, 2012, J PSYCHIATR RES, V46, P1237, DOI 10.1016/j.jpsychires.2012.06.005; Geliebter A, 2006, APPETITE, V46, P31, DOI 10.1016/j.appet.2005.09.002; Gilbert AR, 2009, J AM ACAD CHILD PSY, V48, P936, DOI 10.1097/CHI.0b013e3181b2163c; Gizewski ER, 2010, NEUROPSYCHOBIOLOGY, V62, P182, DOI 10.1159/000319360; Goethals I, 2007, J PSYCHIATR RES, V41, P1005, DOI 10.1016/j.jpsychires.2006.09.003; Joos AAB, 2011, PSYCHIAT RES-NEUROIM, V191, P189, DOI 10.1016/j.pscychresns.2010.11.008; Kaye WH, 2009, NAT REV NEUROSCI, V10, P573, DOI 10.1038/nrn2682; Koskina A, 2013, NEUROSCI BIOBEHAV R, V37, P193, DOI 10.1016/j.neubiorev.2012.11.010; Lao-Kaim N, 2013, EUR PSYCHIAT; Lawrence NS, 2006, NEUROPSYCHOLOGY, V20, P409, DOI 10.1037/0894-4105.20.4.409; Lilenfeld LR, 1998, ARCH GEN PSYCHIAT, V55, P603, DOI 10.1001/archpsyc.55.7.603; Mataix-Cols D, 2009, PSYCHIAT RES, V168, P238, DOI 10.1016/j.psychres.2008.05.007; Matsunaga H, 1999, PSYCHOL MED, V29, P407, DOI 10.1017/S003329179800796X; McAdams CJ, 2011, PSYCHIAT RES-NEUROIM, V194, P54, DOI 10.1016/j.pscychresns.2011.06.016; McClelland J, 2013, EUR EAT DIS IN PRESS; McFadden KL, 2013, J PSYCHIATR NEUROSCI, V38; Micali N, 2011, PSYCHOL MED, V41, P2507, DOI 10.1017/S003329171100078X; Miyake Y, 2010, NEUROIMAGE, V50, P1333, DOI 10.1016/j.neuroimage.2009.12.095; Mohr HM, 2010, PSYCHOL MED, V40, P1519, DOI 10.1017/S0033291709991826; Naruo T, 2001, BMC PSYCHIATRY, V1, DOI 10.1186/1471-244X-1-2; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Rastam M, 2001, DEV MED CHILD NEUROL, V43, P239, DOI 10.1017/S0012162201000457; Rosenberg M. S., 2007, METAWIN STAT SOFTWAR; Sachdev P, 2008, NEUROPSYCHOLOGIA, V46, P2161, DOI 10.1016/j.neuropsychologia.2008.02.031; Santel S, 2006, BRAIN RES, V1114, P138, DOI 10.1016/j.brainres.2006.07.045; Sato Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061108; Schmidt U, 2006, BRIT J CLIN PSYCHOL, V45, P343, DOI 10.1348/014466505X53902; Schulte-Ruther M, 2012, J AM ACAD CHILD PSY, V51, P832, DOI 10.1016/j.jaac.2012.06.007; SRINIVASAGAM NM, 1995, AM J PSYCHIAT, V152, P1630; Suchan B, 2012, BEHAV BRAIN RES; Suda M, 2013, INT J EAT DISORD; Suda M, 2011, BIOL PSYCHIAT, V70, pE35, DOI 10.1016/j.biopsych.2011.03.034; Swinbourne JM, 2007, EUR EAT DISORD REV, V15, P253, DOI 10.1002/erv.784; Thirion B, 2007, NEUROIMAGE, V35, P105, DOI 10.1016/j.neuroimage.2006.11.054; Treasure J, 2010, LANCET, V375, P583, DOI 10.1016/S0140-6736(09)61748-7; Uher R, 2005, BIOL PSYCHIAT, V58, P990, DOI 10.1016/j.biopsych.2005.06.001; Uher R, 2004, AM J PSYCHIAT, V161, P1238, DOI 10.1176/appi.ajp.161.7.1238; van den Eynde F, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-302; van den Heuvel OA, 2009, BRAIN, V132, P853, DOI 10.1093/brain/awn267; Vocks S, 2011, PSYCHOL MED, V41, P1651, DOI 10.1017/S0033291710002382; Wagner A, 2007, AM J PSYCHIAT, V164, P1842, DOI 10.1176/appi.ajp.2007.07040575; Zastrow A, 2009, AM J PSYCHIAT, V166, P608, DOI 10.1176/appi.ajp.2008.08050775; Zhu YK, 2012, EUR EAT DISORD REV, V20, P439, DOI 10.1002/erv.2197; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	59	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97998	10.1371/journal.pone.0097998	http://dx.doi.org/10.1371/journal.pone.0097998			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0UW	24844926	Green Published, Green Submitted, gold			2022-12-25	WOS:000339563400078
J	Wu, QW; Yang, QM; Huang, YF; She, HQ; Liang, J; Yang, QL; Zhang, ZM				Wu, Qiu-Wan; Yang, Qing-Mo; Huang, Yu-Fan; She, Hong-Qiang; Liang, Jing; Yang, Qiao-Lu; Zhang, Zhi-Ming			Expression and Clinical Significance of Matrix Metalloproteinase-9 in Lymphatic Invasiveness and Metastasis of Breast Cancer	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; MMP-9; INVASION; MARKER; D2-40; METALLOPROTEINASES; PODOPLANIN; CARCINOMA; SERUM; NODE	Background: Matrix metalloproteinase 9 (MMP-9) is a type-IV collagenase that is highly expressed in breast cancer, but its exact role in tumor progression and metastasis is unclear. Methods: MMP-9 mRNA and protein expression was examined by real-time reverse transcriptase PCR and immunohistochemical staining, respectively, in 41 breast cancer specimens with matched peritumoral benign breast epithelial tissue and suspicious metastatic axillary lymph nodes. Lymph vessels were labeled with D2-40 and lymphatic microvessel density (LMVD) was calculated. Correlation of MMP-9 protein expression with clinicopathological parameters and LMVD was also evaluated. Results: MMP-9(+) staining in breast cancer specimens (35/41, 85.4%) was higher than in matched epithelium (21/41, 51.2%; P<0.05) and lymph nodes (13/41, 31.7%; P<0.001). Higher MMP-9 mRNA expression was also detected in tumor specimens compared with matched epithelial tissues and lymph nodes (P<0.05). Elevated MMP-9 expression was correlated with lymph node metastasis and LMVD (P<0.05). Conclusion: MMP-9 was overexpressed in breast cancer specimens compared with peritumoral benign breast epithelium and lymph nodes. Moreover, its expression in the matched epithelium and lymph nodes was positively associated with lymph node metastasis, and its expression in lymph nodes was positively associated with lymphangiogenesis in breast cancer. Thus, MMP-9 is a potential marker for breast cancer progression.	[Zhang, Zhi-Ming] Xiamen Univ, Affiliated Hosp 1, Xiamen Canc Ctr, Xiamen, Peoples R China; Xiamen Univ, Affiliated Hosp 1, Dept Breast Surg, Xiamen, Peoples R China	Xiamen University; Xiamen University	Zhang, ZM (corresponding author), Xiamen Univ, Affiliated Hosp 1, Xiamen Canc Ctr, Xiamen, Peoples R China.	zhangzhiming164@aliyun.com			Young Foundation of the Health Department of Fujian Province, China [2011-2-61]; Young Foundation of the Science and Technology Department of Fujian Province, China [2012D053]; Science and Technology Bureau of Xiamen, China [3502Z20104024]	Young Foundation of the Health Department of Fujian Province, China; Young Foundation of the Science and Technology Department of Fujian Province, China; Science and Technology Bureau of Xiamen, China	This work was supported by Young Foundation of the Health Department of Fujian Province, China (No. 2011-2-61), Young Foundation of the Science and Technology Department of Fujian Province, China (No. 2012D053) and Science and Technology Bureau of Xiamen, China (No. 3502Z20104024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achen MG, 2008, ANN NY ACAD SCI, V1131, P225, DOI 10.1196/annals.1413.020; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Daniele A, 2010, ANTICANCER RES, V30, P3521; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; El-Gohary YM, 2008, AM J CLIN PATHOL, V129, P578, DOI 10.1309/2HGNJ1GU57JMBJAQ; Elston C W, 2002, Histopathology, V41, P154; Figueira RCS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-20; Fohn LE, 2011, J AM ACAD DERMATOL, V64, P336, DOI 10.1016/j.jaad.2010.03.005; Hasebe T, 2008, HUM PATHOL, V39, P427, DOI 10.1016/j.humpath.2007.07.016; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Mylona E, 2007, HISTOPATHOLOGY, V50, P338, DOI 10.1111/j.1365-2559.2007.02615.x; Niakosari F, 2005, ARCH DERMATOL, V141, P440, DOI 10.1001/archderm.141.4.440; Pellikainen JM, 2004, CLIN CANCER RES, V10, P7621, DOI 10.1158/1078-0432.CCR-04-1061; Rabban JT, 2008, HUM PATHOL, V39, P175, DOI 10.1016/j.humpath.2007.06.018; Ran Sophia, 2010, Pathophysiology, V17, P229, DOI 10.1016/j.pathophys.2009.11.003; Schacht V, 2005, AM J PATHOL, V166, P913, DOI 10.1016/S0002-9440(10)62311-5; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Suzuki H, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-287; Van der Auwera I, 2006, BRIT J CANCER, V95, P1611, DOI 10.1038/sj.bjc.6603445; Wu ZS, 2008, INT J CANCER, V122, P2050, DOI 10.1002/ijc.23337	20	83	86	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97804	10.1371/journal.pone.0097804	http://dx.doi.org/10.1371/journal.pone.0097804			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845596	Green Submitted, Green Published, gold			2022-12-25	WOS:000339563400062
J	Delbridge, ARD; Grabow, S; Bouillet, P; Adams, JM; Strasser, A				Delbridge, A. R. D.; Grabow, S.; Bouillet, P.; Adams, J. M.; Strasser, A.			Functional antagonism between pro-apoptotic BIM and anti-apoptotic BCL-XL in MYC-induced lymphomagenesis	ONCOGENE			English	Article							B-CELL LYMPHOMAS; DRIVEN LYMPHOMAGENESIS; HOMOZYGOUS DELETIONS; HEMATOPOIETIC-CELLS; TRANSGENIC MICE; DEFICIENT MICE; C-MYC; PUMA; BCL-X(L); DEATH	Genomic analyses revealed that many cancers have acquired abnormalities in their expression of pro-or anti-apoptotic members of the BCL-2 protein family. It is, however, unknown whether changes in pro-or anti-apoptotic BCL-2 family members have similar impact on tumorigenesis or whether changes in one subgroup have disproportionate impact. We compared the consequences of concomitant loss of anti-apoptotic Bclx and pro-apoptotic Bim on MYC-induced lymphomagenesis. Whereas only loss of both Bclx alleles markedly forestalled tumorigenesis, loss of a single Bim allele overcame this blockade. Conversely, loss of even a single Bim allele sufficed to substantially accelerate lymphomagenesis, and only loss of both but not loss of a single allele of Bclx could attenuate this acceleration. The evidence that modest (two-fold) monoallelic changes in the expression of at least some BH3-only proteins can profoundly impact tumorigenesis suggests that such aberrations, imposed by epigenetic or genetic changes, may expedite tumorigenesis more effectively than elevated expression of pro-survival BCL-2 family members. These findings further our understanding of the mechanisms of lymphomagenesis and possibly also cancer therapy.	[Delbridge, A. R. D.; Grabow, S.; Bouillet, P.; Adams, J. M.; Strasser, A.] Walter & Eliza Hall Inst Med Res, Mol Genet Canc Div, Melbourne, Vic 3050, Australia; [Delbridge, A. R. D.; Grabow, S.; Bouillet, P.; Adams, J. M.; Strasser, A.] Univ Melbourne, Dept Mol Biol, Melbourne, Vic, Australia	Walter & Eliza Hall Institute; University of Melbourne	Strasser, A (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Mol Genet Canc Div, 1G Royal Parade, Parkville, Vic 3050, Australia.	strasser@wehi.edu.au	Adams, Jerry M/E-1199-2013; Strasser, Andreas/C-7581-2013; Bouillet, Philippe/E-1241-2013	Strasser, Andreas/0000-0002-5020-4891; Bouillet, Philippe/0000-0002-9012-6058; Adams, Jerry/0000-0002-4360-8628	National Health and Medical Research Council of Australia [461221/1016701, 1020363, 1046010]; Leukemia and Lymphoma Society [7413, 7001-13]; Cancer Council Victoria (CCV) [1052309]; Cancer Council of Victoria; Lady Tata Postdoctoral Fellowship; Melbourne International Research Scholarship (University of Melbourne); Melbourne International Fee Remission Scholarship (University of Melbourne); Australian Postgraduate Award; Cancer Therapeutics CRC Top-up Scholarship; Australian Government (IRISS); Victorian State Government (OIS)	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Cancer Council Victoria (CCV)(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Lady Tata Postdoctoral Fellowship; Melbourne International Research Scholarship (University of Melbourne); Melbourne International Fee Remission Scholarship (University of Melbourne); Australian Postgraduate Award(Australian Government); Cancer Therapeutics CRC Top-up Scholarship(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government (IRISS)(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government (OIS)	We thank PN Kelly (NIH) for previously published work that laid the foundation for the present study, G Siciliano and his team for animal husbandry, the FACS facility and the histology facility at The Walter and Eliza Hall Institute. Work in the authors' laboratory was supported by the National Health and Medical Research Council of Australia (program grant 461221/1016701, Fellowship 1020363, NHMRC Project 1046010), the Leukemia and Lymphoma Society (SCOR grant #7413; 7001-13), the Cancer Council Victoria (CCV grant 1052309), and fellowships from the Cancer Council of Victoria (SG), Lady Tata Postdoctoral Fellowship (SG), Melbourne International Research Scholarship (University of Melbourne, SG), Melbourne International Fee Remission Scholarship (University of Melbourne, SG), Australian Postgraduate Award (ARDD) and Cancer Therapeutics CRC Top-up Scholarship (SG and ARDD). This work was made possible by operational infrastructure grants through the Australian Government (IRISS) and the Victorian State Government (OIS).	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Akhtar RS, 2008, J HISTOCHEM CYTOCHEM, V56, P921, DOI 10.1369/jhc.2008.951749; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cragg MS, 2009, NAT REV CANCER, V9, P321, DOI 10.1038/nrc2615; Delbridge ARD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008789; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Garrison SP, 2008, MOL CELL BIOL, V28, P5391, DOI 10.1128/MCB.00907-07; Happo L, 2010, BLOOD, V116, P5256, DOI 10.1182/blood-2010-04-280818; KAPLAN HENRY S., 1964, NAT CANCER INST MONOGR, V14, P207; Kelly PN, 2013, CELL DEATH DIFFER, V20, P57, DOI 10.1038/cdd.2012.92; Kelly PN, 2007, BLOOD, V109, P4907, DOI 10.1182/blood-2006-10-051847; Kelly PN, 2011, BLOOD, V118, P6380, DOI 10.1182/blood-2011-07-367672; Labi V, 2008, J EXP MED, V205, P641, DOI 10.1084/jem.20071658; Merino D, 2012, BLOOD, V119, P5807, DOI 10.1182/blood-2011-12-400929; Mestre-Escorihuela C, 2007, BLOOD, V109, P271, DOI 10.1182/blood-2006-06-026500; Michalak EM, 2009, CELL DEATH DIFFER, V16, P684, DOI 10.1038/cdd.2008.195; Michalak EM, 2010, GENE DEV, V24, P1608, DOI 10.1101/gad.1940110; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Print CG, 1998, P NATL ACAD SCI USA, V95, P12424, DOI 10.1073/pnas.95.21.12424; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Swanson PJ, 2004, J IMMUNOL, V172, P6684, DOI 10.4049/jimmunol.172.11.6684; Tagawa H, 2005, ONCOGENE, V24, P1348, DOI 10.1038/sj.onc.1208300; TSUJIMOTO Y, 1984, SCIENCE, V224, P1403, DOI 10.1126/science.6610211	27	19	19	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 2	2015	34	14					1872	1876		10.1038/onc.2014.132	http://dx.doi.org/10.1038/onc.2014.132			5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CE9IQ	24858047				2022-12-25	WOS:000352158000014
J	Carter, AM; Gutowski, S; Sternweis, PC				Carter, Angela M.; Gutowski, Stephen; Sternweis, Paul C.			Regulated Localization Is Sufficient for Hormonal Control of Regulator of G Protein Signaling Homology Rho Guanine Nucleotide Exchange Factors (RH-RhoGEFs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE RECRUITMENT; P115 RHOGEF; GTPASE ACTIVATION; PDZ-RHOGEF; DOMAIN; P115-RHOGEF; G-ALPHA(13); REQUIRES; RAC; STIMULATION	The regulator of Gprotein signaling homology (RH) Rho guanine nucleotide exchange factors (RhoGEFs) (p115RhoGEF, leukemia-associated RhoGEF, and PDZ-RhoGEF) contain an RH domain and are specific GEFs for the monomeric GTPase RhoA. The RH domains interact specifically with the alpha subunits of G(12) heterotrimeric GTPases. Activated G alpha(13) modestly stimulates the exchange activity of both p115RhoGEF and leukemia-associated RhoGEF but not PDZ-RhoGEF. Because all three RH-RhoGEFs can localize to the plasma membrane upon expression of activated G alpha(13), cellular localization of these RhoGEFs has been proposed as a mechanism for controlling their activity. We use a small molecule-regulated heterodimerization system to rapidly control the localization of RH-RhoGEFs. Acute localization of the proteins to the plasma membrane activates RhoA within minutes and to levels that are comparable with activation of RhoA by hormonal stimulation of G protein-coupled receptors. The catalytic activity of membrane-localized RhoGEFs is not dependent on activated G alpha(13). We further show that the conserved RH domains can rewire two different RacGEFs to activate Rac1 in response to a traditional activator of RhoA. Thus, RH domains act as independent detectors for activated G alpha(13) and are sufficient to modulate the activity of RhoGEFs by hormones via mediating their localization to substrate, membrane-associated RhoA.	[Carter, Angela M.; Gutowski, Stephen; Sternweis, Paul C.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Sternweis, PC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	Paul.Sternweis@UTsouthwestern.edu		Carter, Angela/0000-0001-5766-3743	National Institute of Health [GM31954]; National Institutes of Health Pharmacological Sciences Training Grant [GM007062]; Robert A. Welch Foundation [I-1262]; Alfred and Mabel Gilman Chair in Molecular Pharmacology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031954, T32GM007062] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Pharmacological Sciences Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Alfred and Mabel Gilman Chair in Molecular Pharmacology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institute of Health Grant GM31954 (to P. C. S.) and by National Institutes of Health Pharmacological Sciences Training Grant GM007062 (to A. M. C.). This work was also supported by Robert A. Welch Foundation Grant I-1262 (to P. C. S.) and by the Alfred and Mabel Gilman Chair in Molecular Pharmacology (to P. C. S.).	Aittaleb M, 2009, CELL SIGNAL, V21, P1569, DOI 10.1016/j.cellsig.2009.06.003; Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; Banerjee J, 2009, BIOCHEMISTRY-US, V48, P8032, DOI 10.1021/bi9010013; Benard V, 2002, METHOD ENZYMOL, V345, P349; Bhattacharyya R, 2003, BIOCHEM J, V371, P709, DOI 10.1042/BJ20021897; Bhattacharyya R, 2000, J BIOL CHEM, V275, P14992, DOI 10.1074/jbc.M000415200; Bhattacharyya R, 2009, CELL SIGNAL, V21, P996, DOI 10.1016/j.cellsig.2009.02.010; Chen Z, 2008, STRUCTURE, V16, P1532, DOI 10.1016/j.str.2008.07.009; Chen Z, 2012, J BIOL CHEM, V287, P25490, DOI 10.1074/jbc.M111.333716; Chen Z, 2010, J BIOL CHEM, V285, P21070, DOI 10.1074/jbc.M110.122549; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Donald S, 2004, FEBS LETT, V572, P172, DOI 10.1016/j.febslet.2004.06.096; Frost JA, 2000, J BIOL CHEM, V275, P19693, DOI 10.1074/jbc.M909860199; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hirotani M, 2002, BIOCHEM BIOPH RES CO, V297, P32, DOI 10.1016/S0006-291X(02)02122-8; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Longhurst DM, 2006, J BIOL CHEM, V281, P12030, DOI 10.1074/jbc.M513756200; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Mao JH, 1998, P NATL ACAD SCI USA, V95, P12973, DOI 10.1073/pnas.95.22.12973; Medina F, 2013, J BIOL CHEM, V288, P11325, DOI 10.1074/jbc.M113.450056; Meyer BH, 2008, J CELL BIOCHEM, V104, P1660, DOI 10.1002/jcb.21732; Rosenfeldt H, 2004, FEBS LETT, V572, P167, DOI 10.1016/j.febslet.2004.06.097; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Sternweis PC, 2007, ADV PROTEIN CHEM, V74, P189, DOI 10.1016/S0065-3233(07)74006-8; Suzuki N, 2003, P NATL ACAD SCI USA, V100, P733, DOI 10.1073/pnas.0234057100; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Wells CD, 2002, J BIOL CHEM, V277, P1174, DOI 10.1074/jbc.M105274200; Wells CD, 2001, J BIOL CHEM, V276, P28897, DOI 10.1074/jbc.M102913200; Yamada T, 2005, J BIOL CHEM, V280, P19358, DOI 10.1074/jbc.M414561200	33	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19737	19746		10.1074/jbc.M114.564930	http://dx.doi.org/10.1074/jbc.M114.564930			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24855647	hybrid, Green Published			2022-12-25	WOS:000339326800045
J	Ge, YH; Wu, FX; Sun, XJ; Xiang, ZH; Yang, LQ; Huang, SD; Lu, ZJ; Sun, YM; Yu, WF				Ge, Yanhu; Wu, Feixiang; Sun, Xuejun; Xiang, Zhenghua; Yang, Liqun; Huang, Shengdong; Lu, Zhijie; Sun, Yuming; Yu, Wei-Feng			Intrathecal Infusion of Hydrogen-Rich Normal Saline Attenuates Neuropathic Pain via Inhibition of Activation of Spinal Astrocytes and Microglia in Rats	PLOS ONE			English	Article							REACTIVE OXYGEN; TACTILE ALLODYNIA; OXIDATIVE STRESS; NERVE INJURY; HYPERALGESIA; CORD; INVOLVEMENT; CONTRIBUTE; MODEL; SENSITIZATION	Background: Reactive oxygen and nitrogen species are key molecules that mediate neuropathic pain. Although hydrogen is an established antioxidant, its effect on chronic pain has not been characterized. This study was to investigate the efficacy and mechanisms of hydrogen-rich normal saline induced analgesia. Methodology/Principal findings: In a rat model of neuropathic pain induced by L5 spinal nerve ligation (L5 SNL), intrathecal injection of hydrogen-rich normal saline relieved L5 SNL-induced mechanical allodynia and thermal hyperalgesia. Importantly, repeated administration of hydrogen-rich normal saline did not lead to tolerance. Preemptive treatment with hydrogen-rich normal saline prevented development of neuropathic pain behavior. Immunofluorochrome analysis revealed that hydrogen-rich normal saline treatment significantly attenuated L5 SNL-induced increase of 8-hydroxyguanosine immunoreactive cells in the ipsilateral spinal dorsal horn. Western blot analysis of SDS/PAGE-fractionated tyrosine-nitrated proteins showed that L5 SNL led to increased expression of tyrosine-nitrated Mn-containing superoxide dismutase (MnSOD) in the spinal cord, and hydrogen-rich normal saline administration reversed the tyrosine-nitrated MnSOD overexpression. We also showed that the analgesic effect of hydrogen-rich normal saline was associated with decreased activation of astrocytes and microglia, attenuated expression of interleukin-1 beta (IL-1 beta) and tumor necrosis factor-a (TNF-alpha) in the spinal cord. Conclusion/Significance: Intrathecal injection of hydrogen-rich normal saline produced analgesic effect in neuropathic rat. Hydrogen-rich normal saline-induced analgesia in neuropathic rats is mediated by reducing the activation of spinal astrocytes and microglia, which is induced by overproduction of hydroxyl and peroxynitrite.	[Ge, Yanhu; Wu, Feixiang; Yang, Liqun; Lu, Zhijie; Sun, Yuming; Yu, Wei-Feng] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Changhai Hosp, Dept Anesthesiol, Shanghai, Peoples R China; [Ge, Yanhu] 309th Hosp CPLA, Dept Anesthesiol, Beijing, Peoples R China; [Sun, Xuejun] Second Mil Med Univ, Fac Naval Med, Dept Diving Med, Shanghai, Peoples R China; [Xiang, Zhenghua] Second Mil Med Univ, Dept Neurobiol, Shanghai, Peoples R China; [Huang, Shengdong] Second Mil Med Univ, Changhai Hosp, Dept Cardiothorac Surg, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Naval Medical University	Yu, WF (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Changhai Hosp, Dept Anesthesiol, Shanghai, Peoples R China.	ywf808@sohu.com	sun, xuejun/A-5561-2010; Yu, Wei/GZL-3831-2022	sun, xuejun/0000-0003-2387-5531; 	National Natural Science Foundation of China [30901403, 31171013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from the National Natural Science Foundation of China (30901403, 31171013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmoaty S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075543; ADAMS MWW, 1980, BIOCHIM BIOPHYS ACTA, V594, P105, DOI 10.1016/0304-4173(80)90007-5; ASTIZ M, 2013, NEUROTOX RES; BALAZS L, 1994, NEUROCHEM RES, V19, P1131, DOI 10.1007/BF00965146; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen H, 2010, BIOCHEM BIOPH RES CO, V393, P308, DOI 10.1016/j.bbrc.2010.02.005; Chen ZM, 2010, PAIN, V149, P100, DOI 10.1016/j.pain.2010.01.015; Chiang CY, 2012, NEUROCHEM RES, V37, P2419, DOI 10.1007/s11064-012-0801-6; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Dhainaut A, 2000, J MED CHEM, V43, P2165, DOI 10.1021/jm991154w; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Fidanboylu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025212; Gao YJ, 2010, NEUROTHERAPEUTICS, V7, P482, DOI 10.1016/j.nurt.2010.05.016; GERLACH M, 1994, J NEUROCHEM, V63, P793, DOI 10.1046/j.1471-4159.1994.63030793.x; GOTZ ME, 1994, PHARMACOL THERAPEUT, V63, P37, DOI 10.1016/0163-7258(94)90055-8; Hackel D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063564; Hald A, 2005, EXP NEUROL, V193, P279, DOI 10.1016/j.expneurol.2005.01.013; Hald A, 2009, CELL MOL NEUROBIOL, V29, P609, DOI 10.1007/s10571-009-9390-6; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hayashida K, 2008, BIOCHEM BIOPH RES CO, V373, P30, DOI 10.1016/j.bbrc.2008.05.165; HUANG ZX, 2014, PAIN; JENNER P, 1994, LANCET, V344, P796, DOI 10.1016/S0140-6736(94)92347-7; Ji RR, 2013, PAIN; Ji RR, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-33; Ji RR, 2006, NEURON GLIA BIOL, V2, P259, DOI 10.1017/S1740925X07000403; Ji XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060733; Khalil Z, 1999, PAIN, V79, P31, DOI 10.1016/S0304-3959(98)00143-2; Kim D, 2010, P NATL ACAD SCI USA, V107, P14851, DOI 10.1073/pnas.1009926107; Kim HK, 2006, PAIN, V122, P53, DOI 10.1016/j.pain.2006.01.013; Kim HK, 2004, PAIN, V111, P116, DOI 10.1016/j.pain.2004.06.008; KIM JA, 2013, NEUROPHARMACOLOGY; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Lee JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073948; Lee KY, 2010, J NEUROPHYSIOL, V103, P382, DOI 10.1152/jn.90906.2008; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Little JW, 2013, PAIN, V154, P978, DOI 10.1016/j.pain.2013.02.018; Liu XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075804; Lu RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029240; Manczak M, 2005, J NEUROCHEM, V92, P494, DOI 10.1111/j.1471-4159.2004.02884.x; Muscoli C, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/950947; Nakamura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073640; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Okada-Ogawa A, 2009, J NEUROSCI, V29, P11161, DOI 10.1523/JNEUROSCI.3365-09.2009; OLANOW CW, 1992, ANN NEUROL, V32, pS2, DOI 10.1002/ana.410320703; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234; Reth M, 2002, NAT IMMUNOL, V3, P1129, DOI 10.1038/ni1202-1129; Salvemini D, 2011, FREE RADICAL BIO MED, V51, P951, DOI 10.1016/j.freeradbiomed.2011.01.026; Salvemini D, 2010, LIFE SCI, V86, P604, DOI 10.1016/j.lfs.2009.06.011; Sun QA, 2011, J SURG RES, V165, pE43, DOI 10.1016/j.jss.2010.09.024; Swartjes M, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-13; Tal M, 1996, NEUROREPORT, V7, P1382, DOI 10.1097/00001756-199605310-00010; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Watkins LR, 1997, PAIN, V71, P225, DOI 10.1016/S0304-3959(97)03369-1; Wei H, 2013, PHARMACOL BIOCHEM BE, V111, P30, DOI 10.1016/j.pbb.2013.08.003; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Yang CM, 2013, MOL NEUROBIOL, V47, P1020, DOI 10.1007/s12035-013-8402-1; Zhang FX, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-15; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072943; Zhang YF, 2011, INT J CARDIOL, V148, P91, DOI 10.1016/j.ijcard.2010.08.058	65	27	32	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97436	10.1371/journal.pone.0097436	http://dx.doi.org/10.1371/journal.pone.0097436			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24857932	gold, Green Submitted, Green Published			2022-12-25	WOS:000336839400015
J	Roullier-Gall, C; Lucio, M; Noret, L; Schmitt-Kopplin, P; Gougeon, RD				Roullier-Gall, Chloe; Lucio, Marianna; Noret, Laurence; Schmitt-Kopplin, Philippe; Gougeon, Regis D.			How Subtle Is the "Terroir'' Effect? Chemistry-Related Signatures of Two "Climats de Bourgogne''	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; VITIS-VINIFERA L.; GEOGRAPHICAL ORIGIN; MULTIVARIATE DISCRIMINATION; GRAPE VARIETIES; PINOT-NOIR; WINE; H-1-NMR; RESVERATROL; VINTAGE	The chemical composition of grape berries is influenced by various environmental conditions often considered to be representative of a "terroir''. If grapes from a given terroir are assumed to reflect this origin in their chemical compositions, the corresponding wine should also reflect it. The aim of this work was therefore to reveal the "terroir'' expression within the chemodiversity of grapes and related wines, using ultrahigh-resolution mass spectrometry. Grapes and corresponding wines, from two distinct - though very proximate - terroirs of Burgundy were analyzed over three vintages (2010, 2011 and 2012). Ultrahigh-resolution mass spectrometry and ultra-high performance liquid chromatography were used as untargeted and targeted approaches to discriminate complex chemical fingerprints for vintages, classes (wines, skins or musts), and terroirs. Statistical analyses revealed that even if vintages have the most significant impact on fingerprints, the most significant terroir differences are seen in the grapes of a given vintage.	[Roullier-Gall, Chloe; Noret, Laurence; Gougeon, Regis D.] Univ Bourgogne, AgroSupDijon, Equipe Proc Alimentaires & Phys Chim, Inst Univ Vigne & Vin,UMR Proc Alimentaires & Mic, Dijon, France; [Roullier-Gall, Chloe; Lucio, Marianna; Schmitt-Kopplin, Philippe] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Analyt BioGeoChem, Neuherberg, Germany; [Schmitt-Kopplin, Philippe] Tech Univ Munich, Chair Analyt Food Chem, Freising Weihenstephan, Germany	Institut Agro; AgroSup Dijon; Universite de Bourgogne; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Schmitt-Kopplin, P (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Analyt BioGeoChem, Neuherberg, Germany.	schmitt-kopplin@helmholtz-muenchen.de; regis.gougeon@u-bourgogne.fr	Gougeon, Régis D/T-4069-2017; Schmitt-Kopplin, Philippe/H-6271-2011	Gougeon, Régis D/0000-0002-5371-5523; Schmitt-Kopplin, Philippe/0000-0003-0824-2664; Lucio, Marianna/0000-0002-5844-0098	Regional Council of Burgundy; Interprofessionnals of Burgundy; Interprofessionnals of Champagne	Regional Council of Burgundy(Region Bourgogne-Franche-Comte); Interprofessionnals of Burgundy; Interprofessionnals of Champagne	Fundings were from the Regional Council of Burgundy, the Interprofessionnals of Burgundy, and the Interprofessionnals of Champagne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali K, 2011, J BIOMOL NMR, V49, P255, DOI 10.1007/s10858-011-9487-3; [Anonymous], PROGR AUTHENTICATION; Boutegrabet L, 2012, APPROCHE METABOLOMIQ; Boutegrabet L, 2012, CHEM-EUR J, V18, P13059, DOI 10.1002/chem.201103788; Boutegrabet L, 2011, ANAL BIOANAL CHEM, V401, P1513, DOI 10.1007/s00216-011-4879-5; Brescia MA, 2002, ANAL CHIM ACTA, V458, P177, DOI 10.1016/S0003-2670(01)01532-X; Capron X, 2007, FOOD CHEM, V101, P1585, DOI 10.1016/j.foodchem.2006.04.019; Catharino RR, 2006, J MASS SPECTROM, V41, P185, DOI 10.1002/jms.976; Charlton AJ, 2010, EUR FOOD RES TECHNOL, V231, P733, DOI 10.1007/s00217-010-1299-2; Chira K, 2011, FOOD CHEM, V126, P1971, DOI 10.1016/j.foodchem.2010.12.056; Cooper HJ, 2001, J AGR FOOD CHEM, V49, P5710, DOI 10.1021/jf0108516; Cortell JM, 2005, J AGR FOOD CHEM, V53, P5798, DOI 10.1021/jf0504770; Cuadros-Inostroza A, 2010, ANAL CHEM, V82, P3573, DOI 10.1021/ac902678t; Fischer U, 1999, FOOD QUAL PREFER, V10, P281, DOI 10.1016/S0950-3293(99)00008-7; Forcisi S, 2013, J CHROMATOGR A, V1292, P51, DOI 10.1016/j.chroma.2013.04.017; Godelmann R, 2013, J AGR FOOD CHEM, V61, P5610, DOI 10.1021/jf400800d; GOLDBERG DM, 1995, J CHROMATOGR A, V708, P89, DOI 10.1016/0021-9673(95)00368-W; Gougeon RD, 2009, P NATL ACAD SCI USA, V106, P9174, DOI 10.1073/pnas.0901100106; He F, 2010, AUST J GRAPE WINE R, V16, P464, DOI 10.1111/j.1755-0238.2010.00107.x; Sawaya ACHF, 2011, CIENCIA TECNOL ALIME, V31, P730, DOI 10.1590/S0101-20612011000300027; Hertkorn N, 2007, ANAL BIOANAL CHEM, V389, P1311, DOI 10.1007/s00216-007-1577-4; JEANDET P, 1995, AM J ENOL VITICULT, V46, P1; Koundouras S, 2006, J AGR FOOD CHEM, V54, P5077, DOI 10.1021/jf0605446; Kumsta M, 2012, HORTIC SCI, V39, P38, DOI 10.17221/126/2010-HORTSCI; Lee JEY, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/7/074003; Leeuwen C. van, 2010, Bulletin de l'OIV, V83, P13; Liger-Belair G, 2009, P NATL ACAD SCI USA, V106, P16545, DOI 10.1073/pnas.0906483106; Lopez-Rituerto E, 2012, J AGR FOOD CHEM, V60, P3452, DOI 10.1021/jf204361d; Lund ST, 2006, SCIENCE, V311, P804, DOI 10.1126/science.1118962; Lundstedt T, 1998, CHEMOMETR INTELL LAB, V42, P3, DOI 10.1016/S0169-7439(98)00065-3; Morlat R, 2006, PLANT SOIL, V281, P55, DOI 10.1007/s11104-005-3769-z; Muller C, 2013, ANAL BIOANAL CHEM; Pereira GE, 2006, ANAL CHIM ACTA, V563, P346, DOI 10.1016/j.aca.2005.11.007; Pereira GE, 2005, J AGR FOOD CHEM, V53, P6382, DOI 10.1021/jf058058q; Pereira GE, 2007, J INT SCI VIGNE VIN, V41, P103; Pineiro Z, 2011, J AGR FOOD CHEM, V59, P11683, DOI 10.1021/jf202254t; Riou C., 1995, Bulletin de l'OIV, V68, P93; Rodriguez-Delgado MA, 2002, FOOD CHEM, V76, P371, DOI 10.1016/S0308-8146(01)00258-8; Romisch U, 2009, EUR FOOD RES TECHNOL, V230, P31, DOI 10.1007/s00217-009-1141-x; Roullier-Gall C, 2014, FOOD CHEM, V152, P100, DOI 10.1016/j.foodchem.2013.11.056; Russell K, 2005, J FOOD QUALITY, V28, P377, DOI 10.1111/j.1745-4557.2005.00041.x; Schmitt-Kopplin P, 2012, BIOGEOSCIENCES; Schmitt-Kopplin P, 2010, P NATL ACAD SCI USA, V107, P2763, DOI 10.1073/pnas.0912157107; SEGUIN G, 1986, EXPERIENTIA, V42, P861, DOI 10.1007/BF01941763; Smeyers-Verbeke J, 2009, EUR FOOD RES TECHNOL, V230, P15, DOI 10.1007/s00217-009-1142-9; Son HS, 2008, J AGR FOOD CHEM, V56, P8007, DOI 10.1021/jf801424u; Suhre K, 2008, NUCLEIC ACIDS RES, V36, pW481, DOI 10.1093/nar/gkn194; Tarr PT, 2013, METABOLOMICS, V9, pS170, DOI 10.1007/s11306-013-0497-x; Theodoridis GA, 2012, ANAL CHIM ACTA, V711, P7, DOI 10.1016/j.aca.2011.09.042; Tziotis D, 2011, EUR J MASS SPECTROM, V17, P415, DOI 10.1255/ejms.1135; van Leeuwen C, 2004, AM J ENOL VITICULT, V55, P207; Vaudour E, 2003, TERROIRS VITICOLES E, V5, P91; Vilanova M, 2007, J SCI FOOD AGR, V87, P1252, DOI 10.1002/jsfa.2833; Villagra E, 2012, FOOD CHEM, V131, P692, DOI 10.1016/j.foodchem.2011.08.078; Wagele B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039860; Zheng SF, 2012, EXPERT SYST APPL, V39, P1687, DOI 10.1016/j.eswa.2011.06.060	56	49	51	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97615	10.1371/journal.pone.0097615	http://dx.doi.org/10.1371/journal.pone.0097615			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858426	Green Submitted, Green Published, gold			2022-12-25	WOS:000336839400021
J	Liao, WY; Ke, TY; Wu, HY				Liao, Wei-Yu; Ke, Ting-Yung; Wu, Hung-Yi			The 3 '-Terminal 55 Nucleotides of Bovine Coronavirus Defective Interfering RNA Harbor Cis-Acting Elements Required for Both Negative- and Positive-Strand RNA Synthesis	PLOS ONE			English	Article							MOUSE HEPATITIS-VIRUS; 3' UNTRANSLATED REGION; RESPIRATORY SYNDROME CORONAVIRUS; SYNTHESIS IN-VITRO; STEM-LOOP-IV; 5'-UNTRANSLATED REGION; MURINE CORONAVIRUS; DENGUE VIRUS; VIRAL-RNA; STRUCTURAL ELEMENTS	The synthesis of the negative-strand [(-)-strand] complement of the similar to 30 kilobase, positive-strand [(+)-strand] coronaviral genome is a necessary early step for genome replication. The identification of cis-acting elements required for (-)-strand RNA synthesis in coronaviruses, however, has been hampered due to insufficiencies in the techniques used to detect the (-)-strand RNA species. Here, we employed a method of head-to-tail ligation and real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) to detect and quantitate the synthesis of bovine coronavirus (BCoV) defective interfering (DI) RNA (-) strands. Furthermore, using the aforementioned techniques along with Northern blot assay, we specifically defined the cis-acting RNA elements within the 3'-terminal 55 nucleotides (nts) which function in the synthesis of (-)- or (+)-strand BCoV DI RNA. The major findings are as follows: (i) nts from -5 to -39 within the 3'-terminal 55 nts are the cis-acting elements responsible for (-)-strand BCoV DI RNA synthesis, (ii) nts from -3 to -34 within the 3'-terminal 55 nts are cis-acting elements required for (+)-strand BCoV DI RNA synthesis, and (iii) the nucleotide species at the 3'-most position (-1) is important, but not critical, for both (-)- and (+)-strand BCoV DI RNA synthesis. These results demonstrate that the 3'-terminal 55 nts in BCoV DI RNA harbor cis-acting RNA elements required for both (-)- and (+)-strand DI RNA synthesis and extend our knowledge on the mechanisms of coronavirus replication. The method of head-to-tail ligation and qRT-PCR employed in the study may also be applied to identify other cis-acting elements required for (-)-strand RNA synthesis in coronaviruses.	[Liao, Wei-Yu; Ke, Ting-Yung; Wu, Hung-Yi] Natl Chung Hsing Univ, Coll Vet Med, Grad Inst Vet Pathobiol, Taichung 40227, Taiwan	National Chung Hsing University	Wu, HY (corresponding author), Natl Chung Hsing Univ, Coll Vet Med, Grad Inst Vet Pathobiol, Taichung 40227, Taiwan.	hwu2@dragon.nchu.edu.tw		Wu, Hung-Yi/0000-0002-1260-6259	National Science Council (NSC) of Republic of China [99-2313-B-005-024]	National Science Council (NSC) of Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by grant 99-2313-B-005-024 from the National Science Council (NSC) of Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005; Alvarez DE, 2008, VIROLOGY, V375, P223, DOI 10.1016/j.virol.2008.01.014; BARIC RS, 1990, VIROLOGY, V177, P646, DOI 10.1016/0042-6822(90)90530-5; Brown CG, 2007, J VIROL, V81, P7716, DOI 10.1128/JVI.00549-07; Chang RY, 1996, J VIROL, V70, P2720, DOI 10.1128/JVI.70.5.2720-2729.1996; CHANG RY, 1994, J VIROL, V68, P8223, DOI 10.1128/JVI.68.12.8223-8231.1994; Deiman BALM, 1998, J VIROL, V72, P3965, DOI 10.1128/JVI.72.5.3965-3972.1998; Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206; Fischer F, 1997, J VIROL, V71, P5148, DOI 10.1128/JVI.71.7.5148-5160.1997; FU KS, 1994, J VIROL, V68, P7458, DOI 10.1128/JVI.68.11.7458-7466.1994; Goebel SJ, 2007, J VIROL, V81, P1274, DOI 10.1128/JVI.00803-06; Gorbalenya AE, 2004, J VIROL, V78, P7863, DOI 10.1128/JVI.78.15.7863-7866.2004; Guan BJ, 2012, J VIROL, V86, P4631, DOI 10.1128/JVI.06265-11; Guan BJ, 2011, J VIROL, V85, P5593, DOI 10.1128/JVI.00263-11; Gustin KM, 2009, J VIROL, V83, P6087, DOI 10.1128/JVI.00160-09; Hardy RW, 2005, J VIROL, V79, P4630, DOI 10.1128/JVI.79.8.4630-4639.2005; Herold J, 2001, MOL CELL, V7, P581, DOI 10.1016/S1097-2765(01)00205-2; HOFMANN MA, 1990, J VIROL, V64, P4108, DOI 10.1128/JVI.64.9.4108-4114.1990; Hsue B, 1997, J VIROL, V71, P7567, DOI 10.1128/JVI.71.10.7567-7578.1997; Hsue B, 2000, J VIROL, V74, P6911, DOI 10.1128/JVI.74.15.6911-6921.2000; Imbert I, 2006, EMBO J, V25, P4933, DOI 10.1038/sj.emboj.7601368; JACOBSON SJ, 1993, J VIROL, V67, P2961, DOI 10.1128/JVI.67.6.2961-2971.1993; Kang HJ, 2006, J VIROL, V80, P10600, DOI 10.1128/JVI.00455-06; Kao CC, 1996, J VIROL, V70, P6826, DOI 10.1128/JVI.70.10.6826-6830.1996; Ke TY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082176; KIM YN, 1993, VIROLOGY, V197, P53, DOI 10.1006/viro.1993.1566; King AMQ., 2012, VIRUS TAXONOMY, P806, DOI 10.1016/ B978-0-12-384684-6.00068-9; KING B, 1982, J VIROL, V42, P700, DOI 10.1128/JVI.42.2.700-707.1982; LAI MMC, 1992, CURR TOP MICROBIOL, V176, P21; LAPPS W, 1987, VIROLOGY, V157, P47, DOI 10.1016/0042-6822(87)90312-6; Li LC, 2008, J MOL BIOL, V377, P790, DOI 10.1016/j.jmb.2008.01.068; LIN YJ, 1994, J VIROL, V68, P8131, DOI 10.1128/JVI.68.12.8131-8140.1994; LIN YJ, 1993, J VIROL, V67, P6110, DOI 10.1128/JVI.67.10.6110-6118.1993; Liu PH, 2007, RNA, V13, P763, DOI 10.1261/rna.261807; Liu PH, 2009, J VIROL, V83, P12084, DOI 10.1128/JVI.00915-09; Liu Q, 2001, J VIROL, V75, P12105, DOI 10.1128/JVI.75.24.12105-12113.2001; MILLER WA, 1986, J MOL BIOL, V187, P537, DOI 10.1016/0022-2836(86)90332-3; Ooms M, 2007, NUCLEIC ACIDS RES, V35, P5253, DOI 10.1093/nar/gkm564; Ozdarendeli A, 2001, J VIROL, V75, P7362, DOI 10.1128/JVI.75.16.7362-7374.2001; Raman S, 2005, J VIROL, V79, P12434, DOI 10.1128/JVI.79.19.12434-12446.2005; Raman S, 2003, J VIROL, V77, P6720, DOI 10.1128/JVI.77.12.6720-6730.2003; SCHENBORN ET, 1985, NUCLEIC ACIDS RES, V13, P6223, DOI 10.1093/nar/13.17.6223; Singh RN, 1997, VIROLOGY, V233, P430, DOI 10.1006/viro.1997.8621; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Spagnolo JF, 2000, J VIROL, V74, P5053, DOI 10.1128/JVI.74.11.5053-5065.2000; TOMPKINS WA, 1974, J NATL CANCER I, V52, P1101, DOI 10.1093/jnci/52.4.1101; VANDERMOST RG, 1995, J VIROL, V69, P3744, DOI 10.1128/JVI.69.6.3744-3751.1995; Villordo SM, 2009, VIRUS RES, V139, P230, DOI 10.1016/j.virusres.2008.07.016; Williams GD, 1999, J VIROL, V73, P8349, DOI 10.1128/JVI.73.10.8349-8355.1999; Woo PCY, 2009, EXP BIOL MED, V234, P1117, DOI 10.3181/0903-MR-94; Wu HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070548; Wu HY, 2010, P NATL ACAD SCI USA, V107, P12257, DOI 10.1073/pnas.1000378107; Wu HY, 2006, J VIROL, V80, P2183, DOI 10.1128/JVI.80.5.2183-2193.2006; You S, 1999, J BIOL CHEM, V274, P33714, DOI 10.1074/jbc.274.47.33714; YU W, 1995, VIROLOGY, V214, P128, DOI 10.1006/viro.1995.9947; YU W, 1995, J VIROL, V69, P2016, DOI 10.1128/JVI.69.4.2016-2023.1995; Zhang GH, 2004, J VIROL, V78, P7619, DOI 10.1128/JVI.78.14.7619-7633.2004; Zhang JC, 2005, VIROLOGY, V333, P301, DOI 10.1016/j.virol.2004.12.015; Zhang X, 2003, RNA, V9, P555, DOI 10.1261/rna.2190803	59	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98422	10.1371/journal.pone.0098422	http://dx.doi.org/10.1371/journal.pone.0098422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852421	Green Submitted, Green Published, gold			2022-12-25	WOS:000338323200070
J	Pang, SL; Wu, HL; Wang, Q; Cai, MX; Shi, WM; Shang, J				Pang, Silin; Wu, Huali; Wang, Qian; Cai, Minxuan; Shi, Weimin; Shang, Jing			Chronic Stress Suppresses the Expression of Cutaneous Hypothalamic-Pituitary-Adrenocortical Axis Elements and Melanogenesis	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; CHRONIC RESTRAINT STRESS; MESSENGER-RNA; HPA AXIS; DIFFERENTIAL EXPRESSION; EPIDERMAL-KERATINOCYTES; ULTRAVIOLET-RADIATION; PREFRONTAL CORTEX; ATOPIC-DERMATITIS	Chronic stress can affect skin function, and some skin diseases might be triggered or aggravated by stress. Stress can activate the central hypothalamic-pituitary-adrenocortical (HPA) axis, which causes glucocorticoid levels to increase. The skin has HPA axis elements that react to environmental stressors to regulate skin functions, such as melanogenesis. This study explores the mechanism whereby chronic stress affects skin pigmentation, focusing on the HPA axis, and investigates the role of glucocorticoids in this pathway. We exposed C57BL/6 male mice to two types of chronic stress, chronic restraint stress (CRS) and chronic unpredictable mild stress (CUMS). Mice subjected to either stress condition showed reduced melanogenesis. Interestingly, CRS and CUMS triggered reductions in the mRNA expression levels of key factors involved in the HPA axis in the skin. In mice administered corticosterone, decreased melanin synthesis and reduced expression of HPA axis elements were observed. The reduced expression of HPA axis elements and melanogenesis in the skin of stressed mice were reversed by RU486 (a glucocorticoid receptor antagonist) treatment. Glucocorticoids had no significant inhibitory effect on melanogenesis in vitro. These results suggest that, high levels of serum corticosterone induced by chronic stress can reduce the expression of elements of the skin HPA axis by glucocorticoid-dependent negative feedback. These activities can eventually result in decreased skin pigmentation. Our findings raise the possibility that chronic stress could be a risk factor for depigmentation by disrupting the cutaneous HPA axis and should prompt dermatologists to exercise more caution when using glucocorticoids for treatment.	[Pang, Silin; Wu, Huali; Wang, Qian; Cai, Minxuan; Shang, Jing] China Pharmaceut Univ, New Drug Screening Ctr, Nanjing, Jiangsu, Peoples R China; [Pang, Silin; Wu, Huali; Wang, Qian; Cai, Minxuan; Shang, Jing] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Shi, Weimin] Shanghai First People Hosp, Shanghai, Peoples R China	China Pharmaceutical University; China Pharmaceutical University	Shang, J (corresponding author), China Pharmaceut Univ, New Drug Screening Ctr, Nanjing, Jiangsu, Peoples R China.	shangjing21cn@163.com			National Science and Technology Infrastructure Program [2012BAI30B001]; Mega-projects of Science Research for the 12th Five-Year Plan of China [2011ZX09401-007]	National Science and Technology Infrastructure Program; Mega-projects of Science Research for the 12th Five-Year Plan of China	This work was supported by 2012-2014 National Science and Technology Infrastructure Program (2012BAI30B001), PI 2011-2013 Mega-projects of Science Research for the 12th Five-Year Plan of China (2011ZX09401-007), PI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar N, 2005, MUTAT RES-FUND MOL M, V571, P121, DOI 10.1016/j.mrfmmm.2004.11.016; Aguilera G, 1996, ENDOCR RES, V22, P433, DOI 10.1080/07435809609043729; Arck PC, 2006, J INVEST DERMATOL, V126, P1697, DOI 10.1038/sj.jid.5700104; Asadi S, 2012, J INVEST DERMATOL, V132, P324, DOI 10.1038/jid.2011.334; Bamberger CM, 1996, ENDOCR REV, V17, P245, DOI 10.1210/er.17.3.245; Bujalska IJ, 2002, J CLIN ENDOCR METAB, V87, P1205, DOI 10.1210/jc.87.3.1205; Bujalska O, 1997, STEROIDS, V62, P77, DOI 10.1016/S0039-128X(96)00163-8; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen A, 2005, MOL ENDOCRINOL, V19, P441, DOI 10.1210/me.2004-0300; Chiba S, 2012, PROG NEURO-PSYCHOPH, V39, P112, DOI 10.1016/j.pnpbp.2012.05.018; Dhabhar FS, 2013, CLIN DERMATOL, V31, P18, DOI 10.1016/j.clindermatol.2011.11.003; Draper N, 2005, J ENDOCRINOL, V186, P251, DOI 10.1677/joe.1.06019; Ermak G, 1997, J INVEST DERMATOL, V108, P160, DOI 10.1111/1523-1747.ep12332925; Evers AWM, 2010, BRIT J DERMATOL, V163, P986, DOI 10.1111/j.1365-2133.2010.09984.x; Flint MS, 2003, STRESS, V6, P59, DOI 10.1080/1025389031000088426; Hadshiew IM, 2004, J INVEST DERMATOL, V123, P455, DOI 10.1111/j.0022-202X.2004.23237.x; Hall JMF, 2012, DERMAT RES PRACT, V2012, DOI 10.1155/2012/403908; Hunter HJA, 2013, BRIT J DERMATOL, V169, P965, DOI 10.1111/bjd.12478; Ito N, 2005, FASEB J, V19, P1332, DOI 10.1096/fj.04-1968fje; Joels M, 2004, STRESS, V7, P221, DOI 10.1080/10253890500070005; Kato JS, 2003, J INVEST DERMATOL, V120, P456, DOI 10.1046/j.1523-1747.2003.12053.x; Kauser S, 2006, FASEB J, V20, P882, DOI 10.1096/fj.05-5257com; Kim NS, 2000, ARCH DERMATOL RES, V292, P233, DOI 10.1007/s004030050480; Kourosh AS, 2010, AM J DRUG ALCOHOL AB, V36, P284, DOI 10.3109/00952990.2010.491883; Krause K, 2007, HORM METAB RES, V39, P166, DOI 10.1055/s-2007-961811; Liu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061574; Lonne-Rahm SB, 2008, J EUR ACAD DERMATOL, V22, P11, DOI 10.1111/j.1468-3083.2007.02202.x; Luger Thomas, 2004, J Dtsch Dermatol Ges, V2, P629; Manolache L, 2007, J EUR ACAD DERMATOL, V21, P921, DOI 10.1111/j.1468-3083.2006.02106.x; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; Meyer U, 2001, HIPPOCAMPUS, V11, P329, DOI 10.1002/hipo.1047; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Perrin MH, 1999, ANN NY ACAD SCI, V885, P312, DOI 10.1111/j.1749-6632.1999.tb08687.x; Ping FF, 2012, INT J BIOCHEM CELL B, V44, P2342, DOI 10.1016/j.biocel.2012.09.025; Raone A, 2007, NEUROSCIENCE, V146, P1734, DOI 10.1016/j.neuroscience.2007.03.027; RIVIER C, 1983, NATURE, V305, P325, DOI 10.1038/305325a0; Rousseau K, 2007, FASEB J, V21, P1844, DOI 10.1096/fj.06-7398com; Schafer-Korting M, 2005, SKIN PHARMACOL PHYS, V18, P103, DOI 10.1159/000084907; Schut C, 2013, ACTA DERM-VENEREOL, V93, P57, DOI 10.2340/00015555-1415; Skobowiat C, 2013, BRIT J DERMATOL, V168, P595, DOI 10.1111/bjd.12096; Skobowiat C, 2013, GENE, V530, P1, DOI 10.1016/j.gene.2013.08.035; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2005, AM J PHYSIOL-ENDOC M, V288, pE701, DOI 10.1152/ajpendo.00519.2004; Slominski A, 2004, EUR J BIOCHEM, V271, P4178, DOI 10.1111/j.1432-1033.2004.04356.x; Slominski A, 1996, INT J DERMATOL, V35, P849, DOI 10.1111/j.1365-4362.1996.tb05049.x; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2005, J INVEST DERMATOL, V124, P13, DOI 10.1111/j.0022-202X.2004.23528.x; Slominski A, 1996, J CLIN ENDOCR METAB, V81, P2746, DOI 10.1210/jc.81.7.2746; Slominski A, 2000, PHYSIOL REV, V80, P979, DOI 10.1152/physrev.2000.80.3.979; Slominski A, 2004, ENDOCRINOLOGY, V145, P941, DOI 10.1210/en.2003-0851; Slominski A, 2001, FASEB J, V15, P1678, DOI 10.1096/fj.00-0850rev; SLOMINSKI A, 2013, J STEROID BIOCHEM, V137, P107, DOI [10.1016/.jsbmb.2013.02.006, DOI 10.1016/J.JSBMB.2013.02.006]; Slominski A, 2007, J CLIN INVEST, V117, P3166, DOI 10.1172/JCI33508; Slominski A, 2007, MOL CELL ENDOCRINOL, V265, P143, DOI 10.1016/j.mce.2006.12.012; Slominski A, 2006, FRONT BIOSCI-LANDMRK, V11, P2230, DOI 10.2741/1966; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Slominski AT, 2012, INT J BIOCHEM CELL B, V44, P2003, DOI 10.1016/j.biocel.2012.07.027; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Spencer JD, 2007, J INVEST DERMATOL, V127, P411, DOI 10.1038/sj.jid.5700538; Sulaimon SS, 2003, VET DERMATOL, V14, P57, DOI 10.1046/j.1365-3164.2003.00327.x; Talaber G, 2013, MOL CELL ENDOCRINOL, V380, P89, DOI 10.1016/j.mce.2013.05.007; Tanida M, 2007, BRAIN RES, V1184, P210, DOI 10.1016/j.brainres.2007.09.058; Tiganescu A, 2011, J INVEST DERMATOL, V131, P30, DOI 10.1038/jid.2010.257; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; Werth VP, 2013, J AM ACAD DERMATOL, V68, P177, DOI 10.1016/j.jaad.2012.09.002; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; YASUMOTO KI, 1995, MOL CELL BIOL, V15, P1833; Zhang XQ, 2009, J INVEST DERMATOL, V129, P1527, DOI 10.1038/jid.2008.371; Zhao X, 2013, NEUROSCIENCE, V246, P82, DOI 10.1016/j.neuroscience.2013.04.046; Zoller NN, 2008, TOXICOL IN VITRO, V22, P747, DOI 10.1016/j.tiv.2007.11.022	74	12	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98283	10.1371/journal.pone.0098283	http://dx.doi.org/10.1371/journal.pone.0098283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24854026	Green Published, Green Submitted, gold			2022-12-25	WOS:000338323200060
J	Curson, ARJ; Burns, OJ; Voget, S; Daniel, R; Todd, JD; McInnis, K; Wexler, M; Johnston, AWB				Curson, Andrew R. J.; Burns, Oliver J.; Voget, Sonja; Daniel, Rolf; Todd, Jonathan D.; McInnis, Kathryn; Wexler, Margaret; Johnston, Andrew W. B.			Screening of Metagenomic and Genomic Libraries Reveals Three Classes of Bacterial Enzymes That Overcome the Toxicity of Acrylate	PLOS ONE			English	Article							PROPIONYL-COENZYME-A; ESCHERICHIA-COLI; DIMETHYLSULFONIOPROPIONATE LYASE; RHIZOBIUM-LEGUMINOSARUM; CLONING VECTORS; TREATMENT-PLANT; ACID; COA; CATABOLISM; REDUCTASE	Acrylate is produced in significant quantities through the microbial cleavage of the highly abundant marine osmoprotectant dimethylsulfoniopropionate, an important process in the marine sulfur cycle. Acrylate can inhibit bacterial growth, likely through its conversion to the highly toxic molecule acrylyl-CoA. Previous work identified an acrylyl-CoA reductase, encoded by the gene acuI, as being important for conferring on bacteria the ability to grow in the presence of acrylate. However, some bacteria lack acuI, and, conversely, many bacteria that may not encounter acrylate in their regular environments do contain this gene. We therefore sought to identify new genes that might confer tolerance to acrylate. To do this, we used functional screening of metagenomic and genomic libraries to identify novel genes that corrected an E. coli mutant that was defective in acuI, and was therefore hyper-sensitive to acrylate. The metagenomic libraries yielded two types of genes that overcame this toxicity. The majority encoded enzymes resembling AcuI, but with significant sequence divergence among each other and previously ratified AcuI enzymes. One other metagenomic gene, arkA, had very close relatives in Bacillus and related bacteria, and is predicted to encode an enoyl-acyl carrier protein reductase, in the same family as FabK, which catalyses the final step in fatty-acid biosynthesis in some pathogenic Firmicute bacteria. A genomic library of Novosphingobium, a metabolically versatile alphaproteobacterium that lacks both acuI and arkA, yielded vutD and vutE, two genes that, together, conferred acrylate resistance. These encode sequential steps in the oxidative catabolism of valine in a pathway in which, significantly, methacrylyl-CoA is a toxic intermediate. These findings expand the range of bacteria for which the acuI gene encodes a functional acrylyl-CoA reductase, and also identify novel enzymes that can similarly function in conferring acrylate resistance, likely, again, through the removal of the toxic product acrylyl-CoA.	[Curson, Andrew R. J.; Burns, Oliver J.; Todd, Jonathan D.; McInnis, Kathryn; Wexler, Margaret; Johnston, Andrew W. B.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Voget, Sonja; Daniel, Rolf] Univ Gottingen, Dept Genom & Appl Microbiol, D-37073 Gottingen, Germany; [Voget, Sonja; Daniel, Rolf] Univ Gottingen, Gottingen Genom Lab, Inst Microbiol & Genet, D-37073 Gottingen, Germany	University of East Anglia; University of Gottingen; University of Gottingen	Curson, ARJ (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	andrew.curson@uea.ac.uk	Curson, Andrew RJ/B-8964-2009; Todd, Jonathan/B-8967-2009; Johnston, Andrew W B/D-1859-2009; Daniel, Rolf/AAQ-5933-2021	Todd, Jonathan/0000-0003-0777-9312; Daniel, Rolf/0000-0002-8646-7925	BBSRC Research Council of the United Kingdom [BB/H002642/1]; NERC Research Council of the United Kingdom [NE/H008586/1]; BBSRC [BB/H002642/1] Funding Source: UKRI; NERC [NE/H008586/1, NE/J01138X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H002642/1] Funding Source: researchfish; Natural Environment Research Council [NE/H008586/1, NE/J01138X/1] Funding Source: researchfish	BBSRC Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC Research Council of the United Kingdom; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the BBSRC (http://www.bbsrc.ac.uk) and NERC (http://www.nerc.ac.uk/) Research Councils of the United Kingdom under grants BB/H002642/1 and NE/H008586/1 respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber BE, 2002, J BIOL CHEM, V277, P12137, DOI 10.1074/jbc.M110802200; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arya AS, 2013, BIOTECHNOL LETT, V35, P1839, DOI 10.1007/s10529-013-1282-7; Asao M, 2013, J BACTERIOL, V195, P4716, DOI 10.1128/JB.00685-13; BALDWIN RL, 1965, BIOCHIM BIOPHYS ACTA, V97, P202, DOI 10.1016/0304-4165(65)90084-X; Balkwill DL, 1997, INT J SYST BACTERIOL, V47, P191, DOI 10.1099/00207713-47-1-191; BERGLER H, 1994, J BIOL CHEM, V269, P5493; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Chan DI, 2010, BIOCHEM J, V430, P1, DOI 10.1042/BJ20100462; Clayden J., 2001, ORGANIC CHEM; Curson ARJ, 2008, ENVIRON MICROBIOL, V10, P757, DOI 10.1111/j.1462-2920.2007.01499.x; Curson ARJ, 2011, NAT REV MICROBIOL, V9, P849, DOI 10.1038/nrmicro2653; Curson ARJ, 2011, ISME J, V5, P1191, DOI 10.1038/ismej.2010.203; Curson ARJ, 2010, ISME J, V4, P144, DOI 10.1038/ismej.2009.93; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dong CH, 2009, MOL PLANT, V2, P59, DOI 10.1093/mp/ssn063; Ferrer M, 2009, J MOL MICROB BIOTECH, V16, P109, DOI 10.1159/000142898; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Francis K, 2009, BIOCHEMISTRY-US, V48, P2403, DOI 10.1021/bi802238j; Fujii K, 2003, INT J SYST EVOL MICR, V53, P47, DOI 10.1099/ijs.0.02301-0; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Heath RJ, 1998, J BIOL CHEM, V273, P30316, DOI 10.1074/jbc.273.46.30316; Heath RJ, 2000, J BIOL CHEM, V275, P40128, DOI 10.1074/jbc.M005611200; Hedlund J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-534; Herrmann G, 2005, FEBS J, V272, P813, DOI 10.1111/j.1742-4658.2004.04518.x; Hetzel M, 2003, EUR J BIOCHEM, V270, P902, DOI 10.1046/j.1432-1033.2003.03450.x; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; Kandasamy V, 2013, APPL MICROBIOL BIOT, V97, P1191, DOI 10.1007/s00253-012-4274-y; KUCHTA RD, 1985, J BIOL CHEM, V260, P3181; Lee SW, 2004, APPL MICROBIOL BIOT, V65, P720, DOI 10.1007/s00253-004-1722-3; Marrakchi H, 2003, BIOCHEM J, V370, P1055, DOI 10.1042/BJ20021699; MARTIN RR, 1973, J BACTERIOL, V115, P198, DOI 10.1128/JB.115.1.198-204.1973; MASSEY LK, 1974, J BACTERIOL, V118, P112, DOI 10.1128/JB.118.1.112-120.1974; Moran MA, 2012, ANNU REV MAR SCI, V4, P523, DOI 10.1146/annurev-marine-120710-100827; Nacke H, 2011, FEMS MICROBIOL ECOL, V78, P188, DOI 10.1111/j.1574-6941.2011.01088.x; Noordkamp DJB, 2000, J SEA RES, V43, P287, DOI 10.1016/S1385-1101(00)00021-6; OOIWA T, 1995, BBA-GEN SUBJECTS, V1243, P216, DOI 10.1016/0304-4165(94)00061-2; Otte ML, 2004, J EXP BOT, V55, P1919, DOI 10.1093/jxb/erh178; Pang H, 2009, CURR MICROBIOL, V58, P404, DOI 10.1007/s00284-008-9346-y; PATEL SS, 1987, J BIOL CHEM, V262, P7132; Payne DJ, 2002, ANTIMICROB AGENTS CH, V46, P3118, DOI 10.1128/AAC.46.10.3118-3124.2002; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Raina JB, 2013, NATURE, V502, P677, DOI 10.1038/nature12677; Raina JB, 2010, TRENDS MICROBIOL, V18, P101, DOI 10.1016/j.tim.2009.12.002; Reisch CR, 2013, MOL MICROBIOL, V89, P774, DOI 10.1111/mmi.12314; Reisch CR, 2011, NATURE, V473, P208, DOI 10.1038/nature10078; Rosenthal RG, 2014, NAT CHEM BIOL, V10, P50, DOI [10.1038/NCHEMBIO.1385, 10.1038/nchembio.1385]; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sato K, 1999, J BIOCHEM-TOKYO, V126, P668, DOI 10.1093/oxfordjournals.jbchem.a022501; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schneider K, 2012, J BACTERIOL, V194, P225, DOI 10.1128/JB.05959-11; Seeliger S, 2002, FEMS MICROBIOL LETT, V211, P65, DOI 10.1111/j.1574-6968.2002.tb11204.x; SHIMOMURA Y, 1994, J BIOL CHEM, V269, P14248; SIEBURTH JM, 1961, J BACTERIOL, V82, P72, DOI 10.1128/JB.82.1.72-79.1961; Simon C, 2009, APPL MICROBIOL BIOT, V85, P265, DOI 10.1007/s00253-009-2233-z; SIMON R, 1989, GENE, V80, P161, DOI 10.1016/0378-1119(89)90262-X; STASKAWICZ B, 1987, J BACTERIOL, V169, P5789, DOI 10.1128/jb.169.12.5789-5794.1987; Sullivan MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015972; Sulzenbacher G, 2004, ACTA CRYSTALLOGR D, V60, P1855, DOI 10.1107/S0907444904020220; Takeuchi M, 2001, INT J SYST EVOL MICR, V51, P1405, DOI 10.1099/00207713-51-4-1405; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan DZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063870; Taniguchi K, 1996, HEPATOLOGY, V24, P1395, DOI 10.1002/hep.510240614; Tapiolas DM, 2010, CORAL REEFS, V29, P621, DOI 10.1007/s00338-010-0608-3; TAYLOR BF, 1991, APPL ENVIRON MICROB, V57, P3581, DOI 10.1128/AEM.57.12.3581-3584.1991; TCHORZEWSKI M, 1994, EUR J BIOCHEM, V226, P841, DOI 10.1111/j.1432-1033.1994.00841.x; Teufel R, 2009, J BACTERIOL, V191, P4572, DOI 10.1128/JB.00068-09; Todd JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035947; Todd JD, 2011, ENVIRON MICROBIOL, V13, P427, DOI 10.1111/j.1462-2920.2010.02348.x; Todd JD, 2010, ENVIRON MICROBIOL, V12, P327, DOI 10.1111/j.1462-2920.2009.02071.x; TRINICK MJ, 1980, J APPL BACTERIOL, V49, P39, DOI 10.1111/j.1365-2672.1980.tb01042.x; Vallina SM, 2007, SCIENCE, V315, P506, DOI 10.1126/science.1133680; Wanders RJA, 2012, J INHERIT METAB DIS, V35, P5, DOI 10.1007/s10545-010-9236-x; Warnecke T, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-25; Wexler M, 2005, ENVIRON MICROBIOL, V7, P1917, DOI 10.1111/j.1462-2920.2005.00854.x; Wexler M, 2001, MOL MICROBIOL, V41, P801, DOI 10.1046/j.1365-2958.2001.02556.x; Wolfe GV, 1997, NATURE, V387, P894, DOI 10.1038/43168; WOOD WB, 1966, J MOL BIOL, V16, P118, DOI 10.1016/S0022-2836(66)80267-X; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yoch DC, 2002, APPL ENVIRON MICROB, V68, P5804, DOI 10.1128/AEM.68.12.5804-5815.2002; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34; Zhou FL, 2011, APPL BIOCHEM BIOTECH, V165, P1770, DOI 10.1007/s12010-011-9393-x	83	14	14	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97660	10.1371/journal.pone.0097660	http://dx.doi.org/10.1371/journal.pone.0097660			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848004	Green Published, Green Submitted, gold			2022-12-25	WOS:000336730600048
J	Lim, CS; Alkon, DL				Lim, Chol Seung; Alkon, Daniel L.			PKC epsilon Promotes HuD-Mediated Neprilysin mRNA Stability NE and Enhances Neprilysin-Induced All Degradation in Brain Neurons	PLOS ONE			English	Article							BETA-DEGRADING ENZYMES; ENDOTHELIN-CONVERTING ENZYME; ALZHEIMERS-DISEASE; TRANSGENIC MICE; HIPPOCAMPAL-NEURONS; SYNAPTIC PLASTICITY; PEPTIDE; ACTIVATION; PROTEINS; EXPRESSION	Amyloid-beta (A beta) peptide accumulation in the brain is a pathological hallmark of all forms of Alzheimer's disease. An imbalance between A beta production and clearance from the brain may contribute to accumulation of neurotoxic A beta and subsequent synaptic loss, which is the strongest correlate of the extent of memory loss in AD. The activity of neprilysin (NEP), a potent A beta-degrading enzyme, is decreased in the AD brain. Expression of HuD, an mRNA-binding protein important for synaptogenesis and neuronal plasticity, is also decreased in the AD brain. HuD is regulated by protein kinase C epsilon (PKC epsilon), and we previously demonstrated that PKC epsilon activation decreases A beta levels. We hypothesized that PKC epsilon acts through HuD to stabilize NEP mRNA, modulate its localization, and support NEP activity. Conversely, loss of PKC epsilon-activated HuD in AD leads to decreased NEP activity and accumulation of A beta. Here we show that HuD is associated with NEP mRNA in cultures of human SK-N-SH cells. Treatment with bryostatin, a PKC epsilon-selective activator, enhanced NEP association with HuD and increased NEP mRNA stability. Activation of PKC epsilon also increased NEP protein levels, increased NEP phosphorylation, and induced cell surface expression. In addition, specific PKC epsilon activation directly stimulated NEP activity, leading to degradation of a monomeric form of A beta peptide and decreased A beta neuronal toxicity, as measured by cell viability. Bryostatin treatment also rescued A beta-mediated inhibition of HuD-NEP mRNA binding, NEP protein expression, and NEP cell membrane translocation. These results suggest that PKC epsilon activation reduces A beta by up-regulating, via the mRNA-binding protein HuD, A beta-degrading enzymes such as NEP. Thus, PKC epsilon activation may have therapeutic efficacy for AD by reducing neurotoxic A beta accumulation as well as having direct anti-apoptotic and synaptogenic effects.	[Lim, Chol Seung; Alkon, Daniel L.] W Virginia Univ, Blanchette Rockefeller Neurosci Inst, Morgantown, WV 26506 USA	West Virginia University	Lim, CS (corresponding author), W Virginia Univ, Blanchette Rockefeller Neurosci Inst, Morgantown, WV 26506 USA.	clim@brni.org						Amadio M, 2009, J ALZHEIMERS DIS, V16, P409, DOI 10.3233/JAD-2009-0967; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Caccamo A, 2005, NEUROBIOL AGING, V26, P645, DOI 10.1016/j.neurobiolaging.2004.06.013; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Choi DS, 2006, P NATL ACAD SCI USA, V103, P8215, DOI 10.1073/pnas.0509725103; Cunha C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/neuro.02.001.2010; Eckman EA, 2005, BIOCHEM SOC T, V33, P1101, DOI 10.1042/BST0331101; El-Amouri SS, 2007, BRAIN RES, V1152, P191, DOI 10.1016/j.brainres.2007.03.072; Hongpaisan J, 2013, NEUROBIOL DIS, V55, P44, DOI 10.1016/j.nbd.2013.03.012; Hongpaisan J, 2011, J NEUROSCI, V31, P630, DOI 10.1523/JNEUROSCI.5209-10.2011; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2002, J NEUROSCI RES, V70, P493, DOI 10.1002/jnr.10390; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Kakiya N, 2012, J BIOL CHEM, V287, P29362, DOI 10.1074/jbc.M112.340372; Kasashima K, 1999, GENES CELLS, V4, P667, DOI 10.1046/j.1365-2443.1999.00292.x; Lee W, 2004, MOL CELL NEUROSCI, V26, P222, DOI 10.1016/j.mcn.2003.10.020; LI CW, 1995, METHOD ENZYMOL, V248, P253; Lim CS, 2012, HIPPOCAMPUS, V22, P2303, DOI 10.1002/hipo.22048; Lim CS, 2005, J NEUROSCI RES, V82, P831, DOI 10.1002/jnr.20692; Longo Frank M, 2004, NeuroRx, V1, P117, DOI 10.1602/neurorx.1.1.117; Malter JS, 2001, J NEUROSCI RES, V66, P311, DOI 10.1002/jnr.10021; Marr RA, 2004, J MOL NEUROSCI, V22, P5, DOI 10.1385/JMN:22:1-2:5; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; Nelson TJ, 2009, J BIOL CHEM, V284, P34514, DOI 10.1074/jbc.M109.016683; Pascale A, 2005, P NATL ACAD SCI USA, V102, P12065, DOI 10.1073/pnas.0504702102; Perrone-Bizzozero N, 2002, J NEUROSCI RES, V68, P121, DOI 10.1002/jnr.10175; Perrone-Bizzozero Nora, 2013, Front Biosci (Schol Ed), V5, P554; Reilly CE, 2001, J NEUROL, V248, P159; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; Siepmann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013134; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; Wang SQ, 2010, J NEUROCHEM, V115, P47, DOI 10.1111/j.1471-4159.2010.06899.x; Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010; Yasojima K, 2001, NEUROSCI LETT, V297, P97, DOI 10.1016/S0304-3940(00)01675-X	38	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97756	10.1371/journal.pone.0097756	http://dx.doi.org/10.1371/journal.pone.0097756			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848988	Green Submitted, Green Published, gold			2022-12-25	WOS:000336730600055
J	Nakavachara, P; Pooliam, J; Weerakulwattana, L; Kiattisakthavee, P; Chaichanwattanakul, K; Manorompatarasarn, R; Chokephaibulkit, K; Viprakasit, V				Nakavachara, Pairunyar; Pooliam, Julaporn; Weerakulwattana, Linda; Kiattisakthavee, Pornpimol; Chaichanwattanakul, Katharee; Manorompatarasarn, Racahnee; Chokephaibulkit, Kulkanya; Viprakasit, Vip			A Normal Reference of Bone Mineral Density (BMD) Measured by Dual Energy X-Ray Absorptiometry in Healthy Thai Children and Adolescents Aged 5-18 Years: A New Reference for Southeast Asian Populations	PLOS ONE			English	Article							BETA-THALASSEMIA; GROWTH-HORMONE; CALCIUM INTAKE; LUMBAR SPINE; TOTAL-BODY; MASS; OSTEOPOROSIS; PREVALENCE; ADJUSTMENT; PUBERTY	Ethnic-specific normative data of bone mineral density (BMD) is essential for the accurate interpretation of BMD measurement. There have been previous reports of normative BMD data for Caucasian and Asian children including Japanese, Chinese, Korean and Indian. However, the normative BMD data for Southeast Asian including Thai children and adolescents are not currently available. The goals of our study were 1) to establish normative data of BMD, bone mineral content (BMC), bone area (BA) and lean body mass (LBM) for healthy Thai children and adolescents; aged 5-18 years measured by dual energy X-ray absorptiometry (DXA, Lunar Prodigy) and 2) to evaluate the relationships between BMD vs. age, sex, puberty, weight, height, calcium intake and the age of menarche in our population. Gender and age-specific BMD (L2-4; LS and total body; TB), BMADLS (apparent BMD of the lumbar spine), BMC (L2-4 and total body), BA (L2-4 and total body) and LBM were evaluated in 367 children (174 boys and 193 girls). All parameters increased progressively with age. A rapid increase in BMD, BMC and BMADLS was observed at earlier ages in girls. Gender and Tanner stage-specific BMD normative data were also generated. The dynamic changes of BMD values from childhood to early and late puberty of Thai children appeared to be consistent with those of Caucasian and Asian populations. Using a multiple-regression, weight and Tanner stage significantly affected BMDLS, BMDTB and BMADLS in both genders. Only in girls, height was found to have significant influence on BMDTB and BMADLS. The positive correlation between BMD and several demographic parameters, except the calcium intake, was observed. In summary, we established a normal BMD reference for Thai children and adolescents and this will be of useful for clinicians and researchers to appropriately assess BMD in Thais and other Southeast Asian children.	[Nakavachara, Pairunyar; Weerakulwattana, Linda; Kiattisakthavee, Pornpimol; Chaichanwattanakul, Katharee] Mahidol Univ, Fac Med, Siriraj Hosp, Div Pediat Endocrinol, Bangkok 10700, Thailand; [Pooliam, Julaporn] Mahidol Univ, Fac Med, Siriraj Hosp, Clin Epidemiol Unit,Off Res & Dev, Bangkok 10700, Thailand; [Manorompatarasarn, Racahnee; Chokephaibulkit, Kulkanya] Mahidol Univ, Fac Med, Siriraj Hosp, Div Pediat Infect Dis, Bangkok 10700, Thailand; [Viprakasit, Vip] Mahidol Univ, Fac Med, Siriraj Hosp, Div Pediat Hematol Oncol,Dept Pediat, Bangkok 10700, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University	Nakavachara, P (corresponding author), Mahidol Univ, Fac Med, Siriraj Hosp, Div Pediat Endocrinol, Bangkok 10700, Thailand.	pairunyar.nak@mahidol.ac.th			Routine to Research (R2R) Grant, Faculty of Medicine Siriraj Hospital, Mahidol University [R2R086/08]	Routine to Research (R2R) Grant, Faculty of Medicine Siriraj Hospital, Mahidol University	This study was funded by Routine to Research (R2R) Grant (R2R086/08), Faculty of Medicine Siriraj Hospital, Mahidol University to PN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwis G, 2010, ACTA PAEDIATR, V99, P1091, DOI 10.1111/j.1651-2227.2010.01713.x; Babu US, 2010, MOL NUTR FOOD RES, V54, P1134, DOI 10.1002/mnfr.200900480; Bachrach LK, 2005, ENDOCRIN METAB CLIN, V34, P521, DOI 10.1016/j.ecl.2005.04.001; Baroncelli GI, 1998, J CLIN ENDOCR METAB, V83, P3150, DOI 10.1210/jc.83.9.3150; Boot AM, 1997, J CLIN ENDOCR METAB, V82, P57, DOI 10.1210/jc.82.1.57; Chailurkit LO, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-853; Cooper C, 2006, OSTEOPOROSIS INT, V17, P337, DOI 10.1007/s00198-005-2039-5; Crabtree NJ, 2004, BONE, V35, P965, DOI 10.1016/j.bone.2004.06.009; DELRIO LD, 1994, PEDIATR RES, V35, P362, DOI 10.1203/00006450-199403000-00018; Department of Health Ministry of Public Health, 2000, REF WEIGHT HEIGHT NU; Department of Health Ministry of Public Health Thailand, 2001, NUTR VAL THAI FOOD; Fewtrell MS, 2005, BONE, V37, P413, DOI 10.1016/j.bone.2005.04.028; Fewtrell MS, 2003, ARCH DIS CHILD, V9, P22; Gilsanz V, 1998, J CLIN ENDOCR METAB, V83, P1420, DOI 10.1210/jc.83.5.1420; Griffin LM, 2012, PEDIATR NEPHROL, V27, P1139, DOI 10.1007/s00467-012-2116-x; Henderson RC, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.e5; Khadilkar AV, 2011, BONE, V48, P810, DOI 10.1016/j.bone.2010.12.013; KROGER H, 1995, BONE, V17, P157, DOI 10.1016/S8756-3282(95)00162-X; Lee SH, 2007, J BONE MINER METAB, V25, P423, DOI 10.1007/s00774-007-0775-7; Mahachoklertwattana P, 2003, CLIN ENDOCRINOL, V58, P273, DOI 10.1046/j.1365-2265.2003.01707.x; MATKOVIC V, 1992, NEW ENGL J MED, V327, P119, DOI 10.1056/NEJM199207093270210; Matsukura T, 2000, OSTEOPOROSIS INT, V11, P858, DOI 10.1007/s001980070045; Maynard LM, 1998, AM J CLIN NUTR, V68, P1111, DOI 10.1093/ajcn/68.5.1111; MAZESS RB, 1990, AM J CLIN NUTR, V51, P1106, DOI 10.1093/ajcn/51.6.1106; Mazziotti G, 2006, TRENDS ENDOCRIN MET, V17, P144, DOI 10.1016/j.tem.2006.03.009; Molgaard C, 1997, ARCH DIS CHILD, V76, P9, DOI 10.1136/adc.76.1.9; NELSON DA, 1995, J BONE MINER RES, V10, P782; Oldroyd B, 2003, EUR J CLIN NUTR, V57, P977, DOI 10.1038/sj.ejcn.1601633; POLLITZER WS, 1989, AM J CLIN NUTR, V50, P1244, DOI 10.1093/ajcn/50.6.1244; Puthanakit T, 2012, JAIDS-J ACQ IMM DEF, V61, P477, DOI 10.1097/QAI.0b013e31826ea89b; Rauch F, 2004, LANCET, V363, P1377, DOI 10.1016/S0140-6736(04)16051-0; Rose SR, 2011, PEDIATR BLOOD CANCER, V57, P1034, DOI 10.1002/pbc.22956; SLOOTWEG MC, 1993, HORM METAB RES, V25, P335, DOI 10.1055/s-2007-1002115; Soliman AT, 1998, METABOLISM, V47, P541, DOI 10.1016/S0026-0495(98)90237-2; Wacker W, 2001, ANN M INT SOC CLIN D; Xu H, 2007, J CLIN DENSITOM, V10, P266, DOI 10.1016/j.jocd.2007.05.005; Zemel BS, 2010, J CLIN ENDOCR METAB, V95, P1265, DOI 10.1210/jc.2009-2057; Zhu ZW, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-126	38	32	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97218	10.1371/journal.pone.0097218	http://dx.doi.org/10.1371/journal.pone.0097218			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847716	Green Submitted, Green Published, gold			2022-12-25	WOS:000336730600024
J	Rundle, CH; Chen, ST; Coen, MJ; Wergedal, JE; Stiffel, V; Lau, KHW				Rundle, Charles H.; Chen, Shin-Tai; Coen, Michael J.; Wergedal, Jon E.; Stiffel, Virginia; Lau, Kin-Hing William			Direct Lentiviral-Cyclooxygenase 2 Application to the Tendon-Bone Interface Promotes Osteointegration and Enhances Return of the Pull-Out Tensile Strength of the Tendon Graft in a Rat Model of Biceps Tenodesis	PLOS ONE			English	Article							CRUCIATE LIGAMENT RECONSTRUCTION; MESENCHYMAL STEM-CELLS; GENE-THERAPY; PATELLAR TENDON; INSERTION SITE; GROWTH-FACTOR; RABBIT MODEL; INDOMETHACIN; CELECOXIB; REGENERATION	This study sought to determine if direct application of the lentiviral (LV)-cyclooxygenase 2 (COX2) vector to the tendon-bone interface would promote osteointegration of the tendon graft in a rat model of biceps tenodesis. The LV-COX2 gene transfer strategy was chosen for investigation because a similar COX2 gene transfer strategy promoted bony bridging of the fracture gap during bone repair, which involves similar histologic transitions that occur in osteointegration. Briefly, a 1.14-mm diameter tunnel was drilled in the mid-groove of the humerus of adult Fischer 344 rats. The LV-COX2 or beta gal control vector was applied directly into the bone tunnel and onto the end of the tendon graft, which was then pulled into the bone tunnel. A poly-L-lactide pin was press-fitted into the tunnel as interference fixation. Animals were sacrificed at 3, 5, or 8 weeks for histology analysis of osteointegration. The LV-COX2 gene transfer strategy enhanced neo-chondrogenesis at the tendon-bone interface but with only marginal effect on de novo bone formation. The tendon-bone interface of the LV-COX2-treated tenodesis showed the well-defined tendon-to-fibrocartilage-to-bone histologic transitions that are indicative of osteointegration of the tendon graft. The LV-COX2 in vivo gene transfer strategy also significantly enhanced angiogenesis at the tendon-bone interface. To determine if the increased osteointegration was translated into an improved pull-out mechanical strength property, the pull-out tensile strength of the LV-COX2-treated tendon grafts was determined with a pull-out mechanical testing assay. The LV-COX2 strategy yielded a significant improvement in the return of the pull-out strength of the tendon graft after 8 weeks. In conclusion, the COX2-based in vivo gene transfer strategy enhanced angiogenesis, osteointegration and improved return of the pull-out strength of the tendon graft. Thus, this strategy has great potential to be developed into an effective therapy to promote tendon-to-bone healing after tenodesis or related surgeries.	[Rundle, Charles H.; Chen, Shin-Tai; Coen, Michael J.; Wergedal, Jon E.; Stiffel, Virginia; Lau, Kin-Hing William] JL Pettis Mem VA Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA USA; [Rundle, Charles H.; Chen, Shin-Tai; Wergedal, Jon E.; Lau, Kin-Hing William] Loma Linda Univ, Sch Med, Dept Med, Loma Linda, CA 92354 USA; [Chen, Shin-Tai; Wergedal, Jon E.; Lau, Kin-Hing William] Loma Linda Univ, Sch Med, Dept Biochem, Loma Linda, CA 92350 USA; [Coen, Michael J.] Loma Linda Univ, Sch Med, Dept Orthoped Surg, Loma Linda, CA USA	Loma Linda University; Loma Linda University; Loma Linda University	Lau, KHW (corresponding author), JL Pettis Mem VA Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA USA.	William.Lau@med.va.gov		Lau, Kin-Hing/0000-0003-1109-5052	Veterans Affair Medical Research RR&D Merit Review grant	Veterans Affair Medical Research RR&D Merit Review grant	This work was supported by a Veterans Affair Medical Research RR&D Merit Review grant. The funders (Department of Veterans Affairs) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian O, 2011, J LEUKOCYTE BIOL, V89, P669, DOI 10.1189/jlb.0810446; Bolt P, 2007, J BONE JOINT SURG AM, V89A, P1315, DOI 10.2106/JBJS.F.00257; Busconi BB, 2008, SPORTS MED ARTHROSC, V16, P187, DOI 10.1097/JSA.0b013e318183c134; Campbell BH, 2004, BIOMECH MODEL MECHAN, V2, P239, DOI [10.1007/s10237-004-0041-z, 10.1007/S10237-004-0041-Z]; Coen MJ, 2011, J GENE MED, V13, P511, DOI 10.1002/jgm.1604; COFIELD RH, 1985, J BONE JOINT SURG AM, V67A, P974, DOI 10.2106/00004623-198567060-00024; Cohen DB, 2009, AM J SPORTS MED, V34, P362; COOPER RR, 1970, J BONE JOINT SURG AM, VA 52, P1; Dimmen S, 2009, J BONE JOINT SURG BR, V91B, P259, DOI 10.1302/0301-620X.91B2.21471; Dimmen S, 2009, KNEE SURG SPORT TR A, V17, P835, DOI 10.1007/s00167-009-0763-7; DINES D, 1982, CLIN ORTHOP RELAT R, P165; Elder CL, 2001, AM J SPORT MED, V29, P801, DOI 10.1177/03635465010290062101; Ferry ST, 2007, AM J SPORT MED, V35, P1326, DOI 10.1177/0363546507301584; Forslund C, 2003, ACTA ORTHOP SCAND, V74, P465, DOI 10.1080/00016470310017802; Gulotta LV, 2011, AM J SPORT MED, V39, P1282, DOI 10.1177/0363546510395485; Gulotta LV, 2010, AM J SPORT MED, V38, P1429, DOI 10.1177/0363546510361235; Heckman DS, 2010, SPORTS MED ARTHROSC, V18, P173, DOI 10.1097/JSA.0b013e3181e892c1; Hettrich CM, 2012, J ORTHOP RES, V30, P769, DOI 10.1002/jor.22006; Klepps S, 2002, ARTHROSCOPY, V18, P1040, DOI 10.1053/jars.2002.36467; Koch BS, 2012, ARTHROSCOPY, V28, P735, DOI 10.1016/j.arthro.2012.02.019; Lau KHW, 2013, BONE, V53, P369, DOI 10.1016/j.bone.2013.01.003; Lim JK, 2004, ARTHROSCOPY, V20, P899, DOI 10.1016/j.arthro.2004.06.035; Lyras D, 2010, INT ORTHOP, V34, P143, DOI 10.1007/s00264-009-0728-y; Ma Y, 2009, AM J SPORT MED, V37, P599, DOI 10.1177/0363546508325960; Marsolais D, 2003, LAB INVEST, V83, P991, DOI 10.1097/01.LAB.0000078688.07696.AC; Mihelic R, 2004, AM J SPORT MED, V32, P1619, DOI 10.1177/0363546504263703; Morrison KD, 2002, HAND CLIN, V18, P169, DOI 10.1016/S0749-0712(02)00009-4; Nakase J, 2010, ARTHROSCOPY, V26, P84, DOI 10.1016/j.arthro.2009.06.029; Nedelec B, 2000, HAND CLIN, V16, P289; Pierre PS, 1995, J BONE JOINT SURG AM, V77A, P1858; Rodeo SA, 1999, AM J SPORT MED, V27, P476, DOI 10.1177/03635465990270041201; Rodeo SA, 2007, J BONE JOINT SURG AM, V89A, P2485, DOI 10.2106/JBJS.C.01627; Rundle CH, 2008, J GENE MED, V10, P229, DOI 10.1002/jgm.1148; RUSSELL JE, 1989, CONNECT TISSUE RES, V23, P51, DOI 10.3109/03008208909103903; Simon S, 2000, ORTHOPAEDIC BASIC SC, P731; Thomopoulos S, 2003, J ORTHOP RES, V21, P413, DOI 10.1016/S0736-0266(03)00057-3; Thomopoulos S, 2002, J ORTHOP RES, V20, P454, DOI 10.1016/S0736-0266(01)00144-9; Tsai WC, 2007, CONNECT TISSUE RES, V48, P46, DOI 10.1080/03008200601071295; Yam PY, 2002, MOL THER, V5, P479, DOI 10.1006/mthe.2002.0558; Yoshikawa T, 2006, AM J SPORT MED, V34, P1918, DOI 10.1177/0363546506294469; Zhao J, 2011, INT ORTHOP, V35, P925, DOI 10.1007/s00264-010-1157-7	41	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98004	10.1371/journal.pone.0098004	http://dx.doi.org/10.1371/journal.pone.0098004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848992	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600075
J	Sugiyama, N; Murayama, A; Suzuki, R; Watanabe, N; Shiina, M; Liang, TJ; Wakita, T; Kato, T				Sugiyama, Nao; Murayama, Asako; Suzuki, Ryosuke; Watanabe, Noriyuki; Shiina, Masaaki; Liang, T. Jake; Wakita, Takaji; Kato, Takanobu			Single Strain Isolation Method for Cell Culture-Adapted Hepatitis C Virus by End-Point Dilution and Infection	PLOS ONE			English	Article							TRANS-ENCAPSIDATION; MUTATIONS; PROTEIN; IDENTIFICATION; CHIMPANZEES; ADAPTATION; PARTICLES; SYSTEM; RNA; NS3	The hepatitis C virus (HCV) culture system has enabled us to clarify the HCV life cycle and essential host factors for propagation. However, the virus production level of wild-type JFH-1 (JFH-1/wt) is limited, and this leads to difficulties in performing experiments that require higher viral concentrations. As the cell culture-adapted JFH-1 has been reported to have robust virus production, some mutations in the viral genome may play a role in the efficiency of virus production. In this study, we obtained cell culture-adapted virus by passage of full-length JFH-1 RNA-transfected Huh-7.5.1 cells. The obtained virus produced 3 log-fold more progeny viruses as compared with JFH-1/wt. Several mutations were identified as being responsible for robust virus production, but, on reverse-genetics analysis, the production levels of JFH-1 with these mutations did not reach the level of cell culture-adapted virus. By using the single strain isolation method by end-point dilution and infection, we isolated two strains with additional mutations, and found that these strains have the ability to produce more progeny viruses. On reverse-genetics analysis, the strains with these additional mutations were able to produce robust progeny viruses at comparable levels as cell culture-adapted JFH-1 virus. The strategy used in this study will be useful for identifying strains with unique characteristics, such as robust virus production, from a diverse population, and for determining the responsible mutations for these characteristics.	[Sugiyama, Nao; Murayama, Asako; Suzuki, Ryosuke; Watanabe, Noriyuki; Wakita, Takaji; Kato, Takanobu] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Shiina, Masaaki] Shin Yurigaoka Gen Hosp, Dept Gastroenterol & Hepatol, Kawasaki, Kanagawa, Japan; [Liang, T. Jake] NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA	National Institute of Infectious Diseases (NIID); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Kato, T (corresponding author), Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan.	takato@nih.go.jp		Shiina, Masaaki/0000-0002-7807-6844	Japan Society for the Promotion of Science; Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054504, ZIADK054505] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, from the Ministry of Health, Labour and Welfare of Japan, and from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa D, 2007, J VIROL, V81, P5036, DOI 10.1128/JVI.01573-06; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Bungyoku Y, 2009, J GEN VIROL, V90, P1681, DOI 10.1099/vir.0.010983-0; Cok SJ, 2003, J BIOL CHEM, V278, P36157, DOI 10.1074/jbc.M302547200; Delgrange D, 2007, J GEN VIROL, V88, P2495, DOI 10.1099/vir.0.82872-0; Dhillon S, 2010, J VIROL, V84, P5494, DOI 10.1128/JVI.02153-09; Feld JJ, 2006, HEPATOLOGY, V43, pS194, DOI 10.1002/hep.21065; GRAKOUI A, 1993, P NATL ACAD SCI USA, V90, P10583, DOI 10.1073/pnas.90.22.10583; Han QX, 2009, VIRUS RES, V145, P63, DOI 10.1016/j.virusres.2009.06.005; HIJIKATA M, 1993, J VIROL, V67, P4665, DOI 10.1128/JVI.67.8.4665-4675.1993; Ishii K, 2008, BIOCHEM BIOPH RES CO, V371, P446, DOI 10.1016/j.bbrc.2008.04.110; Jiang JY, 2012, J VIROL, V86, P8987, DOI 10.1128/JVI.00004-12; Kato T, 2005, J CLIN MICROBIOL, V43, P5679, DOI 10.1128/JCM.43.11.5679-5684.2005; Kato T, 2001, J MED VIROL, V64, P334, DOI 10.1002/jmv.1055; Kato T, 2008, HEPATOLOGY, V48, P732, DOI 10.1002/hep.22422; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Kato T, 2007, J VIROL, V81, P4405, DOI 10.1128/JVI.02334-06; Kaul A, 2007, J VIROL, V81, P13168, DOI 10.1128/JVI.01362-07; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Ma YH, 2008, J VIROL, V82, P7624, DOI 10.1128/JVI.00724-08; Ma YH, 2011, J VIROL, V85, P86, DOI 10.1128/JVI.01070-10; Matsumura T, 2012, HEPATOLOGY, V56, P1231, DOI 10.1002/hep.25763; Mishima K, 2010, VIROLOGY, V405, P361, DOI 10.1016/j.virol.2010.06.020; Murayama A, 2012, J CLIN MICROBIOL, V50, P1943, DOI 10.1128/JCM.00487-12; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Perotti M, 2008, J VIROL, V82, P1047, DOI 10.1128/JVI.01986-07; Russell RS, 2008, P NATL ACAD SCI USA, V105, P4370, DOI 10.1073/pnas.0800422105; Saeed M, 2011, HEPATOLOGY, V54, P425, DOI 10.1002/hep.24399; Steinmann E, 2008, J VIROL, V82, P7034, DOI 10.1128/JVI.00118-08; Suzuki R, 2012, VIROLOGY, V432, P29, DOI 10.1016/j.virol.2012.05.033; Takeuchi T, 1999, GASTROENTEROLOGY, V116, P636, DOI 10.1016/S0016-5085(99)70185-X; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	38	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98168	10.1371/journal.pone.0098168	http://dx.doi.org/10.1371/journal.pone.0098168			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848954	gold, Green Published, Green Submitted			2022-12-25	WOS:000336730600094
J	Bode, M; Kreiner, A; van der Plas, AK; Louw, DC; Horaeb, R; Auel, H; Hagen, W				Bode, Maya; Kreiner, Anja; van der Plas, Anja K.; Louw, Deon C.; Horaeb, Richard; Auel, Holger; Hagen, Wilhelm			Spatio-Temporal Variability of Copepod Abundance along the 20 degrees S Monitoring Transect in the Northern Benguela Upwelling System from 2005 to 2011	PLOS ONE			English	Article							CALANOIDES-CARINATUS; COMMUNITY STRUCTURE; CALANUS-CHILENSIS; HUMBOLDT CURRENT; CURRENT REGION; ZOOPLANKTON; ECOSYSTEM; DYNAMICS; MESOZOOPLANKTON; CALIFORNIA	Long-term data sets are essential to understand climate-induced variability in marine ecosystems. This study provides the first comprehensive analysis of longer-term temporal and spatial variations in zooplankton abundance and copepod community structure in the northern Benguela upwelling system from 2005 to 2011. Samples were collected from the upper 200 m along a transect at 20 degrees S perpendicular to the coast of Namibia to 70 nm offshore. Based on seasonal and interannual trends in surface temperature and salinity, three distinct time periods were discernible with stronger upwelling in spring and extensive warm-water intrusions in late summer, thus, high temperature amplitudes, in the years 2005/06 and 2010/11, and less intensive upwelling followed by weaker warm-water intrusions from 2008/09 to 2009/10. Zooplankton abundance reflected these changes with higher numbers in 2005/06 and 2010/11. In contrast, zooplankton density was lower in 2008/09 and 2009/10, when temperature gradients from spring to late summer were less pronounced. Spatially, copepod abundance tended to be highest between 30 and 60 nautical miles off the coast, coinciding with the shelf break and continental slope. The dominant larger calanoid copepods were Calanoides carinatus, Metridia lucens and Nannocalanus minor. On all three scales studied, i.e. spatially from the coast to offshore waters as well as temporally, both seasonally and interannually, maximum zooplankton abundance was not coupled to the coldest temperature regime, and hence strongest upwelling intensity. Pronounced temperature amplitudes, and therefore strong gradients within a year, were apparently important and resulted in higher zooplankton abundance.	[Bode, Maya; Auel, Holger; Hagen, Wilhelm] Univ Bremen, BreMarE Bremen Marine Ecol, D-28359 Bremen, Germany; [Kreiner, Anja; van der Plas, Anja K.; Louw, Deon C.; Horaeb, Richard] Natl Marine Informat & Res Ctr NatMIRC, Swakopmund, Namibia	University of Bremen	Bode, M (corresponding author), Univ Bremen, BreMarE Bremen Marine Ecol, D-28359 Bremen, Germany.	mabode@uni-bremen.de		Hagen, Wilhelm/0000-0002-7462-9931	German Federal Ministry of Education and Research (BMBF) [03F0650E]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study is embedded in the GENUS project (03F0650E), which is funded by the German Federal Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barange M, 1989, COLLN SCI PAP INT CO, V16, P31; BOYD AJ, 1987, S AFR J MARINE SCI, V5, P107, DOI 10.2989/025776187784522577; Boyer D, 2000, MAR POLLUT BULL, V41, P123, DOI 10.1016/S0025-326X(00)00106-5; Brenning U., 1985, BEITR MEERESKD, V52, P3; BROWN PC, 1991, S AFR J MARINE SCI, V11, P537, DOI 10.2989/025776191784287673; CRAWFORD RJM, 1987, OCEANOGR MAR BIOL, V25, P353; Escribano R, 2000, J MAR BIOL ASSOC UK, V80, P283, DOI 10.1017/S002531549900185X; Escribano R, 1998, FISH OCEANOGR, V7, P245, DOI 10.1046/j.1365-2419.1998.00078.x; Hansen FC, 2005, AFR J MAR SCI, V27, P55, DOI 10.2989/18142320509504068; Heileman S, 2008, UNEP LARGE MARINE EC, V182, P100; Hidalgo P, 2007, PROG OCEANOGR, V75, P501, DOI 10.1016/j.pocean.2007.08.028; Hutchings L, 2009, PROG OCEANOGR, V83, P15, DOI 10.1016/j.pocean.2009.07.046; Hutchings L, 2006, LARGE MARINE ECOSYST; Kollmer WE, 1963, PILCHARD S W AFRICA; Lass HU, 2000, J PHYS OCEANOGR, V30, P2589, DOI 10.1175/1520-0485(2000)030<2589:HACMIT>2.0.CO;2; LONGHURST AR, 1985, PROG OCEANOGR, V15, P1, DOI 10.1016/0079-6611(85)90036-9; Mohrholz V, 2008, CONT SHELF RES, V28, P424, DOI 10.1016/j.csr.2007.10.001; Monteiro P. M. S., 2010, CARBON NUTR FLUXES C, P65; Morgan CA, 2003, MAR ECOL PROG SER, V249, P223, DOI 10.3354/meps249223; O'Toole MJ, 1980, INVESTL REP SEA FISH, P121; OLIVAR MP, 1990, J PLANKTON RES, V12, P1023, DOI 10.1093/plankt/12.5.1023; PETERSON WT, 1988, PROG OCEANOGR, V20, P1, DOI 10.1016/0079-6611(88)90052-3; POSTEL L, 1995, HELGOLANDER MEERESUN, V49, P829, DOI 10.1007/BF02368406; Rebstock GA, 2002, GLOBAL CHANGE BIOL, V8, P71, DOI 10.1046/j.1365-2486.2002.00456.x; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; Schlitzer R, 2013, OCEAN DATA VIEW, V4; SHANNON LV, 1987, S AFR J MARINE SCI, V5, P11, DOI 10.2989/025776187784522261; SHANNON LV, 1992, S AFR J MARINE SCI, V12, P271; Shannon LV, 2003, LARGE MARINE ECOSYST; Shannon LV, 1986, OCEANOGRAPHY MARINE, P65; Shannon V, 2006, LAR MAR ECOSYST, V14, P1; Stander GH, 1964, BENGUELA CURRENT S W; Stander GH, 1962, PILCHARD S W AFRICA; Stander GH, 1969, INVESTIGATIONAL REPO, V81, P46; Timonin A.G., 1993, Russian Journal of Aquatic Ecology, V1, P103; TIMONIN AG, 1992, S AFR J MARINE SCI, V12, P545; Timonin AG, 1991, OCEANOLOGY, V31, P181; Unteruberbacher HK, 1964, 11 INV REP MAR RES L, V11; Verheye HM, 1998, S AFR J MARINE SCI, V19, P317; VERHEYE HM, 1991, PROG OCEANOGR, V28, P91, DOI 10.1016/0079-6611(91)90022-E; VERHEYE HM, 1992, S AFR J MARINE SCI, V12, P561	41	15	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97738	10.1371/journal.pone.0097738	http://dx.doi.org/10.1371/journal.pone.0097738			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844305	Green Submitted, gold, Green Published			2022-12-25	WOS:000339563400053
J	Butler, CL; Lucas, O; Wuchty, S; Xue, B; Uversky, VN; White, M				Butler, Carrie L.; Lucas, Olivier; Wuchty, Stefan; Xue, Bin; Uversky, Vladimir N.; White, Michael			Identifying Novel Cell Cycle Proteins in Apicomplexa Parasites through Co-Expression Decision Analysis	PLOS ONE			English	Article							TOXOPLASMA-GONDII; PLASMODIUM-FALCIPARUM; FUNCTIONAL-ANALYSIS; INTRINSIC DISORDER; MALARIA; REVEALS; SEQUENCE; GENES; IDENTIFICATION; CYTOSKELETON	Hypothetical proteins comprise roughly half of the predicted gene complement of Toxoplasma gondii and Plasmodium falciparum and represent the largest class of uniquely functioning proteins in these parasites. Following the idea that functional relationships can be informed by the timing of gene expression, we devised a strategy to identify the core set of apicomplexan cell division cycling genes with important roles in parasite division, which includes many uncharacterized proteins. We assembled an expanded list of orthologs from the T. gondii and P. falciparum genome sequences (2781 putative orthologs), compared their mRNA profiles during synchronous replication, and sorted the resulting set of dual cell cycle regulated orthologs (744 total) into protein pairs conserved across many eukaryotic families versus those unique to the Apicomplexa. The analysis identified more than 100 ortholog gene pairs with unknown function in T. gondii and P. falciparum that displayed co-conserved mRNA abundance, dynamics of cyclical expression and similar peak timing that spanned the complete division cycle in each parasite. The unknown cyclical mRNAs encoded a diverse set of proteins with a wide range of mass and showed a remarkable conservation in the internal organization of ordered versus disordered structural domains. A representative sample of cyclical unknown genes (16 total) was epitope tagged in T. gondii tachyzoites yielding the discovery of new protein constituents of the parasite inner membrane complex, key mitotic structures and invasion organelles. These results demonstrate the utility of using gene expression timing and dynamic profile to identify proteins with unique roles in Apicomplexa biology.	[Butler, Carrie L.; Lucas, Olivier; Xue, Bin; Uversky, Vladimir N.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL USA; [White, Michael] Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Tampa, FL 33620 USA; [White, Michael] Univ S Florida, Florida Ctr Drug Discovery & Innovat, Tampa, FL USA; [Wuchty, Stefan] NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; National Institutes of Health (NIH) - USA	White, M (corresponding author), Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Tampa, FL 33620 USA.	mwhite.usf@gmail.com	Uversky, Vladimir N./F-4515-2011; xue, bin/E-5617-2011	Uversky, Vladimir N./0000-0002-4037-5857; xue, bin/0000-0002-6344-0623	National Institutes of Health [R01-AI077662, R01-AI089885]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI109843, R01AI077662, R01AI089885] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health to MWW (R01-AI077662 and R01-AI089885). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Anderson-White B, 2012, INT REV CEL MOL BIO, V298, P1, DOI 10.1016/B978-0-12-394309-5.00001-8; Anderson-White BR, 2011, CELL MICROBIOL, V13, P18, DOI 10.1111/j.1462-5822.2010.01514.x; ARNOT DE, 1998, ANN TROP MED PARASIT, V92, P361; Balu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013282; Beck JR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003162; Beck JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001094; Behnke MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012354; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; Bontell IL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r53; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Brehelin L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-35; Brehelin L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-440; Camejo A, 2013, INT J PARASITOLOGY; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Chotivanich K, 2000, J INFECT DIS, V181, P1206, DOI 10.1086/315353; Cross FR, 2011, PHILOS T R SOC B, V366, P3532, DOI 10.1098/rstb.2011.0078; Date SV, 2006, GENOME RES, V16, P542, DOI 10.1101/gr.4573206; DeBarry JD, 2011, MOL BIOL EVOL, V28, P2855, DOI 10.1093/molbev/msr103; Doerig C, 2008, TRENDS PARASITOL, V24, P570, DOI 10.1016/j.pt.2008.08.007; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; DUBREMETZ JF, 1993, PARASITOL RES, V79, P402, DOI 10.1007/BF00931830; ESCALANTE AA, 1995, P NATL ACAD SCI USA, V92, P5793, DOI 10.1073/pnas.92.13.5793; Fox BA, 2011, EUKARYOT CELL, V10, P1193, DOI 10.1128/EC.00297-10; Francia ME, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001444; Frenal K, 2013, TRAFFIC, V14, P895, DOI 10.1111/tra.12081; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gilk SD, 2006, EUKARYOT CELL, V5, P1622, DOI 10.1128/EC.00114-06; Gubbels MJ, 2008, INT J PARASITOL, V38, P1343, DOI 10.1016/j.ijpara.2008.06.004; Hall N, 2002, NATURE, V419, P527, DOI 10.1038/nature01095; Huang F, 2012, BIOCOMPUT-PAC SYM, P128; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Hyman RW, 2002, NATURE, V419, P534, DOI 10.1038/nature01102; Jacot D, 2012, INT J MED MICROBIOL, V302, P195, DOI 10.1016/j.ijmm.2012.07.012; Kremer K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003213; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lorestani A, 2012, CYTOSKELETON, V69, P1069, DOI 10.1002/cm.21077; Lu Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r146; Martin-Benito J, 2002, EMBO J, V21, P6377, DOI 10.1093/emboj/cdf640; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Mohan A, 2008, MOL BIOSYST, V4, P328, DOI 10.1039/b719168e; Muller H, 2010, EMBO J, V29, P3344, DOI 10.1038/emboj.2010.210; Nishi M, 2008, J CELL SCI, V121, P1559, DOI 10.1242/jcs.021089; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; Radke JR, 1998, MOL BIOCHEM PARASIT, V94, P237, DOI 10.1016/S0166-6851(98)00074-7; Reiss M, 2001, J CELL BIOL, V152, P563, DOI 10.1083/jcb.152.3.563; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Sheiner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002392; Shock JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r134; Sims PFG, 2006, EXPERT REV PROTEOMIC, V3, P87, DOI 10.1586/14789450.3.1.87; Sivashankari S, 2006, BIOINFORMATION, V1, P335, DOI 10.6026/97320630001335; Striepen B, 2007, PLOS PATHOG, V3, P691, DOI 10.1371/journal.ppat.0030078; Suvorova ES, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003305; Tedder PMR, 2010, BIOINFORMATICS, V26, P2431, DOI 10.1093/bioinformatics/btq450; Tompa P, 2009, BIOESSAYS, V31, P328, DOI 10.1002/bies.200800151; Toth-Petroczy A, 2008, OPEN PROTEOM J, V1, P46, DOI [10.2174/1875039700801010046, DOI 10.2174/1875039700801010046]; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; van Dooren GG, 2008, P NATL ACAD SCI USA, V105, P13574, DOI 10.1073/pnas.0803862105; Walenta JH, 2001, J CELL BIOL, V152, P923, DOI 10.1083/jcb.152.5.923; Walhout AJM, 2000, YEAST, V17, P88, DOI 10.1002/1097-0061(20000630)17:2<88::AID-YEA20>3.0.CO;2-Y; Weiss LM, 2009, EXPERT REV PROTEOMIC, V6, P303, DOI [10.1586/epr.09.16, 10.1586/EPR.09.16]; Williams Robert W, 2013, Intrinsically Disord Proteins, V1, pe25724, DOI 10.4161/idp.25724; Xue B, 2013, BBA-PROTEINS PROTEOM, V1834, P725, DOI 10.1016/j.bbapap.2013.01.012; Xue B, 2012, J BIOMOL STRUCT DYN, V30, P137, DOI 10.1080/07391102.2012.675145	66	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97625	10.1371/journal.pone.0097625	http://dx.doi.org/10.1371/journal.pone.0097625			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841368	Green Submitted, Green Published, gold			2022-12-25	WOS:000340948600052
J	Howard, TD; Mathias, RA; Seeds, MC; Herrington, DM; Hixson, JE; Shimmin, LC; Hawkins, GA; Sellers, M; Ainsworth, HC; Sergeant, S; Miller, LR; Chilton, FH				Howard, Timothy D.; Mathias, Rasika A.; Seeds, Michael C.; Herrington, David M.; Hixson, James E.; Shimmin, Lawrence C.; Hawkins, Greg A.; Sellers, Matthew; Ainsworth, Hannah C.; Sergeant, Susan; Miller, Leslie R.; Chilton, Floyd H.			DNA Methylation in an Enhancer Region of the FADS Cluster Is Associated with FADS Activity in Human Liver	PLOS ONE			English	Article							AFRICAN-AMERICANS; ACID-METABOLISM; LOCI; VARIANTS; DISEASES; IMPACT; RISK	Levels of omega-6 (n-6) and omega-3 (n-3), long chain polyunsaturated fatty acids (LcPUFAs) such as arachidonic acid (AA; 20:4, n-6), eicosapentaenoic acid (EPA; 20: 5, n-3) and docosahexaenoic acid (DHA; 22: 6, n-3) impact a wide range of biological activities, including immune signaling, inflammation, and brain development and function. Two desaturase steps (Delta 6, encoded by FADS2 and Delta 5, encoded by FADS1) are rate limiting in the conversion of dietary essential 18 carbon PUFAs (18C-PUFAs) such as LA (18: 2, n-6) to AA and a-linolenic acid (ALA, 18: 3, n-3) to EPA and DHA. GWAS and candidate gene studies have consistently identified genetic variants within FADS1 and FADS2 as determinants of desaturase efficiencies and levels of LcPUFAs in circulating, cellular and breast milk lipids. Importantly, these same variants are documented determinants of important cardiovascular disease risk factors (total, LDL, and HDL cholesterol, triglycerides, CRP and proinflammatory eicosanoids). FADS1 and FADS2 lie head-to-head (5' to 5') in a cluster configuration on chromosome 11 (11q12.2). There is considerable linkage disequilibrium (LD) in this region, where multiple SNPs display association with LcPUFA levels. For instance, rs174537, located similar to 15 kb downstream of FADS1, is associated with both FADS1 desaturase activity and with circulating AA levels (p-value for AA levels = 5.95X10(-46)) in humans. To determine if DNA methylation variation impacts FADS activities, we performed genome-wide allele-specific methylation (ASM) with rs174537 in 144 human liver samples. This approach identified highly significant ASM with CpG sites between FADS1 and FADS2 in a putative enhancer signature region, leading to the hypothesis that the phenotypic associations of rs174537 are likely due to methylation differences. In support of this hypothesis, methylation levels of the most significant probe were strongly associated with FADS1 and, to a lesser degree, FADS2 activities.	[Howard, Timothy D.; Hawkins, Greg A.] Wake Forest Sch Med, Ctr Publ Hlth Genom, Ctr Genom & Personalized Med Res, Winston Salem, NC 27157 USA; [Mathias, Rasika A.] Johns Hopkins Univ, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD USA; [Seeds, Michael C.] Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC USA; [Seeds, Michael C.] Wake Forest Sch Med, Sect Pulm Crit Care & Allerg & Immunol Dis, Winston Salem, NC USA; [Herrington, David M.; Sellers, Matthew] Wake Forest Sch Med, Dept Cardiol, Winston Salem, NC USA; [Hixson, James E.; Shimmin, Lawrence C.] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Sergeant, Susan] Wake Forest Sch Med, Program Mol Genet & Gen, Winston Salem, NC USA; [Seeds, Michael C.; Miller, Leslie R.; Chilton, Floyd H.] Wake Forest Hlth Sci, Dept Physiol Pharmacol, Winston Salem, NC USA; [Seeds, Michael C.; Sergeant, Susan; Chilton, Floyd H.] Wake Forest Univ Hlth Sci, Wake Forest Ctr Bot Lipids & Inflammatory Dis Pre, Winston Salem, NC USA	Wake Forest University; Johns Hopkins University; Wake Forest University; Wake Forest University; Wake Forest University; University of Texas System; University of Texas Health Science Center Houston; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University School of Medicine	Howard, TD (corresponding author), Wake Forest Sch Med, Ctr Publ Hlth Genom, Ctr Genom & Personalized Med Res, Winston Salem, NC 27157 USA.	tdhoward@wakehealth.edu		Hixson, James/0000-0002-0849-9315	National Institutes of Health [P50 AT002782]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P50AT002782] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by a grant from the National Institutes of Health, P50 AT002782. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Blanchard H, 2011, BIOCHIMIE, V93, P87, DOI 10.1016/j.biochi.2010.03.002; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Lattka E, 2009, J NUTRIGENET NUTRIGE, V2, P119, DOI 10.1159/000235559; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Marquardt A, 2000, GENOMICS, V66, P175, DOI 10.1006/geno.2000.6196; Mathias RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044926; Mathias RA, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-50; METCALFE LD, 1966, ANAL CHEM, V38, P514, DOI 10.1021/ac60235a044; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109; Sergeant S, 2012, BRIT J NUTR, V107, P547, DOI 10.1017/S0007114511003230; Sigurdsson MI, 2009, GENOME RES, V19, P581, DOI 10.1101/gr.086181.108; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Weaver KL, 2009, J BIOL CHEM, V284, P15400, DOI 10.1074/jbc.M109.004861; Wiench M, 2011, EMBO J, V30, P3028, DOI 10.1038/emboj.2011.210; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; WISSLER RW, 1991, AM J MED, V91, pS3, DOI 10.1016/0002-9343(91)90050-8; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005	29	51	55	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97510	10.1371/journal.pone.0097510	http://dx.doi.org/10.1371/journal.pone.0097510			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842322	Green Published, gold			2022-12-25	WOS:000340948600038
J	Kohorn, BD; Kohorn, SL; Saba, NJ; Martinez, VM				Kohorn, Bruce D.; Kohorn, Susan L.; Saba, Nicholas J.; Martinez, Victoriano Meco			Requirement for Pectin Methyl Esterase and Preference for Fragmented over Native Pectins for Wall-associated Kinase-activated, EDS1/PAD4-dependent Stress Response in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL; RECEPTOR KINASE; WAK1; EXPANSION; GROWTH; OLIGOGALACTURONIDES; METHYLESTERASES; BIOSYNTHESIS; MECHANICS; IMMUNITY	The wall-associated kinases (WAKs) have a cytoplasmic protein kinase domain that spans the plasma membrane and binds pectin in the extracellular matrix of plants. WAKs are required for cell expansion during Arabidopsis seedling development but are also an integral part of the response to pathogens and stress that present oligogalacturonides (OGs), which subsequently bind to WAKs and activate a MPK6 (mitogen-activated protein kinase)-dependent pathway. It was unclear how WAKs distinguish native pectin polymers and OGs to activate one or the other of these two pathways. A dominant allele of WAK2 constitutively activates the stress response, and we show here that the effect is dependent upon EDS1 and PAD4, transcriptional activators involved in the pathogen response. Moreover, the WAK2 dominant allele is suppressed by a null allele of a pectin methyl esterase (PME3) whose activity normally leads to cross-linking of pectins in the cell wall. Although OGs activate a transcriptional response in wild type, the response is enhanced in a pme3/pme3 null, consistent with a competition by OG and native polymers for activation of WAKs. This provides a plausible mechanism for WAKs to distinguish an expansion from a stress pathway.	[Kohorn, Bruce D.; Kohorn, Susan L.; Saba, Nicholas J.; Martinez, Victoriano Meco] Bowdoin Coll, Dept Biol, Brunswick, ME 04011 USA	Bowdoin College	Kohorn, BD (corresponding author), Bowdoin Coll, Dept Biol, Brunswick, ME 04011 USA.	bkohorn@bowdoin.edu	MEDRANO, Vicente/AAW-3249-2020; Meco, Victoriano/A-8398-2016; Meco, Victoriano/GQY-6674-2022	MEDRANO, Vicente/0000-0003-1839-0150; Meco, Victoriano/0000-0003-2244-4967	National Science Foundation [IOS-1146245]; National Center for Research Resources [5P20RR016463-12]; NIGMS from the National Institutes of Health [8 P20 GM103423-12]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103423] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS from the National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation Grant IOS-1146245 (to B. D. K.). Students were also supported by grants from the National Center for Research Resources (5P20RR016463-12) and the NIGMS (8 P20 GM103423-12) from the National Institutes of Health.	Anderson CT, 2010, PLANT PHYSIOL, V152, P787, DOI 10.1104/pp.109.150128; Andreasson E, 2010, TRENDS PLANT SCI, V15, P106, DOI 10.1016/j.tplants.2009.12.001; Bethke G, 2014, PLANT PHYSIOL, V164, P1093, DOI 10.1104/pp.113.227637; Bosch M, 2005, PLANT CELL, V17, P3219, DOI 10.1105/tpc.105.037473; Brutus A, 2010, P NATL ACAD SCI USA, V107, P9452, DOI 10.1073/pnas.1000675107; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Christensen U, 2010, PHYTOCHEMISTRY, V71, P62, DOI 10.1016/j.phytochem.2009.09.019; Decreux A, 2005, PLANT CELL PHYSIOL, V46, P268, DOI 10.1093/pcp/pci026; Decreux A, 2006, PHYTOCHEMISTRY, V67, P1068, DOI 10.1016/j.phytochem.2006.03.009; Denoux C, 2008, MOL PLANT, V1, P423, DOI 10.1093/mp/ssn019; Espino JJ, 2010, PROTEOMICS, V10, P3020, DOI 10.1002/pmic.201000037; Ferrari S., 2013, Frontiers in Plant Science, V4, P49; Guenin S, 2011, NEW PHYTOL, V192, P114, DOI 10.1111/j.1469-8137.2011.03797.x; Harholt J, 2010, PLANT PHYSIOL, V153, P384, DOI 10.1104/pp.110.156588; He ZH, 1998, PLANT J, V14, P55, DOI 10.1046/j.1365-313X.1998.00092.x; He ZH, 1999, PLANT MOL BIOL, V39, P1189, DOI 10.1023/A:1006197318246; Kohorn BD, 2006, PLANT J, V46, P307, DOI 10.1111/j.1365-313X.2006.02695.x; Kohorn BD, 2000, PLANT PHYSIOL, V124, P31, DOI 10.1104/pp.124.1.31; Kohorn BD, 2006, J CELL SCI, V119, P2282, DOI 10.1242/jcs.02968; Kohorn BD, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00088; Kohorn BD, 2009, PLANT J, V60, P974, DOI 10.1111/j.1365-313X.2009.04016.x; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Peaucelle A, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00121; Peaucelle A, 2011, CURR BIOL, V21, P1720, DOI 10.1016/j.cub.2011.08.057; Raiola A, 2011, MOL PLANT MICROBE IN, V24, P432, DOI 10.1094/MPMI-07-10-0157; Rojas ER, 2011, BIOPHYS J, V101, P1844, DOI 10.1016/j.bpj.2011.08.016; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Wagner S, 2013, CELL HOST MICROBE, V14, P619, DOI 10.1016/j.chom.2013.11.006; Wagner TA, 2001, PLANT CELL, V13, P303, DOI 10.1105/tpc.13.2.303; Winship LJ, 2010, TRENDS PLANT SCI, V15, P363, DOI 10.1016/j.tplants.2010.04.005; Wolf S, 2009, MOL PLANT, V2, P851, DOI 10.1093/mp/ssp066	31	43	49	1	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18978	18986		10.1074/jbc.M114.567545	http://dx.doi.org/10.1074/jbc.M114.567545			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24855660	hybrid, Green Published			2022-12-25	WOS:000339062900030
J	Bouwsema, H; van der Sluis, CK; Bongers, RM				Bouwsema, Hanneke; van der Sluis, Corry K.; Bongers, Raoul M.			Effect of Feedback during Virtual Training of Grip Force Control with a Myoelectric Prosthesis	PLOS ONE			English	Article							SENSORY FEEDBACK; TACTILE DISPLAY; CONTROL STRATEGIES; LIMB; REALITY; OBJECT; VARIABILITY; KNOWLEDGE; STROKE; SYSTEM	The aim of this study was to determine whether virtual training improves grip force control in prosthesis use, and to examine which type of augmented feedback facilitates its learning most. Thirty-two able-bodied participants trained grip force with a virtual ball-throwing game for five sessions in a two-week period, using a myoelectric simulator. They received either feedback on movement outcome or on movement execution. Sixteen controls received training that did not focus on force control. Variability over learning was examined with the Tolerance-Noise-Covariation approach, and the transfer of grip force control was assessed in five test-tasks that assessed different aspects of force control in a pretest, a posttest and a retention test. During training performance increased while the variability in performance was decreased, mainly by reduction in noise. Grip force control only improved in the test-tasks that provided information on performance. Starting the training with a task that required low force production showed no transfer of the learned grip force. Feedback on movement execution was detrimental to grip force control, whereas feedback on movement outcome enhanced transfer of grip force control to tasks other than trained. Clinical implications of these results regarding virtual training of grip force control are discussed.	[Bouwsema, Hanneke; Bongers, Raoul M.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [van der Sluis, Corry K.] Univ Groningen, Univ Med Ctr Groningen, Ctr Rehabil, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen	Bouwsema, H (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	r.m.bongers@umcg.nl	Bongers, Raoul/C-1094-2012	Bongers, Raoul/0000-0002-3518-7464	Otto Bock Healthcare GmbH, Vienna, Austria	Otto Bock Healthcare GmbH, Vienna, Austria	This research is performed while Hanneke Bouwsema was financially supported by Otto Bock Healthcare GmbH, Vienna, Austria. By legal contract, Otto Bock had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamovich SV, 2009, NEUROREHABILITATION, V25, P29, DOI 10.3233/NRE-2009-0497; ADAMS JA, 1987, PSYCHOL BULL, V101, P41, DOI 10.1037/0033-2909.101.1.41; AGNEW PJ, 1981, AM J OCCUP THER, V35, P722, DOI 10.5014/ajot.35.11.722; Anderson F, 2012, PROC 9 INT C DIS VIR; Antfolk C, 2013, EXPERT REV MED DEVIC, V10, P45, DOI [10.1586/erd.12.68, 10.1586/ERD.12.68]; Antfolk C, 2010, J MED BIOL ENG, V30, P355, DOI 10.5405/jmbe.766; Antfolk C, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-50; Antfolk C, 2010, J PLAST SURG HAND SU, V44, P50, DOI 10.3109/02844310903259090; Bernstein N.A., 1996, RES ECOL PS; Blank A, 2010, ACM T APPL PERCEPT, V7, DOI 10.1145/1773965.1773966; Bouwsema H, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-16; Bouwsema H, 2012, J REHABIL RES DEV, V49, P1331, DOI 10.1682/JRRD.2011.09.0179; Bouwsema H, 2010, ARCH PHYS MED REHAB, V91, P1442, DOI 10.1016/j.apmr.2010.06.025; Chappell P. H., 2011, Journal of Medical Engineering & Technology, V35, P1, DOI 10.3109/03091902.2010.526983; Chatterjee A., 2008, J PROSTHETICS ORTHOT, V20, P27, DOI [10.1097/01.JPO.0000311041.61628.be, DOI 10.1097/01.JP0.0000311041.61628.BE]; Chatterjee A, 2008, 2008 IEEE REGION 5 CONFERENCE, P75; Cirstea AC, 2007, NEUROREHAB NEURAL RE, V21, P398, DOI 10.1177/1545968306298414; Cohen RG, 2009, EXP BRAIN RES, V193, P69, DOI 10.1007/s00221-008-1596-1; Dakpa R, 1997, CURR ORTHOPAED, V11, P193, DOI 10.1016/S0268-0890(97)90034-7; Dawson Michael R, 2012, Open Biomed Eng J, V6, P5, DOI 10.2174/1874230001206010005; Dawson MR, 2011, EXPERT REV MED DEVIC, V8, P581, DOI [10.1586/erd.11.23, 10.1586/ERD.11.23]; Dingwell JB, 2004, J NEUROPHYSIOL, V91, P1158, DOI 10.1152/jn.00704.2003; Engeberg ED, 2012, PROSTHET ORTHOT INT, V36, P423, DOI 10.1177/0309364612440077; Flanagan JR, 2006, CURR OPIN NEUROBIOL, V16, P650, DOI 10.1016/j.conb.2006.10.005; Gilmore P.E., 2001, PHYS OCCUP THER GERI, V20, P1, DOI [10.1080/J148v20n01_01, DOI 10.1080/J148V20N01_01, DOI 10.1080/J148V20N01_]; Goodman JS, 2004, J APPL PSYCHOL, V89, P248, DOI 10.1037/0021-9010.89.2.248; Gordon K, 2004, EXP BRAIN RES, V159, P478, DOI 10.1007/s00221-004-1970-6; Hebert JS, 2012, J REHABIL RES DEV, V49, P1163, DOI 10.1682/JRRD.2011.10.0207; Heckathorne C. W., 1992, ATLAS LIMB PROSTHETI, V2nd, P151; Holden MK, 2005, CYBERPSYCHOL BEHAV, V8, P187, DOI 10.1089/cpb.2005.8.187; KRIZ G, 1995, ARCH PHYS MED REHAB, V76, P653, DOI 10.1016/S0003-9993(95)80635-0; Kurillo G, 2004, CLIN BIOMECH, V19, P1014, DOI 10.1016/j.clinbiomech.2004.07.003; Kurillo Gregorij, 2005, Technol Health Care, V13, P137; Latash ML, 2007, MOTOR CONTROL, V11, P276, DOI 10.1123/mcj.11.3.276; Latash ML, 2002, EXERC SPORT SCI REV, V30, P26, DOI 10.1097/00003677-200201000-00006; Mah CD, 2003, BIOL CYBERN, V88, P60, DOI 10.1007/s00422-002-0347-9; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; MEEK S G, 1989, Journal of Rehabilitation Research and Development, V26, P53; Melendez-Calderon A, 2011, IEEE T NEUR SYS REH, V19, P298, DOI 10.1109/TNSRE.2011.2125990; Muller H, 2004, J EXP PSYCHOL HUMAN, V30, P212, DOI 10.1037/0096-1523.30.1.212; Newell KM, 2001, PSYCHOL REV, V108, P57, DOI 10.1037//0033-295X.108.1.57; Park JH, 2000, J MOTOR BEHAV, V32, P287, DOI 10.1080/00222890009601379; Peerdeman B, 2011, J REHABIL RES DEV, V48, P719, DOI 10.1682/JRRD.2010.08.0161; Proteau L, 2005, EXP BRAIN RES, V161, P441, DOI 10.1007/s00221-004-2090-z; Pylatiuk C, 2006, J PROSTHET ORTHOT, V18, P57, DOI DOI 10.1097/00008526-200604000-00007; Ranganathan R, 2009, J MOTOR BEHAV, V41, P317, DOI 10.3200/JMBR.41.4.317-330; Resnik L, 2011, J REHABIL RES DEV, V48, P707, DOI 10.1682/JRRD.2010.07.0127; Romkema S, 2013, PHYS THER, V93, P22, DOI 10.2522/ptj.20120058; SALMONI AW, 1984, PSYCHOL BULL, V95, P355, DOI 10.1037/0033-2909.95.3.355; Saunders I, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-60; SCHMIDT RA, 1989, J EXP PSYCHOL LEARN, V15, P352, DOI 10.1037/0278-7393.15.2.352; Schmidt RA, 2005, MOTOR CONTROL LEARNI; Sebelius F., 2005, TECHNOL DISABIL, V17, P131, DOI [10.3233/TAD-2005-17301, DOI 10.3233/TAD-2005-17301]; Shumway-Cook A., 1995, MOTOR CONTROL THEORY; Shute VJ, 2008, REV EDUC RES, V78, P153, DOI 10.3102/0034654307313795; Smurr LM, 2008, J HAND THER, V21, P160, DOI 10.1197/j.jht.2007.09.006; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P582, DOI 10.1152/jn.1989.62.2.582; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P595, DOI 10.1152/jn.1989.62.2.595; Subramanian SK, 2013, NEUROREHAB NEURAL RE, V27, P13, DOI 10.1177/1545968312449695; Van Vliet PM, 2006, DISABIL REHABIL, V28, P831, DOI 10.1080/09638280500534937; Weeks DL, 2000, EXP BRAIN RES, V132, P404, DOI 10.1007/s002210000337; WESTLING G, 1984, EXP BRAIN RES, V53, P277; Zafar M, 2000, MED BIOL ENG COMPUT, V38, P267, DOI 10.1007/BF02347046	63	26	26	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98301	10.1371/journal.pone.0098301	http://dx.doi.org/10.1371/journal.pone.0098301			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865570	Green Published, gold, Green Submitted			2022-12-25	WOS:000336914100050
J	Aci-Seche, S; Sawma, P; Hubert, P; Sturgis, JN; Bagnard, D; Jacob, L; Genest, M; Garnier, N				Aci-Seche, Samia; Sawma, Paul; Hubert, Pierre; Sturgis, James N.; Bagnard, Dominique; Jacob, Laurent; Genest, Monique; Garnier, Norbert			Transmembrane Recognition of the Semaphorin Co-Receptors Neuropilin 1 and Plexin A1: Coarse-Grained Simulations	PLOS ONE			English	Article							HELIX-HELIX INTERACTIONS; GLYCOPHORIN-A; MOLECULAR-DYNAMICS; MEMBRANE-PROTEINS; STRUCTURAL BASIS; ALPHA-HELICES; MODEL MEMBRANES; EGF RECEPTOR; FORCE-FIELD; FREE-ENERGY	The cancer associated class 3 semaphorins require direct binding to neuropilins and association to plexins to trigger cell signaling. Here, we address the role of the transmembrane domains of neuropilin 1 and plexin A1 for the dimerization of the two receptors by characterizing the assembly in lipid bilayers using coarse-grained molecular dynamics simulations. From experimental evidence using a two-hybrid system showing the biochemical association of the two receptors transmembrane domains, we performed molecular simulations in DOPC and POPC demonstrating spontaneously assembly to form homodimers and heterodimers with a very high propensity for right-handed packing of the helices. Inversely, left-handed packing was observed with a very low propensity. This mode of packing was observed uniquely when the plexin A1 transmembrane domain was involved in association. Potential of mean force calculations were used to predict a hierarchy of self-association for the monomers: the two neuropilin 1 transmembrane domains strongly associated, neuropilin 1 and plexin A1 transmembrane domains associated less and the two plexin A1 transmembrane domains weakly but significantly associated. We demonstrated that homodimerization and heterodimerization are driven by GxxxG motifs, and that the sequence context modulates the packing mode of the plexin A1 transmembrane domains. This work presents major advances towards our understanding of membrane signaling platforms assembly through membrane domains and provides exquisite information for the design of antagonist drugs defining a novel class of therapeutic agents.	[Aci-Seche, Samia; Genest, Monique; Garnier, Norbert] Univ Orleans, Ctr Natl Rech Sci UPR, Ctr Biophys Mol, Orleans, France; [Sawma, Paul; Hubert, Pierre; Sturgis, James N.] Univ Aix Marseille, Lab Ingn Syst Macromol UMR, Marseille, France; [Bagnard, Dominique; Jacob, Laurent] Univ Strasbourg, Inst Natl Sante & Rech Med, Strasbourg, France	Universite de Orleans; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Genest, M (corresponding author), Univ Orleans, Ctr Natl Rech Sci UPR, Ctr Biophys Mol, Orleans, France.	monique.genest@cnrs-orleans.fr; norbert.garnier@cnrs-orleans.fr	Bagnard, Dominique/I-6535-2013; Sturgis, James/AAU-8103-2020	Bagnard, Dominique/0000-0002-5261-902X; Sturgis, James/0000-0001-5125-7699; JACOB, Laurent/0000-0003-4767-0442; Garnier, Norbert/0000-0003-1941-1814	French Agence Nationale de la Recherche (InterferenceTM project) [ANR-10-BLAN-1507]	French Agence Nationale de la Recherche (InterferenceTM project)(French National Research Agency (ANR))	This work was supported by a grant from the French Agence Nationale de la Recherche (InterferenceTM project; ANR-10-BLAN-1507). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antipenko A, 2003, NEURON, V39, P589, DOI 10.1016/S0896-6273(03)00502-6; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Audet M, 2012, CELL, V151, P14, DOI 10.1016/j.cell.2012.09.003; Battesti A, 2012, METHODS, V58, P325, DOI 10.1016/j.ymeth.2012.07.018; Beevers AJ, 2010, CHEM SOC REV, V39, P2146, DOI 10.1039/b912944h; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bond PJ, 2006, J AM CHEM SOC, V128, P2697, DOI 10.1021/ja0569104; Bordag N, 2010, CHEM PHYS LIPIDS, V163, P1, DOI 10.1016/j.chemphyslip.2009.07.009; Call ME, 2007, NAT REV IMMUNOL, V7, P841, DOI 10.1038/nri2186; Campbell ID, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004994; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cebecauer M, 2010, J CELL SCI, V123, P309, DOI 10.1242/jcs.061739; Chaudhary B, 2013, CANC IMMUNOL IMMUNOT; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Cymer F, 2011, BIOCHIM BIOPHYS ACTA, V1818, P963; Cymer F, 2010, CELL ADHES MIGR, V4, P299, DOI 10.4161/cam.4.2.11191; Domanski J, 2012, BBA-BIOMEMBRANES, V1818, P984, DOI 10.1016/j.bbamem.2011.08.021; Doura AK, 2004, J MOL BIOL, V341, P991, DOI 10.1016/j.jmb.2004.06.042; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Escher C, 2009, J MOL BIOL, V389, P10, DOI 10.1016/j.jmb.2009.04.002; Feiner L, 1997, NEURON, V19, P539, DOI 10.1016/S0896-6273(00)80370-0; Fink A, 2011, BIOCHIM BIOPHYS ACTA, V1818, P974; Fleishman SJ, 2002, P NATL ACAD SCI USA, V99, P15937, DOI 10.1073/pnas.252640799; Hall BA, 2011, BIOPHYS J, V100, P1940, DOI 10.1016/j.bpj.2011.02.041; Henin J, 2005, J AM CHEM SOC, V127, P8478, DOI 10.1021/ja050581y; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hubert P, 2010, CELL ADHES MIGR, V4, P313, DOI 10.4161/cam.4.2.12430; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Janosi L, 2010, BIOPHYS J, V99, P284, DOI 10.1016/j.bpj.2010.04.005; Janssen BJC, 2012, NAT STRUCT MOL BIOL, V19, P1293, DOI 10.1038/nsmb.2416; Janssen BJC, 2010, NATURE, V467, P1118, DOI 10.1038/nature09468; Klostermann A, 1998, J BIOL CHEM, V273, P7326, DOI 10.1074/jbc.273.13.7326; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li E, 2012, BBA-BIOMEMBRANES, V1818, P183, DOI 10.1016/j.bbamem.2011.08.031; Liu HL, 2010, CELL, V142, P749, DOI 10.1016/j.cell.2010.07.040; Love CA, 2003, NAT STRUCT BIOL, V10, P843, DOI 10.1038/nsb977; MacKenzie KR, 2006, CHEM REV, V106, P1931, DOI 10.1021/cr0404388; MacKenzie KR, 1998, P NATL ACAD SCI USA, V95, P3583, DOI 10.1073/pnas.95.7.3583; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; Matthews EE, 2006, CELL, V127, P447, DOI 10.1016/j.cell.2006.10.016; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; Mineev KS, 2010, J MOL BIOL, V400, P231, DOI 10.1016/j.jmb.2010.05.016; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; Nakamura F, 1998, NEURON, V21, P1093, DOI 10.1016/S0896-6273(00)80626-1; Nasarre C, 2010, ONCOGENE, V29, P2381, DOI 10.1038/onc.2010.9; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Neufeld G, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006718; Nogi T, 2010, NATURE, V467, P1123, DOI 10.1038/nature09473; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; Periole Xavier, 2013, Methods Mol Biol, V924, P533, DOI 10.1007/978-1-62703-017-5_20; Periole X, 2012, J AM CHEM SOC, V134, P10959, DOI 10.1021/ja303286e; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Psachoulia E, 2008, BIOCHEMISTRY-US, V47, P10503, DOI 10.1021/bi800678t; Psachoulia E, 2010, ACCOUNTS CHEM RES, V43, P388, DOI 10.1021/ar900211k; Rohm B, 2000, MECH DEVELOP, V93, P95, DOI 10.1016/S0925-4773(00)00269-0; Roth L, 2009, CELL MOL LIFE SCI, V66, P649, DOI 10.1007/s00018-008-8518-z; Roth L, 2008, MOL BIOL CELL, V19, P646, DOI 10.1091/mbc.E07-06-0625; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Schafer LV, 2011, P NATL ACAD SCI USA, V108, P1343, DOI 10.1073/pnas.1009362108; Sengupta D, 2010, PHYS CHEM CHEM PHYS, V12, P12987, DOI 10.1039/c0cp00101e; Sharma A, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00028; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Yin H, 2007, SCIENCE, V315, P1817, DOI 10.1126/science.1136782; Zachary IC, 2011, BIOCHEM SOC T, V39, P1583, DOI 10.1042/BST20110697	77	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97779	10.1371/journal.pone.0097779	http://dx.doi.org/10.1371/journal.pone.0097779			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858828	gold, Green Published, Green Submitted			2022-12-25	WOS:000336839400025
J	Chhatre, VE; Rajora, OP				Chhatre, Vikram E.; Rajora, Om P.			Genetic Divergence and Signatures of Natural Selection in Marginal Populations of a Keystone, Long-Lived Conifer, Eastern White Pine (Pinus strobus) from Northern Ontario	PLOS ONE			English	Article							MATING SYSTEM; PERIPHERAL-POPULATIONS; LOCAL ADAPTATION; RED SPRUCE; DIVERSITY; RANGE; CLIMATE; EVOLUTION; MIGRATION; CORE	Marginal populations are expected to provide the frontiers for adaptation, evolution and range shifts of plant species under the anticipated climate change conditions. Marginal populations are predicted to show genetic divergence from central populations due to their isolation, and divergent natural selection and genetic drift operating therein. Marginal populations are also expected to have lower genetic diversity and effective population size (N-e) and higher genetic differentiation than central populations. We tested these hypotheses using eastern white pine (Pinus strobus) as a model for keystone, long-lived widely-distributed plants. All 614 eastern white pine trees, in a complete census of two populations each of marginal old-growth, central old-growth, and central second-growth, were genotyped at 11 microsatellite loci. The central populations had significantly higher allelic and genotypic diversity, latent genetic potential (LGP) and N-e than the marginal populations. However, heterozygosity and fixation index were similar between them. The marginal populations were genetically diverged from the central populations. Model testing suggested predominant north to south gene flow in the study area with curtailed gene flow to northern marginal populations. Signatures of natural selection were detected at three loci in the marginal populations; two showing divergent selection with directional change in allele frequencies, and one balancing selection. Contrary to the general belief, no significant differences were observed in genetic diversity, differentiation, LGP, and Ne between old-growth and second-growth populations. Our study provides information on the dynamics of migration, genetic drift and selection in central versus marginal populations of a keystone long-lived plant species and has broad evolutionary, conservation and adaptation significance.	[Chhatre, Vikram E.; Rajora, Om P.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Rajora, Om P.] Univ New Brunswick, Fac Forestry & Environm Management, Fredericton, NB, Canada	Dalhousie University; University of New Brunswick	Rajora, OP (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	Om.Rajora@unb.ca	Chhatre, Vikram/B-6649-2016; Chhatre, Vikram/O-2459-2019	Chhatre, Vikram/0000-0001-6627-2832; Chhatre, Vikram/0000-0001-6627-2832	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 170651]; Dalhousie University; Stora Enso Port Hawkesbury Ltd.; Senior Canada Research Chair in Forest and Conservation Genomics and Biotechnology at UNB; Canada Research Chair Program [CRC950-201869]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Dalhousie University; Stora Enso Port Hawkesbury Ltd.; Senior Canada Research Chair in Forest and Conservation Genomics and Biotechnology at UNB; Canada Research Chair Program(Canada Research Chairs)	This study was funded by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant (RGPIN 170651) to Om P. Rajora. Vikram E. Chhatre was financially supported from the NSERC Discovery grant funds to Om P. Rajora and a graduate scholarship at Dalhousie University. Om P. Rajora held the Stora Enso Senior Chair in Forest Genetics and Biotechnology at Dalhousie University, which was supported by Stora Enso Port Hawkesbury Ltd., and the Senior Canada Research Chair in Forest and Conservation Genomics and Biotechnology at UNB, which was supported by the Canada Research Chair Program (CRC950-201869). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; ALLENDORF FW, 1986, ZOO BIOL, V5, P181, DOI 10.1002/zoo.1430050212; [Anonymous], 1975, EVOLUTION, DOI DOI 10.1111/j.1558-5646.1975.tb00807.x; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Atkins KE, 2010, J THEOR BIOL, V266, P449, DOI 10.1016/j.jtbi.2010.07.014; BEAULIEU J, 1995, CAN J FOREST RES, V25, P1697, DOI 10.1139/x95-183; BEAULIEU J, 1994, CAN J FOREST RES, V24, P1726, DOI 10.1139/x94-223; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; BERGMANN F, 1990, GENETICA, V82, P1, DOI 10.1007/BF00057667; Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; Bridle JR, 2010, ECOL LETT, V13, P485, DOI 10.1111/j.1461-0248.2010.01442.x; Buchert GP, 1997, CONSERV BIOL, V11, P747, DOI 10.1046/j.1523-1739.1997.96074.x; BUCHERT GP, 1994, FOREST CHRON, V70, P427, DOI 10.5558/tfc70427-4; Case TJ, 2000, AM NAT, V155, P583, DOI 10.1086/303351; Crins WJ., 2009, TECHNICAL REPORT SIB; DAVIS MB, 1980, QUATERNARY RES, V14, P240, DOI 10.1016/0033-5894(80)90051-4; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Edelist C, 2006, MOL ECOL, V15, P4623, DOI 10.1111/j.1365-294X.2006.03112.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Gapare WJ, 2005, BIOL CONSERV, V123, P113, DOI 10.1016/j.biocon.2004.11.002; Gaston KJ, 2009, P R SOC B, V276, P1395, DOI 10.1098/rspb.2008.1480; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Hale ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045170; Hofer T, 2009, ANN HUM GENET, V73, P95, DOI 10.1111/j.1469-1809.2008.00489.x; Holliday JA, 2012, P ROY SOC B-BIOL SCI, V279, P1675, DOI 10.1098/rspb.2011.1805; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kremer A, 2012, ECOL LETT, V15, P378, DOI 10.1111/j.1461-0248.2012.01746.x; LESICA P, 1992, CONSERV BIOL, V6, P135, DOI 10.1046/j.1523-1739.1992.610135.x; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Marquardt PE, 2004, MOL ECOL, V13, P3305, DOI 10.1111/j.1365-294X.2004.02341.x; Marriage TN, 2009, HEREDITY, V103, P310, DOI 10.1038/hdy.2009.67; Mehes M, 2009, J PLANT ECOL-UK, V2, P143, DOI 10.1093/jpe/rtp016; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Mimura M, 2010, J EVOLUTION BIOL, V23, P249, DOI 10.1111/j.1420-9101.2009.01910.x; Mosseler A, 2003, THEOR APPL GENET, V106, P931, DOI 10.1007/s00122-002-1156-1; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nijensohn SE, 2005, CAN J FOREST RES, V35, P1041, DOI 10.1139/X05-029; O'Connell LM, 2006, HEREDITY, V97, P418, DOI 10.1038/sj.hdy.6800886; Oksanen J, 2009, COMMUNITY ECOLOGY PA; Pandey M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-48; Pandey M, 2012, AM J BOT, V99, P690, DOI 10.3732/ajb.1100116; Parisod C, 2010, ANN BOT-LONDON, V105, P655, DOI 10.1093/aob/mcq014; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rajora OP, 2000, CAN J BOT, V78, P941, DOI 10.1139/cjb-78-7-941; Rajora OP, 2000, MOL ECOL, V9, P339, DOI 10.1046/j.1365-294x.2000.00886.x; Rajora OP, 2002, CAN J BOT, V80, P1173, DOI [10.1139/b02-105, 10.1139/B02-105]; Rajora OP, 1998, CAN J BOT, V76, P500, DOI 10.1139/cjb-76-3-500; Ritchie J.C., 1987, POSTGLACIAL VEGETATI; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sezen UU, 2005, SCIENCE, V307, P891, DOI 10.1126/science.1105034; Slatkin M, 1991, GENETICS, V139, P457; STEBBINS GL, 1988, P NATL ACAD SCI USA, V85, P5141, DOI 10.1073/pnas.85.14.5141; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Thomas MK, 1953, CLIMATOLOGICAL ATLAS; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wendel G.W., 1990, SILVICS N AM, V654, P476; [No title captured]	69	20	21	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97291	10.1371/journal.pone.0097291	http://dx.doi.org/10.1371/journal.pone.0097291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859159	gold, Green Published, Green Submitted			2022-12-25	WOS:000336839400011
J	Leonard, AV; Thornton, E; Vink, R				Leonard, Anna Victoria; Thornton, Emma; Vink, Robert			NK1 Receptor Blockade Is Ineffective in Improving Outcome following a Balloon Compression Model of Spinal Cord Injury	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SUBSTANCE-P ANTAGONIST; CENTRAL-NERVOUS-SYSTEM; EDEMA FORMATION; PROTEIN EXTRAVASATION; ISCHEMIC-STROKE; BLOOD-FLOW; RAT; BARRIER; RELEASE	The neuropeptide substance P (SP) is a well-known mediator of neurogenic inflammation following a variety of CNS disorders. Indeed, inhibition of SP through antagonism of its receptor, the tachykinin NK1 receptor, has been shown to be beneficial following both traumatic brain injury and stroke. Such studies demonstrated that administration of an NK1 receptor antagonist reduced blood-brain-barrier permeability, edema development and improved functional outcome. Furthermore, our recent studies have demonstrated a potential role for SP in mediating neurogenic inflammation following traumatic spinal cord injury (SCI). Accordingly, the present study investigates whether inhibition of SP may similarly play a neuroprotective role following traumatic SCI. A closed balloon compression injury was induced at T10 in New Zealand White rabbits. At 30 minutes post-injury an NK1 receptor antagonist was administered intravenously. Animals were thereafter assessed for blood spinal cord barrier (BSCB) permeability, spinal water content (edema), intrathecal pressure (ITP), and histological and functional outcome from 5 hours to 2 weeks post-SCI. Administration of an NK1 receptor antagonist was not effective in reducing BSCB permeability, edema, ITP, or functional deficits following SCI. We conclude that SP mediated neurogenic inflammation does not seem to play a major role in BSCB disruption, edema development and consequential tissue damage seen in acute traumatic SCI. Rather it is likely that the severe primary insult and subsequent hemorrhage may be the key contributing factors to ongoing SCI injury.	[Leonard, Anna Victoria; Thornton, Emma] Univ Adelaide, Sch Med Sci, Adelaide, SA, Australia; [Vink, Robert] Univ S Australia, Div Hlth Sci, Adelaide, SA 5001, Australia	University of Adelaide; University of South Australia	Leonard, AV (corresponding author), Univ Adelaide, Sch Med Sci, Adelaide, SA, Australia.	anna.leonard@adelaide.edu.au	Vink, Robert/J-7351-2012; Vink, Robert/S-5616-2019	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Leonard, Anna/0000-0002-9430-3314	Neil Sachse Foundation; University of Adelaide	Neil Sachse Foundation; University of Adelaide	The study was funded by the Neil Sachse Foundation (http://www.nsf.org.au/) and the University of Adelaide. AVL is the Neil Sachse Foundation Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ates O, 2007, J CLIN NEUROSCI, V14, P658, DOI 10.1016/j.jocn.2006.03.023; Barry CM, 2011, BRAIN RES, V1389, P143, DOI 10.1016/j.brainres.2011.02.082; Bozzo A, 2011, J NEUROTRAUM, V28, P1401, DOI 10.1089/neu.2009.1236; Caberlotto L, 2003, EUR J NEUROSCI, V17, P1736, DOI 10.1046/j.1460-9568.2003.02600.x; Corrigan F, 2012, CNS NEUROSCI THER, V18, P513, DOI 10.1111/j.1755-5949.2012.00332.x; Demediuk P, 1990, Adv Neurol, V52, P225; DIETL MM, 1991, BRAIN RES, V539, P211, DOI 10.1016/0006-8993(91)91623-9; Donkin J. D., 2006, EFFECTS NEUROPEPTIDE; Donkin JJ, 2009, J CEREB BLOOD FLOW M; Flanders AE, 1999, AM J NEURORADIOL, V20, P926; FREEDMAN J, 1988, NEUROSCIENCE, V27, P267, DOI 10.1016/0306-4522(88)90236-9; Fukuda S, 2005, BRAIN RES PROTOC, V14, P171, DOI 10.1016/j.brainresprot.2005.01.001; GOODMAN JH, 1976, J NEUROSURG, V44, P418, DOI 10.3171/jns.1976.44.4.0418; Harford-Wright E, 2010, NEUROSCI LETT, V481, P26, DOI 10.1016/j.neulet.2010.06.044; Harrison S, 2001, INT J BIOCHEM CELL B, V33, P555, DOI 10.1016/S1357-2725(01)00031-0; Helps SC, 2012, APPL IMMUNOHISTO M M, V20, P82, DOI 10.1097/PAI.0b013e31821fc8cd; Jaeger CB, 1997, EXP NEUROL, V144, P381, DOI 10.1006/exnr.1996.6405; Jiang MH, 2012, NEUROREPORT, V23, P786, DOI 10.1097/WNR.0b013e3283572206; Kimura A, 2010, ANN NEUROL, V67, P794, DOI 10.1002/ana.22023; KOYANAGI I, 1989, PARAPLEGIA, V27, P190, DOI 10.1038/sc.1989.28; Kwon BK, 2009, J NEUROSURG-SPINE, V10, P181, DOI 10.3171/2008.10.SPINE08217; Leonard AV, 2013, J NEUROTRAUMA; Lever IJ, 2003, NEUROPHARMACOLOGY, V45, P1101, DOI 10.1016/S0028-3908(03)00298-3; Leypold BG, 2008, AM J NEURORADIOL, V29, P1012, DOI 10.3174/ajnr.A0962; Maikos JT, 2007, J NEUROTRAUM, V24, P492, DOI 10.1089/neu.2006.0149; MALCANGIO M, 1994, BRIT J PHARMACOL, V113, P635, DOI 10.1111/j.1476-5381.1994.tb17037.x; Mao L, 2011, BRAIN INJURY, V25, P300, DOI 10.3109/02699052.2010.542432; MARTIN D, 1992, J NEUROSCI RES, V32, P539, DOI 10.1002/jnr.490320409; NEMECEK S, 1977, ACTA NEUROCHIR, V37, P7, DOI 10.1007/BF01401922; Nesic O, 2006, NEUROSCIENCE, V143, P779, DOI 10.1016/j.neuroscience.2006.08.079; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; NOBLE LJ, 1989, BRAIN RES, V482, P57, DOI 10.1016/0006-8993(89)90542-8; NOBLE LJ, 1987, BRAIN RES, V424, P177, DOI 10.1016/0006-8993(87)91208-X; Nyberg F, 2002, AMINO ACIDS, V23, P231, DOI 10.1007/s00726-001-0134-2; OSHAUGHNESSY CT, 1993, EUR J PHARMACOL, V236, P319, DOI 10.1016/0014-2999(93)90605-H; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; SHARMA HS, 1993, NEUROSCIENCE, V57, P443, DOI 10.1016/0306-4522(93)90076-R; Sharma HS, 2005, CURR PHARM DESIGN, V11, P1353, DOI 10.2174/1381612053507837; SHARMA HS, 1991, J NEUROL SCI, V102, P150, DOI 10.1016/0022-510X(91)90063-D; Shepard MJ, 1999, SPINAL CORD, V37, P833, DOI 10.1038/sj.sc.3100927; TARLOV IM, 1953, AMA ARCH NEUROL PSY, V70, P813, DOI 10.1001/archneurpsyc.1953.02320360128010; TARLOV IM, 1954, AMA ARCH NEUROL PSY, V71, P271, DOI 10.1001/archneurpsyc.1954.02320390001001; Thornton E, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042630, 10.1371/journal.pone.0034138]; Thornton E, 2010, MOLECULES, V15, P6598, DOI 10.3390/molecules15096598; Turner RJ, 2006, ACTA NEUROCHIR SUPPL, V96, P263; Turner RJ, 2011, BRAIN RES, V1393, P84, DOI 10.1016/j.brainres.2011.03.066; Vanicky I, 2001, J NEUROTRAUM, V18, P1399, DOI 10.1089/08977150152725687; Vink R, 2003, ACT NEUR S, V86, P257; WANG R, 1993, SURG NEUROL, V39, P348, DOI 10.1016/0090-3019(93)90198-A; Whetstone WD, 2003, J NEUROSCI RES, V74, P227, DOI 10.1002/jnr.10759; WINKLER T, 1994, NEUROSCI RES, V21, P91, DOI 10.1016/0168-0102(94)90072-8; YASHON D, 1973, J NEUROSURG, V38, P693, DOI 10.3171/jns.1973.38.6.0693	52	6	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98364	10.1371/journal.pone.0098364	http://dx.doi.org/10.1371/journal.pone.0098364			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859234	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000336839400069
J	Abdul Wahab, MA; de Nys, R; Webster, N; Whalan, S				Abdul Wahab, Muhammad Azmi; de Nys, Rocky; Webster, Nicole; Whalan, Steve			Larval Behaviours and Their Contribution to the Distribution of the Intertidal Coral Reef Sponge Carteriospongia foliascens	PLOS ONE			English	Article							GREAT-BARRIER-REEF; DIEL VERTICAL MIGRATION; UNDERSTANDING RECRUITMENT; POPULATION-DYNAMICS; SETTLEMENT; CONSEQUENCES; DISPERSAL; ECOLOGY; GROWTH; DEPTH	Sponges (Phylum Porifera) are an evolutionary and ecologically significant group; however information on processes influencing sponge population distributions is surprisingly limited. Carteriospongia foliascens is a common Indo-Pacific sponge, which has been reported from the intertidal to the mesophotic. Interestingly, the distribution of C. foliascens at inshore reefs of the Great Barrier Reef is restricted to the intertidal with no individuals evident in adjacent subtidal habitats. The abundance of C. foliascens and substrate availability was first quantified to investigate the influence of substrate limitation on adult distribution. Pre-settlement processes of larval spawning, swimming speeds, phototaxis, vertical migration, and settlement to intertidal and subtidal substrate cues were also quantified. Notably, suitable settlement substrate (coral rubble) was not limiting in subtidal habitats. C. foliascens released up to 765 brooded larvae sponge(-1) day(-1) during the day, with larvae (80%+/- 5.77) being negatively phototactic and migrating to the bottom within 40 minutes from release. Subsequently, larvae (up to 58.67%+/- 2.91) migrated to the surface after the loss of the daylight cue (nightfall), and after 34 h post-release >98.67% (+/- 0.67) of larvae had adopted a benthic habit regardless of light conditions. Intertidal and subtidal biofilms initiated similar settlement responses, inducing faster (as early 6 h post-release) and more successful metamorphosis (>60%) than unconditioned surfaces. C. foliascens has a high larval supply and larval behaviours that support recruitment to the subtidal. The absence of C. foliascens in subtidal habitats at inshore reefs is therefore proposed to be a potential consequence of post-settlement mortalities.	[Abdul Wahab, Muhammad Azmi] James Cook Univ, AIMS JCU, Townsville, Qld 4811, Australia; [Abdul Wahab, Muhammad Azmi; de Nys, Rocky] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Abdul Wahab, Muhammad Azmi; Webster, Nicole] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Whalan, Steve] So Cross Univ, Sch Environm Sci & Engn, Marine Ecol Res Ctr, Lismore, NSW 2480, Australia	James Cook University; James Cook University; Australian Institute of Marine Science; Southern Cross University	Abdul Wahab, MA (corresponding author), James Cook Univ, AIMS JCU, Townsville, Qld 4811, Australia.	muhammad.abdulwahab@jcu.edu.au	de Nys, Rocky/D-6741-2012; Webster, Nicole S/G-4980-2011	de Nys, Rocky/0000-0003-3869-4928; Webster, Nicole S/0000-0002-4753-5278; Abdul Wahab, Muhammad Azmi/0000-0003-4088-9652; Whalan, Steve/0000-0001-6786-8945	AIMS@JCU; JCUPRS; Australian Research Council [FT120100480]; Reef HQ [LP0990664]	AIMS@JCU; JCUPRS; Australian Research Council(Australian Research Council); Reef HQ	MAAW is supported by an AIMS@JCU and JCUPRS scholarships. NSW is funded through an Australian Research Council Future Fellowship (FT120100480). The study was partly funded through an Australian Research Council linkage grant with Reef HQ (LP0990664). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Wahab MA, 2014, CORAL REEFS, V33, P381, DOI 10.1007/s00338-013-1119-9; Abdul Wahab MA, 2014, MOL PHYLOGENET EVOL, V73, P23, DOI 10.1016/j.ympev.2014.01.004; Abdul Wahab MA, 2011, CORAL REEFS, V30, P451, DOI 10.1007/s00338-011-0727-5; Aerts LAM, 2000, MAR ECOL-P S Z N I, V21, P191, DOI 10.1046/j.1439-0485.2000.00685.x; AMANO S, 1988, BIOL BULL, V175, P181, DOI 10.2307/1541557; AMANO S, 1986, BIOL BULL, V171, P371, DOI 10.2307/1541679; Anderson M. J., 2005, PERMANOVA FORTRAN CO, P24; Anthony KRN, 2003, OECOLOGIA, V134, P23, DOI 10.1007/s00442-002-1095-1; Babcock R, 1996, J EXP MAR BIOL ECOL, V206, P179, DOI 10.1016/S0022-0981(96)02622-6; Bannister RJ, 2012, CONT SHELF RES, V32, P86, DOI 10.1016/j.csr.2011.10.018; BARILE PJ, 1994, J EXP MAR BIOL ECOL, V183, P147; Becerro MA, 1998, MAR ECOL PROG SER, V168, P187, DOI 10.3354/meps168187; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Bridge TCL, 2011, CORAL REEFS, V30, P143, DOI 10.1007/s00338-010-0677-3; Bridge TCL, 2011, MAR ECOL PROG SER, V428, P63, DOI 10.3354/meps09046; Cetina-Heredia P, 2011, CORAL REEFS, V30, P593, DOI 10.1007/s00338-011-0749-z; Collin R, 2010, INVERTEBR BIOL, V129, P121, DOI 10.1111/j.1744-7410.2010.00196.x; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; DAYTON PK, 1989, SCIENCE, V245, P1484, DOI 10.1126/science.245.4925.1484; Diaz MC, 2001, B MAR SCI, V69, P535; dos Santos A, 2008, MAR ECOL PROG SER, V359, P171, DOI 10.3354/meps07341; Duckworth AR, 2011, J EXP MAR BIOL ECOL, V402, P49, DOI 10.1016/j.jembe.2011.03.017; Duran S, 2004, MOL ECOL, V13, P511, DOI 10.1046/j.1365-294X.2004.2080.x; Eckman JE, 1996, J EXP MAR BIOL ECOL, V200, P207, DOI 10.1016/S0022-0981(96)02644-5; Erwin PM, 2008, MAR ECOL PROG SER, V362, P139, DOI 10.3354/meps07464; Ettinger-Epstein P, 2008, MAR ECOL PROG SER, V365, P103, DOI 10.3354/meps07503; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Figueiredo J, 2013, ECOLOGY, V94, P650, DOI 10.1890/12-0767.1; FORWARD RB, 1984, LIMNOL OCEANOGR, V29, P146, DOI 10.4319/lo.1984.29.1.0146; Frohlich H, 1997, MAR BIOL, V128, P115, DOI 10.1007/s002270050075; Gonzalez-Rivero M, 2012, MAR ECOL PROG SER, V444, P133, DOI 10.3354/meps09424; Ilan M., 1988, P745; ILAN M, 1990, BIOL BULL, V179, P279, DOI 10.2307/1542319; Jekely G, 2008, NATURE, V456, P395, DOI 10.1038/nature07590; KIMURA M, 1964, GENETICS, V49, P561; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Lopez-Victoria M, 2006, MAR ECOL PROG SER, V312, P113, DOI 10.3354/meps312113; Maldonado M, 1996, MAR ECOL PROG SER, V138, P169, DOI 10.3354/meps138169; Maldonado M, 2006, CAN J ZOOL, V84, P175, DOI 10.1139/Z05-177; Maldonado M, 1998, MAR ECOL PROG SER, V174, P141, DOI 10.3354/meps174141; Maldonado M, 1999, NATURE, V398, P476, DOI 10.1038/19007; Maldonado M, 1997, MAR ECOL PROG SER, V148, P115, DOI 10.3354/meps148115; Maldonado M, 2008, MAR ECOL-EVOL PERSP, V29, P298, DOI 10.1111/j.1439-0485.2008.00244.x; Maldonado M, 2008, MAR BIOL, V154, P631, DOI 10.1007/s00227-008-0956-5; Manuel JL, 1997, VERTICAL MIGRATION H; Mariani S, 2006, OECOLOGIA, V149, P174, DOI 10.1007/s00442-006-0429-9; McCarthy DA, 2002, MAR ECOL PROG SER, V241, P215, DOI 10.3354/meps241215; Morgan SG, 2010, MAR ECOL PROG SER, V404, P109, DOI 10.3354/meps08476; Pawlik JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062573; Pineda J, 2010, J EXP MAR BIOL ECOL, V392, P9, DOI 10.1016/j.jembe.2010.04.008; Pineda J, 2009, POPUL ECOL, V51, P17, DOI 10.1007/s10144-008-0118-0; Quinn G.P., 2002, EXPT DESIGN DATA ANA, P537, DOI DOI 10.1017/CBO9780511806384; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Stake JL, 2003, J EXP MAR BIOL ECOL, V288, P181, DOI 10.1016/S0022-0981(03)00018-2; Thacker RW, 2005, INTEGR COMP BIOL, V45, P369, DOI 10.1093/icb/45.2.369; Treml EA, 2008, LANDSCAPE ECOL, V23, P19, DOI 10.1007/s10980-007-9138-y; Trussell GC, 2006, MAR ECOL PROG SER, V323, P149, DOI 10.3354/meps323149; Van Soest RWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035105; WAPSTRA M, 1987, TAXONOMY PORIFERA, P281; WARBURTON FE, 1966, ECOLOGY, V47, P672, DOI 10.2307/1933952; Webster NS, 2013, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00444; Whalan S, 2008, MAR ECOL PROG SER, V368, P145, DOI 10.3354/meps07573; Whalan S, 2008, AQUAT BIOL, V3, P111, DOI 10.3354/ab00066; Whalan S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04072; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; WILKINSON CR, 1983, SCIENCE, V219, P410, DOI 10.1126/science.219.4583.410; WILKINSON CR, 1989, CORAL REEFS, V8, P1, DOI 10.1007/BF00304685; WILKINSON CR, 1988, PSZNI MAR ECOL, V9, P321, DOI 10.1111/j.1439-0485.1988.tb00210.x; Wulff JL, 2006, CAN J ZOOL, V84, P146, DOI 10.1139/Z06-019; WULFF JL, 1995, MAR BIOL, V123, P313; Young Craig M., 1995, P249	72	26	26	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98181	10.1371/journal.pone.0098181	http://dx.doi.org/10.1371/journal.pone.0098181			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853091	Green Published, gold, Green Accepted			2022-12-25	WOS:000338323200054
J	Girard, N; Bazille, C; Lhuissier, E; Benateau, H; Llombart-Bosch, A; Boumediene, K; Bauge, C				Girard, Nicolas; Bazille, Celine; Lhuissier, Eva; Benateau, Herve; Llombart-Bosch, Antonio; Boumediene, Karim; Bauge, Catherine			3-Deazaneplanocin A (DZNep), an Inhibitor of the Histone Methyltransferase EZH2, Induces Apoptosis and Reduces Cell Migration in Chondrosarcoma Cells	PLOS ONE			English	Article							ZESTE HOMOLOG 2; GROUP PROTEIN EZH2; CANCER-CELLS; PROSTATE-CANCER; STEM-CELLS; TUMOR; PROLIFERATION; ENHANCER; METHYLATION; EXPRESSION	Objective: Growing evidences indicate that the histone methyltransferase EZH2 (enhancer of zeste homolog 2) may be an appropriate therapeutic target in some tumors. Indeed, a high expression of EZH2 is correlated with poor prognosis and metastasis in many cancers. In addition, 3-Deazaneplanocin A (DZNep), an S-adenosyl-L homocysteine hydrolase inhibitor which induces EZH2 protein depletion, leads to cell death in several cancers and tumors. The aim of this study was to determine whether an epigenetic therapy targeting EZH2 with DZNep may be also efficient to treat chondrosarcomas. Methods: EZH2 expression was determined by immunohistochemistry and western-blot. Chondrosarcoma cell line CH2879 was cultured in the presence of DZNep, and its growth and survival were evaluated by counting adherent cells periodically. Apoptosis was assayed by cell cycle analysis, Apo2.7 expression using flow cytometry, and by PARP cleavage using western-blot. Cell migration was assessed by wound healing assay. Results: Chondrosarcomas (at least with high grade) highly express EZH2, at contrary to enchondromas or chondrocytes. In vitro, DZNep inhibits EZH2 protein expression, and subsequently reduces the trimethylation of lysine 27 on histone H3 (H3K27me3). Interestingly, DZNep induces cell death of chondrosarcoma cell lines by apoptosis, while it slightly reduces growth of normal chondrocytes. In addition, DZNep reduces cell migration. Conclusion: These results indicate that an epigenetic therapy that pharmacologically targets EZH2 via DZNep may constitute a novel approach to treat chondrosarcomas.	[Girard, Nicolas; Bazille, Celine; Lhuissier, Eva; Benateau, Herve; Boumediene, Karim; Bauge, Catherine] Normandie Univ, Caen, France; [Girard, Nicolas; Bazille, Celine; Lhuissier, Eva; Benateau, Herve; Boumediene, Karim; Bauge, Catherine] UNICAEN, MILPAT, EA4652, Caen, France; [Bazille, Celine] CHU Caen, Serv Anat Pathol, F-14000 Caen, France; [Benateau, Herve] CHU Caen, Serv Chirurg Maxillofaciale, F-14000 Caen, France; [Llombart-Bosch, Antonio] Univ Valencia, Dept Pathol, Valencia, Spain	Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; University of Valencia	Bauge, C (corresponding author), Normandie Univ, Caen, France.	catherine.bauge@unicaen.fr	Girard, Nicolas/ABE-3618-2021; BAUGE, Catherine/T-7491-2017	Girard, Nicolas/0000-0001-9909-2299; BAUGE, Catherine/0000-0001-5642-998X; BOUMEDIENE, Karim/0000-0001-6517-8318; Girard, Nicolas/0000-0002-7636-6688	Canceropole Nord-Ouest; Conseil Regional Basse-Normandie; La Ligue contre le cancer; Conseil Regional de Basse-Normandie	Canceropole Nord-Ouest; Conseil Regional Basse-Normandie(Region Normandie); La Ligue contre le cancer(Ligue nationale contre le cancer); Conseil Regional de Basse-Normandie(Region Normandie)	This study was funding by Canceropole Nord-Ouest, Conseil Regional Basse-Normandie and La Ligue contre le cancer. NG is recipient of a fellowship from Conseil Regional de Basse-Normandie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloia L, 2013, DEVELOPMENT, V140, P2525, DOI 10.1242/dev.091553; Angelini A, 2012, J SURG ONCOL, V106, P929, DOI 10.1002/jso.23173; Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Chen YH, 2012, AM J TRANSL RES, V4, P364; Chen YC, 2010, CANCER LETT, V297, P109, DOI 10.1016/j.canlet.2010.05.003; Cheng LL, 2012, CLIN CANCER RES, V18, P4201, DOI 10.1158/1078-0432.CCR-12-0036; Chiba T, 2012, INT J CANCER, V130, P2557, DOI 10.1002/ijc.26264; Choudhury SR, 2011, CARCINOGENESIS, V32, P1525, DOI 10.1093/carcin/bgr171; Crea F, 2012, CANCER METAST REV, V31, P753, DOI 10.1007/s10555-012-9387-3; Crea F, 2012, CRIT REV ONCOL HEMAT, V83, P184, DOI 10.1016/j.critrevonc.2011.10.007; Crea F, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-40; Ding XL, 2014, STEM CELLS DEV, V23, P931, DOI 10.1089/scd.2013.0267; Duchman KR, 2014, CLIN ORTHOP RELAT R, V472, P2516, DOI 10.1007/s11999-014-3600-3; Eskander RN, 2013, INT J GYNECOL CANCER, V23, P997, DOI 10.1097/IGC.0b013e318296a265; Fragola G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003292; Fujii S, 2008, J BIOL CHEM, V283, P17324, DOI 10.1074/jbc.M800224200; Fujiwara T, 2014, J BIOL CHEM, V289, P8121, DOI 10.1074/jbc.M114.548651; Gil-Benso R, 2003, LAB INVEST, V83, P877, DOI 10.1097/01.LAB.0000073131.34648.EA; Hayden A, 2011, BREAST CANCER RES TR, V127, P109, DOI 10.1007/s10549-010-0982-0; Holm K, 2012, MOL ONCOL, V6, P494, DOI 10.1016/j.molonc.2012.06.002; HUNG SC, 2013, PLOS ONE, V8; Italiano A, 2013, ANN ONCOL, V24, P2916, DOI 10.1093/annonc/mdt374; Juan AH, 2011, GENE DEV, V25, P789, DOI 10.1101/gad.2027911; Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678; Li H, 2010, MOL CANCER RES, V8, P1610, DOI 10.1158/1541-7786.MCR-10-0398; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mallen-St Clair J, 2012, GENE DEV, V26, P439, DOI 10.1101/gad.181800.111; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Ougolkov AV, 2008, CLIN CANCER RES, V14, P6790, DOI 10.1158/1078-0432.CCR-08-1013; Pereira CF, 2010, CELL STEM CELL, V6, P547, DOI 10.1016/j.stem.2010.04.013; Puppe J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2354; Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Taniguchi H, 2012, ONCOGENE, V31, P1988, DOI 10.1038/onc.2011.387; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varier RA, 2011, BBA-REV CANCER, V1815, P75, DOI 10.1016/j.bbcan.2010.10.002; Wagner T, 2012, NAT BIOTECHNOL, V30, P622, DOI 10.1038/nbt.2300; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Yu J, 2010, ONCOGENE, V29, P5370, DOI 10.1038/onc.2010.269; Zhao X, 2013, LEUKEMIA, V27, P2341, DOI 10.1038/leu.2013.94; Zhou JB, 2011, BLOOD, V118, P2830, DOI 10.1182/blood-2010-07-294827	46	50	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98176	10.1371/journal.pone.0098176	http://dx.doi.org/10.1371/journal.pone.0098176			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852755	Green Published, Green Submitted, gold			2022-12-25	WOS:000338323200052
J	Huang, JH; Ding, XX; Savini, G; Jiang, ZX; Pan, C; Hua, YJ; Wu, F; Feng, YF; Yu, Y; Wang, QM				Huang, Jinhai; Ding, Xixia; Savini, Giacomo; Jiang, Zhengxuan; Pan, Chao; Hua, Yanjun; Wu, Fan; Feng, Yifan; Yu, Ye; Wang, Qinmei			Central and Midperipheral Corneal Thickness Measured with Scheimpflug Imaging and Optical Coherence Tomography	PLOS ONE			English	Article							ANTERIOR SEGMENT MEASUREMENTS; PACHYMETRY MEASUREMENTS; ULTRASONIC PACHYMETRY; DIURNAL-VARIATION; CONTACT-LENS; REPEATABILITY; REPRODUCIBILITY; AGREEMENT; GALILEI; INTRAOBSERVER	Purpose: To compare corneal thickness measurements using Pentacam (Oculus, Germany), Sirius (CSO, Italy), Galilei (Ziemer, Switzerland), and RTVue-100 OCT (Optovue Inc., USA). Methods: Sixty-six eyes of 66 healthy volunteers were enrolled. Three consecutive measurements were performed with each device. The mean value of the three measurements was used for subsequent analysis. Central corneal thickness (CCT), thinnest corneal thickness (TCT), and midperipheral corneal thickness (MPCT; measured at superior, inferior, nasal, and temporal locations with a distance of 1 mm (CT2mm) or 2.5 mm (CT5mm) from the corneal apex) were analyzed. Differences and agreement between measurements were assessed using the repeated-measures analysis of variance (ANOVA) and Bland-Altman analyses, respectively. Results: Statistically significant differences (p<0.001) among the four devices were revealed in CCT, TCT and CT2mm measurements. The CCT, TCT, and CT2mm values were ranked from the thickest to the thinnest as follows: Galilei>Sirius>Pentacam>RTVue OCT. For these measurements, agreement between measurements by Sirius and Pentacam was good, whereas Galilei overestimated and RTVue underestimated corneal thickness compared to Sirius and Pentacam. As regards CT5mm measurements, Pentacam provided the largest values, whereas RTVue OCT yielded the smallest values. Agreement of the CT5mm measurements was good between the Pentacam, Sirius, moderate between Galilei and the other two Scheimpflug systems, and poor between the RTVue OCT and the remaining devices. Conclusions: The Pentacam and Sirius can be used interchangeably for CCT measurements, while the Galilei and RTVue systematically over- and underestimate CCT, respectively. The three Scheimpflug cameras, but not the RTVue, may be used interchangeably for MPCT measurements.	[Huang, Jinhai; Ding, Xixia; Savini, Giacomo; Pan, Chao; Hua, Yanjun; Wu, Fan; Feng, Yifan; Yu, Ye; Wang, Qinmei] Wenzhou Med Univ, Sch Optometry & Ophthalmol, Wenzhou, Zhejiang, Peoples R China; [Huang, Jinhai; Ding, Xixia; Savini, Giacomo; Pan, Chao; Hua, Yanjun; Wu, Fan; Feng, Yifan; Yu, Ye; Wang, Qinmei] Wenzhou Med Univ, Hosp Eye, Wenzhou, Zhejiang, Peoples R China; [Huang, Jinhai; Ding, Xixia; Wang, Qinmei] Minist Hlth PR China, Key Lab Vis Sci, Wenzhou, Zhejiang, Peoples R China; [Savini, Giacomo] Studio Oculist DAzeglio, Bologna, Italy; [Jiang, Zhengxuan] Anhui Med Univ, Affiliated Hosp 2, Hefei, Anhui, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Anhui Medical University	Wang, QM (corresponding author), Wenzhou Med Univ, Sch Optometry & Ophthalmol, Wenzhou, Zhejiang, Peoples R China.	wqm6@mail.eye.ac.cn	Savini, Giacomo/J-9196-2018; Huang, Jinhai/ABH-4519-2020	Savini, Giacomo/0000-0003-0075-3582; Huang, Jinhai/0000-0001-9952-3175; HUA, YANJUN/0000-0001-6461-3576	Foundation of Wenzhou City Science & Technology Bureau [Y20110045]; health Bureau of Zhejiang Province [2012KYB135]; Scientific Research Fund of Zhejiang Provincial Education Department [Y201223147]	Foundation of Wenzhou City Science & Technology Bureau; health Bureau of Zhejiang Province; Scientific Research Fund of Zhejiang Provincial Education Department	This work was supported in part by the Foundation of Wenzhou City Science & Technology Bureau (Y20110045; www.wzkj.gov.cn); the health Bureau of Zhejiang Province (2012KYB135; www.zjmed.org.cn); and the Scientific Research Fund of Zhejiang Provincial Education Department (Y201223147; www.zjedu.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedei A, 2012, EUR J OPHTHALMOL, V22, pS29, DOI 10.5301/ejo.5000102; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brautaset RL, 2013, CORNEA, V32, P257, DOI 10.1097/ICO.0b013e31825240d7; Chen SH, 2012, ACTA OPHTHALMOL, V90, P449, DOI 10.1111/j.1755-3768.2010.01947.x; Cho P, 2000, CURR EYE RES, V21, P799, DOI 10.1076/ceyr.21.4.799.5542; Ehlers N, 2004, EXP EYE RES, V78, P543, DOI 10.1016/j.exer.2003.09.017; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Hosseini HRJ, 2010, CORNEA, V29, P1091, DOI 10.1097/ICO.0b013e3181cf98e5; Huang JH, 2013, OPHTHALMOLOGY, V120, P1951, DOI 10.1016/j.ophtha.2013.02.022; Huang JH, 2011, OPTOMETRY VISION SCI, V88, P940, DOI 10.1097/OPX.0b013e31821ffe2c; Huang JH, 2011, J CATARACT REFR SURG, V37, P341, DOI 10.1016/j.jcrs.2010.08.044; Ishibazawa A, 2011, CORNEA, V30, P615, DOI 10.1097/ICO.0b013e3181d00800; Jonuscheit S, 2009, J CATARACT REFR SURG, V35, P2127, DOI 10.1016/j.jcrs.2009.07.012; Karimian F, 2012, EUR J OPHTHALMOL, V22, pS33, DOI 10.5301/ejo.5000056; Khoramnia R, 2007, J CATARACT REFR SURG, V33, P830, DOI 10.1016/j.jcrs.2006.12.025; Li HF, 1997, CURR EYE RES, V16, P214, DOI 10.1076/ceyr.16.3.214.15412; Marsich MM, 2000, CORNEA, V19, P792, DOI 10.1097/00003226-200011000-00007; Martin R, 2008, CORNEA, V27, P976, DOI 10.1097/ICO.0b013e318172fc2c; Martin R, 2007, INVEST OPHTH VIS SCI, V48, P3043, DOI 10.1167/iovs.06-1372; Menassa N, 2008, J CATARACT REFR SURG, V34, P1742, DOI 10.1016/j.jcrs.2008.06.024; Miglior S, 2004, BRIT J OPHTHALMOL, V88, P174, DOI 10.1136/bjo.2003.023416; Milla M, 2011, J CATARACT REFR SURG, V37, P310, DOI 10.1016/j.jcrs.2010.08.038; Miranda MA, 2009, OPTOMETRY VISION SCI, V86, P266, DOI 10.1097/OPX.0b013e318196a737; Mohamed S, 2007, INVEST OPHTH VIS SCI, V48, P5499, DOI 10.1167/iovs.07-0591; Nam SM, 2010, OPHTHALMOLOGY, V117, P2096, DOI 10.1016/j.ophtha.2010.03.002; Ou RJ, 2002, AM J OPHTHALMOL, V134, P771, DOI 10.1016/S0002-9394(02)01656-2; Price FW, 1999, OPHTHALMOLOGY, V106, P2216, DOI 10.1016/S0161-6420(99)90508-0; Ponce CMP, 2009, J CATARACT REFR SURG, V35, P1055, DOI 10.1016/j.jcrs.2009.01.022; Rabsilber TM, 2005, J CATARACT REFR SURG, V31, P1607, DOI 10.1016/j.jcrs.2005.01.013; Randleman JB, 2008, OPHTHALMOLOGY, V115, P37, DOI 10.1016/j.ophtha.2007.03.073; Read SA, 2008, INVEST OPHTH VIS SCI, V49, P2911, DOI 10.1167/iovs.08-1833; Read SA, 2009, OPTOMETRY VISION SCI, V86, P170, DOI 10.1097/OPX.0b013e3181981b7e; Savini G, 2011, J CATARACT REFR SURG, V37, P1809, DOI 10.1016/j.jcrs.2011.04.033; Savini G, 2011, J CATARACT REFR SURG, V37, P1679, DOI 10.1016/j.jcrs.2011.03.055	34	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98316	10.1371/journal.pone.0098316	http://dx.doi.org/10.1371/journal.pone.0098316			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24854348	Green Published, Green Submitted, gold			2022-12-25	WOS:000338323200062
J	Liu, HT; Yu, SJ; Zhang, H; Xu, J				Liu, Hongtao; Yu, Shujie; Zhang, Hua; Xu, Jian			Identification of Nitric Oxide as an Endogenous Inhibitor of 26S Proteasomes in Vascular Endothelial Cells	PLOS ONE			English	Article							UBIQUITIN/PROTEASOME-DEPENDENT PROTEOLYSIS; O-GLCNAC; PROTEIN MODIFICATION; NEUTRAL CERAMIDASE; S-NITROSYLATION; SMOOTH-MUSCLE; MOUSE MODEL; UBIQUITIN; DEGRADATION; SYNTHASE	The 26S proteasome plays a fundamental role in almost all eukaryotic cells, including vascular endothelial cells. However, it remains largely unknown how proteasome functionality is regulated in the vasculature. Endothelial nitric oxide (NO) synthase (eNOS)-derived NO is known to be essential to maintain endothelial homeostasis. The aim of the present study was to establish the connection between endothelial NO and 26S proteasome functionality in vascular endothelial cells. The 26S proteasome reporter protein levels, 26S proteasome activity, and the O-GlcNAcylation of Rpt2, a key subunit of the proteasome regulatory complex, were assayed in 26S proteasome reporter cells, human umbilical vein endothelial cells (HUVEC), and mouse aortic tissues isolated from 26S proteasome reporter and eNOS knockout mice. Like the other selective NO donors, NO derived from activated eNOS (by pharmacological and genetic approach) increased O-GlcNAc modification of Rpt2, reduced proteasome chymotrypsin-like activity, and caused 26S proteasome reporter protein accumulation. Conversely, inactivation of eNOS reversed all the effects. SiRNA knockdown of O-GlcNAc transferase (OGT), the key enzyme that catalyzes protein O-GlcNAcylation, abolished NO-induced effects. Consistently, adenoviral overexpression of O-GlcNAcase (OGA), the enzyme catalyzing the removal of the O-GlcNAc group, mimicked the effects of OGT knockdown. Finally, compared to eNOS wild type aortic tissues, 26S proteasome reporter mice lacking eNOS exhibited elevated 26S proteasome functionality in parallel with decreased Rpt2 O-GlcNAcylation, without changing the levels of Rpt2 protein. In conclusion, the eNOS-derived NO functions as a physiological suppressor of the 26S proteasome in vascular endothelial cells.	[Xu, Jian] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Endocrinol Sect, Oklahoma City, OK 73107 USA; Univ Oklahoma, Hlth Sci Ctr, Harold Hamm Oklahoma Diabet Ctr, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Xu, J (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Endocrinol Sect, Oklahoma City, OK 73107 USA.	jian-xu@ouhsc.edu			National Institutes of Health Grant from the COBRE Program of the National Center for Research Resources [P20 RR 024215-05]; National Institute of General Medical Sciences [9P20GM104934-06]; American Heart Association [10SDG2600164]; American Diabetes Association [1-12-JF-58]; Oklahoma Center for Advancement of Science and Technology [HR11-200]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104934] Funding Source: NIH RePORTER	National Institutes of Health Grant from the COBRE Program of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); Oklahoma Center for Advancement of Science and Technology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by an National Institutes of Health Grant from the COBRE Program of the National Center for Research Resources (P20 RR 024215-05) and of the National Institute of General Medical Sciences (9P20GM104934-06) (JX, Project 2). This work was also supported by a National Scientist Development Grant (10SDG2600164) from the American Heart Association (JX), a Junior Faculty Award (1-12-JF-58) from the American Diabetes Association (JX), and a Research Award (HR11-200) from the Oklahoma Center for Advancement of Science and Technology (JX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balligand JL, 2002, CIRC RES, V90, P838, DOI 10.1161/01.RES.0000018173.10175.FF; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bowman AB, 2005, HUM MOL GENET, V14, P679, DOI 10.1093/hmg/ddi064; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Caramori ML, 2012, DIABETES, V61, P739, DOI 10.2337/db11-0617; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; Chanvorachote P, 2005, J BIOL CHEM, V280, P42044, DOI 10.1074/jbc.M510080200; Cheroni C, 2009, HUM MOL GENET, V18, P82, DOI 10.1093/hmg/ddn319; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Desterro JMP, 2000, CELL MOL LIFE SCI, V57, P1207, DOI 10.1007/PL00000760; Edwards CM, 2009, AM J HEMATOL, V84, P268, DOI 10.1002/ajh.21374; EYTAN E, 1989, P NATL ACAD SCI USA, V86, P7751, DOI 10.1073/pnas.86.20.7751; Fekete MR, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-114; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; Franzen R, 2002, FEBS LETT, V532, P441, DOI 10.1016/S0014-5793(02)03727-4; Franzen R, 2002, J BIOL CHEM, V277, P46184, DOI 10.1074/jbc.M204034200; Fu YN, 1998, ANN NY ACAD SCI, V842, P138, DOI 10.1111/j.1749-6632.1998.tb09642.x; Fuchs SY, 1998, ONCOGENE, V17, P1483, DOI 10.1038/sj.onc.1202184; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Glockzin S, 1999, J BIOL CHEM, V274, P19581, DOI 10.1074/jbc.274.28.19581; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; Groettrup M, 1996, NATURE, V381, P166, DOI 10.1038/381166a0; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Hanover JA, 2001, FASEB J, V15, P1865, DOI 10.1096/fj.01-0094rev; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Heessen S, 2003, FEBS LETT, V555, P397, DOI 10.1016/S0014-5793(03)01296-1; HERSHKO A, 1984, P NATL ACAD SCI-BIOL, V81, P1619, DOI 10.1073/pnas.81.6.1619; Hershko A, 1997, CURR OPIN CELL BIOL, V9, P788, DOI 10.1016/S0955-0674(97)80079-8; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HERSHKO A, 1983, CELL, V34, P11, DOI 10.1016/0092-8674(83)90131-9; Jiang JH, 2003, J BIOL CHEM, V278, P49332, DOI 10.1074/jbc.M304738200; Kapadia MR, 2009, NITRIC OXIDE-BIOL CH, V20, P279, DOI 10.1016/j.niox.2009.02.005; Kibbe MR, 2000, J VASC SURG, V31, P364, DOI 10.1016/S0741-5214(00)90166-6; Kim HJ, 2006, MOL PHARMACOL, V69, P1633, DOI 10.1124/mol.105.020487; Kotamraju S, 2003, P NATL ACAD SCI USA, V100, P10653, DOI 10.1073/pnas.1933581100; Lindsten K, 2003, NAT BIOTECHNOL, V21, P897, DOI 10.1038/nbt851; Lindsten K, 2002, J CELL BIOL, V157, P417, DOI 10.1083/jcb.200111034; Liu HT, 2012, ARTERIOSCL THROM VAS, V32, P2131, DOI 10.1161/ATVBAHA.112.253385; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; Magill L, 2004, HAEMATOLOGICA, V89, P1428; Mannick JB, 2002, ARCH BIOCHEM BIOPHYS, V408, P1, DOI 10.1016/S0003-9861(02)00490-3; Martinez-Ruiz A, 2005, P NATL ACAD SCI USA, V102, P8525, DOI 10.1073/pnas.0407294102; Martinez-Ruiz A, 2004, CARDIOVASC RES, V62, P43, DOI 10.1016/j.cardiores.2004.01.013; Martinez-Ruiz A, 2011, FREE RADICAL BIO MED, V51, P17, DOI 10.1016/j.freeradbiomed.2011.04.010; Noman Abu Shadat M, 2009, Innate Immun, V15, P33, DOI 10.1177/1753425908099317; Ooboshi H, 1997, AM J PHYSIOL-HEART C, V273, pH265, DOI 10.1152/ajpheart.1997.273.1.H265; Orlowski RZ, 1999, CELL DEATH DIFFER, V6, P303, DOI 10.1038/sj.cdd.4400505; Overath T, 2012, MOL CELL PROTEOMICS, V11, P467, DOI 10.1074/mcp.M111.015966; Peng ZF, 2008, NITRIC OXIDE-BIOL CH, V18, P136, DOI 10.1016/j.niox.2007.11.002; Queisser MA, 2010, DIABETES, V59, P670, DOI 10.2337/db08-1565; Retzlaff M, 2009, EMBO REP, V10, P1147, DOI 10.1038/embor.2009.153; Rex-Mathes M, 2001, BIOCHIMIE, V83, P583, DOI 10.1016/S0300-9084(01)01305-0; Rogers PA, 2001, J BIOL CHEM, V276, P30980, DOI 10.1074/jbc.M101037200; Ryu IH, 2011, BIOCHEM BIOPH RES CO, V408, P52, DOI 10.1016/j.bbrc.2011.03.115; Schmidt M., 2013, BIOCH BIOPHYS ACTA; Schroder H, 2006, MOL PHARMACOL, V69, P1507, DOI 10.1124/mol.106.023416; Schwartz AL, 1999, ANNU REV MED, V50, P57; Shang TS, 2005, FREE RADICAL BIO MED, V39, P1059, DOI 10.1016/j.freeradbiomed.2005.05.022; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Stangl K, 2010, CARDIOVASC RES, V85, P281, DOI 10.1093/cvr/cvp315; Sumegi M, 2003, BIOCHEM BIOPH RES CO, V312, P1284, DOI 10.1016/j.bbrc.2003.11.074; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Tanioka T, 2011, J BIOL CHEM, V286, P29388, DOI 10.1074/jbc.M110.192732; Tsihlis ND, 2012, NITRIC OXIDE-BIOL CH, V27, P50, DOI 10.1016/j.niox.2012.04.006; Vita JA, 2011, CIRCULATION, V124, pE906, DOI 10.1161/CIRCULATIONAHA.111.078824; Vosseller K, 2002, CURR OPIN CHEM BIOL, V6, P851, DOI 10.1016/S1367-5931(02)00384-8; Wang WJ, 2008, INT J ONCOL, V33, P1037, DOI 10.3892/ijo_00000092; Wei Q, 2006, J BIOL CHEM, V281, P21652, DOI 10.1074/jbc.M602105200; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Whelan SA, 2003, CIRC RES, V93, P1047, DOI 10.1161/01.RES.0000103190.20260.37; Whitsett J, 2007, ARTERIOSCL THROM VAS, V27, P2340, DOI 10.1161/ATVBAHA.107.153742; Xu J, 2007, CIRCULATION, V116, P944, DOI 10.1161/CIRCULATIONAHA.106.684795; Xu J, 2006, ARTERIOSCL THROM VAS, V26, P2688, DOI 10.1161/01.ATV.0000249394.94588.82; Xu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036717; Xu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029649; Xu J, 2009, HYPERTENSION, V54, P625, DOI 10.1161/HYPERTENSIONAHA.109.133736; Zachara N. E., 2011, CURR PROTOC MOL BIOL, DOI [DOI 10.1002/0471142727.MB1706S95, 10.1002/0471142727.mb1706s95]; Zachara NE, 2004, TRENDS CELL BIOL, V14, P218, DOI 10.1016/j.tcb.2004.03.005; Zeidan Q, 2010, MOL BIOL CELL, V21, P1922, DOI 10.1091/mbc.E09-11-0941; Zhang FX, 2012, AM J PHYSIOL-CELL PH, V302, pC1786, DOI 10.1152/ajpcell.00004.2012; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7	86	15	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98486	10.1371/journal.pone.0098486	http://dx.doi.org/10.1371/journal.pone.0098486			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853093	Green Submitted, Green Published, gold			2022-12-25	WOS:000338323200074
J	Vis, DJ; Westerhuis, JA; Hoefsloot, HCJ; Roelfsema, F; Van der Greef, J; Hendriks, MMWB; Smilde, AK				Vis, Daniel J.; Westerhuis, Johan A.; Hoefsloot, Huub C. J.; Roelfsema, Ferdinand; Van der Greef, Jan; Hendriks, Margriet M. W. B.; Smilde, Age K.			Network Identification of Hormonal Regulation	PLOS ONE			English	Article							GASTRIC BYPASS-SURGERY; INSULIN-RESISTANCE; NEGATIVE FEEDBACK; SECRETION; PULSATILE; GLUCOSE; OBESITY; STRESS; THYROTROPIN; RESPONSES	Relations among hormone serum concentrations are complex and depend on various factors, including gender, age, body mass index, diurnal rhythms and secretion stochastics. Therefore, endocrine deviations from healthy homeostasis are not easily detected or understood. A generic method is presented for detecting regulatory relations between hormones. This is demonstrated with a cohort of obese women, who underwent blood sampling at 10 minute intervals for 24-hours. The cohort was treated with bromocriptine in an attempt to clarify how hormone relations change by treatment. The detected regulatory relations are summarized in a network graph and treatment-induced changes in the relations are determined. The proposed method identifies many relations, including well-known ones. Ultimately, the method provides ways to improve the description and understanding of normal hormonal relations and deviations caused by disease or treatment.	[Vis, Daniel J.; Hendriks, Margriet M. W. B.] Univ Med Ctr Utrecht, Dept Metab & Endocrine Dis, Utrecht, Netherlands; [Vis, Daniel J.; Westerhuis, Johan A.; Hoefsloot, Huub C. J.; Smilde, Age K.] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Vis, Daniel J.; Westerhuis, Johan A.; Hoefsloot, Huub C. J.; Van der Greef, Jan; Hendriks, Margriet M. W. B.; Smilde, Age K.] Netherlands Metabol Ctr, Leiden, Netherlands; [Roelfsema, Ferdinand] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Leiden, Netherlands; [Van der Greef, Jan] TNO Qual Life, Zeist, Netherlands	Utrecht University; Utrecht University Medical Center; University of Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Organization Applied Science Research	Vis, DJ (corresponding author), Univ Med Ctr Utrecht, Dept Metab & Endocrine Dis, Utrecht, Netherlands.	science@danielvis.nl		Smilde, Age/0000-0002-3052-4644	TNO Quality of Life; Netherlands Metabolomics Center, part of the Netherlands Genomics Initiative of the Netherlands Organization for Scientific Research	TNO Quality of Life; Netherlands Metabolomics Center, part of the Netherlands Genomics Initiative of the Netherlands Organization for Scientific Research	TNO Quality of Life supported this research from the systems biology program (www.tno.nl) and The Netherlands Metabolomics Center, which is part of the Netherlands Genomics Initiative of the Netherlands Organization for Scientific Research (http://www.metabolomicscentre.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedict C, 2009, PSYCHONEUROENDOCRINO, V34, P455, DOI 10.1016/j.psyneuen.2008.10.010; BERGER M, 1975, BIOCHEM J, V146, P231, DOI 10.1042/bj1460231; Bose M, 2009, CURR OPIN ENDOCRINOL, V16, P340, DOI 10.1097/MED.0b013e32832fa137; Carroll TB, 2010, REV ENDOCR METAB DIS, V11, P147, DOI 10.1007/s11154-010-9143-3; CINCOTTA AH, 1991, METABOLISM, V40, P639, DOI 10.1016/0026-0495(91)90057-4; Cordido F, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/434562; de la Fuente A, 2004, BIOINFORMATICS, V20, P3565, DOI 10.1093/bioinformatics/bth445; DEMPSTER AP, 1972, BIOMETRICS, V28, P157, DOI 10.2307/2528966; Falken Y, 2011, J CLIN ENDOCR METAB, V96, P2227, DOI 10.1210/jc.2010-2876; Johnson ML, 2008, ANAL BIOCHEM, V381, P8, DOI 10.1016/j.ab.2008.07.001; Keenan DM, 1997, AM J PHYSIOL-REG I, V273, pR1182, DOI 10.1152/ajpregu.1997.273.3.R1182; Keenan DM, 2004, AM J PHYSIOL-ENDOC M, V287, pE652, DOI 10.1152/ajpendo.00167.2004; Keenan DM, 1998, AM J PHYSIOL-REG I, V275, pR1939, DOI 10.1152/ajpregu.1998.275.6.R1939; Kok P, 2008, J CLIN ENDOCRINOL ME; Kok P, 2006, AM J PHYSIOL-ENDOC M, V291, pE1038, DOI 10.1152/ajpendo.00567.2005; Kok P, 2006, J CLIN ENDOCR METAB, V91, P3236, DOI 10.1210/jc.2005-2529; Lin E, 2010, AM J PHYSIOL-ENDOC M, V299, pE706, DOI 10.1152/ajpendo.00405.2010; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; Murphy KP., 2002, THESIS UC BERKELEY; Pearl J., 2000, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Pearl J, 1988, MORGAN KAUFMANN SERI, P521; PEREZLOPEZ FR, 1981, ACTA ENDOCRINOL-COP, V97, P7, DOI 10.1530/acta.0.0970007; PERLEY MJ, 1967, J CLIN INVEST, V46, P1954, DOI 10.1172/JCI105685; RE RN, 1976, J CLIN ENDOCR METAB, V43, P338, DOI 10.1210/jcem-43-2-338; Roelfsema F, 2001, J CLIN ENDOCR METAB, V86, P2459, DOI 10.1210/jc.86.6.2459; Roelfsema F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031305; Roelfsema F, 2009, EUR J ENDOCRINOL, V161, P695, DOI 10.1530/EJE-09-0580; Roelfsema F, 2009, J CLIN ENDOCR METAB, V94, P2991, DOI 10.1210/jc.2009-0350; Souhami RL, 2002, TXB MED; Veldhuis JD, 2011, AM J PHYSIOL-REG I, V301, pR1143, DOI 10.1152/ajpregu.00293.2011; Veldhuis JD, 2011, J CLIN ENDOCR METAB, V96, P2874, DOI 10.1210/jc.2011-0084; Veldhuis JD, 2011, AM J PHYSIOL-ENDOC M, V300, pE1158, DOI 10.1152/ajpendo.00054.2011; Veldhuis JD, 2010, AM J PHYSIOL-ENDOC M, V299, pE675, DOI 10.1152/ajpendo.00300.2010; Veldhuis JD, 2008, ENDOCR REV, V29, P823, DOI 10.1210/er.2008-0005; Vis DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032985; Vis DJ, 2009, AM J PHYSL ENDOCRINO; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wickremesekera K, 2005, OBES SURG, V15, P474, DOI 10.1381/0960892053723402	39	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e96284	10.1371/journal.pone.0096284	http://dx.doi.org/10.1371/journal.pone.0096284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852517	gold, Green Published			2022-12-25	WOS:000338323200011
J	Akl, MR; Ayoub, NM; Mohyeldin, MM; Busnena, BA; Foudah, AI; Liu, YY; El Sayed, KA				Akl, Mohamed R.; Ayoub, Nehad M.; Mohyeldin, Mohamed M.; Busnena, Belnaser A.; Foudah, Ahmed I.; Liu, Yong-Yu; El Sayed, Khalid A.			Olive Phenolics as c-Met Inhibitors: (-)-Oleocanthal Attenuates Cell Proliferation, Invasiveness, and Tumor Growth in Breast Cancer Models	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; MOLECULAR-MECHANISMS; SIGNALING PATHWAY; RECEPTOR MET; TAU-PROTEIN; OLEOCANTHAL; OIL; KINASE; MIGRATION; FIBRILLIZATION	Dysregulation of the Hepatocyte growth factor (HGF)/c-Met signaling axis upregulates diverse tumor cell functions, including cell proliferation, survival, scattering and motility, epithelial-to-mesenchymal transition (EMT), angiogenesis, invasion, and metastasis. (-)-Oleocanthal is a naturally occurring secoiridoid from extra-virgin olive oil, which showed antiproliferative and antimigratory activity against different cancer cell lines. The aim of this study was to characterize the intracellular mechanisms involved in mediating the anticancer effects of (-)-oleocanthal treatment and the potential involvement of c-Met receptor signaling components in breast cancer. Results showed that (-)-oleocanthal inhibits the growth of human breast cancer cell lines MDA-MB-231, MCF-7 and BT-474 while similar treatment doses were found to have no effect on normal human MCF10A cell growth. In addition, (-)-oleocanthal treatment caused a dose-dependent inhibition of HGF-induced cell migration, invasion and G1/S cell cycle progression in breast cancer cell lines. Moreover, (-)-oleocanthal treatment effects were found to be mediated via inhibition of HGF-induced c-Met activation and its downstream mitogenic signaling pathways. This growth inhibitory effect is associated with blockade of EMT and reduction in cellular motility. Further results from in vivo studies showed that (-)-oleocanthal treatment suppressed tumor cell growth in an orthotopic model of breast cancer in athymic nude mice. Collectively, the findings of this study suggest that (-)-oleocanthal is a promising dietary supplement lead with potential for therapeutic use to control malignancies with aberrant c-Met activity.	[Akl, Mohamed R.; Mohyeldin, Mohamed M.; Busnena, Belnaser A.; Foudah, Ahmed I.; Liu, Yong-Yu; El Sayed, Khalid A.] NE Louisiana Univ, Sch Pharm, Dept Basic Pharmaceut Sci, Monroe, LA 71209 USA; [Ayoub, Nehad M.] Jordan Univ Sci & Technol, Dept Clin Pharm, Fac Pharm, Irbid, Jordan	University of Louisiana System; University of Louisiana Monroe; Jordan University of Science & Technology	El Sayed, KA (corresponding author), NE Louisiana Univ, Sch Pharm, Dept Basic Pharmaceut Sci, Monroe, LA 71209 USA.	elsayed@ulm.edu	Mohyeldin, Mohamed/AAA-5232-2019; Foudah, Ahmed I./AGZ-2587-2022; Mohyeldin, Mohamed/K-5059-2017	Ayoub, Nehad/0000-0003-2284-4370; Mohyeldin, Mohamed/0000-0001-9052-7620; Liu, Yong-Yu/0000-0002-7968-0162	National Cancer Institute of the National Institutes of Health [R15CA167475]; NATIONAL CANCER INSTITUTE [R15CA167475] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number R15CA167475. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuznait AH, 2013, ACS CHEM NEUROSCI, V4, P973, DOI 10.1021/cn400024q; Agarwal S, 2009, BRIT J CANCER, V100, P941, DOI 10.1038/sj.bjc.6604937; Akl MR, 2013, FITOTERAPIA, V84, P347, DOI 10.1016/j.fitote.2012.12.013; Bellon SF, 2008, J BIOL CHEM, V283, P2675, DOI 10.1074/jbc.M705774200; Busnena BA, 2013, BIOORGAN MED CHEM, V21, P2117, DOI 10.1016/j.bmc.2012.12.050; Castro NE, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2622; Chen HY, 2004, MOL CELL BIOL, V24, P10558, DOI 10.1128/MCB.24.24.10558-10572.2004; Cicerale S, 2009, CHEM SENSES, V34, P333, DOI 10.1093/chemse/bjp006; Cooke VG, 2012, CANCER CELL, V21, P66, DOI 10.1016/j.ccr.2011.11.024; Eder JP, 2009, CLIN CANCER RES, V15, P2207, DOI 10.1158/1078-0432.CCR-08-1306; Elliott BE, 2002, CAN J PHYSIOL PHARM, V80, P91, DOI 10.1139/y02-010; Elnagar AY, 2011, PLANTA MED, V77, P1013, DOI 10.1055/s-0030-1270724; Fogliano V, 2006, MOL NUTR FOOD RES, V50, P5, DOI 10.1002/mnfr.200690002; Francone TD, 2007, MOL CANCER THER, V6, P1460, DOI 10.1158/1535-7163.MCT-06-0466; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; Graveel CR, 2009, P NATL ACAD SCI USA, V106, P12909, DOI 10.1073/pnas.0810403106; Iacono A, 2010, ARTHRITIS RHEUM-US, V62, P1675, DOI 10.1002/art.27437; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim EJ, 2012, MOL CELL BIOCHEM, V359, P431, DOI 10.1007/s11010-011-1039-3; Lawrence RE, 2010, CELL ADHES MIGR, V4, P146, DOI 10.4161/cam.4.1.10973; Li WK, 2009, J NEUROCHEM, V110, P1339, DOI 10.1111/j.1471-4159.2009.06224.x; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Lucas L, 2011, CURR PHARM DESIGN, V17, P754, DOI 10.2174/138161211795428911; Ma PC, 2005, CANCER RES, V65, P1479, DOI 10.1158/0008-5472.CAN-04-2650; Ma PC, 2003, CANCER METAST REV, V22, P309, DOI 10.1023/A:1023768811842; Margarucci L, 2013, CHEM COMMUN, V49, P5844, DOI 10.1039/c3cc41858h; Monti MC, 2012, J NAT PROD, V75, P1584, DOI 10.1021/np300384h; Monti MC, 2011, FOOD FUNCT, V2, P423, DOI 10.1039/c1fo10064e; Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; Nuwer R, 2013, SCI AM, V308, P22, DOI 10.1038/scientificamerican0613-22; PARK M, 1987, P NATL ACAD SCI USA, V84, P6379, DOI 10.1073/pnas.84.18.6379; Peruzzi B, 2006, CLIN CANCER RES, V12, P3657, DOI 10.1158/1078-0432.CCR-06-0818; Pitt J, 2009, TOXICOL APPL PHARM, V240, P189, DOI 10.1016/j.taap.2009.07.018; Ponzo MG, 2009, P NATL ACAD SCI USA, V106, P12903, DOI 10.1073/pnas.0810402106; Reshetnikova G, 2007, CELL BIOL INT, V31, P366, DOI 10.1016/j.cellbi.2007.01.022; Rho OK, 2011, MOL CARCINOGEN, V50, P264, DOI 10.1002/mc.20665; Rosignoli P, 2013, J NUTR BIOCHEM, V24, P1513, DOI 10.1016/j.jnutbio.2012.12.011; Sattler M, 2003, CANCER RES, V63, P5462; Sattler Martin, 2007, Curr Oncol Rep, V9, P102, DOI 10.1007/s11912-007-0005-4; Sattler Martin, 2009, Update Cancer Ther, V3, P109, DOI 10.1016/j.uct.2009.01.001; Scotece M, 2013, CURR MED CHEM, V20, P2467, DOI 10.2174/0929867311320190006; Scotece M, 2012, LIFE SCI, V91, P1229, DOI 10.1016/j.lfs.2012.09.012; Tomaskovic-Crook E, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2416; Tuck AB, 1996, AM J PATHOL, V148, P225; Vougogiannopoulou K, 2014, J NAT PROD; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Wang YM, 2009, CANCER RES, V69, P4093, DOI 10.1158/0008-5472.CAN-09-0309	47	87	88	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97622	10.1371/journal.pone.0097622	http://dx.doi.org/10.1371/journal.pone.0097622			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849787	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600042
J	Borsch-Haubold, AG; Montero, I; Konrad, K; Haubold, B				Boersch-Haubold, Angelika G.; Montero, Inka; Konrad, Kathryn; Haubold, Bernhard			Genome-Wide Quantitative Analysis of Histone H3 Lysine 4 Trimethylation in Wild House Mouse Liver: Environmental Change Causes Epigenetic Plasticity	PLOS ONE			English	Article							DIETARY-PROTEIN RESTRICTION; HIGH-FAT DIET; DNA METHYLATION; GENE-EXPRESSION; PREGNANT RATS; TRANSGENERATIONAL ACTIONS; GLUCOCORTICOID-RECEPTOR; SEX-RATIO; MICE; INHERITANCE	In mammals, exposure to toxic or disease-causing environments can change epigenetic marks that are inherited independently of the intrauterine environment. Such inheritance of molecular phenotypes may be adaptive. However, studies demonstrating molecular evidence for epigenetic inheritance have so far relied on extreme treatments, and are confined to inbred animals. We therefore investigated whether epigenomic changes could be detected after a non-drastic change in the environment of an outbred organism. We kept two populations of wild-caught house mice (Mus musculus domesticus) for several generations in semi-natural enclosures on either standard diet and light cycle, or on an energyenriched diet with longer daylight to simulate summer. As epigenetic marker for active chromatin we quantified genome-wide histone-3 lysine-4 trimethylation (H3K4me3) from liver samples by chromatin immunoprecipitation and high-throughput sequencing as well as by quantitative polymerase chain reaction. The treatment caused a significant increase of H3K4me3 at metabolic genes such as lipid and cholesterol regulators, monooxygenases, and a bile acid transporter. In addition, genes involved in immune processes, cell cycle, and transcription and translation processes were also differently marked. When we transferred young mice of both populations to cages and bred them under standard conditions, most of the H3K4me3 differences were lost. The few loci with stable H3K4me3 changes did not cluster in metabolic functional categories. This is, to our knowledge, the first quantitative study of an epigenetic marker in an outbred mammalian organism. We demonstrate genome-wide epigenetic plasticity in response to a realistic environmental stimulus. In contrast to disease models, the bulk of the epigenomic changes we observed were not heritable.	[Boersch-Haubold, Angelika G.; Haubold, Bernhard] Max Planck Inst Evolutionary Biol, Dept Evolutionary Genet, Plon, Germany; [Montero, Inka] Univ Tubingen, Inst Evolut & Ecol, Tubingen, Germany; [Konrad, Kathryn] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany	Max Planck Society; Eberhard Karls University of Tubingen; University of Cologne	Borsch-Haubold, AG (corresponding author), Max Planck Inst Evolutionary Biol, Dept Evolutionary Genet, Plon, Germany.	aboersch@evolbio.mpg.de			Max Planck Society, Germany	Max Planck Society, Germany(Max Planck Society)	This study was supported by the Max Planck Society, Germany. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anway MD, 2006, ENDOCRINOLOGY, V147, pS43, DOI 10.1210/en.2005-1058; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Burdge GC, 2007, BRIT J NUTR, V97, P435, DOI 10.1017/S0007114507352392; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Cortessis VK, 2012, HUM GENET, V131, P1565, DOI 10.1007/s00439-012-1189-8; Cropley JE, 2012, P ROY SOC B-BIOL SCI, V279, P2347, DOI 10.1098/rspb.2011.2646; Crowcroft P., 1966, MICE ALL; CROWCROFT PETER, 1963, PROC ZOOL SOC LONDON, V140, P517; de Fourmestraux V, 2004, J BIOL CHEM, V279, P50743, DOI 10.1074/jbc.M408014200; Duncan D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-P10; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Engelking LJ, 2005, J CLIN INVEST, V115, P2489, DOI 10.1172/JCI25614; Engelking LJ, 2004, J CLIN INVEST, V113, P1168, DOI 10.1172/JCI200420978; Esteller M, 2002, J PATHOL, V196, P1, DOI 10.1002/path.1024; Fan Z, 2011, MOL CELL ENDOCRINOL, V333, P62, DOI 10.1016/j.mce.2010.12.010; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Furey TS, 2012, NAT REV GENET, V13, P840, DOI 10.1038/nrg3306; Gervin K, 2011, GENOME RES, V21, P1813, DOI 10.1101/gr.119685.110; Gilbert S. F., 2009, ECOLOGICAL DEV BIOL; Hoile SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021668; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Jablonka E, 2002, ANN NY ACAD SCI, V981, P82; Jablonka E, 1995, PHILOS T R SOC B, V350, P133, DOI 10.1098/rstb.1995.0147; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johannes F, 2008, NAT REV GENET, V9, P883, DOI 10.1038/nrg2467; Ka SO, 2009, INT J MOL MED, V23, P633, DOI 10.3892/ijmm_00000174; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Kaati G, 2007, EUR J HUM GENET, V15, P784, DOI 10.1038/sj.ejhg.5201832; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Kuzawa CW, 2011, EPIGENOMICS-UK, V3, P221, DOI [10.2217/EPI.11.11, 10.2217/epi.11.11]; Lachmann M, 1996, J THEOR BIOL, V181, P1, DOI 10.1006/jtbi.1996.0109; Li CCY, 2013, EPIGENETICS-US, V8, P602, DOI 10.4161/epi.24656; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X; Lumey L H, 1992, Paediatr Perinat Epidemiol, V6, P240, DOI 10.1111/j.1365-3016.1992.tb00764.x; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031901; McGowan PO, 2010, ESSAYS BIOCHEM, V48, P275, DOI [10.1042/BSE0480275, 10.1042/bse0480275]; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Montero I, 2013, MOL ECOL, V22, P2549, DOI 10.1111/mec.12271; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Nishikawa S, 2012, TOXICOL PATHOL, V40, P71, DOI 10.1177/0192623311422078; Pembrey ME, 2010, HUM FERTIL, V13, P268, DOI 10.3109/14647273.2010.524721; Rakyan VK, 2006, CURR OPIN GENET DEV, V16, P573, DOI 10.1016/j.gde.2006.09.002; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Richards EJ, 2008, CURR OPIN GENET DEV, V18, P221, DOI 10.1016/j.gde.2008.01.014; Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Seki Y, 2012, ENDOCRINOLOGY, V153, P1031, DOI 10.1210/en.2011-1805; SELANDER RK, 1970, AM ZOOL, V10, P53; Slatkin M, 2009, GENETICS, V182, P845, DOI 10.1534/genetics.109.102798; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Somel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001504; TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Turner BM, 2007, NAT CELL BIOL, V9, P2, DOI 10.1038/ncb0107-2; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Waterland RA, 2007, FASEB J, V21, P3380, DOI 10.1096/fj.07-8229com; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Williams RP, 2009, IBM J RES DEV, V53, P1, DOI 10.1147/JRD.2009.5429026; Wilson IM, 2006, CELL CYCLE, V5, P155, DOI 10.4161/cc.5.2.2367; WRIGHT SL, 1988, BEHAV ECOL SOCIOBIOL, V23, P357, DOI 10.1007/BF00303709; Xie YX, 2007, TOXICOLOGY, V236, P7, DOI 10.1016/j.tox.2007.03.021; Yeh TC, 2011, MOL CELL BIOL, V31, P43, DOI 10.1128/MCB.00801-10; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445; Youngson NA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0337; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	84	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97568	10.1371/journal.pone.0097568	http://dx.doi.org/10.1371/journal.pone.0097568			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849289	Green Published, Green Submitted, gold			2022-12-25	WOS:000336730600037
J	Cao, BB; Hu, Y; Duan, JH; Ma, J; Xu, DK; Yang, XD				Cao, Beibei; Hu, Yan; Duan, Jinhong; Ma, Jie; Xu, Danke; Yang, Xian-Da			Selection of a Novel DNA Aptamer for Assay of Intracellular Interferon-Gamma	PLOS ONE			English	Article							LINKED IMMUNOSORBENT ASSAYS; ANTIBODY-SECRETING CELLS; FLOW-CYTOMETRY ASSAYS; EMERGING CLASS; ELISPOT ASSAY; T-CELLS; CYTOKINE; OPTIMIZATION; ENUMERATION; PROTEIN	Interferon-gamma (IFN-gamma) is a glycoprotein generated by lymphocytes that possesses anti-tumor, antiviral and immunomodulatory functions. IFN-gamma assays are broadly employed in immunological research and clinical diagnostic tests. Intracellular IFN-gamma staining, in particular, is an important immune assay that allows simultaneous determination of cellular phenotype and antigen-specific T cell response. Aptamers have great potential for molecule detection and can bind to target molecules with high affinity and specificity. In this study, a novel 59-mer DNA aptamer (B1-4) was developed for assay of intracellular IFN-gamma. The selected aptamer bound to IFN-gamma with a Kd of 74.5 nM, with minimal cross-reactivity to albumin. The aptamer was also found capable of binding with paraformaldehyde-fixed IFN-gamma. Moreover, B1-4 could enter permeated and paraformaldehyde-fixed lymphocytes, and bound to intracellular IFN-gamma produced by these cells. When FITC-labeled B1-4 was used to stain a group of lymphocytes, the average fluorescence of the cells was positively correlated with the number of PMA-stimulated lymphocytes within the group. A standard curve could thus be established for assessing the fraction of IFN-gamma-producing cells in a cluster of lymphocytes. The selected aptamer hence provides a novel approach for assaying intracellular IFN-gamma generated by a group of lymphocytes, and may have application potential in both scientific research and clinical laboratory test.	[Cao, Beibei; Hu, Yan; Duan, Jinhong; Yang, Xian-Da] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Cao, Beibei; Hu, Yan; Duan, Jinhong; Ma, Jie; Yang, Xian-Da] Peking Union Med Coll, Beijing 100021, Peoples R China; [Ma, Jie] Chinese Acad Med Sci, Canc Inst & Hosp, Beijing 100730, Peoples R China; [Xu, Danke] Nanjing Univ, Sch Chem & Chem Engn, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Nanjing University	Hu, Y (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China.	hyjy2008@hotmail.com; ayangmd@gmail.com			Chinese Ministry of Science and Technology [2011CB911003, 2011CB911004, 2011CB933504]; Chinese Ministry of Education	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Ministry of Education(Ministry of Education, China)	This work was supported by the Chinese Ministry of Science and Technology (2011CB911003, 2011CB911004, 2011CB933504), and the 111 project of the Chinese Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apilux A, 2013, LAB CHIP, V13, P126, DOI 10.1039/c2lc40690j; Balasubrananian V, 1998, MOL PHARMACOL, V53, P926; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Carothers JM, 2006, J AM CHEM SOC, V128, P7929, DOI 10.1021/ja060952q; Cox JH, 2006, METHODS, V38, P274, DOI 10.1016/j.ymeth.2005.11.006; CZERKINSKY CC, 1983, J IMMUNOL METHODS, V65, P109, DOI 10.1016/0022-1759(83)90308-3; Davis KA, 1996, NUCLEIC ACIDS RES, V24, P702, DOI 10.1093/nar/24.4.702; Dixit CK, 2010, ANAL CHEM, V82, P7049, DOI 10.1021/ac101339q; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Han K, 2010, SENSORS-BASEL, V10, P4541, DOI 10.3390/s100504541; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Karlsson AC, 2003, J IMMUNOL METHODS, V283, P141, DOI 10.1016/j.jim.2003.09.001; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; Lee PP, 1996, TRANSPLANTATION, V62, P1297, DOI 10.1097/00007890-199611150-00021; Lovelace P, 2011, METHODS MOL BIOL, V699, P165, DOI 10.1007/978-1-61737-950-5_8; Maecker HT, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-13; Mascini M, 2008, ANAL BIOANAL CHEM, V390, P987, DOI 10.1007/s00216-007-1769-y; Min K, 2008, BIOSENS BIOELECTRON, V23, P1819, DOI 10.1016/j.bios.2008.02.021; Navani NK, 2006, CURR OPIN CHEM BIOL, V10, P272, DOI 10.1016/j.cbpa.2006.04.003; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; Nomura L, 2008, CYTOM PART A, V73A, P984, DOI 10.1002/cyto.a.20602; Nomura LE, 2000, CYTOMETRY, V40, P60, DOI 10.1002/(SICI)1097-0320(20000501)40:1<60::AID-CYTO8>3.0.CO;2-J; Nylander S, 1999, J IMMUNOL METHODS, V224, P69, DOI 10.1016/S0022-1759(99)00010-1; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; PICKER LJ, 1995, BLOOD, V86, P1408, DOI 10.1182/blood.V86.4.1408.bloodjournal8641408; Proske D, 2005, APPL MICROBIOL BIOT, V69, P367, DOI 10.1007/s00253-005-0193-5; Reinsmoen Nancy L, 2013, Methods Mol Biol, V1034, P353, DOI 10.1007/978-1-62703-493-7_22; SEDGWICK JD, 1983, J IMMUNOL METHODS, V57, P301, DOI 10.1016/0022-1759(83)90091-1; Tombelli S, 2005, BIOELECTROCHEMISTRY, V67, P135, DOI 10.1016/j.bioelechem.2004.04.011; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Tuleuova N, 2010, CELL MOL BIOENG, V3, P337, DOI 10.1007/s12195-010-0148-5; Tuleuova N, 2010, ANAL CHEM, V82, P1851, DOI 10.1021/ac9025237; Yan GP, 2013, BIOSENS BIOELECTRON, V44, P57, DOI 10.1016/j.bios.2013.01.010; Yanagisawa N, 2012, ANAL CHEM, V84, P7029, DOI 10.1021/ac3011632; Yang CJ, 2005, P NATL ACAD SCI USA, V102, P17278, DOI 10.1073/pnas.0508821102	36	14	14	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98214	10.1371/journal.pone.0098214	http://dx.doi.org/10.1371/journal.pone.0098214			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849390	Green Published, Green Submitted, gold			2022-12-25	WOS:000336730600099
J	Leclair, P; Lim, CJ				Leclair, Pascal; Lim, Chinten James			CD47-Independent Effects Mediated by the TSP-Derived 4N1K Peptide	PLOS ONE			English	Article							INTEGRIN-ASSOCIATED PROTEIN; C-TERMINAL DOMAIN; CELL-BINDING DOMAIN; T-CELL; VASCULAR ENDOTHELIUM; CD47; ADHESION; RECEPTOR; THROMBOSPONDIN-1; ACTIVATION	4N1K is a peptide fragment derived from the C-terminal, globular domain of thrombospondin which has been shown to mediate integrin-dependent cell adhesion and promote integrin activation acting via the cell-surface receptor, CD47. However, some studies found that 4N1K could act independently of CD47, putting in question the specificity of 4N1K for CD47. This led us to characterize the cellular and non-cellular effects of 4N1K. We found that 4N1K stimulated a potent increase in binding of a variety of non-specific IgG antibodies to cells in suspension. We also found that these same antibodies, as well as CD47-deficient cells, could bind substrate-immobilized 4N1K significantly better than a control peptide, 4NGG. Furthermore, we found that cells treated with 4N1K at higher concentrations inhibited, while lower concentrations promoted cell adhesion to immobilized fibronectin as an integrin substrate. Importantly, both the stimulatory and the inhibitory activity of 4N1K occurred as efficiently in the CD47-deficient JinB8 cells, as it did in the CD47-expressing parental or in JinB8 cells reconstituted with CD47 expression. Given these results, we suggest that 4N1K interacts non-specifically with epitopes commonly found on the cell surface, and conclude that it is not a suitable peptide for use to study the consequences of CD47 receptor ligation.	[Leclair, Pascal; Lim, Chinten James] Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada; [Leclair, Pascal] Univ British Columbia, Dept Cell & Dev Biol, Vancouver, BC V5Z 1M9, Canada; [Leclair, Pascal; Lim, Chinten James] BC Childrens Hosp, Child & Family Res Inst, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; BC Childrens Hospital; Child & Family Research Institute; University of British Columbia	Lim, CJ (corresponding author), Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada.	cjlim@mail.ubc.ca	Lim, Chinten James/G-3777-2013	Lim, Chinten James/0000-0001-6381-7585; Leclair, Pascal/0000-0002-0791-7028	Canadian Institutes of Health Research; National Science and Engineering Research Council; Canadian Foundation for Innovation; Child and Family Research Institute-Michael Cuccione Graduate award; Michael Cuccione Foundation; Child and Family Research Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Child and Family Research Institute-Michael Cuccione Graduate award; Michael Cuccione Foundation; Child and Family Research Institute	This study was supported by grants from the Canadian Institutes of Health Research, National Science and Engineering Research Council, and the Canadian Foundation for Innovation awarded to C.J.L. P.L. received a Child and Family Research Institute-Michael Cuccione Graduate award. C.J.L. was supported by the Michael Cuccione Foundation and holds an investigatorship from the Child and Family Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Adams JC, 2008, J CELL SCI, V121, P784, DOI 10.1242/jcs.021006; Adams JC, 2011, CSH PERSPECT BIOL, V3, DOI [10.1101/cshperspect.a009712, 10.1016/j.biocel.2004.01.004]; Anilkumar N, 2002, J CELL SCI, V115, P2357; Barazi HO, 2002, J BIOL CHEM, V277, P42859, DOI 10.1074/jbc.M206849200; Brittain JE, 2004, J BIOL CHEM, V279, P42393, DOI 10.1074/jbc.M407631200; Brittain JE, 2001, J CLIN INVEST, V107, P1555, DOI 10.1172/JCI10817; Brittain JE, 2001, BLOOD, V97, P2159, DOI 10.1182/blood.V97.7.2159; Brooke G, 2004, J IMMUNOL, V173, P2562, DOI 10.4049/jimmunol.173.4.2562; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Carlson CB, 2005, NAT STRUCT MOL BIOL, V12, P910, DOI 10.1038/nsmb997; Chao MP, 2012, NAT REV CANCER, V12, P58, DOI 10.1038/nrc3171; Chung J, 1997, J BIOL CHEM, V272, P14740, DOI 10.1074/jbc.272.23.14740; Floquet N, 2008, ARCH BIOCHEM BIOPHYS, V478, P103, DOI 10.1016/j.abb.2008.07.015; Frazier WA, 2010, PAGES UNM; Fujimoto TT, 2003, J BIOL CHEM, V278, P26655, DOI 10.1074/jbc.M302194200; Gao AG, 1996, J BIOL CHEM, V271, P21, DOI 10.1074/jbc.271.1.21; GAO AG, 1994, J BIOL CHEM, V269, P29650; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Ide K, 2007, P NATL ACAD SCI USA, V104, P5062, DOI 10.1073/pnas.0609661104; Isenberg JS, 2009, J BIOL CHEM, V284, P1116, DOI 10.1074/jbc.M804860200; Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559; KOSFELD MD, 1993, J BIOL CHEM, V268, P8808; Kvansakul M, 2004, EMBO J, V23, P1223, DOI 10.1038/sj.emboj.7600166; Lagadec P, 2003, BLOOD, V101, P4836, DOI 10.1182/blood-2002-11-3483; Li SS, 2006, BLOOD, V108, P3112, DOI 10.1182/blood-2006-04-016832; Lindberg FP, 1996, J CELL BIOL, V134, P1313, DOI 10.1083/jcb.134.5.1313; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; McDonald JF, 2004, J BIOL CHEM, V279, P17301, DOI 10.1074/jbc.M312782200; McDonald JF, 2003, BIOCHEMISTRY-US, V42, P10001, DOI 10.1021/bi0341408; Meads MB, 2008, CLIN CANCER RES, V14, P2519, DOI 10.1158/1078-0432.CCR-07-2223; Rebres RA, 2001, J BIOL CHEM, V276, P34607, DOI 10.1074/jbc.M106107200; Reinhold MI, 1999, INT IMMUNOL, V11, P707, DOI 10.1093/intimm/11.5.707; Rock MJ, 2010, MOL CELL BIOCHEM, V338, P215, DOI 10.1007/s11010-009-0355-3; Romzek NC, 1998, MOL BIOL CELL, V9, P2715, DOI 10.1091/mbc.9.10.2715; Rose DM, 2007, IMMUNOL REV, V218, P126, DOI 10.1111/j.1600-065X.2007.00536.x; ROSEMBLATT M, 1991, J CLIN INVEST, V87, P6, DOI 10.1172/JCI115002; SCOPSI L, 1986, J HISTOCHEM CYTOCHEM, V34, P1469, DOI 10.1177/34.11.2877024; Sick E, 2012, BRIT J PHARMACOL, V167, P1415, DOI 10.1111/j.1476-5381.2012.02099.x; Ticchioni M, 2001, FASEB J, V15, P341, DOI 10.1096/fj.99-0833com; Tulasne D, 2001, BLOOD, V98, P3346, DOI 10.1182/blood.V98.12.3346; Wandersee NJ, 2004, BLOOD, V103, P710, DOI 10.1182/blood-2003-02-0492; Wang XQ, 1999, J CELL BIOL, V147, P389, DOI 10.1083/jcb.147.2.389	44	19	21	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98358	10.1371/journal.pone.0098358	http://dx.doi.org/10.1371/journal.pone.0098358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848268	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600110
J	Doerfler, H; Sun, XL; Wang, L; Engelmeier, D; Lyon, D; Weckwerth, W				Doerfler, Hannes; Sun, Xiaoliang; Wang, Lei; Engelmeier, Doris; Lyon, David; Weckwerth, Wolfram			mzGroupAnalyzer-Predicting Pathways and Novel Chemical Structures from Untargeted High-Throughput Metabolomics Data	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; SYSTEMS BIOLOGY; ELEMENTAL COMPOSITIONS; FUNCTIONAL GENOMICS; MOLECULAR FORMULAS; OXIDATIVE STRESS; ARABIDOPSIS; RESOLUTION; IDENTIFICATION; FRAGMENTATION	The metabolome is a highly dynamic entity and the final readout of the genotype x environment x phenotype (GxExP) relationship of an organism. Monitoring metabolite dynamics over time thus theoretically encrypts the whole range of possible chemical and biochemical transformations of small molecules involved in metabolism. The bottleneck is, however, the sheer number of unidentified structures in these samples. This represents the next challenge for metabolomics technology and is comparable with genome sequencing 30 years ago. At the same time it is impossible to handle the amount of data involved in a metabolomics analysis manually. Algorithms are therefore imperative to allow for automated m/z feature extraction and subsequent structure or pathway assignment. Here we provide an automated pathway inference strategy comprising measurements of metabolome time series using LC-MS with high resolution and high mass accuracy. An algorithm was developed, called mzGroupAnalyzer, to automatically explore the metabolome for the detection of metabolite transformations caused by biochemical or chemical modifications. Pathways are extracted directly from the data and putative novel structures can be identified. The detected m/z features can be mapped on a van Krevelen diagram according to their H/C and O/C ratios for pattern recognition and to visualize oxidative processes and biochemical transformations. This method was applied to Arabidopsis thaliana treated simultaneously with cold and high light. Due to a protective antioxidant response the plants turn from green to purple color via the accumulation of flavonoid structures. The detection of potential biochemical pathways resulted in 15 putatively new compounds involved in the flavonoid-pathway. These compounds were further validated by product ion spectra from the same data. The mzGroupAnalyzer is implemented in the graphical user interface (GUI) of the metabolomics toolbox COVAIN (Sun & Weckwerth, 2012, Metabolomics 8: 81-93). The strategy can be extended to any biological system.	[Doerfler, Hannes; Sun, Xiaoliang; Wang, Lei; Engelmeier, Doris; Lyon, David; Weckwerth, Wolfram] Univ Vienna, Dept Ecogen & Syst Biol, Vienna, Austria	University of Vienna	Weckwerth, W (corresponding author), Univ Vienna, Dept Ecogen & Syst Biol, Vienna, Austria.	wolfram.weckwerth@univie.ac.at	Weckwerth, Wolfram/G-5811-2010	Lyon, David/0000-0001-5794-0456; Weckwerth, Wolfram/0000-0002-9719-6358; Doerfler, Hannes/0000-0002-3596-784X	Austrian Science Fund (FWF) [P25488, P23441]; China Scholarship Council	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); China Scholarship Council(China Scholarship Council)	The authors thank the Austrian Science Fund (FWF) for financial support to Hannes Dorfler and David Lyon (FWF project P25488 and P23441, respectively). Lei Wang was supported by a grant of the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Garcia B, 2009, RAPID COMMUN MASS SP, V23, P2785, DOI 10.1002/rcm.4182; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Bashandy T, 2009, MOL PLANT, V2, P249, DOI 10.1093/mp/ssn065; Bloor SJ, 2002, PHYTOCHEMISTRY, V59, P343, DOI 10.1016/S0031-9422(01)00460-5; Croteau R., 2000, BIOCH MOL BIOL PLANT, P1250, DOI DOI 10.1201/B11003-3; Doerfler H, 2013, METABOLOMICS, V9, P564, DOI 10.1007/s11306-012-0470-0; Dong CH, 2009, MOL PLANT, V2, P59, DOI 10.1093/mp/ssn063; Dunn WB, 2012, METABOLOMICS; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Giavalisco P, 2008, ANAL CHEM, V80, P9417, DOI 10.1021/ac8014627; Hernandez I, 2009, TRENDS PLANT SCI, V14, P125, DOI 10.1016/j.tplants.2008.12.003; Huang XX, 2010, STUD FUZZ SOFT COMP, V250, P1; Junker BH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-109; Kai K, 2011, PLANT BIOTECHNOL-NAR, V28, P379, DOI 10.5511/plantbiotechnology.11.0704b; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Karp PD, 2002, NUCLEIC ACIDS RES, V30, P59, DOI 10.1093/nar/30.1.59; Kasai HF, 2011, RAPID COMMUN MASS SP, V25, P1051, DOI 10.1002/rcm.4956; Kimura M, 2003, PHOTOCHEM PHOTOBIOL, V77, P226, DOI 10.1562/0031-8655(2003)077&lt;0226:IOAGRB&gt;2.0.CO;2; Kind T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-105; Kind Tobias, 2010, Bioanal Rev, V2, P23, DOI 10.1007/s12566-010-0015-9; Kind T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-234; Lee KW, 2004, CRIT REV FOOD SCI, V44, P437, DOI 10.1080/10408690490886674; March RE, 2004, INT J MASS SPECTROM, V231, P157, DOI 10.1016/j.ijms.2003.10.008; Mari A, 2013, METABOLOMICS, V9, P599, DOI 10.1007/s11306-012-0473-x; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Nishiyama Y, 2001, EMBO J, V20, P5587, DOI 10.1093/emboj/20.20.5587; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Quenzer T.L., 2002, P 50 ANN C MASS SPEC; Reemtsma T, 2009, J CHROMATOGR A, V1216, P3687, DOI 10.1016/j.chroma.2009.02.033; Rogers S, 2009, BIOINFORMATICS, V25, P512, DOI 10.1093/bioinformatics/btn642; Rohn H, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-139; SAITO N, 1995, PHYTOCHEMISTRY, V38, P1027, DOI 10.1016/0031-9422(94)00659-H; Scherling C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012569; Seyoum A, 2006, PHYTOCHEMISTRY, V67, P2058, DOI 10.1016/j.phytochem.2006.07.002; Soga Tomoyoshi, 2007, V358, P129, DOI 10.1007/978-1-59745-244-1_8; Sun XL, 2012, METABOLOMICS, V8, pS81, DOI 10.1007/s11306-012-0399-3; Tohge T, 2005, PLANT J, V42, P218, DOI 10.1111/j.1365-313X.2005.02371.x; Van der Greef J, 2006, PHARMACOGENOMICS, V7, P1087, DOI 10.2217/14622416.7.7.1087; Van Krevelen D., 1950, GRAPHICAL STAT METHO, V29, P269, DOI DOI 10.1520/D0850-11.1; Weckwerth W, 2005, DRUG DISCOV TODAY, V10, P1551, DOI 10.1016/S1359-6446(05)03609-3; Weckwerth W, 2011, J PROTEOMICS, V75, P284, DOI 10.1016/j.jprot.2011.07.010; Weckwerth W, 2011, ANAL BIOANAL CHEM, V400, P1967, DOI 10.1007/s00216-011-4948-9; Wu ZG, 2004, ANAL CHEM, V76, P2511, DOI 10.1021/ac0355449	45	28	28	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e96188	10.1371/journal.pone.0096188	http://dx.doi.org/10.1371/journal.pone.0096188			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846183	Green Submitted, Green Published, gold			2022-12-25	WOS:000339563400006
J	Lorch, JA; Pollak, VE				Lorch, Jonathan A.; Pollak, Victor E.			Continuous Quality Improvement in Daily Clinical Practice: A Proof of Concept Study	PLOS ONE			English	Article							ERYTHROPOIESIS-STIMULATING AGENT; CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; HEMODIALYSIS-PATIENTS; HEMOGLOBIN LEVELS; EPOETIN-ALPHA; MORTALITY; ANEMIA; LEVEL; IRON	Continuous Quality Improvement (CQI) is an iterative process of: planning to improve a product or process, plan implementation, analyzing and comparing results against those expected, and corrective action on differences between actual and expected results. It is little used in clinical medicine. Anemia, a complex problem in End Stage Renal Disease patients, served to test the ability of an unique electronic medical record (EMR) optimized for daily care to empower CQI in practice. We used data collected during daily care, stored in the EMR, and organized to display temporal relationships between clinical, laboratory, and therapeutic events. Our aims were optimal hemoglobin with minimum epoetin, and maintaining stable hemoglobin and epoetin. The study was done on 250 patients treated by maintenance hemodialysis (HD), receiving epoetin prior to February 1, 2010 and followed to July 31, 2011. Repleting iron, ensuring iron sufficiency, slow epoetin reduction, and decision support tools enabling data display over long periods in patient-centered reports were key elements. Epoetin dose, adjusted 6-8 weekly, was based on current clinical conditions and past responses. Hemoglobin increased by months 1-2; epoetin decreased from month 4. By months 16-18, epoetin had decreased 42% to 9,720 units/week while hemoglobin increased 8% to 123.6 g/L. Hemoglobin and epoetin were stable from month 7 onward. New epoetin orders decreased 83%. Transferrin saturation increased after the study start. Individual patient hemoglobin variation decreased by 23%, range by 27%. Mortality, 11.78 per 100 patient years, was 42% less than United States dialysis patient mortality. Allowable epoetin charges decreased by $15.33 per treatment and were $22.88 less than current Medicare allowance. The study validates the hypothesis that an EMR optimized for daily patient care can empower CQI in clinical medicine and serve to monitor medical care quality and cost.	[Lorch, Jonathan A.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Pollak, Victor E.] Univ Colorado, Hlth Sci Ctr, Dept Med, Aurora, CO 80045 USA; [Lorch, Jonathan A.] Rogosin Inst, New York, NY USA; [Pollak, Victor E.] MIQS Inc, Boulder, CO USA	Cornell University; University of Colorado System; University of Colorado Anschutz Medical Campus	Pollak, VE (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Med, Aurora, CO 80045 USA.	vpollak@miqs.com			MIQS, Inc.	MIQS, Inc.	VEP received salary support from MIQS, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2010, CLIN J AM SOC NEPHRO, V5, P1340, DOI 10.2215/CJN.02830310; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Besarab A, 2009, ADV CHRONIC KIDNEY D, V16, P131, DOI 10.1053/j.ackd.2008.12.007; Buntin MB, 2011, HEALTH AFFAIR, V30, P464, DOI 10.1377/hlthaff.2011.0178; Deming W, 1982, OUT CRISIS; Deming W.E., 1986, STAT METHOD VIEWPOIN; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; ESCHBACH JW, 1967, NEW ENGL J MED, V276, P653, DOI 10.1056/NEJM196703232761202; ESCHBACH JW, 1991, AM J KIDNEY DIS, V18, P3; ESCHBACH JW, 1987, NEW ENGL J MED, V316, P73, DOI 10.1056/NEJM198701083160203; Feinstein AR, 1997, AM J MED, V103, P529, DOI 10.1016/S0002-9343(97)00244-1; Fort J, 2010, NEPHROL DIAL TRANSPL, V25, P2702, DOI 10.1093/ndt/gfq073; FRIES JF, 1972, J AMER MED ASSOC, V222, P1536, DOI 10.1001/jama.222.12.1536; Fuller DS, 2013, AM J KIDNEY DIS, V61, P342, DOI 10.1053/j.ajkd.2012.10.002; Goodkin DA, 2003, J AM SOC NEPHROL, V14, P3270, DOI 10.1097/01.ASN.0000100127.54107.57; Hampl H, 2005, AM J NEPHROL, V25, P211, DOI 10.1159/000085881; Heffler S, 2005, HLTH AFF MILLWOOD S; Hsu CY, 2002, J AM SOC NEPHROL, V13, P2783, DOI 10.1097/01.ASN.0000034200.82278.DC; Levin A, 2006, AM J KIDNEY DIS, V47, pS9, DOI 10.1053/j.ajkd.2006.04.023; McFarlane PA, 2010, KIDNEY INT, V78, P215, DOI 10.1038/ki.2010.108; National Research Council, 2012, BEST CAR LOW COST PA; Ofsthun N, 2003, KIDNEY INT, V63, P1908, DOI 10.1046/j.1523-1755.2003.00937.x; POLLAK VE, 1977, ARCH INTERN MED, V137, P446, DOI 10.1001/archinte.137.4.446; Pollak VE, 2001, J INVEST MED, V49, P173, DOI 10.2310/6650.2001.34044; POLLAK VE, 1985, JAMA-J AM MED ASSOC, V253, P62; Pollak VE, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-6; Pollak VE, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-38; Portoles J, 2007, NEPHROL DIAL TRANSPL, V22, P500, DOI 10.1093/ndt/gfl558; Rawlins M, 2008, LANCET, V372, P2152, DOI 10.1016/S0140-6736(08)61930-3; Regidor DL, 2006, J AM SOC NEPHROL, V17, P1181, DOI 10.1681/ASN.2005090997; Servilla KS, 2009, AM J KIDNEY DIS, V54, P498, DOI 10.1053/j.ajkd.2009.05.007; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; U S Renal Data System, 2011, ANN DAT REP ATL CHRO; Weinhandl ED, 2011, AM J NEPHROL, V34, P298, DOI 10.1159/000330693	34	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97066	10.1371/journal.pone.0097066	http://dx.doi.org/10.1371/journal.pone.0097066			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844323	Green Submitted, gold, Green Published			2022-12-25	WOS:000339563400013
J	del Rincon, SV; Widschwendter, M; Sun, D; Ekholm-Reed, S; Tat, J; Teixeira, LK; Ellederova, Z; Grolieres, E; Reed, SI; Spruck, C				del Rincon, S. V.; Widschwendter, M.; Sun, D.; Ekholm-Reed, S.; Tat, J.; Teixeira, L. K.; Ellederova, Z.; Grolieres, E.; Reed, S. I.; Spruck, C.			Cks overexpression enhances chemotherapeutic efficacy by overriding DNA damage checkpoints	ONCOGENE			English	Article							CYCLIN-DEPENDENT KINASE; CELL-CYCLE; UBIQUITIN LIGASE; GENE-EXPRESSION; INDEPENDENT FUNCTION; BLADDER-CANCER; PROGRESSION; P27(KIP1); SKP2; PHOSPHORYLATION	Cdc kinase subunit (Cks) proteins Cks1 and Cks2 are adaptor-like proteins that bind many cyclin-dependent kinases. A wealth of clinical data has shown that Cks proteins are overexpressed in many types of human cancers and this often correlates with increased tumor aggressiveness. Previously, we showed that Cks overexpression abrogates the intra-S-phase checkpoint, a major barrier to oncogene-mediated transformation. Interestingly, the intra-S-phase checkpoint is crucial for the cellular response to replication stress, a major pathway of apoptosis induction by many chemotherapeutic agents. Here, we demonstrate cancer cells that overexpress Cks1 or Cks2 override the intra-S-phase checkpoint in the presence of replication stress-inducing chemotherapies such as 5-Fluorouracil (5-FU) and methotrexate (MTX) leading to enhanced sensitivity in vitro and in vivo. Furthermore, enforced expression of Cks1 in an MTX-resistant breast cancer cell line was found to restore drug sensitivity. Our results suggest that Cks proteins are important determinants of apoptosis induction of replication stress-inducing chemotherapies such as 5-FU.	[del Rincon, S. V.; Sun, D.; Ellederova, Z.; Grolieres, E.; Spruck, C.] Sanford Burnham Med Res Inst, Ctr Canc, Tumor Initiat & Maintenance Program, La Jolla, CA 92037 USA; [Widschwendter, M.] UCL, Dept Gynaecol Oncol, London, England; [Ekholm-Reed, S.; Tat, J.; Teixeira, L. K.; Reed, S. I.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; University of London; University College London; Scripps Research Institute	Spruck, C (corresponding author), Sanford Burnham Med Res Inst, Ctr Canc, Tumor Initiat & Maintenance Program, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA.	cspruck@sanfordburnham.org	Teixeira, Leonardo Karam/S-8773-2016	Teixeira, Leonardo Karam/0000-0001-6117-423X; Widschwendter, Martin/0000-0002-7778-8380	American Cancer Society [RSG-06-020-01]; National Institutes of Health [7R01HD049539-05]; Department of Defense Breast Cancer Research Program [W81XWH-06-1-0344]; National Cancer Institute [CA074224]; UCLH/UCL Comprehensive Biomedical Research Centre grant; Department of Health NIHR Biomedical Research Centres funding scheme; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD049539] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA078343, P30CA030199, R01CA074224] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UCLH/UCL Comprehensive Biomedical Research Centre grant; Department of Health NIHR Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We wish to thank C Torres and Y Altman (Sanford-Burnham Medical Research Institute) for technical assistance with flow cytometry analyses. This work was supported by grants from the American Cancer Society (RSG-06-020-01) and National Institutes of Health (7R01HD049539-05) to CS, Department of Defense Breast Cancer Research Program (W81XWH-06-1-0344) to SVdR, and National Cancer Institute (CA074224) to SIR. Additional support came from a UCLH/UCL Comprehensive Biomedical Research Centre grant and was undertaken at UCLH/UCL, which received a portion of its funding from the Department of Health NIHR Biomedical Research Centres funding scheme.	Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bhatt KV, 2007, ONCOGENE, V26, P1056, DOI 10.1038/sj.onc.1209861; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Bourne Y, 1996, CELL, V84, P863, DOI 10.1016/S0092-8674(00)81065-X; Chaves S, 2010, MOL CELL BIOL, V30, P5284, DOI 10.1128/MCB.00952-10; Chen R, 2011, J INT MED RES, V39, P533, DOI 10.1177/147323001103900222; Harper JW, 2001, CURR BIOL, V11, pR431, DOI 10.1016/S0960-9822(01)00253-6; Inui N, 2003, BIOCHEM BIOPH RES CO, V303, P978, DOI 10.1016/S0006-291X(03)00469-8; Kaiser P, 1999, GENE DEV, V13, P1190, DOI 10.1101/gad.13.9.1190; Kawakami K, 2007, J UROLOGY, V178, P301, DOI 10.1016/j.juro.2007.03.002; Kawakami K, 2006, ONCOL REP, V16, P521; Keller UB, 2007, EMBO J, V26, P2562, DOI 10.1038/sj.emboj.7601691; Krude T, 1999, EXP CELL RES, V247, P148, DOI 10.1006/excr.1998.4342; Kunz C, 2009, PLOS BIOL, V7, P967, DOI 10.1371/journal.pbio.1000091; Lee SW, 2013, HEPATO-GASTROENTEROL, V60, P932, DOI 10.5754/hge121214; Li MH, 2004, INT J ONCOL, V24, P305; Liberal V, 2012, P NATL ACAD SCI USA, V109, P2754, DOI 10.1073/pnas.1102434108; Lin HM, 2007, ONCOL REP, V17, P1541; Liu Z, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-51; Martin-Ezquerra G, 2011, HISTOL HISTOPATHOL, V26, P71, DOI 10.14670/HH-26.71; Martinsson-Ahlzen HS, 2008, MOL CELL BIOL, V28, P5698, DOI 10.1128/MCB.01833-07; Masuda T, 2003, CLIN CANCER RES, V9, P5693; Menghi F, 2011, ONCOLOGIST, V16, P1440, DOI 10.1634/theoncologist.2010-0249; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Patra D, 1996, GENE DEV, V10, P1503, DOI 10.1101/gad.10.12.1503; Patra D, 1999, J BIOL CHEM, V274, P36839, DOI 10.1074/jbc.274.52.36839; Perez-Magan E, 2012, J NEUROPATH EXP NEUR, V71, P882, DOI 10.1097/NEN.0b013e31826bf704; Reynard GJ, 2000, MOL CELL BIOL, V20, P5858, DOI 10.1128/MCB.20.16.5858-5864.2000; Shapira M, 2005, CANCER-AM CANCER SOC, V103, P1336, DOI 10.1002/cncr.20917; Shen DY, 2013, LIVER INT, V33, P137, DOI 10.1111/liv.12014; Slotky M, 2005, BREAST CANCER RES, V7, pR737, DOI 10.1186/bcr1278; Spruck C, 2001, MOL CELL, V7, P639, DOI 10.1016/S1097-2765(01)00210-6; Spruck CH, 2003, SCIENCE, V300, P647, DOI 10.1126/science.1084149; Tanaka F, 2011, INT J ONCOL, V39, P361, DOI 10.3892/ijo.2011.1056; Tedesco D, 2002, GENE DEV, V16, P2946, DOI 10.1101/gad.1011202; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang JJ, 2013, DIS ESOPHAGUS, V26, P729, DOI 10.1111/dote.12013; Wang XC, 2009, BIOCHEM BIOPH RES CO, V379, P1107, DOI 10.1016/j.bbrc.2009.01.028; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Wiese AH, 2007, CANCER DETECT PREV, V31, P282, DOI 10.1016/j.cdp.2007.07.003; Yamamoto S, 2010, HISTOPATHOLOGY, V56, P740, DOI 10.1111/j.1365-2559.2010.03551.x; Yu VPCC, 2005, MOL CELL, V17, P145, DOI 10.1016/j.molcel.2004.11.020	43	10	10	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 9	2015	34	15					1961	1967		10.1038/onc.2014.137	http://dx.doi.org/10.1038/onc.2014.137			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CF7GY	24858038	Green Accepted			2022-12-25	WOS:000352725600010
J	Xianjun, P; Linhong, T; Xiaoman, W; Yucheng, W				Xianjun, P.; Linhong, T.; Xiaoman, W.; Yucheng, W.			De Novo Assembly of Expressed Transcripts and Global Transcriptomic Analysis from Seedlings of the Paper Mulberry (Broussonetia kazinoki x Broussonetia papyifera) (vol 9, e97487, 2014)	PLOS ONE			English	Correction													wang, xiaoman/GQH-0836-2022					Peng XJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0108613, 10.1371/journal.pone.0097487]; XIANJUN P, 2014, PLOS ONE, V0009	2	23	24	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e108613	10.1371/journal.pone.0108613	http://dx.doi.org/10.1371/journal.pone.0108613			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	24848504	Green Published, gold			2022-12-25	WOS:000341774300096
J	Skals, M; Bjaelde, RG; Reinholdt, J; Poulsen, K; Vad, BS; Otzen, DE; Leipziger, J; Praetorius, HA				Skals, Marianne; Bjaelde, Randi G.; Reinholdt, Jesper; Poulsen, Knud; Vad, Brian S.; Otzen, Daniel E.; Leipziger, Jens; Praetorius, Helle A.			Bacterial RTX Toxins Allow Acute ATP Release from Human Erythrocytes Directly through the Toxin Pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI ALPHA-HEMOLYSIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; ESCHERICHIA-COLI; ANION CHANNEL; MODEL MEMBRANES; ION CHANNELS; LEUKOTOXIN; PROTEIN; CFTR; REQUIRES	ATP is as an extracellular signaling molecule able to amplify the cell lysis inflicted by certain bacterial toxins including the two RTX toxins alpha-hemolysin (HlyA) from Escherichia coli and leukotoxin A (LtxA) from Aggregatibacter actinomycetemcomitans. Inhibition of P2X receptors completely blocks the RTX toxin-induced hemolysis over a larger concentration range. It is, however, at present not known how the ATP that provides the amplification is released from the attacked cells. Here we show that both HlyA and LtxA trigger acute release of ATP from human erythrocytes that preceded and were not caused by cell lysis. This early ATP release did not occur via previously described ATP-release pathways in the erythrocyte. Both HlyA and LtxA were capable of triggering ATP release in the presence of the pannexin 1 blockers carbenoxolone and probenecid, and the HlyA-induced ATP release was found to be similar in erythrocytes from pannexin 1 wild type and knock-out mice. Moreover, the voltage-dependent anion channel antagonist TRO19622 had no effect on ATP release by either of the toxins. Finally, we showed that both HlyA and LtxA were able to release ATP from ATP-loaded lipid (1-palmitoyl-2-oleoyl-phosphatidylcholine) vesicles devoid of any erythrocyte channels or transporters. Again we were able to show that this happened in a non-lytic fashion, using calcein-containing vesicles as controls. These data show that both toxins incorporate into lipid vesicles and allow ATP to be released. We suggest that both toxins cause acute ATP release by letting ATP pass the toxin pores in both human erythrocytes and artificial membranes.	[Skals, Marianne; Bjaelde, Randi G.; Poulsen, Knud; Leipziger, Jens; Praetorius, Helle A.] Aarhus Univ, Dept Biomed, Interdisciplinary Nanosci Ctr iNANO, Ctr Insoluble Proteins inSPIN, DK-8000 Aarhus C, Denmark; [Reinholdt, Jesper] Aarhus Univ, Dept Dent, Interdisciplinary Nanosci Ctr iNANO, Ctr Insoluble Proteins inSPIN, DK-8000 Aarhus C, Denmark; [Skals, Marianne; Bjaelde, Randi G.; Leipziger, Jens; Praetorius, Helle A.] Aarhus Univ, MEMBRANES, Interdisciplinary Nanosci Ctr iNANO, Ctr Insoluble Proteins inSPIN, DK-8000 Aarhus C, Denmark; [Vad, Brian S.; Otzen, Daniel E.] Aarhus Univ, Dept Mol Biol & Genet, Interdisciplinary Nanosci Ctr iNANO, Ctr Insoluble Proteins inSPIN, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Praetorius, HA (corresponding author), Aarhus Univ, Dept Biomed, Ole Worms Alle 3,Bldg 1170, DK-8000 Aarhus C, Denmark.	hp@fi.au.dk		Otzen, Daniel/0000-0002-2918-8989; Praetorius, Helle/0000-0002-0970-5061; Leipziger, Jens/0000-0002-6719-7034	Danish Council for Independent Research; Novo Nordisk Fonden; Lundbeck Foundation; Danish Research Foundation (inSPIN); Medical Sciences	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Novo Nordisk Fonden(Novo Nordisk Foundation); Lundbeck Foundation(Lundbeckfonden); Danish Research Foundation (inSPIN); Medical Sciences	This work was supported by The Danish Council for Independent Research, Medical Sciences, Novo Nordisk Fonden, the Lundbeck Foundation, and the Danish Research Foundation (inSPIN).	Adderley SP, 2011, MICROCIRCULATION, V18, P128, DOI 10.1111/j.1549-8719.2010.00073.x; Adderley SP, 2009, AM J PHYSIOL-HEART C, V296, pH1617, DOI 10.1152/ajpheart.01226.2008; Amaral A, 2004, INTENS CARE MED, V30, P1032, DOI 10.1007/s00134-004-2291-8; Bakas L, 1996, BIOPHYS J, V71, P1869, DOI 10.1016/S0006-3495(96)79386-4; Bell PD, 2003, P NATL ACAD SCI USA, V100, P4322, DOI 10.1073/pnas.0736323100; BERGFELD GR, 1992, CARDIOVASC RES, V26, P40, DOI 10.1093/cvr/26.1.40; BHAKDI S, 1986, INFECT IMMUN, V52, P63, DOI 10.1128/IAI.52.1.63-69.1986; BHAKDI S, 1988, EUR J EPIDEMIOL, V4, P135, DOI 10.1007/BF00144740; Borgel D, 2007, AM J RESP CRIT CARE, V176, P878, DOI 10.1164/rccm.200611-1692OC; Brown AC, 2013, J BIOL CHEM, V288, P23607, DOI 10.1074/jbc.M113.486654; Brown AC, 2012, CELL MICROBIOL, V14, P869, DOI 10.1111/j.1462-5822.2012.01762.x; BROWN E, 1990, J CELL BIOL, V111, P2785, DOI 10.1083/jcb.111.6.2785; Burnstock Geoffrey, 2011, Front Biosci (Elite Ed), V3, P896; Cantiello HF, 2001, PFLUG ARCH EUR J PHY, V443, pS22; CAVALIERI SJ, 1982, INFECT IMMUN, V36, P455, DOI 10.1128/IAI.36.2.455-461.1982; Dutta AK, 2002, J PHYSIOL-LONDON, V542, P803, DOI 10.1113/jphysiol.2002.019802; EBERSPACHER B, 1989, INFECT IMMUN, V57, P983; Feranchak AP, 2010, J BIOL CHEM, V285, P8138, DOI 10.1074/jbc.M109.065482; Fitz J Gregory, 2007, Trans Am Clin Climatol Assoc, V118, P199; Forman MS, 2010, TOXINS, V2, P2824, DOI 10.3390/toxins2122824; GAARDER A., 1961, NATURE, V192, P531, DOI 10.1038/192531a0; Grygorczyk R, 1997, AM J PHYSIOL-CELL PH, V272, pC1058; Grygorczyk R, 1996, J MEMBRANE BIOL, V151, P139, DOI 10.1007/s002329900065; Hejl JL, 2013, PFLUG ARCH EUR J PHY, V465, P529, DOI 10.1007/s00424-012-1174-z; Hjorringgaard CU, 2012, J PHYS CHEM B, V116, P7652, DOI 10.1021/jp2098679; IWASE M, 1990, INFECT IMMUN, V58, P1782, DOI 10.1128/IAI.58.6.1782-1788.1990; JORGENSEN SE, 1980, INFECT IMMUN, V27, P988, DOI 10.1128/IAI.27.3.988-994.1980; Kachlany SC, 2010, J DENT RES, V89, P561, DOI 10.1177/0022034510363682; Karakelian D, 1998, BBA-MOL BASIS DIS, V1406, P175, DOI 10.1016/S0925-4439(98)00002-7; Kieba IR, 2007, CELL MICROBIOL, V9, P2689, DOI 10.1111/j.1462-5822.2007.00989.x; KONIG B, 1993, IMMUNOLOGY, V80, P633; Lally ET, 1997, J BIOL CHEM, V272, P30463, DOI 10.1074/jbc.272.48.30463; Lally ET, 1999, TRENDS MICROBIOL, V7, P356, DOI 10.1016/S0966-842X(99)01530-9; Larsen CK, 2011, J MEMBRANE BIOL, V244, P131, DOI 10.1007/s00232-011-9406-2; LEAR JD, 1995, BBA-BIOMEMBRANES, V1238, P34, DOI 10.1016/0005-2736(95)00086-I; Li CH, 1996, J BIOL CHEM, V271, P11623, DOI 10.1074/jbc.271.20.11623; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Massion PB, 2012, INTENS CARE MED, V38, P1326, DOI 10.1007/s00134-012-2620-2; MENESTRINA G, 1987, BIOCHIM BIOPHYS ACTA, V905, P109, DOI 10.1016/0005-2736(87)90014-9; Montalbetti N, 2011, J BIOL CHEM, V286, P38397, DOI 10.1074/jbc.M111.221713; Morova J, 2008, P NATL ACAD SCI USA, V105, P5355, DOI 10.1073/pnas.0711400105; Munksgaard PS, 2014, INFECT IMMUN, V82, P2219, DOI 10.1128/IAI.01647-14; Munksgaard PS, 2012, CELL MICROBIOL, V14, P1904, DOI 10.1111/cmi.12021; Nielsen SB, 2010, J COLLOID INTERF SCI, V345, P248, DOI 10.1016/j.jcis.2010.01.065; Okada SF, 2004, J GEN PHYSIOL, V124, P513, DOI 10.1085/jgp.200409154; Olearczyk J J, 2001, Med Sci Monit, V7, P669; OSTOLAZA H, 1993, BIOCHIM BIOPHYS ACTA, V1147, P81, DOI 10.1016/0005-2736(93)90318-T; Ostolaza H, 1997, J MEMBRANE BIOL, V158, P137, DOI 10.1007/s002329900251; OSTOLAZA H, 1995, FEBS LETT, V371, P303, DOI 10.1016/0014-5793(95)00927-2; Reddy MM, 1996, SCIENCE, V271, P1876, DOI 10.1126/science.271.5257.1876; Reinholdt J, 2013, BBA-PROTEINS PROTEOM, V1834, P546, DOI 10.1016/j.bbapap.2012.12.004; REISIN IL, 1994, J BIOL CHEM, V269, P20584; Roman RM, 1997, J BIOL CHEM, V272, P21970, DOI 10.1074/jbc.272.35.21970; Sabirov RZ, 2004, JPN J PHYSIOL, V54, P7, DOI 10.2170/jjphysiol.54.7; Sabirov RZ, 2001, J GEN PHYSIOL, V118, P251, DOI 10.1085/jgp.118.3.251; Skals M, 2011, PFLUG ARCH EUR J PHY, V462, P669, DOI 10.1007/s00424-011-1010-x; Skals M, 2010, J BIOL CHEM, V285, P15557, DOI 10.1074/jbc.M109.082578; Skalsa M, 2009, P NATL ACAD SCI USA, V106, P4030, DOI 10.1073/pnas.0807044106; Soloaga A, 1999, MOL MICROBIOL, V31, P1013, DOI 10.1046/j.1365-2958.1999.01225.x; Sprague RS, 2008, MICROCIRCULATION, V15, P461, DOI 10.1080/10739680701833804; Sprague RS, 1998, AM J PHYSIOL-HEART C, V275, pH1726, DOI 10.1152/ajpheart.1998.275.5.H1726; Sprague RS, 1996, AM J PHYSIOL-HEART C, V271, pH2717, DOI 10.1152/ajpheart.1996.271.6.H2717; Sridharan M, 2012, AM J PHYSIOL-HEART C, V302, pH553, DOI 10.1152/ajpheart.00998.2011; Sridharan M, 2010, AM J PHYSIOL-HEART C, V299, pH1146, DOI 10.1152/ajpheart.00301.2010; Stumpf A, 2006, CELL PHYSIOL BIOCHEM, V17, P29, DOI 10.1159/000091457; TAICHMAN NS, 1980, INFECT IMMUN, V28, P258, DOI 10.1128/IAI.28.1.258-268.1980; Vad BS, 2010, BIOPHYS J, V98, P576, DOI 10.1016/j.bpj.2009.08.063; Walters MJ, 2013, MOL ORAL MICROBIOL, V28, P342, DOI 10.1111/omi.12028	68	43	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19098	19109		10.1074/jbc.M114.571414	http://dx.doi.org/10.1074/jbc.M114.571414			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24860098	hybrid, Green Published			2022-12-25	WOS:000339062900040
J	Liu, C; Du, WB; Wang, WX				Liu, Chen; Du, Wen-Bo; Wang, Wen-Xu			Particle Swarm Optimization with Scale-Free Interactions	PLOS ONE			English	Article							ECONOMIC-DISPATCH; ALGORITHM; NETWORKS; SYSTEM	The particle swarm optimization (PSO) algorithm, in which individuals collaborate with their interacted neighbors like bird flocking to search for the optima, has been successfully applied in a wide range of fields pertaining to searching and convergence. Here we employ the scale-free network to represent the inter-individual interactions in the population, named SF-PSO. In contrast to the traditional PSO with fully-connected topology or regular topology, the scale-free topology used in SF-PSO incorporates the diversity of individuals in searching and information dissemination ability, leading to a quite different optimization process. Systematic results with respect to several standard test functions demonstrate that SF-PSO gives rise to a better balance between the convergence speed and the optimum quality, accounting for its much better performance than that of the traditional PSO algorithms. We further explore the dynamical searching process microscopically, finding that the cooperation of hub nodes and non-hub nodes play a crucial role in optimizing the convergence process. Our work may have implications in computational intelligence and complex networks.	[Liu, Chen; Du, Wen-Bo] Beihang Univ, Sch Elect & Informat Engn, Beijing, Peoples R China; [Wang, Wen-Xu] Beijing Normal Univ, Sch Management, Beijing 100875, Peoples R China	Beihang University; Beijing Normal University	Du, WB (corresponding author), Beihang Univ, Sch Elect & Informat Engn, Beijing, Peoples R China.	wenbodu@buaa.edu.cn	Armstrong, Jonathan K/A-3069-2008		National Natural Science Foundation of China [61201314, 61231013]; Ministry of Science and Technology of China [2011CB707004, 2012BAG04B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was funded by National Natural Science Foundation of China (Grant Nos. 61201314 and 61231013, http://www.nsfc.gov.cn/) and Ministry of Science and Technology of China (Grant Nos. 2011CB707004 and 2012BAG04B01, http://www.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, PHYS REV LETT, V85, P5234, DOI 10.1103/PhysRevLett.85.5234; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barradas NP, 1997, APPL PHYS LETT, V71, P291, DOI 10.1063/1.119524; Benedetti M, 2006, IEEE ANTENN WIREL PR, V5, P545, DOI 10.1109/LAWP.2006.887553; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bratton D, 2007, 2007 IEEE SWARM INTELLIGENCE SYMPOSIUM, P120, DOI 10.1109/SIS.2007.368035; Clerc M, 2002, IEEE T EVOLUT COMPUT, V6, P58, DOI 10.1109/4235.985692; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Dorigo M, 2005, THEOR COMPUT SCI, V344, P243, DOI 10.1016/j.tcs.2005.05.020; Eberhart R., 1995, P 6 INT S MICR HUM S; Gaing ZL, 2003, IEEE T POWER SYST, V18, P1187, DOI 10.1109/TPWRS.2003.814889; Grimaccia F, 2007, IEEE T ANTENN PROPAG, V55, P781, DOI 10.1109/TAP.2007.891561; Ho SL, 2006, IEEE T MAGN, V42, P1107, DOI 10.1109/TMAG.2006.871426; Jin NB, 2005, IEEE T ANTENN PROPAG, V53, P3459, DOI 10.1109/TAP.2005.858842; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; Kennedy J., 1999, Proceedings of the 1999 Congress on Evolutionary Computation-CEC99 (Cat. No. 99TH8406), P1931, DOI 10.1109/CEC.1999.785509; Kennedy J, 2002, IEEE C EVOL COMPUTAT, P1671, DOI 10.1109/CEC.2002.1004493; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Mendes R, 2004, IEEE T EVOLUT COMPUT, V8, P204, DOI [10.1109/TEVC.2004.826074, 10.1109/tevc.2004.826074]; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Park JB, 2005, IEEE T POWER SYST, V20, P34, DOI 10.1109/TPWRS.2004.831275; Parpinelli RS, 2002, IEEE T EVOLUT COMPUT, V6, P321, DOI 10.1109/TEVC.2002.802452; Peram T, 2003, PROCEEDINGS OF THE 2003 IEEE SWARM INTELLIGENCE SYMPOSIUM (SIS 03), P174, DOI 10.1109/SIS.2003.1202264; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Selvan SE, 2006, IEEE T INF TECHNOL B, V10, P685, DOI 10.1109/TITB.2006.874197; Shi YH, 1998, IEEE C EVOL COMPUTAT, P69, DOI 10.1109/ICEC.1998.699146; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Trelea IC, 2003, INFORM PROCESS LETT, V85, P317, DOI 10.1016/S0020-0190(02)00447-7; Veeramachaneni K, 2005, IEEE T SYST MAN CY C, V35, P344, DOI 10.1109/TSMCC.2005.848191; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Wai RJ, 2011, IEEE T IND ELECTRON, V58, P629, DOI 10.1109/TIE.2010.2046004; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep03055; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893; Zwickl D., 2006, GARLI GENETIC ALGORI	37	132	133	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97822	10.1371/journal.pone.0097822	http://dx.doi.org/10.1371/journal.pone.0097822			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859007	Green Published, gold			2022-12-25	WOS:000336839400027
J	Benzinger, P; Rapp, K; Maetzler, W; Konig, HH; Jaensch, A; Klenk, J; Buchele, G				Benzinger, Petra; Rapp, Kilian; Maetzler, Walter; Koenig, Hans-Helmut; Jaensch, Andrea; Klenk, Jochen; Buechele, Gisela			Risk for Femoral Fractures in Parkinson's Disease Patients with and without Severe Functional Impairment	PLOS ONE			English	Article							RESTLESS LEGS SYNDROME; OSTEOPOROTIC FRACTURES; HIP FRACTURE; OLDER MEN; FALLS; BONE; ASSOCIATION; POPULATION; DISABILITY; DIAGNOSIS	Background: Impaired balance is a major problem in patients with idiopathic Parkinson's disease (PD) resulting in an increased risk of falls and fall-related fractures. Most studies which analyzed the risk of femoral fractures in patients with idiopathic PD were performed either in specialized centers or excluded very frail patients. The current study used a large population-based dataset in order to analyze the risk of femoral fractures in patients with idiopathic PD. Methods: Data from more than 880.000 individuals aged 65 years or older and insured between 2004 and 2009 at a large German health insurance company were used for the analyses. Persons with idiopathic PD were identified by the dispensing of Parkinson-specific medication and by hospital diagnoses, if available. People without PD served as the reference group. Incident femoral fractures were obtained from hospital diagnoses. Analyses were stratified by gender and information on severe functional impairment (care need) as provided by reimbursement claims. Results: Compared with the reference group, persons with idiopathic PD had a more than doubled risk to sustain a femoral fracture. The risk was higher in men (HR = 2.61; 95%-CI: 2.28-2.98) than in women (HR = 1.79; 95%-CI: 1.66-1.94). The increased risk was only observed in people without severe functional impairment. The sensitivity analysis using a refined definition of idiopathic PD patients yielded similar results. Conclusion: The findings confirm the increased risk of femoral fractures in patients with idiopathic PD. The relative risk is particularly high in male PD patients and in patients without severe functional impairment.	[Benzinger, Petra; Rapp, Kilian; Klenk, Jochen] Robert Bosch Krankenhaus Stuttgart, Dept Clin Gerontol & Rehabil, Stuttgart, Germany; [Rapp, Kilian; Jaensch, Andrea; Klenk, Jochen; Buechele, Gisela] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Maetzler, Walter] Univ Hosp Tuebingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Maetzler, Walter] German Ctr Neurodegenerat Dis, DZNE, Tubingen, Germany; [Koenig, Hans-Helmut] Univ Med Ctr Hamburg Eppendorf, Hamburg Ctr Hlth Econ, Dept Hlth Econ & Hlth Serv Res, Hamburg, Germany	Bosch; Robert Bosch Krankenhaus; Ulm University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Hamburg; University Medical Center Hamburg-Eppendorf	Benzinger, P (corresponding author), Robert Bosch Krankenhaus Stuttgart, Dept Clin Gerontol & Rehabil, Stuttgart, Germany.	petra.benzinger@rbk.de	Maetzler, Walter/AAE-5831-2020; König, Hans-Helmut/P-1211-2018; Klenk, Jochen/C-2164-2012; Maetzler, Walter/A-6796-2011; Klenk, Jochen/R-3614-2019; Rapp, Kilian/AAJ-3370-2020	Maetzler, Walter/0000-0002-5945-4694; König, Hans-Helmut/0000-0001-5711-6862; Maetzler, Walter/0000-0002-5945-4694; Klenk, Jochen/0000-0002-5987-447X; Rapp, Kilian/0000-0003-1625-2571	Bundesministerium fur Bildung und Forschung [Forderkennzeichen: 01EC1007A]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	The analysis was supported by the Bundesministerium fur Bildung und Forschung (Forderkennzeichen: 01EC1007A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Raya S, 2009, AGE AGEING, V38, P675, DOI 10.1093/ageing/afp137; Arbouw MEL, 2011, OSTEOPOROSIS INT, V22, P2197, DOI 10.1007/s00198-010-1455-3; Balash Y, 2005, J NEUROL, V252, P1310, DOI 10.1007/s00415-005-0855-3; Becker C, 1998, FACT RES INTERV GER, P55; Benzinger P, 2013, J AM MED DIR ASSOC, V14, P673, DOI 10.1016/j.jamda.2013.03.012; Bhattacharya RK, 2012, MOVEMENT DISORD, V27, P1440, DOI 10.1002/mds.25073; Bleibler F, 2013, OSTEOPOROSIS INT, V24, P835, DOI 10.1007/s00198-012-2020-z; Bloem BR, 2001, J NEUROL, V248, P950, DOI 10.1007/s004150170047; Cirillo DJ, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-39; Clubb VJ, 2006, INJURY, V37, P929, DOI 10.1016/j.injury.2005.11.013; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Fink HA, 2008, OSTEOPOROSIS INT, V19, P1277, DOI 10.1007/s00198-008-0584-4; Fink HA, 2005, J AM GERIATR SOC, V53, P1559, DOI 10.1111/j.1532-5415.2005.53464.x; Genever RW, 2005, AGE AGEING, V34, P21, DOI 10.1093/ageing/afh203; Harrison MB, 2009, MOVEMENT DISORD, V24, P224, DOI 10.1002/mds.22335; Healy GN, 2010, REV ESP CARDIOL, V63, P261, DOI 10.1016/S0300-8932(10)70083-X; Hening W, 2004, SLEEP MED, V5, P237, DOI 10.1016/j.sleep.2004.03.006; Hogl B, 2005, NEUROLOGY, V64, P1920, DOI 10.1212/01.WNL.0000163996.64461.A3; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Icks A, 2008, OSTEOPOROSIS INT, V19, P1139, DOI 10.1007/s00198-007-0534-6; Icks AIA, 2013, ARCH OSTEOPOROS, V8, P1; Ioannidis G, 2009, CAN MED ASSOC J, V181, P265, DOI 10.1503/cmaj.081720; Jankovic J, 2001, ARCH NEUROL-CHICAGO, V58, P1611, DOI 10.1001/archneur.58.10.1611; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; JOHNELL O, 1992, AGE AGEING, V21, P32, DOI 10.1093/ageing/21.1.32; Kanis JA, 2012, OSTEOPOROSIS INT, V23, P2239, DOI 10.1007/s00198-012-1964-3; Latt MD, 2009, MOVEMENT DISORD, V24, P1280, DOI 10.1002/mds.22561; Matinolli M, 2011, ACTA NEUROL SCAND, V123, P193, DOI 10.1111/j.1600-0404.2010.01386.x; Melton LJ, 2006, MOVEMENT DISORD, V21, P1361, DOI 10.1002/mds.20946; Pickering RM, 2007, MOVEMENT DISORD, V22, P1892, DOI 10.1002/mds.21598; Plotnik M, 2011, EXP BRAIN RES, V210, P529, DOI 10.1007/s00221-011-2551-0; Rapp K, 2012, AGE AGEING, V41, P653, DOI 10.1093/ageing/afs044; Schneider JL, 2008, OSTEOPOROSIS INT, V19, P1093, DOI 10.1007/s00198-008-0583-5; Temlett JA, 2006, INTERN MED J, V36, P524, DOI 10.1111/j.1445-5994.2006.01123.x; Trenkwalder C, 2008, MOVEMENT DISORD, V23, P2267, DOI 10.1002/mds.22254; van de Vijver DAMC, 2001, PHARM WORLD SCI, V23, P148, DOI 10.1023/A:1011807919632; van den Bos F, 2013, AGE AGEING, V42, P156, DOI 10.1093/ageing/afs161; Vestergaard P, 2007, CALCIFIED TISSUE INT, V81, P153, DOI 10.1007/s00223-007-9065-6; Wielinski CL, 2005, MOVEMENT DISORD, V20, P410, DOI 10.1002/mds.20347; Wood BH, 2002, J NEUROL NEUROSUR PS, V72, P721, DOI 10.1136/jnnp.72.6.721	40	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97073	10.1371/journal.pone.0097073	http://dx.doi.org/10.1371/journal.pone.0097073			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853110	Green Published, gold, Green Submitted			2022-12-25	WOS:000338323200015
J	Daros, RR; Costa, JHC; von Keyserlingk, MAG; Hotzel, MJ; Weary, DM				Daros, Rolnei R.; Costa, Joao H. C.; von Keyserlingk, Marina A. G.; Hoetzel, Maria J.; Weary, Daniel M.			Separation from the Dam Causes Negative Judgement Bias in Dairy Calves	PLOS ONE			English	Article							BEEF-CALVES; COGNITIVE BIAS; BEHAVIOR; PAIN; STRESS	Negative emotional states in humans are associated with a negative (pessimistic) response bias towards ambiguous cues in judgement tasks. Every mammalian young is eventually weaned; this period of increasing nutritional and social independence from the dam is associated with a pronounced behavioural response, especially when weaning is abrupt as commonly occurs in farm animals. The aim of the current study was to test the effect of separation from the cow on the responses of dairy calves in a judgement task. Thirteen Holstein calves were reared with their dams and trained to discriminate between red and white colours displayed on a computer monitor. These colours predicted reward or punishment outcomes using a go/no-go task. A reward was provided when calves approached the white screen and calves were punished with a timeout when they approached the red screen. Calves were then tested with non-reinforced ambiguous probes (screen colours intermediate to the two training colours). "GO" responses to these probes averaged (6 SE) 72 +/- 3.6 % before separation but declined to 62 +/- 3.6 % after separation from the dam. This bias was similar to that shown by calves experiencing pain in the hours after hot-iron dehorning. These results provide the first evidence of a pessimistic judgement bias in animals following maternal separation and are indicative of low mood.	[Daros, Rolnei R.; Costa, Joao H. C.; von Keyserlingk, Marina A. G.; Weary, Daniel M.] Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC V5Z 1M9, Canada; [Daros, Rolnei R.; Hoetzel, Maria J.] Univ Fed Santa Catarina, Dept Zootecnia & Desenvolvimento Rural, Lab Etol Aplicada & Bem Estar Anim, Florianopolis, SC, Brazil	University of British Columbia; Universidade Federal de Santa Catarina (UFSC)	Weary, DM (corresponding author), Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC V5Z 1M9, Canada.	danweary@mail.ubc.ca	Weary, Daniel M/A-8868-2010; Daros, Ruan R./L-6395-2019; Costa, Joao H. C./M-6660-2014; Hötzel, Maria José/H-6975-2014; von Keyserlingk, Marina/AAB-6353-2019; Costa, Joao H. C./ABD-4749-2021	Weary, Daniel M/0000-0002-0917-3982; Daros, Ruan R./0000-0003-2331-1648; Costa, Joao H. C./0000-0001-9311-4741; Hötzel, Maria José/0000-0003-1034-3202; von Keyserlingk, Marina/0000-0002-1427-3152; Costa, Joao H. C./0000-0001-9311-4741	Natural Sciences and Engineering Research Council of Canada (NSERC); CAPES (Coordenacao de aperfeicoamento de pessoal de nivel superior); ELAP (Emerging Leaders in the Americas Program); CNPq (Conselho Nacional de Desenvolvimento Cientifcco e Tecnologico); CNPq [304123/2012-9]; BBSRC [BB/J004197/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J004197/1] Funding Source: researchfish	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CAPES (Coordenacao de aperfeicoamento de pessoal de nivel superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); ELAP (Emerging Leaders in the Americas Program); CNPq (Conselho Nacional de Desenvolvimento Cientifcco e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC). RRD was supported by scholarships from CAPES (Coordenacao de aperfeicoamento de pessoal de nivel superior) and ELAP (Emerging Leaders in the Americas Program). JHCC was supported by a scholarship from CNPq (Conselho Nacional de Desenvolvimento Cientifcco e Tecnologico). MJH thanks CNPq for their general support through grant number 304123/2012-9. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adobe Systems Inc, 2010, AD PHOT EL 9 0; Bateson M, 2011, CURR BIOL, V21, P1070, DOI 10.1016/j.cub.2011.05.017; Brydges NM, 2011, ANIM BEHAV, V81, P169, DOI 10.1016/j.anbehav.2010.09.030; Burman OHP, 2008, ANIM BEHAV, V76, P801, DOI 10.1016/j.anbehav.2008.02.014; Daros RR, 2014, SEPARATION DAM CAUSE; Douglas C, 2012, APPL ANIM BEHAV SCI, V139, P65, DOI 10.1016/j.applanim.2012.02.018; Doyle RE, 2010, BEHAV PROCESS, V83, P349, DOI 10.1016/j.beproc.2010.01.019; Doyle RE, 2010, APPL ANIM BEHAV SCI, V122, P28, DOI 10.1016/j.applanim.2009.11.003; Eisenberger NI, 2012, PSYCHOSOM MED, V74, P126, DOI 10.1097/PSY.0b013e3182464dd1; Enriquez DH, 2010, LIVEST SCI, V128, P20, DOI 10.1016/j.livsci.2009.10.007; Enriquez D, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-28; Flower FC, 2003, ANIM WELFARE, V12, P339; Haley DB, 2005, J ANIM SCI, V83, P2205; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; Hickey MC, 2003, J ANIM SCI, V81, P2847; Hotzel MJ, 2010, ANIM PROD SCI, V50, P909, DOI 10.1071/AN09136; HUDSON SJ, 1977, APPL ANIM ETHOL, V3, P271, DOI 10.1016/0304-3762(77)90008-6; Loberg JM, 2008, APPL ANIM BEHAV SCI, V111, P222, DOI 10.1016/j.applanim.2007.06.011; MacLeod AK, 1996, J ABNORM PSYCHOL, V105, P286, DOI 10.1037/0021-843X.105.2.286; MARTIN P, 1984, ANIM BEHAV, V32, P1257, DOI 10.1016/S0003-3472(84)80245-6; Matheson SM, 2008, APPL ANIM BEHAV SCI, V109, P374, DOI 10.1016/j.applanim.2007.03.007; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; Neave HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080556; Panksepp J, 2003, SCIENCE, V302, P237, DOI 10.1126/science.1091062; Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002; Pomerantz O, 2012, ANIM COGN, V15, P689, DOI 10.1007/s10071-012-0497-7; *SAS I INC, 2007, SAS ONLINEDOC 9 1 3; Stafford KJ, 2011, APPL ANIM BEHAV SCI, V135, P226, DOI 10.1016/j.applanim.2011.10.018; Veissier I, 2013, APPL ANIM BEHAV SCI, V147, P11, DOI 10.1016/j.applanim.2013.05.002; von Keyserlingk MAG, 2007, HORM BEHAV, V52, P106, DOI 10.1016/j.yhbeh.2007.03.015; Weary DM, 2008, APPL ANIM BEHAV SCI, V110, P24, DOI 10.1016/j.applanim.2007.03.025	31	60	60	1	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98429	10.1371/journal.pone.0098429	http://dx.doi.org/10.1371/journal.pone.0098429			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848635	Green Published, gold			2022-12-25	WOS:000336730600113
J	Hossain, MDT; Yamada, N; Yamamoto, K				Hossain, M. D. Tofazzal; Yamada, Naotaka; Yamamoto, Kohji			Glutathione-Binding Site of a Bombyx mori Theta-Class Glutathione Transferase	PLOS ONE			English	Article							VECTOR ANOPHELES-GAMBIAE; S-TRANSFERASES; EPSILON-CLASS; ACTIVE-SITE; DROSOPHILA-MELANOGASTER; CATALYTIC MECHANISM; STRUCTURAL BASIS; EXPRESSION; SILKWORM; IDENTIFICATION	The glutathione transferase (GST) superfamily plays key roles in the detoxification of various xenobiotics. Here, we report the isolation and characterization of a silkworm protein belonging to a previously reported theta-class GST family. The enzyme (bmGSTT) catalyzes the reaction of glutathione with 1-chloro-2,4-dinitrobenzene, 1,2-epoxy-3-(4-nitrophenoxy)-propane, and 4-nitrophenethyl bromide. Mutagenesis of highly conserved residues in the catalytic site revealed that Glu66 and Ser67 are important for enzymatic function. These results provide insights into the catalysis of glutathione conjugation in silkworm by bmGSTT and into the metabolism of exogenous chemical agents.	[Hossain, M. D. Tofazzal; Yamada, Naotaka; Yamamoto, Kohji] Kyushu Univ, Grad Sch, Fac Agr, Fukuoka 812, Japan	Kyushu University	Yamamoto, K (corresponding author), Kyushu Univ, Grad Sch, Fac Agr, Fukuoka 812, Japan.	yamamok@agr.kyushu-u.ac.jp	Yamamoto, Kohji/AAD-9097-2019		KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT, Tokyo, Japan) [24580078]	KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT, Tokyo, Japan)	This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI, 24580078) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT, Tokyo, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIN P, 1985, FEBS LETT, V179, P267, DOI 10.1016/0014-5793(85)80532-9; Awasthi YC, 2005, METHOD ENZYMOL, V401, P379, DOI 10.1016/S0076-6879(05)01024-4; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; BOARD PG, 1995, BIOCHEM J, V311, P247, DOI 10.1042/bj3110247; Board PG, 2013, BBA-GEN SUBJECTS, V1830, P3267, DOI 10.1016/j.bbagen.2012.11.019; Caccuri AM, 1997, J BIOL CHEM, V272, P29681, DOI 10.1074/jbc.272.47.29681; DANIEL V, 1993, CRIT REV BIOCHEM MOL, V28, P173, DOI 10.3109/10409239309086794; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HABIG WH, 1974, J BIOL CHEM, V249, P7130; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kakuta Y, 2011, BBA-GEN SUBJECTS, V1810, P1355, DOI 10.1016/j.bbagen.2011.06.022; Kanaoka Y, 1997, CELL, V90, P1085, DOI 10.1016/S0092-8674(00)80374-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsson AK, 2010, ARCH BIOCHEM BIOPHYS, V497, P28, DOI 10.1016/j.abb.2010.03.001; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; LISTOWSKY I, 1988, DRUG METAB REV, V19, P305, DOI 10.3109/03602538808994138; Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Mannervik B, 2005, METHOD ENZYMOL, V401, P1, DOI 10.1016/S0076-6879(05)01001-3; Mita K, 2003, P NATL ACAD SCI USA, V100, P14121, DOI 10.1073/pnas.2234984100; Nay B, 1999, INSECT BIOCHEM MOLEC, V29, P71, DOI 10.1016/S0965-1748(98)00106-4; Oakley A, 2011, DRUG METAB REV, V43, P138, DOI 10.3109/03602532.2011.558093; Ranson H, 2005, METHOD ENZYMOL, V401, P226, DOI 10.1016/S0076-6879(05)01014-1; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; Sawicki R, 2003, BIOCHEM J, V370, P661, DOI 10.1042/BJ20021287; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Shokeer A, 2010, BBA-GEN SUBJECTS, V1800, P466, DOI 10.1016/j.bbagen.2010.01.003; Shokeer A, 2010, J BIOL CHEM, V285, P5639, DOI 10.1074/jbc.M109.074757; Singh SP, 2001, EUR J BIOCHEM, V268, P2912, DOI 10.1046/j.1432-1327.2001.02179.x; Tan KL, 1996, BIOCHEM J, V319, P315, DOI 10.1042/bj3190315; Tars K, 2006, J MOL BIOL, V355, P96, DOI 10.1016/j.jmb.2005.10.049; Tu CPD, 2005, METHOD ENZYMOL, V401, P204, DOI 10.1016/S0076-6879(05)01013-X; Wang YJ, 2008, J STRUCT BIOL, V164, P228, DOI 10.1016/j.jsb.2008.08.003; Winayanuwattikun P, 2005, J BIOL CHEM, V280, P31776, DOI 10.1074/jbc.M502612200; Winayanuwattikun P, 2007, BIOCHEM J, V402, P339, DOI 10.1042/BJ20061253; Yamamoto K, 2006, J APPL ENTOMOL, V130, P515, DOI 10.1111/j.1439-0418.2006.01092.x; Yamamoto K, 2013, INSECT MOL BIOL, V22, P523, DOI 10.1111/imb.12041; Yamamoto K, 2005, COMP BIOCHEM PHYS B, V141, P340, DOI 10.1016/j.cbpc.2005.04.012; Yamamoto K, 2007, BIOSCI BIOTECH BIOCH, V71, P553, DOI 10.1271/bbb.60592; Yamamoto K, 2012, BBA-GEN SUBJECTS, V1820, P1469, DOI 10.1016/j.bbagen.2012.04.022; Yamamoto K, 2011, BBA-GEN SUBJECTS, V1810, P420, DOI 10.1016/j.bbagen.2011.01.003; Yamamoto K, 2009, COMP BIOCHEM PHYS C, V149, P461, DOI 10.1016/j.cbpc.2008.10.108; Yamamoto K, 2009, PESTIC BIOCHEM PHYS, V94, P30, DOI 10.1016/j.pestbp.2009.02.008	44	12	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97740	10.1371/journal.pone.0097740	http://dx.doi.org/10.1371/journal.pone.0097740			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848539	Green Submitted, Green Published, gold			2022-12-25	WOS:000336730600052
J	Voigt, RM; Forsyth, CB; Green, SJ; Mutlu, E; Engen, P; Vitaterna, MH; Turek, FW; Keshavarzian, A				Voigt, Robin M.; Forsyth, Christopher B.; Green, Stefan J.; Mutlu, Ece; Engen, Phillip; Vitaterna, Martha H.; Turek, Fred W.; Keshavarzian, Ali			Circadian Disorganization Alters Intestinal Microbiota	PLOS ONE			English	Article							GUT MICROBIOTA; RUMINOCOCCUS-BROMII; METABOLIC SYNDROME; CROHNS-DISEASE; OBESITY; HOMEOSTASIS; CLOCK; DIET; RISK; POPULATIONS	Intestinal dysbiosis and circadian rhythm disruption are associated with similar diseases including obesity, metabolic syndrome, and inflammatory bowel disease. Despite the overlap, the potential relationship between circadian disorganization and dysbiosis is unknown; thus, in the present study, a model of chronic circadian disruption was used to determine the impact on the intestinal microbiome. Male C57BL/6J mice underwent once weekly phase reversals of the light: dark cycle (i.e., circadian rhythm disrupted mice) to determine the impact of circadian rhythm disruption on the intestinal microbiome and were fed either standard chow or a high-fat, high-sugar diet to determine how diet influences circadian disruption-induced effects on the microbiome. Weekly phase reversals of the light: dark (LD) cycle did not alter the microbiome in mice fed standard chow; however, mice fed a high-fat, high-sugar diet in conjunction with phase shifts in the light: dark cycle had significantly altered microbiota. While it is yet to be established if some of the adverse effects associated with circadian disorganization in humans (e. g., shift workers, travelers moving across time zones, and in individuals with social jet lag) are mediated by dysbiosis, the current study demonstrates that circadian disorganization can impact the intestinal microbiota which may have implications for inflammatory diseases.	[Voigt, Robin M.; Forsyth, Christopher B.; Mutlu, Ece; Engen, Phillip; Keshavarzian, Ali] Rush Univ, Med Ctr, Div Gastroenterol, Dept Internal Med, Chicago, IL 60612 USA; [Green, Stefan J.] Univ Illinois, Res Resources Ctr, DNA Serv Facil, Chicago, IL USA; [Green, Stefan J.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Vitaterna, Martha H.; Turek, Fred W.] Northwestern Univ, Ctr Sleep & Circadian Biol, Evanston, IL USA; [Forsyth, Christopher B.] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA; [Keshavarzian, Ali] Rush Univ, Med Ctr, Dept Pharmacol, Chicago, IL 60612 USA; [Keshavarzian, Ali] Rush Univ, Med Ctr, Dept Physiol, Chicago, IL 60612 USA; [Keshavarzian, Ali] Univ Utrecht, Div Pharmacol, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands	Rush University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; Rush University; Rush University; Rush University; Utrecht University	Voigt, RM (corresponding author), Rush Univ, Med Ctr, Div Gastroenterol, Dept Internal Med, Chicago, IL 60612 USA.	robin_voigt@rush.edu		Green, Stefan/0000-0003-2781-359X	National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health [R01AA020216]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020216] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Work was supported by the National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health under award number R01AA020216 to A.K. and F.W.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell GCJ, 2008, FEMS MICROBIOL ECOL, V66, P505, DOI 10.1111/j.1574-6941.2008.00527.x; Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Ananthakrishnan AN, 2013, CLIN GASTROENTEROL H, V11, P965, DOI 10.1016/j.cgh.2013.01.021; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Bailey MT, 2011, BRAIN BEHAV IMMUN, V25, P397, DOI 10.1016/j.bbi.2010.10.023; Bailey MT, 2010, INFECT IMMUN, V78, P1509, DOI 10.1128/IAI.00862-09; Bangsgaard Bendtsen K.M., 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046231.e46231; Batschelet E, 1981, CIRCULAR STAT BIOL; Bhatti P, 2013, OCCUP ENVIRON MED, V70, P231, DOI 10.1136/oemed-2012-101146; Blaut Michael, 2012, Handb Exp Pharmacol, P251, DOI 10.1007/978-3-642-24716-3_11; Bozek K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004882; Braak C.J.F, 2002, CANOCO REFERENCE MAN, P1; Burgess HJ, 2010, SCAND J GASTROENTERO, V45, P759, DOI 10.3109/00365521003749818; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039743; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Conlon M, 2007, EPIDEMIOLOGY, V18, P182, DOI 10.1097/01.ede.0000249519.33978.31; Dvornyk V, 2003, P NATL ACAD SCI USA, V100, P2495, DOI 10.1073/pnas.0130099100; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Everson CA, 2000, AM J PHYSIOL-REG I, V278, pR905, DOI 10.1152/ajpregu.2000.278.4.R905; Frazier Thomas H, 2011, JPEN J Parenter Enteral Nutr, V35, p14S, DOI 10.1177/0148607111413772; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; HOLDEMAN LV, 1976, APPL ENVIRON MICROB, V31, P359, DOI 10.1128/AEM.31.3.359-375.1976; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; Knowles SR, 2008, BIOL PSYCHOL, V77, P132, DOI 10.1016/j.biopsycho.2007.09.010; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; Martinez-Medina M, 2006, INFLAMM BOWEL DIS, V12, P1136, DOI 10.1097/01.mib.0000235828.09305.0c; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; McDonald D, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-7; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; NANJI AA, 1994, ALCOHOL CLIN EXP RES, V18, P1280, DOI 10.1111/j.1530-0277.1994.tb00119.x; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Portaluppi F, 2012, SLEEP MED REV, V16, P151, DOI 10.1016/j.smrv.2011.04.003; Preuss F, 2008, AM J PHYSIOL-REG I, V295, pR2034, DOI 10.1152/ajpregu.00118.2008; Rescigno M, 2011, TRENDS IMMUNOL, V32, P256, DOI 10.1016/j.it.2011.04.003; Alonso VR, 2013, BRIT J NUTR, V109, pS21, DOI 10.1017/S0007114512005235; Sanz Y, 2010, P NUTR SOC, V69, P434, DOI 10.1017/S0029665110001813; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Shibolet O, 2007, AM J PHYSIOL-GASTR L, V292, pG1469, DOI 10.1152/ajpgi.00531.2006; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Summa KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067102; Swanson GR, 2011, EXPERT REV CLIN IMMU, V7, P29, DOI [10.1586/eci.10.83, 10.1586/ECI.10.83]; Tang YM, 2009, SLEEP MED, V10, P597, DOI 10.1016/j.sleep.2008.12.009; TANNOCK GW, 1974, INFECT IMMUN, V9, P591, DOI 10.1128/IAI.9.3.591-598.1974; Teixeira TFS, 2012, NUTR RES, V32, P637, DOI 10.1016/j.nutres.2012.07.003; Tipoe GL, 2008, ALCOHOL CLIN EXP RES, V32, P669, DOI 10.1111/j.1530-0277.2008.00623.x; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wright KP, 2013, SLEEP MED REV, V17, P41, DOI 10.1016/j.smrv.2012.02.002; Ze XL, 2012, ISME J, V6, P1535, DOI 10.1038/ismej.2012.4	56	233	245	7	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97500	10.1371/journal.pone.0097500	http://dx.doi.org/10.1371/journal.pone.0097500			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848969	Green Published, Green Submitted, gold			2022-12-25	WOS:000336730600034
J	Locci, E; Scano, P; Rosa, MF; Nioi, M; Noto, A; Atzori, L; Demontis, R; De-Giorgio, F; d'Aloja, E				Locci, Emanuela; Scano, Paola; Rosa, Maria Francesca; Nioi, Matteo; Noto, Antonio; Atzori, Luigi; Demontis, Roberto; De-Giorgio, Fabio; d'Aloja, Ernesto			A Metabolomic Approach to Animal Vitreous Humor Topographical Composition: A Pilot Study	PLOS ONE			English	Article							ELECTROPHORESIS; MYOINOSITOL; LACTATE	The purpose of this study was to evaluate the feasibility of a 1 H-NMR-based metabolomic approach to explore the metabolomic signature of different topographical areas of vitreous humor (VH) in an animal model. Five ocular globes were enucleated from five goats and immediately frozen at -80 degrees C. Once frozen, three of them were sectioned, and four samples corresponding to four different VH areas were collected: the cortical, core, and basal, which was further divided into a superior and an inferior fraction. An additional two samples were collected that were representative of the whole vitreous body. H-1-NMR spectra were acquired for twenty-three goat vitreous samples with the aim of characterizing the metabolomic signature of this biofluid and identifying whether any site-specific patterns were present. Multivariate statistical analysis (MVA) of the spectral data were carried out, including Principal Component Analysis (PCA), Hierarchical Cluster Analysis (HCA), and Partial Least Squares Discriminant Analysis (PLS-DA). A unique metabolomic signature belonging to each area was observed. The cortical area was characterized by lactate, glutamine, choline, and its derivatives, N-acetyl groups, creatine, and glycerol; the core area was characterized by glucose, acetate, and scyllo-inositol; and the basal area was characterized by branched-chain amino acids (BCAA), betaine, alanine, ascorbate, lysine, and myo-inositol. We propose a speculative approach on the topographic role of these molecules that are mainly responsible for metabolic differences among the as-identified areas. 1 H-NMR-based metabolomic analysis has shown to be an important tool for investigating the VH. In particular, this approach was able to assess in the samples here analyzed the presence of different functional areas on the basis of a different metabolite distribution.	[Locci, Emanuela; Atzori, Luigi] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [Scano, Paola] Univ Cagliari, Dept Chem & Geol Sci, Cagliari, Italy; [Rosa, Maria Francesca; Nioi, Matteo; Demontis, Roberto; d'Aloja, Ernesto] Univ Cagliari, Dept Publ Hlth Clin & Mol Med, Forens Sci Unit, Cagliari, Italy; [Noto, Antonio] Univ Cagliari, Dept Surg, Cagliari, Italy; [De-Giorgio, Fabio] Univ Cattolica Sacro Cuore, Inst Publ Hlth, I-00168 Rome, Italy	University of Cagliari; University of Cagliari; University of Cagliari; University of Cagliari; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	d'Aloja, E (corresponding author), Univ Cagliari, Dept Publ Hlth Clin & Mol Med, Forens Sci Unit, Cagliari, Italy.	ernestodaloja@gmail.com	d'Aloja, Ernesto/P-4539-2017; demontis, roberto/AAX-7153-2020; Atzori, Luigi/A-6169-2016; Locci, Emanuela/G-6524-2018; Nioi, Matteo/V-8635-2019; Scano, Paola/ABI-5154-2020; De Giorgio, Fabio/AAB-7163-2022	d'Aloja, Ernesto/0000-0003-4456-6252; Atzori, Luigi/0000-0002-0606-4959; Locci, Emanuela/0000-0003-0237-4228; Nioi, Matteo/0000-0002-3645-6005; Scano, Paola/0000-0001-8350-8990; De Giorgio, Fabio/0000-0001-7433-0924; Noto, Antonio/0000-0003-3538-0050; Demontis, Roberto/0000-0003-2306-9767				Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; Barba I, 2010, INVEST OPHTH VIS SCI, V51, P4416, DOI 10.1167/iovs.10-5348; Bocaz-Beneventi G, 2002, INT J LEGAL MED, V116, P5, DOI 10.1007/s004140100239; Bollard ME, 2005, NMR BIOMED, V18, P143, DOI 10.1002/nbm.935; Bortolotti F, 2011, MED SCI LAW, V51, pS20, DOI 10.1258/msl.2010.010063; Chebotareva NA, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1478, DOI 10.1134/S0006297907130056; Costa JL, 2014, J CHROMATOGR B, V945, P84, DOI 10.1016/j.jchromb.2013.10.014; Croze ML, 2013, BIOCHIMIE, V95, P1811, DOI 10.1016/j.biochi.2013.05.011; DiMaio D, 2001, FORENSIC PATHOLOGY; El-Sherbeny A, 2004, INVEST OPHTH VIS SCI, V45, P694, DOI 10.1167/iovs.03-0503; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; Gomase VS, 2008, CURR DRUG METAB, V9, P89, DOI 10.2174/138920008783331149; Goodacre R, 2007, J NUTR, V137, p259S, DOI 10.1093/jn/137.1.259S; Holekamp NM, 2010, AM J OPHTHALMOL, V149, P32, DOI 10.1016/j.ajo.2009.07.036; Holekamp NM, 2005, AM J OPHTHALMOL, V139, P302, DOI 10.1016/j.ajo.2004.09.046; Howell GR, 2013, INVEST OPHTH VIS SCI, V54, P4260, DOI 10.1167/iovs.13-12479; KOLLROS PE, 1990, BRAIN RES, V511, P259, DOI 10.1016/0006-8993(90)90170-G; Langford MP, 2007, CLIN OPHTHALMOL, V1, P43; Lindon JC, 2000, CONCEPT MAGNETIC RES, V12, P289, DOI 10.1002/1099-0534(2000)12:5<289::AID-CMR3>3.0.CO;2-W; Madea B., 2013, ENCY FORENSIC SCI, P229; Osuna E, 2001, AM J FOREN MED PATH, V22, P244, DOI 10.1097/00000433-200109000-00008; Palmiere C, 2012, INT J LEGAL MED, V126, P187, DOI 10.1007/s00414-011-0625-y; Rucker JC, 2003, ARCH OPHTHALMOL-CHIC, V121, P909, DOI 10.1001/archopht.121.6.909; Scano P, 2012, MAGN RESON CHEM, V50, P436, DOI 10.1002/mrc.3819; Siegfried CJ, 2010, INVEST OPHTH VIS SCI, V51, P5731, DOI 10.1167/iovs.10-5666; Skeie JM, 2011, J VIS EXP, V47, P2447; Van de Poll MCG, 2013, ENCY HUMAN NUTR, V1, P79; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Young SP, 2009, MOL VIS, V15, P1210; Zeng KH, 2010, MOL CELL NEUROSCI, V45, P192, DOI 10.1016/j.mcn.2010.06.010	30	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97773	10.1371/journal.pone.0097773	http://dx.doi.org/10.1371/journal.pone.0097773			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845217	Green Published, gold, Green Submitted			2022-12-25	WOS:000339563400060
J	Xia, JZ; Liang, SL; Chen, JQ; Yuan, WP; Liu, SG; Li, LH; Cai, WW; Zhang, L; Fu, Y; Zhao, TB; Feng, JM; Ma, ZG; Ma, MG; Liu, SM; Zhou, GS; Asanuma, J; Chen, SP; Du, MY; Davaa, G; Kato, T; Liu, Q; Liu, SH; Li, SG; Shao, CL; Tang, YH; Zhao, X				Xia, Jiangzhou; Liang, Shunlin; Chen, Jiquan; Yuan, Wenping; Liu, Shuguang; Li, Linghao; Cai, Wenwen; Zhang, Li; Fu, Yang; Zhao, Tianbao; Feng, Jinming; Ma, Zhuguo; Ma, Mingguo; Liu, Shaomin; Zhou, Guangsheng; Asanuma, Jun; Chen, Shiping; Du, Mingyuan; Davaa, Gombo; Kato, Tomomichi; Liu, Qiang; Liu, Suhong; Li, Shenggong; Shao, Changliang; Tang, Yanhong; Zhao, Xiang			Satellite-Based Analysis of Evapotranspiration and Water Balance in the Grassland Ecosystems of Dryland East Asia	PLOS ONE			English	Article							GROSS PRIMARY PRODUCTION; NET PRIMARY PRODUCTION; MONGOLIAN PLATEAU; LAND-COVER; CLIMATE; MODIS; CHINA; PRECIPITATION; IMPROVEMENTS; DROUGHTS	The regression tree method is used to upscale evapotranspiration (ET) measurements at eddy-covariance (EC) towers to the grassland ecosystems over the Dryland East Asia (DEA). The regression tree model was driven by satellite and meteorology datasets, and explained 82% and 76% of the variations of ET observations in the calibration and validation datasets, respectively. The annual ET estimates ranged from 222.6 to 269.1 mm yr(-1) over the DEA region with an average of 245.8 mm yr(-1) from 1982 through 2009. Ecosystem ET showed decreased trends over 61% of the DEA region during this period, especially in most regions of Mongolia and eastern Inner Mongolia due to decreased precipitation. The increased ET occurred primarily in the western and southern DEA region. Over the entire study area, water balance (the difference between precipitation and ecosystem ET) decreased substantially during the summer and growing season. Precipitation reduction was an important cause for the severe water deficits. The drying trend occurring in the grassland ecosystems of the DEA region can exert profound impacts on a variety of terrestrial ecosystem processes and functions.	[Xia, Jiangzhou; Liang, Shunlin; Liu, Shaomin; Liu, Qiang; Liu, Suhong; Zhao, Xiang] Beijing Normal Univ, State Key Lab Remote Sensing Sci, Beijing, Peoples R China; [Xia, Jiangzhou; Liang, Shunlin; Liu, Shaomin; Liu, Qiang; Liu, Suhong; Zhao, Xiang] Chinese Acad Sci, State Key Lab Remote Sensing Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China; [Xia, Jiangzhou; Liang, Shunlin; Feng, Jinming; Liu, Qiang; Zhao, Xiang] Beijing Normal Univ, Coll Global Change & Earth Syst Sci, Beijing 100875, Peoples R China; [Liang, Shunlin] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Chen, Jiquan] Nanjing Univ Informat Sci & Technol, Int Ctr Ecol Meteorol & Environm IceMe, Sch Appl Meteorol, Nanjing, Jiangsu, Peoples R China; [Yuan, Wenping; Cai, Wenwen; Fu, Yang] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China; [Liu, Shuguang] Cent South Univ Forestry & Technol, State Engn Lab Southern Forestry Appl Ecol & Tech, Changsha, Hunan, Peoples R China; [Li, Linghao; Chen, Shiping; Shao, Changliang] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China; [Zhang, Li] Chinese Acad Sci, Key Lab Digital Earth Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China; [Zhao, Tianbao; Feng, Jinming; Ma, Zhuguo] Chinese Acad Sci, Inst Atmospher Phys, Key Lab Reg Climate Environm Res Temperate East A, Beijing, Peoples R China; [Ma, Mingguo] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Gansu, Peoples R China; [Liu, Shaomin; Liu, Suhong] Beijing Normal Univ, Sch Geog, Beijing 100875, Peoples R China; [Zhou, Guangsheng] Chinese Acad Meteorol Sci, Beijing, Peoples R China; [Asanuma, Jun] Univ Tsukuba, Ctr Res Isotopes & Environm Dynam, Tsukuba, Ibaraki, Japan; [Du, Mingyuan] Natl Inst Agroenvironm Sci, Dept Agrometeorol, Tsukuba, Ibaraki 305, Japan; [Davaa, Gombo] Inst Meteorol & Hydrol, Juulchin, Ulaanbaatar, Mongolia; [Kato, Tomomichi] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido, Japan; [Li, Shenggong] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China; [Tang, Yanhong] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan	Beijing Normal University; Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; Beijing Normal University; University System of Maryland; University of Maryland College Park; Nanjing University of Information Science & Technology; Beijing Normal University; Central South University of Forestry & Technology; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Beijing Normal University; Chinese Academy of Meteorological Sciences (CAMS); University of Tsukuba; National Institute for Agro-Environmental Sciences (NIAES) Japan; Ministry of Nature Environment &Tourism Mongolia; Hokkaido University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; National Institute for Environmental Studies - Japan	Liang, SL (corresponding author), Beijing Normal Univ, State Key Lab Remote Sensing Sci, Beijing, Peoples R China.; Liang, SL (corresponding author), Chinese Acad Sci, State Key Lab Remote Sensing Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China.	sliang@umd.edu; yuanwpcn@126.com	Du, Mingyuan/AAE-3019-2020; Mingguo, Ma/A-8087-2013; shao, changliang/ACG-3396-2022; Du, Mingyuan/O-9951-2018; Chen, Jiquan/D-1955-2009; Liu, Qiang/HHZ-3181-2022; Kato, Tomomichi/X-7390-2019; liang, shunlin/C-2809-2015; Tang, Yanhong/B-1699-2010; Zhao, Tianbao/I-4890-2015; Kato, Tomomichi/F-7766-2010; Chen, Shiping/AAH-9751-2019; Asanuma, J/A-2877-2008; Li, Sheng-Gong/H-5101-2012	Du, Mingyuan/0000-0003-0373-1661; Du, Mingyuan/0000-0003-0373-1661; Kato, Tomomichi/0000-0003-3757-3243; Tang, Yanhong/0000-0001-7207-1965; Zhao, Tianbao/0000-0002-8295-6537; Kato, Tomomichi/0000-0003-3757-3243; Asanuma, J/0000-0003-1258-5491; Li, Sheng-Gong/0000-0003-4889-9927; Chen, Jiquan/0000-0003-0761-9458; XU, TONGREN/0000-0002-1744-8974; Liu, Shaomin/0000-0003-3627-9288	National High-Technology Research and Development Program of China [2013AA122800]; Freedom Project of the State Key Laboratory of Cryospheric Sciences [SKLCS-ZZ-2013-2-2]; Chinese Academy of Sciences; National Science Foundation for Excellent Young Scholars of China [41322005]; Program for New Century Excellent Talents in University [NCET-12-0060]; NASA-NEWS Program [NN-H-04-Z-YS-005-N]; Cold and Arid Regions Environmental and Engineering Research Institute	National High-Technology Research and Development Program of China(National High Technology Research and Development Program of China); Freedom Project of the State Key Laboratory of Cryospheric Sciences; Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation for Excellent Young Scholars of China; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); NASA-NEWS Program; Cold and Arid Regions Environmental and Engineering Research Institute(Chinese Academy of Sciences)	This study was supported by the National High-Technology Research and Development Program of China (2013AA122800), the Freedom Project (No. SKLCS-ZZ-2013-2-2) of the State Key Laboratory of Cryospheric Sciences, Cold and Arid Regions Environmental and Engineering Research Institute, the Chinese Academy of Sciences, the National Science Foundation for Excellent Young Scholars of China (41322005), Program for New Century Excellent Talents in University (NCET-12-0060) and NASA-NEWS Program (NN-H-04-Z-YS-005-N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; [Anonymous], 2010, J GEOPHYS RES-ATMOS, DOI DOI 10.1029/2010JD013847; Chen JQ, 2013, DRYLAND E ASIA DEA L, P3; Chen Y, 2014, REMOTE SENS ENVIRON, V140, P279, DOI 10.1016/j.rse.2013.08.045; Cong ZT, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR006852; Fisher JB, 2008, REMOTE SENS ENVIRON, V112, P901, DOI 10.1016/j.rse.2007.06.025; Foken T, 2008, ECOL APPL, V18, P1351, DOI 10.1890/06-0922.1; Garcia M, 2013, REMOTE SENS ENVIRON, V131, P103, DOI 10.1016/j.rse.2012.12.016; Global Modeling and Assimilation Office, 2004, REPORT; Henebry GM, 2013, DRYLAND E ASIA LAND, DOI DOI 10.1515/9783110287912.23; HOLBEN BN, 1986, INT J REMOTE SENS, V7, P1417, DOI 10.1080/01431168608948945; Huang C, 2003, INT J REMOTE SENS, V24, P75, DOI 10.1080/01431160305001; John R, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/035033; John R, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/045010; Jung M, 2010, NATURE, V467, P951, DOI 10.1038/nature09396; Kim HW, 2012, KSCE J CIV ENG, V16, P229, DOI 10.1007/s12205-012-0006-1; Li MX, 2011, CHINESE SCI BULL, V56; Li SG, 2007, J HYDROL, V333, P133, DOI 10.1016/j.jhydrol.2006.07.021; Liu YL, 2013, GLOBAL PLANET CHANGE, V108, P85, DOI 10.1016/j.gloplacha.2013.06.008; Lu N, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/045006; McVicar TR, 2012, J HYDROL, V416, P182, DOI 10.1016/j.jhydrol.2011.10.024; Morillas L, 2013, WATER RESOUR RES, V49, P6572, DOI 10.1002/wrcr.20468; Mu QZ, 2011, REMOTE SENS ENVIRON, V115, P1781, DOI 10.1016/j.rse.2011.02.019; Mueller B, 2013, HYDROL EARTH SYST SC, V17, P3707, DOI 10.5194/hess-17-3707-2013; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Qi JG, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/015202; Qian W, 2003, CLIM DYNAM, V21, P77, DOI 10.1007/s00382-003-0319-3; Shi YF, 2007, CLIMATIC CHANGE, V80, P379, DOI 10.1007/s10584-006-9121-7; [施雅风 Shi Yafeng], 2003, [第四纪研究, Quaternary Sciences], V23, P152; Shi YF, 1989, PHYS GEOGRAPHY INNER; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sun G, 2013, DRYLAND E ASIA LAND, P153; Sun G, 2011, ECOHYDROLOGY, V4, P245, DOI 10.1002/eco.194; Vinukollu RK, 2011, REMOTE SENS ENVIRON, V115, P801, DOI 10.1016/j.rse.2010.11.006; Wang Z.W., 2003, ACTA GEOGR SIN, V58, P61; Xiao JF, 2009, EARTH INTERACT, V13, DOI 10.1175/2009EI275.1; Xiao JF, 2008, AGR FOREST METEOROL, V148, P1827, DOI 10.1016/j.agrformet.2008.06.015; Xin XG, 2006, J CLIMATE, V19, P3197, DOI 10.1175/JCLI3794.1; Yu FF, 2003, REMOTE SENS ENVIRON, V87, P42, DOI 10.1016/S0034-4257(03)00144-5; Yuan WP, 2007, AGR FOREST METEOROL, V143, P189, DOI 10.1016/j.agrformet.2006.12.001; Yuan WP, 2012, WATER RESOUR MANAG, V26, P2147, DOI 10.1007/s11269-012-0007-3; Yuan WP, 2010, REMOTE SENS ENVIRON, V114, P1416, DOI 10.1016/j.rse.2010.01.022; Yuan WP, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008119; Zhai JQ, 2010, J CLIMATE, V23, P649, DOI 10.1175/2009JCLI2968.1; Zhang K, 2009, J HYDROL, V379, P92, DOI 10.1016/j.jhydrol.2009.09.047; Zhang K, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000621; Zhang L, 2007, REMOTE SENS ENVIRON, V106, P173, DOI 10.1016/j.rse.2006.08.012; Zhang L, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001504; Zhang Q, 2009, THEOR APPL CLIMATOL, V95, P53, DOI 10.1007/s00704-007-0375-4; Zhao MS, 2005, REMOTE SENS ENVIRON, V95, P164, DOI 10.1016/j.rse.2004.12.011; Zou XK, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021853	51	21	22	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97295	10.1371/journal.pone.0097295	http://dx.doi.org/10.1371/journal.pone.0097295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845063	gold, Green Published			2022-12-25	WOS:000339563400018
J	Gibbons, SM; Jones, E; Bearquiver, A; Blackwolf, F; Roundstone, W; Scott, N; Hooker, J; Madsen, R; Coleman, ML; Gilbert, JA				Gibbons, Sean M.; Jones, Edwin; Bearquiver, Angelita; Blackwolf, Frederick; Roundstone, Wayne; Scott, Nicole; Hooker, Jeff; Madsen, Robert; Coleman, Maureen L.; Gilbert, Jack A.			Human and Environmental Impacts on River Sediment Microbial Communities	PLOS ONE			English	Article							HYPORHEIC-ZONE; BACTERIAL PRODUCTION; SEASONAL DYNAMICS; MAGNITUDE; DIVERSITY; SEQUENCES; ECOSYSTEM; GENES	Sediment microbial communities are responsible for a majority of the metabolic activity in river and stream ecosystems. Understanding the dynamics in community structure and function across freshwater environments will help us to predict how these ecosystems will change in response to human land-use practices. Here we present a spatiotemporal study of sediments in the Tongue River (Montana, USA), comprising six sites along 134 km of river sampled in both spring and fall for two years. Sequencing of 16S rRNA amplicons and shotgun metagenomes revealed that these sediments are the richest (similar to 65,000 microbial 'species' identified) and most novel (93% of OTUs do not match known microbial diversity) ecosystems analyzed by the Earth Microbiome Project to date, and display more functional diversity than was detected in a recent review of global soil metagenomes. Community structure and functional potential have been significantly altered by anthropogenic drivers, including increased pathogenicity and antibiotic metabolism markers near towns and metabolic signatures of coal and coalbed methane extraction byproducts. The core (OTUs shared across all samples) and the overall microbial community exhibited highly similar structure, and phylogeny was weakly coupled with functional potential. Together, these results suggest that microbial community structure is shaped by environmental drivers and niche filtering, though stochastic assembly processes likely play a role as well. These results indicate that sediment microbial communities are highly complex and sensitive to changes in land use practices.	[Gibbons, Sean M.; Gilbert, Jack A.] Univ Chicago, Grad Program Biophys Sci, Chicago, IL 60637 USA; [Gibbons, Sean M.; Scott, Nicole; Gilbert, Jack A.] Argonne Natl Lab, Inst Genom & Syst Biol, Lemont, IL USA; [Gibbons, Sean M.; Jones, Edwin; Bearquiver, Angelita; Blackwolf, Frederick; Roundstone, Wayne; Hooker, Jeff; Madsen, Robert] Chief Dull Knife Coll, Dept Biol, Lame Deer, MT USA; [Coleman, Maureen L.] Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; [Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; University of Chicago	Gilbert, JA (corresponding author), Univ Chicago, Grad Program Biophys Sci, Chicago, IL 60637 USA.	gilbertjack@anl.gov	Gibbons, Sean M./ABH-2562-2020; Gilbert, Jack/AAF-3270-2019	Gibbons, Sean M./0000-0002-8724-7916; Coleman, Maureen/0000-0001-5065-0106	U.S. Department of Energy [DE-AC02-06CH11357]; National Science Foundation EPSCoR; U.S. Nuclear Regulatory Commission [NRC-27-10-1124]; EPA STAR Graduate Fellowship; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009412] Funding Source: NIH RePORTER	U.S. Department of Energy(United States Department of Energy (DOE)); National Science Foundation EPSCoR(National Science Foundation (NSF)); U.S. Nuclear Regulatory Commission; EPA STAR Graduate Fellowship(United States Environmental Protection Agency); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported in part by the U.S. Department of Energy under Contract DE-AC02-06CH11357, by National Science Foundation EPSCoR funds, and by the U.S. Nuclear Regulatory Commission under the grant number NRC-27-10-1124. S.M.G. was supported by an EPA STAR Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Craft JA, 2002, FRESHWATER BIOL, V47, P251, DOI 10.1046/j.1365-2427.2002.00803.x; Darby J, 2009, SPE E REG M; Dionisi HM, 2004, APPL ENVIRON MICROB, V70, P3988, DOI 10.1128/AEM.70.7.3988-3995.2004; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engel AS, 2010, ISME J, V4, P98, DOI 10.1038/ismej.2009.91; Faris KP, 2009, ENVIRON SCI TECHNOL, V43, P6158, DOI 10.1021/es9005465; Feris KP, 2004, APPL ENVIRON MICROB, V70, P2323, DOI 10.1128/AEM.70.4.2323-2331.2004; Feris KP, 2003, MICROB ECOL, V46, P200, DOI 10.1007/s00248-002-0003-x; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Fischer H, 2001, FRESHWATER BIOL, V46, P1335, DOI 10.1046/j.1365-2427.2001.00753.x; Ghai R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023785; Gibbons SM, 2013, P NATL ACAD SCI USA, V110, P4651, DOI 10.1073/pnas.1217767110; Glass E.M., 2010, COLD SPRING HARB PRO, V2010, DOI DOI 10.1101/PDB.PROT5368; Glass EM, 2011, METAGENOMICS COMPLEM, V8, P325, DOI [10.1002/9781118010518.CH37, DOI 10.1002/9781118010518.CH37, 10.1002/9781118010518.ch37]; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Heffern EL, 2004, INT J COAL GEOL, V59, P25, DOI 10.1016/j.coal.2003.07.002; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038; Larsen PE, 2012, FEMS MICROBIOL LETT, V332, P91, DOI 10.1111/j.1574-6968.2012.02588.x; Larsen Peter E, 2011, Microb Inform Exp, V1, P4, DOI 10.1186/2042-5783-1-4; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Logue JB, 2008, BIOSCIENCE, V58, P103, DOI 10.1641/B580205; Loy A, 2005, APPL ENVIRON MICROB, V71, P1373, DOI 10.1128/AEM.71.3.1373-1386.2005; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; MADSEN EL, 1992, MICROB ECOL, V24, P199, DOI 10.1007/BF00174455; Martiny AC, 2013, ISME J, V7, P830, DOI 10.1038/ismej.2012.160; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Naegeli MW, 1997, J N AM BENTHOL SOC, V16, P794, DOI 10.2307/1468172; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pernthaler J, 2013, FRESHWATER MICROBIAL, P97; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pusch M, 1998, FRESHWATER BIOL, V40, P453, DOI 10.1046/j.1365-2427.1998.00372.x; Pusch M, 1997, GROUNDWATER SURFACE; R Core Development Team, 2008, R LANG ENV STAT COMP; Ramsey PW, 2005, ECOL LETT, V8, P1201, DOI 10.1111/j.1461-0248.2005.00821.x; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; VAQUE D, 1992, MAR ECOL PROG SER, V89, P155, DOI 10.3354/meps089155; Waidner LA, 2005, ENVIRON MICROBIOL, V7, P1896, DOI 10.1111/j.1462-2920.2005.00883.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wu C, 2009, J MICROBIOL BIOTECHN, V19, P187, DOI 10.4014/jmb.0804.292; Zeglin LH, 2011, MICROB ECOL, V61, P543, DOI 10.1007/s00248-010-9782-7	46	97	107	6	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97435	10.1371/journal.pone.0097435	http://dx.doi.org/10.1371/journal.pone.0097435			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841417	Green Submitted, gold, Green Published			2022-12-25	WOS:000340948600032
J	Merkestein, M; McTaggart, JS; Lee, S; Kramer, HB; McMurray, F; Lafond, M; Boutens, L; Cox, R; Ashcroft, FM				Merkestein, Myrte; McTaggart, James S.; Lee, Sheena; Kramer, Holger B.; McMurray, Fiona; Lafond, Mathilde; Boutens, Lily; Cox, Roger; Ashcroft, Frances M.			Changes in Gene Expression Associated with FTO Overexpression in Mice	PLOS ONE			English	Article							ADIPOSE-SPECIFIC PROTEIN; OBESITY-ASSOCIATED FTO; DIET-INDUCED OBESITY; MESSENGER-RNA; NUCLEAR-RNA; S-ADENOSYLMETHIONINE; ENERGY-INTAKE; ADIPONECTIN; METHYLATION; N6-METHYLADENOSINE	Single nucleotide polymorphisms in the first intron of the fat-mass-and-obesity-related gene FTO are associated with increased body weight and adiposity. Increased expression of FTO is likely underlying this obesity phenotype, as mice with two additional copies of Fto (FTO-4 mice) exhibit increased adiposity and are hyperphagic. FTO is a demethylase of single stranded DNA and RNA, and one of its targets is the m6A modification in RNA, which might play a role in the regulation of gene expression. In this study, we aimed to examine the changes in gene expression that occur in FTO-4 mice in order to gain more insight into the underlying mechanisms by which FTO influences body weight and adiposity. Our results indicate an upregulation of anabolic pathways and a downregulation of catabolic pathways in FTO-4 mice. Interestingly, although genes involved in methylation were differentially regulated in skeletal muscle of FTO-4 mice, no effect of FTO overexpression on m6A methylation of total mRNA was detected.	[Merkestein, Myrte; McTaggart, James S.; Lee, Sheena; Kramer, Holger B.; Lafond, Mathilde; Boutens, Lily; Ashcroft, Frances M.] Univ Oxford, Dept Physiol, Henry Wellcome Ctr Gene Funct, Oxford, England; [McMurray, Fiona; Cox, Roger] Med Res Council Harwell, Mammalian Genet Unit, Oxford, England	University of Oxford; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Ashcroft, FM (corresponding author), Univ Oxford, Dept Physiol, Henry Wellcome Ctr Gene Funct, Parks Rd, Oxford, England.	frances.ashcroft@dpag.ox.ac.uk	Kramer, Holger/AAL-4433-2020	Kramer, Holger/0000-0002-6400-0945; Cox, Roger/0000-0001-7170-5014; McMurray, Fiona/0000-0003-4147-5064	Wellcome Trust [884655, 089795]; Medical Research Council; Royal Society Research Wolfson Merit Award; Medical Research Council [MC_U142661184] Funding Source: researchfish; MRC [MC_U142661184] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society Research Wolfson Merit Award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Wellcome Trust (grants no 884655 and 089795) and the Medical Research Council (RDC, and MRC studentships held by JST and FM). FMA held a Royal Society Research Wolfson Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONI Y, 1979, J VIROL, V32, P52, DOI 10.1128/JVI.32.1.52-60.1979; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Berulava T, 2012, EUR J HUM GENET; Berulava T, 2010, EUR J HUM GENET, V18, P1054, DOI 10.1038/ejhg.2010.71; Bravard A, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-4; Bravard A, 2011, DIABETES, V60, P258, DOI 10.2337/db10-0281; Bullen JW, 2007, AM J PHYSIOL-ENDOC M, V292, pE1079, DOI 10.1152/ajpendo.00245.2006; CAMPER SA, 1984, MOL CELL BIOL, V4, P538, DOI 10.1128/MCB.4.3.538; CANAANI D, 1979, NUCLEIC ACIDS RES, V6, P2879, DOI 10.1093/nar/6.8.2879; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; CHENKIANG S, 1979, J MOL BIOL, V135, P733, DOI 10.1016/0022-2836(79)90174-8; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Delerive P, 2002, J BIOL CHEM, V277, P3913, DOI 10.1074/jbc.M109409200; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; FINKEL D, 1983, VIROLOGY, V131, P409, DOI 10.1016/0042-6822(83)90508-1; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gao X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014005; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Giller K, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0101; Hess ME, 2013, NAT NEUROSCI, V16, P1042, DOI 10.1038/nn.3449; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hui XY, 2009, J BIOL CHEM, V284, P14050, DOI 10.1074/jbc.M109.001107; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Karra E, 2013, J CLIN INVEST, V123, P3539, DOI 10.1172/JCI44403; Khemawoot P, 2007, BIOCHEM PHARMACOL, V73, P155, DOI 10.1016/j.bcp.2006.09.006; Kumar KG, 2007, AM J PHYSIOL-REG I, V292, pR207, DOI 10.1152/ajpregu.00491.2006; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Loos RJ, 2013, NAT REV ENDOCRINOL; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; McMurray F, 2012, PLOS GENET; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Mulligan MK, 2008, GENES BRAIN BEHAV, V7, P677, DOI 10.1111/j.1601-183X.2008.00405.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Qiao LP, 2011, AM J PHYSIOL-ENDOC M, V300, pE809, DOI 10.1152/ajpendo.00004.2011; Ridley SH, 2001, J CELL SCI, V114, P3991; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shehzad A, 2012, HORM-INT J ENDOCRINO, V11, P8, DOI 10.1007/BF03401534; STOLTZFUS CM, 1982, J VIROL, V42, P918, DOI 10.1128/JVI.42.3.918-931.1982; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; TUCK MT, 1992, INT J BIOCHEM, V24, P379, DOI 10.1016/0020-711X(92)90028-Y; TUCK MT, 1992, BIOCHEM J, V288, P233, DOI 10.1042/bj2880233; Tuck MT, 1999, INT J BIOCHEM CELL B, V31, P837, DOI 10.1016/S1357-2725(99)00041-2; Turyn J, 2008, MOL CELL BIOCHEM, V312, P185, DOI 10.1007/s11010-008-9733-5; van Schothorst EM, 2006, OBESITY, V14, P974, DOI 10.1038/oby.2006.111; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang P, 2011, MOL MED, V17, P523, DOI [10.2119/molmed.2010.000134, 10.2119/molmed.2010.00134]; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wu Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-397; Zhou YJ, 2010, VITAM HORM, V83, P151, DOI 10.1016/S0083-6729(10)83006-7; Zhou YJ, 2009, J BIOL CHEM, V284, P11152, DOI 10.1074/jbc.M900754200; Zong HH, 2012, AM J PHYSIOL-ENDOC M, V302, pE532, DOI 10.1152/ajpendo.00258.2011	57	22	22	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97162	10.1371/journal.pone.0097162	http://dx.doi.org/10.1371/journal.pone.0097162			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842286	gold, Green Submitted, Green Published			2022-12-25	WOS:000340948600018
J	Sun, FB; Yin, Z; Lun, XX; Zhao, Y; Li, RN; Shi, FT; Yu, XX				Sun, Fengbin; Yin, Zhe; Lun, Xiaoxiu; Zhao, Yang; Li, Renna; Shi, Fangtian; Yu, Xinxiao			Deposition Velocity of PM2.5 in the Winter and Spring above Deciduous and Coniferous Forests in Beijing, China	PLOS ONE			English	Article							OZONE DRY DEPOSITION; SULFUR-DIOXIDE; PARTICLE DEPOSITION; SHORT VEGETATION; TROPICAL FOREST; FLUX; SO2; SULFATE; CANOPY; SEASON	To estimate the deposition effect of PM2.5 (particle matter with aerodynamic diameter <2.5 mu m) in forests in northern China, we used the gradient method to measure the deposition velocity of PM2.5 during the winter and spring above a deciduous forest in Olympic Forest Park and above a coniferous forest in Jiufeng National Forest Park. Six aerosol samplers were placed on two towers at each site at heights of 9, 12 and 15 m above the ground surface. The sample filters were exchanged every four hours at 6: 00 AM, 10: 00 AM, 2: 00 PM, 6: 00 PM, 10: 00 PM, and 2: 00 AM. The daytime and nighttime deposition velocities in Jiufeng Park and Olympic Park were compared in this study. The February deposition velocities in Jiufeng Park were 1.2 +/- 1.3 and 0.7 +/- 0.7 cm s(-1) during the day and night, respectively. The May deposition velocities in Olympic Park were 0.9 +/- 0.8 and 0.4 +/- 0.5 cm s(-1) during the day and night, respectively. The May deposition velocities in Jiufeng Park were 1.1 +/- 1.2 and 0.6 +/- 0.5 cm s(-1) during the day and night, respectively. The deposition velocities above Jiufeng National Forest Park were higher than those above Olympic Forest Park. The measured values were smaller than the simulated values obtained by the Ruijgrok et al. (1997) and Wesely et al. (1985) models. However, the reproducibility of the Ruijgrok et al. (1997) model was better than that of the Wesely et al. (1985) model. The Hicks et al. (1977) model was used to analyze additional forest parameters to calculate the PM2.5 deposition, which could better reflect the role of the forest in PM2.5 deposition. [GRAPHICS] .							Forestry Public Welfare Project of China [20130430104]; CFERN & GENE Award Funds on Ecological Paper; Beijing Forestry University	Forestry Public Welfare Project of China; CFERN & GENE Award Funds on Ecological Paper; Beijing Forestry University	This research was financially supported by grant No. 20130430104 from the Forestry Public Welfare Project of China as well as the CFERN & GENE Award Funds on Ecological Paper. Further funding was also provided by Beijing Forestry University for preparing this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beijing Development and Reforming Office, 2012, BEIJ 12 5 FORM EN PL; Beijing Transportation Research Center, 2006, BEIJ TRANSP ANN REP, P32; Chen JR, 2013, CHINA ENERGY, V35, P5; Cheng Z., 2004, J CHINESE URBAN FORE, V2, P37; DUYZER J, 1995, STUD ENVIRON SCI, V64, P21; ELSHOUT AJ, 1978, ATMOS ENVIRON, V12, P785, DOI 10.1016/0004-6981(78)90260-3; Erisman J.W., 1995, STUDIES ENV SCI, V63, P55; Erisman JW, 1997, ATMOS ENVIRON, V31, P321, DOI 10.1016/S1352-2310(96)00223-3; Feliciano MS, 2001, ATMOS ENVIRON, V35, P3633, DOI 10.1016/S1352-2310(00)00539-2; Fumo Yang, 2002, Journal of Tsinghua University (Science and Technology), V42, P1605; Grace J., 1983, PLANT ATMOSPHERE REL; Guo P, 2009, J ANHUI AGR SCI, V37, P11236; Hayashi K, 2009, WATER AIR SOIL POLL, V200, P33, DOI 10.1007/s11270-008-9891-9; Horvath L, 2003, ATMOS ENVIRON, V37, P4419, DOI 10.1016/S1352-2310(03)00584-3; Lamaud E, 2002, ATMOS ENVIRON, V36, P77, DOI 10.1016/S1352-2310(01)00468-X; Matsuda K, 2005, ATMOS ENVIRON, V39, P2571, DOI 10.1016/j.atmosenv.2005.01.011; MATSUDA K, 2007, J JAPAN SOC ATMOSPHE, V42, P261; MATSUDA K, 2002, J JAPAN SOC ATMOSPHE, V37, P387; Matsuda K, 2006, ATMOS ENVIRON, V40, P7557, DOI 10.1016/j.atmosenv.2006.07.003; Matsuda K, 2010, ATMOS ENVIRON, V44, P4582, DOI 10.1016/j.atmosenv.2010.08.015; Ministry of Agriculture of the People's Republic of China, 2006, STAT DAT NAT RUR REN; National Bureau of Statistics of China, 2007, CHIN EN STAT YB; Parkin CS, 1987, P S AER APPL PEST FO, P69; Ruijgrok W, 1997, ATMOS ENVIRON, V31, P399, DOI 10.1016/S1352-2310(96)00089-1; Schindlbacher A, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004590; SLINN WGN, 1982, ATMOS ENVIRON, V16, P1785, DOI 10.1016/0004-6981(82)90271-2; Sorimachi A, 2004, ENVIRON SCI TECHNOL, V38, P3396, DOI 10.1021/es034967p; Sorimachi A, 2003, ATMOS ENVIRON, V37, P3157, DOI 10.1016/S1352-2310(03)00180-8; Tai APK, 2010, ATMOS ENVIRON, V44, P3976, DOI 10.1016/j.atmosenv.2010.06.060; TAKAHASHI A, 2002, J JAPAN SOC ATMOSPHE, V37, P192; The state Department of Environmental Protection, 2012, GB30952012 STAT DEP; Tsai JL, 2010, ATMOS ENVIRON, V44, P1011, DOI 10.1016/j.atmosenv.2009.12.022; WESELY ML, 1985, J GEOPHYS RES-ATMOS, V90, P2131, DOI 10.1029/JD090iD01p02131; WESELY ML, 1977, JAPCA J AIR WASTE MA, V27, P1110, DOI 10.1080/00022470.1977.10470534; WILLIAMS EJ, 1992, J GEOPHYS RES-ATMOS, V97, P7511, DOI 10.1029/92JD00412; Wyers GP, 1997, ATMOS ENVIRON, V31, P333, DOI 10.1016/S1352-2310(96)00188-4; Xu J, 2006, J SAFETY ENV, V6, P79; [杨复沫 Yang Fumo], 2002, [中国环境科学, China Environmental Science], V22, P506; YANG Hao-ming, 2011, ENV SCI TECHNOLOGY C, V24, P98; Zhou ZR, 2009, RENEW SUST ENERG REV, V13, P187, DOI 10.1016/j.rser.2007.05.006	40	37	44	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97723	10.1371/journal.pone.0097723	http://dx.doi.org/10.1371/journal.pone.0097723			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842850	gold, Green Submitted, Green Published			2022-12-25	WOS:000340948600063
J	Esteva-Font, C; Cil, O; Phuan, PW; Su, T; Lee, S; Anderson, MO; Verkman, AS				Esteva-Font, Cristina; Cil, Onur; Phuan, Puay-Wah; Su, Tao; Lee, Sujin; Anderson, Marc O.; Verkman, A. S.			Diuresis and reduced urinary osmolality in rats produced by small-molecule UT-A-selective urea transport inhibitors	FASEB JOURNAL			English	Article						kidney; diuretic; drug discovery	CONCENTRATING DEFECT; CONFORMER GENERATION; NANOMOLAR POTENCY; MICE LACKING; PROTEIN; FAMILY; KIDNEY; MODEL; PERFORMANCE; PHYSIOLOGY	Urea transport (UT) proteins of the UT-A class are expressed in epithelial cells in kidney tubules, where they are required for the formation of a concentrated urine by countercurrent multiplication. Here, using a recently developed high-throughput assay to identify UT-A inhibitors, a screen of 50,000 synthetic small molecules identified UT-A inhibitors of aryl-thiazole, gamma-sultambenzosulfonamide, aminocarbonitrile butene, and 4-isoxazolamide chemical classes. Structure-activity analysis identified compounds that inhibited UT-A selectively by a noncompetitive mechanism with IC50 down to similar to 1 mu M. Molecular modeling identified putative inhibitor binding sites on rat UT-A. To test compound efficacy in rats, formulations and administration procedures were established to give therapeutic inhibitor concentrations in blood and urine. We found that intravenous administration of an indole thiazole or a gamma-sultambenzosulfonamide at 20 mg/kg increased urine output by 3-5-fold and reduced urine osmolality by similar to 2-fold compared to vehicle control rats, even under conditions of maximum antidiuresis produced by 1-deamino-8-D-arginine vasopressin (DDAVP). The diuresis was reversible and showed urea > salt excretion. The results provide proof of concept for the diuretic action of UT-A-selective inhibitors. UT-A inhibitors are first in their class salt-sparing diuretics with potential clinical indications in volume-overload edemas and high-vasopressin- associated hyponatremias.	[Esteva-Font, Cristina; Cil, Onur; Phuan, Puay-Wah; Su, Tao; Lee, Sujin; Verkman, A. S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Esteva-Font, Cristina; Cil, Onur; Phuan, Puay-Wah; Su, Tao; Lee, Sujin; Verkman, A. S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Anderson, Marc O.] San Francisco State Univ, Dept Chem & Biochem, San Francisco, CA 94132 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; California State University System; San Francisco State University	Verkman, AS (corresponding author), Univ Calif San Francisco, Dept Med, 1246 Hlth Sci East Tower, San Francisco, CA 94143 USA.	alan.verkman@ucsf.edu	Su, Tao/T-4411-2019; Cil, Onur/AAK-5166-2020	Su, Tao/0000-0002-9148-6127; Cil, Onur/0000-0001-5178-0199; Lee, Sujin/0000-0001-6701-1730	U.S. National Institutes of Health [DK101373, DK35124, DK72517, EB00415, EY13574]; Fulbright Program; Hacettepe University (Ankara, Turkey) Scientific Recearch Unit [BAB6091]; Ministry of Education, Culture, and Sports of Spain; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000415, R37EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK035124, P30DK072517, R01DK101373, R01DK035124] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fulbright Program; Hacettepe University (Ankara, Turkey) Scientific Recearch Unit; Ministry of Education, Culture, and Sports of Spain; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants DK101373, DK35124, DK72517, EB00415, and EY13574 from the U.S. National Institutes of Health (A. S. V.), a grant from the Fulbright Program and the Ministry of Education, Culture, and Sports of Spain (C. E-F.), and grant BAB6091 from the Hacettepe University (Ankara, Turkey) Scientific Recearch Unit (O. C.). The authors acknowledge OpenEye Scientific (Santa Fe, NM, USA) for its Academic Site License program.	Anderson MO, 2012, J MED CHEM, V55, P5942, DOI 10.1021/jm300491y; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bagnasco SM, 2003, AM J PHYSIOL-RENAL, V284, pF3, DOI 10.1152/ajprenal.00260.2002; Bankir L, 2012, KIDNEY INT, V81, P1179, DOI 10.1038/ki.2012.67; Bondock S, 2013, EUR J MED CHEM, V62, P270, DOI 10.1016/j.ejmech.2012.12.050; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Cil O, 2012, HUM EXP TOXICOL, V31, P1050, DOI 10.1177/0960327112459205; Denton JS, 2013, AM J PHYSIOL-RENAL, V305, pF931, DOI 10.1152/ajprenal.00230.2013; Diana P, 2011, CHEMMEDCHEM, V6, P1300, DOI 10.1002/cmdc.201100078; Doran JJ, 2006, AM J PHYSIOL-REG I, V290, pR1446, DOI 10.1152/ajpregu.00352.2004; Esteva-Font C, 2013, CHEM BIOL, V20, P1235, DOI 10.1016/j.chembiol.2013.08.005; Fenton RA, 2005, J AM SOC NEPHROL, V16, P1583, DOI 10.1681/ASN.2005010031; Fenton RA, 2004, P NATL ACAD SCI USA, V101, P7469, DOI 10.1073/pnas.0401704101; Fenton RA, 2002, AM J PHYSIOL-RENAL, V283, pF817, DOI 10.1152/ajprenal.00263.2001; Fenton RA, 2008, CURR OPIN NEPHROL HY, V17, P513, DOI 10.1097/MNH.0b013e3283050969; Fenton RA, 2009, PFLUG ARCH EUR J PHY, V458, P169, DOI 10.1007/s00424-008-0612-4; Frohlich O, 2006, AM J PHYSIOL-CELL PH, V291, pC600, DOI 10.1152/ajpcell.00413.2005; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hawkins PCD, 2012, J CHEM INF MODEL, V52, P2919, DOI 10.1021/ci300314k; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Klein JD, 2013, FASEB J, V27; Klein JD, 2012, PFLUG ARCH EUR J PHY, V464, P561, DOI 10.1007/s00424-012-1157-0; Knepper MA, 2013, KIDNEY INT, V83, P991, DOI 10.1038/ki.2013.94; Lei TL, 2011, AM J PHYSIOL-RENAL, V301, pF1251, DOI 10.1152/ajprenal.00404.2011; Levin EJ, 2012, P NATL ACAD SCI USA, V109, P11194, DOI 10.1073/pnas.1207362109; Levin MH, 2007, FASEB J, V21, P551, DOI 10.1096/fj.06-6979com; Li F, 2013, KIDNEY INT, V83, P1076, DOI 10.1038/ki.2013.62; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu Y, 2013, BIOORG MED CHEM LETT, V23, P3338, DOI 10.1016/j.bmcl.2013.03.089; Lucien N, 1998, J BIOL CHEM, V273, P12973, DOI 10.1074/jbc.273.21.12973; MAYRAND RR, 1983, J GEN PHYSIOL, V81, P221, DOI 10.1085/jgp.81.2.221; McGann M, 2012, J COMPUT AID MOL DES, V26, P897, DOI 10.1007/s10822-012-9584-8; Pannabecker TL, 2013, AM J PHYSIOL-REG I, V304, pR488, DOI 10.1152/ajpregu.00456.2012; Ren JX, 2011, J CHEM INF MODEL, V51, P1364, DOI 10.1021/ci100464b; Sands JM, 2007, J AM SOC NEPHROL, V18, P670, DOI 10.1681/ASN.2006121314; Sands JM, 2014, ANNU REV PHYSIOL, V76, P387, DOI 10.1146/annurev-physiol-021113-170350; Sands JM, 2013, CHEM BIOL, V20, P1201, DOI 10.1016/j.chembiol.2013.10.003; Sands JM, 2009, SEMIN NEPHROL, V29, P178, DOI 10.1016/j.semnephrol.2009.03.008; SANDS JM, 1992, J AM SOC NEPHROL, V2, P1689; Sands JM, 2004, CURR OPIN NEPHROL HY, V13, P525, DOI 10.1097/00041552-200409000-00008; Shayakul C, 2004, PFLUG ARCH EUR J PHY, V447, P603, DOI 10.1007/s00424-003-1124-x; Shayakul C, 2013, MOL ASPECTS MED, V34, P313, DOI 10.1016/j.mam.2012.12.003; Smith CP, 2009, EXP PHYSIOL, V94, P180, DOI 10.1113/expphysiol.2008.043042; Snyder DS, 2011, J MED CHEM, V54, P5468, DOI 10.1021/jm200505e; Stewart G, 2011, BRIT J PHARMACOL, V164, P1780, DOI 10.1111/j.1476-5381.2011.01377.x; Uchida S, 2005, MOL CELL BIOL, V25, P7357, DOI 10.1128/MCB.25.16.7357-7363.2005; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Yang B, 2002, J BIOL CHEM, V277, P10633, DOI 10.1074/jbc.M200207200; Yao CJ, 2012, J AM SOC NEPHROL, V23, P1210, DOI 10.1681/ASN.2011070751	50	17	22	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2014	28	9					3878	3890		10.1096/fj.14-253872	http://dx.doi.org/10.1096/fj.14-253872			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN8HU	24843071	Green Published			2022-12-25	WOS:000340845900007
J	Lama, S; Auer, RN; Tyson, R; Gallagher, CN; Tomanek, B; Sutherland, GR				Lama, Sanju; Auer, Roland N.; Tyson, Randy; Gallagher, Clare N.; Tomanek, Boguslaw; Sutherland, Garnette R.			Lactate Storm Marks Cerebral Metabolism following Brain Trauma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICARBOXYLIC-ACID CYCLE; OXIDATIVE STRESS; C-13 NMR; COGNITIVE DEFICITS; GLUCOSE-METABOLISM; SUBSTRATE DELIVERY; GLUTAMATE UPTAKE; INJURY; MICRODIALYSIS; ASTROCYTES	Brain metabolism is thought to be maintained by neuronalglial metabolic coupling. Glia take up glutamate from the synaptic cleft for conversion into glutamine, triggering glial glycolysis and lactate production. This lactate is shuttled into neurons and further metabolized. The origin and role of lactate in severe traumatic brain injury (TBI) remains controversial. Using a modified weight drop model of severe TBI and magnetic resonance (MR) spectroscopy with infusion of C-13-labeled glucose, lactate, and acetate, the present study investigated the possibility that neuronal-glial metabolism is uncoupled following severe TBI. Histopathology of the model showed severe brain injury with subarachnoid and hemorrhage together with glial cell activation and positive staining for Tau at 90 min post-trauma. High resolution MR spectroscopy of brain metabolites revealed significant labeling of lactate at C-3 and C-2 irrespective of the infused substrates. Increased C-13-labeled lactate in all study groups in the absence of ischemia implied activated astrocytic glycolysis and production of lactate with failure of neuronal uptake (i.e. a loss of glial sensing for glutamate). The early increase in extracellular lactate in severe TBI with the injured neurons rendered unable to pick it up probably contributes to a rapid progression toward irreversible injury and pan-necrosis. Hence, a method to detect and scavenge the excess extracellular lactate on site or early following severe TBI may be a potential primary therapeutic measure.	[Lama, Sanju; Tyson, Randy; Gallagher, Clare N.; Tomanek, Boguslaw; Sutherland, Garnette R.] Univ Calgary, Dept Clin Neurosci, Fac Med, Calgary, AB T2N 2T9, Canada; [Lama, Sanju; Tyson, Randy; Gallagher, Clare N.; Tomanek, Boguslaw; Sutherland, Garnette R.] Univ Calgary, Hotchkiss Brain Inst, Fac Med, Calgary, AB T2N 2T9, Canada; [Auer, Roland N.] Univ Montreal, Hop Ste Justine, Dept Pathol, Montreal, PQ H3T 1C5, Canada	University of Calgary; University of Calgary; Universite de Montreal	Sutherland, GR (corresponding author), Univ Calgary, Hlth Res Innovat Ctr 1C60, 3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	garnette@ucalgary.ca	Tomanek, Boguslaw/AAD-7594-2019; Tomanek, Boguslaw/J-4720-2014; Auer, Roland/F-6661-2017	Tomanek, Boguslaw/0000-0003-2602-0280; Auer, Roland/0000-0001-9044-3419	Canadian Institutes for Health Research [RT733596]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes for Health Research grant entitled Cerebral Metabolism in Traumatic Brain Injury RT733596 (to G. R. S.).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abi-Saab WM, 2002, J CEREBR BLOOD F MET, V22, P271, DOI 10.1097/00004647-200203000-00004; Alessandri B, 2012, J NEUROTRAUM, V29, P2181, DOI 10.1089/neu.2011.2067; ALVES PM, 1995, NEUROREPORT, V6, P2201, DOI 10.1097/00001756-199511000-00024; ANDERSEN BJ, 1992, BRAIN RES, V585, P190, DOI 10.1016/0006-8993(92)91206-T; ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; Bartnik BL, 2007, J NEUROTRAUM, V24, P1079, DOI 10.1089/neu.2006.0210; Bartnik BL, 2007, J NEUROTRAUM, V24, P181, DOI 10.1089/neu.2006.0038; BECKMANN N, 1991, BIOCHEMISTRY-US, V30, P6362, DOI 10.1021/bi00240a002; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Chen T, 2000, BRAIN RES, V861, P281, DOI 10.1016/S0006-8993(00)01992-2; Chen T, 2000, ACT NEUR S, V76, P359; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Choi HB, 2012, NEURON, V75, P1094, DOI 10.1016/j.neuron.2012.08.032; Clausen T, 2005, J NEUROSURG, V103, P597, DOI 10.3171/jns.2005.103.4.0597; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Dienel GA, 2012, J CEREBR BLOOD F MET, V32, P1107, DOI 10.1038/jcbfm.2011.175; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Gruetter R, 2002, NEUROCHEM INT, V41, P143, DOI 10.1016/S0197-0186(02)00034-7; Hassel B, 1997, J CEREBR BLOOD F MET, V17, P1230, DOI 10.1097/00004647-199711000-00012; HASSEL B, 1992, BRAIN RES, V576, P120, DOI 10.1016/0006-8993(92)90616-H; Holloway R, 2007, ACTA NEUROCHIR, V149, P919, DOI 10.1007/s00701-007-1241-y; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Kaibara T, 1999, J NEUROSURG, V90, P339, DOI 10.3171/jns.1999.90.2.0339; KISHI K, 1994, BIOCHEMISTRY-US, V33, P8694, DOI 10.1021/bi00195a010; KRAIG RP, 1987, J CEREBR BLOOD F MET, V7, P379, DOI 10.1038/jcbfm.1987.80; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Magistretti PJ, 2009, AM J CLIN NUTR, V90, p875S, DOI 10.3945/ajcn.2009.27462CC; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; Makoroff KL, 2005, PEDIATR RADIOL, V35, P668, DOI 10.1007/s00247-005-1441-7; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McKenna MC, 1995, NEUROCHEM RES, V20, P1491, DOI 10.1007/BF00970599; Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000536; Mondragon-Rodriguez S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/940603; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; PEELING J, 1992, MAGNET RESON MED, V24, P123, DOI 10.1002/mrm.1910240113; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Peronnet F, 2006, RESP PHYSIOL NEUROBI, V150, P4, DOI 10.1016/j.resp.2005.04.005; PONTEN U, 1973, J NEUROCHEM, V21, P1127, DOI 10.1111/j.1471-4159.1973.tb07567.x; Reinert M, 2000, ACTA NEUROCHIR SUPPL, V76, P439; Rice AC, 2002, BRAIN RES, V928, P156, DOI 10.1016/S0006-8993(01)03299-1; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Sala N, 2013, J CEREBR BLOOD F MET, V33, P1815, DOI 10.1038/jcbfm.2013.142; Sanchez Jose J, 2013, Acta Neurochir Suppl, V118, P223, DOI 10.1007/978-3-7091-1434-6_42; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; Tyson RL, 2000, NEUROREPORT, V11, P1845, DOI 10.1097/00001756-200006260-00009; Tyson RL, 2003, BRAIN RES, V992, P43, DOI 10.1016/j.brainres.2003.08.027; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; van de Waterbeemd H, 1998, J DRUG TARGET, V6, P151, DOI 10.3109/10611869808997889; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vogel R, 1998, NEUROSCI LETT, V247, P123, DOI 10.1016/S0304-3940(98)00290-0; Weinstein JS, 2010, J CEREBR BLOOD F MET, V30, P15, DOI 10.1038/jcbfm.2009.192; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011	58	36	39	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20200	20208		10.1074/jbc.M114.570978	http://dx.doi.org/10.1074/jbc.M114.570978			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24849602	hybrid, Green Published			2022-12-25	WOS:000339395200033
J	Schanzer, JM; Wartha, K; Croasdale, R; Moser, S; Kunkele, KP; Ries, C; Scheuer, W; Duerr, H; Pompiati, S; Pollman, J; Stracke, J; Lau, W; Ries, S; Brinkmann, U; Klein, C; Umana, P				Schanzer, Juergen M.; Wartha, Katharina; Croasdale, Rebecca; Moser, Samuel; Kuenkele, Klaus-Peter; Ries, Carola; Scheuer, Werner; Duerr, Harald; Pompiati, Sandra; Pollman, Jan; Stracke, Jan; Lau, Wilma; Ries, Stefan; Brinkmann, Ulrich; Klein, Christian; Umana, Pablo			A Novel Glycoengineered Bispecific Antibody Format for Targeted Inhibition of Epidermal Growth Factor Receptor (EGFR) and Insulin-like Growth Factor Receptor Type I (IGF-1R) Demonstrating Unique Molecular Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL LUNG-CANCER; VARIABLE-DOMAIN IMMUNOGLOBULIN; CONSERVED FRAMEWORK REGIONS; ADVANCED SOLID TUMORS; MONOCLONAL-ANTIBODY; ANTITUMOR-ACTIVITY; RECOMBINANT IMMUNOTOXINS; DISULFIDE BONDS; IGG ANTIBODIES; FREE SURVIVAL	In the present study, we have developed a novel one-arm single chain Fab heterodimeric bispecific IgG (OAscFab-IgG) antibody format targeting the insulin-like growth factor receptor type I (IGF-1R) and the epidermal growth factor receptor (EGFR) with one binding site for each target antigen. The bispecific antibody XGFR is based on the "knob-into-hole" technology for heavy chain heterodimerization with one heavy chain consisting of a single chain Fab to prevent wrong pairing of light chains. XGFR was produced with high expression yields and showed simultaneous binding to IGF-1R and EGFR with high affinity. Due to monovalent binding of XGFR to IGF-1R, IGF-1R internalization was strongly reduced compared with the bivalent parental antibody, leading to enhanced Fc-mediated cellular cytotoxicity. To further increase immune effector functions triggered by XGFR, the Fc portion of the bispecific antibody was glycoengineered, which resulted in strong antibody-dependent cell-mediated cytotoxicity activity. XGFR-mediated inhibition of IGF-1R and EGFR phosphorylation as well as A549 tumor cell proliferation was highly effective and was comparable with a combined treatment with EGFR (GA201) and IGF-1R (R1507) antibodies. XGFR also demonstrated potent anti-tumor efficacy in multiple mouse xenograft tumor models with a complete growth inhibition of AsPC1 human pancreatic tumors and improved survival of SCID beige mice carrying A549 human lung tumors compared with treatment with antibodies targeting either IGF-1R or EGFR. In summary, we have applied rational antibody engineering technology to develop a heterodimeric OAscFab-IgG bispecific antibody, which combines potent signaling inhibition with antibody-dependent cell-mediated cytotoxicity induction and results in superior molecular properties over two established tetravalent bispecific formats.	[Schanzer, Juergen M.; Wartha, Katharina; Croasdale, Rebecca; Ries, Carola; Scheuer, Werner] Roche Diagnost GmbH, Discovery Oncol, Pharmaceut Res & Early Dev, D-82372 Penzberg, Germany; [Duerr, Harald; Pompiati, Sandra; Pollman, Jan; Stracke, Jan; Lau, Wilma; Ries, Stefan; Brinkmann, Ulrich] Roche Diagnost GmbH, Large Mol Res, Pharmaceut Res & Early Dev, D-82372 Penzberg, Germany; [Moser, Samuel; Klein, Christian; Umana, Pablo] Roche Glycart AG, CH-8952 Schlieren, Switzerland; [Kuenkele, Klaus-Peter] Boehringer Ingelheim GmbH & Co KG, A-1121 Vienna, Austria	Roche Holding; Roche Holding; Roche Holding; Boehringer Ingelheim	Schanzer, JM (corresponding author), Roche Diagnost GmbH, Discovery Oncol, Pharmaceut Res & Early Dev, Nonnenwald 2, D-82372 Penzberg, Germany.	juergen_michael.schanzer@roche.com	Brinkmann, Ulrich/AAF-8216-2019; Klein, Christian/G-1336-2010	Brinkmann, Ulrich/0000-0002-5558-0212; Klein, Christian/0000-0001-7594-7280	Bavarian Ministry for Science and Education	Bavarian Ministry for Science and Education	This work was supported in part by a grant from the Bavarian Ministry for Science and Education.	BASELGA J, 1994, BREAST CANCER RES TR, V29, P127, DOI 10.1007/BF00666188; Bostrom J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017887; Bowers G, 2001, ONCOGENE, V20, P1388, DOI 10.1038/sj.onc.1204255; Chakravarti A, 2002, CANCER RES, V62, P200; Ciardiello F, 2002, EXPERT OPIN INV DRUG, V11, P755; Croasdale R, 2012, ARCH BIOCHEM BIOPHYS, V526, P206, DOI 10.1016/j.abb.2012.03.016; DiGiammarino EL, 2011, MABS-AUSTIN, V3, P487, DOI 10.4161/mabs.3.5.16326; Dong JY, 2011, J BIOL CHEM, V286, P4703, DOI 10.1074/jbc.M110.184317; Emanuel SL, 2011, MABS-AUSTIN, V3, P38, DOI 10.4161/mabs.3.1.14168; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Gerdes CA, 2013, CLIN CANCER RES, V19, P1126, DOI 10.1158/1078-0432.CCR-12-0989; Goetsch L, 2005, INT J CANCER, V113, P316, DOI 10.1002/ijc.20543; Haluska P, 2008, MOL CANCER THER, V7, P2589, DOI 10.1158/1535-7163.MCT-08-0493; Hust M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-14; Jones HE, 2004, ENDOCR-RELAT CANCER, V11, P793, DOI 10.1677/erc.1.00799; Klein C, 2012, MABS-AUSTIN, V4, P653, DOI 10.4161/mabs.21379; Kontermann RE, 1997, NAT BIOTECHNOL, V15, P629, DOI 10.1038/nbt0797-629; Lee HS, 1999, MOL IMMUNOL, V36, P61, DOI 10.1016/S0161-5890(98)00109-6; Lu D, 2005, J BIOL CHEM, V280, P19665, DOI 10.1074/jbc.M500815200; Lu D, 2004, J BIOL CHEM, V279, P2856, DOI 10.1074/jbc.M310132200; Ludovini V, 2009, ANN ONCOL, V20, P842, DOI 10.1093/annonc/mdn727; Michaelson JS, 2009, MABS-AUSTIN, V1, P128, DOI 10.4161/mabs.1.2.7631; Nagorsen D, 2012, PHARMACOL THERAPEUT, V136, P334, DOI 10.1016/j.pharmthera.2012.07.013; Pappo AS, 2011, J CLIN ONCOL, V29, P4541, DOI 10.1200/JCO.2010.34.0000; Paz-Ares LG, 2011, J CLIN ONCOL, V29, P3783, DOI 10.1200/JCO.2011.34.8888; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; POLLAK MN, 1987, CANCER LETT, V38, P223, DOI 10.1016/0304-3835(87)90218-7; Ramalingam SS, 2011, J CLIN ONCOL, V29, P4574, DOI 10.1200/JCO.2011.36.6799; REITER Y, 1994, PROTEIN ENG, V7, P697, DOI 10.1093/protein/7.5.697; REITER Y, 1994, BIOCHEMISTRY-US, V33, P5451, DOI 10.1021/bi00184a014; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Rosen LS, 2012, CLIN CANCER RES, V18, P3414, DOI 10.1158/1078-0432.CCR-11-3369; Scartozzi M, 2010, INT J CANCER, V127, P1941, DOI 10.1002/ijc.25193; Schaefer G, 2011, CANCER CELL, V20, P472, DOI 10.1016/j.ccr.2011.09.003; Schaefer W, 2011, P NATL ACAD SCI USA, V108, P11187, DOI 10.1073/pnas.1019002108; Schirrmann T, 2010, MABS-AUSTIN, V2, P73, DOI 10.4161/mabs.2.1.10784; Surati M, 2011, EXPERT OPIN BIOL TH, V11, P1655, DOI 10.1517/14712598.2011.626762; Topp MS, 2011, J CLIN ONCOL, V29, P2493, DOI 10.1200/JCO.2010.32.7270; Ueda S, 2006, CANCER SCI, V97, P597, DOI 10.1111/j.1349-7006.2006.00228.x; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; Vecchione L, 2011, EXP CELL RES, V317, P2765, DOI 10.1016/j.yexcr.2011.08.021; Weickhardt A, 2012, J THORAC ONCOL, V7, P419, DOI 10.1097/JTO.0b013e31823c5b11; Wu CB, 2007, NAT BIOTECHNOL, V25, P1290, DOI 10.1038/nbt1345	43	44	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18693	18706		10.1074/jbc.M113.528109	http://dx.doi.org/10.1074/jbc.M113.528109			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24841203	hybrid, Green Published			2022-12-25	WOS:000339062900008
J	Wang, ZS; Humphries, B; Xiao, H; Jiang, YG; Yang, CF				Wang, Zhishan; Humphries, Brock; Xiao, Hua; Jiang, Yiguo; Yang, Chengfeng			MicroRNA-200b Suppresses Arsenic-transformed Cell Migration by Targeting Protein Kinase C alpha and Wnt5b-Protein Kinase C alpha Positive Feedback Loop and Inhibiting Rac1 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; INDUCED MALIGNANT-TRANSFORMATION; MIR-200 FAMILY; RHO GTPASES; REPRESSORS ZEB1; CANCER-CELLS; WNT5A; TUMORIGENESIS; CYTOSKELETON; EXPRESSION	MicroRNA-200b (miR-200b) is a member of miR-200 family that has been found to inhibit cell migration and cancer metastasis; however, the underlying mechanism is not well understood. We previously reported that miR-200 expression is depleted in arsenic-transformed human bronchial epithelial cells with highly migratory and invasive characteristics, whereas stably re-expressing miR-200b strongly suppresses arsenic-transformed cell migration. This study was performed to investigate how miR-200b inhibits arsenic-transformed cell migration. We found that protein kinase C alpha (PKC alpha) is significantly up-regulated in arsenic-transformed cells. Combining bioinformatics analysis with PKC alpha 3'-untranslated region vector luciferase reporter assays, we showed that PKC alpha is a direct target of miR-200b. Inhibiting PKC alpha activity or knocking down PKC alpha expression drastically reduced cell migration, phenocoping the inhibitory effect of overexpressing miR-200b. In contrast, forced expression of PKC alpha in miR-200b overexpressing cells impaired the inhibitory effect of miR-200b on cell migration. In addition, we also found a positive feedback loop between Wnt5b and PKC alpha in arsenic-transformed cells. Knocking down Wnt5b expression reduced phospho-PKC levels and cell migration; and knocking down PKC alpha expression decreased Wnt5b level and cell migration. Moreover, forced expression of PKC alpha increased Wnt5b and phospho-PKC levels and cell migration. Further mechanistic studies revealed that Rac1 is highly activated in arsenic-transformed cells and stably expressing miR-200b abolishes Rac1 activation changing actin cytoskeleton organization. Manipulating PKC alpha or Wnt5b expression levels significantly altered the level of active Rac1. Together, these findings indicate that miR-200b suppresses arsenic-transformed cell migration by targeting PKC alpha and Wnt5b-PKC alpha positive feedback loop and subsequently inhibiting Rac1 activation.	[Wang, Zhishan; Humphries, Brock; Xiao, Hua; Yang, Chengfeng] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Jiang, Yiguo] Guangzhou Med Univ, Inst Chem Carcinogenesis, State Key Lab Resp Dis, Guangzhou 510182, Guangdong, Peoples R China; [Yang, Chengfeng] Michigan State Univ, Ctr Integrat Toxicol, E Lansing, MI 48824 USA	Michigan State University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Michigan State University	Yang, CF (corresponding author), Michigan State Univ, Dept Physiol, 2201 Biomed Phys Sci Bldg, E Lansing, MI 48824 USA.	yangcf@msu.edu		Humphries, Brock/0000-0002-6992-3394; Jiang, Yiguo/0000-0002-9499-2594	National Institutes of Health [R01ES017777]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health (Grant R01ES017777, to C. Y.).	Achanzar WE, 2002, JNCI-J NATL CANCER I, V94, P1888, DOI 10.1093/jnci/94.24.1888; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Luna-Ulloa LB, 2011, IUBMB LIFE, V63, P915, DOI 10.1002/iub.559; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Davalos V, 2012, ONCOGENE, V31, P2062, DOI 10.1038/onc.2011.383; Disanza A, 2005, CELL MOL LIFE SCI, V62, P955, DOI 10.1007/s00018-004-4472-6; Feng XL, 2014, CANCER LETT, V344, P166, DOI 10.1016/j.canlet.2013.11.004; Freeley M, 2011, CELL SIGNAL, V23, P753, DOI 10.1016/j.cellsig.2010.10.013; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hill L, 2013, INT J CANCER, V132, P745, DOI 10.1002/ijc.27708; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Howe EN, 2012, J MAMMARY GLAND BIOL, V17, P65, DOI 10.1007/s10911-012-9244-6; Howe EN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2867; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jiang RR, 2013, ARCH TOXICOL, V87, P991, DOI 10.1007/s00204-012-0933-0; Jonsson M, 1998, BRIT J CANCER, V78, P430, DOI 10.1038/bjc.1998.511; Kikuchi A, 2012, ACTA PHYSIOL, V204, P17, DOI 10.1111/j.1748-1716.2011.02294.x; Konopatskaya O, 2010, TRENDS PHARMACOL SCI, V31, P8, DOI 10.1016/j.tips.2009.10.006; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Li X, 2014, ONCOGENE, V33, P4077, DOI 10.1038/onc.2013.370; Mack NA, 2011, CELL CYCLE, V10, P1571, DOI 10.4161/cc.10.10.15612; Medrano EE, 2007, PIGM CELL RES, V20, P258, DOI 10.1111/j.1600-0749.2007.00383.x; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peng F, 2013, BRIT J CANCER, V109, P3092, DOI 10.1038/bjc.2013.655; Ridley AJ, 2001, J CELL SCI, V114, P2713; Saitoh T, 2001, INT J ONCOL, V19, P347; Smith KR, 2001, AM J PHYSIOL-LUNG C, V280, pL442, DOI 10.1152/ajplung.2001.280.3.L442; Sossey-Alaoui K, 2009, J BIOL CHEM, V284, P33019, DOI 10.1074/jbc.M109.034553; Straub AC, 2009, AM J PATHOL, V174, P1949, DOI 10.2353/ajpath.2009.081016; Sugimura R, 2010, BIRTH DEFECTS RES C, V90, P243, DOI 10.1002/bdrc.20195; Tapio S, 2006, MUTAT RES-REV MUTAT, V612, P215, DOI 10.1016/j.mrrev.2006.02.001; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Urtreger AJ, 2012, IUBMB LIFE, V64, P18, DOI 10.1002/iub.574; Waalkes MP, 2008, CANCER RES, V68, P8278, DOI 10.1158/0008-5472.CAN-08-2099; Wang ZS, 2013, TOXICOL APPL PHARM, V271, P20, DOI 10.1016/j.taap.2013.04.018; Wang ZS, 2012, ENVIRON HEALTH PERSP, V120, P92, DOI 10.1289/ehp.1104061; Wang ZS, 2011, TOXICOL SCI, V121, P110, DOI 10.1093/toxsci/kfr029; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037765; Yang CF, 2006, MOL CELL BIOL, V26, P831, DOI 10.1128/MCB.26.3.831-842.2006; Yang CF, 2005, J BIOL CHEM, V280, P24363, DOI 10.1074/jbc.M411629200; Yoshino H, 2013, J HUM GENET, V58, P508, DOI 10.1038/jhg.2013.31; Zhao CQ, 1997, P NATL ACAD SCI USA, V94, P10907, DOI 10.1073/pnas.94.20.10907; Zhao Y, 2011, CANCER LETT, V313, P54, DOI 10.1016/j.canlet.2011.08.023	49	53	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18373	18386		10.1074/jbc.M114.554246	http://dx.doi.org/10.1074/jbc.M114.554246			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24841200	Green Published, hybrid			2022-12-25	WOS:000338042000036
J	Erion, DM; Lapworth, A; Amor, PA; Bai, GY; Vera, NB; Clark, RW; Yan, QY; Zhu, YM; Ross, TT; Purkal, J; Gorgoglione, M; Zhang, GD; Bonato, V; Baker, L; Barucci, N; D'Aquila, T; Robertson, A; Aiello, RJ; Yan, JL; Trimmer, J; Rolph, TP; Pfefferkorn, JA				Erion, Derek M.; Lapworth, Amanda; Amor, Paul A.; Bai, Guoyun; Vera, Nicholas B.; Clark, Ronald W.; Yan, Qingyun; Zhu, Yimin; Ross, Trenton T.; Purkal, Julie; Gorgoglione, Matthew; Zhang, Guodong; Bonato, Vinicius; Baker, Levenia; Barucci, Nicole; D'Aquila, Theresa; Robertson, Alan; Aiello, Robert J.; Yan, Jiangli; Trimmer, Jeff; Rolph, Timothy P.; Pfefferkorn, Jeffrey A.			The Hepatoselective Glucokinase Activator PF-04991532 Ameliorates Hyperglycemia without Causing Hepatic Steatosis in Diabetic Rats	PLOS ONE			English	Article							PLASMA-GLUCOSE; FATTY LIVER; HIGH-YIELD; INSULIN; EXPRESSION; HYPOGLYCEMIA; HOMEOSTASIS; METABOLISM; DISCOVERY; MK-0941	Hyperglycemia resulting from type 2 diabetes mellitus (T2DM) is the main cause of diabetic complications such as retinopathy and neuropathy. A reduction in hyperglycemia has been shown to prevent these associated complications supporting the importance of glucose control. Glucokinase converts glucose to glucose-6-phosphate and determines glucose flux into the beta-cells and hepatocytes. Since activation of glucokinase in beta-cells is associated with increased risk of hypoglycemia, we hypothesized that selectively activating hepatic glucokinase would reduce fasting and postprandial glucose with minimal risk of hypoglycemia. Previous studies have shown that hepatic glucokinase overexpression is able to restore glucose homeostasis in diabetic models; however, these overexpression experiments have also revealed that excessive increases in hepatic glucokinase activity may also cause hepatosteatosis. Herein we sought to evaluate whether liver specific pharmacological activation of hepatic glucokinase is an effective strategy to reduce hyperglycemia without causing adverse hepatic lipids changes. To test this hypothesis, we evaluated a hepatoselective glucokinase activator, PF-04991532, in Goto-Kakizaki rats. In these studies, PF-04991532 reduced plasma glucose concentrations independent of changes in insulin concentrations in a dose-dependent manner both acutely and after 28 days of sub-chronic treatment. During a hyperglycemic clamp in Goto-Kakizaki rats, the glucose infusion rate was increased approximately 5-fold with PF-04991532. This increase in glucose infusion can be partially attributed to the 60% reduction in endogenous glucose production. While PF-04991532 induced dose-dependent increases in plasma triglyceride concentrations it had no effect on hepatic triglyceride concentrations in Goto-Kakizaki rats. Interestingly, PF-04991532 decreased intracellular AMP concentrations and increased hepatic futile cycling. These data suggest that hepatoselective glucokinase activation may offer glycemic control without inducing hepatic steatosis supporting the evaluation of tissue specific activators in clinical trials.	[Erion, Derek M.; Lapworth, Amanda; Amor, Paul A.; Vera, Nicholas B.; Clark, Ronald W.; Yan, Qingyun; Zhu, Yimin; Ross, Trenton T.; Purkal, Julie; Gorgoglione, Matthew; Bonato, Vinicius; Baker, Levenia; Barucci, Nicole; D'Aquila, Theresa; Robertson, Alan; Aiello, Robert J.; Trimmer, Jeff; Rolph, Timothy P.; Pfefferkorn, Jeffrey A.] Pfizer Worldwide Res & Dev, Cardiovasc Metab & Endocrine Dis Res Unit, Cambridge, MA USA; [Bai, Guoyun; Zhang, Guodong; Yan, Jiangli] Pfizer Worldwide Res & Dev, Groton Ctr Chem, Groton, CT USA	Pfizer; Pfizer	Erion, DM (corresponding author), Pfizer Worldwide Res & Dev, Cardiovasc Metab & Endocrine Dis Res Unit, Cambridge, MA USA.	derek.erion@pfizer.com	Bonato, Vinicius/G-5818-2010	Bonato, Vinicius/0000-0003-2807-5859	Pfizer	Pfizer(Pfizer)	Pfizer provided funding for this study. The funder provided support in the form of salaries for authors DME, AL, PAA, GB, NBV, RWC, QY, YZ, TTR, JP, MG, GZ, VB, LB, NB, TD, AR, RJA, JY, JT, TPR, and JAP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agius L, 2008, BIOCHEM J, V414, P1, DOI 10.1042/BJ20080595; AIELLO RJ, 1984, J DAIRY SCI, V67, P1707, DOI 10.3168/jds.S0022-0302(84)81496-4; Bebernitz GR, 2009, J MED CHEM, V52, P6142, DOI 10.1021/jm900839k; Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; CARO JF, 1995, HORM METAB RES, V27, P19, DOI 10.1055/s-2007-979899; Coghlan M, 2008, EXPERT OPIN INV DRUG, V17, P145, DOI 10.1517/13543784.17.2.145; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Cuesta-Munoz AL, 2004, DIABETES, V53, P2164, DOI 10.2337/diabetes.53.8.2164; De Ceuninck F, 2013, BRIT J PHARMACOL, V168, P339, DOI 10.1111/j.1476-5381.2012.02184.x; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Eiki J, 2011, MOL PHARMACOL, V80, P1156, DOI 10.1124/mol.111.074401; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; FOLCH J, 1957, J BIOL CHEM, V226, P497; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; Futamura M, 2012, DIABETOLOGIA, V55, P1071, DOI 10.1007/s00125-011-2439-3; Gloyn AL, 2003, DIABETES, V52, P2433, DOI 10.2337/diabetes.52.9.2433; HATTERSLEY AT, 1992, LANCET, V339, P1307, DOI 10.1016/0140-6736(92)91958-B; HEALEY EC, 2013, CHRONIC DOSING LIVER; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; KALUZNY MA, 1985, J LIPID RES, V26, P135; Kazierad D., 2013, 73 AM DIAB C CHIC IL; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; KIYOSUE A, 2013, DIABETES OBES METAB; Kozian DH, 2010, HORM METAB RES, V42, P502, DOI 10.1055/s-0030-1249637; MAGNUSON MA, 1989, P NATL ACAD SCI USA, V86, P4838, DOI 10.1073/pnas.86.13.4838; Massa ML, 2011, IUBMB LIFE, V63, P1, DOI 10.1002/iub.411; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Matschinsky FM, 2009, NAT REV DRUG DISCOV, V8, P399, DOI 10.1038/nrd2850; Meininger GE, 2011, DIABETES CARE, V34, P2560, DOI 10.2337/dc11-1200; MILLS SE, 1981, J DAIRY SCI, V64, P1719, DOI 10.3168/jds.S0022-0302(81)82752-X; MOOKHTIEAR KA, 2012, 72 AM DIAB ASS M PHI; Nissim I, 2012, BIOCHEM J, V444, P537, DOI 10.1042/BJ20120163; O'Doherty RM, 1999, DIABETES, V48, P2022, DOI 10.2337/diabetes.48.10.2022; Peter A, 2011, J CLIN ENDOCR METAB, V96, pE1126, DOI 10.1210/jc.2010-2017; Pfefferkorn JA, 2013, EXPERT OPIN DRUG DIS, V8, P319, DOI 10.1517/17460441.2013.748744; Pfefferkorn JA, 2012, J MED CHEM, V55, P1318, DOI 10.1021/jm2014887; REAVEN GM, 1987, J CLIN ENDOCR METAB, V64, P106, DOI 10.1210/jcem-64-1-106; ROSSETTI L, 1993, J CLIN INVEST, V92, P1126, DOI 10.1172/JCI116681; ROSSETTI L, 1987, J CLIN INVEST, V79, P1510, DOI 10.1172/JCI112981; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; SHULMAN GI, 1985, J CLIN INVEST, V76, P757, DOI 10.1172/JCI112032; SMITH D, 1987, METABOLISM, V36, P1167, DOI 10.1016/0026-0495(87)90244-7; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Torres TP, 2009, DIABETES, V58, P78, DOI 10.2337/db08-1119; VANSCHAFTINGEN E, 1992, ADV ENZYME REGUL, V32, P133; Velho G, 1996, J CLIN INVEST, V98, P1755, DOI 10.1172/JCI118974; Waring MJ, 2011, MEDCHEMCOMM, V2, P771, DOI 10.1039/c1md00090j; WILDING JP, 2013, DIABETES OBES METAB; Winzell MS, 2011, EUR J PHARMACOL, V663, P80, DOI 10.1016/j.ejphar.2011.05.009; Wu ZJ, 2004, NAT BIOTECHNOL, V22, P656, DOI 10.1038/nbt0604-656b	53	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97139	10.1371/journal.pone.0097139	http://dx.doi.org/10.1371/journal.pone.0097139			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858947	Green Published, gold, Green Submitted			2022-12-25	WOS:000336839400008
J	Hanaki, KI; Ike, F; Kajita, A; Yasuno, W; Yanagiba, M; Goto, M; Sakai, K; Ami, Y; Kyuwa, S				Hanaki, Ken-Ichi; Ike, Fumio; Kajita, Ayako; Yasuno, Wataru; Yanagiba, Misato; Goto, Motoki; Sakai, Kouji; Ami, Yasushi; Kyuwa, Shigeru			A Broadly Reactive One-Step SYBR Green I Real-Time RT-PCR Assay for Rapid Detection of Murine Norovirus	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; LABORATORY MICE; CAPSID PROTEIN; INFECTION; VIRUS; INACTIVATION; PREVALENCE; SUFFICIENT; SURROGATES; DIVERSITY	A one-step SYBR Green I real-time RT-PCR assay was developed for the detection and quantification of a broad range of murine noroviruses (MNVs). The primer design was based on the multiple sequence alignments of 101 sequences of the open reading frame (ORF)1-ORF2 junction of MNV. The broad reactivity and quantitative capacity of the assay were validated using 7 MNV plasmids. The assay was completed within 1 h, and the reliable detection limit was 10 copies of MNV plasmid or 0.063 median tissue culture infective doses per milliliter of RAW264 cell culture-propagated viruses. The diagnostic performance of the assay was evaluated using 158 mouse fecal samples, 91 of which were confirmed to be positive. The melting curve analysis demonstrated the diversity of MNV in the samples. This is the first report of a broadly reactive one-step SYBR Green I real-time RT-PCR assay for detecting of MNVs. The rapid and sensitive performance of this assay makes it a powerful tool for diagnostic applications.	[Hanaki, Ken-Ichi] Iwate Med Univ, Inst Biomed Sci, Dept Lab Anim Med, Yahaba, Iwate, Japan; [Hanaki, Ken-Ichi; Yasuno, Wataru; Yanagiba, Misato] Iwate Med Univ, Inst Biomed Sci, Ctr Vivo Sci, Yahaba, Iwate, Japan; [Ike, Fumio; Kajita, Ayako] RIKEN BioResource Ctr, Expt Anim Div, Tsukuba, Ibaraki, Japan; [Goto, Motoki] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo 113, Japan; [Sakai, Kouji] NIID, Dept Virol 3, Musashimurayama, Tokyo, Japan; [Ami, Yasushi] NIID, Div Expt Anim Res, Shinjuku Ku, Tokyo, Japan; [Kyuwa, Shigeru] Univ Tokyo, Dept Biomed Sci, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan	Iwate Medical University; Iwate Medical University; RIKEN; University of Tokyo; National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); University of Tokyo	Hanaki, KI (corresponding author), Iwate Med Univ, Inst Biomed Sci, Dept Lab Anim Med, Yahaba, Iwate, Japan.	hanaki@iwate-med.ac.jp	SAKAI, KOUJI/J-4436-2018		MEXT; JSPS KAKENHI [22300141, 23500500]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid (2009a(sic)"2013) for the Strategic Medical Science Research Center from MEXT and by JSPS KAKENHI Grant Numbers 22300141, 23500500. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammann CG, 2009, J VIROL, V83, P13037, DOI 10.1128/JVI.01445-09; Bae J, 2008, APPL ENVIRON MICROB, V74, P477, DOI 10.1128/AEM.02095-06; Baert L, 2008, APPL ENVIRON MICROB, V74, P543, DOI 10.1128/AEM.01039-07; Bailey D, 2008, J VIROL, V82, P7725, DOI 10.1128/JVI.00237-08; Barron EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021435; Belliot G, 2008, APPL ENVIRON MICROB, V74, P3315, DOI 10.1128/AEM.02148-07; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Cannon JL, 2006, J FOOD PROTECT, V69, P2761, DOI 10.4315/0362-028X-69.11.2761; Compton SR, 2008, J AM ASSOC LAB ANIM, V47, P25; Doom CM, 2009, VIROLOGY, V392, P153, DOI 10.1016/j.virol.2009.05.035; Farkas T, 2012, VET MICROBIOL, V160, P463, DOI 10.1016/j.vetmic.2012.06.002; Gonzalez-Hernandez MB, 2012, JOVE-J VIS EXP, DOI 10.3791/4297; Hanaki KI, 2014, J VIROL METHODS, V204, P17, DOI 10.1016/j.jviromet.2014.03.025; Hayashimoto N, 2013, EXP ANIM TOKYO, V62, P41, DOI 10.1538/expanim.62.41; Hensley SE, 2009, J VIROL, V83, P7357, DOI 10.1128/JVI.00623-09; Higgins PDR, 2011, COMP IMMUNOL MICROB, V34, P247, DOI 10.1016/j.cimid.2010.12.002; Hsu CC, 2005, CLIN DIAGN LAB IMMUN, V12, P1145, DOI 10.1128/CDLI.12.10.1145-1151.2005; Hsu CC, 2006, COMPARATIVE MED, V56, P247; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Kitagawa Y, 2010, EXP ANIM TOKYO, V59, P47, DOI 10.1538/expanim.59.47; Kitajima M, 2010, J VIROL METHODS, V169, P269, DOI 10.1016/j.jviromet.2010.07.018; Kitajima M, 2009, MICROBIOL IMMUNOL, V53, P531, DOI 10.1111/j.1348-0421.2009.00152.x; Korn K, 2009, J CLIN MICROBIOL, V47, P1238, DOI 10.1128/JCM.02204-08; Lee J, 2008, APPL ENVIRON MICROB, V74, P2111, DOI 10.1128/AEM.02442-07; Lencioni KC, 2008, COMPARATIVE MED, V58, P522; Liu GL, 2009, J VIROL, V83, P6963, DOI 10.1128/JVI.00284-09; Magulski T, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-107; Mathijs E, 2010, J GEN VIROL, V91, P2723, DOI 10.1099/vir.0.024109-0; McInnes EE, 2011, LAB ANIMAL, V40, P341, DOI 10.1038/laban1111-341; Muller B, 2007, ARCH VIROL, V152, P1709, DOI 10.1007/s00705-007-0989-y; Nelson AM, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-7; Nice TJ, 2013, J VIROL, V87, P327, DOI 10.1128/JVI.01864-12; Pritchett-Corning KR, 2009, LAB ANIM-UK, V43, P165, DOI 10.1258/la.2008.008009; Richards GP, 2012, FOOD ENVIRON VIROL, V4, P6, DOI 10.1007/s12560-011-9072-7; Shortland A, 2014, J GEN VIROL, V95, P413, DOI 10.1099/vir.0.059188-0; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith DB, 2012, J GEN VIROL, V93, P259, DOI 10.1099/vir.0.036392-0; Strong DW, 2012, J VIROL, V86, P2950, DOI 10.1128/JVI.07038-11; Tajima M, 2013, EXP ANIM TOKYO, V62, P127, DOI 10.1538/expanim.62.127; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; Tsunesumi N, 2012, J VET MED SCI, V74, P1221, DOI 10.1292/jvms.12-0106; Varga A, 2006, J VIROL METHODS, V132, P146, DOI 10.1016/j.jviromet.2005.10.004; Ward JM, 2006, TOXICOL PATHOL, V34, P708, DOI 10.1080/01926230600918876; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Wobus CE, 2006, J VIROL, V80, P5104, DOI 10.1128/JVI.02346-05; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	47	17	19	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98108	10.1371/journal.pone.0098108	http://dx.doi.org/10.1371/journal.pone.0098108			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847970	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600087
J	Hothersall, B; Caplen, G; Parker, RMA; Nicol, CJ; Waterman-Pearson, AE; Weeks, CA; Murrell, JC				Hothersall, Becky; Caplen, Gina; Parker, Richard M. A.; Nicol, Christine J.; Waterman-Pearson, Avril E.; Weeks, Claire A.; Murrell, Joanna C.			Thermal Nociceptive Threshold Testing Detects Altered Sensory Processing in Broiler Chickens with Spontaneous Lameness	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; LEG WEAKNESS; RESPONSES; PAIN; BUTORPHANOL; LOCOMOTION; BEHAVIOR; LESIONS	Lameness is common in commercially reared broiler chickens but relationships between lameness and pain (and thus bird welfare) have proved complex, partly because lameness is often partially confounded with factors such as bodyweight, sex and pathology. Thermal nociceptive threshold (TNT) testing explores the neural processing of noxious stimuli, and so can contribute to our understanding of pain. Using an acute model of experimentally induced articular pain, we recently demonstrated that TNT was reduced in lame broiler chickens, and was subsequently attenuated by administration of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). This study extended these findings to a large sample of commercial broilers. It examined factors affecting thermal threshold (Part 1) and the effect of an NSAID drug (meloxicam, 5 mg/kg) and of an opioid (butorphanol; 4 mg/kg) (Part 2). Spontaneously lame and matched non-lame birds (n = 167) from commercial farms were exposed to ramped thermal stimulations via a probe attached to the lateral aspect of the tarsometatarsus. Baseline skin temperature and temperature at which a behavioural avoidance response occurred (threshold) were recorded. In Part 1 bird characteristics influencing threshold were modelled; In Part 2 the effect of subcutaneous administration of meloxicam or butorphanol was investigated. Unexpectedly, after accounting for other influences, lameness increased threshold significantly (Part 1). In Part 2, meloxicam affected threshold differentially: it increased further in lame birds and decreased in non-lame birds. No effect of butorphanol was detected. Baseline skin temperature was also consistently a significant predictor of threshold. Overall, lameness significantly influenced threshold after other bird characteristics were taken into account. This, and a differential effect of meloxicam on lame birds, suggests that nociceptive processing may be altered in lame birds, though mechanisms for this require further investigation.	[Hothersall, Becky; Caplen, Gina; Parker, Richard M. A.; Nicol, Christine J.; Waterman-Pearson, Avril E.; Weeks, Claire A.; Murrell, Joanna C.] Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England	University of Bristol	Hothersall, B (corresponding author), Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England.	B.Hothersall@bristol.ac.uk	Nicol, Christine J/B-4841-2011; Weeks, Claire/C-9136-2012	Nicol, Christine J/0000-0001-6734-2177; Weeks, Claire/0000-0002-4280-9604; Parker, Richard/0000-0002-3933-9728	Biotechnology and Biological Sciences Research Council [BB/G000921/1]; BBSRC [BB/G000921/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk), grant number BB/G000921/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, WELF QUAL ASS PROT P; Baert K, 2003, COMP BIOCHEM PHYS C, V134, P25, DOI 10.1016/S1532-0456(02)00184-9; BARDO MT, 1978, PHARMACOL BIOCHEM BE, V9, P147, DOI 10.1016/0091-3057(78)90027-8; Berg C., 2004, Measuring and auditing broiler welfare, P37, DOI 10.1079/9780851998053.0037; Caplen G, 2014, ANIM WELFARE, V23, P179, DOI 10.7120/09627286.23.2.179; Caplen G, 2013, VET J, V196, P477, DOI 10.1016/j.tvjl.2012.12.007; Caplen G, 2013, VET J, V198, P616, DOI 10.1016/j.tvjl.2013.09.013; Fernandes BCD, 2012, REV BRAS ZOOTECN, V41, P1951, DOI 10.1590/S1516-35982012000800021; Di Giminiani P, 2013, EUR J PAIN, V17, P638, DOI 10.1002/j.1532-2149.2012.00228.x; Fuchs PN, 2000, PAIN, V84, P141, DOI 10.1016/S0304-3959(99)00194-3; GENTLE MJ, 1986, J ANAT, V145, P79; Gentle MJ, 1997, PAIN, V70, P245, DOI 10.1016/S0304-3959(97)03324-6; GENTLE MJ, 1987, PHYSIOL BEHAV, V40, P781, DOI 10.1016/0031-9384(87)90283-6; Gentle MJ, 2001, NEUROSCIENCE, V106, P643, DOI 10.1016/S0306-4522(01)00318-9; Hocking PM, 2005, RES VET SCI, V78, P69, DOI 10.1016/j.rvsc.2004.05.005; Hothersall B, 2011, J NEUROSCI METH, V201, P220, DOI 10.1016/j.jneumeth.2011.07.028; Hothersall B., 2012, ASS VET ABAESTHETIST, P26; Janczak AM, 2012, VET ANAESTH ANALG, V39, P628, DOI 10.1111/j.1467-2995.2012.00737.x; Kemp MH, 2008, VET REC, V163, P175, DOI 10.1136/vr.163.6.175; KESTIN SC, 1992, VET REC, V131, P190, DOI 10.1136/vr.131.9.190; Kestin SC, 2001, VET REC, V148, P195, DOI 10.1136/vr.148.7.195; Knowles TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001545; Krumova EK, 2012, CURR DIABETES REP, V12, P393, DOI 10.1007/s11892-012-0282-7; Lascelles BDX, 2004, AM J VET RES, V65, P1085, DOI 10.2460/ajvr.2004.65.1085; LEY SJ, 1989, PAIN, V39, P353, DOI 10.1016/0304-3959(89)90049-3; Mc Geown D, 1999, VET REC, V144, P668, DOI 10.1136/vr.144.24.668; McGowan KT, 2013, EQUINE VET J, V45, P503, DOI 10.1111/j.2042-3306.2012.00673.x; McKeegan DEF, 2002, NEUROREPORT, V13, P1033, DOI 10.1097/00001756-200206120-00011; McKeegan DEF, 2002, BRAIN RES, V953, P101, DOI 10.1016/S0006-8993(02)03275-4; McMullan S, 2004, J NEUROSCI METH, V138, P133, DOI 10.1016/j.jneumeth.2004.03.020; McNamee PT, 1998, VET REC, V143, P131, DOI 10.1136/vr.143.5.131; Nasr MAF, 2013, APPL ANIM BEHAV SCI, V147, P127, DOI 10.1016/j.applanim.2013.04.015; Nasr MAF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042420; Rasmussen DB, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-32; Sandercock DA, 2011, PHYSIOL BEHAV, V104, P728, DOI 10.1016/j.physbeh.2011.07.018; Sandilands V, 2011, Vet Rec, V168, P77, DOI 10.1136/vr.c5978; Sanotra GS, 2001, WORLD POULTRY SCI J, V57, P55, DOI 10.1079/WPS20010006; Singh PM, 2011, VET REC, V168, DOI 10.1136/vr.d1191; Steele F, 2008, J R STAT SOC A STAT, V171, P5; TREEDE RD, 1992, PROG NEUROBIOL, V38, P397, DOI 10.1016/0301-0082(92)90027-C; Weeks CA, 2000, APPL ANIM BEHAV SCI, V67, P111, DOI 10.1016/S0168-1591(99)00102-1; Whay HR, 1998, VET J, V156, P23, DOI 10.1016/S1090-0233(98)80058-0; Whay HR, 1997, VET J, V154, P155, DOI 10.1016/S1090-0233(97)80053-6; Williams MD, 2012, VET ANAESTH ANALG, V40, P15; Yeomans DC, 1996, PAIN, V68, P141, DOI 10.1016/S0304-3959(96)03177-6	45	7	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97883	10.1371/journal.pone.0097883	http://dx.doi.org/10.1371/journal.pone.0097883			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847799	Green Published, Green Submitted, gold			2022-12-25	WOS:000336730600065
J	Hu, B; Song, JT; Qu, HY; Bi, CL; Huang, XZ; Liu, XX; Zhang, M				Hu, Bo; Song, Jian Tao; Qu, Hai Yan; Bi, Chen Long; Huang, Xiao Zhen; Liu, Xin Xin; Zhang, Mei			Mechanical Stretch Suppresses microRNA-145 Expression by Activating Extracellular Signal-Regulated Kinase 1/2 and Upregulating Angiotensin-Converting Enzyme to Alter Vascular Smooth Muscle Cell Phenotype	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; GENE-EXPRESSION; MOLECULAR-BASIS; SHEAR-STRESS; MODULATION; MYOCARDIN; FLOW; DIFFERENTIATION; PATHWAY; TARGETS	Phenotype modulation of vascular smooth muscle cells (VSMCs) plays an important role in the pathogenesis of various vascular diseases, including hypertension and atherosclerosis. Several microRNAs (miRNAs) were found involved in regulating the VSMC phenotype with platelet-derived growth factor (PDGF) treatment, but the role of miRNAs in the mechanical stretch-altered VSMC phenotype is not clear. Here, we identified miR-145 as a major miRNA contributing to stretch-altered VSMC phenotype by miRNA array, quantitative RT-PCR and gain-and loss-of-function methods. Our data demonstrated that 16% stretch suppressed miR-145 expression, with reduced expression of contractile markers of VSMCs cultured on collagenI; overexpression of miR-145 could partially recover the expression in stretched cells. Serum response factor (SRF), myocardin, and Kruppel-like factor 4 (KLF4) are major regulators of the VSMC phenotype. The effect of stretch on myocardin and KLF4 protein expression was altered by miR-145 mimics, but SRF expression was not affected. In addition, stretch-activated extracellular signal-regulated kinase 1/2 (ERK1/2) and up-regulated angiotensin-converting enzyme (ACE) were confirmed to be responsible for the inhibition of miR-145 expression. Mechanical stretch inhibits miR-145 expression by activating the ERK1/2 signaling pathway and promoting ACE expression, thus modulating the VSMC phenotype.	[Zhang, Mei] Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan 250100, Shandong, Peoples R China; Shandong Univ, Chinese Minist Hlth, Dept Cardiol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	Zhang, M (corresponding author), Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan 250100, Shandong, Peoples R China.	daixh@vip.sina.com			National Basic Research Program of China (973 Program) [2010CB732605, 2011CB503906]; National Natural Science Foundation of China [81270404, 30970709]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program, 2010CB732605, 2011CB503906) and the National Natural Science Foundation of China (81270404, 30970709). The funders had no role in study design, data collection and analysis, preparation of the manuscript or decision to publish.	Albinsson S, 2011, PHYSIOL GENOMICS, V43, P529, DOI 10.1152/physiolgenomics.00146.2010; Albinsson S, 2010, ARTERIOSCL THROM VAS, V30, P1118, DOI 10.1161/ATVBAHA.109.200873; Barauna VG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022803; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Boucher JM, 2011, J BIOL CHEM, V286, P28312, DOI 10.1074/jbc.M111.221945; Cen B, 2004, J CELL BIOCHEM, V93, P74, DOI 10.1002/jcb.20199; Chan MC, 2010, EMBO J, V29, P559, DOI 10.1038/emboj.2009.370; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Deaton RA, 2009, AM J PHYSIOL-HEART C, V296, pH1027, DOI 10.1152/ajpheart.01230.2008; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Haga JH, 2007, J BIOMECH, V40, P947, DOI 10.1016/j.jbiomech.2006.04.011; Halka AT, 2008, CARDIOVASC PATHOL, V17, P98, DOI 10.1016/j.carpath.2007.03.001; He J, 2013, MOLECULES, V18, P1, DOI 10.3390/molecules18010001; HEDIN U, 1988, J CELL BIOL, V107, P307, DOI 10.1083/jcb.107.1.307; Kohlstedt K, 2013, CIRC RES, V112, P1150, DOI 10.1161/CIRCRESAHA.113.301282; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Lu DS, 2011, J R SOC INTERFACE, V8, P1379, DOI 10.1098/rsif.2011.0177; Mack CP, 2011, ARTERIOSCL THROM VAS, V31, P1495, DOI 10.1161/ATVBAHA.110.221135; Mao XQ, 2012, CARDIOVASC RES, V96, P513, DOI 10.1093/cvr/cvs274; Morrow D, 2008, CIRC RES, V103, P1370, DOI 10.1161/CIRCRESAHA.108.187534; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Paravicini TM, 2012, J AM SOC HYPERTENS, V6, P169, DOI 10.1016/j.jash.2012.01.002; Qin XM, 2010, P NATL ACAD SCI USA, V107, P3240, DOI 10.1073/pnas.0914882107; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Rieder MJ, 1997, CIRC RES, V80, P312, DOI 10.1161/01.RES.80.3.312; Song JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047657; Stegemann JP, 2005, J APPL PHYSIOL, V98, P2321, DOI 10.1152/japplphysiol.01114.2004; Taurin S, 2009, J BIOL CHEM, V284, P33789, DOI 10.1074/jbc.M109.048983; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang J, 2013, EXP CELL RES, V319, P1165, DOI 10.1016/j.yexcr.2013.03.010; Weber M, 2010, BIOCHEM BIOPH RES CO, V393, P643, DOI 10.1016/j.bbrc.2010.02.045; WILSON E, 1995, J CLIN INVEST, V96, P2364, DOI 10.1172/JCI118293; Wu W, 2011, CIRCULATION, V124, P633, DOI 10.1161/CIRCULATIONAHA.110.005108; Zhang C, 2005, CELL CYCLE, V8, P3469; Zhang ZY, 2013, CELL SIGNAL, V25, P332, DOI 10.1016/j.cellsig.2012.10.006; Zhou J, 2011, P NATL ACAD SCI USA, V108, P10355, DOI 10.1073/pnas.1107052108	42	60	65	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e96338	10.1371/journal.pone.0096338	http://dx.doi.org/10.1371/journal.pone.0096338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848371	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600011
J	Lin, J; Zhang, Q; Lu, Y; Xue, WR; Xu, Y; Zhu, YC; Hu, XP				Lin, Jun; Zhang, Qiang; Lu, Yi; Xue, Wenrui; Xu, Yue; Zhu, Yichen; Hu, Xiaopeng			Downregulation of HIPK2 Increases Resistance of Bladder Cancer Cell to Cisplatin by Regulating Wip1	PLOS ONE			English	Article							INTERACTING PROTEIN KINASE-2; DNA-DAMAGE RESPONSE; SYSTEMIC CHEMOTHERAPY; TUMOR-SUPPRESSOR; P53 ACTIVITY; APOPTOSIS; DEGRADATION; CARCINOMA; PHOSPHORYLATION; CHEMORESISTANCE	Cisplatin-based combination chemotherapy regimen is a reasonable alternative to cystectomy in advanced/metastatic bladder cancer, but acquisition of cisplatin resistance is common in patients with bladder cancer. Previous studies showed that loss of homeodomain-interacting protein kinase-2 (HIPK2) contributes to cell proliferation and tumorigenesis. However, the role of HIPK2 in regulating chemoresistance of cancer cell is not fully understood. In the present study, we found that HIPK2 mRNA and protein levels are significantly decreased in cisplatin-resistant bladder cancer cell in vivo and in vitro. Downregulation of HIPK2 increases the cell viability in a dose-and time-dependent manner during cisplatin treatment, whereas overexpression of HIPK2 reduces the cell viability. HIPK2 overexpression partially overcomes cisplatin resistance in RT4-CisR cell. Furthermore, we showed that Wip1 (wild-type p53-induced phosphatase 1) expression is upregulated in RT4-CisR cell compared with RT4 cell, and HIPK2 negatively regulates Wip1 expression in bladder cancer cell. HIPK2 and Wip1 expression is also negatively correlated after cisplatin-based combination chemotherapy in vivo. Finally, we demonstrated that overexpression of HIPK2 sensitizes chemoresistant bladder cancer cell to cisplatin by regulating Wip1 expression. Conclusions: These data suggest that HIPK2/Wip1 signaling represents a novel pathway regulating chemoresistance, thus offering a new target for chemotherapy of bladder cancer.	[Lin, Jun; Lu, Yi; Zhu, Yichen] Capital Med Univ, Beijing Friendship Hosp, Dept Urol, Beijing, Peoples R China; [Zhang, Qiang; Xue, Wenrui; Xu, Yue; Hu, Xiaopeng] Capital Med Univ, Beijing Chao Yang Hosp, Dept Urol, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Hu, XP (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Dept Urol, Beijing, Peoples R China.	xiaopenghu@sohu.com						Burger M, 2013, EUR UROL, V63, P234, DOI 10.1016/j.eururo.2012.07.033; Chang JS, 2012, ADV UROL, V2012, DOI 10.1155/2012/364919; Choi DW, 2013, MOL CELL, V51, P374, DOI 10.1016/j.molcel.2013.06.010; Chung J, 2004, CANCER LETT, V203, P155, DOI 10.1016/j.canlet.2003.07.008; Cohen SM, 2000, SCAND J UROL NEPHROL, V34, P105, DOI 10.1080/00365590050509869; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; D'Orazi G, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-63; Esaki T, 1996, INT J CANCER, V65, P479; Goloudina AR, 2012, P NATL ACAD SCI USA, V109, pE68, DOI 10.1073/pnas.1107017108; Gupta S, 2013, CANCER CONTROL, V20, P200, DOI 10.1177/107327481302000308; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Hofmann TG, 2013, BIOESSAYS, V35, P55, DOI 10.1002/bies.201200060; Juffs HG, 2002, LANCET ONCOL, V3, P738, DOI 10.1016/S1470-2045(02)00930-0; Kamat AM, 2007, MOL CANCER THER, V6, P1022, DOI 10.1158/1535-7163.MCT-06-0545; Kirkali Z, 2005, UROLOGY, V66, P4, DOI 10.1016/j.urology.2005.07.062; Krieghoff-Henning E, 2008, FUTURE ONCOL, V4, P751, DOI 10.2217/14796694.4.6.751; Lazzari C, 2011, ONCOGENE, V30, P4802, DOI 10.1038/onc.2011.182; Lu XB, 2008, CANCER METAST REV, V27, P123, DOI 10.1007/s10555-008-9127-x; POLLACK A, 1995, J UROLOGY, V154, P2059, DOI 10.1016/S0022-5347(01)66693-X; Puca R, 2010, ONCOGENE, V29, P4378, DOI 10.1038/onc.2010.183; Puca R, 2008, GYNECOL ONCOL, V109, P403, DOI 10.1016/j.ygyno.2008.02.018; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Said N, 2012, J CLIN INVEST, V122, P1503, DOI 10.1172/JCI61392; Song JY, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.252; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Wang F, 2008, FEBS LETT, V582, P1919, DOI 10.1016/j.febslet.2008.05.012; Wang L, 2012, MOL CANCER THER, V11, P2401, DOI 10.1158/1535-7163.MCT-12-0448; Wei GW, 2007, P NATL ACAD SCI USA, V104, P13040, DOI 10.1073/pnas.0703213104; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743; Witjes JA, 2014, EUR UROL, V65, P778, DOI 10.1016/j.eururo.2013.11.046; Xu N, 2012, BIOCHEM BIOPH RES CO, V425, P468, DOI 10.1016/j.bbrc.2012.07.127; Yang C, 2012, GENE, V496, P8, DOI 10.1016/j.gene.2012.01.012; Yuan G, 2013, ONCOGENE, V32, P375, DOI 10.1038/onc.2012.40	33	6	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98418	10.1371/journal.pone.0098418	http://dx.doi.org/10.1371/journal.pone.0098418			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846322	gold, Green Published, Green Submitted			2022-12-25	WOS:000339563400109
J	Brooks, E; Patel, D; Canal, MM				Brooks, Elisabeth; Patel, Dhruval; Canal, Maria Merce			Programming of Mice Circadian Photic Responses by Postnatal Light Environment	PLOS ONE			English	Article							MPER2 PROTEIN EXPRESSION; SUPRACHIASMATIC NUCLEUS; GANGLION-CELLS; MOTOR-ACTIVITY; BRIGHT LIGHT; TIME-COURSE; ADULT MICE; RHYTHMS; PHASE; ENTRAINMENT	Early life programming has important consequences for future health and wellbeing. A key new aspect is the impact of perinatal light on the circadian system. Postnatal light environment will program circadian behavior, together with cell morphology and clock gene function within the suprachiasmatic nucleus (SCN) of the hypothalamus, the principal circadian clock in mammals. Nevertheless, it is still not clear whether the observed changes reflect a processing of an altered photic input from the retina, rather than an imprinting of the intrinsic molecular clock mechanisms. Here, we addressed the issue by systematically probing the mouse circadian system at various levels. Firstly, we used electroretinography, pupillometry and histology protocols to show that gross retinal function and morphology in the adult are largely independent of postnatal light experiences that modulate circadian photosensitivity. Secondly, we used circadian activity protocols to show that only the animal's behavioral responses to chronic light exposure, but not to constant darkness or the acute responses to a light stimulus depend on postnatal light experience. Thirdly, we used real-time PER2:: LUC rhythm recording to show long-term changes in clock gene expression in the SCN, but also heart, lung and spleen. The data showed that perinatal light mainly targets the long-term adaptive responses of the circadian clock to environmental light, rather than the retina or intrinsic clock mechanisms. Finally, we found long-term effects on circadian peripheral clocks, suggesting far-reaching consequences for the animal's overall physiology.	[Brooks, Elisabeth; Patel, Dhruval; Canal, Maria Merce] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Canal, MM (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	Maria.canal@manchester.ac.uk			Research Councils UK; Biotechnology and Biological Sciences Research Council (BBSRC); Medical Research Council (MRC); Biotechnology and Biological Sciences Research Council [BB/F019718/1] Funding Source: researchfish; BBSRC [BB/F019718/1] Funding Source: UKRI	Research Councils UK(UK Research & Innovation (UKRI)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funding from the Research Councils UK and the Biotechnology and Biological Sciences Research Council (BBSRC) to MMC. EB was a recipient of a Medical Research Council (MRC) doctoral training award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; al Enezi J, 2011, J BIOL RHYTHM, V26, P314, DOI 10.1177/0748730411409719; Albrecht U, 2001, J BIOL RHYTHM, V16, P100, DOI 10.1177/074873001129001791; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brooks E, 2013, NEUROSCI BIOBEHAV R, V37, P551, DOI 10.1016/j.neubiorev.2013.02.012; Brooks E, 2011, BRAIN STRUCT FUNCT, V216, P357, DOI 10.1007/s00429-011-0318-9; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Butcher GQ, 2002, J BIOL CHEM, V277, P29519, DOI 10.1074/jbc.M203301200; Caillol M, 2000, EUR J NEUROSCI, V12, P649, DOI 10.1046/j.1460-9568.2000.00961.x; Cambras T, 2005, DEV BRAIN RES, V157, P27, DOI 10.1016/j.devbrainres.2005.02.014; Cambras T, 1997, AM J PHYSIOL-REG I, V272, pR1039, DOI 10.1152/ajpregu.1997.272.4.R1039; Cambras T, 1998, PHYSIOL BEHAV, V63, P875, DOI 10.1016/S0031-9384(98)00006-7; Cameron MA, 2009, MOL VIS, V15, P2209; Cameron M, 2008, J GENET, V87, P459, DOI 10.1007/s12041-008-0068-5; Canal MM, 2009, CHRONOBIOL INT, V26, P1545, DOI 10.3109/07420520903398542; Canal-Corretger MM, 2003, CHRONOBIOL INT, V20, P441, DOI 10.1081/CBI-120021442; Canal-Corretger MM, 2000, AM J PHYSIOL-REG I, V278, pR201, DOI 10.1152/ajpregu.2000.278.1.R201; Canal-Corretger MM, 2001, CHRONOBIOL INT, V18, P683, DOI 10.1081/CBI-100106081; Canal-Corretger MM, 2001, AM J PHYSIOL-REG I, V280, pR1023, DOI 10.1152/ajpregu.2001.280.4.R1023; Ciarleglio CM, 2011, NAT NEUROSCI, V14, P25, DOI 10.1038/nn.2699; COLWELL CS, 1992, J COMP NEUROL, V324, P135, DOI 10.1002/cne.903240202; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; DEPRESBRUMMER P, 1995, AM J PHYSIOL-REG I, V268, pR1111, DOI 10.1152/ajpregu.1995.268.5.R1111; DIEZNOGUERA A, 1994, AM J PHYSIOL-REG I, V267, pR1118, DOI 10.1152/ajpregu.1994.267.4.R1118; Foster RG, 2005, NAT REV NEUROSCI, V6, P407, DOI 10.1038/nrn1670; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; Gibbs JE, 2009, ENDOCRINOLOGY, V150, P268, DOI 10.1210/en.2008-0638; Gonzalez-Menendez I, 2010, INVEST OPHTH VIS SCI, V51, P4840, DOI 10.1167/iovs.10-5253; Gonzalez-Menendez I, 2010, HISTOL HISTOPATHOL, V25, P73, DOI 10.14670/HH-25.73; Grimm C, 2000, NAT GENET, V25, P63, DOI 10.1038/75614; Hainich EC, 2006, FEBS LETT, V580, P6665, DOI 10.1016/j.febslet.2006.11.019; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; HONMA KI, 1978, AM J PHYSIOL, V235, pR243, DOI 10.1152/ajpregu.1978.235.5.R243; Honma S, 1996, NEUROSCI LETT, V216, P49; Laemle LK, 2002, BRAIN RES, V953, P73, DOI 10.1016/S0006-8993(02)03272-9; Lall GS, 2010, NEURON, V66, P417, DOI 10.1016/j.neuron.2010.04.037; LANUM J, 1978, SURV OPHTHALMOL, V22, P221, DOI 10.1016/0039-6257(78)90070-X; LAVAIL MM, 1987, INVEST OPHTH VIS SCI, V28, P1043; Lavialle M, 2001, GLIA, V34, P88, DOI 10.1002/glia.1044; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; MASON R, 1991, NEUROSCI LETT, V123, P160, DOI 10.1016/0304-3940(91)90920-O; Meijer JH, 2012, PROG BRAIN RES, V199, P143, DOI 10.1016/B978-0-444-59427-3.00009-5; Moore RY, 1997, ANNU REV MED, V48, P253, DOI 10.1146/annurev.med.48.1.253; Morag I, 2011, COCHRANE DATABA 0119, V19, DOI 006910.001002/14651858.CD14006982.pub14651852; Moriya T, 2000, J NEUROSCI RES, V60, P212, DOI 10.1002/(SICI)1097-4547(20000415)60:2<212::AID-JNR10>3.0.CO;2-P; Noell W K, 1966, Invest Ophthalmol, V5, P450; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Ohta H, 2005, NAT NEUROSCI, V8, P267, DOI 10.1038/nn1395; Ohta H, 2006, PEDIATR RES, V60, P304, DOI 10.1203/01.pdr.0000233114.18403.66; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Pendergast JS, 2010, J NEUROSCI, V30, P12179, DOI 10.1523/JNEUROSCI.2607-10.2010; Perlman JM, 2001, PEDIATRICS, V108, P1339, DOI 10.1542/peds.108.6.1339; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; Prolo LM, 2005, J NEUROSCI, V25, P404, DOI 10.1523/JNEUROSCI.4133-04.2005; PROSSER RA, 1994, BRAIN RES, V643, P296, DOI 10.1016/0006-8993(94)90036-1; RAPP LM, 1980, VISION RES, V20, P1127, DOI 10.1016/0042-6989(80)90050-4; Reddy AB, 2010, TRENDS CELL BIOL, V20, P36, DOI 10.1016/j.tcb.2009.10.005; Refinetti R, 2003, CHRONOBIOL INT, V20, P417, DOI 10.1081/CBI-120021443; Silver AC, 2012, BRAIN BEHAV IMMUN, V26, P407, DOI 10.1016/j.bbi.2011.10.001; Smith L, 2009, J NEUROENDOCRINOL, V21, P946, DOI 10.1111/j.1365-2826.2009.01914.x; Strang-Karlsson S, 2010, CHRONOBIOL INT, V27, P1829, DOI 10.3109/07420528.2010.512689; Stratmann M, 2006, J BIOL RHYTHM, V21, P494, DOI 10.1177/0748730406293889; Sudo M, 2003, NEUROSCIENCE, V121, P493, DOI 10.1016/S0306-4522(03)00457-3; Sumova A, 2004, PHYSIOL RES, V53, pS167; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; TAKEO Y, 1984, NEUROENDOCRINOLOGY, V39, P97, DOI 10.1159/000123964; Yamazaki S, 2005, METHOD ENZYMOL, V393, P288, DOI 10.1016/S0076-6879(05)93012-7; Yan L, 2002, EUR J NEUROSCI, V16, P1531, DOI 10.1046/j.1460-9568.2002.02224.x; Yan LL, 2004, EUR J NEUROSCI, V19, P1105, DOI 10.1111/j.1460-9568.2004.03189.x; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshikawa T, 2005, J BIOL RHYTHM, V20, P500, DOI 10.1177/0748730405280775; Zhu HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037833	74	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97160	10.1371/journal.pone.0097160	http://dx.doi.org/10.1371/journal.pone.0097160			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842115	Green Published, gold, Green Submitted			2022-12-25	WOS:000340948600017
J	Drymon, JM; Ajemian, MJ; Powers, SP				Drymon, J. Marcus; Ajemian, Matthew J.; Powers, Sean P.			Distribution and Dynamic Habitat Use of Young Bull Sharks Carcharhinus leucas in a Highly Stratified Northern Gulf of Mexico Estuary	PLOS ONE			English	Article							MOVEMENT PATTERNS; TOP PREDATOR; RECTAL GLAND; FLORIDA; VARIABILITY; AREAS; WATER; AGE	Understanding how animals alter habitat use in response to changing abiotic conditions is important for effective conservation management. For bull sharks (Carcharhinus leucas), habitat use has been widely examined in the eastern and western Gulf of Mexico; however, knowledge of their movements and the factors influencing them is lacking for populations in the more temperate north-central Gulf of Mexico. To examine how changes in hydrographic conditions affected the presence of young bull sharks in Mobile Bay, Alabama, thirty-five sharks were fitted with internal acoustic transmitters and monitored with an acoustic monitoring array consisting of thirty-three receivers between June 2009 and December 2010. Tagged sharks ranged in size from 60 to 114 cm fork length and were detected between the upper and lower portions of Mobile Bay. Despite a variety of freshwater sources associated with this highly productive estuary, sharks were most consistently detected at the largest input to the system - the Mobile and Tensaw Rivers. Our findings suggest a combination of hydrographic factors interact to influence the distribution of juvenile bull sharks in Mobile Bay. The factors affecting the probability of detecting at least one bull shark varied both temporally (2009 vs 2010) and spatially (upper vs lower bay). Electivity analysis demonstrated that bull sharks showed highest affinity for warm water (29-32 degrees C), moderate salinities (10-11 psu) and normoxic waters (5-7 mg/l), although these patterns were not consistent between regions or across years. We suggest future studies coupling telemetry and hydrographic variables should, when possible, consider the interactions of multiple environmental parameters when defining the dynamic factors explaining the spatial distribution of coastal sharks.	[Drymon, J. Marcus; Ajemian, Matthew J.; Powers, Sean P.] Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA; [Drymon, J. Marcus; Ajemian, Matthew J.; Powers, Sean P.] Dauphin Isl Sea Lab, Ctr Ecosyst Based Fishery Management, Dauphin Isl, AL USA	University of South Alabama; Dauphin Island Sea Lab	Drymon, JM (corresponding author), Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA.	mdrymon@disl.org	Nisa-Castro-Neto, Walter/L-3235-2014	Nisa-Castro-Neto, Walter/0000-0001-8389-5599; Powers, Sean/0000-0002-4770-9944	Shelby Center for Ecosystem Based Fishery Management	Shelby Center for Ecosystem Based Fishery Management	This work was funded through a grant from the Shelby Center for Ecosystem Based Fishery Management. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajemian MJ, 2012, ENVIRON BIOL FISH, V95, P79, DOI 10.1007/s10641-011-9858-3; Ajemian MJ, 2011, FORAGING ECOLOGY LAR, P261; Blackburn Jason K., 2007, V50, P331; CHESSON J, 1983, ECOLOGY, V64, P1297, DOI 10.2307/1937838; Curtis TH, 2013, MAR COAST FISH, V5, P28, DOI 10.1080/19425120.2012.756438; Curtis TH, 2011, T AM FISH SOC, V140, P1213, DOI 10.1080/00028487.2011.618352; Drymon JM, 2012, ENVIRON BIOL FISH, V95, P21, DOI 10.1007/s10641-011-9922-z; Dzwonkowski B, 2011, CONT SHELF RES, V31, P939, DOI 10.1016/j.csr.2011.03.001; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.1093/biomet/80.1.27; Froeschke J, 2010, MAR ECOL PROG SER, V407, P279, DOI 10.3354/meps08546; Froeschke JT, 2010, AQUAT BIOL, V11, P65, DOI 10.3354/ab00290; Heithaus MR, 2009, LIMNOL OCEANOGR, V54, P472, DOI 10.4319/lo.2009.54.2.0472; Heupel MR, 2008, AQUAT BIOL, V1, P277, DOI 10.3354/ab00030; Heupel MR, 2011, MAR ECOL PROG SER, V433, P237, DOI 10.3354/meps09191; Heupel MR, 2010, MAR FRESHWATER RES, V61, P1, DOI 10.1071/MF09019; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Kessel ST, 2014, REV FISH BIOL FISHER, V24, P199, DOI 10.1007/s11160-013-9328-4; Kim CK, 2012, J MARINE SYST, V96-97, P103, DOI 10.1016/j.jmarsys.2012.02.008; Knip DM, 2010, MAR ECOL PROG SER, V402, P1, DOI 10.3354/meps08498; Marr CD, 2013, HYDRODYNAMIC MODELIN, P102; Martin RA, 2005, J MAR BIOL ASSOC UK, V85, P1049, DOI 10.1017/S0025315405012105; Matich P, 2012, MAR ECOL PROG SER, V447, P165, DOI 10.3354/meps09497; MCCANDLESS CT, 2007, AM FISHERIES SOC S, V50; Munroe SEM, 2014, REV FISH BIOL FISHER, V24, P317, DOI 10.1007/s11160-013-9333-7; Neer JA, 2005, J FISH BIOL, V67, P370, DOI 10.1111/j.0022-1112.2005.00743.x; NOAA, 1985, GULF MEX COAST OC ZO; Ortega LA, 2009, ENVIRON BIOL FISH, V84, P361, DOI 10.1007/s10641-009-9442-2; Papsons Glenn R., 2007, V50, P301; Park K, 2007, ESTUAR COAST, V30, P54, DOI 10.1007/BF02782967; Pillans RD, 2005, J COMP PHYSIOL B, V175, P37, DOI 10.1007/s00360-004-0460-2; Pillans RD, 2004, COMP BIOCHEM PHYS A, V138, P363, DOI 10.1016/j.cbpb.2004.05.006; Sanchez-Rubio G, 2011, J HYDROL, V396, P72, DOI 10.1016/j.jhydrol.2010.10.034; Schroeder W. W., 1992, COASTAL ESTUARINE ST, P155; Simpfendorfer CA, 2005, ESTUARIES, V28, P78, DOI 10.1007/BF02732755; Simpfendorfer CA, 2004, CRC MAR BIOL SER, P553; Simpfendorfer CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016918; Speed CW, 2010, MAR ECOL PROG SER, V408, P275, DOI 10.3354/meps08581; Ubeda AJ, 2009, ENVIRON BIOL FISH, V84, P293, DOI 10.1007/s10641-008-9436-5; Werry JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049796; Wirsing AJ, 2007, OECOLOGIA, V153, P563, DOI 10.1007/s00442-007-0769-0; Yeiser BG, 2008, MAR FRESHWATER RES, V59, P489, DOI 10.1071/MF07181	41	27	28	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97124	10.1371/journal.pone.0097124	http://dx.doi.org/10.1371/journal.pone.0097124			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841925	gold, Green Published, Green Submitted			2022-12-25	WOS:000340948600016
J	Ito, T; Bai, T; Tanaka, T; Yoshida, K; Ueyama, T; Miyajima, M; Negishi, T; Kawasaki, T; Takamatsu, H; Kikutani, H; Kumanogoh, A; Yukawa, K				Ito, Takuji; Bai, Tao; Tanaka, Tetsuji; Yoshida, Kenji; Ueyama, Takashi; Miyajima, Masayasu; Negishi, Takayuki; Kawasaki, Takahiko; Takamatsu, Hyota; Kikutani, Hitoshi; Kumanogoh, Atsushi; Yukawa, Kazunori			Estrogen-Dependent Proteolytic Cleavage of Semaphorin 4D and Plexin-B1 Enhances Semaphorin 4D-Induced Apoptosis during Postnatal Vaginal Remodeling in Pubescent Mice	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; GROWTH CONE COLLAPSE; R-RAS; KINASE; CELL; ABNORMALITIES; MORPHOLOGY; RECEPTORS; MIGRATION; SYSTEM	Around the fifth week after birth, the vaginal cavity in female mouse pups opens to the overlaying skin. This postnatal tissue remodeling of the genital tract occurs during puberty, and it largely depends upon hormonally induced apoptosis that mainly occurs in the epithelium at the lower part of the mouse vaginal cavity. Previously, we showed that most BALB/c mice lacking the class IV Semaphorin (Sema4D) develop imperforate vagina and hydrometrocolpos; therefore, we reasoned that the absence of Sema4D-induced apoptosis in vaginal epithelial cells may cause the imperforate vagina. Sema4D signals via the Plexin-B1 receptor; nevertheless detailed mechanisms mediating this hormonally triggered apoptosis are not fully documented. To investigate the estrogen-dependent control of Sema4D signaling during the apoptosis responsible for mouse vaginal opening, we examined structural and functional modulation of Sema4D, Plexin-B1, and signaling molecules by analyzing both wild-type and Sema4D-/- mice with or without ovariectomy. Both the release of soluble Sema4D and the conversion of Plexin-B1 by proteolytic processing in vaginal tissue peaked 5 weeks after birth of wild-type BALB/c mice at the time of vaginal opening. Estrogen supplementation of ovariectomized wild-type mice revealed that both the release of soluble Sema4D and the conversion of Plexin-B1 into an active form were estrogen-dependent and concordant with apoptosis. Estrogen supplementation of ovariectomized Sema4D-/- mice did not induce massive vaginal apoptosis in 5-week-old mice; therefore, Sema4D may be an essential apoptosis-inducing ligand that acts downstream of estrogen action in vaginal epithelium during this postnatal tissue remodeling. Analysis of ovariectomized mice also indicated that Sema4D contributed to estrogen-dependent dephosphorylation of Akt and ERK at the time of vaginal opening. Based on our results, we propose that apoptosis in vaginal epithelium during postnatal vaginal opening is induced by enhanced Sema4D signaling that is caused by estrogen-dependent structural changes of Sema4D and Plexin-B1.	[Ito, Takuji; Yoshida, Kenji; Negishi, Takayuki; Yukawa, Kazunori] Meijo Univ, Fac Pharm, Dept Physiol, Nagoya, Aichi 468, Japan; [Bai, Tao; Tanaka, Tetsuji] Wakayama Med Univ, Dept Obstet & Gynecol, Wakayama, Japan; [Ueyama, Takashi] Wakayama Med Univ, Dept Anat & Cell Biol, Wakayama, Japan; [Miyajima, Masayasu] Wakayama Med Univ, Lab Anim Ctr, Wakayama, Japan; [Kawasaki, Takahiko] Grad Univ Adv Studies Sokendai, Natl Inst Genet, Div Brain Funct, Mishima, Shizuoka, Japan; [Takamatsu, Hyota; Kumanogoh, Atsushi] Osaka Univ, Microbial Dis Res Inst, Dept Immunopathol, Suita, Osaka 565, Japan; [Kikutani, Hitoshi] Osaka Univ, Microbial Dis Res Inst, Dept Mol Immunol, Suita, Osaka 565, Japan	Meijo University; Wakayama Medical University; Wakayama Medical University; Wakayama Medical University; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Osaka University; Osaka University	Yukawa, K (corresponding author), Meijo Univ, Fac Pharm, Dept Physiol, Nagoya, Aichi 468, Japan.	kyukawa@meijo-u.ac.jp		Ito, Takuji/0000-0002-5078-0119; Kawasaki, Takahiko/0000-0001-9939-8407	Ministry of Education, Science, Sports and Culture, Japan [19590178]; Research Institute of Meijo University; Grants-in-Aid for Scientific Research [24590895] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Institute of Meijo University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was primarily supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture, Japan (#19590178, http://www.jsps.go.jp/j-grantsinaid/index.html), and partly supported by several grants from the Research Institute of Meijo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artigiani S, 2003, J BIOL CHEM, V278, P10094, DOI 10.1074/jbc.M210156200; Atwal JK, 2003, J NEUROSCI, V23, P7602; Basile JR, 2007, J BIOL CHEM, V282, P34888, DOI 10.1074/jbc.M705467200; Basile JR, 2005, MOL CELL BIOL, V25, P6889, DOI 10.1128/MCB.25.16.6889-6898.2005; Cano-Gauci DF, 1999, J CELL BIOL, V146, P255; Dacquin R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026627; Elhabazi A, 2001, J IMMUNOL, V166, P4341, DOI 10.4049/jimmunol.166.7.4341; Fazzari P, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-55; Giacobini P, 2008, J CELL BIOL, V183, P555, DOI 10.1083/jcb.200806160; Goodman CS, 1999, CELL, V97, P551, DOI 10.1016/S0092-8674(00)80766-7; Guan F, 2006, KIDNEY INT, V69, P1564, DOI 10.1038/sj.ki.5000313; Hirschberg A, 2010, MOL CELL BIOL, V30, P764, DOI 10.1128/MCB.01458-09; Hubner A, 2010, MOL CELL BIOL, V30, P98, DOI 10.1128/MCB.01155-09; Ito T, 2014, MOL MED REP IN PRESS; Ito Y, 2006, EMBO REP, V7, P704, DOI 10.1038/sj.embor.7400737; Janssen BJC, 2010, NATURE, V467, P1118, DOI 10.1038/nature09468; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Li L, 2009, INT J ONCOL, V34, P905, DOI 10.3892/ijo_00000216; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Moretti S, 2008, BLOOD, V111, P2290, DOI 10.1182/blood-2007-06-096529; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Pasterkamp RJ, 2012, NAT REV NEUROSCI, V13, P605, DOI 10.1038/nrn3302; Rodriguez I, 1997, DEV BIOL, V184, P115, DOI 10.1006/dbio.1997.8522; Saito Y, 2009, EMBO REP, V10, P614, DOI 10.1038/embor.2009.63; Shi W, 2000, IMMUNITY, V13, P633, DOI 10.1016/S1074-7613(00)00063-7; Simpson KJ, 2004, INT J DEV BIOL, V48, P675, DOI 10.1387/ijdb.041849ks; SUNDBERG JP, 1994, LAB ANIM SCI, V44, P380; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Yamaguchi W, 2012, MOL CELL NEUROSCI, V49, P290, DOI 10.1016/j.mcn.2011.12.004	30	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97909	10.1371/journal.pone.0097909	http://dx.doi.org/10.1371/journal.pone.0097909			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841081	Green Published, Green Submitted, gold			2022-12-25	WOS:000340948600091
J	Yuan, ZH; Mehta, HJ; Mohammed, K; Nasreen, N; Roman, R; Brantly, M; Sadikot, RT				Yuan, Zhihong; Mehta, Hiren J.; Mohammed, Kamal; Nasreen, Najmunissa; Roman, Robert; Brantly, Mark; Sadikot, Ruxana T.			TREM-1 Is Induced in Tumor Associated Macrophages by Cyclo-Oxygenase Pathway in Human Non-Small Cell Lung Cancer	PLOS ONE			English	Article							IMMUNE-RESPONSES; PROGNOSTIC VALUE; KAPPA-B; EXPRESSION; INFLAMMATION; ACTIVATION; ROLES; MICROENVIRONMENT; ANGIOGENESIS; LEUKOCYTOSIS	It is increasingly recognized that the tumor microenvironment plays a critical role in the initiation and progression of lung cancer. In particular interaction of cancer cells, macrophages, and inflammatory response in the tumor microenvironment has been shown to facilitate cancer cell invasion and metastasis. The specific molecular pathways in macrophages that immunoedit tumor growth are not well defined. Triggering receptor expressed on myeloid cells 1 (TREM-1) is a member of the super immunoglobulin family expressed on a select group of myeloid cells mainly monocyte/macrophages. Recent studies suggest that expression of TREM-1 in tumors may predict cancer aggressiveness and disease outcomes in liver and lung cancer however the mechanism of TREM-1 expression in the setting of cancer is not defined. In this study we demonstrate that tumor tissue from patients with non-small cell lung cancer show an increased expression of TREM-1 and PGE2. Immunohistochemistry and immunofluorescence confirmed that the expression of TREM-1 was selectively seen in CD68 positive macrophages. By employing an in vitro model we confirmed that expression of TREM-1 is increased in macrophages that are co-cultured with human lung cancer cells. Studies with COX-2 inhibitors and siCOX-2 showed that expression of TREM-1 in macrophages in tumor microenvironment is dependent on COX-2 signaling. These studies for the first time define a link between tumor COX-2 induction, PGE2 production and expression of TREM-1 in macrophages in tumor microenvironment and suggest that TREM-1 might be a novel target for tumor immunomodulation.	[Yuan, Zhihong; Mohammed, Kamal; Roman, Robert; Brantly, Mark; Sadikot, Ruxana T.] Vet Affairs Med Ctr, Gainesville, FL 32608 USA; [Yuan, Zhihong; Mehta, Hiren J.; Mohammed, Kamal; Nasreen, Najmunissa; Sadikot, Ruxana T.] Univ Florida, Div Pulm Crit Care & Sleep Med, Gainesville, FL USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); State University System of Florida; University of Florida	Sadikot, RT (corresponding author), Vet Affairs Med Ctr, Gainesville, FL 32608 USA.	rtsadikot@ufl.edu	Brantly, Mark/AAH-2922-2020	Yuan, Zhihong/0000-0002-2300-0463	Department of Veterans Affairs; Veterans Affairs [I01BX001786] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This work was funded by the Department of Veterans Affairs (MR to RTS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2012, CLIN EXP IMMUNOL, V167, P195, DOI 10.1111/j.1365-2249.2011.04515.x; Baird AM, 2013, LUNG CANCER, V79, P83, DOI 10.1016/j.lungcan.2012.10.003; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Beane J, 2008, CANCER PREV RES, V1, P56, DOI 10.1158/1940-6207.CAPR-08-0011; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Brower V, 2012, J NATL CANCER I, V104, P649, DOI 10.1093/jnci/djs235; Carbone DP, 2011, CLIN LUNG CANCER, V12, P261, DOI 10.1016/j.cllc.2011.06.002; Chen J, 2013, J CANCER RES CLIN, V139, P231, DOI 10.1007/s00432-012-1314-z; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Coussens LM, 2001, J EXP MED, V193, pF23, DOI 10.1084/jem.193.6.F23; Detterbeck FC, 2009, CHEST, V136, P260, DOI 10.1378/chest.08-0978; Dower K, 2008, J IMMUNOL, V180, P3520, DOI 10.4049/jimmunol.180.5.3520; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Hallam S, 2009, J PATHOL, V219, P143, DOI 10.1002/path.2602; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Heusinkveld M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-216; Ho CC, 2008, AM J RESP CRIT CARE, V177, P763, DOI 10.1164/rccm.200704-641OC; Holgersson G, 2012, MED ONCOL, V29, P3176, DOI 10.1007/s12032-012-0247-3; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kasuga I, 2001, CANCER-AM CANCER SOC, V92, P2399, DOI 10.1002/1097-0142(20011101)92:9<2399::AID-CNCR1588>3.0.CO;2-W; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Lee Jay M, 2007, Future Oncol, V3, P149, DOI 10.2217/14796694.3.2.149; Liao R, 2012, CANCER SCI, V103, P984, DOI 10.1111/j.1349-7006.2012.02273.x; Lievense LA, 2013, LUNG CANCER, V80, P256, DOI 10.1016/j.lungcan.2013.02.017; Lim BJ, 2010, MOL MED REP, V3, P43, DOI 10.3892/mmr_00000216; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mao JT, 2011, CANCER PREV RES, V4, P984, DOI 10.1158/1940-6207.CAPR-11-0078; Mazzieri R, 2011, CANCER CELL, V19, P512, DOI 10.1016/j.ccr.2011.02.005; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Moysich KB, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-31; Murakami Y, 2007, J IMMUNOL, V178, P1144, DOI 10.4049/jimmunol.178.2.1144; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Ohtaki Y, 2010, J THORAC ONCOL, V5, P1507, DOI 10.1097/JTO.0b013e3181eba692; Ornatowska M, 2007, AM J PHYSIOL-LUNG C, V293, pL1377, DOI 10.1152/ajplung.00140.2007; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qiu R, 2012, J CANCER RES CLIN, V138, P119, DOI 10.1007/s00432-011-1080-3; Sadikot RT, 2007, EUR J IMMUNOL, V37, P1001, DOI 10.1002/eji.200636636; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Sharif O, 2008, IMMUNOBIOLOGY, V213, P701, DOI 10.1016/j.imbio.2008.07.008; Sica A, 2008, CANCER LETT, V267, P204, DOI 10.1016/j.canlet.2008.03.028; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Srivastava MK, 2012, IMMUNOTHERAPY-UK, V4, P291, DOI [10.2217/IMT.11.178, 10.2217/imt.11.178]; Stathopoulos GT, 2008, MOL CANCER RES, V6, P364, DOI 10.1158/1541-7786.MCR-07-0309; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Syed MA, 2010, EXP CELL RES, V316, P3140, DOI 10.1016/j.yexcr.2010.08.009; Takanami I, 1999, ONCOLOGY-BASEL, V57, P138, DOI 10.1159/000012021; Teng MWL, 2010, P NATL ACAD SCI USA, V107, P8328, DOI 10.1073/pnas.1003251107; Tessarz AAS, 2008, IMMUNOL LETT, V116, P111, DOI 10.1016/j.imlet.2007.11.021; Wang R, 2011, LUNG CANCER, V74, P188, DOI 10.1016/j.lungcan.2011.04.009; Wang XQ, 2013, MOL CARCINOGEN, V52, P218, DOI 10.1002/mc.21846; Wu J, 2012, CANCER RES, V72, P3977, DOI 10.1158/0008-5472.CAN-12-0938; Yuan ZH, 2012, INT J BIOCHEM CELL B, V44, P2032, DOI 10.1016/j.biocel.2012.08.001; Zeng H, 2007, EUR J IMMUNOL, V37, P2300, DOI 10.1002/eji.200737270; Zhang BC, 2011, MED ONCOL, V28, P1447, DOI 10.1007/s12032-010-9638-5; Zhang BC, 2011, CLINICS, V66, P1879, DOI 10.1590/S1807-59322011001100006; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	61	45	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e94241	10.1371/journal.pone.0094241	http://dx.doi.org/10.1371/journal.pone.0094241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842612	gold, Green Published, Green Submitted			2022-12-25	WOS:000340948600003
J	Barone, A; Saljo, K; Benktander, J; Blomqvist, M; Mansson, JE; Johansson, BR; Molne, J; Aspegren, A; Bjorquist, P; Breimer, ME; Teneberg, S				Barone, Angela; Saljo, Karin; Benktander, John; Blomqvist, Maria; Mansson, Jan-Eric; Johansson, Bengt R.; Molne, Johan; Aspegren, Anders; Bjorquist, Petter; Breimer, Michael E.; Teneberg, Susann			Sialyl-lactotetra, a Novel Cell Surface Marker of Undifferentiated Human Pluripotent Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN TERATOCARCINOMA CELLS; MONOCLONAL-ANTIBODY; STRUCTURAL-CHARACTERIZATION; SERIES GANGLIOSIDES; BRAIN GANGLIOSIDES; MASS-SPECTROMETRY; DIFFERENTIATION; GLYCOSPHINGOLIPIDS; GLYCOLIPIDS; ANTIGEN	Cell surface glycoconjugates are used as markers for undifferentiated pluripotent stem cells. Here, antibody binding and mass spectrometry characterization of acid glycosphingolipids isolated from a large number (1 x 10(9) cells) of human embryonic stem cell (hESC) lines allowed identification of several novel acid glycosphingolipids, like the gangliosides sialyl-lactotetraosylceramide and sialyl-globotetraosylceramide, and the sulfated glycosphingolipids sulfatide, sulf-lactosylceramide, and sulf-globopentaosylceramide. A high cell surface expression of sialyl-lactotetra on hESC and human induced pluripotent stem cells (hiPSC) was demonstrated by flow cytometry, immunohistochemistry, and electron microscopy, whereas sulfated glycosphingolipids were only found in intracellular compartments. Immunohistochemistry showed distinct cell surface anti-sialyl-lactotetra staining on all seven hESC lines and three hiPSC lines analyzed, whereas no staining of hESC-derived hepatocyte-like or cardiomyocyte-like cells was obtained. Upon differentiation of hiPSC into hepatocyte-like cells, the sialyl-lactotetra epitope was rapidly down-regulated and not detectable after 14 days. These findings identify sialyl-lactotetra as a promising marker of undifferentiated human pluripotent stem cells.	[Barone, Angela; Saljo, Karin; Breimer, Michael E.] Inst Clin Sci, Dept Surg, S-41345 Gothenburg, Sweden; [Benktander, John; Johansson, Bengt R.; Teneberg, Susann] Inst Biomed, Dept Med Biochem & Cell Biol, S-40530 Gothenburg, Sweden; [Blomqvist, Maria; Mansson, Jan-Eric] Inst Biomed, Dept Clin Chem & Transfus Med, S-41345 Gothenburg, Sweden; [Molne, Johan] Inst Biomed, Dept Pathol, S-41345 Gothenburg, Sweden; [Aspegren, Anders; Bjorquist, Petter] Cellartis AB, Cellectis Stem Cells, S-41346 Gothenburg, Sweden	Takara Bio Inc.; Cellartis	Breimer, ME (corresponding author), Sahlgrens Univ Hosp, Dept Surg, Inst Clin Sci, SE-41345 Gothenburg, Sweden.	michael.breimer@clinchem.gu.se; Susann.Teneberg@medkem.gu.se		Molne, Johan/0000-0001-6241-7117; Saljo, Karin/0000-0002-2839-9362	Swedish Research Council Grant [12628]; Swedish Cancer Foundation; Swedish Research Council [342-2004-4434]	Swedish Research Council Grant(Swedish Research Council); Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by Swedish Research Council Grant 12628, the Swedish Cancer Foundation, and governmental grants to the Sahlgrenska University Hospital. The LTQ linear quadrupole ion trap mass spectrometer was obtained by Grant 342-2004-4434 from the Swedish Research Council (to G. H.).	Andrews PD, 2010, BIOCHEM J, V432, P21, DOI 10.1042/BJ20101022; BANSAL R, 1989, J NEUROSCI RES, V24, P548, DOI 10.1002/jnr.490240413; Barone A, 2013, J BIOL CHEM, V288, P10035, DOI 10.1074/jbc.M112.436162; DICK JE, 1994, RES IMMUNOL, V145, P380, DOI 10.1016/S0923-2494(94)80203-3; FREDMAN P, 1988, J NEUROCHEM, V50, P912, DOI 10.1111/j.1471-4159.1988.tb02999.x; FREDMAN P, 1988, BIOCHEM J, V251, P17, DOI 10.1042/bj2510017; Fujitani N, 2013, P NATL ACAD SCI USA, V110, P2105, DOI 10.1073/pnas.1214233110; FUKUDA MN, 1986, J BIOL CHEM, V261, P5145; Heins N, 2004, STEM CELLS, V22, P367, DOI 10.1634/stemcells.22-3-367; Hsu FF, 2004, J AM SOC MASS SPECTR, V15, P536, DOI 10.1016/j.jasms.2003.12.007; Hu BY, 2009, NAT PROTOC, V4, P1614, DOI 10.1038/nprot.2009.186; Ito E, 2012, NEUROCHEM RES, V37, P1315, DOI 10.1007/s11064-012-0735-z; KANNAGI R, 1983, J BIOL CHEM, V258, P8934; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; KARLSSON KA, 1987, METHOD ENZYMOL, V138, P212; KUNDU SK, 1984, BIOCHEM BIOPH RES CO, V118, P82; LEVERY SB, 1994, ARCH BIOCHEM BIOPHYS, V312, P125, DOI 10.1006/abbi.1994.1290; Liang YJ, 2011, STEM CELLS, V29, P1995, DOI 10.1002/stem.750; Liang YJ, 2010, P NATL ACAD SCI USA, V107, P22564, DOI 10.1073/pnas.1007290108; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Molne J, 2008, TRANSPLANTATION, V86, P1407, DOI 10.1097/TP.0b013e31818a6805; Natunen S, 2011, GLYCOBIOLOGY, V21, P1125, DOI 10.1093/glycob/cwq209; NILSSON O, 1985, FEBS LETT, V182, P398, DOI 10.1016/0014-5793(85)80341-0; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Nystedt J, 2010, STEM CELLS, V28, P258, DOI 10.1002/stem.250; Okano H, 2013, CIRC RES, V112, P523, DOI 10.1161/CIRCRESAHA.111.256149; PRIETO PA, 1986, ARCH BIOCHEM BIOPHYS, V249, P243, DOI 10.1016/0003-9861(86)90580-1; Ramirez JM, 2011, STEM CELLS, V29, P1469, DOI 10.1002/stem.681; RIVKIN MJ, 1995, ANN NEUROL, V38, P92, DOI 10.1002/ana.410380116; SCHWARTING GA, 1983, BIOCHEM BIOPH RES CO, V112, P935, DOI 10.1016/0006-291X(83)91707-2; SVENNERHOLM L, 1980, BIOCHIM BIOPHYS ACTA, V617, P97, DOI 10.1016/0005-2760(80)90227-1; SVENNERHOLM L, 1989, BIOCHIM BIOPHYS ACTA, V1005, P109, DOI 10.1016/0005-2760(89)90175-6; SVENNERHOLM L, 1991, J NEUROCHEM, V56, P1763, DOI 10.1111/j.1471-4159.1991.tb02078.x; Takahashi T, 2012, J LIPID RES, V53, P1437, DOI 10.1194/jlr.R026682; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; Ulvestad M, 2013, BIOCHEM PHARMACOL, V86, P691, DOI 10.1016/j.bcp.2013.06.029; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; WIKSTRAND CJ, 1991, J NEUROPATH EXP NEUR, V50, P756, DOI 10.1097/00005072-199111000-00007; Wright AJ, 2009, STEM CELL RES, V3, P3, DOI 10.1016/j.scr.2009.04.001	40	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18846	18859		10.1074/jbc.M114.568832	http://dx.doi.org/10.1074/jbc.M114.568832			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24841197	hybrid, Green Published			2022-12-25	WOS:000339062900019
J	Brazin, KN; Mallis, RJ; Li, C; Keskin, DB; Arthanari, H; Gao, YW; Wu, SL; Karger, BL; Wagner, G; Reinherz, EL				Brazin, Kristine N.; Mallis, Robert J.; Li, Chen; Keskin, Derin B.; Arthanari, Haribabu; Gao, Yuanwei; Wu, Shiaw-Lin; Karger, Barry L.; Wagner, Gerhard; Reinherz, Ellis L.			Constitutively Oxidized CXXC Motifs within the CD3 Heterodimeric Ectodomains of the T Cell Receptor Complex Enforce the Conformation of Juxtaposed Segments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; ANTIGEN RECEPTOR; ALPHA-BETA; NMR DATA; REDOX STATE; ACTIVATION; PROTEIN; THIOREDOXIN; CD3-EPSILON; LYMPHOCYTES	The CD3 epsilon gamma and CD3 epsilon delta heterodimers along with the CD3 zeta zeta homodimer are the signaling components of the T cell receptor (TCR). These invariant dimers are non-covalently associated on the T cell plasma membrane with a clone-specific (i.e. clonotypic) alpha beta heterodimer that binds its cognate ligand, a complex between a particular antigenic peptide, and an MHC molecule (pMHC). These four TCR dimers exist in a 1:1:1:1 stoichiometry. At the junction between the extracellular and transmembrane domains of each mammalianCD3 epsilon, CD3 gamma, and CD3 delta subunit is a highly conserved CXXC motif previously found to be important for thymocyte and T cell activation. The redox state of each CXXC motif is presently unknown. Here we show using LC-MS and a biotin switch assay that these CXXC segments are constitutively oxidized on resting and activated T cells, consistent with their measured reduction potential. NMR chemical shift perturbation experiments comparing a native oxidized CD3 delta CXXC-containing segment with that of a mutant SXXS-containing CD3 delta segment in LPPG (1-palmitoyl-sn-glycero-3-phospho-(1'-racglycerol) (sodium salt)) micelles show extensive chemical shift differences in residues within the membrane-proximal motif as well as throughout the transmembrane and cytoplasmic domains as a result of the elimination of the native disulfide. Likewise, direct comparison of the native CD3 delta segment in oxidizing and reducing conditions reveals numerous spectral differences. The oxidized CXXC maintains the structure within the membrane-proximal stalk region as well as that of its contiguous transmembrane and cytoplasmic domain, inclusive of the ITAM (immunoreceptor tyrosine-based activation motif) involved in signaling. These results suggest that preservation of the CD3 CXXC oxidized state may be essential for TCR mechanotransduction.	[Brazin, Kristine N.; Keskin, Derin B.; Reinherz, Ellis L.] Dana Farber Canc Inst, Lab Immunobiol, Dept Med Oncol, Boston, MA 02115 USA; [Brazin, Kristine N.; Reinherz, Ellis L.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Mallis, Robert J.; Arthanari, Haribabu; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Li, Chen; Gao, Yuanwei; Wu, Shiaw-Lin; Karger, Barry L.] Northeastern Univ, Barnett Inst Chem & Biol Anal, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Northeastern University	Reinherz, EL (corresponding author), Dana Farber Canc Inst, Lab Immunobiol, HIM 419,77 Ave Louis Pasteur, Boston, MA 02115 USA.	ellis_reinherz@dfci.harvard.edu	Mallis, Robert/A-2270-2015	Arthanari, Haribabu/0000-0002-7281-1289	National Institutes of Health Grants [AI100643-01, GM047467, AI375581, P41-EB002026, S10-RR029236, GM15847]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100643, R01AI037581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM015847, F32GM015847, P01GM047467, R01GM015847] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI100643-01 (to E. L. R.), GM047467 (to E. L. R. and G. W.), AI375581, P41-EB002026, and S10-RR029236 (to G. W.) and GM15847 (to B. L. K.).	ACUTO O, 1983, CELL, V34, P717, DOI 10.1016/0092-8674(83)90528-7; Arnaiz-Villena A, 1993, Immunodeficiency, V4, P121; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; BLUMBERG RS, 1990, J BIOL CHEM, V265, P14036; Borroto A, 1998, J BIOL CHEM, V273, P12807, DOI 10.1074/jbc.273.21.12807; Call ME, 2005, ANNU REV IMMUNOL, V23, P101, DOI 10.1146/annurev.immunol.23.021704.115625; Chen W, 2013, IMMUNOL REV, V256, P160, DOI 10.1111/imr.12122; Choi YI, 2014, P NATL ACAD SCI USA, V111, P379, DOI 10.1073/pnas.1314209111; COSSON P, 1991, NATURE, V351, P414, DOI 10.1038/351414a0; Dave VP, 1997, EMBO J, V16, P1360, DOI 10.1093/emboj/16.6.1360; de Saint Basile G, 2004, J CLIN INVEST, V114, P1512, DOI 10.1172/JCI200422588; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Forrester MT, 2009, FREE RADICAL BIO MED, V46, P119, DOI 10.1016/j.freeradbiomed.2008.09.034; Gil J, 2011, J CLIN INVEST, V121, P3872, DOI 10.1172/JCI44254; Haks MC, 1998, EMBO J, V17, P1871, DOI 10.1093/emboj/17.7.1871; Husson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019680; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z; Hyberts SG, 2010, J AM CHEM SOC, V132, P2145, DOI 10.1021/ja908004w; Indu S, 2010, PROTEINS, V78, P1228, DOI 10.1002/prot.22641; Iqbalsyah TM, 2006, PROTEIN SCI, V15, P1945, DOI 10.1110/ps.062271506; JIN YJ, 1990, J BIOL CHEM, V265, P15850; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones DP, 2000, FREE RADICAL BIO MED, V28, P625, DOI 10.1016/S0891-5849(99)00275-0; Judokusumo E, 2012, BIOPHYS J, V102, pL5, DOI 10.1016/j.bpj.2011.12.011; Keller R., 2004, COMPUTER AIDED RESON, V1; Kim ST, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00076; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; KONING F, 1990, EUR J IMMUNOL, V20, P299, DOI 10.1002/eji.1830200211; Kuhns MS, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00159; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; Li YC, 2010, J IMMUNOL, V184, P5959, DOI 10.4049/jimmunol.0900775; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Liu BY, 2014, CELL, V157, P357, DOI 10.1016/j.cell.2014.02.053; Ma ZY, 2010, TRENDS IMMUNOL, V31, P1, DOI 10.1016/j.it.2009.09.008; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; MANOLIOS N, 1990, SCIENCE, V249, P274, DOI 10.1126/science.2142801; MANOLIOS N, 1991, EMBO J, V10, P1643, DOI 10.1002/j.1460-2075.1991.tb07687.x; Metcalfe C, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110010; MEUER SC, 1983, SCIENCE, V222, P1239, DOI 10.1126/science.6606228; MEUER SC, 1984, CELL, V36, P897, DOI 10.1016/0092-8674(84)90039-4; Miyamoto S, 2003, AM HEART J, V146, P465, DOI 10.1016/S0002-8703(03)00311-9; OHMORI H, 1986, JPN J PHARMACOL, V42, P135, DOI 10.1254/jjp.42.135; Piotukh K, 2007, FREE RADICAL BIO MED, V43, P1263, DOI 10.1016/j.freeradbiomed.2007.06.010; REINHERZ EL, 1982, CELL, V30, P735, DOI 10.1016/0092-8674(82)90278-1; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Son A, 2009, ANTIOXID REDOX SIGN, V11, P2595, DOI [10.1089/ars.2009.2522, 10.1089/ARS.2009.2522]; Sun ZYJ, 2004, P NATL ACAD SCI USA, V101, P16867, DOI 10.1073/pnas.0407576101; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Tokgoz H, 2013, PEDIAT ALLERG IMM-UK, V24, P257, DOI 10.1111/pai.12063; Touma M, 2007, J IMMUNOL, V178, P3668, DOI 10.4049/jimmunol.178.6.3668; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wang YB, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000253; Xu CQ, 2006, J BIOL CHEM, V281, P36977, DOI 10.1074/jbc.M607164200; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Zhou YF, 2014, BLOOD, V123, P1785, DOI 10.1182/blood-2013-11-523639; Zhou YF, 2012, BLOOD, V120, P449, DOI 10.1182/blood-2012-01-405134	60	20	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18880	18892		10.1074/jbc.M114.574996	http://dx.doi.org/10.1074/jbc.M114.574996			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24849600	Green Published, hybrid			2022-12-25	WOS:000339062900022
J	Granato, DC; Zanetti, MR; Kawahara, R; Yokoo, S; Domingues, RR; Aragao, AZ; Agostini, M; Carazzolle, MF; Vidal, RO; Flores, IL; Korvala, J; Cervigne, NK; Silva, ARS; Coletta, RD; Graner, E; Sherman, NE; Leme, AFP				Granato, Daniela C.; Zanetti, Mariana R.; Kawahara, Rebeca; Yokoo, Sami; Domingues, Romenia R.; Aragao, Annelize Z.; Agostini, Michelle; Carazzolle, Marcelo F.; Vidal, Ramon O.; Flores, Isadora L.; Korvala, Johanna; Cervigne, Nilva K.; Silva, Alan R. S.; Coletta, Ricardo D.; Graner, Edgard; Sherman, Nicholas E.; Paes Leme, Adriana F.			Integrated Proteomics Identified Up-Regulated Focal Adhesion-Mediated Proteins in Human Squamous Cell Carcinoma in an Orthotopic Murine Model	PLOS ONE			English	Article							CANCER; METABOLISM; EXPRESSION; BINDING; MARKER	Understanding the molecular mechanisms of oral carcinogenesis will yield important advances in diagnostics, prognostics, effective treatment, and outcome of oral cancer. Hence, in this study we have investigated the proteomic and peptidomic profiles by combining an orthotopic murine model of oral squamous cell carcinoma (OSCC), mass spectrometry-based proteomics and biological network analysis. Our results indicated the up-regulation of proteins involved in actin cytoskeleton organization and cell-cell junction assembly events and their expression was validated in human OSCC tissues. In addition, the functional relevance of talin-1 in OSCC adhesion, migration and invasion was demonstrated. Taken together, this study identified specific processes deregulated in oral cancer and provided novel refined OSCC-targeting molecules.	[Granato, Daniela C.; Zanetti, Mariana R.; Kawahara, Rebeca; Yokoo, Sami; Domingues, Romenia R.; Aragao, Annelize Z.; Carazzolle, Marcelo F.; Vidal, Ramon O.; Flores, Isadora L.; Paes Leme, Adriana F.] CNPEM, LNBio, Lab Espectrometria Massas, Lab Nacl Biociencias, Campinas, SP, Brazil; [Agostini, Michelle; Flores, Isadora L.; Cervigne, Nilva K.; Silva, Alan R. S.; Coletta, Ricardo D.; Graner, Edgard] Univ Estadual Campinas, UNICAMP, Fac Odontol Piracicaba, Piracicaba, Brazil; [Agostini, Michelle] Univ Fed Rio de Janeiro, Fac Odontol, Rio De Janeiro, Brazil; [Sherman, Nicholas E.] Univ Virginia, WM Keck Biomed Mass Spectrometry Lab, Charlottesville, VA USA; [Korvala, Johanna] Univ Oulu, Inst Dent, Oulu, Finland	Universidade Estadual de Campinas; Universidade Federal do Rio de Janeiro; University of Virginia; University of Oulu	Leme, AFP (corresponding author), CNPEM, LNBio, Lab Espectrometria Massas, Lab Nacl Biociencias, Campinas, SP, Brazil.	adriana.paesleme@lnbio.cnpem.br	Carazzolle, Marcelo Falsarella/C-6503-2012; Leme, Adriana F Paes/C-9679-2012; Cervigne, Nilva K/L-1341-2016; Aragão, Annelize Z B/I-6535-2012; Graner, Edgard/P-4651-2019; Santos-Silva, Alan/C-9947-2016; Santos-Silva, Alan Roger/B-6121-2008; Agostini, Michelle/I-1275-2012; Agostini, Michelle/AAD-6610-2022; Graner, Edgard/K-4411-2012; Coletta, Ricardo D./B-4909-2015; Flores, Isadora L/H-8329-2014; UNICAMP, CCES -/J-7787-2015; Kawahara, Rebeca/B-1532-2015	Carazzolle, Marcelo Falsarella/0000-0002-5474-2830; Leme, Adriana F Paes/0000-0001-7959-147X; Cervigne, Nilva K/0000-0002-6129-9136; Santos-Silva, Alan/0000-0003-2040-6617; Santos-Silva, Alan Roger/0000-0003-2040-6617; Agostini, Michelle/0000-0002-3648-337X; Graner, Edgard/0000-0002-4737-7935; Coletta, Ricardo D./0000-0001-5285-3046; Flores, Isadora L/0000-0002-6628-2122; Sherman, Nicholas/0000-0003-3206-3113; Rodrigues Zanetti, Mariana/0000-0001-8335-1575; Kawahara, Rebeca/0000-0002-0292-2637; Yokoo, Sami/0000-0003-4658-9319	FAPESP [2009/54067-3, 2010/19278-0, 2011/22421-2, 2009/53839-2, 2011/02267-9]; CNPq [470567/20090, 470549/2011-4, 301702/2011-0, 470268/2013-1, 505413/2013-2]; Science without Borders Program [MEC/MCTI/CAPES/CNPq/FAPs 109/2012]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Science without Borders Program	This work was supported by FAPESP Grants: 2009/54067-3, 2010/19278-0, 2011/22421-2, 2009/53839-2 and 2011/02267-9; CNPq Grants: 470567/20090, 470549/2011-4, 301702/2011-0, 470268/2013-1, and 505413/2013-2; and Science without Borders Program Grant MEC/MCTI/CAPES/CNPq/FAPs 109/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini M, 2014, MOL CANCER THER, V13, P585, DOI 10.1158/1535-7163.MCT-12-1136; Aragao AZB, 2012, J BIOL CHEM, V287, P43071, DOI 10.1074/jbc.M112.364513; Assinder SJ, 2009, INT J BIOCHEM CELL B, V41, P482, DOI 10.1016/j.biocel.2008.02.011; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Choi S, 2008, J DENT RES, V87, P14, DOI 10.1177/154405910808700104; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Doucet A, 2008, MOL CELL PROTEOMICS, V7, P1925, DOI 10.1074/mcp.R800012-MCP200; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Findeisen P, 2012, PROTEOM CLIN APPL, V6, P60, DOI 10.1002/prca.201100058; Fujita Y, 2008, CANCER LETT, V263, P280, DOI 10.1016/j.canlet.2008.01.013; Gelman JS, 2011, J PROTEOME RES, V10, P1583, DOI 10.1021/pr100952f; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heath CH, 2012, ANN SURG ONCOL, V19, P3879, DOI 10.1245/s10434-012-2435-y; Hwang YS, 2013, ARCH ORAL BIOL, V58, P218, DOI 10.1016/j.archoralbio.2012.04.023; Israel M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-70; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Lai MT, 2011, J PATHOL, V224, P367, DOI 10.1002/path.2867; Lynch CD, 2013, MOL BIOL CELL, V24, P21, DOI 10.1091/mbc.E12-05-0377; Mognetti B, 2006, ORAL ONCOL, V42, P448, DOI 10.1016/j.oraloncology.2005.07.014; Myers JN, 2002, CLIN CANCER RES, V8, P293; Leme AFP, 2012, J PROTEOME RES, V11, P279, DOI 10.1021/pr2006439; Panis C, 2013, CANCER LETT, V330, P57, DOI 10.1016/j.canlet.2012.11.020; Shen YF, 2011, J PROTEOME RES, V10, P3929, DOI 10.1021/pr200052c; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Team RDC, 2009, R LANG ENV STAT COMP; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Wang Y, 2012, J CELL BIOL, V196, P375, DOI 10.1083/jcb.201105153; Wang Z, 2008, MOL CELL PROTEOMICS, V7, P1639, DOI 10.1074/mcp.M700520-MCP200; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Wetting HL, 2011, AM J PATHOL, V178, P2389, DOI 10.1016/j.ajpath.2011.01.022; Wong DTW, 1996, CRIT REV ORAL BIOL M, V7, P319, DOI 10.1177/10454411960070040201; Yue JY, 2012, DNA REPAIR, V11, P192, DOI 10.1016/j.dnarep.2011.10.019; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273	38	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98208	10.1371/journal.pone.0098208	http://dx.doi.org/10.1371/journal.pone.0098208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858105	Green Published, gold, Green Submitted			2022-12-25	WOS:000336839400056
J	Maawy, AA; Hiroshima, Y; Zhang, Y; Luiken, GA; Hoffman, RM; Bouvet, M				Maawy, Ali A.; Hiroshima, Yukihiko; Zhang, Yong; Luiken, George A.; Hoffman, Robert M.; Bouvet, Michael			Polyethylene Glycol (PEG) Linked to Near Infrared (NIR) Dyes Conjugated to Chimeric Anti-Carcinoembryonic Antigen (CEA) Antibody Enhances Imaging of Liver Metastases in a Nude-Mouse Model of Human Colon Cancer	PLOS ONE			English	Article							FLUORESCENCE-GUIDED SURGERY; PANCREATIC-CANCER; REAL-TIME; COMPLETE RESECTION; IDENTIFICATION	We report here that polyethylene glycol (PEG) linked to near infrared dyes conjugated to chimeric mouse-human anti-carcinoembryonic antigen (CEA) antibody greatly improves imaging of liver metastases in a nude mouse model of colon-cancer experimental metastases. PEGylated and non-PEGylated DyLight 650 and 750 dyes were conjugated to the chimeric anti-CEA antibody. The dyes were initially injected intravenously into nude mice without tumors. Tissue biodistribution was determined by tissue sonication and analyzing tissue dye concentration profiles over time. PEGylated dyes had significantly lower accumulation in the liver (p = 0.03 for the 650 dyes; p = 0.002 for the 750 dyes) compared to non-PEGylated dyes. In an experimental liver metastasis model of HT-29 colon cancer, PEGylated dyes conjugated to the anti-CEA antibody showed good labeling of metastatic tumors with high contrast between normal and malignant tissue which was not possible with the non-PEGylated dyes since there was so much non-specific accumulation in the liver. PEGylation of the DyLight 650 and 750 NIR dyes significantly altered tissue biodistribution, allowing brighter tissue labeling, decreased accumulation in normal organs, particularly the liver. This enabled high fidelity and high contrast imaging of liver metastases.	[Maawy, Ali A.; Hoffman, Robert M.; Bouvet, Michael] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Hiroshima, Yukihiko; Zhang, Yong; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA; [Hiroshima, Yukihiko] Yokohama City Univ, Yokohama, Kanagawa 232, Japan; [Luiken, George A.] OncoFluor Inc, San Diego, CA USA; [Bouvet, Michael] VA San Diego Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; Anti Cancer Inc; Yokohama City University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Bouvet, M (corresponding author), Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA.	mbouvet@ucsd.edu			National Cancer Institute [CA142669, CA132971]; NATIONAL CANCER INSTITUTE [R01CA142669, R01CA132971] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the National Cancer Institute CA142669 and CA132971 (to M. B. and AntiCancer, Inc). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilefu S, 2010, ANGEW CHEM INT EDIT, V49, P9816, DOI 10.1002/anie.201005684; Bailon P, 2009, EXPERT OPIN DRUG DEL, V6, P1, DOI [10.1517/17425240802650568, 10.1517/17425240802650568 ]; Bouvet M, 2006, CANCER RES, V66, P11293, DOI 10.1158/0008-5472.CAN-06-2662; Bouvet M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003375; Cao HST, 2012, HEPATO-GASTROENTEROL, V59, P1994, DOI 10.5754/hge11836; DELGADO C, 1992, CRIT REV THER DRUG, V9, P249; Gioux S, 2010, MOL IMAGING, V9, P237, DOI 10.2310/7290.2010.00034; Harris JM, 2001, CLIN PHARMACOKINET, V40, P539, DOI 10.2165/00003088-200140070-00005; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Katz MH, 2003, J SURG RES, V113, P151, DOI 10.1016/S0022-4804(03)00234-8; Kaushal S, 2008, J GASTROINTEST SURG, V12, P1938, DOI 10.1007/s11605-008-0581-0; Kishimoto H, 2009, P NATL ACAD SCI USA, V106, P14514, DOI 10.1073/pnas.0906388106; Kobayashi H, 2010, CHEM REV, V110, P2620, DOI 10.1021/cr900263j; Lee BT, 2010, PLAST RECONSTR SURG, V126, P1472, DOI 10.1097/PRS.0b013e3181f059c7; Lee H, 2006, J ORG CHEM, V71, P7862, DOI 10.1021/jo061284u; Maawy AA, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.126016; Matsui A, 2010, SURGERY, V148, P78, DOI 10.1016/j.surg.2009.12.003; Matsui A, 2010, SURGERY, V148, P87, DOI 10.1016/j.surg.2009.12.004; McElroy M, 2008, WORLD J SURG, V32, P1057, DOI 10.1007/s00268-007-9452-1; Metildi CA, 2014, J SURG ONCOL, V109, P451, DOI 10.1002/jso.23507; Metildi CA, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/290634; Metildi CA, 2013, J SURG RES, V179, P87, DOI 10.1016/j.jss.2012.08.052; Metildi CA, 2012, J AM COLL SURGEONS, V215, P126, DOI 10.1016/j.jamcollsurg.2012.02.021; Metildi CA, 2012, J AM COLL SURGEONS, V214, P997, DOI 10.1016/j.jamcollsurg.2012.02.009; Ohnishi S, 2005, MOL IMAGING, V4, P172; Okuda T, 2012, J CLIN NEUROSCI, V19, P1719, DOI 10.1016/j.jocn.2011.12.034; Spinoglio G, 2013, SURG ENDOSC, V27, P2156, DOI 10.1007/s00464-012-2733-2; Tanaka E, 2009, J THORAC CARDIOV SUR, V138, P133, DOI 10.1016/j.jtcvs.2008.09.082; Uchugonova A, 2013, J CELL BIOCHEM, V114, P99, DOI 10.1002/jcb.24305; van Dam GM, 2011, NAT MED, V17, P1315, DOI 10.1038/nm.2472; Verbeek FPR, 2012, J HEPATO-BIL-PAN SCI, V19, P626, DOI 10.1007/s00534-012-0534-6; Verbeek FP, 2013, J UROL; Veronese FM, 1999, FARMACO, V54, P497, DOI 10.1016/S0014-827X(99)00066-X; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927	34	24	25	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97965	10.1371/journal.pone.0097965	http://dx.doi.org/10.1371/journal.pone.0097965			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859320	Green Submitted, Green Published, gold			2022-12-25	WOS:000336839400032
J	Gamero, A; Belloch, C; Ibanez, C; Querol, A				Gamero, Amparo; Belloch, Carmela; Ibanez, Clara; Querol, Amparo			Molecular Analysis of the Genes Involved in Aroma Synthesis in the Species S. cerevisiae, S. kudriavzevii and S. bayanus var. uvarum in Winemaking Conditions	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; NATURAL HYBRIDS; VOLATILE COMPOUNDS; ESTER PRODUCTION; WINE; FERMENTATION; STRAINS; TEMPERATURE; EXPRESSION; CRYOTOLERANT	The Saccharomyces genus is the main yeast involved in wine fermentations to play a crucial role in the production and release of aromatic compounds. Despite the several studies done into the genome-wide expression analysis using DNA microarray technology in wine S. cerevisiae strains, this is the first to investigate other species of the Saccharomyces genus. This research work investigates the expression of the genes involved in flavor compound production in three different Saccharomyces species (S. cerevisiae, S. bayanus var. uvarum and S. kudriavzevii) under low (12 degrees C) and moderate fermentation temperatures (28 degrees C). The global genes analysis showed that 30% of genes appeared to be differently expressed in the three cryophilic strains if compared to the reference strain (mesophilic S. cerevisiae), suggesting a very close cold adaptation response. Remarkable differences in the gene expression level were observed when comparing the three species, S. cerevisiae, S. bayanus var. uvarum and S. kudriavzevii, which will result in different aroma profiles. Knowledge of these differences in the transcriptome can be a tool to help modulate aroma to create wines with the desired aromatic traits.	[Gamero, Amparo; Belloch, Carmela; Ibanez, Clara; Querol, Amparo] CSIC, Inst Agroquim & Tecnol Alimentos, Dept Biotecnol, E-46010 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Querol, A (corresponding author), CSIC, Inst Agroquim & Tecnol Alimentos, Dept Biotecnol, Jaime Roig 11, E-46010 Valencia, Spain.	aquerol@iata.csic.es	Belloch, Carmela/H-4599-2012; Querol, Amparo/H-3782-2012; Lluna, Amparo Gamero/R-2415-2018; Querol, Amparo/AAW-7469-2020; Ibanez, Clara/K-2946-2014	Belloch, Carmela/0000-0002-5136-0482; Querol, Amparo/0000-0002-6478-6845; Lluna, Amparo Gamero/0000-0002-7226-4844; Querol, Amparo/0000-0002-6478-6845; Ibanez, Clara/0000-0003-4427-2393	Spanish Government; PROMETEO grant from the Generalitat Valenciana [PROMETEO/2009/019];  [AGL2009-12673-CO2-01];  [AGL2012-39937-C02-01]	Spanish Government(Spanish GovernmentEuropean Commission); PROMETEO grant from the Generalitat Valenciana; ; 	AGL2009-12673-CO2-01, AGL2012-39937-C02-01 and from the Spanish Government and PROMETEO grant (Project PROMETEO/2009/019) from the Generalitat Valenciana to A. Querol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerny J., 1996, REV SUISSE VITIC ARB, V28, P161; Antonelli A, 1999, J AGR FOOD CHEM, V47, P1139, DOI 10.1021/jf9807317; Antunovics Z., 2003, Bulletin de l'O.I.V., V76, P380; Backhus LE, 2001, FEMS YEAST RES, V1, P111, DOI 10.1016/S1567-1356(01)00019-8; Belloch C, 2008, INT J FOOD MICROBIOL, V122, P188, DOI 10.1016/j.ijfoodmicro.2007.11.083; Belloch C, 2009, APPL ENVIRON MICROB, V75, P2534, DOI 10.1128/AEM.02282-08; Beltran G, 2006, FEMS YEAST RES, V6, P1167, DOI 10.1111/j.1567-1364.2006.00106.x; Bisson LF, 1999, AM J ENOL VITICULT, V50, P107; Coloretti F, 2006, FOOD MICROBIOL, V23, P672, DOI 10.1016/j.fm.2005.11.002; Delcroix Agnes, 1994, American Journal of Enology and Viticulture, V45, P291; Demuyter C, 2004, J APPL MICROBIOL, V97, P1140, DOI 10.1111/j.1365-2672.2004.02394.x; Erasmus DJ, 2003, FEMS YEAST RES, V3, P375, DOI 10.1016/S1567-1356(02)00203-9; Gamero A, 2013, J APPL MICROBIOL, V114, P1405, DOI 10.1111/jam.12126; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Giudici P, 1998, LETT APPL MICROBIOL, V27, P31; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; GOLDNER MC, 2009, J SENS STUD, V24, P243, DOI 10.1111/j.1745-459X.2009.00208.x; Gonzalez SS, 2006, FEMS YEAST RES, V6, P1221, DOI 10.1111/j.1567-1364.2006.00126.x; Hazelwood LA, 2008, APPL ENVIRON MICROB, V74, P2259, DOI 10.1128/AEM.02625-07; Henschke PA, 2000, AUST J GRAPE WINE R, V6, P190; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; KONDO K, 1992, J BIOL CHEM, V267, P16259; Lambrechts M. G., 2000, South African Journal of Enology and Viticulture, V21, P97; LEE S, 1995, J AM SOC BREW CHEM, V53, P153; Llaurado J, 2002, J FOOD SCI, V67, P268, DOI 10.1111/j.1365-2621.2002.tb11396.x; Llaurado JM, 2005, J AGR FOOD CHEM, V53, P1003, DOI 10.1021/jf049324n; Lopes CA, 2010, FEMS YEAST RES, V10, P412, DOI 10.1111/j.1567-1364.2010.00614.x; Marks VD, 2008, FEMS YEAST RES, V8, P35, DOI 10.1111/j.1567-1364.2007.00338.x; Masneuf I, 1998, APPL ENVIRON MICROB, V64, P3887; Masneuf-Pomarede I, 2010, INT J FOOD MICROBIOL, V139, P79, DOI 10.1016/j.ijfoodmicro.2010.01.038; MRSA V, 1993, J BACTERIOL, V175, P2102, DOI 10.1128/JB.175.7.2102-2106.1993; Naumov GI, 2000, RES MICROBIOL, V151, P683, DOI 10.1016/S0923-2508(00)90131-1; Peris D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-407; Pizarro FJ, 2008, APPL ENVIRON MICROB, V74, P6358, DOI 10.1128/AEM.00602-08; QUEROL A, 1992, APPL ENVIRON MICROB, V58, P2948, DOI 10.1128/AEM.58.9.2948-2953.1992; Rojas V, 2001, INT J FOOD MICROBIOL, V70, P283, DOI 10.1016/S0168-1605(01)00552-9; Rossignol T, 2003, YEAST, V20, P1369, DOI 10.1002/yea.1046; Rossouw D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-530; Saerens SMG, 2008, APPL ENVIRON MICROB, V74, P454, DOI 10.1128/AEM.01616-07; Saerens SMG, 2010, MICROB BIOTECHNOL, V3, P165, DOI 10.1111/j.1751-7915.2009.00106.x; Sampaio JP, 2008, APPL ENVIRON MICROB, V74, P2144, DOI 10.1128/AEM.02396-07; Schmidt S, 2011, APPL ENVIRON MICROB, V77, P1751, DOI 10.1128/AEM.01125-10; Sipiczki M, 2008, FEMS YEAST RES, V8, P996, DOI 10.1111/j.1567-1364.2008.00369.x; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Swiegers JH, 2005, ADV APPL MICROBIOL, V57, P131, DOI 10.1016/S0065-2164(05)57005-9; TAYLOR GT, 1979, J I BREWING, V85, P219, DOI 10.1002/j.2050-0416.1979.tb03911.x; Torija MJ, 2003, INT J FOOD MICROBIOL, V85, P127, DOI 10.1016/S0168-1605(02)00506-8; Tosi E, 2009, J APPL MICROBIOL, V107, P210, DOI 10.1111/j.1365-2672.2009.04196.x; VANDIJKEN JP, 1986, FEMS MICROBIOL LETT, V32, P199, DOI 10.1016/0378-1097(86)90291-0; Varela C, 2005, YEAST, V22, P369, DOI 10.1002/yea.1217; Verstrepen KJ, 2003, FEMS YEAST RES, V4, P285, DOI 10.1016/S1567-1356(03)00166-1; VOLLBRECHT D, 1973, ARCH MIKROBIOL, V94, P351, DOI 10.1007/BF00769030; Yoshimoto H, 2002, APPL MICROBIOL BIOT, V59, P501, DOI 10.1007/s00253-002-1041-5	53	20	20	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97626	10.1371/journal.pone.0097626	http://dx.doi.org/10.1371/journal.pone.0097626			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24854353	Green Published, Green Submitted, gold			2022-12-25	WOS:000338323200024
J	Hemmerling, J; Heller, K; Hormannsperger, G; Bazanella, M; Clavel, T; Kollias, G; Haller, D				Hemmerling, Jana; Heller, Katharina; Hoermannsperger, Gabriele; Bazanella, Monika; Clavel, Thomas; Kollias, George; Haller, Dirk			Fetal Exposure to Maternal Inflammation Does Not Affect Postnatal Development of Genetically-Driven Ileitis and Colitis	PLOS ONE			English	Article							CROHNS-DISEASE; BOWEL-DISEASE; EXPRESSION; CELLS; MICROBIOTA; PREGNANCY; SEQUENCES; INTESTINE; PROTEIN; LECTIN	Background: Chronic inflammatory disorders have been increasing in incidence over the past decades following geographical patterns of industrialization. Fetal exposure to maternal inflammation may alter organ functions and the offspring's disease risk. We studied the development of genetically-driven ileitis and colitis in response to maternal inflammation using mouse models. Methods: Disease susceptible (Tnf(Delta ARE/+) and IL10(-/-)) and disease-free (Tnf(+/+) and IL10(-/+)) offspring were raised in inflamed and non-inflamed dams. Ileal, caecal and colonic pathology was evaluated in the offspring at 8 or 12 weeks of age. Ly6G-positive cells in inflamed sections from the distal ileum and distal colon were analysed by immunofluorescence microscopy. Gene expression of pro-inflammatory cytokines was measured in whole tissue specimens by quantitative PCR. Microarray analyses were performed on laser microdissected intestinal epithelium. Caecal bacterial communities were assessed by Illumina sequencing of 16S rRNA amplicons. Results: Disease severity, the number of infiltrated neutrophils as well as Tnf and Il12p40 mRNA expression were independent of maternal inflammation in the offspring of mouse models for ileitis (Tnf(Delta ARE/+)) and colitis (IL10(-/-)). Although TNF-driven maternal inflammation regulated 2,174 (wild type) and 3,345 (Tnf(Delta ARE/+)) genes in the fetal epithelium, prenatal gene expression patterns were completely overwritten after birth. In addition, co-housing experiments revealed no change in phylogenetic diversity of the offspring's caecal microbiota in response to maternal inflammation. This is independent of the offspring's genotype before and after the onset of tissue pathology. Conclusions: Disease risk and activity in mouse models of chronic ileitis and colitis was independent of the fetal exposure to maternal inflammation. Likewise, maternal inflammation did not alter the diversity and composition of offspring's caecal microbiota, clearly demonstrating that changes of the gene expression program in the fetal gut epithelium were not relevant for the development of chronic inflammatory disorders in the gut.	[Hemmerling, Jana; Heller, Katharina; Hoermannsperger, Gabriele; Bazanella, Monika; Clavel, Thomas; Haller, Dirk] Tech Univ Munich, Chair Nutr & Immunol, Freising Weihenstephan, Bavaria, Germany; [Hemmerling, Jana; Heller, Katharina; Hoermannsperger, Gabriele; Bazanella, Monika; Clavel, Thomas; Haller, Dirk] ZIEL Res Ctr Nutr & Food Sci, Freising Weihenstephan, Bavaria, Germany; [Kollias, George] Biomed Sci Res Ctr, Inst Immunol, Athens, Greece	Technical University of Munich	Haller, D (corresponding author), Tech Univ Munich, Chair Nutr & Immunol, Freising Weihenstephan, Bavaria, Germany.	Dirk.Haller@tum.de	Kollias, George/A-7079-2012	Kollias, George/0000-0003-1867-3150; Clavel, Thomas/0000-0002-7229-5595; Haller, Dirk/0000-0002-6977-4085	'Nutritional Adaptation and Epigenetic Mechanisms' program of ZIEL - Research Center for Nutrition and Food Sciences	'Nutritional Adaptation and Epigenetic Mechanisms' program of ZIEL - Research Center for Nutrition and Food Sciences	This work was supported by the 'Nutritional Adaptation and Epigenetic Mechanisms' program of ZIEL - Research Center for Nutrition and Food Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behm BW, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006893; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardenas I, 2011, J IMMUNOL, V187, P980, DOI 10.4049/jimmunol.1100578; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Dominitz JA, 2002, AM J GASTROENTEROL, V97, P641; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Labonte ED, 2003, PROTEIN EXPRES PURIF, V28, P25, DOI 10.1016/S1046-5928(02)00561-2; Malek A, 2001, PLACENTA, V22, pS45, DOI 10.1053/plac.2001.0635; Matsumoto S, 2012, J COMP NEUROL, V520, P479, DOI 10.1002/cne.22705; Morales M, 2000, HEPATO-GASTROENTEROL, V47, P1595; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Oertli M, 2012, J CLIN INVEST, V122, P1082, DOI 10.1172/JCI61029; Renz H, 2012, NAT REV IMMUNOL, V12, P9, DOI 10.1038/nri3112; Renz H, 2011, NAT IMMUNOL, V12, P273, DOI 10.1038/ni0411-273; Roulis M, 2011, P NATL ACAD SCI USA, V108, P5396, DOI 10.1073/pnas.1007811108; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Swamy M, 2010, NAT IMMUNOL, V11, P656, DOI 10.1038/ni.1905; Urakubo A, 2001, SCHIZOPHR RES, V47, P27, DOI 10.1016/S0920-9964(00)00032-3; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vogl T, 2012, INT J MOL SCI, V13, P2893, DOI 10.3390/ijms13032893; von Schillde MA, 2012, CELL HOST MICROBE, V11, P387, DOI 10.1016/j.chom.2012.02.006; Wagner SJ, 2013, INFLAMM BOWEL DIS, V19, P1285, DOI 10.1097/MIB.0b013e318281f573; Werner T, 2011, GUT, V60, P325, DOI 10.1136/gut.2010.216929; Wolfs TGAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005837; Yan X, 2011, INFLAMM BOWEL DIS, V17, P1513, DOI 10.1002/ibd.21539; Yuan YJ, 2012, INT IMMUNOPHARMACOL, V12, P271, DOI 10.1016/j.intimp.2011.11.022	37	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98237	10.1371/journal.pone.0098237	http://dx.doi.org/10.1371/journal.pone.0098237			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849654	Green Published, Green Submitted, gold			2022-12-25	WOS:000336730600101
J	Tatara, AM; Lipner, JH; Das, R; Kim, M; Patel, N; Ntouvali, E; Silva, MJ; Thomopoulos, S				Tatara, Alexander M.; Lipner, Justin H.; Das, Rosalina; Kim, Mike; Patel, Nikunj; Ntouvali, Eleni; Silva, Matthew J.; Thomopoulos, Stavros			The Role of Muscle Loading on Bone (Re)modeling at the Developing Enthesis	PLOS ONE			English	Article							BRACHIAL-PLEXUS PALSY; POSTNATAL-DEVELOPMENT; SHOULDER DYSTOCIA; TENDON ENTHESIS; BISPHOSPHONATES; ALENDRONATE; OSTEOBLAST; RESORPTION; PARALYSIS; OSTEOCYTE	Muscle forces are necessary for the development and maintenance of a mineralized skeleton. Removal of loads leads to malformed bones and impaired musculoskeletal function due to changes in bone (re)modeling. In the current study, the development of a mineralized junction at the interface between muscle and bone was examined under normal and impaired loading conditions. Unilateral mouse rotator cuff muscles were paralyzed using botulinum toxin A at birth. Control groups consisted of contralateral shoulders injected with saline and a separate group of normal mice. It was hypothesized that muscle unloading would suppress bone formation and enhance bone resorption at the enthesis, and that the unloading-induced bony defects could be rescued by suppressing osteoclast activity. In order to modulate osteoclast activity, mice were injected with the bisphosphonate alendronate. Bone formation was measured at the tendon enthesis using alizarin and calcein fluorescent labeling of bone surfaces followed by quantitative histomorphometry of histologic sections. Bone volume and architecture was measured using micro computed tomography. Osteoclast surface was determined via quantitative histomorphometry of tartrate resistant acid phosphatase stained histologic sections. Muscle unloading resulted in delayed initiation of endochondral ossification at the enthesis, but did not impair bone formation rate. Unloading led to severe defects in bone volume and trabecular bone architecture. These defects were partially rescued by suppression of osteoclast activity through alendronate treatment, and the effect of alendronate was dose dependent. Similarly, bone formation rate was increased with increasing alendronate dose across loading groups. The bony defects caused by unloading were therefore likely due to maintained high osteoclast activity, which normally decreases from neonatal through mature timepoints. These results have important implications for the treatment of muscle unloading conditions such as neonatal brachial plexus palsy, which results in shoulder paralysis at birth and subsequent defects in the rotator cuff enthesis and humeral head.	[Tatara, Alexander M.; Lipner, Justin H.; Das, Rosalina; Kim, Mike; Patel, Nikunj; Ntouvali, Eleni; Silva, Matthew J.; Thomopoulos, Stavros] Washington Univ, Dept Orthopaed Surg, St Louis, MO 63130 USA	Washington University (WUSTL)	Thomopoulos, S (corresponding author), Washington Univ, Dept Orthopaed Surg, St Louis, MO 63130 USA.	ThomopoulosS@wudosis.wustl.edu	Lipner, Justin/D-5489-2011	Lipner, Justin/0000-0001-5991-4673; Kim, Hyunmin/0000-0002-5286-5335; Silva, Matthew/0000-0001-7375-4522	National Institutes of Health [R01 AR055580]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055580, P30AR057235] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The research was funded by the National Institutes of Health (R01 AR055580). Micro computed tomography and bone histomorphometry was performed at the Washington University Musculoskeletal Research Center (NIH P30 AR057235). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellido T, 2011, BONE, V49, P50, DOI 10.1016/j.bone.2010.08.008; BIKLE DD, 1994, J BONE MINER RES, V9, P1777; Blitz E, 2009, DEV CELL, V17, P861, DOI 10.1016/j.devcel.2009.10.010; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Carter DR, 1998, SKELETAL GROWTH AND DEVELOPMENT: CLINICAL ISSUES AND BASIC SCIENCE ADVANCES, P99; Das R, 2011, J ORTHOP RES, V29, P281, DOI 10.1002/jor.21234; Evans KD, 2003, BONE, V32, P268, DOI 10.1016/S8756-3282(02)00974-2; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Halasy-Nagy JM, 2001, BONE, V29, P553, DOI 10.1016/S8756-3282(01)00615-9; Iwata K, 2006, BONE, V39, P1053, DOI 10.1016/j.bone.2006.05.006; Kim HM, 2010, J ORTHOP RES, V28, P1391, DOI 10.1002/jor.21128; Kim HM, 2009, J BONE JOINT SURG AM, V91A, P879, DOI 10.2106/JBJS.H.00088; Kirkos JM, 2005, J BONE JOINT SURG BR, V87B, P231, DOI 10.1302/0301-620X.87B2.14739; Liu Y, 2011, J ENG MATER-T ASME, V133, P281; Liu YX, 2012, MECH MATER, V44, P83, DOI 10.1016/j.mechmat.2011.08.005; Mehta SH, 2006, J PERINATOL, V26, P85, DOI 10.1038/sj.jp.7211441; Mollberg M, 2005, ACTA OBSTET GYN SCAN, V84, P654, DOI 10.1111/j.0001-6349.2005.00632.x; Nowlan NC, 2008, J BIOMECH, V41, P249, DOI 10.1016/j.jbiomech.2007.09.031; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; Plotkin LI, 2008, J BONE MINER RES, V23, P1712, DOI 10.1359/JBMR.080617; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Russell RGG, 2007, PEDIATRICS, V119, pS150, DOI 10.1542/peds.2006-2023H; SATO M, 1990, J BONE MINER RES, V5, P31, DOI 10.1002/jbmr.5650050107; Schwartz AG, 2013, BONE, V55, P44, DOI 10.1016/j.bone.2013.03.010; Schwartz AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048630; Sharir A, 2011, DEVELOPMENT, V138, P3247, DOI 10.1242/dev.063768; Thomopoulos S, 2007, J ORTHOP RES, V25, P1154, DOI 10.1002/jor.20418; Weinstein RS, 2009, NEW ENGL J MED, V360, P53, DOI 10.1056/NEJMoa0802633; Wu QQ, 2001, J BIOL CHEM, V276, P35290, DOI 10.1074/jbc.M101055200	30	31	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97375	10.1371/journal.pone.0097375	http://dx.doi.org/10.1371/journal.pone.0097375			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847982	gold, Green Submitted, Green Published			2022-12-25	WOS:000336730600027
J	Carrero-Colon, M; Abshire, N; Sweeney, D; Gaskin, E; Hudson, K				Carrero-Colon, Militza; Abshire, Nathan; Sweeney, Daniel; Gaskin, Erik; Hudson, Karen			Mutations in SACPD-C Result in a Range of Elevated Stearic Acid Concentration in Soybean Seed	PLOS ONE			English	Article							CARRIER-PROTEIN-DESATURASE; OIL; GENE	Soybean oil has a wide variety of uses, and stearic acid, which is a relatively minor component of soybean oil is increasingly desired for both industrial and food applications. New soybean mutants containing high levels of the saturated fatty acid stearate in seeds were recently identified from a chemically mutagenized population. Six mutants ranged in stearate content from 6-14% stearic acid, which is 1.5 to 3 times the levels contained in wild-type seed of the Williams 82 cultivar. Candidate gene sequencing revealed that all of these lines carried amino acid substitutions in the gene encoding the delta-9-stearoyl-acyl-carrier protein desaturase enzyme (SACPD-C) required for the conversion of stearic acid to oleic acid. Five of these missense mutations were in highly conserved residues clustered around the predicted di-iron center of the SACPD-C enzyme. Co-segregation analysis demonstrated a positive association of the elevated stearate trait with the SACPD-C mutation for three populations. These missense mutations may provide additional alleles that may be used in the development of new soybean cultivars with increased levels of stearic acid.	[Carrero-Colon, Militza; Hudson, Karen] ARS, Crop Prod & Pest Control Res Unit, USDA, W Lafayette, IN 47905 USA; [Abshire, Nathan; Sweeney, Daniel; Gaskin, Erik] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA	United States Department of Agriculture (USDA); Purdue University System; Purdue University; Purdue University West Lafayette Campus	Hudson, K (corresponding author), ARS, Crop Prod & Pest Control Res Unit, USDA, W Lafayette, IN 47905 USA.	hudson@ars.usda.gov		Hudson, Karen/0000-0002-7402-2275	USDA-ARS Current Research Information System [3602-21000-006-00D]; ARS [ARS-0424784] Funding Source: Federal RePORTER	USDA-ARS Current Research Information System(United States Department of Agriculture (USDA)USDA Agricultural Research Service); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding for this work was provided through the USDA-ARS Current Research Information System 3602-21000-006-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boersma JG, 2012, CROP SCI, V52, P1736, DOI 10.2135/cropsci2011.08.0411; Byfield GE, 2006, CROP SCI, V46, P840, DOI 10.2135/cropsci2005.06-0172; Clemente TE, 2009, PLANT PHYSIOL, V151, P1030, DOI 10.1104/pp.109.146282; Cooper JL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-9; HAMMOND EG, 1983, CROP SCI, V23, P192; Head K, 2012, MOL BREEDING, V30, P1519, DOI 10.1007/s11032-012-9707-x; Hudson K., 2012, International Journal of Agronomy, V2012, P569817, DOI 10.1155/2012/569817; Lindqvist Y, 1996, EMBO J, V15, P4081, DOI 10.1002/j.1460-2075.1996.tb00783.x; LUNDEEN PO, 1987, CROP SCI, V27, P1102, DOI 10.2135/cropsci1987.0011183X002700060002x; Neff MM, 1998, PLANT J, V14, P387, DOI 10.1046/j.1365-313X.1998.00124.x; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Pantalone VR, 2002, J AM OIL CHEM SOC, V79, P549, DOI 10.1007/s11746-002-0520-8; Rahman SM, 1997, THEOR APPL GENET, V95, P772, DOI 10.1007/s001220050624; Richards E., 2001, CURRENT PROTOCOLS MO, DOI 10.1002/0471142727.mb0203s27; Ruddle P, 2013, CROP SCI, V53, P1887, DOI 10.2135/cropsci2013.02.0120; Ruddle P, 2013, THEOR APPL GENET, V126, P241, DOI 10.1007/s00122-012-1977-5; Zhang P, 2008, CROP SCI, V48, P2305, DOI 10.2135/cropsci2008.02.0084	17	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97891	10.1371/journal.pone.0097891	http://dx.doi.org/10.1371/journal.pone.0097891			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846334	Green Submitted, Green Published, gold			2022-12-25	WOS:000339563400070
J	Hansen, ML; Fallentin, E; Lauridsen, C; Law, I; Federspiel, B; Bksgaard, L; Svendsen, LB; Nielsen, MB				Hansen, Martin Lundsgaard; Fallentin, Eva; Lauridsen, Carsten; Law, Ian; Federspiel, Birgitte; Bksgaard, Lene; Svendsen, Lars Bo; Nielsen, Michael Bachmann			Computed Tomography (CT) Perfusion as an Early Predictive Marker for Treatment Response to Neoadjuvant Chemotherapy in Gastroesophageal Junction Cancer and Gastric Cancer - A Prospective Study	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TUMOR BLOOD-FLOW; GROWTH-FACTOR EXPRESSION; ESOPHAGOGASTRIC JUNCTION; QUANTITATIVE ASSESSMENT; PREOPERATIVE CHEMORADIOTHERAPY; PERIOPERATIVE CHEMOTHERAPY; ESOPHAGEAL-CARCINOMA; MONITORING RESPONSE; 1ST-PASS PERFUSION	Objectives: To evaluate whether early reductions in CT perfusion parameters predict response to pre-operative chemotherapy prior to surgery for gastroesophageal junction (GEJ) and gastric cancer. Materials and Methods: Twenty-eight patients with adenocarcinoma of the gastro-esophageal junction (GEJ) and stomach were included. Patients received three series of chemotherapy before surgery, each consisting of a 3-week cycle of intravenous epirubicin, cisplatin or oxaliplatin, concomitant with capecitabine peroral. The patients were evaluated with a CT perfusion scan prior to, after the first series of, and after three series of chemotherapy. The CT perfusion scans were performed using a 320-detector row scanner. Tumour volume and perfusion parameters (arterial flow, blood volume and permeability) were computed on a dedicated workstation with a consensus between two radiologists. Response to chemotherapy was evaluated by two measures. Clinical response was defined as a tumour size reduction of more than 50%. Histological response was evaluated based on residual tumour cells in the surgical specimen using the standardized Mandard Score 1 to 5, in which values of 1 and 2 were classified as responders, and 3 to 5 were classified as nonresponders. Results: A decrease in tumour permeability after one series of chemotherapy was positively correlated with clinical response after three series of chemotherapy. Significant changes in permeability and tumour volume were apparent after three series of chemotherapy in both clinical and histological responders. A cut-off value of more than 25% reduction in tumour permeability yielded a sensitivity of 69% and a specificity of 58% for predicting clinical response. Conclusion: Early decrease in permeability is correlated with the likelihood of clinical response to pre-operative chemotherapy in GEJ and gastric cancer. As a single diagnostic test, CT Perfusion only has moderate sensitivity and specificity in response assessment of pre-operative chemotherapy making it insufficient for clinical decision purposes.	[Hansen, Martin Lundsgaard; Fallentin, Eva; Lauridsen, Carsten; Nielsen, Michael Bachmann] Rigshosp, Dept Radiol, DK-2100 Copenhagen, Denmark; [Lauridsen, Carsten] Metropolitan Univ Coll, Dept Technol, Bachelors Degree Programme Radiog, Copenhagen, Denmark; [Law, Ian] Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark; [Federspiel, Birgitte] Rigshosp, Dept Pathol, DK-2100 Copenhagen, Denmark; [Bksgaard, Lene] Rigshosp, Dept Oncol, DK-2100 Copenhagen, Denmark; [Svendsen, Lars Bo] Rigshosp, Dept Surg Gastroenterol, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Hansen, ML (corresponding author), Rigshosp, Dept Radiol, DK-2100 Copenhagen, Denmark.	mlundsgaard@dadlnet.dk	Nielsen, Michael Bachmann/U-2749-2018	Nielsen, Michael Bachmann/0000-0002-9380-1688; Law, Ian/0000-0001-9644-7496; Svendsen, Lars Bo/0000-0002-3216-9121	Poul Lundbeck and wife Fund; Civil engineer Johs. E. Ormstrup and wife Grete Ormstrup Fund	Poul Lundbeck and wife Fund; Civil engineer Johs. E. Ormstrup and wife Grete Ormstrup Fund	The authors acknowledge financial support from Poul Lundbeck and wife Fund and Civil engineer Johs. E. Ormstrup and wife Grete Ormstrup Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellomi M, 2007, RADIOLOGY, V244, P486, DOI 10.1148/radiol.2442061189; Chen TW, 2012, CLIN RADIOL, V67, P746, DOI 10.1016/j.crad.2011.07.053; Chen TW, 2009, CLIN RADIOL, V64, P38, DOI 10.1016/j.crad.2008.06.005; Chen YM, 2011, NUCL MED COMMUN, V32, P1005, DOI 10.1097/MNM.0b013e32834a8366; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; d'Assignies G, 2009, RADIOLOGY, V250, P407, DOI 10.1148/radiol.2501080291; Duyndam MCA, 2007, BIOCHEM PHARMACOL, V74, P191, DOI 10.1016/j.bcp.2007.04.003; Fournier LS, 2010, RADIOLOGY, V256, P511, DOI 10.1148/radiol.10091362; Fraioli F, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120174; Goh V, 2008, AM J ROENTGENOL, V191, pW288, DOI 10.2214/AJR.07.3985; Hansen ML, 2013, DIAGNOSTICS, V3, P261, DOI 10.3390/diagnostics3020261; Hayano K, 2007, ONCOL REP, V18, P901; Jiang T, 2012, INVEST RADIOL, V47, P11, DOI 10.1097/RLI.0b013e3182199bb5; Kim DH, 2012, EUR J RADIOL, V81, P3542, DOI 10.1016/j.ejrad.2012.02.012; Koyasu S, 2012, EUR J RADIOL, V81, P43, DOI 10.1016/j.ejrad.2010.11.013; Lee TY, 2003, Q J NUCL MED, V47, P171; Li ZP, 2005, WORLD J GASTROENTERO, V11, P1287, DOI 10.3748/wjg.v11.i9.1287; Lordick F, 2007, LANCET ONCOL, V8, P797, DOI 10.1016/S1470-2045(07)70244-9; Ma GL, 2012, HEPATOB PANCREAT DIS, V11, P407, DOI 10.1016/S1499-3872(12)60199-4; Makari Y, 2007, J SURG ONCOL, V96, P220, DOI 10.1002/jso.20820; MANDARD AM, 1994, CANCER, V73, P2680, DOI 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; Motosugi U, 2012, EUR J RADIOL, V81, P2533, DOI 10.1016/j.ejrad.2011.11.054; Mukai Kota, 2006, Gastric Cancer, V9, P192, DOI 10.1007/s10120-006-0374-7; Ng QS, 2006, AM J ROENTGENOL, V187, P1079, DOI 10.2214/AJR.05.0889; Ott K, 2011, ANN SURG ONCOL, V18, P3316, DOI 10.1245/s10434-011-1743-y; Sahani DV, 2005, RADIOLOGY, V234, P785, DOI 10.1148/radiol.2343040286; Satoh A, 2010, DIGEST SURG, V27, P253, DOI 10.1159/000288703; SIU KF, 1986, ANN SURG, V203, P173, DOI 10.1097/00000658-198602000-00011; Sjoquist KM, 2011, LANCET ONCOL, V12, P681, DOI 10.1016/S1470-2045(11)70142-5; Song T, 2012, DIGEST DIS SCI, V57, P2195, DOI 10.1007/s10620-012-2149-9; Stewart EE, 2012, RADIOLOGY, V264, P68, DOI 10.1148/radiol.12110674; Tacelli N, 2013, EUR RADIOL, V23, P2127, DOI 10.1007/s00330-013-2821-2; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Weber WA, 2001, J CLIN ONCOL, V19, P3058, DOI 10.1200/JCO.2001.19.12.3058; Wieder HA, 2007, EUR J NUCL MED MOL I, V34, P1925, DOI 10.1007/s00259-007-0521-3; Yao J, 2011, ABDOM IMAGING, V36, P15, DOI 10.1007/s00261-010-9609-5; Ychou M, 2011, J CLIN ONCOL, V29, P1715, DOI 10.1200/JCO.2010.33.0597; Zhong XS, 2007, BIOCHEM BIOPH RES CO, V358, P92, DOI 10.1016/j.bbrc.2007.04.083; Zum Buschenfelde CM, 2011, J NUCL MED, V52, P1189, DOI 10.2967/jnumed.110.085803	41	29	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97605	10.1371/journal.pone.0097605	http://dx.doi.org/10.1371/journal.pone.0097605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845062	gold, Green Published, Green Submitted			2022-12-25	WOS:000339563400038
J	Wong, JCY; Jack, MM; Li, Y; O'Neill, C				Wong, Jennifer C. Y.; Jack, Michelle M.; Li, Yan; O'Neill, Christopher			The Epigenetic Bivalency of Core Pancreatic beta-Cell Transcription Factor Genes within Mouse Pluripotent Embryonic Stem Cells Is Not Affected by Knockdown of the Polycomb Repressive Complex 2, SUZ12	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; DEVELOPMENTAL REGULATORS; LYSINE-27 METHYLATION; GLUCOSE-TRANSPORTER; INSULIN-SECRETION; EXPRESSION; CHROMATIN; DIFFERENTIATION; ESTABLISHMENT; ACETYLATION	This study assesses changes in activator and repressor modifications to histones associated with the core transcription factor genes most highly upregulated or downregulated in pancreatic beta-cells relative to expression in an embryonic stem cell line. Epigenetic analysis of the Oct4, Utf1, Nanog and Sox2 (pluripotency) and Pdx1, Nkx6.1, Nkx2.2 and MafA (pancreatic beta-cells) transcription factor genes in embryonic stem cells and a beta-cell line (MIN6) showed the pluripotency genes were enriched for active (histone 3 trimethylated at lysine 4 and histone 3 acetylated at lysine 9) and depleted of repressor modifications (histone 3 trimethylated at lysine 27 and histone 3 trimethylated at lysine 9) around the transcription start site in mouse embryonic stem cells (D3), and this was reversed in MIN6 cells. The beta-cell transcription factors were bivalently enriched for activating (histone 3 trimethylated at lysine 4) and repressor (histone 3 trimethylated at lysine 27) modifications in embryonic stem cells but were monovalent for the activator modification (histone 3 trimethylated at lysine 4) in the beta-cells. The polycomb repressor complex 2 acts as a histone 3 lysine 27 methylase and an essential component of this complex, SUZ12, was enriched at the beta-cell transcription factors in embryonic stem cells and was reduced MIN6. Knockdown of SUZ12 in embryonic stem cells, however, did not reduce the level of histone 3 trimethylated at lysine 27 at beta-cell transcription factor loci or break the transcriptional repression of these genes in embryonic stem cells. This study shows the reduction in the total SUZ12 level was not a sufficient cause of the resolution of the epigenetic bivalency of b-cell transcription factors in embryonic stem cells.	[Wong, Jennifer C. Y.; Li, Yan; O'Neill, Christopher] Univ Sydney, Sydney Med Sch, Kolling Inst Med Res, Ctr Dev & Regenerat Med, Sydney, NSW 2006, Australia; [Jack, Michelle M.] Royal N Shore Hosp, Dept Endocrinol, Sydney, NSW, Australia	University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; University of Sydney	O'Neill, C (corresponding author), Univ Sydney, Sydney Med Sch, Kolling Inst Med Res, Ctr Dev & Regenerat Med, Sydney, NSW 2006, Australia.	chris.oneill@sydney.edu.au			NHMRC; Favoloro Family Bequest, Royal North Shore Hospital	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Favoloro Family Bequest, Royal North Shore Hospital	This work was supported by grants from the NHMRC to CO and by the Favoloro Family Bequest, Royal North Shore Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Ahn JI, 2004, DEV BIOL, V265, P491, DOI 10.1016/j.ydbio.2003.09.041; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Billon N, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r80; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Doss MX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r56; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; FOSTER MC, 1993, BIOPHYS J, V64, P525, DOI 10.1016/S0006-3495(93)81397-3; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; HU ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Juliandi B, 2010, DEV GROWTH DIFFER, V52, P493, DOI 10.1111/j.1440-169X.2010.01175.x; Kelly OG, 2011, NAT BIOTECHNOL, V29, P750, DOI 10.1038/nbt.1931; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lunyak VV, 2008, HUM MOL GENET, V17, pR28, DOI 10.1093/hmg/ddn149; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; ORCI L, 1989, SCIENCE, V245, P295, DOI 10.1126/science.2665080; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Wilson ME, 2003, MECH DEVELOP, V120, P65, DOI 10.1016/S0925-4773(02)00333-7; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	42	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97820	10.1371/journal.pone.0097820	http://dx.doi.org/10.1371/journal.pone.0097820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845830	Green Published, Green Submitted, gold			2022-12-25	WOS:000339563400063
J	Neueder, A; Achilli, F; Moussaoui, S; Bates, GP				Neueder, Andreas; Achilli, Francesca; Moussaoui, Saliha; Bates, Gillian P.			Novel Isoforms of Heat Shock Transcription Factor 1, HSF1 gamma alpha and HSF1 gamma beta, Regulate Chaperone Protein Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING ACTIVITY; FACTOR FAMILY; NUCLEAR-LOCALIZATION; FACTOR ACTIVATION; STRESS-RESPONSE; RAINBOW-TROUT; DANIO-RERIO; EXPRESSION; MOUSE; DISTINCT	The heat shock response, resulting in the production of heat shock proteins or molecular chaperones, is triggered by elevated temperature and a variety of other stressors. Its master regulator is heat shock transcription factor 1 (HSF1). Heat shock factors generally exist in multiple isoforms. The two known isoforms of HSF1 differ in the inclusion (HSF1 alpha) or exclusion (HSF1 beta) of exon 11. Although there are some data concerning the differential expression patterns and transcriptional activities of HSF2 isoforms during development, little is known about the distinct properties of the HSF1 isoforms. Here we present evidence for two novel HSF1 isoforms termed HSF1 gamma alpha and HSF1 gamma beta, and we show that the HSF1 isoform ratio differentially regulates heat shock protein gene transcription. Hsf1 gamma isoforms are expressed in various mouse tissues and are translated into protein. Furthermore, after heat shock, HSF1 gamma isoforms are exported from the nucleus more rapidly or degraded more quickly than HSF1 alpha or HSF1 beta. We also show that each individual HSF1 isoform is sufficient to induce the heat shock response and that expression of combinations of HSF1 isoforms, in particular HSF1 alpha and HSF1 beta, results in a synergistic enhancement of the transcriptional response. In addition, HSF1 gamma isoforms potentially suppress the synergistic effect of HSF1 alpha and HSF1 beta co-expression. Collectively, our observations suggest that the expression of HSF1 isoforms in a specific ratio provides an additional layer in the regulation of heat shock protein gene transcription.	[Neueder, Andreas; Achilli, Francesca; Bates, Gillian P.] Kings Coll London, Dept Med & Mol Genet, London SE1 9RT, England; [Moussaoui, Saliha] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland	University of London; King's College London; Novartis	Bates, GP (corresponding author), Kings Coll London, Dept Med & Mol Genet, London SE1 9RT, England.	gillian.bates@kcl.ac.uk	Neueder, Andreas/K-4319-2015; Bates, Gillian/E-1146-2012	Neueder, Andreas/0000-0002-2389-5236; Bates, Gillian/0000-0002-4041-6305	Medical Research Council [G0801314]; MRC [G0801314] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (Grant G0801314).	Airaksinen S, 2003, COMP BIOCHEM PHYS B, V136, P275, DOI 10.1016/S1096-4959(03)00205-7; Airaksinen S, 2003, COMP BIOCHEM PHYS A, V134, P839, DOI 10.1016/S1095-6433(03)00033-3; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Alastalo TP, 2003, J CELL SCI, V116, P3557, DOI 10.1242/jcs.00671; Benn CL, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-17; Buckley BA, 2002, J EXP BIOL, V205, P3231; Carnemolla A, 2014, HUM MOL GENET, V23, P3641, DOI 10.1093/hmg/ddu073; de Thonel A, 2012, INT J BIOCHEM CELL B, V44, P1593, DOI 10.1016/j.biocel.2012.06.012; DELMAS V, 1992, P NATL ACAD SCI USA, V89, P4226, DOI 10.1073/pnas.89.10.4226; FIORENZA MT, 1995, NUCLEIC ACIDS RES, V23, P467, DOI 10.1093/nar/23.3.467; Fritah S, 2009, MOL BIOL CELL, V20, P4976, DOI 10.1091/mbc.E09-04-0295; Fu S, 2006, PLANTA, V224, P42, DOI 10.1007/s00425-005-0191-y; Fujikake N, 2005, FEBS LETT, V579, P3842, DOI 10.1016/j.febslet.2005.05.074; Fujimoto M, 2004, EMBO J, V23, P4297, DOI 10.1038/sj.emboj.7600435; Fujimoto M, 2010, FEBS J, V277, P4112, DOI 10.1111/j.1742-4658.2010.07827.x; Gagliano N, 2007, DIGEST DIS, V25, P118, DOI 10.1159/000099475; GOODSON ML, 1995, BIOCHEM BIOPH RES CO, V211, P943, DOI 10.1006/bbrc.1995.1903; GOODSON ML, 1995, MOL CELL BIOL, V15, P5288; Gothard LQ, 2003, J BIOL CHEM, V278, P9322, DOI 10.1074/jbc.M209412200; Hall DM, 2000, J APPL PHYSIOL, V89, P749, DOI 10.1152/jappl.2000.89.2.749; He HY, 2003, J BIOL CHEM, V278, P35465, DOI 10.1074/jbc.M304663200; Hockly E, 2003, BRAIN RES BULL, V61, P469, DOI 10.1016/S0361-9230(03)00185-0; Kawabe S, 2011, J EXP ZOOL PART A, V315A, P394, DOI 10.1002/jez.685; Kayani AC, 2008, REJUV RES, V11, P1021, DOI 10.1089/rej.2008.0795; Kregel KC, 1996, J APPL PHYSIOL, V80, P547, DOI 10.1152/jappl.1996.80.2.547; Le Goff P, 1999, BIOCHEM BIOPH RES CO, V259, P15, DOI 10.1006/bbrc.1999.0729; Lecomte S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056085; Locke M, 1996, CELL STRESS CHAPERON, V1, P251, DOI 10.1379/1466-1268(1996)001<0251:DHSRIT>2.3.CO;2; Locke M, 2000, CELL STRESS CHAPERON, V5, P45, DOI 10.1379/1466-1268(2000)005<0045:HSTFAA>2.0.CO;2; Mathew A, 1998, MOL CELL BIOL, V18, P5091, DOI 10.1128/MCB.18.9.5091; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Menezes DL, 2012, MOL CANCER THER, V11, P730, DOI 10.1158/1535-7163.MCT-11-0667; MEZGER V, 1994, DEV BIOL, V166, P819, DOI 10.1006/dbio.1994.1361; MURPHY SP, 1994, MOL CELL BIOL, V14, P5309, DOI 10.1128/MCB.14.8.5309; Nakai A, 1997, MOL CELL BIOL, V17, P469, DOI 10.1128/MCB.17.1.469; Ojima N, 2004, EUR J BIOCHEM, V271, P703, DOI 10.1111/j.1432-1033.2003.03972.x; Ostling P, 2007, J BIOL CHEM, V282, P7077, DOI 10.1074/jbc.M607556200; Rabergh CMI, 2000, J EXP BIOL, V203, P1817; RABINDRAN SK, 1991, P NATL ACAD SCI USA, V88, P6906, DOI 10.1073/pnas.88.16.6906; Rallu M, 1997, P NATL ACAD SCI USA, V94, P2392, DOI 10.1073/pnas.94.6.2392; Raychaudhuri S, 2014, CELL, V156, P975, DOI 10.1016/j.cell.2014.01.055; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; SARGE KD, 1995, NATURE, V374, P126, DOI 10.1038/374126a0; SARGE KD, 1994, BIOL REPROD, V50, P1334, DOI 10.1095/biolreprod50.6.1334; SARGE KD, 1991, GENE DEV, V5, P1902, DOI 10.1101/gad.5.10.1902; Sasi BK, 2014, J MOL BIOL, V426, P116, DOI 10.1016/j.jmb.2013.09.008; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; SISTONEN L, 1992, MOL CELL BIOL, V12, P4104, DOI 10.1128/MCB.12.9.4104; Sullivan EK, 2001, MOL CELL BIOL, V21, P5826, DOI 10.1128/MCB.21.17.5826-5837.2001; Tanabe M, 1999, J BIOL CHEM, V274, P27845, DOI 10.1074/jbc.274.39.27845; TANAKA T, 1995, EMBO J, V14, P341, DOI 10.1002/j.1460-2075.1995.tb07008.x; Trinklein ND, 2004, CELL STRESS CHAPERON, V9, P21, DOI 10.1379/1466-1268(2004)009<0021:TRABOH>2.0.CO;2; Vujanac M, 2005, TRAFFIC, V6, P214, DOI 10.1111/j.1600-0854.2005.00266.x; Westerheide SD, 2012, CURR PROTEIN PEPT SC, V13, P86; Xu YM, 2012, J PROTEOME RES, V11, P2625, DOI 10.1021/pr201151a; Zhang Y, 2001, J CELL BIOCHEM, V82, P692, DOI 10.1002/jcb.1191; ZIMARINO V, 1990, MOL CELL BIOL, V10, P752, DOI 10.1128/MCB.10.2.752	59	17	18	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					19894	19906		10.1074/jbc.M114.570739	http://dx.doi.org/10.1074/jbc.M114.570739			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24855652	hybrid, Green Published			2022-12-25	WOS:000339395200008
J	Kelly, JJ; Minalt, N; Culotti, A; Pryor, M; Packman, A				Kelly, John J.; Minalt, Nicole; Culotti, Alessandro; Pryor, Marsha; Packman, Aaron			Temporal Variations in the Abundance and Composition of Biofilm Communities Colonizing Drinking Water Distribution Pipes	PLOS ONE			English	Article							MYCOBACTERIUM-AVIUM; BACTERIAL COMMUNITIES; ACINETOBACTER; IDENTIFICATION; NITRIFICATION; DISINFECTION; GROWTH; RESISTANCE; SURFACES; SURVIVAL	Pipes that transport drinking water through municipal drinking water distribution systems (DWDS) are challenging habitats for microorganisms. Distribution networks are dark, oligotrophic and contain disinfectants; yet microbes frequently form biofilms attached to interior surfaces of DWDS pipes. Relatively little is known about the species composition and ecology of these biofilms due to challenges associated with sample acquisition from actual DWDS. We report the analysis of biofilms from five pipe samples collected from the same region of a DWDS in Florida, USA, over an 18 month period between February 2011 and August 2012. The bacterial abundance and composition of biofilm communities within the pipes were analyzed by heterotrophic plate counts and tag pyrosequencing of 16S rRNA genes, respectively. Bacterial numbers varied significantly based on sampling date and were positively correlated with water temperature and the concentration of nitrate. However, there was no significant relationship between the concentration of disinfectant in the drinking water (monochloramine) and the abundance of bacteria within the biofilms. Pyrosequencing analysis identified a total of 677 operational taxonomic units (OTUs) (3% distance) within the biofilms but indicated that community diversity was low and varied between sampling dates. Biofilms were dominated by a few taxa, specifically Methylomonas, Acinetobacter, Mycobacterium, and Xanthomonadaceae, and the dominant taxa within the biofilms varied dramatically between sampling times. The drinking water characteristics most strongly correlated with bacterial community composition were concentrations of nitrate, ammonium, total chlorine and monochloramine, as well as alkalinity and hardness. Biofilms from the sampling date with the highest nitrate concentration were the most abundant and diverse and were dominated by Acinetobacter.	[Kelly, John J.; Minalt, Nicole] Loyola Univ, Dept Biol, Chicago, IL 60626 USA; [Culotti, Alessandro; Packman, Aaron] Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL USA; [Pryor, Marsha] Pinellas Cty Util Lab, Largo, FL USA	Loyola University Chicago; Northwestern University	Kelly, JJ (corresponding author), Loyola Univ, Dept Biol, Chicago, IL 60626 USA.	jkelly7@luc.edu	Packman, Aaron/B-7085-2009	Kelly, John/0000-0002-0894-137X	Water Research Foundation [4259]	Water Research Foundation	This work was supported by Water Research Foundation grant 4259 to Aaron Packman and John Kelly. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; [Anonymous], 2005, BERGEYS MANUAL SYSTE; Beumer A, 2010, APPL ENVIRON MICROB, V76, P7367, DOI 10.1128/AEM.00730-10; BIFULCO JM, 1989, APPL ENVIRON MICROB, V55, P2214, DOI 10.1128/AEM.55.9.2214-2219.1989; Bois FY, 1997, WATER RES, V31, P3146, DOI 10.1016/S0043-1354(97)00178-4; Boomer SM, 2009, APPL ENVIRON MICROB, V75, P2464, DOI 10.1128/AEM.01802-08; CARSON LA, 1978, APPL ENVIRON MICROB, V36, P839, DOI 10.1128/AEM.36.6.839-846.1978; CHAO A, 1984, SCAND J STAT, V11, P265; Covert TC, 1999, APPL ENVIRON MICROB, V65, P2492; Critchley MM, 2001, WATER SCIENCE & TECHNOLOGY: WATER SUPPLY, VOL 1, NO 4, P247; CUNLIFFE DA, 1991, APPL ENVIRON MICROB, V57, P3399, DOI 10.1128/AEM.57.11.3399-3402.1991; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eichler S, 2006, APPL ENVIRON MICROB, V72, P1858, DOI 10.1128/AEM.72.3.1858-1872.2006; Emerson D, 2010, ANNU REV MICROBIOL, V64, P561, DOI 10.1146/annurev.micro.112408.134208; Falkinham JO, 2001, APPL ENVIRON MICROB, V67, P1225, DOI 10.1128/AEM.67.3.1225-1231.2001; Forster DH, 1998, EUR J CLIN MICROBIOL, V17, P73, DOI 10.1007/BF01682159; Gomez-Alvarez V, 2012, APPL ENVIRON MICROB, V78, P6095, DOI 10.1128/AEM.01018-12; Hansen SK, 2007, NATURE, V445, P533, DOI 10.1038/nature05514; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Hedrich S, 2011, MICROBIOL-SGM, V157, P1551, DOI 10.1099/mic.0.045344-0; Hoefel D, 2005, APPL ENVIRON MICROB, V71, P6479, DOI 10.1128/AEM.71.11.6479-6488.2005; Hong PY, 2010, APPL ENVIRON MICROB, V76, P5631, DOI 10.1128/AEM.00281-10; HORSBURGH CR, 1991, NEW ENGL J MED, V324, P1332, DOI 10.1056/NEJM199105093241906; Kalmbach S, 1997, APPL ENVIRON MICROB, V63, P4164, DOI 10.1128/AEM.63.11.4164-4170.1997; Lane D.J., 1991, NUCL ACID TECHNIQUES, DOI [10.1099/ijs.0.060731-0, DOI 10.1099/ijs.0.060731-0]; LECHEVALLIER MW, 1988, APPL ENVIRON MICROB, V54, P649, DOI 10.1128/AEM.54.3.649-654.1988; LECHEVALLIER MW, 1993, J AM WATER WORKS ASS, V85, P111; Ledder RG, 2006, J APPL MICROBIOL, V100, P1123, DOI 10.1111/j.1365-2672.2006.02847.x; Lipponen MTT, 2002, WATER RES, V36, P4319, DOI 10.1016/S0043-1354(02)00169-0; Liu Y, 2011, BIOFOULING, V27, P393, DOI 10.1080/08927014.2011.577525; Madigan MT, 2009, BROCK BIOL MICROORGA; Marin M, 1996, APPL MICROBIOL BIOT, V44, P660, DOI 10.1007/BF00172500; Marshall K. C., 1991, ANONYMOUS BIOFOULING, P29; MARSHALL KC, 1988, CAN J MICROBIOL, V34, P503, DOI 10.1139/m88-086; Martiny AC, 2003, APPL ENVIRON MICROB, V69, P6899, DOI 10.1128/AEM.69.11.6899-6907.2003; MCKEON DM, 1995, WATER RES, V29, P1902, DOI 10.1016/0043-1354(95)00013-B; McKew BA, 2011, ISME J, V5, P30, DOI 10.1038/ismej.2010.91; Norton CD, 2004, WATER RES, V38, P1457, DOI 10.1016/j.watres.2003.07.008; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Pryor M, 2004, WATER SCI TECHNOL, V50, P83, DOI 10.2166/wst.2004.0025; Regan JM, 2002, APPL ENVIRON MICROB, V68, P73, DOI 10.1128/AEM.68.1.73-81.2002; Revetta RP, 2010, WATER RES, V44, P1353, DOI 10.1016/j.watres.2009.11.008; Rice E.W., 2012, STANDARD METHODS EXA; RIDGWAY HF, 1982, APPL ENVIRON MICROB, V44, P972, DOI 10.1128/AEM.44.4.972-987.1982; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmeisser C, 2003, APPL ENVIRON MICROB, V69, P7298, DOI 10.1128/AEM.69.12.7298-7309.2003; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SHIREY JJ, 1991, APPL ENVIRON MICROB, V57, P2251, DOI 10.1128/AEM.57.8.2251-2254.1991; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; Szewzyk U, 2000, ANNU REV MICROBIOL, V54, P81, DOI 10.1146/annurev.micro.54.1.81; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Vaerewijck MJM, 2005, FEMS MICROBIOL REV, V29, P911, DOI 10.1016/j.femsre.2005.02.001; WEINBERGER M, 1992, CLIN INFECT DIS, V14, P1229, DOI 10.1093/clinids/14.6.1229; WENTZEL MC, 1986, WATER SA, V12, P209; Wilczak A, 1996, J AM WATER WORKS ASS, V88, P74, DOI 10.1002/j.1551-8833.1996.tb06586.x; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418; Zacheus OM, 2001, WATER RES, V35, P1757, DOI 10.1016/S0043-1354(00)00431-0; Zhang P, 2009, ENVIRON SCI TECHNOL, V43, P3169, DOI 10.1021/es802990e	60	51	51	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98542	10.1371/journal.pone.0098542	http://dx.doi.org/10.1371/journal.pone.0098542			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858562	Green Submitted, Green Published, gold			2022-12-25	WOS:000336839400080
J	Steinwand, BJ; Xu, SL; Polko, JK; Doctor, SM; Westafer, M; Kieber, JJ				Steinwand, Blaire J.; Xu, Shouling; Polko, Joanna K.; Doctor, Stephanie M.; Westafer, Mike; Kieber, Joseph J.			Alterations in Auxin Homeostasis Suppress Defects in Cell Wall Function	PLOS ONE			English	Article							RECEPTOR-LIKE KINASES; CELLULOSE SYNTHASE 5; ANISOTROPIC EXPANSION; ANCHORED PROTEIN; ROOT ELONGATION; SEED COAT; ARABIDOPSIS; GROWTH; BIOSYNTHESIS; EXPRESSION	The plant cell wall is a highly dynamic structure that changes in response to both environmental and developmental cues. It plays important roles throughout plant growth and development in determining the orientation and extent of cell expansion, providing structural support and acting as a barrier to pathogens. Despite the importance of the cell wall, the signaling pathways regulating its function are not well understood. Two partially redundant leucine-rich-repeat receptor-like kinases (LRR-RLKs), FEI1 and FEI2, regulate cell wall function in Arabidopsis thaliana roots; disruption of the FEIs results in short, swollen roots as a result of decreased cellulose synthesis. We screened for suppressors of this swollen root phenotype and identified two mutations in the putative mitochondrial pyruvate dehydrogenase E1 alpha homolog, IAA-Alanine Resistant 4 (IAR4). Mutations in IAR4 were shown previously to disrupt auxin homeostasis and lead to reduced auxin function. We show that mutations in IAR4 suppress a subset of the fei1 fei2 phenotypes. Consistent with the hypothesis that the suppression of fei1 fei2 by iar4 is the result of reduced auxin function, disruption of the WEI8 and TAR2 genes, which decreases auxin biosynthesis, also suppresses fei1 fei2. In addition, iar4 suppresses the root swelling and accumulation of ectopic lignin phenotypes of other cell wall mutants, including procuste and cobra. Further, iar4 mutants display decreased sensitivity to the cellulose biosynthesis inhibitor isoxaben. These results establish a role for IAR4 in the regulation of cell wall function and provide evidence of crosstalk between the cell wall and auxin during cell expansion in the root.	[Steinwand, Blaire J.; Xu, Shouling; Polko, Joanna K.; Doctor, Stephanie M.; Westafer, Mike; Kieber, Joseph J.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Kieber, JJ (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	jkieber@unc.edu	Kieber, Joseph/GLN-6328-2022	Kieber, Joseph/0000-0002-5766-812X; xu, shouling/0000-0002-6741-9506	National Science Foundation [IOS 0624377, MCB-1021704]; Netherlands Organization for Scientific Research (NWO) [825.13.018]; Div Of Molecular and Cellular Bioscience [1021704] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was supported by grants IOS 0624377, MCB-1021704 from the National Science Foundation to JJK and Rubicon grant 825.13.018 of the Netherlands Organization for Scientific Research (NWO) to JKP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL S, 1995, J BIOL CHEM, V270, P19093, DOI 10.1074/jbc.270.32.19093; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Anderson CT, 2010, PLANT PHYSIOL, V152, P787, DOI 10.1104/pp.109.150128; Baskin TI, 2005, ANNU REV CELL DEV BI, V21, P203, DOI 10.1146/annurev.cellbio.20.082503.103053; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Cano-Delgado A, 2003, PLANT J, V34, P351, DOI 10.1046/j.1365-313X.2003.01729.x; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cosgrove DJ, 2002, PLANT CELL PHYSIOL, V43, P1436, DOI 10.1093/pcp/pcf180; Desprez T, 2002, PLANT PHYSIOL, V128, P482, DOI 10.1104/pp.010822; ELIASSON L, 1989, PLANT PHYSIOL, V91, P310, DOI 10.1104/pp.91.1.310; Fagard M, 2000, PLANT CELL, V12, P2409, DOI 10.1105/tpc.12.12.2409; Gish LA, 2011, PLANT J, V66, P117, DOI 10.1111/j.1365-313X.2011.04518.x; Gjetting KSK, 2012, J EXP BOT, V63, P3207, DOI 10.1093/jxb/ers040; Gray WM, 1998, P NATL ACAD SCI USA, V95, P7197, DOI 10.1073/pnas.95.12.7197; GREEN PB, 1980, ANNU REV PLANT PHYS, V31, P51, DOI 10.1146/annurev.pp.31.060180.000411; Guo HQ, 2009, P NATL ACAD SCI USA, V106, P7648, DOI 10.1073/pnas.0812346106; Hager A, 2003, J PLANT RES, V116, P483, DOI 10.1007/s10265-003-0110-x; Harpaz-Saad S, 2012, PLANT SIGNAL BEHAV, V7, P285, DOI 10.4161/psb.18819; Harpaz-Saad S, 2011, PLANT J, V68, P941, DOI 10.1111/j.1365-313X.2011.04760.x; HAUSER MT, 1995, DEVELOPMENT, V121, P1237; He ZH, 1996, J BIOL CHEM, V271, P19789, DOI 10.1074/jbc.271.33.19789; Hematy K, 2008, CURR OPIN PLANT BIOL, V11, P321, DOI 10.1016/j.pbi.2008.02.008; Im KH, 2000, PLANT PHYSIOL, V123, P463, DOI 10.1104/pp.123.2.463; Kaku T, 2002, PLANT CELL PHYSIOL, V43, P21, DOI 10.1093/pcp/pcf004; Lally D, 2001, PLANT CELL, V13, P1317, DOI 10.1105/tpc.13.6.1317; LANG JM, 1982, PROTOPLASMA, V110, P5, DOI 10.1007/BF01314675; LeClere S, 2004, PLANT PHYSIOL, V135, P989, DOI 10.1104/pp.104.040519; Lewis DR, 2013, PLANT CELL, V25, P3329, DOI 10.1105/tpc.113.114868; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LORENCES EP, 1987, J EXP BOT, V38, P960, DOI 10.1093/jxb/38.6.960; Monshausen GB, 2011, PLANT J, V65, P309, DOI 10.1111/j.1365-313X.2010.04423.x; Overvoorde PJ, 2005, PLANT CELL, V17, P3282, DOI 10.1105/tpc.105.036723; Persson S, 2007, P NATL ACAD SCI USA, V104, P15566, DOI 10.1073/pnas.0706592104; Pilling E, 2003, CURR OPIN PLANT BIOL, V6, P611, DOI 10.1016/j.pbi.2003.09.004; Quint M, 2009, PLANT PHYSIOL, V150, P748, DOI 10.1104/pp.109.136671; Roudier F, 2005, PLANT CELL, V17, P1749, DOI 10.1105/tpc.105.031732; Sauer M, 2011, PLANT CELL, V23, P2033, DOI 10.1105/tpc.111.087064; Scheible WR, 2001, P NATL ACAD SCI USA, V98, P10079, DOI 10.1073/pnas.191361598; Schindelman G, 2001, GENE DEV, V15, P1115, DOI 10.1101/gad.879101; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Steinwand BJ, 2010, PLANT PHYSIOL, V153, P479, DOI 10.1104/pp.110.155887; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Sugimoto K, 2000, PLANT PHYSIOL, V124, P1493, DOI 10.1104/pp.124.4.1493; Swarup K, 2008, NAT CELL BIOL, V10, P946, DOI 10.1038/ncb1754; TAIZ L, 1984, ANNU REV PLANT PHYS, V35, P585, DOI 10.1146/annurev.pp.35.060184.003101; Tsang DL, 2011, PLANT PHYSIOL, V156, P596, DOI 10.1104/pp.111.175372; Alarcon MV, 2012, ACTA BIOL CRACOV BOT, V54, P16, DOI 10.2478/v10182-012-0001-3; Wagner TA, 2001, PLANT CELL, V13, P303, DOI 10.1105/tpc.13.2.303; Willats WGT, 2001, PLANTA, V213, P37, DOI 10.1007/s004250000481; Xu SL, 2008, PLANT CELL, V20, P3065, DOI 10.1105/tpc.108.063354	51	21	21	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98193	10.1371/journal.pone.0098193	http://dx.doi.org/10.1371/journal.pone.0098193			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859261	Green Published, gold, Green Submitted			2022-12-25	WOS:000336839400052
J	Yu, XM; Wang, MH; Dong, QZ; Jin, F				Yu, Xinmiao; Wang, Minghao; Dong, Qianze; Jin, Feng			Diversin Is Overexpressed in Breast Cancer and Accelerates Cell Proliferation and Invasion	PLOS ONE			English	Article							JNK; EXPRESSION; PATHWAYS; ER	Diversin was recently reported to play roles in Wnt and JNK pathways. However, the expression pattern and biological roles of diversin in human breast cancer have not been reported. In the present study, we found that diversin was overexpressed in breast cancer specimens by immunohistochemistry and western blot. Significant association was observed between diversin overexpression and TNM stage (p = 0.0036), nodal metastasis (p = 0.0033), negative estrogen receptor expression (p = 0.0012) and triple-negative status (p = 0.0017). Furthermore, colony formation assay and matrigel invasion assay showed that knockdown of diversin expression in MDA-MB-231 cell line with high endogenous expression decreased cell proliferation and cell invasion. Transfection of diversin plasmid in MCF-7 cell line increased cell proliferation and invasion. Further analysis showed that diversin depletion downregulated JNK phosphorylation while its overexpression upregulated JNK phosphorylation. In conclusion, our study demonstrated that diversin was overexpressed in human breast cancers. Diversin could contribute to breast cancer cell proliferation and invasion.	[Yu, Xinmiao] China Med Univ, Dept Surg Oncol & Breast Surg, Affiliated Hosp 1, Shenyang, Peoples R China; [Wang, Minghao; Jin, Feng] China Med Univ, Dept Neurosurg, Affiliated Hosp 1, Shenyang, Peoples R China; [Dong, Qianze] China Med Univ, Dept Pathol, Affiliated Hosp 1, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Jin, F (corresponding author), China Med Univ, Dept Neurosurg, Affiliated Hosp 1, Shenyang, Peoples R China.	jinfengcmu@hotmail.com		Migliaccio, Antimo/0000-0002-4197-2055				Ahn S, 2012, TUMOR BIOL, V33, P1573, DOI 10.1007/s13277-012-0411-6; Badano JL, 2005, NAT REV GENET, V6, P194, DOI 10.1038/nrg1557; Elfagieh M, 2012, TUMOR BIOL, V33, P2371, DOI 10.1007/s13277-012-0500-6; Fang YJ, 2012, TUMOR BIOL, V33, P1907, DOI 10.1007/s13277-012-0451-y; Feiguin F, 2001, DEV CELL, V1, P93, DOI 10.1016/S1534-5807(01)00010-7; Gutierrez GJ, 2010, J BIOL CHEM, V285, P14217, DOI 10.1074/jbc.M110.121848; Haribaskar R, 2009, BIOCHEM BIOPH RES CO, V387, P212, DOI 10.1016/j.bbrc.2009.07.012; Hubner A, 2012, P NATL ACAD SCI USA, V109, P12046, DOI 10.1073/pnas.1209660109; Itoh K, 2009, J CELL SCI, V122, P3791, DOI 10.1242/jcs.057067; Kabbage M, 2012, TUMOR BIOL, V33, P2279, DOI 10.1007/s13277-012-0490-4; Kalea AZ, 2010, CANCER RES, V70, P5628, DOI 10.1158/0008-5472.CAN-10-0595; Kurbel S, 2013, TUMOR BIOL, V34, P1, DOI 10.1007/s13277-012-0602-1; Mao XY, 2012, TUMOR BIOL, V33, P1565, DOI 10.1007/s13277-012-0410-7; Moeller H, 2006, P NATL ACAD SCI USA, V103, P15900, DOI 10.1073/pnas.0603808103; Prabhu JS, 2012, TUMOR BIOL, V33, P315, DOI 10.1007/s13277-012-0343-1; Schwarz-Romond T, 2002, GENE DEV, V16, P2073, DOI 10.1101/gad.230402; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Tang ZP, 2013, TUMOR BIOL, V34, P2835, DOI 10.1007/s13277-013-0843-7; Yasunaga T, 2011, MECH DEVELOP, V128, P376, DOI 10.1016/j.mod.2011.07.004; Yen JH, 2011, J BIOL CHEM, V286, P38913, DOI 10.1074/jbc.M111.252932; Yin YX, 2012, TUMOR BIOL, V33, P1581, DOI 10.1007/s13277-012-0412-5; Zhan X, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-180	22	4	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98591	10.1371/journal.pone.0098591	http://dx.doi.org/10.1371/journal.pone.0098591			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858714	Green Published, Green Submitted, gold			2022-12-25	WOS:000336839400081
J	Qiu, YW; Lv, XF; Su, HH; Jiang, GH; Li, C; Tian, JZ				Qiu, Yingwei; Lv, Xiaofei; Su, Huanhuan; Jiang, Guihua; Li, Cheng; Tian, Junzhang			Structural and Functional Brain Alterations in End Stage Renal Disease Patients on Routine Hemodialysis: A Voxel-Based Morphometry and Resting State Functional Connectivity Study	PLOS ONE			English	Article							GRAY-MATTER VOLUME; CHRONIC KIDNEY-DISEASE; COGNITIVE IMPAIRMENT; FAILURE; CORTEX; ABNORMALITIES; METABOLISM; SYMPTOMS; ATROPHY	Background and Purpose: Cognitive impairment is a well-described phenomenon in end-stage renal disease (ESRD) patients. However, its pathogenesis remains poorly understood. The primary focus of this study was to examine structural and functional brain deficits in ESRD patients. Materials and Methods: Thirty ESRD patients on hemodialysis (without clinical neurological disease) and 30 age- and gender-matched control individuals (without renal or neurological problems) were recruited in a prospective, single-center study. High-resolution structural magnetic resonance imaging (MRI) and resting state functional MRI were performed on both groups to detect the subtle cerebral deficits in ESRD patients. Voxel-based morphometry was used to characterize gray matter deficits in ESRD patients. The impact of abnormal morphometry on the cerebral functional integrity was investigated by evaluating the alterations in resting state functional connectivity when brain regions with gray matter volume reduction were used as seed areas. Results: A significant decrease in gray matter volume was observed in ESRD patients in the bilateral medial orbito-prefrontal cortices, bilateral dorsal lateral prefrontal cortices, and the left middle temporal cortex. When brain regions with gray matter volume reduction were used as seed areas, the integration was found to be significantly decreased in ESRD patients in the fronto-cerebellum circuits and within prefrontal circuits. In addition, significantly enhanced functional connectivity was found between the prefrontal cortex and the left temporal cortex and within the prefrontal circuits. Conclusions: Our study revealed that both the structural and functional cerebral cortices were impaired in ESRD patients on routine hemodialysis.	[Qiu, Yingwei; Su, Huanhuan; Jiang, Guihua; Tian, Junzhang] Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China; [Qiu, Yingwei] Gannan Med Univ, Affiliated Hosp 1, Dept Med Imaging, Ganzhou, Peoples R China; [Lv, Xiaofei] Sun Yat Sen Univ, Ctr Canc, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China; [Lv, Xiaofei] Sun Yat Sen Univ, Ctr Canc, Dept Intervent Radiol, Guangzhou, Guangdong, Peoples R China; [Li, Cheng] Guangdong 2 Prov Peoples Hosp, Dept Renal Transplantat, Guangzhou, Guangdong, Peoples R China	Gannan Medical University; Sun Yat Sen University; Sun Yat Sen University	Qiu, YW (corresponding author), Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China.	qiuyw1201@gmail.com		Qiu, Yingwei/0000-0003-1298-8506; Tian, Junzhang/0000-0002-6212-1882	Natural Scientific Foundation of China [81201084]; Planned Science and Technology Project of Guangdong Province, China [2011B031800044]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Planned Science and Technology Project of Guangdong Province, China	This work was supported by the grants from the Natural Scientific Foundation of China [Grant No. 81201084 for YQ], and the Planned Science and Technology Project of Guangdong Province, China [Grant No. 2011B031800044 for GJ]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alosco ML, 2013, BRAIN BEHAV, V3, P626, DOI 10.1002/brb3.171; Bremer BA, 1997, ANN BEHAV MED, V19, P348, DOI 10.1007/BF02895153; Burruss JW, 2000, RADIOLOGY, V214, P227, DOI 10.1148/radiology.214.1.r00ja43227; Chetelat G, 2008, BRAIN, V131, P60, DOI 10.1093/brain/awm288; Chiu ML, 2010, EUR RADIOL, V20, P1502, DOI 10.1007/s00330-009-1673-2; Denier Niklaus, 2013, Front Psychiatry, V4, P135, DOI 10.3389/fpsyt.2013.00135; Drew DA, 2013, AM J KIDNEY DIS, V61, P271, DOI 10.1053/j.ajkd.2012.08.035; Etgen T, 2012, AM J NEPHROL, V35, P474, DOI 10.1159/000338135; FAZEKAS G, 1995, J NEUROL SCI, V134, P83, DOI 10.1016/0022-510X(95)00226-7; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gili T, 2011, J NEUROL NEUROSUR PS, V82, P58, DOI 10.1136/jnnp.2009.199935; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Grieve SM, 2013, NEUROIMAGE-CLIN, V3, P332, DOI 10.1016/j.nicl.2013.08.016; Herting MM, 2011, NEUROIMAGE, V54, P2582, DOI 10.1016/j.neuroimage.2010.10.030; Hoekzema E, 2010, HUM BRAIN MAPP, V31, P1942, DOI 10.1002/hbm.20988; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Ikram MA, 2008, STROKE, V39, P55, DOI 10.1161/STROKEAHA.107.493494; Jenkins G., 1968, SPECTRAL ANAL ITS AP; John John P, 2009, Indian J Psychiatry, V51, P180, DOI 10.4103/0019-5545.55084; Kamata T, 2000, AM J NEPHROL, V20, P27, DOI 10.1159/000013551; Kanai H, 2001, AM J KIDNEY DIS, V38, pS129, DOI 10.1053/ajkd.2001.27421; Kimmel PL, 2007, ADV CHRONIC KIDNEY D, V14, P328, DOI 10.1053/j.ackd.2007.07.007; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; KUPERMAN S, 1990, J AM ACAD CHILD PSY, V29, P159, DOI 10.1097/00004583-199003000-00001; Kurella M, 2004, J AM GERIATR SOC, V52, P1863, DOI 10.1111/j.1532-5415.2004.52508.x; Liang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071507; Lui S, 2009, AM J PSYCHIAT, V166, P196, DOI 10.1176/appi.ajp.2008.08020183; Maudsley AA, 2010, EPILEPSY RES, V88, P127, DOI 10.1016/j.eplepsyres.2009.10.009; Miglior M, 2009, ROLE BRAIN DERIVED N; Nasser ME, 2012, SAUDI J KIDNEY DIS T, V23, P1208, DOI 10.4103/1319-2442.103561; Pomarol-Clotet E, 2010, MOL PSYCHIATR, V15, P823, DOI 10.1038/mp.2009.146; Prohovnik I, 2007, J CEREBR BLOOD F MET, V27, P1861, DOI 10.1038/sj.jcbfm.9600478; Qiu YW, 2014, DRUG ALCOHOL DEPEN, V134, P314, DOI 10.1016/j.drugalcdep.2013.10.023; Qiu YW, 2013, NEUROSCI LETT, V538, P43, DOI 10.1016/j.neulet.2013.01.019; Rauch A, 2008, P NATL ACAD SCI USA, V105, P6759, DOI 10.1073/pnas.0800312105; Regolisti G, 2013, NEPHROL DIAL TRANSPL, V28, P79, DOI 10.1093/ndt/gfs182; Rogers BP, 2012, ALCOHOL CLIN EXP RES, V36, P294, DOI 10.1111/j.1530-0277.2011.01614.x; Savazzi GM, 2001, NEPHRON, V89, P31, DOI 10.1159/000046040; Sehgal AR, 1997, AM J KIDNEY DIS, V30, P41, DOI 10.1016/S0272-6386(97)90563-1; Skinner H, 2005, BRIT J ANAESTH, V94, P203, DOI 10.1093/bja/aei016; Song SH, 2008, PSYCHIAT CLIN NEUROS, V62, P554, DOI 10.1111/j.1440-1819.2008.01849.x; Stefanidis I, 2005, CLIN NEPHROL, V64, P129; Tamura MK, 2013, AM J KIDNEY DIS, V61, P228, DOI 10.1053/j.ajkd.2012.09.009; Tamura MK, 2011, KIDNEY INT, V79, P14, DOI 10.1038/ki.2010.336; Tryc AB, 2011, NEPHROL DIAL TRANSPL, V26, P2635, DOI 10.1093/ndt/gfq729; Whitwell JL, 2009, J NEUROSCI, V29, P9661, DOI 10.1523/JNEUROSCI.2160-09.2009; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zelazo P. D., 2010, WILEY BLACKWELL HDB, P574, DOI DOI 10.1002/9781444325485.CH22; Zhang LJ, 2013, METAB BRAIN DIS, V28, P647, DOI 10.1007/s11011-013-9438-7; Zhang LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042824	50	43	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98346	10.1371/journal.pone.0098346	http://dx.doi.org/10.1371/journal.pone.0098346			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24854737	Green Published, gold, Green Submitted			2022-12-25	WOS:000338323200064
J	Zhang, L; Zhang, ZZ; Zhang, YR; Hu, G; Chen, LW				Zhang, Lu; Zhang, Zhenzhen; Zhang, Yurong; Hu, Gang; Chen, Liwei			Evaluation of Finnish Diabetes Risk Score in Screening Undiagnosed Diabetes and Prediabetes among US Adults by Gender and Race: NHANES 1999-2010	PLOS ONE			English	Article							LIFE-STYLE INTERVENTION; IMPAIRED GLUCOSE-TOLERANCE; INSULIN-RESISTANCE; TYPE-2; MELLITUS; PERFORMANCE; POPULATION; TOOL; INDIVIDUALS; PROGRESSION	Objective: To evaluate the performance of Finnish Diabetes Risk Score (FINDRISC) in detecting undiagnosed diabetes and prediabetes among U. S. adults by gender and race. Methods: This cross-sectional analysis included participants (aged >= 20 years) from the National Health and Nutrition Examination Survey (NHANES) 1999-2010. Sensitivity, specificity, area under the receiver operating characteristic (ROC) curve and the optimal cutoff points for identifying undiagnosed diabetes and prediabetes were calculated for FINDRISC by gender and race/ethnicity. Results: Among the 20,633 adults (>= 20 years), 49.8% were women and 53.0% were non-Hispanic White. The prevalence of undiagnosed diabetes and prediabetes was 4.1% and 35.6%, respectively. FINDRISC was positively associated with the prevalence of diabetes (OR = 1.48 for 1 unit increase, p < 0.001) and prediabetes (OR = 1.15 for 1 unit increase, p < 0.001). The area under ROC for detecting undiagnosed diabetes was 0.75 for total population, 0.74 for men and 0.78 for women (p = 0.04); 0.76 for White, 0.76 for Black and 0.72 for Hispanics (p = 0.03 for White vs. Hispanics). The area under ROC for detecting prediabetes was 0.67 for total population, 0.66 for men and 0.70 for women (p < 0.001); 0.68 for White, 0.67 for Black and 0.65 for Hispanics (p < 0.001 for White vs. Hispanics). The optimal cutoff point was 10 (sensitivity = 0.75) for men and 12 (sensitivity = 0.72) for women for detecting undiagnosed diabetes; 9 (sensitivity = 0.61) for men and 10 (sensitivity = 0.69) for women for detecting prediabetes. Conclusions: FINDRISC is a simple and non-invasive screening tool to identify individuals at high risk for diabetes in the U. S. adults.	[Zhang, Lu] Louisiana State Univ, Hlth Sci Ctr, Sch Publ Hlth, Program Epidemiol, New Orleans, LA USA; [Zhang, Zhenzhen] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Zhang, Yurong] Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Xian, Shanxi, Peoples R China; [Hu, Gang] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Chen, Liwei] Clemson Univ, Dept Publ Hlth Sci, Clemson, SC 29634 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Michigan State University; Xi'an Jiaotong University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Clemson University	Chen, LW (corresponding author), Clemson Univ, Dept Publ Hlth Sci, Clemson, SC 29634 USA.	liweic@clemson.edu	Hu, Gang/V-7947-2019; Hu, Gang/N-1971-2017	Hu, Gang/0000-0002-6172-8017; Hu, Gang/0000-0002-6172-8017; Zhang, Zhenzhen/0000-0002-9440-3892	Clemson University; School of Public Health at Louisiana State University Health Science Center; Pennington Biomedical Research Center	Clemson University; School of Public Health at Louisiana State University Health Science Center; Pennington Biomedical Research Center	The present study is supported in part from the Clemson University, the School of Public Health at Louisiana State University Health Science Center, and the Pennington Biomedical Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aekplakorn W, 2006, DIABETES CARE, V29, P1872, DOI 10.2337/dc05-2141; Alebiosu Olutayo C, 2013, Indian J Endocrinol Metab, V17, P653, DOI 10.4103/2230-8210.113756; Alssema M, 2011, DIABETOLOGIA, V54, P1004, DOI 10.1007/s00125-010-1990-7; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc12-s064, 10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc11-S062]; American Diabetes Association, 2004, DIABETES CARE, V27, pS11, DOI [10.2337/diacare.27.2007.S11, DOI 10.2337/DIACARE.27.2007.S11]; Baan CA, 1999, DIABETES CARE, V22, P213, DOI 10.2337/diacare.22.2.213; Balkau B, 2008, DIABETES CARE, V31, P2056, DOI 10.2337/dc08-0368; Bang HJ, 2009, ANN INTERN MED, V151, P775, DOI 10.7326/0003-4819-151-11-200912010-00005; Barengo Noel C, 2013, Diabetes Metab Res Rev, DOI 10.1002/dmrr.2462; Bennett CM, 2007, DIABETIC MED, V24, P333, DOI 10.1111/j.1464-5491.2007.02106.x; Bergmann A, 2007, HORM METAB RES, V39, P677, DOI 10.1055/s-2007-985353; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Brodovicz KG, 2011, DIABETIC MED, V28, P1078, DOI 10.1111/j.1464-5491.2011.03315.x; Costa B, 2012, DIABETOLOGIA, V55, P1319, DOI 10.1007/s00125-012-2492-6; Doi Y, 2012, DIABETIC MED, V29, P107, DOI 10.1111/j.1464-5491.2011.03376.x; Franciosi M, 2005, DIABETES CARE, V28, P1187, DOI 10.2337/diacare.28.5.1187; Garca-Alcala H, 2012, DIABET METAB SYND OB, V5, P403, DOI 10.2147/DMSO.S35545; Geiss Linda S., 2012, Morbidity and Mortality Weekly Report, V61, P918; Getaneh A, 2011, ENDOCR PRACT, V17, P210, DOI 10.4158/EP10119.OR; Glumer C, 2004, DIABETES CARE, V27, P727, DOI 10.2337/diacare.27.3.727; Guasch-Ferre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033437; Gurka MJ, 2014, METABOLISM, V63, P218, DOI 10.1016/j.metabol.2013.10.006; HAFFNER SM, 1986, DIABETES CARE, V9, P153, DOI 10.2337/diacare.9.2.153; Heikes KE, 2008, DIABETES CARE, V31, P1040, DOI 10.2337/dc07-1150; Hellgren MI, 2012, DIABETIC MED, V29, P1501, DOI 10.1111/j.1464-5491.2012.03664.x; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b880; Icks A, 2004, DIABETES CARE, V27, P2120, DOI 10.2337/diacare.27.9.2120; Joshi Shashank R, 2005, J Assoc Physicians India, V53, P755; Kahn HS, 2009, ANN INTERN MED, V150, P741, DOI 10.7326/0003-4819-150-11-200906020-00002; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Ku GMV, 2013, PRIM CARE DIABETES, V7, P249, DOI 10.1016/j.pcd.2013.07.004; Lin JW, 2009, DIABETES CARE, V32, P2294, DOI 10.2337/dc09-0694; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Makrilakis K, 2011, DIABETES METAB, V37, P144, DOI 10.1016/j.diabet.2010.09.006; National Center for Health Statistics, NAT HLTH NUTR EX SUR; Nilsen V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-893; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Rathmann W, 2005, ARCH INTERN MED, V165, P436, DOI 10.1001/archinte.165.4.436; Saaristo Timo, 2005, Diab Vasc Dis Res, V2, P67, DOI 10.3132/dvdr.2005.011; Schwarz PEH, 2009, J CLIN ENDOCR METAB, V94, P920, DOI 10.1210/jc.2007-2427; Soriguer F, 2012, MED CLIN-BARCELONA, V138, P371, DOI 10.1016/j.medcli.2011.05.025; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Tankova T, 2011, DIABETES RES CLIN PR, V92, P46, DOI 10.1016/j.diabres.2010.12.020; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Vermunt PWA, 2012, DIABETIC MED, V29, pE223, DOI 10.1111/j.1464-5491.2012.03648.x; Wang J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-633; Winkler G, 2013, MED SCI MONITOR, V19, P67, DOI 10.12659/MSM.883747	49	73	76	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97865	10.1371/journal.pone.0097865	http://dx.doi.org/10.1371/journal.pone.0097865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852786	Green Published, gold			2022-12-25	WOS:000338323200032
J	de Decker, L; Campone, M; Retornaz, F; Berrut, G; Kabeshova, A; Molinie, F; Beauchet, O				de Decker, Laure; Campone, Mario; Retornaz, Frederique; Berrut, Gilles; Kabeshova, Anastasia; Molinie, Florence; Beauchet, Olivier			Association between Oestrogens Receptor Expressions in Breast Cancer and Comorbidities: A Cross-Sectional, Population-Based Study	PLOS ONE			English	Article							HORMONE-RECEPTORS; WOMEN; SURVIVAL; RISK; PROGNOSIS	Background: Breast cancer with oestrogen receptor expression is common in older women. Several factors, such as age and reproductive hormone exposure, have been associated with oestrogen receptor expression in breast cancer. However, the association between comorbidities and the oestrogen receptor expression has been poorly studied. We hypothesized that there was an association between burden comorbidity and breast cancer with oestrogen receptor expression in older women. Objective: To determine whether oestrogen receptor expression in breast cancer was associated with burden comorbidity in community-dwelling women. Methods: A total of 1,707 women with breast cancer registered on the list of a breast cancer registry were included. The recorded data included: age, Charlson Comorbidity Index score >= 1, breast cancer characteristics (coded according to the International Classification of Diseases for Oncology), and breast cancer pathological stage (the pathological-tumour-node-metastasis, Scarff Bloom Richardson, and hormonal status of oestrogen receptor, progesterone receptor, and human epidermal growth factor receptor). Results: Breast cancer with oestrogen receptor expression was identified in 1,378 patients (80.7%). The fully-adjusted logistic regression showed that oestrogen receptor expression was associated with Charlson Comorbidity Index score >= 1 (odds ratio [OR] = 1.91,95%confidence interval [CI] = [1.01-3.61], P = 0.048), progesterone receptor expression (OR = 16.64, 95%CI = [11.62-23.81], P<0.001), human epidermal growth factor receptor (OR = 0.54, 95%CI = [0.34-0.84], P = 0.007), age (OR = 1.02, 95%CI = [1.00-1.03], P = 0.008), Scarff Bloom Richardson grade II and grade III (OR = 0.21with 95%CI = [0.10-0.44] and OR = 0.06 with 95%CI = [0.03-0.12], P<0.001). Conclusion: Our findings provide new data showing an independent positive association between burden comorbidity and breast cancer with oestrogen receptor expression. This result confirms that evaluation of oestrogen receptor expression in breast cancer should not be limited to hormonal factors stratified by age.	[de Decker, Laure; Berrut, Gilles] Nantes Univ Hosp, Div Geriatr Med, Dept Therapeut, EA 1156 12, Nantes, France; [Kabeshova, Anastasia; Beauchet, Olivier] UNAM, Div Geriatr Med, Angers Univ Hosp, Dept Neurosci,UPRES,EA 4638, Angers, France; [Campone, Mario] INSERM, Ouest Canc Inst, UMR U892, Nantes, France; [Retornaz, Frederique] Dept Dept Geriatr, Marseille, France; [Molinie, Florence] Ouest Canc Registry, Nantes, France	Nantes Universite; CHU de Nantes; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm)	de Decker, L (corresponding author), Nantes Univ Hosp, Div Geriatr Med, Dept Therapeut, EA 1156 12, Nantes, France.	laure.dedecker@chu-nantes.fr	Beauchet, Olivier/AAP-8108-2020; MOLINIE, FLORENCE/GRY-6545-2022	MOLINIE, FLORENCE/0000-0002-0645-4017	French Ministry of Health (Projet Hospitalier de Recherche Clinique National) [K20-9]; French National Cancer Institute (INCa)	French Ministry of Health (Projet Hospitalier de Recherche Clinique National); French National Cancer Institute (INCa)(Institut National du Cancer (INCA) France)	This study was financially supported by the French Ministry of Health (Projet Hospitalier de Recherche Clinique National 2005, K20-9) and the French National Cancer Institute (INCa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althuis MD, 2004, CANCER EPIDEM BIOMAR, V13, P1558; Anderson WF, 2009, BREAST CANCER RES TR, V113, P189, DOI 10.1007/s10549-008-9918-3; Anderson WF, 2009, J CLIN ONCOL, V27, P5308, DOI 10.1200/JCO.2009.22.9450; Beitelshees AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015180; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chlebowski RT, 2007, JNCI-J NATL CANCER I, V99, P1695, DOI 10.1093/jnci/djm224; Colonna SV, 2012, BREAST CANCER RES TR, V131, P325, DOI 10.1007/s10549-011-1790-x; Crivellari D, 2010, CRIT REV ONCOL HEMAT, V73, P92, DOI 10.1016/j.critrevonc.2009.02.003; Daidone MG, 2003, CRIT REV ONCOL HEMAT, V45, P313, DOI 10.1016/S1040-8428(02)00144-0; Dunbier AK, 2010, J CLIN ONCOL, V28, P1161, DOI 10.1200/JCO.2009.23.9616; Dunnwald LK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1639; Extermann M, 2000, EUR J CANCER, V36, P453, DOI 10.1016/S0959-8049(99)00319-6; Extermann Martine, 2007, Cancer Control, V14, P13; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; Goodwin PJ, 2002, J CLIN ONCOL, V20, P42, DOI 10.1200/JCO.20.1.42; HABEL LA, 1993, EPIDEMIOL REV, V15, P209, DOI 10.1093/oxfordjournals.epirev.a036107; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kallel I, 2012, J RECEPT SIG TRANSD, V32, P304, DOI 10.3109/10799893.2012.739624; Konecny G, 2003, J NATL CANCER I, V95, P142, DOI 10.1093/jnci/95.2.142; Louwman WJ, 2005, EUR J CANCER, V41, P779, DOI 10.1016/j.ejca.2004.12.025; Missmer SA, 2004, JNCI-J NATL CANCER I, V96, P1856, DOI 10.1093/jnci/djh336; Patnaik JL, 2011, JNCI-J NATL CANCER I, V103, P1101, DOI 10.1093/jnci/djr188; Piccirillo JF, 2004, JAMA-J AM MED ASSOC, V291, P2441, DOI 10.1001/jama.291.20.2441; Pinheiro RL, 2009, BREAST, V18, P8, DOI 10.1016/j.breast.2008.09.001; Raji MA, 2008, ARCH INTERN MED, V168, P2033, DOI 10.1001/archinte.168.18.2033; SATARIANO WA, 1994, ANN INTERN MED, V120, P104, DOI 10.7326/0003-4819-120-2-199401150-00002; Schonberg MA, 2012, J AM GERIATR SOC, V60, P538, DOI 10.1111/j.1532-5415.2011.03820.x; SINGH L, 1988, BRIT J CANCER, V57, P612, DOI 10.1038/bjc.1988.139; Wang N, 2011, BREAST, V20, P519, DOI 10.1016/j.breast.2011.05.009; Yancik R, 2001, JAMA-J AM MED ASSOC, V285, P885, DOI 10.1001/jama.285.7.885; Yang XR, 2011, JNCI-J NATL CANCER I, V103, P250, DOI 10.1093/jnci/djq526	31	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98127	10.1371/journal.pone.0098127	http://dx.doi.org/10.1371/journal.pone.0098127			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848085	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600088
J	Minamikawa, MF; Koyano, R; Kikuchi, S; Koba, T; Sassa, H				Minamikawa, Mai F.; Koyano, Ruriko; Kikuchi, Shinji; Koba, Takato; Sassa, Hidenori			Identification of SFBB-Containing Canonical and Noncanonical SCF Complexes in Pollen of Apple (Malus x domestica)	PLOS ONE			English	Article							GAMETOPHYTIC SELF-INCOMPATIBILITY; NONFUNCTIONAL S-HAPLOTYPES; F-BOX-BROTHERS; SKP1-LIKE PROTEIN; UBIQUITIN LIGASE; NICOTIANA-ALATA; PRUNUS-AVIUM; TUBE GROWTH; RNASE; MULTIPLE	Gametophytic self-incompatibility (GSI) of Rosaceae, Solanaceae and Plantaginaceae is controlled by a single polymorphic S locus. The S locus contains at least two genes, S-RNase and F-box protein encoding gene SLF/SFB/SFBB that control pistil and pollen specificity, respectively. Generally, the F-box protein forms an E3 ligase complex, SCF complex with Skp1, Cullin1 (CUL1) and Rbx1, however, in Petunia inflata, SBP1 (S-RNase binding protein1) was reported to play the role of Skp1 and Rbx1, and form an SCFSLF-like complex for ubiquitination of non-self S-RNases. On the other hand, in Petunia hybrida and Petunia inflata of Solanaceae, Prunus avium and Pyrus bretschneideri of Rosaceae, SSK1 (SLF-interacting Skp1-like protein1) is considered to form the SCFSLF/SFB complex. Here, we isolated pollen-expressed apple homologs of SSK1 and CUL1, and named MdSSK1, MdCUL1A and MdCUL1B. MdSSK1 was preferentially expressed in pollen, but weakly in other organs analyzed, while, MdCUL1A and MdCUL1B were almost equally expressed in all the organs analyzed. MdSSK1 transcript abundance was significantly (> 100 times) higher than that of MdSBP1. In vitro binding assays showed that MdSSK1 and MdSBP1 interacted with MdSFBB1-S-9 and MdCUL1, and MdSFBB1-S-9 interacted more strongly with MdSSK1 than with MdSBP1. The results suggest that both MdSSK1-containing SCFSFBB1 and MdSBP1-containing SCFSFBB1-like complexes function in pollen of apple, and the former plays a major role.	[Minamikawa, Mai F.; Koyano, Ruriko; Kikuchi, Shinji; Koba, Takato; Sassa, Hidenori] Chiba Univ, Grad Sch Hort, Matsudo, Chiba, Japan	Chiba University	Sassa, H (corresponding author), Chiba Univ, Grad Sch Hort, Matsudo, Chiba, Japan.	sassa@faculty.chiba-u.jp	Koba, Takato/AAV-4512-2020; Sassa, Hidenori/Q-7561-2018; Koba, Takato/I-3708-2017; Kikuchi, Shinji/N-7380-2019		Japan Society for the Promotion of Science (JSPS) [24380004]; JSPS	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grants-in-Aid for Scientific Research (B, 24380004) to H. S. from Japan Society for the Promotion of Science (JSPS). M. F. M. was supported by JSPS Research Fellowship for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2009, J JPN SOC HORTIC SCI, V78, P402, DOI 10.2503/jjshs1.78.402; Aguiar B, 2013, J EXP BOT, V64, P2423, DOI 10.1093/jxb/ert098; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chen G, 2010, J EXP BOT, V61, P2027, DOI 10.1093/jxb/erp381; Crane MB, 1942, J GENET, V43, P31, DOI 10.1007/BF02982745; De Franceschi P, 2011, TREE GENET GENOMES, V7, P231, DOI 10.1007/s11295-010-0327-5; De Franceschi P, 2012, J EXP BOT, V63, P4015, DOI 10.1093/jxb/ers108; Franklin-Tong V. E., 2008, P237, DOI 10.1007/978-3-540-68486-2_11; Goldraij A, 2006, NATURE, V439, P805, DOI 10.1038/nature04491; Golz JF, 2001, P NATL ACAD SCI USA, V98, P15372, DOI 10.1073/pnas.261571598; Hauck NR, 2006, GENETICS, V172, P1191, DOI 10.1534/genetics.105.049395; Ho MS, 2006, J BIOMED SCI, V13, P181, DOI 10.1007/s11373-005-9058-2; Hua ZH, 2008, MOL PLANT, V1, P575, DOI 10.1093/mp/ssn032; Hua ZH, 2006, PLANT CELL, V18, P2531, DOI 10.1105/tpc.106.041061; Huang J, 2006, PLANT J, V46, P780, DOI 10.1111/j.1365-313X.2006.02735.x; Kakui H, 2011, PLANT J, V68, P1028, DOI 10.1111/j.1365-313X.2011.04752.x; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Kubo K, 2010, SCIENCE, V330, P796, DOI 10.1126/science.1195243; Lee CB, 2008, J BIOL CHEM, V283, P26965, DOI 10.1074/jbc.M804410200; LEWIS D., 1958, HEREDITY, V12, P233, DOI 10.1038/hdy.1958.26; Lewis D, 1942, J GENET, V43, P211, DOI 10.1007/BF02982754; Li S, 2014, PLANT REPROD, V27, P31, DOI 10.1007/s00497-013-0238-3; Li WT, 2014, GENETICS, V196, P439, DOI 10.1534/genetics.113.158279; Li WT, 2010, SCIENCE, V330, P1827, DOI 10.1126/science.1197908; Luu DT, 2000, NATURE, V407, P649, DOI 10.1038/35036623; Mase N, 2013, MOL BREEDING; Matsumoto D, 2012, PLANT PHYSIOL, V159, P1252, DOI 10.1104/pp.112.197343; MCCLURE BA, 1990, NATURE, V347, P757, DOI 10.1038/347757a0; McClure B, 2011, ANN BOT-LONDON, V108, P647, DOI 10.1093/aob/mcr179; Meng XY, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr016; Meng XY, 2011, ANN BOT-LONDON, V108, P637, DOI 10.1093/aob/mcq253; Minamikawa M, 2010, PLANT MOL BIOL, V74, P143, DOI 10.1007/s11103-010-9662-z; Minamikawa MF, 2013, PLANT BIOTECHNOL-NAR, V30, P119, DOI 10.5511/plantbiotechnology.13.0109a; Nettancourt, 2001, INCOMPATIBILITY INCO; O'Brien M, 2004, SEX PLANT REPROD, V17, P81, DOI 10.1007/s00497-004-0218-8; Okada K, 2008, PLANT MOL BIOL, V66, P389, DOI 10.1007/s11103-007-9277-1; Okada K, 2013, PLANT REPROD, V26, P101, DOI 10.1007/s00497-013-0212-0; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Saito T, 2012, TREE GENET GENOMES, V8, P689, DOI 10.1007/s11295-011-0456-5; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Sassa H, 2007, GENETICS, V175, P1869, DOI 10.1534/genetics.106.068858; Sassa H, 2010, SEX PLANT REPROD, V23, P39, DOI 10.1007/s00497-009-0111-6; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Sijacic P, 2004, NATURE, V429, P302, DOI 10.1038/nature02523; Sims TL, 2001, PLANT MOL BIOL, V47, P771, DOI 10.1023/A:1013639528858; Sonneveld T, 2005, PLANT CELL, V17, P37, DOI 10.1105/tpc.104.026963; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tao R, 2010, SCI HORTIC-AMSTERDAM, V124, P423, DOI 10.1016/j.scienta.2010.01.025; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsukamoto T, 2006, PLANT MOL BIOL, V62, P371, DOI 10.1007/s11103-006-9026-x; Ushijima K, 2004, PLANT J, V39, P573, DOI 10.1111/j.1365-313X.2004.02154.x; Vilanova S, 2006, PLANT PHYSIOL, V142, P629, DOI 10.1104/pp.106.083865; Xu C, 2013, PLANT MOL BIOL, V81, P245, DOI 10.1007/s11103-012-9995-x; Xue YB, 2009, PLANT MOL BIOL, V70, P499, DOI 10.1007/s11103-009-9487-9; Yamane H, 2009, J JPN SOC HORTIC SCI, V78, P137, DOI 10.2503/jjshs1.78.137; Zhang YJ, 2009, ANNU REV PLANT BIOL, V60, P21, DOI 10.1146/annurev.arplant.043008.092108; Zhao L, 2010, PLANT J, V62, P52, DOI 10.1111/j.1365-313X.2010.04123.x; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	59	16	16	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97642	10.1371/journal.pone.0097642	http://dx.doi.org/10.1371/journal.pone.0097642			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847858	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600046
J	Nebenzahl-Guimaraes, H; Borgdorff, MW; Murray, MB; van Soolingen, D				Nebenzahl-Guimaraes, Hanna; Borgdorff, Martien W.; Murray, Megan B.; van Soolingen, Dick			A Novel Approach - The Propensity to Propagate (PTP) Method for Controlling for Host Factors in Studying the Transmission of Mycobacterium Tuberculosis	PLOS ONE			English	Article							DRUG-RESISTANCE; BEIJING GENOTYPE; STRAIN; IDENTIFICATION; EPIDEMIOLOGY; LINEAGE; PRISON	Rationale: Understanding the genetic variations among Mycobacterium tuberculosis (MTB) strains with differential ability to transmit would be a major step forward in preventing transmission. Objectives: To describe a method to extend conventional proxy measures of transmissibility by adjusting for patient-related factors, thus strengthening the causal association found with bacterial factors. Methods: Clinical, demographic and molecular fingerprinting data were obtained during routine surveillance of verified MTB cases reported in the Netherlands between 1993 and 2011, and the phylogenetic lineages of the isolates were inferred. Odds ratios for host risk factors for clustering were used to obtain a measure of each patient's and cluster's propensity to propagate (CPP). Mean and median cluster sizes across different categories of CPP were compared amongst four different phylogenetic lineages. Results: Both mean and median cluster size grew with increasing CPP category. On average, CPP values from Euro-American lineage strains were higher than Beijing and EAI strains. There were no significant differences between the mean and median cluster sizes among the four phylogenetic lineages within each CPP category. Conclusions: Our finding that the distribution of CPP scores was unequal across four different phylogenetic lineages supports the notion that host-related factors should be controlled for to attain comparability in measuring the different phylogenetic lineages' ability to propagate. Although Euro-American strains were more likely to be in clusters in an unadjusted analysis, no significant differences among the four lineages persisted after we controlled for host factors.	[Nebenzahl-Guimaraes, Hanna; van Soolingen, Dick] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Nebenzahl-Guimaraes, Hanna] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Nebenzahl-Guimaraes, Hanna] PT Govt Associate Lab, ICVS 3Bs, Braga, Portugal; [Borgdorff, Martien W.] Publ Hlth Serv, Amsterdam, Netherlands; [Borgdorff, Martien W.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol, NL-1105 AZ Amsterdam, Netherlands; [Murray, Megan B.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [van Soolingen, Dick] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands	Netherlands National Institute for Public Health & the Environment; Universidade do Minho; Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Harvard University; Harvard Medical School; Radboud University Nijmegen	Nebenzahl-Guimaraes, H (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands.	hanna.guimaraes@gmail.com			Portuguese Foundation for Science and Technology (FCT) [SFRH/BD/33902/2009]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	Portuguese Foundation for Science and Technology (FCT) (SFRH/BD/33902/2009 to HN-G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanna AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025075; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; [Anonymous], GLOB TUB CONTR WHO R; Borgdorff MW, 2010, EUR RESPIR J, V36, P339, DOI 10.1183/09031936.00155409; Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Tho DQ, 2012, ANTIMICROB AGENTS CH, V56, P3074, DOI 10.1128/AAC.00319-12; de Beer JL, 2013, J CLIN MICROBIOL, V51, P1193, DOI 10.1128/JCM.03061-12; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; de Steenwinkel JEM, 2012, EMERG INFECT DIS, V18, P660, DOI 10.3201/eid1804.110912; Dillaha J, 2000, ATS INT C MAY 5 10 2; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Ghebremichael S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010893; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Ijaz K, 2004, INT J TUBERC LUNG D, V8, P994; Kiers A, 1997, INT J TUBERC LUNG D, V1, P239; Kik SV, 2008, AM J RESP CRIT CARE, V178, P96, DOI 10.1164/rccm.200708-1256OC; Langlois-Klassen D, 2013, EMERG INFECT DIS, V19, P701, DOI 10.3201/eid1905.121578; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Talarico S, 2011, TUBERCULOSIS, V91, P244, DOI 10.1016/j.tube.2011.01.007; Toungoussova OS, 2003, CLIN INFECT DIS, V37, P665, DOI 10.1086/377205; Valway SE, 1998, NEW ENGL J MED, V338, P633, DOI 10.1056/NEJM199803053381001; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1993, J CLIN MICROBIOL, V31, P1987, DOI 10.1128/JCM.31.8.1987-1995.1993; Verhagen LM, 2011, J INFECT DIS, V203, P1249, DOI 10.1093/infdis/jir013; Wada T, 2009, TUBERCULOSIS, V89, P252, DOI 10.1016/j.tube.2009.05.007; Weniger T, 2010, NUCL ACIDS RES, V38; Yang CG, 2012, CLIN INFECT DIS, V55, P1179, DOI 10.1093/cid/cis670; Yang ZH, 1998, J CLIN MICROBIOL, V36, P1003, DOI 10.1128/JCM.36.4.1003-1007.1998	31	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97816	10.1371/journal.pone.0097816	http://dx.doi.org/10.1371/journal.pone.0097816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849817	gold, Green Published, Green Submitted			2022-12-25	WOS:000336730600063
J	Qu, LS; Liu, JX; Liu, TT; Shen, XZ; Chen, TY; Ni, ZP; Lu, CH				Qu, Li-Shuai; Liu, Jin-Xia; Liu, Tao-Tao; Shen, Xi-Zhong; Chen, Tao-Yang; Ni, Zheng-Pin; Lu, Cui-Hua			Association of Hepatitis B Virus Pre-S Deletions with the Development of Hepatocellular Carcinoma in Qidong, China	PLOS ONE			English	Article							ADVANCED LIVER-DISEASE; GENOTYPE-C; HIGH PREVALENCE; CORE PROMOTER; DNA LEVELS; INFECTION; MUTATIONS; RISK; MUTANTS; VARIANTS	Background/Aim: To investigate the roles of mutations in pre-S and S regions of hepatitis B virus (HBV) on the progression of hepatocellular carcinoma (HCC) in Qidong, China. Methods: We conducted an age matched case-control study within a cohort of 2387 male HBV carriers who were recruited from August, 1996. The HBV DNA sequence in pre-S/S regions was successfully determined in 96 HCC cases and 97 control subjects. In addition, a consecutive series of samples from 11 HCC cases were employed to evaluate the pre-S deletion patterns before and after the occurrence of HCC. Results: After adjustment for age, history of cigarette smoking and alcohol consumption, HBeAg positivity, pre-S deletions, pre-S2 start codon mutations, and T53C mutation were significantly associated with HCC, showing adjusted odds ratios (ORs) from 1.914 to 3.199. HCC patients also had a lower frequency of T31C mutation in pre-S2 gene, compared with control subjects (0.524; 95% CI 0.280-0.982). HBV pre-S deletions were clustered mainly in the 59 end of pre-S2 region. Multivariate analysis showed that pre-S deletions and pre-S2 start codon mutations were independent risk factors for HCC. The OR (95% CI) were 2.434 (1.063-5.573) and 3.065 (1.099-8.547), respectively. The longitudinal observation indicated that the pre-S deletion mutations were not acquired at the beginning of HBV infection, but that the mutations occurred during the long course of liver disease. Conclusion: Pre-S deletions and pre-S2 start codon mutations were independently associated with the development of HCC. The results also provided direct evidence that pre-S deletion mutations were not acquired from the beginning of infection but arose de novo during the progression of liver disease.	[Qu, Li-Shuai; Liu, Jin-Xia; Lu, Cui-Hua] Nantong Univ, Affiliated Hosp, Dept Gastroenterol, Nantong, Jiangsu, Peoples R China; [Liu, Tao-Tao; Shen, Xi-Zhong] Fudan Univ, Dept Gastroenterol, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Chen, Tao-Yang; Ni, Zheng-Pin] Qidong Liver Canc Inst, Qidong, Jiangsu, Peoples R China	Nantong University; Fudan University	Lu, CH (corresponding author), Nantong Univ, Affiliated Hosp, Dept Gastroenterol, Nantong, Jiangsu, Peoples R China.	lucuihua@yeah.net	liu, taotao/GSI-7460-2022	Qu, Lishuai/0000-0001-8562-678X	China Ministry of Health [W201202]; Natural Science Foundation of Jiangsu Province [BK2012225]; Foundation of Jiangsu Province [WS056]; National Nature Science Foundation of China [81302056]	China Ministry of Health; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Foundation of Jiangsu Province; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was financially supported by the China Ministry of Health (W201202), Natural Science Foundation of Jiangsu Province (BK2012225), Foundation of Jiangsu Province (WS056), and National Nature Science Foundation of China (No. 81302056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan HLY, 2008, J CLIN ONCOL, V26, P177, DOI 10.1200/JCO.2007.13.2043; Chen BF, 2006, GASTROENTEROLOGY, V130, P1153, DOI 10.1053/j.gastro.2006.01.011; Chen CH, 2007, GASTROENTEROLOGY, V133, P1466, DOI 10.1053/j.gastro.2007.09.002; Chen CJ, 2009, HEPATOLOGY, V49, pS72, DOI 10.1002/hep.22884; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.immunol.13.1.29; Choi MS, 2007, J VIRAL HEPATITIS, V14, P161, DOI 10.1111/j.1365-2893.2006.00784.x; Fan YF, 2001, HEPATOLOGY, V33, P277, DOI 10.1053/jhep.2001.21163; Fang ZL, 2008, J GEN VIROL, V89, P2882, DOI 10.1099/vir.0.2008/002824-0; Fang ZL, 2008, AM J GASTROENTEROL, V103, P2254, DOI 10.1111/j.1572-0241.2008.01974.x; FERRARI C, 1992, GASTROENTEROLOGY, V103, P255, DOI 10.1016/0016-5085(92)91121-J; Guo X, 2008, J HEPATOL, V49, P718, DOI 10.1016/j.jhep.2008.06.026; Hsieh YH, 2004, CARCINOGENESIS, V25, P2023, DOI 10.1093/carcin/bgh207; Huy TTT, 2003, J CLIN MICROBIOL, V41, P5449, DOI 10.1128/JCM.41.12.5449-5455.2003; Ito K, 2006, CLIN INFECT DIS, V42, P1, DOI 10.1086/498522; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Kurbanov F, 2010, HEPATOL RES, V40, P14, DOI 10.1111/j.1872-034X.2009.00601.x; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Liu CJ, 2002, J MED VIROL, V68, P50, DOI 10.1002/jmv.10169; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Mun HS, 2008, J MED VIROL, V80, P1189, DOI 10.1002/jmv.21208; Pollicino T, 1997, HEPATOLOGY, V26, P495, DOI 10.1002/hep.510260235; Qu LS, 2011, HEPATOL RES, V41, P54, DOI 10.1111/j.1872-034X.2010.00732.x; Qu LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059583; Qu LS, 2014, HEPATOL RES IN PRESS; Raimondo G, 2004, J HEPATOL, V40, P515, DOI 10.1016/j.jhep.2003.11.025; Sugauchi F, 2003, J MED VIROL, V70, P537, DOI 10.1002/jmv.10428; Wang HC, 2003, AM J PATHOL, V163, P2441, DOI 10.1016/S0002-9440(10)63599-7; Yang HI, 2008, JNCI-J NATL CANCER I, V100, P1134, DOI 10.1093/jnci/djn243; Yuen MF, 2008, GUT, V57, P98, DOI 10.1136/gut.2007.119859; Zhong S, 1999, J VIRAL HEPATITIS, V6, P195, DOI 10.1046/j.1365-2893.1999.00154.x	31	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98257	10.1371/journal.pone.0098257	http://dx.doi.org/10.1371/journal.pone.0098257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849936	gold, Green Published, Green Submitted			2022-12-25	WOS:000336730600103
J	Wojcicka, A; Piekielko-Witkowska, A; Kedzierska, H; Rybicka, B; Poplawski, P; Boguslawska, J; Master, A; Nauman, A				Wojcicka, Anna; Piekielko-Witkowska, Agnieszka; Kedzierska, Hanna; Rybicka, Beata; Poplawski, Piotr; Boguslawska, Joanna; Master, Adam; Nauman, Alicja			Epigenetic Regulation of Thyroid Hormone Receptor Beta in Renal Cancer	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; DNA METHYLTRANSFERASE-1; CELL CARCINOMA; METHYLATION; GENE; MICRORNAS; SUPPRESSOR; MIRNA; HYPERMETHYLATION; OVEREXPRESSION	Thyroid hormone receptor beta (THRB) gene is commonly deregulated in cancers and, as strengthened by animal models, postulated to play a tumor-suppressive role. Our previous studies revealed downregulation of THRB in clear cell renal cell carcinoma (ccRCC), but the culpable mechanisms have not been fully elucidated. Since epigenetic regulation is a common mechanism influencing the expression of tumor suppressors, we hypothesized that downregulation of THRB in renal cancer results from epigenetic aberrances, including CpG methylation and microRNA-dependent silencing. Our study revealed that ccRCC tumors exhibited a 56% decrease in THRB and a 37% increase in DNA methyltransferase 1 (DNMT1) expression when compared with paired non-neoplastic control samples. However, THRB CpG methylation analysis performed using BSP, SNaPshot and MSP-PCR consistently revealed no changes in methylation patterns between matched tumor and control samples. In silico analysis resulted in identification of four microRNAs (miR-155, miR-425, miR-592, and miR-599) as potentially targeting THRB transcript. Luciferase assay showed direct binding of miR-155 and miR-425 to 3'UTR of THRB, and subsequent in vivo analyses revealed that transfection of UOK171 cell line with synthetic miR-155 or miR-425 resulted in decreased expression of endogenous TRHB by 22% and 64%, respectively. Finally, real-time PCR analysis showed significant upregulation of miR-155 (354%) and miR-425 (162%) in ccRCC when compared with matched controls. Moreover, microRNA levels were negatively correlated with the amount of THRB transcript in tissue samples. We conclude that CpG methylation is not the major mechanism contributing to decreased THRB expression in ccRCC. In contrast, THRB is targeted by microRNAs miR-155 and miR-425, whose increased expression may be responsible for downregulation of THRB in ccRCC tumors.	[Wojcicka, Anna; Piekielko-Witkowska, Agnieszka; Kedzierska, Hanna; Rybicka, Beata; Poplawski, Piotr; Boguslawska, Joanna; Master, Adam; Nauman, Alicja] Ctr Postgrad Med Educ, Dept Biochem & Mol Biol, Warsaw, Poland; [Wojcicka, Anna] Med Univ Warsaw, Dept Gen Transplant & Liver Surg, Warsaw, Poland	Centre of Postgraduate Medical Education - Poland; Medical University of Warsaw	Nauman, A (corresponding author), Ctr Postgrad Med Educ, Dept Biochem & Mol Biol, Warsaw, Poland.	anauman@cmkp.edu.pl	Rybicka, Beata/V-1024-2019; Poplawski, Piotr/V-1030-2019; Bogusławska, Joanna/I-7189-2019; Piekielko-Witkowska, Agnieszka/V-1011-2019; Wojcicka, Anna/K-4134-2012	Rybicka, Beata/0000-0003-1726-0266; Poplawski, Piotr/0000-0002-9477-7595; Piekielko-Witkowska, Agnieszka/0000-0002-5348-0760; Wojcicka, Anna/0000-0001-5803-6397; Master, Adam/0000-0001-9391-8846; Boguslawska, Joanna/0000-0003-2568-1546	National Science Centre [NN401611940, NN401047638, 2012/05/B/NZ5/01541]; UNESCO/FEBS Collaborative Experimental Scholarship for Central Eastern Europe	National Science Centre(National Science Centre, Poland); UNESCO/FEBS Collaborative Experimental Scholarship for Central Eastern Europe	The study was supported by the National Science Centre grants NN401611940 and NN401047638 (to AN), the UNESCO/FEBS Collaborative Experimental Scholarship for Central & Eastern Europe, 2010 (to AW), and the National Science Centre Grant 2012/05/B/NZ5/01541 (to APW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai E, 2006, INT J CANCER, V119, P288, DOI 10.1002/ijc.21807; Arai E, 2011, INT J CLIN EXP PATHO, V4, P58; Bader AG, 2011, GENE THER, V18, P1121, DOI 10.1038/gt.2011.79; Boguslawska J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024541; Dinda S, 2002, ONCOGENE, V21, P761, DOI 10.1038/sj.onc.1205136; Dunwell TL, 2009, EPIGENETICS-US, V4, P185, DOI 10.4161/epi.4.3.8752; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gal H, 2008, BIOCHEM BIOPH RES CO, V376, P86, DOI 10.1016/j.bbrc.2008.08.107; Hagenkord JM, 2011, CANCER GENET-NY, V204, P285, DOI 10.1016/j.cancergen.2011.06.001; Hatziapostolou M, 2011, CELL MOL LIFE SCI, V68, P1681, DOI 10.1007/s00018-010-0624-z; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Iwasaki Y, 2010, ANN SURG ONCOL, V17, P2222, DOI 10.1245/s10434-010-0956-9; Jacques C, 2013, J CLIN ENDOCR METAB, V98, pE981, DOI 10.1210/jc.2012-4006; Jazdzewski K, 2011, J CLIN ENDOCR METAB, V96, pE546, DOI 10.1210/jc.2010-1594; Joseph B, 2007, J CLIN ENDOCR METAB, V92, P4766, DOI 10.1210/jc.2007-0812; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Jung M, 2009, J CELL MOL MED, V13, P3918, DOI 10.1111/j.1582-4934.2009.00705.x; Kaelin WG, 2004, CLIN CANCER RES, V10, p6290S, DOI 10.1158/1078-0432.CCR-sup-040025; Kamiya Y, 2002, CARCINOGENESIS, V23, P25, DOI 10.1093/carcin/23.1.25; Karpf AR, 2002, ONCOGENE, V21, P5496, DOI 10.1038/sj.onc.1205602; Kim WG, 2013, BBA-GEN SUBJECTS, V1830, P3928, DOI 10.1016/j.bbagen.2012.04.002; Kim WG, 2013, ENDOCRINOLOGY, V154, P25, DOI 10.1210/en.2012-1728; Kimura F, 2003, INT J CANCER, V104, P568, DOI 10.1002/ijc.10988; Kong W, 2014, ONCOGENE, V33, P679, DOI 10.1038/onc.2012.636; Koul H, 2011, AM J CANCER RES, V1, P240; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Larkin J, 2012, NAT REV UROL, V9, P147, DOI 10.1038/nrurol.2011.236; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li Z, 2002, CANCER RES, V62, P1939; Ling YQ, 2010, CANCER GENET CYTOGEN, V196, P140, DOI 10.1016/j.cancergencyto.2009.09.010; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Lopez-Beltran A, 2006, EUR UROL, V49, P798, DOI 10.1016/j.eururo.2005.11.035; Martinez-Iglesias O, 2009, CANCER RES, V69, P501, DOI 10.1158/0008-5472.CAN-08-2198; Master A, 2010, BBA-MOL BASIS DIS, V1802, P995, DOI 10.1016/j.bbadis.2010.07.025; McCabe MT, 2005, CANCER RES, V65, P3624, DOI 10.1158/0008-5472.CAN-04-2158; Neal CS, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-64; Nishi H, 2011, MOL CELL BIOL, V31, P744, DOI 10.1128/MCB.00581-10; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Osanto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038298; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Piekielko-Witkowska A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013690; Puzianowska-Kuznicka M, 2000, CANCER LETT, V155, P145, DOI 10.1016/S0304-3835(00)00416-X; Puzianowska-Kuznicka M, 2006, ACTA BIOCHIM POL, V53, P641, DOI 10.18388/abp.2006_3292; Qi JS, 1999, MOL CELL BIOL, V19, P864; R Core Team, 2022, R LANG ENV STAT COMP; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rio-Machin A, 2013, LEUKEMIA, V27, P925, DOI 10.1038/leu.2012.302; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; SAKURAI A, 1992, BIOCHEM BIOPH RES CO, V185, P78, DOI 10.1016/S0006-291X(05)80957-X; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Su ZX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S5-S15; Takai Daiya, 2003, In Silico Biology, V3, P235; Tryndyak VP, 2006, CANCER BIOL THER, V5, P65, DOI 10.4161/cbt.5.1.2288; Van der Auwera I, 2010, BRIT J CANCER, V103, P532, DOI 10.1038/sj.bjc.6605787; Virtue A, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-66; Watahiki A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024950; White NMA, 2011, J UROLOGY, V186, P1077, DOI 10.1016/j.juro.2011.04.110; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Youssef YM, 2011, EUR UROL, V59, P721, DOI 10.1016/j.eururo.2011.01.004	62	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97624	10.1371/journal.pone.0097624	http://dx.doi.org/10.1371/journal.pone.0097624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849932	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600043
J	Liu, Q; Zhang, ML; Hou, DX; Han, XJ; Jin, Y; Zhao, LH; Nie, XW; Zhou, X; Yun, T; Zhao, YH; Huang, XH; Hou, DR; Yang, N; Wu, ZQ; Li, XL; Li, RF				Liu, Qiang; Zhang, Manling; Hou, Dongxia; Han, Xuejie; Jin, Yong; Zhao, Lihua; Nie, Xiaowei; Zhou, Xin; Yun, Ting; Zhao, Yuhang; Huang, Xianghua; Hou, Daorong; Yang, Ning; Wu, Zhaoqiang; Li, Xueling; Li, Rongfeng			Karyotype Characterization of In Vivo- and In Vitro-Derived Porcine Parthenogenetic Cell Lines	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ACTIVATION; GENERATION; DERIVATION; INSTABILITY; EFFICIENCY; OOCYTES	Mammalian haploid cell lines provide useful tools for both genetic studies and transgenic animal production. To derive porcine haploid cells, three sets of experiments were conducted. First, genomes of blastomeres from 8-cell to 16-cell porcine parthenogenetically activated (PA) embryos were examined by chromosome spread analysis. An intact haploid genome was maintained by 48.15% of blastomeres. Based on this result, two major approaches for amplifying the haploid cell population were tested. First, embryonic stem-like (ES-like) cells were cultured from PA blastocyst stage embryos, and second, fetal fibroblasts from implanted day 30 PA fetuses were cultured. A total of six ES-like cell lines were derived from PA blastocysts. No chromosome spread with exactly 19 chromosomes (the normal haploid complement) was found. Four cell lines showed a tendency to develop to polyploidy (more than 38 chromosomes). The karyotypes of the fetal fibroblasts showed different abnormalities. Cells with 19-38 chromosomes were the predominant karyotype (59.48-60.91%). The diploid cells were the second most observed karyotype (16.17%-22.73%). Although a low percentage (3.45-8.33%) of cells with 19 chromosomes were detected in 18.52% of the fetus-derived cell lines, these cells were not authentic haploid cells since they exhibited random losses or gains of some chromosomes. The haploid fibroblasts were not efficiently enriched via flow cytometry sorting. On the contrary, the diploid cells were efficiently enriched. The enriched parthenogenetic diploid cells showed normal karyotypes and expressed paternally imprinted genes at extremely low levels. We concluded that only a limited number of authentic haploid cells could be obtained from porcine cleavage-stage parthenogenetic embryos. Unlike mouse, the karyotype of porcine PA embryo-derived haploid cells is not stable, long-term culture of parthenogenetic embryos, either in vivo or in vitro, resulted in abnormal karyotypes. The porcine PA embryo-derived diploid fibroblasts enriched from sorting might be candidate cells for paternally imprinted gene research.	[Liu, Qiang; Zhang, Manling; Jin, Yong; Zhao, Lihua; Nie, Xiaowei; Hou, Daorong; Yang, Ning; Wu, Zhaoqiang; Li, Rongfeng] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Liu, Qiang; Zhang, Manling; Jin, Yong; Zhao, Lihua; Nie, Xiaowei; Hou, Daorong; Yang, Ning; Wu, Zhaoqiang; Li, Rongfeng] Nanjing Med Univ, Jiangsu Key Lab Xenotransplantat, Nanjing, Jiangsu, Peoples R China; [Hou, Dongxia; Han, Xuejie; Zhou, Xin; Yun, Ting; Zhao, Yuhang; Huang, Xianghua; Li, Xueling] Inner Mongolia Univ, Natl Educ Minist Mammalian Reprod Biol & Biotechn, Key Lab, Hohhot, Inner Mongolia, Peoples R China	Nanjing Medical University; Nanjing Medical University; Inner Mongolia University	Li, XL (corresponding author), Inner Mongolia Univ, Natl Educ Minist Mammalian Reprod Biol & Biotechn, Key Lab, Hohhot, Inner Mongolia, Peoples R China.	lixueling@hotmail.com; lirongfeng@njmu.edu.cn			National Natural Sciences Foundation of China [30871408, 31371487]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Sciences Foundation of China (30871408 and 31371487). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brevini TAL, 2012, STEM CELL REV REP, V8, P1076, DOI 10.1007/s12015-012-9379-2; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Delhanty JDA, 2005, CYTOGENET GENOME RES, V111, P237, DOI 10.1159/000086894; ECHARD G, 1974, CHROMOSOMA, V45, P133, DOI 10.1007/BF00362307; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Fujishiro S, 2013, STEM CELLS DEV, V22, P473, DOI 10.1089/scd.2012.0173; Hao YH, 2006, MOL REPROD DEV, V73, P77, DOI 10.1002/mrd.20358; Harris D, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103390; KAUFMAN MH, 1983, J EMBRYOL EXP MORPH, V73, P249; KAUFMAN MH, 1978, J EMBRYOL EXP MORPH, V45, P85; KAUFMAN MH, 1982, J EMBRYOL EXP MORPH, V71, P139; KAUFMAN MH, 1974, J EMBRYOL EXP MORPH, V31, P635; Koh S, 2014, THERIOGENOLOGY, V81, P103, DOI 10.1016/j.theriogenology.2013.09.009; Kure-Bayashi S, 2000, THERIOGENOLOGY, V53, P1105, DOI 10.1016/S0093-691X(00)00256-9; Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448; Li W, 2014, CELL STEM CELL, V14, P404, DOI 10.1016/j.stem.2013.11.016; Li W, 2012, NATURE, V490, P407, DOI 10.1038/nature11435; LIN CC, 1980, CAN J GENET CYTOL, V22, P103, DOI 10.1139/g80-013; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Mitalipov SM, 2001, BIOL REPROD, V65, P253, DOI 10.1095/biolreprod65.1.253; MODLINSKI JA, 1975, J EMBRYOL EXP MORPH, V33, P897; Morelli MA, 2005, REPRODUCTION, V130, P761, DOI 10.1530/rep.1.00865; Nikaido L, 2003, GENOME RES, V13, P1402, DOI 10.1101/gr.1055303; Oh SK, 2005, STEM CELLS, V23, P605, DOI 10.1634/stemcells.2004-0297; Park CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022216; Sritanaudomchai H, 2010, HUM REPROD, V25, P1927, DOI 10.1093/humrep/deq144; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; TARKOWSKI AK, 1976, NATURE, V259, P663, DOI 10.1038/259663a0; TARKOWSKI AK, 1966, CYTOGENETICS, V5, P394, DOI 10.1159/000129914; Telugu Bhanu Prakash V L, 2011, J Biol Chem, V286, P28948, DOI 10.1074/jbc.M111.229468; Tsai S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-328; VANDERHOEVEN FA, 1985, J REPROD FERTIL, V75, P593, DOI 10.1530/jrf.0.0750593; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Whitworth KM, 2009, MOL REPROD DEV, V76, P490, DOI 10.1002/mrd.20987; Yang H, 2013, CELL RES, V23, P1187, DOI 10.1038/cr.2013.93; Yang H, 2012, CELL, V149, P605, DOI 10.1016/j.cell.2012.04.002; Yi MS, 2009, SCIENCE, V326, P430, DOI 10.1126/science.1175151; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	41	34	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97974	10.1371/journal.pone.0097974	http://dx.doi.org/10.1371/journal.pone.0097974			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844788	gold, Green Submitted, Green Published			2022-12-25	WOS:000339563400077
J	Martinu, T; Kinnier, CV; Sun, J; Kelly, FL; Nelson, ME; Garantziotis, S; Foster, WM; Palmer, SM				Martinu, Tereza; Kinnier, Christine V.; Sun, Jesse; Kelly, Francine L.; Nelson, Margaret E.; Garantziotis, Stavros; Foster, W. Michael; Palmer, Scott M.			Allogeneic Splenocyte Transfer and Lipopolysaccharide Inhalations Induce Differential T Cell Expansion and Lung Injury: A Novel Model of Pulmonary Graft-versus-Host Disease	PLOS ONE			English	Article							IDIOPATHIC PNEUMONIA SYNDROME; ALLERGIC AIRWAY INFLAMMATION; INNATE IMMUNE ACTIVATION; BONE-MARROW TRANSPLANT; INHALED LIPOPOLYSACCHARIDE; BRONCHIOLITIS OBLITERANS; DENDRITIC CELLS; HYPERRESPONSIVENESS; MICE; HYPERREACTIVITY	Background: Pulmonary GVHD (pGVHD) is an important complication of hematopoietic cell transplant (HCT) and is thought to be a consequence of the HCT conditioning regimen, allogeneic donor cells, and posttransplant lung exposures. We have previously demonstrated that serial inhaled lipopolysaccharide (LPS) exposures potentiate the development of pGVHD after murine allogeneic HCT. In the current study we hypothesized that allogeneic lymphocytes and environmental exposures alone, in the absence of a pre-conditioning regimen, would cause features of pGVHD and would lead to a different T cell expansion pattern compared to syngeneic cells. Methods: Recipient Rag1(-/-) mice received a transfer of allogeneic (Allo) or syngeneic (Syn) spleen cells. After 1 week of immune reconstitution, mice received 5 daily inhaled LPS exposures and were sacrificed 72 hours after the last LPS exposure. Lung physiology, histology, and protein levels in bronchoalveolar lavage (BAL) were assessed. Lung cells were analyzed by flow cytometry. Results: Both Allo and Syn mice that undergo LPS exposures (AlloLPS and SynLPS) have prominent lymphocytic inflammation in their lungs, resembling pGVHD pathology, not seen in LPS-unexposed or non-transplanted controls. Compared to SynLPS, however, AlloLPS have significantly increased levels of BAL protein and enhancement of airway hyperreactivity, consistent with more severe lung injury. This injury in AlloLPS mice is associated with an increase in CD8 T cells and effector CD4 T cells, as well as a decrease in regulatory to effector CD4 T cell ratio. Additionally, cytokine analysis is consistent with a preferential Th1 differentiation and upregulation of pulmonary CCL5 and granzyme B. Conclusions: Allogeneic lymphocyte transfer into lymphocyte-deficient mice, followed by LPS exposures, causes features of pGVHD and lung injury in the absence of a pre-conditioning HCT regimen. This lung disease associated with an expansion of allogeneic effector T cells provides a novel model to dissect mechanisms of pGVHD independent of conditioning.	[Martinu, Tereza; Kelly, Francine L.; Nelson, Margaret E.; Foster, W. Michael; Palmer, Scott M.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Kinnier, Christine V.] Massachusetts Gen Hosp, Dept Gen Surg, Boston, MA 02114 USA; [Sun, Jesse] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Garantziotis, Stavros] NIEHS, Resp Biol Branch, Res Triangle Pk, NC 27709 USA	Duke University; Harvard University; Massachusetts General Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Martinu, T (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	tereza.martinu@duke.edu	Garantziotis, Stavros/A-6903-2009	Garantziotis, Stavros/0000-0003-4007-375X; Palmer, Scott/0000-0002-1370-3771	Parker B. Francis Fellowship Program Award; division of intramural research, NIEHS;  [NIH/NHLBI 1P50-HL084917-01];  [NIH 1 K24 HL91140-01A2];  [RR024 127-03]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024127] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL091140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102605] Funding Source: NIH RePORTER	Parker B. Francis Fellowship Program Award; division of intramural research, NIEHS; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the following grants: NIH/NHLBI 1P50-HL084917-01 (SCCOR), Project 3 (SMP), Training core (to TM); NIH 1 K24 HL91140-01A2 (SMP); RR024 127-03 (TM) (KL2); and Parker B. Francis Fellowship Program Award (TM). This research was also supported, in part, by the division of intramural research, NIEHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afessa B, 2005, CLIN CHEST MED, V26, P571, DOI 10.1016/j.ccm.2005.06.012; Alam R, 1996, AM J RESP CRIT CARE, V153, P1398, DOI 10.1164/ajrccm.153.4.8616572; Brandon JA, 2010, CYTOKINE, V52, P265, DOI 10.1016/j.cyto.2010.08.006; Cieri N, 2013, BLOOD, V121, P573, DOI 10.1182/blood-2012-05-431718; D'Alessio FR, 2009, J CLIN INVEST, V119, P2898, DOI 10.1172/JCI36498; Domingo-Gonzalez R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00126; Dutt S, 2007, J IMMUNOL, V179, P6547, DOI 10.4049/jimmunol.179.10.6547; Fang Qiaoqiao, 2010, Int J Med Sci, V7, P55; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; FERRARA JLM, 1991, NEW ENGL J MED, V324, P667; Garantziotis S, 2007, TRANSPLANTATION, V84, P1012, DOI 10.1097/01.tp.0000286040.85007.89; Hale LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045667; Hasegawa H, 2008, GENE THER, V15, P171, DOI 10.1038/sj.gt.3303051; Hildebrandt GC, 2008, BIOL BLOOD MARROW TR, V14, P385, DOI 10.1016/j.bbmt.2008.01.004; Isogai S, 2004, J ALLERGY CLIN IMMUN, V114, P1345, DOI 10.1016/j.jaci.2004.09.021; John AE, 2003, EUR J IMMUNOL, V33, P1677, DOI 10.1002/eji.200323930; Koya T, 2007, J IMMUNOL, V179, P2787, DOI 10.4049/jimmunol.179.5.2787; Kreisel D, 2011, AM J RESP CELL MOL, V44, P749, DOI 10.1165/rcmb.2010-0099OC; Leong JW, 2011, BLOOD, V117, P2297, DOI 10.1182/blood-2011-01-327247; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Liu QF, 2010, TRANSPL IMMUNOL, V23, P12, DOI 10.1016/j.trim.2010.02.004; Liu T, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-40; Martinu T, 2011, J HEART LUNG TRANSPL, V30, P717, DOI 10.1016/j.healun.2011.01.711; MICHEL O, 1991, CLIN EXP ALLERGY, V21, P441, DOI 10.1111/j.1365-2222.1991.tb01684.x; Miyahara N, 2004, NAT MED, V10, P865, DOI 10.1038/nm1081; Miyahara N, 2004, J IMMUNOL, V172, P2549, DOI 10.4049/jimmunol.172.4.2549; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Moncrieffe H, 2008, IMMUNOLOGY, V125, P459, DOI 10.1111/j.1365-2567.2008.02866.x; Murdoch JR, 2010, AM J RESP CRIT CARE, V182, P464, DOI 10.1164/rccm.200911-1775OC; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Ostanin DV, 2009, AM J PHYSIOL-GASTR L, V296, pG135, DOI 10.1152/ajpgi.90462.2008; Panoskaltsis-Mortari A, 2007, AM J RESP CRIT CARE, V176, P713, DOI 10.1164/rccm.200702-335OC; Panoskaltsis-Mortari A, 2011, AM J RESP CRIT CARE, V183, P1262, DOI 10.1164/rccm.2007-413ST; Perez J, 2011, AM J PHYSIOL-GASTR L, V300, pG843, DOI 10.1152/ajpgi.00254.2010; Sauter CT, 2013, BONE MARROW TRANSPL, V48, P1237, DOI 10.1038/bmt.2013.47; Savov JD, 2005, AM J PHYSIOL-LUNG C, V289, pL329, DOI 10.1152/ajplung.00014.2005; Savov JD, 2003, AM J PHYSIOL-LUNG C, V285, pL940, DOI 10.1152/ajplung.00102.2003; Schaller MA, 2005, EUR J IMMUNOL, V35, P2061, DOI 10.1002/eji.200425715; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; SCHWARTZ DA, 1994, AM J PHYSIOL-LUNG C, V267, pL609, DOI 10.1152/ajplung.1994.267.5.L609; Terwey TH, 2005, BLOOD, V106, P3322, DOI 10.1182/blood-2005-05-1860; Tomita T, 2008, INFLAMM BOWEL DIS, V14, P1630, DOI 10.1002/ibd.20636; Williams KM, 2009, JAMA-J AM MED ASSOC, V302, P306, DOI 10.1001/jama.2009.1018; Wysocki CA, 2004, J IMMUNOL, V173, P845, DOI 10.4049/jimmunol.173.2.845; Xu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040314; YOUSEM SA, 1995, HUM PATHOL, V26, P668, DOI 10.1016/0046-8177(95)90174-4	46	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97951	10.1371/journal.pone.0097951	http://dx.doi.org/10.1371/journal.pone.0097951			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844383	Green Published, Green Submitted, gold			2022-12-25	WOS:000339563400074
J	Qi, JJ; Li, N; Fan, K; Yin, P; Zhao, C; Li, ZX; Lin, Y; Wang, LY; Zha, XL				Qi, Jingjing; Li, Na; Fan, Kun; Yin, Peng; Zhao, Chao; Li, Zengxia; Lin, Yi; Wang, Liying; Zha, Xiliang			beta 1,6 GlcNAc Branches-Modified PTPRT Attenuates Its Activity and Promotes Cell Migration by STAT3 Pathway	PLOS ONE			English	Article							N-ACETYLGLUCOSAMINYLTRANSFERASE-V; PROTEIN-TYROSINE-PHOSPHATASES; SIGNALING PATHWAYS; PANCREATIC-CANCER; BREAST-CARCINOMA; COLON-CANCER; RECEPTOR-T; GLYCOSYLATION; EXPRESSION; ADHESION	Receptor-like protein tyrosine phosphatases (RPTPs) are type I transmembrane glycoproteins with N-glycans whose catalytic activities are regulated by dimerization. However, the intrinsic mechanism involved in dimerizing processes remains obscure. In this study, receptor protein tyrosine phosphatase rho (PTPRT) is identified as a novel substrate of N-Acetylglucosaminyltransferase V (GnT-V). We show that addition of beta 1,6 GlcNAc branches on PTPRT prolongs PTPRT's cell-surface retention time. GnT-V overexpression enhances galectin-3's cell-surface retention and promotes PTPRT's dimerization mediated by galectin-3. Increased dimerization subsequently reduces PTPRT's catalytic activity on the dephosphorylation of signal transducer and activator of transcription 3 (STAT3) at tyrosine residue 705 (pY705 STAT3), then the accumulated pY705 STAT3 translocates into the nucleus. Collectively, these findings provide an insight into the molecular mechanism by which GnT-V promotes cell migration, suggesting that accumulation of beta 1,6 GlcNAc branched N-glycans promotes PTPRT's dimerization and decreases its catalytic activity, resulting in enhanced cell migratory capacity.	[Qi, Jingjing; Li, Na; Fan, Kun; Yin, Peng; Zhao, Chao; Li, Zengxia; Wang, Liying; Zha, Xiliang] Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Shanghai 200433, Peoples R China; [Li, Zengxia; Wang, Liying; Zha, Xiliang] Minist Hlth, Key Lab Glycoconjugate Res, Shanghai, Peoples R China; [Li, Zengxia; Wang, Liying; Zha, Xiliang] Minist Educ, Key Lab Mol Med, Shanghai, Peoples R China; [Qi, Jingjing] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Dept Immunol & Microbiol, Shanghai 200030, Peoples R China; [Lin, Yi] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Pediat, Qingdao, Shandong, Peoples R China	Fudan University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Qingdao University	Wang, LY (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Shanghai 200433, Peoples R China.	liying_wang@hotmail.com; xlzha@shmu.edu.cn	Zhao, Chao/AAG-4497-2020	Zhao, Chao/0000-0001-7349-306X	National Basic Research Program of China [2012CB822104]; National Natural Science Foundation of China [31070721, 81000873, 31370809]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the following grant sponsors: National Basic Research Program of China (2012CB822104), National Natural Science Foundation of China (Nos. 31070721, 81000873, 31370809). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KL, 2008, J BIOL CHEM, V283, P33026, DOI 10.1074/jbc.M803646200; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Deng JH, 2012, CANCER CELL, V21, P642, DOI 10.1016/j.ccr.2012.03.039; Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; Gao FL, 2012, DIGEST DIS SCI, V57, P2055, DOI 10.1007/s10620-012-2152-1; Groen A, 2008, FEBS J, V275, P2597, DOI 10.1111/j.1742-4658.2008.06407.x; Guo HB, 2003, J BIOL CHEM, V278, P52412, DOI 10.1074/jbc.M308837200; Guo HB, 2007, J BIOL CHEM, V282, P22150, DOI 10.1074/jbc.M611518200; Handerson T, 2005, CLIN CANCER RES, V11, P2969, DOI 10.1158/1078-0432.CCR-04-2211; Haura EB, 2005, NAT CLIN PRACT ONCOL, V2, P315, DOI 10.1038/ncponc0195; Huang C, 2012, CYTOKINE GROWTH F R, V23, P25, DOI 10.1016/j.cytogfr.2012.01.003; Ito Y, 2001, INT J CANCER, V91, P631, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1118>3.3.CO;2-6; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; Kim YS, 2006, PROTEOMICS, V6, P1187, DOI 10.1002/pmic.200500400; Lay V, 2012, INT J ONCOL, V41, P759, DOI 10.3892/ijo.2012.1486; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Markowska AI, 2011, J BIOL CHEM, V286, P29913, DOI 10.1074/jbc.M111.226423; Mendelsohn R, 2007, CANCER RES, V67, P9771, DOI 10.1158/0008-5472.CAN-06-4580; Ou YW, 2012, J BIOL CHEM, V287, P32394, DOI 10.1074/jbc.M112.393900; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Scott A, 2011, BIOSCIENCE REP, V31, P303, DOI 10.1042/BSR20100134; Scott LM, 2010, CURR PHARM DESIGN, V16, P1843; Sun JB, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-2; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Wang C, 2010, J CELL BIOCHEM, V109, P113, DOI 10.1002/jcb.22387; Wang LY, 2007, J CELL BIOCHEM, V100, P230, DOI 10.1002/jcb.21071; Weiss A, 1998, CELL, V94, P277, DOI 10.1016/S0092-8674(00)81469-5; Yang Z, 2012, FEBS LETT, V586, P3013, DOI 10.1016/j.febslet.2012.06.025; Zhang XD, 2007, P NATL ACAD SCI USA, V104, P4060, DOI 10.1073/pnas.0611665104; Zhao YQ, 2010, P NATL ACAD SCI USA, V107, P2592, DOI 10.1073/pnas.0914884107	34	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e98052	10.1371/journal.pone.0098052	http://dx.doi.org/10.1371/journal.pone.0098052			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846175	Green Published, Green Submitted, gold			2022-12-25	WOS:000339563400086
J	Reeves, RG; Bryk, J; Altrock, PM; Denton, JA; Reed, FA				Reeves, R. Guy; Bryk, Jaroslaw; Altrock, Philipp M.; Denton, Jai A.; Reed, Floyd A.			First Steps towards Underdominant Genetic Transformation of Insect Populations	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; DRIVE SYSTEMS; EFFICIENT; SNORNA; SET	The idea of introducing genetic modifications into wild populations of insects to stop them from spreading diseases is more than 40 years old. Synthetic disease refractory genes have been successfully generated for mosquito vectors of dengue fever and human malaria. Equally important is the development of population transformation systems to drive and maintain disease refractory genes at high frequency in populations. We demonstrate an underdominant population transformation system in Drosophila melanogaster that has the property of being both spatially self-limiting and reversible to the original genetic state. Both population transformation and its reversal can be largely achieved within as few as 5 generations. The described genetic construct {Ud} is composed of two genes; (1) a UAS-RpL14.dsRNA targeting RNAi to a haploinsufficient gene RpL14 and (2) an RNAi insensitive RpL14 rescue. In this proof-of-principle system the UAS-RpL14.dsRNA knock-down gene is placed under the control of an Actin5c-GAL4 driver located on a different chromosome to the {Ud} insert. This configuration would not be effective in wild populations without incorporating the Actin5c-GAL4 driver as part of the {Ud} construct (or replacing the UAS promoter with an appropriate direct promoter). It is however anticipated that the approach that underlies this underdominant system could potentially be applied to a number of species.	[Reeves, R. Guy; Bryk, Jaroslaw; Denton, Jai A.; Reed, Floyd A.] Max Planck Inst Evolutionary Biol, Dept Evolutionary Genet, Plon, Germany; [Altrock, Philipp M.] Max Planck Inst Evolutionary Biol, Dept Evolutionary Theory, Plon, Germany	Max Planck Society; Max Planck Society	Reeves, RG (corresponding author), Max Planck Inst Evolutionary Biol, Dept Evolutionary Genet, Plon, Germany.	reeves@evolbio.mpg.de	Denton, Jai/G-4985-2015; Altrock, Philipp/X-9063-2018	Denton, Jai/0000-0002-5259-4221; Reed, Floyd/0000-0003-4703-530X; Bryk, Jaroslaw/0000-0002-2791-9709; Altrock, Philipp/0000-0001-7731-3345; Reeves, Richard/0000-0001-9454-6175	Max Planck Society; Deutsche Forschungsgemeinschaft [RE-3062/2-1]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by funds from the Max Planck Society and the Deutsche Forschungsgemeinschaft (RE-3062/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari OS, 2013, CURR BIOL, V23, P671, DOI 10.1016/j.cub.2013.02.059; Allen ML, 2001, J MED ENTOMOL, V38, P701, DOI 10.1603/0022-2585-38.5.701; Altrock PM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002260; Altrock PM, 2010, J THEOR BIOL, V267, P62, DOI 10.1016/j.jtbi.2010.08.004; BARTON NH, 1979, HEREDITY, V43, P341, DOI 10.1038/hdy.1979.87; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen CH, 2007, SCIENCE, V316, P597, DOI [10.1126/science. 1138595, 10.1126/science.1138595]; Cherry S, 2005, GENE DEV, V19, P445, DOI 10.1101/gad.1267905; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; CLARK AG, 1981, HEREDITY, V46, P321, DOI 10.1038/hdy.1981.44; Cook RK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r21; CURTIS CF, 1968, NATURE, V218, P368, DOI 10.1038/218368a0; Davis S, 2001, J THEOR BIOL, V212, P83, DOI 10.1006/jtbi.2001.2357; Dong YM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002458; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Enerly E, 2003, HEREDITAS, V138, P73, DOI 10.1034/j.1601-5223.2003.01710.x; Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Holley CL, 2011, CARDIOVASC DRUG THER, V25, P151, DOI 10.1007/s10557-011-6290-z; Isaacs AT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002017; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; Ito K, 1997, DEVELOPMENT, V124, P761; Jasinskiene N, 2007, AM J TROP MED HYG, V76, P1072, DOI 10.4269/ajtmh.2007.76.1072; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kokoza V, 2001, INSECT BIOCHEM MOLEC, V31, P1137, DOI 10.1016/S0965-1748(01)00120-5; Lindsley DL, 1972, GENETIC VARIATIONS D, V2nd; Marshall JM, 2012, J THEOR BIOL, V294, P153, DOI 10.1016/j.jtbi.2011.10.032; Marygold SJ, 2005, GENETICS, V169, P683, DOI 10.1534/genetics.104.034124; Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216; Nolan T, 2002, J BIOL CHEM, V277, P8759, DOI 10.1074/jbc.C100766200; Ott RL, 1993, INTRO STAT METHODS A; Ramia M, 2012, BIOINFORMATICS, V28, P595, DOI 10.1093/bioinformatics/btr691; SaeboeLarssen S, 1997, MOL GEN GENET, V255, P141, DOI 10.1007/s004380050482; Scott TW, 2002, SCIENCE, V298, P117, DOI 10.1126/science.298.5591.117; SEAGER RD, 1982, GENETICS, V102, P485; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; Sokal R. R., 1981, BIOMETRY; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Weinstein LB, 1999, CURR OPIN CELL BIOL, V11, P378, DOI 10.1016/S0955-0674(99)80053-2; Wilks SS, 1935, ANN MATH STAT, V6, P190, DOI 10.1214/aoms/1177732564; Wilks SS, 1938, ANN MATH STAT, V9, P60, DOI 10.1214/aoms/1177732360; Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937; Wright S, 1931, GENETICS, V16, P0097; Zar JH, 1999, BIOSTATISTICAL ANAL	45	43	44	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97557	10.1371/journal.pone.0097557	http://dx.doi.org/10.1371/journal.pone.0097557			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844466	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000339563400034
J	Woollard, KJ; Lumsden, NG; Andrews, KL; Aprico, A; Harris, E; Irvine, JC; Jefferis, AM; Fang, L; Kanellakis, P; Bobik, A; Chin-Dusting, JPF				Woollard, Kevin J.; Lumsden, Natalie G.; Andrews, Karen L.; Aprico, Andrea; Harris, Emma; Irvine, Jennifer C.; Jefferis, Ann-maree; Fang, Lu; Kanellakis, Peter; Bobik, Alex; Chin-Dusting, Jaye P. F.			Raised Soluble P-Selectin Moderately Accelerates Atherosclerotic Plaque Progression	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; E-DEFICIENT MICE; GLYCOPROTEIN LIGAND-1; PLATELET ACTIVATION; LEUKOCYTE ADHESION; VASCULAR-DISEASE; ARTERIAL INJURY; TISSUE FACTOR; MOUSE MODEL; EXPRESSION	Soluble P-selectin (sP-selectin), a biomarker of inflammatory related pathologies including cardiovascular and peripheral vascular diseases, also has pro-atherosclerotic effects including the ability to increase leukocyte recruitment and modulate thrombotic responses in vivo. The current study explores its role in progressing atherosclerotic plaque disease. Apoe(-/-) mice placed on a high fat diet (HFD) were given daily injections of recombinant dimeric murine P-selectin (22.5 mg/kg/day) for 8 or 16 weeks. Saline or sE-selectin injections were used as negative controls. In order to assess the role of sP-selectin on atherothrombosis an experimental plaque remodelling murine model, with sm22 alpha-hDTR Apoe(-/-) mice on a HFD in conjunction with delivery of diphtheria toxin to induce targeted vascular smooth muscle apoptosis, was used. These mice were similarly given daily injections of sP-selectin for 8 or 16 weeks. While plaque mass and aortic lipid content did not change with sP-selectin treatment in Apoe(-/-) or SM22 alpha-hDTR Apoe(-/-) mice on HFD, increased plasma MCP-1 and a higher plaque CD45 content in Apoe(-/-) HFD mice was observed. As well, a significant shift towards a more unstable plaque phenotype in the SM22 alpha-hDTR Apoe(-/-) HFD mice, with increased macrophage accumulation and lower collagen content, leading to a lower plaque stability index, was observed. These results demonstrate that chronically raised sP-selectin favours progression of an unstable atherosclerotic plaque phenotype.	[Woollard, Kevin J.; Lumsden, Natalie G.; Andrews, Karen L.; Aprico, Andrea; Harris, Emma; Irvine, Jennifer C.; Jefferis, Ann-maree; Fang, Lu; Kanellakis, Peter; Bobik, Alex; Chin-Dusting, Jaye P. F.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	Baker Heart and Diabetes Institute	Chin-Dusting, JPF (corresponding author), Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia.	jaye.chin-dusting@bakeridi.edu.au		Woollard, Kevin/0000-0002-9839-5463	National Heart Foundation; British Heart Foundation; NHMRC; Victorian Government's Operational Infrastructure Support Program	National Heart Foundation(National Heart Foundation of Australia); British Heart Foundation(British Heart Foundation); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	KJW was supported through National Heart Foundation and British Heart Foundation fellowships and part of this work was supported by a National Heart Foundation project grant. JCD was supported in part through a NHMRC senior fellowship. This study was supported in part by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 2000, P NATL ACAD SCI USA, V97, P13835, DOI 10.1073/pnas.250475997; Baltus T, 2003, BLOOD, V102, P1985, DOI 10.1182/blood-2003-04-1175; CELI A, 1994, P NATL ACAD SCI USA, V91, P8767, DOI 10.1073/pnas.91.19.8767; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Chen YC, 2013, CIRC RES, V113, P252, DOI 10.1161/CIRCRESAHA.113.301562; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; CLOWES AW, 1983, LAB INVEST, V49, P327; DAVIES MJ, 1993, BRIT HEART J, V69, P377; ELSTAD MR, 1995, J IMMUNOL, V155, P2109; Epperson TR, 2000, J BIOL CHEM, V275, P7839, DOI 10.1074/jbc.275.11.7839; Gaspari T, 2013, DIABETES VASC DIS RE, V10, P353, DOI 10.1177/1479164113481817; Gear ARL, 2003, MICROCIRCULATION, V10, P335, DOI 10.1038/sj.mn.7800198; GENG YJ, 1995, AM J PATHOL, V147, P251; Gersh BJ, 2010, EUR HEART J, V31, P642, DOI 10.1093/eurheartj/ehq030; Jaipersad AS, 2014, J AM COLL CARDIOL, V63, P1, DOI 10.1016/j.jacc.2013.09.019; JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3; KhewGoodall Y, 1996, BLOOD, V87, P1432, DOI 10.1182/blood.V87.4.1432.bloodjournal8741432; Kisucka J, 2009, BLOOD, V113, P6015, DOI 10.1182/blood-2008-10-186650; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Littlewood TD, 2003, CURR OPIN LIPIDOL, V14, P469, DOI 10.1097/00041433-200310000-00007; Lutgens E, 1999, CARDIOVASC RES, V41, P473, DOI 10.1016/S0008-6363(98)00311-3; Manka D, 2001, CIRCULATION, V103, P1000; Matzdorff AC, 1996, HAEMOSTASIS, V26, P98; Nomura S, 2003, THROMB HAEMOSTASIS, V89, P506; Norman KE, 2000, BLOOD, V96, P3585; Phillips JW, 2003, CIRCULATION, V107, P2244, DOI 10.1161/01.CIR.0000065604.56839.18; Polgar J, 2005, J THROMB HAEMOST, V3, P1590, DOI 10.1111/j.1538-7836.2005.01373.x; Ridker PM, 2001, CIRCULATION, V103, P491, DOI 10.1161/01.CIR.103.4.491; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Schaub FJ, 2000, NAT MED, V6, P790, DOI 10.1038/77521; Schaub FJ, 2003, CIRC RES, V93, P515, DOI 10.1161/01.RES.0000093205.42313.7C; Storey RF, 2000, BRIT J HAEMATOL, V110, P925, DOI 10.1046/j.1365-2141.2000.02208.x; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tan KT, 2005, ANN MED, V37, P61, DOI 10.1080/07853890410018943; Urzainqui A, 2002, IMMUNITY, V17, P401, DOI 10.1016/S1074-7613(02)00420-X; Virani SS, 2011, EUR HEART J, V32, P459, DOI 10.1093/eurheartj/ehq367; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; von Hundelshausen P, 2007, THROMB HAEMOSTASIS, V97, P704, DOI 10.1160/TH07-01-0066; Wang HB, 2007, NAT IMMUNOL, V8, P882, DOI 10.1038/ni1491; Waxman S, 2006, CIRCULATION, V114, P2390, DOI 10.1161/CIRCULATIONAHA.105.540013; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Woollard KJ, 2008, CIRC RES, V103, P1128, DOI 10.1161/CIRCRESAHA.108.180273; Woollard KJ, 2013, CLIN SCI, V125, P221, DOI 10.1042/CS20120576; Woollard KJ, 2010, CURR PHARM DESIGN, V16, P4113; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Woollard KJ, 2006, CIRC RES, V98, P149, DOI 10.1161/01.RES.0000199295.14073.69; Woollard KJ, 2005, CLIN EXP PHARMACOL P, V32, P233, DOI 10.1111/j.1440-1681.2005.04178.x	48	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97422	10.1371/journal.pone.0097422	http://dx.doi.org/10.1371/journal.pone.0097422			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24846287	Green Published, gold, Green Submitted			2022-12-25	WOS:000339563400029
J	Beltran-Beck, B; de la Fuente, J; Garrido, JM; Aranaz, A; Sevilla, I; Villar, M; Boadella, M; Galindo, RC; de la Lastra, JMP; Moreno-Cid, JA; de Mera, IGF; Alberdi, P; Santos, G; Ballesteros, C; Lyashchenko, KP; Minguijon, E; Romero, B; de Juan, L; Dominguez, L; Juste, R; Gortazar, C				Beltran-Beck, Beatriz; de la Fuente, Jose; Garrido, Joseba M.; Aranaz, Alicia; Sevilla, Iker; Villar, Margarita; Boadella, Mariana; Galindo, Ruth C.; Perez de la Lastra, Jose M.; Moreno-Cid, Juan A.; Fernandez de Mera, Isabel G.; Alberdi, Pilar; Santos, Gracia; Ballesteros, Cristina; Lyashchenko, Konstantin P.; Minguijon, Esmeralda; Romero, Beatriz; de Juan, Lucia; Dominguez, Lucas; Juste, Ramon; Gortazar, Christian			Oral Vaccination with Heat Inactivated Mycobacterium bovis Activates the Complement System to Protect against Tuberculosis	PLOS ONE			English	Article							EUROPEAN WILD BOAR; MANDIBULAR LYMPH-NODES; DENDRITIC CELLS; NONOPSONIC PHAGOCYTOSIS; OROPHARYNGEAL TONSILS; IMMUNE-RESPONSES; CYTOKINE PROFILE; RAPID DETECTION; MESSENGER-RNA; COMPONENT C3	Tuberculosis (TB) remains a pandemic affecting billions of people worldwide, thus stressing the need for new vaccines. Defining the correlates of vaccine protection is essential to achieve this goal. In this study, we used the wild boar model for mycobacterial infection and TB to characterize the protective mechanisms elicited by a new heat inactivated Mycobacterium bovis vaccine (IV). Oral vaccination with the IV resulted in significantly lower culture and lesion scores, particularly in the thorax, suggesting that the IV might provide a novel vaccine for TB control with special impact on the prevention of pulmonary disease, which is one of the limitations of current vaccines. Oral vaccination with the IV induced an adaptive antibody response and activation of the innate immune response including the complement component C3 and inflammasome. Mycobacterial DNA/RNA was not involved in inflammasome activation but increased C3 production by a still unknown mechanism. The results also suggested a protective mechanism mediated by the activation of IFN-gamma producing CD8+ T cells by MHC I antigen presenting dendritic cells (DCs) in response to vaccination with the IV, without a clear role for Th1 CD4+ T cells. These results support a role for DCs in triggering the immune response to the IV through a mechanism similar to the phagocyte response to PAMPs with a central role for C3 in protection against mycobacterial infection. Higher C3 levels may allow increased opsonophagocytosis and effective bacterial clearance, while interfering with CR3-mediated opsonic and nonopsonic phagocytosis of mycobacteria, a process that could be enhanced by specific antibodies against mycobacterial proteins induced by vaccination with the IV. These results suggest that the IV acts through novel mechanisms to protect against TB in wild boar.	[Beltran-Beck, Beatriz; de la Fuente, Jose; Villar, Margarita; Boadella, Mariana; Galindo, Ruth C.; Perez de la Lastra, Jose M.; Moreno-Cid, Juan A.; Fernandez de Mera, Isabel G.; Alberdi, Pilar; Santos, Gracia; Ballesteros, Cristina; Gortazar, Christian] SaBio IREC CSIC UCLM JCCM, Ciudad Real, Spain; [de la Fuente, Jose; Galindo, Ruth C.] Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, Stillwater, OK 74078 USA; [Garrido, Joseba M.; Sevilla, Iker; Minguijon, Esmeralda; Juste, Ramon] NEIKER Tecnalia, Dept Anim Hlth, Derio, Bizkaia, Spain; [Aranaz, Alicia] Univ Complutense Madrid, Fac Vet, Dept Sanidad Anim, Madrid, Spain; [Lyashchenko, Konstantin P.] Chembio Diagnost Syst Inc, New York, NY USA; [Romero, Beatriz; de Juan, Lucia; Dominguez, Lucas] Univ Complutense Madrid, Fac Vet, Ctr Vigilancia Sanitaria Vet VISAVET, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Oklahoma State University System; Oklahoma State University - Stillwater; Complutense University of Madrid; Complutense University of Madrid	Gortazar, C (corresponding author), SaBio IREC CSIC UCLM JCCM, Ciudad Real, Spain.	Christian.Gortazar@uclm.es	Villar-Rayo, Marga M/J-4155-2012; Alberdi, Pilar/K-7788-2014; de Juan, Lucía/I-6465-2016; Sevilla, Iker A/O-6060-2014; Gortazar, Christian/E-7918-2012; de la Lastra, José Manuel Pérez/M-4397-2019; Boadella, Mariana/I-8029-2012; Romero, Beatriz/J-5942-2015; Moreno-Cid, Juan/GVS-4289-2022; GARRIDO, JOSEBA M/L-3202-2014; Pérez de la Lastra, José/F-9184-2013; studies, IT VISAVET Account for bibliometric/C-3115-2014; Juste, Ramon/C-3570-2008; Dominguez Rodriguez, Lucas/B-9668-2014; Garcia Fernandez de Mera, Isabel/F-6623-2013	Villar-Rayo, Marga M/0000-0003-4172-9079; Alberdi, Pilar/0000-0002-6999-9735; de Juan, Lucía/0000-0002-7070-6872; Sevilla, Iker A/0000-0003-3968-3390; Gortazar, Christian/0000-0003-0012-4006; de la Lastra, José Manuel Pérez/0000-0003-4663-5565; Boadella, Mariana/0000-0001-6402-9927; Romero, Beatriz/0000-0001-5263-1806; Pérez de la Lastra, José/0000-0003-4663-5565; studies, IT VISAVET Account for bibliometric/0000-0003-3319-0050; Juste, Ramon/0000-0001-6037-5873; Dominguez Rodriguez, Lucas/0000-0001-8843-0010; Minguijon, Esmeralda/0000-0002-7801-7625; Garcia Fernandez de Mera, Isabel/0000-0001-5936-4018; Beltran-Beck, Beatriz/0000-0001-6689-5773; Joseba M., Garrido/0000-0002-7559-0653	Plan Nacional I+D+I from Ministerio de Economia y Competitividad (MINECO), Spain [AGL2011-30041]; FEDER; EU FP7 grant WildTBvac; EU FP7 ANTIGONE project [278976]; MEC, Spain; MINECO [BES-2009-017401]	Plan Nacional I+D+I from Ministerio de Economia y Competitividad (MINECO), Spain; FEDER(European Commission); EU FP7 grant WildTBvac; EU FP7 ANTIGONE project; MEC, Spain(Spanish Government); MINECO(Spanish Government)	This research was supported by Plan Nacional I+D+I AGL2011-30041 from Ministerio de Economia y Competitividad (MINECO), Spain and FEDER. This is also a contribution to EU FP7 grant WildTBvac and the EU FP7 ANTIGONE project number 278976. R. C. Galindo was funded by MEC, Spain. B. Beltran-Beck was supported by MINECO grant BES-2009-017401. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe F, 2012, CLIN EXP IMMUNOL, V169, P213, DOI 10.1111/j.1365-2249.2012.04614.x; ARMSTRONG JA, 1975, J EXP MED, V142, P1, DOI 10.1084/jem.142.1.1; Ballesteros C, 2009, VACCINE, V27, P6662, DOI 10.1016/j.vaccine.2009.08.095; Ballesteros C, 2009, RES VET SCI, V86, P388, DOI 10.1016/j.rvsc.2008.09.003; Behr MA, 2002, LANCET INFECT DIS, V2, P86, DOI 10.1016/S1473-3099(02)00182-2; Blander JM, 2012, NAT REV IMMUNOL, V12, P215, DOI 10.1038/nri3167; Boadella M, 2011, J VET DIAGN INVEST, V23, P77, DOI 10.1177/104063871102300111; BODDINGHAUS B, 1990, J CLIN MICROBIOL, V28, P1751; Carroll MV, 2010, PROTEIN CELL, V1, P859, DOI 10.1007/s13238-010-0101-3; Carroll MV, 2009, MOL IMMUNOL, V46, P3367, DOI 10.1016/j.molimm.2009.07.015; de la Fuente J, 2011, MED HYPOTHESES, V76, P361, DOI 10.1016/j.mehy.2010.10.040; de Saint-Vis B, 1998, J IMMUNOL, V160, P1666; Drumm JE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000460; Ernst JD, 1998, INFECT IMMUN, V66, P1277, DOI 10.1128/IAI.66.4.1277-1281.1998; Ferguson JS, 2004, INFECT IMMUN, V72, P2564, DOI 10.1128/IAI.72.5.2564-2573.2004; Galindo RC, 2009, VET IMMUNOL IMMUNOP, V129, P119, DOI 10.1016/j.vetimm.2008.12.012; Garrido JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024905; Gil O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010030; Greenwald R, 2009, CLIN VACCINE IMMUNOL, V16, P605, DOI 10.1128/CVI.00038-09; Gupta UD, 2009, INDIAN J MED RES, V129, P11; Hewinson RG, 1996, SCAND J IMMUNOL, V43, P490, DOI 10.1046/j.1365-3083.1996.d01-78.x; Johansson E, 2003, VET IMMUNOL IMMUNOP, V91, P183, DOI 10.1016/S0165-2427(02)00310-0; Johnson RP, 2011, NATURE, V473, P456, DOI 10.1038/473456a; Koff WC, 2013, SCIENCE, V340, DOI 10.1126/science.1232910; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Le Cabec V, 2000, INFECT IMMUN, V68, P4736, DOI 10.1128/IAI.68.8.4736-4745.2000; Le Cabec V, 2002, J IMMUNOL, V169, P2003, DOI 10.4049/jimmunol.169.4.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyashchenko KP, 2008, VET MICROBIOL, V132, P283, DOI 10.1016/j.vetmic.2008.05.029; de la Lastra JMP, 2009, VET MICROBIOL, V134, P334, DOI 10.1016/j.vetmic.2008.08.026; Marassi CD, 2011, ACTA TROP, V118, P101, DOI 10.1016/j.actatropica.2011.02.015; Michell SL, 2003, J BIOL CHEM, V278, P16423, DOI 10.1074/jbc.M207959200; Moon MR, 1999, J SURG RES, V82, P48, DOI 10.1006/jsre.1998.5503; Moon MR, 2000, SHOCK, V13, P374; Naranjo V, 2008, ANIM GENET, V39, P316, DOI 10.1111/j.1365-2052.2008.01725.x; Naranjo V, 2006, FEMS IMMUNOL MED MIC, V46, P298, DOI 10.1111/j.1574-695X.2005.00035.x; Naranjo V, 2008, VET MICROBIOL, V127, P1, DOI 10.1016/j.vetmic.2007.10.002; Naranjo V, 2007, PROTEOMICS, V7, P220, DOI 10.1002/pmic.200600527; Naranjo V, 2006, VET MICROBIOL, V116, P224, DOI 10.1016/j.vetmic.2006.03.013; OFEK I, 1995, ANNU REV MICROBIOL, V49, P239, DOI 10.1146/annurev.mi.49.100195.001323; Offit PA, 2008, VACCINES-BASEL, V2, P17, DOI 10.1016/b978-1-4557-0090-5.00004-5; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; PATEL BKR, 1991, J MICROBIOL METH, V13, P99, DOI 10.1016/0167-7012(91)90010-N; RADFORD AJ, 1990, J GEN MICROBIOL, V136, P265, DOI 10.1099/00221287-136-2-265; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; STELANDRE M, 1992, GENE, V121, P79, DOI 10.1016/0378-1119(92)90164-K; Tascon RE, 1998, INFECT IMMUN, V66, P830, DOI 10.1128/IAI.66.2.830-834.1998; van Kooten C, 2008, MOL IMMUNOL, V45, P4064, DOI 10.1016/j.molimm.2008.07.015; Velasco-Velazquez MA, 2003, MICROB PATHOGENESIS, V35, P125, DOI 10.1016/S0882-4010(03)00099-8; Villeneuve C, 2005, J LIPID RES, V46, P475, DOI 10.1194/jlr.M400308-JLR200; Wedlock DN, 2005, NEW ZEAL VET J, V53, P301, DOI 10.1080/00480169.2005.36564; Weingartl HM, 2002, J VIROL METHODS, V104, P203, DOI 10.1016/S0166-0934(02)00085-X; West NP, 2011, VACCINE, V29, P7759, DOI 10.1016/j.vaccine.2011.07.109; Xue T, 2004, INFECT IMMUN, V72, P6324, DOI 10.1128/IAI.72.11.6324-6329.2004; Zar HJ, 2013, THORAX, V68, P283, DOI 10.1136/thoraxjnl-2012-203127	59	43	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e98048	10.1371/journal.pone.0098048	http://dx.doi.org/10.1371/journal.pone.0098048			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842853	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000340948600103
J	Jolly, MK; Rizvi, MS; Kumar, A; Sinha, P				Jolly, Mohit Kumar; Rizvi, Mohd Suhail; Kumar, Amit; Sinha, Pradip			Mathematical Modeling of Sub-Cellular Asymmetry of Fat-Dachsous Heterodimer for Generation of Planar Cell Polarity	PLOS ONE			English	Article							DROSOPHILA; GROWTH; SPECIFICATION; MORPHOGENESIS; EXPRESSION; AFFINITY; PATHWAY; KINASE; ROLES	Planar Cell Polarity (PCP) is an evolutionarily conserved characteristic of animal tissues marked by coordinated polarization of cells or structures in the plane of a tissue. In insect wing epithelium, for instance, PCP is characterized by en masse orientation of hairs orthogonal to its apical-basal axis and pointing along the proximal-distal axis of the organ. Directional cue for PCP has been proposed to be generated by complex sets of interactions amongst three proteins -Fat (Ft), Dachsous (Ds) and Four-jointed (Fj). Ft and Ds are two atypical cadherins, which are phosphorylated by Fj, a Golgi kinase. Ft and Ds from adjacent cells bind heterophilically via their tandem cadherin repeats, and their binding affinities are regulated by Fj. Further, in the wing epithelium, sub-cellular levels of Ft-Ds heterodimers are seen to be elevated at the distal edges of individual cells, prefiguring their PCP. Mechanisms generating this sub-cellular asymmetry of Ft-Ds heterodimer in proximal and distal edges of cells, however, have not been resolved yet. Using a mathematical modeling approach, here we provide a framework for generation of this sub-cellular asymmetry of Ft-Ds heterodimer. First, we explain how the known interactions within Ft-Ds-Fj system translate into sub-cellular asymmetry of Ft-Ds heterodimer. Second, we show that this asymmetric localization of Ft-Ds heterodimer is lost when tissue-level gradient of Fj is flattened, or when phosphorylation of Ft by Fj is abolished, but not when tissue-level gradient of Ds is flattened or when phosphorylation of Ds is abrogated. Finally, we show that distal enrichment of Ds also amplifies Ft-Ds asymmetry. These observations reveal that gradient of Fj expression, phosphorylation of Ft by Fj and sub-cellular distal accumulation of Ds are three critical elements required for generating sub-cellular asymmetry of Ft-Ds heterodimer. Our model integrates the known experimental data and presents testable predictions for future studies.	[Jolly, Mohit Kumar; Rizvi, Mohd Suhail; Kumar, Amit; Sinha, Pradip] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Jolly, MK (corresponding author), Rice Univ, Ctr Theoret Biol Phys, Houston, TX 77005 USA.	mj21@rice.edu; pradips@iitk.ac.in	Jolly, Mohit Kumar/A-1826-2014; kumar, Amit/GLS-4080-2022; Rizvi, Mohd Suhail/AAQ-7692-2020	Jolly, Mohit Kumar/0000-0002-6631-2109; kumar, Amit/0000-0001-8983-6792; Rizvi, Mohd Suhail/0000-0002-4130-4671	project entitled 'Epithelial Morphogenesis and wound healing during animal development: Role of Fat cadherin in fruit fly Drosophila' - Department of Science and Technology (DST), New Delhi [SR/SO/AS-24/2008]	project entitled 'Epithelial Morphogenesis and wound healing during animal development: Role of Fat cadherin in fruit fly Drosophila' - Department of Science and Technology (DST), New Delhi	This work was supported by a project entitled 'Epithelial Morphogenesis and wound healing during animal development: Role of Fat cadherin in fruit fly Drosophila' sponsored by the Department of Science and Technology (DST), New Delhi to Pradip Sinha No. SR/SO/AS-24/2008. Date: February 27, 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PN, 2000, MECH DEVELOP, V96, P197, DOI 10.1016/S0925-4773(00)00392-0; Adler PN, 1998, DEVELOPMENT, V125, P959; Ambegaonkar AA, 2012, CURR BIOL, V22, P1302, DOI 10.1016/j.cub.2012.05.049; Amonlirdviman K, 2005, SCIENCE, V307, P423, DOI 10.1126/science.1105471; Axelrod JD, 2011, WIRES SYST BIOL MED, V3, P588, DOI 10.1002/wsbm.138; Axelrod JD, 2009, SEMIN CELL DEV BIOL, V20, P964, DOI 10.1016/j.semcdb.2009.08.001; Bosveld F, 2012, SCIENCE, V336, P724, DOI 10.1126/science.1221071; Brittle A, 2012, CURR BIOL, V22, P907, DOI 10.1016/j.cub.2012.03.053; Brittle AL, 2010, CURR BIOL, V20, P803, DOI 10.1016/j.cub.2010.03.056; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000628; Casal J, 2002, CURR BIOL, V12, P1189, DOI 10.1016/S0960-9822(02)00974-0; Fischer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060064; Goodrich LV, 2011, DEVELOPMENT, V138, P1877, DOI 10.1242/dev.054080; Hazelwood LD, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-20; Ishikawa HO, 2008, SCIENCE, V321, P401, DOI 10.1126/science.1158159; Lawrence PA, 2007, NAT REV GENET, V8, P555, DOI 10.1038/nrg2125; Le Garrec JF, 2006, DEV DYNAM, V235, P235, DOI 10.1002/dvdy.20617; Ma D, 2003, NATURE, V421, P543, DOI 10.1038/nature01366; Mani M, 2013, P NATL ACAD SCI USA, V110, P20420, DOI 10.1073/pnas.1307459110; Mao YP, 2006, DEVELOPMENT, V133, P2539, DOI 10.1242/dev.02427; Matakatsu H, 2004, DEVELOPMENT, V131, P3785, DOI 10.1242/dev.01254; Matakatsu H, 2012, DEVELOPMENT, V139, P1498, DOI 10.1242/dev.070367; Schamberg S, 2010, B MATH BIOL, V72, P645, DOI 10.1007/s11538-009-9464-0; Simon MA, 2004, DEVELOPMENT, V131, P6175, DOI 10.1242/dev.01550; Simon MA, 2010, CURR BIOL, V20, P811, DOI 10.1016/j.cub.2010.04.016; Strutt H, 2004, DEVELOPMENT, V131, P881, DOI 10.1242/dev.00996; Thomas C, 2012, DEV DYNAM, V241, P27, DOI 10.1002/dvdy.22736; Tomlin CJ, 2007, NAT REV GENET, V8, P331, DOI 10.1038/nrg2098; Tree DRP, 2002, SEMIN CELL DEV BIOL, V13, P217, DOI 10.1016/S1084-9521(02)00042-3; Turner CM, 1998, MECH DEVELOP, V70, P181, DOI 10.1016/S0925-4773(97)00194-9; VILLANO JL, 1995, DEVELOPMENT, V121, P2767; Wallingford JB, 2012, ANNU REV CELL DEV BI, V28, P627, DOI 10.1146/annurev-cellbio-092910-154208; Wang YS, 2006, P NATL ACAD SCI USA, V103, P19800, DOI 10.1073/pnas.0609712104; WONG LL, 1993, J CELL BIOL, V123, P209, DOI 10.1083/jcb.123.1.209; Zhu H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02528; Zhu H, 2009, J THEOR BIOL, V256, P315, DOI 10.1016/j.jtbi.2008.08.029	36	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97641	10.1371/journal.pone.0097641	http://dx.doi.org/10.1371/journal.pone.0097641			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841507	Green Submitted, Green Published, gold			2022-12-25	WOS:000340948600053
J	Linas, BP; Barter, DM; Leff, JA; Assoumou, SA; Salomon, JA; Weinstein, MC; Kim, AY; Schackman, BR				Linas, Benjamin P.; Barter, Devra M.; Leff, Jared A.; Assoumou, Sabrina A.; Salomon, Joshua A.; Weinstein, Milton C.; Kim, Arthur Y.; Schackman, Bruce R.			The Hepatitis C Cascade of Care: Identifying Priorities to Improve Clinical Outcomes	PLOS ONE			English	Article							QUALITY-OF-LIFE; SUSTAINED VIROLOGICAL RESPONSE; TELAPREVIR COMBINATION TREATMENT; HIGH-RISK POPULATIONS; INJECTION-DRUG USERS; VIRUS-INFECTION; COST-EFFECTIVENESS; UNITED-STATES; NATURAL-HISTORY; PEGINTERFERON ALPHA-2B	Background: As highly effective hepatitis C virus (HCV) therapies emerge, data are needed to inform the development of interventions to improve HCV treatment rates. We used simulation modeling to estimate the impact of loss to follow-up on HCV treatment outcomes and to identify intervention strategies likely to provide good value for the resources invested in them. Methods: We used a Monte Carlo state-transition model to simulate a hypothetical cohort of chronically HCV-infected individuals recently screened positive for serum HCV antibody. We simulated four hypothetical intervention strategies (linkage to care; treatment initiation; integrated case management; peer navigator) to improve HCV treatment rates, varying efficacies and costs, and identified strategies that would most likely result in the best value for the resources required for implementation. Main measures: Sustained virologic responses (SVRs), life expectancy, quality-adjusted life expectancy (QALE), costs from health system and program implementation perspectives, and incremental cost-effectiveness ratios (ICERs). Results: We estimate that imperfect follow-up reduces the real-world effectiveness of HCV therapies by approximately 75%. In the base case, a modestly effective hypothetical peer navigator program maximized the number of SVRs and QALE, with an ICER compared to the next best intervention of $48,700/quality-adjusted life year. Hypothetical interventions that simultaneously addressed multiple points along the cascade provided better outcomes and more value for money than less costly interventions targeting single steps. The 5-year program cost of the hypothetical peer navigator intervention was $14.5 million per 10,000 newly diagnosed individuals. Conclusions: We estimate that imperfect follow-up during the HCV cascade of care greatly reduces the real-world effectiveness of HCV therapy. Our mathematical model shows that modestly effective interventions to improve follow-up would likely be cost-effective. Priority should be given to developing and evaluating interventions addressing multiple points along the cascade rather than options focusing solely on single points.	[Linas, Benjamin P.; Barter, Devra M.; Assoumou, Sabrina A.] Boston Med Ctr, Infect Dis Sect, HIV Epidemiol & Outcomes Res Unit, Boston, MA 02118 USA; [Linas, Benjamin P.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Leff, Jared A.; Schackman, Bruce R.] Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY USA; [Salomon, Joshua A.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Weinstein, Milton C.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Kim, Arthur Y.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Boston Medical Center; Boston University; Cornell University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Linas, BP (corresponding author), Boston Med Ctr, Infect Dis Sect, HIV Epidemiol & Outcomes Res Unit, Boston, MA 02118 USA.	Benjamin.Linas@BMC.org	Leff, Jared A./B-7631-2014; Trajman, Anete/C-7679-2016; Salomon, Joshua/S-1929-2019; Salomon, Joshua A/D-3898-2009; Schackman, Bruce R./J-8208-2019; Assoumou, Sabrina/AAF-2087-2021	Leff, Jared A./0000-0001-6995-6009; Trajman, Anete/0000-0002-4000-4984; Salomon, Joshua/0000-0003-3929-5515; Salomon, Joshua A/0000-0003-3929-5515; Schackman, Bruce R./0000-0002-1132-2932; Assoumou, Sabrina/0000-0002-5169-620X	National Institutes on Drug Abuse [R01DA031059, R01DA027379]; National Institute of Allergy and Infectious Disease [K01AI73193]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI073193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027379, R01DA031059] Funding Source: NIH RePORTER	National Institutes on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the National Institutes on Drug Abuse (R01DA031059, R01DA027379) and National Institute of Allergy and Infectious Disease (K01AI73193). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2009, TOT HLTH SERV MEAN M; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Aspinall EJ, 2013, CLIN INFECT DIS, V57, pS80, DOI 10.1093/cid/cit306; Barnett PG, 2001, ADDICTION, V96, P1267, DOI 10.1046/j.1360-0443.2001.96912676.x; Bjornsson E, 2009, SCAND J GASTROENTERO, V44, P878, DOI 10.1080/00365520902898135; Blatt LM, 2000, J VIRAL HEPATITIS, V7, P196; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Centers for Disease Control and Prevention, 2005, NHANES 2005 2010 COM; Chan K, 2013, CLIN GASTROENTEROL H, V11, P1503, DOI 10.1016/j.cgh.2013.05.014; Cheung RC, 2006, DIGEST DIS SCI, V51, P976, DOI 10.1007/s10620-006-9100-x; Chong CAKY, 2003, AM J GASTROENTEROL, V98, P630, DOI 10.1111/j.1572-0241.2003.07332.x; Daltron-Oliveira R, 2013, ANN HEPATOL, V12, P399, DOI 10.1016/S1665-2681(19)31002-6; Davis KL, 2011, J CLIN GASTROENTEROL, V45, pE17, DOI 10.1097/MCG.0b013e3181e12c09; Denniston MM, 2012, HEPATOLOGY, V55, P1652, DOI 10.1002/hep.25556; Dias PT, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-208; Drobnik A, 2011, AM J PUBLIC HEALTH, V101, P2151, DOI 10.2105/AJPH.2011.300251; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Falck-Ytter Y, 2002, ANN INTERN MED, V136, P288, DOI 10.7326/0003-4819-136-4-200202190-00008; Fishbein DA, 2004, JAIDS-J ACQ IMM DEF, V37, P1367, DOI 10.1097/01.qai.0000131932.21612.49; Food and Drug Administration, 2012, TEL PACK INS; Foster GR, 2012, EFFICACY SAFETY TELA; Freeman AJ, 2001, HEPATOLOGY, V34, P809, DOI 10.1053/jhep.2001.27831; Gao X, 2012, EXPERT REV PHARM OUT, V12, P335, DOI [10.1586/erp.12.10, 10.1586/ERP.12.10]; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gardner LI, 2005, AIDS, V19, P423, DOI 10.1097/01.aids.0000161772.51900.eb; Giron-Gonzalez JA, 2007, ANTIVIR THER, V12, P899; Gold MR, 1996, COST EFFECTIVENESS H; Grieve R, 2006, GUT, V55, P1332, DOI 10.1136/gut.2005.064774; Groom H, 2008, J CLIN GASTROENTEROL, V42, P97, DOI 10.1097/MCG.0b013e31802dc56f; Hilsden RJ, 2013, CLIN INFECT DIS, V57, pS90, DOI 10.1093/cid/cit327; Holmberg SD, 2013, NEW ENGL J MED, V368, P1859, DOI 10.1056/NEJMp1302973; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Kamal SM, 2008, AM J GASTROENTEROL, V103, P1283, DOI 10.1111/j.1572-0241.2008.01825.x; Kanwal F, 2014, CLIN GASTROENTEROL H, V12; Lau JYN, 1996, ANN INTERN MED, V124, P868, DOI 10.7326/0003-4819-124-10-199605150-00002; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Liang TJ, 2013, NEW ENGL J MED, V368, P1907, DOI 10.1056/NEJMra1213651; Linas BP, 2011, J VIRAL HEPATITIS, V18, P506, DOI 10.1111/j.1365-2893.2010.01325.x; Linas BP, 2012, CLIN INFECT DIS, V55, P279, DOI 10.1093/cid/cis382; Linas BP, 2013, AIDS IN PRESS; Liu S, 2012, ANN INTERN MED, V156, P279, DOI 10.7326/0003-4819-156-4-201202210-00005; Long EF, 2010, ANN INTERN MED, V153, P778, DOI 10.7326/0003-4819-153-12-201012210-00004; Mangia A, 2005, NEW ENGL J MED, V352, P2609, DOI 10.1056/NEJMoa042608; Mark KE, 2007, PUBLIC HEALTH REP, V122, P37, DOI 10.1177/003335490712200105; McAdam-Marx C, 2011, J MANAGE CARE PHARM, V17, P531, DOI 10.18553/jmcp.2011.17.7.531; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Micromedex 2.0, 2011, MICROMEDEX 2 0 DRUG; Mira JA, 2013, CLIN INFECT DIS, V56, P1646, DOI 10.1093/cid/cit103; Moorman AC, 2013, CLIN INFECT DIS, V56, P40, DOI 10.1093/cid/cis815; Morrill JA, 2005, J GEN INTERN MED, V20, P754, DOI 10.1111/j.1525-1497.2005.0161.x; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; Pearlman BL, 2011, CLIN INFECT DIS, V52, P889, DOI 10.1093/cid/cir076; Pineda JA, 2009, CLIN INFECT DIS, V49, P1274, DOI 10.1086/605676; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Rodger AJ, 1999, HEPATOLOGY, V30, P1299, DOI 10.1002/hep.510300504; Sangiovanni A, 2006, HEPATOLOGY, V43, P1303, DOI 10.1002/hep.21176; Schackman BR, 2008, MED DECIS MAKING, V28, P233, DOI 10.1177/0272989X07311753; Schackman BR, 2007, J URBAN HEALTH, V84, P455, DOI 10.1007/s11524-007-9180-8; Schackman BR, 2010, JAIDS-J ACQ IMM DEF, V55, pS27, DOI 10.1097/QAI.0b013e3181f9c1da; Scott JD, 2009, AIDS PATIENT CARE ST, V23, P925, DOI 10.1089/apc.2009.0099; Serfaty MA, 1997, DRUG ALCOHOL REV, V16, P339, DOI 10.1080/09595239700186721; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Shiffman ML, 2007, NEW ENGL J MED, V357, P124, DOI 10.1056/NEJMoa066403; Siebert U, 2003, GUT, V52, P425, DOI 10.1136/gut.52.3.425; Singal AG, 2010, CLIN GASTROENTEROL H, V8, P280, DOI 10.1016/j.cgh.2009.11.018; Singer ME, 2001, AM J MED, V111, P614, DOI 10.1016/S0002-9343(01)00951-2; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; STASON WB, 1977, NEW ENGL J MED, V296, P732, DOI 10.1056/NEJM197703312961307; Stein K, 2002, Health Technol Assess, V6, P1; Stopka TJ, 2007, PUBLIC HEALTH REP, V122, P68, DOI 10.1177/00333549071220S213; Sutton AJ, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-93; Swain MG, 2010, GASTROENTEROLOGY, V139, P1593, DOI 10.1053/j.gastro.2010.07.009; Swan T, 2012, HEPATITIS C DRUG DEV; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Ubel PA, 2003, ARCH INTERN MED, V163, P1637, DOI 10.1001/archinte.163.14.1637; United States Department of Health and Human Services Center for Medicare Services, 2011, PHYS FEE SCHED; United States Department of Health and Human Services Center for Medicare Services, 2011, CLIN DIAGN LAB FEE S; US Dept of Labor Bureau of Labor Statistics, 2011, CONS PRIC IND ALL UR; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Vera-Llonch M, 2013, ALIMENT PHARM THER, V38, P124, DOI 10.1111/apt.12354; Vickerman P, 2009, SEX TRANSM INFECT, V85, P23, DOI 10.1136/sti.2008.034660; Vlahov D, 2004, ADDICTION, V99, P946, DOI 10.1111/j.1360-0443.2004.00780.x; Walensky RP, 2005, MED DECIS MAKING, V25, P321, DOI 10.1177/0272989X05276955; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Yawn BP, 2002, J FAM PRACTICE, V51, P135; Zeuzem S, 2013, 64 ANN M AM ASS STUD	88	99	100	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97317	10.1371/journal.pone.0097317	http://dx.doi.org/10.1371/journal.pone.0097317			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9SK	24842841	Green Published, gold, Green Submitted			2022-12-25	WOS:000340948600023
J	Ma, J; Chadban, SJ; Zhao, CY; Chen, XC; Kwan, T; Panchapakesan, U; Pollock, CA; Wu, HL				Ma, Jin; Chadban, Steven J.; Zhao, Cathy Y.; Chen, Xiaochen; Kwan, Tony; Panchapakesan, Usha; Pollock, Carol A.; Wu, Huiling			TLR4 Activation Promotes Podocyte Injury and Interstitial Fibrosis in Diabetic Nephropathy	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; ISCHEMIA/REPERFUSION INJURY; PROINFLAMMATORY STATE; KIDNEY-DISEASE; INFLAMMATION; MACROPHAGES; MICE; GLOMERULOSCLEROSIS; CONTRIBUTES; EXPRESSION	Toll like receptor (TLR) 4 has been reported to promote inflammation in diabetic nephropathy. However the role of TLR4 in the complicated pathophysiology of diabetic nephropathy is not understood. In this study, we report elevated expression of TLR4, its endogenous ligands and downstream cytokines, chemokines and fibrogenic genes in diabetic nephropathy in WT mice with streptozotocin (STZ) diabetes. Subsequently, we demonstrated that TLR4(-/-) mice were protected against the development of diabetic nephropathy, exhibiting less albuminuria, inflammation, glomerular hypertrophy and hypercellularity, podocyte and tubular injury as compared to diabetic wild-type controls. Marked reductions in interstitial collagen deposition, myofibroblast activation (alpha-SMA) and expression of fibrogenic genes (TGF-beta and fibronectin) were also evident in TLR4 deficient mice. Consistent with our in vivo results, high glucose directly promoted TLR4 activation in podocytes and tubular epithelial cells in vitro, resulting in NF-kappa B activation and consequent inflammatory and fibrogenic responses. Our data indicate that TLR4 activation may promote inflammation, podocyte and tubular epithelial cell injury and interstitial fibrosis, suggesting TLR4 is a potential therapeutic target for diabetic nephropathy.	[Chadban, Steven J.; Wu, Huiling] Royal Prince Alfred Hosp, Renal Med & Transplant Res Grp, Sydney, NSW, Australia; [Panchapakesan, Usha; Pollock, Carol A.] Royal N Shore Hosp, Kolling Inst Med Res, Renal Res Grp, Sydney, NSW, Australia; [Ma, Jin; Chadban, Steven J.; Zhao, Cathy Y.; Chen, Xiaochen; Kwan, Tony; Panchapakesan, Usha; Pollock, Carol A.; Wu, Huiling] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	University of Sydney; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; University of Sydney	Wu, HL (corresponding author), Royal Prince Alfred Hosp, Renal Med & Transplant Res Grp, Sydney, NSW, Australia.	huiling.wu@sydney.edu.au			National Health and Medical Research Council of Australia [636273]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia (Project Grant #636273) (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2004, J AM SOC NEPHROL, V15, P854, DOI 10.1097/01.ASN.0000121781.89599.16; Banas MC, 2008, J AM SOC NEPHROL, V19, P704, DOI 10.1681/ASN.2007040395; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Brown HJ, 2007, J AM SOC NEPHROL, V18, P1732, DOI 10.1681/ASN.2006060634; Brown HJ, 2006, J AM SOC NEPHROL, V17, P1931, DOI 10.1681/ASN.2005111167; Campbell MT, 2011, J SURG RES, V168, pE61, DOI 10.1016/j.jss.2009.09.053; Cha JJ, 2013, ENDOCRINOLOGY, V154, P2144, DOI 10.1210/en.2012-2080; Chen HY, 2011, DIABETES, V60, P590, DOI 10.2337/db10-0403; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; Devaraj S, 2008, J CLIN ENDOCR METAB, V93, P578, DOI 10.1210/jc.2007-2185; Devaraj S, 2011, CYTOKINE, V55, P441, DOI 10.1016/j.cyto.2011.03.023; Devaraj S, 2011, ARTERIOSCL THROM VAS, V31, P1796, DOI 10.1161/ATVBAHA.111.228924; Kerjaschki D, 2001, J CLIN INVEST, V108, P1583, DOI 10.1172/JCI200114629; Koop K, 2003, J AM SOC NEPHROL, V14, P2063, DOI 10.1097/01.ASN.0000078803.53165.C9; Kuwabara T, 2012, DIABETOLOGIA, V55, P2256, DOI 10.1007/s00125-012-2578-1; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Lim AKH, 2009, DIABETOLOGIA, V52, P1669, DOI 10.1007/s00125-009-1399-3; Lin M, 2013, KIDNEY INT; Lin M, 2012, J AM SOC NEPHROL, V23, P86, DOI 10.1681/ASN.2010111210; Mauer M, 2002, DIABETES, V51, P1572, DOI 10.2337/diabetes.51.5.1572; MCWHINNIE DL, 1986, TRANSPLANTATION, V42, P352, DOI 10.1097/00007890-198610000-00004; Melhem MF, 2002, J AM SOC NEPHROL, V13, P108, DOI 10.1681/ASN.V131108; Meyer TW, 1999, DIABETOLOGIA, V42, P1341, DOI 10.1007/s001250051447; Mora Carmen, 2006, Curr Diab Rep, V6, P463, DOI 10.1007/s11892-006-0080-1; Pulskens WP, 2010, J AM SOC NEPHROL, V21, P1299, DOI 10.1681/ASN.2009070722; Qian Y, 2008, DIABETES, V57, P1439, DOI 10.2337/db08-0061; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tesch GH, 2007, CLIN EXP PHARMACOL P, V34, P1016, DOI 10.1111/j.1440-1681.2007.04729.x; Timmers L, 2008, CIRC RES, V102, P257, DOI 10.1161/CIRCRESAHA.107.158220; Tsuboi N, 2002, J IMMUNOL, V169, P2026, DOI 10.4049/jimmunol.169.4.2026; Tuttle KR, 2005, J AM SOC NEPHROL, V16, P1537, DOI 10.1681/ASN.2005040393; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Venkatareddy M, 2013, J AM SOC NEPHROL; Vernon MA, 2010, SEMIN NEPHROL, V30, P302, DOI 10.1016/j.semnephrol.2010.03.004; WEIBEL ER, 1962, J APPL PHYSIOL, V17, P343, DOI 10.1152/jappl.1962.17.2.343; White SL, 2005, ADV CHRONIC KIDNEY D, V12, P5, DOI 10.1053/j.ackd.2004.10.009; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Wu HL, 2010, J AM SOC NEPHROL, V21, P1878, DOI 10.1681/ASN.2009101048; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zhang BZ, 2008, J AM SOC NEPHROL, V19, P923, DOI 10.1681/ASN.2007090982	42	100	108	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97985	10.1371/journal.pone.0097985	http://dx.doi.org/10.1371/journal.pone.0097985			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842252	Green Published, gold, Green Submitted			2022-12-25	WOS:000340948600097
J	MacLeod, CA; Donaldson, DI				MacLeod, Catherine A.; Donaldson, David I.			PRKCA Polymorphism Changes the Neural Basis of Episodic Remembering in Healthy Individuals	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; RECOGNITION MEMORY; HIPPOCAMPAL ACTIVITY; PERFORMANCE; METAANALYSIS; IMPAIRMENT; RETRIEVAL; INTELLIGENCE; BDNF	Everyday functioning relies on episodic memory, the conscious retrieval of past experiences, but this crucial cognitive ability declines severely with aging and disease. Vulnerability to memory decline varies across individuals however, producing differences in the time course and severity of memory problems that complicate attempts at diagnosis and treatment. Here we identify a key source of variability, by examining gene dependent changes in the neural basis of episodic remembering in healthy adults, targeting seven polymorphisms previously linked to memory. Scalp recorded Event-Related Potentials (ERPs) were measured while participants remembered words, using an item recognition task that requires discrimination between studied and unstudied stimuli. Significant differences were found as a consequence of a Single Nucleotide Polymorphism (SNP) in just one of the tested genes, PRKCA (rs8074995). Participants with the common G/G variant exhibited left parietal old/new effects, which are typically seen in word recognition studies, reflecting recollection-based remembering. During the same stage of memory retrieval participants carrying a rarer A variant exhibited an atypical pattern of brain activity, a topographically dissociable frontally-distributed old/new effect, even though behavioural performance did not differ between groups. Results replicated in a second independent sample of participants. These findings demonstrate that the PRKCA genotype is important in determining how episodic memories are retrieved, opening a new route towards understanding individual differences in memory.	[MacLeod, Catherine A.] Bangor Univ, Inst Med & Social Care Res, Bangor, Gwynedd, Wales; [Donaldson, David I.] Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland	Bangor University; University of Stirling	MacLeod, CA (corresponding author), Bangor Univ, Inst Med & Social Care Res, Bangor, Gwynedd, Wales.	c.a.macleod@bangor.ac.uk	Donaldson, David I/A-5249-2009	Donaldson, David I/0000-0002-8036-3455; MacLeod, Catherine/0000-0002-9314-7380	Economic and Social Research Council [PTA-030-2006-00337]; University of Stirling Department of Psychology Resources Committee	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); University of Stirling Department of Psychology Resources Committee	This work was primarily funded by the Economic and Social Research Council (http://www.esrc.ac.uk) through award reference PTA-030-2006-00337. Funding for the DNA analysis was provided by the University of Stirling Department of Psychology Resources Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 1999, AM J PSYCHIAT, V156, P1358; [Anonymous], 1983, CANADIAN PSYCHOL; BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; BURT DB, 1995, PSYCHOL BULL, V117, P285, DOI 10.1037/0033-2909.117.2.285; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Chabris CF, 2012, PSYCHOL SCI, V23, P1314, DOI 10.1177/0956797611435528; de Frias CM, 2004, BEHAV GENET, V34, P533, DOI 10.1023/B:BEGE.0000038491.06972.8c; de Quervain DJF, 2006, P NATL ACAD SCI USA, V103, P4270, DOI 10.1073/pnas.0510212103; de Quervain DJF, 2012, P NATL ACAD SCI USA, V109, P8746, DOI 10.1073/pnas.1200857109; Deary IJ, 2009, HUM GENET, V126, P215, DOI 10.1007/s00439-009-0655-4; Duzel E, 1997, P NATL ACAD SCI USA, V94, P5973, DOI 10.1073/pnas.94.11.5973; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Galli G, 2011, J COGNITIVE NEUROSCI, V23, P1405, DOI 10.1162/jocn.2010.21442; Gardiner JM, 1998, CONSCIOUS COGN, V7, P1, DOI 10.1006/ccog.1997.0321; Goldberg TE, 2008, BIOL PSYCHOL, V77, P20, DOI 10.1016/j.biopsycho.2007.08.009; Guillem F, 2005, BRAIN COGNITION, V57, P84, DOI 10.1016/j.bandc.2004.08.026; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Hayama HR, 2008, NEUROPSYCHOLOGIA, V46, P1211, DOI 10.1016/j.neuropsychologia.2007.11.021; Henson RNA, 2000, J COGNITIVE NEUROSCI, V12, P913, DOI 10.1162/08989290051137468; Jablensky A, 2011, GENES BRAIN BEHAV, V10, P410, DOI 10.1111/j.1601-183X.2011.00679.x; Kucera H., 1967, COMPUTATIONAL ANAL P; MacKenzie G, 2009, NEUROPSYCHOLOGIA, V47, P2756, DOI 10.1016/j.neuropsychologia.2009.05.025; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Paller KA, 2007, TRENDS COGN SCI, V11, P243, DOI 10.1016/j.tics.2007.04.002; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Papassotiropoulos A, 2011, TRENDS COGN SCI, V15, P381, DOI 10.1016/j.tics.2011.07.005; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pettersson-Yeo W, 2011, NEUROSCI BIOBEHAV R, V35, P1110, DOI 10.1016/j.neubiorev.2010.11.004; Richter-Schmidinger T, 2011, J NEURAL TRANSM, V118, P249, DOI 10.1007/s00702-010-0539-8; Rugg MD, 1998, NATURE, V392, P595, DOI 10.1038/33396; Rugg MD, 2007, TRENDS COGN SCI, V11, P251, DOI 10.1016/j.tics.2007.04.004; Sanchez-Perez AM, 2005, NEUROCHEM INT, V47, P84, DOI 10.1016/j.neuint.2005.04.011; Small BJ, 2004, PSYCHOL AGING, V19, P592, DOI 10.1037/0882-7974.19.4.592; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Trachtenberg AJ, 2012, NEUROBIOL AGING, V33, P323, DOI 10.1016/j.neurobiolaging.2010.03.009; Vizioli L, 2010, J VISION, V10, DOI 10.1167/10.1.15; Wilding EL, 1996, BRAIN, V119, P889, DOI 10.1093/brain/119.3.889; Zimmerman M., 2002, PSYCHIAT DIAGNOSTIC	40	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e98018	10.1371/journal.pone.0098018	http://dx.doi.org/10.1371/journal.pone.0098018			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842701	Green Published, gold			2022-12-25	WOS:000340948600100
J	Mao, XG; Dong, J; Hua, PY; He, GM; Zhang, SY; Rossiter, SJ				Mao, Xiuguang; Dong, Ji; Hua, Panyu; He, Guimei; Zhang, Shuyi; Rossiter, Stephen J.			Heteroplasmy and Ancient Translocation of Mitochondrial DNA to the Nucleus in the Chinese Horseshoe Bat (Rhinolophus sinicus) Complex	PLOS ONE			English	Article							D-LOOP REGION; SEQUENCE VARIATION; EVOLUTION; RECOMBINATION; MTDNA; GENOMES; ORIGIN; NUMT; HIPPOSIDEROS; PSEUDOGENES	The utility and reliability of mitochondrial DNA sequences in phylogenetic and phylogeographic studies may be compromised by widespread and undetected nuclear mitochondrial copies (numts) as well as heteroplasmy within individuals. Both numts and heteroplasmy are likely to be common across diverse taxa yet few studies have characterised their frequencies and variation at the intra-specific level. Here we report the presence of both numts and heteroplasmy in the mitochondrial control region of the Chinese horseshoe bat Rhinolophus sinicus. In total we generated 123 sequences from 18 bats, which contained two different numt clades (i.e. Numt-1 and Numt-2) and one mtDNA clade. The sequence divergence between Numt-1 and Numt-2 was 16.8% and each numt type was found in all four R. sinicus taxa, suggesting either two ancient translocations of mitochondrial DNA into the nucleus from the same source taxon, or a single translocation from different source taxa that occurred before the split of R. sinicus into different lineages. Within the mtDNA clade, phylogenetic relationships among the four taxa of R. sinicus were similar to those seen in previous results. Based on PCR comparisons, heteroplasmy was inferred between almost all individuals of R. sinicus with respect to sequence variation. Consistent with introgression of mtDNA between Central sinicus and septentrionalis, individuals from these two taxa exhibited similar signatures of repeated sequences in the control region. Our study highlights the importance of testing for the presence of numts and heteroplasmy when applying mtDNA markers to phylogenetic studies.	[Mao, Xiuguang; Dong, Ji; Hua, Panyu; He, Guimei; Zhang, Shuyi] E China Normal Univ, Inst Adv Studies Multidisciplinary Sci & Technol, Inst Mol Ecol & Evolut, Shanghai 200062, Peoples R China; [Mao, Xiuguang; Rossiter, Stephen J.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	East China Normal University; University of London; Queen Mary University London	Rossiter, SJ (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	s.j.rossiter@qmul.ac.uk		Rossiter, Stephen/0000-0002-3881-4515; Dong, Ji/0000-0002-8953-5284; He, Guimei/0000-0002-4889-0933	Key Construction Program of the National "985'' Project; 211 Project; Marie Curie International Incoming Fellowship; Royal Society Research Fellowship (UK)	Key Construction Program of the National "985'' Project; 211 Project(Anhui UniversityMinistry of Education, China); Marie Curie International Incoming Fellowship(European Commission); Royal Society Research Fellowship (UK)(Royal Society of London)	This work was funded by a grant awarded to S. Zhang under the Key Construction Program of the National "985'' Project and 211 Project. X. Mao was supported by a Marie Curie International Incoming Fellowship and SJR by a Royal Society Research Fellowship (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bertheau C, 2011, MOL ECOL RESOUR, V11, P1056, DOI 10.1111/j.1755-0998.2011.03050.x; BIJUDUVAL C, 1991, J MOL EVOL, V33, P92, DOI 10.1007/BF02100200; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Calvignac S, 2011, MITOCHONDRION, V11, P246, DOI 10.1016/j.mito.2010.10.004; Castella V, 2001, J EVOLUTION BIOL, V14, P708, DOI 10.1046/j.1420-9101.2001.00331.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; COLLURA RV, 1995, NATURE, V378, P485, DOI 10.1038/378485a0; Csorba G., 2003, HORSESHOE BATS WORLD; Dool SE, 2013, MOL ECOL, V22, P4055, DOI 10.1111/mec.12373; Fumagalli L, 1996, MOL BIOL EVOL, V13, P31, DOI 10.1093/oxfordjournals.molbev.a025568; Gantenbein B, 2005, P ROY SOC B-BIOL SCI, V272, P697, DOI 10.1098/rspb.2004.3017; Hay JM, 2004, HEREDITY, V93, P468, DOI 10.1038/sj.hdy.6800525; Hazkani-Covo E, 2007, MOL BIOL EVOL, V24, P13, DOI 10.1093/molbev/msl149; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; He XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066324; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Hoarau G, 2002, MOL BIOL EVOL, V19, P2261, DOI 10.1093/oxfordjournals.molbev.a004049; HOELZEL AR, 1994, J MOL EVOL, V39, P191; HOELZEL AR, 1993, J MOL EVOL, V37, P190, DOI 10.1007/BF02407355; KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542; Kmiec B, 2006, CURR GENET, V50, P149, DOI 10.1007/s00294-006-0082-1; Larizza A, 2002, J MOL EVOL, V54, P145, DOI 10.1007/s00239-001-0063-4; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Ling L L, 1991, PCR Methods Appl, V1, P63; LOPEZ JV, 1994, J MOL EVOL, V39, P174; Mao XG, 2013, BIOL J LINN SOC, V110, P346, DOI 10.1111/bij.12138; Mao XG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056786; Miraldo A, 2012, MOL ECOL, V21, P1005, DOI 10.1111/j.1365-294X.2011.05422.x; Mjelle KA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-10; Morgan JAT, 2013, MITOCHONDRION, V13, P852, DOI 10.1016/j.mito.2013.06.002; Moulton MJ, 2010, MOL ECOL RESOUR, V10, P615, DOI 10.1111/j.1755-0998.2009.02823.x; Mundy NI, 1996, J HERED, V87, P21, DOI 10.1093/oxfordjournals.jhered.a022948; Nei M., 1987, MOL EVOLUTIONARY GEN; Nilsson MA, 2009, MITOCHONDR DNA, V20, P126, DOI 10.3109/19401730903180112; Nunes MDS, 2013, MOL ECOL, V22, P2106, DOI 10.1111/mec.12256; Petri B, 1996, BIOL CHEM, V377, P661, DOI 10.1515/bchm3.1996.377.10.661; Piganeau G, 2004, MOL BIOL EVOL, V21, P2319, DOI 10.1093/molbev/msh244; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Puechmaille SJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1582; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sbisa E, 1997, GENE, V205, P125, DOI 10.1016/S0378-1119(97)00404-6; Sorenson MD, 1996, P NATL ACAD SCI USA, V93, P15239, DOI 10.1073/pnas.93.26.15239; Spitzenberger F, 2006, ZOOL SCR, V35, P187, DOI 10.1111/j.1463-6409.2006.00224.x; Sun KP, 2013, MITOCHONDR DNA, V24, P451, DOI 10.3109/19401736.2013.766176; Sun KP, 2009, MAMM BIOL, V74, P130, DOI 10.1016/j.mambio.2008.09.002; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thalmann O, 2005, MOL ECOL, V14, P179, DOI 10.1111/j.1365-294X.2004.02382.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Triant DA, 2007, J MAMMAL, V88, P908, DOI 10.1644/06-MAMM-A-204R1.1; Turmelle AS, 2011, MOL ECOL, V20, P357, DOI 10.1111/j.1365-294X.2010.04947.x; Ujvari B, 2007, BIOL LETTERS, V3, P189, DOI 10.1098/rsbl.2006.0587; White DJ, 2008, MOL ECOL, V17, P4925, DOI 10.1111/j.1365-294X.2008.03982.x; Wilkinson GS, 1997, GENETICS, V146, P1035; WILKINSON GS, 1991, GENETICS, V128, P607; Zhang DX, 1996, TRENDS ECOL EVOL, V11, P247, DOI 10.1016/0169-5347(96)10031-8; ZISCHLER H, 1995, NATURE, V378, P489, DOI 10.1038/378489a0	58	7	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e98035	10.1371/journal.pone.0098035	http://dx.doi.org/10.1371/journal.pone.0098035			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24842827	Green Published, gold, Green Submitted			2022-12-25	WOS:000340948600102
J	Oh, KH; Kim, DW; Jung, SM; Cho, SH				Oh, Kyung-Hwan; Kim, Dong Wook; Jung, Su-Mi; Cho, Seung-Hak			Molecular Characterization of Enterotoxigenic Escherichia coli Strains Isolated from Diarrheal Patients in Korea during 2003-2011	PLOS ONE			English	Article							COLONIZATION FACTORS; DEVELOPING-COUNTRIES; PHENOTYPIC PROFILES; CHILDREN; INFECTIONS; DISEASE; EGYPT; ETEC	Enterotoxigenic Escherichia coli (ETEC) is one of the major causes of infectious diarrhea in developing countries. In order to characterize the molecular features of human ETEC isolates from Korea, we investigated the profiles of enterotoxin and colonization factor (CF) genes by polymerase chain reaction (PCR) and performed multilocus sequence typing (MLST) with a total of 291 ETEC strains. The specimens comprised 258 domestic strains isolated from patients who had diarrhea and were from widely separated geographic regions in Korea and 33 inflow strains isolated from travelers visiting other Asian countries. Heat-stable toxin (STh)-possessing ETEC strains were more frequent than heat-labile toxin (LT)-possessing ETEC strains in the domestic isolates, while the detection rates of both enterotoxin genes were similar in the inflow isolates. The profile of CF genes of domestic isolates was similar to that of inflow isolates and the major CF types of the strains were CS3-CS21-CS1/PCF071 and CS2-CS3-CS21. Most of these 2 CF types were detected in ETEC strains that possess both lt and sth genes. The major MLSTST types of domestic isolates were ST171 and ST955. Moreover, the 2 major CF types were usually found concomitantly with the 2 major MLST STs, ST171 and ST955. In conclusion, our genotyping results may provide useful information for guiding the development of geographically specific vaccines against human ETEC isolates.	[Oh, Kyung-Hwan; Jung, Su-Mi; Cho, Seung-Hak] Korea Natl Inst Hlth, Ctr Infect Dis, Div Enter Bacterial Infect, Osong Eup, Chungcheongbuk, South Korea; [Kim, Dong Wook] Hanyang Univ, Coll Pharm, Dept Pharm, Ansan, Kyeonggi Do, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease; Hanyang University	Cho, SH (corresponding author), Korea Natl Inst Hlth, Ctr Infect Dis, Div Enter Bacterial Infect, Osong Eup, Chungcheongbuk, South Korea.	skcho38@korea.kr	Kim, Dong Wook/H-8253-2015	Kim, Dong Wook/0000-0001-5351-7597	Korean National Institute of Health, Seoul, Republic of Korea [KNIH4800-4845-300]	Korean National Institute of Health, Seoul, Republic of Korea	This study was supported by a grant from the Korean National Institute of Health, Seoul, Republic of Korea (KNIH4800-4845-300 to S.H.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Gallas N, 2007, CURR MICROBIOL, V55, P47, DOI 10.1007/s00284-006-0572-x; Binsztein N, 1999, Rev Latinoam Microbiol, V41, P121; Clemens J, 2004, J INFECT DIS, V189, P2299, DOI 10.1086/386288; Cohen D, 2010, FOODBORNE PATHOG DIS, V7, P1159, DOI 10.1089/fpd.2009.0510; Estrada-Garcia T, 2005, EMERG INFECT DIS, V11, P1306, DOI 10.3201/eid1108.050192; Froehlich B, 2005, J BACTERIOL, V187, P6509, DOI 10.1128/JB.187.18.6509-6516.2005; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Lasaro MA, 2008, J BACTERIOL, V190, P2400, DOI 10.1128/JB.00988-07; Levine MM, 2006, VACCINE, V24, P3865, DOI 10.1016/j.vaccine.2006.03.039; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Nada RA, 2010, DIAGN MICR INFEC DIS, V67, P134, DOI 10.1016/j.diagmicrobio.2010.01.011; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nicklasson M, 2010, EMERG INFECT DIS, V16, P143, DOI 10.3201/eid1601.090979; Nirdnoy W, 1997, J CLIN MICROBIOL, V35, P527, DOI 10.1128/JCM.35.2.527-530.1997; Ochoa TJ, 2009, CLIN INFECT DIS, V49, P1694, DOI 10.1086/648069; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Qadri F, 2007, INFECT IMMUN, V75, P3961, DOI 10.1128/IAI.00459-07; Rivera FP, 2010, J CLIN MICROBIOL, V48, P3198, DOI 10.1128/JCM.00644-10; Shaheen HI, 2009, J CLIN MICROBIOL, V47, P189, DOI 10.1128/JCM.01282-08; Shaheen HI, 2004, J CLIN MICROBIOL, V42, P5588, DOI 10.1128/JCM.42.12.5588-5595.2004; Sizemore Donata R, 2004, Expert Rev Vaccines, V3, P585, DOI 10.1586/14760584.3.5.585; Sommerfelt H, 1996, J INFECT DIS, V174, P768, DOI 10.1093/infdis/174.4.768; Svennerholm AM, 2008, EXPERT REV VACCINES, V7, P795, DOI 10.1586/14760584.7.6.795; Turner SM, 2006, J CLIN MICROBIOL, V44, P4528, DOI 10.1128/JCM.01474-06; Valvatne H, 2002, APMIS, V110, P665, DOI 10.1034/j.1600-0463.2002.1100911.x; Viboud GI, 1999, J CLIN MICROBIOL, V37, P2829, DOI 10.1128/JCM.37.9.2829-2833.1999; Walker RI, 2007, VACCINE, V25, P2545, DOI 10.1016/j.vaccine.2006.12.028; Wenneras C, 2004, J HEALTH POPUL NUTR, V22, P370; [WHO] World Health Organization, 2006, WKLY EPIDEMIOL REC, V81, P97	30	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e96896	10.1371/journal.pone.0096896	http://dx.doi.org/10.1371/journal.pone.0096896			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841334	Green Submitted, Green Published, gold			2022-12-25	WOS:000340948600012
J	Xu, L; Wang, H; La, Q; Lu, F; Sun, K; Fang, Y; Yang, M; Zhong, Y; Wu, QH; Chen, JJ; Birks, HJB; Zhang, WJ				Xu, Lu; Wang, Hao; La, Qiong; Lu, Fan; Sun, Kun; Fang, Yang; Yang, Mei; Zhong, Yang; Wu, Qianhong; Chen, Jiakuan; Birks, H. John B.; Zhang, Wenju			Microrefugia and Shifts of Hippophae tibetana (Elaeagnaceae) on the North Side of Mt. Qomolangma (Mt. Everest) during the Last 25000 Years	PLOS ONE			English	Article							RECENT CLIMATE-CHANGE; ICE CORE; POPULATION-STRUCTURE; GLACIAL REFUGIA; MIGRATION CAPACITY; GENETIC DIVERSITY; PLANT DIVERSITY; MOUNT EVEREST; PLATEAU; MICROSATELLITES	Microrefugia at high altitudes or high latitudes are thought to play an important role in the post-glacial colonization of species. However, how populations in such microrefugia have responded to climate changes in alternating cold glacial and warm interglacial stages remain unclear. Here we present evidence to indicate the Rongbuk Valley of the Mt. Qomolangma (Mt. Everest) area, the highest region on earth, had microrefugia for Hippophae tibetana and discuss how this low shrub was adapted to the extreme climate fluctuations of the last 25,000 years by shifts. By integrating geological, glaciological, meteorological, and genetic information, we found that the Rongbuk Valley was not only a glacial microrefugium but also an interglacial microrefugium for H. tibetana: the former was located on the riverbank below 4800 m above sea level (asl) or lower area and the latter at similar to 5000 m asl. Our results show that after the Last Glacial Maximum (LGM), H. tibetana in the valley has undergone upward and downward migrations around similar to 5000 m driven by climate fluctuations and the population in the glacial microrefugium has suffered extinction or extreme contraction. Moreover, with the rise of temperature in the last four decades, the upper limit of H. tibetana has shifted at least 30 m upward. Combining population history and recent range shift of this species is important in predicting the fate of this endemic species to future climate changes.	[Xu, Lu; Wang, Hao; La, Qiong; Lu, Fan; Fang, Yang; Yang, Mei; Zhong, Yang; Wu, Qianhong; Chen, Jiakuan; Zhang, Wenju] Fudan Univ, Sch Life Sci, Inst Biodivers Sci, Shanghai 200433, Peoples R China; [Xu, Lu; Sun, Kun] Northwest Normal Univ, Coll Life Sci, Lanzhou, Peoples R China; [La, Qiong; Zhong, Yang] Tibet Univ, Dept Biol, Lhasa, Peoples R China; [Birks, H. John B.] Univ Bergen, Dept Biol, Bergen, Norway; [Birks, H. John B.] UCL, Environm Change Res Ctr, London, England; [Birks, H. John B.] Univ Oxford, Sch Geog & Environm, Oxford, England	Fudan University; Northwest Normal University - China; Tibet University; University of Bergen; University of London; University College London; University of Oxford	Zhang, WJ (corresponding author), Fudan Univ, Sch Life Sci, Inst Biodivers Sci, Shanghai 200433, Peoples R China.	wjzhang@fudan.edu.cn	Birks, John B/C-3103-2008	Birks, John B/0000-0002-5891-9859	National Basic Research Program of China [2014CB954103]; National Natural Science Foundation of China [41061007, 91131901]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by National Basic Research Program of China (Grant No. 2014CB954103; http://www.973.gov.cn/AreaMana.aspx) and the National Natural Science Foundation of China (Grant No. 41061007 and Grant No. 91131901; http://isisn.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2003, MOL ECOL, V12, P299, DOI 10.1046/j.1365-294X.2003.01731.x; Anderson LL, 2006, P NATL ACAD SCI USA, V103, P12447, DOI 10.1073/pnas.0605310103; Ashcroft MB, 2012, GLOBAL CHANGE BIOL, V18, P1866, DOI 10.1111/j.1365-2486.2012.02661.x; Bennett KD, 2008, QUATERNARY SCI REV, V27, P2449, DOI 10.1016/j.quascirev.2008.08.019; Binney HA, 2009, QUATERNARY SCI REV, V28, P2445, DOI 10.1016/j.quascirev.2009.04.016; Birks HJB, 2008, PLANT ECOL DIVERS, V1, P147, DOI 10.1080/17550870802349146; BURBANK DW, 1991, QUATERNARY RES, V36, P1, DOI 10.1016/0033-5894(91)90013-U; Bush MB, 2004, SCIENCE, V303, P827, DOI 10.1126/science.1090795; Chen XL, 2003, ACTA BOT BOREALI-OCC, V23, P5; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Cornuet JM, 1996, GENETICS, V144, P2001; Dobrowski SZ, 2011, GLOBAL CHANGE BIOL, V17, P1022, DOI 10.1111/j.1365-2486.2010.02263.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fisher PJ, 1996, NUCLEIC ACIDS RES, V24, P4369, DOI 10.1093/nar/24.21.4369; Galbreath KE, 2009, EVOLUTION, V63, P2848, DOI 10.1111/j.1558-5646.2009.00803.x; GASSE F, 1991, NATURE, V353, P742, DOI 10.1038/353742a0; Geffen E, 2007, MOL ECOL, V16, P4241, DOI 10.1111/j.1365-294X.2007.03507.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; Graham CH, 2010, ECOGRAPHY, V33, P1062, DOI 10.1111/j.1600-0587.2010.06430.x; Hampe A, 2013, NEW PHYTOL, V197, P16, DOI 10.1111/nph.12059; Hampe A, 2011, ANNU REV ECOL EVOL S, V42, P313, DOI 10.1146/annurev-ecolsys-102710-145015; Hampton JO, 2004, J APPL ECOL, V41, P735, DOI 10.1111/j.0021-8901.2004.00936.x; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; HARPENDING HC, 1994, HUM BIOL, V66, P591; Harsch MA, 2009, ECOL LETT, V12, P1040, DOI 10.1111/j.1461-0248.2009.01355.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Holderegger R, 2009, J BIOGEOGR, V36, P476, DOI 10.1111/j.1365-2699.2008.02027.x; Hou SG, 2000, CHINESE SCI BULL, V45, P259, DOI 10.1007/BF02884687; [胡恩 Hu En], 2010, [冰川冻土, Journal of Glaciology and Geocryology], V32, P316; Kang SC, 2001, EPISODES, V24, P176; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Korner C, 2000, TRENDS ECOL EVOL, V15, P513, DOI 10.1016/S0169-5347(00)02004-8; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lenoir J, 2013, ENCY BIODIVERSITY, V4, P599; Li B., 1991, QUATERNARY GLACIAL D; Liu XD, 2009, GLOBAL PLANET CHANGE, V68, P164, DOI 10.1016/j.gloplacha.2009.03.017; McLachlan JS, 2005, ECOLOGY, V86, P2088, DOI 10.1890/04-1036; McLaughlin BC, 2012, GLOBAL CHANGE BIOL, V18, P2301, DOI 10.1111/j.1365-2486.2011.02630.x; Moeller DA, 2011, AM NAT, V178, pS44, DOI 10.1086/661783; Mosblech NAS, 2011, J BIOGEOGR, V38, P419, DOI 10.1111/j.1365-2699.2010.02436.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Nie Y, 2010, J GEOGR SCI, V20, P667, DOI 10.1007/s11442-010-0803-8; Opgenoorth L, 2010, NEW PHYTOL, V185, P332, DOI 10.1111/j.1469-8137.2009.03007.x; Owen LA, 2009, QUATERNARY SCI REV, V28, P1412, DOI 10.1016/j.quascirev.2009.02.010; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pauli H, 2007, GLOBAL CHANGE BIOL, V13, P147, DOI 10.1111/j.1365-2486.2006.01282.x; Pearson RG, 2006, TRENDS ECOL EVOL, V21, P111, DOI 10.1016/j.tree.2005.11.022; Pecci M, 2010, GEOGR FIS DIN QUAT, V33, P79; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pope LC, 2000, MOL ECOL, V9, P2041, DOI 10.1046/j.1365-294X.2000.01110.x; Previsic A, 2009, MOL ECOL, V18, P634, DOI 10.1111/j.1365-294X.2008.04046.x; Pritchard JK, 2000, GENETICS, V155, P945; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Ren JW, 2004, CHINESE SCI BULL, V49, P65, DOI 10.1360/03wd0148; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Ruedi M, 2003, MOL ECOL, V12, P1527, DOI 10.1046/j.1365-294X.2003.01828.x; Rull V, 2010, J BIOGEOGR, V37, P1623, DOI 10.1111/j.1365-2699.2010.02340.x; Rull V, 2009, J BIOGEOGR, V36, P481, DOI 10.1111/j.1365-2699.2008.02023.x; Scherrer D, 2011, J BIOGEOGR, V38, P406, DOI 10.1111/j.1365-2699.2010.02407.x; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; Shi YF, 2000, CHINESE SCI BULL, V45, P668, DOI 10.1007/BF02886048; Song ZP, 2003, THEOR APPL GENET, V107, P1492, DOI 10.1007/s00122-003-1380-3; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stott L, 2002, SCIENCE, V297, P222, DOI 10.1126/science.1071627; Team of Scientific Expedition to Mt. Qomolangma C, 1962, REP SCI EXP MT QOM; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thompson LG, 1998, SCIENCE, V282, P1858, DOI 10.1126/science.282.5395.1858; Thompson LG, 1997, SCIENCE, V276, P1821, DOI 10.1126/science.276.5320.1821; Tilman D, 2001, P NATL ACAD SCI USA, V98, P5433, DOI 10.1073/pnas.091093198; Walther GR, 2005, J VEG SCI, V16, P541, DOI 10.1111/j.1654-1103.2005.tb02394.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wang H, 2010, MOL ECOL, V19, P2964, DOI 10.1111/j.1365-294X.2010.04729.x; Wang ZY, 2013, PLATEAU METEOROL, V32, P7; Xie ZC, 1975, THESIS, P1; Yang XC, 2006, J GEOGR SCI, V16, P11; Yang XG, 2012, ACTA METEOROL SIN, V70, P12; Yang XG, 2011, ARCT ANTARCT ALP RES, V43, P147, DOI 10.1657/1938-4246-43.1.147; Yao T, 2007, ARCT ANTARCT ALP RES, V39, P642, DOI 10.1657/1523-0430(07-510)[YAO]2.0.CO;2; Yao TD, 1996, SCI CHINA SER D, V39, P425; Zhang ZR, 1983, DELECTIS FLORAE REIP, P61; Zheng BS, 1976, STUDY QUATERNARY GLA; Zhou YB, 2009, MOL ECOL RESOUR, V9, P370, DOI 10.1111/j.1755-0998.2008.02453.x	87	1	1	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97601	10.1371/journal.pone.0097601	http://dx.doi.org/10.1371/journal.pone.0097601			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841004	Green Submitted, Green Published, gold			2022-12-25	WOS:000340948600050
J	Premkumar, L; Kurth, F; Duprez, W; Groftehauge, MK; King, GJ; Halili, MA; Heras, B; Martin, JL				Premkumar, Lakshmanane; Kurth, Fabian; Duprez, Wilko; Groftehauge, Morten K.; King, Gordon J.; Halili, Maria A.; Heras, Begona; Martin, Jennifer L.			Structure of the Acinetobacter baumannii Dithiol Oxidase DsbA Bound to Elongation Factor EF-Tu Reveals a Novel Protein Interaction Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; ESCHERICHIA-COLI; FUNCTIONAL-CHARACTERIZATION; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; BIOFILM FORMATION; IDENTIFICATION; VIRULENCE; PATHOGEN; OUTBREAK	The multidrug resistant bacterium Acinetobacter baumannii is a significant cause of nosocomial infection. Biofilm formation, that requires both disulfide bond forming and chaperone-usher pathways, is a major virulence trait in this bacterium. Our biochemical characterizations show that the periplasmic A. baumannii DsbA (AbDsbA) enzyme has an oxidizing redox potential and dithiol oxidase activity. We found an unexpected non-covalent interaction between AbDsbA and the highly conserved prokaryotic elongation factor, EF-Tu. EF-Tu is a cytoplasmic protein but has been localized extracellularly in many bacterial pathogens. The crystal structure of this complex revealed that the EF-Tu switch I region binds to the non-catalytic surface of AbDsbA. Although the physiological and pathological significance of a DsbA/EF-Tu association is unknown, peptides derived from the EF-Tu switch I region bound to AbDsbA with submicromolar affinity. We also identified a seven-residue DsbB-derived peptide that bound to AbDsbA with low micromolar affinity. Further characterization confirmed that the EF-Tu- and DsbB-derived peptides bind at two distinct sites. These data point to the possibility that the non-catalytic surface of DsbA is a potential substrate or regulatory protein interaction site. The two peptides identified in this work together with the newly characterized interaction site provide a novel starting point for inhibitor design targeting AbDsbA.	[Premkumar, Lakshmanane; Kurth, Fabian; Duprez, Wilko; Groftehauge, Morten K.; King, Gordon J.; Halili, Maria A.; Heras, Begona; Martin, Jennifer L.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, St Lucia, Qld 4067, Australia	University of Queensland	Premkumar, L (corresponding author), Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, St Lucia, Qld 4067, Australia.	p.lakshmanane@uq.edu.au; j.martin@imb.uq.edu.au	Heras, Begona/H-8686-2014; Halili, Maria A/J-8362-2014; King, Gordon/J-8718-2014; Martin, Jennifer L./A-6039-2010	Heras, Begona/0000-0003-3469-7988; Halili, Maria A/0000-0003-4407-5269; Martin, Jennifer L./0000-0002-9225-8863; Groftehauge, Morten/0000-0002-1823-3713	Australian Research Council	Australian Research Council(Australian Research Council)	These authors were supported by an Australian Research Council Laureate award to J. L. M.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bader M, 1998, J BIOL CHEM, V273, P10302, DOI 10.1074/jbc.273.17.10302; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Balasubramanian S, 2008, INFECT IMMUN, V76, P3116, DOI 10.1128/IAI.00173-08; Barbier M, 2013, MBIO, V4, DOI 10.1128/mBio.00207-13; Barbolla RE, 2003, DIAGN MICR INFEC DIS, V45, P261, DOI 10.1016/S0732-8893(02)00538-2; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Bessette PH, 2001, J BACTERIOL, V183, P980, DOI 10.1128/JB.183.3.980-988.2001; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brady RA, 2006, INFECT IMMUN, V74, P3415, DOI 10.1128/IAI.00392-06; Burall LS, 2004, INFECT IMMUN, V72, P2922, DOI 10.1128/IAI.72.5.2922-2938.2004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chow JY, 2014, ANTIMICROB AGENTS CH, V58, P1802, DOI 10.1128/AAC.02410-13; Cisneros JM, 2002, CLIN MICROBIOL INFEC, V8, P687, DOI 10.1046/j.1469-0691.2002.00487.x; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; Crespo MD, 2012, NAT CHEM BIOL, V8, P707, DOI [10.1038/NCHEMBIO.1019, 10.1038/nchembio.1019]; DAILEY FE, 1993, P NATL ACAD SCI USA, V90, P1043, DOI 10.1073/pnas.90.3.1043; Dallo SF, 2012, SCI WORLD J, DOI 10.1100/2012/128705; de Vries SPW, 2014, MOL MICROBIOL, V91, P522, DOI 10.1111/mmi.12475; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Doidge M, 2010, INFECT CONT HOSP EP, V31, P418, DOI 10.1086/651312; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fu J, 2012, J BOT, V2012, P1, DOI DOI 10.1155/2012/835836; Gaddy JA, 2009, FUTURE MICROBIOL, V4, P273, DOI 10.2217/FMB.09.5; Garcia-Quintanilla M, 2013, CURR PHARM BIOTECHNO, V14, P897; Garnett JA, 2012, P NATL ACAD SCI USA, V109, P3950, DOI 10.1073/pnas.1106733109; Genevaux P, 1999, FEMS MICROBIOL LETT, V173, P403, DOI 10.1016/S0378-1097(99)00110-X; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; Gootz TD, 2008, EXPERT REV ANTI-INFE, V6, P309, DOI 10.1586/14787210.6.3.309; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Heras B, 2015, BRIT J CLIN PHARMACO, V79, P208, DOI 10.1111/bcp.12356; Heras B, 2010, J BIOL CHEM, V285, P18423, DOI 10.1074/jbc.M110.101360; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Ireland PM, 2014, ANTIOXID REDOX SIGN, V20, P606, DOI 10.1089/ars.2013.5375; Jawad A, 1998, J CLIN MICROBIOL, V36, P1938, DOI 10.1128/JCM.36.7.1938-1941.1998; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kawashima T, 1996, NATURE, V379, P511, DOI 10.1038/379511a0; Kidmose RT, 2010, P NATL ACAD SCI USA, V107, P10884, DOI 10.1073/pnas.1003015107; King GJ, 2008, ANAL CHEM, V80, P5036, DOI 10.1021/ac702277q; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Kurth F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080210; Kurz M, 2009, ANTIOXID REDOX SIGN, V11, P1485, DOI [10.1089/ars.2008.2420, 10.1089/ARS.2008.2420]; Landman D, 2002, ARCH INTERN MED, V162, P1515, DOI 10.1001/archinte.162.13.1515; Lee HW, 2008, CLIN MICROBIOL INFEC, V14, P49, DOI 10.1111/j.1469-0691.2007.01842.x; Lin D, 2008, J BACTERIOL, V190, P87, DOI 10.1128/JB.01323-07; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; McConnell MJ, 2013, FEMS MICROBIOL REV, V37, P130, DOI 10.1111/j.1574-6976.2012.00344.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMahon RM, 2014, BBA-PROTEINS PROTEOM, V1844, P1391, DOI 10.1016/j.bbapap.2014.01.013; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Montefour K, 2008, CRIT CARE NURSE, V28, P15; Nieves W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014361; Onarheim H, 2000, Tidsskr Nor Laegeforen, V120, P1028; Otto J, 2001, J BACTERIOL, V183, P2445, DOI 10.1128/JB.183.8.2445-2453.2001; Paxman JJ, 2009, J BIOL CHEM, V284, P17835, DOI 10.1074/jbc.M109.011502; PEEK JA, 1992, P NATL ACAD SCI USA, V89, P6210, DOI 10.1073/pnas.89.13.6210; Porcella SF, 1996, MICROBIOL-SGM, V142, P2481, DOI 10.1099/00221287-142-9-2481; Premkumar L, 2013, ACTA CRYSTALLOGR D, V69, P1981, DOI 10.1107/S0907444913017800; Quan S, 2007, J BIOL CHEM, V282, P28823, DOI 10.1074/jbc.M705291200; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Rinaldi FC, 2009, BIOCHEMISTRY-US, V48, P3508, DOI 10.1021/bi801899x; Rosadini CV, 2008, INFECT IMMUN, V76, P1498, DOI 10.1128/IAI.01378-07; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott RD, 2009, DIRECT MED COSTS HEA; Shouldice SR, 2011, ANTIOXID REDOX SIGN, V14, P1729, DOI 10.1089/ars.2010.3344; Shouldice SR, 2010, ANTIOXID REDOX SIGN, V12, P921, DOI 10.1089/ars.2009.2736; Snyder L, 2003, J MOL BIOL, V334, P349, DOI 10.1016/j.jmb.2003.09.063; Song HW, 1999, J MOL BIOL, V285, P1245, DOI 10.1006/jmbi.1998.2387; Soufo HJD, 2010, P NATL ACAD SCI USA, V107, P3163, DOI 10.1073/pnas.0911979107; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Totsika M, 2009, J BACTERIOL, V191, P3901, DOI 10.1128/JB.00143-09; van Dessel H, 2004, RES MICROBIOL, V155, P105, DOI 10.1016/j.resmic.2003.10.003; Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106; Vivian JP, 2009, J MOL BIOL, V394, P931, DOI 10.1016/j.jmb.2009.09.065; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wright MS, 2014, MBIO, V5, DOI 10.1128/mBio.00963-13; Yu J, 1998, INFECT IMMUN, V66, P3909, DOI 10.1128/IAI.66.8.3909-3917.1998	85	10	10	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					19869	19880		10.1074/jbc.M114.571737	http://dx.doi.org/10.1074/jbc.M114.571737			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24860094	hybrid, Green Published			2022-12-25	WOS:000339395200006
J	Echevarria-Vargas, IM; Valiyeva, F; Vivas-Mejia, PE				Echevarria-Vargas, Ileabett M.; Valiyeva, Fatma; Vivas-Mejia, Pablo E.			Upregulation of miR-21 in Cisplatin Resistant Ovarian Cancer via JNK-1/c-Jun Pathway	PLOS ONE			English	Article							CARCINOMA CELL-LINES; MIGRATION ABILITIES; PROMOTES APOPTOSIS; ANTITUMOR-ACTIVITY; INHIBITS INVASION; DOWN-REGULATION; BREAST-CANCER; AP-1 ACTIVITY; EXPRESSION; MICRORNA	Cisplatin has been the most accepted drug for the treatment of ovarian cancer for almost 40 years. Although the majority of patients with ovarian cancer respond to front-line platinum combination chemotherapy, many patients will develop cisplatin-resistance disease, which is extremely rapid and fatal. Although various mechanisms of cisplatin resistance have been postulated, the key molecules involved in such resistance have not been identified. MiRNAs are endogenously expressed small non-coding RNAs, which are evolutionarily conserved and function as post-transcriptional regulators of gene expression. Dysregulation of miRNAs have been associated with cancer initiation, progression and drug resistance. The oncogenic miRNA-21, one of the best-studied miRNAs, is upregulated in almost all human cancers. However, the regulation of miR-21 in cisplatin resistant ovarian cancer cells has not been assessed. In this study, we measured the miR-21 expression by real-time PCR and found upregulation of miR-21 in cisplatin resistant compared with cisplatin sensitive ovarian cancer cells. Chromatin immunoprecipitation studies demonstrated the association of the c-Jun transcription factor to the pri-mir-21 DNA promoter regions. Blocking the JNK-1, the major activator of c-Jun phosphorylation, reduced the expression of pre-mir-21 and increased the expression of its well-known target gene, PDCD4. Overexpression of miR-21 in cisplatin sensitive cells decreased PDCD4 levels and increased cell proliferation. Finally, targeting miR-21 reduced cell growth, proliferation and invasion of cisplatin resistant ovarian cancer cells. These results suggest that the JNK-1/c-Jun/miR-21 pathway contributes to the cisplatin resistance of ovarian cancer cells and demonstrated that miR-21 is a plausible target to overcome cisplatin resistance.	[Echevarria-Vargas, Ileabett M.; Valiyeva, Fatma; Vivas-Mejia, Pablo E.] Univ Puerto Rico, Ctr Comprehens Canc, San Juan, PR 00936 USA; [Echevarria-Vargas, Ileabett M.; Vivas-Mejia, Pablo E.] Univ Puerto Rico, Dept Biochem, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico	Vivas-Mejia, PE (corresponding author), Univ Puerto Rico, Ctr Comprehens Canc, San Juan, PR 00936 USA.	pablo.vivas@upr.edu			NIH/NCI [1K22CA166226-01A1]; University of Puerto Rico Comprehensive Cancer Center; National Institute of Health; Minority Biomedical Research Support (MBRS) RISE Grant [R25-GM061838 (IEV)]; NATIONAL CANCER INSTITUTE [K22CA166226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061838] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD008149] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Puerto Rico Comprehensive Cancer Center; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minority Biomedical Research Support (MBRS) RISE Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This project was supported partially by the NIH/NCI (1K22CA166226-01A1) to PEVM, institutional seed funds from the University of Puerto Rico Comprehensive Cancer Center (PEVM), National Institute of Health, and Minority Biomedical Research Support (MBRS) RISE Grant Number R25-GM061838 (IEV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nasiry S, 2007, HUM REPROD, V22, P1304, DOI 10.1093/humrep/dem011; Apte SM, 2004, GYNECOL ONCOL, V93, P78, DOI 10.1016/j.ygyno.2003.12.041; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; BEHRENS BC, 1987, CANCER RES, V47, P414; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Braun R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055037; Chan JK, 2014, GYNECOL ONCOL, V132, P739, DOI 10.1016/j.ygyno.2014.01.034; Chen Y, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-86; Chen Y, 2012, J PEDIATR SURG, V47, P1797, DOI 10.1016/j.jpedsurg.2012.05.013; Derfoul A, 2011, CARCINOGENESIS, V32, P1607, DOI 10.1093/carcin/bgr184; Di Leva G, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00153; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Gong C, 2011, J BIOL CHEM, V286, P19127, DOI 10.1074/jbc.M110.216887; Imanaka Y, 2011, J HUM GENET, V56, P270, DOI 10.1038/jhg.2011.1; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kikuchi Y, 2001, Hum Cell, V14, P115; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Kumarswamy R, 2011, RNA BIOL, V8, P706, DOI 10.4161/rna.8.5.16154; Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404; Lou YH, 2011, CLIN INVEST MED, V34, pE281, DOI 10.25011/cim.v34i5.15671; Lou YH, 2010, INT J MOL MED, V26, P819, DOI 10.3892/ijmm_00000530; Ma J, 2010, CANCER GENE THER, V17, P523, DOI 10.1038/cgt.2010.18; Misawa A, 2010, ONCOL RES, V19, P23, DOI 10.3727/096504010X12828372551759; Mudduluru G, 2011, BIOSCIENCE REP, V31, P185, DOI 10.1042/BSR20100065; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Nana-Sinkam SP, 2013, CLIN PHARMACOL THER, V93, P98, DOI 10.1038/clpt.2012.192; Pan XA, 2010, CANCER BIOL THER, V10, P1224, DOI 10.4161/cbt.10.12.14252; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Peng RQ, 2012, J BIOL CHEM, V287, P14301, DOI 10.1074/jbc.M111.337642; Schmandt RE, 2006, CANCER BIOL THER, V5, P1136, DOI 10.4161/cbt.5.9.2953; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Skilling JS, 1996, GYNECOL ONCOL, V60, P72, DOI 10.1006/gyno.1996.0014; Slezak-Prochazka I, 2010, RNA, V16, P1087, DOI 10.1261/rna.1804410; Sood AK, 2001, AM J PATHOL, V158, P1279, DOI 10.1016/S0002-9440(10)64079-5; Sorrentino A, 2008, GYNECOL ONCOL, V111, P478, DOI 10.1016/j.ygyno.2008.08.017; Talotta F, 2009, ONCOGENE, V28, P73, DOI 10.1038/onc.2008.370; van Jaarsveld MTM, 2013, ONCOGENE, V32, P4284, DOI 10.1038/onc.2012.433; Vargas IME, 2013, METHODS MOL BIOL, V1049, P171, DOI 10.1007/978-1-62703-547-7_13; Vasey PA, 2003, BRIT J CANCER, V89, pS23, DOI 10.1038/sj.bjc.6601497; Vivas-Mejia P, 2010, CLIN CANCER RES, V16, P184, DOI 10.1158/1078-0432.CCR-09-1180; Vivas-Mejia PE, 2011, CLIN CANCER RES, V17, P3716, DOI 10.1158/1078-0432.CCR-11-0233; Vivas-Mejia PE, 2009, INT J CANCER, V125, P264, DOI 10.1002/ijc.24341; Wei N, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-70; Wyman SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005311; Xie Z, 2013, ONCOL LETT, V6, P795, DOI 10.3892/ol.2013.1432; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488	51	87	88	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97094	10.1371/journal.pone.0097094	http://dx.doi.org/10.1371/journal.pone.0097094			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865582	gold, Green Published, Green Submitted			2022-12-25	WOS:000336914100010
J	Eshraghi, A; Abu Osman, NA; Karimi, M; Gholizadeh, H; Soodmand, E; Abas, WAW				Eshraghi, Arezoo; Abu Osman, Noor Azuan; Karimi, Mohammad; Gholizadeh, Hossein; Soodmand, Ehsan; Abas, Wan Abu Bakar Wan			Gait Biomechanics of Individuals with Transtibial Amputation: Effect of Suspension System	PLOS ONE			English	Article							LOWER-LIMB AMPUTEES; PATELLAR TENDON BEARING; BELOW-KNEE AMPUTEES; PROSTHETIC COMPONENTS; INTERFACE PRESSURE; DEVIATION INDEX; WALKING; SOCKET; LINER; FOOT	Prosthetic suspension system is an important component of lower limb prostheses. Suspension efficiency can be best evaluated during one of the vital activities of daily living, i.e. walking. A new magnetic prosthetic suspension system has been developed, but its effects on gait biomechanics have not been studied. This study aimed to explore the effect of suspension type on kinetic and kinematic gait parameters during level walking with the new suspension system as well as two other commonly used systems (the Seal-In and pin/lock). Thirteen persons with transtibial amputation participated in this study. A Vicon motion system (six cameras, two force platforms) was utilized to obtain gait kinetic and kinematic variables, as well as pistoning within the prosthetic socket. The gait deviation index was also calculated based on the kinematic data. The findings indicated significant difference in the pistoning values among the three suspension systems. The Seal-In system resulted in the least pistoning compared with the other two systems. Several kinetic and kinematic variables were also affected by the suspension type. The ground reaction force data showed that lower load was applied to the limb joints with the magnetic suspension system compared with the pin/lock suspension. The gait deviation index showed significant deviation from the normal with all the systems, but the systems did not differ significantly. Main significant effects of the suspension type were seen in the GRF (vertical and fore-aft), knee and ankle angles. The new magnetic suspension system showed comparable effects in the remaining kinetic and kinematic gait parameters to the other studied systems. This study may have implications on the selection of suspension systems for transtibial prostheses.	[Eshraghi, Arezoo] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia; [Abu Osman, Noor Azuan; Gholizadeh, Hossein; Abas, Wan Abu Bakar Wan] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia; [Karimi, Mohammad] Isfahan Univ Med Sci, Dept Orthot & Prosthet, Esfahan, Iran; [Soodmand, Ehsan] Tech Univ Chemnitz, Dept Human Locomot, D-09111 Chemnitz, Germany	Universiti Malaya; Universiti Malaya; Isfahan University Medical Science; Technische Universitat Chemnitz	Eshraghi, A (corresponding author), Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia.	arezooeshraghi@yahoo.ca	ABU OSMAN, NOOR AZUAN/B-9265-2010; Gholizadeh, Hossein/G-4838-2010; Karimi, Mohammad Taghi/AFQ-0990-2022; Soodmand, Ehsan/H-5820-2017	ABU OSMAN, NOOR AZUAN/0000-0002-2853-4421; Gholizadeh, Hossein/0000-0001-5847-7985; Karimi, Mohammad Taghi/0000-0001-6162-8131; Eshraghi, Arezoo/0000-0002-1525-8093; Soodmand, Ehsan/0000-0002-4409-7663	Malaysia UM/MOHE/HIR [D000014-16001]; FRGS [FP017-2011A]	Malaysia UM/MOHE/HIR; FRGS	This study was supported by Malaysia UM/MOHE/HIR (Project Number:D000014-16001) and FRGS grant (FP017-2011A). http://www.hir.um.edu.my/http://susci.um.edu.my/?modul=Grants&pilihan=External_Grants&subpilihan=Fundamental_Research_Grant_Scheme_(FRGS). Some of the prosthetic components were donated by Ossur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2012, CLIN BIOMECH, V27, P943, DOI 10.1016/j.clinbiomech.2012.06.004; BAKER PA, 1990, PROSTHET ORTHOT INT, V14, P80; BATENI H, 2002, J PROSTHET ORTHOT, V14, P2; Boutwell E, 2012, J REHABIL RES DEV, V49, P227, DOI 10.1682/JRRD.2010.06.0121; BREAKEY J, 1976, ORTHOTICS PROSTHET, V30, P17; CHEUNG C, 1983, PROSTHET ORTHOT INT, V7, P131; Cimolin V, 2011, RES DEV DISABIL, V32, P377, DOI 10.1016/j.ridd.2010.10.017; COLBORNE GR, 1992, AM J PHYS MED REHAB, V71, P272, DOI 10.1097/00002060-199210000-00004; Dingwell JB, 1996, PROSTHET ORTHOT INT, V20, P101; ENGSBERG JR, 1993, PROSTHET ORTHOT INT, V17, P83; Eshraghi A, 2013, CLIN BIOMECH, V28, P55, DOI 10.1016/j.clinbiomech.2012.10.002; Eshraghi A, 2012, AM J PHYS MED REHAB, V91, P1028, DOI 10.1097/PHM.0b013e318269d82a; Eshraghi A, 2012, PROSTHET ORTHOT INT, V36, P15, DOI 10.1177/0309364611431625; Farahmand F, 2006, SCI IRAN, V13, P261; Gailey R, 2008, J REHABIL RES DEV, V45, P15, DOI 10.1682/JRRD.2006.11.0147; Gholizadeh H, 2012, CLIN BIOMECH, V27, P34, DOI 10.1016/j.clinbiomech.2011.07.004; Goujon H, 2006, PROSTHET ORTHOT INT, V30, P213, DOI 10.1080/03093640600805134; Hachisuka K, 1998, ARCH PHYS MED REHAB, V79, P783, DOI 10.1016/S0003-9993(98)90356-2; Isakov E, 2000, PROSTHET ORTHOT INT, V24, P216, DOI 10.1080/03093640008726550; Kark L, 2012, GAIT POSTURE, V35, P238, DOI 10.1016/j.gaitpost.2011.09.013; KRISTINSSON O, 1993, PROSTHET ORTHOT INT, V17, P49, DOI 10.3109/03093649309164354; LEMAIRE ED, 1994, ARCH PHYS MED REHAB, V75, P1094, DOI 10.1016/0003-9993(94)90084-1; Meier, 1991, J PROSTHET ORTHOT, V3, P150; Melzer I, 2001, J RHEUMATOL, V28, P169; Narita H, 1997, PROSTHET ORTHOT INT, V21, P175; Nolan L, 2000, PROSTHET ORTHOT INT, V24, P117, DOI 10.1080/03093640008726534; Schmalz T, 2002, GAIT POSTURE, V16, P255, DOI 10.1016/S0966-6362(02)00008-5; Schwartz MH, 2008, GAIT POSTURE, V28, P351, DOI 10.1016/j.gaitpost.2008.05.001; Silverman AK, 2008, GAIT POSTURE, V28, P602, DOI 10.1016/j.gaitpost.2008.04.005; SKINNER HB, 1985, AM J PHYS MED REHAB, V64, P82; Smidt GL, 1990, GAIT REHABILITATION; Stergiou N, 2002, CLIN BIOMECH, V17, P615, DOI 10.1016/S0268-0033(02)00072-4; Supan T., 2010, J PROSTHET ORTHOT, V22, P43; TORBURN L, 1990, Journal of Rehabilitation Research and Development, V27, P369; van der Linden ML, 1999, J BIOMECH, V32, P877, DOI 10.1016/S0021-9290(99)00086-X; Vanicek N, 2009, GAIT POSTURE, V29, P415, DOI 10.1016/j.gaitpost.2008.10.062; WINTER DA, 1988, J BIOMECH, V21, P361, DOI 10.1016/0021-9290(88)90142-X; Winter DA., 1987, BIOMECHANICS MOTOR C; Yigiter K, 2002, PROSTHET ORTHOT INT, V26, P206, DOI 10.1080/03093640208726649; Zmitrewicz RJ, 2006, ARCH PHYS MED REHAB, V87, P1334, DOI 10.1016/j.apmr.2006.06.013	40	15	16	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e96988	10.1371/journal.pone.0096988	http://dx.doi.org/10.1371/journal.pone.0096988			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865351	Green Published, Green Submitted, gold			2022-12-25	WOS:000336914100008
J	Harada-Hada, K; Harada, K; Kato, F; Hisatsune, J; Tanida, I; Ogawa, M; Asano, S; Sugai, M; Hirata, M; Kanematsu, T				Harada-Hada, Kae; Harada, Kana; Kato, Fuminori; Hisatsune, Junzo; Tanida, Isei; Ogawa, Michinaga; Asano, Satoshi; Sugai, Motoyuki; Hirata, Masato; Kanematsu, Takashi			Phospholipase C-Related Catalytically Inactive Protein Participates in the Autophagic Elimination of Staphylococcus aureus Infecting Mouse Embryonic Fibroblasts	PLOS ONE			English	Article							INS(1,4,5)P-3 BINDING-PROTEIN; GABA(A) RECEPTOR; BACTERIAL PATHOGENS; SURFACE EXPRESSION; CELL-SURFACE; P130; PRIP; INHIBITION; MODULATION; MATURATION	Autophagy is an intrinsic host defense system that recognizes and eliminates invading bacterial pathogens. We have identified microtubule-associated protein 1 light chain 3 (LC3), a hallmark of autophagy, as a binding partner of phospholipase C-related catalytically inactive protein (PRIP) that was originally identified as an inositol trisphosphate-binding protein. Here, we investigated the involvement of PRIP in the autophagic elimination of Staphylococcus aureus in infected mouse embryonic fibroblasts (MEFs). We observed significantly more LC3-positive autophagosome-like vacuoles enclosing an increased number of S. aureus cells in PRIP-deficient MEFs than control MEFs, 3 h and 4.5 h post infection, suggesting that S. aureus proliferates in LC3-positive autophagosome-like vacuoles in PRIP-deficient MEFs. We performed autophagic flux analysis using an mRFP-GFP-tagged LC3 plasmid and found that autophagosome maturation is significantly inhibited in PRIP-deficient MEFs. Furthermore, acidification of autophagosomes was significantly inhibited in PRIP-deficient MEFs compared to the wild-type MEFs, as determined by LysoTracker staining and time-lapse image analysis performed using mRFP-GFP-tagged LC3. Taken together, our data show that PRIP is required for the fusion of S. aureus-containing autophagosome-like vacuoles with lysosomes, indicating that PRIP is a novel modulator in the regulation of the innate immune system in non-professional phagocytic host cells.	[Harada-Hada, Kae; Harada, Kana; Asano, Satoshi; Kanematsu, Takashi] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Cellular & Mol Pharmacol, Hiroshima, Japan; [Kato, Fuminori; Hisatsune, Junzo; Sugai, Motoyuki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Bacteriol, Hiroshima, Japan; [Tanida, Isei] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Tokyo, Japan; [Ogawa, Michinaga] Natl Inst Infect Dis, Dept Bacteriol 1, Tokyo, Japan; [Hirata, Masato] Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka 812, Japan	Hiroshima University; Hiroshima University; National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Kyushu University	Kanematsu, T (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Cellular & Mol Pharmacol, Hiroshima, Japan.	tkanema2@hiroshima-u.ac.jp	Asano, Satoshi/AAQ-3817-2020; Harada, Kae/AAT-1162-2020; Kato, Fuminori/V-2948-2017	Harada, Kae/0000-0001-7620-9212; Kato, Fuminori/0000-0001-8177-1728; Asano, Satoshi/0000-0003-1537-4307; Tanida, Isei/0000-0001-8999-3990	Funding Program for Next Generation World-Leading Researchers [LS087]; JSPS KAKENHI [25861757, 25861756]; Grants-in-Aid for Scientific Research [25460533, 26670809, 25861757] Funding Source: KAKEN	Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by funding from the Funding Program for Next Generation World-Leading Researchers (LS087) to T. K., and by JSPS KAKENHI (Grant No. 25861757 to K. H-H., Grant No. 25861756 to S. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Chen DD, 2012, MOL CELL, V45, P629, DOI 10.1016/j.molcel.2011.12.036; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Fujii M, 2010, J BIOL CHEM, V285, P4837, DOI 10.1074/jbc.M109.070045; Gao J, 2012, J BIOL CHEM, V287, P10565, DOI 10.1074/jbc.M111.294645; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Hansen TE, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-39; Harada K, 2005, J CELL PHYSIOL, V202, P422, DOI 10.1002/jcp.20136; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Huang J, 2007, CELL CYCLE, V6, P1837, DOI 10.4161/cc.6.15.4511; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanematsu T, 1996, BIOCHEM J, V313, P319, DOI 10.1042/bj3130319; KANEMATSU T, 1992, J BIOL CHEM, V267, P6518; Kanematsu T, 2000, EUR J BIOCHEM, V267, P2731, DOI 10.1046/j.1432-1327.2000.01291.x; Kanematsu T, 2002, EMBO J, V21, P1004, DOI 10.1093/emboj/21.5.1004; Kanematsu T, 2007, J NEUROCHEM, V101, P898, DOI 10.1111/j.1471-4159.2006.04399.x; Kanematsu T, 2007, J PHARMACOL SCI, V104, P285, DOI 10.1254/jphs.CP0070063; Kanematsu T, 2006, J BIOL CHEM, V281, P22180, DOI 10.1074/jbc.M603118200; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Krut O, 2003, INFECT IMMUN, V71, P2716, DOI 10.1128/IAI.71.5.2716-2723.2003; Lerena MC, 2010, CELL MICROBIOL, V12, P10, DOI 10.1111/j.1462-5822.2009.01403.x; Mauthe Mario, 2012, Int J Cell Biol, V2012, P179207, DOI 10.1155/2012/179207; Mizokami A, 2007, J NEUROSCI, V27, P1692, DOI 10.1523/JNEUROSCI.3155-06.2007; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Ogawa M, 2011, CELL HOST MICROBE, V9, P376, DOI 10.1016/j.chom.2011.04.010; Orsi A, 2010, CURR OPIN CELL BIOL, V22, P150, DOI 10.1016/j.ceb.2009.11.013; Otsuki M, 1999, BIOCHEM BIOPH RES CO, V266, P97, DOI 10.1006/bbrc.1999.1784; Schnaith A, 2007, J BIOL CHEM, V282, P2695, DOI 10.1074/jbc.M609784200; Sugiyama G, 2012, BIOCHEMISTRY-US, V51, P3394, DOI 10.1021/bi2018128; Takeuchi H, 2000, BIOCHEM J, V349, P357, DOI 10.1042/0264-6021:3490357; Tattoli I, 2013, EMBO J, V32, P3066, DOI 10.1038/emboj.2013.234; Terunuma M, 2004, J NEUROSCI, V24, P7074, DOI 10.1523/JNEUROSCI.1323-04.2004; Uji A, 2002, LIFE SCI, V72, P443, DOI 10.1016/S0024-3205(02)02275-0; Umebayashi H, 2013, BIOCHEM BIOPH RES CO, V432, P268, DOI 10.1016/j.bbrc.2013.01.119; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Yamaguchi H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000670; Yanagihori S, 2006, ADV ENZYME REGUL, V46, P203, DOI 10.1016/j.advenzreg.2006.01.006; YOSHIDA M, 1994, J BIOCHEM, V115, P973, DOI 10.1093/oxfordjournals.jbchem.a124447; Yoshimura K, 2001, J BIOL CHEM, V276, P17908, DOI 10.1074/jbc.M009677200; Zhang Z, 2013, J BIOL CHEM, V288, P7769, DOI 10.1074/jbc.M112.419317	45	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98285	10.1371/journal.pone.0098285	http://dx.doi.org/10.1371/journal.pone.0098285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865216	gold, Green Published, Green Submitted			2022-12-25	WOS:000336914100047
J	Botto, L; Cunati, D; Coco, S; Sesana, S; Bulbarelli, A; Biasini, E; Colombo, L; Negro, A; Chiesa, R; Masserini, M; Palestini, P				Botto, Laura; Cunati, Diana; Coco, Silvia; Sesana, Silvia; Bulbarelli, Alessandra; Biasini, Emiliano; Colombo, Laura; Negro, Alessandro; Chiesa, Roberto; Masserini, Massimo; Palestini, Paola			Role of Lipid Rafts and GM1 in the Segregation and Processing of Prion Protein	PLOS ONE			English	Article							INFECTED NEUROBLASTOMA-CELLS; RESISTANT MEMBRANE DOMAINS; CEREBELLAR GRANULE CELLS; ENRICHED DOMAINS; CULTURED NEURONS; GANGLIOSIDE GM1; CHOLERA-TOXIN; SURFACE; PRP; PH	The prion protein (PrPC) is highly expressed within the nervous system. Similar to other GPI-anchored proteins, PrPC is found in lipid rafts, membrane domains enriched in cholesterol and sphingolipids. PrPC raft association, together with raft lipid composition, appears essential for the conversion of PrPC into the scrapie isoform PrPSc, and the development of prion disease. Controversial findings were reported on the nature of PrPC-containing rafts, as well as on the distribution of PrPC between rafts and non-raft membranes. We investigated PrPC/ganglioside relationships and their influence on PrPC localization in a neuronal cellular model, cerebellar granule cells. Our findings argue that in these cells at least two PrPC conformations coexist: in lipid rafts PrPC is present in the native folding (alpha-helical), stabilized by chemico-physical condition, while it is mainly present in other membrane compartments in a PrPSc-like conformation. We verified, by means of antibody reactivity and circular dichroism spectroscopy, that changes in lipid raft-ganglioside content alters PrPC conformation and interaction with lipid bilayers, without modifying PrPC distribution or cleavage. Our data provide new insights into the cellular mechanism of prion conversion and suggest that GM1-prion protein interaction at the cell surface could play a significant role in the mechanism predisposing to pathology.	[Botto, Laura; Cunati, Diana; Coco, Silvia; Sesana, Silvia; Bulbarelli, Alessandra; Masserini, Massimo; Palestini, Paola] Univ Milano Bicocca, Sch Med, Dept Hlth Sci, Monza, Italy; [Biasini, Emiliano; Chiesa, Roberto] IRCCS Ist Ric Farmacol Mario Negri, Dept Neurosci, Milan, Italy; [Colombo, Laura] IRCCS Ist Ric Farmacol Mario Negri, Dept Mol Biochem & Pharmacol, Milan, Italy; [Negro, Alessandro] Univ Padua, Dept Biomed Sci, Padua, Italy	University of Milano-Bicocca; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Padua	Botto, L (corresponding author), Univ Milano Bicocca, Sch Med, Dept Hlth Sci, Monza, Italy.	laura.botto@unimib.it	Coco, Silvia/AAD-6719-2022; colombo, laura/AAA-6716-2020; Chiesa, Roberto/G-1561-2017; Palestini, PAOLA/AAD-9376-2019; Biasini, Emiliano/A-3147-2011	colombo, laura/0000-0002-3243-0270; Chiesa, Roberto/0000-0002-3842-3733; Palestini, PAOLA/0000-0002-1045-8838; Biasini, Emiliano/0000-0002-3927-6341; COCO, SILVIA/0000-0002-3883-9472; NEGRO, ALESSANDRO/0000-0003-3142-7632	MIUR (Rome, Italy) [200833SZ2F]; FAR	MIUR (Rome, Italy)(Ministry of Education, Universities and Research (MIUR)); FAR	This investigation was supported by grants from MIUR (Rome, Italy) Prin 2008 (prot. 200833SZ2F) and FAR 60% 2010-2011 to PP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Alonso DOV, 2002, PHILOS T R SOC A, V360, P1165, DOI 10.1098/rsta.2002.0986; Altmeppen Hermann C, 2012, Am J Neurodegener Dis, V1, P15; Bate C, 2004, J BIOL CHEM, V279, P14983, DOI 10.1074/jbc.M313061200; Biasini E, 2012, TRENDS NEUROSCI, V35, P92, DOI 10.1016/j.tins.2011.10.002; Biljan I, 2012, BIOCHEMISTRY-US, V51, P7465, DOI 10.1021/bi3009856; Botto L, 2007, J NEUROSCI RES, V85, P443, DOI 10.1002/jnr.21111; Botto L, 2004, FEBS LETT, V557, P143, DOI 10.1016/S0014-5793(03)01463-7; BREMER EG, 1984, J BIOL CHEM, V259, P6818; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Campana V, 2006, J CELL SCI, V119, P433, DOI 10.1242/jcs.02768; Campana V, 2005, TRENDS CELL BIOL, V15, P102, DOI 10.1016/j.tcb.2004.12.002; Cancellotti E, 2013, EMBO J, V32, P756, DOI 10.1038/emboj.2013.6; Castilla J, 2011, CHEM BIOL, V18, P1345, DOI 10.1016/j.chembiol.2011.11.002; Chigorno V, 2000, EUR J BIOCHEM, V267, P4187, DOI 10.1046/j.1432-1327.2000.01454.x; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; Cordes H, 2008, J IMMUNOL METHODS, V337, P106, DOI 10.1016/j.jim.2008.07.004; Daffara R, 2004, J APPL PHYSIOL, V97, P1575, DOI 10.1152/japplphysiol.00236.2004; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Eckert GP, 2003, BRAIN RES, V962, P144, DOI 10.1016/S0006-8993(02)03986-0; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Endres K, 2009, NEUROBIOL DIS, V36, P233, DOI 10.1016/j.nbd.2009.07.015; Farina F, 2009, J NEUROCHEM, V110, P1038, DOI 10.1111/j.1471-4159.2009.06198.x; Garcia FL, 2000, P NATL ACAD SCI USA, V97, P8334, DOI 10.1073/pnas.97.15.8334; GHIDONI R, 1981, J LIPID RES, V22, P1286; GHIDONI R, 1989, J NEUROCHEM, V53, P1567, DOI 10.1111/j.1471-4159.1989.tb08553.x; Gilch S, 2006, MOL CELL NEUROSCI, V31, P346, DOI 10.1016/j.mcn.2005.10.008; GONATAS NK, 1983, MOL CELL BIOL, V3, P91, DOI 10.1128/MCB.3.1.91; Goold R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1282; Harrison PM, 1997, CURR OPIN STRUC BIOL, V7, P53, DOI 10.1016/S0959-440X(97)80007-3; Hooper NM, 2005, BIOCHEM SOC T, V33, P335, DOI 10.1042/BST0330335; Hornemann S, 1998, P NATL ACAD SCI USA, V95, P6010, DOI 10.1073/pnas.95.11.6010; Jeong JK, 2012, INT J MOL MED, V29, P387, DOI 10.3892/ijmm.2011.864; JOSEPH KC, 1979, J CELL BIOL, V81, P543, DOI 10.1083/jcb.81.3.543; Kakio A, 2003, BIOCHEM BIOPH RES CO, V303, P514, DOI 10.1016/S0006-291X(03)00386-3; Khan MQ, 2010, P NATL ACAD SCI USA, V107, P19808, DOI 10.1073/pnas.1005267107; Korth C, 1999, METHOD ENZYMOL, V309, P106; Kubota T, 2012, J BIOL CHEM, V287, P14023, DOI 10.1074/jbc.M111.318352; Kupfer L, 2009, CURR MOL MED, V9, P826, DOI 10.2174/156652409789105543; Laffont-Proust I, 2005, FEBS LETT, V579, P6333, DOI 10.1016/j.febslet.2005.10.013; Lagerholm BC, 2005, ANNU REV PHYS CHEM, V56, P309, DOI 10.1146/annurev.physchem.56.092503.141211; Lewis V, 2011, FRONT BIOSCI-LANDMRK, V16, P151, DOI 10.2741/3681; Li CM, 2012, J BIOL CHEM, V287, P42784, DOI 10.1074/jbc.M112.410936; Marella M, 2002, J BIOL CHEM, V277, P25457, DOI 10.1074/jbc.M203248200; Matsuzaki K, 1999, BIOCHEMISTRY-US, V38, P4137, DOI 10.1021/bi982345o; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Moore MK, 2000, ANAL BIOCHEM, V279, P241, DOI 10.1006/abio.2000.4482; Morris RJ, 2006, FEBS LETT, V580, P5565, DOI 10.1016/j.febslet.2006.07.053; MUTOH T, 1995, P NATL ACAD SCI USA, V92, P5087, DOI 10.1073/pnas.92.11.5087; Naslavsky N, 1999, J BIOL CHEM, V274, P20763, DOI 10.1074/jbc.274.30.20763; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Palestini P, 1998, BIOCHEMISTRY-US, V37, P3143, DOI 10.1021/bi971838a; Palestini P, 2000, J BIOL CHEM, V275, P9978, DOI 10.1074/jbc.275.14.9978; Prinetti A, 2000, J BIOL CHEM, V275, P11658, DOI 10.1074/jbc.275.16.11658; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Re F, 2008, FEBS LETT, V582, P215, DOI 10.1016/j.febslet.2007.12.003; Riesner D, 2003, BRIT MED BULL, V66, P21, DOI 10.1093/bmb/66.1.21; Sanghera N, 2011, CHEM BIOL, V18, P1422, DOI 10.1016/j.chembiol.2011.08.016; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons M, 1999, MOL BIOL CELL, V10, P3187, DOI 10.1091/mbc.10.10.3187; Swietnicki W, 2000, BIOCHEMISTRY-US, V39, P424, DOI 10.1021/bi991967m; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; TETTAMAN.G, 1973, BIOCHIM BIOPHYS ACTA, V296, P160, DOI 10.1016/0005-2760(73)90055-6; Vila-Vicosa D, 2012, J PHYS CHEM B, V116, P8812, DOI 10.1021/jp3034837; Vincent B, 2008, CURR ALZHEIMER RES, V5, P202, DOI 10.2174/156720508783954749; Walmsley AR, 2009, MOL CELL NEUROSCI, V40, P242, DOI 10.1016/j.mcn.2008.10.012; Yamasaki T, 2012, J GEN VIROL, V93, P668, DOI 10.1099/vir.0.037101-0; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6; Zhang H, 1997, BIOCHEMISTRY-US, V36, P3543, DOI 10.1021/bi961965r; Zou WQ, 2002, J BIOL CHEM, V277, P43942, DOI 10.1074/jbc.M203611200; Zulianello L, 2000, J VIROL, V74, P4351, DOI 10.1128/JVI.74.9.4351-4360.2000	72	34	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98344	10.1371/journal.pone.0098344	http://dx.doi.org/10.1371/journal.pone.0098344			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859148	Green Published, Green Submitted, gold			2022-12-25	WOS:000336839400068
J	Zhang, KW; Liu, HH; Tao, PL; Chen, H				Zhang, Kewei; Liu, Hanhan; Tao, Peilin; Chen, Huan			Comparative Proteomic Analyses Provide New Insights into Low Phosphorus Stress Responses in Maize Leaves	PLOS ONE			English	Article							GLYCINEBETAINE SYNTHESIS; TRANSCRIPTOMIC ANALYSIS; PHOSPHATE DEFICIENCY; ARABIDOPSIS ROOTS; HYDROGEN-PEROXIDE; METABOLIC-CHANGES; SUSPENSION CELLS; RICE LEAVES; PHOTOSYNTHESIS; PLANTS	Phosphorus deficiency limits plant growth and development. To better understand the mechanisms behind how maize responds to phosphate stress, we compared the proteome analysis results of two groups of maize leaves that were treated separately with 1,000 mu M (control, +P) and 5 mu M of KH2PO4 (intervention group, -P) for 25 days. In total, 1,342 protein spots were detected on 2-DE maps and 15.43% had changed (P < 0.05; >= 1.5-fold) significantly in quantity between the +P and -P groups. These proteins are involved in several major metabolic pathways, including photosynthesis, carbohydrate metabolism, energy metabolism, secondary metabolism, signal transduction, protein synthesis, cell rescue and cell defense and virulence. The results showed that the reduction in photosynthesis under low phosphorus treatment was due to the down-regulation of the proteins involved in CO2 enrichment, the Calvin cycle and the electron transport system. Electron transport and photosynthesis restrictions resulted in a large accumulation of peroxides. Maize has developed many different reactive oxygen species (ROS) scavenging mechanisms to cope with low phosphorus stress, including up-regulating its antioxidant content and antioxidase activity. After being subjected to phosphorus stress over a long period, maize may increase its internal phosphorus utilization efficiency by altering photorespiration, starch synthesis and lipid composition. These results provide important information about how maize responds to low phosphorus stress.	[Zhang, Kewei; Liu, Hanhan; Chen, Huan] Shandong Univ, Sch Life Sci, Minist Educ, Key Lab Plant Cell Engn & Germplasm Enhancement, Jinan 250100, Peoples R China; [Tao, Peilin] Xuzhou Biol Engn Tech Coll, Coll Agr Vocat, Xuzhou, Peoples R China	Shandong University	Zhang, KW (corresponding author), Shandong Univ, Sch Life Sci, Minist Educ, Key Lab Plant Cell Engn & Germplasm Enhancement, Jinan 250100, Peoples R China.	zhangkw@sdu.edu.cn	zhang, ke/AAH-8217-2019		National Natural Science Foundation of China [31172028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (31172028) (http://isisn.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquadro A, 2009, ELECTROPHORESIS, V30, P1594, DOI 10.1002/elps.200800549; Alexova R, 2013, PROTEOMICS, V13, P609, DOI 10.1002/pmic.201200266; Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Aryal UK, 2012, J PROTEOME RES, V11, P425, DOI 10.1021/pr200917t; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Baker NR, 1992, CROP PHOTOSYNTHESIS, P289; Bozzo GG, 2006, PLANT CELL ENVIRON, V29, P303, DOI 10.1111/j.1365-3040.2005.01422.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calderon-Vazquez C, 2008, J EXP BOT, V59, P2479, DOI 10.1093/jxb/ern115; Chen ZJ, 2011, PROTEOMICS, V11, P4648, DOI 10.1002/pmic.201100231; Cordell D, 2011, CHEMOSPHERE, V84, P77; Cummins I, 1999, PLANT J, V18, P285, DOI 10.1046/j.1365-313X.1999.00452.x; DemmigAdams B, 1996, PHYSIOL PLANTARUM, V98, P253, DOI 10.1034/j.1399-3054.1996.980206.x; Fan GH, 2005, MODERN INSTRUMENTS, V3, P34; Fontecave M, 2004, TRENDS BIOCHEM SCI, V29, P243, DOI 10.1016/j.tibs.2004.03.007; FOYER C, 1986, PLANTA, V167, P369, DOI 10.1007/BF00391341; Grundy FJ, 2004, CURR OPIN MICROBIOL, V7, P126, DOI 10.1016/j.mib.2004.02.013; Hammond JP, 2008, J EXP BOT, V59, P93, DOI 10.1093/jxb/erm221; Hammond JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024606; Hammond JP, 2004, ANN BOT-LONDON, V94, P323, DOI 10.1093/aob/mch156; Henkes S, 2001, PLANT CELL, V13, P535, DOI 10.1105/tpc.13.3.535; Hernandez G, 2007, PLANT PHYSIOL, V144, P752, DOI 10.1104/pp.107.096958; Igarashi D, 2003, PLANT J, V33, P975, DOI 10.1046/j.1365-313X.2003.01688.x; JACOB J, 1992, PLANT PHYSIOL, V98, P801, DOI 10.1104/pp.98.3.801; Katam R, 2010, J PROTEOME RES, V9, P2236, DOI 10.1021/pr901009n; Kern J, 2009, ADV PHOTOSYNTH RESP, V30, P203; Kim SG, 2011, J KOREAN SOC APPL BI, V54, P667, DOI 10.3839/jksabc.2011.102; Kim ST, 2001, ELECTROPHORESIS, V22, P2103, DOI 10.1002/1522-2683(200106)22:10&lt;2103::AID-ELPS2103&gt;3.0.CO;2-W; Lan P, 2012, MOL CELL PROTEOMICS, V11, P1156, DOI 10.1074/mcp.M112.020461; Lee SK, 2008, PLANT CELL ENVIRON, V31, P1851, DOI 10.1111/j.1365-3040.2008.01890.x; Li KP, 2008, PLANT J, V55, P927, DOI 10.1111/j.1365-313X.2008.03561.x; Li KP, 2007, PROTEOMICS, V7, P1501, DOI 10.1002/pmic.200600960; Li KP, 2007, PLANT SCI, V172, P255, DOI 10.1016/j.plantsci.2006.09.004; Li KP, 2011, GENE, V485, P106, DOI 10.1016/j.gene.2011.06.016; Li LH, 2010, CHINESE SCI BULL, V55, P251, DOI 10.1007/s11434-010-0012-y; Lin WY, 2009, J EXP BOT, V60, P1427, DOI 10.1093/jxb/ern303; Lutts S., 2013, ECOPHYSIOLOGY RESPON, P315, DOI [DOI 10.1007/978-1-4614-4747-4_12, 10.1007/978-1-4614-4747-4_12]; Lv S, 2007, MOL BREEDING, V20, P233, DOI 10.1007/s11032-007-9086-x; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Morcuende R, 2007, PLANT CELL ENVIRON, V30, P85, DOI 10.1111/j.1365-3040.2006.01608.x; Mouillon JM, 1999, PLANT J, V20, P197, DOI 10.1046/j.1365-313x.1999.00591.x; MUKHERJEE SP, 1983, PHYSIOL PLANTARUM, V58, P166, DOI 10.1111/j.1399-3054.1983.tb04162.x; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Portis AR, 2003, PHOTOSYNTH RES, V75, P11, DOI 10.1023/A:1022458108678; PREISS J, 1984, TRENDS BIOCHEM SCI, V9, P24, DOI 10.1016/0968-0004(84)90043-4; Quan RD, 2004, PLANT SCI, V166, P141, DOI 10.1016/j.plantsci.2003.08.018; RAO IM, 1989, PLANT PHYSIOL, V90, P814, DOI 10.1104/pp.90.3.814; Reich PB, 2009, OECOLOGIA, V160, P207, DOI 10.1007/s00442-009-1291-3; Sairam RK, 2002, PLANT SCI, V162, P897, DOI 10.1016/S0168-9452(02)00037-7; Sawada S, 2003, PLANT CELL PHYSIOL, V44, P190, DOI 10.1093/pcp/pcg024; Shanghai Plant Physiology Association, 1999, HDB PLANT PHYS EXP, P126; Shimojima M, 2011, PROG LIPID RES, V50, P234, DOI 10.1016/j.plipres.2011.02.003; SINGH P, 1986, PHYSIOL PLANTARUM, V66, P169, DOI 10.1111/j.1399-3054.1986.tb01252.x; Suriyagoda LDB, 2010, FUNCT PLANT BIOL, V37, P713, DOI 10.1071/FP09284; Torabi S, 2009, PROTEOMICS, V9, P159, DOI 10.1002/pmic.200800350; Tran HT, 2008, PROTEOMICS, V8, P4317, DOI 10.1002/pmic.200800292; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Wang A. G., 1990, PLANT PHYSL COMMUN, V6, P55, DOI DOI 10.1021/ja00874a010; Wang DF, 2008, PLANT PHYSIOL, V148, P557, DOI 10.1104/pp.108.120709; Wang LS, 2012, PLANT CELL PHYSIOL, V53, P1093, DOI 10.1093/pcp/pcs072; Wasaki J, 2006, J EXP BOT, V57, P2049, DOI 10.1093/jxb/erj158; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Wissuwa M, 2005, J EXP BOT, V56, P1943, DOI 10.1093/jxb/eri189; Wu P, 2003, PLANT PHYSIOL, V132, P1260, DOI 10.1104/pp.103.021022; Yan SP, 2006, MOL CELL PROTEOMICS, V5, P484, DOI 10.1074/mcp.M500251-MCP200; Yao YA, 2011, PLANTA, V233, P523, DOI 10.1007/s00425-010-1311-x; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P1159, DOI 10.1073/pnas.0308215100; Zhang HW, 2009, PLANT SOIL, V320, P91, DOI 10.1007/s11104-008-9873-0; Zhao CF, 2005, PROTEOMICS, V5, P961, DOI 10.1002/pmic.200401131	73	95	97	4	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98215	10.1371/journal.pone.0098215	http://dx.doi.org/10.1371/journal.pone.0098215			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858307	Green Published, Green Submitted, gold			2022-12-25	WOS:000336839400057
J	Zhu, M; Li, MY; Zhang, F; Feng, F; Chen, WH; Yang, YT; Cui, JJ; Zhang, D; Linghu, EQ				Zhu, Min; Li, Mingyang; Zhang, Fan; Feng, Fan; Chen, Weihao; Yang, Yutao; Cui, Jiajun; Zhang, Dong; Linghu, Enqiang			FBI-1 Enhances ETS-1 Signaling Activity and Promotes Proliferation of Human Colorectal Carcinoma Cells	PLOS ONE			English	Article							HUMAN BREAST-CARCINOMA; TRANSCRIPTION FACTOR; REPRESSES TRANSCRIPTION; CANCER; PROTOONCOGENE; EXPRESSION; OVEREXPRESSION; POKEMON; GROWTH; GENE	In this study, we investigated a potential regulatory role of FBI-1 in transcription factor activity of ETS-1. The protein interaction was identified between ETS-1 and FBI-1 in lovo cells. The accumulating data showed that FBI-1 promoted the recruitment of ETS-1 to endogenous promoter of its target genes and increase ETS-1 accumulation in the nuclear. Our work also indicated that the FBI-1 enhances ETS-1 transcription factor activity via down-regulating p53-mediated inhibition on ETS-1. Further, FBI-1 plays a role in regulation of colorectal carcinoma cells proliferation. These findings supported that FBI-1 might be a potential molecule target for treating colorectal carcinoma.	[Zhu, Min; Zhang, Dong] Chinese Peoples Liberat Army Gen Hosp, Nan Lou Div, Dept Oncol, Beijing, Peoples R China; [Li, Mingyang] Chinese Peoples Liberat Army Gen Hosp, Nan Lou Div, Dept Gastroenterol, Beijing, Peoples R China; [Zhang, Fan] Chinese Peoples Liberat Army Gen Hosp, Tumor Ctr, Beijing, Peoples R China; [Feng, Fan] Shenyang Mil Command, Gen Hosp, Dept Pharm, Shenyang, Peoples R China; [Chen, Weihao] Chinese Peoples Liberat Army Gen Hosp, Dept Urol, Beijing, Peoples R China; [Yang, Yutao] Capital Med Univ, Beijing Inst Neurosci, Beijing, Peoples R China; [Cui, Jiajun] Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH USA; [Linghu, Enqiang] Chinese Peoples Liberat Army Gen Hosp, Dept Gastroenterol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Capital Medical University; Chinese Academy of Sciences; University System of Ohio; University of Cincinnati; Chinese People's Liberation Army General Hospital	Zhang, D (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Nan Lou Div, Dept Oncol, Beijing, Peoples R China.	zhangd1117@yahoo.com; 13341088278@126.com		Zhang, Fan/0000-0001-6798-2422	Roche's Scientific Corporation Program [03YH606]; Research Fund of Ministry of Public Health [WKJ2006-3-007]	Roche's Scientific Corporation Program; Research Fund of Ministry of Public Health	This work was supported by Roche's Scientific Corporation Program (03YH606), Research Fund of Ministry of Public Health (WKJ2006-3-007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2010, EXP MOL PATHOL, V89, P140, DOI 10.1016/j.yexmp.2010.05.002; Al-Azawi D, 2008, ONCOGENE, V27, P3021, DOI 10.1038/sj.onc.1210964; Alipov G, 2005, HISTOPATHOLOGY, V46, P202, DOI 10.1111/j.1365-2559.2005.02059.x; Behrens P, 2001, INT J MOL MED, V8, P149; Behrens P, 2001, J PATHOL, P19443; Buggy Y, 2004, BRIT J CANCER, V91, P1308, DOI 10.1038/sj.bjc.6602128; Chabottaux V, 2007, CLIN EXP METASTAS, V24, P647, DOI 10.1007/s10585-007-9113-7; Choi WI, 2008, J BIOL CHEM, V283, P29341, DOI 10.1074/jbc.M802477200; Choi WI, 2009, J BIOL CHEM, V284, P12633, DOI 10.1074/jbc.M809794200; Cui JJ, 2011, CELL MOL LIFE SCI, V68, P1091, DOI 10.1007/s00018-010-0511-7; Cui JJ, 2010, MOL BIOL REP, V37, P1627, DOI 10.1007/s11033-009-9575-6; Derer S, 2012, NEOPLASIA, V14, P190, DOI 10.1593/neo.111636; Fang F, 2012, CANCER-AM CANCER SOC, V118, P134, DOI 10.1002/cncr.26251; Jeon BN, 2008, J BIOL CHEM, V283, P33199, DOI 10.1074/jbc.M802935200; Katayama S, 2005, HISTOL HISTOPATHOL, V20, P119, DOI 10.14670/HH-20.119; Lee DK, 2005, J BIOL CHEM, V280, P27783, DOI 10.1074/jbc.M504909200; Lin J, 2009, INT J BIOCHEM CELL B, V41, P1613, DOI 10.1016/j.biocel.2009.02.007; Maeda T, 2005, CANCER RES, V65, P8575, DOI 10.1158/0008-5472.CAN-05-1055; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Mishra DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045308; Myers E, 2005, CLIN CANCER RES, V11, P2111, DOI 10.1158/1078-0432.CCR-04-1192; Qin X, 2008, CELL MOL LIFE SCI, V65, P2752, DOI 10.1007/s00018-008-8273-1; Saeki H, 2002, INT J CANCER, V98, P8, DOI 10.1002/ijc.10163; Shi HJ, 2012, PATHOLOGY, V44, P506, DOI 10.1097/PAT.0b013e3283559cbe; Span PN, 2002, ONCOGENE, V21, P8506, DOI 10.1038/sj.onc.1206040; Swierczewski A, 2012, GINEKOL POL, V83, P439; Waaler J, 2012, CANCER RES, V72, P2822, DOI 10.1158/0008-5472.CAN-11-3336; Yeon HP, 2002, BIOCHEM BIOPH RES CO, V377, P389; Zhang F, 2012, INT J BIOCHEM CELL B, V44, P320, DOI 10.1016/j.biocel.2011.11.002; Zheng CN, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-84	30	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98041	10.1371/journal.pone.0098041	http://dx.doi.org/10.1371/journal.pone.0098041			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24857950	Green Submitted, Green Published, gold			2022-12-25	WOS:000336839400036
J	De Minicis, S; Agostinelli, L; Rychlicki, C; Sorice, GP; Saccomanno, S; Candelaresi, C; Giaccari, A; Trozzi, L; Pierantonelli, I; Mingarelli, E; Marzioni, M; Muscogiuri, G; Gaggini, M; Benedetti, A; Gastaldelli, A; Guido, M; Svegliati-Baroni, G				De Minicis, Samuele; Agostinelli, Laura; Rychlicki, Chiara; Sorice, Gian Pio; Saccomanno, Stefania; Candelaresi, Cinzia; Giaccari, Andrea; Trozzi, Luciano; Pierantonelli, Irene; Mingarelli, Eleonora; Marzioni, Marco; Muscogiuri, Giovanna; Gaggini, Melania; Benedetti, Antonio; Gastaldelli, Amalia; Guido, Maria; Svegliati-Baroni, Gianluca			HCC Development Is Associated to Peripheral Insulin Resistance in a Mouse Model of NASH	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; HEPATOCELLULAR-CARCINOMA; METABOLIC SYNDROME; HEPATIC STEATOSIS; IN-VIVO; DISEASE; CANCER; MECHANISMS; NAFLD; INFLAMMATION	NAFLD is the most common liver disease worldwide but it is the potential evolution to NASH and eventually to hepatocellular carcinoma (HCC), even in the absence of cirrhosis, that makes NAFLD of such clinical importance. Aim: we aimed to create a mouse model reproducing the pathological spectrum of NAFLD and to investigate the role of possible co-factors in promoting HCC. Methods: mice were treated with a choline-deficient L-amino-acid-defined-diet (CDAA) or its control (CSAA diet) and subjected to a low-dose i.p. injection of CCl4 or vehicle. Insulin resistance was measured by the euglycemic-hyperinsulinemic clamp method. Steatosis, fibrosis and HCC were evaluated by histological and molecular analysis. Results: CDAA-treated mice showed peripheral insulin resistance at 1 month. At 1-3 months, extensive steatosis and fibrosis were observed in CDAA and CDAA+CCl4 groups. At 6 months, equal increase in steatosis and fibrosis was observed between the two groups, together with the appearance of tumor. At 9 months of treatment, the 100% of CDAA+CCl4 treated mice revealed tumor versus 40% of CDAA mice. Insulin-like Growth Factor-2 (IGF-2) and Osteopontin (SPP-1) were increased in CDAA mice versus CSAA. Furthermore, Immunostaining for p-AKT, p-c-Myc and Glypican-3 revealed increased positivity in the tumors. Conclusions: the CDAA model promotes the development of HCC from NAFLD-NASH in the presence of insulin resistance but in the absence of cirrhosis. Since this condition is increasingly recognized in humans, our study provides a model that may help understanding mechanisms of carcinogenesis in NAFLD.	[De Minicis, Samuele; Agostinelli, Laura; Rychlicki, Chiara; Saccomanno, Stefania; Candelaresi, Cinzia; Trozzi, Luciano; Pierantonelli, Irene; Mingarelli, Eleonora; Marzioni, Marco; Benedetti, Antonio; Svegliati-Baroni, Gianluca] Univ Politecn Marche, Dept Gastroenterol, Ancona, Italy; [Sorice, Gian Pio; Giaccari, Andrea; Muscogiuri, Giovanna] Univ Cattolica Sacro Cuore, Policlin Gemelli, Div Endocrinol & Metab Dis, Rome, Italy; [Sorice, Gian Pio] ACISMOM, Diabet Care Clin, Rome, Italy; [Giaccari, Andrea] Don Gnocchi Fdn Onlus, Milan, Italy; [Gaggini, Melania; Gastaldelli, Amalia] CNR, Inst Clin Physiol, Cardiometabol Risk Unit, I-56100 Pisa, Italy; [Guido, Maria] Univ Padua, Dept Med, Anat Pathol Unit, Padua, Italy; [Svegliati-Baroni, Gianluca] Univ Politecn Marche, Obes Ctr, Ancona, Italy	Marche Polytechnic University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Fondazione Don Carlo Gnocchi Onlus; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Padua; Marche Polytechnic University	Svegliati-Baroni, G (corresponding author), Univ Politecn Marche, Dept Gastroenterol, Ancona, Italy.	s.deminicis@yahoo.it; g.svegliati@univpm.it	pierantonelli, irene/B-4187-2014; Marzioni, Marco/A-8153-2011; Gaggini, Melania/C-9379-2017; Gastaldelli, Amalia/H-3319-2014; Muscogiuri, Giovanna/K-5817-2016; Giaccari, Andrea/AAA-7824-2022; Benedetti, Antonio/A-8189-2011	Marzioni, Marco/0000-0001-6014-6165; Gaggini, Melania/0000-0002-6311-502X; Gastaldelli, Amalia/0000-0003-2594-1651; Giaccari, Andrea/0000-0002-7462-7792; Benedetti, Antonio/0000-0003-0280-4574; Muscogiuri, Giovanna/0000-0002-8809-4931; svegliati-baroni, gianluca/0000-0003-4399-3359	European Community [HEALTH-F2-2009-241762]; MIUR [2009X84L84_003, 2009YNERCE_002, RBAP10MY35_001]; Ministero della Salute [GR-2010-2306996]	European Community(European Commission); MIUR(Ministry of Education, Universities and Research (MIUR)); Ministero della Salute(Ministry of Health, Italy)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no HEALTH-F2-2009-241762 for the project FLIP, from MIUR grant PRIN 2009 - prot. 2009X84L84_003 and Ministero della Salute grant GR-2010-2306996 to MM, from MIUR grant PRIN 2009 - prot. 2009YNERCE_002, FIRB 2010 - prot RBAP10MY35_001 to GS-B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Berasain C, 2009, ANN NY ACAD SCI, V1155, P206, DOI 10.1111/j.1749-6632.2009.03704.x; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Bugianesi E, 2005, DIABETOLOGIA, V48, P634, DOI 10.1007/s00125-005-1682-x; Burgess A, 2012, PROSTAG OTH LIPID M, V97, P1, DOI 10.1016/j.prostaglandins.2011.10.002; Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006; Chao W, 2008, CYTOKINE GROWTH F R, V19, P111, DOI 10.1016/j.cytogfr.2008.01.005; Day C P, 2005, Gastroenterology, V129, P375, DOI 10.1053/j.gastro.2005.05.041; De Minicis S, 2013, HEPATOLOGY; De Minicis S, 2012, LIVER INT; De Minicis S, 2013, CURR PHARM DESIGN, V19, P5239; Denda A, 2002, JPN J CANCER RES, V93, P125, DOI 10.1111/j.1349-7006.2002.tb01250.x; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Ferrannini E, 2012, DIABETES; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Gastaldelli A, 2001, DIABETES, V50, P1807, DOI 10.2337/diabetes.50.8.1807; Gastaldelli A, 2011, DIABETES RES CLIN PR, V93, pS60, DOI 10.1016/S0168-8227(11)70015-8; GIACCARI A, 1995, DIABETOLOGIA, V38, P518, DOI 10.1007/BF00400719; GIACCARI A, 1992, J CLIN INVEST, V89, P36, DOI 10.1172/JCI115583; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kodama Y, 2009, GASTROENTEROLOGY, V137, P1467, DOI 10.1053/j.gastro.2009.06.045; Koteish A, 2001, SEMIN LIVER DIS, V21, P89, DOI 10.1055/s-2001-12932; Kubes P, 2012, GASTROENTEROLOGY, V143, P1158, DOI 10.1053/j.gastro.2012.09.008; Lehmann R, 2013, DIABETES CARE, V36, P2331, DOI 10.2337/dc12-1760; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; Nakano T, 2011, J HEPATOL, V55, P415, DOI 10.1016/j.jhep.2010.11.028; Nobili V, 2013, J HEPATOL, V58, P1218, DOI 10.1016/j.jhep.2012.12.003; Page JM, 2009, CLIN LIVER DIS, V13, P631, DOI 10.1016/j.cld.2009.07.007; Pekow JR, 2007, CANCER-AM CANCER SOC, V109, P2490, DOI 10.1002/cncr.22701; Peyrou M, 2010, WORLD J GASTROENTERO, V16, P4627, DOI 10.3748/wjg.v16.i37.4627; Spencer MD, 2011, GASTROENTEROLOGY, V140, P976, DOI 10.1053/j.gastro.2010.11.049; Sun BC, 2012, J HEPATOL, V56, P704, DOI 10.1016/j.jhep.2011.09.020; Suzuki M, 2010, ANTICANCER RES, V30, P5055; Svegliati-Baroni G, 2007, GUT, V56, P1296, DOI 10.1136/gut.2006.107946; Svegliati-Baroni G, 2006, J HEPATOL, V44, P1158, DOI 10.1016/j.jhep.2005.10.032; Svegliati-Baroni G, 2011, LIVER INT, V31, P1285, DOI 10.1111/j.1478-3231.2011.02462.x; Svegliati-Baroni G, 2011, GUT, V60, P108, DOI 10.1136/gut.2010.219741; Szabo G, 2012, J HEPATOL, V57, P642, DOI 10.1016/j.jhep.2012.03.035; Vanni E, 2010, DIGEST LIVER DIS, V42, P320, DOI 10.1016/j.dld.2010.01.016; Vinciguerra M, 2008, ANN HEPATOL, V7, P192, DOI 10.1016/S1665-2681(19)31848-4; Wang L, 2007, MOL CELL BIOL, V27, P6497, DOI 10.1128/MCB.00679-07; Yang L, 2014, HEPATOLOGY, V59, P483, DOI 10.1002/hep.26698	50	55	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97136	10.1371/journal.pone.0097136	http://dx.doi.org/10.1371/journal.pone.0097136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24853141	gold, Green Published, Green Submitted			2022-12-25	WOS:000338323200016
J	de Renty, C; DePamphilis, ML; Ullah, Z				de Renty, Christelle; DePamphilis, Melvin L.; Ullah, Zakir			Cytoplasmic Localization of p21 Protects Trophoblast Giant Cells from DNA Damage Induced Apoptosis	PLOS ONE			English	Article							STEM-CELLS; CDK INHIBITORS; MICE LACKING; CYCLE EXIT; DOWN-REGULATION; MOUSE EMBRYOS; DIFFERENTIATION; KINASE; PHOSPHORYLATION; PROLIFERATION	Proliferating trophoblast stem cells (TSCs) can differentiate into nonproliferating but viable trophoblast giant cells (TGCs) that are resistant to DNA damage induced apoptosis. Differentiation is associated with selective up-regulation of the Cip/Kip cyclin-dependent kinase inhibitors p57 and p21; expression of p27 remains constant. Previous studies showed that p57 localizes to the nucleus in TGCs where it is essential for endoreplication. Here we show that p27 also remains localized to the nucleus during TSC differentiation where it complements the role of p57. Unexpectedly, p21 localized to the cytoplasm where it was maintained throughout both the G-and S-phases of endocycles, and where it prevented DNA damage induced apoptosis. This unusual status for a Cip/Kip protein was dependent on site-specific phosphorylation of p21 by the Akt1 kinase that is also up-regulated in TGCs. Although cytoplasmic p21 is widespread among cancer cells, among normal cells it has been observed only in monocytes. The fact that it also occurs in TGCs reveals that p57 and p21 serve nonredundant functions, and suggests that the role of p21 in suppressing apoptosis is restricted to terminally differentiated cells.	[de Renty, Christelle; DePamphilis, Melvin L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA; [Ullah, Zakir] Lahore Univ Management Sci, Sch Sci & Engn, Dept Biol, Lahore, Pakistan	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Lahore University of Management Sciences	Ullah, Z (corresponding author), Lahore Univ Management Sci, Sch Sci & Engn, Dept Biol, Lahore, Pakistan.	zakirullah@lums.edu.pk		Ullah, Zakir/0000-0003-2045-6841	NICHD; LUMS University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000507, ZIAHD000506] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); LUMS University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the NICHD intramural research program and by LUMS University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Ahn J, 2013, APOPTOSIS, V18, P870, DOI 10.1007/s10495-013-0835-5; Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Arman E, 1999, P NATL ACAD SCI USA, V96, P11895, DOI 10.1073/pnas.96.21.11895; Asada M, 2004, MOL CELL BIOL, V24, P8236, DOI 10.1128/MCB.24.18.8236-8243.2004; Asada M, 1999, EMBO J, V18, P1223, DOI 10.1093/emboj/18.5.1223; Baccini V, 2001, BLOOD, V98, P3274, DOI 10.1182/blood.V98.12.3274; Benbrook DM, 2011, CURR CANCER DRUG TAR, V11, P586; Burris HA, 2013, CANCER CHEMOTH PHARM, V71, P829, DOI 10.1007/s00280-012-2043-3; Cleaver JE, 2011, PHOTOCHEM PHOTOBIOL, V87, P1230, DOI 10.1111/j.1751-1097.2011.00995.x; de Renty C, 2014, DEV BIOL, V387, P49, DOI 10.1016/j.ydbio.2013.12.034; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; Dillon RL, 2010, CANCER RES, V70, P4260, DOI 10.1158/0008-5472.CAN-10-0266; Dotto GP, 2000, BBA-REV CANCER, V1471, pM43, DOI 10.1016/S0304-419X(00)00019-6; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Gottifredi V, 2001, MOL CELL BIOL, V21, P1066, DOI 10.1128/MCB.21.4.1066-1076.2001; Guardavaccaro D, 2006, MOL CELL, V22, P1, DOI 10.1016/j.molcel.2006.03.017; Hassel C, 2014, DEVELOPMENT, V141, P112, DOI 10.1242/dev.098871; Hattori N, 2000, MOL BIOL CELL, V11, P1037, DOI 10.1091/mbc.11.3.1037; Heron-Milhavet L, 2006, MOL CELL BIOL, V26, P8267, DOI 10.1128/MCB.00201-06; Heron-Milhavet L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076987; Keramari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013952; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Koon JC, 2010, J BIOL CHEM, V285, P13437, DOI 10.1074/jbc.M110.107011; Koster R, 2010, J CLIN INVEST, V120, P3594, DOI 10.1172/JCI41939; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Matsumoto A, 2011, CELL STEM CELL, V9, P262, DOI 10.1016/j.stem.2011.06.014; Mehrotra S, 2008, GENE DEV, V22, P3158, DOI 10.1101/gad.1710208; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Murohashi M, 2010, STEM CELLS, V28, P113, DOI 10.1002/stem.247; Nacusi LP, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-11; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nicolier M, 2009, BIOL CELL, V101, P455, DOI 10.1042/BC20080164; Oda M, 2010, DEV GROWTH DIFFER, V52, P285, DOI 10.1111/j.1440-169X.2010.01173.x; Rielland M, 2009, DEV BIOL, V334, P325, DOI 10.1016/j.ydbio.2009.07.022; Roberts RM, 2011, BIOL REPROD, V84, P412, DOI 10.1095/biolreprod.110.088724; Rodriguez-Vilarrupla A, 2002, FEBS LETT, V531, P319, DOI 10.1016/S0014-5793(02)03549-4; Romanov VS, 2012, BIOCHEMISTRY-MOSCOW+, V77, P575, DOI 10.1134/S000629791206003X; Rossig L, 2001, MOL CELL BIOL, V21, P5644, DOI 10.1128/MCB.21.16.5644-5657.2001; Scott MT, 2000, J BIOL CHEM, V275, P11529, DOI 10.1074/jbc.275.15.11529; Sher N, 2013, P NATL ACAD SCI USA, V110, P9368, DOI 10.1073/pnas.1304889110; Siddiqui K, 2013, COLD SPRING HARB PER, V5; Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010; Soloveva V, 2004, PLACENTA, V25, P29, DOI 10.1016/S0143-4004(03)00215-7; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Susaki E, 2009, P NATL ACAD SCI USA, V106, P5192, DOI 10.1073/pnas.0811712106; Suzuki A, 2000, ONCOGENE, V19, P1346, DOI 10.1038/sj.onc.1203429; Takahashi K, 2000, MOL HUM REPROD, V6, P1019, DOI 10.1093/molehr/6.11.1019; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tanaka T, 2007, CELL CYCLE, V6, P371, DOI 10.4161/cc.6.3.3835; Tang JJ, 2006, MOL CELL BIOCHEM, V291, P139, DOI 10.1007/s11010-006-9206-7; Tateishi Y, 2012, BIOCHEM BIOPH RES CO, V427, P285, DOI 10.1016/j.bbrc.2012.09.041; Ullah Z, 2014, INTRAMURAL PLURIPOTE; Ullah Z, 2008, GENE DEV, V22, P3024, DOI 10.1101/gad.1718108; Ullah Z, 2011, MOL CELL BIOL, V31, P4129, DOI 10.1128/MCB.05723-11; Ullah Z, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-10; Vazquez R, 2013, BIOCHEM PHARMACOL, V86, P210, DOI 10.1016/j.bcp.2013.04.021; Vincent AJ, 2012, FEBS LETT, V586, P3429, DOI 10.1016/j.febslet.2012.07.063; Warfel NA, 2013, CURR OPIN ONCOL, V25, P52, DOI 10.1097/CCO.0b013e32835b639e; Xia X, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-399; Xu XL, 1998, DEVELOPMENT, V125, P753; Yano M, 2013, LIVER INT, V33, P1218, DOI 10.1111/liv.12176; Yoon MK, 2012, BIOCHEM SOC T, V40, P981, DOI 10.1042/BST20120092; Yuan TL, 2011, CURR BIOL, V21, P173, DOI 10.1016/j.cub.2010.12.047; Zhang PM, 1998, GENE DEV, V12, P3162, DOI 10.1101/gad.12.20.3162; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032; Zhou YQ, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-15; Zielke N, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012948; Zou P, 2011, CELL STEM CELL, V9, P247, DOI 10.1016/j.stem.2011.07.003	72	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97434	10.1371/journal.pone.0097434	http://dx.doi.org/10.1371/journal.pone.0097434			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848107	gold, Green Submitted, Green Published			2022-12-25	WOS:000336730600028
J	Kitazawa, D; Matsuo, T; Kaizuka, K; Miyauchi, C; Hayashi, D; Inoue, YH				Kitazawa, Daishi; Matsuo, Tatsuru; Kaizuka, Kana; Miyauchi, Chie; Hayashi, Daisuke; Inoue, Yoshihiro H.			Orbit/CLASP Is Required for Myosin Accumulation at the Cleavage Furrow in Drosophila Male Meiosis	PLOS ONE			English	Article							CONTRACTILE RING; CENTRAL-SPINDLE; POLO KINASE; CENTROSOME SEPARATION; MEIOTIC CYTOKINESIS; CELL; ANILLIN; PROTEIN; PHOSPHORYLATION; RECRUITMENT	Peripheral microtubules (MTs) near the cell cortex are essential for the positioning and continuous constriction of the contractile ring (CR) in cytokinesis. Time-lapse observations of Drosophila male meiosis showed that myosin II was first recruited along the cell cortex independent of MTs. Then, shortly after peripheral MTs made contact with the equatorial cortex, myosin II was concentrated there in a narrow band. After MT contact, anillin and F-actin abruptly appeared on the equatorial cortex, simultaneously with myosin accumulation. We found that the accumulation of myosin did not require centralspindlin, but was instead dependent on Orbit, a Drosophila ortholog of the MT plus-end tracking protein CLASP. This protein is required for stabilization of central spindle MTs, which are essential for cytokinesis. Orbit was also localized in a mid-zone of peripheral MTs, and was concentrated in a ring at the equatorial cortex during late anaphase. Fluorescence resonance energy transfer experiments indicated that Orbit is closely associated with F-actin in the CR. We also showed that the myosin heavy chain was in close proximity with Orbit in the cleavage furrow region. Centralspindlin was dispensable in Orbit ring formation. Instead, the Polo-KLP3A/Feo complex was required for the Orbit accumulation independently of the Orbit MT-binding domain. However, orbit mutations of consensus sites for the phosphorylation of Cdk1 or Polo did not influence the Orbit accumulation, suggesting an indirect regulatory role of these protein kinases in Orbit localization. Orbit was also necessary for the maintenance of the CR. Our data suggest that Orbit plays an essential role as a connector between MTs and the CR in Drosophila male meiosis.	[Kitazawa, Daishi; Matsuo, Tatsuru; Kaizuka, Kana; Miyauchi, Chie; Hayashi, Daisuke; Inoue, Yoshihiro H.] Kyoto Inst Technol, Insect Biomed Res Ctr, Kyoto 606, Japan	Kyoto Institute of Technology	Inoue, YH (corresponding author), Kyoto Inst Technol, Insect Biomed Res Ctr, Kyoto 606, Japan.	yhinoue@kit.ac.jp			 [2357000400]		This work was supported by Grants-in-Aid for Scientific Research (C) to YHI (2357000400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RR, 1998, GENE DEV, V12, P1483, DOI 10.1101/gad.12.10.1483; Akbari OS, 2009, BMC CELL BIOL, V29, P10; Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Brennan IM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000409; Bringmann H, 2005, NATURE, V436, P731, DOI 10.1038/nature03823; Burkard ME, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000111; Cabernard C, 2010, NATURE, V467, P91, DOI 10.1038/nature09334; Cao LG, 1996, MOL BIOL CELL, V7, P225, DOI 10.1091/mbc.7.2.225; Carmena M, 1998, J CELL BIOL, V143, P659, DOI 10.1083/jcb.143.3.659; D'Avino PP, 2008, J CELL SCI, V121, P1151, DOI 10.1242/jcs.026716; D'Avino PP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000572; D'Avino PP, 2006, J CELL SCI, V119, P4402, DOI 10.1242/jcs.03210; D'Avino PP, 2009, METHODS MOL BIOL, V545, P99, DOI 10.1007/978-1-60327-993-2_6; D'Avino PP, 2005, J CELL SCI, V118, P1549, DOI 10.1242/jcs.02335; Dean SO, 2005, P NATL ACAD SCI USA, V102, P13473, DOI 10.1073/pnas.0506810102; Dechant R, 2003, DEV CELL, V4, P333, DOI 10.1016/S1534-5807(03)00057-1; Ebrahimi S, 2010, J BIOL CHEM, V285, P28667, DOI 10.1074/jbc.M110.103887; Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063; Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379; Fuller Margaret T., 1993, P71; Giansanti MG, 2012, CYTOSKELETON, V69, P869, DOI 10.1002/cm.21063; Giansanti MG, 2004, MOL BIOL CELL, V15, P2509, DOI 10.1091/mbc.E03-08-0603; Giansanti MG, 1999, J CELL SCI, V112, P2323; Giansanti MG, 1998, GENE DEV, V12, P396, DOI 10.1101/gad.12.3.396; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Goldbach P, 2010, MOL BIOL CELL, V21, P1482, DOI 10.1091/mbc.E09-08-0714; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Gregory SL, 2008, CURR BIOL, V18, P25, DOI 10.1016/j.cub.2007.11.050; Inoue YH, 2004, J CELL BIOL, V166, P49, DOI 10.1083/jcb.200402052; Inoue YH, 2000, J CELL BIOL, V149, P153, DOI 10.1083/jcb.149.1.153; Inoue YH, 2012, DYNAMIC ALTERATION C; Kamijo K, 2006, MOL BIOL CELL, V17, P43, DOI 10.1091/mbc.e05-06-0569; Kelm O, 2002, J BIOL CHEM, V277, P25247, DOI 10.1074/jbc.M202855200; Kimura K, 2000, J BIOL CHEM, V275, P17233, DOI 10.1074/jbc.C000212200; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kitazawa D, 2012, J CELL SCI, V125, P3649, DOI 10.1242/jcs.103317; Lemos CL, 2000, EMBO J, V19, P3668, DOI 10.1093/emboj/19.14.3668; Lewellyn L, 2011, J CELL BIOL, V193, P155, DOI 10.1083/jcb.201008138; Lowery LA, 2010, GENETICS, V185, P1311, DOI 10.1534/genetics.110.115626; Maiato H, 2003, CELL, V113, P891, DOI 10.1016/S0092-8674(03)00465-3; Mathe E, 2003, DEVELOPMENT, V130, P901, DOI 10.1242/dev.00315; Miyauchi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058220; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Nishimura Y, 2006, J CELL SCI, V119, P104, DOI 10.1242/jcs.02737; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Piekny AJ, 2008, CURR BIOL, V18, P30, DOI 10.1016/j.cub.2007.11.068; Prokopenko SN, 1999, GENE DEV, V13, P2301, DOI 10.1101/gad.13.17.2301; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; SATTERWHITE LL, 1992, J CELL BIOL, V118, P595, DOI 10.1083/jcb.118.3.595; Shrestha S, 2012, MOL BIOL CELL, V23, P1196, DOI 10.1091/mbc.E11-12-1008; Somers WG, 2003, DEV CELL, V4, P29, DOI 10.1016/S1534-5807(02)00402-1; Somma MP, 2002, MOL BIOL CELL, V13, P2448, DOI 10.1091/mbc.01-12-0589; Straight AF, 2005, MOL BIOL CELL, V16, P193, DOI 10.1091/mbc.E04-08-0758; Szafer-Glusman E, 2011, MOL BIOL CELL, V22, P3779, DOI 10.1091/mbc.E11-06-0569; Tasto JJ, 2003, J CELL BIOL, V160, P1093, DOI 10.1083/jcb.200211126; Bertran MT, 2011, EMBO J, V30, P2634, DOI 10.1038/emboj.2011.179; Tsvetkov AS, 2007, CELL MOTIL CYTOSKEL, V64, P519, DOI 10.1002/cm.20201; Uehara R, 2010, CURR BIOL, V20, P1080, DOI 10.1016/j.cub.2010.04.058; van Impel A, 2009, DEVELOPMENT, V136, P813, DOI 10.1242/dev.026203; Verni F, 2004, CURR BIOL, V14, P1569, DOI 10.1016/j.cub.2004.08.054; Wolfe BA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000110; Zhang L, 2010, CURR BIOL, V20, pR135, DOI 10.1016/j.cub.2009.12.017; Zhao WM, 2005, P NATL ACAD SCI USA, V102, P13158, DOI 10.1073/pnas.0504145102	66	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e93669	10.1371/journal.pone.0093669	http://dx.doi.org/10.1371/journal.pone.0093669			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24850412	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600002
J	Okumura, K; Saito, M; Isogai, E; Miura, I; Wakana, S; Kominami, R; Wakabayashi, Y				Okumura, Kazuhiro; Saito, Megumi; Isogai, Eriko; Miura, Ikuo; Wakana, Shigeharu; Kominami, Ryo; Wakabayashi, Yuichi			Congenic Mapping and Allele-Specific Alteration Analysis of Stmm1 Locus Conferring Resistance to Early-Stage Chemically Induced Skin Papillomas	PLOS ONE			English	Article							TUMOR SUSCEPTIBILITY LOCI; CANCER; MOUSE; MICE; CELLS; ASSOCIATION; CARCINOGEN; BACKCROSS; GENETICS	Genome-wide association studies have revealed that many low-penetrance cancer susceptibility loci are located throughout the genome; however, a very limited number of genes have been identified so far. Using a forward genetics approach to map such loci in a mouse skin cancer model, we previously identified strong genetic loci conferring resistance to early-stage chemically induced skin papillomas on chromosome 7 with a large number of[(FVB/NxMSM/Ms)xFVB/N] F1 backcross mice. In this report, we describe a combination of congenic mapping and allele-specific alteration analysis of the loci on chromosome 7. We used linkage analysis and congenic mouse strains to refine the location of Stmm1 (Skin tumor modifier of MSM 1) locus within a genetic interval of about 3 cM on proximal chromosome 7. In addition, we used patterns of allele-specific imbalances in tumors from F1 backcross and N10 congenic mice to narrow down further the region of Stmm1 locus to a physical distance of about 5.4 Mb. To gain the insight into the function of Stmm1 locus, we carried out a long term BrdU labelling experiments with congenic mice containing Stmm1 locus. Interestingly, we observed a decrease of BrdU-LRCs (Label Retaining Cells) in a congenic strain heterozygous or homozygous for MSM allele of Stmm1. These results suggest that Stmm1 responsible genes may have an influence on papillomagenesis in the two-stage skin carcinogenesis by regulating epidermal quiescent stem cells.	[Okumura, Kazuhiro; Saito, Megumi; Isogai, Eriko; Wakabayashi, Yuichi] Chiba Canc Ctr Res Inst, Dept Carcinogenesis Res, Div Expt Anim Res, Chiba, Japan; [Miura, Ikuo; Wakana, Shigeharu] Riken Bioresource Ctr, Technol & Dev Team Mouse Phenotype Anal, Japan Mouse Clin, Tsukuba, Ibaraki, Japan; [Kominami, Ryo] Niigata Univ, Grad Sch Med & Dent Sci, Dept Mol Genet, Niigata, Japan	Chiba Cancer Center; RIKEN; Niigata University	Wakabayashi, Y (corresponding author), Chiba Canc Ctr Res Inst, Dept Carcinogenesis Res, Div Expt Anim Res, Chiba, Japan.	yuichi_wakabayashi@chiba-cc.jp			MEXT's program "Promotion of Environmental Improvement for Independence of Young Researchers'' under the Special Coordination Funds for Promoting Science and Technology at Niigata University; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [23241066] Funding Source: KAKEN	MEXT's program "Promotion of Environmental Improvement for Independence of Young Researchers'' under the Special Coordination Funds for Promoting Science and Technology at Niigata University; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT's program "Promotion of Environmental Improvement for Independence of Young Researchers'' under the Special Coordination Funds for Promoting Science and Technology at Niigata University, and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmain A, 2002, CELL, V108, P145, DOI 10.1016/S0092-8674(02)00622-0; Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; de Koning JP, 2007, ONCOGENE, V26, P4171, DOI 10.1038/sj.onc.1210206; DIGIOVANNI J, 1992, CARCINOGENESIS, V13, P525, DOI 10.1093/carcin/13.4.525; Dong S, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-10; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; Fujiwara K, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-39; Fujiwara K, 2010, MOL CARCINOGEN, V49, P653, DOI 10.1002/mc.20635; Galvan A, 2010, TRENDS GENET, V26, P132, DOI 10.1016/j.tig.2009.12.008; Gough SM, 2011, BLOOD, V118, P6247, DOI 10.1182/blood-2011-07-328880; Hunter KW, 2008, ANNU REV GENET, V42, P131, DOI 10.1146/annurev.genet.42.110807.091659; Kangsamaksin T, 2007, MOL CARCINOGEN, V46, P579, DOI 10.1002/mc.20355; Kwiatkowska A, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-65; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Morris RJ, 1997, CANCER RES, V57, P3436; MORRIS RJ, 1986, CANCER RES, V46, P3061; MORRIS RJ, 1985, J INVEST DERMATOL, V84, P277, DOI 10.1111/1523-1747.ep12265358; NAGASE H, 1995, NAT GENET, V10, P424, DOI 10.1038/ng0895-424; Nagase H, 2001, CANCER RES, V61, P1305; Okumura K, 2012, CARCINOGENESIS, V33, P2260, DOI 10.1093/carcin/bgs250; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Perez-Losada J, 2011, INTEGR BIOL-UK, V3, P316, DOI 10.1039/c0ib00094a; Peto J, 2001, NATURE, V411, P390, DOI 10.1038/35077256; Ponder BAJ, 2001, NATURE, V411, P336, DOI 10.1038/35077207; Stadler ZK, 2010, J CLIN ONCOL, V28, P4255, DOI 10.1200/JCO.2009.25.7816	25	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97201	10.1371/journal.pone.0097201	http://dx.doi.org/10.1371/journal.pone.0097201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24844776	Green Submitted, Green Published, gold			2022-12-25	WOS:000339563400016
J	Barketi-Klai, A; Monot, M; Hoys, S; Lambert-Bordes, S; Kuehne, SA; Minton, N; Collignon, A; Dupuy, B; Kansau, I				Barketi-Klai, Amira; Monot, Marc; Hoys, Sandra; Lambert-Bordes, Sylvie; Kuehne, Sarah A.; Minton, Nigel; Collignon, Anne; Dupuy, Bruno; Kansau, Imad			The Flagellin FliC of Clostridium difficile Is Responsible for Pleiotropic Gene Regulation during In Vivo Infection	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; CAMPYLOBACTER-JEJUNI; TOXIN-B; STREPTOCOCCUS-MUTANS; DIFFERENT SEROGROUPS; BACILLUS-SUBTILIS; RHO-PROTEINS; P-CRESOL; VIRULENCE; EXPRESSION	Clostridium difficile is the main agent responsible for hospital acquired antibiotic associated diarrhoea. In recent years, epidemic strains have emerged causing more severe infections. Whilst C. difficile has two major virulence factors, toxins TcdA and TcdB, it is generally accepted that other virulence components of the bacterium contribute to disease. Previously, it has been suggested that flagella expression from pathogenic bacteria might be implicated in virulence. In a recent study, we observed an increased mortality in a gnotobiotic mouse model when animals were colonized with an isogenic fliC mutant constructed in the PCR-ribotype 027 (B1/NAP1) strain R20291, while animals survived when colonized by the parental strain or after colonization by other high-toxin-producing C. difficile strains. To understand the reasons for this increased virulence, we compared the global gene expression profiles between the fliC-R20291 mutant and its parental strain using an in vitro and in vivo transcriptomic approach. The latter made use of the gnotobiotic mouse model. Interestingly, in the fliC mutant, we observed considerable up-regulation of genes involved in mobility, membrane transport systems (PTS, ABC transporters), carbon metabolism, known virulence factors and sporulation. A smaller but significant up-regulation of genes involved in cell growth, fermentation, metabolism, stress and antibiotic resistance was also apparent. All of these genes may be associated with the increased virulence of the fliC-R20921 mutant. We confirmed that the fliC mutation is solely responsible for the observed changes in gene expression in the mutant strain since expression profiles were restored to that of the wild-type strain in the fliC-complemented strain. Thus, the absence of FliC is directly or indirectly involved in the high mortality observed in the fliC mutant infected animals. Therefore, we provide the first evidence that when the major structural component of the flagellum is neutralized, deregulation of gene expression can occur during infection.	[Barketi-Klai, Amira; Hoys, Sandra; Lambert-Bordes, Sylvie; Kansau, Imad] Univ Paris 11, Fac Pharm, EA4043, F-92290 Chatenay Malabry, France; [Monot, Marc; Collignon, Anne; Dupuy, Bruno] Inst Pasteur, Lab Pathogenese Bacteries Anaerobies, Paris, France; [Kuehne, Sarah A.; Minton, Nigel] Univ Nottingham, Sch Life Sci, Ctr Biomol Sci, Clostridia Res Grp, Nottingham NG7 2RD, England	UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; University of Nottingham	Kansau, I (corresponding author), Univ Paris 11, Fac Pharm, EA4043, F-92290 Chatenay Malabry, France.	imad.kansau@u-psud.fr	Monot, Marc/F-3058-2015; Kansau, Imad/GRX-4789-2022; Kuehne, Sarah/AAV-3481-2021	Monot, Marc/0000-0003-0738-7335; Kansau, Imad/0000-0002-1893-6822; Kuehne, Sarah/0000-0001-6790-8433; Minton, Nigel/0000-0002-9277-1261	European Union [HEALTH-F3-2008-223585]; Medical Research Council [G0601176] Funding Source: researchfish; MRC [G0601176] Funding Source: UKRI	European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the European Union (HEALTH-F3-2008-223585). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JK, 2010, TRENDS MICROBIOL, V18, P30, DOI 10.1016/j.tim.2009.11.001; Antunes A, 2012, NUCLEIC ACIDS RES, V40, P10701, DOI 10.1093/nar/gks864; Antunes A, 2011, MOL MICROBIOL, V79, P882, DOI 10.1111/j.1365-2958.2010.07495.x; Arora SK, 1998, INFECT IMMUN, V66, P1000, DOI 10.1128/IAI.66.3.1000-1007.1998; Aubry A, 2012, INFECT IMMUN, V80, P3521, DOI 10.1128/IAI.00224-12; Baban ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073026; Baban ST, 2013, PLOS ONE UNPUB; Barketi-Klai A, 2011, J MED MICROBIOL; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blair KM, 2008, SCIENCE, V320, P1636, DOI 10.1126/science.1157877; Boetzkes A, 2012, ARCH MICROBIOL, V194, P675, DOI 10.1007/s00203-012-0802-5; BORGMANN S, 2008, EURO SURVEILL, V13; Brazier JS, 2007, EUROSURVEILLANCE, V12; Breitling R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-34; Burns DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024894; Calabi E, 2002, INFECT IMMUN, V70, P5770, DOI 10.1128/IAI.70.10.5770-5778.2002; Cartman ST, 2010, INT J MED MICROBIOL, V300, P387, DOI 10.1016/j.ijmm.2010.04.008; Cheknis AK, 2009, ANAEROBE, V15, P230, DOI 10.1016/j.anaerobe.2009.09.001; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Dawson LF, 2008, J MED MICROBIOL, V57, P745, DOI 10.1099/jmm.0.47744-0; Dawson LF, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-86; Deneve C, 2009, INT J ANTIMICROB AG, V33, pS24, DOI 10.1016/S0924-8579(09)70012-3; Detmers FJM, 2001, RES MICROBIOL, V152, P245, DOI 10.1016/S0923-2508(01)01196-2; Dietrich C, 2001, INFECT IMMUN, V69, P2116, DOI 10.1128/IAI.69.4.2116-2122.2001; Dingle TC, 2011, INFECT IMMUN, V79, P4061, DOI 10.1128/IAI.05305-11; Dong C, 2007, J MOL BIOL, V365, P146, DOI 10.1016/j.jmb.2006.09.063; Dupuy B, 1998, MOL MICROBIOL, V27, P107, DOI 10.1046/j.1365-2958.1998.00663.x; Eaton KA, 1996, INFECT IMMUN, V64, P2445, DOI 10.1128/IAI.64.7.2445-2448.1996; El Meouche I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083748; Ethapa T., 2013, Journal of Bacteriology, V195, P545; Genth H, 2008, INT J BIOCHEM CELL B, V40, P592, DOI 10.1016/j.biocel.2007.12.014; Goorhuis A, 2008, CLIN INFECT DIS, V47, P1162, DOI 10.1086/592257; GRANT CCR, 1993, INFECT IMMUN, V61, P1764, DOI 10.1128/IAI.61.5.1764-1771.1993; Heap JT, 2010, J MICROBIOL METH, V80, P49, DOI 10.1016/j.mimet.2009.10.018; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hennequin C, 2001, MICROBIOL-UK, V147, P87, DOI 10.1099/00221287-147-1-87; Hoskisson Paul A, 2009, Adv Appl Microbiol, V69, P1, DOI 10.1016/S0065-2164(09)69001-8; Hu KY, 2002, RES MICROBIOL, V153, P405, DOI 10.1016/S0923-2508(02)01339-6; Indra A, 2008, J MED MICROBIOL, V57, P702, DOI 10.1099/jmm.0.47476-0; Janoir C, 2013, INFECT IMMUN, V81, P3757, DOI 10.1128/IAI.00515-13; Johnson M, 2011, INT J MED MICROBIOL, V301, P44, DOI 10.1016/j.ijmm.2010.05.003; JUST I, 1995, J CLIN INVEST, V95, P1026, DOI 10.1172/JCI117747; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Kirov SM, 2004, INFECT IMMUN, V72, P1939, DOI 10.1128/IAI.72.4.1939-1945.2004; Konings WN, 2006, ANTON LEEUW INT J G, V90, P325, DOI 10.1007/s10482-006-9089-3; Konkel ME, 2004, J BACTERIOL, V186, P3296, DOI 10.1128/JB.186.11.3296-3303.2004; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Kuehne SA, 2014, J INFECT DIS, V209, P83, DOI 10.1093/infdis/jit426; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Kuijper E J, 2007, Euro Surveill, V12, pE1; Lazazzera BA, 2001, PEPTIDES, V22, P1519, DOI 10.1016/S0196-9781(01)00488-0; Lillehoj EP, 2002, AM J PHYSIOL-LUNG C, V282, pL751, DOI 10.1152/ajplung.00383.2001; LITWIN CM, 1993, CLIN MICROBIOL REV, V6, P137, DOI 10.1128/CMR.6.2.137-149.1993; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Martin MJ, 2013, J BACTERIOL, V195, P3672, DOI 10.1128/JB.00473-13; MCSWEEGAN E, 1986, INFECT IMMUN, V53, P141, DOI 10.1128/IAI.53.1.141-148.1986; Molle V, 2003, MOL MICROBIOL, V50, P1683, DOI 10.1046/j.1365-2958.2003.03818.x; Permpoonpattana P, 2011, J BACTERIOL, V193, P6461, DOI 10.1128/JB.05182-11; Poly F, 2007, INFECT IMMUN, V75, P3859, DOI 10.1128/IAI.00159-07; Poncet S, 2009, CONTRIB MICROBIOL, V16, P88, DOI 10.1159/000219374; Rabaan AA, 2001, INFECT IMMUN, V69, P4257, DOI 10.1128/IAI.69.7.4257-4267.2001; Rouillard JM, 2003, NUCLEIC ACIDS RES, V31, P3057, DOI 10.1093/nar/gkg426; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Selmer T, 2001, EUR J BIOCHEM, V268, P1363, DOI 10.1046/j.1432-1327.2001.02001.x; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Song YC, 2004, MOL MICROBIOL, V53, P541, DOI 10.1111/j.1365-2958.2004.04175.x; Spigaglia P, 2010, J CLIN MICROBIOL, V48, P2892, DOI 10.1128/JCM.02482-09; Stabler RA, 2010, GUT MICROBES, V1, P269, DOI 10.4161/gmic.1.4.11870; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Stephenson K, 2005, FEMS MICROBIOL REV, V29, P281, DOI 10.1016/j.femsre.2004.10.003; STROM AR, 1993, MOL MICROBIOL, V8, P205, DOI 10.1111/j.1365-2958.1993.tb01564.x; Tasteyre A, 2000, J CLIN MICROBIOL, V38, P3179, DOI 10.1128/JCM.38.9.3179-3186.2000; Tasteyre A, 2001, INFECT IMMUN, V69, P7937, DOI 10.1128/IAI.69.12.7937-7940.2001; Tasteyre A, 2001, J CLIN MICROBIOL, V39, P1178, DOI 10.1128/JCM.39.3.1178-1183.2001; Tsukioka Y, 1997, J BACTERIOL, V179, P1126, DOI 10.1128/jb.179.4.1126-1134.1997; Twine SM, 2009, J BACTERIOL, V191, P7050, DOI 10.1128/JB.00861-09; Waligora AJ, 2001, INFECT IMMUN, V69, P2144, DOI 10.1128/IAI.69.4.2144-2153.2001; Yamashita Y, 1999, INFECT IMMUN, V67, P3693, DOI 10.1128/IAI.67.7.3693-3697.1999	80	28	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e96876	10.1371/journal.pone.0096876	http://dx.doi.org/10.1371/journal.pone.0096876			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841151	gold, Green Submitted, Green Published			2022-12-25	WOS:000340948600011
J	Sigl, R; Ploner, C; Shivalingaiah, G; Kofler, R; Geley, S				Sigl, Reinhard; Ploner, Christian; Shivalingaiah, Giridhar; Kofler, Reinhard; Geley, Stephan			Development of a Multipurpose GATEWAY-Based Lentiviral Tetracycline-Regulated Conditional RNAi System (GLTR)	PLOS ONE			English	Article							FLUORESCENT PROTEINS; MAMMALIAN-CELLS; GENE-EXPRESSION; INTERFERENCE; MECHANISM; REVEALS	RNA interference (RNAi) has become an essential technology for functional gene analysis. Its success, however, depends on the effective expression of RNAi-inducing small double-stranded interfering RNA molecules (siRNAs) in target cells. In many cell types, RNAi can be achieved by transfection of chemically synthesised siRNAs, which results in transient knockdown of protein expression. Expression of double-stranded short hairpin RNA (shRNA) provides another means to induce RNAi in cells that are hard to transfect. To facilitate the generation of stable, conditional RNAi cell lines, we have developed novel one-and two-component vector GATEWAY-compatible lentiviral tetracycline-regulated RNAi (GLTR) systems. The combination of a modified RNA-polymerase-III-dependent H1 RNA promoter (designated 'THT') for conditional shRNA expression with different lentiviral delivery vectors allows (1) the use of fluorescent proteins for colour-coded combinatorial RNAi or for monitoring RNAi induction (pGLTR-FP), (2) selection of transduced cells (pGLTR-S), and (3) the generation of conditional cell lines using a one vector system (pGLTR-X). All three systems were found to be suitable for the analysis of essential genes, such as CDC27, a component of the mitotic ubiquitin ligase APC/C, in cell lines and primary human cells.	[Sigl, Reinhard; Ploner, Christian; Shivalingaiah, Giridhar; Kofler, Reinhard; Geley, Stephan] Med Univ Innsbruck, Bioctr, Div Mol Pathophysiol, A-6020 Innsbruck, Austria; [Kofler, Reinhard] Tyrolean Canc Inst, Innsbruck, Austria; [Ploner, Christian] Med Univ Innsbruck, Univ Clin Plast Reconstruct & Aesthet Surg, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck	Geley, S (corresponding author), Med Univ Innsbruck, Bioctr, Div Mol Pathophysiol, A-6020 Innsbruck, Austria.	Stephan.Geley@i-med.ac.at		Ploner, Christian/0000-0002-0313-2960	FWF [SFB021, P16400, DK W1101-B12]; EU [LSHS-CT-2004-503438]; Tiroler Krebshilfe; Tiroler Zukunftsstiftung; Tiroler Wissenschaftsfonds (TWF); Eva v. Lachmuller, Brixen, Italy	FWF(Austrian Science Fund (FWF)); EU(European Commission); Tiroler Krebshilfe; Tiroler Zukunftsstiftung; Tiroler Wissenschaftsfonds (TWF); Eva v. Lachmuller, Brixen, Italy	This work was supported by FWF grants SFB021 'Cell proliferation and cell death in tumors', P16400, and DK W1101-B12 'MCBO', EU project LSHS-CT-2004-503438 'TRANSFOG' as well as by the Tiroler Krebshilfe, Tiroler Zukunftsstiftung, and Tiroler Wissenschaftsfonds (TWF) and assets of Eva v. Lachmuller, Brixen, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas-Terki T, 2002, HUM GENE THER, V13, P2197, DOI 10.1089/104303402320987888; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Bulliard Y, 2006, J BIOL CHEM, V281, P35742, DOI 10.1074/jbc.M602843200; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Csordas A, 2011, CARDIOVASC RES, V92, P141, DOI 10.1093/cvr/cvr165; DELALUNA S, 1992, METHOD ENZYMOL, V216, P376; DEUSCHLE U, 1995, MOL CELL BIOL, V15, P1907; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Geley S, 2004, EXP GERONTOL, V39, P985, DOI 10.1016/j.exger.2004.03.040; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Higuchi M, 2004, CANCER SCI, V95, P442, DOI 10.1111/j.1349-7006.2004.tb03229.x; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kappel S, 2007, NAT PROTOC, V2, P3257, DOI 10.1038/nprot.2007.458; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pei Y, 2006, NAT METHODS, V3, P670, DOI 10.1038/NMETH911; Pepperkok R, 1999, CURR BIOL, V9, P269, DOI 10.1016/S0960-9822(99)80117-1; Ploner C, 2008, LEUKEMIA, V22, P370, DOI 10.1038/sj.leu.2405039; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Sigl R, 2009, J CELL SCI, V122, P4208, DOI 10.1242/jcs.054197; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Tiscornia G, 2004, P NATL ACAD SCI USA, V101, P7347, DOI 10.1073/pnas.0402107101; TUGENDREICH S, 1993, P NATL ACAD SCI USA, V90, P10031, DOI 10.1073/pnas.90.21.10031; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wirth KG, 2004, GENE DEV, V18, P88, DOI 10.1101/gad.285404; Xia XG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng098; Zhang J, 2007, RNA, V13, P1375, DOI 10.1261/rna.520707	33	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97764	10.1371/journal.pone.0097764	http://dx.doi.org/10.1371/journal.pone.0097764			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841113	Green Published, Green Submitted, gold			2022-12-25	WOS:000340948600071
J	Rountree, AM; Neal, AS; Lisowski, M; Rizzo, N; Radtke, J; White, S; Luciani, DS; Kim, F; Hampe, CS; Sweet, IR				Rountree, Austin M.; Neal, Adam S.; Lisowski, Mark; Rizzo, Norma; Radtke, Jared; White, Sarah; Luciani, Dan S.; Kim, Francis; Hampe, Christiane S.; Sweet, Ian R.			Control of Insulin Secretion by Cytochrome c and Calcium Signaling in Islets with Impaired Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; AMPLIFYING PATHWAYS; OXYGEN-CONSUMPTION; ENERGY-PRODUCTION; CA2+ SENSOR; GLUCOSE; GLUCOKINASE; RELEASE; RESPIRATION; APOPTOSIS	The aim of the study was to assess the relative control of insulin secretion rate (ISR) by calcium influx and signaling from cytochrome c in islets where, as in diabetes, the metabolic pathways are impaired. This was achieved either by culturing isolated islets at low (3 mM) glucose or by fasting rats prior to the isolation of the islets. Culture in low glucose greatly reduced the glucose response of cytochrome c reduction and translocation and ISR, but did not affect the response to the mitochondrial fuel alpha-ketoisocaproate. Unexpectedly, glucose-stimulated calcium influx was only slightly reduced in low glucose-cultured islets and was not responsible for the impairment in glucose-stimulated ISR. A glucokinase activator acutely restored cytochrome c reduction and translocation and ISR, independent of effects on calcium influx. Islets from fasted rats had reduced ISR and cytochrome c reduction in response to both glucose and alpha-ketoisocaproate despite normal responses of calcium. Our data are consistent with the scenario where cytochrome c reduction and translocation are essential signals in the stimulation of ISR, the loss of which can result in impaired ISR even when calcium response is normal.	[Rountree, Austin M.; Neal, Adam S.; Lisowski, Mark; Rizzo, Norma; Radtke, Jared; Kim, Francis; Hampe, Christiane S.; Sweet, Ian R.] Univ Washington, Diabet & Obes Ctr, Dept Med, Seattle, WA 98195 USA; [White, Sarah; Luciani, Dan S.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1Z4, Canada	University of Washington; University of Washington Seattle; University of British Columbia	Sweet, IR (corresponding author), Univ Washington, Diabet & Obes Ctr, Box 358055,850 Republican St, Seattle, WA 98195 USA.	isweet@u.washington.edu	Hampe, Christiane Susanne/GSD-7679-2022	Luciani, Dan/0000-0002-4318-4159; Hampe, Christiane/0000-0001-9111-6671	National Institutes of Health [DK17047]; University of Washington Diabetes and Obesity Center; Washington State Life Sciences Discovery Fund, National Science Foundation [IIP-0750508]; American Diabetes Association/Gail Patrick Estate [1-13-IN-53]; Canadian Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026190, P30DK017047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Diabetes and Obesity Center; Washington State Life Sciences Discovery Fund, National Science Foundation(National Science Foundation (NSF)); American Diabetes Association/Gail Patrick Estate; Canadian Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grant DK17047 (the Diabetes Research Center (DRC) Islet Core and the Immunology and Inflammation Core, and an R24 seed grant supplement), funding from the University of Washington Diabetes and Obesity Center and the Washington State Life Sciences Discovery Fund, National Science Foundation Grant IIP-0750508, and a grant from the American Diabetes Association/Gail Patrick Estate (Grant 1-13-IN-53).; Supported by an operating grant from the Canadian Diabetes Association.	Barg S, 2004, J GEN PHYSIOL, V124, P623, DOI 10.1085/jgp.200409206; BARNES WS, 1993, MED SCI SPORT EXER, V25, P473; Bensellam M, 2009, DIABETOLOGIA, V52, P463, DOI 10.1007/s00125-008-1245-z; BURCH PT, 1981, DIABETES, V30, P923, DOI 10.2337/diabetes.30.11.923; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Deeney JT, 2000, SEMIN CELL DEV BIOL, V11, P267, DOI 10.1006/scdb.2000.0175; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Doliba NM, 2012, DIABETES OBES METAB, V14, P109, DOI 10.1111/j.1463-1326.2012.01652.x; ERECINSKA M, 1991, P NATL ACAD SCI USA, V88, P7600, DOI 10.1073/pnas.88.17.7600; Gilbert M, 2008, J BIOL CHEM, V283, P24334, DOI 10.1074/jbc.M802097200; Gottlieb RA, 2002, METHODS, V26, P341, DOI 10.1016/S1046-2023(02)00040-3; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guzman-Perez A, 2011, 242 ACS NAT M DENV C; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; HENQUIN JC, 1994, DIABETES METAB, V20, P132; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; Henquin JC, 2011, DIABETES RES CLIN PR, V93, pS27, DOI 10.1016/S0168-8227(11)70010-9; Huttemann M, 2011, MITOCHONDRION, V11, P369, DOI 10.1016/j.mito.2011.01.010; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; Jung SR, 2011, J BIOL CHEM, V286, P17422, DOI 10.1074/jbc.M110.202820; Jung SR, 2009, AM J PHYSIOL-ENDOC M, V297, pE717, DOI 10.1152/ajpendo.00282.2009; Luciani DS, 2013, DIABETES, V62, P170, DOI 10.2337/db11-1464; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; Matschinsky F. M., 2010, F1000 MED REP, V2, P43, DOI DOI 10.3410/M2-43; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Matsumoto S, 1999, TRANSPLANTATION, V67, pS220, DOI 10.1097/00007890-199904150-00880; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Philipson LH, 2008, CELL METAB, V7, P280, DOI 10.1016/j.cmet.2008.03.009; Prentki M, 1996, EUR J ENDOCRINOL, V134, P272, DOI 10.1530/eje.0.1340272; Prentki M, 1997, DIABETOLOGIA, V40, pS32, DOI 10.1007/s001250051395; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Remedi MS, 2005, DIABETES, V54, P2925, DOI 10.2337/diabetes.54.10.2925; Rountree AM, 2013, DIABETOLOGIA, V56, P803, DOI 10.1007/s00125-012-2808-6; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Sweet IR, 2006, DIABETES, V55, P3509, DOI 10.2337/db06-0400; Sweet Ian R, 2002, Diabetes Technol Ther, V4, P661, DOI 10.1089/152091502320798303; Sweet Ian R, 2002, Diabetes Technol Ther, V4, P67, DOI 10.1089/15209150252924111; Sweet IR, 2004, BIOCHEM BIOPH RES CO, V314, P976, DOI 10.1016/j.bbrc.2003.12.182; Sweet IR, 2004, DIABETES, V53, P401, DOI 10.2337/diabetes.53.2.401; SWEET IR, 1995, AM J PHYSIOL-ENDOC M, V268, pE775, DOI 10.1152/ajpendo.1995.268.4.E775; Sweet IR, 1996, AM J PHYSIOL-ENDOC M, V271, pE606, DOI 10.1152/ajpendo.1996.271.3.E606; Trus M, 2007, BIOCHEMISTRY-US, V46, P14461, DOI 10.1021/bi7016816; Wiederkehr A, 2012, MOL CELL ENDOCRINOL, V353, P128, DOI 10.1016/j.mce.2011.07.016; Wilson D F, 1977, Adv Exp Med Biol, V94, P279; WOLF BA, 1985, BIOCHEM J, V227, P965, DOI 10.1042/bj2270965; YIN L, 1992, DIABETES, V41, P792; Zawalich WS, 2000, J ENDOCRINOL, V166, P111, DOI 10.1677/joe.0.1660111	50	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19110	19119		10.1074/jbc.M114.556050	http://dx.doi.org/10.1074/jbc.M114.556050			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24841202	Green Published, hybrid			2022-12-25	WOS:000339062900041
J	Shioda, N; Yabuki, Y; Kobayashi, Y; Onozato, M; Owada, Y; Fukunaga, K				Shioda, Norifumi; Yabuki, Yasushi; Kobayashi, Yuka; Onozato, Misaki; Owada, Yuji; Fukunaga, Kohji			FABP3 Protein Promotes alpha-Synuclein Oligomerization Associated with 1-Methyl-1,2,3,6-tetrahydropiridine-induced Neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-BINDING PROTEIN; PARKINSONS-DISEASE; FATTY-ACIDS; LEWY BODIES; BRAIN; MUTATION; DEMENTIA; NEURONS; CELLS; MECHANISMS	alpha-Synuclein (alpha Syn) accumulation in dopaminergic (DA) neurons is partly regulated by long-chain polyunsaturated fatty acids. We found that fatty acid-binding protein 3 (FABP3, H-FABP), a factor critical for arachidonic acid (AA) transport and metabolism in brain, is highly expressed in DA neurons. Fabp3 knock-out (Fabp3(-/-)) mice were resistant to 1-methyl1,2,3,6-tetrahydropiridine- induced DA neurodegeneration in the substantia nigra pars compacta and showed improved motor function. Interestingly, FABP3 interacted with alpha Syn in the substantia nigra pars compacta, and alpha Syn accumulation following 1-methyl-1,2,3,6-tetrahydropiridine treatment was attenuated in Fabp3(-/-) compared with wild-type mice. We confirmed that FABP3 overexpression aggravates AA-induced alpha Syn oligomerization and promotes cell death in PC12 cells, whereas overexpression of a mutant form of FABP3 lacking fatty-acid binding capacity did not. Taken together, alpha Syn oligomerization in DA neurons is likely aggravated by AA through FABP3 in Parkinson disease pathology.	[Shioda, Norifumi; Yabuki, Yasushi; Kobayashi, Yuka; Onozato, Misaki; Fukunaga, Kohji] Tohoku Univ, Dept Pharmacol, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Owada, Yuji] Yamaguchi Univ, Grad Sch Med, Dept Organ Anat, Ube, Yamaguchi 7558505, Japan	Tohoku University; Yamaguchi University	Fukunaga, K (corresponding author), Tohoku Univ, Dept Pharmacol, Grad Sch Pharmaceut Sci, Aoba Ku, 6-3 Aramaki Aoba, Sendai, Miyagi 9808578, Japan.	kfukunaga@m.tohoku.ac.jp	Yabuki, Yasushi/AAF-7931-2021; Fukunaga, Kohji/AAI-8811-2021	Fukunaga, Kohji/0000-0001-8526-2824; Owada, Yuji/0000-0002-5109-0531	"Foundation of Synapse and Neurocircuit Pathology" from the Ministry of Education, Culture, Sports, Science and Technology, Japan [25110705, 25460090, 24102505, 25293124]	"Foundation of Synapse and Neurocircuit Pathology" from the Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported by Grants-in-aid for Scientific Research on Innovative Area "Foundation of Synapse and Neurocircuit Pathology" 25110705 and 25460090 (to N. S.) and 24102505 and 25293124 (to K. F.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Assayag K, 2007, AM J PATHOL, V171, P2000, DOI 10.2353/ajpath.2007.070373; Basso M, 2004, PROTEOMICS, V4, P3943, DOI 10.1002/pmic.200400848; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Binas B, 1999, FASEB J, V13, P805, DOI 10.1096/fasebj.13.8.805; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen H, 2003, AM J EPIDEMIOL, V157, P1007, DOI 10.1093/aje/kwg073; Coe NR, 1998, BBA-LIPID LIPID MET, V1391, P287, DOI 10.1016/S0005-2760(97)00205-1; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dettmer U, 2013, J BIOL CHEM, V288, P6371, DOI 10.1074/jbc.M112.403311; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Ferguson MC, 2010, NEUROPHARMACOLOGY, V59, P31, DOI 10.1016/j.neuropharm.2010.03.013; Fornai F, 2003, J NEUROSCI, V23, P8955; Golovko MY, 2006, BIOCHEMISTRY-US, V45, P6956, DOI 10.1021/bi0600289; Hanhoff T, 2002, MOL CELL BIOCHEM, V239, P45, DOI 10.1023/A:1020502624234; Julien C, 2006, NEUROCHEM INT, V48, P404, DOI 10.1016/j.neuint.2005.12.002; Kawano T, 2006, NAT MED, V12, P225, DOI 10.1038/nm1362; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Lucke C, 2006, J LIPID RES, V47, P1714, DOI 10.1194/jlr.M600003-JLR200; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Mollenhauer B, 2007, NEURODEGENER DIS, V4, P366, DOI 10.1159/000105157; Murphy EJ, 2005, BIOCHEMISTRY-US, V44, P6350, DOI 10.1021/bi047292r; Nguyen SM, 2007, J NEUROSCI METH, V161, P281, DOI 10.1016/j.jneumeth.2006.10.026; NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8; Owada Y, 1996, J CHEM NEUROANAT, V12, P113, DOI 10.1016/S0891-0618(96)00192-5; Owada Y., 2003, FATTY ACID BINDING P, P253; Perrin RJ, 2001, J BIOL CHEM, V276, P41958, DOI 10.1074/jbc.M105022200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; Richieri GV, 2000, BIOCHEMISTRY-US, V39, P7197, DOI 10.1021/bi000314z; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Sharon R, 2003, J BIOL CHEM, V278, P49874, DOI 10.1074/jbc.M309127200; Shioda N, 2010, J NEUROSCI, V30, P3146, DOI 10.1523/JNEUROSCI.4140-09.2010; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Song GX, 2012, J CELL BIOCHEM, V113, P3701, DOI 10.1002/jcb.24243; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Wada-Isoe K, 2008, J NEUROL SCI, V266, P20, DOI 10.1016/j.jns.2007.08.018; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zimmerman AW, 1999, BIOCHEM J, V344, P495, DOI 10.1042/0264-6021:3440495	44	54	55	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18957	18965		10.1074/jbc.M113.527341	http://dx.doi.org/10.1074/jbc.M113.527341			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24855640	Green Published, hybrid			2022-12-25	WOS:000339062900028
J	Blain, C; Gagnon, P				Blain, Caitlin; Gagnon, Patrick			Canopy-Forming Seaweeds in Urchin-Dominated Systems in Eastern Canada: Structuring Forces or Simple Prey for Keystone Grazers?	PLOS ONE			English	Article							BRYOZOAN MEMBRANIPORA-MEMBRANACEA; FRAGILE SSP TOMENTOSOIDES; GREEN SEA-URCHINS; SULFURIC-ACID; PHASE-SHIFTS; MARINE-INVERTEBRATES; COMMUNITY STRUCTURE; ALGAL SUCCESSION; STABLE STATES; NOVA-SCOTIA	Models of benthic community dynamics for the extensively studied, shallow rocky ecosystems in eastern Canada emphasize kelp-urchin interactions. These models may bias the perception of factors and processes that structure communities, for they largely overlook the possible contribution of other seaweeds to ecosystem resilience. We examined the persistence of the annual, acidic (H2SO4), brown seaweed Desmarestia viridis in urchin barrens at two sites in Newfoundland (Canada) throughout an entire growth season (February to October). We also compared changes in epifaunal assemblages in D. viridis and other conspicuous canopy-forming seaweeds, the non-acidic conspecific Desmarestia aculeata and kelp Agarum clathratum. We show that D. viridis can form large canopies within the 2-to-8 m depth range that represent a transient community state termed "Desmarestia bed''. The annual resurgence of Desmarestia beds and continuous occurrence of D. aculeata and A. clathratum, create biological structure for major recruitment pulses in invertebrate and fish assemblages (e.g. from quasi-absent gastropods to >150 000 recruits kg(-1) D. viridis). Many of these pulses phase with temperature-driven mass release of acid to the environment and die-off in D. viridis. We demonstrate experimentally that the chemical makeup of D. viridis and A. clathratum helps retard urchin grazing compared to D. aculeata and the highly consumed kelp Alaria esculenta. In light of our findings and related studies, we propose fundamental changes to the study of community shifts in shallow, rocky ecosystems in eastern Canada. In particular, we advocate the need to regard certain canopy-forming seaweeds as structuring forces interfering with top-down processes, rather than simple prey for keystone grazers. We also propose a novel, empirical model of ecological interactions for D. viridis. Overall, our study underscores the importance of studying organisms together with cross-scale environmental variability to better understand the factors and processes that shape marine communities.	[Blain, Caitlin; Gagnon, Patrick] Mem Univ Newfoundland, Ctr Ocean Sci, Dept Ocean Sci, St John, NF, Canada	Memorial University Newfoundland	Gagnon, P (corresponding author), Mem Univ Newfoundland, Ctr Ocean Sci, Dept Ocean Sci, St John, NF, Canada.	pgagnon@mun.ca		Gagnon, Patrick/0000-0001-5834-0217	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation (CFI)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation)	This study was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC) and Canada Foundation for Innovation (CFI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN JD, 1993, FUNCT ECOL, V7, P305, DOI 10.2307/2390209; Adey WH, 2011, NORTHEAST NAT, V18, P1; Amsler C. D., 2008, P91; AMSLER CD, 1995, PHYCOLOGIA, V34, P424, DOI 10.2216/i0031-8884-34-5-424.1; Amsler CD, 2005, MAR ECOL PROG SER, V294, P141, DOI 10.3354/meps294141; Ankisetty S, 2004, J NAT PROD, V67, P1295, DOI 10.1021/np049965c; Aumack CF, 2011, J PHYCOL, V47, P36, DOI 10.1111/j.1529-8817.2010.00927.x; Begin C, 2004, MAR ECOL PROG SER, V271, P121, DOI 10.3354/meps271121; Blain C, 2013, J EXP MAR BIOL ECOL, V440, P176, DOI 10.1016/j.jembe.2012.12.013; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bruno JF, 2001, MARINE COMMUNITY ECOLOGY, P201; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Caines S, 2012, MAR BIOL, V159, P1817, DOI 10.1007/s00227-012-1972-z; CHAPMAN A R O, 1971, Phycologia, V10, P63, DOI 10.2216/i0031-8884-10-1-63.1; CHAPMAN A R O, 1972, Syesis, V5, P1; CHAPMAN ARO, 1990, HYDROBIOLOGIA, V192, P77, DOI 10.1007/BF00006228; Clark RP, 2004, MAR ECOL PROG SER, V267, P107, DOI 10.3354/meps267107; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Connell SD, 2011, J EXP MAR BIOL ECOL, V400, P296, DOI 10.1016/j.jembe.2011.02.031; CONOVER W. J, 1980, PRACTICAL NONPARAMET; DEAN RL, 1987, J EXP MAR BIOL ECOL, V109, P249, DOI 10.1016/0022-0981(87)90057-8; DEAN RL, 1987, J EXP MAR BIOL ECOL, V109, P217, DOI 10.1016/0022-0981(87)90056-6; Dudgeon SR, 2010, MAR ECOL PROG SER, V413, P201, DOI 10.3354/meps08751; Duffy JE, 2006, MAR ECOL PROG SER, V311, P233, DOI 10.3354/meps311233; DUFFY JE, 1991, ECOLOGY, V72, P1286, DOI 10.2307/1941102; DUGGINS DO, 1990, J EXP MAR BIOL ECOL, V143, P27, DOI 10.1016/0022-0981(90)90109-P; Gagnon P, 2003, J EXP MAR BIOL ECOL, V290, P179, DOI 10.1016/S0022-0981(03)00077-7; Gagnon P, 2005, J PHYCOL, V41, P498, DOI 10.1111/j.1529-8817.2005.00078.x; Gagnon P, 2004, MAR BIOL, V144, P1191, DOI 10.1007/s00227-003-1270-x; Gagnon P, 2006, J EXP MAR BIOL ECOL, V334, P10, DOI 10.1016/j.jembe.2006.01.012; Gagnon P, 2013, MAR BIOL, V160, P439, DOI 10.1007/s00227-012-2101-8; GILINSKY E, 1984, ECOLOGY, V65, P455, DOI 10.2307/1941408; HAGEN NT, 1995, MAR ECOL PROG SER, V123, P95, DOI 10.3354/meps123095; HIMMELMAN J H, 1984, Naturaliste Canadien (Quebec), V111, P337; HIMMELMAN JH, 1990, CAN J FISH AQUAT SCI, V47, P1011, DOI 10.1139/f90-116; Huang YSM, 2006, J EXP MAR BIOL ECOL, V329, P55, DOI 10.1016/j.jembe.2005.08.013; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Iken K, 1999, J EXP MAR BIOL ECOL, V236, P133, DOI 10.1016/S0022-0981(98)00199-3; IRLANDI EA, 1991, OECOLOGIA, V87, P307, DOI 10.1007/BF00634584; KEATS DW, 1990, MAR ECOL PROG SER, V68, P181, DOI 10.3354/meps068181; Kelly JR, 2011, MAR ECOL PROG SER, V437, P69, DOI 10.3354/meps09284; Konar B, 2000, OECOLOGIA, V125, P208, DOI 10.1007/s004420000440; Lauzon-Guay JS, 2010, MAR ECOL PROG SER, V403, P29, DOI 10.3354/meps08494; LUNING K, 1985, MAR BIOL, V87, P119, DOI 10.1007/BF00539419; Lyons DA, 2008, AQUAT BIOL, V2, P17, DOI 10.3354/ab00035; Lyons DA, 2007, MAR BIOL, V153, P179, DOI 10.1007/s00227-007-0795-9; McCullagh P, 1989, GEN LINEAR MODELS; Molis M, 2009, POLAR BIOL, V32, P71, DOI 10.1007/s00300-008-0504-2; Pelletreau KN, 2002, MAR BIOL, V141, P1, DOI 10.1007/s00227-002-0809-6; Petraitis PS, 2010, MAR ECOL PROG SER, V413, P189, DOI 10.3354/meps08691; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ruitton S, 2000, ESTUAR COAST SHELF S, V50, P217, DOI 10.1006/ecss.1999.0546; Sasaki H, 1999, J PHYCOL, V35, P732, DOI 10.1046/j.1529-8817.1999.3540732.x; Saunders M, 2007, MAR ECOL PROG SER, V344, P95, DOI 10.3354/meps06924; Scheibling RE, 1999, CAN J FISH AQUAT SCI, V56, P2300, DOI 10.1139/cjfas-56-12-2300; Scheibling RE, 2009, MAR ECOL PROG SER, V390, P1, DOI 10.3354/meps08207; Scheibling RE, 2006, MAR ECOL PROG SER, V325, P1, DOI 10.3354/meps325001; Schiel D.R., 2001, SCIENCE CONSERV, P5; Shears NT, 2002, OECOLOGIA, V132, P131, DOI 10.1007/s00442-002-0920-x; Snedecor G.W., 1989, AMES IOWA STATE U PR; Sokal R.R., 2012, BIOMETRY PRINCIPLES; Steinberg PD, 2002, J PHYCOL, V38, P621, DOI 10.1046/j.1529-8817.2002.02042.x; TAYLOR RB, 1994, MAR ECOL PROG SER, V115, P271, DOI 10.3354/meps115271; Vadas R.L., 1968, ECOLOGY AGARUM KELP; VADAS RL, 1977, ECOL MONOGR, V47, P337, DOI 10.2307/1942173; Watson J, 2011, ECOL MONOGR, V81, P215, DOI 10.1890/10-0262.1; Wessels H, 2006, J EXP MAR BIOL ECOL, V329, P20, DOI 10.1016/j.jembe.2005.08.006; Wiencke C., 2012, SEAWEED BIOL ECOLOGI, P265, DOI [10.1007/978-3-642-28451-9_13, DOI 10.1007/978-3-642-28451-9_13]; Zamzow JP, 2011, ANTARCT SCI, V23, P107, DOI 10.1017/S095410201000091X	69	15	15	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98204	10.1371/journal.pone.0098204	http://dx.doi.org/10.1371/journal.pone.0098204			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859311	Green Published, Green Accepted, gold			2022-12-25	WOS:000336839400054
J	Ferraris, J; Zarate, S; Jaita, G; Boutillon, F; Bernadet, M; Auffret, J; Seilicovich, A; Binart, N; Goffin, V; Pisera, D				Ferraris, Jimena; Zarate, Sandra; Jaita, Gabriela; Boutillon, Florence; Bernadet, Marie; Auffret, Julien; Seilicovich, Adriana; Binart, Nadine; Goffin, Vincent; Pisera, Daniel			Prolactin Induces Apoptosis of Lactotropes in Female Rodents	PLOS ONE			English	Article							ANTERIOR-PITUITARY GLAND; MESSENGER-RIBONUCLEIC-ACID; ESTROUS-CYCLE; PRL RECEPTOR; TRANSFORMING GROWTH-FACTOR-BETA-1; SIGNAL TRANSDUCER; RAT HYPOTHALAMUS; GENE-EXPRESSION; CELL TURNOVER; SHORT-FORM	Anterior pituitary cell turnover occurring during female sexual cycle is a poorly understood process that involves complex regulation of cell proliferation and apoptosis by multiple hormones. In rats, the prolactin (PRL) surge that occurs at proestrus coincides with the highest apoptotic rate. Since anterior pituitary cells express the prolactin receptor (PRLR), we aimed to address the actual role of PRL in the regulation of pituitary cell turnover in cycling females. We showed that acute hyperprolactinemia induced in ovariectomized rats using PRL injection or dopamine antagonist treatment rapidly increased apoptosis and decreased proliferation specifically of PRL producing cells (lactotropes), suggesting a direct regulation of these cell responses by PRL. To demonstrate that apoptosis naturally occurring at proestrus was regulated by transient elevation of endogenous PRL levels, we used PRLR-deficient female mice (PRLRKO) in which PRL signaling is totally abolished. According to our hypothesis, no increase in lactotrope apoptotic rate was observed at proestrus, which likely contributes to pituitary tumorigenesis observed in these animals. To decipher the molecular mechanisms underlying PRL effects, we explored the isoform-specific pattern of PRLR expression in cycling wild type females. This analysis revealed dramatic changes of long versus short PRLR ratio during the estrous cycle, which is particularly relevant since these isoforms exhibit distinct signaling properties. This pattern was markedly altered in a model of chronic PRLR signaling blockade involving transgenic mice expressing a pure PRLR antagonist (TG(Delta 1-9-G129R-hPRL)), providing evidence that PRL regulates the expression of its own receptor in an isoform-specific manner. Taken together, these results demonstrate that i) the PRL surge occurring during proestrus is a major proapoptotic signal for lactotropes, and ii) partial or total deficiencies in PRLR signaling in the anterior pituitary may result in pituitary hyperplasia and eventual prolactinoma development, as observed in TG(Delta 1-9-G129R-hPRL) and PRLRKO mice, respectively.	[Ferraris, Jimena; Zarate, Sandra; Jaita, Gabriela; Seilicovich, Adriana; Pisera, Daniel] UBA CONICET, Inst Invest Biomed, Buenos Aires, DF, Argentina; [Boutillon, Florence; Bernadet, Marie; Goffin, Vincent] Univ Paris 05, Sorbonne Paris Cite, INSERM, U1151,INEM,Team PRL GH Pathophysiol,Fac Med, F-75993 Paris 14, France; [Auffret, Julien; Binart, Nadine] INSERM, U693, F-94276 Le Kremlin Bicetre, France; [Auffret, Julien; Binart, Nadine] Univ Paris 11, Fac Med Paris Sud, UMR S693, F-94276 Le Kremlin Bicetre, France	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Pisera, D (corresponding author), UBA CONICET, Inst Invest Biomed, Buenos Aires, DF, Argentina.	dpisera@fmed.uba.ar	GOFFIN, Vincent/G-3322-2013; Binart, Nadine/F-2949-2013	GOFFIN, Vincent/0000-0002-8021-3086; Binart, Nadine/0000-0002-5606-3866; JAITA, GABRIELA/0000-0002-6513-0514; Ferraris, Jimena/0000-0001-7472-0439; Pisera, Daniel/0000-0001-8795-1551	Agencia Nacional de Promocion de Ciencia y Tecnica (ANPCYT) [PICT 092, PICT 0088]; Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET); University of Buenos Aires, Argentine [UBACYT M057]; INSERM-CONICET, Argentina; INSERM-CONICET, France; Association for International Cancer Research (AICR) [05-0603]; Institut National de la Sante et de la Recherche Medicale; University Paris Descartes, France; ANPCyT (Argentina); Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET) (Argentina); Bourse Doctorale Universitaire de Mobilite from the Universite Paris Descartes (France)	Agencia Nacional de Promocion de Ciencia y Tecnica (ANPCYT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires, Argentine(University of Buenos Aires); INSERM-CONICET, Argentina; INSERM-CONICET, France; Association for International Cancer Research (AICR); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); University Paris Descartes, France; ANPCyT (Argentina)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET) (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Bourse Doctorale Universitaire de Mobilite from the Universite Paris Descartes (France)	This work was supported by PICT 092 and PICT 0088 Agencia Nacional de Promocion de Ciencia y Tecnica (ANPCYT) http://www.agencia.mincyt.gob.ar/frontend/agencia/fondo/foncyt, Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET) (PIP 2010-2012) www.conicet.gov.ar and University of Buenos Aires (UBACYT M057) www.uba.ar, Argentine; INSERM-CONICET project conjoint de cooperation international 2009-2010 www.conicet.gov.ar, Argentina and France; Association for International Cancer Research (AICR grant #05-0603) http://www.aicr.org.uk/CurrentProjects.stm, the Institut National de la Sante et de la Recherche Medicale and University Paris Descartes, France. Ferraris Jimena obtained fellowships from the ANPCyT (Argentina), Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET) (Argentina) and a Bourse Doctorale Universitaire de Mobilite from the Universite Paris Descartes (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral VC, 2013, GEN COMP ENDOCRINOLO; ARZT E, 1993, ENDOCRINOLOGY, V132, P459, DOI 10.1210/en.132.1.459; Ben-Jonathan N, 2001, ENDOCR REV, V22, P724, DOI 10.1210/er.22.6.724; Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; Berlanga JJ, 1997, MOL ENDOCRINOL, V11, P1449, DOI 10.1210/me.11.10.1449; Bernichtein S, 2010, J ENDOCRINOL, V206, P1, DOI 10.1677/JOE-10-0069; Radl DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018097; Binart N, 2003, MOL ENDOCRINOL, V17, P1066, DOI 10.1210/me.2002-0181; Binart N, 2010, TRENDS ENDOCRIN MET, V21, P362, DOI 10.1016/j.tem.2010.01.008; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Bouilly J, 2012, MOL CELL ENDOCRINOL, V356, P80, DOI 10.1016/j.mce.2011.05.004; Brockman JL, 2002, MOL ENDOCRINOL, V16, P774, DOI 10.1210/me.16.4.774; Buckley AR, 2001, LUPUS, V10, P684, DOI 10.1191/096120301717164912; Candolfi M, 2006, FRONT HORM RES, V35, P9, DOI 10.1159/000094260; Candolfi M, 2005, ENDOCRINOLOGY, V146, P736, DOI 10.1210/en.2004-1276; Candolfi M, 2002, ENDOCRINOLOGY, V143, P3611, DOI 10.1210/en.2002-220377; Chesnokova V, 2013, P NATL ACAD SCI USA, V110, pE3331, DOI 10.1073/pnas.1310589110; Childs AJ, 2006, PHYSL REPROD; CHIU S, 1992, ENDOCRINOLOGY, V130, P1747, DOI 10.1210/en.130.3.1747; Clapp C, 2006, TRENDS ENDOCRIN MET, V17, P301, DOI 10.1016/j.tem.2006.08.002; CLARKE DL, 1993, ENDOCRINOLOGY, V133, P224, DOI 10.1210/en.133.1.224; Cruz-Soto ME, 2002, ENDOCRINOLOGY, V143, P4429, DOI 10.1210/en.2002-220173; DEVITO WJ, 1992, ENDOCRINOLOGY, V130, P2549, DOI 10.1210/en.130.5.2549; Devost D, 1999, MOL CELL ENDOCRINOL, V158, P99, DOI 10.1016/S0303-7207(99)00178-1; Dworakowska D, 2009, BEST PRACT RES CL EN, V23, P525, DOI 10.1016/j.beem.2009.05.004; Fernandez I, 2010, J NEUROENDOCRINOL, V22, P771, DOI 10.1111/j.1365-2826.2010.02011.x; Ferraris J, 2013, NEUROENDOCRINOLOGY; Ferraris J, 2012, AM J PHYSIOL-ENDOC M, V302, pE356, DOI 10.1152/ajpendo.00333.2011; Ferraris J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021806; FLURKEY K, 1982, BIOL REPROD, V26, P835, DOI 10.1095/biolreprod26.5.835; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Goffin V, 2011, NAT REV UROL, V8, P597, DOI 10.1038/nrurol.2011.143; HASHI A, 1995, ENDOCRINOLOGY, V136, P4665, DOI 10.1210/en.136.10.4665; Huang C, 2009, ENDOCRINOLOGY, V150, P1618, DOI 10.1210/en.2008-1003; Jabbour H N, 1997, Rev Reprod, V2, P14; Jahn GA, 1997, BIOL REPROD, V57, P894, DOI 10.1095/biolreprod57.4.894; Jaita G, 2005, ENDOCRINOLOGY, V146, P4737, DOI 10.1210/en.2005-0279; Jaita G, 2011, ENDOCRINE, V39, P21, DOI 10.1007/s12020-010-9407-4; Jin L, 1997, J CLIN ENDOCR METAB, V82, P963, DOI 10.1210/jc.82.3.963; Kelly MA, 1997, NEURON, V19, P103, DOI 10.1016/S0896-6273(00)80351-7; KROWN KA, 1992, ENDOCRINOLOGY, V131, P595, DOI 10.1210/en.131.2.595; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma FY, 2005, ENDOCRINOLOGY, V146, P93, DOI 10.1210/en.2004-0800; Ma FY, 2005, ENDOCRINOLOGY, V146, P5112, DOI 10.1210/en.2005-0770; Melmed S, 2011, NAT REV ENDOCRINOL, V7, P257, DOI 10.1038/nrendo.2011.40; MICHAEL SD, 1976, P SOC EXP BIOL MED, V153, P254, DOI 10.3181/00379727-153-39522; MOREL G, 1994, NEUROENDOCRINOLOGY, V59, P78, DOI 10.1159/000126641; NAGANO M, 1994, J BIOL CHEM, V269, P13337; Nevalainen MT, 1997, J CLIN INVEST, V99, P618, DOI 10.1172/JCI119204; Newey PJ, 2013, NEW ENGL J MED, V369, P2012, DOI 10.1056/NEJMoa1307557; Nolan LA, 1998, J NEUROENDOCRINOL, V10, P207, DOI 10.1046/j.1365-2826.1998.00191.x; OISHI Y, 1993, ANAT RECORD, V235, P111, DOI 10.1002/ar.1092350111; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; Pisera D, 2004, AM J PHYSIOL-ENDOC M, V287, pE767, DOI 10.1152/ajpendo.00052.2004; Radl DB, 2008, NEUROENDOCRINOLOGY, V88, P43, DOI 10.1159/000116117; Rouet V, 2010, P NATL ACAD SCI USA, V107, P15199, DOI 10.1073/pnas.0911651107; Saiardi A, 1997, NEURON, V19, P115, DOI 10.1016/S0896-6273(00)80352-9; Sangeeta Devi Y, 2013, MOL CELL ENDOCRINOL; Schuff KG, 2002, J CLIN INVEST, V110, P973, DOI 10.1172/JCI200215912; Shao R, 2008, BIOL REPROD, V79, P748, DOI 10.1095/biolreprod.108.070003; SHIU RPC, 1983, ENDOCRINOLOGY, V113, P159, DOI 10.1210/endo-113-1-159; Silveyra P, 2007, AM J PHYSIOL-ENDOC M, V292, pE820, DOI 10.1152/ajpendo.00467.2006; Stankiewicz TR, 2012, J BIOL CHEM, V287, P16835, DOI 10.1074/jbc.M111.302166; TAKAHASHI S, 1984, CELL TISSUE RES, V235, P497, DOI 10.1007/BF00226945; Recouvreux MV, 2012, ENDOCRINOLOGY, V153, P3861, DOI 10.1210/en.2012-1007; Recouvreux MV, 2011, ENDOCRINOLOGY, V152, P2722, DOI 10.1210/en.2010-1464; Zaldivar V, 2011, NEUROENDOCRINOLOGY, V93, P106, DOI 10.1159/000323760; Zaldivar V, 2009, NEUROENDOCRINOLOGY, V90, P292, DOI 10.1159/000235618; Zarate S, 2010, FRONT HORM RES, V38, P25, DOI 10.1159/000318491; Zarate S, 2009, AM J PHYSIOL-ENDOC M, V296, pE664, DOI 10.1152/ajpendo.90785.2008; Zarate S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041299	71	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97383	10.1371/journal.pone.0097383	http://dx.doi.org/10.1371/journal.pone.0097383			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859278	Green Published, Green Submitted, gold			2022-12-25	WOS:000336839400014
J	Guillot, M; Taylor, PM; Rialland, P; Klinck, MP; Martel-Pelletier, J; Pelletier, JP; Troncy, E				Guillot, Martin; Taylor, Polly M.; Rialland, Pascale; Klinck, Mary P.; Martel-Pelletier, Johanne; Pelletier, Jean-Pierre; Troncy, Eric			Evoked Temporal Summation in Cats to Highlight Central Sensitization Related to Osteoarthritis-Associated Chronic Pain: A Preliminary Study	PLOS ONE			English	Article							DEGENERATIVE JOINT DISEASE; 2ND PAIN; NMDA RECEPTOR; WIND-UP; SENSITIVITY; SENSATIONS; DIAGNOSIS; RESPONSES; NEURONS; RELIEF	In cats, osteoarthritis causes significant chronic pain. Chronicity of pain is associated with changes in the central nervous system related to central sensitization, which have to be quantified. Our objectives were 1) to develop a quantitative sensory testing device in cats for applying repetitive mechanical stimuli that would evoke temporal summation; 2) to determine the sensitivity of this test to osteoarthritis-associated pain, and 3) to examine the possible correlation between the quantitative sensory testing and assessment using other pain evaluation methods. We hypothesized that mechanical sub-threshold repetitive stimuli would evoke temporal summation, and that cats with osteoarthritis would show a faster response. A blinded longitudinal study was performed in 4 non-osteoarthritis cats and 10 cats with naturally occurring osteoarthritis. Quantification of chronic osteoarthritis pain-related disability was performed over a two week period using peak vertical force kinetic measurement, motor activity intensity assessment and von Frey anesthesiometer-induced paw withdrawal threshold testing. The cats afflicted with osteoarthritis demonstrated characteristic findings consistent with osteoarthritis-associated chronic pain. After a 14-day acclimation period, repetitive mechanical sub-threshold stimuli were applied using a purpose-developed device. Four stimulation profiles of predetermined intensity, duration and time interval were applied randomly four times during a four-day period. The stimulation profiles were different (P<0.001): the higher the intensity of the stimulus, the sooner it produced a consistent painful response. The cats afflicted with osteoarthritis responded more rapidly than cats osteoarthritis free (P = 0.019). There was a positive correlation between the von Frey anesthesiometer-induced paw withdrawal threshold and the response to stimulation profiles #2 (2N/0.4 Hz) and #4 (2N/0.4 Hz): Rho(s) = 0.64 (P = 0.01) and 0.63 (P = 0.02) respectively. This study is the first report of mechanical temporal summation in awake cats. Our results suggest that central sensitization develops in cats with naturally occurring osteoarthritis, providing an opportunity to improve translational research in osteoarthritis-associated chronic pain.	[Guillot, Martin; Rialland, Pascale; Klinck, Mary P.; Troncy, Eric] Univ Montreal, Fac Vet Med, Dept Biomed Sci, GREPAQ, St Hyacinthe, PQ J2S 7C6, Canada; [Guillot, Martin; Rialland, Pascale; Klinck, Mary P.; Martel-Pelletier, Johanne; Pelletier, Jean-Pierre; Troncy, Eric] Univ Montreal, Notre Dame Hosp, Ctr Hosp, Osteoarthrit Res Unit, Montreal, PQ H3C 3J7, Canada; [Taylor, Polly M.] Gravel Head Farm, Topcat Metrol, Nr Ely, Cambs, England	Universite de Montreal; Universite de Montreal	Troncy, E (corresponding author), Univ Montreal, Fac Vet Med, Dept Biomed Sci, GREPAQ, St Hyacinthe, PQ J2S 7C6, Canada.	eric.troncy@umontreal.ca	Pelletier, Jean-Pierre/AAG-2896-2019; Martel-Pelletier, Johanne/AAG-2928-2019; Troncy, Eric/J-6650-2013; Taylor, Polly/M-3239-2015	Troncy, Eric/0000-0003-0209-5261; Taylor, Polly/0000-0003-1322-3468	Quebec Bio-Imaging Network of the Fonds de recherche du Quebec - Sante [5886]; ArthroLab, Inc. from the Natural Sciences and Engineering Research Council (NSERC) of Canada; New Opportunities Fund grant [9483]; Leader Opportunity Fund grant [24601]; Alexander Graham Bell NSERC Canada Graduate Scholarship; Canadian Institutes of Health Research - MENTOR Strategic Training Initiative in Health Research Program; NSERC of Canada [406726]; Fonds de recherche du Quebec - Nature et Technologies [144812]; ArthroLab, Inc.;  [327158-2008];  [441651-2013];  [RDCPJ 418399-11]	Quebec Bio-Imaging Network of the Fonds de recherche du Quebec - Sante; ArthroLab, Inc. from the Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); New Opportunities Fund grant; Leader Opportunity Fund grant; Alexander Graham Bell NSERC Canada Graduate Scholarship; Canadian Institutes of Health Research - MENTOR Strategic Training Initiative in Health Research Program(Canadian Institutes of Health Research (CIHR)); NSERC of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de recherche du Quebec - Nature et Technologies; ArthroLab, Inc.; ; ; 	This study was supported in part by a Pilot Study grant from the Quebec Bio-Imaging Network (#5886) of the Fonds de recherche du Quebec - Sante (Pr. Eric Troncy), by a Discovery grant (#327158-2008, #441651-2013, supporting salaries) and a Collaborative Research and Development grant (#RDCPJ 418399-11, supporting operations and salaries) in partnership with ArthroLab, Inc. from the Natural Sciences and Engineering Research Council (NSERC) of Canada (Pr. Eric Troncy), as well as an ongoing New Opportunities Fund grant (#9483) and a Leader Opportunity Fund grant (#24601), supporting pain/function equipment from the Canada Foundation for Innovation (Pr. Eric Troncy). The funding sources were not involved in the study design, collection, analysis and interpretation of data, writing of the manuscript, nor in the decision to submit the manuscript for publication. Dr. Martin Guillot was the recipient of an Alexander Graham Bell NSERC Canada Graduate Scholarship for doctorate research, and a Doctoral Scholarship from the Canadian Institutes of Health Research - MENTOR Strategic Training Initiative in Health Research Program. Dr. Pascale Rialland received a doctoral Industrial Innovation Scholarship from a partnership including NSERC of Canada (#406726), Fonds de recherche du Quebec - Nature et Technologies (#144812) and ArthroLab, Inc. Dr. Mary Klinck was the recipient of a Zoetis - Morris Animal Foundation (#D10-901) doctoral scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt-Nielsen L, 2011, BEST PRACT RES CL RH, V25, P209, DOI 10.1016/j.berh.2010.01.013; Arendt-Nielsen L, 2011, REGION ANESTH PAIN M, V36, P585, DOI 10.1097/AAP.0b013e31822b0db0; Arendt-Nielsen L, 2010, PAIN, V149, P573, DOI 10.1016/j.pain.2010.04.003; Beale BS, 2005, VET CLIN N AM-SMALL, V35, P655, DOI 10.1016/j.cvsm.2005.01.001; Bennett D, 2012, J FELINE MED SURG, V14, P65, DOI 10.1177/1098612X11432828; Bennett D, 2009, J FELINE MED SURG, V11, P997, DOI 10.1016/j.jfms.2009.09.016; Boyce-Rustay JM, 2010, NEUROPHARMACOLOGY, V58, P537, DOI 10.1016/j.neuropharm.2009.08.008; Brown H, 2006, APPL MIXED MODELS ME, P107; Brown H, 2006, APPL MIXED MODELS ME, P215; Brydges NM, 2012, VET J, V193, P545, DOI 10.1016/j.tvjl.2012.01.019; D'Anjou MA, 2008, VET SURG, V37, P166, DOI 10.1111/j.1532-950X.2007.00363.x; DICKENSON AH, 1987, NEUROPHARMACOLOGY, V26, P1235, DOI 10.1016/0028-3908(87)90275-9; Dixon MJ, 2010, LAB ANIM-UK, V44, P247, DOI 10.1258/la.2010.009080; Dolgin E, 2010, NAT MED, V16, P1237, DOI 10.1038/nm1110-1237; Frakes EP, 2011, CURR MED RES OPIN, V27, P2361, DOI 10.1185/03007995.2011.633502; Guillot M, 2013, VET J, V196, P360, DOI 10.1016/j.tvjl.2013.01.009; Guillot M, 2012, VET SURG, V41, P328, DOI 10.1111/j.1532-950X.2012.00976.x; Hardie EM, 2002, J AM VET MED ASSOC, V220, P628, DOI 10.2460/javma.2002.220.628; Hendiani JA, 2003, J PAIN, V4, P203, DOI 10.1016/S1526-5900(03)00557-1; Herrero JF, 2000, PROG NEUROBIOL, V61, P169, DOI 10.1016/S0301-0082(99)00051-9; Imamura M, 2008, ARTHRIT RHEUM-ARTHR, V59, P1424, DOI 10.1002/art.24120; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Klinck MP, 2012, CAN VET J, V53, P1181; Lascelles BDX, 2010, J VET INTERN MED, V24, P487, DOI 10.1111/j.1939-1676.2010.0495.x; Lascelles BDX, 2007, J VET INTERN MED, V21, P410, DOI 10.1892/0891-6640(2007)21[410:EOCOMA]2.0.CO;2; Lascelles BDX, 2013, VET J, V197, P115, DOI 10.1016/j.tvjl.2013.02.025; Lascelles BDX, 2010, VET SURG, V39, P2, DOI 10.1111/j.1532-950X.2009.00597.x; Littell R. C, 2006, SAS MIXED MODELS, P159; Lomas LM, 2005, PSYCHOPHARMACOLOGY, V180, P84, DOI 10.1007/s00213-005-2153-2; Mease PJ, 2011, J RHEUMATOL, V38, P1546, DOI 10.3899/jrheum.100759; MENDELL LM, 1965, NATURE, V206, P97, DOI 10.1038/206097a0; Moreau M, 2013, RES VET SCI, V95, P219, DOI 10.1016/j.rvsc.2013.01.020; Navratilova E, 2013, ANN NY ACAD SCI, V1282, P1, DOI 10.1111/nyas.12095; PRICE DD, 1977, PAIN, V3, P57, DOI 10.1016/0304-3959(77)90035-5; PRICE DD, 1994, PAIN, V59, P165, DOI 10.1016/0304-3959(94)90069-8; Slingerland LI, 2011, VET J, V187, P304, DOI 10.1016/j.tvjl.2009.12.014; Staud R, 2001, PAIN, V91, P165, DOI 10.1016/S0304-3959(00)00432-2; Staud R, 2011, CURR RHEUMATOL REP, V13, P513, DOI 10.1007/s11926-011-0206-6; Stroup W. W, 2013, GEN LINEAR MIXED MOD, P413; Suokas AK, 2012, OSTEOARTHR CARTILAGE, V20, P1075, DOI 10.1016/j.joca.2012.06.009; Vierck CJ, 1997, J NEUROPHYSIOL, V78, P992, DOI 10.1152/jn.1997.78.2.992; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; YEOMANS DC, 1995, BRAIN RES, V670, P297, DOI 10.1016/0006-8993(94)01349-M; Zamprogno H, 2010, AM J VET RES, V71, P1417, DOI 10.2460/ajvr.71.12.1417; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	45	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97347	10.1371/journal.pone.0097347	http://dx.doi.org/10.1371/journal.pone.0097347			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859251	gold, Green Published, Green Submitted			2022-12-25	WOS:000336839400013
J	Halliday, DWR; MacDonald, SWS; Sherf, SK; Tanaka, JW				Halliday, Drew W. R.; MacDonald, Stuart W. S.; Sherf, Suzanne K.; Tanaka, James W.			A Reciprocal Model of Face Recognition and Autistic Traits: Evidence from an Individual Differences Perspective	PLOS ONE			English	Article							SPECTRUM QUOTIENT AQ; SEX-DIFFERENCES; CHILDREN; DISORDER; SKILLS; POPULATION; PERCEPTION; REGRESSION; IDENTITY; AMYGDALA	Although not a core symptom of the disorder, individuals with autism often exhibit selective impairments in their face processing abilities. Importantly, the reciprocal connection between autistic traits and face perception has rarely been examined within the typically developing population. In this study, university participants from the social sciences, physical sciences, and humanities completed a battery of measures that assessed face, object and emotion recognition abilities, general perceptual-cognitive style, and sub-clinical autistic traits (the Autism Quotient (AQ)). We employed separate hierarchical multiple regression analyses to evaluate which factors could predict face recognition scores and AQ scores. Gender, object recognition performance, and AQ scores predicted face recognition behaviour. Specifically, males, individuals with more autistic traits, and those with lower object recognition scores performed more poorly on the face recognition test. Conversely, university major, gender and face recognition performance reliably predicted AQ scores. Science majors, males, and individuals with poor face recognition skills showed more autistic-like traits. These results suggest that the broader autism phenotype is associated with lower face recognition abilities, even among typically developing individuals.	[Halliday, Drew W. R.; MacDonald, Stuart W. S.; Tanaka, James W.] Univ Victoria, Victoria, BC, Canada; [Sherf, Suzanne K.] Penn State Univ, State Coll, PA USA; [Halliday, Drew W. R.; Tanaka, James W.] Ctr Autism Res Technol & Educ, Victoria, BC, Canada	University of Victoria; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Tanaka, JW (corresponding author), Univ Victoria, Victoria, BC, Canada.	jtanaka@uvic.ca	Scherf, K. Suzanne/H-5911-2019	Scherf, K. Suzanne/0000-0002-0696-6362	Temporal Dynamics of Learning Center (NSF) [SBE-0542013]; National Institute of Child Health and Human Development (NIH) [HD-46526]; Natural Sciences and Engineering Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046526] Funding Source: NIH RePORTER	Temporal Dynamics of Learning Center (NSF)(National Science Foundation (NSF)); National Institute of Child Health and Human Development (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Natural Sciences and Engineering Research(Natural Sciences and Engineering Research Council of Canada (NSERC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was supported by grants from the Temporal Dynamics of Learning Center (NSF Grant #SBE-0542013), National Institute of Child Health and Human Development (NIH Grant HD-46526) and the Natural Sciences and Engineering Research.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Austin EJ, 2005, PERS INDIV DIFFER, V38, P451, DOI 10.1016/j.paid.2004.04.022; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 1998, AUTISM, V2, P297; Baron-Cohen Simon, 1995, MINDBLINDNESS ESSAY; Bate S, 2010, PERS INDIV DIFFER, V48, P239, DOI 10.1016/j.paid.2009.10.005; Dawson G, 2002, CHILD DEV, V73, P700, DOI 10.1111/1467-8624.00433; Dawson G, 2005, DEV PSYCHOPATHOL, V17, P679, DOI 10.1017/S0954579405050327; DeGutis J, 2013, COGNITION, V126, P87, DOI 10.1016/j.cognition.2012.09.004; Dennett HW, 2012, BEHAV RES METHODS, V44, P587, DOI 10.3758/s13428-011-0160-2; Duchaine B, 2009, COGN NEUROPSYCHOL, V26, P620, DOI 10.1080/02643291003616145; Frith U, 1991, AUTISM ASPERGERS SYN; Hadjikhani N, 2004, NEUROIMAGE, V22, P1141, DOI 10.1016/j.neuroimage.2004.03.025; Hoekstra RA, 2008, J AUTISM DEV DISORD, V38, P1555, DOI 10.1007/s10803-008-0538-x; Joseph RM, 2002, J CHILD PSYCHOL PSYC, V43, P1, DOI [DOI 10.1111/1469-7610.00142, https://doi.org/10.1111/1469-7610.00142]; Kleinhans NM, 2010, NEUROPSYCHOLOGIA, V48, P3665, DOI 10.1016/j.neuropsychologia.2010.07.022; Lainhart JE, 2002, AM J MED GENET, V113, P231, DOI 10.1002/ajmg.10615; Li Jingguang, 2010, Commun Integr Biol, V3, P295; LORD C, 1982, J AUTISM DEV DISORD, V12, P317, DOI 10.1007/BF01538320; Lundqvist D., 1998, KAROLINSKA DIRECTED; Mars AE, 1998, J PEDIATR-US, V132, P500, DOI 10.1016/S0022-3476(98)70027-7; McGugin RW, 2012, VISION RES, V69, P10, DOI 10.1016/j.visres.2012.07.014; McPartland J, 2004, J CHILD PSYCHOL PSYC, V45, P1235, DOI 10.1111/j.1469-7610.2004.00318.x; OSTERLING J, 1994, J AUTISM DEV DISORD, V24, P247, DOI 10.1007/BF02172225; Pierce K, 2008, BIOL PSYCHIAT, V64, P552, DOI 10.1016/j.biopsych.2008.05.013; Rehnman J, 2007, ACTA PSYCHOL, V124, P344, DOI 10.1016/j.actpsy.2006.04.004; Rhodes G, 2013, NEUROPSYCHOLOGIA, V51, P2702, DOI 10.1016/j.neuropsychologia.2013.08.016; Scherf KS, 2008, J CHILD PSYCHOL PSYC, V49, P838, DOI 10.1111/j.1469-7610.2008.01903.x; Scherf KS, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00026; Schultz RT, 2005, INT J DEV NEUROSCI, V23, P125, DOI 10.1016/j.ijdevneu.2004.12.012; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331; Serra M, 2003, J AUTISM DEV DISORD, V33, P303, DOI 10.1023/A:1024458618172; Spreen O, 1998, COMPENDIUM NEUROPSYC; Swettenham J, 1998, J CHILD PSYCHOL PSYC, V39, P747, DOI 10.1111/1469-7610.00373; Tanaka JW, 2012, J CHILD PSYCHOL PSYC, V53, P1259, DOI 10.1111/j.1469-7610.2012.02571.x; Tanaka JW, 2010, J CHILD PSYCHOL PSYC, V51, P944, DOI 10.1111/j.1469-7610.2010.02258.x; von dem Hagen EAH, 2011, CEREB CORTEX, V21, P493, DOI 10.1093/cercor/bhq062; Weigelt S, 2012, NEUROSCI BIOBEHAV R, V36, P1060, DOI 10.1016/j.neubiorev.2011.12.008; Werling DM, 2013, CURR OPIN NEUROL, V26, P146, DOI 10.1097/WCO.0b013e32835ee548; Wolf JM, 2008, AUTISM RES, V1, P329, DOI 10.1002/aur.56; Yardley L, 2008, J PSYCHOSOM RES, V65, P445, DOI 10.1016/j.jpsychores.2008.03.013	42	26	26	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e94013	10.1371/journal.pone.0094013	http://dx.doi.org/10.1371/journal.pone.0094013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK3KS	24853862	Green Submitted, Green Published, gold			2022-12-25	WOS:000338323200001
J	Yi, JR; Liang, XM; Zhao, G; He, XM				Yi, Jingru; Liang, Xin M.; Zhao, Gang; He, Xiaoming			An Improved Model for Nucleation-Limited Ice Formation in Living Cells during Freezing	PLOS ONE			English	Article							CRYOPRESERVATION; TRANSPORT; MEMBRANES; TISSUES; WATER; HEPATOCYTES; CRYOSURGERY; MECHANISMS; KINETICS; OOCYTES	Ice formation in living cells is a lethal event during freezing and its characterization is important to the development of optimal protocols for not only cryopreservation but also cryotherapy applications. Although the model for probability of ice formation (PIF) in cells developed by Toner et al. has been widely used to predict nucleation-limited intracellular ice formation (IIF), our data of freezing Hela cells suggest that this model could give misleading prediction of PIF when the maximum PIF in cells during freezing is less than 1 (PIF ranges from 0 to 1). We introduce a new model to overcome this problem by incorporating a critical cell volume to modify the Toner's original model. We further reveal that this critical cell volume is dependent on the mechanisms of ice nucleation in cells during freezing, i.e., surface-catalyzed nucleation (SCN) and volume-catalyzed nucleation (VCN). Taken together, the improved PIF model may be valuable for better understanding of the mechanisms of ice nucleation in cells during freezing and more accurate prediction of PIF for cryopreservation and cryotherapy applications.	[Yi, Jingru; Liang, Xin M.; Zhao, Gang] Univ Sci & Technol China, Ctr Biomed Engn, Dept Elect Sci & Technol, Hefei 230026, Anhui, Peoples R China; [Liang, Xin M.] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA; [He, Xiaoming] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Washington; University of Washington Seattle; University System of Ohio; Ohio State University	Zhao, G (corresponding author), Univ Sci & Technol China, Ctr Biomed Engn, Dept Elect Sci & Technol, Hefei 230026, Anhui, Peoples R China.	ZhaoG@ustc.edu.cn; he.429@osu.edu	He, Xiaoming/C-5499-2008; Zhao, Gang/C-8125-2011	He, Xiaoming/0000-0003-0125-6086; Zhao, Gang/0000-0002-0201-1825	National Natural Science Foundation of China [51076149, 51276179]; Fundamental Research Funds for the Central Universities [WK 2100230009]; XML [WK 2100230013]; National Science Foundation [NSF CBET-1154965]; National Institutes of Health [NIH R01EB012108]; American Cancer Society [120936-RSG-11-109-01-CDD]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012108] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); XML; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Natural Science Foundation of China (Nos. 51076149, 51276179) to GZ and the Fundamental Research Funds for the Central Universities to GZ (WK 2100230009) and XML (WK 2100230013), and was supported by National Science Foundation (NSF CBET-1154965), National Institutes of Health (NIH R01EB012108), and American Cancer Society (120936-RSG-11-109-01-CDD) to XH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya T., 2010, OPEN BIOTECHNOL J, V4, P26, DOI [10.2174/1874070701004010026, DOI 10.2174/1874070701004010026]; Anger JT, 2003, J UROLOGY, V170, P1079, DOI 10.1097/01.ju.0000084820.98430.b8; Berrada MS, 2001, CRYOLETTERS, V22, P353; Bischof JC, 2006, CRYOBIOLOGY, V53, P367; Borini A, 2009, SEMIN REPROD MED, V27, P443, DOI 10.1055/s-0029-1241053; Chao BH, 2004, CRYOBIOLOGY, V49, P10, DOI 10.1016/j.cryobiol.2004.04.005; Gage AA, 2007, J AM COLL SURGEONS, V205, P342, DOI 10.1016/j.jamcollsurg.2007.03.007; He XM, 2006, J APPL PHYS, V100, DOI 10.1063/1.2336304; He Xiaoming, 2011, Open Biomed Eng J, V5, P47, DOI 10.2174/1874120701105010047; Hunt CJ, 2007, TRANSFUS MED HEMOTH, V34, P293, DOI 10.1159/000104458; KARLSSON JOM, 1994, J APPL PHYS, V75, P4442, DOI 10.1063/1.355959; Karlsson JOM, 1996, BIOMATERIALS, V17, P243, DOI 10.1016/0142-9612(96)85562-1; Li AP, 1999, CHEM-BIOL INTERACT, V121, P17, DOI 10.1016/S0009-2797(99)00088-5; Liu J, 1997, CRYOBIOLOGY, V35, P1, DOI 10.1006/cryo.1997.2018; Liu J, 2009, J NANOSCI NANOTECHNO, V9, P4521, DOI 10.1166/jnn.2009.1264; MAZUR P, 1984, AM J PHYSIOL, V247, pC125, DOI 10.1152/ajpcell.1984.247.3.C125; MAZUR P, 1965, ANN NY ACAD SCI, V125, P658, DOI 10.1111/j.1749-6632.1965.tb45420.x; MAZUR P, 1963, J GEN PHYSIOL, V47, P347, DOI 10.1085/jgp.47.2.347; MAZUR P, 1977, CRYOBIOLOGY, V14, P251, DOI 10.1016/0011-2240(77)90175-4; Muller-Schweinitzer E, 2009, ORGANOGENESIS, V5, P97, DOI 10.4161/org.5.3.9495; PITT RE, 1989, CRYOBIOLOGY, V26, P44, DOI 10.1016/0011-2240(89)90032-1; PITT RE, 1991, CRYOBIOLOGY, V28, P72, DOI 10.1016/0011-2240(91)90009-D; SCHEIWE MW, 1987, CRYOBIOLOGY, V24, P473, DOI 10.1016/0011-2240(87)90051-4; Thirumala S, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/19/195104; TONER M, 1992, AICHE J, V38, P1512, DOI 10.1002/aic.690381004; TONER M, 1990, BIOPHYS J, V57, pA76; TONER M, 1990, J MEMBRANE BIOL, V115, P261, DOI 10.1007/BF01868641; Toner Mehmet, 1993, Advances in Low-Temperature Biology, V2, P1; TOSCANO WM, 1975, MECH ENG, V97, P60; Weng LD, 2011, J PHYS CHEM B, V115, P14721, DOI 10.1021/jp2054348; Yan JF, 2008, NANOMED-NANOTECHNOL, V4, P79, DOI 10.1016/j.nano.2007.11.002; Yang G, 2011, CRYOBIOLOGY, V63, P38, DOI 10.1016/j.cryobiol.2011.04.007; Yang G, 2011, ANN BIOMED ENG, V39, P580, DOI 10.1007/s10439-010-0158-4	33	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e98132	10.1371/journal.pone.0098132	http://dx.doi.org/10.1371/journal.pone.0098132			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24852166	Green Submitted, Green Published, gold			2022-12-25	WOS:000338323200048
J	Cardona, A; Pagani, L; Antao, T; Lawson, DJ; Eichstaedt, CA; Yngvadottir, B; Shwe, MTT; Wee, J; Romero, IG; Raj, S; Metspalu, M; Villems, R; Willerslev, E; Tyler-Smith, C; Malyarchuk, BA; Derenko, MV; Kivisild, T				Cardona, Alexia; Pagani, Luca; Antao, Tiago; Lawson, Daniel J.; Eichstaedt, Christina A.; Yngvadottir, Bryndis; Ma Than Than Shwe; Wee, Joseph; Romero, Irene Gallego; Raj, Srilakshmi; Metspalu, Mait; Villems, Richard; Willerslev, Eske; Tyler-Smith, Chris; Malyarchuk, Boris A.; Derenko, Miroslava V.; Kivisild, Toomas			Genome-Wide Analysis of Cold Adaptation in Indigenous Siberian Populations	PLOS ONE			English	Article							POSITIVE SELECTION; BLOOD-PRESSURE; SMOOTH-MUSCLE; BIOINFORMATICS; IDENTIFICATION; ASSOCIATION; PATHWAYS; SOFTWARE; PATTERNS; SEQUENCE	Following the dispersal out of Africa, where hominins evolved in warm environments for millions of years, our species has colonised different climate zones of the world, including high latitudes and cold environments. The extent to which human habitation in (sub-)Arctic regions has been enabled by cultural buffering, short-term acclimatization and genetic adaptations is not clearly understood. Present day indigenous populations of Siberia show a number of phenotypic features, such as increased basal metabolic rate, low serum lipid levels and increased blood pressure that have been attributed to adaptation to the extreme cold climate. In this study we introduce a dataset of 200 individuals from ten indigenous Siberian populations that were genotyped for 730,525 SNPs across the genome to identify genes and non-coding regions that have undergone unusually rapid allele frequency and long-range haplotype homozygosity change in the recent past. At least three distinct population clusters could be identified among the Siberians, each of which showed a number of unique signals of selection. A region on chromosome 11 (chr11: 66-69 Mb) contained the largest amount of clustering of significant signals and also the strongest signals in all the different selection tests performed. We present a list of candidate cold adaption genes that showed significant signals of positive selection with our strongest signals associated with genes involved in energy regulation and metabolism (CPT1A, LRP5, THADA) and vascular smooth muscle contraction (PRKG1). By employing a new method that paints phased chromosome chunks by their ancestry we distinguish local Siberian-specific long-range haplotype signals from those introduced by admixture.	[Cardona, Alexia; Pagani, Luca; Eichstaedt, Christina A.; Yngvadottir, Bryndis; Kivisild, Toomas] Univ Cambridge, Dept Archaeol & Anthropol, Cambridge, England; [Pagani, Luca; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Hinxton, England; [Antao, Tiago] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Lawson, Daniel J.] Univ Bristol, Dept Math, Bristol BS8 1TW, Avon, England; [Ma Than Than Shwe; Wee, Joseph] Natl Canc Ctr Singapore, Singapore, Singapore; [Romero, Irene Gallego] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Raj, Srilakshmi] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA; [Metspalu, Mait; Villems, Richard] Univ Tartu, Inst Mol & Cell Biol, Dept Evolutionary Biol, EE-50090 Tartu, Estonia; [Metspalu, Mait; Villems, Richard; Kivisild, Toomas] Estonian Bioctr, Tartu, Estonia; [Willerslev, Eske] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, Copenhagen, Denmark; [Malyarchuk, Boris A.; Derenko, Miroslava V.] Russian Acad Sci, Inst Biol Problems N, Magadan, Russia	University of Cambridge; Wellcome Trust Sanger Institute; University of Oxford; Wellcome Centre for Human Genetics; University of Bristol; National Cancer Centre Singapore (NCCS); University of Chicago; Cornell University; University of Tartu; Estonian Biocentre; University of Copenhagen; Institute of Biological Problems of the North; Russian Academy of Sciences	Cardona, A (corresponding author), Univ Cambridge, Dept Archaeol & Anthropol, Cambridge, England.	ac812@cam.ac.uk	Willerslev, Eske/AAA-5686-2019; Metspalu, Mait/G-8671-2015; Malyarchuk, Boris/D-5783-2018; Derenko, Miroslava/J-1495-2018; Antao, Tiago/C-3615-2009; Kivisild, Toomas/P-5889-2017; Pagani, Luca/G-8511-2017; Willerslev, Eske/A-9619-2011; Lawson, Daniel/A-8550-2011	Metspalu, Mait/0000-0003-3099-9161; Malyarchuk, Boris/0000-0002-0304-0652; Derenko, Miroslava/0000-0002-1849-784X; Antao, Tiago/0000-0002-7269-5513; Kivisild, Toomas/0000-0002-6297-7808; Pagani, Luca/0000-0002-6639-524X; Willerslev, Eske/0000-0002-7081-6748; Lawson, Daniel/0000-0002-5311-6213; Gallego Romero, Irene/0000-0003-1613-8998; Cardona, Alexia/0000-0002-7877-5565	ERC [FP7 - 261213]; Wellcome Trust [098051]	ERC(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This research was supported by ERC Starting Investigator grant (FP7 - 261213) to T. K. http://erc.europa.eu/. LP and CTS were supported by The Wellcome Trust (098051). http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beall CM, 2006, INTEGR COMP BIOL, V46, P18, DOI 10.1093/icb/icj004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bjerregaard P, 2003, SCAND J PUBLIC HEALT, V31, P92, DOI 10.1080/14034940210133924; Bluthgen Nils, 2005, Genome Inform, V16, P106; Cann HM, 2002, SCIENCE, V296, P261; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Cannon B, 2010, NAT MED, V16, P965, DOI 10.1038/nm0910-965; Chea J, 2012, CELL CYCLE, V11, P2885, DOI 10.4161/cc.21280; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; COCKERHAM CC, 1973, GENETICS, V74, P679; De Lorenzo F, 1999, QJM-INT J MED, V92, P747, DOI 10.1093/qjmed/92.12.747; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Fedorova SA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-127; Franceschini N, 2013, DIABETOLOGIA; Frisancho A., 1993, HUMAN ADAPTATION ACC, DOI [10.3998/mpub.9951, DOI 10.3998/MPUB.9951]; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goebel T, 1999, EVOL ANTHROPOL, V8, P208; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hancock AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040032; Hancock AM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001375; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kim HR, 2008, J CELL MOL MED, V12, P2165, DOI 10.1111/j.1582-4934.2008.00552.x; Kuzmin YV, 2008, J ARCHAEOL RES, V16, P163, DOI 10.1007/s10814-007-9019-6; Lappalainen S, 2009, CLIN ENDOCRINOL, V70, P725, DOI 10.1111/j.1365-2265.2008.03388.x; Lawson DJ, 2012, ANNU REV GENOM HUM G, V13, P337, DOI 10.1146/annurev-genom-082410-101510; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; LEBLANC J, 1975, J APPL PHYSIOL, V39, P181, DOI 10.1152/jappl.1975.39.2.181; Lee JM, 2003, GENOME RES, V13, P875, DOI 10.1101/gr.737703; Leonard WR, 2005, ANNU REV ANTHROPOL, V34, P451, DOI 10.1146/annurev.anthro.34.081804.120558; Levin LPP M. G., 1964, PEOPLES SIBERIA; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lincoln TM, 2001, J APPL PHYSIOL, V91, P1421, DOI 10.1152/jappl.2001.91.3.1421; Loh PR, 2013, GENETICS, V193, P1233, DOI 10.1534/genetics.112.147330; Metspalu M, 2011, AM J HUM GENET, V89, P731, DOI 10.1016/j.ajhg.2011.11.010; Phinney Stephen D, 2004, Nutr Metab (Lond), V1, P2, DOI 10.1186/1743-7075-1-2; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Pitulko VV, 2004, SCIENCE, V303, P52, DOI 10.1126/science.1085219; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2021, R LANG ENV STAT COMP; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Reynolds JE, 2009, ARCTIC, V59; Richards MP, 2001, P NATL ACAD SCI USA, V98, P6528, DOI 10.1073/pnas.111155298; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Schreurs M, 2010, OBES REV, V11, P380, DOI 10.1111/j.1467-789X.2009.00642.x; Shephard R.J., 1996, HLTH CONSEQUENCES MO, DOI [10.1017/CBO9780511983726, DOI 10.1017/CBO9780511983726]; Snodgrass JJ, 2008, AM J PHYS ANTHROPOL, V137, P145, DOI 10.1002/ajpa.20851; Turchin MC, 2012, NAT GENET, V44, P1015, DOI 10.1038/ng.2368; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Winkler CA, 2010, ANNU REV GENOM HUM G, V11, P65, DOI 10.1146/annurev-genom-082509-141523; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	68	78	90	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98076	10.1371/journal.pone.0098076	http://dx.doi.org/10.1371/journal.pone.0098076			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24847810	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600085
J	Cruz, GMQ; Metcalfe, CJ; de Setta, N; Cruz, EAO; Vieira, AP; Medina, R; Van Sluys, MA				Cruz, Guilherme M. Q.; Metcalfe, Cushla J.; de Setta, Nathalia; Cruz, Edgar A. O.; Vieira, Andreia Prata; Medina, Rosario; Van Sluys, Marie-Anne			Virus-Like Attachment Sites and Plastic CpG Islands: Landmarks of Diversity in Plant Del Retrotransposons	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; TRANSPOSABLE ELEMENTS; LTR-RETROTRANSPOSONS; COPY NUMBER; DNA; GENOME; DIVERSIFICATION; INTEGRASE; EVOLUTION; REVEALS	Full-length Del elements from ten angiosperm genomes, 5 monocot and 5 dicot, were retrieved and putative attachment (att) sites were identified. In the 2432 Del elements, two types of U5 att sites and a single conserved type of U3 att site were identified. Retroviral att sites confer specificity to the integration process, different att sites types therefore implies lineage specificity. While some features are common to all Del elements, CpG island patterns within the LTRs were particular to lineage specific clusters. All eudicot copies grouped into one single clade while the monocots harbour a more diverse collection of elements. Furthermore, full-length Del elements and truncated copies were unevenly distributed amongst chromosomes. Elements of Del lineage are organized in plants into three clusters and each cluster is composed of elements with distinct LTR features. Our results suggest that the Del lineage efficiently amplified in the monocots and that one branch is probably a newly emerging sub-lineage. Finally, sequences in all groups are under purifying selection. These results show the LTR region is dynamic and important in the evolution of LTR-retrotransposons, we speculate that it is a trigger for retrotransposon diversification.	[Cruz, Guilherme M. Q.; Metcalfe, Cushla J.; Cruz, Edgar A. O.; Vieira, Andreia Prata; Medina, Rosario; Van Sluys, Marie-Anne] Univ Sao Paulo, IB, Dept Bot, BR-09500900 Sao Paulo, Brazil; [de Setta, Nathalia] Univ Fed ABC UFABC, Sao Paulo, Brazil	Universidade de Sao Paulo	Van Sluys, MA (corresponding author), Univ Sao Paulo, IB, Dept Bot, BR-09500900 Sao Paulo, Brazil.	mavsluys@usp.br	Metcalfe, Cushla/GSI-8011-2022; de Setta, Nathalia/C-6069-2012; Ochoa Cruz, Andres/H-9670-2012; Metcalfe, Cushla/D-2476-2013; Vieira, Andreia/HGC-4528-2022; Van Sluys, Marie-Anne/A-8483-2012; Setta, Nathalia/D-8780-2015; Metcalfe, Cushla/AAE-4078-2019	de Setta, Nathalia/0000-0002-4807-5410; Ochoa Cruz, Andres/0000-0003-0498-6156; Metcalfe, Cushla/0000-0001-9375-3332; Van Sluys, Marie-Anne/0000-0002-6506-2734; Metcalfe, Cushla/0000-0001-9375-3332; Medina Rodriguez, Rosario Alejandra/0000-0001-9836-5339	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2008/52074-0, 2009/09217-7, 2009/51632-1, 2012/14610-2, 2008/58243-8, 2012/02671-7 AVP]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [308197/2010-0, 565783/2008-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Bioenergy Research Program (2008/52074-0 to MAVS), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo fellowship (2009/09217-7 to CJM, 2009/51632-1 to NS and 2012/14610-2 to RM) and scholarships (2008/58243-8 to GMQC and 2012/02671-7 AVP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (308197/2010-0 to MAVS) and a Conselho Nacional de Desenvolvimento Cientifico e Tecnologico scholarship (565783/2008-4 to EAOC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baucom RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000732; Baucom RS, 2009, GENOME RES, V19, P243, DOI 10.1101/gr.083360.108; Benachenhou F, 2013, MOBILE DNA-UK, V4, DOI 10.1186/1759-8753-4-5; Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; Bera S, 2009, J MOL BIOL, V389, P183, DOI 10.1016/j.jmb.2009.04.007; Bousios A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-89; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Brown HEV, 1999, J VIROL, V73, P9011, DOI 10.1128/JVI.73.11.9011-9020.1999; Cantu D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-408; Chiu R, 2000, J VIROL, V74, P8292, DOI 10.1128/JVI.74.18.8292-8298.2000; Chiu TK, 2004, CURR TOP MED CHEM, V4, P965, DOI 10.2174/1568026043388547; Craigie R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006890; Domingues DS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-137; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Han MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-520; Haren L, 1999, ANNU REV MICROBIOL, V53, P245, DOI 10.1146/annurev.micro.53.1.245; Jordan IK, 1999, J MOL EVOL, V49, P352, DOI 10.1007/PL00006558; Kang SY, 2008, J MICROBIOL BIOTECHN, V18, P1044; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Le Rouzic A, 2013, GENOME BIOL EVOL, V5, P77, DOI 10.1093/gbe/evs130; Lisch D, 2013, NAT REV GENET, V14, P49, DOI 10.1038/nrg3374; Llorens C, 2011, NUCLEIC ACIDS RES, V39, pD70, DOI 10.1093/nar/gkq1061; Manetti ME, 2009, MOL GENET GENOMICS, V281, P261, DOI 10.1007/s00438-008-0408-4; Masuda T, 1998, J VIROL, V72, P8396, DOI 10.1128/JVI.72.10.8396-8402.1998; Matsuoka Y, 1999, MOL BIOL EVOL, V16, P208, DOI 10.1093/oxfordjournals.molbev.a026103; McCarthy EM, 2003, BIOINFORMATICS, V19, P362, DOI 10.1093/bioinformatics/btf878; Nachman MW, 1996, GENETICS, V142, P537; Navarro-Quezada A, 2002, P NATL ACAD SCI USA, V99, P268, DOI 10.1073/pnas.012422299; Nowotny M, 2009, EMBO REP, V10, P144, DOI 10.1038/embor.2008.256; Paterson AH, 2009, PLANT PHYSIOL, V149, P125, DOI 10.1104/pp.108.129262; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Perlman PS, 2004, SCIENCE, V303, P182, DOI 10.1126/science.1093514; Senigl F, 2008, J VIROL, V82, P7818, DOI 10.1128/JVI.00419-08; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Suoniemi A, 1997, GENETICA, V100, P219, DOI 10.1023/A:1018398016018; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vernhettes S, 1998, MOL BIOL EVOL, V15, P827, DOI 10.1093/oxfordjournals.molbev.a025988; Vitte C, 2005, CYTOGENET GENOME RES, V110, P91, DOI 10.1159/000084941; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wicker T, 2007, GENOME RES, V17, P1072, DOI 10.1101/gr.6214107; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhao FQ, 2009, GENOME RES, V19, P1384, DOI 10.1101/gr.091363.109	45	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97099	10.1371/journal.pone.0097099	http://dx.doi.org/10.1371/journal.pone.0097099			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849372	Green Submitted, Green Published, gold			2022-12-25	WOS:000336730600020
J	de Souza, AR; Mourao, CA; do Nascimento, FS; Lino-Neto, J				de Souza, Andre Rodrigues; Mourao Junior, Carlos Alberto; do Nascimento, Fabio Santos; Lino-Neto, Jose			Sexy Faces in a Male Paper Wasp	PLOS ONE			English	Article							CANADENSIS L HYMENOPTERA; MATE CHOICE; REPRODUCTIVE STATUS; POLISTES-EXCLAMANS; SEXUAL SELECTION; FEMALE CHOICE; SIGNAL; TAIL; RECOGNITION; ORNAMENTS	Sexually selected signals are common in many animals, though little reported in social insects. We investigated the occurrence of male visual signals mediating the dominance relationships among males and female choice of sexual partner in the paper wasp Polistes simillimus. Males have three conspicuous, variable and sexually dimorphic traits: black pigmentation on the head, a pair of yellow abdominal spots and body size differences. By conducting behavioral assays, we found that none of the three visual traits are associated with male-male dominance relationship. However, males with higher proportion of black facial pigmentation and bigger yellow abdominal spots are more likely chosen as sexual partners. Also, after experimentally manipulating the proportion of black pigment on males' face, we found that females may evaluate male facial coloration during the choice of a sexual partner. Thus, the black pigmentation on P. simillimus male's head appears to play a role as a sexually selected visual signal. We suggest that sexual selection is a common force in Polistes and we highlight the importance of this group as a model for the study of visual communication in insects.	[de Souza, Andre Rodrigues] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil; [Mourao Junior, Carlos Alberto] Univ Fed Juiz de Fora, Dept Fisiol, Juiz De Fora, MG, Brazil; [do Nascimento, Fabio Santos] Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, Sao Paulo, Brazil; [Lino-Neto, Jose] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Juiz de Fora; Universidade de Sao Paulo; Universidade Federal de Vicosa	de Souza, AR (corresponding author), Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil.	andrebioufjf@gmail.com	Mourao-Junior, Carlos Alberto/GLT-3294-2022; de Souza, André Rodrigues/C-9069-2015; Nascimento, Fabio S/E-4191-2013	Mourao-Junior, Carlos Alberto/0000-0001-7199-5365; de Souza, André Rodrigues/0000-0002-1124-4874; Nascimento, Fabio S/0000-0002-3731-7111	CNPq [143246/2011-9]; Fapesp [2010/10027-5]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by CNPq (143246/2011-9) to A.R. de Souza and Fapesp (2010/10027-5) to F.S. Nascimento. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON M, 1982, NATURE, V299, P818, DOI 10.1038/299818a0; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Andersson Malte, 1994; Backwell PRY, 1996, BEHAV ECOL SOCIOBIOL, V38, P407, DOI 10.1007/s002650050258; Baer B, 2003, BEHAV ECOL SOCIOBIOL, V54, P521, DOI 10.1007/s00265-003-0673-5; BEANI L, 1992, J KANSAS ENTOMOL SOC, V65, P211; BEANI L, 1988, BEHAV ECOL SOCIOBIOL, V22, P257, DOI 10.1007/BF00299840; Beani Laura, 1996, P113; Berglund A, 1996, BIOL J LINN SOC, V58, P385, DOI 10.1111/j.1095-8312.1996.tb01442.x; Birkhead TR, 1998, SPERM COMPETITION SE; Boomsma JJ, 2005, ANNU REV ENTOMOL, V50, P395, DOI 10.1146/annurev.ento.50.071803.130416; BORGIA G, 1995, ANIM BEHAV, V49, P1291, DOI 10.1006/anbe.1995.0161; Cappa F, 2013, ANIM BEHAV, V86, P801, DOI 10.1016/j.anbehav.2013.07.020; Cole BJ, 1997, BEHAV ECOL SOCIOBIOL, V40, P79, DOI 10.1007/s002650050318; Dapporto L, 2007, CURR BIOL, V17, pR504, DOI 10.1016/j.cub.2007.05.002; de Heij ME, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.48; De Souza AR, 2012, ENTOMOL EXP APPL, V144, P244, DOI 10.1111/j.1570-7458.2012.01285.x; EICKWORT K, 1969, INSECT SOC, V16, P67, DOI 10.1007/BF02224464; Enteman W, 1904, COLORATION POLISTES; EVANS MR, 1992, BEHAV ECOL SOCIOBIOL, V29, P421; Fitzpatrick S, 1998, AM NAT, V151, P157, DOI 10.1086/286109; Gamboa GJ, 2004, ANN ZOOL FENN, V41, P789; Gonzalez G, 1999, J ANIM ECOL, V68, P1225, DOI 10.1046/j.1365-2656.1999.00364.x; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Hebets EA, 2005, BEHAV ECOL, V16, P75, DOI 10.1093/beheco/arh133; HILL GE, 1991, NATURE, V350, P337, DOI 10.1038/350337a0; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Ishay JS, 2002, J ELECTRON MICROSC, V51, P401, DOI 10.1093/jmicro/51.6.401; Izzo AS, 2012, ANIM BEHAV, V83, P839, DOI 10.1016/j.anbehav.2012.01.005; Izzo AS, 2011, THESIS U MICHIGAN; Land MF, 1972, ANNU REV ENTOMOL, V42, P147; MOLLER AP, 1989, NATURE, V339, P132; Monnin T, 2006, ANN ZOOL FENN, V43, P515; POLAK M, 1992, J INSECT BEHAV, V5, P531, DOI 10.1007/BF01058198; POLAK M, 1993, BEHAV ECOL, V4, P325, DOI 10.1093/beheco/4.4.325; Reeve H.K., 1991, P99; SEARCY WA, 1992, AM ZOOL, V32, P71; Sledge MF, 2001, BEHAV ECOL SOCIOBIOL, V49, P401, DOI 10.1007/s002650000311; Strassmann J, 2001, INSECT SOC, V48, P1, DOI 10.1007/PL00001737; Tannure-Nascimento IC, 2008, P ROY SOC B-BIOL SCI, V275, P2555, DOI 10.1098/rspb.2008.0589; Tibbetts EA, 2004, NATURE, V432, P218, DOI 10.1038/nature02949; Tibbetts EA, 2002, P ROY SOC B-BIOL SCI, V269, P1423, DOI 10.1098/rspb.2002.2031; Tibbetts EA, 2011, ETHOLOGY, V117, P1138, DOI 10.1111/j.1439-0310.2011.01967.x; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	44	23	23	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98172	10.1371/journal.pone.0098172	http://dx.doi.org/10.1371/journal.pone.0098172			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849073	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600095
J	Eggers, C; Schwartz, F; Pedrosa, DJ; Kracht, L; Timmermann, L				Eggers, Carsten; Schwartz, Frank; Pedrosa, David J.; Kracht, Lutz; Timmermann, Lars			Parkinson's Disease Subtypes Show a Specific Link between Dopaminergic and Glucose Metabolism in the Striatum	PLOS ONE			English	Article							BASAL GANGLIA; RESTING TREMOR; PROGRESSION; DYSFUNCTION; PET	Background: Previous studies have shown different clinical and imaging pattern in tremordominant and akinetic-rigid Parkinson's disease (PD) subtypes. The association between dopaminergic and glucose metabolism has in contrast not been investigated yet. Therefore, this study compared PD subtypes with respect to clinical and imaging findings with the aim of establishing a relationship between clinical subtypes, dopamine and glucose metabolism. Methods: Two groups of a total of 64 idiopathic PD patients (42 male, 22 female, mean age 56 +/- 10.9 years) were analysed: akinetic-rigid (AR, n = 32) and tremor-dominant (TD, n = 32) patients. Both were compared with respect to differential involvement of local striatal dopamine and glucose metabolism using [F-18]-fluoro-L-dopa (F-dopa) and [F-18]-fluorodeoxyglucose (FDG)-PET. Results: The analysis of PD subgroups showed significant differences in the F-dopa uptake in the anterior putamen. Using the results of the local striatal dopamine difference as a volume of interest for the FDG-analysis, analysis of AR patients revealed a significantly lower normalised cerebral metabolic rate of glucose (nCMRGlc) within the ventral striatum. Conclusions: The dual tracer study illlustrates clear differences between TD and AR subtypes in the ventral striatum. In accordance with previous FP-CIT-SPECT studies, it discloses congruent results for the presynaptic dopaminergic system and extends the knowledge about an additional involvement of local metabolic activity in the caudate and anterior putamen. The findings corroborate the specific role of distinct PD subtypes within the cerebello-thalamo-cortical-circuits. Multitracer PET imaging may thus enhance the knowledge about the clinical segregation into subtypes.	[Eggers, Carsten; Schwartz, Frank; Pedrosa, David J.; Timmermann, Lars] Univ Hosp Cologne, Dept Neurol, Cologne, Germany; [Kracht, Lutz] Max Planck Inst Neurol Res, D-50931 Cologne, Germany	University of Cologne; Max Planck Society	Eggers, C (corresponding author), Univ Hosp Cologne, Dept Neurol, Cologne, Germany.	carsten.eggers@uk-koeln.de		Timmermann, Lars/0000-0002-5301-3580; Pedrosa, David/0000-0002-5403-1959	German Research Foundation (DFG) [Klinische Forschergruppe KFO 219, EG 350/1-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG, Klinische Forschergruppe KFO 219; (EG 350/1-1)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; BARON JC, 1994, REV NEUROL-FRANCE, V150, P599; Benninger DH, 2009, J NEUROL, V256, P256, DOI 10.1007/s00415-009-0092-2; Borghammer P, 2012, ACTA NEUROL SCAND, V125, P303, DOI 10.1111/j.1600-0404.2011.01556.x; Borghammer P, 2009, NEUROIMAGE, V47, P1514, DOI 10.1016/j.neuroimage.2009.05.040; Breit S, 2006, J NEURAL TRANSM, V113, P187, DOI 10.1007/s00702-005-0311-7; Dhawan V, 2002, J NUCL MED, V43, P1324; Eckert T, 2007, LANCET NEUROL, V6, P926, DOI 10.1016/S1474-4422(07)70245-4; Eggers C, 2009, J NEUROL SCI, V276, P27, DOI 10.1016/j.jns.2008.08.029; Eggers C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046813; Eggers C, 2011, MOVEMENT DISORD, V26, P416, DOI 10.1002/mds.23468; Ghaemi M, 2002, MOVEMENT DISORD, V17, P782, DOI 10.1002/mds.10125; Hallett Mark, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS85, DOI 10.1016/S1353-8020(11)70027-X; Halliday GM, 2010, ANN NY ACAD SCI, V1184, P188, DOI 10.1111/j.1749-6632.2009.05118.x; Herman T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055193; Hilker R, 2005, NEUROLOGY, V65, P1716, DOI 10.1212/01.wnl.0000191154.78131.f6; Hu MTM, 2000, BRAIN, V123, P340, DOI 10.1093/brain/123.2.340; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Jankovic J, 2001, ARCH NEUROL-CHICAGO, V58, P1611, DOI 10.1001/archneur.58.10.1611; Jellinger KA, 1999, J NEURAL TRANSM-SUPP, P1; Jokinen P, 2009, PARKINSONISM RELAT D, V15, P88, DOI 10.1016/j.parkreldis.2008.03.005; Kaasinen V, 2006, J NEUROL, V253, P340, DOI 10.1007/s00415-005-0993-7; Kassubek J, 2002, NEUROSCI LETT, V323, P29, DOI 10.1016/S0304-3940(02)00111-8; Kostic VS, 2012, NEUROLOGY, V78, P409, DOI 10.1212/WNL.0b013e318245d23c; Lozza C, 2002, NEUROIMAGE, V17, P688, DOI 10.1006/nimg.2002.1245; Ma Y, 2002, SYNAPSE, V45, P125, DOI 10.1002/syn.10090; Mure H, 2011, NEUROIMAGE, V54, P1244, DOI 10.1016/j.neuroimage.2010.09.028; Niethammer M, 2013, NEUROIMAGE, V78, P204, DOI 10.1016/j.neuroimage.2013.03.070; PEPPARD RF, 1992, ARCH NEUROL-CHICAGO, V49, P1262, DOI 10.1001/archneur.1992.00530360060019; Polito C, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.09.004; Rajput AH, 2009, NEUROLOGY, V73, P206, DOI 10.1212/WNL.0b013e3181ae7af1; Rosenberg-Katz K, 2013, NEUROLOGY, V80, P1476, DOI 10.1212/WNL.0b013e31828cfaa4; Rossi C, 2010, EUR J NEUROL, V17, P626, DOI 10.1111/j.1468-1331.2009.02898.x; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; van Rooden SM, 2011, MOVEMENT DISORD, V26, P51, DOI 10.1002/mds.23346	35	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e96629	10.1371/journal.pone.0096629	http://dx.doi.org/10.1371/journal.pone.0096629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24848641	gold, Green Published, Green Submitted			2022-12-25	WOS:000336730600013
J	Liu, M; Zhao, R; Chen, Y; Zhang, J; Compton, SG; Chen, XY				Liu, Min; Zhao, Rui; Chen, Yan; Zhang, Jian; Compton, Stephen G.; Chen, Xiao-Yong			Competitive Exclusion among Fig Wasps Achieved via Entrainment of Host Plant Flowering Phenology	PLOS ONE			English	Article							POLLINATOR SPECIFICITY; COEVOLVING FIG; FICUS; MUTUALISM; CONSEQUENCES; LONGEVITY; EVOLUTION; BREAKDOWN; SOFTWARE; HISTORY	Molecular techniques are revealing increasing numbers of morphologically similar but co-existing cryptic species, challenging the niche theory. To understand the co-existence mechanism, we studied phenologies of morphologically similar species of fig wasps that pollinate the creeping fig (F. pumila) in eastern China. We compared phenologies of fig wasp emergence and host flowering at sites where one or both pollinators were present. At the site where both pollinators were present, we used sticky traps to capture the emerged fig wasps and identified species identity using mitochondrial DNA COI gene. We also genotyped F. pumila individuals of the three sites using polymorphic microsatellites to detect whether the host populations were differentiated. Male F. pumila produced two major crops annually, with figs receptive in spring and summer. A small partial third crop of receptive figs occurred in the autumn, but few of the second crop figs matured at that time. Hence, few pollinators were available to enter third crop figs and they mostly aborted, resulting in two generations of pollinating wasps each year, plus a partial third generation. Receptive figs were produced on male plants in spring and summer, timed to coincide with the release of short-lived adult pollinators from the same individual plants. Most plants were pollinated by a single species. Plants pollinated by Wiebesia sp. 1 released wasps earlier than those pollinated by Wiebesia sp. 3, with little overlap. Plants occupied by different pollinators were not spatially separated, nor genetically distinct. Our findings show that these differences created mismatches with the flight periods of the other Wiebesia species, largely 'reserving' individual plants for the resident pollinator species. This pre-emptive competitive displacement may prevent long term co-existence of the two pollinators.	[Liu, Min; Zhao, Rui; Zhang, Jian; Chen, Xiao-Yong] E China Normal Univ, Sch Ecol & Environm Sci, Tiantong Natl Field Stn Forest Ecosyst, Shanghai 200062, Peoples R China; [Chen, Yan] Mianyang Normal Univ, Ecol Secur & Protect Key Lab Sichuan Prov, Mianyang, Sichuan, Peoples R China; [Compton, Stephen G.] Univ Leeds, Fac Biol Sci, Sch Biol, Leeds, W Yorkshire, England	East China Normal University; Mianyang Teachers' College; University of Leeds	Chen, XY (corresponding author), E China Normal Univ, Sch Ecol & Environm Sci, Tiantong Natl Field Stn Forest Ecosyst, Shanghai 200062, Peoples R China.	xychens@hotmail.com	Chen, Xiao-Yong/B-1467-2009	Chen, Xiao-Yong/0000-0002-4795-8940; Liu, Min/0000-0001-7672-7482; Compton, Stephen/0000-0002-1247-8058	National Natural Science Foundation of China [31270416]; Ministry of Education of China [20110076110013]; Leader Fund of Minhang Human Resources and Social Security Bureau; Graduate School of East China Normal University [CX2011003, XRZZ2011023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Leader Fund of Minhang Human Resources and Social Security Bureau; Graduate School of East China Normal University	Funding came from the National Natural Science Foundation of China (31270416); Doctoral Program of the Ministry of Education of China (20110076110013); the Leader Fund of Minhang Human Resources and Social Security Bureau; Graduate School of East China Normal University (CX2011003 and XRZZ2011023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, P NATL ACAD SCI USA, V106, P20342, DOI 10.1073/pnas.0902213106; Anstett MC, 1996, J BIOGEOGR, V23, P459, DOI 10.1111/j.1365-2699.1996.tb00007.x; BRONSTEIN JL, 1990, ECOLOGY, V71, P2145, DOI 10.2307/1938628; Chen Y, 2014, ACTA OECOL, V57, P142, DOI 10.1016/j.actao.2013.10.001; Chen Y, 2012, MOL ECOL, V21, P1687, DOI 10.1111/j.1365-294X.2012.05491.x; Chen Yan, 2010, Shengwu Duoyangxing, V18, P1, DOI 10.3724/SP.J.1003.2010.001; Compton SG, 2009, AFR ENTOMOL, V17, P215, DOI 10.4001/003.017.0212; CONDIT IRA J., 1955, HILGARDIA, V23, P323; Cook JM, 2003, TRENDS ECOL EVOL, V18, P241, DOI 10.1016/S0169-5347(03)00062-4; Cornille A, 2012, P ROY SOC B-BIOL SCI, V279, P1731, DOI 10.1098/rspb.2011.1972; Cruaud A, 2012, SYST BIOL, V61, P1029, DOI 10.1093/sysbio/sys068; Dambroski HR, 2007, J EVOLUTION BIOL, V20, P2101, DOI 10.1111/j.1420-9101.2007.01435.x; Dull C, 1992, THESIS U MIAMI CORAL; Elzinga JA, 2007, TRENDS ECOL EVOL, V22, P432, DOI 10.1016/j.tree.2007.05.006; Fenner Michael, 1998, Perspectives in Plant Ecology Evolution and Systematics, V1, P78, DOI 10.1078/1433-8319-00053; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; GALIL J, 1968, NEW PHYTOL, V67, P745, DOI 10.1111/j.1469-8137.1968.tb05497.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Harrison RD, 2000, P ROY SOC B-BIOL SCI, V267, P911, DOI 10.1098/rspb.2000.1089; JANZEN DH, 1979, ANNU REV ECOL SYST, V10, P13, DOI 10.1146/annurev.es.10.110179.000305; Kerdelhue C, 1997, BIOTROPICA, V29, P69, DOI 10.1111/j.1744-7429.1997.tb00007.x; KJELLBERG F, 1987, EVOLUTION, V41, P693, DOI 10.1111/j.1558-5646.1987.tb05846.x; KJELLBERG F, 1988, P K NED AKAD C BIOL, V91, P117; Kjellberg F, 2005, BIOL ECOLOGY EVOLUTI, V1, P539; Kjellberg F, 2014, ACTA OECOL, V57, P73, DOI 10.1016/j.actao.2013.11.002; Lin RC, 2011, BIOTROPICA, V43, P200, DOI 10.1111/j.1744-7429.2010.00686.x; Liu M, 2013, MOL ECOL, V22, P4384, DOI 10.1111/mec.12406; Liu M, 2009, CONSERV GENET RESOUR, V1, P189, DOI 10.1007/s12686-009-9046-3; Luo GT, 2000, CHINESE J ECOL, V19, P73; Ma Weiliang, 1989, Acta Ecologica Sinica, V9, P9; Michaloud G, 1996, J BIOGEOGR, V23, P513, DOI 10.1111/j.1365-2699.1996.tb00013.x; Molbo D, 2003, P NATL ACAD SCI USA, V100, P5867, DOI 10.1073/pnas.0930903100; Molbo D, 2004, MOL ECOL, V13, P1613, DOI 10.1111/j.1365-294X.2004.02158.x; Ni J, 2010, PALAEOGEOGR PALAEOCL, V289, P44, DOI 10.1016/j.palaeo.2010.02.008; OLLERTON J, 1992, TRENDS ECOL EVOL, V7, P274, DOI 10.1016/0169-5347(92)90175-B; Patel A, 1996, J ECOL, V84, P667, DOI 10.2307/2261330; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Ronsted N, 2008, SYMBIOSIS, V45, P45; Sambrook J., 1989, MOL CLONING LAB MANU; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Smith CM, 1996, J BIOGEOGR, V23, P477, DOI 10.1111/j.1365-2699.1996.tb00009.x; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Suleman N, 2011, PLANT SYST EVOL, V296, P245, DOI 10.1007/s00606-011-0491-6; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomson JD, 2010, PHILOS T R SOC B, V365, P3187, DOI 10.1098/rstb.2010.0115; Tzeng HY, 2006, BOT STUD, V47, P307; VALDEYRON G, 1979, EVOLUTION, V33, P673, DOI 10.1111/j.1558-5646.1979.tb04720.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang R, 2009, POPUL ECOL, V51, P307, DOI 10.1007/s10144-008-0126-0; WARE AB, 1992, BIOTROPICA, V24, P544, DOI 10.2307/2389018; Whipple AV, 2009, J EVOLUTION BIOL, V22, P793, DOI 10.1111/j.1420-9101.2009.01690.x; Zhang DY, 2004, ECOL LETT, V7, P165, DOI 10.1111/j.1461-0248.2004.00569.x; Zhang J, 2011, AM J BOT, V98, pE170, DOI 10.3732/ajb.1000340; Zhang Y, 2012, EVOL ECOL, V26, P513, DOI 10.1007/s10682-011-9525-3; 李宏庆, 2001, 生态学报, V21, P1385	55	15	18	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97783	10.1371/journal.pone.0097783	http://dx.doi.org/10.1371/journal.pone.0097783			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849458	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600060
J	Rhodes, HJ; Stevenson, RJ; Ego, CL				Rhodes, Heather J.; Stevenson, Rachel J.; Ego, Courtney L.			Male-Male Clasping May Be Part of an Alternative Reproductive Tactic in Xenopus laevis	PLOS ONE			English	Article							FROG CRINIA-GEORGIANA; VOCAL COMMUNICATION; SEX RECOGNITION; BEHAVIOR; COMPETITION; STRATEGIES; POLYANDRY; DIVERSITY; ANURANS; BUFO	Male Xenopus laevis frogs have been observed to clasp other males in a sustained, amplectant position, the purpose of which is unknown. We examined three possible hypotheses for this counter-intuitive behavior: 1) clasping males fail to discriminate the sex of the frogs they clasp; 2) male-male clasping is an aggressive or dominant behavior; or 3) that males clasp other males to gain proximity to breeding events and possibly engage in sperm competition. Our data, gathered through a series of behavioral experiments in the laboratory, refute the first two hypotheses. We found that males did not clasp indiscriminately, but showed a sex preference, with most males preferentially clasping a female, but a proportion preferentially clasping another male. Males that clasped another male when there was no female present were less likely to "win'' reproductive access in a male-male-female triad, indicating that they did not establish dominance through clasping. However, those males did gain proximity to oviposition by continued male-male clasping in the presence of the female. Thus, our findings are consistent with, but cannot confirm, the third hypothesis of male-male clasping as an alternative reproductive tactic.	[Rhodes, Heather J.; Stevenson, Rachel J.; Ego, Courtney L.] Denison Univ, Dept Biol, Granville, OH 43023 USA; [Stevenson, Rachel J.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Denison University; Brown University	Rhodes, HJ (corresponding author), Denison Univ, Dept Biol, Granville, OH 43023 USA.	rhodesh@denison.edu		Rhodes, Heather J./0000-0003-0333-683X	Denison University; J. Reid and Polly Anderson Endowed Fund	Denison University; J. Reid and Polly Anderson Endowed Fund	This work has been supported by Denison University start up funds to HJR; Denison University Research Fund award to HJR; and J. Reid and Polly Anderson Endowed Fund awards to RJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arak A., 1983, P181; Belanger RM, 2009, J HERPETOL, V43, P184, DOI 10.1670/08-054R1.1; Bowcock H, 2009, COPEIA, P29, DOI 10.1643/CE-08-036; CREWS D, 1986, SCIENCE, V231, P121, DOI 10.1126/science.3941893; Darwin G., 1871, P423; Donner KO, 1965, SOC SCI FENNICA COMM, V28, P1; ELEPFANDT A, 1996, BIOL XENOPUS, P97; Elliott TM, 2007, J EXP BIOL, V210, P2836, DOI 10.1242/jeb.003988; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; Haddad CFB, 2005, BIOSCIENCE, V55, P207, DOI 10.1641/0006-3568(2005)055[0207:RMIFAT]2.0.CO;2; Halliday T.R., 1983, P3; Hettyey A., 2005, Herpetological Review, V36, P33; Hettyey A, 2007, BEHAV ECOL SOCIOBIOL, V61, P1303, DOI 10.1007/s00265-007-0361-y; JENNIONS MD, 1992, ANIM BEHAV, V44, P1091, DOI 10.1016/S0003-3472(05)80321-5; Kelley DB, 2004, CURR OPIN NEUROBIOL, V14, P751, DOI 10.1016/j.conb.2004.10.015; KELLEY DB, 1982, HORM BEHAV, V16, P158, DOI 10.1016/0018-506X(82)90016-2; Kelley DB, 1999, DESIGN OF ANIMAL COMMUNICATION, P9; KELLEY DB, 1996, BIOL XENOPUS; Koenig WD, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P451, DOI 10.1017/CBO9780511542602.020; LUCAS JR, 1995, AM NAT, V146, P365, DOI 10.1086/285805; Marco A, 2002, ETHOL ECOL EVOL, V14, P1; PICKER MD, 1983, BEHAVIOUR, V84, P74, DOI 10.1163/156853983X00291; Rhen T, 2002, J NEUROENDOCRINOL, V14, P517, DOI 10.1046/j.1365-2826.2002.00820.x; Roberts JD, 2011, ADV STUD BEHAV, V43, P1, DOI 10.1016/B978-0-12-380896-7.00001-0; Roberts JD, 1999, ANIM BEHAV, V57, P721, DOI 10.1006/anbe.1998.1019; Taborsky M, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P1, DOI 10.1017/CBO9780511542602.002; TINSLEY RC, 1996, BIOL XENOPUS, P35; Tobias ML, 2010, BEHAV ECOL SOCIOBIOL, V64, P1791, DOI 10.1007/s00265-010-0991-3; Tobias ML, 2004, ANIM BEHAV, V67, P353, DOI 10.1016/j.anbehav.2003.03.016; Vignal C, 2007, P ROY SOC B-BIOL SCI, V274, P479, DOI 10.1098/rspb.2006.3744; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; WELLS KD, 1977, ANIM BEHAV, V25, P666, DOI 10.1016/0003-3472(77)90118-X; Xu F, 2012, BEHAV ECOL, V23, P307, DOI 10.1093/beheco/arr187; YAGER DD, 1996, BIOL XENOPUS, P121; Yu TL, 2012, ZOOL SCI, V29, P347, DOI 10.2108/zsj.29.347; Zamudio KR, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P300, DOI 10.1017/CBO9780511542602.012	36	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97761	10.1371/journal.pone.0097761	http://dx.doi.org/10.1371/journal.pone.0097761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	24849114	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600056
J	Du, MW; Li, Y; Tian, XL; Duan, LS; Zhang, MC; Tan, WM; Xu, DY; Li, ZH				Du, Mingwei; Li, Yi; Tian, Xiaoli; Duan, Liusheng; Zhang, Mingcai; Tan, Weiming; Xu, Dongyong; Li, Zhaohu			The Phytotoxin Coronatine Induces Abscission-Related Gene Expression and Boll Ripening during Defoliation of Cotton	PLOS ONE			English	Article							ETHYLENE BIOSYNTHESIS; FRUIT ABSCISSION; DIFFERENTIAL EXPRESSION; METHYL JASMONATE; LEAF ABSCISSION; IN-VITRO; QUALITY; ACID; INDUCTION; SYNTHASE	Defoliants can increase machine harvest efficiency of cotton (Gossypium hirusutum L.), prevent lodging and reduce the time from defoliation to harvest. Coronatine (COR) is a chlorosis-inducing non-host-specific phytotoxin that induces leaf and/or fruit abscission in some crops. The present study investigates how COR might induce cotton leaf abscission by modulating genes involved in cell wall hydrolases and ACC (ethylene precursor) in various cotton tissues. The effects of COR on cotton boll ripening, seedcotton yield, and seed development were also studied. After 14 d of treatment with COR, cells within the leaf abscission zone (AZ) showed marked differentiation. Elevated transcripts of GhCEL1, GhPG and GhACS were observed in the AZs treated with COR and Thidiazuron (TDZ). The relative expression of GhCEL1 and GhACS in TDZ treated plants was approximately twice that in plants treated with COR for 12 h. However, only GhACS expression increased in leaf blade and petiole. There was a continuous increase in the activity of hydrolytic enzymes such as cellulase (CEL) and polygalacturonase (PG), and ACC accumulation in AZs following COR and TDZ treatments, but there was greater increase in ACC activity of COR treated boll crust, indicating that COR had greater ripening effect than TDZ. Coronatine significantly enhanced boll opening without affecting boll weight, lint percentage and seed quality. Therefore, COR can be a potential cotton defoliant with different physiological mechanism of action from the currently used TDZ.	[Du, Mingwei; Li, Yi; Tian, Xiaoli; Duan, Liusheng; Zhang, Mingcai; Tan, Weiming; Li, Zhaohu] China Agr Univ, Coll Agron & Biotechnol, Engn Res Ctr Plant Growth Regulator, State Key Lab Plant Physiol & Biochem,Minist Educ, Beijing 100094, Peoples R China; [Xu, Dongyong] Hebei Prov Engn Res Ctr Cotton Seed, Hejian, Hebei, Peoples R China	China Agricultural University	Li, ZH (corresponding author), China Agr Univ, Coll Agron & Biotechnol, Engn Res Ctr Plant Growth Regulator, State Key Lab Plant Physiol & Biochem,Minist Educ, Beijing 100094, Peoples R China.	lizhaohu@cau.edu.cn	Duan, Liusheng/F-8954-2011; li, zh/HII-5698-2022	Duan, Liusheng/0000-0003-0323-9378	National Natural Science Foundation of China [31301257]; Special Fund for Agro-scientific Research in the Public Interest [201203057-02]; China Agriculture Research System [CARS-18-18]; China Postdoctoral Science Foundation [2013M530077]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; China Agriculture Research System; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (31301257), the Special Fund for Agro-scientific Research in the Public Interest (201203057-02), China Agriculture Research System (CARS-18-18), and China Postdoctoral Science Foundation (2013M530077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander L, 2002, J EXP BOT, V53, P2039, DOI 10.1093/jxb/erf072; Ayala F, 2001, PHYSL COTTON DEFOLIA, P1240; Bange MP, 2011, AGRON J, V103, P390, DOI 10.2134/agronj2010.0293; Barry CS, 2000, PLANT PHYSIOL, V123, P979, DOI 10.1104/pp.123.3.979; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; Benedetti CE, 1998, PLANT PHYSIOL, V116, P1037, DOI 10.1104/pp.116.3.1037; Braun Y, 2009, SENSORS-BASEL, V9, P4272, DOI 10.3390/s90604272; Brown KM, 1997, PHYSIOL PLANTARUM, V100, P567, DOI 10.1034/j.1399-3054.1997.1000319.x; Brummell DA, 1999, PLANT MOL BIOL, V40, P615, DOI 10.1023/A:1006269031452; Burns JK, 2003, J AM SOC HORTIC SCI, V128, P309, DOI 10.21273/JASHS.128.3.0309; Cintas NA, 2002, PLANT DIS, V86, P992, DOI 10.1094/PDIS.2002.86.8.921A; Collins GD, 2007, COTT RES C; Faircloth JC, 2004, CROP SCI, V44, P165, DOI 10.2135/cropsci2004.0165; Fan XT, 1998, PLANTA, V204, P444, DOI 10.1007/s004250050278; FERGUSON IB, 1985, PLANT PHYSIOL, V77, P969, DOI 10.1104/pp.77.4.969; Garcia-Garrido JM, 2000, J EXP BOT, V51, P1443, DOI 10.1093/jexbot/51.349.1443; Gonzalez-Carranza ZH, 2002, PLANT PHYSIOL, V128, P534, DOI 10.1104/pp.010610; Gonzalez-Carranza ZH, 2007, J EXP BOT, V58, P3719, DOI 10.1093/jxb/erm222; Gwathmey C. O., 1997, Journal of Cotton Science, V1, P1; Gwathmey CO, 2006, ENCY PEST MANAGEMENT, V1, P1; Haider G, 2000, BIOL CHEM, V381, P741, DOI 10.1515/BC.2000.094; Hartmond U, 2000, J AM SOC HORTIC SCI, V125, P547, DOI 10.21273/JASHS.125.5.547; KENDE H, 1993, ANNU REV PLANT PHYS, V44, P283, DOI 10.1146/annurev.pp.44.060193.001435; KENYON JS, 1992, PLANT PHYSIOL, V100, P219, DOI 10.1104/pp.100.1.219; Koch T, 1999, PLANT PHYSIOL, V121, P153, DOI 10.1104/pp.121.1.153; Koda Y, 1996, PHYTOCHEMISTRY, V41, P93, DOI 10.1016/0031-9422(95)00517-X; Kumar A, 1996, PLANT J, V9, P147, DOI 10.1046/j.1365-313X.1996.09020147.x; LANAHAN MB, 1994, PLANT CELL, V6, P521, DOI 10.1105/tpc.6.4.521; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malladi A, 2008, J EXP BOT, V59, P3729, DOI 10.1093/jxb/ern224; METZGER JD, 1984, J PLANT GROWTH REGUL, V3, P141, DOI 10.1007/BF02041999; Mishra A, 2008, S AFR J BOT, V74, P282, DOI 10.1016/j.sajb.2007.12.001; Miyamoto K, 1997, PHYSIOL PLANTARUM, V100, P631, DOI 10.1034/j.1399-3054.1997.1000326.x; Nakatsuka A, 1998, PLANT PHYSIOL, V118, P1295, DOI 10.1104/pp.118.4.1295; PALMER DA, 1993, APPL ENVIRON MICROB, V59, P1619, DOI 10.1128/AEM.59.5.1619-1626.1993; Parra-Lobato MC, 2011, J EXP BOT, V62, P4447, DOI 10.1093/jxb/err124; Patterson SE, 2001, PLANT PHYSIOL, V126, P494, DOI 10.1104/pp.126.2.494; PERNER B, 1994, J PHYTOPATHOL, V142, P27, DOI 10.1111/j.1439-0434.1994.tb00004.x; Roberts JA, 2002, ANNU REV PLANT BIOL, V53, P131, DOI 10.1146/annurev.arplant.53.092701.180236; Sakamoto M, 2008, PLANT J, V56, P13, DOI 10.1111/j.1365-313X.2008.03577.x; Schuler G, 2004, FEBS LETT, V563, P17, DOI 10.1016/S0014-5793(04)00239-X; Siebert JD, 2006, J COTTON SCI, V10, P146; SMITH CW, 1986, AGRON J, V78, P814, DOI 10.2134/agronj1986.00021962007800050014x; SNIPES CE, 1992, FIELD CROP RES, V28, P327, DOI 10.1016/0378-4290(92)90018-5; SNIPES CE, 1994, FIELD CROP RES, V37, P137, DOI 10.1016/0378-4290(94)90042-6; SNIPES CE, 1994, WEED SCI, V42, P13, DOI 10.1017/S0043174500084095; Stelmach BA, 1999, PHYTOCHEMISTRY, V51, P187, DOI 10.1016/S0031-9422(99)00017-5; Stewart EM, 2000, FIELD CROP RES, V67, P83, DOI 10.1016/S0378-4290(00)00093-9; Sunilkumar G, 2006, P NATL ACAD SCI USA, V103, P18054, DOI 10.1073/pnas.0605389103; SUTTLE JC, 1985, PLANT PHYSIOL, V78, P272, DOI 10.1104/pp.78.2.272; SUTTLE JC, 1988, PLANT PHYSIOL, V86, P241, DOI 10.1104/pp.86.1.241; Taylor JE, 2001, NEW PHYTOL, V151, P323, DOI 10.1046/j.0028-646x.2001.00194.x; Uppalapati SR, 2005, PLANT J, V42, P201, DOI 10.1111/j.1365-313X.2005.02366.x; van Nocker SJSPR., 2009, STEWART POSTHARVEST, V5, P5, DOI DOI 10.2212/SPR.2009.1.5; Wang HF, 2010, PROTOPLASMA, V247, P111, DOI 10.1007/s00709-010-0159-z; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; WILKINSON JQ, 1995, SCIENCE, V270, P1807, DOI 10.1126/science.270.5243.1807; Wu HL, 2012, J PLANT GROWTH REGUL, V31, P113, DOI 10.1007/s00344-011-9224-x; Xia XJ, 2011, NEW PHYTOL, V191, P706, DOI 10.1111/j.1469-8137.2011.03745.x; Xie ZX, 2008, J PLANT PHYSIOL, V165, P375, DOI 10.1016/j.jplph.2007.06.001; Yuan RC, 2005, J EXP BOT, V56, P1867, DOI 10.1093/jxb/eri176	61	15	21	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97652	10.1371/journal.pone.0097652	http://dx.doi.org/10.1371/journal.pone.0097652			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	24845465	gold, Green Submitted, Green Published			2022-12-25	WOS:000339563400041
J	McMillan, M; Pereg, L				McMillan, Mary; Pereg, Lily			Evaluation of Reference Genes for Gene Expression Analysis Using Quantitative RT-PCR in Azospirillum brasilense	PLOS ONE			English	Article							IN-VITRO GROWTH; HOUSEKEEPING GENES; SURFACE COLONIZATION; FLOCCULATION; SELECTION; DIFFERENTIATION; QUANTIFICATION; NORMALIZATION; STRESS; FLCA	Azospirillum brasilense is a nitrogen fixing bacterium that has been shown to have various beneficial effects on plant growth and yield. Under normal conditions A. brasilense exists in a motile flagellated form, which, under starvation or stress conditions, can undergo differentiation into an encapsulated, cyst-like form. Quantitative RT-PCR can be used to analyse changes in gene expression during this differentiation process. The accuracy of quantification of mRNA levels by qRT-PCR relies on the normalisation of data against stably expressed reference genes. No suitable set of reference genes has yet been described for A. brasilense. Here we evaluated the expression of ten candidate reference genes (16S rRNA, gapB, glyA, gyrA, proC, pykA, recA, recF, rpoD, and tpiA) in wild-type and mutant A. brasilense strains under different culture conditions, including conditions that induce differentiation. Analysis with the software programs BestKeeper, NormFinder and GeNorm indicated that gyrA, glyA and recA are the most stably expressed reference genes in A. brasilense. The results also suggested that the use of two reference genes (gyrA and glyA) is sufficient for effective normalisation of qRT-PCR data.	[McMillan, Mary; Pereg, Lily] Univ New England, Sch Sci & Technol, Armidale, NSW, Australia	University of New England	Pereg, L (corresponding author), Univ New England, Sch Sci & Technol, Armidale, NSW, Australia.	lily.pereg@une.edu.au		McMillan, Mary/0000-0002-2336-3985	University of New England	University of New England	Funding provided by the University of New England. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bashan Y, 2002, APPL ENVIRON MICROB, V68, P2637, DOI 10.1128/AEM.68.6.2637-2643.2002; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Cappelli K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-49; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Edwards KJ, 2001, J APPL MICROBIOL, V91, P29, DOI 10.1046/j.1365-2672.2001.01339.x; Gerk LP, 2000, APPL ENVIRON MICROB, V66, P2175, DOI 10.1128/AEM.66.5.2175-2184.2000; Gonzalez A, 2013, FEBS LETT, V587, P2682, DOI 10.1016/j.febslet.2013.07.007; Hansen M, 2001, J BACTERIOOGY, V183; Herschkovitz Y, 2005, MICROB ECOL, V50, P277, DOI 10.1007/s00248-004-0148-x; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jacob TR, 2011, BIOTECHNOL LETT, V33, P1177, DOI 10.1007/s10529-011-0552-5; Joo MY, 2013, MED MYCOL, V51, P892, DOI 10.3109/13693786.2013.824623; KATUPITIYA S, 1995, APPL ENVIRON MICROB, V61, P1987, DOI 10.1128/AEM.61.5.1987-1995.1995; Kozera Bo, 2013, J APPL GENET, P1; Neretin LN, 2003, ENVIRON MICROBIOL, V5, P660, DOI 10.1046/j.1462-2920.2003.00452.x; Nielsen KK, 2005, APPL ENVIRON MICROB, V71, P2949, DOI 10.1128/AEM.71.6.2949-2954.2005; Pereg-Gerk L, 1998, MOL PLANT MICROBE IN, V11, P177, DOI 10.1094/MPMI.1998.11.3.177; Pereg-Gerk L, 2004, SOIL BIOL BIOCHEM, V36, P1245, DOI 10.1016/j.soilbio.2004.04.005; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Qin LX, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-23; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; SADASIVAN L, 1987, J BACTERIOL, V169, P1670, DOI 10.1128/jb.169.4.1670-1677.1987; SADASIVAN L, 1985, J BACTERIOL, V163, P716, DOI 10.1128/JB.163.2.716-723.1985; Schloter M, 1998, SYMBIOSIS, V25, P159; Steenhoudt O, 2000, FEMS MICROBIOL REV, V24, P487, DOI 10.1111/j.1574-6976.2000.tb00552.x; Suslov O, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni176; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Takle GW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-50; Theis T, 2007, J MICROBIOL METH, V70, P355, DOI 10.1016/j.mimet.2007.05.011; Vandecasteele SJ, 2001, J BACTERIOL, V183, P7094, DOI 10.1128/JB.183.24.7094-7101.2001; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Zhao WJ, 2011, J IND MICROBIOL BIOT, V38, P1279, DOI 10.1007/s10295-010-0906-3	34	39	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e98162	10.1371/journal.pone.0098162	http://dx.doi.org/10.1371/journal.pone.0098162			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	24841066	Green Published, gold, Green Submitted			2022-12-25	WOS:000340948600111
J	Lin, Y; Fang, ZF; Che, LQ; Xu, SY; Wu, D; Wu, CM; Wu, XQ				Lin, Yan; Fang, Zheng-feng; Che, Lian-qiang; Xu, Sheng-yu; Wu, De; Wu, Cai-mei; Wu, Xiu-qun			Use of Sodium Butyrate as an Alternative to Dietary Fiber: Effects on the Embryonic Development and Anti-Oxidative Capacity of Rats	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; SUBSTRATE-INDUCED REGULATION; OXIDATIVE STRESS; MONOCARBOXYLATE TRANSPORTER; CELL PROLIFERATION; GENE-EXPRESSION; IMPROVES; SUPPLEMENTATION; MECHANISMS; PLACENTA	In this study, we evaluated the effect of replacing dietary fiber with sodium butyrate on reproductive performance and antioxidant defense in a high fat diet during pregnancy by using a rat model. Eighty virgin female Sprague Dawley rats were fed one of four diets-(1) control diet (C group), (2) high fat + high fiber diet (HF group), (3) high-fat + 5% sodium butyrate diet (SB group), and (4) HF diet + alpha-cyano-4-hydroxy cinnamic acid (CHC group)-intraperitoneally on days 8, 10, 12, 14, and 16 of gestation. SB and dietary fiber had similar effects on improving fetal number and reducing the abortion rate; however, the anti-oxidant capacity of maternal serum, placenta, and fetus was superior in the HF group than in the SB group. In comparison, CHC injection decreased reproductive performance and antioxidant defense. Both dietary fiber (DF) and SB supplementation had a major but different effect on the expression of anti-oxidant related genes and nutrient transporters genes. In summary, our data indicate that SB and DF showed similar effect on reproductive performance, but SB cannot completely replace the DF towards with respect to redox regulation in high-fat diet; and SB might influence offspring metabolism and health differently to DF.	[Wu, De] Sichuan Agr Univ, Key Lab Anim Dis Resistance Nutr, Minist Educ, Yaan, Sichuan, Peoples R China; Sichuan Agr Univ, Inst Anim Nutr, Yaan, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Wu, D (corresponding author), Sichuan Agr Univ, Key Lab Anim Dis Resistance Nutr, Minist Educ, Yaan, Sichuan, Peoples R China.	pig2pig@sina.com		Lin, Yu-Hsuan/0000-0001-9393-3886; Chen, Sue-Huie/0000-0001-6737-2966; CHANG, LI-REN/0000-0003-0853-3904				Abrahamse SL, 1999, CARCINOGENESIS, V20, P629, DOI 10.1093/carcin/20.4.629; Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x; Andoh A, 1999, JPEN-PARENTER ENTER, V23, pS70, DOI 10.1177/014860719902300518; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; BOERNER P, 1988, J CELL PHYSIOL, V137, P117, DOI 10.1002/jcp.1041370114; Borthakur A, 2012, AM J PHYSIOL-GASTR L, V303, pG1126, DOI 10.1152/ajpgi.00308.2012; Buege J A, 1978, Methods Enzymol, V52, P302; Che L, 2011, REPROD DOMEST ANIM, V46, P1061, DOI 10.1111/j.1439-0531.2011.01787.x; Chung HW, 2012, NEPHROL DIAL TRANSPL, V27, P2213, DOI 10.1093/ndt/gfr613; CLAUSEN MR, 1994, GASTROENTEROLOGY, V106, P423, DOI 10.1016/0016-5085(94)90601-7; Clemens R, 2012, J NUTR, V142, p1390S, DOI 10.3945/jn.112.160176; Cuff MA, 2002, J PHYSIOL-LONDON, V539, P361, DOI 10.1113/jphysiol.2001.014241; da Silva CS, 2013, PHYSIOL BEHAV, V110, P148, DOI 10.1016/j.physbeh.2013.01.006; Dalmasso G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002476; Daly K, 2006, DNA CELL BIOL, V25, P49, DOI 10.1089/dna.2006.25.49; Das ZC, 2010, CELL REPROGRAM, V12, P95, DOI 10.1089/cell.2009.0068; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; Dgen L, 2009, ACTA AGR SCAND, V59, P150; Lopez-Oliva ME, 2013, BRIT J NUTR, V109, P4, DOI 10.1017/S0007114512000517; FERNANDEZMEJIA C, 1993, PANCREAS, V8, P589, DOI 10.1097/00006676-199309000-00010; Fung KYC, 2012, BRIT J NUTR, V108, P820, DOI 10.1017/S0007114512001948; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Gill RK, 2005, AM J PHYSIOL-CELL PH, V289, pC846, DOI 10.1152/ajpcell.00112.2005; Goicoa S, 2006, CLONING STEM CELLS, V8, P140, DOI 10.1089/clo.2006.8.140; GOODGER AM, 1993, J REPROD FERTIL, V99, P451, DOI 10.1530/jrf.0.0990451; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Hamer HM, 2009, CLIN NUTR, V28, P88, DOI 10.1016/j.clnu.2008.11.002; Hara H, 1999, J NUTR, V129, P942, DOI 10.1093/jn/129.5.942; Hashimoto T, 2007, FASEB J, V21, P2602, DOI 10.1096/fj.07-8174com; Ichikawa H, 2002, DIGEST DIS SCI, V47, P1141, DOI 10.1023/A:1015014829605; Kirat D, 2010, J COMP PHYSIOL B, V180, P57, DOI 10.1007/s00360-009-0382-0; Kumar AP, 2010, J FOOD BIOCHEM, V34, P15, DOI 10.1111/j.1745-4514.2009.00284.x; Kuo Dar-Chih, 2009, J Biomed Sci, V16, P15, DOI 10.1186/1423-0127-16-15; Le Gall M, 2009, BRIT J NUTR, V102, P1285, DOI 10.1017/S0007114509990213; Lecumberri E, 2007, NUTRITION, V23, P332, DOI 10.1016/j.nut.2007.01.013; Lee SH, 2002, J ANIM SCI, V80, P2840; Li N, 2010, J PEDIATR GASTR NUTR, V51, P414, DOI 10.1097/MPG.0b013e3181dd913a; Lin Y, 2012, NUTRITION, V28, P1037, DOI 10.1016/j.nut.2012.01.002; Lin Y, 2011, BRIT J NUTR, V106, P510, DOI 10.1017/S0007114511000614; Liu LM, 2012, J EXP ZOOL PART B, V318B, P224, DOI 10.1002/jez.b.22440; Lu H, 2012, J ANIM SCI, V90, P430, DOI 10.2527/jas.53817; Mangian HF, 2009, JPEN-PARENTER ENTER, V33, P607, DOI 10.1177/0148607109336599; Marzioni D, 1998, HUM REPROD, V13, P1717, DOI 10.1093/humrep/13.6.1717; Moslehi M, 2013, CELL BIOCHEM BIOPHYS, V66, P817, DOI 10.1007/s12013-013-9526-7; MURASE M, 1995, J CHROMATOGR B, V664, P415, DOI 10.1016/0378-4347(94)00491-M; Nagai A, 2010, PLACENTA, V31, P126, DOI 10.1016/j.placenta.2009.11.013; REMESY C, 1992, NUTR RES, V12, P1235, DOI 10.1016/S0271-5317(05)80780-8; Russo I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032841; Salminen S, 1998, BRIT J NUTR, V80, pS147, DOI 10.1079/BJN19980108; Sauer J, 2007, J NUTR BIOCHEM, V18, P736, DOI 10.1016/j.jnutbio.2006.12.012; Scharlau D, 2009, MUTAT RES-REV MUTAT, V682, P39, DOI 10.1016/j.mrrev.2009.04.001; Sharma B, 2011, PSYCHOPHARMACOLOGY, V215, P677, DOI 10.1007/s00213-011-2164-0; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Shin JH, 2013, GENE REGUL SYST BIO, V7, P57, DOI 10.4137/GRSB.S11243; Tappenden KA, 1998, AM J CLIN NUTR, V68, P118, DOI 10.1093/ajcn/68.1.118; Tzanetakou IP, 2011, OPEN CARDIOVASC MED, V5, P103, DOI 10.2174/1874192401105010103; Zimmermann AK, 2007, J BIOL CHEM, V282, P29296, DOI 10.1074/jbc.M702853200; Zubova S G, 2008, Tsitologiia, V50, P964	58	163	166	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97838	10.1371/journal.pone.0097838	http://dx.doi.org/10.1371/journal.pone.0097838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24896252	Green Published, gold, Green Submitted			2022-12-25	WOS:000338323200031
J	Zhang, DP; Chen, L; Li, DH; Lv, B; Chen, Y; Chen, JG; Yan, XJ; Liang, JS				Zhang, Dongping; Chen, Li; Li, Dahong; Lv, Bing; Chen, Yun; Chen, Jingui; Yan, Xuejiao; Liang, Jiansheng			OsRACK1 Is Involved in Abscisic Acid- and H2O2-Mediated Signaling to Regulate Seed Germination in Rice (Oryza sativa, L.)	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; PROTEOMIC ANALYSIS; INNATE IMMUNITY; ABA CATABOLISM; RACK1; DORMANCY; PROTEIN; GENE; TRANSCRIPTION; NETWORKS	The receptor for activated C kinase 1 (RACK1) is one member of the most important WD repeat-containing family of proteins found in all eukaryotes and is involved in multiple signaling pathways. However, compared with the progress in the area of mammalian RACK1, our understanding of the functions and molecular mechanisms of RACK1 in the regulation of plant growth and development is still in its infancy. In the present study, we investigated the roles of rice RACK1A gene (OsRACK1A) in controlling seed germination and its molecular mechanisms by generating a series of transgenic rice lines, of which OsRACK1A was either over-expressed or under-expressed. Our results showed that OsRACK1A positively regulated seed germination and negatively regulated the responses of seed germination to both exogenous ABA and H2O2. Inhibition of ABA biosynthesis had no enhancing effect on germination, whereas inhibition of ABA catabolism significantly suppressed germination. ABA inhibition on seed germination was almost fully recovered by exogenous H2O2 treatment. Quantitative analyses showed that endogenous ABA levels were significantly higher and H2O2 levels significantly lower in OsRACK1A-down regulated transgenic lines as compared with those in wildtype or OsRACK1A-up regulated lines. Quantitative real-time PCR analyses showed that the transcript levels of OsRbohs and amylase genes, RAmy1A and RAmy3D, were significantly lower in OsRACK1A-down regulated transgenic lines. It is concluded that OsRACK1A positively regulates seed germination by controlling endogenous levels of ABA and H2O2 and their interaction.	[Zhang, Dongping; Chen, Li; Lv, Bing; Chen, Yun; Yan, Xuejiao; Liang, Jiansheng] Yangzhou Univ, Coll Biosci & Biotechnol, Dept Biotechnol, Yangzhou, Jiangsu, Peoples R China; [Li, Dahong] Huanghuai Univ, Dept Biol Engn, Zhumadian City, Henan Province, Peoples R China; [Chen, Jingui] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA	Yangzhou University; Huanghuai University; United States Department of Energy (DOE); Oak Ridge National Laboratory	Liang, JS (corresponding author), Yangzhou Univ, Coll Biosci & Biotechnol, Dept Biotechnol, Yangzhou, Jiangsu, Peoples R China.	jsliang@yzu.edu.cn	Chen, Jin-Gui/AFV-6337-2022; Chen, Jin-Gui/A-4773-2011; Zhang, Dongping/AAD-9164-2019	Chen, Jin-Gui/0000-0002-1752-4201; Chen, Jin-Gui/0000-0002-1752-4201; Zhang, Dongping/0000-0001-8564-8348; Yu, Jianming/0000-0001-5326-3099	National Science Foundation of China [31271622]; Hi-Tech Research and Development Program ("863" project) from the Ministry of Science and Technology of China [2008AA10Z120]; College Postgraduate Research and Innovation Project in Jiangsu Province; University Innovation Training Program of Jiangsu Province	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program ("863" project) from the Ministry of Science and Technology of China; College Postgraduate Research and Innovation Project in Jiangsu Province; University Innovation Training Program of Jiangsu Province	This work was supported by the National Science Foundation of China (grant no: 31271622 to JSL) and the Hi-Tech Research and Development Program ("863" project) from the Ministry of Science and Technology of China (grant no: 2008AA10Z120 to JSL), and by the College Postgraduate Research and Innovation Project in Jiangsu Province (to DPZ) and University Innovation Training Program of Jiangsu Province (to SJY) for research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DR, 2011, CELL COMMUN SIGNAL, V9, P823; Bahin E, 2011, PLANT CELL ENVIRON, V34, P980, DOI 10.1111/j.1365-3040.2011.02298.x; Bailly C, 2004, SEED SCI RES, V14, P93, DOI 10.1079/SSR2004159; Bailly C, 2008, CR BIOL, V331, P806, DOI 10.1016/j.crvi.2008.07.022; Barba-Espin G, 2010, PLANT CELL ENVIRON, V33, P981, DOI 10.1111/j.1365-3040.2010.02120.x; Bassel GW, 2008, PLANT PHYSIOL, V147, P143, DOI 10.1104/pp.107.110841; Bassel GW, 2011, P NATL ACAD SCI USA, V108, P9709, DOI 10.1073/pnas.1100958108; Belmonte MF, 2013, P NATL ACAD SCI USA, V110, pE435, DOI 10.1073/pnas.1222061110; Chaudhuri A., 2013, J PLANT BIOCH PHYSL, DOI [10.4172/jpbp.1000103, DOI 10.4172/JPBP.1000103]; Chen JG, 2006, J EXP BOT, V57, P2697, DOI 10.1093/jxb/erl035; Chen SH, 2004, J BIOL CHEM, V279, P17861, DOI 10.1074/jbc.M313727200; Chen Y, 2006, PLANT PHYSIOL, V140, P302, DOI 10.1104/pp.105.069872; Cheng WH, 2002, PLANT CELL, V14, P2723, DOI 10.1105/tpc.006494; Diaz-Vivancos P, 2013, PLANT CELL REP, V32, P1491, DOI 10.1007/s00299-013-1473-7; El-Maarouf-Bouteau H, 2008, PLANT SIGNAL BEHAV, V3, P175, DOI 10.4161/psb.3.3.5539; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Gallardo K, 2001, PLANT PHYSIOL, V126, P835, DOI 10.1104/pp.126.2.835; Guo J., 2007, INT J PLANT DEV BIOL, V1, P95; Guo JJ, 2011, PLANT PHYSIOL, V155, P370, DOI 10.1104/pp.110.160663; Guo JJ, 2009, J EXP BOT, V60, P3819, DOI 10.1093/jxb/erp221; He DL, 2011, PROTEOMICS, V11, P2693, DOI 10.1002/pmic.201000598; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Howell KA, 2009, PLANT PHYSIOL, V149, P961, DOI 10.1104/pp.108.129874; Ishibashi Yushi, 2013, Ann Bot, V111, P95, DOI 10.1093/aob/mcs240; Ishibashi Y, 2008, PLANT SIGNAL BEHAV, V3, P183, DOI 10.4161/psb.3.3.5540; Ishida S, 1996, PLANT CELL PHYSIOL, V37, P439, DOI 10.1093/oxfordjournals.pcp.a028965; ISHIDA S, 1993, P NATL ACAD SCI USA, V90, P11152, DOI 10.1073/pnas.90.23.11152; Islas-Flores T, 2012, PLANT SIGNAL BEHAV, V7, P132, DOI 10.4161/psb.7.1.18485; Islas-Flores T, 2009, PHYSIOL PLANTARUM, V137, P264, DOI 10.1111/j.1399-3054.2009.01280.x; IWASAKI Y, 1995, PLANT CELL PHYSIOL, V36, P505, DOI 10.1093/oxfordjournals.pcp.a078786; Kim ST, 2008, PROTEOMICS, V8, P3577, DOI 10.1002/pmic.200800183; Kundu N, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24012; Leymarie J, 2012, PLANT CELL PHYSIOL, V53, P96, DOI 10.1093/pcp/pcr129; Li Da-hong, 2008, Zhongguo Shuidao Kexue, V22, P447; Li DC, 2011, ENZYM RES, V2011, DOI DOI 10.1016/J.CATT0D.2011.04.007; Liu Jian, 2012, PLoS One, V7, pe33817, DOI 10.1371/journal.pone.0033817; Liu YG, 2010, J EXP BOT, V61, P2979, DOI 10.1093/jxb/erq125; Muller K, 2010, PROTEOMICS, V10, P406, DOI 10.1002/pmic.200900548; Muller K, 2009, NEW PHYTOL, V184, P885, DOI 10.1111/j.1469-8137.2009.03005.x; Nakashima A, 2008, PLANT CELL, V20, P2265, DOI 10.1105/tpc.107.054395; Nonogaki H, 2010, PLANT SCI, V179, P574, DOI 10.1016/j.plantsci.2010.02.010; Okamoto M, 2010, PLANT J, V62, P39, DOI 10.1111/j.1365-313X.2010.04135.x; Oracz K, 2007, PLANT J, V50, P452, DOI 10.1111/j.1365-313X.2007.03063.x; Oracz K, 2009, PLANT PHYSIOL, V150, P494, DOI 10.1104/pp.109.138107; QUARRIE SA, 1988, PLANTA, V173, P330, DOI 10.1007/BF00401020; Sagi M, 2006, PLANT PHYSIOL, V141, P336, DOI 10.1104/pp.106.078089; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Wamaitha MJ, 2012, RICE, V5, DOI 10.1186/1939-8433-5-35; Wang PT, 2008, NEW PHYTOL, V178, P703, DOI 10.1111/j.1469-8137.2008.02431.x; Yang PF, 2007, PROTEOMICS, V7, P3358, DOI 10.1002/pmic.200700207; Ye NH, 2012, J EXP BOT, V63, P1809, DOI 10.1093/jxb/err336; Zhu GH, 2009, PLANT CELL PHYSIOL, V50, P644, DOI 10.1093/pcp/pcp022	53	33	37	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97120	10.1371/journal.pone.0097120	http://dx.doi.org/10.1371/journal.pone.0097120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	25072699	Green Published, gold			2022-12-25	WOS:000336914100011
J	Liu, W; Deng, LS; Song, YC; Redell, M				Liu, Wei; Deng, Lisheng; Song, Yongcheng; Redell, Michele			DOT1L Inhibition Sensitizes MLL-Rearranged AML to Chemotherapy	PLOS ONE			English	Article							RNA EXPRESSION LEVELS; HISTONE H2AX; H3K79 METHYLTRANSFERASE; METHYLATION; LINEAGE; CELLS; LEUKEMIA; CHEMORESISTANCE; TRANSLOCATIONS; RECRUITMENT	DOT1L, the only known histone H3-lysine 79 (H3K79) methyltransferase, has been shown to be essential for the survival and proliferation of mixed-linkage leukemia (MLL) gene rearranged leukemia cells, which are often resistant to conventional chemotherapeutic agents. To study the functions of DOT1L in MLL-rearranged leukemia, SYC-522, a potent inhibitor of DOT1L developed in our laboratory, was used to treat MLL-rearranged leukemia cell lines and patient samples. SYC-522 significantly inhibited methylation at H3K79, but not H3K4 or H3K27, and decreased the expression of two important leukemia-relevant genes, HOXA9 and MEIS1, by more than 50%. It also significantly reduced the expression of CCND1 and BCL2L1, which are important regulators of cell cycle and anti-apoptotic signaling pathways. Exposure of MLL-rearranged leukemia cells to this compound caused cell cycle arrest and promoted differentiation of those cells, both morphologically and by increased CD14 expression. SYC-522 did not induce apoptosis, even at 10 mM for as long as 6 days. However, treatment with this DOT1L inhibitor decreased the colony formation ability of primary MLL-rearranged AML cells by up to 50%, and promoted monocytic differentiation. Notably, SYC-522 treatment significantly increased the sensitivity of MLL-rearranged leukemia cells to chemotherapeutics, such as mitoxantrone, etoposide and cytarabine. A similar sensitization was seen with primary MLL-rearranged AML cells. SYC-522 did not affect chemotherapy-induced apoptosis in leukemia cells without MLL-rearrangement. Suppression of DOT1L activity inhibited the mitoxantrone-induced increase in the DNA damage response marker, cH2AX, and increased the level of cPARP, an intracellular marker of apoptosis. These results demonstrated that SYC-522 selectively inhibited DOT1L, and thereby altered gene expression, promoted differentiation, and increased chemosensitivity by preventing DNA damage response. Therefore, inhibition of DOT1L, in combination with DNA damaging chemotherapy, represents a promising approach to improving outcomes for MLL-rearranged leukemia.	[Liu, Wei; Redell, Michele] Baylor Coll Med, Dept Pediat, Hematol Oncol Sect, Houston, TX 77030 USA; [Deng, Lisheng; Song, Yongcheng] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Redell, M (corresponding author), Baylor Coll Med, Dept Pediat, Hematol Oncol Sect, Houston, TX 77030 USA.	mlredell@txch.org		Redell, Michele/0000-0002-2515-3703	Cancer Prevention & Research Institute of Texas [RP110050]; NIH/NHLBI [K08 HL085018]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL085018] Funding Source: NIH RePORTER	Cancer Prevention & Research Institute of Texas; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Cancer Prevention & Research Institute of Texas RP110050 (Y.S. and M. R.), www.cprit.state.tx.us; NIH/NHLBI K08 HL085018 (M.R.), www.nhlbi.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuzeid WM, 2009, J CLIN INVEST, V119, P1974, DOI 10.1172/JCI33816; Anglin JL, 2012, J MED CHEM, V55, P8066, DOI 10.1021/jm300917h; Nguyen AT, 2011, BLOOD, V117, P6912, DOI 10.1182/blood-2011-02-334359; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Balgobind BV, 2011, LEUKEMIA, V25, P1239, DOI 10.1038/leu.2011.90; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Chen L, 2013, MANAGE COMMUN Q, V27, P3, DOI 10.1177/0893318913475485; Daigle SR, 2013, BLOOD, V122, P1017, DOI 10.1182/blood-2013-04-497644; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Dantzer F, 2000, BIOCHEMISTRY-US, V39, P7559, DOI 10.1021/bi0003442; Deng LS, 2013, MEDCHEMCOMM, V4, P822, DOI 10.1039/c3md00021d; Deshpande AJ, 2013, BLOOD, V121, P2533, DOI 10.1182/blood-2012-11-465120; Dreyer ZE, 2011, J CLIN ONCOL, V29, P214, DOI 10.1200/JCO.2009.26.8938; Eissenberg JC, 2010, DEV BIOL, V339, P240, DOI 10.1016/j.ydbio.2009.08.017; Ferrando AA, 2003, BLOOD, V102, P262, DOI 10.1182/blood-2002-10-3221; Gannon OM, 2013, CLIN CANCER RES, V19, P428, DOI 10.1158/1078-0432.CCR-12-2505; Guenther MG, 2008, GENE DEV, V22, P3403, DOI 10.1101/gad.1741408; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Mohan M, 2010, NAT REV CANCER, V10, P720, DOI 10.1038/nrc2915; Neff T, 2013, BLOOD, V121, P4847, DOI 10.1182/blood-2013-02-474833; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Redell MS, 2013, BLOOD, V121, P1083, DOI 10.1182/blood-2012-04-421925; Roberts JM, 1999, CELL, V98, P129, DOI 10.1016/S0092-8674(00)81007-7; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schultz N, 2003, NUCLEIC ACIDS RES, V31, P4959, DOI 10.1093/nar/gkg703; Smulson ME, 1998, CANCER RES, V58, P3495; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Taron M, 2004, HUM MOL GENET, V13, P2443, DOI 10.1093/hmg/ddh260; Thiel AT, 2013, HAEMATOLOGICA, V98, P918, DOI 10.3324/haematol.2012.074195; Wakeman TP, 2012, EMBO J, V31, P2169, DOI 10.1038/emboj.2012.50; Walensky LD, 2006, CELL DEATH DIFFER, V13, P1339, DOI 10.1038/sj.cdd.4401992; Wang HY, 2005, J CELL PHYSIOL, V202, P492, DOI 10.1002/jcp.20141; Wang LF, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-97; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Wiltshire T, 2007, MOL PHARMACOL, V71, P1051, DOI 10.1124/mol.106.029504; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307	41	79	88	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98270	10.1371/journal.pone.0098270	http://dx.doi.org/10.1371/journal.pone.0098270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858818	gold, Green Published, Green Submitted			2022-12-25	WOS:000336839400062
J	Li, MM; Wu, MQ; Xu, J; Du, J; Yan, CH				Li, Min-ming; Wu, Mei-qin; Xu, Jian; Du, Juan; Yan, Chong-huai			Body Burden of Hg in Different Bio-Samples of Mothers in Shenyang City, China	PLOS ONE			English	Article							BLOOD MERCURY LEVELS; UMBILICAL-CORD BLOOD; MATERNAL FISH INTAKE; PRENATAL EXPOSURE; METHYLMERCURY EXPOSURE; INORGANIC MERCURY; BREAST-MILK; GROWTH-RETARDATION; LACTATING WOMEN; PREGNANT-WOMEN	Hg is an accumulative and neuro-toxic heavy metal which has a wide range of adverse effects in human health. However, few studies are available on body burden of Hg level in different bio-samples of pregnant women in Chinese population. Therefore, this study evaluated Hg levels in different maternal bio-samples in Shenyang city, China and investigated the correlation of Hg levels in different bio-samples. From October to December 2008, 200 pregnant women about to deliver their babies at ShengJing Hospital (Shenyang city, northeast of China) participated in this study. The geometric mean (GM) of Hg levels in cord blood, maternal venous blood, breast milk, and maternal urine were 2.18 mu g/L, 1.17 mu g/L, 1.14 mu g/L, and 0.73 mu g/L, respectively, and the GM of maternal hair Hg level was 404.45 mu g/kg. There was a strong correlation between cord blood and maternal blood total Hg level (r = 0.713, P<0.001). Frequency of fish consumption more than or equal to 3 times per week during pregnancy was suggested as a significant risk factor of prenatal Hg exposure (unadjusted OR 3.5, adjusted OR 2.94, P<0.05). This study provides evidence about Hg burden of mothers and the risk factors of prenatal Hg exposure in Shenyang city, China.	[Li, Min-ming; Wu, Mei-qin; Xu, Jian; Yan, Chong-huai] Shanghai Jiao Tong Univ, Xinhua Hosp, MOE Shanghai Key Lab Childrens Environm Hlth, Sch Med, Shanghai 200030, Peoples R China; [Du, Juan] China Med Univ, Shengjing Hosp, Dept Gynecol & Obstet, Shenyang, Peoples R China	Shanghai Jiao Tong University; China Medical University	Yan, CH (corresponding author), Shanghai Jiao Tong Univ, Xinhua Hosp, MOE Shanghai Key Lab Childrens Environm Hlth, Sch Med, Shanghai 200030, Peoples R China.	yanch@shkeylab-ceh.org	Wu, Meiqin/HHS-2963-2022		Science and Technology Commission of Shanghai Municipality [09DZ2200900]; Natural Science Foundation of China [30872806]; Shanghai Municipal Health Bureau, China [SNXD 2011056]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Health Bureau, China	This work was supported by a grant from the Science and Technology Commission of Shanghai Municipality (09DZ2200900), Natural Science Foundation of China (Grant No. 30872806), and Shanghai Municipal Health Bureau, China (SNXD 2011056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrad DA, 2007, ENVIRON HEALTH PERSP, V115, P609, DOI 10.1289/ehp.9303; Bernhard D, 2005, IUBMB LIFE, V57, P805, DOI 10.1080/15216540500459667; Bose-O'Reilly S, 2010, CURR PROB PEDIATR AD, V40, P186, DOI 10.1016/j.cppeds.2010.07.002; Carrington CD, 2004, REGUL TOXICOL PHARM, V40, P272, DOI 10.1016/j.yrtph.2004.07.006; Cernichiari E, 1995, NEUROTOXICOLOGY, V16, P705; Cernichiari E, 1995, NEUROTOXICOLOGY, V16, P613; Chinese Nutrition Society, 2010, DIET GUID CHIN INH, V2010, P44; Counter SA, 2004, TOXICOL APPL PHARM, V198, P209, DOI 10.1016/j.taap.2003.11.032; Crinnion WJ, 2010, ALTERN MED REV, V15, P101; Dastoor AP, 2004, ATMOS ENVIRON, V38, P147, DOI 10.1016/j.atmosenv.2003.08.037; DOI R, 1984, B ENVIRON CONTAM TOX, V33, P69, DOI 10.1007/BF01625513; Dorea JG, 2004, BRIT J NUTR, V92, P21, DOI 10.1079/BJN20041163; Fok TF, 2007, ENVIRON INT, V33, P84, DOI 10.1016/j.envint.2006.08.002; Gao Y, 2007, ENVIRON RES, V105, P390, DOI 10.1016/j.envres.2007.05.015; Garcia-Esquinas E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-841; Goldman LR, 2001, PEDIATRICS, V108, P197, DOI 10.1542/peds.108.1.197; Grandjean P, 1998, ENVIRON RES, V77, P165, DOI 10.1006/enrs.1997.3804; Grandjean P, 2005, ENVIRON HEALTH PERSP, V113, P905, DOI 10.1289/ehp.7842; Grandjean P, 1997, NEUROTOXICOL TERATOL, V19, P417, DOI 10.1016/S0892-0362(97)00097-4; Grandjean P, 1999, AM J EPIDEMIOL, V150, P301, DOI 10.1093/oxfordjournals.aje.a010002; Gundacker C, 2002, PEDIATRICS, V110, P873, DOI 10.1542/peds.110.5.873; Guo BQ, 2013, TOXICOLOGY, V304, P57, DOI 10.1016/j.tox.2012.11.019; Halldorsson TI, 2007, AM J EPIDEMIOL, V166, P687, DOI 10.1093/aje/kwm133; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Jackson LW, 2011, HUM REPROD, V26, P2887, DOI 10.1093/humrep/der250; Jedrychowski W, 2006, ANN EPIDEMIOL, V16, P439, DOI 10.1016/j.annepidem.2005.06.059; Jo Eun Mi, 2010, J Prev Med Public Health, V43, P377, DOI 10.3961/jpmph.2010.43.5.377; Kim BM, 2011, SCI TOTAL ENVIRON, V410, P26, DOI 10.1016/j.scitotenv.2011.08.060; KIM DS, 2011, TOXICOL ENV HEALTH, V3, P254, DOI DOI 10.1007/s13530-011-0099-9; Kim NS, 2010, SCI TOTAL ENVIRON, V408, P4841, DOI 10.1016/j.scitotenv.2010.06.026; Kowalski R, 2009, ECOL CHEM ENG S, V16, P155; MASON HJ, 1994, OCCUP ENVIRON MED, V51, P287, DOI 10.1136/oem.51.4.287-a; Miao LJ, 2013, MODERN FOOD SCI TECH, V29, P687; Morrissette J, 2004, ENVIRON RES, V95, P363, DOI 10.1016/j.envres.2003.12.007; Morton J, 2004, BIOMARKERS, V9, P47, DOI 10.1080/13547500410001670312; Myers GJ, 2003, LANCET, V361, P1686, DOI 10.1016/S0140-6736(03)13371-5; Nesheim M, 2007, SEAFOOD CHOICES BALA, P67; Ng DKK, 2007, PEDIATR INT, V49, P80, DOI 10.1111/j.1442-200X.2007.02303.x; NRC (National Research Council), 2000, TOX EFF METH, P250; Office of Science and Technology Office of Water US EPA (United States Environmental Protection Agency), 2001, WAT QUAL CRIT PROC H, P18; Oken E, 2004, AM J EPIDEMIOL, V160, P774, DOI 10.1093/aje/kwh282; Oken E, 2008, AM J EPIDEMIOL, V167, P1171, DOI 10.1093/aje/kwn034; OLSTAD ML, 1987, J DENT RES, V66, P1179, DOI 10.1177/00220345870660061701; Oskarsson A, 1996, ARCH ENVIRON HEALTH, V51, P234, DOI 10.1080/00039896.1996.9936021; Pacyna EG, 2006, ATMOS ENVIRON, V40, P4048, DOI 10.1016/j.atmosenv.2006.03.041; Pesch A, 2002, J EXPO ANAL ENV EPID, V12, P252, DOI 10.1038/sj.jea.7500228; Ramirez GB, 2000, PEDIATRICS, V106, P774, DOI 10.1542/peds.106.4.774; Ramon R, 2008, SCI TOTAL ENVIRON, V392, P69, DOI 10.1016/j.scitotenv.2007.11.025; Ramon R, 2009, AM J CLIN NUTR, V90, P1047, DOI 10.3945/ajcn.2009.27944; Reus IS, 2003, J BIOCHEM MOL TOXIC, V17, P161, DOI 10.1002/jbt.10074; Rice DC, 2004, ENVIRON RES, V95, P406, DOI 10.1016/j.envres.2003.08.013; RICHARDSON RA, 1976, CLIN CHEM, V22, P1604; Rogers I, 2004, J EPIDEMIOL COMMUN H, V58, P486, DOI 10.1136/jech.2003.013565; Sakamoto M, 2004, ENVIRON SCI TECHNOL, V38, P3860, DOI 10.1021/es034983m; Sakamoto M, 2007, ENVIRON RES, V103, P106, DOI 10.1016/j.envres.2006.03.004; Schettler T, 2001, ENVIRON HEALTH PERSP, V109, P813, DOI 10.2307/3454643; Scheulhammer AM, 2007, AMBIO, V36, P12, DOI 10.1579/0044-7447(2007)36[12:EOEMOT]2.0.CO;2; Schober SE, 2003, JAMA-J AM MED ASSOC, V289, P1667, DOI 10.1001/jama.289.13.1667; Stern AH, 2003, ENVIRON HEALTH PERSP, V111, P1465, DOI 10.1289/ehp.6187; Steuerwald U, 2000, J PEDIATR-US, V136, P599, DOI 10.1067/mpd.2000.102774; Unuvar E, 2007, SCI TOTAL ENVIRON, V374, P60, DOI 10.1016/j.scitotenv.2006.11.043; US Department of Health and Human Services US Environmental Protection Agency, 2004, WHAT YOU NEED KNOW M; US EPA (United States Environmental Protection Agency), 1997, CHAR HUM HLTH WILDL, VVII; Vahter M, 2000, ENVIRON RES, V84, P186, DOI 10.1006/enrs.2000.4098; Weil M, 2005, JAMA-J AM MED ASSOC, V293, P1875, DOI 10.1001/jama.293.15.1875; Weiner R, 1996, S AFR MED J, V86, P943; Wilson SJ, 2006, ATMOS ENVIRON, V40, P4621, DOI 10.1016/j.atmosenv.2006.03.042; Wu MQ, 2013, J ENVIRON SCI-CHINA, V25, P386, DOI 10.1016/S1001-0742(12)60061-8; Wu Y, 2006, ENVIRON SCI TECHNOL, V40, P5312, DOI 10.1021/es060406x; Yoshida M, 2002, TOHOKU J EXP MED, V196, P79, DOI 10.1620/tjem.196.79; Zalups RK, 1997, J TOXICOL ENV HEALTH, V50, P173, DOI 10.1080/009841097160564; Zalups RK, 1999, CHEM-BIOL INTERACT, V123, P171, DOI 10.1016/S0009-2797(99)00135-0	72	26	29	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98121	10.1371/journal.pone.0098121	http://dx.doi.org/10.1371/journal.pone.0098121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858815	Green Published, gold, Green Submitted			2022-12-25	WOS:000336839400044
J	Santos, J; Gouveia, MJ; Vale, N; Delgado, MD; Goncalves, A; da Silva, JMT; Oliveira, C; Xavier, P; Gomes, P; Santos, LL; Lopes, C; Barros, A; Rinaldi, G; Brindley, PJ; da Costa, JMC; Sousa, M; Botelho, MC				Santos, Julio; Gouveia, Maria Joao; Vale, Nuno; Delgado, Maria de Lurdes; Goncalves, Ana; Teixeira da Silva, Jose M.; Oliveira, Cristiano; Xavier, Pedro; Gomes, Paula; Santos, Lucio L.; Lopes, Carlos; Barros, Alberto; Rinaldi, Gabriel; Brindley, Paul J.; Correia da Costa, Jose M.; Sousa, Mario; Botelho, Monica C.			Urinary Estrogen Metabolites and Self-Reported Infertility in Women Infected with Schistosoma haematobium	PLOS ONE			English	Article							HUMAN CANCERS; HEALTH; BREAST; QUANTIFICATION; BIOMARKERS; QUINONES; PROSTATE; MANSONI; DISEASE; EGGS	Background: Schistosomiasis is a neglected tropical disease, endemic in 76 countries, that afflicts more than 240 million people. The impact of schistosomiasis on infertility may be underestimated according to recent literature. Extracts of Schistosoma haematobium include estrogen-like metabolites termed catechol-estrogens that down regulate estrogen receptors alpha and beta in estrogen responsive cells. In addition, schistosome derived catechol-estrogens induce genotoxicity that result in estrogen-DNA adducts. These catechol estrogens and the catechol-estrogen-DNA adducts can be isolated from sera of people infected with S. haematobium. The aim of this study was to study infertility in females infected with S. haematobium and its association with the presence of schistosome-derived catechol-estrogens. Methodology/Principal Findings: A cross-sectional study was undertaken of female residents of a region in Bengo province, Angola, endemic for schistosomiasis haematobia. Ninety-three women and girls, aged from two (parents interviewed) to 94 years were interviewed on present and previous urinary, urogenital and gynecological symptoms and complaints. Urine was collected from the participants for egg-based parasitological assessment of schistosome infection, and for liquid chromatography diode array detection electron spray ionization mass spectrometry (LC/UV-DAD/ESI-MSn) to investigate estrogen metabolites in the urine. Novel estrogen-like metabolites, potentially of schistosome origin, were detected in the urine of participants who were positive for eggs of S. haematobium, but not detected in urines negative for S. haematobium eggs. The catechol-estrogens/DNA adducts were significantly associated with schistosomiasis (OR 3.35; 95% CI 2.32-4.84; P <= 0.001). In addition, presence of these metabolites was positively associated with infertility (OR 4.33; 95% CI 1.13-16.70; P <= 0.05). Conclusions/Significance: Estrogen metabolites occur widely in diverse metabolic pathways. In view of the statistically significant association between catechol-estrogens/DNA adducts and self-reported infertility, we propose that an estrogen-DNA adduct mediated pathway in S. haematobium-induced ovarian hormonal deregulation could be involved. In addition, the catechol-estrogens/DNA adducts described here represent potential biomarkers for schistosomiasis haematobia.	[Santos, Julio; Santos, Lucio L.; Lopes, Carlos] Clin Sagrada Esperanca, Luanda, Angola; [Gouveia, Maria Joao; Vale, Nuno; Gomes, Paula] Univ Porto, Fac Sci, Dept Chem & Biochem, CIQUP, P-4100 Oporto, Portugal; [Delgado, Maria de Lurdes; Correia da Costa, Jose M.; Botelho, Monica C.] INSA, Natl Inst Hlth, Oporto, Portugal; [Goncalves, Ana; Teixeira da Silva, Jose M.; Oliveira, Cristiano; Xavier, Pedro; Barros, Alberto] Ctr Reprod Genet Prof Alberto Barros, Oporto, Portugal; [Santos, Lucio L.] Portuguese Inst Oncol, Expt Therapeut & Pathol Res Grp, Oporto, Portugal; [Lopes, Carlos] Univ Porto, Inst Biomed Sci Abel Salazar ICBAS, Dept Pathol & Mol Immunol, P-4100 Oporto, Portugal; [Barros, Alberto] Univ Porto, Fac Med, Dept Genet, P-4100 Oporto, Portugal; [Rinaldi, Gabriel; Brindley, Paul J.] George Washington Univ, Sch Med & Hlth Sci, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA; [Rinaldi, Gabriel; Brindley, Paul J.] George Washington Univ, Sch Med & Hlth Sci, Res Ctr Neglected Dis Poverty, Washington, DC 20052 USA; [Rinaldi, Gabriel] Univ Republica, Fac Med, Dept Genet, UDELAR, Montevideo, Uruguay; [Correia da Costa, Jose M.; Botelho, Monica C.] Univ Porto, Ctr Study Anim Sci, CECA ICETA, P-4100 Oporto, Portugal; [Sousa, Mario] Univ Porto, Multidisciplinary Unit Biomed Res UMIB, Inst Biomed Sci Abel Salazar ICBAS, Dept Microscopy,Lab Cell Biol, P-4100 Oporto, Portugal	Universidade do Porto; Universidade de Coimbra; Universidade do Porto; Universidade do Porto; George Washington University; George Washington University; Universidad de la Republica, Uruguay; Universidade do Porto; Universidade do Porto	Botelho, MC (corresponding author), INSA, Natl Inst Hlth, Oporto, Portugal.	monicabotelho@hotmail.com	Sousa, Mário/A-7340-2019; Gouveia, Maria/AAV-9144-2020; Botelho, Monica C/E-7170-2014; Santos, Lúcio Lara/AAE-2822-2021; Santos, Magda/J-4509-2015; Gomes, Paula/C-6698-2008; Barros, Alberto/L-3094-2013	Sousa, Mário/0000-0002-3009-3290; Botelho, Monica C/0000-0003-0466-8465; Santos, Lúcio Lara/0000-0002-0521-5655; Santos, Magda/0000-0003-0626-3015; Xavier, Pedro/0000-0002-3871-5568; Rinaldi, Gabriel/0000-0002-7767-4922; Gomes, Paula/0000-0002-6018-4724; Barros, Alberto/0000-0002-8700-3698; Brindley, Paul J./0000-0003-1765-0002; Gouveia, Maria/0000-0003-3747-5520; Vale, Nuno/0000-0002-1283-1042	National Funds through FCT-Foundation for Science and Technology [PEst-OE/AGR/UI0211/2011, Fcomp-01-0124-FEDER-015893]	National Funds through FCT-Foundation for Science and Technology	Centre for the Study of Animal Science (CECA) is funded by National Funds through FCT-Foundation for Science and Technology, under the "PEst-OE/AGR/UI0211/2011" project. Multidisciplinary Unit of Biomedical Research (UMIB) is funded by National Funds through FCT-Foundation for Science and Technology, under the "Fcomp-01-0124-FEDER-015893" project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adisa J, 2012, AFR HEALTH SCI, V12, P563, DOI 10.4314/ahs.v12i4.26; Bailey SL, 2011, J TRAVEL MED, V18, P61, DOI 10.1111/j.1708-8305.2010.00476.x; BALASCH J, 1995, HUM REPROD, V10, P1725, DOI 10.1093/oxfordjournals.humrep.a136163; Bindseil E, 1991, In Vivo, V5, P175; Botelho MC, 2009, EXP PARASITOL, V122, P250, DOI 10.1016/j.exppara.2009.04.001; Botelho MC, 2013, INT J PARASITOL, V43, P17, DOI 10.1016/j.ijpara.2012.10.023; Botelho MC, 2011, VIRULENCE, V2, P267, DOI 10.4161/viru.2.4.16734; Botelho MC, 2010, EXP PARASITOL, V126, P526, DOI 10.1016/j.exppara.2010.06.012; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Brindley PJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001961; BULLOUGH CHW, 1976, BRIT J OBSTET GYNAEC, V83, P819, DOI 10.1111/j.1471-0528.1976.tb00751.x; Cavalieri EL, 1997, P NATL ACAD SCI USA, V94, P10937, DOI 10.1073/pnas.94.20.10937; Cavalieri E, 2006, ANN NY ACAD SCI, V1089, P286, DOI 10.1196/annals.1386.042; Cavalieri E, 2006, BBA-REV CANCER, V1766, P63, DOI 10.1016/j.bbcan.2006.03.001; Cavalieri EL, 2011, J STEROID BIOCHEM, V125, P169, DOI 10.1016/j.jsbmb.2011.03.008; Dzeing-Ella A, 2009, AM J TROP MED HYG, V81, P549, DOI 10.4269/ajtmh.2009.08-0498; ELMAHGOUB S, 1982, INT J GYNECOL OBSTET, V20, P201, DOI 10.1016/0020-7292(82)90072-8; FELDMEIER H, 1979, TROPENMED PARASITOL, V30, P417; Goverde AJ, 1996, HUM REPROD, V11, P531, DOI 10.1093/HUMREP/11.3.531; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000559; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans Pharmaceuticals, 2012, IARC MONOGR EVAL CAR, V100, P1; Jourdan PM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001170; King CH, 2010, ACTA TROP, V113, P95, DOI 10.1016/j.actatropica.2009.11.012; Kini Suresh, 2009, BMJ Case Rep, V2009, DOI 10.1136/bcr.01.2009.1481; Kjetland EF, 2012, TRENDS PARASITOL, V28, P58, DOI 10.1016/j.pt.2011.10.008; Kjetland EF, 2010, FERTIL STERIL, V94, P1551, DOI 10.1016/j.fertnstert.2009.12.050; Layman LC, 2002, J MED GENET, V39, P153, DOI 10.1136/jmg.39.3.153; Leutscher P, 1998, TROP MED INT HEALTH, V3, P327, DOI 10.1046/j.1365-3156.1998.00230.x; Lopes LV, 2012, PAN AFR MED J, V12; Lu Weiqin, 2007, Drug Discov Today Dis Models, V4, P67, DOI 10.1016/j.ddmod.2007.10.005; Markushin Y, 2006, PROSTATE, V66, P1565, DOI 10.1002/pros.20484; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Poggensee G, 1999, PARASITOL TODAY, V15, P378, DOI 10.1016/S0169-4758(99)01497-0; Ramarakoto CE, 2008, T ROY SOC TROP MED H, V102, P767, DOI 10.1016/j.trstmh.2008.03.007; Rinaldi G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001348; Schanz A, 2010, FERTIL STERIL, V93, DOI 10.1016/j.fertnstert.2009.05.043; Shiff C, 2006, T ROY SOC TROP MED H, V100, P847, DOI 10.1016/j.trstmh.2005.10.010; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Takougang Innocent, 2004, Afr J Health Sci, V11, P111; The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO), 2009, REV GLOSS ART TERM; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Young ND, 2012, NAT GENET, V44, P221, DOI 10.1038/ng.1065; Zahid M, 2013, INT J CANCER, V133, P2642, DOI 10.1002/ijc.28275	45	35	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e96774	10.1371/journal.pone.0096774	http://dx.doi.org/10.1371/journal.pone.0096774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	25334008	Green Published, gold, Green Submitted			2022-12-25	WOS:000336730600015
J	Smith, RG; Atwood, LW; Warren, ND				Smith, Richard G.; Atwood, Lesley W.; Warren, Nicholas D.			Increased Productivity of a Cover Crop Mixture Is Not Associated with Enhanced Agroecosystem Services	PLOS ONE			English	Article							WEED MANAGEMENT; FUNCTIONAL-ROLE; SECALE-CEREALE; DIVERSITY; STABILITY; SYSTEMS; BIODIVERSITY; AGRICULTURE; TERMINATION; RESILIENCE	Cover crops provide a variety of important agroecological services within cropping systems. Typically these crops are grown as monocultures or simple graminoid-legume bicultures; however, ecological theory and empirical evidence suggest that agroecosystem services could be enhanced by growing cover crops in species-rich mixtures. We examined cover crop productivity, weed suppression, stability, and carryover effects to a subsequent cash crop in an experiment involving a five-species annual cover crop mixture and the component species grown as monocultures in SE New Hampshire, USA in 2011 and 2012. The mean land equivalent ratio (LER) for the mixture exceeded 1.0 in both years, indicating that the mixture over-yielded relative to the monocultures. Despite the apparent over-yielding in the mixture, we observed no enhancement in weed suppression, biomass stability, or productivity of a subsequent oat (Avena sativa L.) cash crop when compared to the best monoculture component crop. These data are some of the first to include application of the LER to an analysis of a cover crop mixture and contribute to the growing literature on the agroecological effects of cover crop diversity in cropping systems.	[Smith, Richard G.; Atwood, Lesley W.; Warren, Nicholas D.] Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA	University System Of New Hampshire; University of New Hampshire	Smith, RG (corresponding author), Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA.	richard.smith@unh.edu	Atwood, Lesley/GQZ-8910-2022; Johnston, Emma/B-7210-2009	Smith, Richard G./0000-0002-3571-5888; Johnston, Emma/0000-0002-2117-366X; Atwood, Lesley/0000-0001-9022-2181	NERA (North East Regional Association of agricultural experiment station) [NE-1047]; New Hampshire Agricultural Experiment Station	NERA (North East Regional Association of agricultural experiment station); New Hampshire Agricultural Experiment Station	This work was supported by NERA (North East Regional Association of agricultural experiment station directors) project NE-1047 http://nimss.umd.edu/lgu_v2/homepages/home.cfm?trackID = 13656. Partial funding was provided by the New Hampshire Agricultural Experiment Station. This is scientific contribution number 2533. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ateh CM, 1996, WEED TECHNOL, V10, P347, DOI 10.1017/S0890037X00040070; Cardinale BJ, 2013, ECOLOGY, V94, P1697, DOI 10.1890/12-1334.1; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Clark A., 2007, SUSTAINABLE AGR RES; Creamer NG, 1997, HORTSCIENCE, V32, P866, DOI 10.21273/HORTSCI.32.5.866; Freyre R., 2000, HortTechnology, V10, P374; Jolliffe PA, 2000, J ECOL, V88, P371, DOI 10.1046/j.1365-2745.2000.00470.x; Kumar V, 2009, HORTSCIENCE, V44, P730, DOI 10.21273/HORTSCI.44.3.730; Lavorel S, 1997, TRENDS ECOL EVOL, V12, P474, DOI 10.1016/S0169-5347(97)01219-6; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; Liebman M, 2000, WEED RES, V40, P27, DOI 10.1046/j.1365-3180.2000.00164.x; Lin BB, 2011, BIOSCIENCE, V61, P183, DOI 10.1525/bio.2011.61.3.4; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Mirsky SB, 2013, WEED TECHNOL, V27, P193, DOI 10.1614/WT-D-12-00078.1; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; MOHLER CL, 1993, WEED RES, V33, P487, DOI 10.1111/j.1365-3180.1993.tb01965.x; Schmid B, 2008, J PLANT ECOL, V1, P95, DOI 10.1093/jpe/rtn011; Smith RG, 2010, WEED RES, V50, P37, DOI 10.1111/j.1365-3180.2009.00745.x; Smith RG, 2008, ECOSYSTEMS, V11, P355, DOI 10.1007/s10021-008-9124-5; Smith RG, 2011, WEED TECHNOL, V25, P680, DOI 10.1614/WT-D-10-00156.1; Snapp SS, 2005, AGRON J, V97, P322; Teasdale JR, 1998, HORTSCIENCE, V33, P1163, DOI 10.21273/HORTSCI.33.7.1163; Teasdale JR, 1996, J PROD AGRIC, V9, P475, DOI 10.2134/jpa1996.0475; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Tooker JF, 2012, J APPL ECOL, V49, P974, DOI 10.1111/j.1365-2664.2012.02173.x; Trenbath B. R., 1974, Advances in Agronomy, V26, P177, DOI 10.1016/S0065-2113(08)60871-8; TRENBATH BR, 1993, FIELD CROP RES, V34, P381, DOI 10.1016/0378-4290(93)90123-5; Trenbath BR, 1999, AGROFOREST SYST, V45, P81, DOI 10.1023/A:1006285319817; Vandermeer J.H., 1989, ECOLOGY INTERCROPPIN, DOI [10.1017/CBO9780511623523, DOI 10.1017/CBO9780511623523]; Wortman SE, 2012, AGRON J, V104, P699, DOI 10.2134/agronj2011.0422; Wortman SE, 2013, WEED SCI, V61, P162, DOI 10.1614/WS-D-12-00066.1; Wortman SE, 2012, AGRON J, V104, P1425, DOI 10.2134/agronj2012.0185	34	122	122	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97351	10.1371/journal.pone.0097351	http://dx.doi.org/10.1371/journal.pone.0097351			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	25054325	gold, Green Published, Green Submitted			2022-12-25	WOS:000336730600026
J	Liu, Y; Wang, FY; Wu, Y; Tan, SN; Wen, QL; Wang, J; Zhu, XM; Wang, X; Li, CM; Ma, X; Pan, H				Liu, Yan; Wang, Fengyu; Wu, Yuan; Tan, Sainan; Wen, Qiaolian; Wang, Jing; Zhu, Xiaomei; Wang, Xi; Li, Congmin; Ma, Xu; Pan, Hong			Variations of CITED2 Are Associated with Congenital Heart Disease (CHD) in Chinese Population	PLOS ONE			English	Article							PITX2C EXPRESSION; DEFECTS; MUTATIONS; MICE; MALFORMATIONS; HIF-1-ALPHA; ATRIAL; GROWTH; CELLS; GATA4	CITED2 was identified as a cardiac transcription factor which is essential to the heart development. Cited2-deficient mice showed cardiac malformations, adrenal agenesis and neural crest defects. To explore the potential impact of mutations in CITED2 on congenital heart disease (CHD) in humans, we screened the coding region of CITED2 in a total of 700 Chinese people with congenital heart disease and 250 healthy individuals as controls. We found five potential disease-causing mutations, p.P140S, p.S183L, p.S196G, p.Ser161delAGC and p.Ser192_Gly193delAGCGGC. Two mammalian two-hybrid assays showed that the last four mutations significantly affected the interaction between p300CH1 and CITED2 or HIF1A. Further studies showed that four CITED2 mutations recovered the promoter activity of VEGF by decreasing its competitiveness with HIF1A for binding to p300CH1 and three mutations decreased the consociation of TFAP2C and CITED2 in the transactivation of PITX2C. Both VEGF and PITX2C play very important roles in cardiac development. In conclusion, we demonstrated that CITED2 has a potential causative impact on congenital heart disease.	[Liu, Yan; Wen, Qiaolian; Zhu, Xiaomei; Wang, Xi; Ma, Xu; Pan, Hong] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Liu, Yan; Wen, Qiaolian; Zhu, Xiaomei; Wang, Xi; Ma, Xu; Pan, Hong] Natl Res Inst Family Planning, Beijing, Peoples R China; [Wang, Fengyu; Li, Congmin] Henan Res Inst Populat & Family Planning, Key Lab Populat Defects Intervent Technol Henan P, Zhengzhou, Peoples R China; [Wu, Yuan] Xiamen Univ, Dept Cardiac Surg, Xiamen Heart Ctr, Organ Transplantat Inst, Xiamen, Peoples R China; [Tan, Sainan] Family Planning Inst Hunan Prov, Key Lab Genet & Birth Hlth Hunan Prov, Chang Sha, Peoples R China; [Wang, Jing] Capital Med Univ, Sch Basic Med Sci, Dept Med Genet, Beijing, Peoples R China; [Ma, Xu] World Hlth Org, Collaborating Ctr Res Human Reprod, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Research Institute for Family Planning - China; Xiamen University; Capital Medical University; World Health Organization	Li, CM (corresponding author), Henan Res Inst Populat & Family Planning, Key Lab Populat Defects Intervent Technol Henan P, Zhengzhou, Peoples R China.	13838377996@163.com; nicgr@263.net; 13174483538@126.com		Liu, Yali/0000-0003-0037-6326; Zhang, Junjie/0000-0001-8809-1485; Liu, Yehao/0000-0002-6381-6440; Li, Yuhui/0000-0002-9778-4512	National Basic Research Program of China [2010CB529504]; National Natural Science Foundation of China [81300131]; Applied Basic Research Program of Qinghai Province [QH2013-z-744]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Applied Basic Research Program of Qinghai Province	This work was supported by the National Basic Research Program of China (2010CB529504), the National Natural Science Foundation of China (81300131) and the Applied Basic Research Program of Qinghai Province (QH2013-z-744). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2008, ARTHRITIS RHEUM-US, V58, P3798, DOI 10.1002/art.24073; Amati F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-497; Andrews JE, 2000, MECH DEVELOP, V95, P305, DOI 10.1016/S0925-4773(00)00362-2; Bamforth SD, 2004, NAT GENET, V36, P1189, DOI 10.1038/ng1446; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Bentham J, 2010, HUM MOL GENET, V19, P3394, DOI 10.1093/hmg/ddq251; Bhattacherjee V, 2009, INT J DEV BIOL, V53, P1097, DOI 10.1387/ijdb.072489vb; Blue GM, 2012, MED J AUSTRALIA, V197, P155, DOI 10.5694/mja12.10811; Campione M, 2001, DEV BIOL, V231, P252, DOI 10.1006/dbio.2000.0133; Chen CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046256; Ching YH, 2005, NAT GENET, V37, P423, DOI 10.1038/ng1526; Crider KS, 2011, GENOME MED, V3, DOI 10.1186/gm223; Freedman SJ, 2003, NAT STRUCT BIOL, V10, P504, DOI 10.1038/nsb936; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Li DY, 2010, STROKE, V41, pS92, DOI 10.1161/STROKEAHA.110.594929; Li Q, 2012, BIOCHEM BIOPH RES CO, V423, P895, DOI 10.1016/j.bbrc.2012.06.099; MacDonald ST, 2013, EUR HEART J, V34, P2557, DOI 10.1093/eurheartj/ehs056; Ruiz-Perez VL, 2007, DEVELOPMENT, V134, P2903, DOI 10.1242/dev.007542; Satoda M, 2000, NAT GENET, V25, P42, DOI 10.1038/75578; Sperling S, 2005, HUM MUTAT, V26, P575, DOI 10.1002/humu.20262; Xiong F, 2013, CARDIOVASC PATHOL, V22, P141, DOI 10.1016/j.carpath.2012.07.001; Xu B, 2007, DEV BIOL, V301, P130, DOI 10.1016/j.ydbio.2006.08.072; Xu M, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-7; Yang Xiao-fei, 2010, Zhonghua Er Ke Za Zhi, V48, P293; Yin Z, 2002, P NATL ACAD SCI USA, V99, P10488, DOI 10.1073/pnas.162371799	26	255	264	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98157	10.1371/journal.pone.0098157	http://dx.doi.org/10.1371/journal.pone.0098157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	25237849	gold, Green Published, Green Submitted			2022-12-25	WOS:000336730600093
J	Liu, J; Gaj, T; Patterson, JT; Sirk, SJ; Barbas, CF				Liu, Jia; Gaj, Thomas; Patterson, James T.; Sirk, Shannon J.; Barbas, Carlos F., III			Cell-Penetrating Peptide-Mediated Delivery of TALEN Proteins via Bioconjugation for Genome Engineering	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; EMBRYO MICROINJECTION; VECTOR TOOLKIT; KNOCKOUT RATS; GENE-TRANSFER; BASIC DOMAIN; IN-VIVO; DNA; RECOGNITION; EFFECTORS	Transcription activator-like (TAL) effector nucleases (TALENs) have enabled the introduction of targeted genetic alterations into a broad range of cell lines and organisms. These customizable nucleases are comprised of programmable sequence-specific DNA-binding modules derived from TAL effector proteins fused to the non-specific FokI cleavage domain. Delivery of these nucleases into cells has proven challenging as the large size and highly repetitive nature of the TAL effector DNA-binding domain precludes their incorporation into many types of viral vectors. Furthermore, viral and non-viral gene delivery methods carry the risk of insertional mutagenesis and have been shown to increase the off-target activity of site-specific nucleases. We previously demonstrated that direct delivery of zinc-finger nuclease proteins enables highly efficient gene knockout in a variety of mammalian cell types with reduced off-target effects. Here we show that conjugation of cell-penetrating poly-Arg peptides to a surface-exposed Cys residue present on each TAL effector repeat imparted cell-penetrating activity to purified TALEN proteins. These modifications are reversible under reducing conditions and enabled TALEN-mediated gene knockout of the human CCR5 and BMPR1A genes at rates comparable to those achieved with transient transfection of TALEN expression vectors. These findings demonstrate that direct protein delivery, facilitated by conjugation of chemical functionalities onto the TALEN protein surface, is a promising alternative to current non-viral and viral-based methods for TALEN delivery into mammalian cells.	[Barbas, Carlos F., III] Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell & Mol Biol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Barbas, CF (corresponding author), Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	carlos@scripps.edu	Liu, Jia/E-5758-2014	Patterson, James/0000-0001-6006-7184; liu, juanjuan/0000-0001-6941-0372; Ma, Leina/0000-0003-3964-632X; Lin, Xiukun/0000-0002-0306-4953; Spincemaille, Pascal/0000-0002-8821-1341; Prince, Martin/0000-0002-9883-0584; Saloner, David/0000-0002-6989-8547	US National Institutes for Health [DP1CA174426]; NATIONAL CANCER INSTITUTE [DP1CA174426] Funding Source: NIH RePORTER	US National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by US National Institutes for Health (DP1CA174426). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Beumer K, 2006, GENETICS, V172, P2391, DOI 10.1534/genetics.105.052829; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen Z, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt710; Choi JM, 2006, NAT MED, V12, P574, DOI 10.1038/nm1385; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Guo J, 2010, J MOL BIOL, V400, P96, DOI 10.1016/j.jmb.2010.04.060; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Holkers M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1446; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jin LH, 2001, FREE RADICAL BIO MED, V31, P1509, DOI 10.1016/S0891-5849(01)00734-1; Kanaar R, 1998, TRENDS CELL BIOL, V8, P483, DOI 10.1016/S0962-8924(98)01383-X; Kim SS, 2011, METHODS MOL BIOL, V721, P339, DOI 10.1007/978-1-61779-037-9_21; Kumar P, 2008, CELL, V134, P577, DOI 10.1016/j.cell.2008.06.034; Li LJ, 2013, MOL THER, V21, P1259, DOI 10.1038/mt.2013.65; Lo TW, 2013, GENETICS, V195, P331, DOI 10.1534/genetics.113.155382; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mino T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056633; Mitsui H, 2006, J INVEST DERMATOL, V126, P1804, DOI 10.1038/sj.jid.5700335; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Pooga M, 1998, FASEB J, V12, P67, DOI 10.1096/fasebj.12.1.67; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Ru Renli, 2013, Cell Regen, V2, P5, DOI 10.1186/2045-9769-2-5; Segal DJ, 2013, ANNU REV GENOM HUM G, V14, P135, DOI 10.1146/annurev-genom-091212-153435; Stella S, 2013, ACTA CRYSTALLOGR D, V69, P1707, DOI 10.1107/S0907444913016429; Tan WF, 2013, P NATL ACAD SCI USA, V110, P16526, DOI 10.1073/pnas.1310478110; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Van Tendeloo VFI, 2000, GENE THER, V7, P1431, DOI 10.1038/sj.gt.3301252; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009	48	200	240	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85755	10.1371/journal.pone.0085755	http://dx.doi.org/10.1371/journal.pone.0085755			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24626155	gold, Green Published			2022-12-25	WOS:000330240500068
